REPORTED_TERM,DESC_CODED,LLT_NAME_COMPL,PT_NAME_COMPL,HLGT_NAME_COMPL,HLT_NAME_COMPL,SOC_CODE,INC_CODE_J,ART_CODE,INC_CODE
GRADE 2 HAND-FOOT SYNDROME,Palmar-plantar erythrodysaesthesia syndrome,HAND AND FOOT SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10019111,10033553,10019111
BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
ACUTE ONSET IMBALANCE,Balance disorder,BALANCE DISORDER,BALANCE DISORDER,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10049848,10049848,10049848
PSEUDOCIRRHOSIS,pseudocirrhosis,PSEUDOCIRRHOSIS,PSEUDOCIRRHOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10076501,10076501,10076501
HYPERHIDROSIS,Hyperhidrosis,HYPERHIDROSIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10020642,10020642,10020642
DRUG INEFFECTIVE WITH NO ADR,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
SUICIDE,Completed suicide,SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042462,10010144,10042462
SEPTIC SHOCK FOLLOWING NECROTIZING FASCIITIS OF THE LOWER LEG CAUSED BY ESCHERICHIA COLI,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
INSULIN RESISTANCE FOLLOWING PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,Insulin resistance,INSULIN RESISTANCE,INSULIN RESISTANCE,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10022489,10022489,10022489
CONFUSION STATE AND SEVERE HYPONATREMIA IN PATIENTS RECEIVING ACE INHIBITORS AND SSRI,Bewilderment,BEWILDERMENT,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10004541,10010305,10004541
INAPPETENCE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
UNSTEADINESS,Balance disorder,UNSTEADINESS,BALANCE DISORDER,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10046260,10049848,10046260
DILATED INTRAHEPATIC DUCT FOLLOWING BILIARY OBSTRUCTION DUE TO MULTIPLE CHOLELITHIASIS,Dilatation intrahepatic duct acquired,DILATATION INTRAHEPATIC DUCT ACQUIRED,DILATATION INTRAHEPATIC DUCT ACQUIRED,BILE DUCT DISORDERS,STRUCTURAL AND OTHER BILE DUCT DISORDERS,10019805,10052383,10052383,10052383
TOXIC EFFECT WHICH COULD HAVE LED TO RAPID DEATH,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
OTOTOXICITY,ototoxicity,OTOTOXICITY,OTOTOXICITY,AURAL DISORDERS NEC,EAR DISORDERS NEC,10013993,10033109,10033109,10033109
GYNAECOLOGICAL BLEEDING,Genital haemorrhage,GENITAL BLEEDING,GENITAL HAEMORRHAGE,REPRODUCTIVE TRACT DISORDERS NEC,REPRODUCTIVE TRACT DISORDERS NEC (EXCL NEOPLASMS),10038604,10061178,10061178,10071812
BRAIN LESION,Central nervous system lesion,BRAIN LESION,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10067294,10051290,10067294
THE BABY HAD LOW BIRTH WEIGHT WHICH MIGHT BE ATTRIBUTED TO INTRAUTERINE PROPRANOLOL EXPOSURE,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
WORSENING OF IMMUNE THROMBOCYTOPENIA FOLLOWING LACK OF DRUG EFFECT DURING PREGNANCY,Autoimmune thrombocytopenia,AUTOIMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10050245,10074667,10050245
DRUG EXPOSURE IN UTERO,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
FAECES SOFT,Faeces soft,FAECES SOFT,FAECES SOFT,GASTROINTESTINAL SIGNS AND SYMPTOMS,FAECAL ABNORMALITIES NEC,10017947,10074859,10074859,10074859
ZOLEDRONATE USED FOR CHOLANGIOCARCINOMA,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
FINGOLIMOD-INDUCED SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
ANAPHYLACTIC SHOCK,Anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
EXPERIENCED SEVERE EPISODE OF PRURITIS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
SYMPTOMATIC BLURRING OF VISION FOLLOWING DRUG INTOLERANCE OF LATANOPROST 0.005%,Vision blurred,BLURRING OF VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047513,10047513,10005888
LESION WAS MINIMALLY TENDER,Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
HEMOGLOBIN LOW,Haemoglobin decreased,HEMOGLOBIN LOW,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018889,10018884,10055600
INEFFECTIVE IN REDUCING HIS HEART RATE,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
SLUGGISH SENSORIUM,Depressed level of consciousness,SENSORIUM DECREASED,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010768,10012373,10040019
GRADE 3 ORAL MUCOSITIS,oral mucositis,MUCOSITIS ORAL,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028130,10042128,10028130
SPUTUM BLOODY,Haemoptysis,SPUTUM BLOODY,HAEMOPTYSIS,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10041804,10018964,10041804
CARDIAC ALLOGRAFT DYSFUNCTION,Heart graft dysfunction,HEART GRAFT DYSFUNCTION,COMPLICATIONS OF TRANSPLANTED HEART,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10064694,10010184,10064694
ANAPHYLAXIS,anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
THICKNESS OF SUBCUTANEOUS ADIPOSE TISSUE INCREASED  (18 MM) AT LOWER ABDOMINAL REGION,Injection site hypertrophy,INJECTION SITE SUBCUTANEOUS FATTY HYPERTROPHY,INJECTION SITE HYPERTROPHY,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022101,10022072,10022101
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
CONGESTION OF ORGANS FOLLOWING ANAPHYLACTIC SHOCK,Visceral congestion,VISCERAL CONGESTION,VISCERAL CONGESTION,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10066397,10066397,10066397
SHE HAS TRIED TAKING UP TO EIGHT EXTRA STRENGTH 500 MG EACH ACETAMINOPHINTABLETS WITHOUT SUCCESS,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DID NOT RESPOND TO ALEMTUZUMAB,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
EPIDURAL HAEMATOMA,Extradural haematoma,EXTRADURAL HAEMATOMA,EXTRADURAL HAEMATOMA,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10015769,10015769,10015769
METHOTREXATE ASSOCIATED EBV-POSITIVE DIFFUSE B-CELL LYMPHOPROLIFERATIVE DISORDER STAGE 4,Epstein-Barr virus associated lymphoproliferative disorder,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10068349,10068349,10068349
GRADE IV ANAL ULCER,anal ulcer,ANAL ULCER,ANAL ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,ANAL AND RECTAL ULCERS AND PERFORATION,10017947,10002180,10002180,10002180
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DECREASED WHITE BLOOD CELL OF   GRADE 3,White blood cell count decreased,WHITE BLOOD CELL COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10047942
SHOOTING PAINS IN HER LEGS AND FEET,Pain in limb,PAIN IN LIMB,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033447,10033425,10033447
PROGRESSIVE WORSENING OF THE CONDITION,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
COLD,Nasopharyngitis,COLD,NASOPHARYNGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10010106,10028810,10009851
MYCOBACTERIUM TUBERCULOSIS COMPLEX IN PLEURAL BIOPSY,Mycobacterium tuberculosis pneumonia,MYCOBACTERIUM TUBERCULOSIS PNEUMONIA,PULMONARY TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10028462,10037440,10028462
PERICARDITIS,Pericarditis,PERICARDITIS,PERICARDITIS,PERICARDIAL DISORDERS,NONINFECTIOUS PERICARDITIS,10007541,10034484,10034484,10034484
"NON-HEALING, INFECTED WOUND OVER THE DORSUM OF HIS LEFT HAND AND DEEP, PURULENT 5X3CM WOUND OVER THE DORSUM OF THE LEFT HAND WITH EXTENSION TO EXTENSOR TENDONS",wound infection,WOUND INFECTION,WOUND INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10048038,10048038,10048038
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
HEPATIC FUNCTION DISORDER,hepatic function disorder,HEPATIC FUNCTION DISORDER,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019674,10019670,10019674
DRESS SYNDROME,DRESS syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
MILD SYMMETRICAL PITTING EDEMA OF BILATERAL LOWER EXTREMITIES EXTENDED UPTO MID THIGHS,Oedema peripheral,EDEMA OF LOWER EXTREMITIES,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030109,10030124,10054498
ERYTHEMATOUS CRUSTING OF LIPS AND NARES,Scab,CRUST,SCAB,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10039509,10039509,10011468
IMPAIRED SWALLOWING,Swallowing impaired,SWALLOWING IMPAIRED,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10042647,10013950,10042647
TRACHEITIS,Tracheitis,TRACHEITIS,TRACHEITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10044302,10044302,10044302
ASCITIS,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
NUMBNESS OF TONGUE,Hypoaesthesia oral,NUMBNESS OF TONGUE,HYPOAESTHESIA ORAL,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SIGNS AND SYMPTOMS,10017947,10029852,10057371,10029852
COLONIZED STOOL WITH VANCOMYCIN-RESISTANT ENTEROCOCCUS,Enterococcus colonization,ENTEROCOCCUS COLONIZATION,BACTERIAL DISEASE CARRIER,ANCILLARY INFECTIOUS TOPICS,INFECTIOUS DISORDERS CARRIER,10021881,10067911,10004017,10067911
ALANINE AMINOTRANSFERASE INCREASED (SGPT: 120 IU/L) DUE TO INTENTIONAL DRUG OVERDOSE,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
INTENSE HEMATURIA,Haematuria,HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018867,10018867,10019450
BILATERAL ACUTE IRIS TRANSILLUMINATION,iris transillumination defect,IRIS TRANSILLUMINATION DEFECT,IRIS TRANSILLUMINATION DEFECT,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","IRIS AND CILIARY BODY STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10053677,10053677,10053677
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
URINARY SYMPTOMS FOLLOWING OFF LABEL USE OF METHOTREXATE FOR MORPHEA PROFUNDA,Urinary tract disorder NOS,URINARY TRACT DISORDER NOS,URINARY TRACT DISORDER,GENITOURINARY TRACT DISORDERS NEC,GENITAL AND URINARY TRACT DISORDERS NEC,10038359,10046567,10046566,10046567
SPINAL SUBARACHNOID HEMORRHAGE IN THE CONTEXT OF CORTICAL SUPERFICIAL SIDEROSIS COMPLICATED,Metallosis of globe,SIDEROSIS OF GLOBE,METALLOSIS OF GLOBE,INJURIES NEC,EYE INJURIES NEC,10022117,10040665,10027440,10040665
DRUG USE FOR UNAPPROVED INDICATION (OFF LABEL USE),drug use for unapproved indication (off label use),OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DEVELOPING CHEST AND BACK PAIN,Back pain,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003988,10003988,10003988
GRADE II/III ENCEPHALOPATHY,grade II/III encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
LACK OF DRUG EFFECT,LACK OF DRUG EFFECT,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LEFT LUMBO-CRURAL SCIATICA,Sciatica,SCIATICA,SCIATICA,SPINAL CORD AND NERVE ROOT DISORDERS,LUMBAR SPINAL CORD AND NERVE ROOT DISORDERS,10029205,10039674,10039674,10039674
SOME MEMORY LOSS,Memory loss,MEMORY LOSS,AMNESIA,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027176,10001949,10027176
5 YEARS' OLD FEMALE WITH EB TREATED WITH AMITRIPTYLINE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HYPOKALEMIA (K = 3.2 MMOL/L),Hypokalaemia,HYPOKALEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021018
DEVELOPED SEROSANGUIOUS BLISTERS ON THE LEFT KNEE,Blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
CREATININE LEVEL OF 148 ÎœM/L,Blood creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
LOSS OF APPETITE,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
NECROTIZING PANCREATITIS (ACUTE),Pancreatitis necrotising,NECROTIZING PANCREATITIS,PANCREATITIS NECROTISING,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033654,10033654,10028891
NO THERAPEUTIC RESPONSE,Therapy non-responder,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
SEVERE CHOLESTASIS,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
PATIENT WAS ADMINISTERED FLUDARABINE PHOSPHATE AS PART OF BONE MARROW CONDITIONING REGIMEN FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION (OFF LABEL USE) WITH NO ADVERSE EVENT,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DYSPHAGIA,Dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
"EVALUATION OF HAEMATOMA WAS OBSERVED FROM OEDEMA, DIFFERENT STAGES OF BLISTERS TO NECROTIC SUPERFICIAL CHANGES",haematoma,HAEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10018852
RECURRENT ACEI INDUCED ANGIOEDEMA REFRACTORY TO FFP,Angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
FUNGAL INFECTION,Fungal infection,FUNGAL INFECTION,FUNGAL INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017533,10017533,10017533
OFF LABEL USE WITH CLARITHROMYCIN WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
COMPLICATIONS OF ACUTE AIRWAY OBSTRUCTION FOLLOWING ANESTHESIA,Airway complication of anesthesia,AIRWAY COMPLICATION OF ANESTHESIA,AIRWAY COMPLICATION OF ANAESTHESIA,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,ANAESTHETIC AND ALLIED PROCEDURAL COMPLICATIONS,10022117,10054305,10049979,10054305
RENAL FAILURE NEONATAL,Renal failure neonatal,RENAL FAILURE NEONATAL,RENAL FAILURE NEONATAL,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038447,10038447,10038447
PALE,pale,PALE,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033532,10033546,10033532
GRADE 4 THROMBOCYTOPENIA FOLLOWIND DRUG INTERACTION OF CAPCETABINE AND BRIVUDINE,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
"EARLY MORNING DYSTONIA AT THE RIGHT FOOT, SLIGHT URINARY URGENCY, MILD ATTENTIVE DEFICITS, DAYTIME SLEEPINESS, ANXIETY, MILD POSTURAL AND KINETIC TREMOR OF THE UPPER LEFT LIMB, MILD BRADYKINESIA,PEAK",Dystonia,DYSTONIA,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10013983,10013983,10013983
10.8X10E3 OF WHITE BLOOD CELLS,White blood cell count increased,WBC INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056739,10047943,10056739
WORSENED DYSPNOEA,Dyspnoea,DYSPNEA EXACERBATED,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013970,10013968,10013965
REBOUND EFFECT,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
DIFFICULTIES IN MANAGING ABNORMAL BLOOD PRESSURE,Blood pressure abnormal,BLOOD PRESSURE ABNORMAL,BLOOD PRESSURE ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005728,10005728,10005728
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
"MILD CONJUNCTIVOCHALASIS IN BOTH EYES, MORE PROMINENT IN THE LEFT EYE",Conjunctivochalasis,CONJUNCTIVOCHALASIS,CONJUNCTIVOCHALASIS,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CONJUNCTIVAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10064132,10064132,10064132
LIP SWELLING,Lip swelling,LIP SWELLING,LIP SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10024570,10024570,10024570
NECROSIS OF MUCOUS TISSUES,necrosis of mucous tissues,NECROSIS,NECROSIS,TISSUE DISORDERS NEC,NECROSIS NEC,10018065,10028851,10028851,10028851
LOSS OF CONSCIOUSNESS FOLLOWING METHOTREXATE OVERDOSE DUE TO WRONG DOSE ADMINISTRATION,loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
ORBITAL SWELLING,orbital oedema,ORBITAL OEDEMA,ORBITAL OEDEMA,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","ORBITAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10031051,10031051,10031051
FINASTERIDE FOR PATTERNED HAIR LOSS IN PREMENOPAUSAL WOMEN,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FEVER (38 DEGREE C),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
FACIAL PUFFINESS,Swelling face,FACIAL PUFFINESS,SWELLING FACE,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10042682,10042682,10016063
ORAL MUCOSA ULCER,oral ulceration,ORAL ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10031027,10028034,10031027
SPONTANEOUS ABORTION,Abortion spontaneous,SPONTANEOUS ABORTION,ABORTION SPONTANEOUS,ABORTIONS AND STILLBIRTH,ABORTIONS SPONTANEOUS,10036585,10000234,10000234,10041687
"COALESCING ERYTHEMATOUS MACULA ON THE FACE, UPPER AND LOWER LIMBS, AND BODY TRUNK",Rash macular,ERYTHROMACULAR RASH,RASH MACULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015283,10037867,10015283
CLINICAL DETERIORATION,General physical health deterioration,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10049438,10049438,10049438
VOCAL TICKS,Vocal tic,VOCAL TIC,TIC,CHANGES IN PHYSICAL ACTIVITY,TIC DISORDERS,10037175,10066771,10043833,10066771
"DESPITE TREATMENT, THE PATIENT EXPERIENCED RELAPSE",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PROGRESSION OF THE DISEASE/DIED,Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
"AZITHROMYCIN USED FOR THE TREATMENT OF SEVERE, PERSISTENT NON-ATOPIC ASTHMA (OFF LABEL USE WITH NO ADVERSE EVENT)",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEMORRHAGIC INFARCTION IN THE LUNG AND SPLEEN,fungal clump,HEMORRHAGIC INFARCTION,HAEMORRHAGIC INFARCTION,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10055282,10019013,10055282
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,Acute generalised exanthematous pustulosis,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10048799
BLEEDING EVENTS,Haemorrhage,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10005103
RELAPSE FOLLOWING REBOUND EFFECT OF CYCLOPHOSPHAMIDE,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
BLURRED VISION,Vision blurred,BLURRED VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047513,10047513,10005886
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
ABDOMEN DISTENDED,Abdominal distension,DISTENDED ABDOMEN,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10013480
POSTOPERATIVE HAEMORRHAGE,Post procedural haemorrhage,POSTOPERATIVE HAEMORRHAGE,POST PROCEDURAL HAEMORRHAGE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10054709,10051077,10054709
WIDE ABSCESS IN LEFT PAROTID-MASSETER REGION EXTENDED FROM FLOOR HIS MOUTH UP TO THE IPSILATERAL INFERIOR PARAPHARYNGEAL COMPARTMENT,Abscess oral,ABSCESS ORAL,ABSCESS ORAL,INFECTIONS - PATHOGEN UNSPECIFIED,DENTAL AND ORAL SOFT TISSUE INFECTIONS,10021881,10000311,10000311,10000311
ALT 606,Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
DEXAMETHASONE STOPPED DUE TO INTOLERANCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
OLANZAPINE MAY HAVE AGGRAVATED THE PREVIOUS HISTORY OF METABOLIC DISEASE,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
VISUAL HALLUCINATIONS,Hallucination visual,HALLUCINATION VISUAL,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019068,10019075,10019068
ALTERED SENSORIUM,sensorium decreased,SENSORIUM DECREASED,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10040019,10012373,10040019
RIB FRACTURE,Rib fracture,RIB FRACTURE,RIB FRACTURE,BONE AND JOINT INJURIES,THORACIC CAGE FRACTURES AND DISLOCATIONS,10022117,10039117,10039117,10039117
MYOCLONUS ASSOCIATED WITH CLOZAPINE,Myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
TWO WEEK HISTORY OF LEFT ILIAC FOSSA PAIN AND A THREE-DAY HISTORY OF VAGINAL BLEEDING,vaginal bleeding,VAGINAL BLEEDING,VAGINAL HAEMORRHAGE,VULVOVAGINAL DISORDERS (EXCL INFECTIONS AND INFLAMMATIONS),VULVOVAGINAL DISORDERS NEC,10038604,10046883,10046910,10046883
FATAL DISSEMINATED MYCOBACTERIUM TUBERCULOSIS REACTIVATION,Tuberculosis,MYCOBACTERIUM TUBERCULOSIS INFECTION REACTIVATED,TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10028458,10044755,10028458
COLD,Nasopharyngitis,COLD,NASOPHARYNGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10010106,10028810,10009851
ACUTE TOXIC HEPATITIS,Hepatitis acute toxic,HEPATITIS ACUTE TOXIC,HEPATITIS TOXIC,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10052553,10019795,10052553
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
CONFLUENT AND DIFFUSE ERYTHEMA ON POSTERIOR TRUNK SPREADING TO UPPER BUTTOCKS,Erythema,ERYTHEMA DIFFUSE,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015159,10015150,10015159
MID INFEROLATERAL WALL ANEURISM,Aneurysm of heart (wall),ANEURYSM OF HEART (WALL),CARDIAC ANEURYSM,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10002351,10007513,10002351
AGITATION,agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
BLOOD UREA NITROGEN INCREASED (3000 G/L),Blood urea increased,BLOOD UREA NITROGEN INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005855,10005851,10005855
COLD SWEAT,Cold sweat,COLD SWEAT,COLD SWEAT,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10009866,10009866,10009866
WERNICKE'S ENCEPHALOPATHY,Wernicke's encephalopathy,WERNICKE'S ENCEPHALOPATHY,WERNICKE'S ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10047911,10047911,10047911
PULMONARY RALES,Rales,RALES,RALES,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10037833,10037833,10037833
PERIPHERAL NEUROPATHY,Neuropathy peripheral,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10080342
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
PANTOPRAZOLE INDUCED ACUTE INTERSTITIAL NEPHRITIS,acute interstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10000819,10048302,10000819
BRONCHIOLITIS OBLITERANS WITH ORGANIZING PNEUMONIA/LATE-ONSET NON-INFECTIOUS PULMONARY COMPLICATIONS/DIAGNOSED AS BOOP,Organising pneumonia,BRONCHIOLITIS OBLITERANS WITH ORGANISING PNEUMONIA,ORGANISING PNEUMONIA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10066847,10067472,10066847
LIPS WERE BLUE,Cyanosis,BLUE LIPS,CYANOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10011707,10011703,10005881
INTRAVASCULAR IMMUNE HEMOLYTIC ANAEMIA,intravascular immune hemolytic anaemia,IMMUNE HEMOLYTIC ANEMIA DRUG-INDUCED,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10055213,10018916,10055213
BILATERAL CEREBRAL INFARCTION,cerebral infarction,CEREBRAL INFARCTION,CEREBRAL INFARCTION,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008118,10008118,10008118
NOT FEELING HIMSELF,feeling abnormal,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10016322,10016322,10016322
NAUSEA/VOMITING,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
OF COFFEE-GROUND VOMIT,Haematemesis,HAEMATEMESIS,HAEMATEMESIS,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018830,10018830,10018830
CMV REACTIVATION WITH TISSUE INVASIVE DISEASE OF THE ORAL MUCOSA,Oral mucosal disorder,ORAL MUCOSAL DISORDER,ORAL DISORDER,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE DISORDERS NEC,10017947,10056468,10067621,10056468
ACUTE CHEST PAIN,acute chest pain,ACUTE CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10066987,10008479,10066987
BIRTH WEIGHT JUST ABOVE THE AGE-ADJUSTED 10TH CENTILE,Low birth weight baby,LOW BIRTH WEIGHT BABY,LOW BIRTH WEIGHT BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10067508,10067508,10067508
BLOOD PRESSURE DECREASED 3 MONTHS LATER/RAPID DECREASE IN BLOOD PRESSURE,blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
PATIENT WAS FOUND DEAD/HOSPITAL THE RESUSCITATION WAS NOT STARTED DUE SEVERE CARDIAC FAILURE AND CARDINAL SUDDEN DEATH WAS DIAGNOSED,Death,FOUND DEAD,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10017066,10011906,10017066
"AN ACUTE EPISODE OF PAINFUL RASH, THE RASH HAD EXTENDED TO HER LOWER EXTREMITIES, WITH MARKED SWELLING OF BOTH PINNAE",Rash,PAINFUL RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10074762,10037844,10074762
HYPERSEGMENTED NEUTROPHILS (WITH  6 LOBES) DUE TO METHOTREXATE TOXICITY,Neutrophil hypersegmented morphology present,NEUTROPHIL HYPERSEGMENTED MORPHOLOGY PRESENT,NEUTROPHIL HYPERSEGMENTED MORPHOLOGY PRESENT,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029374,10029374,10029374
"PATIENT WAS APPLYING LONG-ACTING INSULIN OVER THE CLOTHES WITHOUT A SPECIFIC TIME INTERVAL, DIDN'T USE ROTATIONAL TECHNIQUE",Product use issue,PRODUCT USE ISSUE,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076309,10076309,10076309
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
EPSTEIN-BARR VIRUS ASSOCIATED B-CELL LYMPHOMA,Epstein-Barr virus associated lymphoma,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,B-CELL LYMPHOMAS NEC,10029104,10071441,10071441,10071441
LARGE B-CELL LYMPHOMA,Diffuse large B-cell lymphoma,DIFFUSE LARGE B-CELL LYMPHOMA,DIFFUSE LARGE B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,DIFFUSE LARGE B-CELL LYMPHOMAS,10029104,10012818,10012818,10012818
MEDIASTINAL HEMATOMA,mediastinal hematoma,MEDIASTINAL HEMATOMA,MEDIASTINAL HAEMATOMA,THORACIC DISORDERS (EXCL LUNG AND PLEURA),MEDIASTINAL DISORDERS,10038738,10055375,10049941,10055375
OXALIPLATIN-INDUCED NEUROPATHY,Neuropathy peripheral,NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029328,10029331,10029328
TUBERCULOSIS,Tuberculosis,TUBERCULOSIS,TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10044755,10044755,10044755
PATIENT REMAINED ON HER HOME AND HAD SELF TREATED HER RASH WITH DIPHENHYDRAMINE,Self-medication,SELF-MEDICATION,SELF-MEDICATION,THERAPEUTIC PROCEDURES AND SUPPORTIVE CARE NEC,THERAPEUTIC PROCEDURES NEC,10042613,10050729,10050729,10050729
LEFT LOWER LOBE COLLAPSE WITH BASILAR OPACITIES AS WELL AS PATCHY GROUND GLASS OPACITIES,Chest X-ray abnormal,GROUND GLASS OPACITY ON CHEST X-RAY,CHEST X-RAY ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10072880,10008499,10072880
MENINGITIS,meningitis,MENINGITIS,MENINGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10027199,10027199,10027199
PATIENT TREATED WITH RIBOFLAVIN FOR MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY (OFF LABEL USE FOR INDICATION) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
HYPOXEMIA,Hypoxia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021141,10021143,10021142
CORTICOSTEROID CONTACT DERMATITIS,Dermatitis contact,CONTACT DERMATITIS,DERMATITIS CONTACT,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10012442,10012442,10010790
"RUSTING AND VESICULAR LESIONS OF THE LEFT SCALP IN THE C2 DERMATOME, VESICULAR LESION EXTENDING BEYOND THE C2 DERMATOME ONTO THE LEFT FOREHEAD AND CHEEK.",blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
ACUTE KIDNEY INJURY,acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
SEVERE TOXIC EPIDERMAL NECROLYSIS ON 90 PERCENT OF THE BODY SURFACE AREA WITH SEVERE MUCOSAL INVOLVEMENT,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SHALLOW ULCER IN LEFT AND RIGHT LOWER EXTREMITY,leg ulcer,LEG ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10068310,10040943,10068310
RESTLESS,Restlessness,RESTLESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038743,10038743,10038740
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,Acute generalised exanthematous pustulosis,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10048799
DRUG USE FOR UNAPPROVED INDICATION,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
AMYLASE INCREASED (MORE THAN 500U/L),Amylase increased,AMYLASE INCREASED,AMYLASE INCREASED,GASTROINTESTINAL INVESTIGATIONS,DIGESTIVE ENZYMES,10022891,10002016,10002016,10002016
SYMPTOMATIC CHOLELITHIASIS,cholelithiasis,CHOLELITHIASIS,CHOLELITHIASIS,GALLBLADDER DISORDERS,CHOLECYSTITIS AND CHOLELITHIASIS,10019805,10008629,10008629,10008629
FEBRILE,febrile reaction,FEBRILE REACTION,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016289,10037660,10016289
NECK PAIN,Neck pain,NECK PAIN,NECK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10028836,10028836,10028836
HERPES ZOSTER,herpes zoster,HERPES ZOSTER,HERPES ZOSTER,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10019974,10019974,10019974
LISTERIOSIS/LISTERIA MONOCYTOGENES,listeria monocytogenes,LISTERIA MONOCYTOGENES INFECTION,LISTERIOSIS,BACTERIAL INFECTIOUS DISORDERS,LISTERIA INFECTIONS,10021881,10024640,10024641,10024640
FIBROSIS STAGE 4,Hepatic fibrosis,FIBROSIS LIVER,HEPATIC FIBROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10019668,10019668,10016648
INVOLUNTARY CONTRACTIONS,Muscle contractions involuntary,MUSCLE CONTRACTIONS INVOLUNTARY,MUSCLE CONTRACTIONS INVOLUNTARY,NEUROMUSCULAR DISORDERS,NEUROMUSCULAR DISORDERS NEC,10029205,10028293,10028293,10028293
"HER TD SYMPTOMS DID NOT RESPOND TO SWITCHING AND DISCONTINUATION OF THE NEUROLEPTICS, CLONAZEPAM, PROPRANOLOL AND VITAMIN E.",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PROLONGED QTC AT 645 MILLISECONDS  FOLLOWING LOPERAMIDE TOXICITY DUE TO LOPERAMIDE ABUSE,Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
CREATININE LEVELS INCREASED (237 UMOL/L),Blood creatinine increased,BLOOD CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005483,10005483,10005483
ACR,Urine albumin/creatinine ratio abnormal,URINE ALBUMIN/CREATININE RATIO ABNORMAL,URINE ALBUMIN/CREATININE RATIO ABNORMAL,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10053544,10053544,10053544
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER/GI,Post transplant lymphoproliferative disorder,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10051358,10051358,10051358
SEVERE HUMORAL IMMUNODEFICIENCY,Humoral immune defect,DEFICIENCY OF HUMORAL IMMUNITY,HUMORAL IMMUNE DEFECT,IMMUNODEFICIENCY SYNDROMES,IMMUNODEFICIENCY DISORDERS NEC,10021428,10012134,10020464,10012134
MYOCLONIC SEIZURES,Myoclonic seizure NOS,MYOCLONIC SEIZURE NOS,MYOCLONIC EPILEPSY,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10049588,10054859,10049588
SIGNIFICANT DROP IN THE PLATELET COUNT,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
BLEOMYCIN-INDUCED PULMONARY FIBROSIS (CHEST X-RAY AND HIGH RESOLUTION COMPUTED TOMOGRAPHY (HRCT) OF LUNGS SHOWED NEWLY OCCURED BILATERAL INTERSTITIAL PULMONARY FIBROSIS),Interstitial lung disease,INTERSTITIAL PULMONARY FIBROSIS,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022619,10022611,10022619
BENZODIAZEPINE OVERDOSE/OVERDOSE FOR SUICIDE ATTEMPT,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
SEVERE VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
"PROGRESSION (RETROBULBAR ABSCESS, PERIANAL AND PERISCROTAL ABSCESSES)",Abscess,ABSCESS,ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10000269,10000269,10000269
PSEUDOANEURYSM,Vascular pseudoaneurysm,PSEUDOANEURYSM,VASCULAR PSEUDOANEURYSM,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,CARDIAC AND VASCULAR PROCEDURAL COMPLICATIONS,10022117,10048977,10048975,10048977
LEARNING DIFFICULTIES,Learning disability,LEARNING DISABILITY,LEARNING DISABILITY,COGNITIVE AND ATTENTION DISORDERS AND DISTURBANCES,LEARNING DISORDERS,10037175,10024092,10024092,10024092
ABDOMINAL PAIN WITH TENDERNESS ON PALPATION,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
TRIAMCINOLONE ACETONIDE INJECTIONS INTO BOTH EYES WITH PARTIAL AND TRANSITORY RESPONSES,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PSEUDOMONAS AERUGINOSA,Pseudomonas infection,INFECTION PSEUDOMONAS AERUGINOSA,PSEUDOMONAS INFECTION,BACTERIAL INFECTIOUS DISORDERS,PSEUDOMONAL INFECTIONS,10021881,10021860,10061471,10021860
CEFEPIME INDUCED NEUTROPENIA (NEUTROPHIL COUNT DECREASED),neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ENLARGED TESTICLE WAS DETECTED WAS DETECTED IPSILATERAL BY CLINICAL EXAMINATION WITH NODULAR INDURATIONS,Swelling (r) testicle,SWELLING (R) TESTICLE,TESTICULAR SWELLING,TESTICULAR AND EPIDIDYMAL DISORDERS,TESTICULAR AND EPIDIDYMAL DISORDERS NEC,10038604,10042677,10043354,10042677
FENOFIBRATE MONOTHERAPY-INDUCED RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
ACUTE RENAL INSUFFICIENCY,Acute kidney injury,ACUTE RENAL INSUFFICIENCY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10050440,10069339,10050440
PRURITUS GENERALISED,Pruritus generalised,PRURITUS GENERALISED,PRURITUS GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10052576,10052576,10052576
SEPTICEMIA DUE TO DRUG OVERDOSE AND ACCIDENTAL OVERDOSE FOLLOWING MEDICATION ERROR,Sepsis,SEPTICEMIA,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040089
ANAEMIA,anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
PAIN LEVELS INCREASED CONSTANTLY,Pain aggravated,PAIN AGGRAVATED,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033376,10033371,10033376
ACUTE RENAL FAILURE DUE TO NEUROLEPTIC MALIGNANT SYNDROME FOLLOWING DRUG EXPOSURE DURING PREGNANCY,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
ACUTE TUBULAR NECROSIS (ATN) DUE TO INCREASED VANCOMYCIN DRUG LEVELS FOLLOWING DRUG INTERACTION WITH PIPERACILLIN SODIUM/TAZOBACTAM SODIUM,Renal tubular necrosis,ACUTE TUBULAR NECROSIS,RENAL TUBULAR NECROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL VASCULAR AND ISCHAEMIC CONDITIONS,10038359,10001099,10038540,10001099
GLOBAL CONTINUOUS HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
PROFOUND HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
INADEQUATE EFFICACY OF THE ANTIPLATELET DRUG,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
TACHYPNEA,Tachypnoea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043088
SPINAL CORD COMPRESSION,spinal cord compression,SPINAL CORD COMPRESSION,SPINAL CORD COMPRESSION,SPINAL CORD AND NERVE ROOT DISORDERS,SPINAL CORD AND NERVE ROOT DISORDERS NEC,10029205,10041549,10041549,10041549
DORSAL EPIDURAL MASS (HYPERTROPHIC EPIDURAL FAT) COMPRESSING THE SPINAL CORD,Epidural lipomatosis,EPIDURAL LIPOMATOSIS,EPIDURAL LIPOMATOSIS,SPINAL CORD AND NERVE ROOT DISORDERS,SPINAL CORD AND NERVE ROOT DISORDERS NEC,10029205,10067599,10067599,10067599
LOW CONCENTRATION OF FIBRINOGEN (98MG/DL),Blood fibrinogen decreased,FIBRINOGEN DECREASED,BLOOD FIBRINOGEN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10016596,10005520,10016596
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
AST INCREASED,Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
"CHEMICAL (CYTOSTATIC) GRADE IIB-PARCEL III, FRONT DORSAL LEFT PRE-LEG, DIGITAL FILMS IIV, ABOUT 2%",Chemical burn of skin,CHEMICAL BURN OF SKIN,CHEMICAL BURN OF SKIN,"EXPOSURES, CHEMICAL INJURIES AND POISONING",CHEMICAL INJURIES,10022117,10057941,10057941,10057941
ORTHOPNEA,Orthopnoea,ORTHOPNEA,ORTHOPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10031123,10031123,10031122
HOMOCYSTEINE LEVEL ELEVATED,Blood homocysteine increased,HOMOCYSTEINE LEVEL INCREASED,BLOOD HOMOCYSTEINE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10050415,10049733,10050415
WEIGHT GAIN,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
AGGRESSIVE,Aggression,AGGRESSIVENESS,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001488,10001488,10001494
DETERIORATION OF THE NEUROLOGICAL STATUS,Neurological decompensation,NEUROLOGICAL STATUS DETERIORATION,NEUROLOGICAL DECOMPENSATION,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10064098,10068357,10064098
ALASP INCREASED (89MMOL/L),alasp increased (89mmol/l),ALANINE AMINOTRANSFERASE INCREASE,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001550,10001551,10001550
RENAL ARTERY RUPTURE,renal artery rupture,ARTERY RUPTURE,ARTERIAL RUPTURE,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10003237,10003173,10003237
CREPITUS ON PALPATION,crepitation,CREPITATIONS,CREPITATIONS,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10011376,10011376,10011376
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
ANEJACULATION,Anejaculation,ANEJACULATION,EJACULATION FAILURE,SEXUAL FUNCTION AND FERTILITY DISORDERS,ERECTION AND EJACULATION CONDITIONS AND DISORDERS,10038604,10073936,10014328,10073936
ACUTE HEPATIC FAILURE,Acute hepatic failure,ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10000804
AQUEOUS FLUID FROM AN ANTERIOR CHAMBER TAP WAS POSITIVE FOR VARICELLA ZOSTER VIRUS PCR,Varicella zoster virus infection,VARICELLA ZOSTER VIRUS INFECTION,VARICELLA ZOSTER VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10075611,10075611,10075611
AUTOIMMUNE HEPATITIS TRIGGERED BY NEUROFURANTOIN,Autoimmune hepatitis,AUTOIMMUNE HEPATITIS,AUTOIMMUNE HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10003827,10003827,10003827
SEPSIS DUE TO E. COLI WORSENING DUE TO LACK OF EFFECT OF ANTIBIOTICS,Escherichia sepsis,ESCHERICHIA SEPSIS,ESCHERICHIA SEPSIS,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10015296,10015296,10015296
CYSTOID MACULA EDEMA,Cystoid macular oedema,CYSTOID MACULAR EDEMA,CYSTOID MACULAR OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","RETINAL, CHOROID AND VITREOUS INFECTIONS AND INFLAMMATIONS",10015919,10058202,10058202,10051240
ABSENT RED REFLEX IN THE LEFT EYE,red reflex abnormal,RED REFLEX ABNORMAL,RED REFLEX ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",OPHTHALMIC HISTOPATHOLOGY AND IMAGING PROCEDURES,10022891,10074603,10074603,10074603
WIDESPREAD PAINFUL PRURITIC SKIN ERUPTIONS,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
ONSET AND PROGRESSION OF OBSTRUCTIVE SLEEP APNEA,Obstructive sleep apnea syndrome,OBSTRUCTIVE SLEEP APNEA SYNDROME,SLEEP APNOEA SYNDROME,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10055577,10040979,10055577
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
WORSENING METABOLIC ACIDOSIS,worsening metabolic acidosis,METABOLIC ACIDOSIS WORSENED,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027421,10027417,10027421
GENERALIZED SKIN ERUPTIONS,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
HYPOGLYCEMIA (FINGER STICK GLUCOSE-35 MG/DL) FOLLOWING DRUG TOXICITY,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
CT IMAGES SHOWED GROUND GLASS OPACITY IN THE LEFT LOWER LOBE,Computerised tomogram thorax abnormal,GROUND GLASS OPACITY IN THORACIC CT,COMPUTERISED TOMOGRAM THORAX ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10072879,10057799,10072879
ABNORMAL BEHAVIOUR,Abnormal behaviour,ABNORMAL BEHAVIOUR,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10061422,10061422,10061422
UMBILICAL HERNIA,umbilical hernia,UMBILICAL HERNIA,UMBILICAL HERNIA,ABDOMINAL HERNIAS AND OTHER ABDOMINAL WALL CONDITIONS,UMBILICAL HERNIAS,10017947,10045458,10045458,10045458
EXTERNAL GENITALIA REVEALED A SWOLLEN LABIUM WITH A 4 X 5 CM EXCORIATION,Genital swelling,GENITAL SWELLING,GENITAL SWELLING,REPRODUCTIVE TRACT DISORDERS NEC,REPRODUCTIVE TRACT SIGNS AND SYMPTOMS NEC,10038604,10067639,10067639,10067639
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
ACUTE ONSET PLEURITIC CHEST PAIN,Pleuritic pain,PLEURITIC PAIN,PLEURITIC PAIN,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10035623,10035623,10035623
EXPERIENCED APPLICATION SITE HYPEREMIA ON ONE HALF OF THE UPPER ARM,Vaccination site reaction,VACCINATION SITE REACTION,VACCINATION SITE REACTION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10059080,10059080,10059080
SEPTIC SHOCK DUE TO LEMIERRE SYNDROME,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
PRECLUDED FOOD SWALLOWING,precluded food swallowing,SWALLOWING DIFFICULT,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10042645,10013950,10042645
MILD DIAPHORESIS,Hyperhidrosis,DIAPHORESIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042670,10020642,10012703
BULLOUS ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,Acute generalised exanthematous pustulosis,ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10062372
CHEST PAIN - CARDIAC FOLLOWING CARDIOTOXICITY,Angina pectoris,CHEST PAIN - CARDIAC,ANGINA PECTORIS,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10008481,10002383,10008481
FAILED TREATMENT WITH IBUPROFEN,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
HYPERSEXUALITY,Hypersexuality,HYPERSEXUALITY,HYPERSEXUALITY,"SEXUAL DYSFUNCTIONS, DISTURBANCES AND GENDER IDENTITY DISORDERS",SEXUAL DESIRE DISORDERS,10037175,10066364,10066364,10066364
FUROSEMIDE WAS GIVEN FOR TREATMENT OF HYPERCALCEMIA (OFF LABEL USE FOR INDICATION),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
STAGE 3 BISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAWS,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
UNBEARABLE PAIN IN THE BACK,Back pain,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003988,10003988,10003988
INCREASED LIBIDO,INCREASED LIBIDO,INCREASED LIBIDO,LIBIDO INCREASED,"SEXUAL DYSFUNCTIONS, DISTURBANCES AND GENDER IDENTITY DISORDERS",SEXUAL DESIRE DISORDERS,10037175,10021669,10024421,10021669
DRUG TOXICITY,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
KLEBSIELLA PNEUMONAIE SEPSIS,Klebsiella sepsis,KLEBSIELLA SEPSIS,KLEBSIELLA SEPSIS,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10054160,10054160,10054160
WALKING DISORDER,Gait disturbance,WALKING DIFFICULTY,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10012794,10017577,10047810
INCREASE IN HEART RATE/ A RAISE IN HEART RATE,Heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
GREATER SEVERITY OF SON'S IRRITABILITY/MORE FREQUENT QUARRELS WITH HIM/NUMEROUS CONFLICTS WITH PARENTS,Irritability,IRRITABILITY,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10022998,10022998,10022998
ESCHERICHIA SEPSIS,escherichia sepsis,ESCHERICHIA SEPSIS,ESCHERICHIA SEPSIS,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10015296,10015296,10015296
FLAPPING TREMORS,Asterixis,FLAPPING TREMOR,ASTERIXIS,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10057580,10003547,10057580
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
MODERATE HYPERKALEMIA,Hyperkalemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020647,10020646,10020647
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
ERYTHEMA OF HIS LEFT LOWER EXTREMITY,erythema of his left lower extremity,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
POROKERATOSIS OF MIBELLI,Porokeratosis,POROKERATOSIS,POROKERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL NEC,10010331,10036175,10036175,10036175
FEV 0.61-22%,FEV decreased,FEV DECREASED,FORCED EXPIRATORY VOLUME DECREASED,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY AND PULMONARY FUNCTION DIAGNOSTIC PROCEDURES,10022891,10016555,10016987,10016555
EYE DISORDER,Eye disorder,EYE DISORDER,EYE DISORDER,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10015916,10015916,10015916
IRINOTECAN USED FOR STAGE IIIB WELL-DIFFERENTIATED ADENOCARCINOMA OF THE COLON,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEMORRHAGE FROM THE DIGESTIVE TRACT,Gastrointestinal haemorrhage,HEMORRHAGE OF DIGESTIVE TRACT,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018991,10017955,10055270
NEPHROCALCINOSIS,Nephrocalcinosis,NEPHROCALCINOSIS,NEPHROCALCINOSIS,UROLITHIASES,RENAL LITHIASIS,10038359,10029146,10029146,10029146
DRUG EXPOSURE DURING PREGNANCY,DRUG EXPOSURE DURING PREGNANCY,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
SEVERE BLEEDING,Bleeding,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10005103,10055798,10005103
BACTEREMIA FROM ESCHERICIA COLI,bacteraemia,BACTERAEMIA,BACTERAEMIA,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10003997,10003997,10003997
LEFT LUNG - PNEUMONIA\ BILATERAL PNEUMONIA,Bilateral pneumonia,BILATERAL PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10058686,10035664,10058686
RAISED TROUGH LEVELS SECONDARY TO KNOWN DRUG INTERACTIONS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
PSYCHOMOTOR DELAY,Psychomotor retardation,PSYCHOMOTOR RETARDATION,PSYCHOMOTOR RETARDATION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10037213,10037213,10037213
"FACIAL MYOCLONUS, GENERALIZED MYOCLONUS",Myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
NASAL OBSTRUCTION,nasal obstruction,NASAL OBSTRUCTION,NASAL OBSTRUCTION,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10028748,10028748,10028748
RECURRENT EPISODES OF PNEUMONIA,Recurrent episodes of pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
DROWSINESS,drowsiness,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
NO CLINICAL IMPROVEMENT (LACK OF DRUG EFFECT WITH NO ADVERSE EVENT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HYPOGLYCEMIA,hypoglycemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10021005,10020993,10021005
REPEATED OVER-LIMIT INCREASES IN CK,Blood creatine phosphokinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
MUSCULAR WEAKNESS,Muscular weakness,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028372,10028372,10028372
INSULIN ADMINISTERED DURING PREGNANCY (DRUG EXPOSURE DURING PREGNANCY),Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
DRESS SYNDORME,dress syndorme,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
KOUNIS SYNDROME/ KS INDUCED BY DICLOFENAC POTASSIUM,Kounis syndrome,KOUNIS SYNDROME,KOUNIS SYNDROME,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10069167,10069167,10069167
EPISTAXIS/SEVERE EPISTAXIS,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
PROGRESSIVE RESPIRATORY FAILURE DUE TO UC RELATED INTERSTIAL LUNG DISEASE/ACUTE HYPOXIC RESPIRATORY FAILURE,Respiratory failure,HYPOXIC RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10074615,10038695,10074615
SEVERE AND PROGRESSIVE HEMARTHROSIS DUE TO THROMBOCYTOPENIA,Haemarthrosis,HEMARTHROSIS,HAEMARTHROSIS,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10018829,10018829,10019409
FRANK HAEMATURIA,Haematuria,FRANK HAEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10017332,10018867,10017332
THROMBOPHLEBITIS,Thrombophlebitis,THROMBOPHLEBITIS,THROMBOPHLEBITIS,EMBOLISM AND THROMBOSIS,PERIPHERAL EMBOLISM AND THROMBOSIS,10047065,10043570,10043570,10043570
PERIPHERIES WERE COLD,Peripheral coldness,PERIPHERAL COLDNESS,PERIPHERAL COLDNESS,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10034568,10034568,10034568
MILD IRON-DEFICIENCY ANEMIA,iron deficiency anaemia,IRON DEFICIENCY ANAEMIA,IRON DEFICIENCY ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIA DEFICIENCIES,10005329,10022972,10022972,10022972
REOCCURRENCE OF BECHETâ€™S DISEASE,bechet disease,BEHCET'S DISEASE,BEHCET'S SYNDROME,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10004212,10004213,10004212
DYSPEPTIC PROBLEMS,Dyspepsia,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,DYSPEPTIC SIGNS AND SYMPTOMS,10017947,10013946,10013946,10013946
PATIENT EXPERIENCED NO MARKED RELIEF (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
S. MALTOPHILIA INFECTION,Stenotrophomonas maltophilia infection,STENOTROPHOMONAS MALTOPHILIA INFECTION,STENOTROPHOMONAS INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10051953,10054138,10051953
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
GENITAL PAIN,genital pain,GENITAL PAIN,GENITAL PAIN,REPRODUCTIVE TRACT DISORDERS NEC,REPRODUCTIVE TRACT SIGNS AND SYMPTOMS NEC,10038604,10061979,10061979,10061979
COUGH,cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
PROPAFENONE INTOXICATION,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
MULTIPLE BLISTERS WITH SOME DESQUAMATION,desquamation,DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10012528,10040844,10012528
FULMINANT HEPATIC FAILURE,hepatic failure,HEPATIC FAILURE,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10019663,10019663,10019663
FREE INTRAPELVIC AIR IN THE BILARY AND PORTAL VENOUS SYSTEMS,Portal venous gas,PORTAL VENOUS GAS,PORTAL VENOUS GAS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10064711,10064711,10064711
SECONDARY AMENORRHEA,Amenorrhoea,SECONDARY AMENORRHOEA,AMENORRHOEA,MENSTRUAL CYCLE AND UTERINE BLEEDING DISORDERS,MENSTRUATION WITH DECREASED BLEEDING,10038604,10039809,10001928,10039809
INTENSE PHOTOPHOBIA,INTENSE PHOTOPHOBIA,PHOTOPHOBIA,PHOTOPHOBIA,OCULAR SENSORY SYMPTOMS NEC,OCULAR SENSATION DISORDERS,10015919,10034960,10034960,10034960
PATIENT TREATED WITH HYDROXYCHLOROQUINE SULFATE FOR KIKUCHI-FUJIMOTO WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MACROPHAGE ACTIVATION SYNDROME,Histiocytosis haematophagic,MACROPHAGE ACTIVATION SYNDROME,HISTIOCYTOSIS HAEMATOPHAGIC,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10053867,10048595,10053867
DERANGED LIVER FUNCTION,Hepatic function abnormal,FUNCTION LIVER ABNORMAL,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019670,10019670,10017475
SEVERE PANCYTOPENIA (PLATELET COUNT 72X10E9/L),Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
DISORIENTATION,Disorientation,DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013395
DISSEMINATED INTRAVASCULAR COAGULATION,Disseminated intravascular coagulation,DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10013442,10013442,10013442
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
ACUTE NEUTROPENIA,neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
RIGHT ATAXIC HEMIPARESIS,Hemiparesis,HEMIPARESIS,HEMIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019465,10019465,10019465
ECLAMPTIC SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
MOON FACE APPEARANCE,Cushingoid,MOON FACE,CUSHINGOID,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10027953,10011655,10027953
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HYPERPIGMENTATION OF THE TREATED SKIN AREA FOLLOWING OFF LABEL USE OF BLEOMYCIN FOR AGGRESSIVE FIBROMATOSIS,Skin hyperpigmentation,HYPERPIGMENTATION SKIN,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10040865,10040865,10020715
SOMEWHAT RIGID,Muscle rigidity,RIGIDITY,MUSCLE RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10039168,10028330,10039168
DIABETIC UREMIC SYNDROME,Azotaemia,UREMIC SYNDROME,AZOTAEMIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE COMPLICATIONS,10038359,10046330,10003885,10046374
MYELITIS RECURRENCE,myelitis,MYELITIS,MYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10028524,10028524,10028524
CARDIOGENIC SHOCK,Cardiogenic shock,CARDIOGENIC SHOCK,CARDIOGENIC SHOCK,HEART FAILURES,HEART FAILURES NEC,10007541,10007625,10007625,10007625
BILATERAL RESTING TREMOR,Resting tremor,RESTING TREMOR,RESTING TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10071390,10071390,10071390
HEPATOSPLENOMEGALY,Hepatosplenomegaly,HEPATOSPLENOMEGALY,HEPATOSPLENOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019847,10019847,10019847
DISEASE PROGRESSION,Adenocarcinoma lung stage IV,ADENOCARCINOMA LUNG STAGE IV,LUNG ADENOCARCINOMA STAGE IV,RESPIRATORY AND MEDIASTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,NON-SMALL CELL NEOPLASMS MALIGNANT OF THE RESPIRATORY TRACT CELL TYPE SPECIFIED,10029104,10001165,10025038,10001165
NIFEDIPINE GIVEN FOR THREATENED PRETERM LABOR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
GRADE 4 BONE MARROW DEPRESSION,Bone marrow failure,BONE MARROW DEPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10005986
CHEMOTHERAPY WAS TERMINATED DUE TO NEPHROPATHY AND RENAL INSUFFICIENCY,renal  insufficiency,RENAL INSUFFICIENCY,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038474,10038435,10038474
OVERT OBSCURE GASTROINTESTINAL BLEEDING (OGIB),Gastrointestinal haemorrhage,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017955
"HISTOLOGY OF A BIOPSY TAKEN FROM BLISTER SHOWED A SUBEPIDERMAL BULLA, ALONG WITH DERMAL EDEMA AND A SCANT LYMPHOHISTIOCYTIC PERIVASCULAR INFILTRATE WITH SPORADIC EOSINOPHILS",Blister,BULLAE,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006554,10005191,10006554
HYPERTHYROIDISM,Hyperthyroidism,HYPERTHYROIDISM,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10020850,10020850,10020850
FUNDUS EXAMINATION SHOWED VERY MILD MACULAR GRANULARITY,Macular degeneration,MACULAR DEGENERATION,MACULAR DEGENERATION,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10025409,10025409,10025409
NEUTROPENIC FEVER,Neutropenic fever,NEUTROPENIC FEVER,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10051312,10016288,10051312
HYPOCALCEMIA (8.2 MG/DL),Hypocalcaemia,HYPOCALCEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020947,10020947,10020949
PSYCHOTIC SYMPTOMS/SERTRALINE INDUCED PSYCHOSIS,Substance-induced psychotic disorder,DRUG-INDUCED PSYCHOSIS,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10013708,10072388,10013708
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
DETIORATION OF CLOSTRIDIUM DIFFICILE COLITIS DESPITE TREATMENT WITH METRONIDAZOLE,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
MULTIPLE DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
BRADYCARDIA NEONATAL,Bradycardia neonatal,BRADYCARDIA NEONATAL,BRADYCARDIA NEONATAL,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10056471,10056471,10056471
INTENSIFICATION OF MISPERCEPTION PHENOMENA,Perceptual disturbance,PERCEPTUAL DISTURBANCE,ILLUSION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10034378,10021403,10034378
TOTAL BILIRUBIN 1.1 TO 5.3 MG/DL,Blood bilirubin increased,BILIRUBIN TOTAL INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056806,10005364,10056806
"ILEFT FACIAL SWELLING, INCREASED FACIAL SWELLING, PROGRESSIVE FACIAL SWELLING",Swelling face,SWELLING FACE,SWELLING FACE,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10042682,10042682,10042682
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
SUDDEN UNEXPLAINED DEATH IN EPILEPSY,Sudden unexplained death in epilepsy,SUDDEN UNEXPLAINED DEATH IN EPILEPSY,SUDDEN UNEXPLAINED DEATH IN EPILEPSY,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10063894,10063894,10063894
DID NOT RESPOND DILTIAZEM,therapy non-responder,THERAPY NON-RESPONDER,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051082,10051082,10051082
CEFAZOLIN-INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
"POSITIVE BLOOD CULTURES INCLUDED ENTEROCOCCI,ELIZABETHKINGIA MENINGOSEPTICA, STAPHYLOCOCCUS HAEMOLYTICUS, AND ESCHERICHIA COLI",Escherichia test positive,ESCHERICHIA TEST POSITIVE,ESCHERICHIA TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,BACTERIA IDENTIFICATION AND SEROLOGY (EXCL MYCOBACTERIA),10022891,10070090,10070090,10070090
DETERIORATION OF EGFR IS STRONGLY LINKED TO ENHANCED PLATELET ACTIVITY DURING DAPT,Renal impairment,RENAL FUNCTION AGGRAVATED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038453,10062237,10038453
HYPOTHERMIE MAJEURE,hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
ACUTE RESPIRATORY DISTRESS,Acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
REBOUND EFFECT,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
EMPHYSEMATOUS GASTRODUODENITIS,emphysematous gastritis,EMPHYSEMATOUS GASTRITIS,GASTRITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10078759,10061971,10078759
ACUTE CONFUSION,Confusional state,ACUTE CONFUSION STATE,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10000694,10010305,10000693
OXALIPLATINâ€‘INDUCED NEUROTOXICITY,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
RECURRENT ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
TRANSIENT REVERSIBLE ACUTE MYOCARDIAL INJURY IN ASSOCIATION WITH METFORMIN TOXICITY FOLLOWING INTENTIONAL PRODUCT USE ISSUE,Cardiomyopathy,MYOCARDIAL DISORDER,CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10028591,10007636,10028591
HIGH LEUCOCYTE COUNT WITH NEUTROPHIL PREDOMINANCE IN BLOOD SMEAR,White blood cell count increased,LEUKOCYTE COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047943,10047943,10048553
PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY DUE TO JC VIRUS INFECTION,Progressive multifocal leukoencephalopathy,PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10036807,10036807,10036806
BLOOD BICARBONATE INCREASED (79 MG/DL),Blood bicarbonate increased,BLOOD BICARBONATE INCREASED,BLOOD BICARBONATE INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10005360,10005360,10005360
CMV REACTIVATION (3 EPISODES),Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION REACTIVATION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10058666,10011831,10058666
DISEASE PROGRESSION,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
IL-10 AND IL-6 LEVELS IN VITREOUS SAMPLE WERE 32 AND 288 PG/ML,Interleukin level increased,INTERLEUKIN LEVEL INCREASED,INTERLEUKIN LEVEL INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNE RESPONSE PROTEIN ANALYSES NEC,10022891,10063322,10063322,10063322
RESPIRATORY FAILURE,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
DESPITE THE OCCURRENCE OF RETROGRADE EJACULATION (RE) WITH CLOZAPINE,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HYPERACTIVE,hyperactive,HYPERACTIVE,PSYCHOMOTOR HYPERACTIVITY,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10020554,10037211,10020554
VOMITUS,vomitus,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
BOTH KIDNEYS WERE PALPABLY ENLARGED,Glabellar frown lines,GLABELLAR FROWN LINES,SKIN WRINKLING,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,SKIN DYSTROPHIES,10040785,10052609,10040954,10052609
HYPOCALCEMIA (5.21 MG/DL),Hypocalcaemia,HYPOCALCEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020947,10020947,10020949
EPIGASTRIC PAIN,epigastric pain,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
MYOPIA,Myopia,MYOPIA,MYOPIA,VISION DISORDERS,REFRACTIVE AND ACCOMMODATIVE DISORDERS,10015919,10028651,10028651,10028651
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
PHARYNGEAL HYPEREMIA,pharyngeal hyperemia,PHARYNGEAL HYPEREMIA,PHARYNGEAL ERYTHEMA,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),PHARYNGEAL DISORDERS (EXCL INFECTIONS AND NEOPLASMS),10038738,10075001,10057009,10075001
IMMUNOSUPPRESSION-ASSOCIATED GASTROINTESTINAL KAPOSI'S SARCOMA (GASTRIC POLYPOID LESION ON STOMACH AND DUODENUM),Kaposi's sarcoma,"KAPOSI'S SARCOMA, GASTROINTESTINAL SITES",KAPOSI'S SARCOMA,SOFT TISSUE NEOPLASMS MALIGNANT AND UNSPECIFIED,KAPOSI'S SARCOMAS,10029104,10023291,10023284,10023291
ANEMIA,anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
FLARE OF PEMPHIGUS FOLLOWING LACK OF DRUG EFFECT OF PREDNISOLONE,Pemphigus,PEMPHIGUS,PEMPHIGUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10034280,10034280,10034280
PATIENT TREATED WITH PREDNISONE AND BORTEZOMIB FOR SPORADIC LATE-ONSET NEMALINE MYOPATHY [OFF LABEL USE],Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEMI-COMATOSE STATE,semi-coma,SEMI-COMA,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039950,10012373,10039950
PERICARDITIS,Pericarditis,PERICARDITIS,PERICARDITIS,PERICARDIAL DISORDERS,NONINFECTIOUS PERICARDITIS,10007541,10034484,10034484,10034484
SKIN RASH,skin rash,SKIN RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040913,10037844,10040913
COMPLAINTS OF GENERALISED WEAKNESS/PROGRESSIVE WEAKNESS,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
NO RESPONSE TO THE CLINICAL TREATMENT,No therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
PNEUMOCYSTIS PNEUMONIA,Pneumocystis jirovecii pneumonia,PNEUMOCYSTIS PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10035661,10073755,10035661
DEPRESSIVE STUPOR,Depression,DEPRESSIVE STUPOR,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012407,10012378,10012407
E.COLI SEPSIS,E.coli sepsis,ESCHERICHIA SEPSIS,ESCHERICHIA SEPSIS,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10015296,10015296,10015296
"4-YEAR OLD PATIENT WAS TREATED WITH IBUPROFEN, NOT OTHERWISE SPECIFIED, DOSAGE INFORMATION NOT PROVIDED  (OFF LABEL USE)/ ADMINISTRATION FOR ACUTE PHARYNGITIS",Product use issue,DRUG USE IN UNAPPROVED POPULATION,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10071551,10076309,10071551
DISSEMINATED MORBILIFORM ERYTHEMATOUS LESIONS,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
DIFFUSE RASH,diffuse Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
COLCHICINE INTOXICATION,drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
"ON EGD,MODERATE STENOSIS MEASURING 1CMX9MM WAS FOUND 29 CM FROM INCISORS AND WAS TRAVERSED WITH MILD RESISTANCE,STENOSIS WAS FOUND 30CM FROM INCISORS,SEVERE STENOSIS WAS FOUND 6CM FURTHER",Oesophageal stenosis,ESOPHAGEAL STENOSIS,OESOPHAGEAL STENOSIS,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,OESOPHAGEAL STENOSIS AND OBSTRUCTION,10017947,10030194,10030194,10015448
GRADE II ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
STAPHYLOCOCCUS INFECTION-ASSOCIATED MESANGIAL PROLIFERATIVE GLOMERULONEPHRITIS,Glomerulonephritis proliferative,GLOMERULONEPHRITIS PROLIFERATIVE,GLOMERULONEPHRITIS PROLIFERATIVE,NEPHROPATHIES,GLOMERULONEPHRITIS AND NEPHROTIC SYNDROME,10038359,10018376,10018376,10018376
PATIENT WAS TREATED WITH BORTEZOMIB IN POEMS SYNDROME (DRUG USE FOR UNAPPROVED INDICATION WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DYSESTHESIA OF HANDS AND LOWER LEGS,Dysaesthesia,DYSESTHESIA EXTREMITY,DYSAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10062820,10013886,10049919
RIGHT FACIAL DROOP,Facial paralysis,FACIAL DROOP,FACIAL PARALYSIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),FACIAL CRANIAL NERVE DISORDERS,10029205,10016062,10016062,10016044
ELEVATION OF LIVER ENZYMES ALT (3.38),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
TACHYCARDIC,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
HEPATOTOXICITY,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
EPIDURAL ABSCESS/ EPIDURAL ABSCESS AT L3/L4,Extradural abscess,EPIDURAL ABSCESS,EXTRADURAL ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10061846,10061846,10015010
"HEADACHE, ANXIETY, PALPITATIONS, IRRITABILITY AND INSOMNIA",Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
DIFFUSE LIVER LESION,Hepatic lesion,HEPATIC LESION,HEPATIC LESION,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10061998,10061998,10061998
ANTIBODY MEDIATED REJECTION PROLONGED DESPITE THE TREATMENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
GLYCEMIC CONTROL WORSENED TRANSIENTLY AFTER INITIATION OF STEROID THERAPY FOLLOWING CORTICOSTEROID INDUCED INSULIN RESISTANCE,Blood glucose abnormal,BLOOD GLUCOSE ABNORMAL,BLOOD GLUCOSE ABNORMAL,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10005554,10005554,10005554
NEONATAL RENAL FAILURE,Renal failure neonatal,RENAL FAILURE NEONATAL,RENAL FAILURE NEONATAL,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038447,10038447,10038447
TREMORS,Tremor neonatal,TREMOR NEONATAL,TREMOR NEONATAL,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044575,10044575,10044575
ELEVATED TUMOR MARKER LEVELS,elevated tumor marker levels,TUMOUR MARKER INCREASED,TUMOUR MARKER INCREASED,CYTOGENETIC INVESTIGATIONS,CELL MARKER ANALYSES,10022891,10048621,10048621,10048621
WEAK,Weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
HELLP SYNDROME,HELLP syndrome,HELLP SYNDROME,HELLP SYNDROME,MATERNAL COMPLICATIONS OF PREGNANCY,HYPERTENSION ASSOCIATED DISORDERS OF PREGNANCY,10036585,10049058,10049058,10049058
WATERY DIARRHEA OF >1000 ML/DAY/DIARRHEA WORSENED,Diarrhoea,WATERY DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10047849,10012735,10047849
ANOREXIA,Decreased appetite,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10002646
ACUTE LUNG TOXICITY AND ACUTE HYPERSENSITIVITY REACTION FOLLOWING TREATMENT WITH BLEOMYCIN,Hypersensitivity,HYPERSENSITIVITY REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020756,10020751,10020756
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
CIRCULATORY FAILURE,Circulatory collapse,CIRCULATORY FAILURE,CIRCULATORY COLLAPSE,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10009195,10009192,10009195
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
SUICIDE BY PROPRANOLOL INTOXICATION,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
"PP65 ANTIGENEMIA ASSAY FOR CIRCULATING CMV ANTIGEN WAS POSITIVE (53 POSITIVE CELLS PER 50,000 TOTAL CELLS)",Cytomegalovirus test positive,CMV ANTIGEN POSITIVE,CYTOMEGALOVIRUS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10050541,10051620,10050548
"NON-HODGKIN'S LYMPHOMA, DIFFUSE LARGE B-CELL TYPE",non-hodgkin's lymphoma,NON-HODGKIN'S LYMPHOMA,NON-HODGKIN'S LYMPHOMA,LYMPHOMAS NON-HODGKIN'S UNSPECIFIED HISTOLOGY,NON-HODGKIN'S LYMPHOMAS NEC,10029104,10029547,10029547,10029547
MENINGITIS,meningitis,MENINGITIS,MENINGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10027199,10027199,10027199
UNCONSCIOUS,Unconscious partial,UNCONSCIOUS PARTIAL,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10045480,10012373,10045480
HYPOGLYCAEMIA,HYPOGLYCAEMIA,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
PRURITUS,pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
MIXED INTOXICATION OF MORPHINE AND METHADONE,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
EIGHT COURSES OF CHOP CHEMOTHERAPY SHOWED PARTIAL RESPONSE OF THE TUMOR (SUBTHERAPEUTIC RESPONSE),Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
PERSISTENT THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
NIGHTMARES,Nightmare,NIGHTMARES,NIGHTMARE,SLEEP DISORDERS AND DISTURBANCES,PARASOMNIAS,10037175,10029412,10029412,10029414
LOW ADHERENCE,product use issue,PRODUCT USE ISSUE,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076309,10076309,10076309
EROSIVE LIPS,Lip erosion,LIP EROSION,LIP EROSION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10051992,10051992,10051992
SUBFEBRILE,Pyrexia,SUBFEBRILE,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10041021,10037660,10078900
ISOSORBIDE MONONITRATE USED FOR UNCONTROLLED ESSENTIAL HYPERTENSION,Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
TRANSIENT STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
SKIN LESION HAD RECURRED AND WAS ULCERATED AND BLOODY,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
MULTIPLE SKIN LINEAR HYPERPIGMENTATIONS AT THE LEVEL OF THE SUPERIOR ANTERIOR AND POSTERIOR THORACIC REGIONS AND OF THE LOWER BACK,Skin hyperpigmentation,SKIN HYPERPIGMENTATION,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10040865,10040865,10040865
FOURNIER GANGRENE,Necrotising fasciitis,FOURNIER'S GANGRENE,NECROTISING FASCIITIS,INFECTIONS - PATHOGEN UNSPECIFIED,MUSCLE AND SOFT TISSUE INFECTIONS,10021881,10017068,10028885,10017068
DOMPERIDONE IN A DOSE OF 45 MG IS OVERDOSED ACCORDING TO A DEAR-DOCTOR-LETTER (MAXIMUM OF 30 MG).,Medication error,MEDICATION ERROR,MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10027091,10027091,10027091
ENTEROVIRAL MENINGOENCEPHALITIS,Meningoencephalitis viral,MENINGOENCEPHALITIS VIRAL,MENINGOENCEPHALITIS VIRAL,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10074672,10074672,10074672
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
THE PATIENT WAS TREATED WITH METHOTREXATE FOR DEEP VULVOPERINEAL ULCERATION (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
INEFFECTIVE TREATMENT (POOR PAIN MANAGEMENT),Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
DEXTROMETHORPHAN ABUSE,drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
BREAST CALCIPHYLAXIS,calciphylaxis,CALCIPHYLAXIS,CALCIPHYLAXIS,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10051714,10051714,10051714
PREDNISONE TREATMENT FAILURE,treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
MCR-1 AND NDM-9 IN A CLINAL CARBAPENEM RESISTANT E.COLI ISOLATE,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
HEMORRHAGIC SHOCK FOLLOWING HENOCH-SCHONLEIN PURPURA,Shock haemorrhagic,HEMORRHAGIC SHOCK,SHOCK HAEMORRHAGIC,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10049771,10049771,10050841
FALLS,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
DYSESTHESIA,Dysaesthesia,DYSESTHESIA,DYSAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10013886,10013886,10062872
DERANGED LIVER ENZYMES,Hepatic enzyme abnormal,LIVER ENZYME ABNORMAL,HEPATIC ENZYME ABNORMAL,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10062685,10062685,10024677
SLIGHT INCREASE IN GAMMA-GLUTAMYL-TRANSFERASE (C-GT) (MEAN VALUE 110.0 U/L),gamma GT increased,GAMMA GT INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10017670,10017693,10017670
SLIGHT ELEVATION OF SERUM CREATININE LEVELS,serum creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
CRESCENTIC GLOMERULONEPHRITIS DUE TO GOODPASTURE'S DISEASE PROGRESSION,crescentic glomerulonephritis,CRESCENTIC GLOMERULONEPHRITIS,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,NEPHROPATHIES,GLOMERULONEPHRITIS AND NEPHROTIC SYNDROME,10038359,10011379,10018378,10011379
ACUTE LIVER INJURY FOLLOWING DRUG INTERACTION BETWEEN ETORICOXIB AND CURCUMA,acute liver injury,ACUTE LIVER INJURY,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067970,10067125,10067970
URTICARIA,urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
MATERNAL EXPOSURE DURING PREGNANCY/ PATIENT RECEIVED DIGOXIN AND SOTALOL DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
PERITONITIS WHICH WAS IDENTIFIED AS COLONIC IN ORIGIN,Peritonitis,PERITONITIS,PERITONITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10034674,10034674,10034674
SLEEPINESS,Somnolence,SLEEPINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041014,10041349,10041014
HEPARIN-INDUCED THROMBOCYTOPENIA,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
NEONATAL ABSTINENCE SYNDROME,neonatal abstinence syndrome,NEONATAL ABSTINENCE SYNDROME,DRUG WITHDRAWAL SYNDROME NEONATAL,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10074192,10013756,10074192
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
HYPERSOMNOLENT,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
PERIPHERAL OEDEMA,Oedema peripheral,PERIPHERAL OEDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030124,10030124,10034611
CEREBRAL VENOUS THROMBOSIS,Cerebral venous thrombosis,CEREBRAL VENOUS THROMBOSIS,CEREBRAL VENOUS THROMBOSIS,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CEREBROVASCULAR VENOUS AND SINUS THROMBOSIS,10029205,10008138,10008138,10008138
PATIENT DEVELOPED SECONDARY INFECTION FOLLOWING NICOLAU SYNDROME,Infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
CNS DEPRESSION,Depressed level of consciousness,CNS DEPRESSION,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10012383,10012373,10009710
CARBAMAZEPINE-INDUCED BRUGADA-TYPE ELECTROCARDIOGRAPHIC PATTERN,Electrocardiogram abnormal,BRUGADA-TYPE ECG,ELECTROCARDIOGRAM ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10069779,10014363,10069779
SHE DID NOT RESPONDED TO DESMOPRESSIN ACETATE TREATMENT (LACK OF DRUG EFFECT WITH NO ADVERSE EVENT),Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA EBV+,Diffuse large B-cell lymphoma,DIFFUSE LARGE B-CELL LYMPHOMA,DIFFUSE LARGE B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,DIFFUSE LARGE B-CELL LYMPHOMAS,10029104,10012818,10012818,10012818
LOPERAMIDE INDUCED CARDIOTOXICITY FOLLOWING LOPERAMIDE ABUSE AND OVERDOSE,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
STERILE ABSCESS,Abscess sterile,ABSCESS STERILE,ABSCESS STERILE,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10000317,10000317,10000317
INTENTIONAL DRUG MISUSE,Intentional drug misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
CYANOSIS,cyanosis,CYANOSIS,CYANOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10011703,10011703,10011703
GRADE 1 PIGMENTATION,pigmentation,PIGMENTATION,PIGMENTATION DISORDER,PIGMENTATION DISORDERS,PIGMENTATION CHANGES NEC,10040785,10035018,10062080,10035018
STEVENS-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
"FIRST LINE TREATMENT FAILURE WITH RABEPRAZOLE SODIUM, AMOXICILLIN, CLARITHROMYCIN AND METRONIDAZOLE",Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
VITAMIN B12 DEFICIENCY (184 PG/L),Vitamin B12 deficiency,VITAMIN B12 DEFICIENCY,VITAMIN B12 DEFICIENCY,VITAMIN RELATED DISORDERS,WATER SOLUBLE VITAMIN DEFICIENCIES,10027433,10047609,10047609,10047609
"SUDDEN VISION LOSS OCCURED, WITH DISTORTION OF STRAIGHT LINES",Blindness transient,TEMPORARY VISION LOSS,BLINDNESS TRANSIENT,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10053620,10005184,10053620
PLEOCYTOSIS,Pleocytosis,PLEOCYTOSIS,PLEOCYTOSIS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10035551,10035551,10035551
INR INCREASED (3.4),International normalised ratio increased,INR INCREASED,INTERNATIONAL NORMALISED RATIO INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10022402,10022595,10022402
BROADENING QRS COMPLEX,Electrocardiogram QRS complex prolonged,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10014380,10014380,10014380
WORSENING OF DIABETES COMPENSATION,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
CUTANEOUS LESIONS ON THE HANDS APPEARING DURING ONE CURE,cutaneous lesions on the hands appearing during one cure,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
SINUS TACHYCARDIA FOLLOWING OFF LABEL USE OF DRUG,Sinus tachycardia,SINUS TACHYCARDIA,SINUS TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040752,10040752,10040752
ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
UPPER ABDOMINAL PAIN,Abdominal pain upper,ABDOMINAL PAIN UPPER,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000087,10000087,10000087
VENTRICULAR FIBRILLATION,Ventricular fibrillation,VENTRICULAR FIBRILLATION,VENTRICULAR FIBRILLATION,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047290,10047290,10047290
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
IMPULSE CONTROL DISORDERS LIKE GAMBLING ADDICTION OR HYPER SEXUALITY,Impulse-control disorder,IMPULSE-CONTROL DISORDER,IMPULSE-CONTROL DISORDER,IMPULSE CONTROL DISORDERS NEC,IMPULSE CONTROL DISORDERS,10037175,10061215,10061215,10061215
INTESTINAL OBSTRUCTION,Intestinal obstruction,INTESTINAL OBSTRUCTION,INTESTINAL OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION NEC,10017947,10022687,10022687,10022687
CLONUS,clonus,CLONUS,CLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10009346,10009346,10009346
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
BLOOD PRESSURE: 146/106 MMHG,Blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
SEVERE HYPERTRIGLYCERIDEMIA,Hypertriglyceridemia,HYPERTRIGLYCERIDEMIA,HYPERTRIGLYCERIDAEMIA,LIPID METABOLISM DISORDERS,ELEVATED TRIGLYCERIDES,10027433,10020870,10020869,10020870
SKIN ERUPTION,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
XANTHOPSIA,Xanthopsia,XANTHOPSIA,XANTHOPSIA,VISION DISORDERS,VISUAL COLOUR DISTORTIONS,10015919,10048216,10048216,10048216
PNEUMOPATHY/ PULMONARY INVOLVEMENT/ WORSENING OF THE PULMONARY LESIONS,pneumopathy,PNEUMOPATHY,LUNG DISORDER,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10049490,10025082,10049490
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
PREMATURE BABY,Premature baby,PREMATURE BABY,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036590,10036590,10036590
HEAMOGLOBIN FELL,hemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10019483,10018884,10019483
HER LIPS AND TONSILS WERE HYPEREMIC,Tonsillitis,TONSILLITIS,TONSILLITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10044008,10044008,10044008
ORAL SOLUTION TAKEN BY INHALATION,Incorrect route of drug administration,INCORRECT ROUTE OF DRUG ADMINISTRATION,INCORRECT ROUTE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064304,10064304,10064304
CRYPTOCOCCUS NEOFORMANS INFECTION,Cryptococcosis,CRYPTOCOCCUS NEOFORMANS INFECTION,CRYPTOCOCCOSIS,FUNGAL INFECTIOUS DISORDERS,CRYPTOCOCCAL INFECTIONS,10021881,10011493,10011490,10011493
FATAL INTOXICATION / DEXTROMETHORPHAN WAS FOUND IN TOXIC RANGE (ABOVE 0.1 G/ML),Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
HYPOCALCAEMIA,hypocalcaemia,HYPOCALCAEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020947,10020947,10020947
POSITIVE P-ANCA,positive P-ANCA,P-ANCA POSITIVE,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10060173,10060136,10060173
ISCHAEMIC ENTERITIS ASSOCIATE WITH ANAEMIA,Ischaemic enteritis,ISCHAEMIC ENTERITIS,ISCHAEMIC ENTERITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10074063,10074063,10074063
N-TERMINAL OF PRO-BRAIN NATRIURETIC PEPTIDE (NT-PROBNP)7043 PG/ML,N-terminal prohormone brain natriuretic peptide increased,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10071662,10071662,10071662
UPPER RESPIRATORY TRACT INFECTIONS,Upper respiratory tract infection,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10046306,10046306,10046306
OCCUPATIONAL CHLORHEXIDINE-INDUCED SEVERE ANAPHYLAXIS,severe anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
PULMONARY THROMBOEMBOLISM,Pulmonary embolism,PULMONARY THROMBOEMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037436,10037377,10037436
"LIVER BIOPSY REVEALED CENTRIZONAL BILIRUBINOSTASIS, A PORTAL INFILTRATE RICH IN EOSINOPHILS AND CHOLANGITIS",Cholestasis,BILIARY STASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10004673
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,Drug reaction with eosinophilia and systemic symptoms,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10073508,10073508,10073508
GLUCOSURIA,glucosuria,GLUCOSURIA,GLYCOSURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10068405,10018473,10068405
MOOD,mood altered,MOOD ALTERED,MOOD ALTERED,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10027940,10027940,10027940
ILL-APPEARING,illness,ILLNESS,ILL-DEFINED DISORDER,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10080284,10061520,10080284
BLOOD CREATINE INCREASED,Blood creatine increased,BLOOD CREATINE INCREASED,BLOOD CREATINE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005464,10005464,10005464
RAPIDLY GROWING ULCERATED NODULE (3.5X3 CM) WITH LESIONS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
PROTHROMBIN TIME INCREASED (17.6 SEC),Prothrombin time prolonged,PROTHROMBIN TIME INCREASED,PROTHROMBIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037063,10037063,10037061
SYMPTOMS OF AUTONOMIC INSTABILITY,Autonomic nervous system imbalance,AUTONOMIC INSTABILITY,AUTONOMIC NERVOUS SYSTEM IMBALANCE,NEUROMUSCULAR DISORDERS,AUTONOMIC NERVOUS SYSTEM DISORDERS,10029205,10049218,10003840,10049218
JOINT SWELLING,Joint swelling,JOINT SWELLING,JOINT SWELLING,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023232,10023232,10023232
ELEVATED ALANINE AMINOTRANSFERASE (581 U/L),Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
MYALGIA,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
INFECTED FIBROEPITHELIAL STROMAL POLYP OF THE VULVA,Fibroepithelial polyp,FIBROEPITHELIAL POLYP,ACROCHORDON,CUTANEOUS NEOPLASMS BENIGN,SKIN NEOPLASMS BENIGN,10029104,10077924,10000591,10077924
HIGH-GRADE FEVER,Hyperpyrexia,HYPERPYREXIA,HYPERPYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10020741,10020741,10020741
PANCREATITIS,Pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
LOCAL HAEMATOMA,Haematoma,HAEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10018852
CUSHING SYNDROME SECONDARY TO ADVERSE INTERACTION BETWEEN RINTONAVIR AND INTRA-ARTICULAR TRIAMCINOLONE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
SEVERE ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
"SHE CONTINUED TO HAVE ""UNRESPONSIVE"" OR ""TRANCE-LIKE"" EPISODES EVERY OTHER DAY",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
QUICK REVERSAL OF SKIN LESIONS (IN THE FORM OF SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS),Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
CAMPYLOBACTER GASTROENTERITIS,Campylobacter gastroenteritis,CAMPYLOBACTER GASTROENTERITIS,CAMPYLOBACTER GASTROENTERITIS,BACTERIAL INFECTIOUS DISORDERS,CAMPYLOBACTER INFECTIONS,10021881,10007048,10007048,10007048
SENSORY DISTURBANCES IN THE HANDS,sensory disturbances in the hands,SENSORY DISTURBANCE,SENSORY DISTURBANCE,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10040026,10040026,10040026
PERSISTENT DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
ST-SEGMENT ELEVATION,ST-segment elevation,ST SEGMENT ELEVATION,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041894,10014392,10041894
PRESUMPTIVE DIAGNOSIS OF SEPTICAEMIA,Sepsis,SEPTICAEMIA NOS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040050,10040047,10040082
SEPTIC SHOCK FOLLOWING LEUCONEUTROPENIA,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
DISEASE RECURRENCE,disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
SEVERE COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
EUTOCIC VAGINAL DELIVERY (2570 G MALE),Delivery,NORMAL DELIVERY,DELIVERY,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS","NORMAL PREGNANCY, LABOUR AND DELIVERY",10036585,10029759,10067647,10029759
APPETITE LOSS,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
WHOLE-BODY SKIN RASH,Rash generalised,GENERALISED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037858,10037858,10018095
LATE ONSET HEPATIC VENO-OCCLUSIVE DISEASE,Venoocclusive liver disease,VENOOCCLUSIVE LIVER DISEASE,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10047216,10047216,10047216
RIGHT ANKLE CLONUS,Clonus,CLONUS,CLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10009346,10009346,10009346
TACHYPNOEA,Tachypnoea,TACHYPNOEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043089
TRANSAMINASES INCREASED,Transaminases increased,TRANSAMINASES INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054889,10054889,10054889
"DESPITE LINEZOLID (INTRAVENOUS) AND AMIKACIN (INHALED) THERAPY, PULMONARY FUNCTION AND BODY MASS DECLINED",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
METHYLPREDNISOLONE INDUCED ECCHYMOSIS (PERSISTENT BROWN BLOTCHES ON EXTERIOR SURFACES OF BOTH HANDS),Ecchymosis,ECCHYMOSIS,ECCHYMOSIS,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10014080,10014080,10014080
RISPERIDONE INDUCED HYPERPROLATINEMIA,Hyperprolactinaemia,HYPERPROLACTINEMIA,HYPERPROLACTINAEMIA,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPERFUNCTION,10014698,10020737,10020737,10020739
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
PERIPHERAL EDEMA,Oedema peripheral,PERIPHERAL EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030124,10030124,10034570
INTRAVENOUS CYCLOPHOSPHAMIDE WAS INEFFECTIVE FOR HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
ARRHYTHMIA,Arrhythmia,ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10003119
ACCIDENTAL DRUG OVERDOSE,Accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
INGESTING FOOD WAS HARDLY POSSIBLE ANYMORE AND SHE SUFFERED FROMPAIN WHEN SWALLOWING,dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
MULTIPLE SPONTANEOUS HEMORRHAGIC MANIFESTATIONS SUCH AS BLEEDING GUMS AND SPONTANEOUS HEMATOMA IN THE RIGHT THIGH,hemorrhage,HEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10019524,10055798,10019524
"RELAPSE OF HEPATITIS C VIRUS INFECTION DUE TO NO RESPONSE TO RIBAVIRIN, DACLATASVIR AND SIMEPREVIR AND PEG-IFN",Chronic hepatitis C,CHRONIC HEPATITIS C GENOTYPE 1B,CHRONIC HEPATITIS C,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10076788,10008912,10076788
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
GROANING,Irritability,IRRITABLE,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10023000,10022998,10023000
HEPARIN INDUCED THROMBOCYTOPENIA,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
INCREASED WEIGHT,Weight increased,WEIGHT INCREASED,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047899
DIFFICULTY BREATHING,Dyspnoea,DIFFICULTY BREATHING,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10012791
EDEMA AND ERYTHEMA OF THE LARGE LIPS,Edema lip,EDEMA LIP,LIP OEDEMA,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10014231,10024558,10014231
ACUTE CORONARY SYNDROME,Acute coronary syndrome,ACUTE CORONARY SYNDROME,ACUTE CORONARY SYNDROME,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10051592,10051592,10051592
TACROLIMUS LEVEL INCREASED,drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
INTRODUCTION OF BETAMETHASONE IN THE 27TH WEEK OF PREGNANCY,Foetal exposure during pregnancy,"FOETAL EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071426,10071404,10071426
KNEE EDEMA,Edema knees,EDEMA KNEES,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10050067,10030124,10050067
PRURITIC ULCERATED LESION ON MEDIAL THIGH,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
RESTING TREMOR ON RIGHT HAND,resting tremor ,RESTING TREMOR,RESTING TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10071390,10071390,10071390
METHOTREXATE AND IMATINIB FOR SLERODERMATOUS CGVHD (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
EPIGASTRIC TENDERNESS,Tenderness epigastric,TENDERNESS EPIGASTRIC,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10043227,10000097,10043227
POLYNEUROPATHY (GARDE 3),Polyneuropathy,POLYNEUROPATHY NOS,POLYNEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10036118,10036105,10036118
ESCITALOPRAM DOSE-DEPENDENT HYPONATREMIA,Hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
SENSATION OF THROAT CLOSURE,throat constriction,THROAT CONSTRICTION,THROAT TIGHTNESS,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10043517,10043528,10043517
ACUTE URTICARIA,Urticaria,ACUTE URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046737,10046735,10001106
MEDICATION PRECIPITATED VISUAL HALLUCINATIONS (OF NUMBERS ON THE WALL),Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DRUG EXPOSURE DURING PREGNANCY,maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
AST INCREASED (477 IU/DL),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
GENERALIZED ERYTHRODERMA,generalized erythroderma,ERYTHRODERMA,DERMATITIS EXFOLIATIVE GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10015277,10012456,10015277
HYPOXIA,Hypoxia,HYPOXIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021143,10021143,10021143
ITCHY MACULOPAPULAR RASH,Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
GRADE 3 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
"ACUTE RENAL FAILURE, ANURIC",Acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
PROPRANOLOL USED IN A 68-YEAR-OLD PATIENT FOR HEPATIC CIRRHOSIS (DRUG USE FOR UNAPPROVED INDICATION AND DRUG USE IN UNAPPROVED AGE GROUP),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DIRECT BILIRUBIN INCREASED (3.84 MG/DL),Bilirubin conjugated increased,DIRECT BILIRUBIN INCREASED,BILIRUBIN CONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10013038,10004685,10013038
BLOOD HEMOGLOBIN WAS 11.8 G/DL,Haemoglobin decreased,HEMOGLOBIN LOW,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018889,10018884,10055600
LIVER BIOPSY PERFORMED REVEALING MILD DIFFUSE HEPATIC STEATOSIS,hepatic steatosis,HEPATIC STEATOSIS,HEPATIC STEATOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019708,10019708,10019708
HYPERPROLACTINAEMIA,hyperprolactinaemia,HYPERPROLACTINAEMIA,HYPERPROLACTINAEMIA,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPERFUNCTION,10014698,10020737,10020737,10020737
"DIFFUSE SYMMETRICAL WHITE MATTER LESIONS INVOLVING THE CEREBRAL HEMISPHERES, BRAINSTEM AND CEREBELLAR PEDUNCLES",White matter lesion,WHITE MATTER LESION,WHITE MATTER LESION,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10072731,10072731,10072731
HALLUCINATIONS,Hallucination,HALLUCINATIONS,HALLUCINATION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019063,10019063,10019077
"MINOR HAEMORRHAGE, HAEMATOMA AND ECCHYMOSIS ON THE LEFT ABDOMINAL WALL",Abdominal wall haematoma,ABDOMINAL WALL HAEMATOMA,ABDOMINAL WALL HAEMATOMA,ABDOMINAL HERNIAS AND OTHER ABDOMINAL WALL CONDITIONS,ABDOMINAL WALL CONDITIONS NEC,10017947,10067383,10067383,10067383
RAPID WORSENING OF ANEMIA/ NON-REGENERATIVE ANEMIA/ ANEMIA WORSENED WITH HEMOGLOBIN OF 4.8 G/DL,Anaemia,ANEMIA AGGRAVATED,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002036,10002034,10054309
PSEUDO-IBD,Inflammatory bowel disease,IBD,INFLAMMATORY BOWEL DISEASE,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10021972,10021972,10021184
GENERAL PHYSICAL HEALTH DETERIORATION,General physical health deterioration,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10049438,10049438,10049438
IGA VASCULITIS,Vasculitis,VASCULITIS,VASCULITIS,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10047115,10047115,10047115
THE PATIENT WAS ADMINISTERED 2 MG INTRAVENOUS (IV) LORAZEPAM WITHOUT IMPROVEMENT IN SYMPTOMS,drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
BRAIN OEDEMA,Brain oedema,BRAIN OEDEMA,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10048962,10048962,10048962
EXACERBATION OF DISEASE,Condition aggravated,DISEASE AGGRAVATION,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10013097,10010264,10013097
DAYTIME SLEEPINESS/DROWSY DURING THE DAY,Somnolence,DAYTIME SLEEPINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10011865,10041349,10011865
"10 YEAR OLD PATIENT WAS TREATED WITH IMATINIB FOR PDGFRB P N666H MUTATION AND ASSOCIATED HAND AND FOOT CONTRACTURES, FACIAL COARSENESS (OFF LABEL USE FOR UNAPPROVED POPULATION)",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RIGHT HEART FAILURE,Right ventricular failure,RIGHT HEART FAILURE,RIGHT VENTRICULAR FAILURE,HEART FAILURES,RIGHT VENTRICULAR FAILURES,10007541,10039152,10039163,10039152
BRONCHIAL BREATHING AND CRACKLES WERE HEARD AT THE LEFT LOWER ZONE,Breath sounds abnormal,BREATH SOUNDS ABNORMAL,BREATH SOUNDS ABNORMAL,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10064780,10064780,10064780
CEFTAZIDIME INDUCED MULTIFOCAL FIXED DRUG ERUPTION,Fixed eruption,FIXED DRUG ERUPTION,FIXED ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10016740,10016741,10016740
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
MUCOUS MEMBRANE DISORDER SUCH AS STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
BILATERAL PEDAL EDEMA,pedal edema,PEDAL EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10034206,10030124,10034206
FEVER (HIGH-GRADE TEMPERATURE OF 39Â°C),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
"LOW PLATELET COUNT AND THROMBOSIS IN THE FONTAN CANAL, HIT WAS HIGHLY SUSPECTED/ MASSIVE THROMBOSIS/DISSEMINATED THROMBI",Thrombosis,THROMBOSIS,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10043607,10043607,10043607
RENAL FAILURE FOLLOWOING RHABDOMYOLYSIS DUE TO STATIN- ERYTHROMYCIN INTERACTION,renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
TINGLING IN FINGERS AND TOES,tingling feet/hands,TINGLING FEET/HANDS,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10043877,10033775,10043877
AGGRESSIVE,Aggression,AGGRESSIVE BEHAVIOR,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001490,10001488,10062375
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
SPIROMETRY ABNORMAL,Spirometry abnormal,SPIROMETRY ABNORMAL,SPIROMETRY ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY AND PULMONARY FUNCTION DIAGNOSTIC PROCEDURES,10022891,10041630,10041630,10041630
CALCINEURIN INHIBITOR (CNI) NEPHROTOXITY,Nephropathy toxic,NEPHROTOXICITY,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10067571
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
DIFFICULTY SWALLOWING,Dysphagia,SWALLOWING DIFFICULT,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10042645,10013950,10042645
HEIGHT OF THE PATIENT DROPPED BY 4 CM,Body height decreased,BODY HEIGHT DECREASED,BODY HEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10056812,10056812,10056812
WIDESPREAD MACULOPAPULAR RASH,Rash maculo-papular,GENERALIZED MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10077181,10037868,10077163
MUSCLE CONTRACTURE,Muscle contracture,MUSCLE CONTRACTURE,MUSCLE CONTRACTURE,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10062575,10062575,10062575
OFF-LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
"HISTOPATHOLOGIC EXAMINATION SHOWING LYMPHOCYTIC INFILTRATE INCLUDING CD8+ T CELLS AT THE DERMO-EPIDERMAL INTERFACE, EXTENDING INTO THE MID-EPIDERMIS AND UPPER EPIDERMIS WITH NECROSIS OF KERATINOCYTES",Lymphocytic infiltration,LYMPHOCYTIC INFILTRATION,LYMPHOCYTIC INFILTRATION,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10062049,10062049,10062049
LOW GRADE FEVERS,low grade fevers,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
EXTENSIVE EROSIONS WITH NECROTIC CHANGES DUE TO BACTERIA AND CANDIDA ALBICANS INFECTION FOLLOWING UNINTENTIONAL OVERDOSE OF METHOTREXATE DUE TO WRONG DOSE ADMINISTRATION,infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
COMA DUE TO CIRCULATORY ARREST FOLLOWING DRUG POISONING AND DRUG INTERACTION BETWEEN QUININE (SALT NOT SPECIFIED) AND LOPERAMIDE,coma due to circulatory arrest,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
LOW HAEMOGLOBIN,Haemoglobin decreased,HAEMOGLOBIN LOW,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018889,10018884,10018889
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
PERIPHERAL EDEMA,Oedema peripheral,PERIPHERAL EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030124,10030124,10034570
LINEZOLID-INDUCED MYELOSUPPRESSION FOLLOWING DRUG TOXICITY DUE TO PROLONGED TREATMENT DURATION,Bone marrow failure,MYELOSUPPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10028584
RELAPSE,Chronic myeloid leukaemia recurrent,CHRONIC MYELOID LEUKAEMIA RECURRENT,CHRONIC MYELOID LEUKAEMIA RECURRENT,LEUKAEMIAS,LEUKAEMIAS CHRONIC MYELOID,10029104,10075081,10075081,10075081
"ON PATHOLOGY OF THE UPPER LIMBS, OCCLUSIVE THROMBI WERE IDENTIFIED IN THE VEINS AND ARTERIES.",Venous thrombosis limb,VENOUS THROMBOSIS LIMB,VENOUS THROMBOSIS LIMB,EMBOLISM AND THROMBOSIS,PERIPHERAL EMBOLISM AND THROMBOSIS,10047065,10061408,10061408,10061408
MULTIPLE TENDER SWELLINGS IN BOTH FOREARMS,multiple tender swellings in both forearms,SWELLING OF LIMBS,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042702,10048959,10042702
BILATERAL EAR CANAL ATRESIA (MICROTIA) WITH NORMAL SENSORINEURAL CONDUCTION,microtia,MICROTIA,MICROTIA,EAR AND LABYRINTHINE DISORDERS CONGENITAL,EXTERNAL EAR DISORDERS CONGENITAL,10010331,10027555,10027555,10027555
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
DEHYDRATION,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
GRADE II CYTOMEGALOVIRUS INFECTION FOLLOWING IMMUNOSUPPRESSIVE TREATMENT,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011831,10011831,10011831
REDUCTION OF IMMUNOSUPPRESSION CAUSED RECURRENCE OF RAYNAUD'S PHENOMENON AND INTESTINAL PSEUDO-OBSTRUCTION,Raynaud's phenomenon,RAYNAUD'S PHENOMENON,RAYNAUD'S PHENOMENON,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10037912,10037912,10037912
MUSCLE STIFFNESS,Muscle stiffness,MUSCLE STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10028339,10052904,10028339
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
MYOCARDITIS/ CLINICALLY SUSPECTED MYOCARDITIS,Myocarditis,MYOCARDITIS,MYOCARDITIS,MYOCARDIAL DISORDERS,NONINFECTIOUS MYOCARDITIS,10007541,10028606,10028606,10028606
INTOLERANCE,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
CHEMOTHERAPY-INDUCED INTERSTITIAL LUNG DISEASE,interstitial lung disease,INTERSTITIAL LUNG DISEASE,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022611,10022611,10022611
FOCAL STATUS EPILEPTICUS,Status epilepticus,STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10041962,10041962,10041962
INADEQUATE RESPIRATORY EFFORTS,respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
LIMB NUMBNESS,Hypoaesthesia,NUMBNESS OF LIMBS,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10029847,10020937,10029847
PERSISTENT CGV WITH SUPERIMPOSED STAPHYLOCOCCUS AUREUS INFECTION,staphylococcus aureus infection,STAPHYLOCOCCUS AUREUS INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10075981,10058080,10075981
PSYCHOMOTOR RETARDATION,psychomotor retardation,PSYCHOMOTOR RETARDATION,PSYCHOMOTOR RETARDATION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10037213,10037213,10037213
OCCUPATIONAL CONTACT DERMATITIS CAUSED BY HYDROXYCHLOROQUINE SULFATE,Occupational exposure to product,OCCUPATIONAL EXPOSURE TO DRUG,OCCUPATIONAL EXPOSURE TO PRODUCT,"EXPOSURES, CHEMICAL INJURIES AND POISONING",OCCUPATIONAL EXPOSURES,10022117,10068469,10073311,10068469
LOSS OF VISUAL ACUITY IN THE RIGHT EYE,Visual acuity lost,VISUAL ACUITY LOST,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047530,10047531,10047530
DIFFUSE CORTICAL ATROPHY,Cerebral atrophy,CEREBRAL ATROPHY,CEREBRAL ATROPHY,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10008096,10008096,10008096
DISEASE PROGRESSION,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
EPIGASTRIC PAIN,Abdominal pain upper,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
OXALIPLATIN-INDUCED IDIOPATHIC THROMBOCYTOPENIC PURPURA,Immune thrombocytopenic purpura,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IMMUNE THROMBOCYTOPENIC PURPURA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10021245,10074667,10021245
HEMOPHAGOCYTIC SYNDROME WORSENED DRASTICALLY DESPITE ADMINISTRATION OF METHYLPREDNISOLONE AND IMMUNOGLOBULIN,Hemophagocytic syndrome,HEMOPHAGOCYTIC SYNDROME,HISTIOCYTOSIS HAEMATOPHAGIC,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10058139,10048595,10058139
NON-SPECIFIC DERMATITIS ASSOCIATING LYMPHOCYTIC INFLAMMATORY ELEMENTS WITH SOME PLASMA CELLS,Dermatitis,DERMATITIS,DERMATITIS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10012431,10012431,10012431
SEVERAL EPISODS OF JERKY MOVEMENTS,Dyskinesia,JERKY MOVEMENT NOS,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10023189,10013916,10023189
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
"HAD CONSTANT PAIN FROM THE THORACIC LEVEL WHICH RADIATED TO THE CERVICAL AND LUMBAR AREAS, THAT DID NOT IMPROVE WITH THE ANALGESIA",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
POOR CONCENTRATION,Disturbance in attention,POOR CONCENTRATION,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10027346,10013496,10036149
RECURRENT BACTERIAL INFECTIONS,Bacterial infection,BACTERIAL INFECTION,BACTERIAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10060945,10060945,10060945
DRUG OVERDOSE,drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
MYALGIA,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
LACK OF EFFICACY,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PATIENT'S GENERAL CLINICAL CONDITIONS GRADUALLY DETERIORATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
INVOLUNTARY AND SUSTAINED MOVEMENT,dyskinesia,INVOLUNTARY MOVEMENT (NOS),DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10022895,10013916,10022895
DIASTOLIC PRESSURE INCREASED (VALUE-140 MM/HG),Blood pressure diastolic increased,DIASTOLIC BLOOD PRESSURE INCREASED,BLOOD PRESSURE DIASTOLIC INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005739,10005739,10012753
LYMPHOEDEMA FOLLOWING OFF LABEL USE OF IMIQUIMOD,Lymphoedema,LYMPHOEDEMA,LYMPHOEDEMA,LYMPHATIC VESSEL DISORDERS,LYMPHOEDEMAS,10047065,10025282,10025282,10025282
CRYSTAL NEPHROPATHY SECONDARY TO CIPROFLOXACIN,crystal nephropathy,CRYSTAL NEPHROPATHY,CRYSTAL NEPHROPATHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10071503,10071503,10071503
NIKOLSKY'S SIGN POSITIVE,Nikolsky's sign,NIKOLSKY'S SIGN,NIKOLSKY'S SIGN,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10029415,10029415,10029415
INTERACTIONS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
CARDIAC ARREST DUE TO PHEOCHROMOCYTOMA CRISIS PRECIPITATED BY HYDROCORTISONE AND EPINEPHRINE,cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
THREE EPISODES OF POSTOPERATIVE EMESIS,Procedural vomiting,POSTOPERATIVE VOMITING,PROCEDURAL VOMITING,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,GASTROINTESTINAL AND HEPATOBILIARY PROCEDURAL COMPLICATIONS,10022117,10047707,10066963,10036238
SERPENTINE SUPRAVENOUS HYPERPIGMENTATION IN HIS RIGHT ARM AND LEFT ARM,Infusion site discolouration,INFUSION SITE HYPERPIGMENTATION,INFUSION SITE DISCOLOURATION,ADMINISTRATION SITE REACTIONS,INFUSION SITE REACTIONS,10018065,10065480,10065460,10065480
DYSPNEA,Dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
INTERACTION BETWEEN MEALS AND LD/CD ABSORPTION.,Labelled drug-food interaction medication error,LABELED DRUG-FOOD INTERACTION MEDICATION ERROR,LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT MONITORING ERRORS AND ISSUES,10022117,10064374,10064374,10064379
FINE CRACKLES,Rales,CRACKLES LUNG,RALES,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10054910,10037833,10054910
CUTANEOUS DRUG ERUPTION CAUSED BY AMOXICILLIN,Drug eruption,DRUG ERUPTION,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10013687,10013687,10013687
LOSS OF APPETITE,Appetite absent,APPETITE ABSENT,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003017,10061428,10003017
POSTURING,Posturing,POSTURING,POSTURING,CHANGES IN PHYSICAL ACTIVITY,STEREOTYPIES AND AUTOMATISMS,10037175,10036437,10036437,10036437
INADVERTENTLY RECEIVED 40 ML OF 2% LIDOCAINE,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
PROGRESSIVE BILATERAL VISION LOSS,Blindness,VISION LOSS,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047522,10005169,10047522
LEFT EXTERNAL ILIAC LYMPH NODE,Lymphadenopathy,LYMPH NODE DISORDER,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10049158,10025197,10049158
SKIN FRAGILITY,Skin fragility,SKIN FRAGILITY,SKIN FRAGILITY,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040851,10040851,10040851
MUSCULAR WEAKNESS,Muscular weakness,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028372,10028372,10028372
"THE PATIENT WAS TREATED WITH TOPICAL  KETOCONAZOLE, SUBCONJUCTIVAL FLUCONAZOLE INJECTION AND ORAL ITRACONAZOLE WITH PARTIAL RESPONSE TO THE TREATMENT (OCULAR BASIDIOBOLOMYCOSIS)",fungal eye infection,FUNGAL EYE INFECTION,EYE INFECTION FUNGAL,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017530,10015933,10017530
HETEROGENEOUS MASS IN THE POUCH OF DOUGLAS/ CONCERN FOR A PELVIC ABSCESS/ BACTERIAL TRANSLOCATION,Bacterial translocation,BACTERIAL TRANSLOCATION,BACTERIAL TRANSLOCATION,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10070545,10070545,10070545
WATERY DIARRHOEA,Diarrhoea,WATERY DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10047849,10012735,10047849
PROCALCITONIN LEVEL OF 23.94 NG/ML,Procalcitonin increased,PROCALCITONIN INCREASED,PROCALCITONIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10067081,10067081,10067081
MYCOPHENOLATE MOFETIL USEDFOR MULTIPHASIC DISSEMINATED ENCEPHALOMYELITIS(OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MORPHOEA,Morphoea,MORPHOEA,MORPHOEA,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),CONNECTIVE TISSUE DISORDERS NEC,10028395,10027982,10027982,10027982
ORTHOPNEA,Orthopnoea,ORTHOPNEA,ORTHOPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10031123,10031123,10031122
PRECURSOR B-LYMPHOBLASTIC LEUKEMIA ACUTE,B precursor type acute leukaemia,PRECURSOR B-LYMPHOBLASTIC LEUKEMIA ACUTE,B PRECURSOR TYPE ACUTE LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE LYMPHOCYTIC,10029104,10066104,10003890,10066109
IMATINIB RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
EEG REVEALED STATUS EPILEPTICUS,Status epilepticus,STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10041962,10041962,10041962
MYCOBACTERIUM WAS CULTURED FROM THE INITIAL PLEURAL FLUID SAMPLE. THIS WAS SUBSEQUENTLY IDENTIFIED AS MYCOBACTERIUM BOVIS BCG STRAIN,Disseminated Bacillus Calmette-Guerin infection,DISSEMINATED BCG,DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10069636,10076666,10069636
CHILLS,chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
BLURRED VISION,Vision blurred,BLURRED VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047513,10047513,10005886
"THEREFORE, THE DIAGNOSIS OF XE ASSOCIATED WITH SECONDARY CAUSES OF DYSLIPOPROTEINEMIAS",eruptive xanthoma,ERUPTIVE XANTHOMA,XANTHOMA,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10015144,10048214,10015144
FEVER/ LOW-GRADE FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
TACHYCARDIAC ATRIAL FIBRILLATION,Atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
NO ADVERSE DRUG REACTION,No adverse event,NO ADVERSE DRUG REACTION,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067481,10067482,10067481
THERE HAD BEEN NO IMPROVEMENT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PAPULES,Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
INFLAMMATORY BOWEL DISEASE,Inflammatory bowel disease,INFLAMMATORY BOWEL DISEASE,INFLAMMATORY BOWEL DISEASE,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10021972,10021972,10021972
PATIENT EXPERIENCED EXTREMITY TREMORS WHILE BEING TREATED WITH LITHIUM CARBONATE FOR BIPOLAR DISORDER,Tremor,TREMOR LIMB,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044572,10044565,10044572
PALE,pale,PALE,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033532,10033546,10033532
USE OF BENDAMUSTINE HYDROCHLORIDE FOR ACQUIRED VON WILLEBRAND DISEASE (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PATIENT FAILED LONG TERM IMMUNOTHERAPY WITH HYDROXYCHLORIQUINE AND AZATHIOPRINE DUE TO EFFECT SIDE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
DRUG INTOLERANCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
DARK URINE,Chromaturia,URINE COLOUR ABNORMAL,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10064748,10008796,10064748
SECONDARY MALIGNANCY (OVARIAN),Second primary malignancy,SECOND PRIMARY MALIGNANCY,SECOND PRIMARY MALIGNANCY,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10039801,10039801,10039801
PERSISTENT ACTIVE DISEASE (1 UD),Hematological malignancy,HEMATOLOGICAL MALIGNANCY,HAEMATOLOGICAL MALIGNANCY,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),HAEMATOLOGIC NEOPLASMS NEC,10029104,10066481,10066476,10066481
"STARTED TO EXTEND TO THE TRUNK AND LIMBS, INTENSIFY ON THE FACE AND EVOLVE TOWARDS GIANT VESICLES ON THE CHEEKS",Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DAILY URINE OUTPUT DECREASED (800 TO 200 ML),Urine output decreased,URINE OUTPUT DECREASED,URINE OUTPUT DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059895,10059895,10059895
APICAL THROMBUS,Intracardiac thrombus,INTRACARDIAC THROMBUS,INTRACARDIAC THROMBUS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048620,10048620,10048620
BORDERLINE PERSONALITY DISORDER,Borderline personality disorder,BORDERLINE PERSONALITY DISORDER,BORDERLINE PERSONALITY DISORDER,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,PERSONALITY DISORDERS WITH DRAMATIC BEHAVIOUR (CLUSTER B),10037175,10006034,10006034,10006034
CARDIORESPIRATORY ARREST,cardiorespiratory arrest,ARREST CARDIAC,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10003109,10007515,10003109
MULTIPLE DRUG POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
RESIDUAL DYSARTHRIA,Dysarthria,DYSARTHRIA,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10013887,10013887,10013887
BLIND SPOT ENLARGEMENT IN BOTH EYES,blind spot enlarged,BLIND SPOT ENLARGED,VISUAL FIELD DEFECT,NEUROLOGICAL DISORDERS OF THE EYE,NEUROLOGIC VISUAL PROBLEMS NEC,10029205,10005168,10047555,10005168
UNBALANCED HYPERTENSION,labile hypertension,LABILE HYPERTENSION,LABILE HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10049079,10049079,10049079
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
PATIENT'S RAYNAUD PHENOMENON DID NOT IMPROVE WITH INITIAL THERAPY (LACK OF DRUG EFFECT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PALMAR-PLANTAR ERYTHRODYSESTHESIA SYNDROME (GRADE 3),Palmar-plantar erythrodysaesthesia syndrome,PALMAR-PLANTAR ERYTHRODYSESTHESIA SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10033553,10033553,10054524
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
THINKING TANGENTIALITY AND VISCOSITY,Thinking abnormal,THINKING ABNORMAL,THINKING ABNORMAL,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10043431,10043431,10043431
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
MUCOCUTANEOUS ULCERATION WITH EXPRESSION OF CD30 AND CD45,oral ulceration,ORAL ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10031027,10028034,10031027
DEHYDRATION,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
SIGHT DETERIORATION,Visual impairment,VISION ABNORMAL,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10000186,10047571,10047508
PNEUMONIA DUE TO PERSISTENT SEVERE BONE MARROW APLASIA,pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
"RISPERIDONE UP TO 9 MG, OLANZAPINE UP TO 30 MG AND PALIPERIDONE UP TO 15 MG WITH LITTLE IMPROVEMENT.",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
REPEATED SHIVERING,Chills,SHIVERING,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10040558,10008531,10040558
NEUROLEPTIC MALIGNANT SYNDROME,Neuroleptic malignant syndrome,NEUROLEPTIC MALIGNANT SYNDROME,NEUROLEPTIC MALIGNANT SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10029282,10029282,10029282
PLEURAL AND PERICARDIAL EFFUSIONS,Pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
CYTOLYSIS,Cytolysis,CYTOLYSIS,CELL DEATH,METABOLISM DISORDERS NEC,CELL METABOLISM DISORDERS NEC,10027433,10066456,10057248,10066456
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
DETERIORATION IN THE LEVEL OF CONSCIOUSNESS,Consciousness decreased,CONSCIOUSNESS DECREASED,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010768,10012373,10010768
PATIENT PRESENTED WITH HISTORY OF LETHARGY DROWSINESS AND MENTAL CONFUSION,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
THE PATIENT EXPERIENCED SUICIDAL IDEATION AND TOOK 100 TABLETS OF A COMMERCIAL CAFFEINE PREPARATION (ESTARON MOCHA) ORALLY,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
PRURITUS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
SUSPECT CHRONIC GVHD OF LIVER,Suspect chronic GVHD of liver,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10072160,10072160,10072160
PNEUMOTHORAX,pneumothorax,PNEUMOTHORAX,PNEUMOTHORAX,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035759,10035759,10035759
VEILLONELLA PARVULA INFECTION,Veillonella infection,VEILLONELLA INFECTION,VEILLONELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10054140,10054140,10054140
UNCLEAR ENUNCIATION,Dysarthria,SLURRED SPEECH,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041053,10013887,10041053
ABSCESSES,Abscess intestinal,ABSCESS INTESTINAL,ABSCESS INTESTINAL,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10000285,10000285,10000285
IMATINIB RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
"TOPIRAMATE-INDUCED CHEST PAIN / INTERMITTENT PAIN IN THE CENTER OF HER CHEST, THAT WOULD COME AND GO, AS WELL AS A CONSTANT BURNING PAIN",Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
BENEFICIAL EFFECTS OF A BETA-BLOCKING AGENT (CARVEDILOL) ON BILATERAL ATHEROSCLEROTIC RENAL-ARTERY STENOSIS,Therapeutic response unexpected,UNEXPECTED BENEFICIAL THERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE UNEXPECTED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10076884,10043417,10076885
INTRA-UTERINE SAC WITHOUT EMBRYO WITH SPONTANEOUS MISCARRIAGE,Anembryonic gestation,BLIGHTED OVUM,ANEMBRYONIC GESTATION,ABORTIONS AND STILLBIRTH,ABORTION RELATED CONDITIONS AND COMPLICATIONS,10036585,10005160,10079814,10005160
METFORMIN TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
RESPIRATORY ARREST,Respiratory arrest,RESPIRATORY ARREST,RESPIRATORY ARREST,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038669,10038669,10038669
MORAXELLA CATARRHALIS INFECTION,Moraxella catarrhalis infection,MORAXELLA CATARRHALIS INFECTION,MORAXELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,MORAXELLA INFECTIONS,10021881,10054145,10062204,10054145
RUBOR,rubor,REDNESS GUM,GINGIVAL ERYTHEMA,DENTAL AND GINGIVAL CONDITIONS,GINGIVAL DISORDERS NEC,10017947,10049376,10067419,10049376
ABSENT GAG REFLEX,Areflexia,LOSS OF GAG REFLEX,AREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10058606,10003084,10058606
ANEMIA,anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
IMMEDIATE ALLERGIC REACTION TO AMOXICILLIN/CLAVULANIC ACID,Immediate hypersensitivity reaction,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
ECCHYMOSES,ecchymoses,ECCHYMOSES,ECCHYMOSIS,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10014079,10014080,10014079
MUSCLE ABSCESS,Muscle abscess,MUSCLE ABSCESS,MUSCLE ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,MUSCLE AND SOFT TISSUE INFECTIONS,10021881,10049206,10049206,10049206
INFECTION LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
DYSTONIA PRIMARILY AROUND THE NECK AND MOUTH AND ALSO IN THE LIMBS,Dystonia,DYSTONIA,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10013983,10013983,10013983
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
SIGNIFICANT INTRAVENTRICULAR HEMORRHAGE / SIGNIFICANT INTRAVENTRICULAR HEMORRHAGE DUE TO PLATELET DYSFUNCTION,Intraventricular haemorrhage,INTRAVENTRICULAR HEMORRHAGE,INTRAVENTRICULAR HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10022840,10022840,10055299
DYSGEUSIA,Dysgeusia,DYSGEUSIA,DYSGEUSIA,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10013911,10013911,10013911
BONE EXPOSURE IN JAW AFTER 6 MONTHS,Exposed bone in jaw,EXPOSED BONE IN JAW,EXPOSED BONE IN JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10071014,10071014,10071014
RENAL IMPAIRMENT,Renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
PATIENT WAS EXPOSED TO EPINEPHRINE VIA MOTHER,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
MYOCARDIAL INFARCTION,Myocardial infarction,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10028596,10028596,10028596
GLUCOCORTICOID-INDUCED OSTEOPOROSIS,Osteoporosis,OSTEOPOROSIS STEROID-INDUCED,OSTEOPOROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10031287,10031282,10031287
ELEVATED ALANINE AMINOTRANSFERASE (GPT): 110 U/L,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
PROCALCITONIN ELEVATED  (2.14 ÎœG/ L),Procalcitonin increased,PROCALCITONIN INCREASED,PROCALCITONIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10067081,10067081,10067081
SLUGGISHNESS,Sluggishness,SLUGGISHNESS,SLUGGISHNESS,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10041052,10041052,10041052
32 YRS OLD FEMALE WITH BEHCET'S DISEASE RECEIVED ASPIRIN DURING PREGNANCY,Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
HE DID NOT RESPOND TO STANDARD INDUCTION THERAPY,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ASPHYXIA/ ASPHYXIA SECONDARY TO SPONTANEOUS EPIGLOTTIC HEMATOMA,Asphyxia,ASPHYXIA,ASPHYXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10003497,10003497,10003497
MOTOR AND SENSORY SYMPTOMS IN UPPER LIMBS,Motor dysfunction,UPPER LIMB MOTOR DEFICIT,MOTOR DYSFUNCTION,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10079473,10061296,10079473
SPEECH DIFFICULTIES,Speech disorder,SPEECH DISORDER,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041466,10041466,10041466
USE OF MYCOPHENOLATE MOFETIL FOR SYSTEMIC LUPUS ERYTHEMATOSUS/LUPUS NEPHRITIS (OFF LABEL USE) WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"TREATED WITH PARACETAMOL, IBUPROFEN AND VALPROIC ACID BUT NO REDUCTION EITHER IN INTENSITY OR FREQUENCY OF PAIN",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
MODERATELY IMPAIRED KIDNEY FUNCTION,Impaired renal function,IMPAIRED RENAL FUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10021523,10062237,10021523
USE OF FLUOROURACIL FOR CUTANEOUS SQUAMOUS CELL CARCINOMA (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LOW GRADE FEVER OF 38.2 CENTIGRADE,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
THE INTERNATIONAL NORMALIZED RATIO (INR) ON ADMISSION WAS 16.39,international normalised ratio increased,INTERNATIONAL NORMALISED RATIO INCREASED,INTERNATIONAL NORMALISED RATIO INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10022595,10022595,10022595
BRADYCARDIC ARREST,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
SPRUE-LIKE ENTEROPATHY,Sprue-like enteropathy,SPRUE-LIKE ENTEROPATHY,SPRUE-LIKE ENTEROPATHY,MALABSORPTION CONDITIONS,MALABSORPTION SYNDROMES,10017947,10079622,10079622,10079622
GASTROINTESTINAL SIDE EFFECTS,gastrointestinal disorder NOS,GASTROINTESTINAL DISORDER NOS,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017945,10017944,10017945
TUMOR PROGRESSION,Neoplasm progression,TUMOR PROGRESSION,NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS UNSPECIFIED MALIGNANCY AND SITE UNSPECIFIED NEC,10029104,10058218,10061309,10053563
FATAL PULMONARY HEMORRHAGE,Pulmonary hemorrhage,PULMONARY HEMORRHAGE,PULMONARY HAEMORRHAGE,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10037397,10037394,10037397
"COCAINE, FLUOXETINE, IBUPROFEN TOXICITY",Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
RESPIRATORY FAILURE,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
GRADE 4 HEMATOLOGICAL TOXICITIES,Haematotoxicity,HEMATOTOXICITY,HAEMATOTOXICITY,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10061188,10061188,10061196
BRAIN CT SHOWED HYPERINTENSITIES IN BOTH OCCIPITAL LOBES,Computerised tomogram abnormal,CT ABNORMAL,COMPUTERISED TOMOGRAM ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",IMAGING PROCEDURES NEC,10022891,10011600,10010235,10011600
THUS SUGGESTING A CAUSAL ASSOCIATION BETWEEN THE ONSET OF SOS/VOD AND OXALIPLATIN,Venoocclusive liver disease,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
EXTENSIVE WHITE MATTER HYPERINTENSITIES,White matter lesion,WHITE MATTER HYPERINTENSITIES,WHITE MATTER LESION,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10070557,10072731,10070557
"MALIGNANT HEART RHYTHM DISTURBANCES (BIGEMINY, TRIGEMINY, 17 INSERTIONS OF DIVERSIFORM VENTRICULAR SALVOES, 237 SINGLE SUPRAVENTRICULAR EXTRASYSTOLES)",Arrhythmia,CARDIAC ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10007518
LIGHT-HEADEDNESS,Balance disorder,BALANCE DISORDER,BALANCE DISORDER,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10049848,10049848,10049848
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
RECURRENT BLOOD CULTURE POSITIVE FOR CAMPYLOBACTER FETUS SSP. FETUS FOLLOWING IMMUNOSUPRESSION,Campylobacter infection,CAMPYLOBACTER INFECTION,CAMPYLOBACTER INFECTION,BACTERIAL INFECTIOUS DISORDERS,CAMPYLOBACTER INFECTIONS,10021881,10051226,10051226,10051226
DIFFUSED MACULO-PAPULAR RASH,Rash maculo-papular,MACULO-PAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025423
BLOOD CD4 LYMPHOCYTE CELL COUNT WAS EXTREMELY LOW,CD4 lymphocytes decreased,CD4 LYMPHOCYTES LOW,CD4 LYMPHOCYTES DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10007840,10007839,10007840
INTENTIONAL DRUG OVERDOSE,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
PAGET'S DISEASE OF BONE (PDB),Paget's disease of bone,PAGET'S DISEASE OF BONE,OSTEITIS DEFORMANS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10033363,10031151,10033363
LACK OF DRUG EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HEMATOLOGICAL ABNORMALITIES,Blood disorder,BLOOD DISORDER NOS,BLOOD DISORDER,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10005493,10061590,10005493
POOR ACTIVITY,decreased activity,DECREASED ACTIVITY,DECREASED ACTIVITY,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10011953,10011953,10011953
HYPOALBUMINAEMIA,Hypoalbuminaemia,HYPOALBUMINAEMIA,HYPOALBUMINAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020942,10020942,10020942
HYPOPHOSPHATEMIA,hypophosphatemia,HYPOPHOSPHATEMIA,HYPOPHOSPHATAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",PHOSPHORUS METABOLISM DISORDERS,10027433,10021059,10021058,10021059
PETECHIAE ON BOTH LOWER LEGS,Petechiae,PETECHIAE,PETECHIAE,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10034754,10034754,10034754
SEVERE MUSCLE PAIN,Myalgia,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028322
"POLYARTHRITIS (LEFT KNEE, BILATERAL ANKLES, LEFT WRIST, LEFT TMZ, DIFFUSE ENTHESITIS)",Polyarthritis,POLYARTHRITIS,POLYARTHRITIS,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10036030,10036030,10036030
HEMORRHAGE SUBARACHNOID,Hemorrhage subarachnoid,HEMORRHAGE SUBARACHNOID,SUBARACHNOID HAEMORRHAGE,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10019587,10042316,10019587
REDUCTION IN URINE OUTPUT WITH DARK URINE,urine color abnormal,URINE COLOR ABNORMAL,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10064752,10008796,10064752
BORTEZOMIB USED FOR THE TREATMENT OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ARIPIPRAZOLE INDUCED ACUTE MYOPIA (BINOCULAR MYOPIA OF -7 DIOPTERS IN RIGHT EYE AND -8 DIOPTER IN LEFT EYE),Acute myopia,ACUTE MYOPIA,ACUTE MYOPIA,VISION DISORDERS,REFRACTIVE AND ACCOMMODATIVE DISORDERS,10015919,10078300,10078300,10078300
TACHYPNEA,Tachypnoea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043088
NEW CAVITARY NODULES WERE SEEN IN RIGHT LUNG,Pulmonary mass,LUNG NODULE,PULMONARY MASS,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10049498,10056342,10049498
CHOLANGITIS,Cholangitis,CHOLANGITIS,CHOLANGITIS,BILE DUCT DISORDERS,BILE DUCT INFECTIONS AND INFLAMMATIONS,10019805,10008604,10008604,10008604
"PATIENT TREATED WITH HYDROXYCHLOROQUINE, RITODRINE, PREDNISOLONE AND MAGNESIUM SULFATE DURING PREGNANCY (DRUG EXPOSURE DURING PREGNANCY)",Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
SEVERE PAPULOPUSTULAR ACNE ON FACE AND BACK,Acne,ACNE PAPULAR,ACNE,SKIN APPENDAGE CONDITIONS,ACNES,10040785,10000512,10000496,10000512
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
THROMBOCYTOPENIA (PLATELET COUNT 3000/MCL),Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
RECEIVED CETIRIZINE HYDROCHLORIDE FOR ATOPIC DERMATITIS (OFF LABEL USE WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
VAGINAL BLEEDING,Vaginal haemorrhage,VAGINAL BLEEDING,VAGINAL HAEMORRHAGE,VULVOVAGINAL DISORDERS (EXCL INFECTIONS AND INFLAMMATIONS),VULVOVAGINAL DISORDERS NEC,10038604,10046910,10046910,10046883
"PLATELETS DECREASED TO 30,000/MM3",Platelets decreased,PLATELETS DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035545,10035528,10035545
MACULOPAPULAR VESICULAR RASH,maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
LABELED DRUG-DRUG INTERACTION MEDICATION ERROR,Labeled drug-drug interaction medication error,LABELED DRUG-DRUG INTERACTION MEDICATION ERROR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT MONITORING ERRORS AND ISSUES,10022117,10064378,10064373,10064378
NEUROPATHY,neuropathy,NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029328,10029331,10029328
"SIGNIFICANT FACIAL OEDEMA (LIP AND EYES), SPORADICALLY, FACIAL ANGIOEDEMA (OF EYES, LIPS), BEING PARADOXICALLY AGGRAVATED",Angioedema aggravated,ANGIOEDEMA AGGRAVATED,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10048331,10002424,10048331
HYPOSMIA,Hyposmia,HYPOSMIA,HYPOSMIA,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OLFACTORY NERVE DISORDERS,10029205,10050515,10050515,10050515
GRADE 3 PERIPHERAL NEUROPATHY,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
DRUG USE IN UNAPPROVED POPULATION,Product use issue,DRUG USE IN UNAPPROVED POPULATION,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10071551,10076309,10071551
BILATERAL TALIPES,Talipes,TALIPES,TALIPES,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS OF LIMBS CONGENITAL,10010331,10043101,10043101,10043101
CHEEK PAIN,facial pain,FACIAL PAIN,FACIAL PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10016059,10016059,10016059
REOCCURRENCE OF EPILEPTIC CRISIS,Epileptic seizure,EPILEPTIC SEIZURE,EPILEPSY,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10015052,10015037,10015052
HEPATIC FIBROSIS AND PERISINUSOIDAL FIBROSIS,Hepatic fibrosis and perisinusoidal fibrosis,HEPATIC FIBROSIS,HEPATIC FIBROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10019668,10019668,10019668
FLUCONAZOLE FAILURE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
NECROSIS OF MAXILLA,Stomatitis necrotising,MOUTH NECROSIS,STOMATITIS NECROTISING,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028028,10042135,10028028
BLOOD HAEMOGLOBIN LEVEL DECREASED,retroperitoneal haematoma,RETROPERITONEAL HAEMATOMA,RETROPERITONEAL HAEMATOMA,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL HAEMORRHAGES,10017947,10058360,10058360,10058360
ABNORMAL SERUM BIOCHEMISTRY RESULTS INCLUDED SERUM CREATININE 158 ÎœMOL/L,Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
STOMACH CRAMPS,Abdominal pain upper,STOMACH CRAMPS,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10049901,10000087,10049901
PROGRESSION OF EBV POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA DESPITE ADMINISTRATION OF IMMUNOCHEMOTHERAPY,diffuse large B-cell lymphoma,DIFFUSE LARGE B-CELL LYMPHOMA,DIFFUSE LARGE B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,DIFFUSE LARGE B-CELL LYMPHOMAS,10029104,10012818,10012818,10012818
PULSELESS POLYMORPHIC VENTRICULAR TACHYCARDIA,polymorphic ventricular tachycardia,POLYMORPHIC VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10036095,10047302,10036095
INCOHERENT SPEECH,Speech disorder,INAPPROPRIATE SPEECH,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10059488,10041466,10059488
CHRONIC KIDNEY INSUFFICIENCY,chronic kidney insufficiency,RENAL INSUFFICIENCY,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038474,10038435,10038474
GRADE 3-4 INFECTION,Infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
HIS RENAL FUNCTION DETERIORATED,Renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
OPIUM ABUSE,Drug abuse,OPIOID ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10030887,10013654,10030887
DRESS SYNDROME,Drug reaction with eosinophilia and systemic symptoms,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
SEVERE RIGHT AND LEFT UPPER QUADRANT ABDOMINAL PAIN,Abdominal pain upper,UPPER ABDOMINAL PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000087,10000087,10046272
NEPHROPATHY,Nephropathy,NEPHROPATHY,NEPHROPATHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10029151,10029151,10029151
LACK OF DRUG EFFECT (VORICONAZOLE IN TALAROMYCES (PENICILLIUM) MARNEFFEI) INFECTION,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
BLOOD PRESSURE (BP) 145/95 MMHG/BP 182/111 MMHG,Blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
WHOLE BODY INCREASING EDEMA,Oedema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10014210
PROGRESSIVE PERIPHERAL NEUROPATHY,peripheral neuropathy,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10080342,10029331,10080342
ACUTE EXACERBATION OF THE BEHCET DISEASE,Behcet's syndrome,BEHCET'S DISEASE,BEHCET'S SYNDROME,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10004212,10004213,10004212
COMPARTMENT SYNDROME OF HER LEFT LOWER EXTREMITY FOLLOWING DIPHENHYDRAMINE OVERDOSE,Compartment syndrome,COMPARTMENT SYNDROME,COMPARTMENT SYNDROME,MUSCLE DISORDERS,MYOPATHIES,10028395,10010121,10010121,10010121
LUNG INFECTION,lung infection,LUNG INFECTION,LUNG INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10061229,10061229,10061229
ACNEIFORM RASH OF GRADE 2 AFFLICTING THE HEAD AND TORSO,rash acneiform,RASH ACNEIFORM,DERMATITIS ACNEIFORM,SKIN APPENDAGE CONDITIONS,ACNES,10040785,10037847,10012432,10037847
DEMISE OF A 27-28 WEEKS FETUS,Foetal exposure during pregnancy,FOETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071404,10071404,10071404
LEUKOCYTE 22000/MM3,White blood cell count decreased,LEUKOCYTE COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10048552
HEMORRHAGIC,Hemorrhagic disorder,HEMORRHAGIC DISORDER,HAEMORRHAGIC DISORDER,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),BLEEDING TENDENCIES,10005329,10055279,10019009,10055279
CIRCULATORY CONGESTION,Hypervolaemia,HYPERVOLAEMIA,HYPERVOLAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME INCREASED,10027433,10020919,10020919,10020919
COUGHING,Cough,COUGHING,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011232
OXYCODONE HYDROCHLORIDE FOR THE TREATMENT OF BRUISED RIBS,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
LOCALISED SKIN REACTION,Skin reaction,LOCALISED SKIN REACTION,SKIN REACTION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10024777,10040914,10024777
PEL-LIKE LYMPHOMA ASSOCIATED WITH EPSTEIN-BARR VIRUS (EBV),Primary effusion lymphoma,PRIMARY EFFUSION LYMPHOMA,PRIMARY EFFUSION LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,B-CELL LYMPHOMAS NEC,10029104,10065857,10065857,10065857
GGT 69 U/L,Gamma-glutamyltransferase increased,GGT INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056910,10017693,10056910
ASCITES,ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
PAPULE,Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
MILD KIDNEY FAILURE,Acute kidney injury,ACUTE KIDNEY FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10000821
HYDROXYCHLOROQUINE SULFATE USED FOR TREATMENT OF PULMONARY HEMOSIDEROSIS (OFF LABEL USE) WITH NO ADVERSE EVENT,hydroxychloroquine sulfate used for treatment of pulmonary hemosiderosis (off label use) with no adverse event,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
COMPLAINED OF HAVING A COLD SENSATION,Feeling cold,SENSATION OF COLD,FEELING COLD,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10016326,10016326,10039997
CNS COMA FOLLOWING EXPOSURE TO MORPHINE (TOXIC AGENT),Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
LESS OVERNIGHT SLEEP,Sleep decreased,SLEEP DECREASED,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10040982,10022437,10040982
HYPOGLYCAEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
CHOLINERGIC SYNDROME,Cholinergic syndrome,CHOLINERGIC SYNDROME,CHOLINERGIC SYNDROME,NEUROMUSCULAR DISORDERS,AUTONOMIC NERVOUS SYSTEM DISORDERS,10029205,10008674,10008674,10008674
MYOCARDIAL FIBROSIS,myocardial fibrosis,MYOCARDIAL FIBROSIS,MYOCARDIAL FIBROSIS,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10028594,10028594,10028594
ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
HYPOKALAEMIA,hypokalaemia,HYPOKALAEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021015
HYPOFIBRINOGENEMIA,hypofibrinogenemia,HYPOFIBRINOGENEMIA,HYPOFIBRINOGENAEMIA,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULATION FACTOR DEFICIENCIES,10005329,10020978,10051125,10020978
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
PREDOMINANTLY SENSITIVE POLYNEUROPATHY,polyneuropathy,POLYNEUROPATHY,POLYNEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10036105,10036105,10036105
SHOCK DUE TO HAEMOLYSIS,Shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
SEVERE LEFT LEG PAIN,Pain in extremity,UNILATERAL LEG PAIN,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10052410,10033425,10052410
MUSCLE PAIN AND CRAMPING,Myalgia,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028322
DIFFICULTY IN WALKING,Gait disturbance,DIFFICULTY IN WALKING,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10012794,10017577,10012794
RHINORRHOEA/ NASAL DRIPPING,Rhinorrhoea,RHINORRHOEA,RHINORRHOEA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10039101,10039101,10039101
GRANULOMA GLUTAEALE INFANTUM,Granuloma,GRANULOMA,GRANULOMA,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10018691,10018691,10018691
SLURRED SPEECH,Dysarthria,SLURRED SPEECH,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041053,10013887,10041053
PORTAL HYPERTENSION,Portal hypertension,PORTAL HYPERTENSION,PORTAL HYPERTENSION,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10036200,10036200,10036200
APPLICATION SITE INDURATION WITH DIAMETER 3X5CM,Vaccination site induration,VACCINATION SITE INDURATION,VACCINATION SITE INDURATION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10065117,10065117,10065117
MILD TRICUSPID INSUFFICIENCY,Tricuspid valve incompetence,TRICUSPID INSUFFICIENCY,TRICUSPID VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,TRICUSPID VALVULAR DISORDERS,10007541,10044640,10044640,10044635
FEVER (TEMPERATURE NOS),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
SERUM CREATININE LEVEL WAS 510 ÎœMOL/L,Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
INTENSIFIED FUNGAL LESIONS IN THE ESOPHAGUS MUCOSA,Gastrointestinal fungal infection,GASTROINTESTINAL FUNGAL INFECTION,GASTROINTESTINAL FUNGAL INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10049479,10049479,10049479
VERTIGE,Vertigo,VERTIGO,VERTIGO,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10047340,10047340,10047340
INFLAMMATORY LESIONS IN THE FORM OF ABSCESSES OF THE LEFT ILIACUS MUSCLE AND MASSIVE ABSCESSES OF THE PIRIFORMIS MUSCLE EXTENDING THROUGH THE GREATER SCIATIC FORAMEN INTO THE LEFT BUTTOCK,Muscle abscess,MUSCLE ABSCESS,MUSCLE ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,MUSCLE AND SOFT TISSUE INFECTIONS,10021881,10049206,10049206,10049206
HAD NO EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
FROSTED BRANCH ANGIITIS/ SEVERE RETINAL VASCULITIS,frosted branch angiitis,FROSTED BRANCH ANGIITIS,RETINAL VASCULITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","RETINAL, CHOROID AND VITREOUS INFECTIONS AND INFLAMMATIONS",10015919,10070741,10038905,10070741
DIVERTICULITIS,Diverticulitis,SIGMOID DIVERTICULITIS,DIVERTICULITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10072616,10013538,10072616
ARRHYTHMIA,arrhythmia,ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10003119
PATIENT WAS NOW IN A VEGETATIVE STATE,Persistent vegetative state,PERSISTENT VEGETATIVE STATE,APALLIC SYNDROME,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10034715,10002941,10034715
ACUTE PROFOUND CEREBELLAR SYNDROME SECONDARY TO LAMOTRIGINE TOXICITY CAUSED BY ESCITALOPRAM,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
OFF LABEL USE,OFF LABEL USE,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ACUTE ADRENAL CRISIS FOLLOWING INADEQUATE ADAPTATION OF GLUCOCORTICOID DOSAGE TO THE ACUTE STRESS SITUATION,Adrenal crisis,ADRENAL CRISIS,ADRENOCORTICAL INSUFFICIENCY ACUTE,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001346,10001389,10001346
OEDEMA PERIPHERAL,Oedema peripheral,OEDEMA LOWER LIMB,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030109,10030124,10030109
BRADYCARDIA,bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
MILD JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
PAIN ABDOMINAL,Pain abdominal,PAIN ABDOMINAL,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10033374,10000081,10033374
MULTIFOCAL PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
SUB-THERAPEUTIC INR,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
"A TEMPERATURE OF 39Â°C, CHILLS",Pyrexia,FEVER CHILLS,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016559,10037660,10016559
TEAR DEFICIENCY,tearing decreased,TEARING DECREASED,LACRIMATION DECREASED,EYE DISORDERS NEC,LACRIMATION DISORDERS,10015919,10043170,10023642,10043170
THROMBOCYTOPENIA (PLATELET COUNT: 126000/MCL),Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
PATIENT TREATED WITH PREDNISOLONE FOR BEHCET'S DISEASE BUT DISEASE OFTEN RELAPSED WHEN PREDNISOLONE WAS TAPERED,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
MOTHER WAS TREATED WITH HYDROXYCHLOROQUINE,Fetal exposure during pregnancy,FETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071421,10071404,10071421
REBOUND EFFECT,rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
DEEP PALPATION IN THE LOWER ABDOMINAL QUADRANTS,Palpitations,PALPITATION,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033556
VESICULAR MURMUR,Breath sounds abnormal,VESICULAR BREATHING ABNORMAL,BREATH SOUNDS ABNORMAL,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10066106,10064780,10066106
EXPOSURE TO METFORMIN AND OTHER SUBSTANCES IN GESTATIONAL WEEK,Foetal exposure during pregnancy,FOETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071404,10071404,10071404
PATIENT INCREASED HER DOSE,Intentional product misuse,INTENTIONAL PRODUCT MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10074903,10074903,10074903
LARGE SKIN VASCULITIS,Cutaneous vasculitis,SKIN VASCULITIS NOS,CUTANEOUS VASCULITIS,SKIN VASCULAR ABNORMALITIES,SKIN VASCULITIDES,10040785,10040949,10011686,10040949
BLOATING,Abdominal distension,BLOATING,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10005265,10000060,10005265
HIGH GRADE FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PNEUMONIA,pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
RENAL DYSFUNCTION,Renal impairment,KIDNEY DYSFUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10023417
RIGHT THIGH SWELLING,Oedema peripheral,LEG EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030109,10030124,10024127
CROHNâ€™S DISEASE,Crohn's disease,CROHN'S DISEASE,CROHN'S DISEASE,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10011401,10011401,10011401
ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
RENAL CELL CARCINOMA,renal cell carcinoma,RENAL CELL CARCINOMA,RENAL CELL CARCINOMA,RENAL AND URINARY TRACT NEOPLASMS MALIGNANT AND UNSPECIFIED,RENAL NEOPLASMS MALIGNANT,10029104,10067946,10067946,10067946
THROMBOCYTOPENIA (VALUE NOS),Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
APPLICATION SITE OEDEMA AND ERYTHEMA IN DIAMETER OF 5X5 CM OF THE LEFT UPPER ARM,Vaccination site inflammation,VACCINATION SITE INFLAMMATION,VACCINATION SITE INFLAMMATION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10068878,10068878,10068878
PROTHROMBIN TIME PROLONGATION TO 19.9 SEC,Prothrombin time prolonged,PROTHROMBIN TIME PROLONGED,PROTHROMBIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037063,10037063,10037063
PARTIAL RESPONSE OF PREDNISONE (SUBTHERAPEUTIC RESPONSE) WITH NO REPORTED ADVERSE EVENT,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
HAND-FOOT SYNDROME,Palmar-plantar erythrodysaesthesia syndrome,HAND AND FOOT SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10019111,10033553,10019111
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
WIDE-RANGE SUBCUTANEOUS EMPHYSEMA FROM SUBCUTANEOUS TISSUE OF HYPOGASTRIC REGION TO BILATERAL SCROTUM AND BUTTOCKS,Subcutaneous emphysema,SUBCUTANEOUS EMPHYSEMA,SUBCUTANEOUS EMPHYSEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS CONDITIONS NEC,10040785,10042344,10042344,10042344
RAISED LACTATE,Blood lactic acid increased,LACTATE INCREASED,BLOOD LACTIC ACID INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10023660,10005635,10023660
LACK OF EFFICACY,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
HYPOTENSIVE,Hypotension,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021107
MENTAL AND MOTOR SLOWING,Motor activity retarded,MOTOR ACTIVITY RETARDED,HYPOKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10027992,10021021,10027992
BILATERAL ATYPICAL ULNAR FRACTURES,bilateral atypical ulnar fractures,ATYPICAL FRACTURE,ATYPICAL FRACTURE,BONE AND JOINT INJURIES,FRACTURES AND DISLOCATIONS NEC,10022117,10072395,10072395,10072395
SEVERE AND PROLONGED MYELOSUPPRESSION,Bone marrow failure,MYELOSUPPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10028584
PERIORAL EDEMA,perioral edema,PERIORAL EDEMA,CIRCUMORAL OEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10057806,10052250,10057806
ACUTELY HYPOXIC (SPO2 85%),Hypoxia,HYPOXIC,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021144,10021143,10021144
A WIDESPREAD ITCHY MACULOPAPULAR RASH,Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
MULTIPLE DRUG OVERDOSE PRESCRIBED,Multiple drug overdose prescribed,MULTIPLE DRUG OVERDOSE PRESCRIBED,PRESCRIBED OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10062765,10051076,10062765
FLARE-UP OF RADIOTHERAPY TOXICITY,Radiotoxicity,RADIOTOXICITY,RADIATION INJURY,INJURIES BY PHYSICAL AGENTS,RADIATION INJURIES,10022117,10069763,10037760,10069763
ACUTE LIVER INJURY,Liver injury,ACUTE LIVER INJURY,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067970,10067125,10067970
TACHYCARDIC,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
SHORT-TERM UNCONSCIOUSNESS,unconsciousness,UNCONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10045481,10024855,10045481
HIGH ANION GAP METABOLIC ACIDOSIS,High anion gap metabolic acidosis,HIGH ANION GAP METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10069033,10027417,10069033
PULMONARY AND CNS ASPERGILLOSIS,Pulmonary aspergillosis,PULMONARY ASPERGILLOSIS,BRONCHOPULMONARY ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10059259,10006473,10059259
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
TRICUSPID REGURGITATION FOLLOWING ENDOMYOCARDIAL FIBROSIS,tricuspid regurgitation,TRICUSPID REGURGITATION,TRICUSPID VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,TRICUSPID VALVULAR DISORDERS,10007541,10049217,10044640,10049217
DIFFICULTY IN SWALLOWING,Dysphagia,SWALLOWING DIFFICULT,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10042645,10013950,10042645
SUDDEN ONSET OF DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
EPISODES OF NON-SUSTAINED VENTRICULAR TACHYCARDIA DUE TO HEMORRHAGIC INFARCTION,Non-sustained ventricular tachycardia,NON-SUSTAINED VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10060731,10047302,10060731
HYPERLIPIDAEMIA FOLLOWING WORSENING DIABETIC CONTROL,Hyperlipidaemia,HYPERLIPIDAEMIA,HYPERLIPIDAEMIA,LIPID METABOLISM DISORDERS,HYPERLIPIDAEMIAS NEC,10027433,10062060,10062060,10062060
ERYSIPELAS,Erysipelas,ERYSIPELAS,ERYSIPELAS,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10015145,10015145,10015145
ERYTHEMATOUS,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
UNSTEADY ON HER FEET,Gait disturbance,UNSTEADY GAIT,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017582,10017577,10046261
LITHIUM-INDUCED DELIRIUM,delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
SEVERE ENTEROPATHY WITH VILLOUS ATROPHY,Microvillous inclusion disease,MICROVILLOUS ATROPHY,MICROVILLOUS INCLUSION DISEASE,GASTROINTESTINAL TRACT DISORDERS CONGENITAL,INTESTINAL DISORDERS CONGENITAL,10010331,10068504,10068494,10068504
HEPATITIS B ANTIBODY NEGATIVE/ NINP/ NEITHER INFECTED NOR PROTECTED,Hepatitis B antibody negative,HEPATITIS B ANTIBODY NEGATIVE,HEPATITIS B ANTIBODY NEGATIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10019734,10019734,10019734
RHINITIS,Rhinitis,RHINITIS,RHINITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10039083,10039083,10039083
FALLS,fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
ANURIC,Anuric,ANURIA,ANURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10002847,10002847,10002847
RIGHT HEMIPLEGIA,Hemiplegia,RIGHT HEMIPLEGIA,HEMIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10039154,10019468,10039154
ALLERGY,Hypersensitivity,HYPERSENSITIVITY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020751,10020751,10020751
RASH ACCOMPANIED BY ITCHING ON THE FOREARM APPEARED,rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
CISPLATIN RESISTANT NON-SEMINOMATOUS TESTICULAR GERM  CELL TUMOUR,cisplatin resistant non-seminomatous testicular germ  cell tumour,TESTICULAR GERM CELL TUMOR,TESTICULAR GERM CELL TUMOUR,REPRODUCTIVE NEOPLASMS MALE MALIGNANT AND UNSPECIFIED,REPRODUCTIVE NEOPLASMS MALE UNSPECIFIED MALIGNANCY,10029104,10075819,10075811,10075819
KNEE-ARTHRITIS WITH IMPORTANT SYNOVIAL EFFUSION,Knee arthritis,KNEE ARTHRITIS,ARTHRITIS,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10067624,10003246,10067624
SEVERE HYPOCALCEMIA (CALCIUM DROPPED TO 6.6 MG/DL),Hypocalcaemia,HYPOCALCEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020947,10020947,10020949
MODERATE PERIPHERAL NEUROPATHY (GRADE 3),Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
SLURRED SPEECH,slurred speech,SLURRED SPEECH,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041053,10013887,10041053
PNEUMONIAE,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
SEVERE TOXIC EPIDERMAL NECROLYSIS ON 90 PERCENT OF THE BODY SURFACE AREA WITH SEVERE MUCOSAL INVOLVEMENT,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
INFARCTION,Infarction,INFARCTION,INFARCTION,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10061216,10061216,10061216
HYPERTRIGLYCERIDEMIA,HYPERTRIGLYCERIDEMIA,HYPERTRIGLYCERIDEMIA,HYPERTRIGLYCERIDAEMIA,LIPID METABOLISM DISORDERS,ELEVATED TRIGLYCERIDES,10027433,10020870,10020869,10020870
UPPER GASTROINTESTINAL HEMORRHAGE (GRADE 3),Upper gastrointestinal haemorrhage,UPPER GASTROINTESTINAL HEMORRHAGE,UPPER GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10046274,10046274,10055356
SEVERE MITRAL REGURGITATION,Mitral regurgitation,MITRAL REGURGITATION,MITRAL VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,MITRAL VALVULAR DISORDERS,10007541,10027718,10027727,10027718
LESION WAS INDURATED AND MILDLY INFILTRATED,Induration,INDURATION,INDURATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10060708,10060708,10060708
CARDIOTOXICITY,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
EPISTAXIS,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
NEUTROPHILS INCREASED (80%),Neutrophil count increased,NEUTROPHILS INCREASED,NEUTROPHIL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029381,10029368,10029381
HYPERSENSITIVITY REACTION CAUSED BY THE NASAL SPRAY CONTAINING BAC,Reaction to preservatives,REACTION TO DRUG PRESERVATIVES,REACTION TO PRESERVATIVES,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10037976,10064788,10037976
INCREASED LEVEL OF PROCALCITONIN,Procalcitonin increased,PROCALCITONIN INCREASED,PROCALCITONIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10067081,10067081,10067081
ANXIOUS,Anxiety,FEELING ANXIOUS,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10016323,10002855,10016323
BLEEDING ESOPHAGEAL VARICES,Oesophageal varices haemorrhage,BLEEDING ESOPHAGEAL VARICES,OESOPHAGEAL VARICES HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,GASTRIC AND OESOPHAGEAL HAEMORRHAGES,10017947,10030210,10030210,10005112
HEPATOMEGALY,Hepatomegaly,HEPATOMEGALY,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10019842
TORSADE DE POINTES,Torsade de Pointes,TORSADE DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044066
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) OF THE SKIN AND INTESTINES,Acute graft versus host disease in intestine,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10066264,10066264,10066264
EDEMA OF PENIS,Penile oedema,EDEMA OF PENIS,PENILE OEDEMA,PENILE AND SCROTAL DISORDERS (EXCL INFECTIONS AND INFLAMMATIONS),PENILE DISORDERS NEC (EXCL ERECTION AND EJACULATION),10038604,10066774,10066774,10014242
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
COUGH,cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
ACUTE DIARRHEA/ ACUTE DIARRHEA (UPON TAKING THE PILLS),Diarrhoea,ACUTE DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10055955,10012735,10000706
PHARMACODYNAMIC/PHARMACOKINETIC DRUG INTERACTIONS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
SKIN ERYTHEMA,Erythema,SKIN ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10040842,10015150,10040842
OLIGURIC,Urine output decreased,URINE OUTPUT DECREASED,URINE OUTPUT DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059895,10059895,10059895
AGGRAVATION OF PULMONARY ASPERGILLOSIS,Bronchopulmonary aspergillosis,PULMONARY ASPERGILLOSIS,BRONCHOPULMONARY ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10059259,10006473,10059259
BILATERAL VESTIBULAR DYSFUNCTION,bilateral vestibular dysfunction,VESTIBULAR FUNCTION DISORDER,VESTIBULAR DISORDER,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR DISORDERS NEC,10013993,10047388,10047386,10047388
NEUTROPHILIA,Neutrophilia,NEUTROPHILIA,NEUTROPHILIA,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10029379,10029379,10029379
CEREBRAL TOXOPLASMOSIS,cerebral toxoplasmosis,CEREBRAL TOXOPLASMOSIS,CEREBRAL TOXOPLASMOSIS,PROTOZOAL INFECTIOUS DISORDERS,TOXOPLASMA INFECTIONS,10021881,10057854,10057854,10057854
PERICARDIAL THICKENING,pericardial thickening,PERICARDIAL THICKENING,PERICARDIAL FIBROSIS,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10078287,10048724,10078287
ELEVATED C-REACTIVE PROTEIN 31 MG/L,C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
THYROID-STIMULATING HORMONE DERCREASED,Blood thyroid stimulating hormone decreased,BLOOD THYROID STIMULATING HORMONE DECREASED,BLOOD THYROID STIMULATING HORMONE DECREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),PITUITARY ANALYSES ANTERIOR,10022891,10005832,10005832,10005832
TOXIC SHOCK FOLLOWING SEVERE SEPSIS,Toxic shock syndrome,TOXIC SHOCK SYNDROME,TOXIC SHOCK SYNDROME,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10044248,10044248,10044248
MICRO-ORGANISM HAVING A HIGH GENTAMICIN MIC,gentamicin MIC,MINIMUM INHIBITORY CONCENTRATION INCREASED,MINIMUM INHIBITORY CONCENTRATION INCREASED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,MICROBIOLOGY AND SEROLOGY TESTS NEC,10022891,10080997,10080997,10080997
ATYPICAL HEMOLYTIC UREMIC SYNDROME,Atypical Hemolytic Uremic Syndrome,ATYPICAL HEMOLYTIC UREMIC SYNDROME,ATYPICAL HAEMOLYTIC URAEMIC SYNDROME,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC MECHANICAL FACTOR,10005329,10079841,10079840,10079841
"HEPATIC CYTOLYSIS AND ACUTE HEPATIC FAILURE INDUCED BY A TRIPLE DRUG INTERACTION (PONATINIB, VORICONAZOLE, AZITHROMYCIN)",hepatic cytolysis,HEPATIC CYTOLYSIS,HEPATOCELLULAR INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10049199,10019837,10049199
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
IMMEDIATE-TYPE HYPERSENSITIVITY REACTION (GRADE 3),Type I hypersensitivity,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
PERIVASCULAR DERMATITIS,Perivascular dermatitis,PERIVASCULAR DERMATITIS,PERIVASCULAR DERMATITIS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10064986,10064986,10064986
HIGH DOSE OF SLEEPINESS-PREVENTING MEDICINE (ESTARON MOCHAÂ®) FOR SUICIDE ATTEMPT,Suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
BLOOD PRESSURE REDUCTION,Blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
DRUG ALLERGY,Drug hypersensitivity,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
GASTRO-INTESTINAL INTOLERANCE,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
NAIL'S BLUE COLORATION,Nail discolouration,NAIL DISCOLORATION,NAIL DISCOLOURATION,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10028692,10028692,10028691
LEUKOCYTOSIS,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
ABNORMAL DREAMS,Abnormal dreams,ABNORMAL DREAMS,ABNORMAL DREAMS,SLEEP DISORDERS AND DISTURBANCES,PARASOMNIAS,10037175,10000125,10000125,10000125
METRONIDAZOLE INDUCED ENCEPHALOPATHY,Toxic encephalopathy,DRUG-INDUCED ENCEPHALOPATHY,TOXIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10049035,10044221,10049035
AIRWAY EDEMA,Respiratory tract oedema,AIRWAY EDEMA,RESPIRATORY TRACT OEDEMA,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10070774,10070774,10070778
OSTEOLYTIC SOFT TISSUE MASS ASSOCIATED WITH BONY EROSION,Osteolysis,OSTEOLYSIS,OSTEOLYSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10031248,10031248,10031248
ACICLOVIR INDUCED POSTERIOR LEUCOENCEPHALOPATHY,Leukoencephalopathy,LEUKOENCEPHALOPATHY,LEUKOENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10024382,10024382,10024382
SERUM GAMMA-GLOBULIN LEVEL WERE HIGH (19 G/L),Immunoglobulins increased,GLOBULIN GAMMA SERUM PLASMA INCREASED,IMMUNOGLOBULINS INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10056733,10021500,10056733
RASH ON HIS BACK AND UPPER CHEST,rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
PERIOSTEAL REACTION,Bone disorder,PERIOSTEAL DISORDER,BONE DISORDER,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10034549,10005956,10034549
TOXIC ENCEPHALOPATHY INDUCED BY ISONIAZID,Toxic encephalopathy,TOXIC ENCEPHALOPATHY,TOXIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10044221,10044221,10044221
INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTERED,Inappropriate schedule of vaccine administered,INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTERED,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10063976,10021597,10063976
GGT INCREASED -411 IU/L,Gamma-glutamyltransferase increased,GGT INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056910,10017693,10056910
ALT INCREASED (353 UNITS NOS),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
THE PATIENT DEVELOPED PAROXYSMAL LIMB CONVULSIONS FOLLOWING HYPERAMMONEMIC ENCEPHALOPATHY,Convulsion,CONVULSION,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10010904,10039906,10010904
"NAUSEA WAS EXTENSIVELY TREATED WITH ONDANSETRON, PROMETHAZINE, MECLIZINE, WITHOUT BENEFITS/ WEANING OFF TOPIRAMATE WHICH HAD BEEN INEFFECTIVE 
(LACK OF DRUG EFFECT) WITH NO ADR",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
RECEIVED 2 DOSES OF 30 MG EACH OF DEXTROMETHORPHAN WITHIN 24 HOURS,drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
CT REVEALED A LARGE INFILTRATE PROXIMAL IN THE RIGHT UPPER LEG,Computerised tomogram abnormal,CT ABNORMAL,COMPUTERISED TOMOGRAM ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",IMAGING PROCEDURES NEC,10022891,10011600,10010235,10011600
PERICARDIAL EFFUSION,Pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
ACUTE OVERDOSE FOLLOWING VOLUNTARY MASSIVE INTAKE OF CLONAZEPAM,acute overdose,ACUTE OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067695,10033295,10067695
INVASIVE PULMONARY ASPERGILLUS,Pulmonary aspergillosis,PULMONARY ASPERGILLOSIS,BRONCHOPULMONARY ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10059259,10006473,10059259
SKIN WAS DRY,Dry skin,SKIN DRY,DRY SKIN,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10013786,10013786,10040835
ACUTE MYOCARDIAL INFARCTION (ECG SHOWED RECURRENT ST SEGMENT ELEVATION IN LEADS V1-V4),Acute myocardial infarction,ST SEGMENT ELEVATION MYOCARDIAL INFARCTION,ACUTE MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10064345,10000891,10064345
PRODUCT USE ISSUE,Product use issue,PRODUCT USE ISSUE,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076309,10076309,10076309
MORBILLIFORM RASH,morbilliform rash,MORBILLIFORM RASH,RASH MORBILLIFORM,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10027970,10037870,10027970
DIGOXIN POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
GRADE II ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
PROGRESSIVE DISEASE,Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
SWELLING OF THE PENIS AND SCROTUM,Swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
MULTI-ORGAN FAILURE DUE TO TOXIC EPIDERMAL NECROLYSIS,Multiple organ dysfunction syndrome,MULTI-ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028154
BLACK HAIRY TONGUE (BHT) ASSOCIATED WITH USE OF AMOXICILLIN/CLAVULANATE,black hairy tongue,BLACK HAIRY TONGUE,TRICHOGLOSSIA,TONGUE CONDITIONS,TONGUE DISORDERS,10017947,10004974,10080276,10004974
FAILED TREATMENT WITH IBUPROFEN,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
"WEAKNESS IN THE RIGHT ANKLE DORSIFLEXOR, WEAKNESS OF THE RIGHT KNEE EXTENSOR AND FIRST TOE DORSIFLEXOR MUSCLE DEVELOPED (TRANSIENT PARALYSIS)",Monoplegia,TRANSIENT PARALYSIS OF LIMB,MONOPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10044399,10027926,10044399
HYPERTONIA,Hypertonia,HYPERTONIA,HYPERTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10020852,10020852,10020852
"PREDNISONE WAS STARTED WITH A GOOD RESPONSE, BUT SYMPTOMS RECURRED  FOLLOWING TAPERING","prednisone was started with a good response, but symptoms recurred  following tapering",REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
LACTIC ACIDOSIS,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
RENAL IMPAIRMENT,Renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
OCULAR MALALIGNMENT IN THE WAKING STATE,Strabismus,STRABISMUS,STRABISMUS,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10042159,10042159,10042159
URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
"GRADE 2 HAND-FOOT SYNDROME DURING TREATMENT WITH VINORELBINE, CAPECITABINE AND GRANULOCYTECOLONY STIMULATING FACTOR",Hand and foot syndrome,HAND AND FOOT SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10019111,10033553,10019111
DRUG USE FOR UNAPPROVED INDICATION,drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
AITL,Angioimmunoblastic T-cell lymphoma,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S T-CELL,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMAS,10029104,10002449,10002449,10002449
SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
PRURITIC SKIN LESIONS/SKIN LESION,skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
ENTEROCOCCUS FAECALIS BACTERAEMIA DUE TO FEBRILE NEUTROPENIA,Enterococcal infection,ENTEROCOCCUS FAECALIS INFECTION,ENTEROCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,ENTEROCOCCAL INFECTIONS,10021881,10051978,10061124,10051978
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PAINFUL SWELLING AND ERYTHEMA SURROUNDING THE SURGICAL WOUND ON THE LEFT KNEE,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
PARESTHESIA LOWER LIMB,Paraesthesia,PARESTHESIA LOWER LIMB,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10052409,10033775,10054531
CRAVING FOR FOOD,Food craving,FOOD CRAVING,FOOD CRAVING,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10056465,10056465,10056465
PERINEAL ANAESTHESIA,perineal anaesthesia,ANAESTHESIA,ANAESTHESIA,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10002091,10002091,10002091
WITHDRAWAL SYMPTOMS,Withdrawal syndrome,WITHDRAWAL SYMPTOM,WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10073281,10048010,10073281
PERIPHERAL JOINT PAIN/GOUT EPISODE/ EXPERIENCED GOUT EPISODE,disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
UNFAVOURABLE DRUG INTERACTION BETWEEN PHENPROCOUMON AND RIFAMPICIN,Drug interaction,DRUG-DRUG PHARMACOKINETIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10065994,10013710,10065994
MILD CUTANEOUS DRUG REACTION,Skin reaction,SKIN REACTION,SKIN REACTION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040914,10040914,10040914
PATIENT CONTINUES TO BE SYMPTOMATIC,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
PATIENT RECEIVED MYCOPHENOLATE MOFETIL DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
URINE COLOR ABNORMAL,Chromaturia,URINE COLOR ABNORMAL,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10064748,10008796,10064752
SEDATED,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
LYMPHOCYTIC PLEOCYTOSIS OF 41 CELLS/MM3,Pleocytosis,PLEOCYTOSIS,PLEOCYTOSIS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10035551,10035551,10035551
CONFUSED,Confusional state,CONFUSED,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010298
SERUM  SALICYLIC ACID LEVEL ABNORMAL,drug level,DRUG LEVEL,DRUG LEVEL,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10061823,10061823,10061823
HYPEROSMOLAR HYPERGLYCAEMIA SYNDROME AGGRAVATED,Hyperglycaemic hyperosmolar nonketotic syndrome,HYPEROSMOLAR HYPERGLYCAEMIC SYNDROME,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEUROLOGICAL,10027433,10078893,10063554,10078893
ORAL MUCOSITIS (GRADE 3),mucositis oral,MUCOSITIS ORAL,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028130,10042128,10028130
DIFFUSE ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
DRUG RESISTANCE (MUTATION),Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
DIPHENHYDRAMINE AND HYDROCORTISONE WAS ADMINISTERED WITH LITTLE IMPROVEMENT.,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PAINFUL ULCERATED PLAQUE ON THE ANTERIOR SURFACE OF LEG,Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
ASPIRATION PNEUMONIA FOLLOWED BY BONE MARROW SUPPRESSION,aspiration pneumonia followed by bone marrow suppression,ASPIRATION PNEUMONIA,PNEUMONIA ASPIRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10003525,10035669,10003525
ANTECOLLIS,Torticollis,ANTECOLLIS,TORTICOLLIS,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10065261,10044074,10065261
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
HEPATIC ENCEPHALOPATHY FOLLOWING NODULAR REGENERATIVE HYPERPLASIA SYNDROME,Hepatic encephalopathy,HEPATIC ENCEPHALOPATHY,HEPATIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10019660,10019660,10019660
INFECTION,bone Infection,BONE INFECTION,OSTEOMYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,BONE AND JOINT INFECTIONS,10021881,10061017,10031252,10061017
FALLS,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
DRUG INDUCED HEPATOTOXICITY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
PROTEINURIA,Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
LIGHTHEADEDNESS,Dizziness,LIGHTHEADEDNESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10024461,10013573,10024492
TRIIODOTHYRONINE (FT3) OF 2.32 PG/ML,Tri-iodothyronine free decreased,TRI-IODOTHYRONINE FREE DECREASED,TRI-IODOTHYRONINE FREE DECREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),THYROID ANALYSES,10022891,10053791,10053791,10053791
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
WHITE SPUTUM,Sputum discoloured,SPUTUM DISCOLORED,SPUTUM DISCOLOURED,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10041807,10041807,10041806
SEVERE MUCOSAL DAMAGE,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
SKIN RASH,Rash,SKIN RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040913
CARDIAC ARREST DUE TO HYPERKALEMIA,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
SEVERE VENO-OCCLUSIVE DISEASE,Severe veno-occlusive disease,VENOOCCLUSIVE DISEASE,VENOOCCLUSIVE DISEASE,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10062173,10062173,10062173
HAEMOGLOBIN DECREASED,Haemoglobin decreased,HAEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10018884
NEUTROPHILS DECREASED OF GRADE 2,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
COUGH,cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
BILATERAL AND SIMULTANEOUS NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY RELATED TO SILDENAFIL INTAKE,nonarteritic anterior ischemic optic neuropathy,NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY,OPTIC ISCHAEMIC NEUROPATHY,OCULAR HAEMORRHAGES AND VASCULAR DISORDERS NEC,OPTIC NERVE BLEEDING AND VASCULAR DISORDERS,10015919,10068249,10030924,10068249
FLUDARABINE PHOSPHATE USED IN CHILD BELOW AGE 18,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG INEFFECTIVE,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
DRUG EXPOSURE DURING PREGNANCY WITH NO ADR,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
BLOOD DRAW SHOWED REDUCED TOTAL PROTEIN,Protein total decreased,PROTEIN TOTAL DECREASED,PROTEIN TOTAL DECREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10037014,10037014,10037014
WEAKNESS,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
INR INCREASED (7.7),International normalised ratio increased,INR INCREASED,INTERNATIONAL NORMALISED RATIO INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10022402,10022595,10022402
"EAR WAS MODERATELY SWOLLEN, ERYTHEMATOUS, WARM AND TENDER",Erythema ear,ERYTHEMA EAR,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10052440,10015150,10052440
PATIENT WAS ADMINISTERED METHOTREXATE AND CISPLATIN FOR THE TREATMENT OF METASTATIC CHONDROSARCOMA (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SHOWED NO EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
RESPIRATORY FAILURE,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
POOR RESPONSE TO TREATMENT  WITH NO ADR,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
EDEMA EXTENTED TO WHOLE BODY,EDEMA,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014210,10030095,10014210
HAEMOPTYSIS,Haemoptysis,HAEMOPTYSIS,HAEMOPTYSIS,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10018964,10018964,10018964
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME FOLLOWING VASO-OCCLUSIVE CRISIS WITH MORPHINE OVERDOSE,Posterior reversible encephalopathy syndrome,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10071066,10071066,10071066
MODERATE PERICARDIAL EFFUSION,pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
"RASH ACNEIFORM, GRADE 2 ACNE LIKE RASH",rash acneiform,RASH ACNEIFORM,DERMATITIS ACNEIFORM,SKIN APPENDAGE CONDITIONS,ACNES,10040785,10037847,10012432,10037847
THYROTOXICOSIS,Hyperthyroidism,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
RESISTANCE TO CONVENTIONAL PHARMACOLOGICAL TREATMENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PHYSICAL DISORDERS,Physical impairment,PHYSICAL IMPAIRMENT,PHYSICAL DISABILITY,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10076322,10048624,10076322
MEDICATION-RELATED OSTEONECROSIS OF THE JAW STAGE 3 [MAXILLA (QUADRANT I) AND MANDIBLE (QUADRANT IV)],Osteonecrosis of Jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
"WBC ELEVATED (16,000 PER MICROL)",White blood cell count increased,WBC INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056739,10047943,10056739
VINCRISTINE INDUCED UNILATERAL VOCAL CORD PALSY,vincristine induced unilateral vocal cord palsy,VOCAL CORD PALSY,VOCAL CORD PARALYSIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),VAGUS NERVE DISORDERS,10029205,10078852,10047674,10078852
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HYPOXIA,Hypoxia,HYPOXIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021143,10021143,10021143
DELAYED GRAFT FUNCTION/ DECREASED GRAFT FUNCTION DUE TO BK VIRUS NEPHROPATHY,Complications of transplanted kidney,KIDNEY GRAFT DYSFUNCTION,COMPLICATIONS OF TRANSPLANTED KIDNEY,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10051366,10010185,10051366
PORTAL HYPERTENSION,portal hypertension,PORTAL HYPERTENSION,PORTAL HYPERTENSION,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10036200,10036200,10036200
FETAL EXPOSURE TO SODIUM VALPROATE,Foetal exposure during pregnancy,FETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071404,10071404,10071421
DRUG MISUSE,Intentional drug misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
HYPERTHYROIDISM,Hyperthyroidism,HYPERTHYROIDISM,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10020850,10020850,10020850
WARFARIN-INDUCED SKIN NECROSIS,skin necrosis,SKIN NECROSIS,SKIN NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040893,10040893,10040893
THROMBUS OF RENAL TRANSPLANT ARTERY FOLLOWING CARBAPENUM-RESISTANT KLEBSIELLA PNEUMONIAE BLOOD STREAM INFECTION,Infective thrombosis,INFECTIVE THROMBOSIS,INFECTIVE THROMBOSIS,INFECTIONS - PATHOGEN UNSPECIFIED,VASCULAR INFECTIONS,10021881,10058016,10058016,10058016
ATTEMPTED SEXUAL ASSAULT ON AN OLDER NEIGHBOR,Sexual abuse,SEXUAL ASSAULT,SEXUAL ABUSE,LEGAL ISSUES,CRIMINAL ACTIVITY,10041244,10040467,10040461,10040467
GASTROINTESTINAL TRACT IRRITATION,Gastrointestinal tract irritation,GASTROINTESTINAL TRACT IRRITATION,GASTROINTESTINAL TRACT IRRITATION,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10070840,10070840,10070840
BACK MYALGIA ON EZETIMIBE TREATMENT,Myalgia,LOCALISED MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10063543,10028411,10063543
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
"A BLOOD SMEAR SHOWED ANISOPOIKILOCYTOSIS, TEAR DROP FORMS, HEMIGHOST RED CELLS, MATURE LYMPHOCYTES AND SMUDGE CELLS",Anisocytosis,ANISOCYTOSIS,ANISOCYTOSIS,RED BLOOD CELL DISORDERS,RED BLOOD CELL ABNORMAL FINDINGS NEC,10005329,10002536,10002536,10002536
DIVERGENT SQUINT,Strabismus,DIVERGENT SQUINT,STRABISMUS,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10015694,10042159,10013529
PLURIFOCAL CUTANEOUS LEISHMANIASIS,Cutaneous leishmaniasis,CUTANEOUS LEISHMANIASIS,CUTANEOUS LEISHMANIASIS,PROTOZOAL INFECTIOUS DISORDERS,LEISHMANIA INFECTIONS,10021881,10011668,10011668,10011668
ASAT INCREASED (94 MMOL/L),asat increased (94 mmol/l),ASPARTATE AMINOTRANSFERASE INCREASE,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003480,10003481,10003480
A LOW REACTIVITY TO LIGHT,Light reflex sluggish,LIGHT REFLEX SLUGGISH,PUPILLARY REFLEX IMPAIRED,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10024463,10037532,10024463
VASOGENIC EDEMA FOLLOWING POSTERIOR REVERSIBLE ENCEPHALOPATHY,Vasogenic cerebral edema,VASOGENIC CEREBRAL EDEMA,VASOGENIC CEREBRAL OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10067278,10067275,10067278
WATERY STOOLS,stools watery,STOOLS WATERY,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10042157,10012735,10042157
MENINGITIS,Meningitis,MENINGITIS,MENINGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10027199,10027199,10027199
REBOUND PHENOMENON,rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
NON-SEMINOMA TESTICULAR CANCER,Non-seminoma testicular cancer,NON-SEMINOMA TESTICULAR CANCER,TESTIS CANCER,REPRODUCTIVE NEOPLASMS MALE MALIGNANT AND UNSPECIFIED,TESTICULAR NEOPLASMS MALIGNANT,10029104,10029557,10057644,10029557
MYOCARDIAL INFARCTION,Myocardial infarction,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10028596,10028596,10028596
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
UNCONTROLLABLE LOW SYSTEMIC BLOOD PRESSURE,Hypotension,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10024895
POSSIBLE DRUG-DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
ADRENAL STEROID SUPPRESSION,Adrenal suppression,ADRENAL SUPPRESSION,ADRENAL SUPPRESSION,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001382,10001382,10001382
"MILD, PERSISTENT DYSPNEA",Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
ACUTE VENOUS THROMBOSIS OF THE LEFT LOWER LEG,DVT of calf,DVT OF CALF,DEEP VEIN THROMBOSIS,EMBOLISM AND THROMBOSIS,PERIPHERAL EMBOLISM AND THROMBOSIS,10047065,10013878,10051055,10013878
PNEUMONIA,pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
AUTOIMMUNE HEPATITIS,Autoimmune hepatitis,AUTOIMMUNE HEPATITIS,AUTOIMMUNE HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10003827,10003827,10003827
ALKALINE PHOSPHATASE INCREASED (159 U/L),Blood alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
CYANOSIS,cyanosis,CYANOSIS,CYANOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10011703,10011703,10011703
HYPOTHYROIDISM,Hypothyroidism,HYPOTHYROIDISM,HYPOTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPOFUNCTION DISORDERS,10014698,10021114,10021114,10021114
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
SEIZURE WORSENING/ A SEIZURE RELAPSE AFTER 40 MONTHS OF FREEDOM,Condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
ANOXIC BRAIN INJURY WITH SWELLING AND POSSIBLE HERNIATION,Brain injury,BRAIN INJURY,BRAIN INJURY,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10067967,10067967,10067967
SHIVERING,Shivering,SHIVERING,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10040558,10008531,10040558
STAPHYLOCOCCUS AUREUS-INDUCED SEPSIS WITH MULTIPLE DIFFUSE PELVIC ABSCESSES,Pelvic abscess,PELVIC ABSCESS,PELVIC ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10034236,10034236,10034236
INTRACRANIAL HYPERTENSION,intracranial hypertension,INTRACRANIAL HYPERTENSION,INTRACRANIAL PRESSURE INCREASED,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10022764,10022773,10022764
SMVT REFRACTORY TO DRUGS : DISOPYRAMIDE AND AMIODARONE (LACK OF DRUG EFFECT WITH NO ADVERSE EVENT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
BRAINSTEM ATROPHY,atrophy,ATROPHY,ATROPHY,TISSUE DISORDERS NEC,TROPHIC DISORDERS,10018065,10003694,10003694,10003694
BRADYCARDIC AND HYPOTENSIVE DECOMPENSATION,Decompensation cardiac,DECOMPENSATION CARDIAC,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10011949,10007554,10011949
CREATININE KINASE INCREASED (587 U/L),Blood creatine phosphokinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
"DESPITE METHYLPREDNISOLONE, CYCLOPHOSHAMIDE, IVIG AND RITUXIMAB, HIS CONDITION DETERIORATED AND INTERSTITIAL LUNG DISEASE PROGRESSED",Interstitial lung disease,INTERSTITIAL LUNG DISEASE,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022611,10022611,10022611
CENTRAL NERVOUS SYSTEM EXCITATION,Central nervous system disorder,CENTRAL NERVOUS SYSTEM DISORDER,NERVOUS SYSTEM DISORDER,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10007943,10029202,10007943
ACCIDENTAL DRUG OVERDOSE,Accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
PRURITUS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
"DRY COUGH, FATIGUE AND DYSPNOEA WITH 9 MONTHS OF EVOLUTION",cough,DRY COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10013773,10011224,10013773
DROWSY,Drowsiness,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
ERRORS DUE TO DUPLICATION AND SIMILARITY OF GENERIC PHARMACEUTICAL BOXES,Product packaging confusion,PRODUCT PACKAGING CONFUSION,PRODUCT PACKAGING CONFUSION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT CONFUSION ERRORS AND ISSUES,10022117,10074776,10074776,10074776
"AFTER REPLACEMENT, THE PATIENT STARTED BLEEDING EXCESSIVELY AND AN INTACT PREGNANCY WAS DIAGNOSED",Haemorrhage in pregnancy,HAEMORRHAGE IN PREGNANCY,HAEMORRHAGE IN PREGNANCY,MATERNAL COMPLICATIONS OF PREGNANCY,HAEMORRHAGIC COMPLICATIONS OF PREGNANCY,10036585,10018981,10018981,10018981
MULTIPLE DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
MULTIPLE CEREBRAL METASTATIC TUMORS,multiple cerebral metastatic tumors,BRAIN CANCER METASTATIC,BRAIN CANCER METASTATIC,NERVOUS SYSTEM NEOPLASMS MALIGNANT AND UNSPECIFIED NEC,CENTRAL NERVOUS SYSTEM NEOPLASMS MALIGNANT NEC,10029104,10055093,10055093,10055093
C-REACTIVE PROTEIN INCREASED (125 MG/DL),C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
PROCALCITONIN LEVEL:4.76 NG/ML,Procalcitonin increased,PROCALCITONIN INCREASED,PROCALCITONIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10067081,10067081,10067081
ARCHING OF THE NECK AND TONGUE BITING,tongue biting,TONGUE BITING,TONGUE BITING,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10050467,10050467,10050467
AGRANULOCYTOSIS,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
PATIENT'S OVERALL STATUS DECLINED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
"EDEMA OF THE FACE, TRUNK AND EXTREMITIES",Generalised oedema,EDEMA GENERALIZED,GENERALISED OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10018092,10018092,10014223
GRADE 5 LUNG INFECTION,Lung infection,LUNG INFECTION,LUNG INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10061229,10061229,10061229
STEVENS-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
ACUTE EPISODE OF RECTAL BLEEDING,rectal bleeding,RECTAL BLEEDING,RECTAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,INTESTINAL HAEMORRHAGES,10017947,10038035,10038063,10038035
SEPTIC SHOCK DUE TO STAPHYLOCOCCAL TOXIC SHOCK SYNDROME FOLLOWING RAPID PROGRESSION OF WOUND INFECTION (SKIN ULCERATION),Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
BONE METASTASES IN VERTEBRAE C7 AND D1/NEW BONE METASTASIS,Bone metastases,BONE METASTASES,METASTASES TO BONE,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10005993,10027452,10005993
FMF ATTACK WITH FEVER/FLARE,Familial mediterranean fever,FAMILIAL MEDITERRANEAN FEVER,FAMILIAL MEDITERRANEAN FEVER,IMMUNE SYSTEM DISORDERS CONGENITAL,IMMUNE SYSTEM ABNORMALITIES CONGENITAL,10010331,10016207,10016207,10016207
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
ULCERATIVE LESIONS WERE OBSERVED DEEP IN THE POSTERIOR WALL OF THE GASTRIC,Gastric mucosal lesion,GASTRIC MUCOSAL LESION,GASTRIC MUCOSAL LESION,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL MUCOSAL DYSTROPHIES AND SECRETION DISORDERS,10017947,10061164,10061164,10061164
ELECTROCARDIOGRAM QTC INTERVAL PROLONGED (450 MSEC),Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
ACUTE KIDNEY INJURY FOLLOWING DRUG INTERACTION BETWEEN PIPERACILLIN/TAZOBACTAM AND VANCOMYCIN,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
CLINICAL INTOLERANCY,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
GENERALIZED PERSPIRING,Hyperhidrosis,SWEATING,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042670,10020642,10042661
G2 ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
MAJOR ORAL ERYTHEMA MULTIFORM,Oral mucosal erythema,ORAL MUCOSAL ERYTHEMA,ORAL MUCOSAL ERYTHEMA,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SIGNS AND SYMPTOMS,10017947,10067418,10067418,10067418
SINUS BRADYCARDIA,Sinus bradycardia,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040741,10040741,10040741
WORST OF ALL REMAININING OF RLS SYMPTOM,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
UNCONSCIOUSNESS,Unconsciousness,UNCONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10045481,10024855,10045481
ACANTHAMOEBA GRANULOMATOUS AMOEBIC ENCEPHALITIS,Encephalitis,ENCEPHALITIS,ENCEPHALITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10014581,10014581,10014581
"EDEMA OF THE HANDS, FEET",Oedema peripheral,EDEMA EXTREMITIES,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10055917,10030124,10014220
EOSINOPHILIA,eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
WAKEUP,Awakening early,AWAKENING EARLY,TERMINAL INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10003867,10068932,10003867
DESQUAMATION,Skin exfoliation,DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10012528,10040844,10012528
HEMATOMAS OF SEVERAL DIMENSIONS SPREAD BY THE UPPER AND LOWER LIMBS,Haematoma,HEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10019428
RECURRENT FALLS/FALL,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
INTOXICATION,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
PARONYCHIA,Paronychia,PARONYCHIA,PARONYCHIA,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10034016,10034016,10034016
BK POLYOMAVIRUS-ASSOCIATED NEPHROPATHY GRADE B,Polyomavirus-associated nephropathy,BK VIRUS NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065333,10065381,10065333
WORSENING LVEF TO 22%,Ejection fraction decreased,LEFT VENTRICULAR EJECTION FRACTION DECREASED,EJECTION FRACTION DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10053222,10050528,10053222
LIVER DAMAGE,Liver injury,LIVER DAMAGE,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067125,10067125,10024668
DRUG EXPOSURE DURING PREGNANCY (WITH NO ADVERSE EVENT),Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
INFERIOR ARCUATE DEFECT,Arcuate scotoma,ARCUATE SCOTOMA,VISUAL FIELD DEFECT,NEUROLOGICAL DISORDERS OF THE EYE,NEUROLOGIC VISUAL PROBLEMS NEC,10029205,10003081,10047555,10003081
SEMI-CONSCIOUS STATE,unconscious partial,UNCONSCIOUS PARTIAL,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10045480,10012373,10045480
SPORADIC MOVEMENTS OF HIS LOWER EXTREMITIES,Dyskinesia,MOVEMENTS INVOLUNTARY OF LIMBS,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028043,10013916,10028043
PROGRESSIVE DYSPHAGIA,progressive dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
FEELING SICK,Feeling sick,FEELING SICK,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016365,10025482,10016365
BLOOD ALUMINIUM INCREASED,Blood aluminium increased,BLOOD ALUMINIUM INCREASED,BLOOD ALUMINIUM INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,TOXICOLOGY LABORATORY ANALYSES,10022891,10005321,10005321,10005321
RECURRENT LEUKOPENIA,LEUKOPENIA,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
ACUTE PAIN IN DORSOSACRAL REGION AND IN LOWER LIMBS,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
BENIGN PROSTATIC HYPERPLASIA,Benign prostatic hyperplasia,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,PROSTATIC DISORDERS (EXCL INFECTIONS AND INFLAMMATIONS),PROSTATIC NEOPLASMS AND HYPERTROPHY,10038604,10004446,10004446,10004446
CANDIDA ALBICANS PERITONITIS,Candida infection,CANDIDA ALBICANS INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10054230,10074170,10054230
OSTEOMYELITIS,Osteomyelitis,OSTEOMYELITIS,OSTEOMYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,BONE AND JOINT INFECTIONS,10021881,10031252,10031252,10031252
EXPOSURE DURING PREGNANCY,Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
PYRIDOXINE-INDUCED SENSORY ATAXIC GANGLIONOPATHY,Peripheral sensory neuropathy,SENSORY NEUROPATHY,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10062975,10034620,10062975
INJECTION SITE ERYTHEMA/ 6 X 6 CM ERYTHEMATOUS AREA,vaccination site reaction,VACCINATION SITE REACTION,VACCINATION SITE REACTION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10059080,10059080,10059080
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
MOUTH ULCERATIONS,Mouth ulcerations,MOUTH ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028034,10028034,10028034
PAIN IN THE JOINTS AND MUSCLES,muscle pain,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028322,10028411,10028322
PTT INCREASED (103 SECS),Activated partial thromboplastin time prolonged,PTT PROLONGED,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037276,10000636,10037276
HERPES SIMPLEX VIRUS INFECTION,Herpes virus infection,HERPES VIRUS INFECTION,HERPES VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10019973,10019973,10019973
DERAILMENTS,Derailment,DERAILMENT,DERAILMENT,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10012411,10012411,10012411
BABY WAS BORN PREMATURELY AT 28 WEEKS,Premature delivery,PREMATURE DELIVERY,PREMATURE DELIVERY,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036595,10036595,10036595
MILD ERYTHEMA,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
"FLAIRING OF ADULT ONSET STILLâ€™S DISEASE DUE TO LACK OF DRUG EFFECT OF PREDNISOLONE, METHYLPREDNISOLONE AND AZATHIOPRINE",Still's disease adult onset,STILL'S DISEASE ADULT ONSET,STILL'S DISEASE,JOINT DISORDERS,RHEUMATOID ARTHROPATHIES,10028395,10064056,10042061,10064056
CREATININE INCREASED TO 196 MMOL/L,Blood creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
STRIDOR,Stridor,STRIDOR,STRIDOR,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),"LARYNGEAL SPASM, OEDEMA AND OBSTRUCTION",10038738,10042241,10042241,10042241
NEUROPATHY,Neuropathy peripheral,NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029328,10029331,10029328
GENERALIZED MALAISE,generalized malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
JAW AND TONGUE CLAUDICATION,Tongue pain,TONGUE PAIN,GLOSSODYNIA,TONGUE CONDITIONS,TONGUE SIGNS AND SYMPTOMS,10017947,10043969,10018388,10043969
GALLBLADER COMPLETELY FILLED WITH STONES,Gallstones,GALLSTONES,CHOLELITHIASIS,GALLBLADDER DISORDERS,CHOLECYSTITIS AND CHOLELITHIASIS,10019805,10017650,10008629,10017650
NEUTROPENIA,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
HGB DECREASED (7 G/DL),Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
MOTOR APHASIA,Aphasia,APHASIA MOTOR,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002949,10002948,10002949
PYURIA,Pyuria,PYURIA,PYURIA,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10037686,10037686,10037686
LACK OF DRUG EFFECT/INADEQUATE TREATMENT,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
INTERSTITIAL LUNG DISEASE,Interstitial lung disease,INTERSTITIAL LUNG DISEASE,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022611,10022611,10022611
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
MULTI ORGAN FAILURE FOLLOWING HEMOPHAGOCYTIC SYNDROME,multi-organ failure,MULTI-ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028154
OFFLABEL USE OF METHOTREXATE FOR EXTRA-RENAL RHABDOID TUMOUR (WITH NO ADR),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PROFOUND ENCEPHALOPATHY DUE TO ACUTE-ON-CHRONIC LIVER FAILURE,Hepatic encephalopathy,HEPATIC ENCEPHALOPATHY,HEPATIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10019660,10019660,10019660
SKIN NECROSIS ASSOCIATED WITH INTRAMUSCULAR INJECTION OF DICLOFENAC,Skin necrosis,SKIN NECROSIS,SKIN NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040893,10040893,10040893
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
SWELLING IN HER RIGHT KNEE,Joint swelling,SWELLING OF R KNEE,JOINT SWELLING,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10042704,10023232,10042704
ACUTE LIVER FAILURE,Acute hepatic failure,ACUTE LIVER FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10049844
MOON FACE,moon face,MOON FACE,CUSHINGOID,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10027953,10011655,10027953
STATININDUCED NECROTIZING AUTOIMMUNE MYOPATHY,Immune-mediated necrotising myopathy,IMMUNE-MEDIATED NECROTISING MYOPATHY,IMMUNE-MEDIATED NECROTISING MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10072155,10072155,10072155
MURAL WALL THICKENING,Gastrointestinal wall thickening,GASTROINTESTINAL WALL THICKENING,GASTROINTESTINAL WALL THICKENING,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10075724,10075724,10075724
DROWSY,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
MILD NEUTROPENIA,neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
INTESTINAL HAEMORRHAGE,Intestinal haemorrhage,INTESTINAL HAEMORRHAGE,INTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,INTESTINAL HAEMORRHAGES,10017947,10059175,10059175,10059175
DERANGED LIVER FUNCTION,deranged liver function,DERANGED LIVER FUNCTION TESTS,LIVER FUNCTION TEST ABNORMAL,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10012412,10024690,10012412
"THE LESIONS ON THE PATIENT'S FACE HAD ULCERATED AND CRUSTED OVER, ALONG WITH THE BULLA AND EROSIONS FORMING OVER LARGE AREAS OF HIS TRUNK AND EXTREMITIES",Scab,CRUST,SCAB,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10039509,10039509,10011468
PLEURAL EFFUSION,pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
DEVELOPED MEDICATION-RELATED OSTEONECROSIS OF THE JAW STAGE 3 [MANDIBLE (QUADRANT IV)],Osteonecrosis of Jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
SPLENOMEGALY,Splenomegaly,SPLENOMEGALY,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041660,10041660,10041660
ABDUCENS PARESIS,VIth nerve palsy,VITH NERVE PALSY,VITH NERVE PARALYSIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),EYE MOVEMENT DISORDERS,10029205,10047640,10047641,10047640
VORICONAZOLE USED FOR BULLOUS NECROTIC PURPURA,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
VALPROATE ASSOCIATED HAIR LOSS,Alopecia,HAIR LOSS,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10019045,10001760,10019045
CHRONIC INGESTION OF HIGH DOSES OF PYRIDOXINE THAT REACHED 30 MG/DAY (VITAMIN-B6 LEVEL-60.2 NG/ML,,,,,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",10027432,10047618,10047618,
FAT ATROPHY AND DEPIGMENTATION/DEPIGMENTATION AROUND THE INJECTED AREA,Retinal depigmentation,RETINAL DEPIGMENTATION,RETINAL DEPIGMENTATION,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10038846,10038846,10038846
REMAINED IN DEEP COMA,coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
WORSENING OF NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ALLERGIC MYOCARDIAL ISCHEMIA SECONDARY TO IBUPROFEN,Myocardial ischaemia,ISCHEMIA MYOCARDIAL,MYOCARDIAL ISCHAEMIA,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10028600,10028600,10023033
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
CUSHINGOID FACE,Cushingoid facies,CUSHINGOID FACIES,CUSHINGOID,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011656,10011655,10011656
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
MENTAL AND MOTOR SLOWING,Mental disorder,MENTAL DISORDER,MENTAL DISORDER,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10061284,10061284,10061284
HEPATOMEGALY,Hepatomegaly,HEPATOMEGALY,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10019842
INFECTION,Infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
DRUG DEPENCY,Drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
WHITE BLOOD CELL COUNT DECREASED,White blood cell count decreased,WHITE BLOOD CELL COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10047942
"PATIENT CAME BACK WITH COMPLAINTS OF INCREASED LETHARGY, DROWSINESS AND IMPAIRED CONSCIOUSNESS",Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
PATENT DUCTUS ARTERIOSUS,Patent ductus arteriosus,PATENT DUCTUS ARTERIOSUS,PATENT DUCTUS ARTERIOSUS,CARDIAC AND VASCULAR DISORDERS CONGENITAL,PERSISTENT FOETAL CIRCULATION DISORDERS,10010331,10034130,10034130,10034130
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
LEFT SIDED FACIAL WEAKNESS,Facial paresis,FACIAL WEAKNESS,FACIAL PARESIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),FACIAL CRANIAL NERVE DISORDERS,10029205,10051271,10051267,10051271
MYOPIA,Myopia,MYOPIA,MYOPIA,VISION DISORDERS,REFRACTIVE AND ACCOMMODATIVE DISORDERS,10015919,10028651,10028651,10028651
HISTORIES OF HEROIN ABUSE WHERE CARFENTANIL WAS SUBSTITUTED OR ADDED,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
NEW LESIONS OF PANSCLEROTIC MORPHOEA APPEARED FOLLOWING DOSE REDUCTION OF PREDNISONE (REBOUND EFFECT),Morphoea,MORPHOEA,MORPHOEA,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),CONNECTIVE TISSUE DISORDERS NEC,10028395,10027982,10027982,10027982
ALLERGIC SKIN REACTION,Allergic skin reaction,ALLERGIC SKIN REACTION,DERMATITIS ALLERGIC,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10001729,10012434,10001729
TENDERNESS TO 2 1/2 INCHES,tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
NON-SEMINOMA TESTICULAR CANCER,Non-seminoma testicular cancer,NON-SEMINOMA TESTICULAR CANCER,TESTIS CANCER,REPRODUCTIVE NEOPLASMS MALE MALIGNANT AND UNSPECIFIED,TESTICULAR NEOPLASMS MALIGNANT,10029104,10029557,10057644,10029557
THE PATIENT WAS UNABLE TO TOLERATE A TRIAL OF INDOMETHACIN,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
"WORSENING OF KLEBSIELLA PNEUMONIAE INFECTION (KPC) DESPITE THE TREATMENT WITH COLISTIN, MEROPENEM AND AMIKACIN",Klebsiella infection,KLEBSIELLA PNEUMONIAE INFECTION,KLEBSIELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10052209,10061259,10052209
ANAEMIC,Anaemic,ANAEMIC,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002088,10002034,10002088
ELEVATED FREE T4,Thyroxine free increased,FREE T4 INCREASED,THYROXINE FREE INCREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),THYROID ANALYSES,10022891,10051882,10055163,10051882
NEURODEVELOPMENTAL DISORDER,neurodevelopmental disorder,NEURODEVELOPMENTAL DISORDER,NEURODEVELOPMENTAL DISORDER,DEVELOPMENTAL DISORDERS NEC,PERVASIVE DEVELOPMENTAL DISORDERS NEC,10037175,10064062,10064062,10064062
ALLERGY,Hypersensitivity,HYPERSENSITIVITY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020751,10020751,10020751
EXPERIENCING TOXICITIES OF LETHARGY AND MILD DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
MUSCLE STIFFNESS,Musculoskeletal stiffness,MUSCLE STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10028339,10052904,10028339
ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
ANURIA,Anuria,ANURIA,ANURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10002847,10002847,10002847
ELEVATED SERUM LACTATE,Blood lactic acid increased,LACTATE INCREASED,BLOOD LACTIC ACID INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10023660,10005635,10023660
SWELLING IN THE PERIORBITAL AND AURICULAR REGIONS/ SWELLING AROUND THE EYES AND IN THE REGION AROUND EARS,Eye swelling,PERIORBITAL SWELLING,EYE SWELLING,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10056647,10015967,10056647
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
BLOOD CREATINE PHOSPHOKINASE INCREASED,Blood creatine phosphokinase increased,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10005470,10005470,10005470
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
REMNANT LIVER FAILURE,Liver failure,LIVER FAILURE,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10024678,10019663,10024678
BENDAMUSTINE FOR RELAPSED HODGKIN'S LYMPHOMA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"SYNOSTOSIS OF THE JOINTS, OF METACARPOPHALENGEAL PROXIMAL AND DISTAL INTRAPHALENGEAL JOINTS IN DIGITS 2-5/BILATERAL SYNOSTOIS OF SHORTENED FIRST TOE FOLLOWING DRUG EXPOSURE IN UTERO",Synostosis,SYNOSTOSIS,SYNOSTOSIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS OF TRUNK CONGENITAL (EXCL SPINE),10010331,10042856,10042856,10042856
BLOODSHOTS EYES DUE TO SUBCONJUNCTIVAL HAEMORRHAGE FOLLOWED BY PANCYTOPENIA,bloodshots eyes due to subconjunctival haemorrhage followed by pancytopenia,SUBCONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,OCULAR HAEMORRHAGES AND VASCULAR DISORDERS NEC,CONJUNCTIVAL AND CORNEAL BLEEDING AND VASCULAR DISORDERS,10015919,10042341,10010719,10042341
LACTATE DEHYDROGENASE INCREASED (2894U/L),Blood lactate dehydrogenase increased,LACTATE DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10023654,10005630,10023654
PSYCHOTIC INDUCED ANXIETY FOLLOWING DELIVERY,anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
SECOND BLIND SPOT/NASAL SCOTOMA IN THE RIGHT EYE,Visual field defect,SCOTOMA,VISUAL FIELD DEFECT,NEUROLOGICAL DISORDERS OF THE EYE,NEUROLOGIC VISUAL PROBLEMS NEC,10029205,10039729,10047555,10039729
METFORMIN-INDUCED LACTACIDOSIS WAS CONFIRMED,lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
THYMUS ENLARGEMENT,Thymus enlargement,THYMUS HYPERTROPHY,THYMUS ENLARGEMENT,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",THYMUS DISORDERS,10005329,10043682,10065588,10043682
SUPRAVENTRICULAR TACHYCARDIA,supraventricular tachycardia,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10042604,10042604,10042604
SEVERE BK POLYOMAVIRUS-INDUCED HEMORRHAGIC CYSTITIS,Cystitis haemorrhagic,HEMORRHAGIC CYSTITIS,CYSTITIS HAEMORRHAGIC,BLADDER AND BLADDER NECK DISORDERS (EXCL CALCULI),BLADDER INFECTIONS AND INFLAMMATIONS,10038359,10011793,10011793,10019598
ADHESIVE BANDS,Ileus adhesive,ILEUS ADHESIVE,ILEUS,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION NEC,10017947,10056322,10021328,10056322
MICTURITION DIFFICULTIES,micturition frequency decreased,MICTURITION FREQUENCY DECREASED,MICTURITION FREQUENCY DECREASED,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10059042,10059042,10059042
CANDIDA LUSITANIAE THRUSH,Candida infection,CANDIDA LUSITANIAE INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10070984,10074170,10070984
EEG ABNORMALITIES,EEG abnormal,EEG ABNORMAL,ELECTROENCEPHALOGRAM ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10014276,10014408,10014276
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
"HYPOREGENERATIVE, NORMOCYTIC ANEMIA (HB: 8.6 G/DL)",Normocytic anaemia,NORMOCYTIC ANEMIA,NORMOCYTIC ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10029784,10029784,10029785
PERIORBITAL EDEMA,Periorbital oedema,PERIORBITAL EDEMA,PERIORBITAL OEDEMA,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10034545,10034545,10054541
MUCOSITIS,mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
MILD INCREASE IN RIGHT EYE FLOATERS,Vitreous floaters,EYE FLOATERS,VITREOUS FLOATERS,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","CHOROID AND VITREOUS STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10016779,10047654,10015924
NEPHROGENIC DIABETES INSIPIDUS,Nephrogenic diabetes insipidus,NEPHROGENIC DIABETES INSIPIDUS,NEPHROGENIC DIABETES INSIPIDUS,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10029147,10029147,10029147
DIARRHEA,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
NEUROLOGICAL REACTION,Neurological symptom,NEUROLOGIC REACTION,NEUROLOGICAL SYMPTOM,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10029290,10060860,10029290
ASCITES IN THE PELVIS,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
WALKING INSTABILITY,Gait disturbance,GAIT ABNORMAL,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017573,10017577,10017573
SEVERE LEFT VENTRICULAR DYSFUNCTION,left ventricular dysfunction,LEFT VENTRICULAR DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10049694,10049694,10049694
5 KG OF WEIGHT LOSS,weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
IMMEDIATE ALLERGIC REACTION TO AMOXICILLIN/CLAVULANIC ACID,immediate hypersensitivity reaction,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
ITCHY RED RASHES,Rash pruritic,ITCHY RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10023092
WORSENING LEARNING OUTCOMES/ PROBLEMS IN CONCENTRATING ATTENTION IN CONNECTION WITH GROWING REQUIREMENTS,Condition aggravated,DISEASE AGGRAVATION,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10013097,10010264,10013097
RASHES ON LIMBS AND TRUNK,Rash generalised,GENERALISED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037858,10037858,10018095
APPARENT SWELLING OF LOWER EXTREMITIES,swelling of legs,SWELLING OF LEGS,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042700,10048959,10042700
DRUG INDUCED LIVER INJURY,drug induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
CEREBRAL HEMORRHAGE,Cerebral haemorrhage,CEREBRAL HEMORRHAGE,CEREBRAL HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008111,10008111,10008114
MESANGIAL LUPUS NEPHRITIS CLASS II,Lupus nephritis,LUPUS NEPHRITIS,LUPUS NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10025140,10025140,10025140
POST-BULLOUS  EROSIONS,Bullous eruption,BULLOUS ERUPTION,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006559,10012441,10006559
PROCALCITONIN LEVELS INCREASED (1.670NG/DL),Procalcitonin increased,PROCALCITONIN INCREASED,PROCALCITONIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10067081,10067081,10067081
NEUTROPHILIA AT 12.5 X 10E9/L,neutrophilia at 12.5 x 10 e9/L,NEUTROPHILIA,NEUTROPHILIA,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10029379,10029379,10029379
PRESENCE OF YELLOWISH SKIN,Yellow skin,YELLOW SKIN,YELLOW SKIN,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10048245,10048245,10048245
DISTURBANCE OF TONGUE SENSATION/SENSORY DISTURBANCE OF THE TONGUE,Hypoaesthesia oral,TONGUE SENSATION LOSS OF,HYPOAESTHESIA ORAL,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SIGNS AND SYMPTOMS,10017947,10043978,10057371,10043978
ISOLATED CUTANEOUS BLISTERS,Blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
DISSEMINATED HERPES ZOSTER,Herpes zoster disseminated,HERPES ZOSTER DISSEMINATED,HERPES ZOSTER DISSEMINATED,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10065038,10065038,10065038
AIDS CHOLANGIOPATHY,AIDS cholangiopathy,AIDS CHOLANGIOPATHY,AIDS CHOLANGIOPATHY,VIRAL INFECTIOUS DISORDERS,RETROVIRAL INFECTIONS,10021881,10067092,10067092,10067092
POSITIVE BRUDZINSKI'S SIGN,Brudzinski's sign,BRUDZINSKI'S SIGN,BRUDZINSKI'S SIGN,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10064010,10064010,10064010
CHEST X-RAY DEMONSTRATED HILAR AND APICAL INFILTRATES ON THE LEFT,Chest X-ray abnormal,CHEST X-RAY ABNORMAL,CHEST X-RAY ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10008499,10008499,10008499
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
GASTRIC ULCER,Gastric ulcer,GASTRIC ULCER,GASTRIC ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,GASTRIC ULCERS AND PERFORATION,10017947,10017822,10017822,10017822
"DESPITE ANTIBIOTIC THERAPY, THE PATIENT DEVELOPED AN ABSCESS ON THE DORSAL SIDE OF THE WRIST AND THE EXTENSOR FUNCTION OF THE WRIST AND FINGERS DETERIORATED AND ABSCESS PROGRESSED",Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
TOENAILS WERE DISCOLORED,Nail discolouration,TOENAIL DISCOLORATION,NAIL DISCOLOURATION,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10068212,10028692,10068211
TREATMENT WITH VITAMIN C AND IRON FOR SCURY IN A BREAST FEEDING PATIENT (DRUG EXPOSURE VIA LACTATION WITH NO ADR),Maternal exposure during breast feeding,EXPOSURE DURING BREAST FEEDING,MATERNAL EXPOSURE DURING BREAST FEEDING,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071402,10080752,10071402
HYPOGLYCEMIAS,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
DUODENITIS,Duodenitis,DUODENITIS,DUODENITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10013864,10013864,10013864
FLUDARADINE ADMINISTERED IN 12.25 YEAR FOR CONDITIONING REGIMEN,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
VIRAL MYOCARDITIS,Viral myocarditis,VIRAL MYOCARDITIS,VIRAL MYOCARDITIS,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10047470,10047470,10047470
HYPERTENSION ARTÃ‰RIELLE,Hypertension arterial,HYPERTENSION ARTERIAL,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020775,10020772,10020775
BLEEDING MOUTH,Bleeding mouth,BLEEDING MOUTH,MOUTH HAEMORRHAGE,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE HAEMORRHAGES,10017947,10049331,10028024,10049331
OEDEMA TO EXTREMITIES,Oedema peripheral,OEDEMA OF EXTREMITIES,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10055917,10030124,10030115
FELT UNWELL,Malaise,FEELING UNWELL,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016365,10025482,10016370
PRURITUS OCCURRED 1 DAY AFTER WITHDRAWAL,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,Post transplant lymphoproliferative disorder,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10051358,10051358,10051358
EPISODIC IRRITABILITY,EPISODIC IRRITABILITY,IRRITABILITY,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10022998,10022998,10022998
RENAL DYSFUNCTION,Renal disorder,RENAL DISORDER,RENAL DISORDER,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL DISORDERS NEC,10038359,10038428,10038428,10038428
GENERALIZED DISTURBANCES OF LEFT VENTRICULAR FUNCTION,Left ventricular dysfunction,LEFT VENTRICULAR DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10049694,10049694,10049694
DIARRHOEA SHOWED NO RESPONSE TO LOPERAMIDE,Therapy non-responder,THERAPY NON-RESPONDER,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051082,10051082,10051082
TACHYPNEIC,Tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
WEIGHT GAIN,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
APHASIA,Aphasia,APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002948,10002948,10002948
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
DERMATOLOGIC SIDE EFFECTS OF CORTISONE,Dermatosis steroid-induced,SKIN DISORDER,SKIN DISORDER,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040831,10040831,10040831
DRUG EXPOSURE IN UTERO,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
RECURRENT ENDOMETRIOSIS (ENDOMETRIOSIS ON THE BOWEL AND THE VAGINAL VAULT),Endometriosis,ENDOMETRIOSIS,ENDOMETRIOSIS,"UTERINE, PELVIC AND BROAD LIGAMENT DISORDERS",UTERINE DISORDERS NEC,10038604,10014778,10014778,10014778
DELUSIONAL IDEAS OF REFERENCE (STRANGERS WERE WATCHING HER AND TALKING ABOUT HER),Delusion,DELUSIONS,DELUSION,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10012239,10012239,10012260
"DRUG DEPENDENT SUPPRESSION OF MYELOID PROGENITORS, PRIMITIVE MULTIPOTENTIAL PROGENITORS AND ERYTHROID PROGENITORS",Hematopoiesis suppressed,HEMATOPOIESIS SUPPRESSED,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10019447,10065553,10019447
FEBRILE,febrile reaction,FEBRILE REACTION,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016289,10037660,10016289
GENERAL FATIGUE,Fatigue,FATIGABILITY GENERALIZED,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10073917,10016256,10016253
ALLERGY TO CEFTRIAXONE,Allergic reaction to antibiotics,ALLERGIC REACTION TO ANTIBIOTICS,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10001720,10013700,10001720
MENTAL IMPAIRMENT,Mental impairment,MENTAL IMPAIRMENT,MENTAL IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10027374,10027374,10027374
HEMOGLOBIN 10.7 G/DL,Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER WITH NO ADVERSE EVENT",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
ATG WAS TRIED TO TREAT ACUTE GVHD IN ORDER TO WEAN OFF STEROID BUT WITHOUT SUCCESS (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DIFFUSE THIGH PAIN,pain in thigh,PAIN IN THIGH,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10048973,10033425,10048973
HB DECREASED - 2.8 G/DL,Haemoglobin decreased,HB DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10019171,10018884,10019171
"PATIENT WAS TREATED WITH PREDNISOLONE HOWEVER, GAIT DISTURBANCE PERSISTED (LACK OF DRUG EFFECT WITH NO ADR)",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
ANAPHYLACTIC SHOCK,Anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
CONDITION WORSENED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
KIDNEY DYSFUCTION SECONDARY TO VANCOMYCIN AND CEFEPIME,renal dysfucntion,KIDNEY DYSFUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10023417,10062237,10023417
BLOOD UREA NITROGEN,blood urea nitrogen increased,BLOOD UREA NITROGEN INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005855,10005851,10005855
ASPIRATION,Aspiration,ASPIRATION,ASPIRATION,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10003504,10003504,10003504
PATIENT WITH METHOTREXATE FOR PRURITUS (DRUG USE FOR UNAPPROVED INDICATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
OTHER BLOOD CULTURES PERFORMED ON D6 BECAUSE OF HECTIC FEVER WERE POSITIVE TO VEILLONELLA PARVULA,Veillonella test positive,VEILLONELLA TEST POSITIVE,VEILLONELLA TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,BACTERIA IDENTIFICATION AND SEROLOGY (EXCL MYCOBACTERIA),10022891,10070009,10070009,10070009
SEROTONIN TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
MUSCLE PAIN IN THE LOWER EXTREMITIES,Muscle pain,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028322,10028411,10028322
FEBRILE NEUTROPENIA (0.05X10*9 WBC/L),Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
HEPATITIS B,Hepatitis B,HEPATITIS B,HEPATITIS B,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10019731,10019731,10019731
PROLONGATION OF THE QTC INTERVAL (690 MSEC),Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
CARDIORESPIRATORY ARREST,Cardio-respiratory arrest,CARDIO-RESPIRATORY ARREST,CARDIO-RESPIRATORY ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007617,10007617,10007617
"GENERALISED MALAISE, FEVER AND POLYARTHRITIS DESPITE THE TREATMENT",Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
HYPOTHYROIDISM,Hypothyroidism,HYPOTHYROIDISM,HYPOTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPOFUNCTION DISORDERS,10014698,10021114,10021114,10021114
COLD AT THE PERIPHERY,Cold,COLD,NASOPHARYNGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10009851,10028810,10009851
PREMATURE RUPTURE OF THE MEMBRANES,premature rupture of the membranes,PREMATURE RUPTURE OF MEMBRANES,PREMATURE RUPTURE OF MEMBRANES,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036603,10036603,10036603
"WBC INCREASED(21,860 PER MICROL; NEUTROPHIL FRACTION 88.8%)",White blood cell count increased,WBC INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056739,10047943,10056739
ERYTHEMATOUS MACULES AND PATCHES (RIGHT EYE),Macule,MACULE,MACULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10025421,10025421,10025421
"NUMEROUS LESIONS,LARGEST MEASURING 4X3 CM WITH A CENTRAL AREA OF NECROSIS,SURROUNDED BY FRESH COLOURED VESICLES ON AN ERYTHEMATOUS BASE (SIMILAR LESIONS SEEN ON THE SCROTUM,CHEST,RIGHT TEMPLE AND CORNER OF MOUTH)",vesicles,VESICLES,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10047368,10005191,10047368
MYCOPHENOLATE WAS ADMINISTERED FOR NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS DETERIORATED,off-label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ACUTE FLACCID PARALYSIS,Paralysis,FLACCID PARALYSIS,PARALYSIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10033809,10033799,10016744
HEMOGLOBIN DECREASED (2.5 G/DL),Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
BRONCHOSPASM,bronchospasm,BRONCHOSPASM,BRONCHOSPASM,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10006482,10006482,10006482
STEROID RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
QUETIAPINE-INDUCED SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
PROFUSE SWEATING,Sweating,SWEATING,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042661,10020642,10042661
CYANOTIC,cyanotic,CYANOTIC,CYANOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10011709,10011703,10011709
DRUG DEPENDENCE,drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ACUTE KIDNEY INJURY DUE TO METFORMIN-INDUCED LACTIC ACIDOSIS,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
MULTIPLE DRUG POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
TRANSAMINASES INCREASED,Transaminases increased,TRANSAMINASES INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054889,10054889,10054889
TONIC-CLONIC CONVULSIVE SPASMS OCCURRED AND PERSISTED,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
EROSIVE GASTRODUODENITIS,erosive gastroduodenitis,EROSIVE GASTRODUODENITIS,GASTRITIS EROSIVE,GASTROINTESTINAL ULCERATION AND PERFORATION,GASTRIC ULCERS AND PERFORATION,10017947,10067514,10017865,10067514
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
POST-OP PHT CRISIS,Pulmonary hypertensive crisis,PULMONARY HYPERTENSIVE CRISIS,PULMONARY HYPERTENSIVE CRISIS,PULMONARY VASCULAR DISORDERS,PULMONARY HYPERTENSIONS,10038738,10068726,10068726,10068726
SOMNOLENCE,somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
ANAEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
"PHYSICAL EXAMINATION REVEALED ERYTHEMATOUS PAPULOSQUAMOUS LESIONS CHARACTERIZED BY ANNULAR SCALY MARGINS AND A DUSKY CENTRE OVER THE ARMS, CHEST, ABDOMEN, LOWER BACK AND LEGS",Papulosquamous rash,PAPULOSQUAMOUS RASH,RASH PAPULOSQUAMOUS,EPIDERMAL AND DERMAL CONDITIONS,PAPULOSQUAMOUS CONDITIONS,10040785,10033739,10037879,10033739
FUROSEMIDE-INDUCED ACUTE PANCREATITIS,Acute pancreatitis,ACUTE PANCREATITIS,PANCREATITIS ACUTE,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10000971,10033647,10000971
ERYTHMATOUS PLAQUE WOIH ATROPHIC AREAS,Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
HAND-FOOT SYNDROME,hand and foot syndrome,HAND AND FOOT SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10019111,10033553,10019111
CHOLESTATIC HEPATITIS,Hepatitis cholestatic,CHOLESTATIC HEPATITIS,HEPATITIS CHOLESTATIC,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10019754,10019754,10008639
DYSURIA,dysuria,DYSURIA,DYSURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10013990,10013990,10013990
MOTOR BLOCK,regional nerve block,REGIONAL NERVE BLOCK,NERVE BLOCK,THERAPEUTIC PROCEDURES AND SUPPORTIVE CARE NEC,ANAESTHESIA AND ALLIED PROCEDURES,10042613,10038286,10029173,10038286
ALTERED CONSIOUSNESS,Altered state of consciousness,CONSCIOUSNESS ABNORMAL,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010765,10001854,10010765
SYSTEMIC LUPUS ERYTHEMATOSUS FLARED FOLLOWING REBOUND EFFECT OF PREDNISOLONE,Systemic lupus erythematosus,SYSTEMIC LUPUS ERYTHEMATOSUS,SYSTEMIC LUPUS ERYTHEMATOSUS,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),LUPUS ERYTHEMATOSUS (INCL SUBTYPES),10028395,10042945,10042945,10042945
"EVIDENCE OF CLINICAL THYROTOXICOSIS, WHICH WAS UNRESPONSIVE TO CARBIMAZOLE OR PROPANOLOL",drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
"SHE WAS DISORIENTED TO TIME, PERSON, OR PLACE",Disorientation,DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013395
APPETITE LOSS,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
CALOR,calor,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10005911
BABY'S MOTHER RECEIVED PREDNISONE DURING PREGNANCY,Foetal exposure during pregnancy,"FETAL EXPOSURE DURING PREGNANCY, SECOND TRIMESTER",FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071424,10071404,10071425
SEVERE DYSPEPTIC SYNDROME,Dyspepsia,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,DYSPEPTIC SIGNS AND SYMPTOMS,10017947,10013946,10013946,10013946
ULCERATION OF THE THIGHS AND MULTIPLE NODULES ON THE SHOULDERS AND TRUNK,Skin ulcer,SKIN ULCERATION,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040947,10040943,10040947
SNORING BREATH,Snoring,SNORING,SNORING,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10041235,10041235,10041235
FUNCTIONAL DISABILITY / LIMITING MOBILITY,Mobility decreased,MOBILITY DECREASED,MOBILITY DECREASED,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10048334,10048334,10048334
DYSPNEA/ OUT OF BREATH,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
THROMBOTIC THROMBOCYTOPAENIC PURPURA,Thrombotic thrombocytopenic purpura,THROMBOTIC THROMBOCYTOPENIC PURPURA,THROMBOTIC THROMBOCYTOPENIC PURPURA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043648,10043648,10043648
PATHOGEN RESISTANCE,Pathogen resistance,PATHOGEN RESISTANCE,PATHOGEN RESISTANCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10034133,10034133,10034133
INCREASE IN MLOSSI/DISEASE ACTIVITY INCREASED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DRUG CROSS-REACTIVITY,Drug cross-reactivity,DRUG CROSS-REACTIVITY,THERAPEUTIC PRODUCT CROSS-REACTIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10076743,10079645,10076743
"CHOLECYSTITIS WITH FINDINGS OF SEDIMENT, WITH IKTERUS AND SECONDARY HEPATOPATHY FOLLOWING PANCYTOPENIA",Cholecystitis,CHOLECYSTITIS,CHOLECYSTITIS,GALLBLADDER DISORDERS,CHOLECYSTITIS AND CHOLELITHIASIS,10019805,10008612,10008612,10008612
MYELOSUPPRESSION,Bone marrow failure,MYELOSUPPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10028584
MILD NEUTROPHILIA,Neutrophilia,NEUTROPHILIA,NEUTROPHILIA,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10029379,10029379,10029379
REBOUND EFFECT,rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
INCREASE IN MLOSSI/INCREASED CENTRAL NERVOUS SYSTEM ACTIVITY,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
BLINDNESS DUE TO ASPERGILLUS NIDULANS INVASIVE INFECTION,Blindness,BLINDNESS,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10005169,10005169,10005169
MYCOPHENOLATE MOFETIL USED FOR THE TREATMENT OF TYPE 1 AUTOIMMUNE HEPATITIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CULTURES GREWVEILLONELLA,Veillonella infection,VEILLONELLA INFECTION,VEILLONELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10054140,10054140,10054140
PURULENT PERICARDITIS SECONDARY TO OESOPHAGEAL PERICARDIAL FISTULA AND ITS DETERIORATION DESPITE EARLY ANTIBIOTICS WITH VANCOMYCIN AND PIPERACILLIN-TAZOBACTAM ( LACK OF DRUG EFFECT),Purulent pericarditis,PURULENT PERICARDITIS,PURULENT PERICARDITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CARDIAC INFECTIONS,10021881,10051071,10051071,10051071
DELAYED HYPERSENSITIVITY,Delayed type hypersensitivity,DELAYED TYPE HYPERSENSITIVITY,TYPE IV HYPERSENSITIVITY REACTION,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10012210,10053613,10012210
DEATH,Death,DEATH,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10011906,10011906,10011906
BEING AGGRESSIVE,Aggression,AGGRESSIVENESS,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001488,10001488,10001494
REFRACTORY VENTRICULAR TACHYCARDIA,Ventricular tachycardia,VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047302,10047302,10047302
SYSTEMIC LUPUS ERYTHEMATOSUS FLARE UP,SLE flare,SLE FLARE,SYSTEMIC LUPUS ERYTHEMATOSUS,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),LUPUS ERYTHEMATOSUS (INCL SUBTYPES),10028395,10065992,10042945,10065992
CRP 277.22 MG/L,CRP increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
BLOOD IMMUNOGLOBULIN M DECREASED (0.2 G/L),blood immunoglobulin M decreased,BLOOD IMMUNOGLOBULIN M DECREASED,BLOOD IMMUNOGLOBULIN M DECREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10005600,10005600,10005600
OLANZEPINE INDUCED HYPOTHERMIA,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
ACUTE OVERDOSE,acute overdose,ACUTE OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067695,10033295,10067695
"HYPOMANIC EPISODE MANIFESTING ON THE SECOND DAY OF STIMULATION/HYPOMANIC  EPISODE,  WHICH  WAS CONSIDERED  TO  BE  RELATED  WITH  SERTRALINE",Hypomania,HYPOMANIA,HYPOMANIA,MANIC AND BIPOLAR MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH MANIC SYMPTOMS,10037175,10021030,10021030,10021030
BACLOFEN TREATMENT WAS INEFFECTIVE,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
RESPIRATORY ARREST DUE TO TYPE II KOUNIS SYNDROME WITH SEVERE ANAPHYLACTIC SHOCK SECONDARY TO PARENTAL AMOXICILLIN/CLAVULANIC ACID ADMINISTRATION,Respiratory arrest,RESPIRATORY ARREST,RESPIRATORY ARREST,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038669,10038669,10038669
EXTENSIVE HAEMORRHAGE IN THE STOMACH,Gastric haemorrhage,GASTRIC HEMORRHAGE,GASTRIC HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,GASTRIC AND OESOPHAGEAL HAEMORRHAGES,10017947,10017789,10017788,10017789
HYPERTENSION,hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
FOUR LOBULATED NODULAR LESIONS OVER BOTH FRONTAL AND RIGHT TEMPORAL LOBES/MULTIPLE BRAIN LESIONS,brain lesion,BRAIN LESION,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10067294,10051290,10067294
BLOOD UREA NITROGEN ELEVATED,blood urea nitrogen elevated,BLOOD UREA NITROGEN INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005855,10005851,10005855
MINIMAL PERICARDIAL EFFUSION,Pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
OPIATE TOXICITY,Toxicity to various agents,OPIATE TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10030881,10070863,10030881
LOW-GRADE ANEMIA (HB 11.9 G/100 ML),anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
LYMPHOCYTIC INFILTRATION,Lymphocytic infiltration,LYMPHOCYTIC INFILTRATION,LYMPHOCYTIC INFILTRATION,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10062049,10062049,10062049
BILATERAL LEG OEDEMA,Oedema peripheral,OEDEMA LOWER LIMB,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030109,10030124,10030109
SINUS TACHYCARDIA (99/MIN),Sinus tachycardia,SINUS TACHYCARDIA,SINUS TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040752,10040752,10040752
DRUG INTERACTION,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
PAROSMIA,Parosmia,PAROSMIA,PAROSMIA,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OLFACTORY NERVE DISORDERS,10029205,10034018,10034018,10034018
DIARRHEA,diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
ADENO VARICELLA VIRUS REACTIVATION,Adenovirus infection,ADENOVIRUS INFECTION,ADENOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,ADENOVIRAL INFECTIONS,10021881,10060931,10060931,10060931
"SLEEPING BADLY POSSIBLY CAUSED ALSO ANXIOUSNESS, NERVOUSNESS AND DEPRESSED MOOD",Depressed mood,DEPRESSED MOOD,DEPRESSED MOOD,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10012374,10012374,10012374
PERIPHERAL CORNEAL VASCULARISATION IN BOTH EYES,peripheral corneal neovascularisation,PERIPHERAL CORNEAL NEOVASCULARISATION,CORNEAL NEOVASCULARISATION,OCULAR HAEMORRHAGES AND VASCULAR DISORDERS NEC,CONJUNCTIVAL AND CORNEAL BLEEDING AND VASCULAR DISORDERS,10015919,10075419,10055665,10075419
HYPERPIGMENTATION,hyperpigmentation,HYPERPIGMENTATION SKIN,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10020715,10040865,10020715
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
DIFFUSE MUSCLE ACHES,diffuse muscle aches,MUSCLE ACHE,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028287,10028411,10028287
USE OF NIFEDIPINE FOR TREATMENT OF REFLEX SYMPATHETIC DYSTROPHY(UNAPPROVED INDICATION)- OFF LABEL USE WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TONIC CLONIC CONTRACTIONS,Tonic clonic movements,TONIC CLONIC MOVEMENTS,TONIC CLONIC MOVEMENTS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10051171,10051171,10051171
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
HEMOPERITONEUM,Peritoneal haemorrhage,HEMOPERITONEUM,PERITONEAL HAEMORRHAGE,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL HAEMORRHAGES,10017947,10018935,10034666,10019518
UPPER-LIMB DYSTONIA,Dystonia,DYSTONIA,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10013983,10013983,10013983
PROGRESSION OF ANTI-GBM ASSOCIATED GLOMERULONEPHRITIS (CRESCENT FORMATION IN 18 OUT OF 25 GROMELURI) DUE TO LACK OF DRUG EFFECT,Glomerulonephritis rapidly progressive,CRESCENTIC GLOMERULONEPHRITIS,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,NEPHROPATHIES,GLOMERULONEPHRITIS AND NEPHROTIC SYNDROME,10038359,10011379,10018378,10011379
LIVER FAILURE DUE TO HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,liver failure,LIVER FAILURE,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10024678,10019663,10024678
SADDLE ANESTHESIA,Sensory loss,LOSS OF SENSATION,SENSORY LOSS,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10040030,10040030,10024874
ACUTE KIDNEY INJURY IN SETTING OF IV CONTRAST ADMINISTRATION,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
MONITORING REVEALED INCESSANT TORSADES DE POINTES FOLLOWING LOPERAMIDE ABUSE,Torsade de pointes,TORSADES DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044067
SLIGHT HYPOGAMMAGLOBULINEMIA,Hypogammaglobulinemia,HYPOGAMMAGLOBULINEMIA,HYPOGAMMAGLOBULINAEMIA,IMMUNODEFICIENCY SYNDROMES,PRIMARY IMMUNODEFICIENCY SYNDROMES,10021428,10054427,10020983,10054427
AST INCREASED (77 IU/L),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
ACUTE ALLERGIC REACTION,Hypersensitivity,ACUTE ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10000656,10020751,10000656
EXERTIONAL DYSPNEA,Dyspnoea exertional,EXERTIONAL DYSPNEA,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013971,10013971,10055548
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
PATIENT TREATED WITH MYCOPHENOLATE AND HYDROXYCHLOROQUINE FOR CHRONIC URTICARIA (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PAIN IN THE RIGHT EYE,eye pain,EYE PAIN,EYE PAIN,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10015958,10015958,10015958
BILATERAL PLEURAL EFFUSION,Pleural effusion,BILATERAL PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10078037,10035598,10078037
HEMATOCRIT DECREASED (6.2 PER CENT),Haematocrit decreased,HEMATOCRIT DECREASED,HAEMATOCRIT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018838,10018838,10019423
PATIENT RECEIVED MOXIFLOXACIN MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS,Patient received moxifloxacin multidrug-resistant pulmonary tuberculosis,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
"MIRTAZAPINE AND WAS TITRATED UP TO 30MG QDAY; HOWEVER, DUE TO INTOLERABLE SIDE EFFECTS, THIS TREATMENT WAS DISCONTINUED",Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
FOOD INTAKE REDUCED,hypophagia,HYPOPHAGIA,HYPOPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10063743,10063743,10063743
CHILLS,chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
STAGE 2 OSTEONECROSIS OF THE LOWER JAW,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
AUDITORY HALLUCINATIONS,"Hallucination, auditory",AUDITORY HALLUCINATIONS,"HALLUCINATION, AUDITORY",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019070,10019070,10003785
ACUTE LEFT-SIDED FACIAL WEAKNESS,Facial paresis,FACIAL WEAKNESS,FACIAL PARESIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),FACIAL CRANIAL NERVE DISORDERS,10029205,10051271,10051267,10051271
CHRONIC MYELOGENOUS LEUKEMIA,Chronic myeloid leukaemia,CHRONIC MYELOGENOUS LEUKEMIA,CHRONIC MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS CHRONIC MYELOID,10029104,10009013,10009013,10009012
"AT EACH TREATMENT MODIFICATION, THE SYMPTOMS WERE PARTIALLYRELIEVED IN THE SHORT TERM BUT THEN QUICKLY WORSEN",subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
"PROGRESSIVE LUMPS AND HYPERMETABOLIC SOFT TISSUE NODULES INVOLVING SKIN, SUBCUTANEOUS FAT, MUSCLE THROUGHOUT CHEST,NECK,ABDOMEN, PELVIS AND AXILLA",Nodule,NODULE,NODULE,TISSUE DISORDERS NEC,MASS CONDITIONS NEC,10018065,10054107,10054107,10054107
GENERALISED EXANTHEMA FOR 24 H,Exanthema generalised,EXANTHEMA GENERALISED,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10058693,10037858,10058693
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
MYALGIA,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
SKIN BIOPSY REVEALED NECROTIC KERATINOCYTES,Epidermal necrosis,KERATINOCYTE NECROSIS,EPIDERMAL NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10059292,10059284,10059292
COMMIT SUICIDE BY INGESTING 6750 MG OF PROPAFENON,suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
FIRST-DEGREE AVB,Atrioventricular block first degree,FIRST DEGREE ATRIOVENTRICULAR BLOCK,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10003674,10003674,10016699
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
ELEVATED PLASMA METANEPHRINES AND NORMETANEPRHINES,Blood catecholamines increased,BLOOD CATECHOLAMINES INCREASED,BLOOD CATECHOLAMINES INCREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),ADRENAL MEDULLA TESTS,10022891,10005414,10005414,10005414
"HEPARIN (TARGET APTT 1.5 TIMES) AND WARFARIN (TARGET INR 2-3) WERE USED IN COMBINATION; HOWEVER, SINCE THE THROMBUS INCREASED",Thrombosis,THROMBOSIS,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10043607,10043607,10043607
CARDIAC ARREST,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
MULTI-ORGAN FAILURE DUE TO GASTRIC PERFORATION INDUCED BY NAPROXEN USE FOLLOWED BY SHORT TERM HIGH DOSE DEXAMETHASONE,multi-organ failure,MULTI-ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028154
LOWER EXTREMITY PERIPHERAL NEUROPATHY (BOTH MOTOR AND SENSORY),lower extremity peripheral neuropathy (both motor and sensory),PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10080342,10029331,10080342
UPPER RESPIRATORY INFECTION,upper respiratory infection,UPPER RESPIRATORY INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10046300,10046306,10046300
LIVER FUNCTION DISORDER,Hepatic function abnormal,HEPATIC FUNCTION DISORDER,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019674,10019670,10019674
"PARKINSONISM FOLLOWING DRUG INTERACTION BETWEEN QUETIAPINE, VALPROIC ACID AND ARIPIPRAZOLE",Parkinsonism,PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034010,10034010,10034010
IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (HEPATOCELLULAR PATTERN),drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
INTERSTITIAL LUNG DISEASE,Interstitial lung disease,INTERSTITIAL LUNG DISEASE,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022611,10022611,10022611
HEPATITIS SECONDARY TO PHENOBARBITAL HYPERSENSITIVITY,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
FIBROMYALGIA,Fibromyalgia,FIBROMYALGIA,FIBROMYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10048439,10048439,10048439
ESCITALOPRAM ASSOCIATED  GALACTORRHEA AND HYPERPROLACTENEMIA,Galactorrhoea,GALACTORRHEA,GALACTORRHOEA,BREAST DISORDERS,LACTATION DISORDERS,10038604,10017600,10017600,10017592
BREATHLESSNESS RAPIDLY WORSENED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
CLASSICAL HODGKIN LYMPHOMA,Hodgkin's disease,HODGKIN'S DISEASE,HODGKIN'S DISEASE,LYMPHOMAS HODGKIN'S DISEASE,HODGKIN'S DISEASE NEC,10029104,10020206,10020206,10020206
COUGH,cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
REDNESS IN HER BOTH EYES,Ocular hyperaemia,REDNESS OF EYES,OCULAR HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10015963,10030041,10038205
MINOR DYSMORPHIC FACIAL FEATURES,Facial dysmorphism,FACIAL DYSMORPHISM,DYSMORPHISM,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL DISORDERS CONGENITAL NEC,10010331,10016045,10066054,10016045
HYPOKINESIA,hypokinesia,HYPOKINESIA,HYPOKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10021021,10021021,10021021
DEPRESSED CONSCIOUSNESS,Depressed level of consciousness,CONSCIOUSNESS DECREASED,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010768,10012373,10010768
BREATHLESSNESS,Dyspnoea,BREATHLESSNESS,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10006345
PROBABLE ASPERGILLOSIS/ INVASIVE FUNGAL INFECTION,Bronchopulmonary aspergillosis,INVASIVE BRONCHOPULMONARY ASPERGILLOSIS,BRONCHOPULMONARY ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10022881,10006473,10022881
PROGRESSIVELY HYPOTENSIVE,Hypotension,HYPOTENSION AGGRAVATED,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10048348,10021097,10048348
CANDIDA ALBICANS COLONY FORMING UNITS,Candida infection,CANDIDA ALBICANS INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10054230,10074170,10054230
DRUG-INDUCED SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,Drug-induced cutaneous lupus erythematosus,DRUG-INDUCED CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS-LIKE SYNDROME,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),LUPUS ERYTHEMATOSUS (INCL SUBTYPES),10028395,10074893,10050551,10074893
PANCYTOPENIA DUE TO ACUTE POISONING FOLLOWING OFF LABEL USE OF METHOTREXATE DURING PREGNANCY,pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
"CLONAZEPAM 0.5 MG TID FOR DYSTONIA, BUT NO CLINICAL IMPROVEMENT WAS OBSERVED.",Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
MILD LEUKOCYTOSIS (WHITE CELL COUNT: 1.3X10E10/L),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
GAINING WEIGHT,weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
"MEDICATED WITH CARBAMAZEPINE (1200 MG/DAY), LATER WITH PREGABALIN (400MG/DAY), MAINTAINING THE CYCLIC ANNUAL OR BIANNUAL CRISIS",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
VOMITUS,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
MATERNAL INTAKE OF CLONIDINE DURING AND AFTER PREGNANCY,Drug exposure via breast milk,DRUG EXPOSURE VIA BREAST MILK,EXPOSURE VIA BREAST MILK,"EXPOSURES, CHEMICAL INJURIES AND POISONING",PATHWAYS AND SOURCES OF EXPOSURE,10022117,10051075,10080751,10051075
PLATELET FUNCTION ASSAYS ABNORMALLY PROLONGED,Platelet function test abnormal,PLATELET FUNCTION TEST ABNORMAL,PLATELET FUNCTION TEST ABNORMAL,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10061539,10061539,10061539
NUMBNESS AND PAIN IN THE FINGERTIPS OF THE HANDS AND FEET INDUCED BY POSTOPERATIVE ADJUVANT CHEMOTHERAPY,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
ANTI-PYRETIC RESISTANT FEVER,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
TENDERNESS OF LOWER LIMBS ON PALPATION,Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
SERUM SICKNESS-LIKE REACTION,Serum sickness-like reaction,SERUM SICKNESS-LIKE REACTION,SERUM SICKNESS-LIKE REACTION,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10040402,10040402,10040402
DIZZINESS/DROWSINESS DURING THE DAY,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
AIR EMBOLISM,Air embolism,AIR EMBOLISM,AIR EMBOLISM,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10001526,10001526,10001526
FAINTING,Syncope,FAINTING,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10016169
AST IN PROGRESSIVE INCREASE (36 - 44 - 58 - 88 U/L),AST increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
MACULOPAPULAR ERUPTION (RASH),Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
"NON-PRURITIC DUSKY, GREY TWO-TONED MACULES AND PATCHES",Macule,MACULE,MACULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10025421,10025421,10025421
HEPATIC FAILURE,Hepatic failure,HEPATIC FAILURE,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10019663,10019663,10019663
WORSENED DROWSINESS,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
INTRACTABLE NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
NONE OF THE THERAPY WAS EFFECTIVE,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HEMATURIA FOLLOWING HENOCH-SCHOENLEIN PURPURA,Hematuria,HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10019450,10018867,10019450
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
ALLERGY,Hypersensitivity,ALLERGY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001738,10020751,10001738
SIGNIFICANTLY REDUCED BONE DENSITY,Bone density decreased,BONE DENSITY DECREASED,BONE DENSITY DECREASED,MUSCULOSKELETAL AND SOFT TISSUE INVESTIGATIONS (EXCL ENZYME TESTS),MUSCULOSKELETAL AND SOFT TISSUE IMAGING PROCEDURES,10022891,10049470,10049470,10049470
HYPERTENSION,hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
"BRAIN BIOPSY REVEALED EDEMA, BLEEDING AND DESTRUCTION OF BRAIN PARENCHYMA AS WELL AS INFILTRATION BY ABNORMAL, SMALL CIRCULAR CELLS AROUND THE BLOOD VESSELS",Biopsy brain abnormal,BIOPSY BRAIN ABNORMAL,BIOPSY BRAIN ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CENTRAL NERVOUS SYSTEM HISTOPATHOLOGY PROCEDURES,10022891,10004742,10004742,10004742
PARONYCHIA,Paronychia,PARONYCHIA,PARONYCHIA,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10034016,10034016,10034016
HALOS IN HIS VISION IN BOTH HIS EYES,Vision halo,VISION HALO,HALO VISION,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047520,10019099,10047520
BRONCHITIS,bronchitis,BRONCHITIS,BRONCHITIS,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10006451,10006451,10006451
CATARACT,Cataract,CATARACT,CATARACT,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",CATARACT CONDITIONS,10015919,10007739,10007739,10007739
INCREASED HBV DNA VIRAL LOAD DUE TO LAMIVUDINE RESISTANCE CAUSED BY GENE MUTATION,Hepatitis B DNA increased,HBV VIRAL LOAD INCREASED,HEPATITIS B DNA INCREASED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10068375,10068379,10068375
SIGNS OF HEART FAILURE (NEW YORK HEART ASSOCIATION CLASS III),Cardiac failure chronic,HEART FAILURE NYHA CLASS III,CARDIAC FAILURE CHRONIC,HEART FAILURES,HEART FAILURES NEC,10007541,10064081,10007558,10064081
SEVERE BLEPHARITIS FOLLOWING DUPILUMAB-INDUCED CONJUCTIVITIS (MILD BULBER IN BOTH EYES),Blepharitis,BLEPHARITIS,BLEPHARITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","LID, LASH AND LACRIMAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10005148,10005148,10005148
TRYPTASE DECREASED (LESS THAN 1 NG/ML),tryptase decreased,TRYPTASE DECREASED,TRYPTASE DECREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOLOGY ANALYSES NEC,10022891,10063343,10063343,10063343
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
UPON TREATMENT COMPLETION GLYCEMIA WENT UP TO 230 MG/DL,Blood glucose increased,GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10018421,10005557,10018421
INCREASED VARUS AT HER ANKLES,Talipes,CONGENITAL VARUS DEFORMITY OF FOOT NOS,TALIPES,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS OF LIMBS CONGENITAL,10010331,10010669,10043101,10010669
SHE COLLAPSED,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
DRUG INDUCED HEPATOTOXICITY [DRUG-INDUCED LIVER INJURY],Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
RELAPSE OF IDIOPATHIC ANTERIOR UVEITIS FOLLOWING TAPERING OF PREDNISOLONE,Iridocyclitis,ANTERIOR UVEITIS,IRIDOCYCLITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10002709,10022941,10002709
ISCHAEMIA,Hepatic ischaemia,HEPATIC ISCHAEMIA,HEPATIC ISCHAEMIA,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10056328,10056328,10056328
CARCINOEMBRYONIC ANTIGEN INCREASED,Carcinoembryonic antigen increased,CARCINOEMBRYONIC ANTIGEN INCREASED,CARCINOEMBRYONIC ANTIGEN INCREASED,CYTOGENETIC INVESTIGATIONS,CELL MARKER ANALYSES,10022891,10007266,10007266,10007266
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
STUPOR,Stupor,STUPOR,STUPOR,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042264,10042264,10042264
"NUMBNESS IN BOTH FEET, THE ANTERIOR PART OF THE LOWER CALVES AND THE LEFT ARM",numbness in feet,NUMBNESS IN FEET,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10049800,10020937,10049800
INFANT TREATED WITH DEXAMETHASONE FOR FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (DRUG USE FOR UNAPPROVED POPULATION)- OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
PATIENT'S CONDITON DID NOT IMPROVE (LACK OF DRUG EFFECT WITH NO ADR),drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
MEDIUM MYDRIASIS,medium mydriasis,MYDRIASIS,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10028521,10028521,10028521
NEUTROPENIA (ABSOLUTE NEUTROPHIL COUNT OF 0/MM3),Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
ACUTE MYELOID LEUKAEMIA,Acute myeloid leukaemia,ACUTE MYELOID LEUKAEMIA NOS,ACUTE MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10000884,10000880,10000884
OLMESARTAN ENTEROPATHY,sprue-like enteropathy,SPRUE-LIKE ENTEROPATHY,SPRUE-LIKE ENTEROPATHY,MALABSORPTION CONDITIONS,MALABSORPTION SYNDROMES,10017947,10079622,10079622,10079622
"CONTINUOUS AGGRATION OF URTICARIA RASHES FOLLOWING LACK OF DRUG EFFECT OF PREDNISOLONE,MONTELUKAST AND FEXOFENADINE/RECURRENCE OF URTICARIA SYMPTOMS FOLLOWING PREDNISOLONE TAPER",urticarial rash,URTICARIAL RASH,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046758,10046735,10046758
OSTEOMYELITIS,Osteomyelitis,OSTEOMYELITIS,OSTEOMYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,BONE AND JOINT INFECTIONS,10021881,10031252,10031252,10031252
DEPRESSED MOOD,depreesed mood,DEPRESSED MOOD,DEPRESSED MOOD,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10012374,10012374,10012374
"THE PATIENT SUDDENLY DEVELOPED AN EPISODE OF POLYMORPHIC VENTRICULAR TACHYCARDIA AND SHE
THEN HAD 2 MORE EPISODES OF POLYMORPHIC VENTRICULAR FIBRILLATION",Ventricular fibrillation,VENTRICULAR FIBRILLATION,VENTRICULAR FIBRILLATION,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047290,10047290,10047290
MYELOTOXICITY,Myelosuppression,MYELOSUPPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10028584,10065553,10028584
MASSIVE EDEMA OF THE FACE AND PERIORBITAL REGION,Face oedema,EDEMA FACE,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10016029,10016029,10014222
EXPANSION OF OEDEMA,Oedema aggravated,OEDEMA AGGRAVATED,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10048376,10030095,10048376
FEBRILE PEAK,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
COMA/ CNS DEPRESSION,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
"AFTER 4 WEEKS TREATMENT WITH ACYCLOVIR, THE PATIENT WAS PARTLY RECOVERY WITH SOME RESIDUAL PERSONALITY CHANGE (SUBTHERAPEUTIC RESPONSE) WITH NO ADR",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
"DARK DISCOLORATION OF HIS EARS, NOSE, FINGERS AND TOES",Skin discolouration,SKIN DISCOLORATION,SKIN DISCOLOURATION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040829,10040829,10040828
PATIENT WAS NOT SEIZURE-FREE DESPITE ADEQUATE AED TREATMENT (LACK OF EFFICACY),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
MILD CHRONIC GVHD,Chronic graft versus host disease,CHRONIC GRAFT VERSUS HOST DISEASE,CHRONIC GRAFT VERSUS HOST DISEASE,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10066261,10066261,10066261
FUNGAL INFECTIONS,Fungal infection,FUNGAL INFECTION,FUNGAL INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017533,10017533,10017533
"FAILED TREATMENTS INCLUDED VARIOUS TOPICAL THERAPIES, INCLUDING STEROIDS",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
FATIGUE GRADE 1,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
"REFRACTORY TO FIRST-LINE TREATMENT WITH RITUXIMAB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
BACTEREMIA,bacteremia,BACTEREMIA,BACTERAEMIA,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10003999,10003997,10003999
ACCIDENTAL OVERDOSE WITH MULTIPLE DRUGS WHICH WAS SUGGESTIVE OF TOXICITY,Multiple drug overdose accidental,MULTIPLE DRUG OVERDOSE ACCIDENTAL,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10062763,10000381,10062763
LYMPHOPENIA,lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
LVEF 24%,Ejection fraction abnormal,EJECTION FRACTION ABNORMAL,EJECTION FRACTION ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10014331,10014331,10014331
NEONATAL MORBIDITY DUE TO MATERNAL USE OF TWO ANTIDEPRESSANT DRUGS,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
H INFLUENZAE INFECTION,hemophilus influenza infection,HEMOPHILUS INFLUENZA INFECTION,HAEMOPHILUS INFECTION,BACTERIAL INFECTIOUS DISORDERS,HAEMOPHILUS INFECTIONS,10021881,10060625,10061190,10060625
ACUTE ISCHEMIC LESION WAS OBSERVED AT LEFT POSTERIOR INFERIOR CEREBELLAR ARTERY AT CEREBELLUM WITH ADDITIONAL LESION AT LEFT LATERAL MEDULLA DUE TO CERVICAL ARTERY DISSECTION AND VERTEBRAL ARTERY DISSECTION,acute ischemic lesion was observed at left posterior inferior cerebellar artery at cerebellum with additional lesion at left lateral medulla due to cervical artery dissection and vertebral artery dissection,ISCHEMIA,ISCHAEMIA,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10054438,10061255,10054438
HIGH BLOOD PRESSURE (195/115 MMHG),Hypertension,BLOOD PRESSURE HIGH,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10005747
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
GENITAL RASH,Genital rash,GENITAL RASH,GENITAL RASH,REPRODUCTIVE TRACT DISORDERS NEC,REPRODUCTIVE TRACT SIGNS AND SYMPTOMS NEC,10038604,10018175,10018175,10018175
"GIVEN THE LACK OF A CLINICAL RESPONSE, IMATINIB TREATMENT WAS STOPPED (LACK OF DRUG EFFECT)",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
TSH VALUES DECREASED ERRONEOUSLY(0.13MIU/L) DUE TO INTERFERENCE BY EXOGENOUS BIOTIN THUS CONFUSING AND COMPLICATING THE CLINICAL PICTURE,False positive laboratory result,FALSE POSITIVE LABORATORY RESULT,FALSE POSITIVE INVESTIGATION RESULT,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",INVESTIGATIONS NEC,10022891,10056669,10070748,10056669
SHARP CHEST PAIN WORSENED,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
ARTHRALGIA,Arthralgia,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
"DURING THE COURSE OF TREATMENT, THE PATIENT DEVELOPED A TENDER, BRISK, ERYTHEMATOUS REACTION IN THE PALMAR AND DORSAL ASPECTS OF THE HAND, NECESSITATING SEVERAL SHORT BREAKS FROM TREATMENT",erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
WEIGHT FLUCTUATION/YO-YO EFFECT,weight fluctuation,WEIGHT FLUCTUATION,WEIGHT FLUCTUATION,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10049040,10049040,10049040
C-REACTIVE PROTEIN INCREASED (47 MG/DL),C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
CEREBRITIS,cerebritis,CEREBRITIS,ENCEPHALITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10054860,10014581,10054860
BILATERAL CATARACTS,bilateral cataracts,BILATERAL CATARACTS,CATARACT,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",CATARACT CONDITIONS,10015919,10004558,10007739,10004558
HER TRANSFUSION NEEDS REMAINED THE SAME,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DETACHED VITREOUS WAS OPAQUE DUE OCULAR LYMPHOMA,Vitreous detachment,VITREOUS DETACHMENT,VITREOUS DETACHMENT,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","CHOROID AND VITREOUS STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10047650,10047650,10047650
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
NEUTROPENIC FEVER,Neutropenic fever,NEUTROPENIC FEVER,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10051312,10016288,10051312
RESISTANT TO IMATINIB,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
NITROGEN RETENTION,nitrogen retention,NITROGEN RETENTION,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10029427,10005851,10029427
SPONTANEOUS ABORTION,Abortion spontaneous,SPONTANEOUS ABORTION,ABORTION SPONTANEOUS,ABORTIONS AND STILLBIRTH,ABORTIONS SPONTANEOUS,10036585,10000234,10000234,10041687
SHORTNESS OF BREATH AT REST,Dyspnoea at rest,DYSPNOEA AT REST,DYSPNOEA AT REST,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013969,10013969,10013969
ACNE,Acne,ACNE,ACNE,SKIN APPENDAGE CONDITIONS,ACNES,10040785,10000496,10000496,10000496
ACUTE PORPHYRIA/VARIEGATE PORPHYRIA,Porphyria acute,VARIEGATE PORPHYRIA,PORPHYRIA ACUTE,METABOLIC AND NUTRITIONAL DISORDERS CONGENITAL,INBORN ERRORS OF PORPHYRIN METABOLISM,10010331,10047030,10036182,10047030
OLIGOHYDRAMNIOS FOLLOWING OFF LABEL USE OF DRUG IN POPULATION,Oligohydramnios,OLIGOHYDRAMNIOS,OLIGOHYDRAMNIOS,"PLACENTAL, AMNIOTIC AND CAVITY DISORDERS (EXCL HAEMORRHAGES)",AMNIOTIC FLUID AND CAVITY DISORDERS OF PREGNANCY NEC,10036585,10030289,10030289,10030289
INTERACTING MEDICATIONS : VERAPAMIL AND DABIGATRAN,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
LEUKOCYTOSIS WITH A LEFT SHIFT (WBC COUNT: 31980 X 10E9/L),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
SPONTANEOUS SPINAL EPIDURAL HAEMATOMA/EPIDURAL HAEMATOMA AT T8-T10 LEVEL,spinal epidural haematoma,SPINAL EPIDURAL HAEMATOMA,SPINAL EPIDURAL HAEMATOMA,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10050162,10050162,10050162
BRONCHIAL WHEEZING,Wheezing,WHEEZING,WHEEZING,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10047924,10047924,10047924
NEUTROPENIA OF  GRADE 3/ GRADE 3 OR HIGHER NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ILEUS,Ileus,ILEUS,ILEUS,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION NEC,10017947,10021328,10021328,10021328
GIVEN PATIENT METHADONE WITHOUT MEDICAL PRESCRIPTION,Prescription drug used without a prescription,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076639,10076639,10076639
CMV REACTIVATION,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION REACTIVATION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10058666,10011831,10058666
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
EXACERBATION OF PROTEINURIA,Proteinuria,PROTEINURIA AGGRAVATED,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10048433,10037032,10048433
THROMBOPENIA,Thrombocytopenia,THROMBOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043569
M BOVIS INFECTION,mycobacterial infection,MYCOBACTERIAL INFECTION,MYCOBACTERIAL INFECTION,MYCOBACTERIAL INFECTIOUS DISORDERS,ATYPICAL MYCOBACTERIAL INFECTIONS,10021881,10062207,10062207,10062207
ECTOPIC PREGNANCY,Ectopic pregnancy,ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,MATERNAL COMPLICATIONS OF PREGNANCY,MATERNAL COMPLICATIONS OF PREGNANCY NEC,10036585,10014166,10014166,10014166
SWELLING OF THE BUCCAL MANDIBULAR CORTICAL WHICH APPEARED ALSO ERODED BOTH ON THE LINGUAL AND,Oral mucosa erosion,ORAL MUCOSA EROSION,ORAL MUCOSA EROSION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10064594,10064594,10064594
"POOR METABOLIC CONTROL, THE LAST GLYCATED HEMOGLOBIN VALUE BEING 9.2%",Diabetes mellitus inadequate control,DIABETES MELLITUS INADEQUATE CONTROL,DIABETES MELLITUS INADEQUATE CONTROL,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012607,10012607,10012607
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
NECROTIC ESCHAR,Injection site necrosis,INJECTION SITE NECROSIS,INJECTION SITE NECROSIS,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022082,10022082,10022082
"ATTEMPTS TO LOWER THE DOSAGE OF RISPERIDONE BELOW 0.25 MG PER DAY, HOWEVER RESULTED IN THE PATIENT BECOMING MORE WITHDRAWN, SUSPICIOUS AND LESS INTERACTIVE",Withdrawal syndrome,WITHDRAWAL SYMPTOM,WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10073281,10048010,10073281
ACUTE NEUTROPENIA,neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ENTEROCOCCUS,enterococcal infection,ENTEROCOCCAL INFECTION,ENTEROCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,ENTEROCOCCAL INFECTIONS,10021881,10061124,10061124,10061124
NAUSEA FOLLOWING OFF LABEL USE OF DIAZOXIDE FOR INSULINOMA AND OCTREOTIDE,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
"PAIN,EPIPHORA AND PHOTOPHOBIA IN BOTH EYES SUGGESTING DEVELOPMENT OF CONJUCTIVTIS",Photophobia,PHOTOPHOBIA,PHOTOPHOBIA,OCULAR SENSORY SYMPTOMS NEC,OCULAR SENSATION DISORDERS,10015919,10034960,10034960,10034960
DEVELOPED RECURRENT CDI DESPITE MULTIPLE COURSES,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PATIENT RECEIVED TRAETMENT WITH ORAL MESALAZINE 1.5G TWICE DAILY BUT INTESTINAL SYMPTOMS DID NOT IMPROVE (LACK OF EFFECT WITH NO ADR),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ABDOMINAL DISTENSION,Abdominal distension,ABDOMINAL DISTENSION,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10000060
ACUTE OVERDOSE,acute overdose,ACUTE OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067695,10033295,10067695
"MOTTLING AND CYANOSIS AFFECTED HIS FINGERS, TOES, NOSE AND GENITALIA WITHIN ONE WEEK",Cyanosis,CYANOSIS,CYANOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10011703,10011703,10011703
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO PAIN STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10062495,10045555,10062495
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
DRESS SYNDROME,Drug reaction with eosinophilia and systemic symptoms,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
SUSPECTED MEDICATION INDUCED LIVER- AND PANCREAS TOXICITY,Pancreatic toxicity,PANCREATIC TOXICITY,PANCREATIC TOXICITY,EXOCRINE PANCREAS CONDITIONS,PANCREATIC DISORDERS NEC,10017947,10076205,10076205,10076205
TACHYPNEIC (22 RESPIRATORY INCURSIONS PER MINUTE),Tachypnoea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043088
POTENTIAL PULMONARY TOXICITY,pulmonary toxicity,PULMONARY TOXICITY,PULMONARY TOXICITY,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10061924,10061924,10061924
"CK VALUES ROSE UP TO 1025 AND 1867 U/L, RESPECTIVELY",Blood creatine phosphokinase increased,CREATINE KINASE HIGH,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011335,10005470,10011335
RENAL DISORDER,renal disorder ,RENAL DISORDER,RENAL DISORDER,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL DISORDERS NEC,10038359,10038428,10038428,10038428
CORRECTED CALCIUM RISED DUE TO SUSPECTED CALCITONIN TACHYPHYLAXIS,Adjusted calcium increased,CORRECTED CALCIUM INCREASED,ADJUSTED CALCIUM INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10078260,10078260,10078261
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
LOWER EXTREMITY EDEMA,Oedema peripheral,EDEMA LOWER LIMB,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030109,10030124,10014232
ERYTHEMA IN DIAMETER OF 3 CM X 4CM WITH A PUSTULA AT THE APPLICATION SITE AND OEDEMA OF WHOLE THIGH WITH PAIN AND SENSITIVITY TO PRESSURE,Vaccination site pustule,VACCINATION SITE PUSTULE,VACCINATION SITE PUSTULE,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10066047,10066047,10066047
DEHYDRATION,dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HAEMOPHAGOCYTIC SYNDROME,Histiocytosis haematophagic,HISTIOCYTOSIS HAEMATOPHAGIC,HISTIOCYTOSIS HAEMATOPHAGIC,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10048595,10048595,10048595
"PATIENT RECEIVED ASPIRIN, WARFARIN AND CLOPIDOGREL",Drug administration error,DRUG ADMINISTRATION ERROR,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064295,10064295,10064295
SYNOVIAL INFLAMMATION,Synovitis,SYNOVITIS,SYNOVITIS,SYNOVIAL AND BURSAL DISORDERS,SYNOVIAL DISORDERS,10028395,10042868,10042868,10042868
SEVERE ERYTHEMA IN AND AROUND AREA OF INJECTION,Injection site erythema,INJECTION SITE ERYTHEMA,INJECTION SITE ERYTHEMA,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022061,10022061,10022061
PULMONARY EDEMA FOLLOWING INTENTIONAL OVERDOSE,pulmonary edema,PULMONARY EDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037375,10037423,10037375
BILATERAL KIDNEY AGENESIAS FOLLOWING DRUG EXPOSURE IN UTERO,Renal agenesis congenital,RENAL AGENESIS CONGENITAL,RENAL APLASIA,RENAL AND URINARY TRACT DISORDERS CONGENITAL,RENAL DISORDERS CONGENITAL,10010331,10038356,10064655,10038356
DISTURBED CONSCIOUSNESS,Altered state of consciousness,CONSCIOUSNESS DISTURBED,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010770,10001854,10010770
EXPERIENCING TOXICITIES OF LETHARGY AND MILD DIARRHOEA,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
IGM LOW,IgM low,IGM DECREASED,BLOOD IMMUNOGLOBULIN M DECREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10021277,10005600,10021277
GENERALIZED SKIN ERYTHEMA,Erythema,SKIN ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10040842,10015150,10040842
LEUKOPENIA (WBC COUNT 1800 CUMM) FOLLOWING DRUG EXPOSURE DURING PREGNANCY,Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
RA SYMPTOMS INCREASED FOLLOWING DISCONTINUATION OF THE TREATMENT WITH METHOTREXATE (REBOUND EFFECT),Rheumatoid arthritis,RHEUMATOID ARTHRITIS,RHEUMATOID ARTHRITIS,JOINT DISORDERS,RHEUMATOID ARTHROPATHIES,10028395,10039073,10039073,10039073
C-REACTIVE PROTEIN INCREASED (116 MG/L),C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
CRUSTED LESIONS ON THE SCALP,skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
THIS THROMBUS WASFORMED DESPITE LONG-TERM ORAL ANTICOAGULATION WITH WAR-FARIN.,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
MUCOUS MEMBRANE DISORDER SUCH AS STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
LEUKOPENIA (GRADE 3),Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
INFERIOR VENA CAVA SYNDROME SECONDARY TO DISSEMINATED HISTOPLASMOSIS DUE TO IMMUNOSUPRESSION,Inferior vena cava syndrome,INFERIOR VENA CAVA SYNDROME,INFERIOR VENA CAVA SYNDROME,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10070911,10070911,10070911
RESPIRATORY DEPRESSION/ OPIOID-INDUCED RESPIRATORY DEPRESSION (OIRD),Respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
MOTOR SYMPTOMS WERE NOT SIGNIFICANTLY AMELIORATED BY THESE DRUGS IN EITHER PATIENT/BEING OF NO BENEFIT ON THE MOTOR DISTURBANCES,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
POLYOMAVIRUS NEPHROPATHY/ BK VIRUS NEPHROPATHY (VIREMIA >104 COPIES/ML),Polyomavirus-associated nephropathy,BK VIRUS NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065333,10065381,10065333
"ST SEGMENT, UPWARDS CONVEX, WITH A J-POINT ELEVATION AND NEGATIVE T WAVES FOLLOWING SEVERE HYPOKALEMIA (1.5 MMOL/L) FOLLOWING ACUTE OVERDOSE",Electrocardiogram ST segment abnormal,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10014390,10014390,10014390
PREGABALIN CONCENTRATION IN WHOLE BLOOD OF 108 MG/L (IN COMBINATION WITH A MIXTURE OF OTHER DRUGS) PRIMARILY VENLAFAXINE,Drug level increased,DRUG LEVEL IN BLOOD INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013721,10013722,10013721
EZETIMIBE INTOLERANCE/STATIN INTOLERANCE,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
INCREASED LEVEL OF INTACT PARATHYROID HORMONE (361 PG/ML),Parathyroid hormone increased,PARATHYROID HORMONE INCREASED,BLOOD PARATHYROID HORMONE INCREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),PARATHYROID ANALYSES,10022891,10033956,10005703,10033956
"LYMPHADENOPATHY INVOLVING THE CERVICAL, AXILLARY, AND INGUINAL REGIONS",lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
MELENIC DEPOSITIONS,Melena,MELENA,MELAENA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10027162,10027141,10027162
SINUS TACHYCARDIA OF 106 BEATS PER MINUTE (BPM) WITH A QTC INTERVAL OF 438 MS,tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
CT SHOWED SEVERE EDEMA OF THE TOTAL INTESTINAL WALL,Gastrointestinal oedema,INTESTINAL EDEMA,GASTROINTESTINAL OEDEMA,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10058070,10058061,10058065
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
DISORIENTED,Disorientation,DISORIENTATED,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013394
MULTIPLE CEREBRAL ABSCESSES,Brain abscess,BRAIN ABSCESS,BRAIN ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10006105,10006105,10006105
EPISTAXIS,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
"THE PHARMACOKINETIC INTERACTION BETWEEN VALPROIC ACID, ITS EXCIPIENTS AND DOLUTEGRAVIR AS WELL AS DARUNAVIR/RITONAVIR AND DOLUTEGRAVIR, WAS THOUGHT TO LEAD TO LOWER PLASMA LEVELS OF DOLUTEGRAVIR",Drug-drug pharmacokinetic interaction,DRUG-DRUG PHARMACOKINETIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10065994,10013710,10065994
TREATMENT FAILURE WITH NEW THROMBUS,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
URINE SECRETION WAS MINIMAL,Urine output decreased,URINE OUTPUT DECREASED,URINE OUTPUT DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059895,10059895,10059895
FEELING OF FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
RESPIRATORY RATE 36 BREATHS/MIN,Respiratory rate increased,RESPIRATORY RATE HIGH,RESPIRATORY RATE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10038711,10038712,10038711
HEMORRHAGES IN THE RIGHT EYE/BLEEDING IN THE LEFT EYE,Eye haemorrhage,EYE HEMORRHAGE,EYE HAEMORRHAGE,OCULAR HAEMORRHAGES AND VASCULAR DISORDERS NEC,OCULAR BLEEDING AND VASCULAR DISORDERS NEC,10015919,10015926,10015926,10015928
PERIPHERAL NERVE DISORDER NOS,Neuropathy peripheral,PERIPHERAL NERVE DISORDER NOS,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10051174,10029331,10051174
NIFEDIPINE ADMINISTERED TO TREAT PRE-ECLAMPSIA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
MOON FACE,moon face,MOON FACE,CUSHINGOID,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10027953,10011655,10027953
CANDIDA ALBICANS INFECTION,Candida albicans infection,CANDIDA ALBICANS INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10054230,10074170,10054230
FAILED TO SHOW RESPONSE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DEHYDRATED,dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
CLEFT PALATE,Cleft palate,CLEFT PALATE,CLEFT PALATE,GASTROINTESTINAL TRACT DISORDERS CONGENITAL,PALATE DISORDERS CONGENITAL,10010331,10009269,10009269,10009269
LEFT SIDED CORNEAL PERFORATION/RIGHT SIDED SPONTANEOUS CORNEAL PERFORATION,Corneal perforation,CORNEAL PERFORATION,CORNEAL PERFORATION,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CORNEAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10011039,10011039,10011039
A FECAL OCCULT BLOOD TEST WAS POSITIVE FOLLOWING SEVER BONE MARROW SUPPRESSION,Occult blood positive,FECAL OCCULT BLOOD POSITIVE,OCCULT BLOOD POSITIVE,GASTROINTESTINAL INVESTIGATIONS,FAECAL ANALYSES NEC,10022891,10061880,10061880,10016299
TYPE 1 HYPERSENSITIVITY,Type I hypersensitivity,TYPE I HYPERSENSITIVITY,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10045240,10045240,10045240
SEPSIS (STAPHYLOCOCCUS EPIDERMIDIS MRSA),Staphylococcal sepsis,SEPSIS MRSA,STAPHYLOCOCCAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10049253,10056430,10049253
SPATIAL AND TEMPORAL DISORIENTATION,spatial disorientation,SPATIAL DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10062700,10013395,10062700
PATIENT RECEIVED IMATINIB FOR PULMONARY ARTERIAL HYPERTENSION WHO FUNCTIONAL CLASS IV (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MACULAR EDEMA UO,Macular oedema,MACULAR EDEMA,MACULAR OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","RETINAL, CHOROID AND VITREOUS INFECTIONS AND INFLAMMATIONS",10015919,10025415,10025415,10054467
CHOLESTASIS,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
PATIENT TREATED WITH CISPLATIN FOR LUNG ADENOCARCINOMA (OFF LABEL USE) WITH NO ADVERSE EVENTS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FOCAL NODULAR HYPERPLASIA AFTER TREATMENT WITH OXALIPLATIN,Focal nodular hyperplasia,FOCAL NODULAR HYPERPLASIA,FOCAL NODULAR HYPERPLASIA,HEPATIC AND BILIARY NEOPLASMS BENIGN,HEPATOBILIARY NEOPLASMS BENIGN,10029104,10052285,10052285,10052285
SYNCOPAL EPISODE,Syncope,SYNCOPAL ATTACK,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042771,10042772,10042771
BK INFECTION,BK virus infection,BK VIRUS INFECTION,BK VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10055181,10055181,10055181
THE PATIENT USED SULFAMETHOXAZOLE/TRIMETHOPRIM (CO-TRIMOXAZOLE) FOR PJP INFECTION (LACK OF DRUG EFFECT),Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
INTENSE NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
VOMITING FOLLOWING OFF LABEL USE OF DRUG,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
ANGIOEDEMA,Angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
STATE OF CLOUDED CONSCIOUSNESS,Depressed level of consciousness,DEPRESSED LEVEL OF CONSCIOUSNESS,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10012373,10012373,10012373
EMERGENCY CAESAREAN SECTION/ AT 33 WEEKS,Premature baby 33 to 36 weeks,PREMATURE BABY 33 TO 36 WEEKS,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10053594,10036590,10053594
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
"SHORT STENOTIC, ULCERATED SEGMENTS IN TRANSVERSE AND ASCENDING COLON WITH ACTIVE OOZING",Intestinal stenosis,INTESTINAL STENOSIS,INTESTINAL STENOSIS,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION NEC,10017947,10022699,10022699,10022699
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
LACK OF RESPONSE TO ANTI-D,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
PNEUMOCYSTIS JIROVECI PNEUMONIA,Pneumocystis jirovecii pneumonia,PNEUMOCYSTIS JIROVECI PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10073755,10073755,10064108
DRUG PRESCRIBING ERROR,Drug prescribing error,DRUG PRESCRIBING ERROR,DRUG PRESCRIBING ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT PRESCRIBING ERRORS AND ISSUES,10022117,10064296,10064296,10064296
MULTIPLE EPISODES OF VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
LEFT SHOULDER PAIN,Shoulder pain,SHOULDER PAIN,MUSCULOSKELETAL PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10040617,10028391,10040617
SEVERE NEUTROPAENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
GASTROINTESTINAL PERFORATION,Gastrointestinal perforation,GASTROINTESTINAL PERFORATION,GASTROINTESTINAL PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,"GASTROINTESTINAL ULCERS AND PERFORATION, SITE UNSPECIFIED",10017947,10018001,10018001,10018001
GRADE 1 FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
NEONATAL RESPIRATORY DISTRESS SYNDROME,Neonatal respiratory distress syndrome,NEONATAL RESPIRATORY DISTRESS SYNDROME,NEONATAL RESPIRATORY DISTRESS SYNDROME,NEONATAL RESPIRATORY DISORDERS,NEONATAL HYPOXIC CONDITIONS,10038738,10028974,10028974,10028974
IGE MEDIATED HYPERSENSITIVITY REACTION,Type I hypersensitivity,HYPERSENSITIVITY TYPE I,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10045240,10045240,10020762
INCREASING LYMPHADENOPATHY,lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
PLEURAL EFFUSION,Pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
HEMODYNAMIC INSTABILITY,Hemodynamic instability,HEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10058270,10052076,10058270
DRUG-FOOD INTERACTION,Food interaction,FOOD INTERACTION,FOOD INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10016948,10016948,10016948
CONSTIPATION,constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
VENTRICULAR THICKENING (17-MM SEPTUM),Ventricular hypertrophy,VENTRICULAR WALL THICKENING,VENTRICULAR HYPERTROPHY,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10051987,10047295,10051987
FEBRILE NEUTROPENIA,febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
UNSATISFACTORY DIABETES COMPENSATION,Drug effect decreased,DRUG EFFECT DECREASED,DRUG EFFECT DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013678,10013678,10013678
PATIENT DETERIORATED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
ACUTE ABDOMEN,acute abdomen,ACUTE ABDOMEN,ACUTE ABDOMEN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10000647,10000647,10000647
NON-HEALING SOCKET,Impaired healing,WOUND HEALING DELAYED,IMPAIRED HEALING,TISSUE DISORDERS NEC,HEALING ABNORMAL NEC,10018065,10048036,10021519,10048036
INTRAUTERINE DEATH AT 24 WEEKS OF PREGNANCY,Intra-uterine death,INTRA-UTERINE DEATH,FOETAL DEATH,ABORTIONS AND STILLBIRTH,STILLBIRTH AND FOETAL DEATH,10036585,10022747,10055690,10022747
THERAPY-RELATED MYELOID NEOPLASM,myelodysplastic syndrome transformation,MYELODYSPLASTIC SYNDROME TRANSFORMATION,MYELODYSPLASTIC SYNDROME TRANSFORMATION,LEUKAEMIAS,MYELODYSPLASTIC SYNDROMES,10029104,10067387,10067387,10067387
HYPERPIGMENTATION ON ACK AND BOTH LOWER LIMBS INDUCED BY PROLONGED USE OF CHLOROQUINE,Skin hyperpigmentation,HYPERPIGMENTATION SKIN,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10040865,10040865,10020715
"PAPULES AND PUSTULES AFFECTING HIS ANTERIOR CHEST, UPPER BACK AND UPPER LIMBS",papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
"LEFT ACHILLES REFLEX WAS ABSENT,",Hyporeflexia,TENDON REFLEX DECREASED,HYPOREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10043245,10021089,10043245
DEVELOPMENTAL DELAY,Developmental delay,DEVELOPMENTAL DELAY,DEVELOPMENTAL DELAY,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10012559,10012559,10012559
PATIENT HAD A FASTING MORNING CORTISOL LEVEL OF 5 UG/DL,Cortisol decreased,CORTISOL DECREASED,CORTISOL DECREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),ADRENAL CORTEX TESTS,10022891,10011198,10011198,10011198
PRETERM BIRTH,Premature delivery,PREMATURE DELIVERY,PREMATURE DELIVERY,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036595,10036595,10036595
MYOSITIS,Myositis,MYOSITIS,MYOSITIS,MUSCLE DISORDERS,MUSCLE INFECTIONS AND INFLAMMATIONS,10028395,10028653,10028653,10028653
HIGH BLOOD PRESSURE (145/85 MMHG),Hypertension,BLOOD PRESSURE HIGH,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10005747
MURPHY'S SIGN POSITIVE,murphy's sign positive,MURPHY'S SIGN POSITIVE,MURPHY'S SIGN POSITIVE,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10052900,10052900,10052900
"BASE EXCESS NEGATIVE (-4.9,-7.9)",Base excess negative,BASE EXCESS NEGATIVE,BASE EXCESS NEGATIVE,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10060915,10060915,10060915
VENTRICULAR FIBRILLATION DUE TO DILATED CARDIOMYOPATHY FOLLOWING CARDIOTOXICITY,Ventricular fibrillation,VENTRICULAR FIBRILLATION,VENTRICULAR FIBRILLATION,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047290,10047290,10047290
"MILD, ITCHY ERYTHEMATOUS VESICULAR RASHES AROUND THE UMBILICUS",Rash erythematous,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015243
SIMPLE PARTIAL SEIZURE OCCURRED IN THE RIGHT UPPER LIMB,Simple partial seizures,SIMPLE PARTIAL SEIZURES,SIMPLE PARTIAL SEIZURES,SEIZURES (INCL SUBTYPES),PARTIAL SIMPLE SEIZURES NEC,10029205,10040703,10040703,10040703
INCREASED PRODUCTIVE COUGH,Productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
CEFTRIAXONE AND CLINDAMYCIN WERE GIVEN FOR SEVEN DAYS WITHOUT ANY IMPROVEMENT ( LACK OF DRUG EFFECT) WITH NO ADVERSE DRUG REACTION,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
ERYTHEMATOVESICULAR RASH -- PHOTOSENSITIVITY,Solar dermatitis,SOLAR ERYTHEMA,SOLAR DERMATITIS,EPIDERMAL AND DERMAL CONDITIONS,PHOTOSENSITIVITY AND PHOTODERMATOSIS CONDITIONS,10040785,10072196,10041303,10072196
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
HEMODYNAMIC INSTABILITY,hemodynamic instability,HEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10058270,10052076,10058270
REBOUND EFFECT,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
NARCOTIC INTOXICATION,narcotic intoxication,NARCOTIC INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10053259,10070863,10053259
VENTRICULAR ARRHYTHMIA,ventricular arrhythmia,VENTRICULAR ARRHYTHMIA,VENTRICULAR ARRHYTHMIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047281,10047281,10047281
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
SMALL PROXIMAL DIVERTICULUM FOLLOWING DICLOFENAC INDUCED COLONIC STRICTURES,Diverticulum intestinal,DIVERTICULUM INTESTINAL,DIVERTICULUM INTESTINAL,DIVERTICULAR DISORDERS,DIVERTICULA,10017947,10013559,10013559,10013559
VENTRICULAR FIBRILLATION,Ventricular fibrillation,VENTRICULAR FIBRILLATION,VENTRICULAR FIBRILLATION,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047290,10047290,10047290
SYMPTOMS DID NOT IMPROVE (LACK OF DRUG EFFECT WITH NO ADVERSE EVENT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
TYPE II HYPERSENSITIVITY REACTIONS (GRADE 2),Type II hypersensitivity,TYPE II HYPERSENSITIVITY,TYPE II HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10054000,10054000,10054000
"MASSIVE, INTENSIFYING, ERYTHEMATOUS-FOLLICULAR RASH",rash follicular,RASH FOLLICULAR,RASH FOLLICULAR,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10037857,10037857,10037857
AUTOIMMUNE ENCEPHALOPATHIES,Autoimmune encephalopathy,AUTOIMMUNE ENCEPHALOPATHY,AUTOIMMUNE ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10075691,10075691,10075691
ACCIDENTAL OVERDOSE,accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
"CONFLUENT ERYTHEMATOUS PLAQUES, PARTLY BULLOUS ON THE TORSO AND LIMBS",Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
METABOLIC ENCEPHALOPATHY,Metabolic encephalopathy,METABOLIC ENCEPHALOPATHY,METABOLIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10062190,10062190,10062190
PAIN IN RIGHT THIGH REGION,Pain in extremity,PAIN IN THIGH,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10048973,10033425,10048973
PERITONITIS,Peritonitis,PERITONITIS,PERITONITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10034674,10034674,10034674
PERSISTENCE OF FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
ANAPHYLAXIS,Anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
USE OF TEMOZOLOMIDE FOR SUSPECTED URINARY TRACT INFECTION (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEAD WAS LARGE WITH A PROMINENT FOREHEAD AND A SADDLE NOSE,Dysmorphism,FACIAL DYSMORPHISM,DYSMORPHISM,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL DISORDERS CONGENITAL NEC,10010331,10016045,10066054,10016045
NEUTROPHILS DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
FATIGABILITY,Fatigue,FATIGUABILITY,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016259,10016256,10016259
FAILED IMATINIB AT 400MG DAILY AS FIRST-LINE THERAPY,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
SORE THROAT,Oropharyngeal pain,SORE THROAT,OROPHARYNGEAL PAIN,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10041367,10068319,10041367
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
TACHYPNOEA,Tachypnoea,TACHYPNOEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043089
CHEILITIS,cheilitis,CHEILITIS,CHEILITIS,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE DISORDERS NEC,10017947,10008417,10008417,10008417
MODERATE DIARRHEA FOLLOWING ACUTE CHLOROQUINE POISONING DUE TO OVERDOSE,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
INCREASE WEIGHT,increase weight,WEIGHT INCREASED,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047899
MATERNAL EXPOSURE DURING BREAST FEEDING/EXPOSURE DURING BREAST FEEDING,maternal exposure during breast feeding,MATERNAL EXPOSURE DURING BREAST FEEDING,MATERNAL EXPOSURE DURING BREAST FEEDING,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10080752,10080752,10080752
DRUG EXPOSURE DURING PREGNANCY WITHOUT ADVERSE EVENT,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
MEDICATION-RELATED OSTEONECROSIS OF THE JAW STAGE 2 [MANDIBLE (QUADRANT III)],osteonecrosis of the jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
HER SERUM CREATININE WAS 7.0 MG/DL,Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
SHE DID NOT RESPOND,Therapy non-responder,THERAPY NON-RESPONDER,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051082,10051082,10051082
"PARADOXICAL REACTION OF AGITATION WITH AGGRESSION, ANXIETY AND SCARIFICATION 3 DAYS AFTER THE INTRODUCTION",anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
INCREASED SERUM POTASSIUM,Blood potassium increased,POTASSIUM SERUM INCREASED,BLOOD POTASSIUM INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10040379,10005725,10036456
CONDITION WORSENING,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
HEPATITIS,Hepatitis,HEPATITIS,HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019717,10019717,10019717
TALL PEAKED T WAVES,Electrocardiogram T wave amplitude increased,ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10051159,10051159,10051159
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HYDROXYCHLOROQUINE-INDUCED DRUG ERUPTION (ERYTHEMA MULTIFORME),Erythema multiforme,ERYTHEMA MULTIFORME,ERYTHEMA MULTIFORME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10015218,10015218,10015218
GRAND MAL SEIZURE,Grand mal seizure,GRAND MAL SEIZURE,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10018663,10018100,10018663
IBUPROFEN IN A FATAL OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
"MATERNAL EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",Maternal exposure during pregnancy,"MATERNAL EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10074500,10071408,10074500
LOW ENERGY,asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
ADYNAMIC RENAL BONE DISEASE,Low turnover osteopathy,ADYNAMIC BONE DISEASE,LOW TURNOVER OSTEOPATHY,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10060881,10063000,10060881
PROGRESSION OF GASTROINTESTINAL STROMAL TUMOR FOLLOWING FAILURE OF IMATINIB,Gastrointestinal stromal tumor,GASTROINTESTINAL STROMAL TUMOR,GASTROINTESTINAL STROMAL TUMOUR,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,GASTROINTESTINAL NEOPLASMS MALIGNANCY UNSPECIFIED NEC,10029104,10062427,10051066,10062427
NICOLAU'S SYNDROME,Embolia cutis medicamentosa,NICOLAU SYNDROME,EMBOLIA CUTIS MEDICAMENTOSA,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10058731,10058729,10058731
"SKIN CONDITION SPREAD OUT TO THE BACK, THIGHS AND UPPER ARMS/ AFFECTING MORE THAN 30 % OF TOTAL SKIN AREA",Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
ACUTE PAIN IN EPIGASTRIC REGION,Abdominal pain upper,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
VISION HAD DE- CREASED TO NO LIGHT PERCEPTION,Vision decreased,VISION DECREASED,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047516,10047571,10047516
FEVER FOLLOWING PANCYTOPENIA,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
FOETAL EXPOSURE DURING PREGNANCY,Foetal exposure during pregnancy,FOETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071404,10071404,10071404
SGOT 204 IU/L,Aspartate aminotransferase increased,SGOT INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10040524,10003481,10040524
LEUKOCYTOSIS WITH A WHITE BLOOD CELL COUNT OF 29.6X10E3/MCL,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA,B-cell type acute leukaemia,B-CELL TYPE ACUTE LEUKAEMIA,B-CELL TYPE ACUTE LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE LYMPHOCYTIC,10029104,10003917,10003917,10003917
INFLUENZA VIRAL INFECTION,Influenza,INFLUENZA,INFLUENZA,VIRAL INFECTIOUS DISORDERS,INFLUENZA VIRAL INFECTIONS,10021881,10022000,10022000,10022000
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
BKV-ASSOCIATED HEMORRHAGIC CYSTITIS,BK virus infection,BK VIRUS INFECTION,BK VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10055181,10055181,10055181
SEVER HYPERGLYCEMIA,Hyperglycemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020639,10020635,10020639
RENAL FUNCTION RAPIDLY DETERIORATED DUE TO SUSPECTED NON-ADHERENCE TO IMMUNE SUPPRESSANTS,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
DYSPNEA AT EXERTION,Dyspnea exertional,DYSPNEA EXERTIONAL,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013966,10013971,10013966
EXTENSIVE TENDEREDEMAOF THE FACE,Edema face,EDEMA FACE,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014222,10016029,10014222
RIGHT ILIAC MUSCLE WAS MARKEDLY SWOLLEN,Muscle swelling,MUSCLE SWELLING,MUSCLE SWELLING,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10064470,10064470,10064470
ACUTE TOXIC HEPATITIS,Hepatitis toxic,HEPATITIS ACUTE TOXIC,HEPATITIS TOXIC,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10052553,10019795,10052553
"SYMMETRICAL MACULAR RASH ON HIS GLUTEAL AREA, INCLUDING INTERGLUTEAL CLEFT AND GLUTEAL FOLD, AND ON HIS UPPER INNER THIGHS",macular rash,MACULAR RASH,RASH MACULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025418,10037867,10025418
"GASTRIC LARGE, MULTIPLE, ELEVATED AND ULCERATED BLEEDING VASCULAR LESIONS WITH FLAT PIGMENTED SPOTS AND CLEAN BASE/ADDED PROPRANOLOL(OFF LABEL USE)",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SECOND FEBRILE EPISODE,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
SUBSTANTIAL SEXUAL ADVERSE EFFECTS,Sexual disorder NOS,SEXUAL DISORDER NOS,SEXUAL DYSFUNCTION,SEXUAL FUNCTION AND FERTILITY DISORDERS,SEXUAL FUNCTION AND FERTILITY DISORDERS NEC,10038604,10040476,10040477,10040476
TREMORS,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
BIPOLAR DISORDER AND DELAYED SUBCORTICAL DEMENTIA ONSET FOLLOWING ACUTE LITHIUM TOXICITY,Bipolar disorder,BIPOLAR DISORDER,BIPOLAR DISORDER,MANIC AND BIPOLAR MOOD DISORDERS AND DISTURBANCES,BIPOLAR DISORDERS,10037175,10057667,10057667,10057667
BEST CORRECTED VISUAL ACUITY WAS 20/25 OD AND 20/50 OS,Visual acuity reduced,BEST-CORRECTED DISTANCE VISUAL ACUITY DECREASED,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10070552,10047531,10070552
ERUPTION,Rash,ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10015138
"DIFFUSE, ERYTHEMATOUS, MACULOPAPULAR RASH, WHICH HAD BEGUN ON HER HEAD AND FACE AND HAD RAPIDLY PROGRESSED TO HER TRUNK AND HANDS",Rash erythematous,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015243
CHEST PAIN,chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
INEFFECTIVENSS,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
TRANSIENT HYPOTENSION,transient hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
HYPOGLYCEMIA (20 MG/DL),Hypoglycemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10021005,10020993,10021005
STEVENS-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042030
TROPONIN INCREASED,Troponin increased,TROPONIN INCREASED,TROPONIN INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10058267,10058267,10058267
DEHYDRATION,dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
NEUTROPENIA OF GRADE 3/ GRADE 3 OR HIGHER NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
SUBTHERAPEUTIC INR,subtherapeutic INR,SUBTHERAPEUTIC INR,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10072371,10060321,10072371
RECURRENT GRADE 3/4 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
BEHAVIORAL OR PSYCHOTIC TROUBLES,Psychotic disorder,PSYCHOTIC DISORDER,PSYCHOTIC DISORDER,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10061920,10061920,10061920
EMESIS,Vomiting,EMESIS,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10014542
ACRODERMATITIS ENTEROPATHICA DUE TO ZINC DEFICIENCY,Acrodermatitis enteropathica,ACRODERMATITIS ENTEROPATHICA,ACRODERMATITIS ENTEROPATHICA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL NEC,10010331,10000596,10000596,10000596
ANTIBIOTIC-INDUCED SKIN RASH,Rash,SKIN RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040913
BULLOUS PEMPHIGOID,Pemphigoid,BULLOUS PEMPHIGOID,PEMPHIGOID,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006567,10034277,10006567
ANAPHYLACTIC REACTION,Anaphylactic reaction,ANAPHYLACTIC REACTION,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002198,10002198,10002198
DRUG EXANTHEMA,Rash,EXANTHEMA,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10015587
PERSISTENT FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
ACUTE HEPATITIS,Hepatitis acute,HEPATITIS ACUTE,HEPATITIS ACUTE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019727,10019727,10019727
ACUTE NECROTIZING PANCREATITIS WITH PERIPANCREATIC NECROSIS,Pancreatitis necrotising,NECROTIZING PANCREATITIS,PANCREATITIS NECROTISING,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033654,10033654,10028891
ELECTROCARDIOGRAM ST SEGMENT ELEVATION,Electrocardiogram ST segment elevation,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10014392,10014392,10014392
"SHE RECIEVED DIAZEPAM 10MG IVX2 ON HOSPITAL DAY 1 AND 2 SHE REPORTED ANXIETY, RESTLESSNESS, NAUSEA, ABDOMINAL PAIN, AND DIARRHEA",Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
PERIORAL EXUDATION AND CRUSTING,Scab,CRUST,SCAB,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10039509,10039509,10011468
"OLIGOHYDRAMNIOS, ANTEPARTUM","Oligohydramnios, antepartum","OLIGOHYDRAMNIOS, ANTEPARTUM",OLIGOHYDRAMNIOS,"PLACENTAL, AMNIOTIC AND CAVITY DISORDERS (EXCL HAEMORRHAGES)",AMNIOTIC FLUID AND CAVITY DISORDERS OF PREGNANCY NEC,10036585,10030291,10030289,10030291
TOTAL TESTOSTERONE DECREASED (2.77 NG/ML),Blood testosterone decreased,TESTOSTERONE DECREASED,BLOOD TESTOSTERONE DECREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),REPRODUCTIVE HORMONE ANALYSES,10022891,10043368,10005814,10043368
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
ENALAPRIL USED FOR ACUTE NEPHRITIC SYNDROME,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
BLURRED VISION,blurred vision,BLURRED VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10005886,10047513,10005886
SEVERE CUTANEOUS INFECTION (CAUSED BY GROUP A STREPTOCOCCI),severe cutaneous infection (caused by group A Streptococci),SKIN INFECTION,SKIN INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10040872,10040872,10040872
DISC HERNIATION,Herniated disc,HERNIATED DISC,INTERVERTEBRAL DISC PROTRUSION,MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES (INCL INTERVERTEBRAL DISC DISORDERS),INTERVERTEBRAL DISC DISORDERS NEC,10028395,10050330,10050296,10050330
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
SEPTIC SHOCK DUE TO PANCYTOPENIA,septic shock due to pancytopenia,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
"SEVERE T CELL LYMPHOPENIA (CD3: 479, CD4:108)/SECONDARY IMMUNODEFICIENCY",Lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
BLEEDING,Haemorrhage,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10005103
EXACERBATION OF ATAXIA FOLLOWING PARTIAL RESPONSE,Ataxia aggravated,ATAXIA AGGRAVATED,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10048320,10003591,10048320
BLOOD PRESSURE 150/70 MM HG SUPINE,Blood pressure 150/70 mm hg supine,BLOOD PRESSURE,BLOOD PRESSURE MEASUREMENT,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005727,10076581,10005727
SUBCONJUNCTIVAL APPLICATION(INCORRECT ROUTE OF ADMINISTRATION),Wrong route of administration,WRONG ROUTE OF ADMINISTRATION,INCORRECT ROUTE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10048057,10064304,10048057
ACUTE DRUG-INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
PATIENT DIED DESPITE THE COMBINATION OF CORTICOSTEROIDS AND PLASMA EXCHANGES,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ASCITES,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
HYPOGAMMAGLOBULINEMIA,"Hypogammaglobulinemia, unspecified","HYPOGAMMAGLOBULINEMIA, UNSPECIFIED",HYPOGAMMAGLOBULINAEMIA,IMMUNODEFICIENCY SYNDROMES,PRIMARY IMMUNODEFICIENCY SYNDROMES,10021428,10020986,10020983,10020986
PATIENT WAS GIVEN FLUDARABINE AS CONDITIONING REGIMEN (OFF LABEL USE) WITH NO ADVERSE DRUG REACTION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
GRADE 2 AND 3 ANAEMIA,Grade 2 and 3 anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
COMATOSE,Coma,COMATOSE,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10058472,10010071,10058472
URINARY CATHETER SPECIMEN GREW CARBAPENEM RESISTANT E.COLI,Escherichia coli infection,ESCHERICHIA COLI INFECTION,ESCHERICHIA INFECTION,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10054242,10061126,10054242
KLEBSIELLA SEPTIC SHOCK DUE TO TRANSIENT SEVERE IMMUNODEFICIENCY SECONDARY TO CHEMOTHERAPY,Klebsiella infection,KLEBSIELLA INFECTION,KLEBSIELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10061259,10061259,10061259
DRUG EXPOSURE IN UTERO,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
RIGHT HEMI-DIAPHRAGM PARESIS,Paresis,PARESIS,PARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10033985,10033985,10033985
INSOMNIA,Insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
GENERALISED MYOCLONIA,Myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
ESOTROPIA,esotropia,ESOTROPIA,STRABISMUS,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10015475,10042159,10015475
INTRAHEPATIC CHOLANGIOCARCINOMA WITH SI OBSTRUCTION METASTASIS PROGRESSED FOLLOWING LACK OF DRUG EFFECT,Cholangiocarcinoma,INTRAHEPATIC CHOLANGIOCARCINOMA,CHOLANGIOCARCINOMA,HEPATOBILIARY NEOPLASMS MALIGNANT AND UNSPECIFIED,BILE DUCT NEOPLASMS MALIGNANT,10029104,10073077,10008593,10073077
BEHAVIOURAL DISTURBANCE,behavior disorder,BEHAVIOR DISORDER,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004204,10061422,10004204
CHEST PAIN,chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
INCREASED BILIRUBIN,Bilirubin increased,BILIRUBIN INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10004690,10005364,10004690
WORSENING METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
INFANTILE HEMANGIOMAS TREATED WITH ORAL PROPRANOLOL,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SAPOVIRUS TEST POSITIVE,Sapovirus test positive,SAPOVIRUS TEST POSITIVE,SAPOVIRUS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10070383,10070383,10070383
RHABDOMYOLYSIS DUE TO STATIN- ERYTHROMYCIN INTERACTION LEADING TO RENAL FAILURE,rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
NO SIGNIFICANT IMPROVEMENT IN SYMPTOMS IN A PATIENT TREATED WITH DEXAMETHASONE FOR GAMMAKNIFE RADIOSURGERY-INDUCED BRAIN RADIATION NECROSIS (LACK OF DRUG EFFECT WITH NO ADR),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
THE PATIENT DID NOT KNOW THE INDICATION OF EACH DRUG OR THE EQUIVALENCE BETWEEN GENERICS AND TRADENAMES. THE PATIENT WAS TAKING THE MEDICATION IN A WRONG WAY,Inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
KLEBSIELLA INFECTION,Klebsiella infection,KLEBSIELLA INFECTION,KLEBSIELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10061259,10061259,10061259
MEROPENEM RELATED LIVER PATHOLOGY,Liver disorder,LIVER DISORDER,LIVER DISORDER,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10024670,10024670,10024670
NODULES OVER BILATERAL PALMS ANS AN ISOLATED 0.5 CM NODULE ON HER ELBOW,Nodule,NODULE,NODULE,TISSUE DISORDERS NEC,MASS CONDITIONS NEC,10018065,10054107,10054107,10054107
DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
DYSPNEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
THE PATIENT EXPERIENCED METRONIDAZOLE INJECTION INFILTRATION,Injection site infiltration,INJECTION SITE INFILTRATION,INJECTION SITE EXTRAVASATION,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022077,10022062,10022077
ERYTHEMATOUS ERUPTION WITH PUSTULES OCCURRED ON THE LOWER LIMBS AND SPREAD TO THE UPPER LIMBS AND THE TRUNK,Erythematous eruption,ERYTHEMATOUS ERUPTION,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015241,10037855,10015241
INTAKE OF IBUPROFEN TOGETHER WITH NSAIDS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
BK POLYOMAVIRUS-ASSOCIATED NEPHROPATHY GRADE A,Polyomavirus-associated nephropathy,BK VIRUS NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065333,10065381,10065333
GENERALISED PAIN,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
INTERACTION BETWEEN MEPACRINE AND CHLOROQUINE MAY HAVE RESULTED IN INCREASED BIOAVAILABILITY AND HENCE TOXICITY OF CHLOROQUINE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
FEW NUMBER OF SEIZURES/LOWER NUMBER OF SEIZURES,Seizure,SEIZURES,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039910
HCV INFECTION,Viral infection,VIRAL INFECTION,VIRAL INFECTION,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10047461,10047461,10047461
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
SEVERE HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
FIRST-DEGREE ATRIOVENTRICULAR BLOCK,Atrioventricular block first degree,FIRST DEGREE ATRIOVENTRICULAR BLOCK,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10003674,10003674,10016699
WORSENING SOMNAMBULISM/NOCTURNAL DISRUPTIVE BEHAVIORS,somnambulism,SOMNAMBULISM,SOMNAMBULISM,SLEEP DISORDERS AND DISTURBANCES,PARASOMNIAS,10037175,10041347,10041347,10041347
"LACK OF DRUG EFFECT (PRESENTED WITH RECURRENT VENTRICULAR TACHYCARDIA (VT) DESPITE TREATMENT WITH
AMIODARONE)",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
MPE,Rash maculo-papular,MACULO-PAPULAR EXANTHEMA,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10049195,10037868,10049195
INTOLERANCE,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
DRUG EXPOSURE DURING PREGNANCY,"drug exposure during pregnancy, third trimester","DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
"FAILED TRIALS OF SSRI, TCA AND ANXIOLYTIC",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
LACTATE DEHYDROGENASE INCREASED (1672 U/L),,,,,ENZYME INVESTIGATIONS NEC,10014938,10023654,10005630,
USE OF MYCOPHENOLATE MOFETIL FOR LUPUS NEPHRITIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PNEUMOPERITONEUM,Pneumoperitoneum,PNEUMOPERITONEUM,PNEUMOPERITONEUM,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10048299,10048299,10048299
DIFFUSE GASTRITIS,gastritis,GASTRITIS,GASTRITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTRITIS (EXCL INFECTIVE),10017947,10017853,10017853,10017853
UPPER LIMB TONIC SEIZURE,Tonic convulsion,TONIC SEIZURE,TONIC CONVULSION,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10043997,10043994,10043996
ASPERGILLUS FUMIGATUS PNEUMONIA,Aspergillus fumigatus infection,ASPERGILLUS FUMIGATUS INFECTION,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003494,10074171,10003494
STRONG PAIN JUST ABOVE THE INJECTION SITE,Injection site pain,INJECTION SITE PAIN,INJECTION SITE PAIN,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022086,10022086,10022086
BALANCE DISORDER,Balance disorder,BALANCE DISORDER,BALANCE DISORDER,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10049848,10049848,10049848
DRUG INDUCED ACUTE INTERSTITIAL NEPHRITIS,Tubulointerstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029135,10048302,10000819
CEREBELLAR LESION,Central nervous system lesion,CEREBELLAR LESION NOS,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10049441,10051290,10049441
PERSISTENT AND WORSENING LETHARGY,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
"PATIENT WAS TAKING CA-VIT D TABLETS AND ALSO HCTZ, WHICH TOGETHER CAN CAUSE SIGNIFICANT HYPERCALCEMIA",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
HYPOCARBIA,Carbon dioxide blood decreased,CARBON DIOXIDE BLOOD DECREASED,CARBON DIOXIDE DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10007221,10007223,10007221
C-REACTIVE PROTEIN,C-reactive protein abnormal,C-REACTIVE PROTEIN ABNORMAL,C-REACTIVE PROTEIN ABNORMAL,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10068559,10068559,10068559
SPONTANEOUS DEEP VENOUS THROMBOSIS,Deep vein thrombosis,DEEP VENOUS THROMBOSIS NOS,DEEP VEIN THROMBOSIS,EMBOLISM AND THROMBOSIS,PERIPHERAL EMBOLISM AND THROMBOSIS,10047065,10012107,10051055,10012107
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HIGH FIBRINOGEN LEVELS (589 MG/DL),Blood fibrinogen increased,FIBRINOGEN INCREASED,BLOOD FIBRINOGEN INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10016597,10005521,10016597
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
MULTIPLE PLEOMORPHIC ULCERS IN THE FUNDUS,Gastric ulcer haemorrhage,BLEEDING GASTRIC ULCER,GASTRIC ULCER HAEMORRHAGE,GASTROINTESTINAL ULCERATION AND PERFORATION,GASTRIC ULCERS AND PERFORATION,10017947,10017826,10017826,10005115
HIGH FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
UPPER RESPIRATORY AIRWAY OBSTRUCTION,Upper airway obstruction,UPPER AIRWAY OBSTRUCTION,UPPER AIRWAY OBSTRUCTION,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10067775,10067775,10067775
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
ZOLPIDEM WITHDRAWAL DELIRIUM,Withdrawal symptom,WITHDRAWAL SYMPTOM,WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10073281,10048010,10073281
DIPLOPIA,Diplopia,DIPLOPIA,DIPLOPIA,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10013036,10013036,10013036
"TOTAL LACK OF ENERGY, STOPPED LEAVING THE HOUSE BECAUSE â€œHE DID NOT HAVE HAVE THE STRENGTHâ€",loss of energy,LOSS OF ENERGY,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10024862,10003549,10024862
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
PAROTID MEC,Mucoepidermoid carcinoma of salivary gland,MUCOEPIDERMOID CARCINOMA OF SALIVARY GLAND,MUCOEPIDERMOID CARCINOMA OF SALIVARY GLAND,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,SALIVARY GLAND NEOPLASMS MALIGNANT,10029104,10073371,10073371,10073371
FALLING ASLEEP EARLY,Advanced sleep phase,ADVANCED SLEEP PHASE,ADVANCED SLEEP PHASE,SLEEP DISTURBANCES (INCL SUBTYPES),DISTURBANCES IN SLEEP PHASE RHYTHM,10029205,10001423,10001423,10001423
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
NIFEDIPINE GIVEN FOR THREATENED PRETERM LABOR,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
ACUTE INFLAMMATORY SYNDROME PARADOXICALLY INDUCED BY DE NOVO PURINE INHIBITORS SYNTHESIS BEFORE RENAL TRANSPLANTATION,Paradoxical drug reaction,PARADOXICAL DRUG REACTION,PARADOXICAL DRUG REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048958,10048958,10048958
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
WITH RESOLUTION OF THE COUGH WITHIN A DAY THAT PERSISTED UNTIL DEATH FROM CARCINOMATOSIS 4 MONTHS LATER,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
INADEQUATE ADAPTATION OF GLUCOCORTICOID DOSAGE TO THE ACUTE STRESS SITUATION,Inappropriate dose of drug administered,INAPPROPRIATE DOSE OF DRUG ADMINISTERED,INCORRECT DOSE ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021590,10064355,10021590
VENTRICULITIS,ventriculitis,VENTRICULITIS,CNS VENTRICULITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10047303,10009719,10047303
PERICARDITIS FOLLOWING ASPERGILLUS FUMIGATUS INFECTION,Pericarditis infective,PERICARDITIS INFECTIVE,PERICARDITIS INFECTIVE,INFECTIONS - PATHOGEN UNSPECIFIED,CARDIAC INFECTIONS,10021881,10062491,10062491,10062491
EDEMA OF THE DORSUM OF THE RIGHT HAND,Oedema peripheral,EDEMA HANDS,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10058204,10030124,10050065
NON-NECROTIZING GRANULOMAS,Granuloma,GRANULOMA,GRANULOMA,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10018691,10018691,10018691
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
PROGRESSIVE DISEASE,Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
MIXED TYPE IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY,Mixed liver injury,MIXED LIVER INJURY,MIXED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10066758,10066758,10066758
INTOLERANCE TO COLCHICINE WITH DIARRHEA AND ABDOMINAL PAIN,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
HEMARTHROSIS,Hemarthrosis,HEMARTHROSIS,HAEMARTHROSIS,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10019409,10018829,10019409
ABDOMINAL DISCOMFORT,abdominal discomfort,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10000059,10000059,10000059
FALL,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
STARTING NONPROLIFERATIVE DIABETIC RETINOPATHY,Diabetic retinopathy,DIABETIC RETINOPATHY,DIABETIC RETINOPATHY,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINOPATHIES NEC,10015919,10012689,10012689,10012689
"FACIAL, PERIORBITAL, UPPER AND LOWER LIMB OEDEMA",oedema face,OEDEMA FACE,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030101,10016029,10030101
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
PALPITATIONS,palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
UPPER AND LOWER EXTREMITIES WERE VERY SMALL,Limb deformity,LIMB DEFORMITY,LIMB DEFORMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES (INCL INTERVERTEBRAL DISC DISORDERS),EXTREMITY DEFORMITIES,10028395,10053652,10053652,10053652
HAEMOGLOBIN DECREASED (1.62 MMOL/L),haemoglobin decreased (1.62 mmol/l),HAEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10018884
POOR COMPLIANCE TO RIBAVIRIN THERAPY (INADEQUATE DOSING OR NON ADHERENCE),Product use issue,PRODUCT USE ISSUE,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076309,10076309,10076309
"HE REGULARLY TOOK ACETYLSALICYLIC ACID 100 MG, NEBIVOLOL 2.5 MG, AMLODIPINE 5 HE REGULARLY TOOK ACETYLSALICYLIC ACID 100 MG, NEBIVOLOL 2.5 MG, AMLODIPINE 5 PERSISTED",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
VOCAL TIC,Tic,VOCAL TIC,TIC,CHANGES IN PHYSICAL ACTIVITY,TIC DISORDERS,10037175,10066771,10043833,10066771
SEVERE PULMONARY HYPERTENSION FOLLOWING CISPLATIN INDUCED NON-ISCHAEMIC CARDIOMYOPATHY,Pulmonary hypertension,PULMONARY HYPERTENSION,PULMONARY HYPERTENSION,PULMONARY VASCULAR DISORDERS,PULMONARY HYPERTENSIONS,10038738,10037400,10037400,10037400
INTAKE OF 360 MG OF DEXTROMETHORPHAN SUPERIOR TO THE THEORETICAL LETHAL DOSE,overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
USE OF METHOTREXATE AND HYDROXYCHLOROQUINE FOR SINONASAL AND LARYNGEAL SARCOIDOSIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
EOSINOPHILIA,Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
"SIGNIFICANT DETERIORATION IN HIS CONFUSION, AGITATION, AND IMPULSIVITY SINCE HIS INITIAL PRESENTATION",Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
SIGNIFICANT COLLATERAL VEINS AROUND THE STOMA,Varicose vein,VARICOSE VEIN,VARICOSE VEIN,VENOUS VARICES,VARICOSE VEINS NEC,10047065,10046996,10046996,10046996
DEATH WAS CAUSED BY AN OVERDOSE OF FENTANYL,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
RED SPOTS,Redness,REDNESS,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10038198,10015150,10038198
TABLETS HAD GONE DOWN THE WRONG TRACT IN HIS THROAT/TABLETS HAD GONE DOWN THE WRONG PASSAGE/ASPIRATION OF MEDICINE,medication aspiration ,MEDICATION ASPIRATION,FOREIGN BODY ASPIRATION,INJURIES NEC,CHEST AND RESPIRATORY TRACT INJURIES NEC,10022117,10063553,10017000,10063553
ANAEMIA GRADE 1,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
GRADE 1 BILATERAL NEPHROCALCINOSIS,Nephrocalcinosis,NEPHROCALCINOSIS,NEPHROCALCINOSIS,UROLITHIASES,RENAL LITHIASIS,10038359,10029146,10029146,10029146
BROCHOSPASM,Bronchospasm,BRONCHOSPASM,BRONCHOSPASM,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10006482,10006482,10006482
DECREASED CONSCIOUSNESS,Depressed level of consciousness,CONSCIOUSNESS DECREASED,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010768,10012373,10010768
DEVELOPED AKINETIC MUTISM AT THE AGE OF 82,Locked-in syndrome,AKINETIC MUTISM,LOCKED-IN SYNDROME,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10001542,10024792,10001542
METASTASES TO AXILLARY LYMPH NODES (2 POINTS),Metastases to lymph nodes,METASTASES TO LYMPH NODES,METASTASES TO LYMPH NODES,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027459,10027459,10027459
LEFT LEG ISCHEMIA WORSENED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
PATIENT DEVELOPED WORSENING OF SHOULDER PAIN DESPITE INCREASING DOSE OF DEFLAZACORT (LACK OF DRUG EFFECT),Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HYPOCALCAEMIA,Hypocalcaemia,HYPOCALCAEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020947,10020947,10020947
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
VACCINATION SITE REACTION,Vaccination site reaction,VACCINATION SITE REACTION,VACCINATION SITE REACTION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10059080,10059080,10059080
DRUG EXPOSURE DURING PREGNANCYWITH NO ADR,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ACTIVATED PARTIAL THROMBOPLASTIN TIME WAS > 130 SECONDS,Activated partial thromboplastin time prolonged,ACTIVATED PARTIAL THROMBOPLASTIN TIME INCREASED,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10000634,10000636,10000634
ENTEROCOCCUS COLONISATION (ENTEROCOCCUS GALLINARUM IN THE PERITONEAL FLUID),Enterococcus colonisation,ENTEROCOCCUS COLONISATION,BACTERIAL DISEASE CARRIER,ANCILLARY INFECTIOUS TOPICS,INFECTIOUS DISORDERS CARRIER,10021881,10067915,10004017,10067915
BILATERAL THIGH AND KNEE PAIN,Pain in extremity,PAIN IN THIGH,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10048973,10033425,10048973
DRUG-DRUG INTERACTION,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
HIV-1 PERSISTENT VIREMIA,HIV viraemia,HIV VIREMIA,HIV VIRAEMIA,VIRAL INFECTIOUS DISORDERS,RETROVIRAL INFECTIONS,10021881,10077716,10077716,10077718
CONGENITAL ANOMALY,congenital anomaly,CONGENITAL ANOMALY,CONGENITAL ANOMALY,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10010356,10010356,10010356
ABSENCE OF PULSATION IN THE RIGHT POPLITEAL AND DORSALIS PEDIS ARTERY,Pulse absent,PULSE ABSENT,PULSE ABSENT,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10037469,10037469,10037469
"ALT OF 1,105, 210 U/L",Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
WORSENING HYPOKALAEMIA,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
INTERMITTENT FEBRILE PEAKS,reaction febrile,REACTION FEBRILE,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037946,10037660,10037946
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
TACHYPNEIC,Tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
DISEASE PROGRESSION,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
I THINK I JUST WASN'T USING ENOUGH OF IT FOR TWO YEARS. . .. HER ECZEMA LOOKS SO MUCH BETTER EVEN AFTER 24 HOURS!,Underdose,UNDERDOSE,UNDERDOSE,OVERDOSES AND UNDERDOSES NEC,UNDERDOSES NEC,10022117,10057362,10057362,10057362
CEPHALGIA,Headache,CEPHALGIA,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10008013
WORSENING OF LEFT LOWER LIP AND CHIN FULLNESS (CELLULITIS AGGRAVATED),Cellulitis,CELLULITIS AGGRAVATED,CELLULITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10048395,10007882,10048395
DIABIGATRAN OVERDOSE,Drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
ATROPHY OF PROXIMAL MUSCULATURE ON UPPER AND LOWER EXTREMITIES WAS FOUND,Muscle atrophy,MUSCLE ATROPHY,MUSCLE ATROPHY,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028289,10028289,10028289
GASTROINTESTINAL DISORDER,Gastrointestinal disorder,COLOPATHY,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10049897,10017944,10049897
WHITE CELL COUNT (WCC) OF 46 (REF: 4-10.8 K/UL),White blood cell count high,WHITE BLOOD CELL COUNT HIGH,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10051771,10047943,10051771
LACTATE DEHYDROGENASE INCREASED (708 U/L),Blood lactate dehydrogenase increased,LACTATE DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10023654,10005630,10023654
PULMONARY EMBOLISM,Pulmonary embolism,PULMONARY EMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037377,10037377,10037377
ACUTE COLITIS,Colitis,COLITIS,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009887,10009887,10009887
METABOLIC ACIDOSIS FOLLOWING ACUTE KIDNEY INJURY DUE TO STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
SKIN LESION,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
STATIN INDUCED ANTI-HMGCR POSITIVE AUTOIMMUNE NECROTIZING AUTOIMMUNE MYOSITIS,Necrotising myositis,NECROTISING MYOSITIS,NECROTISING MYOSITIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10074769,10074769,10074769
RESPIRATORY TRACT INFECTION,Respiratory tract infection,RESPIRATORY TRACT INFECTION,RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10062352,10062352,10062352
IMATINIB-INTOLERANCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
MACROCYTIC ANEMIA (HEMOGLOBIN 9-10 GRAM PER LITRE) DUE TO MYELODYSPLASTIC SYNDROME,Anaemia macrocytic,MACROCYTIC ANEMIA,ANAEMIA MACROCYTIC,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002064,10002064,10025381
OSTEOMALACIA FROM A TENOFOVIR INDUCED FANCONI'S SYNDROME,osteomalacia,OSTEOMALACIA,OSTEOMALACIA,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10031250,10031250,10031250
ASEPTIC HIGH FEVER (38.2 DEGREE CELCIUS),aseptic high fever (38.2 degree celcius),PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
SCEDOSPORIUM APIOSPERMUM INFECTION/ DISSEMINATED SCEDOSPORIUM APIOSPERMUM INFECTION,Scedosporium infection,SCEDOSPORIUM APIOSPERMUM INFECTION,SCEDOSPORIUM INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10076593,10059045,10076593
WEAK PULSE,Pulse abnormal,PULSE WEAK,PULSE ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10037494,10037466,10037494
MODERATE SIZE PERICARDIAL EFFUSION LOCALIZED CIRCUMFERENTIALLY,Pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
PATIENT WAS GIVEN METHYLPREDNISOLONE IV FOR LYMPHOCYTIC COLITIS BUT DIARHHEA FAILED TO IMPROVE ON IV METHYLPREDNISOLONE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DELAYED HYPERSENSITIVITY,Type IV hypersensitivity reaction,DELAYED TYPE HYPERSENSITIVITY,TYPE IV HYPERSENSITIVITY REACTION,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10012210,10053613,10012210
LITHIUM-INDUCED END STAGE RENAL DISEASE.,End stage renal disease,END STAGE RENAL DISEASE,END STAGE RENAL DISEASE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10077512,10077512,10077512
LEFT SIDED CATARACT,cataract,CATARACT,CATARACT,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",CATARACT CONDITIONS,10015919,10007739,10007739,10007739
HEPARIN INDUCED THROMBOCYTOPENIA RESULTING IN AN ILIAC VEIN THROMBOSIS,heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
PRIMARY RESISTANCE TO IMATINIB,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
TYPE II AMIODARONE INDUCED THYROTOXICOSIS,thyrotoxicosis,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
ASTHMA-LIKE CONDITION/ SYMPTOMS 'ASTHMA-LIKE' TO ASPIRIN,asthma,ASTHMA,ASTHMA,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10003553,10003553,10003553
HEPATOTOXICITY,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
SEIZURE,seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
STAGE 3 MEDICATION-RELATED OSTEONECROSIS OF THE JAW (RIGHT MANDIBLE),Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
"HEADACHE, ANXIETY, PALPITATIONS, IRRITABILITY AND INSOMNIA",Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
3 KNEE HEMARTHROSES INCREASED BLEEDING SYMPTOM FOLLOWING PLATELET DYSFUNCTION,Haemarthrosis,KNEE HEMARTHROSIS,HAEMARTHROSIS,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10077722,10018829,10077747
RESPIRATORY DISTRESS/RESPIRATORY FUNCTIONAL SYNDROME ACCENTUATED,Distress respiratory syndrome newborn,DISTRESS RESPIRATORY SYNDROME NEWBORN,NEONATAL RESPIRATORY DISTRESS SYNDROME,NEONATAL RESPIRATORY DISORDERS,NEONATAL HYPOXIC CONDITIONS,10038738,10013494,10028974,10013494
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
"HYPERTENSION BECAME RESISTANT DESPITE TREATMENT WITH IRBESARTAN, HCTZ, NICARDIPINE, BISOPROLOL",therapy non-responder,THERAPY NON-RESPONDER,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051082,10051082,10051082
WEIGHT GAIN (VALUE NOS),Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
LACK OF EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
NON COMPLIANCE OF MEDICATION,Inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
THE PATIENT GAVE BIRTH TO A HEALTHY BOY,live birth,LIVE BIRTH,LIVE BIRTH,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS","NORMAL PREGNANCY, LABOUR AND DELIVERY",10036585,10049550,10049550,10049550
HIGH LFT'S,high LFT'S,LIVER FUNCTION TEST INCREASED,LIVER FUNCTION TEST INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10077692,10077692,10077692
SWEATING,Hyperhidrosis,SWEATING,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042670,10020642,10042661
FALL,fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
ANGIOEDEMA,angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
SYNCOPE,syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
VENTRICULAR TACHYCARDIA FOLLOWING PROLONGED QTC,Ventricular tachycardia,VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047302,10047302,10047302
SEPSIS DUE TO KOCURIA KRISTINAE ENDOCARDITIS WORSENING DESPITE ADEQUATE ANTIBIOTIC THERAPY,Bacterial sepsis,BACTERIAL SEPSIS,BACTERIAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10053840,10053840,10053840
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
"EBV-POSITIVE LYMPHOPROLIFERATIVE DISEASE AND MULTIPLE RELAPSE WITH MEDULLARY, SPLENIC AND HEPATIC INFILTRATION",Epstein-Barr virus associated lymphoproliferative disorder,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10068349,10068349,10068349
LESIONS WITH SURROUNDING ERYTHEMA,plaques,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
SUDDEN ONSET DIAPHORESIS,Hyperhidrosis,DIAPHORESIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042670,10020642,10012703
PALE WITH COLD EXTREMITIES,cold extremities,COLD EXTREMITIES,PERIPHERAL COLDNESS,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10009857,10034568,10009857
TAKOTSUBO CARDIOMYOPATHY,Takotsubo cardiomyopathy,CARDIOMYOPATHY,CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10007636,10007636,10007636
IGA DEFICIENCY,IgA deficiency,IGA DEFICIENCY,SELECTIVE IGA IMMUNODEFICIENCY,IMMUNODEFICIENCY SYNDROMES,PRIMARY IMMUNODEFICIENCY SYNDROMES,10021428,10021260,10039915,10021260
ANTIBODY-MEDIATED REJECTION GRADE 2,Transplant rejection,ANTIBODY-MEDIATED REJECTION,TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10064683,10044439,10064683
CHILLS AND SHIVERING,chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
VACCINATION PROVIDES INCOMPLETE PROTECTION TO ECULIZUMAB RECIPIENTS,Vaccination failure,VACCINATION FAILURE,VACCINATION FAILURE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,VACCINATION RELATED COMPLICATIONS,10022117,10046862,10046862,10046862
DRY MOUTH,dry mouth,DRY MOUTH,DRY MOUTH,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10013781,10013781,10013781
AGGRAVATION OF EXISTING DISORDER,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
HYPERAMMONEMIA,Hyperammonemia,HYPERAMMONEMIA,HYPERAMMONAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020576,10020575,10020576
TOXICITIES WERE GRADE 2 HAND-FOOT SYNDROME GRADE 2 MUCOSITIS,mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
PERIPHERAL POLYNEUROPATHY,Peripheral neuropathy,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10080342,10029331,10080342
"UNEXPECTEDLY, PLUERAL EFFUSION  PROGRESSIVELY INCREASED AGAIN IN THE TWO WEEKS AFTER CHOP CHEMPTHERAPY",Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
PATIENT WAS ADMINISTERED BICALUTAMIDE AND LEUPRORELIN ACETATE FOR THE TREATMENT OF METASTATIC PROSTATE GLEASON GRADE 9(4+5) ADENOCARCINOMA (OFF LABEL USE) WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PATIENT WAS ADMINISTERED MYCOPHENOLATE MOFETIL AND METHOTREXATE FOR THE TREATMENT OF MICROSCOPIC POLYANGIITIS (OFF LABEL USE) WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
IRON DEFICIENCY,iron deficiency,IRON DEFICIENCY,IRON DEFICIENCY,IRON AND TRACE METAL METABOLISM DISORDERS,IRON DEFICIENCIES,10027433,10022970,10022970,10022970
CUTANEOUS RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
BLISTERS AND ULCERS APPEARED IN THE ORAL MUCOSA AND ON THE LIPS,Lip blister,BLISTER OF LIP,LIP BLISTER,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE DISORDERS NEC,10017947,10049307,10049307,10005205
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
PATIENT EXPERIENCED PURE CELL RED APLASIA/ REVERSIBLE SEVERE SYMPTOMATIC PURE RED CELL APLASIA,Aplasia pure red cell,APLASIA PURE RED CELL,APLASIA PURE RED CELL,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10002965,10002965,10002965
PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
REMISSION OF SEIZURES/EPILEPSY WITH FOCAL SEIZURES,Focal epilepsy,FOCAL EPILEPSY,PARTIAL SEIZURES,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10065337,10061334,10065337
WORSENING CHOLESTASIS,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
HYPOGLYCEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
ELEVATED MOOD,Euphoric mood,ELEVATED MOOD,EUPHORIC MOOD,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10014483,10015535,10014483
TRANSDERMAL PATCH AND MINIPILL PRESCRIBED FOR CYCLE IRREGULARITY,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
METHADONE OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
"USE OF METHOTREXATE, MYCOPHENOLATE AND CYCLOPHOSPHAMIDE IN EOSINOPHILLIC FASCIITIS (OFF LABEL USE)",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ACUTE RENAL FAILURE/HAEMATURIA AND DYSURIA,Acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
"LACK OF DRUG EFFECT OF METHOTRAXTE, ETANERCEPT, ANAKINRA, ADALIMUMAB, TOCILIZUMAB, INFLIXIMAB","lack of drug effect of methotraxte, etanercept, anakinra, adalimumab, tocilizumab, infliximab",LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
NEUROLEPTIC MALIGNANT SYNDROME,Neuroleptic malignant syndrome,NEUROLEPTIC MALIGNANT SYNDROME,NEUROLEPTIC MALIGNANT SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10029282,10029282,10029282
PATIENT TREATED WITH SERTRALINE HYDROCHLORIDE FOR NODULAR PRURIGO DUE TO PRIMARY BILIARY CHOLANGITIS WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DIFFICULTY BREATHING,Dyspnoea,DIFFICULTY BREATHING,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10012791
CORRECTED QT INTERVAL AT 1.2,Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10014383,10014387,10014383
ASIPIRIN AND CLOPIDOGREL WERE TAKEN TOGETHER,drug administration error,DRUG ADMINISTRATION ERROR,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064295,10064295,10064295
BULBAR PALSY,Bulbar palsy,BULBAR PALSY,BULBAR PALSY,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),MIXED CRANIAL NERVE DISORDERS,10029205,10006542,10006542,10006542
GROSS HEMATURIA FOLLOWING DRUG TOXICITY,hematuria,HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10019450,10018867,10019450
OFF LABEL USE OF IMATINIB FOR LOA LOA MICROFILAREMIA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
STREPTOCOCCUS VIRIDANS INFECTION,streptococcus viridins infection,STREPTOCOCCUS VIRIDANS GROUP INFECTION,ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10054287,10054265,10054287
MILD PERICARDIAL EFFUSION (7 MM) WITH FIBRINOUS MATERIAL,Pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
DEHYDRATION,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
DRUG EXPOSURE DURING PREGNANCY IN FIRST TRIMESTER WITH NO ADVERSE EVENT,"Drug exposure during pregnancy, first trimester","DRUG EXPOSURE DURING PREGNANCY, FIRST TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076617,10073513,10076617
OSTEOARTHRITIS DUE TO ESCHERICHIA COLI,Arthritis bacterial,ARTHRITIS BACTERIAL,ARTHRITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10053555,10053555,10053555
COMPUTERIZED AXIAL TOMOGRAPHY SHOWED NONSPECIFIC BILATERAL PATCHY PARENCHYMAL AIR-SPACE DISEASE,Computerised tomogram abnormal,COMPUTERIZED AXIAL TOMOGRAPHY ABNORMAL,COMPUTERISED TOMOGRAM ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",IMAGING PROCEDURES NEC,10022891,10010235,10010235,10062401
MULTILOBAR PNEUMONIA,Pneumonia,MULTILOBAR PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10028161,10035664,10028161
LYMPHANGITIC CARCINOMATOSIS FROM PRIMARY LUNG ADENOCARCINOMA,lymphangitic carcinomatosis from primary lung adenocarcinoma,CARCINOMATOSIS,METASTATIC NEOPLASM,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10007506,10061289,10007506
MYCOPHENOLATE MOFETIL AND HYDROXYCHLOROQUINE FOR PULMONARY HEMOSIDEROSIS WITHOUT ADVERSE EVENT,Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
LIMITED MOBILITY,Mobility decreased,MOBILITY DECREASED,MOBILITY DECREASED,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10048334,10048334,10048334
AN EIGHT MONTHS PREGNANT MOTHER ERRONEOUSLY TOOK ONE TABLET,Medication error,MEDICATION ERROR,MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10027091,10027091,10027091
ORAL ULCERS,Mouth ulceration,ORAL ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028034,10028034,10031027
STEVENS JOHNSON SYNDROME,Stevens Johnson Syndrome,STEVENS JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042030,10042033,10042030
PATIENT'S SYMPTOMS WERE RESISTANT TO ORAL PREDNISOLONE AND IMATINIB,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
DIAGNOSIS OF PAROXYSMAL SYMPATHETIC HYPERACTIVITY,Paroxysmal sympathetic hyperactivity,PAROXYSMAL SYMPATHETIC HYPERACTIVITY,PAROXYSMAL SYMPATHETIC HYPERACTIVITY,NEUROMUSCULAR DISORDERS,AUTONOMIC NERVOUS SYSTEM DISORDERS,10029205,10078476,10078476,10078476
REOCCURRING  OF MPA (MICROSCOPIC POLYANGIITIS) FOLLOWING REBOUND EFFECT OF PREDNISONE,rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
DECREASED ORAL INTAKE,Hypophagia,ORAL INTAKE REDUCED,HYPOPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10063889,10063743,10063889
SECONDARY THROMBOTIC MICROANGIOPATHY,Thrombotic microangiopathy,THROMBOTIC MICROANGIOPATHY,THROMBOTIC MICROANGIOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10043645,10043645,10043645
 [...]),2018-04-03,0,,,,PRODUCT MONITORING ERRORS AND ISSUES,10064373,10064373,
CHILLS,chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
JAUNDICED,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
ACUTE RESPIRATORY DISTRESS SYNDROME FOLLOWING INFLUENZA A H1N1 INFECTION AND SEPTIC SHOCK,Acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
SODIUM OF 139 MEQ/L,Blood sodium increased,SODIUM INCREASED,BLOOD SODIUM INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10041272,10005803,10041272
POOR COGNITION,Cognitive impairment,COGNITIVE IMPAIRMENT,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10009846,10057668,10009846
ALKALINE PHOSPHATASES ARE ELEVATED,Blood alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
ODYNOPHAGIA,odynophagia,ODYNOPHAGIA,ODYNOPHAGIA,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE PAIN AND PARAESTHESIA,10017947,10030094,10030094,10030094
RESPIRATORY ARREST,respiratory arrest,RESPIRATORY ARREST,RESPIRATORY ARREST,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038669,10038669,10038669
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
SHOWED WBC INCREASED/NEUTROPHILIA,neutrophilia,NEUTROPHILIA,NEUTROPHILIA,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10029379,10029379,10029379
COGNITIVE IMPAIRMENT WITH HEAT INTOLERANCE,Cognitive impairment,COGNITIVE IMPAIRMENT,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10009846,10057668,10009846
DRUG-INDUCED HEPATITIS,Drug-induced liver injury,DRUG-INDUCED HEPATITIS,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10013762,10072268,10013762
"EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED IMMUNE THROMBOCYTOPENIA RESISTANT TO SEVERAL LINES OF THERAPIES, WHICH WAS IN FACT A FORM OF AAT",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CXR SHOWED BILATERAL UPPER AND MID ZONE OPACIFICATION WITH SPARING OF BOTH BASES,Computerised tomogram thorax abnormal,GROUND GLASS OPACITY IN THORACIC CT,COMPUTERISED TOMOGRAM THORAX ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10072879,10057799,10072879
MULTIPLE SUBCUTANOEUS ABSCESSES DUE TO DEEP DERMAL DERMATOPHYTOSIS (GROIN) CAUSED BY TRICHOPHYTON RUBRUM,Groin abscess,GROIN ABSCESS,GROIN ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10050269,10050269,10050269
LOW BONE DENSITY,Bone density decreased,BONE DENSITY DECREASED,BONE DENSITY DECREASED,MUSCULOSKELETAL AND SOFT TISSUE INVESTIGATIONS (EXCL ENZYME TESTS),MUSCULOSKELETAL AND SOFT TISSUE IMAGING PROCEDURES,10022891,10049470,10049470,10049470
PREDNISOLONE AND IVIG GIVEN BUT WITHOUT ANY RESPONSE(LACK OF DRUG EFFECT) WITH NO ADR,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PATIENT TREATED WITH ZOLEDRONIC ACID FOR NON-INFECTIOUS OSTEOMYELITIS OF JAW (OFF LABEL USE) WITH NO ADVERSE EVENTS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
OOZING TYPE EPISTAXIS DUE TO PSEUDOANEURYSM,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
BACK MYALGIA ON EZETIMIBE TREATMENT,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
RECURRENT DRUG FEVER OF 39.2 DEGREE C  (102.6 DEGREE F),Pyrexia,DRUG FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037662,10037660,10013697
SLEEP DISORDER,Sleep disorder,SLEEP DISORDER,SLEEP DISORDER,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10040984,10040984,10040984
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
PROFUSE WATERY DIARRHEA,Diarrhoea,WATERY DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10047849,10012735,10055422
ANNULAR POLYCYCLIC ERYTHEMA IN SUN-EXPOSED AREAS OF THE SKIN,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
ORGANIZING PNEUMONIA,Organizing pneumonia,ORGANIZING PNEUMONIA,ORGANISING PNEUMONIA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10067471,10067472,10067471
MILD HEARING LOSS,Deafness,HEARING LOSS,DEAFNESS,HEARING DISORDERS,HEARING LOSSES,10013993,10011878,10011878,10019246
PROBLEMS WITH CO-ORDINATION/MOBILITY,Coordination abnormal,COORDINATION IMPAIRED,COORDINATION ABNORMAL,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10010949,10010947,10010950
ILEUS,ileus,ILEUS,ILEUS,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION NEC,10017947,10021328,10021328,10021328
300-FOLD INCREASE OF ALANINE AMINOTRANFERASE (ALT),Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
FELL DOWN FROM ROOF OF FOUR STOREY BUILDING,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
ELONGATION OF THE PR INTERVAL TILL THE LEVEL OF 480 MSEC,Electrocardiogram PR prolongation,PR INTERVAL PROLONGED,ELECTROCARDIOGRAM PR PROLONGATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10036471,10053657,10036471
SLIGHT WORSENING OF RENAL FUNCTION,Function kidney decreased,FUNCTION KIDNEY DECREASED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10017474,10062237,10017474
INFLAMATION OF SYNOVIAL MEMBRANE,Synovitis,SYNOVITIS,SYNOVITIS,SYNOVIAL AND BURSAL DISORDERS,SYNOVIAL DISORDERS,10028395,10042868,10042868,10042868
FATAL FULMINANT HYPEREOSINOPHILIC SYNDROME FOLLOWING LACK OF DRUG EFFECT,Hypereosinophilic syndrome,HYPEREOSINOPHILIC SYNDROME,HYPEREOSINOPHILIC SYNDROME,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10048643,10048643,10048643
PNEUMATOSIS INTESTINALIS,Pneumatosis intestinalis,PNEUMATOSIS INTESTINALIS,PNEUMATOSIS INTESTINALIS,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10057030,10057030,10057030
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
WORSENING OF DYSARTHRIA AND DYSPHAGIA,dysarthria,DYSARTHRIA,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10013887,10013887,10013887
PUSTULAR SKIN ERUPTION,rash pustular,RASH PUSTULAR,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037888,10037888,10037888
"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER WITH NO ADR",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
NON-SPECIFIC ABDOMINAL PAIN/EPIGASTRIC PAIN,Epigastric pain,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
ON AN UNSPECIFIED DATE THE PATIENT DEVELOPED ENDOCARDITIS DUE TO LACK OF EFFICACY (THE PLEDGET CULTURES TURNED POSITIVE FOR BURKHOLDERIA CEPACIA).,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ASCITES,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
CONDITION DETERIORATED RAPIDLY,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
GENERALIZED ERYTHEMA,generalized erythema,GENERALIZED ERYTHEMA,GENERALISED ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10062433,10051576,10062433
SHE WAS FEBRILE,febrile,FEBRILE REACTION,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016289,10037660,10016289
WORSENING CEREBRAL EDEMA,Oedema,OEDEMA AGGRAVATED,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10048376,10030095,10048376
ADRENAL INSUFFICIENCY FOLLOWING A SINGLE INTRA-ARTICULAR INJECTION OF TRIAMCINOLONE ACETONIDE,adrenal insufficiency,ADRENAL INSUFFICIENCY,ADRENAL INSUFFICIENCY,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001367,10001367,10001367
HHV6 REACTIVATION,Human herpesvirus 6 infection,HUMAN HERPESVIRUS 6 INFECTION REACTIVATION,HUMAN HERPESVIRUS 6 INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10066845,10020431,10066845
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
GAMMA HEAVY CHAIN DISEASE (GAMMA-HCD),heavy chain disease,HEAVY CHAIN DISEASE,HEAVY CHAIN DISEASE,PLASMA CELL NEOPLASMS,PLASMA CELL NEOPLASMS NEC,10029104,10019350,10019350,10019350
LITTLE IMPROVEMENT,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
"COMPLAINTS OF DISTRESS, INNER SENSE OF UNEASE, INABILITY TO STAY STILL, A FEELING OF CONSTANT MOBILITY IN FEET, FIDGET",discomfort,DISCOMFORT,DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10013082,10013082,10013082
LOCAL INFLAMMATORY REACTIONIN THE AREA OF THE NASAL DORSUM,Administration site inflammation,ADMINISTRATION SITE INFLAMMATION,ADMINISTRATION SITE INFLAMMATION,ADMINISTRATION SITE REACTIONS,ADMINISTRATION SITE REACTIONS NEC,10018065,10074704,10074704,10074704
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
"THE PATIENT RECEIVED 2 CYCLES OF BEP (BLEOMYCIN, ETOPOSIDE, CISPLATIN) CHEMOTHERAPY FOLLOWED BY A RETROPERITONEAL LYMPHAD-ENECTOMY SINCE THE LYMPH NODES WERE STILL PRESENT AFTER CHEMOTHERAPY.",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PARTIAL SEIZURE,Partial seizures,PARTIAL SEIZURES,PARTIAL SEIZURES,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10061334,10061334,10061334
ANTIEPILEPTICS TOXICITY,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
BILATERAL CENTRAL BRONCHIECTASIS,Bronchiectasis,BRONCHIECTASIS,BRONCHIECTASIS,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHIAL CONDITIONS NEC,10038738,10006445,10006445,10006445
GGT WAS 3 TIMES UPPER LIMIT OF NORMAL,GGT increased,GGT INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056910,10017693,10056910
OSTEOARTHRITIS,Osteoarthritis,OSTEOARTHRITIS,OSTEOARTHRITIS,JOINT DISORDERS,OSTEOARTHROPATHIES,10028395,10031161,10031161,10031161
HYPONATRAEMIA,Hyponatraemia,HYPONATRAEMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021036
AZOOSPERMIA FOLLOWING OFF LABEL USE OF CYCLOPHOSPHAMIDE,Azoospermia,AZOOSPERMIA,AZOOSPERMIA,SEXUAL FUNCTION AND FERTILITY DISORDERS,SPERMATOGENESIS AND SEMEN DISORDERS,10038604,10003883,10003883,10003883
MYASTHENIA GRAVIS,Myasthenia gravis,MYASTHENIA GRAVIS,MYASTHENIA GRAVIS,NEUROMUSCULAR DISORDERS,NEUROMUSCULAR JUNCTION DYSFUNCTION,10029205,10028417,10028417,10028417
ACUTE PANCREATITIS DUE TO SPHINCTER OF ODDI DYSFUNCTION AGGRAVATION/HYPERTONIC,Pancreatitis acute,ACUTE PANCREATITIS,PANCREATITIS ACUTE,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033647,10033647,10000971
THE PATIENT HAD MODERATE DISEASE ACTIVITY OF RHEUMATOID ARTHRITIS DURING 2 YEARS DESPITE METHOTREXATE AND INFLIXIMAB,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PERSON WAS NOT RESPONSIVE/UNRESPONSIVE TO VERBAL STIMULI,Unresponsive to stimuli,UNRESPONSIVE TO VERBAL STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10063552,10045555,10063552
DOPED WITH ALLOPURINOL,Performance enhancing product use,DRUG DOPING,PERFORMANCE ENHANCING PRODUCT USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT USE ISSUES,10022117,10076471,10079763,10076471
TEICOPLANIN ALLERGY,DRUG ALLERGY,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
RENAL FUNCTION SLIGHTLY ALTERED,Renal function abnormal,RENAL FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038451,10062237,10038451
PATIENT TREATED WITH AMITRIPTYLINE FOR NAUSEA (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"STENT THROMBOSIS IS A MULTIFACTORIAL PHENOMENON, WHICH WAS CLEARLY NOT ONLY DRIVEN BY THE LACK OF CLOPIDOGREL EFFICACY DURING MTH",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
GASTROINTESTINAL BLEEDING,Gastrointestinal haemorrhage,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017936
ADVERSE REACTION,Adverse reaction,ADVERSE REACTION,ADVERSE REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10067484,10067484,10067484
THROMBOCYTOPENIA (THROMBOCYTE COUNT NOS) DUE TO ACQUIRED FACTOR X DEFICIENCY WORSENING,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
SEVERE ANEMIA (5 G/DL) WHICH WAS SECONDARY TO ZIDOVUDINE THERAPY,Anaemia,SECONDARY ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10039812,10002034,10054606
MINERALOCORTICOID EXCESS SYNDROME,Acquired apparent mineralocorticoid excess,ACQUIRED APPARENT MINERALOCORTICOID EXCESS,ACQUIRED APPARENT MINERALOCORTICOID EXCESS,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10080230,10080230,10080230
GRANULOCYTOPENIA,Granulocytopenia,GRANULOCYTOPENIA,GRANULOCYTOPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10018687,10018687,10018687
POOR TOLERANCE TO IFOSFAMIDE,poor tolerance to ifosfamide,DRUG INTOLERANCE NOS,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048697,10061822,10048697
PULMONARY METASTASES,Metastases to lung,PULMONARY METASTASES,METASTASES TO LUNG,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027458,10027458,10037420
RIGHT VENTRICULAR DIASTOLIC COMPRESSION,Right ventricular diastolic collapse,RIGHT VENTRICULAR DIASTOLIC COLLAPSE,RIGHT VENTRICULAR DIASTOLIC COLLAPSE,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10079613,10079613,10079613
STEVENS-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
PERICARDITIS RECURRENCE FOLLOWING TAPERING OF PREDNISONE,Pericarditis,PERICARDITIS,PERICARDITIS,PERICARDIAL DISORDERS,NONINFECTIOUS PERICARDITIS,10007541,10034484,10034484,10034484
RIGIDITY,Muscle rigidity,RIGIDITY,MUSCLE RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10039168,10028330,10039168
ELEVATED BLOOD AMMONIUM LEVELS,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
LI IS THOUGHT TO HAVE INDUCED HYPOTHYROIDISM AND FINALLY MC,Myxoedema coma,MYXEDEMA COMA,MYXOEDEMA COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10060819,10060819,10060834
INFARCTION,Infarction,INFARCTION,INFARCTION,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10061216,10061216,10061216
TELANGIECTASIS,Telangiectasia,TELANGIECTASIS,TELANGIECTASIA,SKIN VASCULAR ABNORMALITIES,TELANGIECTASIA AND RELATED CONDITIONS,10040785,10043189,10043189,10043193
SPONTANEOUS PERFORATION OF THE SIGMOID COLON FOLLOWING INTESTINAL ISCHEMIA,Large intestine perforation,PERFORATION OF COLON,LARGE INTESTINE PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,INTESTINAL ULCERS AND PERFORATION NEC,10017947,10010001,10023804,10034418
COAGULATION DISORDER,Coagulopathy,COAGULATION DISORDER,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009731,10009802,10009731
ACCELERATED JUNCTIONAL RHYTHM,accelerated junctional rhythm,ACCELERATED JUNCTIONAL RHYTHM,NODAL RHYTHM,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10080072,10029470,10080072
DETERIORATION OF EGFR IS STRONGLY LINKED TO ENHANCED PLATELET ACTIVITY DURING DAPT,Renal impairment,RENAL FUNCTION AGGRAVATED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038453,10062237,10038453
"EARLY MORNING DYSTONIA AT THE RIGHT FOOT, SLIGHT URINARY URGENCY, MILD ATTENTIVE DEFICITS, DAYTIME SLEEPINESS, ANXIETY, MILD POSTURAL AND KINETIC TREMOR OF THE UPPER LEFT LIMB, MILD BRADYKINESIA,PEAK",Attentiveness decreased,ATTENTIVENESS DECREASED,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10003740,10013496,10003740
DOSE WAS SLOWLY TITRATED UP TO 10 MG THREE TIMES A DAY,Extra dose administered,EXTRA DOSE ADMINISTERED,EXTRA DOSE ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064366,10064366,10064366
METFORMIN-INDUCED SEVERE LACTIC ACIDOSIS,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
HYPERCAPNIC HYPEROXEMIC RESPIRATORY FAILURE DUE TO PROGRESSION OF CUTANEOUS AND PULMONARY KAPOSI SARCOMA FOLLOWING IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,Respiratory failure,HYPERCAPNIC RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10060842,10038695,10060842
SEVERE HYPERTONIA,severe hypertonia,HYPERTONIA,HYPERTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10020852,10020852,10020852
DECREASED APPETITE,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
UNREST,Restlessness,UNREST,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10045556,10038743,10045556
ACHILLES TENDON RUPTURE (RIGHT AND LEFT),Tendon rupture,ACHILLES TENDON RUPTURE,TENDON RUPTURE,INJURIES NEC,"MUSCLE, TENDON AND LIGAMENT INJURIES",10022117,10000439,10043248,10000439
PROGRESSIVE PATCHY CONSOLIDATION,Lung consolidation,LUNG CONSOLIDATION,LUNG CONSOLIDATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025080,10025080,10025080
INCREASINGLY CONFUSED,Confusional state,CONFUSED,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010298
CARDIAC ARREST DUE TO VENTRICULAR FEBRILATION,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
POOR SLEEP FOLLOWING OPIOID WITHDRAWAL,Poor quality sleep,POOR SLEEP,POOR QUALITY SLEEP,SLEEP DISTURBANCES (INCL SUBTYPES),SLEEP DISTURBANCES NEC,10029205,10064816,10062519,10036160
PEDAL EDEMA,Oedema peripheral,PEDAL EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10055950,10030124,10034206
EPSTEIN BARR VIRUS ASSOCIATED LYMPHOPLASMACYTIC LYMPHOMA,Epstein Barr virus associated lymphoplasmacytic lymphoma,LYMPHOPLASMACYTOID LYMPHOMA/IMMUNOCYTOMA,LYMPHOPLASMACYTOID LYMPHOMA/IMMUNOCYTOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,LYMPHOPLASMACYTOID LYMPHOMAS/IMMUNOCYTOMAS,10029104,10025342,10025342,10025342
WORSENING IN DUCHENNE MUSCULAR DYSTROPHY FOLLOWING WITHDRAWAL OF DEFLAZACORT (REBOUND EFFECT) DESPITE PREDNISONE USE,Duchenne muscular dystrophy,DUCHENNE MUSCULAR DYSTROPHY,DUCHENNE MUSCULAR DYSTROPHY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,NON-SITE SPECIFIC MUSCLE DISORDERS CONGENITAL,10010331,10013801,10013801,10013801
CANDIDA TROPICALIS,Candida infection,CANDIDA TROPICALIS INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10066457,10074170,10066457
CEFAZOLIN-INDUCED ANAPHYLAXIS WITH SYMPTOMS RELATED TO  CUTANEOUS AND CARDIOVASCULAR SYSTEM`,anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
WORSENING OF CARNITINE INSUFFICIENCY (13 MMOL/MICRO LITER),Carnitine deficiency,CARNITINE DEFICIENCY,CARNITINE DEFICIENCY,LIPID METABOLISM DISORDERS,LIPID METABOLISM AND DEPOSIT DISORDERS NEC,10027433,10058892,10058892,10058892
"INTRAVENOUS AMIODARONE, LIDOCAINE WERE INEFFECTIVE",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PUPILS WERE MID DILATED WITH A SLUGGISH LIGHT REACTIONIN BOTH EYES,Mydriasis,DILATED PUPILS,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10013014,10028521,10013014
REBOUND EFFECT,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
MULTIDRUG POISONING/MULTI-DRUG INTOXICATIONS,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
"CLOZAPINEINDUCED, DILATED CARDIOMYOPATHY",Dilated cardiomyopathy,DILATED CARDIOMYOPATHY,CONGESTIVE CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10056419,10056370,10056419
REFRACTORY RESPIRATORY DISTRESS SYNDROME FOLLOWING HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
PATIENT WAS TREATED FOR RHEUMATOID ARTHRITIS AND HAD FAILED TO RESPOND TO CONVENTIONAL DMARD THERAPY WITH METHOTREXATE AND SULFASALAZINE (LACK OF EFFICACY),lack of efficacy,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HYPONATREMIA,hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
SEVERE DRY EYE AFFECTING THE LEFT EYE,Dry eye syndrome,DRY EYE SYNDROME,DRY EYE,EYE DISORDERS NEC,LACRIMATION DISORDERS,10015919,10013777,10013774,10013777
RAISED CREATINE KINASE (CK) LEVEL (879IU/L),Blood creatine phosphokinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
CHOLESTATIC,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
WEIGHT LOSS FOLLOWING INTENSIVE DEHYDRATION,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
HYPONATREMIA,hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
HYPOGLYCEMIC EPISODES,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
ATRIAL FIBRILLATION,atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
"ERRATIC, RESTLESS AND EUPHORIC BEHAVIOR",Abnormal behaviour,BEHAVIOR DISORDER,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004207,10061422,10004204
PROTEINURIA,Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
REPEATED INFECTIONS,Recurrent infection,RECURRENT INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10067860,10021789,10067860
ACUTE FEVER,Fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
LYMPHOCYTIC INFILTRATION,lymphocytic infiltration,LYMPHOCYTIC INFILTRATION,LYMPHOCYTIC INFILTRATION,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10062049,10062049,10062049
MENINGOCOCCAL INFECTIONS PRESENTING AS SEPSIS POST VACCINATION WITH BOTH ACWY AND B VACCINES/ SUSPECTED VACCINATION FAILURE,Vaccination failure,VACCINATION FAILURE,VACCINATION FAILURE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,VACCINATION RELATED COMPLICATIONS,10022117,10046862,10046862,10046862
"DIARRHEA, CLOSTRIDIUM DIFFICILE",Clostridium difficile colitis,"DIARRHEA, CLOSTRIDIUM DIFFICILE",CLOSTRIDIUM DIFFICILE COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10006835,10009657,10012734
"APPLICATION SITE OEDEMA, REDNESS AND PAIN OF THE RIGHT UPPER ARM",Vaccination site inflammation,VACCINATION SITE INFLAMMATION,VACCINATION SITE INFLAMMATION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10068878,10068878,10068878
WEIGHT LOSS ( PATIENT LOST 10 KG IN THE SPACE OF SIX WEEKS),weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
DIARRHEA STAGE 2  (6XD) [DIARRHEA],Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
HEPATITIS B REACTIVATION,Hepatitis B reactivation,HEPATITIS B REACTIVATION,HEPATITIS B REACTIVATION,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10058827,10058827,10058827
ACETAMINOPHEN HEPATOTOXICITY,Drug-induced liver injury,DRUG-INDUCED HEPATOTOXICITY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072937,10072268,10072937
UNRESPONSIVE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
EBV INFECTION,ebv infection,EBV INFECTION,EPSTEIN-BARR VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,EPSTEIN-BARR VIRAL INFECTIONS,10021881,10014077,10015108,10014077
RELAPSE OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS ASSOCIATED PSEUDOTUMOUR FOLLOWING REBOUND EFFECT,rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DYSSOMNIA,dyssomnia,DYSSOMNIA,DYSSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DYSSOMNIAS,10037175,10061827,10061827,10061827
AG HAD RECENTLY STOPPED TAKING HER PSYCHOTROPICS,Therapy cessation,THERAPY CESSATION BY PATIENT,THERAPY CESSATION,THERAPEUTIC PROCEDURES AND SUPPORTIVE CARE NEC,THERAPEUTIC PROCEDURES NEC,10042613,10072907,10065154,10072907
"BULLOUS ERUPTIONS ON THE PALATAL ARCHES, SWOLLEN PALATAL TONSILS",Bullous eruption,BULLOUS ERUPTION,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006559,10012441,10006559
GLYCEMIA WORSENING,Hyperglycaemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020639
DYSPNEA/BREATHLESSNESS,Dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
NINP/ NEITHER INFECTED NOR PROTECTED,Hepatitis B antibody negative,HEPATITIS B ANTIBODY NEGATIVE,HEPATITIS B ANTIBODY NEGATIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10019734,10019734,10019734
IMATINIB AND DASATINIB RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
SWEAT DROPS ON HIS FOREHEAD,sweating,SWEATING,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042661,10020642,10042661
GASTROINTESTINAL DISORDER,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
ACTIVE BLEEDING FROM A PULSATILE VESSEL IN THE ASCENDING COLON CONSISTENT WITH A DIEULAFOY'S LESION,Gastrointestinal haemorrhage,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017936
ELECTROLYTE DISORDER DUE TO VOMITING FOLLOWING HYPERMETHOTREXATEMIA,Electrolyte imbalance,ELECTROLYTE IMBALANCE,ELECTROLYTE IMBALANCE,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10014418,10014418,10014418
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
SLIGHTLY HYPOTHERMIC AT 35.6Â°C,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
"BROAD NASAL BRIDGE, BLUNT NASAL TIP AND ANTEVERTED NOSTRILS","broad nasal bridge, blunt nasal tip and anteverted nostrils",NOSE DEFORMITY,NOSE DEFORMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES (INCL INTERVERTEBRAL DISC DISORDERS),"MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES OF SKULL, FACE AND BUCCAL CAVITY",10028395,10061875,10061875,10061875
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
HEPATOTOXICITY FOLLOWING ATT,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
SPEECH AND SWALLOWING DIFFICULTIES,difficulty in speech,SPEECH SLURRED,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041472,10013887,10041472
PATIENT TREATED WITH MYCOPHENOLATE MOFETIL FOR AUTOIMMUNE HEPATITIS (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PATIENT TREATED WITH MAGNESIUM SULFATE FOR PREMATURE LABOR (OFF LABEL USE) WITH NO ADVERSE EVENTS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
1.5-MM HYPOPYON WITH A FIBRIN CLOT IN THE LEFT EYE,Hypopyon,HYPOPYON,HYPOPYON,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10021086,10021086,10021086
THERAPEUTIC FAILURE (LACK OF DRUG EFFECT WITH NO ADR),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DELIRIUM FOLLOWING HYPERVITAMINOSIS D,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
PROGRESSION OF DYSPNEA,Dyspnea exacerbated,DYSPNEA EXACERBATED,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013965,10013968,10013965
PATIENT WAS TREATED WITH EXEMESTANE AND BLEOMYCIN FOR AGGRESSIVE FIBROMATOSIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ACCIDENTAL ERLOTINIB OVERDOSE,Accidental overdose,DRUG OVERDOSE ACCIDENTAL,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10013737
WEIGHT GAIN,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
VENTRICULAR-FIBRILLATION-ARREST,ventricular fibrillation,VENTRICULAR FIBRILLATION,VENTRICULAR FIBRILLATION,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047290,10047290,10047290
ALLERGIC RASH,Allergic rash,ALLERGIC RASH,DERMATITIS ALLERGIC,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10001717,10012434,10001717
"MULTIPLE ABSCESSES IN THE LUNG, LIVER AND SPLEEN",Liver abscess,ABSCESS OF LIVER,LIVER ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,HEPATOBILIARY AND SPLEEN INFECTIONS,10021881,10024652,10024652,10000300
HEMODYNAMIC STATUS DETERIORATED,Haemodynamic instability,HEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10052076,10052076,10058270
SPEECH DISORDER,Speech disorder,SPEECH DISORDER,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041466,10041466,10041466
RASH MACULO-PAPULAR,Rash maculo-papular,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10037868
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
PANCREATITIS,Pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
"PRURITIC RASHES ON SKIN OF THE FACE, TRUNK AND EXTREMITIES",Pruritic rash,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037085,10037884,10037085
NUCHAL RIGIDITY,Nuchal rigidity,NUCHAL RIGIDITY,NUCHAL RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10058483,10058483,10058483
PRURITIC RASH ON HIS HANDS,pruritic rash,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037085,10037884,10037085
BLOOD PRESSURE DECREASED (72/53 MM/HG) FOLLOWING MULTIPLE DRUG OVERDOSE DUE TO SUICIDAL INTENT,Blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
THREE MONTHS HISTORY OF UNINTENTIONAL WEIGHT LOSS OF ABOUT 20 KG,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
BRAIN EDEMA DUE TO NARCOTIC INTOXICATION,brain edema,BRAIN EDEMA,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10006121,10048962,10006121
BOWEL PERISTALSIS INCREASED,bowel peristalsis increased,BOWEL PERISTALSIS INCREASED,GASTROINTESTINAL HYPERMOTILITY,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL SPASTIC AND HYPERMOTILITY DISORDERS,10017947,10052536,10052402,10052536
OEDEMA,Oedema,OEDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10030095
RIGHT HEMIPARESIS,right hemiparesis,HEMIPARESIS (RIGHT),HEMIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019467,10019465,10019467
MYELITIS,Myelitis,MYELITIS,MYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10028524,10028524,10028524
PATCHY BLISTERING TRUNK LESIONS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
REDDENING OF THE LIPS,Lip erythema,LIP REDNESS,LIP ERYTHEMA,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SIGNS AND SYMPTOMS,10017947,10024564,10080124,10024564
AMOXICILLIN-CLAVULANIC ACID-INDUCED LIVER INJURY,drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
SHOCK SYMPTOM,Shock symptom,SHOCK SYMPTOM,SHOCK SYMPTOM,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040581,10040581,10040581
SUBCUTANEOUS HEMORRHAGE,Haemorrhage subcutaneous,HAEMORRHAGE SUBCUTANEOUS,HAEMORRHAGE SUBCUTANEOUS,SKIN VASCULAR ABNORMALITIES,SKIN HAEMORRHAGES,10040785,10018999,10018999,10018999
DIFFUSE LEFT VENTRICULAR HYPOKINESIA,Left ventricular hypokinesia,LEFT VENTRICULAR HYPOKINESIA,VENTRICULAR HYPOKINESIA,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10050166,10050510,10050166
NUMBNESS IN HER FEET,numbness in feet,NUMBNESS IN FEET,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10049800,10020937,10049800
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
DRUG OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
CHILLS IN LEFT LOWER EXTERMITY,Chills in left lower extermity,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
PALMOPLANTAR PRURITUS/OROPHARYNGEAL PRURITUS,Pruritus allergic,PRURITUS ALLERGIC,PRURITUS ALLERGIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10063438,10063438,10063438
PAINFUL SKIN TOXICITY RHAGADES ON THE FINGERS OF LOWER LIMBS,Skin toxicity,SKIN TOXICITY,SKIN TOXICITY,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10059516,10059516,10059516
NEW PAIN IN THE RIBS,Musculoskeletal chest pain,RIB PAIN,MUSCULOSKELETAL CHEST PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10048711,10050819,10048722
NECROTIC CHANGES OF FINGER III OF THE RIGHT UPPER EXTREMITY,Extremity necrosis,EXTREMITY NECROSIS,EXTREMITY NECROSIS,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10059385,10059385,10059385
HUMAN HERPESVIRUS 8 INFECTION,Human herpesvirus 8 infection,HUMAN HERPESVIRUS 8 INFECTION,HUMAN HERPESVIRUS 8 INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10066435,10066435,10066435
DRUG EXPOSURE DURING PREGNANCY WITH NO ADR,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
LYMPHOCYTE COUNT WAS 0/MM3/PROFOUND LYMPHOPENIA,lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
ITCHINESS,itch,ITCH,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023082,10037087,10023082
"PATIENT DID NOT RORARTE INJECTION SITE, (NS) SUBCUTANEOUS TISSUE ATROPHY",Wrong technique in product usage process,WRONG INJECTION TECHNIQUE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10064737,10076573,10064737
VAGINAL BLEEDING DURING FIRST TRIMESTER OF PREGNANCY,Haemorrhage in pregnancy,HAEMORRHAGE IN PREGNANCY,HAEMORRHAGE IN PREGNANCY,MATERNAL COMPLICATIONS OF PREGNANCY,HAEMORRHAGIC COMPLICATIONS OF PREGNANCY,10036585,10018981,10018981,10018981
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PARTIAL THROMBOPLASTIN TIME PROLONGED (132 S),Activated partial thromboplastin time prolonged,PARTIAL THROMBOPLASTIN TIME PROLONGED,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10034094,10000636,10034094
PHENOBARBITAL WAS INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
MUSCLE TWITCHING,muscle twitching,MUSCLE TWITCHING,MUSCLE TWITCHING,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028347,10028347,10028347
HEPATITIS B CORE ANTIBODY POSITIVE,Hepatitis B core antibody positive,HEPATITIS B CORE ANTIBODY POSITIVE,HEPATITIS B CORE ANTIBODY POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10071344,10071344,10071344
"INABILITY TO WALK AND SELF-CARE, EXTREME NATURE OF SOCIAL DISINHIBITION",Disinhibition,SOCIAL DISINHIBITION,DISINHIBITION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10041246,10013142,10041246
INCREASING HBA1C LEVELS,HbA1C increased,HBA1C INCREASED,GLYCOSYLATED HAEMOGLOBIN INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10052424,10018484,10052424
EASY BRUISING,Contusion,BRUISING,CONTUSION,INJURIES NEC,SKIN INJURIES NEC,10022117,10050584,10050584,10006504
PROTHROMBIN TIME 19.4 SEC,Prothrombin time shortened,PROTHROMBIN TIME DECREASED,PROTHROMBIN TIME SHORTENED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037070,10037070,10037059
"ASYMPTOMATIC ERYTHEMA ON HER BACK THAT RAPIDLY EXTENDED, COVERING HER WHOLE BODY",Generalised erythema,GENERALIZED ERYTHEMA,GENERALISED ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10051576,10051576,10062433
ADMINISTRATION OF RIBAVIRIN FOR HEPATITIS E INFECTION (UNAPPROVED INDICATION)-OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LACTIC ACIDOSIS,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
BK VIRUS-ASSOCIATED HEMORRHAGIC CYSTITIS,Cystitis haemorrhagic,HEMORRHAGIC CYSTITIS,CYSTITIS HAEMORRHAGIC,BLADDER AND BLADDER NECK DISORDERS (EXCL CALCULI),BLADDER INFECTIONS AND INFLAMMATIONS,10038359,10011793,10011793,10019598
MUSCLE SPASM / LEFT SIDED SPASMS WITH JERKING AND STIFFNESS,Muscle spasms,MUSCLE SPASM,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028334,10028334,10028333
EPILEPTIC SEIZURE WITH CHARACTERISTICS OF GRAND MAL/ACUTE EPILEPTIC STATUS,Status epilepticus,"GRAND MAL STATUS, EPILEPTIC",STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10018664,10041962,10018664
SWEATING,sweating,SWEATING,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042661,10020642,10042661
ERUPTION,Rash,ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10015138
GLOSSITIS POSITIVE,Glossitis,GLOSSITIS,GLOSSITIS,TONGUE CONDITIONS,TONGUE DISORDERS,10017947,10018386,10018386,10018386
DRUG-INDUCED PARKINSONISM,Parkinsonism,DRUG-INDUCED PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10013707,10034010,10013707
RENAL PAIN,Renal pain,RENAL PAIN,RENAL PAIN,URINARY TRACT SIGNS AND SYMPTOMS,URINARY TRACT SIGNS AND SYMPTOMS NEC,10038359,10038490,10038490,10038490
ABNORMAL FINDINGS IN THE COMPLETE BLOOD COUNT TEST,Complete blood count abnormal,COMPLETE BLOOD COUNT ABNORMAL,FULL BLOOD COUNT ABNORMAL,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),BLOOD COUNTS NEC,10022891,10010136,10017412,10010136
GIANT CELL ARTERITIS,Temporal arteritis,GIANT CELL ARTERITIS,TEMPORAL ARTERITIS,VASCULAR INFLAMMATIONS,ARTERIAL INFLAMMATIONS,10047065,10018250,10043207,10018250
THROMBUS OF RENAL ARTERY FOLLOWING ARTERIAL RUPTURE,thrombus of renal artery following arterial rupture,THROMBUS,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10080924,10043607,10080924
PULMONARY ARTERIAL HYPERTENSION,Pulmonary arterial hypertension,PULMONARY ARTERIAL HYPERTENSION,PULMONARY ARTERIAL HYPERTENSION,PULMONARY VASCULAR DISORDERS,PULMONARY HYPERTENSIONS,10038738,10064911,10064911,10064911
HYPERKALEMIA FOLLOWING INTENTIONAL OVERDOSE,hyperkalemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020647,10020646,10020647
LOWER PROLACTIN LEVEL,Prolactin levels decreased,PROLACTIN LEVELS DECREASED,BLOOD PROLACTIN DECREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),PITUITARY ANALYSES ANTERIOR,10022891,10036827,10005779,10036827
LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
BILATERAL END-EXPIRATORY WHEEZING ON LUNG AUSCULTATION,Wheezing,WHEEZING EXPIRATORY,WHEEZING,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10047925,10047924,10047925
"CLOZAPINEINDUCED, DILATED CARDIOMYOPATHY",Dilated cardiomyopathy,DILATED CARDIOMYOPATHY,CONGESTIVE CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10056419,10056370,10056419
SECONDARY MALIGNANCY (OVARIAN),Ovarian cancer,OVARIAN CANCER,OVARIAN CANCER,REPRODUCTIVE NEOPLASMS FEMALE MALIGNANT AND UNSPECIFIED,OVARIAN NEOPLASMS MALIGNANT (EXCL GERM CELL),10029104,10033128,10033128,10033128
LIPASE ELEVATION TO 156.3 U/L WITH METABOLIC ALKALOSIS,Lipase increased,LIPASE INCREASED,LIPASE INCREASED,GASTROINTESTINAL INVESTIGATIONS,DIGESTIVE ENZYMES,10022891,10024574,10024574,10024574
EOSINOPHILIA (19.4%),Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
SEVERE DETERIORATION AND ACUTE EXACERBATION,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
ENDOSCOPIC FOLLOW UP SHOWED EXACERBATION,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
VESICULAR LESIONS ON HER FINGERS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
DISEASE PROGRESSION/STAGE IV PERIPHERAL CD30+ T-CELL LYMPHOMA (NOT OTHERWISE SPECIFIED),T-cell lymphoma stage IV,T-CELL LYMPHOMA NOS STAGE IV,T-CELL LYMPHOMA STAGE IV,LYMPHOMAS NON-HODGKIN'S T-CELL,ANAPLASTIC LARGE CELL LYMPHOMAS T- AND NULL-CELL TYPES,10029104,10042978,10042984,10042978
ASPARTATE AMINOTRANSFERASE INCREASED (1115 U/L),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
ACTINIC KERATOSIS,Actinic keratosis,ACTINIC KERATOSIS,ACTINIC KERATOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,SKIN PRENEOPLASTIC CONDITIONS NEC,10040785,10000614,10000614,10000614
SUDDEN ONSET AND PROGRESSIVE AGGRAVATION,Disease aggravation,DISEASE AGGRAVATION,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10013097,10010264,10013097
ATRIAL PACING WITH PROLONGED PR INTERVAL,PR interval prolonged,PR INTERVAL PROLONGED,ELECTROCARDIOGRAM PR PROLONGATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10036471,10053657,10036471
ANOREXIA,anorexia,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10002646,10061428,10002646
LITHIUM OVERDOSE FOR SUICIDE ATTEMPT,suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
HAND PARESTHESIA,Paraesthesia,PARESTHESIA HAND,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10049230,10033775,10054530
HYPONATREMIA (129MMOL / L),hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
RASHES,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
INTOLERANCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
THROMBOCYTOSIS,Thrombocytosis,THROMBOCYTOSIS,THROMBOCYTOSIS,PLATELET DISORDERS,THROMBOCYTOSES,10005329,10043563,10043563,10043563
METASTASES TO LUMBAR SPINE,Metastases to spine,METASTASES TO SPINE,METASTASES TO SPINE,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027468,10027468,10027468
RECEIVED A SELF-RECEDING CONVULSION/ SELF TERMINATING SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
PANCOLITIS,pancolitis,PANCOLITIS,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10033573,10009887,10033573
FOUR LIMB SPASM,Muscle spasms,SPASMS,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10041408,10028334,10041408
SEIZURES,Seizures,SEIZURES,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039910,10039906,10039910
HBV REACTIVATION FOLLOWING TREATMENT WITH R-CHOP,Hepatitis B reactivation,HEPATITIS B REACTIVATION,HEPATITIS B REACTIVATION,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10058827,10058827,10058827
FEBRILE NEUTROPAENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
SMALL CORPUS CALLOSUM,Congenital central nervous system anomaly,CORPUS CALLOSUM AGENESIS,CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY,NEUROLOGICAL DISORDERS CONGENITAL,CENTRAL NERVOUS SYSTEM DISORDERS CONGENITAL NEC,10010331,10063756,10010411,10063756
PATIENT WAS ADMINISTERED CISPLATIN FOR PRIMARY HEPATIC YOLK SAC TUMOUR(OFF-LABEL USE FOR INDICATION WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FALLS,fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
"WHITE BLOOD CELL COUNT OF 12,300",White blood cell count normal,WHITE BLOOD CELL COUNT NORMAL,WHITE BLOOD CELL COUNT NORMAL,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047944,10047944,10047944
EPILEPSY,Epilepsy,EPILEPSY,EPILEPSY,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10015037,10015037,10015037
PNEUMONIA CAUSED BY FUNGAL INFECTION,Pneumonia fungal,PNEUMONIA FUNGAL,PNEUMONIA FUNGAL,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10061354,10061354,10061354
PHENYTOIN INDUCED AGRANULOCYTOSIS AND RASH,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
DYSPNEA ON EXERTION,dyspnea on exertion,DYSPNEA EXERTIONAL,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013966,10013971,10013966
SERUM LACTATE DEHYDROGENASE INCREASED,Blood lactate dehydrogenase increased,LACTATE DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10023654,10005630,10023654
INTRAVENOUS LIDOCAINE WAS GIVEN WITHOUT EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
CREATININE CONTINUED TO INCREASE,Blood creatinine increased,BLOOD CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005483,10005483,10005483
WOUND HEALING RESPONSE WAS POOR FOR ULCERATIONS (SUBTHERAPEUTIC RESPONSE),wound healing response was poor for ulcerations (Subtherapeutic response),SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
SLOW DECREASE OF PARAMETERS IN PERIPHERAL BLOOD MORPHOLOGY,Slow decrease of parameters in peripheral blood morphology,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10019483,10018884,10019483
NEUTROPENIA GRADE 3,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
BREATHING WITH INCREASING DIFFICULTY,Dyspnoea,DIFFICULTY BREATHING,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10012791
ABSENCE STATUS EPILEPTICUS REOCCURRED /ASE PERSISTED,Absence seizure,ABSENCE SEIZURE,PETIT MAL EPILEPSY,SEIZURES (INCL SUBTYPES),ABSENCE SEIZURES,10029205,10000331,10034759,10000331
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
RIGORS,Rigors,RIGORS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10039177,10008531,10039177
ACTINOMYCOSIS IN A MUCOSAL LESION,Actinomycosis,ACTINOMYCOSIS,ACTINOMYCOSIS,BACTERIAL INFECTIOUS DISORDERS,ACTINOMYCOTIC INFECTIOUS DISORDERS,10021881,10000620,10000620,10000620
PRURUGENOUS EDEMA ON FACE AND HANDS,Face oedematous,FACE OEDEMATOUS,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10016030,10016029,10016030
NO URINE PRODUCTION,Urine formation failure of,URINE FORMATION FAILURE OF,ANURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10046641,10002847,10046641
PHARMACOKINETIC DRUG INTERACTION,pharmacokinetic interaction,PHARMACOKINETIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10067220,10013710,10067220
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
SPLENIC THROMBOSIS DUE TO DRESS SYNDROME,Splenic thrombosis,SPLENIC THROMBOSIS,SPLENIC THROMBOSIS,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10074601,10074601,10074601
PATIENT WAS UNABLE TO TOLERATE MORE THAN 500 UG/DAY OF COLCHICINE WHILE BEING TREATED FOR RHEUMATOID ARTHRITIS (DRUG USED FOR UNAPPROVED INDICATION),Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
FAILURE OF TREATMENT,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
IISCHEMIC COLITIS FOLLOWING GASTROINTESTINAL VASCULITIS FLARE,ischaemic colitis,ISCHAEMIC COLITIS,COLITIS ISCHAEMIC,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10055744,10009895,10055744
BLOOD CELL COUNT SHOWED A DECREASE IN HEMOGLOBIN LEVELS,Hemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10019483,10018884,10019483
DYSPEPTIC PROBLEMS FOLLOWING METFORMIN THERAPY,Dyspepsia,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,DYSPEPTIC SIGNS AND SYMPTOMS,10017947,10013946,10013946,10013946
ANEMIA DUE TO LOW CONCENTRATION OF VITAMIN B12 (HB- 10.1 G/DL),Anaemia vitamin B12 deficiency,ANEMIA VITAMIN B12 DEFICIENCY,ANAEMIA VITAMIN B12 DEFICIENCY,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIA DEFICIENCIES,10005329,10002080,10002080,10054315
DRAMATICALLY REDUCED BONE MASS,Dramatically reduced bone mass,BONE MASS DECREASED,BONE DENSITY DECREASED,MUSCULOSKELETAL AND SOFT TISSUE INVESTIGATIONS (EXCL ENZYME TESTS),MUSCULOSKELETAL AND SOFT TISSUE IMAGING PROCEDURES,10022891,10005991,10049470,10005991
LOSS OF HEMATOLOGIC RESPONSE,No therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
DILATED CARDIOMYOPATHY DUE TO HYDROXYCHLOROQUINE,Dilated cardiomyopathy,DILATED CARDIOMYOPATHY,CONGESTIVE CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10056419,10056370,10056419
ESCHERICHIA COLI INFECTION,Escherichia infection,ESCHERICHIA COLI INFECTION,ESCHERICHIA INFECTION,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10061126,10061126,10054242
CMV ANTIGENEMIA (7 CELLS/63000 CELLS),Cytomegalovirus test positive,CMV ANTIGEN POSITIVE,CYTOMEGALOVIRUS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10050541,10051620,10050548
NUMBNESS IN HER RIGHT UPPER LIMB,Hypoaesthesia,NUMBNESS OF UPPER ARM,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10029853,10020937,10029853
HYPONATREMIA,Hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
RESTLESS SLEEP WITH APNEA,Sleep disorder,SLEEP DISORDER,SLEEP DISORDER,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10040984,10040984,10040984
EPIGASTRALGIA,Abdominal pain upper,EPIGASTRALGIA,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10048944
EDEMA AND HYPEREMIA OF LEFT UPPER ARM IN DIAMETER OF 10X10/ PALPATORY PAINFULLY SENSITIVE,Vaccination site reaction,VACCINATION SITE REACTION,VACCINATION SITE REACTION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10059080,10059080,10059080
MARKED MOTOR IMPERSISTENCE,marked motor impersistence,MOTOR DYSFUNCTION,MOTOR DYSFUNCTION,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10061296,10061296,10061296
DRUG EXPOSURE IN UTERO,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SMALL KIDNEYS,small kidney,SMALL KIDNEY,KIDNEY SMALL,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL STRUCTURAL ABNORMALITIES AND TRAUMA,10038359,10041135,10023435,10041135
ACUTE PARACETAMOL TOXICITY/ FATAL POISONING,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
SHE BECAME CUSHINGOID,cushingoid,CUSHINGOID,CUSHINGOID,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011655,10011655,10011655
DESPITE USE OF AMOXICILLIN/ CLAVULANIC ACID WORSENING OF THE CLINICAL IMAGE AND CONTINUING FEBRILE,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HYPERVITAMINOSIS D,hypervitaminosis D,HYPERVITAMINOSIS D,HYPERVITAMINOSIS D,VITAMIN RELATED DISORDERS,HYPERVITAMINOSES NEC,10027433,10020917,10020917,10020917
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
FEVER,Fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
CONFUSION,confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
MILD NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
INTERMITTENT SUPRAVENTRICULAR TACHYCARDIA,Supraventricular tachycardia,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10042604,10042604,10042604
ABDOMINAL PAIN/AORTIC RUPTURE,abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
BALANCE DISTURBANCES,Balance disorder,BALANCE DISORDER,BALANCE DISORDER,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10049848,10049848,10049848
TINGLING IN ALL EXTREMITIES,tingling of extremity,TINGLING OF EXTREMITY,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10063451,10033775,10063451
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
DUODENAL MUCOSAL ATROPHY,Duodenal villi atrophy,DUODENAL VILLI ATROPHY,INTESTINAL VILLI ATROPHY,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL MUCOSAL DYSTROPHIES AND SECRETION DISORDERS,10017947,10049473,10049443,10049473
BACTERIAL INFECTION OF THE NATIVE CYCTIC KIDNEY DISEASE,Bacterial infection,BACTERIAL INFECTION,BACTERIAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10060945,10060945,10060945
PRE-SYNCOPE,Presyncope,PRE-SYNCOPE,PRESYNCOPE,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10036653,10036653,10036507
ERYTHEMATOUS MARGIN,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
JOINT EFFUSION,joint effusion,JOINT EFFUSION,JOINT EFFUSION,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023215,10023215,10023215
MODERATE MITRAL REGURGITATION,Mitral valve incompetence,MITRAL REGURGITATION,MITRAL VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,MITRAL VALVULAR DISORDERS,10007541,10027718,10027727,10027718
HYPERKALAEMIA,Hyperkalaemia,HYPERKALAEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020646,10020646,10020646
GASTROINTESTINAL SYMPTOMS,gastrointestinal symptoms,GASTROINTESTINAL SYMPTOM NOS,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10018011,10017944,10018011
"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER WITH NO ADVERSE EVENT",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
HEPATOSPLENOMEGALY,Hepatosplenomegaly,HEPATOSPLENOMEGALY,HEPATOSPLENOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019847,10019847,10019847
THERAY FAILURE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
TRANSAMINASE LEVELS REMAINED ELEVATED,transaminases increased,TRANSAMINASES INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054889,10054889,10054889
IRRITABLE,Irritability,IRRITABLE,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10023000,10022998,10023000
MULTIPLE DRUG POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
MURPHY'S SIGN,murphy's sign,MURPHY'S SIGN POSITIVE,MURPHY'S SIGN POSITIVE,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10052900,10052900,10052900
PROLONGED OFF-PERIODS,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
FIBRIN DEGRADATION PRODUCTS INCREASED (>20 UG/ML),Fibrin degradation products increased,FIBRIN DEGRADATION PRODUCTS INCREASED,FIBRIN DEGRADATION PRODUCTS INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10016588,10016588,10016588
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
HIV-1 PERSISTENT VIREMIA,HIV viraemia,HIV VIREMIA,HIV VIRAEMIA,VIRAL INFECTIOUS DISORDERS,RETROVIRAL INFECTIONS,10021881,10077716,10077716,10077718
OFF LABEL USE FOR FLUDARABINE PHOSPHATE AND ALEMTUZUMAB AS THEY WERE ADMINISTERED AS PART OF BONE MARROW CONDITIONING REGIMEN FOR STEM CELL TRANSPLANT,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
DYSTONIA,Dystonia,DYSTONIA,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10013983,10013983,10013983
METHOTREXATE WAS GIVEN AS PROPHYLAXIS FOR GRAFT-VERSUS-HOST DISEASE(OFF LABEL USEWITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MODERATE INFLAMMATION WITH EOSINOPHILS IN BOTH THE BLISTER AREA AND THE UNDERLYING DERMIS,inflammation,INFLAMMATION,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10061218,10061218,10061218
IT WAS A CORONARY SYNDROME IN ONE PATIENT,Acute coronary syndrome,ACUTE CORONARY SYNDROME,ACUTE CORONARY SYNDROME,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10051592,10051592,10051592
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
SHE APPEARED CONFUSED,Confusional state,CONFUSED,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010298
LEFT LOWER EXTREMITY NUMBNESS,Numbness of extremities,NUMBNESS OF EXTREMITIES,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10049111,10020937,10049111
PARTIAL REMISSION OF THEIR SYMPTOMATOLOGY,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
QUEASY,Nausea,QUEASY,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10037730,10028813,10037730
"PLATELET COUNT, 10,000/ÎœL",Platelet count decreased,PLATELET COUNT LOW,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035529,10035528,10035529
LACTIC ACIDOSIS,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,Drug reaction with eosinophilia and systemic symptoms,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10073508,10073508,10073508
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
PYRETIC,pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
ACUTE KIDNEY INJURY FOLLOWING MINIMAL CHANGE DISEASE AND ACUTE TUBULAR NECROSIS,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
PATIENT SHOWED POOR TOLERANCE TO ALL THE MEDICATIONS,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
PATIENT RECEIVED ZOLEDRONIC ACID FOR LUNG SMALL CELLS CARCINOMA,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
PURPURA WAS OBSERVED ON RIGHT CALF AND LEFT THIGH,Purpura,PURPURA,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037549,10037549,10037549
GUILLAIN-BARRE SYNDROME,Guillain-Barre syndrome,GUILLAIN-BARRE SYNDROME,GUILLAIN-BARRE SYNDROME,PERIPHERAL NEUROPATHIES,ACUTE POLYNEUROPATHIES,10029205,10018767,10018767,10018767
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
ACUTE HYPOXEMIC RESPIRATORY FAILURE,Respiratory failure,HYPOXIC RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10074615,10038695,10074615
QUININE POISONING DUE TO ERRONEOUSLY PRESCRIBED BECAUSE OF HAVING A HISTORY OF MALARIAL INFECTION,Cinchonism,CINCHONISM,CINCHONISM,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10009189,10009189,10009189
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
EMPIRICALLY ('OFF-LABEL' USE) OF LATANOPROST AND ACETAZOLAMIDE FOR BILATERAL UVEAL EFFUSION SYNDROME (UES) (OFF LABEL USE FOR INDICATION WITH NO ADR),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEVERE HYPOGLYCEMIA (34 MG/DL),Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
MULTIORGAN FAILURE,Multiple organ dysfunction syndrome,MULTIORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028162
GRANULOMATOUS HEPATITIS,hepatitis granulomatous,HEPATITIS GRANULOMATOUS,GRANULOMATOUS LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019774,10018704,10019774
SMALL BOWEL PERFORATION,Small intestinal perforation,SMALL INTESTINE PERFORATION,SMALL INTESTINAL PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,INTESTINAL ULCERS AND PERFORATION NEC,10017947,10041103,10041103,10041131
PATIENT HAD SECOND LINE TREATMENT WITH MYCOPHENOLATE FOR IGG4-RELATED DISEASE INVOLVING LARYNX (OFF LABEL USE) WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CSF ANALYSIS SHOWED GLUCOSE 1.91 MMOL/L,CSF glucose decreased,CSF GLUCOSE DECREASED,CSF GLUCOSE DECREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10011537,10011537,10011537
LIP SMACKING,Tardive dyskinesia,LIP SMACKING,TARDIVE DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10024567,10043118,10024567
PATIENT HAD ONGOING SYMPTOMS DESPITE PREDNISOLONE AND MONTELUKAST (LACK OF DRUG EFFECT WITH NO ADVERSE EVENT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
MUSCULOSKELETAL PAIN,Musculoskeletal pain,MUSCULOSKELETAL PAIN,MUSCULOSKELETAL PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10028391,10028391,10028391
VISUAL AND AUDITORY HALLUCINATORY ACTIVITY,auditory and visual hallucinations,AUDITORY AND VISUAL HALLUCINATIONS,"HALLUCINATIONS, MIXED",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10003777,10019079,10003777
DIAPHORESIS,Diaphoresis,DIAPHORESIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10012703,10020642,10012703
NAUSEA FOR 3 DAYS,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ACUTE MYELOID LEUKEMIA,Second primary malignancy,SECOND PRIMARY MALIGNANCY,SECOND PRIMARY MALIGNANCY,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10039801,10039801,10039801
DERMAL AND EPIDERMAL BLISTERS WITH MIXED IN AMMATION INCLUDING EOSINOPHILS (H&E STAIN OF THE AFFECTED EPIDERMIS AND DERMO-EPIDERMAL JUNCTION SHOWED INCREASED EOSINOPHILIC IN LTRATION.,Eosinophilia,EOSINOPHILIC INFILTRATION,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10078757,10014950,10078757
ROAD TRAFFIC CRASHES,Road traffic accident,DRIVER IN MOTOR VEHICLE ACCIDENT,ROAD TRAFFIC ACCIDENT,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10066118,10039203,10066118
POTTER'S SYNDROME,Potter's syndrome,POTTER'S SYNDROME,POTTER'S SYNDROME,RENAL AND URINARY TRACT DISORDERS CONGENITAL,RENAL DISORDERS CONGENITAL,10010331,10036462,10036462,10036462
AGGRESSION,Aggression,AGGRESSION,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001488,10001488,10001488
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
SERUM CREATININE INCREASED (5.7 MG/DL),Serum creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
VASOPLEGIC SYNDROME,Vasoplegic syndrome,VASOPLEGIC SYNDROME,VASOPLEGIA SYNDROME,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,CARDIAC AND VASCULAR PROCEDURAL COMPLICATIONS,10022117,10067654,10067080,10067654
IVABRADINE WAS PRESCRIBED AFTER A  NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION,Product use in unapproved population,PRODUCT USE IN UNAPPROVED POPULATION,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10077011,10076309,10077011
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
PULMONARY HEMOSIDEROSIS RELAPSE (TWO RELAPSE),Pulmonary hemosiderosis,PULMONARY HEMOSIDEROSIS,PULMONARY HAEMOSIDEROSIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10037399,10037396,10037399
TRISMUS/SERTRALINE INDUCED REVERSIBLE MYOPATHY WITH RHABDOMYOLYSIS AND TRISMUS,Trismus,TRISMUS,TRISMUS,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10044684,10044684,10044684
COMBINED DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
CEFIXIME INDUCED HYPOTHERMIA WITH A TEMPERATURE OF 33.2 C,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
CONVULSIVE STATUS EPILEPTICUS,Status epilepticus,CONVULSIVE STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10057955,10041962,10057955
EDEMA OF LOWER LIMBS,Edema of lower limbs,EDEMA LOWER LIMB,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014232,10030124,10014232
CHRONIC ALLOGRAFT DYSFUNCTION FOLLOWING POLYOMAVIRUS-ASSOCIATED MEPHROPATHY,Transplant dysfunction,GRAFT DYSFUNCTION,TRANSPLANT DYSFUNCTION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10074860,10074860,10059677
SUICIDAL IDEATION,Suicidal ideation,SUICIDAL IDEATION,SUICIDAL IDEATION,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042458,10042458,10042458
PANENTERITIS,Enteritis,ENTERITIS,ENTERITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10014866,10014866,10014866
FEVER (38.2 DEGREE CELSIUS),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
HYPERTHYROID SYMPTOMS INCLUDING 15LB,Hyperthyroidism,HYPERTHYROIDISM,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10020850,10020850,10020850
DETERIORATION OF JUVENILE DERMATOMYOSITIS FOLLOWING LACK OF EFFECT OF METHYLPREDNISOLONE AND PREDNISOLONE,Dermatomyositis,JUVENILE DERMATOMYOSITIS,DERMATOMYOSITIS,EPIDERMAL AND DERMAL CONDITIONS,CONNECTIVE TISSUE DISORDERS,10040785,10078425,10012503,10078425
DIARRHEA,diarrhoea nos,DIARRHOEA NOS,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012745,10012735,10012745
CUSHINGâ€™S SYNDROME BY TOPICAL TRIAMCINOLONE,Cushing's syndrome,CUSHING'S SYNDROME,CUSHING'S SYNDROME,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011652,10011652,10011652
NONSPECIFIC INTERSTITIAL PNEUMONITIS SECONDARY TO IMATINIB TREATMENT,Nonspecific interstitial pneumonitis,INTERSTITIAL PNEUMONITIS,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022618,10022611,10022618
MULTI-ORGAN RADIATION RECALL INJURY,Recall phenomenon,RADIATION RECALL SYNDROME,RECALL PHENOMENON,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,SKIN PROCEDURAL COMPLICATIONS,10022117,10037768,10060856,10037768
METABOLIC ACIDOSIS,metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
PULMONARY HYPERTENSION,pulmonary hypertension,PULMONARY HYPERTENSION,PULMONARY HYPERTENSION,PULMONARY VASCULAR DISORDERS,PULMONARY HYPERTENSIONS,10038738,10037400,10037400,10037400
BLOOD CULTURES PERFORMED ON D2 GREW POSITIVE TO PARVIMONAS MICRA,Parvimonas test positive,PARVIMONAS TEST POSITIVE,PARVIMONAS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,BACTERIA IDENTIFICATION AND SEROLOGY (EXCL MYCOBACTERIA),10022891,10078107,10078107,10078107
STEVENS-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
OCCULT FECAL BLOOD,Occult blood,FECAL OCCULT BLOOD,OCCULT BLOOD,GASTROINTESTINAL INVESTIGATIONS,FAECAL ANALYSES NEC,10022891,10061878,10061878,10016297
A POSSIBLE SEIZURE,a possible seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
CARDIAC ARREST,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
PATIENT TREATED WITH CELECOXIB AND DOXYCYCLINE FOR RIGHT TEMPORAL GLIOBLASTOMA (OFF LABEL USE FOR INDICATION) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
GRADE 3 NEUTROPENIA,neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
INDAPAMIDE-INDUCED BILATERAL CHOROIDAL EFFUSION/ BILATERAL CHOROIDAL EFFUSIONS,choroidal effusion,CHOROIDAL EFFUSION,CHOROIDAL EFFUSION,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","CHOROID AND VITREOUS STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10063970,10063970,10063970
PERIPHERAL NEUROPATHY,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
BURNING SENSATION OF THROAT,Throat irritation,BURNING IN THROAT,THROAT IRRITATION,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10006778,10043521,10006778
ANXIETY SYMPTOMS OCCURRED WITH INCREASED FREQUENCY,Anxiety aggravated,ANXIETY AGGRAVATED,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10048339,10002855,10048339
ALPHA HEMOLYTIC STREPTOCOCCAL INFECTION,Alpha haemolytic streptococcal infection,ALPHA HEMOLYTIC STREPTOCOCCAL INFECTION,ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10054265,10054265,10054286
DISSEMINATED CANDIDIASIS IN AN IMMUNOCOMPROMISED PATIENT FOLLOWING NEUTROPENIC ENTEROCOLITIS AND CASPOFUNGIN RESISTANCE,Systemic candida,DISSEMINATED CANDIDIASIS,SYSTEMIC CANDIDA,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10013431,10042938,10013431
HYPERCHOLESTEROLEMIA,hypercholesterolemia,HYPERCHOLESTEROLEMIA,HYPERCHOLESTEROLAEMIA,LIPID METABOLISM DISORDERS,ELEVATED CHOLESTEROL,10027433,10020604,10020603,10020604
BLOOD PRESSURE DECLINED TO 79/58 MMHG,Blood pressure dropped,BLOOD PRESSURE DROPPED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005744,10005734,10005744
DERMAL LESIONS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
HEADACHES,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
LOWER URINE QUANTITIES,Urine output decreased,URINE OUTPUT DECREASED,URINE OUTPUT DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059895,10059895,10059895
HYPOKALAEMIA,Hypokalaemia,HYPOKALAEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021015
PREMATURE DELIVERY,Premature delivery,PREMATURE DELIVERY,PREMATURE DELIVERY,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036595,10036595,10036595
THIRD LINE CLOFARABINE-BASED CHEMOTHERAPY WAS UNSUCCESSFUL,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ACUTE DYSTONIA,Dystonia,ACUTE DYSTONIA,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10066608,10013983,10066608
INTENTIONAL SUSPECTED SUICIDE,Completed suicide,COMPLETED SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10010144,10010144,10010144
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
EVEN AFTER TREATMENT WITH METOCLOPROMIDE SYMPTOMS LIKE NAUSEA PERSISTS (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ACUTE HEMOLYTIC ANEMIA,Haemolytic anaemia,ACUTE HEMOLYTIC ANEMIA,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10066625,10018916,10066624
AGGRAVATION OF LISTERIOSIS (CENTRAL NERVOUS SYSTEM (CNS) LISTERIA INFECTION),listeria infection,LISTERIA INFECTION,LISTERIOSIS,BACTERIAL INFECTIOUS DISORDERS,LISTERIA INFECTIONS,10021881,10024638,10024641,10024638
THIAMAZOLE INDUCED AGRANULOCYTOSIS,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER (GRADE 1),Acute graft versus host disease in liver,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10066263,10066263,10066263
POSTOPERATIVE HAEMORRHAGE,Post procedural haemorrhage,POSTOPERATIVE HAEMORRHAGE,POST PROCEDURAL HAEMORRHAGE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10054709,10051077,10054709
NEUTROPHILES DECREASED (GRADE 4),Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ZUNGENVERAENDERUNG,Tongue disorder,TONGUE DISORDER,TONGUE DISORDER,TONGUE CONDITIONS,TONGUE DISORDERS,10017947,10043951,10043951,10043951
NO ADR,No adverse event,NO ADVERSE DRUG EFFECT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067481,10067482,10052808
MATERNAL APAP LEVEL WAS 293 MCG/ML AND SALICYLATE LEVEL WAS 12.6 MG/ DL,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
DRUG-DRUG INTERACTION OF ARIPIPRAZOLE AND FLUOXETINE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
"PATIENT UNDER 6 YEARS OF AGE TREATED WITH HYDROXYCHLOROQUINE AND MMF FOR JUVENILE DERMATOMYOSITIS (OFF LABEL USE FOR INDICATION FOR BOTH, AND FOR POPULATION (WITH HYDROXYCHLOROQUINE))",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
OEDEMA,Oedema,OEDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10030095
DIFFUSE ERYTHEMA,erythema diffuse,ERYTHEMA DIFFUSE,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015159,10015150,10015159
SPONTANEOUS ACALCULOUS NIEMEIER TYPE GALLBLADDER PERFORATION AND NECROSIS,Gallbladder perforation,GALLBLADDER PERFORATION,GALLBLADDER PERFORATION,GALLBLADDER DISORDERS,GALLBLADDER DISORDERS NEC,10019805,10017639,10017639,10017639
BILATERAL LUNG INFILTRATES,bilateral lung infiltrates,BILATERAL PULMONARY INFILTRATES,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10070790,10025102,10070790
CHOLINERGIC SYNDROME,Cholinergic syndrome,CHOLINERGIC SYNDROME,CHOLINERGIC SYNDROME,NEUROMUSCULAR DISORDERS,AUTONOMIC NERVOUS SYSTEM DISORDERS,10029205,10008674,10008674,10008674
PROGRESSIVE CONDYLOMA ACUMINATA,Anogenital warts,CONDYLOMA ACUMINATUM,ANOGENITAL WARTS,CUTANEOUS NEOPLASMS BENIGN,SKIN NEOPLASMS BENIGN,10029104,10010291,10059313,10010291
GASTRIC INTOLERANCE,Gastric disorder,GASTRIC DISORDER,GASTRIC DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10056819,10056819,10056819
MYOCLONIC JERKS,Myoclonus,MYOCLONIC JERKS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028621,10028622,10028621
TYPE 1 ALLERGIC HYPERSENSITIVITY,Type I hypersensitivity,TYPE I HYPERSENSITIVITY,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10045240,10045240,10045240
RHABDOMYOLYSIS,rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
PERTUSSIS,Pertussis,PERTUSSIS,PERTUSSIS,BACTERIAL INFECTIOUS DISORDERS,BORDETELLA INFECTIONS,10021881,10034738,10034738,10034738
BK NEPHROPATHY,Polyomavirus-associated nephropathy,BK VIRUS NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065333,10065381,10065333
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
FREQUENT URINATING OF SMALL AMOUNT,Frequency urinary,FREQUENCY URINARY,POLLAKIURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10017366,10036018,10017366
HEPATIC ENZYME INCREASED,Hepatic enzyme increased,HEPATIC ENZYME INCREASED,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10060795,10060795,10060795
"COMPLETE HAIR LOSS ON BOTH THIGHS,SCALPS,EYEBROWS,EYELASHES/ALOPECIA AREATA/ALOPECIA UNIVERSALIS/ AUTOIMMUNE ALOPECIA/PATCHY BODY HAIR LOSS/NON-SCARRING ALOPECIA CHEST,AXILLAE,PUBIC/ALOPECIA  TOTALIS",Alopecia universalis,ALOPECIA UNIVERSALIS,ALOPECIA UNIVERSALIS,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001767,10001767,10001767
MOUTH DRYNESS,Dry mouth,DRY MOUTH,DRY MOUTH,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10013781,10013781,10013781
FREQUENT UPSETS,Depressed mood,FEELING SAD,DEPRESSED MOOD,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10016364,10012374,10016364
WHITE BLOOD CELL COUNT WAS 0.1  X10 CELLS/LITER,White blood cell count decreased,WHITE BLOOD CELL COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10047942
VOMITING/  EMESIS,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
CRANIOSYNOSTOSIS SECONDARY TO CORONAL AND LAMBDODIAL SUTURE CLOSURES FOLLOWING DRUG EXPOSURE IN UTERO,Craniosynostosis,CRANIOSYNOSTOSIS,CRANIOSYNOSTOSIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS OF SKULL CONGENITAL,10010331,10049889,10049889,10049889
ADMINISTRATION TO THE PREGNANT PATIENT,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
FALLS,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
TACHYCARDIA,tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
MEROPENEM RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
HYPOCALCAEMIA,Hypocalcaemia,HYPOCALCAEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020947,10020947,10020947
HRTV INFECTION EXACERBATED BY ETOPOSIDE AND DEXAMETHSONE TREATMENT,Condition aggravated,EXACERBATION OF DISEASE,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10013097,10010264,10015576
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
BLOATING,Abdominal distension,BLOATING,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10005265,10000060,10005265
DEVELOPMENT OF ABDOMINAL BLOATING WITH MIGLITOL,Abdominal distension,ABDOMINAL BLOATING,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10005265,10000060,10048746
FLARE OF SYSTEMIC LUPUS ERYTHEMATOSUS FOLLLOWING TREATMENT NON-COMPLIANCE OF HYDROXYCHLOROQUINE,Systemic lupus erythematosus,SLE FLARE,SYSTEMIC LUPUS ERYTHEMATOSUS,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),LUPUS ERYTHEMATOSUS (INCL SUBTYPES),10028395,10065992,10042945,10065992
GRANULOMA IN RENAL ALLOGRAFT,granuloma,GRANULOMA,GRANULOMA,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10018691,10018691,10018691
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
EROSION FOLLOWING OFF LABEL USE,Skin erosion,SKIN EROSION,SKIN EROSION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040840,10040840,10040840
PROLONGED THERAPY WITH FLUCONAZOLE 150 MG PER DAY DURING10MONTHS,Drug administration duration too long,DRUG ADMINISTRATION DURATION TOO LONG,INCORRECT DRUG ADMINISTRATION DURATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064312,10064307,10064312
PREMATURITY,Premature baby,PREMATURITY,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036590,10036590,10036615
RECURRENCE OF FEVER FOLLOWING INADVERTENTLY DISCONTINUATION OF THERAPY WITH AMOXICILLIN,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
ANXIETY,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
PAINLESS JAUNDICE,jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
ORAL CANDIDIASIS,Oral candidiasis,ORAL CANDIDIASIS,ORAL CANDIDIASIS,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10030963,10030963,10030963
EXOGENOUS CUSHING SYNDROME DUE TO MISUSE OF CLOBETASOL PROPIONATE 0.05% OINTMENT,Cushing's syndrome,"CUSHING'S SYNDROME, STEROID-INDUCED",CUSHING'S SYNDROME,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10068501,10011652,10068501
HEPATOMEGALY,Hepatomegaly,HEPATOMEGALY,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10019842
ANOREXIA,Decreased appetite,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10002646
MACULOPAPULAR EXANTHEMA,Maculo-papular exanthema,MACULO-PAPULAR EXANTHEMA,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10049195,10037868,10049195
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
HIGH-DOSE INTRAVENOUS FUROSEMIDE FAILED TO REDUCE THE PULMONARY CONGESTION,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
"DON'T REALLY WANT TO USE HEROIN, WANT MORE PREGABS, PATIENT DON'T KNOW WHY",Unexpected beneficial therapeutic response,UNEXPECTED BENEFICIAL THERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE UNEXPECTED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10076885,10043417,10076885
MILD ELEVATION IN CREATININE,Blood creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
"DESPITE BEING ON MAXIMUM DOSES OF EPINEPHRINE, NOREPINEPHRINE, DOPAMINE AND VASOPRESSIN INFUSIONS, SHE REMAINED HYPOTENSIVE",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
GAINED WEIGHT,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
FLU-LIKE SYMPTOMS,flu-like symptoms,FLU-LIKE SYMPTOMS,INFLUENZA LIKE ILLNESS,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10016797,10022004,10016797
VALULAR OBSTRUCTION,Cardiac valve disease,HEART VALVE DISORDERS,CARDIAC VALVE DISEASE,CARDIAC VALVE DISORDERS,CARDIAC VALVE DISORDERS NEC,10007541,10019316,10061406,10019316
GRADE 4 HEMATOLOGICAL TOXICITIES,Haematotoxicity,HAEMATOTOXICITY,HAEMATOTOXICITY,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10061188,10061188,10061188
BIATRIAL ENLARGEMENT,biatrial enlargement,ATRIAL ENLARGEMENT,ATRIAL ENLARGEMENT,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10079340,10079340,10079340
CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
"BACKGROUND ERYTHEMA WITH MORBILLIFORM PAPULES, PLAQUES, AND PATCHES ON THE BILATERAL FLANKS, BACK, BUTTOCKS, ARMS, LEGS, AND CENTRAL NECK",Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
IMPAIRED QOL,Quality of life decreased,QUALITY OF LIFE DECREASED,QUALITY OF LIFE DECREASED,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",INVESTIGATIONS NEC,10022891,10067620,10067620,10067620
1+ KETONURIA,Ketonuria,KETONURIA,KETONURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10023388,10023388,10023388
ABSENCE OF RADIUS,radius absence,HAND DEFORMITY,HAND DEFORMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES (INCL INTERVERTEBRAL DISC DISORDERS),EXTREMITY DEFORMITIES,10028395,10061194,10061194,10061194
HEPATOMEGALY,hepatomegaly,HEPATOMEGALY,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10019842
WORSENED BREATHING,Dyspnoea,BREATHING DIFFICULT,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10006338
PROTEIN 52,Protein total abnormal,PROTEIN TOTAL ABNORMAL,PROTEIN TOTAL ABNORMAL,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10037012,10037012,10037012
"FEVERISH,INDURATED ERYTHEMA APPEARED ON DORSUM OF LEFT HAND AND WRIST",Skin induration,SKIN INDURATION,SKIN INDURATION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10051837,10051837,10051837
THE PATIENT WAS EXPOSED TO BETAMETHASONE IN UTERO (DRUG EXPOSURE IN UTERO),foetal exposure during pregnancy,FOETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071404,10071404,10071404
MILD MYALGIA,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
BLOODY DIARRHEA WITH ASSOCIATED ABDOMINAL CRAMPING,Abdominal pain,ABDOMINAL CRAMPS,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000055,10000081,10000057
VOMITTING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PRODUCTIVE COUGH,Productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
FOODBORNE ILLNESS,Food poisoning,FOOD POISONING,FOOD POISONING,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10016952,10016952,10016952
ERYTHROCYTE SEDIMENTATION RATE OF 48 MM/H,Red blood cell sedimentation rate increased,ERYTHROCYTE SEDIMENTATION RATE INCREASED,RED BLOOD CELL SEDIMENTATION RATE INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),HAEMATOLOGICAL ANALYSES NEC,10022891,10049187,10049187,10015264
"HIS RIGHT ARM POSSIBLY PARALYZED (NOT RESPONDING TO PAINFUL STIMULI),",unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
RENAL PHOSPHOLIPIDOSIS/ RENAL IMPAIRMENT,Renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
URINARY CALCIUM-CREATININE RATIO WAS 0.08,Urine calcium/creatinine ratio decreased,URINE CALCIUM/CREATININE RATIO DECREASED,URINE CALCIUM/CREATININE RATIO DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10058614,10058614,10058614
WORSENING HYPOXAEMIA,hypoxaemia,HYPOXAEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021141,10021143,10021141
FAILED COMBINATION WITH LEFLUNOMIDE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CHRONIC URTICARIA,Urticaria chronic,CHRONIC URTICARIA,URTICARIA CHRONIC,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10052568,10052568,10009159
RIGIDITY,rigidity,RIGIDITY,MUSCLE RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10039168,10028330,10039168
EPISTAXIS,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
PARTIAL THROMBOPLASTIN TIME INCREASED (65.5),Activated partial thromboplastin time prolonged,PARTIAL THROMBOPLASTIN TIME PROLONGED,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10034094,10000636,10034094
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
MILD FUNCTION KIDNEY DECREASED (E-GFR 89.52 ML/MIN),Glomerular filtration rate decreased,GLOMERULAR FILTRATION RATE DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018358,10018358,10018358
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DEPRESSED MOOD,Depressed mood,DEPRESSED MOOD,DEPRESSED MOOD,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10012374,10012374,10012374
DRUG INDUCED- TORSADES DE POINTES,Torsade de pointes,TORSADES DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044067
BLOOD PRESSURE DECREASED (60/40 MMHG),Blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
WORSENING OF DIGITAL GANGRENE DUE TO ISCHEMIA CAUSED BY THE WORSENING OF CHILDHOOD POLYARTERITIS NODUSA,Gangrene,PERIPHERAL GANGRENE,GANGRENE,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10034574,10017711,10034574
SUICIDAL IDEATION,Suicidal ideation,SUICIDAL IDEATION,SUICIDAL IDEATION,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042458,10042458,10042458
QUEASY,Nausea,QUEASY,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10037730,10028813,10037730
MACROCYTIC ANEMIA ATTRIBUTED TO DEHYDRATION,macrocytic anemia,MACROCYTIC ANEMIA,ANAEMIA MACROCYTIC,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10025381,10002064,10025381
SEVERE THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
TOTAL PROTEIN DROPPED (49.6 G/L) DUE TO STEVENS JOHNSON SYNDROME,Protein total decreased,PROTEIN TOTAL DECREASED,PROTEIN TOTAL DECREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10037014,10037014,10037014
ABDOMINAL CRAMPS,abdominal cramps,ABDOMINAL CRAMPS,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000057,10000081,10000057
PROFOUND ASTHENIA/ WORSENING OFASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
NEUTROPHILIA,Neutrophilia,NEUTROPHILIA,NEUTROPHILIA,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10029379,10029379,10029379
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
THE PATIENT STARTED WITH SEVERAL TACHYARRHYTHMIAS,tachyarrhythmia,TACHYARRHYTHMIA,TACHYARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10049447,10049447,10049447
TUBERCULOUS MENINGOENCEPHALITIS FOLLOWING SELF DISCONTINUATION OF DRUG,Encephalitis,MENINGOENCEPHALITIS,ENCEPHALITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10027282,10014581,10027282
IDIOPATHIC RECURRENT STUPOR,Stupor,STUPOR,STUPOR,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042264,10042264,10042264
COMATOSE STATE,Coma,COMATOSE,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10058472,10010071,10058472
TENDONS AFFECTIONS,Tendon disorder,TENDON DISORDER,TENDON DISORDER,"TENDON, LIGAMENT AND CARTILAGE DISORDERS",TENDON DISORDERS,10028395,10043239,10043239,10043239
SHAKINESS,Shakiness,SHAKINESS,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10040527,10044565,10040527
EXHAUSTION ALSO PROGRESSED,Fatigue,EXHAUSTION,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10015667,10016256,10015667
DRUG INTERACTION,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
LEFT-HANDED HEMIPLEGIA/LEFT-SIDED HEMIPLEGIA,Hemiplegia,HEMIPLEGIA (LEFT),HEMIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019469,10019468,10019469
DIAPHORESIS,Hyperhidrosis,DIAPHORESIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042670,10020642,10012703
PRIMARY CUTANEOUS CD30+ ANAPLASTIC LARGE-CELL LYMPHOMA (T-CELL LYMPHOPROLIFERATION),Anaplastic large cell lymphoma T- and null-cell types,"ANAPLASTIC LARGE-CELL LYMPHOMA, PRIMARY CUTANEOUS TYPE",ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,LYMPHOMAS NON-HODGKIN'S T-CELL,ANAPLASTIC LARGE CELL LYMPHOMAS T- AND NULL-CELL TYPES,10029104,10065863,10002227,10065863
LACK OF EFFECT OF METHYLPREDNISOLONE AND METHOTREXATE,lack of effect of methylprednisolone and methotrexate,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
THICK EXPECTORATION OF DIFFICULT ELIMINATION,Sputum retention,SPUTUM EXPECTORATION DIFFICULT,SPUTUM RETENTION,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10041810,10059685,10041810
FEBRILE,febrile,FEBRILE REACTION,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016289,10037660,10016289
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
EDEMA,edema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014210,10030095,10014210
PLATELET COUNT DECREASED (79X10E3/MCL),platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
PREVIOUS HYPERSENSITIVITY REACTION,Hypersensitivity,HYPERSENSITIVITY REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020756,10020751,10020756
ANAPHYLACTIC SHOCK,Anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
THE MOTHER RECEIVED FROVATRIPTAN AND CARBAMAZEPINE DURING PREGNANACY,Fetal exposure during pregnancy,FETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071421,10071404,10071421
MITRAL REGURGITATION,mitral regurgitation,MITRAL REGURGITATION,MITRAL VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,MITRAL VALVULAR DISORDERS,10007541,10027718,10027727,10027718
METASTASES TO LYMPH NODES,Metastases to lymph nodes,METASTASES TO LYMPH NODES,METASTASES TO LYMPH NODES,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027459,10027459,10027459
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
NEPHROTOXICITY,Nephropathy toxic,NEPHROTOXICITY,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10067571
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
MAJOR PULMONARY EDEMA,Pulmonary edema,PULMONARY EDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037375,10037423,10037375
PSEUDOMONAS AERUGINOSA WAS CULTURED AND SUBSEQUENTLY THE PATIENT DEVELOPED SEPTICEMIA AND DIED DESPITE INTENSIVE ANTIBIOTIC AND ANTIMYCOTIC TREATMENT,Septicemia due to pseudomonas,SEPTICEMIA DUE TO PSEUDOMONAS,PSEUDOMONAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,PSEUDOMONAL INFECTIONS,10021881,10040095,10058877,10040095
BILATERAL LOWER LOBE LUNG CONSOLIDATION,Lung consolidation,LUNG CONSOLIDATION,LUNG CONSOLIDATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025080,10025080,10025080
ANAEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
AVERSION TO FOOD,Food aversion,FOOD AVERSION,FOOD AVERSION,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10049238,10049238,10049238
REDUCED VISUAL ACUITY,Visual acuity reduced,VISUAL ACUITY DECREASED,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047531,10047531,10049061
"BRAFV600E-MUTATED PILOCYTIC ASTROCYTOMA WORSENED FOLLOWING NON-RESPONSIVENESS TO VINCRISTINE, TEMOZOLOMIDE AND CARBOPLATIN","Astrocytoma, low grade",JUVENILE PILOCYTIC ASTROCYTOMA,"ASTROCYTOMA, LOW GRADE",NERVOUS SYSTEM NEOPLASMS BENIGN,GLIOMAS BENIGN,10029104,10023265,10065869,10023265
PAINLESS LOSS OF VISION DUE TO CILIORETINAL ARTERY OCCLUSION,Blindness,LOSS OF VISION,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047522,10005169,10024881
GRADE 1 DECLINE OF HEMOGLOBIN,Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
GFR DECREASED (30-44 ML/MIN),Glomerular filtration rate decreased,GFR DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018214,10018358,10018214
TACHYCARDIA,tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
DIRECT BILIRUBIN INCREASED (17 MG/DL),Bilirubin conjugated increased,DIRECT BILIRUBIN INCREASED,BILIRUBIN CONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10013038,10004685,10013038
PATIENT RECEIVED A DOZEN OR SO GRAMS OF PARACETAMOL,intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
UNMASKING IRIS LINKED TO SYPHILIS,Unmasking of previously unidentified disease,UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE,UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076269,10076269,10076269
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
PATIENT RECEIVED MYCOPHENOLATE MOFETIL DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
UNRESPONSIVE ON HER KITCHEN FLOOR APPROXIMATELY 13 HOURS,unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ADMINISTRATION OF MYCOPHENOLATE FOR CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (PRODUCT USED FOR UNAPPROVED INDICATION)- OFF LABEL USE WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FRONTAL LOBE CONTUSION,Brain contusion,BRAIN CONTUSION,BRAIN CONTUSION,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10052346,10052346,10052346
CRP INCREASED (208.5 MG/L),C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
PATIENT SHOWED NO RESPONSE TO DRUG (LACK OF DRUG EFFECT) WITH NO ADR,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HYPOVOLAEMIA,Hypovolaemia,HYPOVOLAEMIA,HYPOVOLAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10021137,10021137,10021137
MULTIPLE TENSE VESICLES/SEROUS VESICLES WERE NOTED CENTRALLY,Blister,VESICLES,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10047367,10005191,10047368
MASSIVE TIREDNESS UNDER CARBAMAZEPINE,Fatigue,TIREDNESS,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10043890
SYSTEMIC BCG-OSIS,Disseminated Bacillus Calmette-Guerin infection,DISSEMINATED BCG,DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10069636,10076666,10069636
PATIENT WAS GIVEN METHOTREXATE IN CASE OF CUTANEOUS LUPUS ERYTHEMATOSUS (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
POSTTRANSPLANT LYMPHO-PROLIFERATIVE DISORDER (PTLD),Post transplant lymphoproliferative disorder,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10051358,10051358,10051358
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
"LEUKOCYTOSIS (LEUCOCYTE: 16.7 G/L) / TEMPORARILY DECREASED, THEREAFTER INCREASED",Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
LACK OF DRUG EFFECT/DISCONTINUED THE MEDICATION AS IT DID NOT HELP HER ANYWAY,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
DECREASED BILATERAL BREATH SOUNDS/ BILATERAL DIMINISHED BREATH SOUNDS,Breath sounds abnormal,BREATH SOUNDS DECREASED,BREATH SOUNDS ABNORMAL,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10006333,10064780,10006333
GRADE 1 NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
LYMPHOPROLIFERATIVE DISORDER,Lymphoproliferative disorder,LYMPHOPROLIFERATIVE DISORDER,LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10061232,10061232,10061232
TRANSIENT AND LIMITED RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
LOCALLY ADVANCED STAGE IIIB/LUNG CANCER/ WITH PROVEN MEDIASTINAL INVOLVEMENT,Lung adenocarcinoma stage III,ADENOCARCINOMA OF LUNG STAGE IIIB,LUNG ADENOCARCINOMA STAGE III,RESPIRATORY AND MEDIASTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,NON-SMALL CELL NEOPLASMS MALIGNANT OF THE RESPIRATORY TRACT CELL TYPE SPECIFIED,10029104,10001183,10025037,10001183
LARGER BULLAE IN A PERIAXILLARY DISTRIBUTION,Blister,BULLAE,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006554,10005191,10006554
SWELLING,swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
KNEE PAIN,Arthralgia,KNEE PAIN,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023477,10003239,10023477
"MULTIPLE DISSEMINATED LESIONS WITH DIAMETER FROM 1 TO 4 CM PRESENTED IN VARIOUS FORMS AS ERYTHEMATOUS, FOLLICULAR PLAQUES AND NODULES,VERRUCOUS HYPERPLASIA WITH SCALES,CRUSTS AND EROSION",Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
BLUE AND PULSELESS,Pulse absent,PULSELESS,PULSE ABSENT,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10037497,10037469,10037495
GASTROINTESTINAL BLEEDING FOLLOWING TREATMENT WITH IBUPROFEN,Gastrointestinal bleeding,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017936,10017955,10017936
IRREVERSIBLE CARDIAC ARREST,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
NUMBNESS,Hypoaesthesia,NUMBNESS,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10029829,10020937,10029829
MACULAR TOXICITY/RETINAL TOXICITY,Retinal toxicity,RETINAL TOXICITY,RETINAL TOXICITY,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10048955,10048955,10048955
EPISODES OF HEARTBURN,angina pectoris,ANGINA PECTORIS,ANGINA PECTORIS,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10002383,10002383,10002383
COLLAPSED (UNCONSCIOUS) DUE TO DEHYDRATION,Loss of consciousness,UNCONSCIOUS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10045479
RESPIRATORY DEPRESSION,Respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
"SCALY PLAQUES LOCATED WITHIN THE FACE, UPPER CHEST, UPPER BACK AND ENTIRE UPPER",Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
ACCIDENTAL OVERDOSE,accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
TREMOR IN HIS RIGHT UPPER EXTREMITY AND A FIRM HYPOGASTRIUM,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
ANGIOEDEMA,angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
CONFIRMED PERTUSSIS INFECTION/WHOOPING COUGH,Pertussis,PERTUSSIS,PERTUSSIS,BACTERIAL INFECTIOUS DISORDERS,BORDETELLA INFECTIONS,10021881,10034738,10034738,10034738
HE HAD BEEN RECEIVING CLONAZEPAM BECAUSE OF THE DIAGNOSIS OF MAJOR DEPRESSIVE DISORDER,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SINUS PRESSURE,sinus pressure,SINUS PRESSURE,PARANASAL SINUS DISCOMFORT,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10040751,10052438,10040751
AN INFANT BOY WITH STEROID RESISTANT IDIOPATHIC MEMBRANOUS GLOMERULONEPHROPATHY WAS ADMINISTERED PREDNISONE AND MYCOPHENOLATE MOFETIL (OFF LABEL) WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ABDOMINAL DISTENSION,Abdominal distension,ABDOMINAL DISTENSION,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10000060
THE PATIENT DEVELOPED LETHARGY,the patient developed lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
COMBINED DRUG INTOXICATION,drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
TUMOR,Gum swelling,GUM SWELLING,GINGIVAL SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10018789,10018291,10018789
APPETITE LOSS,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
MULTIPLE ORAL APHTHOUS ULCERS,Aphthous ulcer,APHTHOUS ULCER,APHTHOUS ULCER,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10002959,10002959,10002959
TAKOTSUBO CARDIOMYOPATHY,Takotsubo cardiomyopathy,TAKOTSUBO SYNDROME,STRESS CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10067676,10066286,10067676
MODERATE ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
PELVIC MASS PROGRESSIVELY INCREASED IN SIZE,Ovarian germ cell teratoma,OVARIAN GERM CELL TERATOMA,OVARIAN GERM CELL TERATOMA,REPRODUCTIVE NEOPLASMS FEMALE MALIGNANT AND UNSPECIFIED,OVARIAN GERM CELL NEOPLASMS MALIGNANT,10029104,10073265,10073265,10073265
NEUROPATHY,Neuropathy,NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029328,10029331,10029328
ENTEROCOCCUS FECALIS,Enterococcal infection,ENTEROCOCCAL INFECTION,ENTEROCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,ENTEROCOCCAL INFECTIONS,10021881,10061124,10061124,10061124
ACUTE ERLOTINIB OVERDOSE,Overdose,ACUTE OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067695,10033295,10067695
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
METFORMIN INTOXICATION,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
FEVER (40 DEGREE C),Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
THE PATIENT BECAME PREGNANT DESPITE HAVING AN LNG-IUS,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
PURULENT SECRETIONS,Purulent discharge,PURULENT DISCHARGE,PURULENT DISCHARGE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10037569,10037569,10037569
TOXICITY TO VARIOUS AGENTS,Toxicity to various agents,TOXICITY TO VARIOUS AGENTS,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10070863,10070863,10070863
CORNEAL LEUCOMA IN BOTH EYES,Adherent leucoma,ADHERENT LEUCOMA,CORNEAL LEUKOMA,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CORNEAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10001276,10066968,10001276
LIVE BIRTH,Live birth,LIVE BIRTH,LIVE BIRTH,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS","NORMAL PREGNANCY, LABOUR AND DELIVERY",10036585,10049550,10049550,10049550
AMIODARONE-INDUCED SIADH,Inappropriate antidiuretic hormone secretion,SIADH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,POSTERIOR PITUITARY DISORDERS,10014698,10040626,10053198,10040626
DEVELOPMENT OF ANGIOEDEMA,development of angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
RENAL ALLOGRAFT MALAKOPLAKIA,Complications of transplanted kidney,COMPLICATIONS OF TRANSPLANTED KIDNEY,COMPLICATIONS OF TRANSPLANTED KIDNEY,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10010185,10010185,10010185
THE DOSE DECREASE ON ADMISSION CAUSED UNCONTROLLED PARKINSON'S SYNDROME,Inappropriate dose of drug administered,INAPPROPRIATE DOSE OF DRUG ADMINISTERED,INCORRECT DOSE ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021590,10064355,10021590
REBLEEDING,Haemorrhage,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10005103
SEIZURE-LIKE ACTIVITY (LOSS OF CONSCIOUSNESS),consciousness loss,CONSCIOUSNESS LOSS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010771,10024855,10010771
GRADE4 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
FLARE OF ARTHRITIS,Arthritis flare up,ARTHRITIS FLARE UP,ARTHRITIS,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10060697,10003246,10060697
PROXIMAL LOWER EXTREMITY WEAKNESS,Lower extremity dysfunction,LOWER EXTREMITY DYSFUNCTION,MUSCULOSKELETAL DISORDER,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10070758,10048592,10070758
CONJUNCTIVITIS,Conjunctivitis,CONJUNCTIVITIS,CONJUNCTIVITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10010741,10010741,10010741
IRREGULAR THERAPY/ PATIENT ABANDONED TREATMENTS SEVERAL TIMES,Intentional product use issue,INTENTIONAL PRODUCT USE ISSUE,INTENTIONAL PRODUCT USE ISSUE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT USE ISSUES,10022117,10076308,10076308,10076308
NAUSEA/ INTERMITTENT NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ASPARTATE TRANSAMINASE INCREASED (0.73 MICROKAT/L),Aspartate transaminase increased (0.73 microkat/l),AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
ECZEMATOUS LESIONS,Eczema,ECZEMA,ECZEMA,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10014184,10014184,10014184
"TRAMADOL, IN CONCENTRATIONS ABOVE THE THERAPEUTIC RANGE / CORONER DID NOT BELIEVE THAT THE",Accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
PREMATURE RUPTURE OF MEMBRANES AT 35 WEEKS GESTATION WITH PREMATURE DELIVERY,Premature rupture of membranes,PREMATURE RUPTURE OF MEMBRANES,PREMATURE RUPTURE OF MEMBRANES,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036603,10036603,10036603
HEMORRHAGIC SHOCK FOLLOWING POST-LT MYCOTIC ANEURYSM OF THE HEPATIC ARTERY,hemorrhagic shock,HEMORRHAGIC SHOCK,SHOCK HAEMORRHAGIC,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10050841,10049771,10050841
ACRAL EDEMA,edema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014210,10030095,10014210
RETRO-PLACENTAL HEMATOMA,Retroplacental hematoma,RETROPLACENTAL HEMATOMA,RETROPLACENTAL HAEMATOMA,MATERNAL COMPLICATIONS OF PREGNANCY,HAEMORRHAGIC COMPLICATIONS OF PREGNANCY,10036585,10054890,10054798,10054890
NASOPHARYNGEAL SWAB WAS POSITIVE FOR INFLUENZA B,Influenza,INFLUENZA B VIRUS INFECTION,INFLUENZA,VIRAL INFECTIOUS DISORDERS,INFLUENZA VIRAL INFECTIONS,10021881,10022003,10022000,10022003
URINE DRUG SCREENING TEST SHOWED HIGH LEVELS OF BENZODIAZEPINES,Urine drug screen positive,URINE DRUG SCREEN POSITIVE,DRUG SCREEN POSITIVE,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,TOXICOLOGY LABORATORY ANALYSES,10022891,10051105,10049177,10051105
PNEUMONITIS,Pneumonitis,PNEUMONITIS,PNEUMONITIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10035742,10035742,10035742
HYPOMAGNESAEMIA,hypomagnesaemia,HYPOMAGNESAEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021027,10021027,10021027
RASHES,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
SELF-TERMINATED SEIZURE / RECEIVED A SELF-RECEDING CONVULSION,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
SIADH DUE TO AMIODARONE MAY BE MASKED BY THE USE OF TOLVAPTAN,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
DYSPHONIA,dysphonia,DYSPHONIA,DYSPHONIA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10013952,10013952,10013952
DECEASED DUE TO HEART FAILURE,Heart failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10019279,10007554,10019279
PAROXYSMAL ANXIETY,anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
GRADE 2 PROTEINURIA 2+,Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
ALTERED LEVEL OF CONSCIOUSNESS,altered level of consciousness,CONSCIOUSNESS DECREASED,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010768,10012373,10010768
LDH INCREASED (399 IU/L),Blood lactate dehydrogenase increased,LDH INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10024051,10005630,10024051
POST-SURGICAL ILEUS WORSENED BY HIGH-DOSE NARCOTICS,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
"ULCERS ON BOTH PALATINE PILLARS (GREY IN COLOUR, 3 CM IN SIZE)",Mouth ulceration,ORAL ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028034,10028034,10031027
METABOLIC ACIDOSIS WITH 825 MG/DL GLYCEMIC INDEX,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
"SHE HAD POSITIVE PREGNANCY/SHE WAS ON ACE INHIBITORS, ASPIRIN AND TICAGRELOR/TICAGRELOR WERE SWITCHED TO CLOPIDOGREL/BETA BLOCKER AND LATER TO CLEXANE",Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
DEHYDRATION,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
RESPIRATORY DEPRESSION,Respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
DARK URINE,Chromaturia,URINE DISCOLORATION,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10046629,10008796,10046628
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
SYNCOPE,Syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
PROGRESSIVE ABDOMINAL PAIN,Abdominal pain aggravated,ABDOMINAL PAIN AGGRAVATED,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10048358,10000081,10048358
LESIONS PERSISTED ACTIVE DESPITE STEROIDS (3 MONTHLY MPDN PULSES AND PDN),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
NEPHROTOXICITY,nephrotoxicity,NEPHROTOXICITY,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10067571
DEHYDRATED,Water excessive loss of,WATER EXCESSIVE LOSS OF,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10047836,10012174,10047836
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,Epstein-Barr virus associated lymphoproliferative disorder,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10068349,10068349,10068349
NEW ONSET LOWER BACK PAIN,Back pain,LOW BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10024891,10003988,10024891
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
RESPIRATORY DEPRESSION,Respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
SEPTIC SHOCK FOLLOWING MULTIDRUG RESISTANT ELIZABETHKINGIA MENINGOSEPTICA BACTEREMIA,Gram-negative bacteremia,GRAM-NEGATIVE BACTEREMIA,BACTERAEMIA,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10054228,10003997,10054228
IMMEDIATE ALLERGIC REACTION TO AMOXICILLIN/CLAVULANIC ACID,immediate hypersensitivity reaction,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
RESPIRATORY INSUFFICIENCY DUE TO TUMORAL PROGRESSION,Neoplasm progression,TUMOR PROGRESSION,NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS UNSPECIFIED MALIGNANCY AND SITE UNSPECIFIED NEC,10029104,10058218,10061309,10053563
STREPTOCOCCUS ORALIS BACTERAEMIA,Streptococcal bacteraemia,STREPTOCOCCAL BACTERAEMIA,STREPTOCOCCAL BACTERAEMIA,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10051018,10051018,10051018
ACUTE JAUNDICE FOLLOWING CEFTRIAXONE-INDUCED CHOLELITHIASIS,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
INTERMITTENT PAIN,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
SPINAL SUBARACHNOID HEMORRHAGE IN THE CONTEXT OF CORTICAL SUPERFICIAL SIDEROSIS COMPLICATED,Spinal subarachnoid haemorrhage,SPINAL SUBARACHNOID HEMORRHAGE,SPINAL SUBARACHNOID HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10073564,10073564,10073569
ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
ANTI-3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE-POSITIVE STATIN-INDUCED AUTOIMMUNE NECROTIZING MYOSITIS,Immune-mediated adverse reaction,IMMUNE-MEDIATED ADVERSE REACTION,IMMUNE-MEDIATED ADVERSE REACTION,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10077665,10077665,10077665
PRURITIC DERMATOSIS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
SUPRAVENTRICULAR TACHYCARDIA,Supraventricular tachycardia,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10042604,10042604,10042604
CEREBRAL VERTEX SUBARACHNOID HAEMORRHAGE,cerebral vertex subarachnoid haemorrhage,SUBARACHNOID HAEMORRHAGE,SUBARACHNOID HAEMORRHAGE,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10042316,10042316,10042316
INAPPETENCE/LOSS OF APPETITE G3,Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
HAEMORRHAGE,Haemorrhage,HAEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10055798
ANGIOEDEMA,Angioedema,FACE ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10079442,10002424,10079442
DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE EVENT,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
THROBBING HEADACHE,Headache,THROBBING HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10058140,10019211,10058140
NEPHRITIS,nephritis,NEPHRITIS,NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029117,10029117,10029117
CUTANEOUS GVHD,cutaneous GVHD,GRAFT VERSUS HOST DISEASE IN SKIN,GRAFT VERSUS HOST DISEASE IN SKIN,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10064675,10064675,10064675
"EARLY MORNING DYSTONIA AT THE RIGHT FOOT, SLIGHT URINARY URGENCY, MILD ATTENTIVE DEFICITS, DAYTIME SLEEPINESS, ANXIETY, MILD POSTURAL AND KINETIC TREMOR OF THE UPPER LEFT LIMB, MILD BRADYKINESIA,PEAK",Daytime sleepiness,DAYTIME SLEEPINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10011865,10041349,10011865
RECURRING AIRWAY INFECTIONS,Respiratory tract infection,RESPIRATORY TRACT INFECTION,RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10062352,10062352,10062352
EXTENSIVE SKIN BLISTERING FOLLOWING WORSENING OF DIABETIC KETOACIDOSIS DUE TO LACK OF DRUG EFFECT,Blister,BLISTERING,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005214,10005191,10005214
THE PATIENT RECEIVED PROPHYLACTIC SUBCUTANEOUS ENOXAPARIN 40 MG THROUGHOUT HER ADMISSION INCLUDING POSTOPERATIVELY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
NONSTEROIDAL ANTI-INFLAMMATORY DRUG HYPERSENSITIVITY,Hypersensitivity,HYPERSENSITIVITY REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020756,10020751,10020756
LOW PLATELET COUNT,Platelet count decreased,PLATELET COUNT LOW,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035529,10035528,10035529
PUPILS BECAME FULLY DILATED AND NON-REACTIVE,Pupils dilated,PUPILS DILATED,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10037535,10028521,10037535
ASPIRIN AND CLOPIDOGREL TAKEN TOGETHER,Drug administration error,DRUG ADMINISTRATION ERROR,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064295,10064295,10064295
HEMATOCRIT DECREASED (45),Haematocrit decreased,HEMATOCRIT DECREASED,HAEMATOCRIT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018838,10018838,10019423
CANDIDA,Candida infection,CANDIDA INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10074170,10074170,10074170
JAUNDICED,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
RED MACULOPAPULAR RASH,Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
ADENOCARCINOMA OF DISTAL TRANSVERSE COLON AND ILIUM DESCENDING COLON,Adenocarcinoma of colon,ADENOCARCINOMA OF COLON,ADENOCARCINOMA OF COLON,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,COLORECTAL NEOPLASMS MALIGNANT,10029104,10001167,10001167,10001167
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
ABSCESSES IN THE LEFT HIP MUSCLES,Muscle abscess,MUSCLE ABSCESS,MUSCLE ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,MUSCLE AND SOFT TISSUE INFECTIONS,10021881,10049206,10049206,10049206
WORSENING OF HYPOXIC RESPIRATORY FAILURE FOLLOWING LACK OF DRUG EFFECT,Respiratory failure,HYPOXIC RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10074615,10038695,10074615
LEUKOCYTOSIS (LEUKOCYTE COUNT: 18X10E9/L),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
"DRUG INTERACTION BETWEEN ENALAPRIL, CIPROFLOXACIN AND METFORMIN / ACUTE KIDNEY INJURY ASSOCIATION WITH CIPROFLOXACIN AND ENALAPRIL",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
SUBCLINICAL STATUS EPILEPTICUS,status epilepticus,STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10041962,10041962,10041962
PERI-ORBITAL AND MUCOSAL HYPERPIGMENTATION,Skin hyperpigmentation,HYPERPIGMENTATION SKIN,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10040865,10040865,10020715
CONCOMITANT USE OF ACETYLSALICYLIC ACID AND TELMISARTAN,drug administration error,DRUG ADMINISTRATION ERROR,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064295,10064295,10064295
TONIC SEIZURES,Tonic convulsion,TONIC CONVULSION,TONIC CONVULSION,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10043994,10043994,10043994
POLYMICROBIAL NEUTROPENIC SEPSIS DUE TO ALBENDAZOLE-INDUCED MYELOSUPPRESSION,polymicrobial neutropenic sepsis due to albendazole-induced myelosuppression,NEUTROPENIC SEPSIS,NEUTROPENIC SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10049151,10049151,10049151
EZETIMIBE INTOLERANCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
ARTHRALGIA,arthralgia,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
"PATIENT ATTEMPTING TO COMMIT SUICIDE BY INGESTING A LARGE AMOUNT OF PILLS [INCLUDING TRAZODONE; SODIUM VALPROATE, ESTAZOLAM AND FLUDIAZEPAM]",suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
SEVERE HCQ-INDUCED RETINAL TOXICITY FOLLOWING OFF LABEL USE OF HYDROXYCHLOROQUINE,Retinal toxicity,RETINAL TOXICITY,RETINAL TOXICITY,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10048955,10048955,10048955
"INTERMITTENT CONFUSION TO THE EXTENT THE PATIENT WAS GETTING LOST, MISSING APPOINTMENTS",confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PERSISTENT HYPERGLYCEMIA DESPITE TREATMENT,hyperglycaemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020639
ABUSE,abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
VITILIGO LIKE HYPOPIGMENTATION FOLLOWING OFF LABEL USE OF IMIQUIMOD FOR GIANT FACIAL INVASIVE SQUAMOUS CELL CARCINOMA,Skin hypopigmentation,SKIN HYPOPIGMENTATION,SKIN HYPOPIGMENTATION,PIGMENTATION DISORDERS,HYPOPIGMENTATION DISORDERS,10040785,10040868,10040868,10040868
DRUG EXPOSURE IN UTERO,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
BODY TEMPERATURE ELEVATION UP TO 37.6 C,Body temperature increased,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10005911
NUCHAL STIFFNESS,Neck stiffness,NECK STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10028843,10052904,10028843
BEZOAR IN THE STOMACH AND DUODENUM FOLLOWING MASSIVE OVERDOSE WITH FERROUS FUMARATE,bezoar,BEZOAR,BEZOAR,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10004542,10004542,10004542
PRESCRIBED FUROSEMIDE WITHOUT CLINICAL IMPROVEMENT.,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
RECURRENT ISCHEMIC STROKE IN SPITE OF DOUBLE ANTIPLATELET THERAPY/RECURRENT ISCHEMIC STROKE IN SPITE OF DOUBLE ANTIPLATELET THERAPY/DOUBLE ANTI-PLATELET THERAPY FAILED TO ENSURE PROTECTION/DESPITE TREATMENT WITH CLOPIDOGREL AND ASPIRIN,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
GENERALIZED TONIC-CLONIC-SEIZURE LIKE ACTIVITY DUE TO RESPIRATORY DEPRESSION,Generalized tonic-clonic seizure,GENERALIZED TONIC-CLONIC SEIZURE,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10062448,10018100,10062448
TREATMENT FAILURE DUE TO POSSIBLE DRUG-DRUG INTERACTION WITH PANTOPRAZOLE SODIUM SESQUIHYDRATE (DIRECT ACTING ANTIVIRALS TREATMENT FAILURE),Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
DYSPNEA,DYSPNEA,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
"SWELLING, CRUSTING AND BLEEDING OVER LIPS",Scab,CRUST,SCAB,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10039509,10039509,10011468
SENSORY PERIPHERAL NEUROPATHY,sensory peripheral neuropathy,SENSORY PERIPHERAL NEUROPATHY,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10040039,10034620,10040039
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
DRUG RESISTANCE (MUTATION),Gene mutation,GENE MUTATION,GENE MUTATION,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,CHROMOSOMAL ABNORMALITIES NEC,10010331,10064571,10064571,10064571
SMALL CELL LUNG CARCINOMA,Small cell lung cancer,SMALL CELL CARCINOMA OF THE LUNG,SMALL CELL LUNG CANCER,RESPIRATORY AND MEDIASTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,RESPIRATORY TRACT SMALL CELL CARCINOMAS,10029104,10041067,10041067,10041058
GESTATIONAL DIABETES,Gestational diabetes,GESTATIONAL DIABETES,GESTATIONAL DIABETES,MATERNAL COMPLICATIONS OF PREGNANCY,PREGNANCY COMPLICATED BY MATERNAL DISORDERS,10036585,10018209,10018209,10018209
DRUG EXPOSURE IN UTERO,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
ASYMPTOMATIC RASH CONSISTING OF ERYTHEMATOUS PLAQUES,Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
BLISTERS ON LIMBS AND TRUNKS/SUBEPIDERMAL BLISTER,Blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
G1 HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
PELVIC MASS PROGRESSIVELY INCREASED IN SIZE,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
DRUG ABUSE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
FRACTURE,Fracture NOS,FRACTURE NOS,FRACTURE,BONE AND JOINT INJURIES,FRACTURES AND DISLOCATIONS NEC,10022117,10017089,10017076,10017089
DIAPHORESIS,diaphoresis,DIAPHORESIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10012703,10020642,10012703
VISUAL HALLUCINATIONS,"Hallucination, visual",VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019075,10019075,10047570
PLATELET COUNT NADIR OF 10X109/L/ RELAPSED WITH PLATELET NADIR OF 5X109/L,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
GASTRIC RETURNS WERE ORANGE IN COLOUR AND HIS URINE WAS ALSO COLOURED DEEPLY ORANGE,Urine colouring orange,URINE COLOURING ORANGE,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10080168,10008796,10080168
BLOOD PRESSURE INCREASED (144/82 TORR) DUE TO CINCHONISM FOLLOWING INTENTIONAL DRUG ABUSE,Blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
LYMPHADENOPATHY,Lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
TYPE 2 CHOROIDAL NEOVASCULARIZATION,Choroidal neovascularization,CHOROIDAL NEOVASCULARIZATION,CHOROIDAL NEOVASCULARISATION,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS,10015919,10060837,10060823,10060837
SUFFERED PROGRESSIVE KIDNEY FAILURE FOLLOWING SEPTICAEMIA PSEUDOMONAL,Renal failure,KIDNEY FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10023418
PULMONARY HEMORRHAGE,pulmonary hemorrhage,PULMONARY HEMORRHAGE,PULMONARY HAEMORRHAGE,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10037397,10037394,10037397
GLYCOSYLATED HEMOGLOBIN (A1C) (6.3PERCENT),Glycosylated hemoglobin increased,GLYCOSYLATED HEMOGLOBIN INCREASED,GLYCOSYLATED HAEMOGLOBIN INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10055590,10018484,10055590
DIFFUSE VIOLACEOUS ERYTHEMA,Erythema diffuse,ERYTHEMA DIFFUSE,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015159,10015150,10015159
A BROWN SKIN LESION OF ABOUT 13 X 6 CM WAS OBSERVED AT THE LEFT LOWER ABDOMINAL AREA AND A RAISED SKIN MASS OF ABOUT 9 X 6 CM WAS FOUND IN THE MIDDLE,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
RENAL COLIC,Renal colic,RENAL COLIC,RENAL COLIC,URINARY TRACT SIGNS AND SYMPTOMS,URINARY TRACT SIGNS AND SYMPTOMS NEC,10038359,10038419,10038419,10038419
A GENERALIZED TONIC CLONIC SEIZURE,Generalised tonic-clonic seizure,GENERALIZED TONIC-CLONIC SEIZURE,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10018100,10018100,10062448
HEADACHES,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
MULTIPLE DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
IMATINIB-RESISTANT CML,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
THERAPY-RELATED ACUTE MYELOID LEUKAEMIA,Therapy-Related Acute Myeloid Leukaemia,ACUTE MYELOID LEUKAEMIA,ACUTE MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10000880,10000880,10000880
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
PATIENT RETURNED WITH SYMPTOMS/LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ITCHING,itching,ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023084,10037087,10023084
DIABETIC POLYNEUROPATHY,Diabetic neuropathy,DIABETIC POLYNEUROPATHY,DIABETIC NEUROPATHY,PERIPHERAL NEUROPATHIES,CHRONIC POLYNEUROPATHIES,10029205,10012685,10012680,10012685
PATIENT WAS ADMINISTERED MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF IMMUNE RELATED HEPATITIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
EDEMA,Edema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014210,10030095,10014210
LIPIDIC PROFILE DAMAGE,Lipids abnormal,ABNORMAL LIPID PROFILE,LIPIDS ABNORMAL,LIPID ANALYSES,LIPOPROTEIN AND LIPID TESTS NEC,10022891,10000157,10024588,10000157
"THE BILATERAL BICEPS,TRICEPS AND PERIOSTEAL REFLEXES WERE (+) AND BILATERAL KNEE JERK REFLEXES WERE (+-++)",reflexes abnormal,REFLEXES ABNORMAL,REFLEXES ABNORMAL,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10038254,10038254,10038254
RIGHT EYE LOOKED BLOOD SHOT,right eye looked blood shot,EYE INFECTION,EYE INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10015929,10015929,10015929
MSUCLE ACHS AND PAINS,Muscle ache,MUSCLE ACHE,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028287,10028411,10028287
WEIGHT LOSS,weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ASPARTATE AMINOTRANSFERASE INCREASED (60 IU/L),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
COMA AND METABOLIC ACIDOSIS EARLY IN SEVERE ACUTE PARACETAMOL POISONING,metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
SKIN LESION LOCATED AT RIGHT UPPER LEG,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
TREATMENT SWITCHED BECAUSE OF INEFFICACY (LACK OF DRUG EFFECT WITH NO ADVERSE EVENT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HYPERCHLOREMIC,hyperchloremia,HYPERCHLOREMIA,HYPERCHLORAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,CHLORIDE IMBALANCE,10027433,10020599,10020597,10020599
PROGRESSION OF PRE EXISTING DISEASE,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
LACK OF DRUG EFFECT OF ITP THERAPY AND APATINIB,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
IBUPROFEN TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
ANAPHYLAXIS,anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
PROTEINURIA 0.874 G/DAY,Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
ARRHYTHMIAS FOLLOWING TYPE 2 DIABETES MELLITUS/CONDUCTION ABNORMALITIES/ARRHYTHMIAS,arrhythmias,ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10003119
WORSENING OF TROPICAL PULMONARY EOSINOPHILIA FOLLOWING INCOMPLETE RESPONSE OF DIETHYLCARBAMAZINE,pulmonary eosinophilia,PULMONARY EOSINOPHILIA,PULMONARY EOSINOPHILIA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10037382,10037382,10037382
DRUG HYPERSENSITIVITY/DRUG ALLERGY,Drug hypersensitivity,SPECIFIC ALLERGY (DRUG),DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10041423,10013700,10041423
"HYPER PIGMENTED PATCHES WITH EXFOLIATED SKIN IN THE INVOLVED AREAS WERE LEFT ARM (9%), RIGHT ARM (1%), RIGHT LOWER LIMB (2%), LEFT LOWER LIMB (4%),BACK(1%),SCROTUM (1%),BUTTOCK(1%).",Skin exfoliation,EXFOLIATION OF SKIN,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040844,10040844,10015661
"MULTIPLE, ASYMPTOMATIC HAEMORRHAGIC BLISTERS ON HIS HANDS AND FEET",Blood blister,BLOOD BLISTER,BLOOD BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005372,10005372,10005372
PERIPHERAL EDEMA,Oedema peripheral,PERIPHERAL EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030124,10030124,10034570
IRRITABILITY,Irritability,IRRITABILITY,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10022998,10022998,10022998
QT PROLONGATION,QT interval prolonged,QT INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037703,10014387,10037703
ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
"-BLOCKER THERAPY IS CONTRAINDICATED, AND ITS ADMINISTRATION CONTRIBUTED TO THE DEVELOPMENT OF CARDIOGENIC SHOCK",Cardiogenic shock,CARDIOGENIC SHOCK,CARDIOGENIC SHOCK,HEART FAILURES,HEART FAILURES NEC,10007541,10007625,10007625,10007625
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CHRONIC ENTEROVIRAL MENINGOENCEPHALITIS FOLLOWING HYPOGAMMAGLOBULINEMIA (IG LEVELS 418 MG/DL),Meningoencephalitis viral,MENINGOENCEPHALITIS VIRAL,MENINGOENCEPHALITIS VIRAL,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10074672,10074672,10074672
AT THE TIME OF PREGNANCY PATIENT RECEIVED PREDNISONE,"Maternal exposure during pregnancy, first trimester","MATERNAL EXPOSURE DURING PREGNANCY, FIRST TRIMESTER",MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10074501,10071408,10074501
REFRACTORY AHT,hypertension arterial,HYPERTENSION ARTERIAL,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020775,10020772,10020775
MONOSOMY 7 IN PH-NEGATIVE CELLS ASSOCIATED SEVERE MYELODYSPLASIA,Chromosome 7 changes,CHROMOSOME 7 CHANGES,CHROMOSOME ANALYSIS ABNORMAL,CYTOGENETIC INVESTIGATIONS,CHROMOSOME ANALYSES,10022891,10078940,10008817,10078940
UNCAL HERNIATION FOLLOWING VENTRICULITIS DESPITE ANTIBIOTIC THERAPY,Brain herniation,BRAIN HERNIATION,BRAIN HERNIATION,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10006126,10006126,10006126
SCAR,scar,SCAR,SCAR,INJURIES NEC,SKIN INJURIES NEC,10022117,10039580,10039580,10039580
MILD LEUKOPENIA,Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
NOT RESPOND TO THE TREATMENT,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
"HBV-DNA WAS INCREASED TO 2.1, 2.3 LOG COPIES/ML",Hepatitis B DNA increased,HBV DNA INCREASED,HEPATITIS B DNA INCREASED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10062602,10068379,10062602
MARKED TISSUE EOSINOPHILIA,Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
MENTAL AND BEHAVIOURAL DISORDERS,behavioural disorder,BEHAVIOURAL DISORDER,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004210,10061422,10004210
GENERALISED RASH,generalised rash,GENERALISED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10018095,10037858,10018095
HEMOLYTIC ANEMIA,hemolytic anemia,HEMOLYTIC ANEMIA,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10019493,10018916,10019493
FELT UNWELL,feeling unwell,FEELING UNWELL,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016370,10025482,10016370
GRADE 3 HYPONATREMIA,hyponatremia,HYPONATRAEMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021036
HYPERPARATHYROIDISM (31 PMOL/L),hyperparathyroidism,HYPERPARATHYROIDISM,HYPERPARATHYROIDISM,PARATHYROID GLAND DISORDERS,HYPERPARATHYROID DISORDERS,10014698,10020705,10020705,10020705
MEDICATION-RELATED OSTEONECROSIS OF THE JAW,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
"DESPITE THERAPY WITH DOPAMINE, NORADRENALINE AND BICARBONATE, HE HAD NO IMPROVEMENT AND WAS ADMITTED TO THE ICU",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
REDUCED HAEMOGLOBIN (34 G/L),Haemoglobin decreased,HAEMOGLOBIN LOW,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018889,10018884,10018889
REFRACTORY GVHD,No therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
SOME WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
PATIENT WAS TREATED WITH ARIPIPRAZOLE FOR HALLUCINATIONS (OFF LABEL USE) WITH NO ADR,OFF LABEL USE,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TRANSIENT COAGULOPATHY,Coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
STEATOHEPATITIS,Non-alcoholic steatohepatitis,NON-ALCOHOLIC STEATOHEPATITIS,NON-ALCOHOLIC STEATOHEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10053219,10053219,10053219
TOXICITY TO VARIOUS AGENTS,Toxicity to various agents,TOXICITY TO VARIOUS AGENTS,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10070863,10070863,10070863
LACTIC ACIDOSIS,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
THROMBUS WAS DESCRIBED AT THE END OF THE VENOUS CATHETER IN THE UPPER VENA CAVA,Vena cava thrombosis,SUPERIOR VENACAVAL THROMBOSIS,VENA CAVA THROMBOSIS,EMBOLISM AND THROMBOSIS,VENA CAVAL EMBOLISM AND THROMBOSIS,10047065,10042570,10047195,10042570
ASPERGILLUS TAMARII INFECTION,Aspergillus infection,ASPERGILLUS INFECTION,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10074171,10074171,10074171
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
"AT LEAST FOUR LOBULATED NODULAR LESIONS OVER BOTH FRONTAL AND RIGHT TEMPORAL LOBES/ MULTIPLE BRAIN LESIONS, MAINLY RIGHT CEREBRUM WITH MASS EFFECT",at least four lobulated nodular lesions over both frontal and right temporal lobes,BRAIN LESION,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10067294,10051290,10067294
"INTENTIONAL DRUG OVERDOSE OF LEVOTHYROXINE, OLANZAPINE AND CITALOPRAM HYDROBROMIDE",Multiple drug overdose intentional,MULTIPLE DRUG OVERDOSE INTENTIONAL,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10062764,10022523,10062764
OLIGOHYDRAMNIOS AND NEONATAL RENAL FAILURE IS REPORTED IN A PREMATURE INFANT WHOSE MOTHER HAD USED ENALAPRIL IN WEEKS 32 - 35 OF HER PREGNANCY.,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
OVER-SPENDING,Behaviour abnormal,BEHAVIOUR ABNORMAL,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004206,10061422,10004206
"SELECTIVE ANAPHYLAXIS EPISODES/ 1 HOUR AFTER INTAKE OF CUMULATIVE DOSE OF 120 MG OF ETORICOXIB STARTED PALM-PLANTAR PRURITUS, OROPHARYNGEAL PRURITUS, LIP EDEMA AND DYSPNEA/THE SECOND EPISODE OCCURRED FEW MINUTES AFTER INTAKE OF 90 MG OF ETORICOXIB",Anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
PATIENT WAS TREATED WITH MYCOPHENOLATE MOFETIL FOR CROHN'S DISEASE (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
WORSENING OF DYSPNEA,Condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
MAJOR CONGENITAL MALFORMATIONS,Congenital anomaly,CONGENITAL ANOMALY NOS,CONGENITAL ANOMALY,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10010357,10010356,10010357
CYSTOISOSPORIASIS (CYSTOISOSPORA BELLI),Isosporiasis,ISOSPORIASIS,ISOSPORIASIS,PROTOZOAL INFECTIOUS DISORDERS,ISOSPORA INFECTIONS,10021881,10023076,10023076,10023076
HYPOREFLEXIA,hyporeflexia,HYPOREFLEXIA,HYPOREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10021089,10021089,10021089
DRUG VACCINE INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
AED OUTCOME FAILURE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DEATH FROM FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
LIQUEFIED HAEMATOMA,Haematoma,HAEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10018852
ORAL ULCER,Mouth ulceration,ORAL ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028034,10028034,10031027
PNEUMOCYSTIS JIROVECI PNEUMONIA,Pneumocystis jiroveci pneumonia infection,PNEUMOCYSTIS JIROVECI PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10064108,10073755,10064108
HYDROXYCHLOROQUINE USED IN YOUNG CHILD WITHOUT ADVERSE EVENT,Drug use for unapproved population,DRUG USE IN UNAPPROVED POPULATION,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10071551,10076309,10071551
INTENSIVE CARE INCLUDING ACYCLOVIR THERAPY DID NOT SUCCEED (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
WALKING DISABILITY,walking disability,WALKING DISABILITY,WALKING DISABILITY,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10053204,10053204,10053204
SMALL PERICARDIAL EFFUSION,Pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
CHRONIC MYELOID LEUKEMIA,Chronic myeloid leukaemia,CHRONIC MYELOID LEUKEMIA,CHRONIC MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS CHRONIC MYELOID,10029104,10009013,10009013,10009015
AV BLOCK FOLLOWING EXPOSURE TO TOXIC AGENT,Atrioventricular block,AV BLOCK,ATRIOVENTRICULAR BLOCK,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10019255,10003671,10003846
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
PRURITUS,pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
STEROID INDUCED DIABETES,Diabetes steroid-induced,DIABETES STEROID-INDUCED,DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012628,10012601,10012628
VISUAL IMPAIRMENT,Visual impairment,VISUAL IMPAIRMENT,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047571,10047571,10047571
ACHING  JOINTS,Arthralgia,ACHING JOINTS,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10033511,10003239,10000449
AGRANULOCYTOSIS PROGRESSED FROM LOCAL TO SYSTEMIC WITH SEPTIC SHOCK,septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
INCREASED CARDIAC ENZYMES,Cardiac enzymes increased,CARDIAC ENZYMES INCREASED,MYOCARDIAL NECROSIS MARKER INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10007548,10075211,10007548
CHLOROQUINE OVERDOSE,Drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
NON-SPECIFIC HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
ALT INCREASED (1102 U/L),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
MACULOPAPULAR LESIONS WERE ALSO FOUND MAINLY IN THE TRUNK AND EXTREMITIES,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
SWOLLEN,injection site swelling,INJECTION SITE SWELLING,INJECTION SITE SWELLING,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10053425,10053425,10053425
IMATINIB USED FOR REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
AFTER ONLY TWO CYCLES SHE WAS CLINICALLY DETERIORATING AND WAS ADMITTED TO THE HOSPITAL WITH FATIGUE AND HYPOXIA,General physical health deterioration,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10049438,10049438,10049438
FAT PAD (BUFFALO HUMP) AT BASE OF POSTERIOR NECK,buffalo hump,BUFFALO HUMP,LIPOHYPERTROPHY,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,LIPODYSTROPHIES,10040785,10006539,10062315,10006539
PROGRESSIVELY WORSENING HEADACHES,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
GENE MUTATIONS (PTPN11 C.1517A>C: P.Q506P (43%),gene mutations (PTPN11 c.1517A>C: p.Q506P (43%),ACQUIRED GENE MUTATION,ACQUIRED GENE MUTATION,GENERAL SYSTEM DISORDERS NEC,ACQUIRED GENE MUTATIONS AND OTHER ALTERATIONS,10018065,10069754,10069754,10069754
CONFUSION,confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
LACK OF SIGNIFICANT CLINICAL IMPROVEMENT WAS OBSERVED,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ERYTHEMA,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
ACUTE RENAL FAILURE FOLLOWING CEFTRIAXONE-INDUCED IMMUNE HEMOLYSIS,acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
SWELLING,swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
RELAPSING MACROSCOPIC HAEMATURIA/RECURRENT MACROSCOPIC HAEMATURIA,Haematuria,MACROSCOPIC HAEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10017332,10018867,10059802
ACUTE EPIGASTRIC PAIN,Abdominal pain upper,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
CHOLESTASIS,cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
BP FALLS DOWN,fall in blood pressure,FALL IN BLOOD PRESSURE,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10016174,10005734,10016174
FESTINATING GAIT,Parkinsonian gait,FESTINATING GAIT,PARKINSONIAN GAIT,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10017579,10056242,10016474
OFF LABEL USE OF FLUDARABINE FOR CONDITIONING REGIMEN FOR HSCT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
OFF LABEL USE,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
METASTATIC MELANOMA LOCALISED AT THE LEGS (BRESLOW THICKNESS-5 MM),Metastatic malignant melanoma,METASTATIC MELANOMA,METASTATIC MALIGNANT MELANOMA,SKIN NEOPLASMS MALIGNANT AND UNSPECIFIED,SKIN MELANOMAS (EXCL OCULAR),10029104,10027481,10027480,10027481
HEMATOMA ON THE LEFT ABDOMINAL WALL,Abdominal wall haematoma,ABDOMINAL WALL HEMATOMA,ABDOMINAL WALL HAEMATOMA,ABDOMINAL HERNIAS AND OTHER ABDOMINAL WALL CONDITIONS,ABDOMINAL WALL CONDITIONS NEC,10017947,10067383,10067383,10067838
CMV COLITIS,Cytomegalovirus colitis,CMV COLITIS,CYTOMEGALOVIRUS COLITIS,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10048983,10048983,10051359
IMATINIB MESILATE-INDUCED NON SPECIFIC INTERSTITIAL PNEUMONITIS,Interstitial lung disease,INTERSTITIAL PNEUMONITIS,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022618,10022611,10022618
STATIN ASSOCIATED NECROTIZING AUTOIMMUNE MYOPATHY,Immune-mediated necrotizing myopathy,IMMUNE-MEDIATED NECROTIZING MYOPATHY,IMMUNE-MEDIATED NECROTISING MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10072156,10072155,10072156
OFLOXACIN-INDUCED TENDINOPATHY,TENDINOPATHY,TENDINOPATHY,TENDON DISORDER,"TENDON, LIGAMENT AND CARTILAGE DISORDERS",TENDON DISORDERS,10028395,10080130,10043239,10080130
EXAM REVEALED VISION OF 20/40,Visual acuity reduced,VISUAL ACUITY REDUCED,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047531,10047531,10047531
SKIN PIGMENTATION,skin pigmentation,SKIN PIGMENTATION,PIGMENTATION DISORDER,PIGMENTATION DISORDERS,PIGMENTATION CHANGES NEC,10040785,10040910,10062080,10040910
SEVERE ACUTE THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
THE APTIENT WAS ICTERIC,Icterus,ICTERUS,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10021207,10023126,10021207
FLACCID BULLAE AND NECROTIC LESIONS,flaccid bullae and necrotic lesions,BULLAE,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006554,10005191,10006554
NEPHROTOXICITY,Nephropathy toxic,NEPHROTOXICITY,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10067571
EJECTION SYSTOLIC MURMUR (GRADE II/VI) AT THE LEFT LOWER STERNAL EDGE,Cardiac murmur,SYSTOLIC EJECTION MURMUR,CARDIAC MURMUR,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC AUSCULTATORY INVESTIGATIONS,10022891,10050568,10007586,10050568
COLONIC HEMORRHAGE IN COUMADIN OVERDOSE AND SYNCOPE EPISODES WITH MULTIPLE TRAUMA,Syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
MASSIVE DIARRHEA,Diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
MACULAR ERYTHRODERMA,Dermatitis exfoliative generalised,ERYTHRODERMA,DERMATITIS EXFOLIATIVE GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10015277,10012456,10015277
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
DRUG-INDUCED LUNG DISEASE SECONDARY TO FLUOXETINE,Lung disorder,LUNG DISEASE,LUNG DISORDER,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10051054,10025082,10051054
MIGRAINOUS TYPE OF HEADACHE,migrainous type of headache,MIGRAINE HEADACHE,MIGRAINE,HEADACHES,MIGRAINE HEADACHES,10029205,10027602,10027599,10027602
STRIDOR,stridor,STRIDOR,STRIDOR,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),"LARYNGEAL SPASM, OEDEMA AND OBSTRUCTION",10038738,10042241,10042241,10042241
RETINAL EXAMINATION DISCLOSE A STAGE III OF HYPERTENSIVE RETINOPATHY FOLLOWING SCLERODERMA RENAL CRISIS,Retinopathy hypertensive,HYPERTENSIVE RETINOPATHY,RETINOPATHY HYPERTENSIVE,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINOPATHIES NEC,10015919,10038926,10038926,10020839
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"IN SPITE OF THE STRONG LDL-C LOWERING EFFECT OF STATINS AND EZETIMIBE, LDL-C IS NOT ADEQUATELY CONTROLLED IN THIS POPULATION",Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
SWELLING OF LEFT LOWER EXTREMITY,Oedema peripheral,EDEMA LOWER LIMB,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030109,10030124,10014232
PRURITIC RASH OVER HIS TRUNK AND LIMBS,rash pruritic,RASH PRURITIC,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10037884
DIED DUE TO PROGRESSIVE METASTATIC UROTHELIAL CARCINOMA,Metastasis,METASTASES NOS,METASTASIS,METASTASES,METASTASES TO UNKNOWN AND UNSPECIFIED SITES,10029104,10027449,10062194,10027449
PULMONARY TUBERCULOSIS WORSENED FOLLOWING TREATMENT WITH PREDNISOLONE DURING PREGNANCY,Pulmonary tuberculosis,PULMONARY TUBERCULOSIS AGGRAVATED,PULMONARY TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10037441,10037440,10037441
UREA 258 MG/DL,Blood urea increased,UREA HIGH,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10046352,10005851,10046352
"COLONOSCOPY REVEALED THREE LESIONS IN THE RIGHT COLON: EROSION-ULCERATION AND TWO CONCENTRIC ""DIAPHRAGM-LIKE"" STRICTURES PASSABLE BY SCOPE, WITH MUCOSAL LESION",Colonoscopy abnormal,COLONOSCOPY ABNORMAL,COLONOSCOPY ABNORMAL,GASTROINTESTINAL INVESTIGATIONS,GASTROINTESTINAL AND ABDOMINAL IMAGING PROCEDURES,10022891,10010008,10010008,10010008
PULMONARY EMBOLISM,Pulmonary embolism,PULMONARY EMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037377,10037377,10037377
SOMNOLENT,somnolent,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
AGGRESSIVE,Aggression,AGGRESSIVENESS,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001488,10001488,10001494
EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
RAPID PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
GRAFT LOSS FOLLOWING KLEBSIELLA PNEUMONIAE NEWDELHI METALLO-BETA-LACTAMASE,Graft loss,GRAFT LOSS,GRAFT LOSS,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10048748,10048748,10048748
PULMONARY HYPERTENSION,pulmonary hypertension,PULMONARY HYPERTENSION,PULMONARY HYPERTENSION,PULMONARY VASCULAR DISORDERS,PULMONARY HYPERTENSIONS,10038738,10037400,10037400,10037400
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
CEPHALEXIN INDUCED TOXIC EPIDERMAL NECROLYSIS,toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
EMBOLIA CUTIS MEDICAMENTOSA,Embolia cutis medicamentosa,NICOLAU SYNDROME,EMBOLIA CUTIS MEDICAMENTOSA,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10058731,10058729,10058731
INCREASED PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
DIGESTIVE INTOLERANCE,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
DELUSIONS,Delusion,DELUSIONS,DELUSION,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10012239,10012239,10012260
MELOXICAM INDUCED EARLY TOXIC EPIDERMAL NECROSIS,toxic epidermal necrosis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
CSF GLUCOSE INCREASED (100 MG/DL),CSF glucose increased,CSF GLUCOSE INCREASED,CSF GLUCOSE INCREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10050763,10050763,10050763
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
ANOREXIA,Decreased appetite,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10002646
DIFFICULTY WALKING,Gait disturbance,DIFFICULTY IN WALKING,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10012794,10017577,10012794
CHILLINESS / SENSATION OF COLD AT NIGHT,Feeling cold,CHILLINESS,FEELING COLD,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008530,10016326,10008530
DRUG-INDUCED PULMONARY EOSINOPHILIA,Pulmonary eosinophilia,PULMONARY EOSINOPHILIA,PULMONARY EOSINOPHILIA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10037382,10037382,10037382
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
APPLICATION SITE PAIN AND PRESSURE SENSITIVITY,Vaccination site pain,VACCINATION SITE PAIN,VACCINATION SITE PAIN,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10068879,10068879,10068879
RIGHT UPPER LIMB PARALYSIS,Monoplegia,MONOPLEGIA,MONOPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10027926,10027926,10027926
PULMONARY FUNCTION ABNORMAL,Pulmonary function test abnormal,PULMONARY FUNCTION TEST ABNORMAL,PULMONARY FUNCTION TEST ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY AND PULMONARY FUNCTION DIAGNOSTIC PROCEDURES,10022891,10061602,10061602,10061602
PATIENT TREATED WITH MYCOPHENOLATE MOFETIL FOR SARCOIDOSIS (OFF LABEL USE FOR INDICATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RAPID LOSS OF TUFTS OF HAIR,Hair loss,HAIR LOSS,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10019045,10001760,10019045
DRUG-INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
PARTIAL RESPONSE,partial response,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
GAPS IN MEMORY FOLLOWING MULTIPLE DRUG POISONING,Memory impairment,MEMORY IMPAIRED,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027175,10027175,10027174
FEBRILE NEUTROPENIA,febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
C-REACTIVE PROTEIN INCREASED (11.2 MG/DL),C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
SEIZURES,Seizures,SEIZURES,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039910,10039906,10039910
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
CORNEAL EDEMA,Corneal oedema,CORNEAL EDEMA,CORNEAL OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CORNEAL INFECTIONS, OEDEMAS AND INFLAMMATIONS",10015919,10011033,10011033,10011007
TRANSIENT ELEVATION IN LIVER ENZYME (AST 54 U/L),transient elevation in liver enzyme (AST 54 U/L),AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
ACUTE RESPIRATORY FAILURE,Acute respiratory failure,ACUTE RESPIRATORY FAILURE,ACUTE RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10001053,10001053,10001053
VENTRICULAR FIBRILLATION,ventricular fibrillation,VENTRICULAR FIBRILLATION,VENTRICULAR FIBRILLATION,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047290,10047290,10047290
PLEURAL EFFUSION,Pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
HIGH BLOOD GLUCOSE AT 501 MG/DL,hyperglycemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020639,10020635,10020639
ARTHRALGIA,arthralgia,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
LACK OF EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
IMMUNOSUPRESSION,Immunosuppression,IMMUNOSUPPRESSION,IMMUNOSUPPRESSION,IMMUNODEFICIENCY SYNDROMES,IMMUNODEFICIENCY DISORDERS NEC,10021428,10062016,10062016,10062016
SEIZURES HAD BECOME MORE FREQUENT USING ONLY VALPROAT,seizures had become more frequent using only valproat,EPILEPSY AGGRAVATED,EPILEPSY,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10015038,10015037,10015038
ELEVATED DIGOXIN LEVEL OF 3.6 NG/ML,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
ABDOMINAL DISTENSION,Abdominal distension,ABDOMINAL DISTENSION,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10000060
FREE-FLOATING THROMBUS-LIKE APPEARANCE IN THE LEFT ATRIUM,Atrial thrombosis,ATRIAL THROMBOSIS,ATRIAL THROMBOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048632,10048632,10048632
LINEZOLID LEVELS DECREASED FOLLOWING DRUG INTERACTION (AUC: 65.8 MGH/L,,,,,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,10044260,10013718,10013718,
ENTEROBACTER CLOACAE RESISTANT TO GENTAMICINE,Pathogen resistance,ANTIBIOTIC RESISTANT STRAIN,PATHOGEN RESISTANCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10002737,10034133,10002737
CIRCULATORY INSTABILITY FOLLOWING SEPTICEMIA,circulatory instability,CIRCULATORY INSTABILITY,CARDIOVASCULAR DISORDER,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10009197,10007649,10009197
KNEE EDEMA IN BOTH KNEES,edema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014210,10030095,10014210
INADEQUATE RESPONSE TO LEVOTHYROXINE THERAPY WITH NO REPORTED ADR,LOE,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
MENINGITIS MENINGOCOCCAL,Meningitis meningococcal,MENINGITIS MENINGOCOCCAL,MENINGITIS MENINGOCOCCAL,BACTERIAL INFECTIOUS DISORDERS,NEISSERIA INFECTIONS,10021881,10027249,10027249,10027249
CEFTRIAXONE INDUCED NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
SUTURE RUPTURE,Suture rupture,SUTURE RUPTURE,SUTURE RUPTURE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10048547,10048547,10048547
"DESPITE ALL THE THERAPIES, THE PATIENT DEVELOPED TONIC-CLONIC SEIZURES",drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
SUICIDE,Completed suicide,SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042462,10010144,10042462
PANTOPRAZOLEINDUCED ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
LIMBAL EDEMA IN BOTH EYES,Eye oedema,EYE EDEMA,EYE OEDEMA,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10052139,10052139,10054378
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOM/ (DIHS/DRESS) TRIGGERED BY HSV REACTIVATION,DRESS syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
EPIDURAL HEMATOMA,epidural hematoma,EPIDURAL HEMATOMA,EXTRADURAL HAEMATOMA,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10015013,10015769,10015013
DIPLOPIA,diplopia,DIPLOPIA,DIPLOPIA,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10013036,10013036,10013036
ATTEMPTED HOMICIDE,Homicide,HOMICIDE,HOMICIDE,LEGAL ISSUES,CRIMINAL ACTIVITY,10041244,10020364,10020364,10020364
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
ADENOSINE AND THEN AMIODARONE WERE TRIED UNSUCCESSFULLY,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PERSISTENTLY ELEVATED PAP,pulmonary arterial pressure increased,PULMONARY ARTERIAL PRESSURE INCREASED,PULMONARY ARTERIAL PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10037324,10037324,10037324
TACHYPNOEA,Tachypnoea,TACHYPNOEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043089
ELEVATED WHITE CELL COUNT AT 31X10E9/L,White blood cell increased,WHITE BLOOD CELL INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10049183,10047943,10049183
THIRD-DEGREE MOBILITY OF THE LOWER-RIGHT CUSPID (43),Tooth loss,TOOTH LOSS,TOOTH LOSS,DENTAL AND GINGIVAL CONDITIONS,TOOTH MISSING,10017947,10044044,10044044,10044044
REPEATED EPISTAXES,repeated epistaxes,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
OVERDOSE OF PRESCRIBED MEDICATION,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
MICROCYTIC ANEMIA,Microcytic anaemia,MICROCYTIC ANEMIA,MICROCYTIC ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10027538,10027538,10027539
MULTIORGAN FAILURE,Multiple organ dysfunction syndrome,MULTIORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028162
SUSPECT SEROTONINE SYNDROME,Serotonin syndrome,SEROTONIN SYNDROME,SEROTONIN SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10040108,10040108,10040108
DROWSINESS,drowsiness,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
GRADUALLY BECAME UNABLE TO WALK,Gait inability,UNABLE TO WALK,GAIT INABILITY,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017581,10017581,10049278
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
TRANSIENT URINE AMYLASE INCREASED (1571 U/L),Amylase increased,URINE AMYLASE INCREASED,AMYLASE INCREASED,GASTROINTESTINAL INVESTIGATIONS,DIGESTIVE ENZYMES,10022891,10046612,10002016,10046612
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DELAYED HYPERSENSITIVITY REACTION,Type IV hypersensitivity reaction,DELAYED TYPE HYPERSENSITIVITY,TYPE IV HYPERSENSITIVITY REACTION,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10012210,10053613,10012210
EPIGASTRIC PAIN,Abdominal pain upper,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
"AFTER THE LAST CYCLE, THE PATIENT DEVELOPED OHSS/MODERATE OHSS",Ovarian hyperstimulation syndrome,OVARIAN HYPERSTIMULATION SYNDROME,OVARIAN HYPERSTIMULATION SYNDROME,OVARIAN AND FALLOPIAN TUBE DISORDERS,OVARIAN AND FALLOPIAN TUBE DISORDERS NEC,10038604,10033266,10033266,10033266
GENERALISED MALAISE,Malaise,GENERAL MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10018066,10025482,10018066
"BULGING OF BOTH CORTICAL OF THE IPSILATERAL MANDIBLE BRANCH/SCLEROTIC INTENSIFICATION WITH MANDIBULAR BONE GROWTH/METASTATIC FOCI ARE SEEN IN RIGHT ORBIT, RIBS ON BOTH SIDES, SACRAL COLUMN/LEFT HUMERUS, BOTH SCAPULAE AND RIGHT FEMORAL DIAPHYSIS",Bone disorder,BONE DISORDER,BONE DISORDER,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10005956,10005956,10005956
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HYPOXIA,Hypoxia,HYPOXIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021143,10021143,10021143
CONTRACTURES,contractures,CONTRACTURE,MUSCLE CONTRACTURE,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10061785,10062575,10061785
PROGRESSION OF LOW BACK PAIN,Low back pain,LOW BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10024891,10003988,10024891
PATIENT TREATED WITH METHOTREXATE FOR ANTERIOR UVEITIS (OFF LABEL USE FOR INDICATION) WITH NO ADR.,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"PATIENT EXPERIENCED TRANSIENT HEPATIC TOXICITIES, HAEMATOLOGICAL TOXICITY AND DIARRHOEA WHICH ALL RECOVERED WITHIN TWO TO THREE WEEKS AND TRANSAMINITIS GRADE 4 (OUTCOME NOT REPORTED). SUDDEN DEATH OCC",Haematotoxicity,HEMATOTOXICOSIS,HAEMATOTOXICITY,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10050545,10061188,10058003
OLMESARTAN INDUCED ENTEROPATHY,Sprue-like enteropathy,SPRUE-LIKE ENTEROPATHY,SPRUE-LIKE ENTEROPATHY,MALABSORPTION CONDITIONS,MALABSORPTION SYNDROMES,10017947,10079622,10079622,10079622
RASH,rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
JAUNDICE WITH MULTIPLE AREAS OF EXCORIATION AND HEPATOMEGALY,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
RIGIDITY UNCHANGED,Rigidity,RIGIDITY,MUSCLE RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10039168,10028330,10039168
PATIENT DIED WITH EVIDENCE OF MULTIPLE ORGAN FAILURE FOLLOWING HEMOLYSIS INDUCED BY CEFTRIAXONE,Multiple organ dysfunction syndrome,MULTIPLE ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028237
ABDOMINAL CRAMPY PAINS,Abdominal crampy pains,ABDOMINAL CRAMPY PAINS,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000058,10000081,10000058
THESE MEDICATIONS WERE POORLY TOLERATED DUE TO NAUSEA AND FLUID RETENTION,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
LOCALISED ERYTHEMA WITH IRRITATION,Vaccination site erythema,VACCINATION SITE ERYTHEMA,VACCINATION SITE ERYTHEMA,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10059079,10059079,10059079
PATIENT TREATED WITH HYDROXYCHLOROQUINE AND METHOTREXATE FOR HYPOCOMPLEMENTAEMIC URTICARIAL VASCULITIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BEHAVIORAL CHANGES,Abnormal behaviour,BEHAVIOR ABNORMAL,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10061422,10061422,10004203
PERSISTENTLY POOR CLINICAL CONDITION,reduced general condition,REDUCED GENERAL CONDITION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10057364,10049438,10057364
RIGORS,rigors,RIGORS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10039177,10008531,10039177
SARCOIDOSIS FOLLOWING  IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,Sarcoidosis,SARCOIDOSIS,SARCOIDOSIS,IMMUNE DISORDERS NEC,ACUTE AND CHRONIC SARCOIDOSIS,10021428,10039486,10039486,10039486
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
SILDENAFIL AND ILOPROST GIVEN TO NEW BORN (DRUG USED FOR UNAPPROVED POPULATION) OFF LABEL USE WITH NO ADVERSE DRUG REACTION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LINGUAL HEMATOMA,Haematoma,HAEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10018852
CRP INCREASED (18.8 MG/DL),C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
HEADACHE AND ACCOMPANYING AUTONOMIC SIGNS NOT ONLY HAD NEVER GONE COMPLETELY AWAY,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
LACK OF THERAPEUTIC EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LICHENOID DRUG ERUPTION,Drug eruption lichen planus-like,DRUG ERUPTION LICHEN PLANUS-LIKE,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10013690,10013687,10013690
LOST A CUMULATIVE FLUID OF ~35 L AND HIS BODY WEIGHT WAS 88 KG (IN 13 DAYS),fluid loss,FLUID LOSS,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10016802,10012174,10016802
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
RHABDOMYOLYSIS FOLLOWING LACTIC ACIDOSIS (BLOOD LACTATE 20 MMOL/L),Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
POSTERIOR SYNECHIAE,Iris adhesions,SYNECHIAE POSTERIOR,IRIS ADHESIONS,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","IRIS AND CILIARY BODY STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10036367,10022945,10062785
BLOOD IMMUNOGLOBULIN G DECREASED (5.2 G/L),Blood immunoglobulin G decreased,BLOOD IMMUNOGLOBULIN G DECREASED,BLOOD IMMUNOGLOBULIN G DECREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10005595,10005595,10005595
CUSHING SYNDROME FOLLOWING INTRA-ARTICULAR TRIAMCINOLONE ACETONIDE ADMINISTRATION,Cushingâ€™s syndrome,CUSHING'S SYNDROME,CUSHING'S SYNDROME,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011652,10011652,10011652
MARKED  INCREASE IN POSTPRANDIAL  SENSOR GLUCOSE LEVELS (NON-FASTING MAXIMUM SENSOR GLUCOSE LEVEL OF GREATER THAN 200 MG/DL),Hyperglycaemia,POSTPRANDIAL HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10075824,10020635,10075823
POSSIBLE HYPERSENSITIVITY VASCULITIS,hypersensitivity vasculitis,HYPERSENSITIVITY VASCULITIS,HYPERSENSITIVITY VASCULITIS,SKIN VASCULAR ABNORMALITIES,SKIN VASCULITIDES,10040785,10020764,10020764,10020764
PERSISTENT COUGHING,Cough,COUGHING,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011232
RENAL TUBULAR ACIDOSIS,Renal tubular acidosis,RENAL TUBULAR ACIDOSIS,RENAL TUBULAR ACIDOSIS,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10038535,10038535,10038535
BACK PAIN,Back pain,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003988,10003988,10003988
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,Acute generalised exanthematous pustulosis,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10048799
SWELLING FACE,Swelling face,SWELLING FACE,SWELLING FACE,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10042682,10042682,10042682
OLIGURIA (250 ML IN 12H),Oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
MELENA,Melena,MELENA,MELAENA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10027162,10027141,10027162
SKIN LESIONS OF EOSINOPHILIC ANULAR ERYTHEMA REAPPEARED ONCE AGAIN AFTER REDUCING THE PREDNISOLONE DOSE FOLLOWING REBOUND EFFECT,Erythema annulare,ERYTHEMA ANNULARE,ERYTHEMA ANNULARE,EPIDERMAL AND DERMAL CONDITIONS,PAPULOSQUAMOUS CONDITIONS,10040785,10015153,10015153,10015153
STAGE 2 BISPHOSPHONATE-RELATED JAW NECROSIS,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
RIGHT PUPIL WAS DILATED AND NOT REACTIVE TO LIGHT,Pupils dilated,PUPILS DILATED,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10037535,10028521,10037535
"PERSISTENT, PROGRESSIVE, AND PAINLESS VISION LOSS OF BOTH EYES",Vision loss,VISION LOSS,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047522,10005169,10047522
NO RESPONSE TO INTRAVENOUS IMMUNOGLOBULIN AND INTRAVENOUS METHYLPREDNISOLONE (LACK OF DRUG EFFFECT) WITH NO ADR,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
BRADYCARDIA TO THE 40'S,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
PERIFOVEAL INTERDIGITATION ZONE LOSS FOLLOWING HYDROXYCHLOROQUINE TOXICITY,Retinal disorder,RETINAL FOVEA DISORDER,RETINAL DISORDER,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10048896,10038853,10048896
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
HR INCREASED UP TO 120 BPM,heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
BLOOD PRESSURE INCREASED (155/88),Blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
HYPERGLYCAEMIA,Hyperglycaemia,HYPERGLYCAEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020635
ORAL METHOTREXATE WAS INEFFECTIVE AS WELL,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
REFLEXES ABSENT,Areflexia,REFLEXES ABSENT,AREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10003084,10003084,10038256
"SWOLLEN FACE/CHEEKS TO BE VISIBLY ENLARGED AND PUFFY, SUGGESTIVE OF A CUSHINGOID APPEARANCE",Cushingoid,CUSHINGOID FACIES,CUSHINGOID,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011656,10011655,10011656
TREMOR,tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
DENTAL COMPLICATIONS,Tooth disorder,DENTAL DISORDER NOS,TOOTH DISORDER,DENTAL AND GINGIVAL CONDITIONS,DENTAL DISORDERS NEC,10017947,10012322,10044034,10012322
FUNGAL INFECTIVE ENDOCARDITIS,Fungal endocarditis,FUNGAL ENDOCARDITIS,FUNGAL ENDOCARDITIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017529,10017529,10017529
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
METHADONE ABUSE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
WEIGHT LOSS ( 25 POUND),Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
AGRANULOCYTOSIS,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
AKATHISIA,Akathisia,AKATHISIA,AKATHISIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10001540,10001540,10001540
DEPRESSION,Depression,DEPRESSION,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012378,10012378,10012378
C-REACTIVE PROTEIN INCREASED (19.39 MG/DL),c-reactive protein increased (19.39 mg/dL),C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
AUTOIMMUNE HEPATITIS,autoimmune hepatitis,AUTOIMMUNE HEPATITIS,AUTOIMMUNE HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10003827,10003827,10003827
DOCETAXEL-INDUCED SCLERODERMA,Scleroderma,SCLERODERMA,SCLERODERMA,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),CONNECTIVE TISSUE DISORDERS NEC,10028395,10039710,10039710,10039710
RITUXIMAB USED TO TREAT ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
BONE MINERAL CONTENT DECREASED,Bone density decreased,BONE MINERAL CONTENT DECREASED,BONE DENSITY DECREASED,MUSCULOSKELETAL AND SOFT TISSUE INVESTIGATIONS (EXCL ENZYME TESTS),MUSCULOSKELETAL AND SOFT TISSUE IMAGING PROCEDURES,10022891,10059474,10049470,10059474
ARTERIAL HYPERTENSION,Hypertension arterial,HYPERTENSION ARTERIAL,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020775,10020772,10020775
CRACKED TEETH,Injury to teeth,INJURY TO TEETH,TOOTH INJURY,INJURIES NEC,SITE SPECIFIC INJURIES NEC,10022117,10022357,10044043,10022357
ANURIC DUE TO SEPTICEMIA FOLLOWING LISTERIA MONOCYTOGENES INFECTION,Anuria,ANURIA,ANURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10002847,10002847,10002847
"SHE HAD TRIED SEVERAL ANTIPSYCHOTIC MEDICATIONS AT ADEQUATE DOSES AND DURATION, ALL TO NO AVAIL",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
ACUTE PROFOUND CEREBELLAR SYNDROME SECONDARY TO LAMOTRIGINE TOXICITY CAUSED BY ESCITALOPRAM,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
THROMBOCYTOPENIA (LESS THAN 20K/MICROLITRE),Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
MYOPATHY,Myopathy,MYOPATHY,MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10028641,10028641,10028641
NEUTROPENIA GRADE 4,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ACUTE RENAL FAILURE,acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
WEIGHT GAIN,weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
LEFT-SIDED NASAL OBSTRUCTION,nasal obstruction,NASAL OBSTRUCTION,NASAL OBSTRUCTION,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10028748,10028748,10028748
DEHYDRATION,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
WANDERING ATRIAL PACEMAKER,Wandering pacemaker,WANDERING ATRIAL PACEMAKER,WANDERING PACEMAKER,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10047817,10047818,10047817
ATYPICAL NODULAR CUTANEOUS LUPUS MUCINOSIS DUE TO NON ADHERANCE OF PREDNISONE,Lichen myxoedematosus,PAPULAR MUCINOSIS,LICHEN MYXOEDEMATOSUS,EPIDERMAL AND DERMAL CONDITIONS,PAPULOSQUAMOUS CONDITIONS,10040785,10055087,10055046,10055087
ALTERED MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
ADMINISTRATION OF ONDANSETRON IN A PREGNANT WOMAN (DRUG EXPOSURE DURING FIRST TRIMESTER),Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, FIRST TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076617,10073513,10076617
MENINGOCOCCAL INFECTIONS PRESENTING AS SEPSIS,Meningococcal sepsis,MENINGOCOCCAL SEPSIS,MENINGOCOCCAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,NEISSERIA INFECTIONS,10021881,10027280,10027280,10027280
APATHIC,Apathy,APATHY,APATHY,MOOD DISORDERS AND DISTURBANCES NEC,MOOD DISORDERS NEC,10037175,10002942,10002942,10002942
STEROID INDUCED MYOPATHY,Myopathy,STEROID MYOPATHY,MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10028646,10028641,10042024
WORSENING OF DYSPNEA WITH RESPIRATORY FAILURE TYPE II,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
PROLONGED VENTRICULAR ASYSTOLE DUE TO DRUG INTERACTION,Ventricular asystole,VENTRICULAR ASYSTOLE,VENTRICULAR ASYSTOLE,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047284,10047284,10047284
PATIENT TREATED WITH DORZOLAMIDE HYDROCHLORIDE FOR CYSTOID MACULAR OEDEMA (OFF LABEL USE FOR INDICATION) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LOWER ABDOMINAL PAIN,lower abdominal pain,LOWER ABDOMINAL PAIN,ABDOMINAL PAIN LOWER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10024940,10000084,10024940
DEMENTIA,Dementia,DEMENTIA,DEMENTIA,MENTAL IMPAIRMENT DISORDERS,DEMENTIA (EXCL ALZHEIMER'S TYPE),10029205,10012267,10012267,10012267
INVASIVE PULMONARY ASPERGILLOSIS,Invasive bronchopulmonary aspergillosis,INVASIVE BRONCHOPULMONARY ASPERGILLOSIS,BRONCHOPULMONARY ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10022881,10006473,10022881
LAMIVUDINE RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
A TINY NODULE IN THE POSTERIOR SEGMENT OF RIGHT UPPER LUNG DUE TO CEREBRAL TOXOPLASMOSIS,a tiny nodule in the posterior segment of right upper lung due to cerebral toxoplasmosis,LUNG NODULE,PULMONARY MASS,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10049498,10056342,10049498
ITCHING MAINLY IN THE EVENING,Pruritus,ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023084,10037087,10023084
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,Inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
VANCOMYCIN-ASSOCIATED ACUTE KIDNEY INJURY WITH A STEEP RISE IN SERUM CREATININE,acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE EVENT IN SECOND CHILD OF MONOZYGOTIC TWIN,drug exposure during pregnancy first trimester,"DRUG EXPOSURE DURING PREGNANCY, FIRST TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076617,10073513,10076617
SINUS TACHYCARDIA,Sinus tachycardia,SINUS TACHYCARDIA,SINUS TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040752,10040752,10040752
QUININE POISONING,accidental poisoning,ACCIDENTAL POISONING,ACCIDENTAL POISONING,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10000383,10000383,10000383
WAS NO RESPONSE TO TREATMENT WITH OPIOIDS,no therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
OFF LABEL USE,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TRANSIENT ACUTE LEUKOENCEPHALOPATHY,Leukoencephalopathy,LEUKOENCEPHALOPATHY,LEUKOENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10024382,10024382,10024382
SQUAMOUS CELL CARCINOMA,Squamous cell carcinoma,SQUAMOUS CELL CARCINOMA,SQUAMOUS CELL CARCINOMA,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10041823,10041823,10041823
CUTANEOUS HYPERSENSITIVITY,hypersensitivity,HYPERSENSITIVITY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020751,10020751,10020751
HEMATOMA,Haematoma,HEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10019428
ASPARTATE AMINOTRANSFERASE INCREASED,Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
MENTAL AND MOTOR SLOWING,Movements reduced,MOVEMENTS REDUCED,HYPOKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028045,10021021,10028045
ECG SHOWED SINUS TACHYCARDIA,sinus tachycardia,SINUS TACHYCARDIA,SINUS TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040752,10040752,10040752
INTRAVASCULAR HEMOLYSIS FOLLOWING DISSEMINATED INTRAVASCULAR COAGULATION,Intravascular haemolysis,INTRAVASCULAR HEMOLYSIS,INTRAVASCULAR HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10022822,10022822,10060647
ABSCESS FORMATION NEAR AORTIC ROOT,abscess,ABSCESS,ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10000269,10000269,10000269
STOMAL VARICES HAEMORRHAGE,Bleeding varicose vein,BLEEDING VARICOSE VEIN,BLEEDING VARICOSE VEIN,VENOUS VARICES,VARICOSE VEINS NEC,10047065,10005144,10005144,10005144
SOMATOFORM AUTONOMIC DYSFUNCTION OF RESPIRATORY SYSTEM,Autonomic nervous system imbalance,AUTONOMIC DYSFUNCTION,AUTONOMIC NERVOUS SYSTEM IMBALANCE,NEUROMUSCULAR DISORDERS,AUTONOMIC NERVOUS SYSTEM DISORDERS,10029205,10049559,10003840,10049559
12-15 CM EXANTHEMA AROUND APPLICATION SITE,exanthema,EXANTHEMA,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015587,10037844,10015587
MEGALOMANIC BEHAVIOUR,behaviour disorder,BEHAVIOUR DISORDER,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004207,10061422,10004207
INTRACRANIAL COMPLICATIONS/ INTRACRANIAL COMPLICATIONS OF ANTICOAGULATION,Craniocerebral injury,INTRACRANIAL INJURY OF OTHER AND UNSPECIFIED NATURE,CRANIOCEREBRAL INJURY,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10022767,10070976,10022767
ANOMALY CONGENITAL,Congenital anomaly,ANOMALY CONGENITAL,CONGENITAL ANOMALY,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10010356,10010356,10002617
PATIENT WAS ADMINISTERED WITH MYCOPHENOLATE MOFETIL FOR AUTOIMMUNE GLIAL FIBRILLARY ACIDIC PROTEIN ASTROCYTOPATHY (OFF LABEL USE FOR INDICATION WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ITCHINESS,Pruritus,ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023084,10037087,10023084
SLIGHT ELEVATION OF CRP,CRP increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
GASTRIC OUTLET OBSTRUCTION FOLLOWING TRAMADOL ADDICTION DUE TO TRAMADOL ABUSE,gastric outlet obstruction,GASTRIC OUTLET OBSTRUCTION,OBSTRUCTION GASTRIC,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,GASTRIC AND PYLORIC STENOSIS AND OBSTRUCTION,10017947,10062499,10029957,10062499
HYPOGLOSSAL NERVE PALSY,Hypoglossal nerve paresis,HYPOGLOSSAL NERVE PARESIS,HYPOGLOSSAL NERVE PARESIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),HYPOGLOSSAL NERVE DISORDERS,10029205,10067129,10067129,10067129
CUTANEOUS GRAFT VERSUS HOST DISEASE,graft versus host disease in skin,GRAFT VERSUS HOST DISEASE IN SKIN,GRAFT VERSUS HOST DISEASE IN SKIN,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10064675,10064675,10064675
ORAL MUCOSAL INFECTION DUE TO HSV-1,Herpes simplex,HSV INFECTION,HERPES SIMPLEX,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10063570,10019948,10063570
EXERCISE INTOLERANCE,Exercise tolerance decreased,EXERCISE TOLERANCE DECREASED,EXERCISE TOLERANCE DECREASED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10051301,10051301,10051301
PERIVASCULAR INFILTRATES OF ATYPICAL LYMPHOCYTES IN THE EPIDERMIS AND SUBCUTANEOUS TISSUES,lymphocytic infiltration,LYMPHOCYTIC INFILTRATION,LYMPHOCYTIC INFILTRATION,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10062049,10062049,10062049
MUTISM,mutism,MUTISM,MUTISM,COMMUNICATION DISORDERS AND DISTURBANCES,COMMUNICATIONS DISORDERS,10037175,10028403,10028403,10028403
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
AIHA,Autoimmune haemolytic anaemia,AUTOIMMUNE HEMOLYTIC ANEMIA,AUTOIMMUNE HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC IMMUNE,10005329,10073785,10073785,10003825
RENAL INSUFFICIENCY,Renal failure,RENAL INSUFFICIENCY,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038474,10038435,10038474
REBOUND OF CALCIUM LEVELS,Calcium blood increased,CALCIUM BLOOD INCREASED,BLOOD CALCIUM INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10006952,10005396,10006952
LACK OF DRUG EFFECT,lack of drug effect,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
LOW WEIGHT FOR GESTATIONAL AGE,birth weight low,BIRTH WEIGHT LOW,LOW BIRTH WEIGHT BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10004958,10067508,10004958
SWELLING IN THE RIGHT STERNOCLAVICULAR JOINT,swelling in the right sternoclavicular joint,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
16 DAYS AFTER THE TREATMENT PATIENT FELT GENERALIZED MYALGIA,Polymyalgia,POLYMYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10036097,10028411,10036097
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
A MANIC EPISODE DEVELOPED IN THE PATIENT DESPITE HER COMPLIANCE WITH THE PHARMACOLOGIC TREATMENT/ ABSENCE OF CLINICAL IMPROVEMENT,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
EDEMA AND HYPEREMIA OF LEFT UPPER ARM IN DIAMETER OF 10X10/ PALPATORY PAINFULLY SENSITIVE,Inflammation,INFLAMMATION LOCALISED,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10021958,10061218,10021958
STEVENS-JOHNSON SYNDROME INDUCED BY SODIUM VALPROATE,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
NEUTROPENIA ON ERIBULIN,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
NECROSIS,necrosis,NECROSIS,NECROSIS,TISSUE DISORDERS NEC,NECROSIS NEC,10018065,10028851,10028851,10028851
TACHYCARDIC,Tachycardia ,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
PRURITIS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
PRIMARY RESISTANCE TO IMATINIB,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
NIFEDIPINE GIVEN FOR THREATENED PRETERM LABOR,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
NO ADVERSE DRUG REACTION,no adverse drug reaction,NO ADVERSE DRUG REACTION,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067481,10067482,10067481
MEROPENEM-INDUCED IMMUNE THROMBOCYTOPENIA,Meropenem-induced immune thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
OVERDOSE,overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
HIS PAIN TO BE UNRESPONSIVE TO CONVENTIONAL DRUG TREATMENT (LACK OF DRUG EFFECT FOR GABAPENTIN),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
DIARRHOEA (GRADE 1/PERSISTENT),diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
BLOOD GLUCOSE LEVEL DECREASED FREQUENTLY,Blood glucose decreased,BLOOD GLUCOSE DECREASED,BLOOD GLUCOSE DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10005555,10005555,10005555
FACIAL ERYTHEMA,Erythema,ERYTHEMA FACIAL,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015212,10015150,10015212
SEVERE CHRONIC LITHIUM INTOXICATION,Lithium toxicity,LITHIUM TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10050501,10070863,10050501
BLANCHING ERYTHEMA OF THE TRUNK AND ARMS,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
SIGMOID DIVERTICULAR PERFORATION,Diverticular perforation,DIVERTICULAR PERFORATION,DIVERTICULAR PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,"GASTROINTESTINAL ULCERS AND PERFORATION, SITE UNSPECIFIED",10017947,10061820,10061820,10061820
BRADYCARDIA,bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,posterior reversible encephalopathy syndrome,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10071066,10071066,10071066
PETECHIAE ON THE WHOLE BODY,Petechiae,PETECHIAE,PETECHIAE,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10034754,10034754,10034754
HEMORRHAGIC SHOCK,Shock haemorrhagic,HEMORRHAGIC SHOCK,SHOCK HAEMORRHAGIC,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10049771,10049771,10050841
RESPIRATORY FAILURE DUE TO PNEUMOTHORAX,respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
SINUS TACHYCARDIA (HEART RATE 160 BEATS PER MINUTE),Sinus tachycardia,SINUS TACHYCARDIA,SINUS TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040752,10040752,10040752
POLYNEUROPATHY,Polyneuropathy,POLYNEUROPATHY,POLYNEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10036105,10036105,10036105
LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
URINARY INCONTINENCE/INCREASED URINARY FREQUENCY Q20-30 MIN,urinary incontinence,URINARY INCONTINENCE,URINARY INCONTINENCE,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046543,10046543,10046543
NEUTROPENIA,neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ORTHOSTATIC LIGHTHEADEDNESS,lightheadedness,LIGHTHEADEDNESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10024492,10013573,10024492
LUPUS LIKE REACTION IN IMIQUIOD TREATED SKIN,Lupus-like syndrome,LUPUS-LIKE SYNDROME,LUPUS-LIKE SYNDROME,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),LUPUS ERYTHEMATOSUS (INCL SUBTYPES),10028395,10050551,10050551,10050551
"HER PROBLEMS WERE NOT CHANGING, THUS THEY WERE APPEARING MORE OFTEN",Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
PAINFUL ULCERATIONS TO HER ORAL AND GENITAL MUCOSA,mucosal ulceration,MUCOSAL ULCERATION,MUCOSAL ULCERATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028124,10028124,10028124
INCREASING DIFFICULTY URINATING,Dysuria,URINATION DIFFICULTY,DYSURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10013990,10013990,10046599
GENERALIZED PRURITUS,Pruritus generalised,GENERALIZED PRURITUS,PRURITUS GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10052576,10052576,10018123
BODY TEMPERATURE INCREASED,body temperature increased,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10005911
SYMPTOMS BECAME POORLY CONTROLLED ON ORAL DOPAMINERGIC THERAPY,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
EXTRAPYRAMIDAL SIDE-EFFECTS OF RISPERIDONE,Extrapyramidal disorder,EXTRAPYRAMIDAL SYMPTOMS,EXTRAPYRAMIDAL DISORDER,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10015835,10015832,10015835
PHLEBITIS,Phlebitis,PHLEBITIS,PHLEBITIS,VASCULAR INFLAMMATIONS,PHLEBITIS NEC,10047065,10034879,10034879,10034879
SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
LOCAL UROGENITAL MANIFESTATION. PATIENT WITH ST.P. TUR-B AND EVIDENCE OF PT1 HIGH GRADE (G3) TUMOR,Bladder cancer,BLADDER CANCER,BLADDER CANCER,RENAL AND URINARY TRACT NEOPLASMS MALIGNANT AND UNSPECIFIED,BLADDER NEOPLASMS MALIGNANT,10029104,10005003,10005003,10005003
DID NOT RESPOND TO THE LEVETIRACETAM,drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
LYMPHADENOPATHY,lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
SEVERE LIVER IMPAIRMENT,severe liver impairment,HEPATIC IMPAIRMENT,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10052254,10019670,10052254
TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
"MILD PERIPORTAL FIBROSIS, GRADE II, STAGE II",Hepatic fibrosis,HEPATIC FIBROSIS,HEPATIC FIBROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10019668,10019668,10019668
BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
WARFARIN-RELATED NEPHROPATHY,Nephropathy,NEPHROPATHY,NEPHROPATHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10029151,10029151,10029151
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
ATYPICAL FEMORAL FRACTURE,Atypical femur fracture,ATYPICAL FEMUR FRACTURE,ATYPICAL FEMUR FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10070884,10070884,10070884
ELEVATED ASPARTATE AMINOTRANSFERASE (324 U/L),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
RENAL PHOSPHORUS WASTING,Hyperphosphaturia,HYPERPHOSPHATURIA,HYPERPHOSPHATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10051232,10051232,10051232
FEVER ABOVE 39 DEGREES C WITHOUT EVIDENCE OF INFECTION,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
CREATININE CLEARANCE DECREASED,Creatinine renal clearance decreased,CREATININE CLEARANCE DECREASED,CREATININE RENAL CLEARANCE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011363,10011372,10011363
PAIN IN THE CHEST,Pain chest,PAIN CHEST,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033387,10008479,10033387
LIGHTHEADEDNESS,Dizziness,LIGHTHEADEDNESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10024461,10013573,10024492
COGNITIVE IMPAIRMENT,Cognitive disorder,COGNITIVE IMPAIRMENT,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10057668,10057668,10009846
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
EPIGASTRIC PAIN,Abdominal pain upper,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
POLYPNEIA,Polypnea,POLYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10058232,10043089,10058232
GASTROINTESTINAL SYMPTOMS,Gastrointestinal disorder,GASTROINTESTINAL SYMPTOM NOS,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10018011,10017944,10018011
ACUTE WORSENING OF LOWER EXTREMITY WEAKNESS,Muscular weakness,LOWER EXTREMITIES WEAKNESS OF,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10024947,10028372,10024947
FEVER,Fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
ROTAVIRUS INFECTION,Rotavirus infection,ROTAVIRUS INFECTION,ROTAVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,ROTAVIRAL INFECTIONS,10021881,10067470,10067470,10067470
UREA 203 MG/DL,Blood urea increased,UREA HIGH,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10046352,10005851,10046352
 46.0 ng/ml,2018-09-19,1,,,,THERAPEUTIC DRUG MONITORING ANALYSES,10013722,10013722,
"PREGABALIN WAS 32 MG/L (APPROXIMATE CONCENTRATION, NOT DETERMINED ACCURATELY AS THE CONCENTRATION FELL MARGINALLY ABOVE THE CALIBRATION RANGE)",Drug level increased,DRUG LEVEL IN BLOOD INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013721,10013722,10013721
BILATERAL PULMONARY INFILTRATES,Bilateral pulmonary infiltrates,BILATERAL PULMONARY INFILTRATES,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10070790,10025102,10070790
OEDEMA (IN HINDSIGHT LIKELY DUE TO THE CALCIUM CHANNEL BLOCKER),Oedema,OEDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10030095
DIURETIC-INDUCED ORTHOSTATIC HYPOTENSION,Orthostatic hypotension,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10031127,10031127,10031127
"DRUG INEFFECTIVE OLMESARTAN, DULOXETINE, PANTOPRAZOL AND FUROSEMIDE",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
CONFUSION,confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
COMPRESSED THE SPINAL CORD TO ITS LEFT DUE TO GRANULOMA,Spinal cord compression,SPINAL CORD COMPRESSION,SPINAL CORD COMPRESSION,SPINAL CORD AND NERVE ROOT DISORDERS,SPINAL CORD AND NERVE ROOT DISORDERS NEC,10029205,10041549,10041549,10041549
VA BLOCK,atrioventricular block,ATRIOVENTRICULAR BLOCK,ATRIOVENTRICULAR BLOCK,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10003671,10003671,10003671
ANAPHYLAXIS,anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
FATAL ACUTE-ON-CHRONIC PROPRANOLOL INGESTION/ SUICIDE BY PROPRANOLOL INTOXICATION,Completed suicide,SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042462,10010144,10042462
SWELLING OF JOINTS,swelling of joints,JOINT SWELLING,JOINT SWELLING,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023232,10023232,10023232
BIBASILAR RALES,Rales,RALES,RALES,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10037833,10037833,10037833
HIS SYMPTOMS PERSISTED FOR 2 WEEKS DESPITE USE OF ACETAMINOPHEN,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
COMPLETE THROMBOSIS OF THE STENT,Vascular stent thrombosis,STENT THROMBOSIS,VASCULAR STENT THROMBOSIS,COMPLICATIONS ASSOCIATED WITH DEVICE,VASCULAR COMPLICATIONS ASSOCIATED WITH DEVICE,10018065,10076859,10063934,10076859
XANTHOGRANULOMATOUS PYELONEPHRITIS,Xanthogranulomatous pyelonephritis,XANTHOGRANULOMATOUS PYELONEPHRITIS,PYELONEPHRITIS CHRONIC,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10074389,10037601,10074389
AUDITORY HALLUCINATION,"Hallucination, auditory",AUDITORY HALLUCINATIONS,"HALLUCINATION, AUDITORY",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019070,10019070,10003785
EROSIONS ON THE GLANS OF THE PENIS,Mucosal erosion,MUCOSAL EROSION,MUCOSAL EROSION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10061297,10061297,10061297
LDH INCREASED (1046.4U/L),Blood lactate dehydrogenase increased,LDH INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10024051,10005630,10024051
SUSTAINED TACHYCARDIA PERSISTED UNTIL 35 WEEKS,Lack of drug effect ,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
"INSUFFICIENT SOURCE CONTROL DESPITE MONTHS OF ANTIFUNGAL THERAPY, EVENTUALLY RESULTING IN ASPLENECTOMY",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
INTOXICATION DUE TO THE USE OF ADULTERANT COCAINE (LEVAMISOLE AND HYDROXYZINE),intoxication,INTOXICATION,POISONING,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10022727,10061355,10022727
INTOLERANT TO AZATHIOPRINE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
PARADOXICAL EFFECT WITH ANXIETY ATTACKS,paradoxical drug reaction,PARADOXICAL DRUG REACTION,PARADOXICAL DRUG REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048958,10048958,10048958
DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
PARTIAL REMISSION BECAUSE OF BORTEZOMIB,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
EPSTEIN-BARR VIRUS-ASSOCIATED B-CELL LYMPHOPROLIFERATIVE DISORDER OF THE SKIN,Epstein-Barr virus associated lymphoproliferative disorder,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10068349,10068349,10068349
"DIAROHEA WAS NOT RESPONDING TO METRONIDAZOLE, LOPERAMIDE,ORNIDAZOLE, RIFAXIMIN",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
A CASE OF DEATH ASSOCIATED WITH CHLORPROMAZINE AGRANULOCYTOSIS/AGRANULOCYTOSIS AND CHLORPROMAZINE,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
RIGHT BUNDLE-BRANCH  BLOCK,Right bundle branch block,RIGHT BUNDLE BRANCH BLOCK,BUNDLE BRANCH BLOCK RIGHT,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10039147,10006582,10039147
OEDEMA,oedema,OEDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10030095
"INVASIVE VASCULAR GROWTH, AS WELL AS DISSEMINATION TO THE BRAIN",Cerebral aspergillosis,CEREBRAL ASPERGILLOSIS,CEREBRAL ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10051597,10051597,10051597
LEFT LOWER EXTREMITY WEAKNESS,Muscular weakness,WEAKNESS IN EXTREMITY,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10047868,10028372,10065702
BONE MARROW DEPRESSION,bone marrow depression,BONE MARROW DEPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10005986
SECONDARY ACUTE RENAL FAILURE,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
CHOLESTATIC AND LIVER DAMAGE,Cholestatic liver injury,CHOLESTATIC LIVER INJURY,CHOLESTATIC LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067969,10067969,10067969
LITHIUM-INDUCED END STAGE RENAL DISEASE,End stage renal disease,END STAGE RENAL DISEASE,END STAGE RENAL DISEASE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10077512,10077512,10077512
ULCERATED LESIONS IN BASIS OF PENIS,Penile ulceration,ULCERATION AROUND PENIS,PENILE ULCERATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10045347,10034322,10045347
"AGRANULOCYTOSIS PROGRESSED FROM LOCAL TO SYSTEMIC WITH SEPTIC SHOCK AND MULTI-ORGAN FAILURE (RENAL DYSFUNCTION, LIVER DYSFUNCTION, PLATELET DYSFUCTION)",septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
ACUTE MATERNAL INTOXICATION,acute maternal intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
HEMOGLOBIN DECREASED (6.3 G/DL),Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
COLONIC ADENOCARCINOMA/ MUCINOUS ADENOCARCINOMA,mucinous adenocarcinoma of colon,MUCINOUS ADENOCARCINOMA OF COLON,ADENOCARCINOMA OF COLON,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,COLORECTAL NEOPLASMS MALIGNANT,10029104,10073374,10001167,10073374
HEPATIC ENCEPHALOPATHY,Hepatic encephalopathy,HEPATIC ENCEPHALOPATHY,HEPATIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10019660,10019660,10019660
DISSEMINATED PAPULOERYTHEMATOUS DRUG ERUPTION,Drug eruption,PAPULOERYTHEMATOUS DRUG ERUPTION,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058163,10013687,10058163
BONE INFECTION (BACTERIAL),osteomyelitis,OSTEOMYELITIS,OSTEOMYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,BONE AND JOINT INFECTIONS,10021881,10031252,10031252,10031252
ASYMMETRIC DEEP TENDON REFLEXES DECREASED,Reflexes decreased,REFLEXES DECREASED,HYPOREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10038257,10021089,10038257
DRUG NON-COMPLIANCE,Inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
ANEMIA,anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
RAPIDLY DEVELOPING BLISTERING EXANTHEMA OF PURPURIC MACULES,Blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
PERSISTANT BLOODY VAGINAL DISCHARGE,persistant bloody vaginal discharge,BLOODY VAGINAL DISCHARGE,VAGINAL HAEMORRHAGE,VULVOVAGINAL DISORDERS (EXCL INFECTIONS AND INFLAMMATIONS),VULVOVAGINAL DISORDERS NEC,10038604,10049851,10046910,10049851
VERY LETHARGIC,Lethargy,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024262
ACUTE SYSTOLIC HEART FAILURE EXACERBATION,acute systolic heart failure,ACUTE SYSTOLIC HEART FAILURE,ACUTE LEFT VENTRICULAR FAILURE,HEART FAILURES,LEFT VENTRICULAR FAILURES,10007541,10077979,10063081,10077979
BLOOD GLUCOSE WAS OUT OF NORMAL RANGE,Blood glucose abnormal,BLOOD GLUCOSE ABNORMAL,BLOOD GLUCOSE ABNORMAL,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10005554,10005554,10005554
ALT ELEVATION,Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
PURPURIC ERUPTION WITH VASCULITIC LESIONS OF THE EXTREMITIES,purpura,PURPURA,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037549,10037549,10037549
GENERAL MALAISE,Malaise,GENERAL MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10018066,10025482,10018066
OSTEOPENIA,Osteopenia,OSTEOPENIA,OSTEOPENIA,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10049088,10049088,10049088
VIROLOGICAL FAILURE DUE TO DRUG RESISTANCE TO EMTRICITABINE AND TENOFOVIR FOLLOWING DRUG EXPOSURE DURING PREGNANCY,Virologic failure,VIROLOGIC FAILURE,VIROLOGIC FAILURE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10065648,10065648,10065648
MOTHER UNDER MTD MAINTENANCE THERAPY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
GRADE2 HEMATOLOGICAL TOXICITY,Hematotoxicity,HEMATOTOXICITY,HAEMATOTOXICITY,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10061196,10061188,10061196
WIDESPREAD RASH,Rash generalised,WIDESPREAD RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10047984,10037858,10047984
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
DIFFUSE STRIAE DISTENSAE,diffuse striae distensae,STRIAE DISTENSAE,SKIN STRIAE,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,SKIN HYPOPLASIAS AND ATROPHIES,10040785,10057065,10040925,10057065
REPERCUSSIONS,Quality of life decreased,QUALITY OF LIFE DECREASED,QUALITY OF LIFE DECREASED,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",INVESTIGATIONS NEC,10022891,10067620,10067620,10067620
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
DID NOT TOLERATE METFORMIN,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
GENERALIZED MACULOPAPULAR EXANTHEMA,Rash maculo-papular,MACULO-PAPULAR EXANTHEMA,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10049195,10037868,10049195
OCCUPATIONAL ALLERGIC CONTACT DERMATITIS FOLLOWING DRUG CROSS-REACTIVITY,allergic contact dermatitis,ALLERGIC CONTACT DERMATITIS,DERMATITIS CONTACT,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10056265,10012442,10056265
ACUTE MYOPATHY FOLLOWING DRUG INTERACTION,Myopathy,ACUTE MYOPATHY,MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10066646,10028641,10066646
HYPERSENSITIVITY-RELATED SKIN TOXICITY,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
MELAENA,Haemorrhage,HAEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10055798
"MIXED PRESCRIBED DRUG INTERACTION (ACCESS TO: METHADONE, CODEINE, FLUOXETINE, PREGABALIN,
AMITRIPTYLINE AND DIAZEPAM)",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
MYCOPHENOLATE MOFETIL USED FOR GIVEN INDICATION (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BRAIN COMPUTED TOMOGRAPHY SHOWED MICROVASCULAR ISCHAEMIA,Cerebral ischaemia,ISCHEMIA CEREBROVASCULAR,CEREBRAL ISCHAEMIA,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10055750,10008120,10023030
TSUKAMURELLA INCHONENSIS INFECTION FOLLOWING OFF LABEL USE,Bacterial infection,GRAM-POSITIVE BACTERIAL INFECTION,BACTERIAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10053021,10060945,10053021
FAILED IN MANAGEMENT OF COMPLEX REGIONAL PAIN SYNDROME,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PERSISTENT VISUAL DISTURBANCES,Visual disturbances,VISUAL DISTURBANCES,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047545,10047571,10047545
DELAYED ALLOGRAFT FUNCTION,delayed graft function,DELAYED GRAFT FUNCTION,DELAYED GRAFT FUNCTION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10076664,10076664,10076664
STEROID MYOPATHY,Myopathy,MYOPATHY STEROID-INDUCED,MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10028647,10028641,10028647
RIGHT UPPER QUADRANT TENDERNESS,Abdominal tenderness,ABDOMINAL TENDERNESS,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000097,10000097,10000097
ASPERGILLIUS ANTIGENEMIA AND FUMIGATUS INFECTION,Aspergillus infection,ASPERGILLUS INFECTION,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10074171,10074171,10074171
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
SEPTIC SHOCK FOLLOWING LACK OF DRUG EFFECT,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
DRESS SYNDROME INDUCED BY VALPROATE,DRESS syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
HYPERPIGMENTATION/POST VACCINATION LOCAL REACTIONS,Injection site discolouration,INJECTION SITE HYPERPIGMENTATION,INJECTION SITE DISCOLOURATION,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022070,10051572,10022070
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
METFORMIN OVERDOSE,Drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
BIPOLAR MOOD DISORDER,Bipolar disorder,BIPOLAR DISORDER,BIPOLAR DISORDER,MANIC AND BIPOLAR MOOD DISORDERS AND DISTURBANCES,BIPOLAR DISORDERS,10037175,10057667,10057667,10057667
EOSINOPHILIC MASTITIS,Mastitis,MASTITIS,MASTITIS,INFECTIONS - PATHOGEN UNSPECIFIED,BREAST INFECTIONS,10021881,10026883,10026883,10026883
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
"RESISTANCE (M41L, K70R, L210W, T215Y AND M184V) CONFERRING RESISTANCE TO FTC AND POSSIBLE RESISTANCE TO TFV",Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
"VISUAL HALLUCINATIONS, NAUSEA, VOMITING, CONSTIPATION, FLATULENCE, DIARRHEA, ABDOMINAL SWELLING, TREMORS, INCREASED PULSE RATE, DECREASED URINATION AND WEIGHT LOSS (+/- 6 KG)",flatulence,FLATULENCE,FLATULENCE,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10016766,10016766,10016766
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
CREATININE CLEARANCE LESS THAN 15 ML/MIN,Creatinine renal clearance decreased,CREATININE CLEARANCE DECREASED,CREATININE RENAL CLEARANCE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011363,10011372,10011363
SWELLING AT INCISION SITE,Swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
TACHYCARDIC,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
CHEST RADIOGRAPH SHOWED BILATERAL OPACITIES AND COMPUTERIZED TOMOGRAPHY RELVEALED EXTENSIVE AND DIFFUSE LUNG GROUND-GLASS OPACITIES,Computerised tomogram thorax abnormal,GROUND GLASS OPACITY IN THORACIC CT,COMPUTERISED TOMOGRAM THORAX ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10072879,10057799,10072879
SMALL HEAD CIRCUMFERENCE/MICROCEPHALY,Microcephaly,MICROCEPHALY,MICROCEPHALY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS OF SKULL CONGENITAL,10010331,10027534,10027534,10027534
INCREASING EXCRUCIATING PAIN,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
PATIENT FAILED TO RESPOND TO PEMETREXED (LACK OF DRUG EFFECT) WITH NO ADVERSE EVENT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
BULLOUS DRUG ERUPTION/ BULLOUS DRUG ERUPTION WITH LEUKEMIC CELL INFILTRATE,bullous eruption,BULLOUS ERUPTION,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006559,10012441,10006559
DIVALPROEX WAS SUCCESSFULLY USED IN A 7-YEAR-OLD BOY SUFFERING FROM TREATMENT-REFRACTORY SCHOOL REFUSAL,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
BICLUTAMIDE-ASSOCIATED ACUTE LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
SOFTER TO LIQUID BOWEL MOMENTS MORE THAN THREE TIMES A DAY,softer to liquid bowel moments more than three times a day,SOFT STOOLS,FAECES SOFT,GASTROINTESTINAL SIGNS AND SYMPTOMS,FAECAL ABNORMALITIES NEC,10017947,10048838,10074859,10048838
TYPICAL CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
LIP EROSION,Lip erosion,LIP EROSION,LIP EROSION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10051992,10051992,10051992
FIXED DRUG REACTION,Fixed eruption,FIXED DRUG ERUPTION,FIXED ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10016740,10016741,10016740
RECURRENT METRONIDAZOLE-INDUCED PANCREATITIS,Pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
FINE-GRAINED MACULOPAPULAR RASH PARTIALLY TRANSFERRED TO CHEEKS AND EXTREMITIES,Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
BILATERAL HEARING LOSS DUE TO CHRONIC ENTEROVIRAL MENINGOENCEPHALITIS FOLLOWING HYPOGAMMAGLOBULINEMIA (IG LEVELS 418 MG/DL),Deafness bilateral,HEARING LOSS BILATERAL,DEAFNESS BILATERAL,HEARING DISORDERS,HEARING LOSSES,10013993,10052556,10052556,10057844
PAIN AGGRAVATION,Pain,PAIN AGGRAVATED,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033396,10033371,10033376
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
KIDNEY RUPTURE WITH BLEEDING INTO RETROPERITONEUM,kidney rupture,KIDNEY RUPTURE,KIDNEY RUPTURE,INJURIES NEC,RENAL AND URINARY TRACT INJURIES NEC,10022117,10023434,10023434,10023434
CT NECK WAS SUGGESTIVE OF THYROID ABSCESS,Thyroid gland abscess,THYROID GLAND ABSCESS,THYROID GLAND ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10051878,10051878,10051878
COGNITIVE BEHAVIOUR,cognitive disorder,COGNITIVE DISORDER,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10057668,10057668,10057668
ARRHYTHMIA,Arrhythmia,ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10003119
SEVERE MOBILE NODULES (DIAMETER 5MM) IN THE RADIATION FIELD AREA,nodule,NODULE,NODULE,TISSUE DISORDERS NEC,MASS CONDITIONS NEC,10018065,10054107,10054107,10054107
CD30+ LYMPHOPROLIFERATIVE DISORDER OF THE SKIN,Lymphoproliferative disorder,LYMPHOPROLIFERATIVE DISORDER,LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10061232,10061232,10061232
SWELLING OF LIPS,Lip swelling,SWELLING OF LIPS,LIP SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10024570,10024570,10042703
SECOND PATIENT DEVELOPED WORSENING CYANOSIS IN THE SETTING OF AN ENLARGING ILIOFEMORAL THROMBUS,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
SENSORY LEVEL ABNORMAL,Sensory level abnormal,SENSORY LEVEL ABNORMAL,SENSORY LEVEL ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10061567,10061567,10061567
CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY,Chemotherapy induced peripheral neuropathy,CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10079545,10029331,10079545
C-REACTIVE PROTEIN (CRP) OF 1.29 MG/L,C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
PARTIAL IMMOBILITY,Immobile,IMMOBILE,IMMOBILE,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10021417,10021417,10021417
MIXED ACUTE CARDIAC ALLOGRAFT REJECTION FOLLOWED BY LACK OF DRUG EFFECT,Heart transplant rejection,HEART TRANSPLANT REJECTION,HEART TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10019315,10019315,10019315
ANTIEPILEPTIC DRUGS WERE NOT TOLERATED,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
AMNESTIC APHASIA,Aphasia,AMNESTIC APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10054194,10002948,10054194
SYMMETRICAL HIGH SIGNAL INTENSITY LESION IN BILATERAL BASAL GANGLIA IN BRAIN MRI DUE TO CHOREA DUE TO STEROID INDUCED HYPERGLYCEMIA,Nuclear magnetic resonance imaging brain abnormal,BASAL GANGLIA MRI SIGNAL CHANGES,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CENTRAL NERVOUS SYSTEM IMAGING PROCEDURES,10022891,10079655,10029818,10079655
SIRS,Systemic inflammatory response syndrome,SIRS,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10062357,10051379,10062357
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
DRUG-INDUCED ASEPTIC MENINGITIS,Aseptic meningitis,ASEPTIC MENINGITIS,MENINGITIS ASEPTIC,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10003458,10027201,10003458
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
WEAKNESS,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
SEVERE NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
SEROMA CLASSIFIED SURGICAL WOUND INFECTION WITH ESCHERICHIA COLI,Escherichia coli infection,ESCHERICHIA COLI INFECTION,ESCHERICHIA INFECTION,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10054242,10061126,10054242
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
"A PHARMACODYNAMIC INTERACTION BETWEEN CLOPIDOGREL AND HEPARIN IS POSSIBLE, LEADING TO INCREASED RISK OF BLEEDING.",Drug interaction,DRUG-DRUG PHARMACODYNAMIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10065993,10013710,10065993
ASPIRATION PNEUMONITIS,Pneumonia aspiration,ASPIRATION PNEUMONITIS,PNEUMONIA ASPIRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10003526,10035669,10003526
"LICHENOID PLAQUES ON FACE, THE NECK, CLEAVAGE AND ARMS",Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
SIGNIFICANT ARTHRALGIA,Arthralgia,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
THYREOTOXICOSIS WITH TRACK POSITIVITY FOLLOWING LEMTRADA THERAPY,Hyperthyroidism,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
IFOSFAMIDE-INDUCED ENCEPHALOPATHY,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
OFF LABEL USE,OFF LABEL USE,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
VERTICAL GAZE PALSY,Gaze palsy,GAZE PALSY,GAZE PALSY,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10056696,10056696,10056696
CHEMOTHERAPY INDUCED NAUSEA AND VOMITING,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
POTENTIAL INTERACTION BETWEEN THESE 2 DRUGS MAY HAVE PRECIPITATED CSE IN OUR PTS/DRUG INTERACTION (BACLOFEN AND DALFAMPRIDINE),Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
HIGH GRADE FEVER,high grade fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
COMA,coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
BONE MARROW DEPRESSION,Bone marrow failure,BONE MARROW DEPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10005986
VARICOSE VEIN OPERATION,varicose vein operation,VARICOSE VEIN OPERATION,VARICOSE VEIN OPERATION,VASCULAR THERAPEUTIC PROCEDURES,VENOUS THERAPEUTIC PROCEDURES,10042613,10062168,10062168,10062168
EPSTEINâ€“BARR VIRUS REACTIVATION,Epstein-Barr virus infection reactivation,EPSTEIN-BARR VIRUS INFECTION REACTIVATION,EPSTEIN-BARR VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,EPSTEIN-BARR VIRAL INFECTIONS,10021881,10015109,10015108,10015109
MACULOPAPULAR RASH,maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
GENERALIZED ERYTHEMA,Generalized erythema,GENERALIZED ERYTHEMA,GENERALISED ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10062433,10051576,10062433
DIABETIC GLOMERULOSCLEROSIS,Intercapillary glomerulosclerosis,DIFFUSE DIABETIC GLOMERULOSCLEROSIS,INTERCAPILLARY GLOMERULOSCLEROSIS,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10012814,10022530,10012814
BLURRED VISION,Vision blurred,BLURRED VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047513,10047513,10005886
PULMONARY FUNCTION RAPIDLY DETERIORATED WITHIN 50 MINUTES FROM THE MOMENT OF HOSPITAL,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
METHOTREXATE USED FOR TREATMENT OF SARCOIDOSIS,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
DRUG-DRUG INTERACTIONS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
DETERIORATION OF RENAL FUNCTION,Renal function abnormal,RENAL FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038451,10062237,10038451
ACUTE KIDNEY FAILURE,Acute kidney failure,ACUTE KIDNEY FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10000821,10069339,10000821
PURPURA,Purpura,PURPURA,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037549,10037549,10037549
HAD TRIVIAL FALL FOLLOWING BILATERAL ATYPICAL ULNAR FRACTURES,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
DRUG-INDUCED IMMUNE THROMBOCYTOPENIA,Immune thrombocytopenic purpura,AUTOIMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10050245,10074667,10050245
RISPERIDONE (3 MG/D) WAS PRESCRIBED BUT DISCONTINUED AFTER 2 WEEKS BECAUSE OF WORSENING OF RLS. INDEED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
MULTIPLE DRUG OVERDOSE PRESCRIBED,Prescribed overdose,MULTIPLE DRUG OVERDOSE PRESCRIBED,PRESCRIBED OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10062765,10051076,10062765
ORTHOSTATIC HYPOTENSION,Orthostatic hypotension,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10031127,10031127,10031127
EYE DISCHARGE,Eye discharge,EYE DISCHARGE,EYE DISCHARGE,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10015915,10015915,10015915
TACHYPNEA,tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
POSTOPERATIVE WAKE UP DELAY,Unconscious,UNCONSCIOUS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10045479,10024855,10045479
TROPONIN INCREASED,Troponin increased,TROPONIN INCREASED,TROPONIN INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10058267,10058267,10058267
OVARIAN SUPPRESSION FAILURE DUE TO THE TREATMENT FAILURE,Ovarian failure,OVARIAN FAILURE,OVARIAN FAILURE,OVARIAN AND FALLOPIAN TUBE DISORDERS,OVARIAN AND FALLOPIAN TUBE DISORDERS NEC,10038604,10033165,10033165,10033165
MUSCLE TONE DECREASED,Muscle tone decreased,MUSCLE TONE DECREASED,HYPOTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10028344,10021118,10028344
INCREASE IN FASTING BLOOD GLUCOSE,Fasting blood glucose increased,FASTING BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10050786,10005557,10050786
HYDROXYCHLOROQUINE INDUCED CONGESTIVE HEART FAILURE/CARDIOMYOPATHY/CARDIAC TOXICITY,Cardiomyopathy,CARDIOMYOPATHY,CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10007636,10007636,10007636
ACUTE ISCHEMIC LESION WAS OBSERVED AT LEFT POSTERIOR INFERIOR CEREBELLAR ARTERY AT CEREBELLUM WITH ADDITIONAL LESION AT LEFT LATERAL MEDULLA DUE TO CERVICAL ARTERY DISSECTION AND VERTEBRAL ARTERY DISSECTION,acute ischemic lesion was observed at left posterior inferior cerebellar artery at cerebellum with additional lesion at left lateral medulla due to cervical artery dissection and vertebral artery dissection,ISCHEMIA,ISCHAEMIA,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10054438,10061255,10054438
HEPATITIS ACUTE,Hepatitis acute,HEPATITIS ACUTE,HEPATITIS ACUTE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019727,10019727,10019727
SPIKING FEVER,spiking fever,FEVERISH,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10073718,10037660,10073718
URINARY URGENCY,Micturition urgency,URINARY URGENCY,MICTURITION URGENCY,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10027566,10027566,10046593
LIMITING SELF-CARE ACTIVITIES OF DAILY LIFE,Loss of personal independence in daily activities,ACTIVITIES OF DAILY LIVING IMPAIRED,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10050954,10079487,10050954
MILDLY ATAXIC,ataxic,ATAXIC,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003596,10003591,10003596
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SYSTEMIC IMMUNOSUPPRESSION WITH MYCOPHENOLATE MOFETIL IN A 1 MONTH OLD PATIENT (DRUG USE IN UNAPPROVED POPULATION WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
IN A STATE OF DEEP SHOCK/HYPOVOLEMIC SHOCK,Hypovolemic shock,HYPOVOLEMIC SHOCK,HYPOVOLAEMIC SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10021140,10021138,10021140
LIVER FAILURE DUE TO MINOCYCLINE-INDUCED HEPATITIS,Hepatic failure,LIVER FAILURE,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10019663,10019663,10024678
MYELOPATHY FOLLOWING INTRATHECAL CHEMOTHERAPY,Myelopathy,MYELOPATHY,MYELOPATHY,SPINAL CORD AND NERVE ROOT DISORDERS,SPINAL CORD AND NERVE ROOT DISORDERS NEC,10029205,10028570,10028570,10028570
TREATMENT TOXICITY,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
MELENA,Melaena,MELENA,MELAENA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10027141,10027141,10027162
LIP SWELLING,Lip swelling,LIP SWELLING,LIP SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10024570,10024570,10024570
FASCICULATION,fasciculation,FASCICULATION,MUSCLE CONTRACTIONS INVOLUNTARY,NEUROMUSCULAR DISORDERS,NEUROMUSCULAR DISORDERS NEC,10029205,10016225,10028293,10016225
CHEST PAIN,chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
POVIDONE-IODINE INGESTION,accidental exposure to product,ACCIDENTAL INGESTION OF PRODUCT,ACCIDENTAL EXPOSURE TO PRODUCT,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,ACCIDENTAL EXPOSURES TO PRODUCT,10022117,10073320,10073317,10073320
HEMATOMA IN THE SITE OF INJECTION,Injection site haematoma,HEMATOMA INJECTION SITE,INJECTION SITE HAEMATOMA,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022066,10022066,10019432
CUTANEOUS LICHEN PLANUS,Lichen planus,LICHEN PLANUS,LICHEN PLANUS,EPIDERMAL AND DERMAL CONDITIONS,PAPULOSQUAMOUS CONDITIONS,10040785,10024429,10024429,10024429
LDH INCREASED ( 5540 U/L),Blood lactate dehydrogenase increased,LDH INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10024051,10005630,10024051
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
HELICOBACTER PYLORI INFECTION,Helicobacter infection,HELICOBACTER PYLORI INFECTION,HELICOBACTER INFECTION,BACTERIAL INFECTIOUS DISORDERS,HELICOBACTER INFECTIONS,10021881,10019377,10054263,10019377
HYPERSENSITIVITY REACTIONS GRADE 3,Hypersensitivity,HYPERSENSITIVITY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020751,10020751,10020751
SUBJECTIVE INEFFICACY,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
TYPE 1 RESPIRATORY FAILURE FOLLOWING PNEUMOCYSTIS JIROVECII PNEUMONIA,Respiratory Failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
"SMALL HAEMORRHAGE, BLEEDING SPOT ON THE FOREARM",Haemorrhage subcutaneous,BLEEDING SPOT SUBCUTANEOUS,HAEMORRHAGE SUBCUTANEOUS,SKIN VASCULAR ABNORMALITIES,SKIN HAEMORRHAGES,10040785,10005132,10018999,10005132
INTERMITTENT CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
"RIFAMPICIN-INDUCED THROMBOCYTOPENIA (NADIR OF 27,000 PLATELETS)",Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
KTG RECORDING DISORDERS,Foetal monitoring abnormal,CARDIOTOCOGRAPHY ABNORMAL,FOETAL MONITORING ABNORMAL,FOETAL AND NEONATAL INVESTIGATIONS,FOETAL AND NEONATAL DIAGNOSTIC PROCEDURES,10022891,10071512,10071507,10071512
SYSTEMIC LIDOCAINE TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
FEBRILE EPISODES PERSISTED DESPITE EMPIRICAL TREATMENT WITH WIDE SPECTRUM ANTIBIOTICS,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
DEVICE EXPULSION,Device expulsion,DEVICE EXPULSION,DEVICE EXPULSION,DEVICE ISSUES,DEVICE ISSUES NEC,10077536,10012578,10012578,10012578
CYTOMEGALOVIRUS REACTIVATION FOLLOWING MYELOTOXICITY,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION REACTIVATION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10058666,10011831,10058666
4 G PER DAY,Off label use,OFF LABEL DOSING,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10074165,10053762,10074165
"AST OF 861,124 U/L",Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
IMMUNE-MEDIATED SEVERE THROMBOCYTOPENIA SECONDARY TO CEFTRIAXONE OR TRIMETHOPRIM/ SULFAMETHOXAZOLE (PLATELET COUNT 9 X 10E9/L AND 7 X 10E9/L),Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
LOWER POTASSIUM LEVELS,Blood potassium decreased,POTASSIUM LOW,BLOOD POTASSIUM DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10036452,10005724,10036452
PROGRESSIVE LEFT KNEE PAIN,Arthralgia,PAIN KNEE,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023477,10003239,10033458
KIDNEY FAILURE,Renal failure,KIDNEY FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10023418
LIVE BIRTH,Live birth,LIVE BIRTH,LIVE BIRTH,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS","NORMAL PREGNANCY, LABOUR AND DELIVERY",10036585,10049550,10049550,10049550
HYPERLACTAEMIA OF 22 MG/DL (REFERENCE VALUES: 4.5 - 18),Hyperlactacidaemia,HYPERLACTACIDEMIA,HYPERLACTACIDAEMIA,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10020660,10020660,10054412
CARDIAC FAILURE,Cardiac failure,CARDIAC FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10007554,10007554,10007554
BROWN STOOL IN HIS RECTAL VAULT AND WARM EXTREMITIES,Stools abnormal,STOOLS ABNORMAL,ABNORMAL FAECES,GASTROINTESTINAL SIGNS AND SYMPTOMS,FAECAL ABNORMALITIES NEC,10017947,10042154,10000133,10042154
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
AT 3MONTHS PATIENT RECEIVED INTRACAVERNOUS INJECTION OF 20 MCG ALPROSTADIL/BUT INAPPROPRIATE RIGIDITY FOR INTERCOURSE,Erectile dysfunction,ERECTILE DYSFUNCTION NOS,ERECTILE DYSFUNCTION,SEXUAL FUNCTION AND FERTILITY DISORDERS,ERECTION AND EJACULATION CONDITIONS AND DISORDERS,10038604,10052003,10061461,10052003
LACK OF SLEEP AFFECTED THE PATIENT'S MOOD / SLEEPING BADLY POSSIBLY CAUSED ALSO ANXIOUSNESS,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
OFF WHITE EXUDATE AT THE LEVEL OF LEFT TONSIL,Tonsillar exudate,TONSILLAR EXUDATE,TONSILLAR EXUDATE,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),PHARYNGEAL DISORDERS (EXCL INFECTIONS AND NEOPLASMS),10038738,10078257,10078257,10078257
"MODERATE TO SEVERE VASOSPASM IN BILATERAL MIDDLE CEREBRAL ARTERY (MCA), ANTERIOR CEREBRAL ARTERY (ACA), AND POSTERIOR CEREBRAL ARTERY (PCA) TERRITORIES",Cerebral vasoconstriction,VASOSPASM CEREBRAL,CEREBRAL VASOCONSTRICTION,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS NEC,10029205,10050521,10059109,10047164
PROGRESSIVE DECREASE OF THE RENAL FUNCTION,Renal function abnormal,RENAL FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038451,10062237,10038451
RECTAL OBSTRUCTION,Rectal obstruction,RECTAL OBSTRUCTION,RECTAL OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,ANAL AND RECTAL STENOSIS AND OBSTRUCTION,10017947,10065707,10065707,10065707
SKIN BIOPSY SHOWED EDEMA IN THE UPPER PORTION OF DERMIS WITH A PERIVASCULAR INFILTRATE OF POLYMORPHONUCLEAR CELLS,Skin oedema,UPPER DERMIS EDEMA,SKIN OEDEMA,SKIN VASCULAR ABNORMALITIES,SKIN VASCULAR CONDITIONS NEC,10040785,10076432,10058679,10076436
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
FLUCTUATING SOMNOLENCE,somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
MIOSIS,miosis,MIOSIS,MIOSIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10027646,10027646,10027646
PROGRESSIVE DISEASE,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
MILD REDUCTION OF BREATH SOUNDS,breath sounds decreased,BREATH SOUNDS DECREASED,BREATH SOUNDS ABNORMAL,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10006333,10064780,10006333
"PATIENT WAS GIVEN A BRIEF COURSE OF TREATMENT WITH PREDNISONE, 60 MG, DAILY FOR 1 WEEK, WHICH HE WAS UNABLE TO TOLERATE, LEADING TO DISCONTINUATION",Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
PATIENT REQUIRED PREDNISONE AND NAPROXEN DURING BREAST FEEDING (OFF LABEL USE WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BROWNISH MELANONYCHIA IN THE FIRST FINGER NAILS OF BOTH HANDS/MELANONYCHIA INDUCED BY VENLAFAXINE HYDROCHLORIDE,Nail pigmentation,MELANONYCHIA,NAIL PIGMENTATION,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10058330,10058455,10058330
COLLAPSE,Syncope,FAINT,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10016167
"THROMBOCYTOPENIA (13,000 MM^3)",Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG INTOLERANCE,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
TYMPANITES,Tympanites,TYMPANITES,FLATULENCE,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10045213,10016766,10045213
"DESPITE AN INITIAL IMPROVEMENT IN SYMPTOMS, THERE WAS A SUBOPTIMAL RESPONSE AFTER A 10-WEEK TRIAL",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
HYPERGLYCEMIA,Hyperglycemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020639,10020635,10020639
PATIENT ADMINISTERED ACETAZOLAMIDE FOR POST HYPERCAPNIC ALCALOSIS AT A WEEKLY DOSE OF 250 MG (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BRONCHIAL MUCOUS MEMBRANE APPEARED TO BE INFLAMED,mucosal inflammation,MUCOSAL INFLAMMATION,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028116,10028116,10028116
LIVER DYSFUNCTION,Hepatic dysfunction NOS,HEPATIC DYSFUNCTION NOS,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019657,10019670,10019657
LABELED DRUG-DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
METABOLIC SYNDROME,metabolic syndrome,METABOLIC SYNDROME,METABOLIC SYNDROME,METABOLISM DISORDERS NEC,METABOLIC DISORDERS NEC,10027433,10052066,10052066,10052066
LACK OF EFFICACY,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,Posterior reversible encephalopathy syndrome,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10071066,10071066,10071066
RADIOULNAR SYNOSTOSIS,Radioulnar synostosis,RADIOULNAR SYNOSTOSIS,RADIOULNAR SYNOSTOSIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS OF LIMBS CONGENITAL,10010331,10037798,10037798,10037798
PITYRIASIS RUBRA PILARIS-LIKE REACTION INDUCED BY IMATINIB,Pityriasis rubra pilaris,PITYRIASIS RUBRA PILARIS,PITYRIASIS RUBRA PILARIS,EPIDERMAL AND DERMAL CONDITIONS,PAPULOSQUAMOUS CONDITIONS,10040785,10035116,10035116,10035116
SKIN TENDERNESS FOLLOWING DRUG TOXICITY DUE TO DRUG INTERACTION,skin tenderness,SKIN TENDERNESS,PAIN OF SKIN,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10051797,10033474,10051797
AGRANULOCYTOSIS INDUCED BY CLOZAPINE,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
"SPORADIC SYSTOLIC PEAKS OF LOW SPEED (STUMP FLOW) AND AN ABNORMAL MIXED AV FLOW IN THE RIGHT CERVICAL VENOUS PLEXUS, SUSPICIOUS FOR AV FISTULA.",Pulseless disease,PULSELESS DISEASE,TAKAYASU'S ARTERITIS,VASCULAR INFLAMMATIONS,ARTERIAL INFLAMMATIONS,10047065,10037496,10043097,10037496
COMA AND METABOLIC ACIDOSIS EARLY IN SEVERE ACUTE PARACETAMOL POISONING,coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
OEDEMA,Oedema,OEDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10030095
DRUG-INDUCED JEJUNAL DIVERTICULAR ULCER WITH GASTROINTESTINAL BLEEDING,Jejunal ulcer,JEJUNAL ULCER,JEJUNAL ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,INTESTINAL ULCERS AND PERFORATION NEC,10017947,10023177,10023177,10023177
CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
RASH,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
ALANINE AMINOTRANSFERASE INCREASED (96 U/L),Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
THROMBOCYTOPENIA (PLATELETS COUNT 15000 PER CUBIC MILLIMETER),Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
MYELEMIA,Myelocytosis,MYELEMIA,MYELOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10051809,10051809,10051813
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
BARTTER SYNDROME,bartter's syndrome,BARTTER'S SYNDROME,BARTTER'S SYNDROME,RENAL AND URINARY TRACT DISORDERS CONGENITAL,RENAL AND URINARY TRACT DISORDERS CONGENITAL NEC,10010331,10050839,10050839,10050839
METHOTREXATE TOXICITY RESULTING FROM SIMULTANEOUS ADMINISTRATION OF METHOTREXATE AND PHENYLBUTAZONE,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
HEPATIC FUNCTION DISORDER,Hepatic function abnormal,HEPATIC FUNCTION DISORDER,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019674,10019670,10019674
INCREASE IN CREATININE KINASE (CK) OF 9890U/L,Blood creatine phosphokinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
PEPTIC ULCER,Peptic ulcer,PEPTIC ULCER,PEPTIC ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,PEPTIC ULCERS AND PERFORATION,10017947,10034341,10034341,10034341
RECURRENT TRUNCAL DYSTONIA,dystonia,DYSTONIA,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10013983,10013983,10013983
PATIENT TREATED WITH MYCOPHENOLATE MOFETIL AND CYCLOPHOSPHAMIDE FOR UVEAL EFFUSION SYNDROME (DRUG USE FOR UNAPPROVED INDICATION) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEMATOCRIT DECREASED (0.398),Haematocrit decreased,HEMATOCRIT DECREASED,HAEMATOCRIT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018838,10018838,10019423
PATIENT TREATED UNSUCCESSFULLY WITH PREDNISONE FOR ACQUIRED HEMOPHILIA A (LACK OF DRUG EFFECT) WITH NO ADR,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
TACHYCARDIA,tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
ALTERED MENTAL FUNCTION,Mental impairment,MENTAL FUNCTION DECREASED,MENTAL IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10027352,10027374,10027372
BRONCHOALVEOLAR LAVAGE SHOWED PRESENCE OF CANDIDA,Candida infection,CANDIDA INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10074170,10074170,10074170
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
ISCHEMIC COLITIS,Colitis ischaemic,ISCHEMIC COLITIS,COLITIS ISCHAEMIC,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009895,10009895,10023037
ACUTE TOXIC HEPATITIS,Hepatitis toxic,HEPATITIS ACUTE TOXIC,HEPATITIS TOXIC,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10052553,10019795,10052553
OPIOID DEPENDENCY,Drug dependence,OPIOID TYPE DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10030892,10013663,10030892
DIARRHEA,Diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
PNEUMOCYSTIS JIROVECII PNEUMONIA,Pneumocystis jirovecii pneumonia,PNEUMOCYSTIS JIROVECII PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10073755,10073755,10073755
POLYOMAVIRUS NEPHROPATHY GRADE B,Polyomavirus-associated nephropathy,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065381,10065381,10065381
AST AND ALT LEVELS WERE >1000 U/L,Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
BLOOD PROLACTIN INCREASED,Blood prolactin increased,BLOOD PROLACTIN INCREASED,BLOOD PROLACTIN INCREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),PITUITARY ANALYSES ANTERIOR,10022891,10005780,10005780,10005780
CLINICAL WORSENING,Pneumonia,COMMUNITY ACQUIRED PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10010120,10035664,10010120
"WITH SURFACE OOZING, CRUSTING AND BLEEDING POINTS OVER",wound haemorrhage,WOUND BLEEDING,WOUND HAEMORRHAGE,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10051373,10051373,10051386
WOUND SWELLED,wound swelled,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
RAPID PROGRESSION OF WOUND INFECTION (SKIN ULCERATION) INTO STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,Skin ulcer,SKIN ULCERATION,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040947,10040943,10040947
ABDOMINAL CRAMPS,abdominal cramps,ABDOMINAL CRAMPS,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000057,10000081,10000057
SEVERE BRADYKINESIA,Bradykinesia,BRADYKINESIA,BRADYKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10006100,10006100,10006100
ABDOMINAL PAIN IN THE RIGHT HYPOCHONDRIUM,Hypochondrium pain right,HYPOCHONDRIUM PAIN RIGHT,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10020966,10000087,10020966
PATIENT AGE 3 MONTHS WAS VACCINATED WITH TRIMOVAX VACCINE,Drug administered to patient of inappropriate age,INAPPROPRIATE AGE AT VACCINE ADMINISTRATION,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10067927,10071062,10067927
"HISTORY OF 37 PANCREATITIS ATTACKS WITHIN THE LAST 25 YEARS, DESPITE TREATMENT WITH FIBRATES, OMEGA 3 FATTY ACIDS",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PREGNANT WOMEN WAS TREATED WITH ASPIRIN AND CLOPIDOGREL,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HYPOGLYCAEMIA (BLOOD GLUCOSE LEVEL NOS),Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
MYELITIS RECURRENCE,Myelitis,MYELITIS,MYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10028524,10028524,10028524
DIFFUSE PAPULAR ERYTHEMA,Rash papular,PAPULAR SKIN ERUPTION,RASH PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037876,10037876,10033730
MULTIPLE DRUG POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
SYSTEMIC LIDOCAINE TOXICITY,Systemic lidocaine toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
SEVERE AXONAL POLYNEUROPATHY WITHOUT DEMYELINATING PATTERN,Peripheral sensory neuropathy,SENSORY POLYNEUROPATHY AXONAL,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10040040,10034620,10040040
USE OF MYCOPHENOLATE MOFETIL IN TYPE I AUTOIMMUNE HEPATITIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INSUFFICIENT CONTROL OF BLOOD PRESSURE,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
PERSISTENT HEMODYNAMIC INSTABILITY,Haemodynamic instability,HEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10052076,10052076,10058270
AN URGENT CESAREAN SECTION/PREGNANCY WEEK 31,Premature delivery,PREMATURE DELIVERY,PREMATURE DELIVERY,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036595,10036595,10036595
TRAUMATISATION,psychological trauma,PSYCHOLOGICAL TRAUMA,PSYCHOLOGICAL TRAUMA,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,PSYCHIATRIC SYMPTOMS NEC,10037175,10071368,10071368,10071368
MULTIPLE ITCHY AND PAINFUL ERYTHEMATOUS PATCHES,multiple itchy and painful erythematous patches,ITCHY,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023089,10037087,10023089
HEPATIC NECROSIS,Hepatic necrosis,HEPATIC NECROSIS,HEPATIC NECROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019692,10019692,10019692
PATIENT DESCRIBED THAT HER ORAL MUCOSA WAS FLAKING OFF,Oral mucosal exfoliation,ORAL MUCOSAL EXFOLIATION,ORAL MUCOSAL EXFOLIATION,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SIGNS AND SYMPTOMS,10017947,10064487,10064487,10064487
LUNG NODULE,Pulmonary mass,LUNG NODULE,PULMONARY MASS,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10049498,10056342,10049498
FELT FATIGUABILITY,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
DERMATITIS,Dermatitis,DERMATITIS,DERMATITIS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10012431,10012431,10012431
ABDOMINAL PAIN TYPE,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
"MEDICATIONS WITH LEVODOPA AND SELEGILINE. MAOB INHIBITOR, STARTING AT 3 YEARS WERE PARTIALLY EFFECTIVE TO INDUCE SITTING WITH SUPPORT FOR HER.",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PERSISTENT HYPERKALEMIA,Hyperkalaemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020646,10020646,10020647
FEVER AT NIGHT,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
NEUROTOXICITY,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
ACUTE TOXICITY OF CONCOMITANT CHEMORADIOTHERAPY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
VISCERAL LEISHMANIASIS/A BONE MARROW SMEAR SHOWED THE PRESENCE OF AMASTYGOTES OF LEISHMANIA,Visceral leishmaniasis,VISCERAL LEISHMANIASIS,VISCERAL LEISHMANIASIS,PROTOZOAL INFECTIOUS DISORDERS,LEISHMANIA INFECTIONS,10021881,10047505,10047505,10047505
ACUTE RENAL FAILURE,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
INTENTIONAL SUSPECTED SUICIDE,Completed suicide,COMPLETED SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10010144,10010144,10010144
SEVERE BRADYCARDIA INTO THE 30'S,bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
MILD DEGREE OF ARTERIAL SCLEROSIS FINDINGS IN THE OCULAR FUNDUS,Retinal arteriosclerosis,RETINAL ARTERIOSCLEROSIS,ARTERIOSCLEROTIC RETINOPATHY,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINOPATHIES NEC,10015919,10038825,10063452,10038825
RAISED TROUGH LEVELS SECONDARY TO KNOWN DRUG INTERACTIONS,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
HYPOTHERMIA,hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
CLOTS,Thrombosis,CLOT BLOOD,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10009667,10043607,10009667
HIATAL HERNIA,Hiatal hernia,HIATAL HERNIA,HIATUS HERNIA,ABDOMINAL HERNIAS AND OTHER ABDOMINAL WALL CONDITIONS,DIAPHRAGMATIC HERNIAS,10017947,10020024,10020028,10020024
RENAL FAILURE,Renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
RITUXIMAB USED FOR TREATMENT OF FOLLICULAR LYMPHOMA,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
GENERALISED FLUSHING,generalised flushing,GENERALISED FLUSHING,FLUSHING,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10018083,10016825,10018083
"BLOOD PRESSURE - 155/70 MMHG, PATHOLOGICAL ECG FINDINGS, LEFT VENTRICULAR HYPERTROPHY, DIASTOLIC DYSFUNCTION",Blood pressure abnormal,BLOOD PRESSURE ABNORMAL,BLOOD PRESSURE ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005728,10005728,10005728
ELEVATED CREATINE KINASE AND CREATININE LEVELS,Creatine kinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
CELL-MEDIATED TYPE IV REACTION,cell mediated allergic reaction,CELL MEDIATED ALLERGIC REACTION,TYPE IV HYPERSENSITIVITY REACTION,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10007874,10053613,10007874
GRADE 1 TRANSAMINASES INCREASED/ REVERZIBLE INCREASE OF LIVER TRANSAMINASES,Transaminases increased,TRANSAMINASES INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054889,10054889,10054889
NTERFERING WITH URINATION AND MOBILIZATION,Urination difficulty,URINATION DIFFICULTY,DYSURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046599,10013990,10046599
SIROLIMUS BLOOD CONCENTRATION INCREASED,Drug level increased,RAISED DRUG LEVELS IN BLOOD,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013721,10013722,10037811
POSITIVE D DIMER TO 844,Fibrin D dimer increased,FIBRIN D DIMER HIGH,FIBRIN D DIMER INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10016580,10016581,10016580
GASTROENTERITIS,gastroenteritis,GASTROENTERITIS,GASTROENTERITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10017888,10017888,10017888
PROGRESSIVE DISEASE,Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
DROWSY,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
SENSATION OF SOMEONE TOUCHING HIS BACK,Illusion,FALSE SENSATION,ILLUSION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10016201,10021403,10016201
GAIT DISTURBANCE,Gait disturbance,GAIT DISTURBANCE,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017577,10017577,10017577
DRESS WITH MYOCARDIAL INVOLVEMENT,Cardiac dysfunction,CARDIAC DYSFUNCTION,CARDIAC DYSFUNCTION,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10079751,10079751,10079751
"VISION WORSENED AND PROGRESSION OF THE PRIMARY LESION WAS EVIDENT ON IMAGING, DID NOT RECOGNIZE 1-IN. PICTURES",Visual impairment,VISION ABNORMAL,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10000186,10047571,10047508
ERYTHEMATOUS RASH AND AN ATTACK OF THE MUCOSA,Mucosal pain,MUCOSAL PAIN,MUCOSAL PAIN,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10075187,10075187,10075187
DECREASED HCO3-20MMOL/L,Blood bicarbonate decreased,BLOOD BICARBONATE DECREASED,BLOOD BICARBONATE DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10005359,10005359,10005359
SHORTNESS OF BREATH WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
"SMALL AREAS OF ANNULAR DESQUAMATION WITH A FEW PINPOINT PUSTULES THE INTERTRIGINOUS SITES AND ON THE LOW BACK , INNER THIGHS AND BUTTOCKS",Desquamation,DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10012528,10040844,10012528
HAEMODIALYSIS,Haemodialysis,HAEMODIALYSIS,HAEMODIALYSIS,RENAL AND URINARY TRACT THERAPEUTIC PROCEDURES,RENAL THERAPEUTIC PROCEDURES,10042613,10018875,10018875,10018875
ENLARGED STOMACH,enlarged stomach,STOMACH DILATATION,GASTRIC DILATATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10042100,10017779,10042100
INCREASED LEVEL OF UREA (81 MG/DL),Blood urea increased,UREA INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10046353,10005851,10046353
TORSADES DE POINTES ARRYTHMIA SECONDARY TO LONG QT,Torsade de pointes,TORSADES DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044067
MINOR DISEASE RESPONSE AT WEEK 12,subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
"LACK OF DRUG EFFECT (RECURRENT ICD SHOCKS DUE TO VF STORM, DESPITE ANTI-ARRHYTHMIC THERAPY)/ DESPITE AMIODARONE RELOADING AND BETA BLOCKER DOSE ESCALATION/ MEXILETINE WAS NOT EFFECTIVE",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PATIENT RECEIVED ENOXAPARIN DURING 19TH WEEK OF PREGNANCY,"Drug exposure during pregnancy, second trimester","DRUG EXPOSURE DURING PREGNANCY, SECOND TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076616,10073513,10076616
MENTAL STATUS CONTINUED TO DETERIORATE,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
RASH MACULO-PAPULAR,Rash maculo-papular,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10037868
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
COMA,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
"BLISTERS OF THE LATERAL TONGUE, ORAL MUCOSA, LIPS AND SCROTUM",tongue blistering,TONGUE BLISTERING,TONGUE BLISTERING,TONGUE CONDITIONS,TONGUE SIGNS AND SYMPTOMS,10017947,10043942,10043942,10043942
HER LEGS SWELL BY EVENING TIME/ FEET SWELLING,Swelling of feet,SWELLING OF FEET,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042693,10048959,10042693
SEVERE MUSCLE PAIN,Myalgia,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028322
WEIGHT INCREASED,Weight increased,WEIGHT INCREASED,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047899
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
"INCREASED 1,25-DIHYDROXYCHOLECALCIFEROL (167 PG/DL)","Blood 1,25-dihydroxycholecalciferol increased","BLOOD 1,25-DIHYDROXYCHOLECALCIFEROL INCREASED","BLOOD 1,25-DIHYDROXYCHOLECALCIFEROL INCREASED","METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",VITAMIN ANALYSES,10022891,10053810,10053810,10053810
WORSENING OF GENERAL SYMPTOMS,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
LEUKOCYTOSIS (17600 - 97.1% NEUTROPHILS AND 0% LYMPHOCYTES),Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
SUBTHERAPEUTIC RESPONSE,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
SHOCK CAUSED BY RUPTURE OF RENAL ARTERY FOLLOWNG THROMBUS OF RENAL TRANSPLANT ARTERY,Shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
CONSTIPATION,Constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
KIDNEY INJURY,Injury to kidney,INJURY TO KIDNEY,RENAL INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10022221,10061481,10022221
PSYCHOMOTOR DEVELOPMENT WAS LESS THAN THAT OF AN 8-MTH OLD INFANT,Psychomotor skills impaired,PSYCHOMOTOR DEVELOPMENT IMPAIRED,PSYCHOMOTOR SKILLS IMPAIRED,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10037208,10049215,10037208
SUDDEN HYPERTENSIVE EMERGENCY,Hypertensive emergency,HYPERTENSIVE EMERGENCY,HYPERTENSIVE EMERGENCY,VASCULAR HYPERTENSIVE DISORDERS,ACCELERATED AND MALIGNANT HYPERTENSION,10047065,10058179,10058179,10058179
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
ATRAUMATIC GENITOURINARY BLEEDING,genital bleeding,GENITAL BLEEDING,GENITAL HAEMORRHAGE,REPRODUCTIVE TRACT DISORDERS NEC,REPRODUCTIVE TRACT DISORDERS NEC (EXCL NEOPLASMS),10038604,10071812,10061178,10071812
ACTIVATED PARTIAL THROMBOPLASTIN TIME INCREASED,activated partial thromboplastin time increased,ACTIVATED PARTIAL THROMBOPLASTIN TIME INCREASED,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10000634,10000636,10000634
LOWER LIMB EDEMA,lower limb edema,EDEMA LIMBS,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10050068,10030124,10050068
GFR DECREASED (VIREMIA GREATER THAN EQUAL TO 10E4 COPIES/ML),Glomerular filtration rate decreased,GFR DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018214,10018358,10018214
TRUNCAL AND LIMB ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
COMA/CNS DEPRESSION,Depressed level of consciousness,CNS DEPRESSION,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10012383,10012373,10009710
PLEURAL AND PERICARDIAL EFFUSIONS,Pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
RECURRENT PSYCHOTIC SYMPTOMS/ACUTE PSYCHOTIC SYMPTOMS,Psychotic symptom,PSYCHOTIC SYMPTOM,PSYCHOTIC SYMPTOM,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10079254,10079254,10079254
"DUE TO A PRESCRIPTION MISTAKE, THE PATIENT WAS STARTED ON PAROXETINE 20 MG INSTEAD OF HIS USUAL",wrong drug administered,WRONG DRUG ADMINISTERED,WRONG DRUG ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10048055,10048055,10048055
DIAPHORESIS,Hyperhidrosis,DIAPHORESIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042670,10020642,10012703
CHEMOTHERAPY INDUCED NEUTROPENIA,Neutropenia,CHEMOTHERAPY INDUCED NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10076734,10029354,10076734
ILD RELATED TO HIS UC WITH PULMONARY FIBROSIS THAT WAS RESISTANT TO INCREASING DOSES OF SYSTEMICSTEROIDS AND MYCOPHENOLATE MOFETIL.,Interstitial lung disease,INTERSTITIAL LUNG DISEASE,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022611,10022611,10022611
DYSPHAGIA,dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
MYCOPHENOLATE MOFETIL WAS USED TO TREAT SYSTEMIC LUPUS ERYTHEMATOSUS AND MYASTHENIA GRAVIS OVERLAP (OFF LABEL USE) WITH NO REPORTED ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEMODYNAMIC INSTABILITY,Haemodynamic instability,HEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10052076,10052076,10058270
PLAQUES,Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
PALPITATION,Palpitations,PALPITATION,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033556
FALLS,fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
GASTROINTESTINAL BLEEDING,Gastrointestinal haemorrhage,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017936
A LARGE NUMBER OF RED PAPULES,Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
HYPOKALEMIA,hypokalemia,HYPOKALEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021018,10021015,10021018
POOR ADHERENCE TO IMMUNOSUPPRESSIVE MEDICATIONS,Product use issue,PRODUCT USE ISSUE,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076309,10076309,10076309
THOUGHT ABOUT SUICIDE,Suicidal ideation,SUICIDAL IDEATION,SUICIDAL IDEATION,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042458,10042458,10042458
DEPRESSIVE-CATATONIC STATE ASSOCIATED WITH CORTICOSTEROID TREATMENT DSM-IV,Catatonia,CATATONIC STATE,CATATONIA,CHANGES IN PHYSICAL ACTIVITY,DECREASED PHYSICAL ACTIVITY LEVELS,10037175,10007781,10007776,10007781
METHOTREXATE WAS GIVEN TO TREAT PLAQUE PSORIASIS WITH LITTLE BENEFIT,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
CEREBELLAR BRAIN ABSCESS,Brain abscess,BRAIN ABSCESS,BRAIN ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10006105,10006105,10006105
"PATIENT DESPITE FIVE DAYS OF IV CEFAZOLIN TREATMENT, THE WOUND CONTINUED TO OOZE YELLOW DISCHARGE (LACK OF DRUG EFFECT) WITH NO ADVERSE EVENT",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SEVERE CHOLESTASIS,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
EDEMAS,Oedema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10014210
CARDIOMEGALY,Cardiomegaly,CARDIOMEGALY,CARDIOMEGALY,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10007632,10007632,10007632
ENCEPHALOPATHY FOLLOWING ACUTE FULMINANT HEPATITIS,encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
DABIGATRAN FAILURE/ APIXABAN FAILED,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
MILD DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
COMATOSE,comatose,COMATOSE,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10058472,10010071,10058472
LEVOTHYROXINE PSEUDOMALABSORPTION,malabsorption,MALABSORPTION,MALABSORPTION,MALABSORPTION CONDITIONS,MALABSORPTION SYNDROMES,10017947,10025476,10025476,10025476
"WELL DEFINED PATCHES OF ERYTHEMA, CENTRED ON THE INJECTION SITES",Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
LONGSTANDING HYPERTENSION THAT WAS RESISTANT TO PHARMACOLOGICAL THERAPY WITH FIVE DIFFERENT ANTIHYPERTENSIVE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
LEFT-SIDED FACIAL PALSY,Facial paralysis,FACIAL PALSY,FACIAL PARALYSIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),FACIAL CRANIAL NERVE DISORDERS,10029205,10016060,10016062,10016060
HYPERTENSIVE EMERGENCY,hypertensive emergency,HYPERTENSIVE EMERGENCY,HYPERTENSIVE EMERGENCY,VASCULAR HYPERTENSIVE DISORDERS,ACCELERATED AND MALIGNANT HYPERTENSION,10047065,10058179,10058179,10058179
DOUBLED THE DOSE OF BETAMETHASONE FOR ONE MONTH,doubled the dos eof betamethasone for one month,INTENTIONAL DOSE INCREASE,INTENTIONAL PRODUCT USE ISSUE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT USE ISSUES,10022117,10065971,10076308,10065971
RECURRENT STENT THROMBOSIS DUE TO LACK OF DRUG EFFECT OF DUAL ANTIPLATELET THERAPY,Vascular stent thrombosis,STENT THROMBOSIS,VASCULAR STENT THROMBOSIS,COMPLICATIONS ASSOCIATED WITH DEVICE,VASCULAR COMPLICATIONS ASSOCIATED WITH DEVICE,10018065,10076859,10063934,10076859
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
"DESPITE CEFOTAXIM, THE PATIENT HAD TO BE VENTILATED, AND HEMOFILTRATION BECAME NECESSARY BECAUSE OF ACUTE RENAL INSUFFICIENCY",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
INCREASED DIRECT BILIRUBIN 6.01,Direct bilirubin increased,DIRECT BILIRUBIN INCREASED,BILIRUBIN CONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10013038,10004685,10013038
HEPATIC FAILURE,Hepatic failure,HEPATIC FAILURE,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10019663,10019663,10019663
RESPIRATORY FAILURE,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
CONSTIPATION WORSENED,Constipation,CONSTIPATION AGGRAVATED,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10048346,10010774,10048346
CLOACAL PERSISTENCE,Persistent cloaca,PERSISTENT CLOACA,PERSISTENT CLOACA,REPRODUCTIVE TRACT AND BREAST DISORDERS CONGENITAL,REPRODUCTIVE TRACT DISORDERS CONGENITAL NEC,10010331,10069442,10069442,10069442
SMALL FOR GESTATIONAL AGE,Small for gestational age,SMALL FOR GESTATIONAL AGE,SMALL FOR DATES BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10041093,10041092,10041093
EXCESSIVE THIRST,excessive thirst,EXCESSIVE THIRST,THIRST,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10015608,10043458,10015608
COMPLEMENT FACTOR C3 DECREASED (37.5 MG/DL),Complement factor C3 decreased,COMPLEMENT FACTOR C3 DECREASED,COMPLEMENT FACTOR C3 DECREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNE RESPONSE PROTEIN ANALYSES NEC,10022891,10050981,10050981,10050981
CRISIS GOTOSAS,Gout attack,GOUT ATTACK,GOUT,PURINE AND PYRIMIDINE METABOLISM DISORDERS,DISORDERS OF PURINE METABOLISM,10027433,10070518,10018627,10070518
SHOULDER PAIN,shoulder pain,SHOULDER PAIN,MUSCULOSKELETAL PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10040617,10028391,10040617
SUBARACHNOID HAEMORRHAGE,Subarachnoid haemorrhage,SUBARACHNOID HAEMORRHAGE,SUBARACHNOID HAEMORRHAGE,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10042316,10042316,10042316
RESPIRATORY FAILURE,respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
HYPOGLYCAEMIA WITH A NADIR BLOOD GLUCOSE OF 2.3MMOL/L,hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
INCREASED SERUM CREATININE (640 MICROMOLES/L),Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
NONCOMPLIANT WITH HIS AMLODIPINE,noncompliant with his amlodipine,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
SEVERE EPIGASTRIC TENDERNESS,Abdominal tenderness,TENDERNESS EPIGASTRIC,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10043227,10000097,10043227
VIBICES APPEARED ON THE FLANKS AND AT THE BASE OF THE THIGHS,vibices,VIBICES,HAEMORRHAGE SUBCUTANEOUS,SKIN VASCULAR ABNORMALITIES,SKIN HAEMORRHAGES,10040785,10062922,10018999,10062922
HEMOGLOBIN VALUE WAS 10.6 G/DL,Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
"FOLLOWING A DOSE INCREASE OF HYDROCHLOROTHIAZIDE TO 25 MG, PATIENT DEVELOPED SYMPTOMATIC",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
POLYMORPHIC VENTRICULAR TACHYCARDIA/VENTRICULAR ARRHYTHMIA (POLYMORPHIC VT AND VF),Ventricular tachycardia,POLYMORPHIC VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10028158,10047302,10036095
ABDOMINAL PAIN,abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
RECURRENT THROMBOEMBOLIC EVENTS,Embolism,THROMBOEMBOLIC EVENT,EMBOLISM,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10043566,10061169,10043565
INCREASED ACYCLOVIR DOSAGE (52 MG/KG/DAY) CAUSED TRANSIENT RENAL DYSFUNCTION,kidney dysfunction,KIDNEY DYSFUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10023417,10062237,10023417
PROGRESSION OF PRE-EXISTING CANCER,progression of pre-existing cancer,PROGRESSION OF PRE-EXISTING CANCER,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10057096,10051398,10057096
WEIGHT GAIN,Weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
MULTIPLE DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
SEVERE BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
EXTRAPYRAMIDAL SYMPTOMS,extrapyramidal symptoms,EXTRAPYRAMIDAL SYMPTOMS,EXTRAPYRAMIDAL DISORDER,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10015835,10015832,10015835
ELEVATED LIVER ENZYMES,elevated liver enzymes,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
LIQUID DIARRHEA (8-10 TIMES PER DAY),Watery diarrhea,WATERY DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10055422,10012735,10055422
SUDDEN COMPLETE LOSS OF VISION DUE TO METFORMIN ASSOCIATED LACTIC ACIDOSIS,Blindness,LOSS OF VISION,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047522,10005169,10024881
HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
METHOTREXATE INTOXICATION,drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
TOXICITIES WERE GRADE 2 HAND-FOOT SYNDROME GRADE 2 MUCOSITIS,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
NECROSIS,necrosis,NECROSIS,NECROSIS,TISSUE DISORDERS NEC,NECROSIS NEC,10018065,10028851,10028851,10028851
PORTAL HEPATITIS FOLLOWING ACUTE AND ACCIDENTAL METHOTREXATE OVERDOSE AND INTOXICATION DUE TO DRUG PRESCRIBING ERROR AND DRUG INTERACTION,hepatitis,HEPATITIS,HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019717,10019717,10019717
HERPETIFORM DISPOSITION,herpetiform disposition,HERPETIFORM LESION,HERPES VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10020006,10019973,10020006
PERIPHERAL NERVE DISORDER NOS,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
RENAL FUNCTION ABNORMAL,renal function abnormal,RENAL FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038451,10062237,10038451
HUGE GLYCEMIC VARIABILITY,Blood glucose fluctuation,BLOOD GLUCOSE FLUCTUATION,BLOOD GLUCOSE FLUCTUATION,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10049803,10049803,10049803
LIVER FAILURE,Hepatic failure,LIVER FAILURE,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10019663,10019663,10024678
"VENLAFAXINE 75MG, WITHOUT EFFECT",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
"DISSEMINATED INFECTION IN STOOL, BLOOD, THROAT AND URINE",Klebsiella infection,KLEBSIELLA PNEUMONIAE INFECTION,KLEBSIELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10052209,10061259,10052209
EROSION ON THE UPPER EYELID,Eyelid erosion,EYELID EROSION,EYELID EROSION,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","LID, LASH AND LACRIMAL STRUCTURAL DISORDERS",10015919,10060762,10060762,10060762
6-MERCAPTOPURINE TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
DRUG RESISTANCE TO IMATINIB MESILATE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
BILATERAL ENDOGENOUS FUSARIUM SOLANI ENDOPHTHALMITIS,Infectious endophthalmitis,INFECTIOUS ENDOPHTHALMITIS,ENDOPHTHALMITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10073350,10014801,10073350
CASPOFUNGIN RESISTANT YEAST INFECTION,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
SIGNS OF INFECTION,infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
MYOCARDIAL HYPERTROPHY,myocardial hypertrophy,MYOCARDIAL HYPERTROPHY,CARDIAC HYPERTROPHY,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10072733,10007572,10072733
AGITATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
HB DECREASED (3.3 G/DL),Haemoglobin decreased,HB DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10019171,10018884,10019171
GROSS HAEMORRHAGE,haemorrhage,HAEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10055798
INCREASED BLOOD LITHIUM CONCENTRATION/INCREASE IN BLOOD LEVELS OF LITHIUM,Antipsychotic drug level increased,BLOOD LITHIUM LEVEL INCREASED,ANTIPSYCHOTIC DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10063687,10063686,10063687
DYSPHAGIA,Dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
PROTEINURIA (UACR 19.2MG/MMOL),Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
NUMEROUS VENTRICULAR ARRHYTHMIAS,ventricular arrhythmia,VENTRICULAR ARRHYTHMIA,VENTRICULAR ARRHYTHMIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047281,10047281,10047281
AN ANTIEMETIC USED OFF-LABEL AS A GALACTOGOGUE INTERNATIONALLY/STARTED ON DOMPERIDONE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
ELEVATION OF NATRIURETIC B-PEPTIDE,Brain natriuretic peptide increased,BRAIN NATRIURETIC PEPTIDE INCREASED,BRAIN NATRIURETIC PEPTIDE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10053405,10053405,10053405
CYTOPENIA DUE TO TYPE 2 HYPERSENSITIVITY REACTION,Cytopenia,CYTOPENIA,CYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10066274,10066274,10066274
QUININE-INDUCED HYPOGLYCEMIA,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
THE PATIENT DIED OF PROGRESSIVE DISSEMINATED OROPHARYNGEAL HISTOPLASMOSIS DESPITE INITIATING TREATMENT WITH ORAL ITRACONAZOLE,Histoplasmosis disseminated,DISSEMINATED HISTOPLASMOSIS,HISTOPLASMOSIS DISSEMINATED,FUNGAL INFECTIOUS DISORDERS,HISTOPLASMA INFECTIONS,10021881,10020144,10020144,10013440
INR IS 8,International normalised ratio increased,INR INCREASED,INTERNATIONAL NORMALISED RATIO INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10022402,10022595,10022402
DECREASE IN VIBRATION AND PAIN SENSATION UPTO THE LEVEL OF UMBLICUS,Decreased vibratory sense,DECREASED VIBRATORY SENSE,DECREASED VIBRATORY SENSE,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10067502,10067502,10067502
HIGH BLOOD PRESSURE (190/110 MMHG),Hypertension,BLOOD PRESSURE HIGH,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10005747
DRUG-INDUCED BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
HIVES OVER THE FACE AND LOWER BACK.,Urticaria,HIVES,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10020197
RENAL FAILURE ACUTE ON CHRONIC,Acute kidney injury,RENAL FAILURE ACUTE ON CHRONIC,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038440,10069339,10038440
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,Peripheral arterial occlusive disease,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10062585,10062585,10062585
INAPPROPRIATE DOSING,Incorrect dose administered,INCORRECT DOSE ADMINISTERED,INCORRECT DOSE ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064355,10064355,10064355
ELEVATED TRANSAMINASES,Transaminases increased,TRANSAMINASES INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054889,10054889,10054889
OLANZAPINE INTOXICATION,drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
"TRANSIENT THROMBOCYTOPENIA WITH A NADIR COUNT OF 43,000/LL FOLLOWING OFF LABEL USE",Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
POOR GLYCO-METABOLIC CONTROL,Metabolic disorder,GLUCOSE METABOLISM ABNORMAL,METABOLIC DISORDER,METABOLISM DISORDERS NEC,METABOLIC DISORDERS NEC,10027433,10058106,10058097,10058106
BACKGROUND PAIN OF DIABETIC NEUROPATHY WAS AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
PATIENT TREATED WITH RITUXIMAB AND BENDAMUSTINE FOR AGGRESIVE FOLLICULAR LYMPHOMA YEILDED PARTIAL RESPONSE (SUBTHERAPEUTIC RESPONSE),Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
MILD TENDERNESS TO PALPATION OF THE EPIGASTRIUM,epigastralgia,EPIGASTRALGIA,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10048944,10000087,10048944
SERUM QUININE CONCENTRATION INCREASED (VALUE-8 MG/DL),Drug level increased,DRUG LEVEL IN BLOOD INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013721,10013722,10013721
COLITIS ULCERATIVE AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
HRCT REVEALED A NODULAR CONSOLIDATION WITH HALO SIGN IN LEFT UPPER LOBE DUE TO INVASIVE PULMONARY ASPERGILLUS FUMIGATUS INFECTION,Lung consolidation,LUNG CONSOLIDATION,LUNG CONSOLIDATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025080,10025080,10025080
URINE OUTPUT DECREASED,Urine output decreased,URINE OUTPUT DECREASED,URINE OUTPUT DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059895,10059895,10059895
PATIENT WAS TREATED WITH MYCOPHENOLATE MOFETIL FOR MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
VALACICLOVIR 1 G THREE TIMES DAILY IS NOT THE RECOMMENDED DOSAGE FOR THE TREATMENT OF HSV INFECTION IN ADULTS AND IN ADOLESENTS,Inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HAND FOOT SYNDROME (GRADE 3),Hand and foot syndrome,HAND AND FOOT SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10019111,10033553,10019111
LUNG MYCOSIS,Pulmonary mycosis,PULMONARY MYCOSIS,PULMONARY MYCOSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10037422,10037422,10037422
VERTEBROGENIC PAIN SYNDROME,Spinal pain,VERTEBROGENIC PAIN SYNDROME,SPINAL PAIN,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10066999,10072005,10066999
NAUSEA FOLLOWING OFF LABEL USE OF DRUG,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
NODULAR MELANOMA WITH A NEVOID PATTERN,Nodular melanoma,NODULAR MELANOMA,NODULAR MELANOMA,SKIN NEOPLASMS MALIGNANT AND UNSPECIFIED,SKIN MELANOMAS (EXCL OCULAR),10029104,10029488,10029488,10029488
INFLAMMATION OF LAST 60 CM OF ILEUM,Enteritis,ILEITIS,ENTERITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10021312,10014866,10021312
METHOTREXATE OVERDOSE,Overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
VISCERAL LEISHMANIASIS,Visceral Leishmaniasis,VISCERAL LEISHMANIASIS,VISCERAL LEISHMANIASIS,PROTOZOAL INFECTIOUS DISORDERS,LEISHMANIA INFECTIONS,10021881,10047505,10047505,10047505
DRUG EXPOSURE DURING LACTATION,Drug exposure via breast milk,DRUG EXPOSURE VIA BREAST MILK,EXPOSURE VIA BREAST MILK,"EXPOSURES, CHEMICAL INJURIES AND POISONING",PATHWAYS AND SOURCES OF EXPOSURE,10022117,10051075,10080751,10051075
HYPOCHLOREMIA HYPOCHLOREMIA (65 MEQ/L,Hypochloraemia,HYPOCHLOREMIA,HYPOCHLORAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,CHLORIDE IMBALANCE,10027433,10020955,10020955,10020957
SQUAMOUS CELL METAPLASIA,Metaplasia,SQUAMOUS CELL METAPLASIA,METAPLASIA,TISSUE DISORDERS NEC,TROPHIC DISORDERS,10018065,10067121,10054949,10067121
AGITATED,Agitation,AGITATED,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001495
PARESTHESIA OF THE LEFT EXTREMITIES,Paraesthesia,PARESTHESIA,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10033775,10033775,10033987
AKINESIS,Akinesia,AKINESIA,AKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10001541,10001541,10001541
TREATMENT NONCOMPLIANCE,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
STAGE 2 OSTEONECROSIS OF THE MAXILLA,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
PROGRESSIVE WEAKNESS OF BILATERAL PROXIMAL UPPER LIMB MUSCLES,Muscular weakness,MUSCLE WEAKNESS UPPER LIMB,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10065895,10028372,10065895
RESPIRATORY ARREST,Respiratory arrest,RESPIRATORY ARREST,RESPIRATORY ARREST,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038669,10038669,10038669
RIGHT LEG PAIN,Pain in extremity,UNILATERAL LEG PAIN,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10052410,10033425,10052410
LITHIUM OVERDOSE FOR SUICIDE ATTEMPT,drug overdose deliberate self-inflicted,DRUG OVERDOSE DELIBERATE SELF-INFLICTED,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10013738,10022523,10013738
GLUTEUS HEMATOMA,Muscle haemorrhage,MUSCLE HAEMORRHAGE,MUSCLE HAEMORRHAGE,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028309,10028309,10028309
DISSOCIATED,dissociation,DISSOCIATION,DISSOCIATION,DISSOCIATIVE DISORDERS,DISSOCIATIVE STATES,10037175,10013457,10013457,10013457
MUCOUS MEMBRANE DISORDER SUCH AS STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
HYPOGLYCEMIA,Hypoglycemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10021005,10020993,10021005
SO WE DECIDED TO REINTRODUCE FLECAINIDE TREATMENT 100 MG B.I.D.,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
SPECIFIC GRAVITY INCREASED FROM 1.007 TO 1.016 WITHIN 4 HOURS OF ADMINISTRATION OF METHOTREXATE,Specific gravity urine increased,SPECIFIC GRAVITY URINE INCREASED,SPECIFIC GRAVITY URINE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINALYSIS NEC,10022891,10050773,10050773,10050773
AGRANULOCYTOSIS WAS SECONDARY TO MYCOPHENOLATE MOFETIL AND VALGANCICLOVIR DRUG INTERACTION/DDI OF MODERATE SEVERITY WAS FOUND FOR THE ASSOCIATION OF MYCOPHENOLATE MOFETIL,Drug interaction,DRUG-DRUG PHARMACOKINETIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10065994,10013710,10065994
ANTI-GAD ANTIBODY POSITIVE (343 U/ML),Anti-GAD antibody positive,ANTI-GAD ANTIBODY POSITIVE,ANTI-GAD ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10059728,10059728,10059728
DYSPHAGIA,dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
ORAL ENANTHEMA,Enanthema,ENANTHEMA,ENANTHEMA,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10014579,10014579,10014579
MODERATE CYTOPENIA,Cytopenia,CYTOPENIA,CYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10066274,10066274,10066274
INTENTIONAL OVERDOSE,intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
DETERIORATING VISUAL ACUITY,Visual acuity reduced,DETERIORATION OF VISUAL ACUITY,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047531,10047531,10012546
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
UNRESPONSIVE TO PROLONGED COURSES OF ITRACONAZOLE (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DIARRHOEA,diarrheoa,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
EOSINOPHILIA (0.6X10E9/L),Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
TIGHTNESS IN CHEST,tightness in chest,TIGHTNESS IN CHEST,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043858,10008469,10043858
HYPERREFLEXIA/TREMOR,Hyperreflexia,HYPERREFLEXIA,HYPERREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10020745,10020745,10020745
CHOROIDAL DETACHMENTS,Choroidal detachment,CHOROIDAL DETACHMENT,CHOROIDAL DETACHMENT,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","CHOROID AND VITREOUS STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10008783,10008783,10008783
ACUTE LEFT-SIDED ABDOMINAL AND LOWER BACK PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
"THE WOMEN RECEIVED ALPRAZOLAM AND OMPRAZOLE,SODIUM CITRATE,RANITIDINE,DEXMEDETOMIDINE,ROCURONIUM BROMIDE,PROPOFOL,LUVOBUPIVACAINE,LIDOCAINE/EPINEPHRINE,DICLOFENAC,PARACETAMOL AND UNSPECIFIED OPIOID ANALGESIC DURING PREGNANCY",maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
TUBERCULOUS TONSILLITIS,Tonsillitis bacterial,TONSILLITIS BACTERIAL,TONSILLITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10065235,10065235,10065235
CENTRAL/PARACENTRAL SCOTOMA DEPRESSION WITH SCOTOMA DENSER BELOW THE HORIZONTAL MIDLINE,Scotoma,SCOTOMA,VISUAL FIELD DEFECT,NEUROLOGICAL DISORDERS OF THE EYE,NEUROLOGIC VISUAL PROBLEMS NEC,10029205,10039729,10047555,10039729
SPINAL EPIDURAL HEMATOMA,Spinal epidural haematoma,SPINAL EPIDURAL HEMATOMA,SPINAL EPIDURAL HAEMATOMA,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10050162,10050162,10055381
"LEUKOPENIA, STOMATITIS, MTX FOR ECTOPIC PREGNANCY, DRUG USE VIA UNAPPROVED ADMINISTRATION ROUTE (MTX VIA INTRA-AMNIOTIC ROUTE)",Product use issue,DRUG USE VIA UNAPPROVED ADMINISTRATION ROUTE,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10062592,10076309,10062592
PROGRESSION OF PANCREATIC CARCINOSARCOMA,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
FOETAL DISTRESS,Foetal distress syndrome,FOETAL DISTRESS,FOETAL DISTRESS SYNDROME,FOETAL COMPLICATIONS,FOETAL COMPLICATIONS NEC,10036585,10016854,10016855,10016854
DISTURBANCE IN CONSCIOUSNESS (GCS 1/1/1),Altered state of consciousness,CONSCIOUSNESS DISTURBED,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010770,10001854,10010770
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
FATIGUE/INCREASED DAYTIME SLEEPINESS,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
DETERIORATING VENTRICULAR FUNCTION,Ventricular failure,VENTRICULAR FAILURE,VENTRICULAR FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10060953,10060953,10060953
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SWELLING OF LOWER LIMBS,Swelling of limbs,SWELLING OF LIMBS,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042702,10048959,10042702
STRANGE BEHAVIOURS,Abnormal behavior,ABNORMAL BEHAVIOR,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10079615,10061422,10079615
PATIENT WAS TREATED WITH FLUDARABINE FOR BONE MARROW CONDITIONING REGIMEN (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CONSTIPATION,Constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
TINNITUS,Tinnitus,TINNITUS,TINNITUS,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10043882,10043882,10043882
NEUTROPENIA GRADE 2 FOLLOWING TOXICITY OF CAPECITABINE DUE TO PRESSENCE OF HETEROZYGOSITY IN A DPYD *9A AND A TYMS 3RC ALLELE,NEUTROPENIA,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
HYPOKALEMIA (POTASSIUM LEVEL 1.9 MMOL/L),Hypokalaemia,HYPOKALEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021018
HISTOPATHOLOGIC EXAMINATION OF A LESION FROM THE LEFT ELBOW SHOWED SIGNS OF INCIPIENT INTRAEPIDERMAL BLISTER FORMATION,Blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
BONE MARROW DEPRESSION,Bone marrow failure,BONE MARROW DEPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10005986
CERVICAL LYMPHADENOPATHY,cervical lymphadenopathy,LYMPHADENOPATHY CERVICAL,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025200,10025197,10025200
SLOUGHING OF SKIN,Skin exfoliation,SLOUGHING OF SKIN,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10041041,10040844,10041041
"COMMON BILE DUCT LITHIASIS/THIS CASE REFERS TO A 65 YEAR OLD FEMALE WITH THE FOLLOWING EVENTS: LIVER ABSCESS, PNEUMONIA AND PANCYTOPENIA.",choledocholithiasis,CHOLEDOCHOLITHIASIS,BILE DUCT STONE,BILE DUCT DISORDERS,OBSTRUCTIVE BILE DUCT DISORDERS (EXCL NEOPLASMS),10019805,10049891,10004637,10049891
INTENTIONAL SUSPECTED SUICIDE,Completed suicide,COMPLETED SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10010144,10010144,10010144
RHEUMATOID FACTOR POSITIVE,Rheumatoid factor positive,RHEUMATOID FACTOR POSITIVE,RHEUMATOID FACTOR POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10039080,10039080,10039080
SEVERE AND TREATMENT-REFRACTORY DEFICITS,treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
URINARY TRACT INFECTION,Urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
HYPERGLYCAEMIA,Hyperglycaemia,HYPERGLYCAEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020635
COMPLETELY CONFUSED,Confusional state,CONFUSED,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010298
MUCOUS MEMBRANE DISORDER SUCH AS STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
PERICARDIAL EFFUSION,Pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
ULCERATION,Ulcer,ULCER,ULCER,TISSUE DISORDERS NEC,ULCERS NEC,10018065,10045285,10045285,10045285
SUPPURATION,Infection,SUPPURATIVE INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10075828,10021789,10075828
ACUTE PANCREATITIS,Acute pancreatitis,ACUTE PANCREATITIS,PANCREATITIS ACUTE,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10000971,10033647,10000971
SUSPECTED DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
DISEASE PROGRESSION,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
LOSE CONSIOUSNESS (JCS 200),Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
LOW OXYGEN SATURATION (62.4%),Oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
BILATERAL CATARACT IN THE EYES,Cataract,BILATERAL CATARACTS,CATARACT,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",CATARACT CONDITIONS,10015919,10004558,10007739,10004558
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
ITP SHOWED REFRACTORY TO PREDNISOLONE (LACK OF DRUG EFFECT WITH NO ADR),ITP showed refractory to prednisolone (lack of drug effect),LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
DIARRHEA,Diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
COMPLETE HEART BLOCK FOLLOWING CARDIOMYOPATHY,Atrioventricular block complete,COMPLETE HEART BLOCK,ATRIOVENTRICULAR BLOCK COMPLETE,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10010141,10003673,10010141
MULTIFOCAL ABSCESSING PNEUMONIA DUE TO THIAMAZOLE INDUCED AGRANULOCYTOSIS,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
PERIPHERAL BLAST FORMATION,Blast cells present,PERIPHERAL BLAST CELLS PRESENT,BLAST CELLS PRESENT,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),HAEMATOLOGICAL ANALYSES NEC,10022891,10077239,10057107,10077239
TORSADE DE POINTES,Torsade de pointes,TORSADE DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044066
UNCOORDINATED AND FLACCID ON THE RIGHT SIDE OF THE BODY/ SELF-RESOLVING RIGHT-SIDED HEMIPARESIS/ INTERMITTENT EPISODES OF HEMIPLEGIA PERSISTED,Hemiplegia,FLACCID HEMIPLEGIA,HEMIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10016743,10019468,10016743
MICROSPORIDIA,Microsporidia infection,MICROSPORIDIA INFECTION,MICROSPORIDIA INFECTION,PROTOZOAL INFECTIOUS DISORDERS,PROTOZOAL INFECTIONS NEC,10021881,10053982,10053982,10053982
LYMPHOPENIA,lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
DISSEMINATED INTRAVASCULAR COAGULATION FOLLOWING AUTO IMMUNE HEMOLYTIC ANEMIA,Disseminated intravascular coagulation,DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10013442,10013442,10013442
MYALGIA,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
VERTEBRAL FRACTURE,Vertebral fracture,VERTEBRAL FRACTURE,SPINAL FRACTURE,BONE AND JOINT INJURIES,SPINAL FRACTURES AND DISLOCATIONS,10022117,10047333,10041569,10047333
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
GASTROINTESTINAL STROMAL TUMOR PROGRESSION,Gastrointestinal stromal tumor,GASTROINTESTINAL STROMAL TUMOR,GASTROINTESTINAL STROMAL TUMOUR,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,GASTROINTESTINAL NEOPLASMS MALIGNANCY UNSPECIFIED NEC,10029104,10062427,10051066,10062427
MALNUTRITION DUE TO PROGRESSIVE WEIGHT LOSS FOLLOWING OFF LABEL USE OF ILOPROST TROMETAMOL,malnutrition,MALNUTRITION,MALNUTRITION,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10061273,10061273,10061273
"DRUG TOXICITY, AGITATION, HALLUCINATION",Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
STEVENS JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042030
ALP 444 U/L,Blood alkaline phosphatase increased,ALP INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001771,10059570,10001771
KLEBSIELLA PNEUMONIAE STRAIN,klebsiella pneumoniae infection,KLEBSIELLA PNEUMONIAE INFECTION,KLEBSIELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10052209,10061259,10052209
BLOOD PRESSURE 65/40 MMHG,Low blood pressure,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10024895,10021097,10024895
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DRUG-INDUCED LIVER INJURY,drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
SEVERE FUNGAL INFECTION,fungal infection,FUNGAL INFECTION,FUNGAL INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017533,10017533,10017533
DYSURIC TROUBLES,Dysuria,DYSURIA,DYSURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10013990,10013990,10013990
GENERALISED ERYTHEMATOUS MACULOPAPULAR RASH,maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
ALUMINUM TOXICITY FOLLOWING SUCRALFATE ADMINISTRATION,Metal poisoning,METAL POISONING,METAL POISONING,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10027439,10027439,10027439
DETERIORATION OF EGFR IS STRONGLY LINKED TO ENHANCED PLATELET ACTIVITY DURING DAPT,Renal impairment,RENAL FUNCTION AGGRAVATED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038453,10062237,10038453
LEG MUSCLE WEAKNESS,Muscular weakness,MUSCLE WEAKNESS LOWER LIMB,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10065776,10028372,10065776
"USE OF MYCOPHENOLATE MOFETIL FOR IGA NEPHROPATHY, MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS AND GLOMERULOCLEROSIS (OFF LABEL USE)",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BMI WAS 42.4KG/M2 (OBESITY),obesity,OBESITY,OBESITY,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10029883,10029883,10029883
RENAL IMPAIRMENT,renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
SPONGIOSIS,Eczema,EPIDERMA SPONGIOSIS,ECZEMA,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10062582,10014184,10062582
PHOTOPHOBIA,Photophobia,PHOTOPHOBIA,PHOTOPHOBIA,OCULAR SENSORY SYMPTOMS NEC,OCULAR SENSATION DISORDERS,10015919,10034960,10034960,10034960
POORLY TOLERATED,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
LEISHMANIA AMASTIGOTES IN LYMPH NODE BIOPSY/ L DONOVANI COMPLEX IN PERIPHERAL BLOOD PCR/ VISCERAL LEISHMANIASIS,Visceral leishmaniasis,VISCERAL LEISHMANIASIS,VISCERAL LEISHMANIASIS,PROTOZOAL INFECTIOUS DISORDERS,LEISHMANIA INFECTIONS,10021881,10047505,10047505,10047505
TINNITUS,Tinnitus,TINNITUS,TINNITUS,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10043882,10043882,10043882
FISTULA,Oral cavity fistula,ORAL CAVITY FISTULA,ORAL CAVITY FISTULA,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL FISTULAE,10017947,10065720,10065720,10065720
PARADOXICAL REACTION OF TUBERCULOSIS DURING ANTITUBERCULOSIS THERAPY,Paradoxical drug reaction,PARADOXICAL DRUG REACTION,PARADOXICAL DRUG REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048958,10048958,10048958
ERYTHEMA I HIS LEFT SHOULDER,vaccination site erythema,VACCINATION SITE ERYTHEMA,VACCINATION SITE ERYTHEMA,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10059079,10059079,10059079
UPPER RESPIRATORY TRACT INFECTION,Upper respiratory tract infection,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10046306,10046306,10046306
DRUG PRESCRIBED FOR UNAPPROVED INDICATION,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
LACK OF EFFECT/NO RESPONSE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
BOWEL OBSTRUCTION,Intestinal obstruction,BOWEL OBSTRUCTION,INTESTINAL OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION NEC,10017947,10022687,10022687,10006055
MARKED ANXIETY,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
HEMATURIA,hematuria,HAEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018867,10018867,10018867
GENERALIZED PRURITUS WITH SKIN RASH,skin rash,SKIN RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040913,10037844,10040913
REFRACTORY HYPERTENSION/ PERSISTENTLY ELEVATED BLOOD PRESSURE VALUES,Hypertension,REFRACTORY HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10038274,10020772,10038274
EMOTIONAL LABILITY FOLLOWING DEVP,Affect lability,EMOTIONAL LABILITY,AFFECT LABILITY,MOOD DISORDERS AND DISTURBANCES NEC,AFFECT ALTERATIONS NEC,10037175,10014554,10054196,10014555
OROPHARYNGEAL ULCERATION,Pharyngeal ulceration,PHARYNGEAL ULCERATION,PHARYNGEAL ULCERATION,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),PHARYNGEAL DISORDERS (EXCL INFECTIONS AND NEOPLASMS),10038738,10034834,10034834,10034834
THROMBOPENIA,Thrombopenia,THROMBOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043569,10043554,10043569
OFF LABEL USE OF METHOTREXATE IN IGA KAPPA ANAPLASTIC MYELOMA THAT EVOLVED FROM MULTIPLE MYELOMA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"HEARING, PRESSURE, AND TINNITUS IN THE LEFT EAR FAILED TO IMPROVE DURING THE NEXT MONTH",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CHEMOTHERAPY-INDUCED ORAL MUCOSITIS GRADE 3 FOLLOWING RATOULTELLA PLANTICOLA INFECTION,Mucositis oral,MUCOSITIS ORAL,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028130,10042128,10028130
ACUTE GVHD OF SKIN STAGE II,Graft versus host disease in skin,GRAFT VERSUS HOST DISEASE IN SKIN,GRAFT VERSUS HOST DISEASE IN SKIN,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10064675,10064675,10064675
TRANSIENT LOSS OF CONSCIOUSNESS,Loss of consciousness,TRANSIENT LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10077573,10024855,10077573
SEVERE INFECTIONS,severe infections,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
NO RESPONSE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
CIRCULATORY SYMPTOMS,cardiac disorder nos,CARDIAC DISORDER NOS,CARDIAC DISORDER,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10007540,10061024,10007540
FIXED AND PINPOINT PUPILS,pin-point pupils,PIN-POINT PUPILS,MIOSIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10035051,10027646,10035051
FAILED DURING SEX,Sexual problem,SEXUAL PROBLEM,SEXUAL DYSFUNCTION,SEXUAL FUNCTION AND FERTILITY DISORDERS,SEXUAL FUNCTION AND FERTILITY DISORDERS NEC,10038604,10040486,10040477,10040486
"SKIN EXAMINATION REVEALED MULTIPLE 1-3MM, SOFT, SKIN COLORED TO YELLOWISH,DOME-SHAPED,UMBLICAL PAPULES ON FOREHEAD,BILATERAL LATERAL/MALAR CHEEKS",Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
SEVERE ASYMPTOMATIC SINUS BRADYCARDIA/MILD BRADYCARDIA/HEART RATE 38 BEATS PER MINUTE,Sinus bradycardia,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040741,10040741,10040741
DIFFUSE ERYTHEMA OVER THE ENTIRE BODY,diffuse erythema over the entire body,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
"THIN UPPER LIP, LONG PHILTRUM AND BROAD NASAL BRIDGE FOLLOWING DRUG EXPOSURE IN UTERO",Dysmorphism,FACIAL DYSMORPHISM,DYSMORPHISM,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL DISORDERS CONGENITAL NEC,10010331,10016045,10066054,10016045
BRONCHOALVEOLAR LAVAGE WAS POSITIVE FOR SCEDOSPORIUM APIOSPERMUM,Scedosporium infection,SCEDOSPORIUM APIOSPERMUM INFECTION,SCEDOSPORIUM INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10076593,10059045,10076593
STRONG POSITIVE ACETONE IN THE URINE,Urine ketone body present,URINARY ACETONE PRESENT,URINE KETONE BODY PRESENT,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10023390,10057597,10046513
BILATERAL SUPERIOR AND INFERIOR LOBER BRANCHES TRUNK THROMBOSIS,Thrombosis,THROMBOSIS,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10043607,10043607,10043607
"PSORIASIFORM PLAQUES PREDOMINANTLY ON HANDS, FEET, AND SCALP AS WELL AS SEVERE NAIL DYSTROPHY",Plaque psoriasis,PLAQUE PSORIASIS,PSORIASIS,EPIDERMAL AND DERMAL CONDITIONS,PSORIATIC CONDITIONS,10040785,10071117,10037153,10071117
RIGHT UPPER QUADRANT PAIN,upper abdominal pain,UPPER ABDOMINAL PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10046272,10000087,10046272
CONFUSIONS,Confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
UNDIAGNOSED PHEOCHROMOCYTOMA,unmasking of previously unidentified disease,UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE,UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076269,10076269,10076269
CAMPYLOBACTER JEJUNI INFECTION,Campylobacter infection,CAMPYLOBACTER JEJUNI INFECTION,CAMPYLOBACTER INFECTION,BACTERIAL INFECTIOUS DISORDERS,CAMPYLOBACTER INFECTIONS,10021881,10054229,10051226,10054229
PROGRESSION OF PRIMARY MYEOFIBROSIS COMPLICATED WITH MYELODYSPLASTIC SYNDROME FOLLOWING TREATMENT FAILURE,Myelofibrosis,MYELOFIBROSIS,MYELOFIBROSIS,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),MYELOPROLIFERATIVE DISORDERS (EXCL LEUKAEMIAS),10029104,10028537,10028537,10028537
LOWER LIMB SWELLING AND PAIN,Inflammation,INFLAMMATION,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10061218,10061218,10061218
SECONDARY INTRACRANIAL HYPERTENSION,Intracranial pressure increased,INTRACRANIAL HYPERTENSION,INTRACRANIAL PRESSURE INCREASED,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10022764,10022773,10022764
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
SCATTERED INTRARETINAL HEMORRHAGES,Retinal hemorrhage,RETINAL HEMORRHAGE,RETINAL HAEMORRHAGE,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINAL BLEEDING AND VASCULAR DISORDERS (EXCL RETINOPATHY),10015919,10038870,10038867,10038870
UNCOMFORTABLE WITH DIFFUSE RASH,Skin discomfort,SKIN DISCOMFORT,SKIN DISCOMFORT,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040830,10040830,10040830
SEVERE CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
PRESCRIBED DOSE OF CITALOPRAM WAS TWICE THE RECOMMENDED GERIATRIC DOSE,drug dose prescribing error,DRUG DOSE PRESCRIBING ERROR,DRUG PRESCRIBING ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT PRESCRIBING ERRORS AND ISSUES,10022117,10064300,10064296,10064300
SEVERE HEPATOPULMONARY SYNDROME DUE TO VITAMIN A-INDUCED CHRONIC LIVER DISEASE FOLLOWING DRUG INTOXICATION,Hepatopulmonary syndrome,HEPATOPULMONARY SYNDROME,HEPATOPULMONARY SYNDROME,PULMONARY VASCULAR DISORDERS,VASCULAR PULMONARY DISORDERS NEC,10038738,10052274,10052274,10052274
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
ANXIOUSNESS,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
RETICULOCYTES INCREASED (11.0%),Reticulocyte count increased,RETICULOCYTE COUNT INCREASED,RETICULOCYTE COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10038792,10038792,10038792
COCCIDIOIDOMYCOSIS,Coccidioidomycosis,COCCIDIOIDOMYCOSIS,COCCIDIOIDOMYCOSIS,FUNGAL INFECTIOUS DISORDERS,COCCIDIOIDES INFECTIONS,10021881,10009825,10009825,10009825
CONFUSIONAL STATE,Confusional state,CONFUSIONAL STATE,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010305,10010305,10010305
HYPERCAPNIA,Hypercapnia,HYPERCAPNIA,HYPERCAPNIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10020591,10020591,10020591
"WITH POVIDONE, IODINATED INGESTION",wrong route of administration,WRONG ROUTE OF ADMINISTRATION,INCORRECT ROUTE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10048057,10064304,10048057
INFECTION CAUSED BY KP-HUB-ST147 AND RESISTANT TO MEROPENEM,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
PERSECUTORY IDEATION,Persecutory delusion,PERSECUTORY DELUSION,PERSECUTORY DELUSION,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10034702,10034702,10034702
DRUG OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
HYPOTENSION (90/60 MMHG),Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
LEFT EYE PAIN,Eye pain,EYE PAIN,EYE PAIN,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10015958,10015958,10015958
AN ADDITIVE EFFECT TO LITHIUM-INDUCED STABILISATION OF MOOD FLUCTUATIONS SINCE THE SECOND WEEK OF LACOSAMIDE ADDITION.,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
STEVENS-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
MIXED HYPERLIPIDEMIA,hyperlipidemia,HYPERLIPIDEMIA,HYPERLIPIDAEMIA,LIPID METABOLISM DISORDERS,HYPERLIPIDAEMIAS NEC,10027433,10020667,10062060,10020667
ACETYLSALICYLIC ACID EXPOSURE DURING PREGNANCY DURING FIRST-TRIMESTER,Foetal exposure during pregnancy,"FOETAL EXPOSURE DURING PREGNANCY, FIRST TRIMESTER",FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071422,10071404,10071422
URINARY TRACT INFECTION,urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
PROTRACTED INFLAMMATORY REACTION,Inflammation,INFLAMMATORY REACTION,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10021995,10061218,10021995
HEPATIC FUNCTION DISORDER,Hepatic function disorder,HEPATIC FUNCTION DISORDER,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019674,10019670,10019674
NEUROPATHIC PAIN,neuropathic pain,NEUROPATHIC PAIN,NEURALGIA,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10054095,10029223,10054095
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
DARK BROWN URINE,Chromaturia,BROWN URINE,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10058129,10008796,10058129
LISTERIA SEPSIS,Listeria sepsis,LISTERIA SEPSIS,LISTERIA SEPSIS,BACTERIAL INFECTIOUS DISORDERS,LISTERIA INFECTIONS,10021881,10063085,10063085,10063085
"CATA-STROPHIC INFARCTS INVOLVING BOTH KIDNEYS, BOWEL AND LIVER, A LARGE NEWCEREBRAL INFARCT",Renal infarct,RENAL INFARCTION,RENAL INFARCT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL VASCULAR AND ISCHAEMIC CONDITIONS,10038359,10038470,10038470,10038471
AN EMPTY BOTTLE OF CARBAMAZEPINE WAS IDENTIFIED BY MEDICAL PERSONNEL,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
FEW MUCOSAL EROSIONS ON THE LIPS AND IN THE MOUTH,Mucosal erosion,MUCOSAL EROSION,MUCOSAL EROSION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10061297,10061297,10061297
MEPHENESIN 12G/DAY,drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
NOCTURNAL HYPERPHAGIA ASSOCIATED WITH AMNESIA,Hyperphagia,HYPERPHAGIA,HYPERPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10020710,10020710,10020710
DRUG OVERDOSE DEATHS/ACCIDENTAL,Accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
TUMOR,tumor,GUM SWELLING,GINGIVAL SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10018789,10018291,10018789
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
"REPORT ON TWO PATIENTS ADMINISTERED NAC CONSISTING OF DOCETAXEL, OXALIPLATIN AND S-1/CASES CURATIVE LAPAROSCOPIC RESECTION WAS PERFORMED",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
DEHYDRATION,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
WORSENING HYPONATREMIA,hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
RETROPERITONEAL HEMORRHAGE,Retroperitoneal haemorrhage,RETROPERITONEAL HEMORRHAGE,RETROPERITONEAL HAEMORRHAGE,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL HAEMORRHAGES,10017947,10038980,10038980,10038981
NO ADVERSE DRUG REACTION,No adverse drug reaction,NO ADVERSE DRUG REACTION,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067481,10067482,10067481
ODYNOPHAGIA,Odynophagia,ODYNOPHAGIA,ODYNOPHAGIA,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE PAIN AND PARAESTHESIA,10017947,10030094,10030094,10030094
LEPTOMENINGEAL CARCINOMATOSIS TREATED WITH TEMOZOLOMIDE (DRUG USE FOR UNAPPROVED INDICATION WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
CARDIAC ARREST DUE TO POLYMORPHIC VENTRICULAR TACHYCARDIA AND VENTRICULAR FIBRILLATION,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
NIGHTMARE,Nightmare,NIGHTMARE,NIGHTMARE,SLEEP DISORDERS AND DISTURBANCES,PARASOMNIAS,10037175,10029412,10029412,10029412
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
DIFFUSE ENCEPHALOPATHY,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
EXUDATIVE RETINAL DETACHMENT,retinal detachment,RETINAL DETACHMENT,RETINAL DETACHMENT,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10038848,10038848,10038848
DEHYDRATION,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
BIOPSIES SHOWED CHRONIC ACTIVE COLITIS WITH ABUNDANT INTRACELLULAR FUNGAL ELEMENT,Biopsy colon abnormal,BIOPSY COLON ABNORMAL,BIOPSY COLON ABNORMAL,GASTROINTESTINAL INVESTIGATIONS,GASTROINTESTINAL HISTOPATHOLOGY PROCEDURES,10022891,10004760,10004760,10004760
DIFFICULTY BREATHING,Dyspnoea,DIFFICULTY BREATHING,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10012791
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
COARSE CRACKLES WERE HEARD IN RIGHT LUNG FIELD,Rales,CRACKLES LUNG,RALES,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10054910,10037833,10054910
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
INTERCEPTED MEDICATION ERROR,Intercepted medication error,INTERCEPTED MEDICATION ERROR,INTERCEPTED MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10064382,10064382,10064382
MYCOPHENOLATE MOFETIL USED FOR LUNG TRANSPLANT,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
ACUTE MYOPIA,acute myopia,ACUTE MYOPIA,ACUTE MYOPIA,VISION DISORDERS,REFRACTIVE AND ACCOMMODATIVE DISORDERS,10015919,10078300,10078300,10078300
ENTEROCOCCUS FAECALIS INFECTION,Enterococcal infection,ENTEROCOCCUS FAECALIS INFECTION,ENTEROCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,ENTEROCOCCAL INFECTIONS,10021881,10051978,10061124,10051978
ACUTE PORTAL VEIN THROMBOSIS ON REPEAT ABDOMINAL ULTRASOUND (FIGURE 2) DESPITE ONGOING ANTICOAGULATION WITH APIXABAN.,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
IMATINIB-INDUCED HYPERPIGMENTATION,Oral pigmentation,ORAL PIGMENTATION,ORAL PIGMENTATION,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SIGNS AND SYMPTOMS,10017947,10077552,10077552,10077552
ACUTELY SHORT OF BREATH/BREATHING BECAME LABORED,Dyspnoea,LABORED BREATHING,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10023557,10013968,10023552
INCREASE IN SPLEEN SIZE,Spleen enlarged,SPLEEN ENLARGED,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041637,10041660,10041637
INCREASED SERUM CREATININE (3.2 MG/DL),Blood creatinine increased,INCREASED SERUM CREATININE,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10021678
AMYOPATHIC DERMATOMYOSITIS,Dermatomyositis,DERMATOMYOSITIS,DERMATOMYOSITIS,EPIDERMAL AND DERMAL CONDITIONS,CONNECTIVE TISSUE DISORDERS,10040785,10012503,10012503,10012503
HYPERKINETIC SHOCK,shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
MORPHINE ADDICTION,Drug addiction,DRUG ADDICTION,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013658,10013663,10013658
SEVERE HIP PAIN,Pain in hip,PAIN IN HIP,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10033432,10003239,10033432
OXOPROLINEMIA,Hyperprolinaemia,HYPERPROLINEMIA,HYPERPROLINAEMIA,METABOLIC AND NUTRITIONAL DISORDERS CONGENITAL,INBORN ERRORS OF AMINO ACID METABOLISM,10010331,10058509,10058509,10058515
MINOR MANIPULATION (POSITIVE NIKOLSKY SIGN),Nikolsky's sign,NIKOLSKY'S SIGN,NIKOLSKY'S SIGN,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10029415,10029415,10029415
VENTRICULAR DYSARRHYTHEMIA,Ventricular arrhythmia,VENTRICULAR ARRHYTHMIA,VENTRICULAR ARRHYTHMIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047281,10047281,10047281
OEDEMA OVER THE NOSE,Nose oedema,NOSE OEDEMA,NASAL OEDEMA,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10029800,10028750,10029800
"PATIENT RECEIVED FIRST DOSE ON 01 MAR 2016, SECOND DOSE ON 20 APR 2016 AND THIRD DOSE ON 29 NOV 2016",Inappropriate schedule of vaccine administered,INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTERED,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10063976,10021597,10063976
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HIS COMMUNICATION WITH PEOPLE DECREASED AND HE WAS SOCIALLY ISOLATED,Communication disorder,COMMUNICATION DISORDER,COMMUNICATION DISORDER,COMMUNICATION DISORDERS AND DISTURBANCES,COMMUNICATIONS DISORDERS,10037175,10061046,10061046,10061046
DEVELOPMENT OF ANGIOEDEMA,development of angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
POSTURAL INSTABILITY,Balance disorder,EQUILIBRIUM LOSS,BALANCE DISORDER,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10049848,10049848,10050073
BREATHLESSNESS,breathlessness,BREATHLESSNESS,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10006345,10013968,10006345
IMMUNE-MEDIATED IDR/DRUG HYPERSENSITIVITY TO CNIS,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
BREASTFED INFANT WHO COULD NOT TOLERATE SERTRALINE AND PAROXETINE,Exposure via breast milk,DRUG EXPOSURE VIA BREAST MILK,EXPOSURE VIA BREAST MILK,"EXPOSURES, CHEMICAL INJURIES AND POISONING",PATHWAYS AND SOURCES OF EXPOSURE,10022117,10051075,10080751,10051075
THE BLISTERS ARE FILLED WITH SEROUS FLUID,Blister,BLISTERS,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005216
PROGRESSIVE COGNITIVE DECLINE,cognitive impairment,COGNITIVE IMPAIRMENT,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10009846,10057668,10009846
WORSENING OF RIGHT EMPYEMA DUE TO LACK OF DRUG EFFECT OF ANTIBIOTICS,Empyema,EMPYEMA,EMPYEMA,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10014568,10014568,10014568
CARDIAC SYMPTOMS,Cardiac disorder,HEART DISORDER,CARDIAC DISORDER,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10019277,10061024,10019277
GFR DECREASED (15-29 ML/MIN),Glomerular filtration rate decreased,GFR DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018214,10018358,10018214
SEVERE THROMBOCYTOPENIA (PLATELET 5000/UL),Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
COLLAGENOUS COLITIS,Colitis microscopic,COLITIS COLLAGENOUS,COLITIS MICROSCOPIC,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10048928,10056979,10048928
DRUG RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
"DISEASE PROGRESSION FOLLOWING TREATMENT FAILURE OF GC, GD AND PEMETREXED THERAPIES",disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
TROPONIN I INCREASED (8.13 NG/ML),Troponin I increased,TROPONIN I INCREASED,TROPONIN I INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10058268,10058268,10058268
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
RENAL FAILURE,Renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
SULFASALAZINE AND HYDROXYCHLOROQUINE TREATMENT WAS INEFFECTIVE,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
CHILLS,chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
CARDIORESPIRATORY ARREST/ CARDIORESPIRATORY ARREST SECONDARY TO VENTRICULAR TACHYCARDIA,Cardio-respiratory arrest,CARDIO-RESPIRATORY ARREST,CARDIO-RESPIRATORY ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007617,10007617,10007617
PSYCHOSIS,Psychotic disorder,PSYCHOSIS,PSYCHOTIC DISORDER,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10037234,10061920,10037234
ALP INCREASED,Blood alkaline phosphatase increased,ALP INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001771,10059570,10001771
PALPITATIONS/SENSATION OF MISSED BEATS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
NEUROLOGICAL TOXICITY,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
MUSCULAR WEAKNESS,Muscular weakness,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028372,10028372,10028372
ACUTE LUNG INJURY,Acute lung injury,ACUTE LUNG INJURY,ACUTE LUNG INJURY,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10069351,10069351,10069351
PRIMAQUINE-INDUCED HAEMOLYTIC ANAEMIA,Haemolytic anaemia,HAEMOLYTIC ANAEMIA DRUG-INDUCED,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10018918,10018916,10018918
EPISODES OF SYMPTOMATIC HYPOGLYCEMIA,Hypoglycaemia,HYPOGLYCEMIC REACTION,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10021003,10020993,10021009
DIFFICULTY SWALLOWING/ DYSPHAGIA,Dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
FOCAL BASAL GANGLIA INFARCTS,Basal ganglia infarction,BASAL GANGLIA INFARCTION,BASAL GANGLIA INFARCTION,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10069020,10069020,10069020
NEPHROTOXICITY,Nephropathy toxic,NEPHROTOXICITY,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10067571
PERSISTANT LOW VISUAL ACUITY DUE TO DENSE BILATERAL CORNEAL BAND KERATOPATHY,Visual acuity reduced,VISUAL ACUITY REDUCED,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047531,10047531,10047531
PSEUDOMONAS URINARY TRACT INFECTION,Urinary tract infection pseudomonal,URINARY TRACT INFECTION PSEUDOMONAL,URINARY TRACT INFECTION PSEUDOMONAL,BACTERIAL INFECTIOUS DISORDERS,PSEUDOMONAL INFECTIONS,10021881,10062279,10062279,10062279
PERIPHERAL NEUROPATHY,Neuropathy peripheral,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10080342
HORIZONTAL ISOLATED DIPLOPIA IN BINOCULAR VISION,Diplopia,BINOCULAR DIPLOPIA,DIPLOPIA,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10076680,10013036,10076680
ERYTHRODERMA,erythroderma,ERYTHRODERMA,DERMATITIS EXFOLIATIVE GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10015277,10012456,10015277
DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE EVENTS,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
CONTINUOUS MYOCLONIC JERKS INVOLVING THE RIGHT SIDE OF THE BODY WITH IMPAIRED AWARENESS,Altered state of consciousness,CONSCIOUSNESS ABNORMAL,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010765,10001854,10010765
ALTERED MENTAL STATUS,mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
DELAYED HYPERSENSITIVITY,Delayed type hypersensitivity,DELAYED TYPE HYPERSENSITIVITY,TYPE IV HYPERSENSITIVITY REACTION,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10012210,10053613,10012210
NEPHROTIC SYNDROME DUE T O  AMYLOIDOSIS,Nephrotic syndrome,NEPHROTIC SYNDROME,NEPHROTIC SYNDROME,NEPHROPATHIES,GLOMERULONEPHRITIS AND NEPHROTIC SYNDROME,10038359,10029164,10029164,10029164
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
GRADE 1 ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
GENERALISED EXFOLIATIVE MACULOPAPULAR ERUPTION,Rash maculo-papular,GENERALISED MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10077181,10037868,10077181
PILOTâ€™S IMPAIRED PERFORMANCE DUE TO HIS USE OF POTENTIALLY IMPAIRING MEDICATIONS,Performance status decreased,PERFORMANCE STATUS DECREASED,PERFORMANCE STATUS DECREASED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10048919,10048919,10048919
HYPERAMMONAEMIA,Hyperammonaemia,HYPERAMMONAEMIA,HYPERAMMONAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020575,10020575,10020575
HEART FAILURE,Heart failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10019279,10007554,10019279
MILD RESIDUAL LOWER EXTREMITY NUMBNESS PERSISTED (SUB THERAPEUTIC EFFECT) WITH NO ADVERSE DRUG REACTION.,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
"PATIENT RECEIVED DUAL ANTIPLATELET THERAPY WITH ASPIRIN AND CLOPIDOGREL, AND ANTICOAGULANT PATIENT RECEIVED DUAL ANTIPLATELET THERAPY WITH ASPIRIN AND CLOPIDOGREL, AND ANTICOAGULANT",Labelled drug-drug interaction medication error,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT MONITORING ERRORS AND ISSUES,10022117,10064373,10064373,10064373
INFECTION,bone infection,BONE INFECTION,OSTEOMYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,BONE AND JOINT INFECTIONS,10021881,10061017,10031252,10061017
OCULOMOTOPARESIS,Oculomotor paresis,OCULOMOTOR PARESIS,IIIRD NERVE PARESIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),EYE MOVEMENT DISORDERS,10029205,10030076,10054202,10030076
RECURRENT  LEFT-SIDED  PNEUMOTHORAX DUE TO PNEUMONIA (PSEUDOMONAS AERUGINOSA) PROGRESSION,pneumothorax,PNEUMOTHORAX,PNEUMOTHORAX,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035759,10035759,10035759
CONSCIOUSNESS ABNORMAL/ALTERED STATE OF CONSCIOUSNESS,Consciousness abnormal,CONSCIOUSNESS ABNORMAL,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010765,10001854,10010765
HELLP SYNDROME,HELLP syndrome,HELLP SYNDROME,HELLP SYNDROME,MATERNAL COMPLICATIONS OF PREGNANCY,HYPERTENSION ASSOCIATED DISORDERS OF PREGNANCY,10036585,10049058,10049058,10049058
DEPRESSION,Depression,DEPRESSION,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012378,10012378,10012378
GAZE FIXATION,Gaze palsy,GAZE PALSY,GAZE PALSY,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10056696,10056696,10056696
FEMALE BABY BORN AT 31 WEEKS OF PREGNANCY,Premature baby,PREMATURE BABY 26 TO 32 WEEKS,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10053593,10036590,10053593
EARLY ONSET DRUG-INDUCED HYPERTENSION ( (BP  >95TH  CENTILE),Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
CHERRY RED SPOTS AT THE MACULA,red eye,RED EYE,OCULAR HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10038189,10030041,10038189
"DESPITE TREATMENT WITH LAMOTRIGINE AND LEVETIRACETAM, SEIZURE CONTROL WAS NOT ACHIEVED/SEIZURE CONTROL WAS NOT ACHIEVED UNDER LAMOTRIGINE AND LEVETIRACETAM",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
DECREASED HAEMOGLOBIN TO 6.8 G/DL,Haemoglobin decreased,DECREASED HAEMOGLOBIN,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10056184
RED ITCHY RASH ON HIS FACE AND TORSO,itchy rash,ITCHY RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023092,10037884,10023092
ALLERGY,ALLERGY,ALLERGY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001738,10020751,10001738
ALANINE AMINOTRANSFERASE INCREASED (133U/L),Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
KETONEMIA,Acetonaemia,KETONEMIA,ACETONAEMIA,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10057592,10000410,10057599
ESCHERICHIA COLI-INDUCED ECTHYMA GANGRENOSUM,Ecthyma,ECTHYMA GANGRENOSUM,ECTHYMA,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10069756,10014141,10069756
POOR LEFT VENTRICULAR SYSTOLIC FUNCTION,Left ventricular systolic dysfunction,LEFT VENTRICULAR SYSTOLIC DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10069501,10049694,10069501
INATTENTION,Disturbance in attention,ATTENTION IMPAIRED,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10013496,10013496,10003738
IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (CHOLESTATIC PATTERN),Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
HEART RHYTHM ISSUE,Cardiac disorder,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10061024,10061024,10061024
"HIS WIFE'S ADDICTION TO DRUGS (PROMETAZIN, PENTAZIN, TEGRETOL, PIRITON, DIAZEPAM, ARTANE AND MOGARDON).",Drug dependence,DRUG ADDICTION,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013658,10013663,10013658
HEMOLYTIC UREMIC SYNDROME RECURRENCE,Hemolytic uremic syndrome,HEMOLYTIC UREMIC SYNDROME,HAEMOLYTIC URAEMIC SYNDROME,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC MECHANICAL FACTOR,10005329,10019515,10018932,10019515
INTERMITTENT PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
CRP INCREASED (40.2 MG/L),C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
CHRONIC USE OF ACETAMINOPHEN,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
BONE MARROW SUPPRESSION,Bone marrow failure,BONE MARROW DEPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10005986
TUMOUR HAEMORRHAGE,Tumour haemorrhage,TUMOUR HAEMORRHAGE,TUMOUR HAEMORRHAGE,NEOPLASM RELATED MORBIDITIES,ONCOLOGIC COMPLICATIONS AND EMERGENCIES,10029104,10049750,10049750,10049750
COMA,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
DRY MOUTH,Dry mouth,DRY MOUTH,DRY MOUTH,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10013781,10013781,10013781
GENERALIZED PAIN,general body pain,GENERAL BODY PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10048971,10033371,10048971
PYOMYOSITIS,Pyomyositis,PYOMYOSITIS,PYOMYOSITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10037652,10037652,10037652
"LEFT CAROTID JUGULAR, LEFT AXILLARY AND RIGHT INGUNAL LENTICULAR ADENOPATHIES",Lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
"MASSIVE RIGHT SPERMATIC CORD, RIGHT THENAR AND EPIDIDYMAL HEMATOMA FOLLOWING HENOCH-SCHOENLEIN PURPURA",Hematoma,HEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10019428,10018852,10019428
BILATERAL THIGH EDEMA,edema thigh,EDEMA THIGH,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10050070,10030124,10050070
DRUG OVERDOSE,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
GRADE 1 RESPIRATORY DISTRESS SYNDROME,Respiratory distress syndrome (neonatal),RESPIRATORY DISTRESS SYNDROME (NEONATAL),NEONATAL RESPIRATORY DISTRESS SYNDROME,NEONATAL RESPIRATORY DISORDERS,NEONATAL HYPOXIC CONDITIONS,10038738,10038690,10028974,10038690
FEVER (UP TO 38.6 ÂºC),fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
ANTI-MYELOPEROXIDASE ANTIBODIES POSITIVE,Antineutrophil cytoplasmic antibody positive,MYELOPEROXIDASE ANTIBODY TEST POSITIVE,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10060156,10060136,10060156
DRUG OVERDOSE ACCIDENTAL,drug overdose accidental,DRUG OVERDOSE ACCIDENTAL,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10013737,10000381,10013737
HYPOTHERMIA,HYPOTHERMIA,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
SERUM  GLUTAMIC OXALOACETIC TRANSAMINASE INCREASED,SGOT increased,SGOT INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10040524,10003481,10040524
POISONING ASSOCIATED WITH INAPPROPRIATE USE OF A EUTECTIC MIXTURE OF LIDOCAINE AND PRILOCAINE,Poisoning,POISONING,POISONING,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10061355,10061355,10061355
DRUG EXPOSURE IN UTERO,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
WEIGHT  LOSS,weight  loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
FULL-BLOWN ADDICTION TO OPIOIDS,Drug use disorder,OPIOID USE DISORDER,DRUG USE DISORDER,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10079385,10079381,10079385
INFECTION,Infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
CHRONIC SUBDURAL HAEMATOMAS,chronic subdural haematomas,SUBDURAL HAEMATOMA,SUBDURAL HAEMATOMA,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10042361,10042361,10042361
NOCTURNAL COUGHING,Cough,COUGHING,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011232
INITIAL SOMNOLENCE WITH CARBAMAZEPINE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
ADVERSE EVENT,Adverse event,ADVERSE EVENT,ADVERSE EVENT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10060933,10060933,10060933
A FIXED FLEXION DEFORMITY OF THE LITTLE FINGER WITH EXTENSION AT METACARPAL PHALANGEAL JOINT AND FLEXION AT THE DISTAL INTERPHALANGEAL JOINT,Finger deformity,FINGER DEFORMITY,FINGER DEFORMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES (INCL INTERVERTEBRAL DISC DISORDERS),EXTREMITY DEFORMITIES,10028395,10061156,10061156,10061156
HEMIBALLISMUS,Ballismus,HEMIBALLISMUS,BALLISMUS,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10058510,10058504,10058510
EXFOLIATIVE DERMATITIS,Dermatitis exfoliative,EXFOLIATIVE DERMATITIS,DERMATITIS EXFOLIATIVE,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10012455,10012455,10015665
LYMPH NODE ENLARGEMENT,Lymph nodes enlarged,LYMPH NODES ENLARGED,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025186,10025197,10025186
FEVER AGGRAVATED,fever aggravated,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
BLACK STOOLS,Faeces discoloured,BLACK STOOLS,FAECES DISCOLOURED,GASTROINTESTINAL SIGNS AND SYMPTOMS,FAECAL ABNORMALITIES NEC,10017947,10004977,10016100,10004977
ACUTE TOXIC ENCEPHALOPATHY FOLLOWING SEVERE ACUTE NEUROTOXICITY,acute toxic encephalopathy following severe acute neurotoxicity,ENCEPHALOPATHY TOXIC ACUTE,TOXIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10014639,10044221,10014639
BRAIN MRI REVEALED CYTOTOXIC EDEMA,Cytotoxic oedema,CYTOTOXIC EDEMA,CYTOTOXIC OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10067276,10067276,10067279
ALT INCREASED (1520 IU/L),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
LEFT EYE MILD HYPEREMIA,Hyperaemia,HYPEREMIA,HYPERAEMIA,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10020565,10020565,10020619
PROGRESSIVE DISEASE,Acute myeloid leukaemia,ACUTE MYELOBLASTIC LEUKEMIA,ACUTE MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10060354,10000880,10000878
EROSIONS IN THE ORAL MUCOSA,erosions in the oral mucosa,ORAL MUCOSA EROSION,ORAL MUCOSA EROSION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10064594,10064594,10064594
CAPECITABINE INDUCED INTERMITTENT CORONARY VASOSPASM,Arteriospasm coronary,CORONARY VASOSPASM,ARTERIOSPASM CORONARY,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10011107,10003225,10011110
PULSATILE VISUAL PHENOMENON,Visual impairment,VISUAL PHENOMENA,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047574,10047571,10047574
TREATMENT RESISTANT AMR,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
MULTIPLE LARGE WELL-CIRCUMSCRIBED ERYTHEMATOUS PLAQUES ON HIS TRUNK,Erythematous rash,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015243,10037855,10015243
DISTURBED CONSCIOUSNESS ACCOMPANYING HYPOGLYCAEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
BLOOD PRESSURE BECAME LABILE,Labile blood pressure,BLOOD PRESSURE LABILE,LABILE BLOOD PRESSURE,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,BLOOD PRESSURE DISORDERS NEC,10047065,10005752,10023533,10005752
DREAMS ABNORMAL,Abnormal dreams,DREAMS ABNORMAL,ABNORMAL DREAMS,SLEEP DISORDERS AND DISTURBANCES,PARASOMNIAS,10037175,10000125,10000125,10013632
GASTRIC AND DISTAL INTESTINAL LINEAR PNEUMATOSIS,Gastric pneumatosis,GASTRIC PNEUMATOSIS,GASTRIC PNEUMATOSIS,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10079517,10079517,10079517
MYOCARDITIS,Myocarditis,MYOCARDITIS,MYOCARDITIS,MYOCARDIAL DISORDERS,NONINFECTIOUS MYOCARDITIS,10007541,10028606,10028606,10028606
SEVERE DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
SUBARACHNOID AND INTRACRANIAL HEMORRHAGE,Subarachnoid hemorrhage,SUBARACHNOID HEMORRHAGE,SUBARACHNOID HAEMORRHAGE,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10042320,10042316,10042320
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
"PRURITIC MACULOPAPULAR RASH ON HER FACE, CHEST, ARMS AND LEGS",Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
HEPATOSPLENOMEGALY,hepatosplenomegaly,HEPATOSPLENOMEGALY,HEPATOSPLENOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019847,10019847,10019847
DIFFUSE LARGE B-CELL LYMPHOMA,Diffuse large B-cell lymphoma,DIFFUSE LARGE B-CELL LYMPHOMA,DIFFUSE LARGE B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,DIFFUSE LARGE B-CELL LYMPHOMAS,10029104,10012818,10012818,10012818
"SIGNIFICANT MAINLY GASTROINTESTINAL TOXICITY G3/ GASTROINTESTINAL TOXICITY G3 (NAUSEA, VOMITING)",Gastrointestinal toxicity,GASTROINTESTINAL TOXICITY,GASTROINTESTINAL TOXICITY,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10059024,10059024,10059024
SINUS NODE DYSFUNCTION,Sinus node dysfunction,SINUS NODE DYSFUNCTION,SINUS NODE DYSFUNCTION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10075889,10075889,10075889
DISEASE PROGRESSION,Multiple myeloma,MULTIPLE MYELOMA,PLASMA CELL MYELOMA,PLASMA CELL NEOPLASMS,PLASMA CELL MYELOMAS,10029104,10028228,10035226,10028228
MOTOR COORDINATION AND VISUAL-SPATIAL AND VISUAL-MOTOR PROCESSING SKILLS WERE BORDERLINE OR IMPAIRED,Disorientation,SPATIAL DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10062700,10013395,10062700
DROWSINESS,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
PROMINENT CLONUS OF THE LOWER EXTREMITIES,Clonus,CLONUS,CLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10009346,10009346,10009346
DYSTONIA,Dystonia,DYSTONIA,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10013983,10013983,10013983
"MILD ERYTHEMATOUS, SQUAMOUS AND MILDLY EDEMATOUS SKIN LESIONS WHICH WERE MORE PROMINENT ON THE DORSAL ASPECTS OF BOTH HANDS",Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
THE NEONATE'S MOTHER RECEIVED CLOMIFENE AND MENOTROPIN BEFORE PREGNANCY,Maternal exposure before pregnancy,MATERNAL EXPOSURE BEFORE PREGNANCY,MATERNAL EXPOSURE BEFORE PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071406,10071406,10071406
HYPOTENSIVE,hypotensive,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021107,10021097,10021107
"WORSENING OF DISEASE, WE OBSERVED FURTHER WORSENING OF CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME",Antiphospholipid syndrome,ANTIPHOSPHOLIPID SYNDROME,ANTIPHOSPHOLIPID SYNDROME,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10002817,10002817,10002817
PATIENT HAD A PRESYNCOPAL EPISODE,Presyncope,PRESYNCOPE,PRESYNCOPE,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10036653,10036653,10036653
INTRAMURAL HEMATOMA,intramural hematoma,ARTERIAL INTRAMURAL HEMATOMA,ARTERIAL INTRAMURAL HAEMATOMA,ANEURYSMS AND ARTERY DISSECTIONS,ANEURYSMS AND DISSECTIONS NON-SITE SPECIFIC,10047065,10074975,10074971,10074975
SEVERE BLOATING AND WINDS,bloating,BLOATING,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10005265,10000060,10005265
COAGULOPATHY FOLLOWING BISMUTH SUBSALICYLATE OVERDOSE,Coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
JOHN IS TAKING 30-35 IBUPROFEN PLUS CODEINE TABLETS EVERY DAY,intentional product misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
"TENDERNESS AND SWELLING WERE OBSERVED IN THE LEFT SACROILIAC JOINT, BILATERAL FINGER, KNEE, ANKLE JOINTS",Arthritis,JOINT INFLAMMATION,ARTHRITIS,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10023217,10003246,10023217
DRUG-INDUCED EXANTHEMA,Drug eruption,EXANTHEMATIC DRUG ERUPTION,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10056963,10013687,10056963
CONTINUOUS MYOCLONIC JERKS/CONTINUOUS MYOCLONIC JERKS INVOLVING THE RIGHT SIDE OF THE BODY WITH IMPAIRED AWARENESS,Myoclonus,MYOCLONIC JERKS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028621,10028622,10028621
ANTI-DSDNA ANTIBODY POSITIVE,Double stranded DNA antibody positive,ANTI-DSDNA ANTIBODY POSITIVE,DOUBLE STRANDED DNA ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10069914,10069907,10069914
DRUG INTOLERANCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
THE PATIENT WAS TREATED WITH PREDNISONE FOR PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL IMMUNOGLOBULIN DEPOSITS AND HAD PARTIAL RESPONSE(PARTIAL RESPONSE WITH NO ADVERSE EVENTS),subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
TRANSAMINASES ELEVATED,Transaminases increased,TRANSAMINASES INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054889,10054889,10054889
MRI SHOWED MULTIPLE NEW T2 AND FLAIR HYPERINTENSITIES,Hyperintensity in brain deep nuclei,HYPERINTENSITY IN BRAIN DEEP NUCLEI,HYPERINTENSITY IN BRAIN DEEP NUCLEI,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10079392,10079392,10079392
PROMINENT PARANOID DELUSIONS,paranoid delusions,PARANOID DELUSIONS,DELUSION,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10033867,10012239,10033867
STEROID-INDUCED DIABETES MELLITUS (BLOOD GLUCOSE-27.9 MMOL/L),Diabetes mellitus,DIABETES STEROID-INDUCED,DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012628,10012601,10012628
PALPITATION,Palpitations,PALPITATION,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033556
BRONCHOALVEOLAR LAVAGE CULTURES GREW PSEUDOMONAS AERUGINOSA,Pseudomonas infection,INFECTION PSEUDOMONAS AERUGINOSA,PSEUDOMONAS INFECTION,BACTERIAL INFECTIOUS DISORDERS,PSEUDOMONAL INFECTIONS,10021881,10021860,10061471,10021860
PULMONARY EMPHYSEMA,Emphysema,EMPHYSEMA PULMONARY,EMPHYSEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10014563,10014561,10014563
MYOCLONUS AND DELIRIUM INDUCED GABAPENTIN OVERDOSE,Myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
THERAPEUTIC EFFECT INCOMPLETE,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
CONDITION DETERIORATED,condition deteriorated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
HYPOCALCEMIA/PARESTHESIA/MYALGIA,Hypocalcemia,HYPOCALCEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020949,10020947,10020949
BRONCHOSPASM,Bronchospasm,BRONCHOSPASM,BRONCHOSPASM,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10006482,10006482,10006482
WEAKNESS,Weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
IGM DEFICIENCIES (SERUM IGM LEVEL: 0.28 G/L),Blood immunoglobulin M decreased,IGM DECREASED,BLOOD IMMUNOGLOBULIN M DECREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10021277,10005600,10021277
HER WEIGHT DECLINED 1 KG FURTHER TO 53.6 KG,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
BONE PAIN,Bone pain,BONE PAIN,BONE PAIN,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10006002,10006002,10006002
"INITIATED ON FLUOROURACIL AND OXALIPLATIN, BUT WITH ONLY TRANSIENT RESPONSE",Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
NEOPLASTIC MENINGITIS,Metastases to meninges,NEOPLASTIC MENINGITIS,METASTASES TO MENINGES,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10066062,10051696,10066062
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,Posterior reversible encephalopathy syndrome,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10071066,10071066,10071066
CONDITION AGGRAVATED,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
AUTOIMMUNE THYROIDITIS,autoimmune thyroiditis,AUTOIMMUNE THYROIDITIS,AUTOIMMUNE THYROIDITIS,THYROID GLAND DISORDERS,ACUTE AND CHRONIC THYROIDITIS,10014698,10049046,10049046,10049046
DRUG INDUCED HEMOLYSIS,Haemolysis,HEMOLYSIS,HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10018910,10018910,10019491
"25-YEAR-OLD SUICIDAL WOMAN INGESTED 20 CAPSULES OF REDOTEX, 500 MG SUMATRIPTAN, 2 IBUPROFEN TABLETS",Suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
WEAKNESS ALL OVER,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
PULMONARY HYPERTENSION,pulmonary hypertension,PULMONARY HYPERTENSION,PULMONARY HYPERTENSION,PULMONARY VASCULAR DISORDERS,PULMONARY HYPERTENSIONS,10038738,10037400,10037400,10037400
"HAND AND FINGERS WERE
 ERYTHEMATOUS AND SWOLLEN",Peripheral swelling,SWELLING OF FINGERS,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042694,10048959,10042694
OXYGEN SATURATION 80%,Oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
COLLAPSE CIRCULATORY,Circulatory collapse,COLLAPSE CIRCULATORY,CIRCULATORY COLLAPSE,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10009192,10009192,10009909
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
"USE OF CISPLATIN, FLUOROURACIL AND DACARBAZINE FOR PARATHYROID CARCINOMA (OFF LABEL USE) WITH NO ADR",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"APATIC HYPOBULIC SYNDROME WITH HYPODYNAMOGENIA, BRADYPSYCHISM, SOCIAL FUNCTION IMPAIREMENT, ANHEDONIA AND HYPOENERGY/APATHETIC-HYPOBULIC SYNDROME",Bradypsychic response,BRADYPSYCHIC RESPONSE,BRADYPHRENIA,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10006103,10050012,10006103
MACULAR TOXICITY,Macular opacity,MACULAR OPACITY,MACULAR OPACITY,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10025416,10025416,10025416
THE COMBINATION OF BOTH FACTORS (LATE OPIOID WITHDRAWAL DUE TO PHARMACOLOGICAL INTERACTIONS AND SERTRALINE-INDUCED MANIA) MAY HAVE INFLUENCED THE HIGH LEVEL OF SEVERITY OF THE SYMPTOMS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
PROGRESSION OF METASTATIC ATYPICAL TERATOID RHABDOID TUMOR OF CNS,Atypical teratoid/rhabdoid tumour of CNS,ATYPICAL TERATOID/RHABDOID TUMOR OF CNS,ATYPICAL TERATOID/RHABDOID TUMOUR OF CNS,NERVOUS SYSTEM NEOPLASMS MALIGNANT AND UNSPECIFIED NEC,CENTRAL NERVOUS SYSTEM NEOPLASMS MALIGNANT NEC,10029104,10065907,10065907,10065870
PAIN CONTROL HAD NO BENEFIT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
BILATERAL MICRONODULAR PULMONARY INFILTRATE,Lung infiltration,PULMONARY INFILTRATION,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025102,10025102,10037411
TREMORS,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
ERYTHEMATOUS LESIONS/PRURITIC AND ERYTHEMATOUS LESIONS,Rash erythematous,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015243
TREATMENT NON-COMPLIANCE,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
LOWER LIMB MYALGIA AFTER EZETIMIB INTAKE,Myalgia of lower extremities,MYALGIA OF LOWER EXTREMITIES,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10051587,10028411,10051587
PULMONARY INFECTION,Lung infection,LUNG INFECTION,LUNG INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10061229,10061229,10061229
MEMORY DISTURBANCES,Memory impairment,MEMORY DISTURBANCE,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027175,10027175,10027172
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
RESPIRATORY ACIDOSIS,Respiratory acidosis,RESPIRATORY ACIDOSIS,RESPIRATORY ACIDOSIS,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10038661,10038661,10038661
ALTERED MENTAL STATUS ALSO WORSENED,mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
CMV REACTIVATION,CMV reactivation,CYTOMEGALOVIRUS INFECTION REACTIVATION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10058666,10011831,10058666
NAUSEOUS,Nausea,NAUSEOUS,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028823
NEUROSYMPTOMATIC [NEUROLOGICAL SYMPTOMS],Neurological symptom,NEUROLOGIC SYMPTOMS,NEUROLOGICAL SYMPTOM,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10060860,10060860,10029291
CUSHINGOID APPEARANCE,Cushingoid,CUSHINGOID,CUSHINGOID,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011655,10011655,10011655
PREDNISONE STARTED WITH GOOD RESPONSE BUT GVHD FLARED UP WITH EACH ATTEMPT TO TAPER STEROID DOSE (REBOUND EFFECT),Acute graft versus host disease,ACUTE GRAFT VERSUS HOST DISEASE,ACUTE GRAFT VERSUS HOST DISEASE,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10066260,10066260,10066260
SEPTIC SHOCK,septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
ACUTE RENAL FAILURE,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
WE COULD NOT CONTROL THE ASCITES FLUID,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
"DYSPNEA AND COUGH WORSENED, COPD WAS SEVERE AT GRADE 3 AND LUNG FUNCTIONS WERE AT 40%",Chronic obstructive pulmonary disease,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10009033,10009033,10009033
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
PALPITATIONS,palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
ELEVATED BILIRUBIN,elevated bilirubin,BILIRUBIN INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10004690,10005364,10004690
VISUAL IMPAIRMENT,visual impairment,VISUAL IMPAIRMENT,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047571,10047571,10047571
"DIFFICULTIES WITH MENTAL MANIPULATION AND ABSTRACTION WITHIN THE VERBAL DOMAIN
AND REDUCED CAPACITY TO MANIPULATE VERBAL INFORMATION IN MEMORY/ COGNITIVE DETERIORATION/IMPAIRED COGNITION",Cognitive disorder,COGNITIVE IMPAIRMENT,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10057668,10057668,10009846
SMALL GASTRIC FUNDAL POLYPS,Gastric polyps,FUNDIC GLAND POLYP,GASTRIC POLYPS,BENIGN NEOPLASMS GASTROINTESTINAL,BENIGN NEOPLASMS GASTROINTESTINAL (EXCL ORAL CAVITY),10017947,10051194,10017817,10051194
BEHAVIOURAL DISORDER,Abnormal behaviour,BEHAVIOURAL DISORDER,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004207,10061422,10004210
SHOCK DUE TO KLEBSIELLA SEPSIS,Shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
HYPOTENSIVE,hypotensive,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021107,10021097,10021107
FAILED TO ACHIEVE HEMOSTASIS,treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
ALTERED MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
DUODENAL ULCER,Duodenal ulcer,DUODENAL ULCER,DUODENAL ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,DUODENAL ULCERS AND PERFORATION,10017947,10013836,10013836,10013836
PAROXYSMAL FAST ATRIAL FIBRILLATION FOLLOWING PNEUMOCYSTIS JIROVECI PNEUMONIA,Atrial fibrillation,PAROXYSMAL ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003661,10003658,10034039
TONSILLOPHARYNGITIS,Pharyngitis,PHARYNGITIS,PHARYNGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10034835,10034835,10034835
GASTROINTESTINAL BLEEDING FOLLOWING ESOPHAGITIS,Gastrointestinal haemorrhage,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017936
HEMOGLOBIN 9.6 G/DL,Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
MULTIPLE DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
METOCLOPRAMIDE SWITCHED TO ONDANSETRON AFTER SHOWING NO IMPROVEMENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
THE PATIENT HAD ADMINISTERED DAPSONE FOR FLU-LIKE SYMPTOMS AND JOINT PAIN(OFF LABEL USE FOR THE INDICATION),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
IMMOBILITY,immobility,IMMOBILE,IMMOBILE,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10021417,10021417,10021417
PRESENCE OF STEATOSIS IN HEPATOCYTES,Hepatic steatosis,STEATOSIS HEPATIC,HEPATIC STEATOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019708,10019708,10041970
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
"ELECTROMYOGRAPHY SHOWED A SENSORIMOTOR AXONAL POLYNEUROPATHY, WITH DISTAL-PROXIMAL GRADIENT/PERIPHERAL NEUROTOXICITY CAUSED BY METRONIDAZOLE",Acute motor-sensory axonal neuropathy,ACUTE MOTOR-SENSORY AXONAL NEUROPATHY,ACUTE MOTOR-SENSORY AXONAL NEUROPATHY,PERIPHERAL NEUROPATHIES,ACUTE POLYNEUROPATHIES,10029205,10076657,10076657,10076657
6 WEEK LONG AMENORRHEA,Amenorrhoea,AMENORRHEA,AMENORRHOEA,MENSTRUAL CYCLE AND UTERINE BLEEDING DISORDERS,MENSTRUATION WITH DECREASED BLEEDING,10038604,10001928,10001928,10001927
LYMPHOPENIA,Lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
HYPOGLYCAEMIC COMA,Hypoglycaemic coma,HYPOGLYCAEMIC COMA,HYPOGLYCAEMIC COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10021000,10021000,10021000
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
STERILE ABSCESS,Abscess sterile,ABSCESS STERILE,ABSCESS STERILE,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10000317,10000317,10000317
ACUTE KIDNEY INJURY FOLLOWING VITAMIN D TOXICITY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
LIFE THREATENING MASSIVE OVERDOSES/DRUG OVERDOSE,drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
VOMIT,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
D-DIMER POSITIVE (GREATER THAN 5000 NG/ML),Fibrin D dimer increased,FIBRIN D DIMER INCREASED,FIBRIN D DIMER INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10016581,10016581,10016581
SMALL BOWEL STENOSIS,Small intestine stenosis,SMALL INTESTINE STENOSIS,SMALL INTESTINAL STENOSIS,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,DUODENAL AND SMALL INTESTINAL STENOSIS AND OBSTRUCTION,10017947,10041132,10062263,10041132
RESTING TREMOR,resting tremor,RESTING TREMOR,RESTING TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10071390,10071390,10071390
"TREATED ELSEWHERE AS CAPILLARY HEMANGIOMA OF INFANCY (CHI), WITH ORAL PROPRANOLOL, WHICH HAD FAILED TO RESULT IN ANY SYMPTOMATIC RELIEF",Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
"INTENSIFICATION OF CUTANEOUS LESIONS ON TRUNK AND LIMBS ASSOCIATED WITH GENERAL SYMPTOMS, AND REACHING PALMS AND SOLES",Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
UNCONTROLLABLE LOW SYSTEMIC BLOOD PRESSURE,Hypotension,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10024895
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CONFUSED,confused,CONFUSED,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010298,10010305,10010298
HUNGRY BONE SYNDROME,Hungry bone syndrome,HUNGRY BONE SYNDROME,HUNGRY BONE SYNDROME,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10062623,10062623,10062623
VISUAL HALLUCINATION,"Hallucination, visual",HALLUCINATION VISUAL,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019075,10019075,10019068
ATAXIC GAIT,Ataxic gait,ATAXIC GAIT,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003597,10003591,10003597
MYELOTOXICITY DUE TO DRUG TOXICITY (TOXIC PANCYTOPENIA),Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
GENERALIZED WEAKNESS,Asthenia,WEAKNESS GENERALISED,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047864,10003549,10047864
TOENAILS WERE SPLIT-THICKENED,Nail disorder,NAIL DISORDER,NAIL DISORDER,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10028694,10028694,10028694
PROGRESSIVE IMBALANCE WHILE WALKING,Gait disturbance,ABNORMAL GAIT,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10000136,10017577,10000136
ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
MIXED INTOXICATION OF DIPHENHYDRAMINE AND ALCOHOL,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
RECURRENCE OF PRURITIC RASH ON ADMINISTRATION OF PYRAZINAMIDE,rash pruritic,RASH PRURITIC,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10037884
"BILATERAL, ASYMETRIC NEUROSENSORY HEARING IMPAIRMENT",Deafness neurosensory,DEAFNESS NEUROSENSORY,DEAFNESS NEUROSENSORY,HEARING DISORDERS,HEARING LOSSES,10013993,10011891,10011891,10011891
HE SUFFERED A FALL,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
NON-PERFORATED SIGMOID DIVERTICULITIS,Sigmoid diverticulitis,SIGMOID DIVERTICULITIS,DIVERTICULITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10072616,10013538,10072616
QTC INTERVAL WAS PROLONGED WITH 544 MS,electrocardiogram QTc interval prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
BUPRENORPHINE WITHDRAWAL-ASSOCIATED ACUTE PSYCHOSIS,Withdrawal psychosis,WITHDRAWAL PSYCHOSIS,REBOUND PSYCHOSIS,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10074838,10074833,10074838
HEART RATE DECREASED,heart rate decreased,HEART RATE DECREASED,HEART RATE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019301,10019301,10019301
GRANULOMATOUS INFLAMMATION,Granulomatous disease,GRANULOMATOUS DISEASE,GRANULOMA,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10018701,10018691,10018701
FACE MALFORMATIONS FOLLOWING DRUG EXPOSURE IN UTERO,face malformation,FACE MALFORMATION,DYSMORPHISM,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL DISORDERS CONGENITAL NEC,10010331,10016027,10066054,10016027
LEUKOPENIA,Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
ADMINISTRATION DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
BILATERAL IRIDOCYCLITIS,Iridocyclitis,IRIDOCYCLITIS,IRIDOCYCLITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10022941,10022941,10022941
FOUND IT DIFFICULT TO CONCENTRATE,Mental concentration difficult,MENTAL CONCENTRATION DIFFICULT,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10027347,10013496,10027347
ANOREXIA,anorexia,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10002646,10061428,10002646
UNCONSCIOUS,unconscious ,UNCONSCIOUS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10045479,10024855,10045479
ACUTE OVERDOSE,acute overdose,ACUTE OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067695,10033295,10067695
QRS WIDENING,QRS widening,QRS WIDENED,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037699,10014380,10037699
A CHEMISTRY PANEL SHOWED TOTAL BILIRUBIN 6.0 MG/DL (TOTAL BILIRUBIN INCREASED),Blood bilirubin increased,BILIRUBIN TOTAL INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056806,10005364,10056806
LEUKOCYTOSIS (41000.CUBIC MM),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
TORSADES DE POINTES FOLLOWING INTENTIONAL LOPERAMIDE OVERDOSE,torsades de pointes,TORSADES DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044067,10044066,10044067
CHRONIC LYMPHOCYTIC LEUKAEMIA PROGRESSION,Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
"MILD INFEROMEDIAL SYMBLEPHARON FOLLOWING EPITHELIAL CARCINOMA OF THE CONJUNCTIVA/ IN SITU EPITHELIAL CARCINOMA (TISN0M0, AJCC 2010 STAGING) OF THE CONJUNCTIVA",Symblepharon,SYMBLEPHARON,SYMBLEPHARON,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CONJUNCTIVAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10042736,10042736,10042736
G2 DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
GENERALIZED PERITONITIS,Peritonitis,PERITONITIS,PERITONITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10034674,10034674,10034674
"AFTER PERSISTENT BLISTER FORMATION, THE MYCOPHENOLATE MOFETIL WAS DISCONTINUED",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
LACTIC DEHYDROGENASE WAS 720 U/L,lactic dehydrogenase increased,LACTIC DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10023679,10005630,10023679
"SPONTANEOUS PAIN AND TENDERNESS IN BOTH THIGHS, UPPER ARMS, AND BACK","Spontaneous pain and tenderness in both thighs, upper arms, and back",TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
PATIENT HAD RELAPSE OF PERICARDIAL EFFUSION AFTER THE DISCONTINUATION OF PREDNISONE (REBOUND EFFECT),pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
VALPROATE TAKEN AT 24-HOUR INTERVAL WERE 110 AND 119 MG/DL,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
PROGRESSIVE HEARING LOSS,Deafness,HEARING LOSS,DEAFNESS,HEARING DISORDERS,HEARING LOSSES,10013993,10011878,10011878,10019246
COMA/CNS DEPRESSION,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
RETICULOCYTE COUNT INCREASED (5%),Reticulocyte count increased,RETICULOCYTE COUNT INCREASED,RETICULOCYTE COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10038792,10038792,10038792
FOETAL EXPOSURE DURING PREGNANCY,Foetal exposure during pregnancy,FOETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071404,10071404,10071404
MEDIAL LEFT TEMPORAL LOBE SWELLING,Brain oedema,BRAIN SWELLING,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10058952,10048962,10058952
SWELLING OF LEFT PAROTID GLAND,Parotid gland enlargement,PAROTID SWELLING,PAROTID GLAND ENLARGEMENT,SALIVARY GLAND CONDITIONS,SALIVARY GLAND ENLARGEMENTS,10017947,10034028,10034023,10034028
MALNUTRITION,Malnutrition,MALNUTRITION,MALNUTRITION,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10061273,10061273,10061273
SLIT LAMP EXAMINATION REVEALED HYPEREMIA,Hyperaemia,HYPEREMIA,HYPERAEMIA,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10020565,10020565,10020619
REFRACTIVE HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
HIVES,Hives,HIVES,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10020197,10046735,10020197
DIARRHOEA,diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
HAIR LOSS,hair loss,HAIR LOSS,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10019045,10001760,10019045
TENDERNESS BELOW THE NAVEL,Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
DRUG-INDUCED KIDNEY INJURY,Renal injury,RENAL INJURY,RENAL INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10061481,10061481,10061481
ACUTE WORSENING OF THE PATIENTâ€™S PARKINSONISM,Parkinson's disease aggravated,PARKINSON'S DISEASE AGGRAVATED,PARKINSON'S DISEASE,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034006,10061536,10034006
HAEMOGLOBIN LOW,Haemoglobin decreased,HAEMOGLOBIN LOW,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018889,10018884,10018889
PERSISTENT URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
GABAPENTIN-INDUCED URINARY INCONTINENCE,rine incontinence,URINE INCONTINENCE,URINARY INCONTINENCE,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046645,10046543,10046645
SUBCUTANEOUS SKIN NODULE ON LEFT FOOT,Skin mass,SUBCUTANEOUS NODULE,SKIN MASS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS CONDITIONS NEC,10040785,10042348,10067868,10042348
SEVERE CEFTRIAXONE-INDUCED HEMOLYTIC ANEMIA (HEMOGLOBIN OF 0.4 G/DL),Haemolytic anaemia,HEMOLYTIC ANEMIA DRUG-INDUCED,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10018918,10018916,10055208
FRONTAL HEADACHE,frontal headache,FRONTAL HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10048967,10019211,10048967
SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
CROSSED EYES,Strabismus,STRABISMUS,STRABISMUS,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10042159,10042159,10042159
SEVERE CARDIOVASCULAR TOXICITY,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
HEMATOMA INJECTION SITE,Hematoma injection site,HEMATOMA INJECTION SITE,INJECTION SITE HAEMATOMA,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10019432,10022066,10019432
BLOOD EXTRAVASATIONS IN THE SUBECARDIAL AREA FOLLOWING INTOXICATION WITH OPIATES AND AMFETAMINE,Extravasation blood,EXTRAVASATION BLOOD,EXTRAVASATION BLOOD,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10015867,10015867,10015867
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
QT PROLONGATION (438 MS),QT prolonged,QT PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037705,10014387,10037705
ELEVATED INR (5.93),International normalised ratio increased,INR INCREASED,INTERNATIONAL NORMALISED RATIO INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10022402,10022595,10022402
DESPITE THE THERAPY WITH MONTELUKAST THE PATIENT STILL EXPERIENCED A FEV1 DROP (LACK OF DRUG EFFECT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LACK OF DRUG EFFECT,LACK OF DRUG EFFECT,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
FLUSHING,flushing,FLUSHING,FLUSHING,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10016825,10016825,10016825
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS FOLLOWING REBOUND EFFECT OF PREDNISONE,Bronchopulmonary aspergillosis allergic,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10006474,10006474,10001707
PATIENT TREATED WITH FLUDARABINE PHOSPHATE FOR BONE MARROW CONDITIONING REGIMEN (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MENINGOENCEPHALITIS CAUSED BY CRYPTOCOCCUS NEOFORMANS DUE TO IMMUNOSUPPRESSION,Encephalitis,MENINGOENCEPHALITIS,ENCEPHALITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10027282,10014581,10027282
SEVERE CRUSHING CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
LACK OF DRUG EFFECT WITH NO ADR,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
BLOATING,Abdominal distension,BLOATING,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10005265,10000060,10005265
DISSEMINATED FUSARIOSIS/FUSARIUM SPP. INFECTION,Fusarium infection,FUSARIUM INFECTION,FUSARIUM INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10051919,10051919,10051919
B CELL LYMPHOMA RECURRENT,B-cell lymphoma recurrent,B-CELL LYMPHOMA RECURRENT,B-CELL LYMPHOMA RECURRENT,LYMPHOMAS NON-HODGKIN'S B-CELL,B-CELL LYMPHOMAS NEC,10029104,10003902,10003902,10003902
FUNGAL PNEUMONIA,Pneumonia fungal,PNEUMONIA FUNGAL,PNEUMONIA FUNGAL,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10061354,10061354,10061354
PRAMIPEXOLE WAS NOT EFFECTIVE FOR MUSCLE CRAMPS,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
BLURRED VISION,blurred vision,BLURRED VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10005886,10047513,10005886
SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
HAND-PLANTAR PRURITIS,Localized itching,LOCALIZED ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10058733,10037087,10058733
"CONSTRICTING RETROSTERNAL CHEST PAIN OF SUDDEN ONSET AT REST, RADIATING TO THE UPPER LEFT LIMB AND LASTING MORE THAN 30 MINUTES",Retrosternal chest pain,RETROSTERNAL CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10038986,10008479,10038986
MAJOR CONGENITAL MALFORMATIONS,Congenital anomaly,CONGENITAL ANOMALY NOS,CONGENITAL ANOMALY,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10010357,10010356,10010357
URINE RETENTION,urine retention,URINARY RETENTION,URINARY RETENTION,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046555,10046555,10046555
CHILLS,chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
COMATOSE,Coma,COMATOSE,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10058472,10010071,10058472
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SERUM KETONES INCREASED (3.2 MMOL/L),Blood ketone body increased,BLOOD KETONE BODY INCREASED,BLOOD KETONE BODY INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10057594,10057594,10057594
LEFT PERINEUM NERVE PALSY,left perineum nerve palsy,PERIPHERAL NERVE PALSY,PERIPHERAL NERVE PALSY,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10058530,10058530,10058530
MATERNAL INTAKE OF SODIUM VALPROATE DURING PREGNANCY,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
ENCEPHALOPATHY FOLLOWING DRUG INTERACTION BETWEEN VORICONAZOLE AND VINCRISTINE,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
LEUKOCYTOPENIA (GRADE 3),Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
CARCINOID CRISIS OCCURRED,Carcinoid crisis,CARCINOID CRISIS,CARCINOID CRISIS,NEOPLASTIC AND ECTOPIC ENDOCRINOPATHIES,ECTOPIC ENDOCRINE DISORDERS,10014698,10072251,10072251,10072251
URINE VOLUME INCREASED (2.2-5.7 L URINE VOLUME/DAY),Urine output increased,URINE VOLUME INCREASED,URINE OUTPUT INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059896,10059896,10046683
LVEF DECREASED (35-40 PERCENT),Ejection fraction decreased,LEFT VENTRICULAR EJECTION DECREASED,EJECTION FRACTION DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10024118,10050528,10024118
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
TYPE I VARIANT OF KOUNIS SYNDROME,Kounis syndrome,KOUNIS SYNDROME TYPE I,KOUNIS SYNDROME,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10074934,10069167,10074934
VENTRICULAR EXTRASYSTOLE,Ventricular extrasystole,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047289,10047289,10047289
OSTEOPOROSIS,Osteoporosis,OSTEOPOROSIS,OSTEOPOROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10031282,10031282,10031282
SKIN LESION,skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
POSTERIOR SYNECHIAE FOLLOWING OFF LABEL USE OF MYCOPHENOLATE FOR BLAU-JABS SYNDROME,Iris adhesions,POSTERIOR SYNECHIAE OF IRIS,IRIS ADHESIONS,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","IRIS AND CILIARY BODY STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10036367,10022945,10036367
PATIENT WAS TREATED WITH DIAZOXIDE AND NIFEDIPINE FOR HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY (OFF LABEL USE) WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
AST INCREASED (118 U),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
PURPLE CRYSTALS CONSISTENT WITH KAYEXELATE RESIN PARTICLES WERE IDENTIFIED WITHIN THE AREAS OF MUCOSAL ULCERATION,Mucosal ulceration,MUCOSAL ULCERATION,MUCOSAL ULCERATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028124,10028124,10028124
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
IN UTERO EXPOSURE TO CLOZAPINE AND RISPERIDONE,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
STAPHYLOCOCCUS EPIDERMIDIS INFECTION FOLLOWING CALCINOSIS CUTIS FOLLOWING PREDNISONE AND EXTRAVASATION OF CALCIUM GLUCONATE INVOLVING FIRST THE RIGHT FOREARM AND HAND AND THEN LEFT FOOT,Staphylococcal infection,STAPHYLOCOCCUS EPIDERMIDIS INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10054154,10058080,10054154
ONGOING SECOND RELAPSE,Recurrent cancer,RECURRENT CANCER,RECURRENT CANCER,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10038111,10038111,10038111
LOW WBC COUNT (4X10E9/L),White blood cell count decreased,WBC DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056731,10047942,10056731
FEVER (38.8  DEGREE CELSIUS),fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
MODERATE CYTOPENIA,Cytopenia,CYTOPENIA,CYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10066274,10066274,10066274
REPEATED INFECTIONS,Infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
TUBERCULOSIS INFECTION,Tuberculosis,TUBERCULOSIS,TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10044755,10044755,10044755
CARDIOTOXICITY SECONDARY TO CHRONIC LOPERAMIDE OVERDOSE,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
ALOPECIA AREATA (CHARACTERISTIC OPHIASIS PATTERN EXTENDING FROM HER OCCIPITAL TO PARIETAL AND FRONTOTEMPORAL SCALP AREAS),Alopecia areata,ALOPECIA AREATA,ALOPECIA AREATA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001761,10001761,10001761
HYPERAMMONEMIA,hyperammonemia,HYPERAMMONEMIA,HYPERAMMONAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020576,10020575,10020576
OFF LABEL USE,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PNEUMOCYSTIS PNEUMONIA,Pneumocystis pneumonia,PNEUMOCYSTIS PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10035661,10073755,10035661
NEUTROPHILIC FIGURATE ERYTHEMA AFTER COLD EXPOSURE,Erythema annulare,ERYTHEMA ANNULARE,ERYTHEMA ANNULARE,EPIDERMAL AND DERMAL CONDITIONS,PAPULOSQUAMOUS CONDITIONS,10040785,10015153,10015153,10015153
DISEASE PROGRESSION,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
INEFFICACY,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DORSAL HAND FOOT SYNDROME,hand and foot syndrome secondary to chemotherapy,HAND AND FOOT SYNDROME SECONDARY TO CHEMOTHERAPY,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10048776,10033553,10048776
NONRESPONSIVE TO VERBAL OR TACTILE STIMULI DUE TO MORPHINE OVERDOSE FOLLOWING WRONG DOSE ADMINISTRATION,Unresponsive to stimuli,UNRESPONSIVE TO VERBAL STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10063552,10045555,10063552
"PATIENT WAS TREATED WITH TIMOLOL, LATANOPROST, BRIMONIDINE TARTARATE AND DORZOLAMIDE FOR SECONDARY GLAUCOMA, DURING FOLLOW-UP, HER IOP REMAINED IN HIGH LEVEL DESPITE MAXIMUM MEDICATIONS.",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
DISSEMINATED HISTOPLASMOSIS DUE TO IMMUNOSUPPRESSION,Histoplasmosis disseminated,DISSEMINATED HISTOPLASMOSIS,HISTOPLASMOSIS DISSEMINATED,FUNGAL INFECTIOUS DISORDERS,HISTOPLASMA INFECTIONS,10021881,10020144,10020144,10013440
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
ASPARTATE AMINOTRANSFERASE INCREASED (242 IU/L),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
"DESPITE THE TREATMENT, THE PATIENTS'S CONDITION DETERIORATED (CONDITION AGGRAVATED)",Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
"MYCOBACTERIUM AVIUM COMPLEX INFECTION LOCALIZED IN GUT, SPLEEN AND BONE MARROW",Mycobacterium avium complex infection,MYCOBACTERIUM AVIUM COMPLEX INFECTION,MYCOBACTERIUM AVIUM COMPLEX INFECTION,MYCOBACTERIAL INFECTIOUS DISORDERS,ATYPICAL MYCOBACTERIAL INFECTIONS,10021881,10058806,10058806,10058806
ANOREXIA,anorexia,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10002646,10061428,10002646
"THIS ABNORMALLY PAINFUL SENSATION HAD NO RESPONSE TO ORAL ACETAMINOPHEN,NSAID,GABAPENTIN AND MORPHINE",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SERUM CREATININE LEVEL INCREASED TO 1.34 MG/DL,Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
PROPAFENONE INTOXICATION,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
"SKIN FRAGILITY AGGRAVATED BY PHOTOEXPOSITION, APPEARED DURING IMATINIB THERAPY",Skin fragility,SKIN FRAGILITY,SKIN FRAGILITY,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040851,10040851,10040851
PATIENT HAD SELF-DISCONTINUED MESALAZINE AS THE PATIENT WAS SYMPTOM FREE(TREATMENT NON-COMPLIANCE),Product use issue,PRODUCT USE ISSUE,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076309,10076309,10076309
BURNING SENSATION FOLLOWING DRUG TOXICITY DUE TO DRUG INTERACTION,burning sensation,BURNING SENSATION,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10006784,10006784,10006784
COUGHING,cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
PRIMARY HEPATIC BURKITT LYMPHOMA FOLLOWING EPSTEIN-BARR VIRAEMIA,Burkitt's lymphoma,BURKITT'S LYMPHOMA,BURKITT'S LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,BURKITT'S LYMPHOMAS,10029104,10006595,10006595,10006595
"N THE LEFT MAXILLARY, A LARGE AREA OF BONE RAREFACTION AND EROSION EXTENDING FROM THE AREA OF",Bone erosion,BONE EROSION,BONE EROSION,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10051728,10051728,10051728
FEVER,Fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
GASTRIC OUTLET OBSTRCTION IN FIRST AND SECOND PART OF DUODENUM DUE TO CHRONIC DRUG OVERDOSE DUE TO ADDICTION/ DRUG ABUSE,Gastric outlet obstruction,GASTRIC OUTLET OBSTRUCTION,OBSTRUCTION GASTRIC,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,GASTRIC AND PYLORIC STENOSIS AND OBSTRUCTION,10017947,10062499,10029957,10062499
WITH WIDESPREAD CREPITATIONS ON CHEST AUSCULTATION,crepitations,CREPITATIONS,CREPITATIONS,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10011376,10011376,10011376
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PH: 7.01,Blood pH decreased,PH DECREASED,BLOOD PH DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10034778,10005706,10034778
VASOPLEGIC SHOCK,shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
EXERCISE-INDUCED DYSPNEA,Dyspnea exertional,DYSPNEA EXERTIONAL,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013966,10013971,10013966
ACUTE LUNG INJURY,Acute lung injury,ACUTE LUNG INJURY,ACUTE LUNG INJURY,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10069351,10069351,10069351
NEUTROPHILIA,neutrophilia,NEUTROPHILIA,NEUTROPHILIA,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10029379,10029379,10029379
SEIZURE,seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
RELAPSED,Psychotic episode,PSYCHOTIC EPISODE,PSYCHOTIC DISORDER,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10037254,10061920,10037254
CONDUCTION DISORDERS/ CARDIAC MUSCLE REPOLARIZATION DISORDERS/NON-PAROXYSMAL NODAL TACHYCARDIA,Conduction disorder,CONDUCTION DISORDER,CONDUCTION DISORDER,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10010276,10010276,10010276
"LEFT VENTRICULAR THROMBOSIS, EMBOLIC STROKE, INTRACRANIAL HEMORRHAGE, HEADACHE, MACROSCOPIC HAEMATURIA AND REPORTED SUBTHERAPEUTIC RESPONSE TO CLOPIDOGREL",Embolic stroke,EMBOLIC STROKE,EMBOLIC STROKE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10014498,10014498,10014498
CEREBRAL NOCARDIOSIS,Central nervous system infection,CENTRAL NERVOUS SYSTEM INFECTION,CENTRAL NERVOUS SYSTEM INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10061036,10061036,10061036
DRUG ABUSE/PREGABALIN ABUSE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
TALKATIVE,Logorrhoea,TALKATIVENESS,LOGORRHOEA,COMMUNICATION DISORDERS AND DISTURBANCES,SPEECH AND LANGUAGE USAGE DISTURBANCES,10037175,10043111,10024796,10043111
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ALOPECIA ARREATA (FORETOP AND EYEBROW)/SEVERAL ALOPECIA ARREATA LESIONS/HAIR LOSS,Alopecia areata,ALOPECIA AREATA,ALOPECIA AREATA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001761,10001761,10001761
BLEEDING FROM HER MOUTH,Haemorrhage,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10005103
LONG QT SYNDROME,Long QT syndrome,LONG QT SYNDROME,LONG QT SYNDROME,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10024803,10024803,10024803
PALPABLE PURPURA ON LEG,Palpable purpura,PALPABLE PURPURA,PALPABLE PURPURA,SKIN VASCULAR ABNORMALITIES,SKIN VASCULITIDES,10040785,10056872,10056872,10056872
SOMATULINA ADMINISTERED EVERY 14 DAYS/EVERY 3 WEEKS,Inappropriate schedule of drug administration,DRUG DOSE ADMINISTRATION INTERVAL TOO SHORT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064319,10021597,10064319
OBLIGATORY THIRST,Thirst,THIRST,THIRST,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10043458,10043458,10043458
RESTLESSNESS,Restlessness,RESTLESSNESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038743,10038743,10038743
NECROTISING FASCITIS DUE TO STREPTOCOCCUS (PYOGENS),necrotising fascitis,NECROTISING FASCIITIS,NECROTISING FASCIITIS,INFECTIONS - PATHOGEN UNSPECIFIED,MUSCLE AND SOFT TISSUE INFECTIONS,10021881,10028885,10028885,10028885
BOWEL WALL THICKENING AND INFLAMMATORY STRANDING INVOLVING THE CAECUM FOLLOWING STRONGYLOIDES STERCORALIS HYPERINFECTION,small bowel obstruction,SMALL BOWEL OBSTRUCTION,SMALL INTESTINAL OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,DUODENAL AND SMALL INTESTINAL STENOSIS AND OBSTRUCTION,10017947,10041055,10041101,10041055
DRUG EXPOSURE DURING PREGNANCY WITH NO ADR,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
PALLOR,Pallor,PALLOR,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033546,10033546,10033546
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
PATIENT URINATES LESS OFTEN,Urine output decreased,URINE VOLUME DECREASED,URINE OUTPUT DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059895,10059895,10046681
ARTICULAR PAIN,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
CANCER CACHEXIA FOLLOWING TONGUE CANCER,Cachexia,CANCER CACHEXIA,CACHEXIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10064015,10006895,10064015
PREECLAMPSIA  WITH  FETAL  DISTRES,preeclampsia  with  fetal  distress,PRE-ECLAMPSIA,PRE-ECLAMPSIA,MATERNAL COMPLICATIONS OF PREGNANCY,HYPERTENSION ASSOCIATED DISORDERS OF PREGNANCY,10036585,10036485,10036485,10036485
DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
LIVER IRON CONTENT WAS ELEVATED (2.181 MG/G),Liver iron concentration increased,LIVER IRON CONCENTRATION INCREASED,LIVER IRON CONCENTRATION INCREASED,HEPATOBILIARY INVESTIGATIONS,HEPATOBILIARY HISTOPATHOLOGY PROCEDURES,10022891,10074354,10074354,10074354
DISSEMINATED INTRAVASCULAR COAGULOPATHY,Disseminated intravascular coagulation,DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10013442,10013442,10013442
CHEST RADIOGRAPH REVEALED SYMMETRIC LUNG HYPERINFLATION WITH DIFFUSE INTERSTITIAL PROMINENCE,Lung hyperinflation,LUNG HYPERINFLATION,LUNG HYPERINFLATION,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10059487,10059487,10059487
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEPTIC SHOCK DUE TO ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
DECREASE OF MOTOR STRENGTH,motor activity retarded,MOTOR ACTIVITY RETARDED,HYPOKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10027992,10021021,10027992
MULTIDRUG RESISTANCE HIV DUE TO SEROCONVERSION FOLLOWING TREATMENT NONCOMPLIANCE,multidrug resistance HIV due to seroconversion following treatment noncompliance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
ALOPECIA FOLLOWING DRUG EXPOSURE DURING PREGNANCY,alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
SUICIDAL IDEATION,suicidal ideation,SUICIDAL IDEATION,SUICIDAL IDEATION,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042458,10042458,10042458
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
INTENTIONAL OVERDOSE,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
TUBULAR NECROSIS,Renal tubular necrosis,TUBULAR NECROSIS,RENAL TUBULAR NECROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL VASCULAR AND ISCHAEMIC CONDITIONS,10038359,10045144,10038540,10045144
DRUG DEPENDENCE,drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
SUICIDE,Suicide,SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042462,10010144,10042462
RESTLESSNESS,Restlessness,RESTLESSNESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038743,10038743,10038743
DRUG INDUCED KIDNEY INJURY,Renal injury,INJURY TO KIDNEY,RENAL INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10022221,10061481,10022221
DIFFUSE HYPOTONIA,Hypotonia,HYPOTONIA,HYPOTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10021118,10021118,10021118
METHYLPREDNISOLONE AND BASILIXIMAB SHOWED NO RESPONSE FOR GRAFT-VERSUS-HOST DISEASE (LACK OF DRUG EFFECT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PARTIAL SEIZURES WITH SECONDARY GENERALISATION,Partial seizures with secondary generalisation,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10056209,10056209,10056209
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
APPLICATION SITE HYPEREMIA 1CM,Vaccination site erythema,VACCINATION SITE ERYTHEMA,VACCINATION SITE ERYTHEMA,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10059079,10059079,10059079
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
SEVERE GENERALIZED EDEMA,Generalised oedema,GENERALIZED EDEMA,GENERALISED OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10018092,10018092,10018112
NEUROPATHY GRADE 1,Neuropathy peripheral,NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029328,10029331,10029328
ANTI-HBE ANTIBODY POSITIVE,Hepatitis B e antibody positive,ANTI-HBE ANTIBODY POSITIVE,HEPATITIS B E ANTIBODY POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10052024,10071348,10052024
CARDIAC TAMPONADE,Cardiac tamponade,CARDIAC TAMPONADE,CARDIAC TAMPONADE,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10007610,10007610,10007610
"WEIGHT GAIN; ON EXAMINATION, SHE WAS OBESE (BMI 35 KGM-2)",weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
"TREATMENT WITH SPIRAMYCIN AND PYRIMETHAMINE AT THE 34TH WEEK OF GESTATION (DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER WITH NO ADVERSE EVENT)",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
C REACTIVE PROTEIN INCREASED (10.74 MG/DL),C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
HYPOALBUMINAEMIA,Hypoalbuminaemia,HYPOALBUMINAEMIA,HYPOALBUMINAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020942,10020942,10020942
HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
C-REACTIVE PROTEIN 20.16 MG/DL,C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
PREMATURE DELIVERY,Premature delivery,PREMATURE DELIVERY,PREMATURE DELIVERY,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036595,10036595,10036595
HEART RATE HIGH (110 PER MINUTE),Heart rate increased,HEART RATE HIGH,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019302,10019303,10019302
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
CONVULSION,Seizure,CONVULSION,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10010904,10039906,10010904
SUBUNGUAL HYPERKERATOSIS,Hyperkeratosis,HYPERKERATOSIS,HYPERKERATOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,HYPERKERATOSES,10040785,10020649,10020649,10020649
"WHEN USING OMEPRAZOLE WITH LEDIPASVIR/SOFOSBUVIR, AN INCREASE OF GS- 331007 CONCENTRATIONS WAS ESTABILISHED",Drug interaction,PHARMACOKINETIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10067220,10013710,10067220
INSIDIOUS PROGRESSIVE NUMBNESS,Hypoaesthesia,NUMBNESS,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10029829,10020937,10029829
EROSION OF THE NOSTRILS,Skin erosion,SKIN EROSION,SKIN EROSION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040840,10040840,10040840
HYDROURETERONEPHROSIS,hydroureteronephrosis,URETEROHYDRONEPHROSIS,HYDRONEPHROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL OBSTRUCTIVE DISORDERS,10038359,10059683,10020524,10059683
HIGH LEVEL OF C- REACTIVE PROTEIN DURING FAMILIAL MEDITERRANEAN FEVER ATTACKS FOLLOWING NON COMPLIANCE TO COLCHICINE,C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
ILLNESS WAS EXACERBATED AND THE PATIENT'S OVERALL CONDITION PROGRESSIVELY WORSENED FOLLOWING LACK OF DRUG EFFECT,Pelvic neoplasm,PELVIC TUMOR,PELVIC NEOPLASM,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS UNSPECIFIED MALIGNANCY AND SITE UNSPECIFIED NEC,10029104,10048936,10061336,10074117
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
BLOOD PRESSURE INITIALLY DROPPED,blood pressure dropped,BLOOD PRESSURE DROPPED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005744,10005734,10005744
CYTOMEGALOVIRUS RETINITIS BILATERAL DUE TO CMV INFECTION,Cytomegalovirus chorioretinitis,CYTOMEGALOVIRUS RETINITIS,CYTOMEGALOVIRUS CHORIORETINITIS,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011835,10048843,10011835
SECOND RELAPSE,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
TUMOR,tumor,GUM SWELLING,GINGIVAL SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10018789,10018291,10018789
2 EPISODES OF FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
NEUTROPHIL <500/MM2,neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
SUB-ACUTE OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
DRY SKIN ON THE RIGHT THIGH,Vaccination site dryness,VACCINATION SITE DRYNESS,VACCINATION SITE DRYNESS,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10076159,10076159,10076159
WEAK PULSE,Pulse weak,PULSE WEAK,PULSE ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10037494,10037466,10037494
DID NOT WALK MUCH,Walking disability,WALKING DISABILITY,WALKING DISABILITY,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10053204,10053204,10053204
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES),Posterior reversible encephalopathy syndrome,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10071066,10071066,10071066
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
FOCAL NEUROLOGIC SIGNS WITH PARESTHESIA,Paraesthesia,PARESTHESIA,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10033775,10033775,10033987
DIGESTIVE COMPLICATIONS,Digestion impaired,DIGESTION IMPAIRED,DYSPEPSIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,DYSPEPTIC SIGNS AND SYMPTOMS,10017947,10012980,10013946,10012980
DIFFICULTY WITH BALANCE,Balance disorder,BALANCE DIFFICULTY,BALANCE DISORDER,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10004070,10049848,10004070
FLECAINIDE INDUCED TYPE II BRUGADA PATTERN,Brugada syndrome,BRUGADA SYNDROME,BRUGADA SYNDROME,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10059027,10059027,10059027
HAEMATEMESIS,Haematemesis,HAEMATEMESIS,HAEMATEMESIS,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018830,10018830,10018830
DYSMICROBISM,Dysbacteriosis,INTESTINAL BACTERIA FLORA DISTURBANCE,DYSBACTERIOSIS,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10066382,10064389,10066382
PATIENT TREATED WITH METHOTREXATE FOR CHRONIC KIDNEY DISEASE (OFF LABEL FOR UNDERLYING CONDITION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RAPIDLY GROWING ULCERATED NODULE (3.5X3 CM),Nodule skin,NODULE SKIN,SKIN MASS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS CONDITIONS NEC,10040785,10029494,10067868,10029494
WEIGHT GAIN OF 13 KG,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
QRSD 126 MS,Electrocardiogram QRS complex prolonged,QRS INCREASE IN TIME,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037694,10014380,10037694
HIGH FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
THINKING ABNORMAL/THINKING IRRATIONAL,thinking abnormal,THINKING IRRATIONAL,THINKING ABNORMAL,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10043435,10043431,10043435
NIFEDIPINE USED DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
FASTING TRIGLYCERIDE 1.2MMOL/L,Triglyceride increased,TRIGLYCERIDE INCREASED,BLOOD TRIGLYCERIDES INCREASED,LIPID ANALYSES,TRIGLYCERIDE ANALYSES,10022891,10044659,10005839,10044659
SEPTIC SHOCK FOLLOWING SEVERE SEPSIS,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
PATIENT HAD PREDNISONE THROUGHOUT THE COURSE OF PREGNANCY (DRUG EXPOSURE DURING PREGNANCY),Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
SEVERE ANAPHYLAXIS TO TRIAMCINOLONE,Anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
HEPATIC STEATOSIS,Hepatic steatosis,HEPATIC STEATOSIS,HEPATIC STEATOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019708,10019708,10019708
EOSINOPHILIC INFILTRATION,Eosinophilic infiltration,EOSINOPHILIC INFILTRATION,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10078757,10014950,10078757
STEVENS-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
EXPOSED TO METAMIZOLE SODIUM DURING PREGNANCY WITH NO ADVERSE DRUG REACTION,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
BLOODY STOOLS,bloody stools,BLOODY STOOL,HAEMATOCHEZIA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10005873,10018836,10005873
PROGRESSIVE DYSPHAGIA TO BOTH SOLIDS AND LIQUIDS,Dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
CARDIAC AND RESPIRATORY  FAILURE AND THE SIGNS OF ACUTE KIDNEY INJURY FOLLOWING WORSENING OF KLEBSIELLA PNEUMONIAE INFECTION,Cardiac failure,CARDIAC FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10007554,10007554,10007554
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
RELAPSE OF TDT-NEGATIVE T-CELL LYMPHOBLASTIC LYMPHOMA,disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
PAIN FROM HIS RIGHT ACHILLES TENDON,Tendon pain,TENDON PAIN,TENDON PAIN,"TENDON, LIGAMENT AND CARTILAGE DISORDERS",TENDON DISORDERS,10028395,10066371,10066371,10066371
GI BLEEDING,Gastrointestinal haemorrhage,GI BLEED,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10018230
PURULENT DISCHARGE,Purulent discharge,PURULENT DISCHARGE,PURULENT DISCHARGE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10037569,10037569,10037569
CARDIAC-TYPE CHEST PAIN,Chest pain - cardiac,CHEST PAIN - CARDIAC,ANGINA PECTORIS,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10008481,10002383,10008481
DIFFUSE ERYTHEMA,Erythema,ERYTHEMA DIFFUSE,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015159,10015150,10015159
SEXUAL DYSFUNCTION,sexual dysfunction,SEXUAL DYSFUNCTION,SEXUAL DYSFUNCTION,SEXUAL FUNCTION AND FERTILITY DISORDERS,SEXUAL FUNCTION AND FERTILITY DISORDERS NEC,10038604,10040477,10040477,10040477
HYPOMAGNESEMIA,hypomagnesemia,HYPOMAGNESEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021028,10021027,10021028
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
FUNGAL SEPSIS BY CANDIDA PARAPSILOSIS,Fungal sepsis,FUNGAL SEPSIS,FUNGAL SEPSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10058872,10058872,10058872
"SKIN RASH DUE TO OLANZAPINE, HALOPERIDOL AND QUETIAPINE",Drug eruption,DRUG RASH,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10013687,10013687,10062948
SEVERE HYPONATRAEMIA LEADING TO SEIZURES AND CARDIAC ARREST(PATIENT WAS SUCCESSFULLY RESUSCITATED AND SURVIVED),Hyponatraemia,HYPONATRAEMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021036
"PROSTATE ABNORMALITIES WITH CHRONIC GRANULOMATOUS INFLAMMATION, CHRONIC GRANULOMATOUS INFLATION IN PROSTATE",Granulomatous prostatitis,GRANULOMATOUS PROSTATITIS,PROSTATITIS,MALE REPRODUCTIVE TRACT INFECTIONS AND INFLAMMATIONS,PROSTATE AND SEMINAL VESICLES INFECTIONS AND INFLAMMATIONS,10038604,10057092,10036978,10057092
LOSS OF APPETITE,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
LEUKOCYTOSIS (UNITS NOS),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
HYPERAMMONAEMIA,Hyperammonaemia,HYPERAMMONAEMIA,HYPERAMMONAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020575,10020575,10020575
AGGRESSION TOWARDS OTHERS,aggression,AGGRESSION,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001488,10001488,10001488
SGPT (143 U/L),Alanine aminotransferase increased,SGPT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10040526,10001551,10040526
"CLONAZEPAM DOSING WAS ADJUSTED TO 0.5 MG EACH MORNING AND 1 MG EACH EVENING, WITH MILD BENEFIT",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
MULTIPLE PATHOLOGICAL FRACTURES OF C5-TH3 WITH SPINAL CORD COMPRESSION,Thoracic vertebral fracture,THORACIC VERTEBRAL FRACTURE,THORACIC VERTEBRAL FRACTURE,BONE AND JOINT INJURIES,SPINAL FRACTURES AND DISLOCATIONS,10022117,10049948,10049948,10049948
INTERACTION OF SIMVASTATIN WITH TICAGRELOR,Drug interaction,DRUG-DRUG PHARMACOKINETIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10065994,10013710,10065994
ACCIDENT,Accident,ACCIDENT,ACCIDENT,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10000369,10000369,10000369
URIC ACID INCREASED (17 MG/DL),Blood uric acid increased,URIC ACID INCREASED,BLOOD URIC ACID INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10066980,10005861,10066980
SEVERE HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
BETAMETHASONE AND SALBUTAMOL USED AT 26 WEEKS OF GESTATION,Maternal exposure during pregnancy,"MATERNAL EXPOSURE DURING PREGNANCY, SECOND TRIMESTER",MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10074499,10071408,10074499
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
STAGE 2 MEDICATION-RELATED OSTEONECROSIS OF THE JAWS,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
BILATERAL INFLAMMATORY EDEMA OF THE TWO THIGHS AND THE LEFT ARM,Oedema,INFLAMMATORY EDEMA REACTION,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10021993,10030095,10021991
ITCHINESS,itchy,ITCHY,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023089,10037087,10023089
CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
DESPITE COMBINED THERAPY HE WAS STILL DEVELOPING NEW BULLAE (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DIFFUSE MYALGIA,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
CHRONIC COUGH,chronic cough,CHRONIC COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10066656,10011224,10066656
SEROUS RETINAL DETACHMENT OF POSTERIOR POLE WITH MARKED RETINAL FOLDS IN MACULAR AREA,Serous retinal detachment,SEROUS RETINAL DETACHMENT,SEROUS RETINAL DETACHMENT,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10040114,10040114,10040114
METFORMIN INTOXICATION,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
INCREASING DIFFICULTY SWALLOWING RESULTING FROM INVOLVEMENT OF THE ORAL MUCOSA,Swallowing difficult,SWALLOWING DIFFICULT,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10042645,10013950,10042645
PULSE RATE 90 PER MINUTE,Heart rate increased,PULSE RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10037490,10019303,10037490
CONFUSION,confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
FIXED DRUG ERUPTION,fixed drug eruption,FIXED DRUG ERUPTION,FIXED ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10016740,10016741,10016740
VISUAL HALLUCINATIONS,"Hallucination, visual",VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019075,10019075,10047570
"SLIGHTLY CLOUDY, RED-COLORED URINE",Cloudy urine,CLOUDY URINE,URINE ABNORMALITY,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10009686,10046607,10009686
HAEMORRHAGIC GANGRENOUS NECROSIS OF THE SMALL INTESTINE AND COLON,haemorrhagic gangrenous necrosis of the small intestine and colon,NECROSIS INTESTINAL,GASTROINTESTINAL NECROSIS,GASTROINTESTINAL VASCULAR CONDITIONS,GASTROINTESTINAL NECROSIS AND GANGRENE (EXCL GANGRENOUS HERNIA),10017947,10028861,10017982,10028861
STAGE 3 BISPHOSPHONATE-RELATED OSTEONECROSIS OF JAW IN THE LEFT POSTERIOR MANDIBLE,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
COMA/CNS DEPRESSION,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
DISORIENTATION,Disorientation,DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013395
RESTLESS BEHAVIOR FOLLOWING MULTIPLE DRUG POISONING,Restlessness,RESTLESSNESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038743,10038743,10038743
PNEUMOPERITONEUM FOLLOWING VISCERAL PERFORATION,Pneumoperitoneum,PNEUMOPERITONEUM,PNEUMOPERITONEUM,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10048299,10048299,10048299
DRUG-INDUCED HAEMOLYTIC ANAEMIA,Haemolytic anaemia,HAEMOLYTIC ANAEMIA DRUG-INDUCED,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10018918,10018916,10018918
UNABLE TO TOLERATE ANY OF THE ANTI-INFLAMMATORIES BECAUSE OF ASSOCIATED ABDOMINAL DISCOMFOR,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
"STRESS ECG REVELAED SINUS TACHYCARDIA 120/MIN, ST ELEVATION, GIANT R WAVE AND MONOPHASIC QRS-ST COMPLEX",ST segment elevation,ST SEGMENT ELEVATION,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041894,10014392,10041894
DID NOT ACHIEVE A GOOD BIOCHEMICAL RESPONSE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
INDIRECT HYPERBILIRUBINAEMIA (90.63 MICROMOL/L),Hyperbilirubinaemia,INDIRECT HYPERBILIRUBINAEMIA,HYPERBILIRUBINAEMIA,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10075822,10020578,10075822
16 YEAR OLD (LESS THAN 18 YEARS) PATIENT RECEIVED FLUDARABINE AS A CONDITIONING REGIMEN FOR ALLOGENEIC STEM CELL TRANSPLANTATION (OFF LABEL USE) WITH NO ADVERSE DRUG REACTION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER CENTRAL NERVOUS SYSTEM, DIFFUSE LARGE B-CELL TYPE",Central nervous system lymphoma,CENTRAL NERVOUS SYSTEM LYMPHOMA,CENTRAL NERVOUS SYSTEM LYMPHOMA,LYMPHOMAS NEC,LYMPHOMAS UNSPECIFIED NEC,10029104,10007953,10007953,10007953
LEPTOMENINGEAL DISEASE,Metastases to meninges,LEPTOMENINGEAL DISEASE,METASTASES TO MENINGES,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10070973,10051696,10070973
CHEMOTHERAPY-INDUCED PERIPHERAL SENSORY POLYNEUROPATHY,Peripheral sensory neuropathy,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10034620,10034620,10034620
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
BILOMA (GRADE IIIA),Biloma,BILOMA,BILOMA,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10059118,10059118,10059118
SEVERE NEUTROPENIA,severe neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
EXACERBATED HER ABDOMINAL PAIN,Abdominal pain aggravated,ABDOMINAL PAIN AGGRAVATED,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10048358,10000081,10048358
FEVERS TO 104F,pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
MAJOR CONGENITAL MALFORMATIONS,Congenital anomaly,CONGENITAL ANOMALY NOS,CONGENITAL ANOMALY,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10010357,10010356,10010357
BILATERAL GLAUCOMA DUE TO CLOBETASOL CREAM FOR ECZEMA,Glaucoma,GLAUCOMA BOTH EYES,GLAUCOMA,GLAUCOMA AND OCULAR HYPERTENSION,GLAUCOMAS (EXCL CONGENITAL),10015919,10018322,10018304,10018322
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
SYNCOPAL EPISODE,Syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
VISUAL DISTURBANCES FOLLOWING OFF LABEL USE OF ACETAZOLAMIDE,Visual impairment,VISUAL DISTURBANCES,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047543,10047571,10047545
CERVICAL EPIDURAL HEMATOMA,epidural hematoma,EPIDURAL HEMATOMA,EXTRADURAL HAEMATOMA,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10015013,10015769,10015013
SEVERE SEPTIC SHOCK FOLLOWING LACK OF DRUG EFFECT,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
TUBERCULOSIS,Tuberculosis,TUBERCULOSIS,TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10044755,10044755,10044755
SYNDROME OF INAPPROPRIATE DIURESIS,Polyuria,DIURESIS,POLYURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY TRACT SIGNS AND SYMPTOMS NEC,10038359,10013523,10036142,10013523
ATTEMPTED SUICIDE BY TAKING A HIGH DOSE OF VERAPAMIL,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
FIRST DEVELOPED PR PROLONGATION,Electrocardiogram PR prolongation,PR PROLONGATION,ELECTROCARDIOGRAM PR PROLONGATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10036473,10053657,10036473
HYPERGAMMAGLOBULINAEMIA,Hypergammaglobulinaemia,HYPERGAMMAGLOBULINAEMIA,HYPERGAMMAGLOBULINAEMIA,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10020630,10020630,10020630
CREATINE KINASE ELEVATED,creatine kinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
METHOTREXATE FOR SCLERODERMATOUS GRAFT VERSUS HOST DISEASE PROPHYLAXIS AND IMATINIB MESILATE FOR SCLERODERMATOUS GRAFT VERSUS HOST DISEASE (OFF LABEL USE WITH NO ADR),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SENSATION OF XEROSTOMIA,Xerostomia,XEROSTOMIA,DRY MOUTH,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10048223,10013781,10048223
TRANSIENT TACHYPNEA,Tachypnoea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043088
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
PATIENT WAS TREATED WITH ACETAZOLAMIDE FUROSEMIDE AND SPIROLACTONE FOR HEADACHE (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FANCONI SYNDROME,Fanconi syndrome acquired,FANCONI SYNDROME ACQUIRED,FANCONI SYNDROME ACQUIRED,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10052607,10052607,10052607
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
AGITATION,agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
MILD SKIN DETACHMENT,Skin exfoliation,SKIN EXFOLIATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040844,10040844,10040844
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
EXCESSIVE HIGH PLASMA CONCENTRATIONS OF APIXABAN,drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
SPEECH DISORDER,Speech disorder,SPEECH DISORDER,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041466,10041466,10041466
MODEST INCREASE IN EPSTEIN-BARR VIRUS DNA LEVELS,Viral load increased,VIRAL LOAD INCREASED,VIRAL LOAD INCREASED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10062180,10062180,10062180
TREMOR,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
RENAL DYSFUNCTION,kidney dysfunction,KIDNEY DYSFUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10023417,10062237,10023417
PATIENT DEVELOPED MULTI-ORGAN FAILURE,multi-organ failure,MULTI-ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028154
PARTIAL RESPONSE,PARTIAL RESPONSE,THERAPY PARTIAL RESPONDER,THERAPY PARTIAL RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10078115,10078115,10078115
DISSEMINATED CRYPTOCOCCOSIS BY CRYPTOCOCCUS NEOFORMANS WITH EXTRACUTANEOUS AND CNS INVOLVEMENT,Disseminated cryptococcosis,DISSEMINATED CRYPTOCOCCOSIS,DISSEMINATED CRYPTOCOCCOSIS,FUNGAL INFECTIOUS DISORDERS,CRYPTOCOCCAL INFECTIONS,10021881,10013439,10013439,10013439
HBV VIROLOGICAL BREAKTHROUGH FOLLOWING DRUG DRUG INTERACTION,Hepatitis B,HEPATITIS B,HEPATITIS B,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10019731,10019731,10019731
KAPOSI'S SARCOMA ASSOCIATED WITH HHV-8 VIREMIA,Kaposi's sarcoma,KAPOSI'S SARCOMA,KAPOSI'S SARCOMA,SOFT TISSUE NEOPLASMS MALIGNANT AND UNSPECIFIED,KAPOSI'S SARCOMAS,10029104,10023284,10023284,10023284
DRUG USE FOR UNAPPROVED INDICATION,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
MILD COLITIS,Colitis,COLITIS,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009887,10009887,10009887
ERYTHEMA OEDEMATOUS IN THE BOTH FOREARMS AND TRUNK,Erythema,ERYTHEMA OEDEMATOUS,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015236,10015150,10015236
INFECTION WITH ACTINOMYCES,Actinomycosis,ACTINOMYCOSIS,ACTINOMYCOSIS,BACTERIAL INFECTIOUS DISORDERS,ACTINOMYCOTIC INFECTIOUS DISORDERS,10021881,10000620,10000620,10000620
MYOCARDIAL OEDEMA,myocardial oedema,MYOCARDIAL OEDEMA,MYOCARDIAL OEDEMA,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10064966,10064966,10064966
"MEROPENEM FOR THE TREATMENT OF HIS RECURRENT RESPIRATORY SEPSIS, AND HIS VPA LEVELS BECAME UNDETECTABLE",drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
CHEST TIGHTNESS,chest tightness,CHEST TIGHTNESS,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008492,10008469,10008492
PANCREATITIS,Pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
POSSIBLE ALLERGIC REACTION TO ACETAMINOPHEN,allergic reaction,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
MULTIPLE ORGAN DYSFUNCTION SYNDROME FOLLOWING ARDS,Multiple organ dysfunction syndrome,MULTIPLE ORGAN DYSFUNCTION SYNDROME,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10077361,10077361,10077361
HIGH PROLACTIN LEVELS,Blood prolactin increased,INCREASED PROLACTIN LEVEL,BLOOD PROLACTIN INCREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),PITUITARY ANALYSES ANTERIOR,10022891,10036828,10005780,10021675
EATING DISORDERS,Eating disorder,EATING DISORDER,EATING DISORDER,EATING DISORDERS AND DISTURBANCES,EATING DISORDERS NEC,10037175,10014062,10014062,10014062
TREMOR,tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
HERPETIFORM VESICLES OVER LEFT UPPER LIMB FROM C2 TO T2 DERMATOMES,Herpes virus infection,HERPETIFORM LESION,HERPES VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10020006,10019973,10020006
OUR TRIAL OF DOCETAXEL AND CIPLATIN FAILED TO SHOW ANY RESPONSE (LACK OF DRUG FFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CARDIOTOXICITY,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
"PATIENT EXPERIENCED TRANSIENT HEPATIC TOXICITIES, HAEMATOLOGICAL TOXICITY AND DIARRHOEA WHICH ALL RECOVERED WITHIN TWO TO THREE WEEKS AND TRANSAMINITIS GRADE 4 (OUTCOME NOT REPORTED). SUDDEN DEATH OCC",stroke,STROKE,CEREBROVASCULAR ACCIDENT,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10042244,10008190,10042244
INTENSE LOCAL IRRITATION AS A RESULT OF IMIQUIMOD APPLICATION,Skin irritation,SKIN IRRITATION,SKIN IRRITATION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10040880,10040880,10040880
DELAYED TYPE HYPERSENSITIVITY,Delayed type hypersensitivity,DELAYED TYPE HYPERSENSITIVITY,TYPE IV HYPERSENSITIVITY REACTION,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10012210,10053613,10012210
LEUCOPENIA (LEUCOCYTES NOS) FOLLOWING OFF LABEL USE OF MYCOPHENOLATE MOFETIL,Leukopenia,LEUCOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024283
SEVERE EXTRAPYRAMIDAL SIDE EFFECTS,Extrapyramidal disorder,EXTRAPYRAMIDAL SYMPTOMS,EXTRAPYRAMIDAL DISORDER,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10015835,10015832,10015835
"SEPTIC EMBOLI IN BOTH LUNGS DUE TO DISSEMINATED TRICHOSPORON ASAHII FUNGEMIA, CANDIDA GLABRATA INFECTION AND CRYPTOCOCCUS NEOFORMANS INFECTION",Septic embolus,SEPTIC EMBOLI,SEPTIC EMBOLUS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040067,10040067,10040066
UNABLE TO MAINTAIN AN UPRIGHT POSTURE WHEN SITTING,Posture abnormal,POSTURE ABNORMAL,POSTURE ABNORMAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10036436,10036436,10036436
LOW PERIPHERAL  OXYGEN SATURATION,Oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
PARTIAL INABILITY TO READ,Reading disorder,READING DISORDER,READING DISORDER,COGNITIVE AND ATTENTION DISORDERS AND DISTURBANCES,LEARNING DISORDERS,10037175,10037999,10037999,10037999
SHORT NECK,short neck,SHORT NECK,NECK DEFORMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES (INCL INTERVERTEBRAL DISC DISORDERS),SPINE AND NECK DEFORMITIES,10028395,10073036,10061307,10073036
HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
BEGAN WAKING SUDDENLY AFTER SEVERAL HOURS OF SLEEP,Insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
PARENCHYMAL HAEMORRHAGE,intracranial haemorrhage,INTRACRANIAL HAEMORRHAGE,HAEMORRHAGE INTRACRANIAL,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10073792,10018985,10073792
LOCALIZED ITCHY RASH NEAR THE SC [SUBCUTANEOUS] ADMINISTRATION SITE,itchy rash,ITCHY RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023092,10037884,10023092
BILATERAL OPTIC NEUROPATHY DUE TO COMBINED ETHAMBUTOL AND ISONIAZID TREATMENT,Optic neuropathy,OPTIC NEUROPATHY,OPTIC NEUROPATHY,VISION DISORDERS,VISUAL PATHWAY DISORDERS,10015919,10061323,10061323,10061323
POOR APPETITE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
BLOOD CULTURES TAKEN REVEALED THE PRESENCE OF METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS (MSSA),Staphylococcal sepsis,METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS SEPSIS,STAPHYLOCOCCAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10078717,10056430,10078717
DRUG TOXICITY FOLLOWING INTERACTION WITH PHENYLBUTAZONE,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
ANGIOEDEMA/LEFT PALPEBRAL DISCREET ANGIOEDEMA,Angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
PERIODICAL RASH ON THE SKIN OF HANDS AND FOREARMS,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
"CHRONIC RENAL, CARDIAC AND PULMONARY INSUFFICIENCY CONTRIBUTED TO ACETAMINOPHEN TOXICITY IN THIS PATIENT",Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
PCV DECREASED (30.5%),Haematocrit decreased,PCV DECREASED,HAEMATOCRIT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10034186,10018838,10034186
INCREASED PLASMA LOAD(453 COPIES/ML) DUE TO DRUG RESISTANCE TO EMTRICITABINE AND TENOFOVIR FOLLOWING DRUG EXPOSURE DURING PREGNANCY,Viral load increased,VIRAL LOAD INCREASED,VIRAL LOAD INCREASED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10062180,10062180,10062180
UNCONTROLLABLE PYREXIA,uncontrollable pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
TACHYCARDIC,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
GENERAL CONDITION WAS DETERIORATING,General physical health deterioration,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10049438,10049438,10049438
HYPERTRICHOSIS IN SUN EXPOSED AREAS,Hypertrichosis,HYPERTRICHOSIS,HYPERTRICHOSIS,SKIN APPENDAGE CONDITIONS,HYPERTRICHOSES,10040785,10020864,10020864,10020864
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
SEVERE MUSCLE PAIN,Myalgia,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028322
TOLERATED POORLY,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
PUS,Purulent discharge,PURULENT DISCHARGE,PURULENT DISCHARGE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10037569,10037569,10037569
"PATIENT STILL RATIONALIZED HIS SOCIAL ANXIETY, AVOIDANT BEHAVIOR AND SYMPTOMS OF SELECTIVE MUTISM.",drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
"HEADACHE/LEFT VENTRICULAR THROMBOSIS, EMBOLIC STROKE, INTRACRANIAL HEMORRHAGE, HEADACHE, MACROSCOPIC HAEMATURIA AND REPORTED SUBTHERAPEUTIC RESPONSE TO CLOPIDOGREL",Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
ANXIETY,anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
DELIRIOUS CONDITION,Delirium,DELIRIOUS,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012217
STOMATOCOCCAL INFECTION,stomatococcal infection,STOMATOCOCCAL INFECTION,STOMATOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10068385,10068385,10068385
VENTRICULAR DYSRHYTHMIA,Ventricular arrhythmia,VENTRICULAR ARRHYTHMIA,VENTRICULAR ARRHYTHMIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047281,10047281,10047281
SELF-POISONING WITH FIFTY 500 MG PARACETAMOL TABLETS,Poisoning deliberate self-inflicted,POISONING DELIBERATE SELF-INFLICTED,POISONING DELIBERATE,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10036001,10036000,10036001
SODIUM INCREASED (150 MMOL/L),Blood sodium increased,SODIUM INCREASED,BLOOD SODIUM INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10041272,10005803,10041272
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
DRUG HYPERSENSITIVITY,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
HYPERKALEMIA,hyperkalemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020647,10020646,10020647
TREATMENT NONCOMPLIANCE,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
VENTRICULAR FIBRILLATION,Ventricular fibrillation,VENTRICULAR FIBRILLATION,VENTRICULAR FIBRILLATION,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047290,10047290,10047290
HYPOGLYCEMIA,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
PORTAL HYPERTENSION DUE TO SOS,Sinusoidal obstruction syndrome,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
EPIGASTRIC PAIN,Epigastric pain,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
FACIAL OEDEMA,facial oedema,OEDEMA FACE,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030101,10016029,10030101
"DESPITE THERAPY WITH VALPORATE AND CARBAMZEPINE, SHE EXPERIENCED SPORADIC SEIZURES",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LEUCOCYTOPENIA,leucocytopenia,LEUCOCYTOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10068178,10024384,10068178
NECROTIZING FASCIITIS,Necrotising fasciitis,NECROTIZING FASCIITIS,NECROTISING FASCIITIS,INFECTIONS - PATHOGEN UNSPECIFIED,MUSCLE AND SOFT TISSUE INFECTIONS,10021881,10028885,10028885,10055647
PSA LEVEL WAS GRADUALLY INCREASED,Prostatic specific antigen increased,PSA INCREASED,PROSTATIC SPECIFIC ANTIGEN INCREASED,CYTOGENETIC INVESTIGATIONS,CELL MARKER ANALYSES,10022891,10037102,10036975,10037102
"COTRIMOXAZOLE INTERACTIONS CAN INVOLVE THE CYTOCHROME P450 ENZYME SYSTEM. HYPOGLYCAEMIC AGENTS ARE METABOLIZED BY THESE CYTOCHROMES AND THEY CAN ACCUMULATE, LEADING TO A MAJOR RISK OF HYPOGLYCAEMIA",Drug interaction,DRUG-DRUG PHARMACOKINETIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10065994,10013710,10065994
LOCAL FIBROSIS IN THE AREAS OF SEVERE HYPOKINESIS,Myocardial fibrosis,MYOCARDIAL FIBROSIS,MYOCARDIAL FIBROSIS,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10028594,10028594,10028594
GENE MUTATIONS (VAF) DNMT3A C.2192_2193INSAAAG: P.F731LFSX4 (18%),acquired gene mutation,ACQUIRED GENE MUTATION,ACQUIRED GENE MUTATION,GENERAL SYSTEM DISORDERS NEC,ACQUIRED GENE MUTATIONS AND OTHER ALTERATIONS,10018065,10069754,10069754,10069754
QRS WIDENED FOLLOWING MULTIPLE DRUG OVERDOSE,Electrocardiogram QRS complex prolonged,QRS WIDENED,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037699,10014380,10037699
PARTIAL EFFECT OF CHEMOTHERAPY,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
BETA-D-GLUCAN LEVEL INCREASED (272 PG/ML),Blood beta-D-glucan increased,BLOOD BETA-D-GLUCAN INCREASED,BLOOD BETA-D-GLUCAN INCREASED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,FUNGUS IDENTIFICATION AND SEROLOGY,10022891,10051793,10051793,10051793
DIARRHEA,Diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
HER STOMACH CAN NO MORE BEAR THE AGGRESSION,Gastric disorder,GASTRIC DISORDER,GASTRIC DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10056819,10056819,10056819
ANGIOEDEMA,Angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
IRREVERSIBLE LIVER CIRRHOSIS,hepatic cirrhosis,HEPATIC CIRRHOSIS,HEPATIC CIRRHOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10019641,10019641,10019641
SINGLE NSAID INDUCED URTICARIA/ANGIOEDEMA/ANAPHYLAXIS (SNIUAA),Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
EEG SHOWED SLOW-WAVE ACTIVITY,Electroencephalogram abnormal,WAVE SLOWING,ELECTROENCEPHALOGRAM ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10047851,10014408,10047851
BULLOUS SYSTEMIC LUPUS ERYTHEMATOSUS FOLLOWING LACK OF DRUG EFFECT,Systemic lupus erythematosus rash,SYSTEMIC LUPUS ERYTHEMATOSUS RASH,SYSTEMIC LUPUS ERYTHEMATOSUS RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10042946,10042946,10042946
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
SLOUGHING ON THE HANDS AND FEET,sloughing on the hands and feet,SLOUGHING,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10041036,10040844,10041036
"RAPIDLY PROGRESSING LYMPHADENOPATHIES (CERVICAL, SUBCLAVICULAR, SUB AND SUS-DIAPHRAGMATIC)",Lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
MUMBLING,Speech disorder,MUMBLING,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10075193,10041466,10075193
RESTLESS STATE,restless state,RESTLESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038740,10038743,10038740
HAEMATEMESIS,Haematemesis,HAEMATEMESIS,HAEMATEMESIS,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018830,10018830,10018830
INTERSTITIAL PNEUMONITIS,Interstitial pneumonitis,INTERSTITIAL PNEUMONITIS,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022618,10022611,10022618
SWOLLEN ABDOMEN,Abdominal distension,SWOLLEN ABDOMEN,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10042714,10000060,10042714
"DIFFUSE ERYTHEMA AND PEELING OF SKIN MAINLY INVOLVING THE FACE, TRUNK, BACK AND EXTREMITIES",Erythema diffuse,ERYTHEMA DIFFUSE,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015159,10015150,10015159
"EXPERIENCED REPEATED REACTIONS FOLLOWING THE INTAKE OF SEVERAL ANTIHISTAMINES WITH URTICARIA AND ANGIOEDEMA (HYDROXYZINE CETIRIZINE) AND URTICARIA, ANGIOEDEMA, AND SYNCOPE (FEXOFENADINE)",Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
MODERATE DYSPNOEA/AGGRAVATED DYSPNEA,Dyspnoea,DYSPNEA EXACERBATED,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013970,10013968,10013965
DIARRHEA WITH LIQUID STOOLS WITHOUT BLOOD,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
"DESPITE COMMENCING LEVOTHYROXINE, SHE REMAINED BRADYCARDIC AND WAS DEPENDENT ON ISOPRENALINE TO MAINTAIN THE SATISFACTORY HEART RATE (LACK OF DRUG EFFECT)",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ONE EPISODE OF TONIC-CLONIC SEIZURE ATTACK,tonic-clonic seizures,TONIC-CLONIC SEIZURES,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10044000,10018100,10044000
SPLENIC ABSCESS,splenic abscess,SPLENIC ABSCESS,SPLENIC ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,HEPATOBILIARY AND SPLEEN INFECTIONS,10021881,10041643,10041643,10041643
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
BILATERAL GYNECOMASTIA,gynecomastia,GYNECOMASTIA,GYNAECOMASTIA,BREAST DISORDERS,BREAST DISORDERS NEC,10038604,10018801,10018800,10018801
PROXIMAL MUSCLE WEAKNESS,Muscular weakness,PROXIMAL MUSCLE WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10079474,10028372,10079474
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
PARADOXICAL REACTION,Paradoxical drug reaction,PARADOXICAL DRUG REACTION,PARADOXICAL DRUG REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048958,10048958,10048958
SLIGHT SWELLING OF THE TONGUE,Swelling of tongue,SWELLING OF TONGUE,SWOLLEN TONGUE,TONGUE CONDITIONS,TONGUE SIGNS AND SYMPTOMS,10017947,10042706,10042727,10042706
"BULLOUS HAEMORRHAGIC RASH ON THE THIGHS, FLANKS AND ABDOMEN, ASSOCIATED WITH A SHARP DROP IN PLATELET COUNT.",bullous rash,BULLOUS RASH,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006569,10012441,10006569
KNEE EDEMA IN THE RIGHT KNEE,edema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014210,10030095,10014210
PATIENT RECEIVED PREDNISONE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
REDNESS OF THE SKIN,Skin red,SKIN RED,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10040916,10015150,10040916
PERSISTENT SYMPTOMATIC FEVER (MAINLY NOCTURNAL) 40 DEGRESS C,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
CHRONIC INTAKE OF AT LEAST 4000 MG OF ACETAMINOPHEN FROM 3 DIFFERENT SOURCES PER DAY FOR THE PAST YEAR,Incorrect drug administration duration,DRUG ADMINISTRATION DURATION TOO LONG,INCORRECT DRUG ADMINISTRATION DURATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064312,10064307,10064312
LUNG CONSOLIDATION FOLLOWING ACUTE PULMONARY TOXICITY,Lung consolidation,LUNG CONSOLIDATION,LUNG CONSOLIDATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025080,10025080,10025080
BRUISES ON HER LEFT LEG AND LEFT ARM,Contusion,BRUISE,CONTUSION,INJURIES NEC,SKIN INJURIES NEC,10022117,10050584,10050584,10006502
RETROBULBAR NEURITIS FOLLOWED BY OPTIC ATROPHY,retrobulbar neuritis,RETROBULBAR NEURITIS,OPTIC NEURITIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OPTIC NERVE DISORDERS NEC,10029205,10038962,10030942,10038962
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
WORSENING OF SCEDOSPORIUM APIOSPERMUM INFECTION DESPITE SYSTEMIC COMBINED TREATMENT AND APPROPRIATE POSACONAZOLE LEVELS,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
EXTENSIVE FIBROSIS,hepatic fibrosis,HEPATIC FIBROSIS,HEPATIC FIBROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10019668,10019668,10019668
DUE TO PERSISTENCE OF BCR-ABL FUSION TRANSCRIPT DESPITE TKI THERAPY (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
SERUM CREATININE ELEVATED,Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
MOST INTENTIONAL OVERDOSES,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
ALT INCREASED (134 U/L),ALT increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
THINNING OF HAIR SHAFT,Alopecia,HAIR THINNING,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10019050,10001760,10019050
IMATINIB AND DASATINIB RESISTANT,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
MULTIPLE STAGE 3 ULCERATED INFECTED WOUNDS ON BOTH ELBOWS AND RIGHT UPPER THIGH,Ulcer,ULCER,ULCER,TISSUE DISORDERS NEC,ULCERS NEC,10018065,10045285,10045285,10045285
GENERALIZED TOXICODERMA,Toxic skin eruption,TOXICODERMA,TOXIC SKIN ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10044259,10057970,10044259
RESPIRATORY TRACT DAMAGE SECONDARY TO MEDICATION ASPIRATION/TABLETS HAD GONE DOWN THE WRONG PASSAGE/ASPIRATION OF MEDICINE,Foreign body aspiration,MEDICATION ASPIRATION,FOREIGN BODY ASPIRATION,INJURIES NEC,CHEST AND RESPIRATORY TRACT INJURIES NEC,10022117,10063553,10017000,10063553
LACK OF ADEQUATE RESPONSE TO PREDNISOLONE THERAPY ADMINISTERED FOR TREATMENT OF KHE AND KMP-LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ENTEROBACTER CLOACAE BACTEREMIA,Enterobacter cloacae bacteremia,ENTEROBACTER BACTEREMIA,ENTEROBACTER BACTERAEMIA,BACTERIAL INFECTIOUS DISORDERS,ENTEROBACTER INFECTIONS,10021881,10058884,10058857,10058884
RECURRENT ENDOMETRIOSIS,endometriosis,ENDOMETRIOSIS,ENDOMETRIOSIS,"UTERINE, PELVIC AND BROAD LIGAMENT DISORDERS",UTERINE DISORDERS NEC,10038604,10014778,10014778,10014778
PATIENT DEVELOPED POLYURIA,Polyuria,POLYURIA,POLYURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY TRACT SIGNS AND SYMPTOMS NEC,10038359,10036142,10036142,10036142
STOMATITIS AND OTHER MUCOSAL MEMBRANE DISORDERS,Mucous membrane disorder,MUCOUS MEMBRANE DISORDER,MUCOUS MEMBRANE DISORDER,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028133,10028133,10028133
ACUTE KIDNEY INJURY,acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
IRREGULAR HEART RATE,Heart rate irregular,HEART RATE IRREGULAR,HEART RATE IRREGULAR,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019304,10019304,10019304
RIGHT-SIDED ANTERIOR UVEITIS,Anterior uveitis,ANTERIOR UVEITIS,IRIDOCYCLITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10002709,10022941,10002709
MUSCLE PAIN,Myalgia,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028322
TYPE II RESPIRATORY FAILURE FOLLOWING MYASTHENIA GRAVIS,type II respiratory failure following myasthenia gravis,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
LYMPHOCYTOSIS,Lymphocytosis,LYMPHOCYTOSIS,LYMPHOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10025280,10025280,10025280
HEPATOTOXICITY,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
CONCENTRATION IMPAIRED,Concentration impaired,CONCENTRATION IMPAIRED,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10010249,10013496,10010249
PSEUDOEPHEDRINE TOXICITY,drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
CARDIO RESPIRATORY ARREST (ACR),Cardio-respiratory arrest,CARDIO-RESPIRATORY ARREST,CARDIO-RESPIRATORY ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007617,10007617,10007617
HYPOXEMIA,hypoxemia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021142,10021143,10021142
ANISOCORIA,Pupils unequal,ANISOCORIA,PUPILS UNEQUAL,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10002535,10037538,10002535
RIGHT BUNDLE BRANCH BLOCK AND LEFT POSTERIOR FASCICULAR BLOCK DUE TO HYPERKALEMIA,Right bundle branch block and left posterior fascicular block,RIGHT BUNDLE BRANCH BLOCK AND LEFT POSTERIOR FASCICULAR BLOCK,BUNDLE BRANCH BLOCK BILATERAL,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10039149,10006579,10039149
INDURATION/POST VACCINATION LOCAL REACTIONS,Vaccination site induration,VACCINATION SITE INDURATION,VACCINATION SITE INDURATION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10065117,10065117,10065117
PHYSICAL DECONDITIONING DUE TO HYPOGLYCAEMIA,Asthenia,PHYSICAL DECONDITIONING,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10051588,10003549,10051588
DRUG INDUCED TUBULOINTERSTITIAL NEPHRITIS,Tubulointerstitial nephritis,TUBULOINTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10048302,10048302,10048302
DETERIORATION OF MUSCLE CLONUS AND RIGIDITY,Myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
BLOODY NASAL DISCHARGE,nasal discharge,NASAL DISCHARGE,RHINORRHOEA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10028737,10039101,10028737
ENTEROBACTER GERGOVIAE STRAIN,enterobacter infection,ENTEROBACTER INFECTION,ENTEROBACTER INFECTION,BACTERIAL INFECTIOUS DISORDERS,ENTEROBACTER INFECTIONS,10021881,10051910,10051910,10051910
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
CEFTRIAXONE INDUCED PSEUDOLITHIASIS,Pseudocholelithiasis,PSEUDOCHOLELITHIASIS,PSEUDOCHOLELITHIASIS,GALLBLADDER DISORDERS,CHOLECYSTITIS AND CHOLELITHIASIS,10019805,10066884,10066884,10066884
DESQUAMATION,desquamation,DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10012528,10040844,10012528
APRAXIA OF LEFT ARM/ ELONGATION AND DISMEMBERMENT FEELING IN HER LEFT ARM,Apraxia,APRAXIA,APRAXIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10003062,10003062,10003062
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
OFF LABEL USE,OFF LABEL USE,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ORAL PAIN,Oral pain,ORAL PAIN,ORAL PAIN,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE PAIN AND PARAESTHESIA,10017947,10031009,10031009,10031009
FN,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
GASTROINTESTINAL DISORDERS,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
LUNG TRANSPLANT,lung transplant,LUNG TRANSPLANT,LUNG TRANSPLANT,RESPIRATORY TRACT THERAPEUTIC PROCEDURES,BRONCHIAL AND PULMONARY THERAPEUTIC PROCEDURES,10042613,10025127,10025127,10025127
SEVERE COAGULOPATHY AS A CONSEQUENCE OF L-ASP ADMINISTRATION,Coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
EPISODES OF BRADYCARDIA-INDUCED SUSTAINED VENTRICULAR TACHYCARDIA,Bradytachycardia,BRADYTACHYCARDIA,SINUS NODE DYSFUNCTION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10050109,10075889,10050109
MODERATE PERICARDIAL EFFUSION,Pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
ELASTICITY DRASTICCALLY REDUCED,Skin atrophy,LOSS OF SKIN ELASTICITY,SKIN ATROPHY,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,SKIN HYPOPLASIAS AND ATROPHIES,10040785,10024875,10040799,10024875
LEMIERREâ€™S SYNDROME,Lemierre syndrome,LEMIERRE SYNDROME,LEMIERRE SYNDROME,BACTERIAL INFECTIOUS DISORDERS,FUSOBACTERIUM INFECTIONS,10021881,10065552,10065552,10065552
DEATH,death,DEATH,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10011906,10011906,10011906
PATIENT WAS TREATED WITH GEMFIBROZIL AND EPA ETHYL ESTER THROUGHOUT PREGNANCY (DRUG EXPOSURE DURING PREGNANCY),drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
SERUM LEVEL OF LACTIC DEHYDROGENASE ELEVATED FOLLOWING ACCIDENTAL INGESTION OF METHOTREXATE,serum lactic dehydrogenase increased,SERUM LACTIC DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10040320,10005630,10040320
HYPOALBUMINAEMIA (17G/L),Hypoalbuminaemia,HYPOALBUMINAEMIA,HYPOALBUMINAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020942,10020942,10020942
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
PATIENT USED MYCOPHENOLATE MOFETIL DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
BILATERAL RENAL FIBROMUSCOLAR DYSPLASIA,Renal dysplasia,RENAL DYSPLASIA,RENAL DYSPLASIA,RENAL AND URINARY TRACT DISORDERS CONGENITAL,RENAL DISORDERS CONGENITAL,10010331,10038433,10038433,10038433
PATIENT HAD TO USE WHEELCHAIR AFTER USING LEVOFLOXACIN,Wheelchair user,WHEELCHAIR USER,WHEELCHAIR USER,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10047920,10047920,10047920
STEVENS-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
A WIDE-STARING,Staring,STARING,STARING,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10041953,10041953,10041953
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
INABILITY TO MAINTAIN CONTROL OF THE AIRPLANE,Aircraft accident,AIRCRAFT ACCIDENT,ACCIDENT,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10001535,10000369,10001535
SKIN DISORDER (GRADE 2),Skin disorder,SKIN DISORDER,SKIN DISORDER,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040831,10040831,10040831
SULPHAMETHOXAZOLE INDUCED CRYSTALLURIA,crystalluria sulfonamide,CRYSTALLURIA SULFONAMIDE,CRYSTALLURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10011513,10011509,10011513
"DIFFICULTIES IN CONCENTRATION DUE TO THE ""VOICES WHO THREATENED HER""",Disturbance in attention,ATTENTION CONCENTRATION DIFFICULTY,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10003729,10013496,10003729
LIVER FAILURE,Hepatic failure,LIVER FAILURE,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10019663,10019663,10024678
DIFFICULTIES WITH VISUAL ACCOMMODATION,Visual accommodation disturbance of,VISUAL ACCOMMODATION DISTURBANCE OF,ACCOMMODATION DISORDER,VISION DISORDERS,REFRACTIVE AND ACCOMMODATIVE DISORDERS,10015919,10047528,10000389,10047528
PROGRESSIVE AXIAL HYPOTONIA,Hypotonia,HYPOTONIA,HYPOTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10021118,10021118,10021118
HYPOTONIC-HYPORESPONSIVE EPISODE,Hypotonic-hyporesponsive episode,HYPOTONIC-HYPORESPONSIVE EPISODE,HYPOTONIC-HYPORESPONSIVE EPISODE,NEUROMUSCULAR DISORDERS,NEUROMUSCULAR DISORDERS NEC,10029205,10021121,10021121,10021121
PATIENT TREATED WITH METHOTREXATE FOR INTERSTITIAL ECTOPIC PREGNANCY (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SPEAKING IN TONGUES,Disorganised speech,DISORGANISED SPEECH,DISORGANISED SPEECH,COMMUNICATION DISORDERS AND DISTURBANCES,SPEECH AND LANGUAGE USAGE DISTURBANCES,10037175,10076227,10076227,10076227
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
COLONOSCOPY REVEALED OEDEMATOUS THICKENING OF THE BOWEL WALL WITH ULCERATION AND ERYTHEMA,Gastrointestinal wall thickening,BOWEL WALL THICKENING,GASTROINTESTINAL WALL THICKENING,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10075727,10075724,10075727
INFLAMMATION,Inflammation,INFLAMMATION,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10061218,10061218,10061218
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS SYNDROME,Drug reaction with eosinophilia and systemic symptoms,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10073508,10073508,10073508
"GRADE 2 MUCOSITIS DURING TREATMENT WITH VINORELBINE, CAPECITABINE AND GRANULOCYTE-COLONY STIMULATING FACTOR",Mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
LONG QT SYNDROME (LQTS),Long QT syndrome,LONG QT SYNDROME,LONG QT SYNDROME,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10024803,10024803,10024803
GRAFT DYSFUNCTION,Transplant dysfunction,GRAFT DYSFUNCTION,TRANSPLANT DYSFUNCTION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10074860,10074860,10059677
FEVER (38.5 DEGREE CELCIUS),fever,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
"PYRAMIDAL IRRITATION WITH BRISK, DIFFUSE,  POLYKINETIC REFLEXES OF THE LOWER LIMBS, A PLANTAR REFLEX IN TRIPLE
FLEXION",Reflexes abnormal,REFLEXES ABNORMAL,REFLEXES ABNORMAL,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10038254,10038254,10038254
PARTIAL HELLP SYNDROME,HELLP syndrome,HELLP SYNDROME,HELLP SYNDROME,MATERNAL COMPLICATIONS OF PREGNANCY,HYPERTENSION ASSOCIATED DISORDERS OF PREGNANCY,10036585,10049058,10049058,10049058
LYMPHOCYTOSIS 29 K/ML,Lymphocytosis,LYMPHOCYTOSIS,LYMPHOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10025280,10025280,10025280
GASTROINTESTINAL COMPLAINTS,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
LDH INCREASED (LDH-300 U/L),Blood lactate dehydrogenase increased,LDH INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10024051,10005630,10024051
ASTHENIC,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
VOICES WHO THREATENED HER,"Hallucination, auditory",HALLUCINATION AUDITORY,"HALLUCINATION, AUDITORY",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019070,10019070,10019064
BONE EXPOSURE,Bone exposure,EXPOSED BONE IN JAW,EXPOSED BONE IN JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10071014,10071014,10071014
VANDETANIB-INDUCED CORNEA VERTICILLATE,cornea verticillata,CORNEA VERTICILLATA,CORNEA VERTICILLATA,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CORNEAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10077604,10077604,10077604
NOSOCOMIAL INVASIVE ASPERGILLOSIS,Cerebral aspergillosis,CEREBRAL ASPERGILLOSIS,CEREBRAL ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10051597,10051597,10051597
PERIPHERAL NEUROPATHY,peripheral neuropathy,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10080342,10029331,10080342
TREMOR,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
EPSTEIN-BARR VIRUS-RELATED PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA,Epstein-Barr virus infection,EPSTEIN-BARR VIRUS INFECTION,EPSTEIN-BARR VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,EPSTEIN-BARR VIRAL INFECTIONS,10021881,10015108,10015108,10015108
HYPERFIBRINOGEN 808 MG/DL,Hyperfibrinogenaemia,HYPERFIBRINOGENAEMIA,HYPERFIBRINOGENAEMIA,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10051124,10051124,10051124
FEVER (101.6 F),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
ATRIAL FIBRILLATION,Atrial Fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
USE OF MYCOPHENOLATE MOFETIL AS IMMUNOSUPPRESSANT DRUG THERAPY FOR RELAPSE OF GRANULOMATOSIS WITH POLYANGIITIS (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PERSISTANT ABDOMINAL PAIN THAT NECESSITATED TRAMADOL ADMINISTRATION (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ANEMIA GRADE 2,anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
INSOMNIA,insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
OSCILLOPSIA,oscillopsia,OSCILLOPSIA,OSCILLOPSIA,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10052087,10052087,10052087
BILATERAL ADRENAL HYPERPLASIA,bilateral adrenal hyperplasia,HYPERPLASIA ADRENAL,HYPERADRENALISM,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10020719,10020562,10020719
PARACETAMOL INTOXICATION,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RECURRENT PNEUMONIA,recurrent pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
RECURRENT SYMPTOMATIC POSTOPERATIVE EPIDURAL HEMATOMA,Spinal epidural haematoma,SPINAL EPIDURAL HEMATOMA,SPINAL EPIDURAL HAEMATOMA,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10050162,10050162,10055381
APPETITE LOSS,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
"PAIN IN THE AREA OF THE LEFT RIB ARCH, AS WELL AS IN THE LEFT LUMBAR REGION, WHICH INCREASES DURING",Back pain,LOW BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10024891,10003988,10024891
SIMVASTATIN-DEPENDENT MYOPATHY,myopathy,MYOPATHY,MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10028641,10028641,10028641
FLARE OF CUA,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
INADEQUATE GLYCEMIC CONTROL,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
RENAL TUBULOPATHY,renal tubular disorder,RENAL TUBULAR DISORDER,RENAL TUBULAR DISORDER,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10038537,10038537,10038537
HYPONATRAEMIA,Hyponatraemia,HYPONATRAEMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021036
CARDIOGENIC SHOCK FOLLOWING DISSEMINATED MUCORMYCOSIS,Cardiogenic shock,CARDIOGENIC SHOCK,CARDIOGENIC SHOCK,HEART FAILURES,HEART FAILURES NEC,10007541,10007625,10007625,10007625
ACUTE INTRACRANIAL HEMATOMA FOLLOWING DRUG ABUSE,intracranial hematoma,INTRACRANIAL HAEMATOMA,INTRACRANIAL HAEMATOMA,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10059491,10059491,10059491
INCREASED CARDIAC CONDUCTION TIMES AND A RAPID SUPRAVENTRICULAR TACHYARRHYTHMIA,supraventricular tachyarrhythmia,SUPRAVENTRICULAR TACHYARRHYTHMIA,SUPRAVENTRICULAR TACHYARRHYTHMIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10065342,10065342,10065342
DYSPHAGIA,dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
STENT THROMBOSIS,coronary stent thrombosis,CORONARY STENT THROMBOSIS,VASCULAR STENT THROMBOSIS,COMPLICATIONS ASSOCIATED WITH DEVICE,VASCULAR COMPLICATIONS ASSOCIATED WITH DEVICE,10018065,10063933,10063934,10063933
RASHES,rashes,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
"PARTIAL DIMENSIONAL AND METABOLIC RESPONSE (SUBTHERAPEUTIC RESPONSE WITH NO ADR) AFTER RECEIVING TREATMENT WITH VINBLASTINE, DOXORUBICIN AND CISPLATIN","partial dimensional and metabolic response (subtherapeutic response with no ADR) after receiving treatment with vinblastine, doxorubicin and cisplatin",SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
BACLOFEN INTOXICATION,drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
THYROTOXICOSIS,thyrotoxicosis,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
LEG NUMBNESS,Hypoaesthesia,NUMBNESS IN LEG,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10029839,10020937,10029839
SEVERE TUMOR PROGRESSION,Neoplasm progression,TUMOR PROGRESSION,NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS UNSPECIFIED MALIGNANCY AND SITE UNSPECIFIED NEC,10029104,10058218,10061309,10053563
DESPITE TREATMENT PATIENT HAD PERSISTING NORMOCYSTIC ANEMIA AND ACUTE PHASE RESPONSE (LACK OF DRUG EFFECT) WITH NO ADVERSE EVENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
FUROSEMIDE-INDUCED SEVERE SECONDARY HYPERPARATHYROIDISM BONES,Hyperparathyroidism secondary,HYPERPARATHYROIDISM SECONDARY,HYPERPARATHYROIDISM SECONDARY,PARATHYROID GLAND DISORDERS,HYPERPARATHYROID DISORDERS,10014698,10020708,10020708,10020708
INCREASED INSTABILITY,Unstable feeling,UNSTABLE FEELING,FEELING ABNORMAL,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10046253,10016322,10046253
"TYPE 2 LEPRA REACTION, REACTIVATION LEPROSY",Infection reactivation,INFECTION REACTIVATION,INFECTION REACTIVATION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10070891,10070891,10070891
FLUDARABINE USED FOR CONDITIONING IN ALLOGENIC STEM CELL TRANSPLANT FOR MULTIPLE MYELOMA (OFF LABEL USE FOR INDICATION WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NON-HIV-RELATED PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY DUE TO CHEMOTHERAPY INDUCED IMMUNODEFICIENCY,Progressive multifocal leukoencephalopathy,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10036807,10036807,10036807
CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
DERANGEMENT OF THE LIVER FUNCTION,Hepatic function abnormal,IMPAIRED LIVER FUNCTION,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019674,10019670,10021520
LONG TERM THERAPY WITH TADALAFIL IN CIRRHOTIC PORTAL HYPERTENSION (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SYNCOPE,Syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
SEVERE LACTIC ACIDOSIS,lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
METHEMOGLOBINEMIA(POTENTIALLY FATAL),Methaemoglobinaemia,METHEMOGLOBINEMIA,METHAEMOGLOBINAEMIA,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10027496,10027496,10027506
LEUKOPENIA FOLLOWING OFF LABEL USE OF MYCOPHENOLATE MOFETIL,leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
MUSCLE ATROPHY,Muscle atrophy,MUSCLE ATROPHY,MUSCLE ATROPHY,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028289,10028289,10028289
LETHARGIC,Lethargy,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024262
RECTUS SHEATH HEMATOMA,Abdominal wall haematoma,RECTUS SHEATH HEMATOMA,ABDOMINAL WALL HAEMATOMA,ABDOMINAL HERNIAS AND OTHER ABDOMINAL WALL CONDITIONS,ABDOMINAL WALL CONDITIONS NEC,10017947,10071751,10067383,10071749
DISEASE REFRACTORY TO TREATMENT/RESISTANT TO HIGH DOSE CORTICOSTEROIDS ASSOCIATED WITH METHOTREXATE (LACK OF DRUG EFFECT WITH NO ADR),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
"ASPIRIN, HEPARIN AND CLOPIDOGREL TAKEN TOGETHER",Drug administration error,DRUG ADMINISTRATION ERROR,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064295,10064295,10064295
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
CREATINE KINASE LEVEL OF 24140U/L/HYPERCKAEMIA,CK increased,CK INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10009219,10005470,10009219
SIGNIFICANT BONE PAIN,bone pain,BONE PAIN,BONE PAIN,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10006002,10006002,10006002
"MULTIORGAN FAILURE DUE TO CEFUROXIME-INDUCED IMMUNE HEMOLYTIC ANEMIA, DISSEMINATED INTRAVASCULAR COAGULATION AND SEVERE HYPOXIC-ISCHEMIC ENCEPHALOPATHY",Multiple organ dysfunction syndrome,MULTIORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028162
DEHYDRATION,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
PAROTITIS RIGHT,Parotitis,PAROTITIS,PAROTITIS,INFECTIONS - PATHOGEN UNSPECIFIED,DENTAL AND ORAL SOFT TISSUE INFECTIONS,10021881,10034038,10034038,10034038
HYPOGLYCEMIA,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
UNABLE TO TOLERATE ANY OF THE ANTI-INFLAMMATORIES BECAUSE OF ASSOCIATED ABDOMINAL DISCOMFORT,Abdominal discomfort,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10000059,10000059,10000059
BILATERAL DIFFUSE SUBPLEURAL NODULES,Pulmonary mass,LUNG NODULE,PULMONARY MASS,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10049498,10056342,10049498
DEHYDRATED,dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
BILIRUBIN TOTAL INCREASED (3.1 MG/DL),Blood bilirubin increased,BILIRUBIN TOTAL INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056806,10005364,10056806
CONFUSION,Confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
MODERATE SPLENOMEGALY (15 CM),Splenomegaly,SPLENOMEGALY,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041660,10041660,10041660
MULTIPLE ORGAN FAILURE,multiple organ failure,MULTIPLE ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028237,10077361,10028237
LIPOHYPERTROPHY,Lipohypertrophy,LIPOHYPERTROPHY,LIPOHYPERTROPHY,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,LIPODYSTROPHIES,10040785,10062315,10062315,10062315
"HOSPITALISED WITH UNEXPLAINED SYMPTOMS, DIED SEVERAL DAYS LATER IN HOSPITAL",Hospitalisation,HOSPITALIZATION NOS,HOSPITALISATION,THERAPEUTIC PROCEDURES AND SUPPORTIVE CARE NEC,THERAPEUTIC PROCEDURES NEC,10042613,10050451,10054112,10050451
CHLOROQUINE INDUCED CARDIOMYOPATHY DUE TO OFF LABEL USE OF CHLOROQUINE,cardiomyopathy,CARDIOMYOPATHY,CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10007636,10007636,10007636
HEART BLOCK,Atrioventricular block,HEART BLOCK,ATRIOVENTRICULAR BLOCK,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10019252,10003671,10019252
HYPOGONADISM OF OPIOID-IATROGENIC ORIGIN,Hypogonadism,HYPOGONADISM,HYPOGONADISM,ENDOCRINE DISORDERS OF GONADAL FUNCTION,ENDOCRINE ABNORMALITIES OF GONADAL FUNCTION NEC,10014698,10058359,10058359,10058359
SUBRETINAL HEMORRHAGE FOLLOWING METFORMIN-ASSOCIATED LACTIC ACIDOSIS (LACTATE LEVEL 9.5MMOL/L) SECONDARY TO INTERACTION WITH ABACAVIR AND TENOFOVIR,Retinal haemorrhage,SUBRETINAL HEMORRHAGE,RETINAL HAEMORRHAGE,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINAL BLEEDING AND VASCULAR DISORDERS (EXCL RETINOPATHY),10015919,10062963,10038867,10062981
PARACETAMOL INTOXICATION,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
LIVER DAMAGE,Liver injury,LIVER DAMAGE,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067125,10067125,10024668
NO IMPROVEMENT IN BACK PAIN AND KIDNEY FAILURE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
NO AMELIORATION OF PAIN SYMPTOMS WAS OBSERVED,Drug ineffective,DRUG EFFECT LACK OF,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013684
PATIENT'S CONDITION DETERIORATED DURING TARGETED ANTIBIOTIC THERAPY/FAILURE OF CLASSIC ANTIBIOTIC THERAPY,treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
CYSTOID MACULAR EDEMA IN RIGHT EYE AND LEFT EYE,Cystoid macular edema,CYSTOID MACULAR EDEMA,CYSTOID MACULAR OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","RETINAL, CHOROID AND VITREOUS INFECTIONS AND INFLAMMATIONS",10015919,10051240,10058202,10051240
LOWER GASTROINTESTINAL BLEEDING,lower gastrointestinal bleeding,LOWER GASTROINTESTINAL BLEEDING,LOWER GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,INTESTINAL HAEMORRHAGES,10017947,10071838,10050953,10071838
ALANINE AMINOTRANSFERASE WAS ELEVATED UP TO 108 U/L,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
LOSS OF CONSCIOUSNESS,loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
BLOOD IMMUNOGLOBULIN M DECREASED (<0.2),Blood immunoglobulin M decreased (<0.2),BLOOD IMMUNOGLOBULIN M DECREASED,BLOOD IMMUNOGLOBULIN M DECREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10005600,10005600,10005600
NIFEDIPINE GIVEN FOR PREMATURE PRELABOR RUPTURE OF MEMBRANES,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
XANTHOMAS,Xanthoma,XANTHOMA,XANTHOMA,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10048214,10048214,10048214
REACTIVE LYMPHADENOPATHY,lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
HIGH-FREQUENCY TREMOR,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
CONSTRICTED PUPILS THAT WERE MINIMALLY RESPONSIVE,Pupillary reflex impaired,PUPILLARY REACTION SLOW,PUPILLARY REFLEX IMPAIRED,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10037530,10037532,10037530
INTRACRANIAL PRESSURE AFTER RECEIVING SPIRONOLACTONE/RECURRENCE/WORSENING OF IDIOPATHIC INTRACRANIAL HYPERTENSION,Idiopathic intracranial hypertension,IDIOPATHIC INTRACRANIAL HYPERTENSION,IDIOPATHIC INTRACRANIAL HYPERTENSION,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10078904,10078904,10078904
PATIENT WAS TREATED WITH COLCHICINE FOR HYPOALBUMINEMIA (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BP 60 MM/HG,Hypotension,LOW BP,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10024896
TENOFOVIR DISOPROXIL FUMARATE-ASSOCIATED RENAL TUBULAR DYSFUNCTION,Renal tubular dysfunction,RENAL TUBULAR DYSFUNCTION,RENAL TUBULAR DYSFUNCTION,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10050335,10050335,10050335
NEUTROPHIL COUNT DECREASED,White blood cell count decreased,WHITE BLOOD CELL COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10047942
CRAMPS,Muscle spasms,CRAMPS,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028294,10028334,10011293
MULTIPLE PIGMENTED MACULES ON THE TRUNK WHERE HE PREVIOUSLY HAD EROSIONS,macule,MACULE,MACULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10025421,10025421,10025421
METHADONE OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
SEVERE (GRADE 4) SYMPTOMS APPEARED,hypersensitivity reaction,HYPERSENSITIVITY REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020756,10020751,10020756
ACUTE INTERSTITIAL NEPHRITIS INDUCED BY PROTON-PUMP INHIBITOR,acute interstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10000819,10048302,10000819
DRYNESS OF THE EYES,Dry eye,DRYNESS OF EYES,DRY EYE,EYE DISORDERS NEC,LACRIMATION DISORDERS,10015919,10013774,10013774,10013792
FAINTNESS,Fainting,FAINTING,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10016169,10042772,10016169
SHE BECAME HYPOTENSIVE/ BP 95/56,Hypotension,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021107
ANKLE BRACHIAL PRESSURE INDEX ON RIDHT SIDE WAS 0.33 ON RIGHT SIDE,Ankle brachial index decreased,ANKLE BRACHIAL INDEX DECREASED,ANKLE BRACHIAL INDEX DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10062760,10062760,10062760
"PATIENT RECEIVED ASPIRIN, WARFARIN",Drug administration error,DRUG ADMINISTRATION ERROR,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064295,10064295,10064295
"SYMPTOMS OF TREMOR/ SHOWED A TREMOR, SHIVERING AND MOTOR RESTLESSNESS MOST LIKELY AS PART OF WITHDRAWAL SYMPTOMS FROM DIAZEPAM",Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
WET GANGRENE DUE TO DIFFUSE SYSTEMIC SCLEROSIS AND ITS WORSENING FOLLOWING LACK OF DRUG EFFECT,Gangrene,WET GANGRENE,GANGRENE,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10063586,10017711,10063586
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
SCEDOSPORIUM BOYDII INFECTION,scedosporium boydii,SCEDOSPORIUM INFECTION,SCEDOSPORIUM INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10059045,10059045,10059045
HEART FAILURE,heart failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10019279,10007554,10019279
RESPIRATORY TRACT INFECTION,Respiratory tract infection,RESPIRATORY TRACT INFECTION,RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10062352,10062352,10062352
ANAPHYLACTIC REACTION,Anaphylactic reaction,ANAPHYLACTIC REACTION,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002198,10002198,10002198
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
ATYPICAL FEMUR FRACTURE,Atypical femur fracture,ATYPICAL FEMUR FRACTURE,ATYPICAL FEMUR FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10070884,10070884,10070884
NONCONVULSIVE STATUS EPILEPTICUS,Status epilepticus,NONCONVULSIVE STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10057769,10041962,10057769
PULMONARY VENOUS CONGESTION,Pulmonary congestion,PULMONARY VENOUS CONGESTION,PULMONARY CONGESTION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10065383,10037368,10065383
PARTIAL AND TRANSIENT RESPONSE TO STEROIDS,Therapy partial responder,THERAPY PARTIAL RESPONDER,THERAPY PARTIAL RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10078115,10078115,10078115
CONSTIPATION,Constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
DIABETES INSIPIDUS RELAPSE DUE TO REBOUND EFFECT OF DESMOPRESSIN,diabetes insipidus,DIABETES INSIPIDUS,DIABETES INSIPIDUS,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,POSTERIOR PITUITARY DISORDERS,10014698,10012599,10012599,10012599
BILATERAL LOWER EXTREMITY PITTING EDEMA,Oedema peripheral,EDEMA OF LOWER EXTREMITIES,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030109,10030124,10054498
METHYLPREDNISOLONE AND PLASMA EXCHANGE-REFRACTORY ANTI-MOG ANTIBODY ENCEPHALOMYELITIS WITH NO ADR,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
STENT THROMBOSIS DUE TO INSUFFICIENT RESPONSE WAS SUSPECTED,Vascular stent thrombosis,STENT THROMBOSIS,VASCULAR STENT THROMBOSIS,COMPLICATIONS ASSOCIATED WITH DEVICE,VASCULAR COMPLICATIONS ASSOCIATED WITH DEVICE,10018065,10076859,10063934,10076859
GRADE 1 ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
AKÃšTNEHO KORONÃRNEHO SYNDRÃ“MU / ACUTE CORONARY SYNDROME,Acute coronary syndrome,ACUTE CORONARY SYNDROME,ACUTE CORONARY SYNDROME,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10051592,10051592,10051592
FEVER,Fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
LACTIC ACIDOSIS,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
ACIDOSIS,Acidosis,ACIDOSIS,ACIDOSIS,ACID-BASE DISORDERS,MIXED ACID-BASE DISORDERS,10027433,10000486,10000486,10000486
MENINGOCOCCAL INFECTIONS PRESENTING AS SEPSIS,Meningococcal sepsis,MENINGOCOCCAL SEPSIS,MENINGOCOCCAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,NEISSERIA INFECTIONS,10021881,10027280,10027280,10027280
LEFT HEMIPARESIS FOLLOWING CEREBRAL ABSCESSES CAUSED BY SCEDOSPORIUM APIOSPERMUM.,Hemiparesis,HEMIPARESIS (LEFT),HEMIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019466,10019465,10019466
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
ASCITES,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
TACHYCARDIA (HEART RATE 130-137 BEATS PER MINUTE)/TACHYCARDIC,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
MILD TENDERNESS TO PALPATION OF THE EPIGASTRIUM,tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
VISUAL HALLUCINATIONS,visual hallucinations,VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10047570,10019075,10047570
INEFFECTIVE PRE-TREATMENT WITH NO AE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
CIPROFLOXACINE INDUCED STEVEN-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
HYPOTONIC-HYPORESPONSIVE EPISODE,Hypotonic-hyporesponsive episode,HYPOTONIC-HYPORESPONSIVE EPISODE,HYPOTONIC-HYPORESPONSIVE EPISODE,NEUROMUSCULAR DISORDERS,NEUROMUSCULAR DISORDERS NEC,10029205,10021121,10021121,10021121
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
TORSADE DE POINTES,Torsade de pointes,TORSADE DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044066
"DESPITE TREATMENT WITH MILRINONE, ANTITHYMOCYTE GLOBULIN, MYCOFENOLATE MOFETIL, AND METHYLPREDNISOLONE, THE PATIENT HAD WORSENING END ORGAN FUNCTION",Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
PULSE UNUSALLY HIGH,High pulse rate,HIGH PULSE RATE,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10020081,10019303,10020081
HYPERTRIGLYCERIDAEMIA,Hypertriglyceridaemia,HYPERTRIGLYCERIDAEMIA,HYPERTRIGLYCERIDAEMIA,LIPID METABOLISM DISORDERS,ELEVATED TRIGLYCERIDES,10027433,10020869,10020869,10020869
DIFFUSE FISTULISATION WITHIN THE MYOCARDIUM FOLLOWING CORONARY VASCULOPATHY DUE TO CORONARY ENDOTHELIAL DYSFUNCTION,Congenital coronary artery malformation,CORONARY ARTERY FISTULA,CONGENITAL CORONARY ARTERY MALFORMATION,CARDIAC AND VASCULAR DISORDERS CONGENITAL,ARTERIAL DISORDERS CONGENITAL,10010331,10069441,10061060,10069441
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
PROGRESSIVE ST SEGMENT ELEVATION,Electrocardiogram ST segment elevation,ST SEGMENT ELEVATION,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041893,10014392,10041894
"PRESCRIBED VALACICLOVIR AT 1 G THREE TIMES A DAY, WHICH IS SIGNIFICANTLY HIGHER THAN THE RECOMMENDED DOSE OF 500 MG DAILY (OFF LABEL USE)",off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
POLYARTHRALGIA,Arthralgia,POLYARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10036029,10003239,10036029
SEVERE DIGESTIVE SIDE EFFECTS,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
CARDIOTOXICITY IN BETA BLOCKER OVERDOSE,cardiotoxicity in beta blocker overdose,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
INTERMITTENT AGITATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
EOSINOPHIL COUNT OF 19.1K/UL/ EOSINOPHILIA,Eosinophil count increased,EOSINOPHIL COUNT INCREASED,EOSINOPHIL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10014945,10014945,10014945
LITHIUM INTOXICATION,lithium toxicity,LITHIUM TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10050501,10070863,10050501
EPISTAXIS,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
SCLERODERMA (EXACERBATION),Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
5-FLUOROURACIL TOXICITY,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
CYTOMEGALOVIRUS REACTIVATION ACCOMPANIED BY VARICELLA ZOSTER VIRUS REACTIVATION OR REINFECTION,Varicella zoster virus infection,VARICELLA ZOSTER VIRUS INFECTION,VARICELLA ZOSTER VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10075611,10075611,10075611
CRP INCREASED 24 MG/DL,C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
MILD DYSMETRIA,Dysmetria,DYSMETRIA,DYSMETRIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10013936,10013936,10013936
MILD DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
DIARRHEAL SYNDROME FOLLOWING OFF LABEL USE OF COLCHICINE FOR PERICARDITIS AND DRUG INTERACTION BETWEEN COLCHICINE AND AMLODIPINE,Diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
TREMOR,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
POOR LIGHT REACTION OF PUPIL,Pupillary light reflex tests abnormal,PUPILLARY REACTION ABNORMAL,PUPILLARY LIGHT REFLEX TESTS ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",OPHTHALMIC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10037529,10037525,10037529
HYPOGLYCAEMIC ENCEPHALOPATHY,Hypoglycaemic encephalopathy,HYPOGLYCAEMIC ENCEPHALOPATHY,HYPOGLYCAEMIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10021002,10021002,10021002
OLMESARTAN-INDUCED ENTEROCOLOPATHY,Sprue-like enteropathy,SPRUE-LIKE ENTEROPATHY,SPRUE-LIKE ENTEROPATHY,MALABSORPTION CONDITIONS,MALABSORPTION SYNDROMES,10017947,10079622,10079622,10079622
INCREASED NEED FOR SLEEP,Hypersomnia,SLEEP EXCESSIVE,HYPERSOMNIA,SLEEP DISTURBANCES (INCL SUBTYPES),NARCOLEPSY AND HYPERSOMNIA,10029205,10041000,10020765,10041000
PRODUCTIVE COUGH,Productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
49 YRS OLD MAN HAD SEVERE GASTRITIS PRECIPITATING AN ACUTE GASTROINTESTINAL BLEED AND A SEVERE ANAPHYLACTIC REACTION TO ASPIRIN,Gastritis,GASTRITIS,GASTRITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTRITIS (EXCL INFECTIVE),10017947,10017853,10017853,10017853
GIDDINESS,Giddiness,GIDDINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10018263,10013573,10018263
HEMOGLOBIN DECREASED (11.4 G/100ML),Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
FIXED DILATED PUPIL OF THE RIGHT EYE,Fixed dilated pupil,FIXED DILATED PUPIL,PUPIL FIXED,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10016738,10037515,10016738
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
TINEA PEDIS,Tinea pedis,TINEA PEDIS,TINEA PEDIS,FUNGAL INFECTIOUS DISORDERS,TINEA INFECTIONS,10021881,10043873,10043873,10043873
THE MUCOSAL SITE WAS POSITIVE FOR NEISSERIA GONORRHOEAE,Gonorrhoea,NEISSERIA GONORRHOEAE INFECTION,GONORRHOEA,BACTERIAL INFECTIOUS DISORDERS,NEISSERIA INFECTIONS,10021881,10051970,10018612,10051970
ANXIETY,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
EPISTAXIS,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
SPONTANEOUS ORAL BLEEDING,Mouth haemorrhage,ORAL MUCOSA BLEEDING,MOUTH HAEMORRHAGE,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE HAEMORRHAGES,10017947,10030985,10028024,10030985
ALKALINE PHOSPHATASE LEVEL INCREASED,ALKALINE PHOSPHATASE LEVEL INCREASED,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
TRICYCLIC OVERDOSE ASSOCIATED WITH ABSENT BRAINSTEM REFLEXES,Reflexes abnormal,REFLEXES ABNORMAL,REFLEXES ABNORMAL,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10038254,10038254,10038254
EYELIDS SLIGHTLY SWELLED,Eyelid oedema,SWELLING OF EYELID,EYELID OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","LID, LASH AND LACRIMAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10042690,10015993,10042690
CENTROLOBULAR HEPATOCELLULAR NECROSIS,Hepatic necrosis,NECROSIS HEPATOCELLULAR,HEPATIC NECROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10028859,10019692,10028859
METHOTREXATE INDUCED CENTRAL NERVOUS SYSTEM TOXICITY,Neurotoxicity,CENTRAL NERVOUS SYSTEM TOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10071216,10029350,10071216
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
BANDEMIA (BAND NEUTROPHILS 15 %),Bandaemia,BANDEMIA,BANDAEMIA,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10072081,10072081,10072091
BODY TEMPERATURE WAS 38.50C (101.30F),Body temperature increased,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10005911
SHOCK WITH BLOOD PRESSURE 65/40 MM HG,low blood pressure,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10024895,10021097,10024895
LEUKOCYTOSIS (7400 CELLS/MICROL),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
PROGRESSION,Multiple myeloma,MULTIPLE MYELOMA,PLASMA CELL MYELOMA,PLASMA CELL NEOPLASMS,PLASMA CELL MYELOMAS,10029104,10028228,10035226,10028228
HYPERREFLEXIA/TREMOR,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
ACUTE ENCEPHALOPATHY,Encephalopathy,ENCEPHALOPATHY ACUTE,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014626,10014625,10014626
ENTEROCOLITIS INFECTIOUS,Enterocolitis infectious,ENTEROCOLITIS INFECTIOUS,ENTEROCOLITIS INFECTIOUS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10058838,10058838,10058838
ABDOMINAL PROLAPSE DISTENTION,distention,DISTENTION,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10013482,10000060,10013482
NO ADVERSE DRUG REACTION,no adverse drug reaction,NO ADVERSE DRUG REACTION,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067481,10067482,10067481
CARDIOGENIC SHOCK,Cardiogenic shock,CARDIOGENIC SHOCK,CARDIOGENIC SHOCK,HEART FAILURES,HEART FAILURES NEC,10007541,10007625,10007625,10007625
"PERFORATED DUODENAL ULCER, LIKELY SECONDARY TO STEROIDS",Duodenal ulcer perforation,DUODENAL ULCER PERFORATION,DUODENAL ULCER PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,DUODENAL ULCERS AND PERFORATION,10017947,10013849,10013849,10013849
GAMMA-GLUTAMYLTRANSFERASE INCREASED 2460 U/L,Gamma-glutamyltransferase increased,GAMMA-GLUTAMYLTRANSFERASE INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10017693,10017693,10017693
CONSTIPATION,Constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
OLMESARTAN-ASSOCIATED ENTEROPATHY,Sprue-like enteropathy,SPRUE-LIKE ENTEROPATHY,SPRUE-LIKE ENTEROPATHY,MALABSORPTION CONDITIONS,MALABSORPTION SYNDROMES,10017947,10079622,10079622,10079622
TUMEFACTIVE DEMYELINATING LESIONS,Tumefactive multiple sclerosis,TUMEFACTIVE MULTIPLE SCLEROSIS,TUMEFACTIVE MULTIPLE SCLEROSIS,DEMYELINATING DISORDERS,MULTIPLE SCLEROSIS ACUTE AND PROGRESSIVE,10029205,10078556,10078556,10078556
ACTINIC KERATOSIS,actinic keratosis,ACTINIC KERATOSIS,ACTINIC KERATOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,SKIN PRENEOPLASTIC CONDITIONS NEC,10040785,10000614,10000614,10000614
HYPOPHOSPHATEMIA (1.7 MG/DL),Hypophosphataemia,HYPOPHOSPHATEMIA,HYPOPHOSPHATAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",PHOSPHORUS METABOLISM DISORDERS,10027433,10021058,10021058,10021059
SERUM CREATININE WAS HIGH (1.33 MG%),Blood creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
UPPER RIGHT HEMIPARESIS,Hemiparesis,HEMIPARESIS (RIGHT),HEMIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019467,10019465,10019467
BACTERIAL OSTEOMYELITIS OF LEFT HIP AND SACRUM DUE TO PARAPLEGIA,Osteomyelitis bacterial,OSTEOMYELITIS BACTERIAL,OSTEOMYELITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10065237,10065237,10065237
DECREASED HEMOGLOBIN (5.89 MMOL/L),Decreased hemoglobin,DECREASED HEMOGLOBIN,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10011964,10018884,10011964
WORSENING OF HEPATITIS TO NEAR GRADE 3 LEVELS DUE TO STEROID RESISTANCE,Hepatitis,HEPATITIS,HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019717,10019717,10019717
DID NOT LEAD TO CLINICALLY RELEVANT LDL-C LOWERING,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
SEVERE LIFE-THREATENING PRIMARY GRAFT DYSFUNCTION DETERIORATED DESPITE APPROPRIATE IMMUNOSUPPRESSIVE TREATMENT INCLUDING A COURSE OF ANTITHYMOCYTE GLOBULINE,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
INCREASING WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEMOPHAGOCYTIC SYNDROME DUE TO HERPES VIRUS INFECTION,Haemophagocytic lymphohistiocytosis,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,HISTIOCYTOSIS HAEMATOPHAGIC,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10071583,10048595,10071583
UNCONSCIOUSNESS,Loss of consciousness,UNCONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10045481
"RHABDOMYOLYSIS/HAVING IN CONSIDERATION THE COMPLAINTS OF THE PATIENT, THE CHANGES FOUND IN THE OBJECTIVE EXAM AND THE ANALYTICAL EVALUATION, HAS RAISED THE HYPOTHESIS OF HYPOTHYROIDISM DIAGNOSIS, WITH ASSOCIATED RHA",rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
STEATOFIBROSIS,Steatohepatitis,STEATOHEPATITIS,STEATOHEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10076331,10076331,10076331
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
WHITE BLOOD CELL COUNT WAS 22.87 WITH A LEFT-SIDED SHIFT,Shift to the left,SHIFT TO THE LEFT,SHIFT TO THE LEFT,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056383,10056383,10056383
MUCOUS MEMBRANE DISORDER SUCH AS STOMATITIS,Mucous membrane disorder,MUCOUS MEMBRANE DISORDER,MUCOUS MEMBRANE DISORDER,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028133,10028133,10028133
NEUTROPHILIC LEUKOCYTOSIS,neutrophilic leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
SEVERE DEPRESSED MOOD,Depressed mood,DEPRESSED MOOD,DEPRESSED MOOD,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10012374,10012374,10012374
ASCITES,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
MYOCLONUS,Myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
METHOTREXATE (MTX) ASSOCIATED EPSTEIN-BARR VIRUS-POSITIVE MUCOCUTANEOUS ULCER/SKIN ULCER,Skin ulcer,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040943,10040943,10040943
CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
INCREASED TSH LEVELS (200UIU/ML),Blood thyroid stimulating hormone increased,INCREASED TSH,BLOOD THYROID STIMULATING HORMONE INCREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),PITUITARY ANALYSES ANTERIOR,10022891,10044718,10005833,10021690
PATIENT WAS BEDRIDDEN,Bedridden,BEDRIDDEN,BEDRIDDEN,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10048948,10048948,10048948
CHRONIC DISEASE RELATED ANAEMIA,Anaemia of chronic disease,ANAEMIA OF CHRONIC DISEASE,ANAEMIA OF CHRONIC DISEASE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS DUE TO CHRONIC DISORDERS,10005329,10002073,10002073,10002073
GRADE 3-4 STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
CHOLESTATIC JAUNDICE DUE TO HYPERSENSITIVITY TO CEFACLOR,Jaundice cholestatic,CHOLESTATIC JAUNDICE,JAUNDICE CHOLESTATIC,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023129,10023129,10008640
ALLERGIC REACTION,drug allergy,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
BACTERIAL PNEUMONIA,Pneumonia bacterial,PNEUMONIA BACTERIAL,PNEUMONIA BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10060946,10060946,10060946
CEREBRAL HEMORRHAGE,Cerebral haemorrhage,CEREBRAL HEMORRHAGE,CEREBRAL HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008111,10008111,10008114
CONSTIPATION,constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
IBANDRONATE SODIUM-RELATED OSTEONECROSIS OF LEFT MANDIBLE STAGE II,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
LACK OF EFFICACY,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SPORADIC OCCURENCE OF REDNESS AND BLISTERS ON PALMS OF HANDS AND SOLES OF FEET,blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
DRUG INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
A RELAPSE OF HYPERCHOLESTEROLEMIA WAS OBSERVED,rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
DRUG INDUCED COLONIC NECROSIS FOLLOWING RIGHT COLON COLITIS,Gastrointestinal necrosis,INTESTINAL NECROSIS,GASTROINTESTINAL NECROSIS,GASTROINTESTINAL VASCULAR CONDITIONS,GASTROINTESTINAL NECROSIS AND GANGRENE (EXCL GANGRENOUS HERNIA),10017947,10028856,10017982,10022686
IGNIFICANT IMPROVEMENT WAS OBSERVED WITH DIMINISH OF SUBRETINAL NEOVASCULAR MEMBRANE,Pre-existing condition improved,PRE-EXISTING CONDITION IMPROVED,PRE-EXISTING CONDITION IMPROVED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10036495,10036495,10036495
EPSTEIN-BARR VIRUS ASSOCIATED HODGKIN DISEASE-LIKE LYMPHOPROLIFERATIVE DISORDER,Epstein-barr virus associated Hodgkin disease-like lymphoproliferative disorder,HODGKIN'S-LIKE,PSEUDOLYMPHOMA,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10020349,10037127,10020349
ANURIC,anuria,ANURIA,ANURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10002847,10002847,10002847
FUNGAL INFECTION,Fungal infection,FUNGAL INFECTION,FUNGAL INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017533,10017533,10017533
SERIAL TESTING GAVE RISE TO INCREASED ANXIETY,anxiety aggravated,ANXIETY AGGRAVATED,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10048339,10002855,10048339
HE WAS TREATED WITH THREE CYCLES OF ITRACONAZOLE AND AMOROLFINE NAIL LACQUER WITHOUT MUCH IMPROVEMENT (SUBTHERAPEUTIC RESPONSE WITH NO ADR),Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
OVERWHELMING SADNESS FEELING,Depressed mood,DEPRESSED MOOD,DEPRESSED MOOD,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10012374,10012374,10012374
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
HILAR LYMPHADENOPATHY,hilar lymphadenopathy,HILAR LYMPHADENOPATHY,HILAR LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10020094,10020094,10020094
SYNOVIAL DISORDER,Synovial disorder,SYNOVIAL DISORDER,SYNOVIAL DISORDER,SYNOVIAL AND BURSAL DISORDERS,SYNOVIAL DISORDERS,10028395,10061374,10061374,10061374
ACUTE MYELOGENOUS LEUKEMIA WITH SIGN OF MYELODYSPLASIA,Acute myeloid leukaemia,ACUTE MYELOID LEUKEMIA,ACUTE MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10000880,10000880,10000886
MYCOBACTERIAL INFECTION,Mycobacterial infection,MYCOBACTERIAL INFECTION,MYCOBACTERIAL INFECTION,MYCOBACTERIAL INFECTIOUS DISORDERS,ATYPICAL MYCOBACTERIAL INFECTIONS,10021881,10062207,10062207,10062207
HAEMOLYSIS,Haemolysis,HAEMOLYSIS,HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10018910,10018910,10018910
THE TABLETS COMATOSED HER,Comatose,COMATOSE,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10058472,10010071,10058472
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
"SEPTIC SHOCK WITH ORGAN FAILURE (KIDNEY, LIVER, RESPIRATORY INSUFFICIENCY WITHOUT PNEUMONIA, CIRCULATION",Circulatory collapse,CIRCULATORY FAILURE,CIRCULATORY COLLAPSE,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10009195,10009192,10009195
CARDIORESPIRATORY ARREST,Respiratory arrest,RESPIRATORY ARREST,RESPIRATORY ARREST,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038669,10038669,10038669
COUGH,cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
DROWSY FOLLOWING ACUTE CHLOROQUINE POISONING DUE TO OVERDOSE,Drowsiness,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
LONGSTANDING HTN/DIFFICULT-TO-CONTROL HTN/RESISTANT HYPERTENSION,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
MACROVESICULAR STEATOSIS,Hepatic steatosis,HEPATIC STEATOSIS,HEPATIC STEATOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019708,10019708,10019708
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
TACHYPNEIC AT APPROXIMATELY 30/MINUTE,Tachypnoea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043088
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
CYTOMEGALOVIRUS ASSOCIATED HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,Haemophagocytic lymphohistiocytosis,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,HISTIOCYTOSIS HAEMATOPHAGIC,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10071583,10048595,10071583
RIGHT HEMIPLEGIA,Hemiplegia,RIGHT HEMIPLEGIA,HEMIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10039154,10019468,10039154
REACTIVATION OF EBV AND HHV-7,Herpes virus infection,HERPES VIRUS INFECTION,HERPES VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10019973,10019973,10019973
CHANGE IN THE BEHAVIOR,abnormal behavior,ABNORMAL BEHAVIOR,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10079615,10061422,10079615
DIFFICULTY OF CHEWING,difficulty of chewing,CHEWING DIFFICULTY,MASTICATION DISORDER,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10067464,10026882,10067464
"VISUAL HALLUCINATIONS, NAUSEA, VOMITING, CONSTIPATION, FLATULENCE, DIARRHEA, ABDOMINAL SWELLING, TREMORS, INCREASED PULSE RATE, DECREASED URINATION AND WEIGHT LOSS (+/- 6 KG)",constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
C-PEPTIDE DECREASED,Insulin C-peptide decreased,INSULIN C-PEPTIDE DECREASED,INSULIN C-PEPTIDE DECREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),"GASTROINTESTINAL, PANCREATIC AND APUD HORMONE ANALYSES",10022891,10022476,10022476,10022476
PRURITUS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
"PATIENT STILL RATIONALIZED HIS SOCIAL ANXIETY, AVOIDANT BEHAVIOR AND SYMPTOMS OF SELECTIVE MUTISM.",social avoidant behaviour,SOCIAL AVOIDANT BEHAVIOUR,SOCIAL AVOIDANT BEHAVIOUR,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10041243,10041243,10041243
BRONCHOPNEUMONIA FOLLOWING DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS SYNDROME,Pneumonia,BRONCHOPNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10006469,10035664,10006469
REM BEHAVIOR DISORDER,Rapid eye movement sleep behavior disorder,RAPID EYE MOVEMENT SLEEP BEHAVIOR DISORDER,RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER,SLEEP DISORDERS AND DISTURBANCES,PARASOMNIAS,10037175,10077300,10077299,10077300
AGGRVATED PERIPHERAL POLYNEUROPATHY,polyneuropathy,POLYNEUROPATHY,POLYNEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10036105,10036105,10036105
SYMPTOMS OF ORTHOSTATIC HYPOTENSION AND BRADYCARDIA WERE AGGRAVATED BY RIVASTIGMINE,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
PRIMARY RESISTANCE TO IMATINIB,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
SKIN LESIONS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
FUNCTIONALITY IMPAIRMENT,Activities of daily living impaired,ACTIVITIES OF DAILY LIVING IMPAIRED,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10050954,10079487,10050954
"CONOTRUNCAL CARDIAC DEFECT (HEART DISEASE CONGENITAL, CONGENITAL CARDIOVASCULAR ANOMALY, CONGENITAL CARDIAC SEPTAL DEFECT)",Heart disease congenital,HEART DISEASE CONGENITAL,HEART DISEASE CONGENITAL,CARDIAC AND VASCULAR DISORDERS CONGENITAL,CARDIAC DISORDERS CONGENITAL NEC,10010331,10019273,10019273,10019273
CORNEAS WERE OPACIFIED FOLLOWING INTENTIONAL ACUTE OVERDOSE,Corneal opacity,CORNEAL OPACITY,CORNEAL OPACITY,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CORNEAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10011035,10011035,10011035
SMALL DROPS OF BLOOD ON THE MEATUS OF THE PENIS OVER THE PREVIOUS TWO DAYS,Haematuria,HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018867,10018867,10019450
WARFARIN FOR ATRIAL FIBRILLATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
GASTRIC CARCINOID,carcinoid tumour of the stomach,CARCINOID TUMOUR OF THE STOMACH,CARCINOID TUMOUR OF THE STOMACH,ENDOCRINE NEOPLASMS MALIGNANT AND UNSPECIFIED,CARCINOID TUMOURS,10029104,10007281,10007281,10007281
PROBABLE PERICARDITIS,Pericarditis,PERICARDITIS,PERICARDITIS,PERICARDIAL DISORDERS,NONINFECTIOUS PERICARDITIS,10007541,10034484,10034484,10034484
ACUTE HEART FAILURE,Cardiac failure acute,ACUTE HEART FAILURE,CARDIAC FAILURE ACUTE,HEART FAILURES,HEART FAILURES NEC,10007541,10007556,10007556,10000803
AGITATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
SEVERE DIARRHEA,severe diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
PHOTO-ONYCHOLYSIS,Onycholysis,ONYCHOLYSIS,ONYCHOLYSIS,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10030337,10030337,10030337
"EVEN AFTER INCREASING THE DOSE OF TRANSDERMAL FENTANYL TO 75 MG PER HOUR, THESE INTERVENTIONS WERE UNSUCCESSFUL/ DECREASED DEXAMETHASONE EFFICACY ON NEUROPATHIC PAIN SYMPTOMS",Drug effect decreased,DRUG EFFECT DECREASED,DRUG EFFECT DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013678,10013678,10013678
SINFUL THOUGHTS,sinful thoughts,THOUGHT DISORDER,THINKING ABNORMAL,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10079962,10043431,10079962
LITHIUM TOXICITY IN THIS PATIENT INCLUDED THE POSSIBILITY OF INCREASED STOMACH PH FOLLOWING SLEEVE GASTRECTOMY,Toxicity to various agents,LITHIUM TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10050501,10070863,10050501
GRADE 4 AST ELEVATION,alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
MILD PARENCHUMAL CHOLESTASIS,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
HIGH-LEVEL VIREMIA,BK virus infection,BK VIRUS INFECTION,BK VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10055181,10055181,10055181
CHRONIC RENAL FAILURE FOLLOWING DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS SYNDROME,Chronic kidney disease,CHRONIC RENAL FAILURE,CHRONIC KIDNEY DISEASE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038444,10064848,10009119
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
PRIOR FAILURE TO RIBAVIRIN AND INTERFERON (TREATMENT FAILURE) WITH NO ADR,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
HIGH MARKERS OF OSTEORESORPTION,Resorption bone increased,RESORPTION BONE INCREASED,RESORPTION BONE INCREASED,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10038642,10038642,10038642
SEVERE SEXUAL DISORDERS,Sexual dysfunction,SEXUAL DYSFUNCTION,SEXUAL DYSFUNCTION,SEXUAL FUNCTION AND FERTILITY DISORDERS,SEXUAL FUNCTION AND FERTILITY DISORDERS NEC,10038604,10040477,10040477,10040477
DIFFICULTY BREATHING,Dyspnoea,DIFFICULTY BREATHING,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10012791
SERUM OSMOLALITY WAS 220 MOSM/KG,Blood osmolarity decreased,SERUM OSMOLALITY DECREASED,BLOOD OSMOLARITY DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",WATER AND ELECTROLYTE ANALYSES NEC,10022891,10040358,10005696,10040358
ADRENALINE (EPINEPHRINE) INJECTION FAILED TO STOP THE BLEED,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
HE THEN UNDERWENT CAPEOX WITH BEVACIZUMAB THERAPY AND COMPUTED TOMOGRAPHY FINDINGS SHOWED PARTIAL RESPONSE,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
VESICOBULLOUS LESIONS INVOLVING NEARLY 90% OF HER SKIN AND MUCOUS MEMBRANES,Mucosa vesicle,MUCOSAL BULLA,MUCOSA VESICLE,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028107,10028103,10028107
FAILED TO RESPOND DURING THE TREATMENT PERIOD,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
DRUG RESISTANCE,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
CYTARABINE AND CELECOXIB USED FOR ATYPICAL TERATOID RHABDOID TUMOR GRADE IV,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
CRYPTOSPORIDIOSIS,Cryptosporidiosis infection,CRYPTOSPORIDIOSIS,CRYPTOSPORIDIOSIS INFECTION,PROTOZOAL INFECTIOUS DISORDERS,CRYPTOSPORIDIA INFECTIONS,10021881,10011501,10011502,10011501
DIARRHOEA 5-6 TIMES A DAY WITHOUT ABDOMINAL PAIN (FOLLOWING LACK OF DRUG EFFECT),Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
PULMONARY EMBOLISM AFFECTING FIRST ORDER BRANCH OF LEFT PULMONARY ARTERY WITH BILATERAL MILD PLEURAL EFFUSION FOLLOWING OVARIAN HYPER STIMULATION SYNDROME,pulmonary embolism,PULMONARY EMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037377,10037377,10037377
TYPICAL DYSMORPHIC FEATURES,Body dysmorphic disorder,BODY DYSMORPHIC DISORDER,BODY DYSMORPHIC DISORDER,ANXIETY DISORDERS AND SYMPTOMS,OBSESSIVE-COMPULSIVE DISORDERS AND SYMPTOMS,10037175,10052793,10052793,10052793
IFOSFAMIDE NEUROTOXICITY,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
DRUG ALLERGY,Drug hypersensitivity,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
ALANINE AMINOTRANSFERASE 1423 U/L,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
REVERSIBLE DEMENTIA AND APPARENT BRAIN ATROPHY DURING VALPROATE THERAPY/ GENERALIZED CORTICAL AND CEREBELLAR ATROPHY,Cerebral atrophy,CEREBRAL ATROPHY,CEREBRAL ATROPHY,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10008096,10008096,10008096
LATE CHRONIC ANEMIA/RELAPSED,Anaemia,CHRONIC ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10072868,10002034,10072870
"BLOTCHY, ITCHY RASH THAT APPEARED ON HER HANDS, NECK, AND STOMACH",Blotchy,BLOTCHY,RASH MACULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10005876,10037867,10005876
ELECTROCARDIOGRAPHY SHOWED NON-SUSTAINED VENTRICULAR TACHYCARDIA (20 RUNS OF PREMATURE VENTRICULAR CONTRACTIONS),Ventricular extrasystoles,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047289,10047289,10047289
PAIN IN THE LEFT LOWER LEG AND LEFT ELBOW,Pain in extremity,PAIN OF EXTREMITIES,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033425,10033425,10033471
ANTINUCLEAR ANTIBODIES(ANA) WERE POSITIVE,Antinuclear antibody positive,ANA POSITIVE,ANTINUCLEAR ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10002031,10060055,10060060
GRADE 2 XEROSTOMIA,Xerostomia,XEROSTOMIA,DRY MOUTH,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10048223,10013781,10048223
SHOCK,shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
LETHARGIC,lethargic,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024262,10024264,10024262
SUBJECTIVE DISCOMFORT,discomfort,DISCOMFORT,DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10013082,10013082,10013082
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
WIDE AND DEHISCENT ANTERIOR AND POSTERIOR FONTANELLE,enlarged fontanelle,ENLARGED FONTANELLE,DELAYED FONTANELLE CLOSURE,MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES (INCL INTERVERTEBRAL DISC DISORDERS),"MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES OF SKULL, FACE AND BUCCAL CAVITY",10028395,10054068,10054034,10054068
JUNCTIONAL RHYTHMS,Nodal rhythm,JUNCTIONAL RHYTHM,NODAL RHYTHM,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10049840,10029470,10049840
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ANXIETY AND DEPRESSION,Anxiety depression,ANXIETY DEPRESSION,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10002858,10012378,10002858
HIGH BLOOD GLUCOSE WERE OBSERVED,Blood glucose increased,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10005557,10005557,10005557
LOW RETICULOCYTE COUNT (4.30%),Reticulocyte count decreased,RETICULOCYTE COUNT LOW,RETICULOCYTE COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10038793,10038790,10038793
SYSTEMIC ERYTHEMA,Generalised erythema,GENERALISED ERYTHEMA,GENERALISED ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10051576,10051576,10051576
INAPPETENCE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
INTOXICATION,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
HAEMOPTYSIS,Haemoptysis,HAEMOPTYSIS,HAEMOPTYSIS,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10018964,10018964,10018964
STOMACH EROSION FOLLOWING CYTOMEGALOVIRUS INFECTION IN THE UPPER GASTROINTESTINAL TRACT/CYTOMEGALOVIRUS INFECTION OF STOMACH,Gastritis erosive,STOMACH EROSION,GASTRITIS EROSIVE,GASTROINTESTINAL ULCERATION AND PERFORATION,GASTRIC ULCERS AND PERFORATION,10017947,10017783,10017865,10042103
CYTOMEGALOVIRUS RELATED COLITIS,Cytomegalovirus colitis,CYTOMEGALOVIRUS COLITIS,CYTOMEGALOVIRUS COLITIS,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10048983,10048983,10048983
 ibuprofen was administered to the child (despite aforementioned instructions).,2018-02-21 00:00:00,,,,,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10074899,10078504,
DRUG OVERDOSE/OXYCODONE OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
HYPERTONIA,Hypertonia,HYPERTONIA,HYPERTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10020852,10020852,10020852
PATIENT WAS TREATED WITH METHOTREXATE FOR CERVICAL ECTOPIC PREGNANCY (OFF LABEL USE) WITH NO ADVERSE EVENTS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
RENAL FAILURE,Renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
TUMOR PROLIFERATION,Tumor progression,TUMOR PROGRESSION,NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS UNSPECIFIED MALIGNANCY AND SITE UNSPECIFIED NEC,10029104,10053563,10061309,10053563
HYPERWARFARINIZATION,Drug level above therapeutic,DRUG LEVEL ABOVE THERAPEUTIC,DRUG LEVEL ABOVE THERAPEUTIC,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10061132,10061132,10061132
NO IMPROVEMENT,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
SWELLING,swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
FELT DIZZY,Dizziness,DIZZY,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10018263,10013573,10013580
SCATTERED 3-4 CM ABSCESS WITH SURROUNDING ERYTHEMA AND WARMTH WERE PRESENT ON ABDOMEN AND LEFT ANTEROLATERAL LEG,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
WHITE BLOOD CELLS (27000/MICROLITRE),White blood cell count increased,WBC INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056739,10047943,10056739
SEROTONIN SYNDROME,Serotonin syndrome,SEROTONIN SYNDROME,SEROTONIN SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10040108,10040108,10040108
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
SYSTEMIC LUPUS ERYTHEMATOSUS,Systemic lupus erythematosus,SYSTEMIC LUPUS ERYTHEMATOSUS,SYSTEMIC LUPUS ERYTHEMATOSUS,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),LUPUS ERYTHEMATOSUS (INCL SUBTYPES),10028395,10042945,10042945,10042945
CONFUSED,Confused,CONFUSED,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010298,10010305,10010298
ELEVATED LIVER ENZYMES,elevated liver enzymes,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
OCULAR SURFACE ADHESIONS,adhesion,ADHESION,ADHESION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10059837,10059837,10059837
ALWAYS STOPPED THE THERAPY HERSELF WITHIN 3 WEEKS OF THERAPY,Intentional product misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
FREE T3 9.48 PG/ML,Tri-iodothyronine free increased,FREE T3 HIGH,TRI-IODOTHYRONINE FREE INCREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),THYROID ANALYSES,10022891,10017352,10053790,10017352
HEMIPLAGIA DUE TO COCCIDIODES MENINGITIS,Hemiplegia,HEMIPLEGIA,HEMIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019468,10019468,10019468
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SERIOUS HYPONATREMIA INDUCED BY A COMBINATION OF ANGIOTENSIN II RECEPTOR BLOCKER AND THIAZIDE CAUSED DETERIORATION OF COGNITIVE FUNCTIONS AND PSYCHOLOGICALSYMPTOMS,Cognitive disorder,COGNITIVE FUNCTION ABNORMAL,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10048599,10057668,10048599
RENAL FUNCTION IMPAIRMENT,Renal function abnormal,RENAL FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038451,10062237,10038451
GGT INCREASED (8.61 MICROKAT/L),GGT Increased (8.61 microkat/l),GGT INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056910,10017693,10056910
FEELING OF SADNESS,feeling sad,FEELING SAD,DEPRESSED MOOD,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10016364,10012374,10016364
"POOR CLINICAL RESPONSE WITH CYCLOPHOSPHAMIDE, INFLIXIMAB, ADALIMUMAB AND RITUXIMAB /LITTLE RESPONSE MYCOPHENOLATE AND METHOTREXATE (SUBTHERAPEUTIC EFFECT WITH NO ADVERSE EVENT)",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
INCOMPLETE ATYPICAL FEMUR FRACTURE,Atypical femur fracture,ATYPICAL FEMUR FRACTURE,ATYPICAL FEMUR FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10070884,10070884,10070884
PROSTRATION,prostration,PROSTRATION,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10036985,10016256,10036985
AN INCREASE IN LEVEL OF TRANSAMINASES FOLLOWING UNINTENTIONAL OVERDOSE OF METHOTREXATE DUE TO WRONG DOSE ADMINISTRATION,transaminases increased,TRANSAMINASES INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054889,10054889,10054889
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
METHEMOGLOBINEMIA,methemoglobinemia,METHEMOGLOBINEMIA,METHAEMOGLOBINAEMIA,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10027506,10027496,10027506
LIVER FUNCTION WAS MARGINALLY ABNORMAL,liver disorder,LIVER DISORDER,LIVER DISORDER,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10024670,10024670,10024670
BLOOD PRESSURE IS 74/50,Blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
DESPITE VORICONAZOLE AND AMPHOTERICIN INJECTIONS THE PATIENT DEVELOPED WORSENING INFILTRATES WITHIN THE HOST CORNEA (LACK OF DRUG EFFECT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PATIENT PRESENTED WITH A RARE ANGIOINVASIVE FUNGAL INFECTION CAUSED BY THE ORGANISM RHIZOPUS FOLLOWING HIGH DOSE STEROID THERAPY,Rhizopus infection,RHIZOPUS INFECTION,MUCORMYCOSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10070989,10028098,10070989
PRURITUS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
YELLOWING OF THE SKIN,Yellow skin,SKIN COLOURING YELLOW,YELLOW SKIN,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040818,10048245,10040818
CONSTRICTIVE PERICARDITIS,Pericarditis constrictive,CONSTRICTIVE PERICARDITIS,PERICARDITIS CONSTRICTIVE,PERICARDIAL DISORDERS,NONINFECTIOUS PERICARDITIS,10007541,10034487,10034487,10010783
UNCONTROLLED SEPSIS SECONDARY TO ENTEROBACTER PNEUMONIA AND MUCORMYCOSIS,sepsis secondary,SEPSIS SECONDARY,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040053,10040047,10040053
ANURIA,Anuria,ANURIA,ANURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10002847,10002847,10002847
COGNITIVE DISORDERS,Cognitive disorder,COGNITIVE DISORDERS,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10057668,10057668,10048598
ACUTE PARAPLEGIA/COMPLETE PARAPLEGIA (ASIA)/GRADUAL PARAPLEGIA THIRTY-SIX TO FORTY-EIGHT HOURS POSTOPERATIVELY,Acute paraplegia,ACUTE PARAPLEGIA,PARAPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10000980,10033892,10000980
"AFTER AND AS A RESULT OF STARTING STEROID THERAPY, PATIENT DEVELOPED A DYSPHORIC STATE",Dysphoria,DYSPHORIA,DYSPHORIA,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10013954,10013954,10013954
URINARY OCCULT BLOOD POSITIVE (3+),Blood urine present,URINARY OCCULT BLOOD POSITIVE,BLOOD URINE PRESENT,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINALYSIS NEC,10022891,10052287,10018870,10052287
INCREASE IN LIVER ENZYMES,Hepatic enzyme increased,HEPATIC ENZYME INCREASED,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10060795,10060795,10060795
ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
"TWO DAYS EARLIER, DUE TO A PRESCRIPTION MISTAKE, HE WAS STARTED ON PAROXETINE 20 MG INSTEAD OF HIS USUAL FLUOXETINE 20 MG",drug prescribing error,DRUG PRESCRIBING ERROR,DRUG PRESCRIBING ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT PRESCRIBING ERRORS AND ISSUES,10022117,10064296,10064296,10064296
SUDDEN DEATH/WAS FOUND UNCONSCIOUS,Sudden death,SUDDEN DEATH,SUDDEN DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10042434,10042434,10042434
INDIRECT BILIRUBIN INCREASED (81.39 MICROMOL/L),Blood bilirubin unconjugated increased,INDIRECT BILIRUBIN INCREASED,BLOOD BILIRUBIN UNCONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10021709,10005370,10021709
DEHYDRATED,dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
INTERSTITIAL FIBROSIS,Kidney fibrosis,RENAL INTERSTITIAL FIBROSIS,KIDNEY FIBROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL DISORDERS NEC,10038359,10038475,10023421,10038475
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
HHV8-POSITIVE KAPOSI'S SARCOMA ASSOCIATED WITH MYASTHENIA GRAVIS,Kaposi's sarcoma,KAPOSI'S SARCOMA,KAPOSI'S SARCOMA,SOFT TISSUE NEOPLASMS MALIGNANT AND UNSPECIFIED,KAPOSI'S SARCOMAS,10029104,10023284,10023284,10023284
EMOTIONAL RESPONSE NOT APPROPRIATE FOR THE SITUATION/ AFFECT: REDUCED,Emotional poverty,EMOTIONAL POVERTY,EMOTIONAL POVERTY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10014557,10014557,10014557
EPIDURAL BLEEDING,Spinal epidural haemorrhage,SPINAL EPIDURAL BLEEDING,SPINAL EPIDURAL HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10049236,10049236,10071886
INTESTINAL ANGIOEDEMA/ INTESTINAL ANGIOEDEMA ASSOCIATED WITH ICAAS,Intestinal angioedema,INTESTINAL ANGIOEDEMA,INTESTINAL ANGIOEDEMA,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10076229,10076229,10076229
SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
DEPERSONALIZATION,depersonalization,DEPERSONALIZATION,DEPERSONALISATION/DEREALISATION DISORDER,DISSOCIATIVE DISORDERS,DISSOCIATIVE STATES,10037175,10012359,10077805,10012359
SHOCK DUE TO SEPSIS FOLLOWING MULTIPLE INFECTIONS,Shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
DRUG INTERACTION BETWEEN VORICONAZOLE AND TACROLIMUS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
AMNESIA OF NOCTURNAL URINATION,Amnesia,AMNESIA,AMNESIA,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10001949,10001949,10001949
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
RHABDOMYOLYSIS DUE TO THE INTERACTION OF CIPROFLOXACIN WITH SIMVASTATIN,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
DOSE OF EPHEDRINE WAS LARGE AND INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
VASOSPASTIC CORONARY EVENT,vasospastic coronary event,CORONARY VASOSPASM,ARTERIOSPASM CORONARY,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10011110,10003225,10011110
CONFUSION,confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
THERAPY-RELATED ACUTE MYELOID LEUKEMIA,Acute myeloid leukaemia,TREATMENT RELATED ACUTE MYELOID LEUKEMIA,ACUTE MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10066355,10000880,10066353
ADENO VARICELLA VIRUS REACTIVATION,varicella infection,VARICELLA ZOSTER VIRUS INFECTION,VARICELLA ZOSTER VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10075611,10075611,10075611
HYBRID THERAPY FAILURE IN HELICOBACTER PYLORI ERADICATION,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
CALCIUM DECREASED (1.88 MMOL/L),Blood calcium decreased,CALCIUM DECREASED,BLOOD CALCIUM DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10006954,10005395,10006954
KETOCONAZOLE USE FOR CUSHING SYNDROME (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"THE PATIENT DID NOT TOLERATE THE TREATMENT WELL, WITH ORAL CANDIDIASIS AND PROSTRATION",Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
DROWSINESS,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
FALL/FRACTURE,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
HYPERVITAMINOSIS D FOLLOWING SELF MEDICATION OF VITAMIN D SUPPLEMENTS FOR 2 YEARS,hypervitaminosis D,HYPERVITAMINOSIS D,HYPERVITAMINOSIS D,VITAMIN RELATED DISORDERS,HYPERVITAMINOSES NEC,10027433,10020917,10020917,10020917
DIFFUSE ABDOMINAL PAIN NOT ASSOCIATED WITH FOOD INTAKE,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
BROMOCRIPTINE-RESISTANT INVASIVE GIANT PROLACTINOMAS,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
NEW PINK PAPULES AND VESICLES EXTENDING BEYOND THE C2 DERMATOME ONTO THE LEFT FOREHEAD AND CHEEK,Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
LISTLESS,listless,LISTLESS,LISTLESS,MOOD DISORDERS AND DISTURBANCES NEC,MOOD DISORDERS NEC,10037175,10024642,10024642,10024642
MYOPERICARDITIS,Myocarditis,MYOPERICARDITIS,MYOCARDITIS,MYOCARDIAL DISORDERS,NONINFECTIOUS MYOCARDITIS,10007541,10028650,10028606,10028650
METHAEMOGLOBINAEMIA FOLLOWING OFF LABEL USE OF RASBURICASE,Methaemoglobinaemia,METHAEMOGLOBINAEMIA,METHAEMOGLOBINAEMIA,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10027496,10027496,10027496
APPETITE LOSS,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
POSITIVE RHEUMATOID FACTOR,Rheumatoid factor positive,RHEUMATOID FACTOR POSITIVE,RHEUMATOID FACTOR POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10039080,10039080,10039080
NEUROLOGIC SYMPTOMS,Neurological symptom,NEUROLOGIC SYMPTOMS,NEUROLOGICAL SYMPTOM,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10060860,10060860,10029291
FEVER (39 DEGREE CELSIUS),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
URINARY TRACT INFECTION WITH E. COLI,Urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
GRANULOMATOUS CHRONIC INFLAMMATORY REACTION,Inflammation,INFLAMMATORY REACTION,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10021995,10061218,10021995
HEPATIC FUNCTION ABNORMAL,Hepatic function abnormal,HEPATIC FUNCTION ABNORMAL,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019670,10019670,10019670
SUICIDE ATTEMPT,Suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
DRUG EXPOSURE DURING PREGNANACY WITH NO ADR,"drug exposure during pregnancy, third trimester","DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
MUCOUS MEMBRANE DISORDER SUCH AS STOMATITIS,Mucous membrane disorder,MUCOUS MEMBRANE DISORDER,MUCOUS MEMBRANE DISORDER,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028133,10028133,10028133
SEVERE HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
ASCITES,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
LIMB PAIN,Pain in extremity,PAIN IN LIMB,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033425,10033425,10033447
WORSENING OF ASCITES,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
PRURITUS,pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
REPEATED EPISODES OF CMV AND HHV6 REACTIVATIONS,cytomegalovirus infection reactivation,CYTOMEGALOVIRUS INFECTION REACTIVATION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10058666,10011831,10058666
OPIOID NEONATAL ABSTINENCE SYNDROME,Neonatal abstinence syndrome,NEONATAL ABSTINENCE SYNDROME,DRUG WITHDRAWAL SYNDROME NEONATAL,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10074192,10013756,10074192
THE PATIENT USED MYCOPHENOLATE MOFETIL AS AN IMMUNOSUPPRESSANT FOR PNEUMOCYSTIS JIROVECII PNEUMONIA INFECTION (OFF LABEL USE) WITH NO ADVERE REACTION.,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MODDERATE-VOLUME HAEMOPERITONEUM,Haemoperitoneum,HAEMOPERITONEUM,PERITONEAL HAEMORRHAGE,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL HAEMORRHAGES,10017947,10018935,10034666,10018935
LEUKOCYTOSIS (INCREASED POLYMORPHONUCLEAR LEUKOCYTES LEVEL) WITH NEUTROPHIL POLYNUCLEOSIS,hyperleukocytosis,HYPERLEUKOCYTOSIS,HYPERLEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10078862,10078862,10078862
GENERALIZED MILD ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN GENERALIZED,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000082,10000081,10058826
EVOLUTION TO PLASMA CELL LEUKAEMIA FOLLOWING DISEASE PROGRESSION OF PLASMA CELL MYELOMA,Plasma cell leukaemia,PLASMA CELL LEUKAEMIA,PLASMA CELL LEUKAEMIA,PLASMA CELL NEOPLASMS,PLASMA CELL MYELOMAS,10029104,10035222,10035222,10035222
MULTIPLE ORAL ULCERS FOLLOWED BY METHOTREXATE TOXICITY,multiple oral ulcers followed by methotrexate toxicity,ORAL ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10031027,10028034,10031027
BRADYCARDIC DUE TO LOPERAMIDE TOXICITY FOLLOWING DRUG MISUSE,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
SLEEPLESSNESS,Insomnia,SLEEPLESSNESS,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10041017,10022437,10041017
THE PATIENT IS TREATED WITH IMIQUIMOD FOR AMELANOTIC MELANOMA (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
COMA/CNS DEPRESSION,Depressed level of consciousness,CNS DEPRESSION,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10012383,10012373,10009710
PATIENT TREATED WITH METHOTREXATE FOR MORPHOEA PROFUNDA (OFF LABEL USE)  WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
IMMEDIATE SUPERFICIAL VENOUS THROMBOPHLEBITIS,Thrombophlebitis arm superficial,THROMBOPHLEBITIS ARM SUPERFICIAL,THROMBOPHLEBITIS SUPERFICIAL,EMBOLISM AND THROMBOSIS,PERIPHERAL EMBOLISM AND THROMBOSIS,10047065,10043573,10043595,10043573
URINARY INCONTINENCE,Urinary incontinence,URINARY INCONTINENCE,URINARY INCONTINENCE,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046543,10046543,10046543
IMPAIRED CHEWING,Mastication disorder,CHEWING DIFFICULTY,MASTICATION DISORDER,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10067464,10026882,10067464
ONE RECURRENCE OF ATRIAL FIBRILLATION,Atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
IRRITABILITY,irritability,IRRITABILITY,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10022998,10022998,10022998
TACHYPNOEA,Tachypnoea,TACHYPNOEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043089
HAEMOLYTIC ANEMIA FOLLOWING ALLERGY TO RIFAMPICIN (RBC-2800000/CUBIC MM),Haemolytic anaemia,HEMOLYTIC ANEMIA,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10018916,10018916,10019493
"REFRACTORY KAWASAKI DISEASE,DIFFUSE AND FUSIFORM ANEURYSMS OF CORONARY ARTERIES,RECRUDENSCENCE OF FEVER IN CONTEXT OF LACK OF EFFECT",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
DETERIORATION OF RENAL FUNCTION DUE TO SULPHAMETHOXAZOLE INDUCED CRYSTALLURIA,renal function aggravated,RENAL FUNCTION AGGRAVATED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038453,10062237,10038453
DIPLOPIA,diplopia,DIPLOPIA,DIPLOPIA,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10013036,10013036,10013036
HAEMOPHILUS INFLUENZAE INFECTION,Haemophilus infection,HAEMOPHILUS INFLUENZAE INFECTION,HAEMOPHILUS INFECTION,BACTERIAL INFECTIOUS DISORDERS,HAEMOPHILUS INFECTIONS,10021881,10018952,10061190,10018952
METHYLPREDNISOLONE WAS ADMINISTERED FOR ENCEPHILITIS BUT NO IMPROVEMENT WAS OBSERVED (LACK OF DRUG EFFECT WITH NO ADVERSE EVENTS),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SEVERE ABDOMINAL PAIN ASSOCIATED WITH NON-BLOODY NON-BILIOUS VOMITUS,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
TRYPTASE INCREASED (155 MICROG/L),Tryptase increased,TRYPTASE INCREASED,TRYPTASE INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOLOGY ANALYSES NEC,10022891,10063342,10063342,10063342
FLACTUATING THROMBOCYTOPENIA/SEVERE THROMBOCTOPENIA WITH CLINICAL EVEIDENCE OF PURPURA,thrombocytopenic purpura,THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIC PURPURA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043561,10043561,10043561
WEIGHT LOSS OF 5 KG IN ONE MONTH WITH SEVERE ASTHENIA,weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
GRADE II NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
TREATMENT OF IDIOPATHIC LIPOATROPHIC LOBULAR PANNICULITIS WITH HYDROXYCHLOROQUINE (OFF LABEL USE WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LACK OF DRUG EFFECT,vaccination failure,VACCINATION FAILURE,VACCINATION FAILURE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,VACCINATION RELATED COMPLICATIONS,10022117,10046862,10046862,10046862
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
DEVELOPMENTAL DELAY FOLLOWING DRUG EXPOSURE IN UTERO,developmental delay,DEVELOPMENTAL DELAY,DEVELOPMENTAL DELAY,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10012559,10012559,10012559
SLOW MOVEMENT,Movements reduced,MOVEMENTS REDUCED,HYPOKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028045,10021021,10028045
BROWNISH PIGMENTATION,Pigmentation disorder,SKIN PIGMENTATION,PIGMENTATION DISORDER,PIGMENTATION DISORDERS,PIGMENTATION CHANGES NEC,10040785,10040910,10062080,10040910
CREATINE KINASE HIGH,Blood creatine phosphokinase increased,CREATINE KINASE HIGH,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011335,10005470,10011335
SCROTAL SWELLING,Scrotal swelling,SCROTAL SWELLING,SCROTAL SWELLING,PENILE AND SCROTAL DISORDERS (EXCL INFECTIONS AND INFLAMMATIONS),SCROTAL DISORDERS NEC,10038604,10039759,10039759,10039759
PATIENT SUCCESSFULLY TREATED WITH STEMETIL IN THE FIRST 12 WEEKS OF PREGNANCY,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
AFFECTED WITH BLOOD PRESSURE 65/40 MM HG,Low blood pressure,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10024895,10021097,10024895
DIGOXIN USED FOR FETAL SUPRAVENTRICULAR TACHYCARDIA (SVT),Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
T3 TOTAL REDUCED (39 NG/DL),T3 decreased,T3 DECREASED,TRI-IODOTHYRONINE DECREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),THYROID ANALYSES,10022891,10043052,10044594,10043052
OVERDOSE,overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
MILD BLEEDING DIATHESIS FOLLOWING PANCYTOPENIA,Haemorrhagic diathesis,HEMORRHAGIC DIATHESIS,HAEMORRHAGIC DIATHESIS,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),BLEEDING TENDENCIES,10005329,10062713,10062713,10062720
SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
"INTENTIONAL INGESTION OF SMALL QUANTITIES OF METHOTREXATE, PREDNISOLONE AND METHYLPREDNISOLONE",intentional drug misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
RASH ACNEIFORM,Dermatitis acneiform,RASH ACNEIFORM,DERMATITIS ACNEIFORM,SKIN APPENDAGE CONDITIONS,ACNES,10040785,10037847,10012432,10037847
EXTRASPINAL OSTEOARTICULAR MULTIDRUG-RESISTANT TUBERCULOSIS,Tuberculosis,MULTIDRUG RESISTANT TUBERCULOSIS,TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10070578,10044755,10070578
MILD FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
INTENTIONAL INGESTION OF 65 G PARACETAMOL EACH TIME,Intentional drug misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
"THE WOUNDSITE, WHICH BECAME HOT, PAINFUL, AND INTENSELY PRURITIC IMMEDIATELY",Pruritic rash,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037085,10037884,10037085
DECREASED DIURESIS,Oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
AKINESIA OF THE ANTERIOR MID-APICAL SEGMENTS,Ventricular hypokinesia,VENTRICULAR REGIONAL AKINESIA,VENTRICULAR HYPOKINESIA,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10074317,10050510,10074317
ORAL INTOLERANCE,Oral intake reduced ,ORAL INTAKE REDUCED,HYPOPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10063889,10063743,10063889
INTERMITTENT FEVER,Pyrexia,INTERMITTENT FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10022571,10037660,10058698
"RHABDOMYOLYSIS SECONDARY TO FALLS, DISTAL RADIUS FRACTURE AND HEAD TRAUMA",Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
ADMINISTRATION OF FUROSEMIDE DURING PREGNANCY,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
G250E MUTATION,Gene mutation,GENE MUTATION,GENE MUTATION,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,CHROMOSOMAL ABNORMALITIES NEC,10010331,10064571,10064571,10064571
CEFTRIAXONE-INDUCED PROGRESSIVE PSEUDOLITHIASIS (ABDOMINAL CT CLEARLY DEMONSTRATED MULTIPLE GALLSTONES WITH BILIARY SLUDGE),Pseudocholelithiasis,PSEUDOCHOLELITHIASIS,PSEUDOCHOLELITHIASIS,GALLBLADDER DISORDERS,CHOLECYSTITIS AND CHOLELITHIASIS,10019805,10066884,10066884,10066884
PROGRESSIVE HYPOXEMIC RESPIRATORY FAILURE DUE TO THE MASSIVE DISSEMINATION OF THE FILARIFORM LARVAE WITH THE USE OF DEXAMETHASONE,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
OLIGODACTYLY,Adactyly,OLIGODACTYLY,ADACTYLY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS OF LIMBS CONGENITAL,10010331,10070979,10049207,10070979
UNCOMFORTABLE SIZE OF TENNIS BALL - BIG AND RED,redness,REDNESS,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10038198,10015150,10038198
GASTROINTESTINAL BLEEDING,Gastrointestinal haemorrhage,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017936
ORGANS INJURY,Multiorgan failure,MULTIORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028162,10077361,10028162
"HAD BEEN ALSO RECEIVING AMISULPRIDE [SOLIAN], WHICH LOWERED THE SEIZURE THRESHOLD",Convulsive threshold lowered,THRESHOLD CONVULSION LOWERED,CONVULSIVE THRESHOLD LOWERED,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10010927,10010927,10043513
SUBSEQUENT AGGRAVATION OF THE KALIEMIA (MAXIMUM OF 6.9MMOL/L),Concomitant disease aggravated,CONCOMITANT DISEASE AGGRAVATED,CONCOMITANT DISEASE AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010253,10010253,10010253
ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
RAISED POTASSIUM,potassium increased,POTASSIUM INCREASED,BLOOD POTASSIUM INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10036450,10005725,10036450
CLINICAL SEPSIS DUE TO PROLONGED MYELOSUPPRESSION,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
WORSENED THE AGITATION AND AGGRESSION (SEIZURE DISORDER),Agitation,AGITATION AGGRAVATED,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001498,10001497,10001498
UNSTABLE BLOOD GLUCOSE DUE TO INSULIN ANTIBODY PRODUCTION,Diabetes mellitus inadequate control,LOSS OF CONTROL OF BLOOD SUGAR,DIABETES MELLITUS INADEQUATE CONTROL,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10024858,10012607,10024858
THROMBOSIS,Thrombosis,THROMBOSIS,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10043607,10043607,10043607
ALLERGIES TO SULFONAMIDES AND AZITHROMYCIN,drug allergy,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
INTERSTITIAL NEPHRITIS,Tubulointerstitial nephritis,NEPHRITIS INTERSTITIAL,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029134,10048302,10029134
HAEMOGLOBIN DECREASED,Haemoglobin decreased,HAEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10018884
TUNNEL INFECTION,Device related infection,DEVICE RELATED INFECTION,DEVICE RELATED INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10064687,10064687,10064687
YELLOW EYES,Ocular icterus,CONJUNCTIVA COLORING YELLOW,OCULAR ICTERUS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10010693,10058117,10062414
RESPIRATORY DEPRESSION,Respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
FETAL GOITRE,Goitre,GOITRE,GOITRE,THYROID GLAND DISORDERS,THYROID DISORDERS NEC,10014698,10018498,10018498,10018498
"LEUKOCYTOSIS (LEUKOCYTE COUNT 16,700 MM3)",Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
LOW BLOOD PRESSURE,Hypotension,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10024895
MUSCLE STIFFNESS,Musculoskeletal stiffness,MUSCLE STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10028339,10052904,10028339
RENAL TOXICITY,Nephropathy toxic,TOXICITY RENAL,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10044258
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ALANINE AMINOTRANSFERASE SIGNIFICANTLY INCREASED,alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
HYPERPROLACTINEMIA,HYPERPROLACTINEMIA,HYPERPROLACTINEMIA,HYPERPROLACTINAEMIA,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPERFUNCTION,10014698,10020739,10020737,10020739
FISTULA,Fistula,FISTULA,FISTULA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,SOFT TISSUE DISORDERS NEC,10028395,10016717,10016717,10016717
WORD FINDING DIFFICULTY,Aphasia,WORD FINDING DIFFICULTY,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10067711,10002948,10067711
CIRRHOSIS,Hepatic cirrhosis,CIRRHOSIS LIVER,HEPATIC CIRRHOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10019641,10019641,10009211
MYELODYSPLASTIC SYNDROME,Myelodysplastic syndrome,MYELODYSPLASTIC SYNDROME,MYELODYSPLASTIC SYNDROME,LEUKAEMIAS,MYELODYSPLASTIC SYNDROMES,10029104,10028533,10028533,10028533
ORAL MUCOSA WAS COVERED WITH RED EDGED EROSIONS,Oral mucosa erosion,ORAL MUCOSA EROSION,ORAL MUCOSA EROSION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10064594,10064594,10064594
PATIENT WAS NOT DRUG COMPLIANT,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
MYELOSUPPRESSION,Myelosuppression adult,MYELOSUPPRESSION ADULT,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10028585,10065553,10028585
MALAISE,malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
DISSEMINATION OF ADENOVIRUS INFECTION FOLLOWING SUB-THERAPEUTIC EFFECT OF RIBAVIRIN,Adenovirus infection,ADENOVIRUS INFECTION,ADENOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,ADENOVIRAL INFECTIONS,10021881,10060931,10060931,10060931
MILD SYMMETRICAL PITTING EDEMA OF BILATERAL LOWER EXTREMITIES EXTENDED UPTO MID THIGHS,Oedema,PITTING EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10035076,10030095,10054547
MACULOPAPULAR ERUPTION,Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
CONSTIPATION,Constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
METFORMIN TOXICITY,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
STATIN-INDUCED MYALGIAS,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
ACUTE RESPIRATORY DISTRESS SYNDROME,Acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
NEPHROTOXICITY INDUCED BY METHOTREXATE (SERUM CONCENTRATION- 280 MCMOL/L),nephrotoxicity,NEPHROTOXICITY,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10067571
LEUKOPENIA,Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
RETROSTERNAL CHEST PAIN,retrosternal Chest pain,RETROSTERNAL CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10038986,10008479,10038986
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
MYOGLOBIN ELEVATED,Myoglobin blood increased,MYOGLOBIN BLOOD INCREASED,MYOGLOBIN BLOOD INCREASED,MUSCULOSKELETAL AND SOFT TISSUE INVESTIGATIONS (EXCL ENZYME TESTS),MUSCULOSKELETAL AND SOFT TISSUE TESTS NEC,10022891,10028625,10028625,10028625
DRUG-DRUG INTERACTION BETWEEN COTRIMOXAZOLE AND SACUBITRIL/VALSARTAN,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
NEURAL TUBE DEFECT,Neural tube defect,NEURAL TUBE DEFECT,NEURAL TUBE DEFECT,NEUROLOGICAL DISORDERS CONGENITAL,CENTRAL NERVOUS SYSTEM DISORDERS CONGENITAL NEC,10010331,10052046,10052046,10052046
PERIORAL CYANOSIS,Cyanosis,CYANOSIS,CYANOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10011703,10011703,10011703
TEMPORARY HYPOTHYROIDISM DUE TO THE HIGH EXPOSITION OF HIGH IODINE,Secondary hypothyroidism,SECONDARY HYPOTHYROIDISM,SECONDARY HYPOTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPOFUNCTION DISORDERS,10014698,10039840,10039840,10039840
DIARRHEA,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
MYELITIS,myelitis,MYELITIS,MYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10028524,10028524,10028524
PLASMA OSMOLALITY REVEALED A VALUE OF 248 MOSM PER KG,Blood osmolarity decreased,SERUM OSMOLALITY DECREASED,BLOOD OSMOLARITY DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",WATER AND ELECTROLYTE ANALYSES NEC,10022891,10040358,10005696,10040358
CHEST TIGHTNESS WITH EXERTION,chest tightness,CHEST TIGHTNESS,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008492,10008469,10008492
HIGH LEVELS OF URINARY PORPHOBILINOGEN,Urine porphobilinogen increased,PORPHOBILINOGEN HIGH,URINE PORPHOBILINOGEN INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",HAEM METABOLISM ANALYSES,10022891,10036177,10046658,10036177
LABIAL CYANOSIS,Cyanosis,CYANOSIS,CYANOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10011703,10011703,10011703
RIGHT LATEROCOLLIS,Torticollis,CERVICAL DYSTONIA,TORTICOLLIS,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10064124,10044074,10064124
 normal(0.74-1.52 mmol/L),2018-03-27 00:00:00,1,,,,MINERAL AND ELECTROLYTE ANALYSES,10040371,10050196,
WEIGHT GAIN OF 8 KG,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
CARDIAC TAMPONADE,Cardiac tamponade,CARDIAC TAMPONADE,CARDIAC TAMPONADE,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10007610,10007610,10007610
AGGRESSIVE BEHAVIOR,Aggressive behavior,AGGRESSIVE BEHAVIOR,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10062375,10001488,10062375
VIOLENT EPISODES AND SELF INJURIES,Aggression,VIOLENT BEHAVIOR,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10047428,10001488,10057073
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
"SKIN ERUPTION ON THE FACE, OLECRANON, AND HANDS AND FEET",Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
BULLOUS PEMPHIGOID,Pemphigoid,BULLOUS PEMPHIGOID,PEMPHIGOID,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006567,10034277,10006567
CONDUCT PROBLEMS,Conduct disorder,CONDUCT DISORDER,CONDUCT DISORDER,COGNITIVE AND ATTENTION DISORDERS AND DISTURBANCES,ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOUR DISORDERS,10037175,10064478,10064478,10064478
2/6 SYSTOLIC EJECTION MURMUR LOUDEST AT THE LEFT MIDSTERNAL BORDER WITH SOME RADIATION TO THE BACK,Cardiac murmur,SYSTOLIC EJECTION MURMUR,CARDIAC MURMUR,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC AUSCULTATORY INVESTIGATIONS,10022891,10050568,10007586,10050568
LARGE SUPERFICIAL HAEMATOMA LYING POSTEROLATERAL TO THE RIGHT 5-11TH RIBS,Haematoma,HAEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10018852
LESS CONCENTRATES AND IS INEFFICIENT,Fatigue,TIREDNESS,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10043890
DAWN PHENOMENON,Dawn phenomenon,DAWN PHENOMENON,DAWN PHENOMENON,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10052097,10052097,10052097
"WAS COMMENCED ON TINZAPARIN AND ASPIRIN. DESPITE THIS, ONE MONTH LATER SHE HAD A STROKE",Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
URINARY TRACT INFECTION,urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
HAD MINIMAL IMPROVEMENT WITH FUROSEMIDE,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
MULTIPLE ORGAN FAILURE DUE TO DRUG INDUCED HEMOLYTIC ANEMIA,Multiple organ dysfunction syndrome,MULTIPLE ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028237
TOXICITIES WERE GRADE 2 HAND-FOOT SYNDROME GRADE 2 MUCOSITIS,hand and foot syndrome,HAND AND FOOT SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10019111,10033553,10019111
INSIGNIFICANT IMPROVEMENT IN FREQUENCY OF FLUSHING WITH CETIRIZINE,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
CHEST RADIOGRAPH REVEALED INCREASED INTERSTITIAL SHADOWING,Chest X-ray abnormal,PULMONARY INTERSTITIAL SHADOW,CHEST X-RAY ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10037416,10008499,10037416
PATIENT WAS TREATED WITH METHOTREXATE FOR INTERSTITIAL ECTOPIC PREGNANCY TERMINATION WITH NO ADR (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
STAPHYLOCOCCUS AUREUS SKIN INFECTION,staphylococcus aureus skin infection,STAPHYLOCOCCUS AUREUS SKIN INFECTION,STAPHYLOCOCCAL SKIN INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10066412,10066409,10066412
"HIV-1 RNA WAS 27,316 COPIES/ML",Blood HIV RNA increased,HIV VIRAL LOAD INCREASED,BLOOD HIV RNA INCREASED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10049832,10049827,10049832
"PATIENT STRUGGLED TO CONTROL HIS ANXIETY SYMPTOMS WITH MULTIPLE PHARMACOLOGICAL TRIALS INCLUDING CITALOPRAM, SERTRALINE AND LORAZEPAM.",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
HEADACHE FOLLOWING INTOLERANCE TO MYCOPHENOLATE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
PHYSICAL AND MENTAL STRESS,Stress,STRESS,STRESS,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10042209,10042209,10042209
INDURATION,Induration,INDURATION,INDURATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10060708,10060708,10060708
SPECIFIC GRAVITY INCREASED FROM 1.006 TO 1.017 WITHIN 2 HOURS OF ADMINISTRATION OF HD-MTX,Specific gravity urine increased,SPECIFIC GRAVITY URINE INCREASED,SPECIFIC GRAVITY URINE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINALYSIS NEC,10022891,10050773,10050773,10050773
TOXIC SHOCK SYNDROME,Toxic shock syndrome,TOXIC SHOCK SYNDROME,TOXIC SHOCK SYNDROME,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10044248,10044248,10044248
PANCREATITIS,pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HE ALSO DESCRIBED SHOOTING PAINS IN HIS RIGHT ARM COMING FROM THE DARKENED VEINS,Pain,SHOOTING PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10050007,10033371,10050007
BRADYCARDIA WITH AV DISSOCIATION,bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
EPISODES OF POLYMORPHIC VENTRICULAR TACHYCARDIA,polymorphic ventricular tachycardia,POLYMORPHIC VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10036095,10047302,10036095
HUMAN ESTEROVIRUS INFECTION,Viral infection,INFECTION VIRAL,VIRAL INFECTION,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10047461,10047461,10021876
EPSTEINâ€“BARR VIRUS REACTIVATION,Epstein-Barr virus infection reactivation,EPSTEIN-BARR VIRUS INFECTION REACTIVATION,EPSTEIN-BARR VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,EPSTEIN-BARR VIRAL INFECTIONS,10021881,10015109,10015108,10015109
RIGIDITY,rigidity,RIGIDITY,MUSCLE RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10039168,10028330,10039168
MILD BLURRING OF VISION IN THE RIGHT EYE,Blurring of vision,BLURRING OF VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10005888,10047513,10005888
FACTOR VIII INCREASED (MORE THAN 250 U/DL),Coagulation factor VIII level increased,COAGULATION FACTOR VIII LEVEL INCREASED,COAGULATION FACTOR VIII LEVEL INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10009770,10009770,10009770
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PANCYTOPENIA,pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
HYPERTENSION (GRADE2),Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
DRUG-INDUCED TORSADES DE POINTES,Torsade de pointes,TORSADES DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044067
"PREGNANT PATIENT WAS EXPOSED TO ANTIHYPERTENSIVE TREATMENT OF CANDESARTAN, QUINAPRIL AND HYDROCHLOROTHIAZIDE",Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
FRACTURE OF THE ANTERIOR LEFT MAXILLARY SINUS WALL,Jaw fracture,FRACTURED MAXILLA,JAW FRACTURE,BONE AND JOINT INJURIES,"SKULL FRACTURES, FACIAL BONE FRACTURES AND DISLOCATIONS",10022117,10017295,10023149,10017295
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
DEVELOPED LONG QT WITH AMIODARONE,Electrocardiogram QT prolonged,QT PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037705,10014387,10037705
AGITATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
HYPERCOAGULABLE STATE,Hypercoagulability,HYPERCOAGULABILITY,HYPERCOAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10075816,10020608,10075816
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
"INTERACTION BETWEEN QUETIAPINE, VALPROIC ACID AND LORAZEPAM",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
HYPERTENSION BECAME MORE DIFFICULT TO CONTROL,Hypertension,HYPERTENSION NOT ADEQUATELY CONTROLLED,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020783,10020772,10020783
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ANURESIS,Anuria,ANURIA,ANURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10002847,10002847,10002847
HIGH FEVER (39 DEGREE C),fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
SEVERE WEAKNESS,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
GENERALIZED RASH,Generalized rash,GENERALIZED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10049201,10037858,10049201
ASYNCHRONOUS CONTRACTION OF THE VENTRICLES (DYSSYNCHRONY),Ventricular dyssynchrony,VENTRICULAR DYSSYNCHRONY,VENTRICULAR DYSSYNCHRONY,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10071186,10071186,10071186
RESPIRATORY FAILURE,respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
RESTING TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
AGGRAVATION OF THE RHEUMATOID ARTHRITIS,Rheumatoid arthritis aggravated,RHEUMATOID ARTHRITIS AGGRAVATED,RHEUMATOID ARTHRITIS,JOINT DISORDERS,RHEUMATOID ARTHROPATHIES,10028395,10039074,10039073,10039074
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
BUN INCREASED (28 MG/DL),Blood urea increased,BUN INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10006576,10005851,10006576
RENAL CRYOGLOBULINAEMIC VASCULITIS,renal vasculitis,RENAL VASCULITIS,RENAL VASCULITIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL VASCULAR AND ISCHAEMIC CONDITIONS,10038359,10038546,10038546,10038546
DIFFUSE RENAL PARENCHYMAL DISEASE,Nephropathy,RENAL DISEASE,NEPHROPATHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10051051,10029151,10051051
HIV-1 PERSISTENT VIREMIA,HIV viraemia,HIV VIREMIA,HIV VIRAEMIA,VIRAL INFECTIOUS DISORDERS,RETROVIRAL INFECTIONS,10021881,10077716,10077716,10077718
DIFFUSE MUSCLE AND JOINT PAIN,Arthralgia,PAIN IN JOINT,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10033434
GASTROINTESTINAL DISORDERS FOLLOWING COLCHICINE  INTOXIFICATION,gastrointestinal disorders,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
LEUKOCYTOSIS,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
LEVEL OF METFORMIN COLLECTED WERE 49.3 MCG/ML (TOXIC FROM 5.00 MCG/ML),Drug level increased,DRUG LEVEL IN BLOOD INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013721,10013722,10013721
CEFEPIME-INDUCED NEUTROPENIA (ANC DROPPED TO 20/MICROLITRE),Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
SEVERE METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
HODGKIN'S LYMPHOMA WAS PROVED REFRACTORY TO ABVD REGIMEN,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
A NEW FLARE APPEARED,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
FAILURE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
"STARTED ON ASPIRIN, NIFEDIPINE, AND TOPICAL NITROGLYCERIN WITH NO IMPROVEMENT",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
THE HORN DRUG INTERACTION PROBABILITY SCALE INDICATED A POSSIBLE INTERACTION BETWEEN WARFARIN AND THE INFLUENZA VACCINATION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
OPTIC ATROPHY,optic atrophy,OPTIC ATROPHY,OPTIC ATROPHY,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC",OPTIC DISC ABNORMALITIES NEC,10015919,10030910,10030910,10030910
"IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (MIXED I.E., HEPATOCELLULAR AND CHOLESTATIC PATTERN)",Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
PAINFUL TUMEFACTION AT THE FIRST LEFT METATARSAL BONE FOLLOWING FUNGAL INFECTION,bone swelling,BONE SWELLING,BONE SWELLING,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10053631,10053631,10053631
SWELLING OF THE NECK OF UNCLEAR ORIGIN,neck swelling,NECK SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10049568,10042674,10049568
A FRACTURE OF THE NASAL BONES,fractured nose,FRACTURED NOSE,FACIAL BONES FRACTURE,BONE AND JOINT INJURIES,"SKULL FRACTURES, FACIAL BONE FRACTURES AND DISLOCATIONS",10022117,10017300,10016042,10017300
INTESTINAL PERFORATION,Intestinal perforation,INTESTINAL PERFORATION,INTESTINAL PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,INTESTINAL ULCERS AND PERFORATION NEC,10017947,10022694,10022694,10022694
BLOOD METHOTREXATE LEVEL AS HIGH AS 4.2 UM/L,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
TOTAL DEAFNESS DUE TO DRUG OVERDOSE AND ACCIDENTAL OVERDOSE FOLLOWING MEDICATION ERROR,Deafness,DEAFNESS TOTAL,DEAFNESS,HEARING DISORDERS,HEARING LOSSES,10013993,10048934,10011878,10048934
BLOOD PRESSURE LOW (70/40),Hypotension,BLOOD PRESSURE LOW,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10005753
PROFUSE WATERY DIARRHEA,Diarrhoea,WATERY DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10047849,10012735,10055422
IMPROVEMENT OCCURRED AFTER INTRODUCTION OF STEROIDS AND ASPIRIN,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
EXACERBATION OF INFLAMMATORY ARTHRITIS,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DROWSINESS,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
PRISTINAMYCIN-INDUCED LEUKOCYTOCLASTIC VASCULITIS,Leucocytoclastic vasculitis,LEUCOCYTOCLASTIC VASCULITIS,HYPERSENSITIVITY VASCULITIS,SKIN VASCULAR ABNORMALITIES,SKIN VASCULITIDES,10040785,10024278,10020764,10024278
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEROTONIN SYNDROME,Serotonin syndrome,SEROTONIN SYNDROME,SEROTONIN SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10040108,10040108,10040108
AEROBIC EXERCISE CAPACITY WAS SLIGHTLY REDUCED,Exercise capacity decreased,EXERCISE CAPACITY DECREASED,EXERCISE TOLERANCE DECREASED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10052325,10051301,10052325
QTC PROLONGATION,Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
IMMUNE-MEDIATED NECROTISING MYOPATHY,Immune-mediated necrotising myopathy,IMMUNE-MEDIATED NECROTISING MYOPATHY,IMMUNE-MEDIATED NECROTISING MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10072155,10072155,10072155
ACUTE INTERSTITIAL NEPHRITIS (AIN) DUE TO INCREASED VANCOMYCIN DRUG LEVELS FOLLOWING DRUG INTERACTION WITH PIPERACILLIN SODIUM/TAZOBACTAM SODIUM AND SUBSEQUENT USE OF AMPICILLIN/SULBACTAM,Tubulointerstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029135,10048302,10000819
PAIN ON THE RIGHT HIP,Arthralgia,PAIN IN HIP,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10011249,10003239,10033432
MYCOBACTERIUM ABSCESSUS BACTERAEMIA DUE TO SYSTEMIC LUPUS ERYTHEMATOSUS DETERIORATED FOLLOWING LACK OF DRUG EFFECT,Bacteraemia,BACTERAEMIA,BACTERAEMIA,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10003997,10003997,10003997
GASTROINTESTINAL DISORDER,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
INTENTIONAL ABUSE OF DRUG,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
RECEIVING ATORVASTATIN EVERY 2ND AND 3RD DAY,Intentional product misuse,INTENTIONAL MISUSE IN DOSING FREQUENCY,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065972,10074903,10065972
"PRURIGINOUS WHEALS ON FACE, ABDOMEN",Urticaria generalised,URTICARIA GENERALISED,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10052569,10046735,10052569
SEVERE HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
MILD DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
OVERDOSE,Overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
LACK OF EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
RETICULOCYTE COUNT INCREASED (15%),Reticulocyte count increased,RETICULOCYTE COUNT INCREASED,RETICULOCYTE COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10038792,10038792,10038792
PANTOPRAZOLE INDUCED SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS AT UPPER CHEST AND BACK,Subacute cutaneous lupus erythematosus,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,EPIDERMAL AND DERMAL CONDITIONS,CONNECTIVE TISSUE DISORDERS,10040785,10057903,10057903,10057903
RELAPSE OF PSYCHOSIS FOLLOWING A PERIOD OF MEDICATION NON-ADHERENCE,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
DRUG ADDICTION,Drug addiction,DRUG ADDICTION,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013658,10013663,10013658
"PATIENT WAS TREATED WITH  ITRACONAZOLE FOR LOBOMYCOSIS, BUT WITH NO COMPLETE RESOLUTION OF THE LESIONS (SUBTHERAPEUTIC RESPONSE) WITH NO ADVERSE EVENTS",Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
"CONTINUOUS, IRREGULAR WAVE-LIKE MOVEMENTS OF THE ENTIRE ABDOMINAL WALL ENSUED AND PERSISTED UNINTERRUPTED",Electromyogram abnormal,MUSCULAR CONTRACTION WAVE ABNORMAL,ELECTROMYOGRAM ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10028353,10014431,10028353
BULLOUS ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,acute generalised exanthematous pustulosis,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10048799
DYSLIPIDEMIA,dyslipidemia,DYSLIPIDEMIA,DYSLIPIDAEMIA,LIPID METABOLISM DISORDERS,LIPID METABOLISM AND DEPOSIT DISORDERS NEC,10027433,10058110,10058108,10058110
PANCREATITIS/RECURRENT PANCREATITIS,Pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
COMA,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
QTC PROLONGATION (QTC 556 MS) FOLLOWING CESSATION OF EXCESSIVE LOPERAMIDE MISUSE,Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
CONTINUOUS DETERIORATED STATE OF THE PATIENT,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
TREATMENT FAILURE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
HYPOGLYCEMIA,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
STEROID INDUCED PSYCHOSIS,psychosis,PSYCHOSIS,PSYCHOTIC DISORDER,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10037234,10061920,10037234
PATIENT WAS NOT RESPONSIVE TO TREATMENT,Therapy non-responder,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
GENTAMICIN-INDUCED MACULAR INFARCTION,Retinal infarction,RETINAL INFARCTION,RETINAL INFARCTION,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINAL BLEEDING AND VASCULAR DISORDERS (EXCL RETINOPATHY),10015919,10051742,10051742,10051742
DIPLOPIA,Diplopia,DIPLOPIA,DIPLOPIA,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10013036,10013036,10013036
DISORGANISED BEHAVIOUR,Abnormal behaviour,BEHAVIOUR DISORDER,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004207,10061422,10004207
NAIL NECROSIS,Nail necrosis,NAIL NECROSIS,NAIL NECROSIS,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10074602,10074602,10074602
INCREASE IN LESIONS AND WORSENING OF CLINICAL PICTURE AFTER INITIATION OF LEVETIRACETAM THERAPY,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
DIFFUSE MUSCLE PAIN,Myalgia,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028322
COAGULOPATHY,Coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
NON-PRURITIC URTICARIA ON HER LOWER EXTREMITIES AND ABDOMEN,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
DRUG EXPOSURE DURING PREGNANCY,DRUG EXPOSURE DURING PREGNANCY,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
LEFT FLANK PAIN,flank pain,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10016750,10016750,10016750
MYOCLONUS/CLOZAPINE-INDUCED MYOCLONUS,Myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
IMMUNOSUPPRESSION RELATED PRIMARY INTRAOCULAR LYMPHOMA IN LEFT EYE,Ocular lymphoma,OCULAR LYMPHOMA,OCULAR LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,B-CELL LYMPHOMAS NEC,10029104,10075324,10075324,10075324
"PLATELET LEVELS STARTED TO DECREASE FROM ONE MILLION TO 500,000 WITH A PROGRESSIVE DECLINE TO 123,000/ML ON DAY 12,",Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
CLONAZEPAM USED FOR ADAPTATION DISORDER,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
SEVERE HEART FAILURE FOLLOWING CHLOROQUINE INDUCED CARDIOMYOPATHY DUE TO OFF LABEL USE OF CHLOROQUINE,Heart failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10019279,10007554,10019279
SKIN DETACHMENT OF UP TO 10% OF THE BODY SURFACE AREA WERE PRESENT,Skin exfoliation,SKIN PEELING,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10034218,10040844,10040908
HYPERKERATOTIC PAPULES,Hyperkeratosis,HYPERKERATOSIS,HYPERKERATOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,HYPERKERATOSES,10040785,10020649,10020649,10020649
ELEVATED C REACTIVE PROTEIN LEVEL OF 145 MG/L,C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
ACUTE DETERIORATION/ACUTE EXACERBATION OF HEPATIC FUNCTION DURING ANTIBIOTIC TREATMENT,Hepatic function abnormal,ACUTE DERANGEMENT OF LIVER FUNCTION,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10000704,10019670,10000704
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
DRUG-INDUCED CHOLESTATIC LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
PATHOLOGIC LIPOGRAM,Lipids abnormal,LIPIDS ABNORMAL,LIPIDS ABNORMAL,LIPID ANALYSES,LIPOPROTEIN AND LIPID TESTS NEC,10022891,10024588,10024588,10024588
CANDIDIASIS,Candida infection,CANDIDIASIS,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10007152,10074170,10007152
ASEPTIC MENINGITIS,aseptic meningitis,ASEPTIC MENINGITIS,MENINGITIS ASEPTIC,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10003458,10027201,10003458
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
CUSHINGOID APPEARANCE,Cushingoid,CUSHING-LIKE BUILD,CUSHINGOID,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011654,10011655,10011654
"PATIENT WAS TREATED WITH METHOTREXATE, MYCOPHENOLATE MOFETIL AND HYDROXYCHLOROQUINE SULFATE FOR JUVENILE DERMATOMYOSITIS, RAYNAUD'S PHENOMENON, SCLERODACTILY, AND GOUGEROT-SJOGREN'S SYNDROME WITH NO ADR (OFF LABEL USE)",off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
WATER INTOXICATION,Water intoxication,WATER INTOXICATION,WATER INTOXICATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME INCREASED,10027433,10047837,10047837,10047837
THE PATIENT RAN OUT OF DEFLAZACORT AND WAS TAKING PREDNISONE DAILY TO SUBSTITUTE,missed dose,MISSED DOSE,DRUG DOSE OMISSION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10074624,10064294,10074624
SMALL PUSTULES AND SCALES DEVELOPED MAINLY AROUND THE MOUTH AND THE NASOLABIAL GROOVE,Skin exfoliation,SCALES,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10039518,10040844,10039518
EXTREME EMACIATION,Cachexia,EMACIATION,CACHEXIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10014494,10006895,10014494
NO IMPROVEMENT WITH THE METHYLPREDNISOLONE AND VINCRISTINE SULFATE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CONSTIPATION AND DIARRHOEA,Gastrointestinal motility disorder,ALTERNATION BETWEEN CONSTIPATION AND DIARRHEA,GASTROINTESTINAL MOTILITY DISORDER,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL DYSKINETIC DISORDERS,10017947,10059629,10061173,10059634
RENAL FAILURE,renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
ANXIETY,anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
RIGHT CORTICAL VENOUS THROMBOSIS,Cerebral venous thrombosis,CEREBRAL VENOUS THROMBOSIS,CEREBRAL VENOUS THROMBOSIS,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CEREBROVASCULAR VENOUS AND SINUS THROMBOSIS,10029205,10008138,10008138,10008138
ACUTE INTERSTITIAL NEPHRITIS INDUCED BY PROTON-PUMP INHIBITOR,acute interstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10000819,10048302,10000819
LEUKEMIC MENINGEAL INFILTRATION,leukemic meningeal infiltration,LEUKEMIC INFILTRATION MENINGES,CENTRAL NERVOUS SYSTEM LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS NEC,10029104,10075852,10066231,10075852
ANAPHYLAXIS TO BETA-LACTAM ANTIBIOTIC,Anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
DRUG EXPOSURE IN PREGNANCY(WITH NO ADR),Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
MODERATE HYPOTENSION (90/50 MMHG) FOLLOWING DEHYDRATION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
LEFT LUNG APLASIA,aplasia,APLASIA,APLASIA,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10002961,10002961,10002961
ELEVATED ESR,elevated ESR,ESR INCREASED,RED BLOOD CELL SEDIMENTATION RATE INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),HAEMATOLOGICAL ANALYSES NEC,10022891,10015480,10049187,10015480
HER CPK LEVEL WAS MARKEDLY ELEVATED WITHOUT ANY EVIDENCE,CPK increase ,CPK INCREASE,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011267,10005470,10011267
SECONDARY STAPHYLOCOCCUS AUREUS INFECTION,secondary staphylococcus aureus infection,STAPHYLOCOCCUS AUREUS INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10075981,10058080,10075981
DEPRESSIVE MOOD DISTURBANCE FOLLOWING OFF LABEL USE OF MYCOPHENOLATE MOFETIL,Depressed mood,DEPRESSED MOOD,DEPRESSED MOOD,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10012374,10012374,10012374
COMBINED CENTRAL NERVOUS SYSTEM DEPRESSION,Central nervous system depression NOS,CENTRAL NERVOUS SYSTEM DEPRESSION NOS,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10007941,10012373,10007941
HYPOXEMIC RESPIRATORY FAILURE,respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER/ GASTROINTESTINAL,post transplant lymphoproliferative disorder,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10051358,10051358,10051358
BLOOD-TINGED SPUTUM,Haemoptysis,SPUTUM BLOODY,HAEMOPTYSIS,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10041804,10018964,10041804
STEROID DEMENTIA SYNDROME,Drug-induced dementia,DRUG-INDUCED DEMENTIA,DEMENTIA,MENTAL IMPAIRMENT DISORDERS,DEMENTIA (EXCL ALZHEIMER'S TYPE),10029205,10013759,10012267,10013759
HAND-AND-FOOT SYNDROME,Palmar-plantar erythrodysaesthesia syndrome,HAND-AND-FOOT SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10019111,10033553,10019126
PARALLEL TRANSVERSE LINEAR DEPRESSIONS WERE APPRECIABLE IN ALL THE FINGERNAILS AND  TOENAILS/ WELL DEFINED RIDGES ON FINGERNAILS,Nail disorder,NAIL DISORDER,NAIL DISORDER,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10028694,10028694,10028694
HEPATITIS E VIRUS REPLICATION (GENOTYPE 3),Hepatitis E,HEPATITIS E,HEPATITIS E,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10019768,10019768,10019768
ANTITUBERCULAR DRUG INDUCED EXANTHEMATOUS REACTION,Rash,EXANTHEMA,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10015587
NON-SPECIFIC ST-SEGMENT DEPRESSION IN LEADS V5 AND V6 COMPATIBLE WITH MYOCARDIAL ISCHEMIA,Electrocardiogram ST-T segment depression,ELECTROCARDIOGRAM ST-T SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST-T SEGMENT DEPRESSION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10049224,10049224,10049224
CLINICAL CONDITION WAS WORSEN,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
LEFT FRONTAL MENINGIOMA ATTACHED TO THE SPHENOID RIDGE OR SPHENOID PLANE,meningioma,MENINGIOMA,MENINGIOMA,NERVOUS SYSTEM NEOPLASMS MALIGNANT AND UNSPECIFIED NEC,NERVOUS SYSTEM NEOPLASMS UNSPECIFIED MALIGNANCY NEC,10029104,10027191,10027191,10027191
WHITE BLOOD CELL COUNT DECREASED (NADIR OF 0.8 X 10E9/L),White blood cell count decreased,WHITE BLOOD CELL COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10047942
DRUG-INDUCED IMMUNE THROMBOCYTOPENIA,Immune thrombocytopenic purpura,AUTOIMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10050245,10074667,10050245
"WITH MARKS LOST IN MEMORY, FLUENCY AND ATTENTION ONLY",Speech disorder,SPEECH DISORDER,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041466,10041466,10041466
APPETITE LOST,decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
KLEBSIELLA PNEUMONIAE MENINGITIS WORSENING DESPITE ANTIBIOTIC THERAPY,Meningitis bacterial,MENINGITIS BACTERIAL,MENINGITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10027202,10027202,10027202
SHORTLY AFTER INTRAVENOUS EPHEDRINE TREATMENT THE ELECTROCARDIOGRAM REVEALED NONSUSTAINED VENTRICULAR TACHYCARDIA AND THE PATIENT DEVELOPED SIGNS OF RESPIRATORY FAILURE,Ventricular tachycardia,VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047302,10047302,10047302
CHRONIC HEPATITIS,Chronic hepatitis,CHRONIC HEPATITIS,CHRONIC HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10008909,10008909,10008909
CONGESTIVE HEART FAILURE,Cardiac failure congestive,CONGESTIVE HEART FAILURE,CARDIAC FAILURE CONGESTIVE,HEART FAILURES,HEART FAILURES NEC,10007541,10007559,10007559,10010684
GLOBAL LEFT VENTRICULAR HYPOKINESIA,Ventricular hypokinesia,VENTRICULAR HYPOKINESIA,VENTRICULAR HYPOKINESIA,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10050510,10050510,10050510
PRURITUS,pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
LOW LEVEL OF CONSCIOUSNESS,Depressed level of consciousness,CONSCIOUSNESS DECREASED,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010768,10012373,10010768
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CONSTIPATION,Constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
FUROSEMIDE-INDUCED SEVERE HYPOKALIEMIA WITH RHABDOMYOLYSIS AND ACUTE KIDNEY INJURY,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
DYSPNEA ON EXERTION,Dyspnoea exertional,DYSPNEA EXERTIONAL,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013971,10013971,10013966
IDIOPATHIC PYODERMA GANGRENOSUM,Pyoderma gangrenosum,PYODERMA GANGRENOSUM,PYODERMA GANGRENOSUM,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10037635,10037635,10037635
DIFFUCULTY IN STANDING FROM A SEATED POSITION AND CLIMBING STAIRS,Movement disorder,MOVEMENT DISORDER,MOVEMENT DISORDER,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028035,10028035,10028035
DARKENING OF EYELASHES,Eyelash hyperpigmentation,EYELASH DARKENING,EYELASH HYPERPIGMENTATION,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","LID, LASH AND LACRIMAL STRUCTURAL DISORDERS",10015919,10064122,10064121,10064122
FIRST-DEGREE ATRIOVENTRICULAR BLOCK,First degree atrioventricular block,FIRST DEGREE ATRIOVENTRICULAR BLOCK,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10016699,10003674,10016699
SEPTIC SHOCK DUE TO TOXIC BONE MARROW DAMAGE,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
TENDON REFLEXES WERE DIMINISHED,Hyporeflexia,TENDON REFLEX DECREASED,HYPOREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10043245,10021089,10043245
EOSINOPHILIA,eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
HYPOPROTEINEMIA,Hypoproteinaemia,HYPOPROTEINEMIA,HYPOPROTEINAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10021083,10021083,10021084
"ANTIBIOTIC - INDUCED PROLONGEDSEVERE CANALICULAR AND HEPATOCELLULAR CHOLESTASIS
WITH CENTRILOBULAR",Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
DYSPNEA,dyspnea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
PERSISTENT CONJUNCTIVAL INFLAMMATION AFTER GRADUAL TAPERING CORTECOSTEROIDS DOSE,conjunctivitis,CONJUNCTIVITIS,CONJUNCTIVITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10010741,10010741,10010741
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
MEDIAN FEMORAL CORTICAL EROSION,Bone erosion,CORTICAL BONE EROSION,BONE EROSION,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10051762,10051728,10051762
ALLERGY TO ASPIRIN,Drug hypersensitivity,ALLERGIC REACTION TO ANALGESICS,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10072246,10013700,10072246
ALT FLARES,Alanine aminotransferase increased,ALT FLARE UP,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10068307,10001551,10068307
ADVANCED ATHEROSCLEROTIC LESIONS,Arteriosclerosis,ATHEROSCLEROSIS,ARTERIOSCLEROSIS,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10003601,10003210,10003601
MILD ENCEPHALOPATHY,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
URTICARIAL RASH,Urticaria,URTICARIAL RASH,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046758,10046735,10046758
FOCAL NECROSIS WITH PRESENCE OF BILE IN THE CYTOPLASM OF THE HEPATOCYTES,Necrosis liver focal,NECROSIS LIVER FOCAL,HEPATIC NECROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10028868,10019692,10028868
SHE HAD BEEN TAKING SIMVASTATIN TILL 4TH MONTH OF PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MICROLITIASE BILIAR,Biliary microlithiasis,BILIARY MICROLITHIASIS,CHOLELITHIASIS,GALLBLADDER DISORDERS,CHOLECYSTITIS AND CHOLELITHIASIS,10019805,10078850,10008629,10078850
SKIN EXFOLIATION,Skin exfoliation,DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10012528,10040844,10012528
NECROTIC ESCHAR MEASURING 4CMX2CM ASSOCIATED WITH CALCIUM GLUCONATE EXTRAVASATION,necrosis skin,NECROSIS SKIN,SKIN NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10028879,10040893,10028879
HYPERURICEMIA,hyperuricemia,HYPERURICEMIA,HYPERURICAEMIA,PURINE AND PYRIMIDINE METABOLISM DISORDERS,DISORDERS OF PURINE METABOLISM,10027433,10020907,10020903,10020907
SEVERE HYPERTRIGLYCERIDEMIA-INDUCED ACUTE PANCREATITIS,Acute pancreatitis,ACUTE PANCREATITIS,PANCREATITIS ACUTE,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10000971,10033647,10000971
STUPOR,stupor,STUPOR,STUPOR,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042264,10042264,10042264
DRY SKIN,Dry skin,DRY SKIN,DRY SKIN,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10013786,10013786,10013786
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
ACCUMULATION OF MESALAZINE PILLS IN THE MEDIUM ILEUM IN A PATIENT WITH CROHN'S DISEASE,tablet clumping,TABLET CLUMPING,PRODUCT PHYSICAL ISSUE,"PRODUCT QUALITY, SUPPLY, DISTRIBUTION, MANUFACTURING AND QUALITY SYSTEM ISSUES",PRODUCT PHYSICAL ISSUES,10077536,10069257,10071134,10069257
DERMATOFIBROMA,Fibrous histiocytoma,DERMATOFIBROMA,FIBROUS HISTIOCYTOMA,CUTANEOUS NEOPLASMS BENIGN,SKIN NEOPLASMS BENIGN,10029104,10012494,10053717,10012494
OSTEOPENIC BONE DISEASE WITH MULTIPLE PATHOLOGIC FRACTURES,Pathological fracture,PATHOLOGICAL FRACTURE,PATHOLOGICAL FRACTURE,FRACTURES,FRACTURES NEC,10028395,10034156,10034156,10034156
HYPERTRANSAMINASEMIA,Hypertransaminasaemia,HYPERTRANSAMINASEMIA,HYPERTRANSAMINASAEMIA,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10068237,10068237,10068238
IMMEDIATE ALLERGIC REACTION,immediate allergic reaction,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
ALLERGIC INTERSTITIAL NEPHRITIS,nephritis interstitial,NEPHRITIS INTERSTITIAL,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029134,10048302,10029134
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
SINUS TACHYCARDIA (RATE 105-120/MIN) WITH NO OTHER ABNORMALITIES ON ECG,Sinus tachycardia,SINUS TACHYCARDIA,SINUS TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040752,10040752,10040752
"INVASIVE MUCORMYCOSIS AFFECTING VASCULATURE AS WELL AS PARENCHYMA OF HER LUNGS, BRAIN, HEART AND LIVER",mucormycosis,MUCORMYCOSIS,MUCORMYCOSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10028098,10028098,10028098
SENSORY DISTURBANCES IN BOTH LEGS ESPECIALLY AT NIGHT IN BED,Sensory disturbance,SENSORY DISTURBANCE,SENSORY DISTURBANCE,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10040026,10040026,10040026
"PATIENT WAS PRESCRIBED PREDNISONE FOR SEVERE HEPATITIS,WITHOUT IMPROVEMENT(LACK OF DRUG EFFECT)-WITH NO ADR",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DISCONTINUATION OF BOSENTAN DUE TO INEFFICIENCY,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
TRANSIENT SORENESS OF THE MOUTH,Sore mouth,SORE MOUTH,ORAL PAIN,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE PAIN AND PARAESTHESIA,10017947,10041362,10031009,10041362
CUTANEOUS ULCERATION IN LEG/ LEG ULCERATION WORSENING,skin ulcer,SKIN ULCERATION,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040947,10040943,10040947
HENOCH-SCHONLEIN PURPURA RELATED TO SPIRAMICIN WITH DIGESTIVE EXPRESSION,Henoch-Schonlein purpura,HENOCH-SCHONLEIN PURPURA,HENOCH-SCHONLEIN PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10019617,10019617,10019617
CEFATOXINE INDUCED ALLERGIC AGRANULOCYTOSIS,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
PATIENT RECEIVED INTRATHECAL THERAPY WITH METHOTREXATE 300 MG (INSTEAD OF PRESCRIBED 12 MG),wrong dose administered,WRONG DOSE ADMINISTERED,INCORRECT DOSE ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10048054,10064355,10048054
TACROLIMUS ADMINISTERED TO A 13YEAR OLDâ€,Tacrolimus administered to a 13year oldâ€,INTENTIONAL PRODUCT USE ISSUE,INTENTIONAL PRODUCT USE ISSUE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT USE ISSUES,10022117,10076308,10076308,10076308
MALAISE,malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
EXTENDED-SPECTRUM-BETA-LACTAMASE KLEBSIELLA PNEUMONIAE BACTEREMIA,Klebsiella bacteraemia,KLEBSIELLA BACTEREMIA,KLEBSIELLA BACTERAEMIA,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10058856,10058856,10058883
CORONAVIRUS INFECTION,Coronavirus test positive,CORONAVIRUS TEST POSITIVE,CORONAVIRUS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10070255,10070255,10070255
BRADYPNEA,Bradypnoea,BRADYPNEA,BRADYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10006102,10006102,10006101
POSSIBLE INTERACTION BETWEEN DRUGS WITH CHOLINOLYTIC EFFECT,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
BILATERAL AVASCULAR NECROSIS OF THE FEMORAL HEADS FOLLWING PARADOXICAL EMBOLISM CASUSED BY COAGULOPATHY,Osteonecrosis,AVASCULAR NECROSIS FEMORAL HEAD,OSTEONECROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10003860,10031264,10003860
BILATERAL EXTRAPYRAMIDAL HYPERTONIA,Hypertonia,HYPERTONIA,HYPERTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10020852,10020852,10020852
SYMPTOMS OF ORTHOSTATIC HYPOTENSION AND BRADYCARDIA WERE AGGRAVATED BY RIVASTIGMINE,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
CARDIOMYOPATHY,Cardiomyopathy,CARDIOMYOPATHY,CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10007636,10007636,10007636
ALT INCREASED (200 IU),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
NO POSITIVE RESPONSE SHOWN TO THIS INITIAL PHASE OF TREATMENT,Therapy non-responder,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
CEREBRAL MASS EFFECT,Intracranial mass,CEREBRAL MASS EFFECT,INTRACRANIAL MASS,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10067086,10077667,10067086
ATRIAL FIBRILLATION WITH CONTROLLED VENTRICULAR FIBRILLATION,Atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
PATIENT HAD IRREGULAR COMPLIANCE WITH HYDROXYCHLOROQUINE SULFATE,Inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
ADRENAL SUPPRESSION,adrenal suppression,ADRENAL SUPPRESSION,ADRENAL SUPPRESSION,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001382,10001382,10001382
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
NUMBNESS,Numbness,NUMBNESS,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10029829,10020937,10029829
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
SYMPTOMATIC TERTIARY ADRENAL INSUFFICIENCY AS A RESULT OF ABRUPT DISCONTINUATION  OF  LONG-TERM  USE  OF  TOPICAL  CORTICOSTEROIDS,adrenal insufficiency,ADRENAL INSUFFICIENCY,ADRENAL INSUFFICIENCY,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001367,10001367,10001367
LUNG INFECTION,Lung infection,LUNG INFECTION,LUNG INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10061229,10061229,10061229
CHRONIC ALLOGRAFT DYSFUNCTION DUE TO BK VIRUS NEPHROPATHY,Complications of transplanted kidney,KIDNEY GRAFT DYSFUNCTION,COMPLICATIONS OF TRANSPLANTED KIDNEY,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10051366,10010185,10051366
ELEVATED LIVER ENZYMES,Hepatic enzyme increased,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
ACCIDENTAL OVERDOSE WITH MULTIPLE DRUGS WHICH WAS SUGGESTIVE OF TOXICITY,Multiple drug overdose accidental,MULTIPLE DRUG OVERDOSE ACCIDENTAL,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10062763,10000381,10062763
REFRACTORY TO IVIG AND METHYLPREDNISOLONE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
EVENT BEHAVIORAL DEPENDENCE CRITERIA OF GABAPENTINOIDS,Drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
FETAL GROWTH RESTRICTION,Fetal growth restriction,FETAL GROWTH RESTRICTION,FOETAL GROWTH RESTRICTION,FOETAL COMPLICATIONS,FOETAL GROWTH COMPLICATIONS,10036585,10070532,10070531,10070532
PARANOID DELUSIONS ASSOCIATED VISUAL AND AUDITORY HALLUCINATIONS SPIKED UP,Paranoid delusions,PARANOID DELUSIONS,DELUSION,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10033867,10012239,10033867
RASH,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
NECROTIZING IMMUNE-MEDIATED MYOPATHY ASSOCIATED WITH STATINS,Immune-mediated necrotising myopathy,IMMUNE-MEDIATED NECROTISING MYOPATHY,IMMUNE-MEDIATED NECROTISING MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10072155,10072155,10072155
WORSENING OF THE ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
ALLERGIC SKIN RASH WITH EOSINOPHILIA,Allergic rash,ALLERGIC RASH,DERMATITIS ALLERGIC,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10001717,10012434,10001717
CEFTAZIDIME INDUCED ACUTE INTERSTITIAL NEPHRITIS,Tubulointerstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029135,10048302,10000819
STROKE,Stroke,STROKE,CEREBROVASCULAR ACCIDENT,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10042244,10008190,10042244
"EXPOSURE TO CYAMEMAZINE, LAMOTRIGINE, LOXAPINE, MIANSERIN, PROPRANOLOL AND VENLAFAXINE VIA TRANSPLANT",Exposure via transplant,EXPOSURE VIA TRANSPLANT,EXPOSURE VIA TRANSPLANT,"EXPOSURES, CHEMICAL INJURIES AND POISONING",PATHWAYS AND SOURCES OF EXPOSURE,10022117,10079736,10079736,10079736
ESCHERICHIA COLI SEPSIS,Escherichia sepsis,ESCHERICHIA SEPSIS,ESCHERICHIA SEPSIS,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10015296,10015296,10015296
ZOLEDRONIC ACID-RELATED FANCONI SYNDROME,Fanconi syndrome,FANCONI SYNDROME,FANCONI SYNDROME,RENAL AND URINARY TRACT DISORDERS CONGENITAL,RENAL DISORDERS CONGENITAL,10010331,10016219,10016219,10016219
BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
"EVEN AFTER ADEQUATE TRIAL OF TWO MOOD STABILIZERS FROM DIFFERENT CLASSES INCLUDING LITHIUM, PATIENT NEITHER",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CONGESTIVE LIVER,Hepatic congestion,HEPATIC CONGESTION,HEPATIC CONGESTION,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019645,10019645,10019645
THROMBOPENIA,thrombopenia,THROMBOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043569,10043554,10043569
MULTIPLE DRUG OVERDOSE INTENTIONAL,Intentional overdose,MULTIPLE DRUG OVERDOSE INTENTIONAL,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10062764,10022523,10062764
DECOMPENSATED DIABETES,decompensated diabetes,DECOMPENSATED DIABETES,DIABETIC METABOLIC DECOMPENSATION,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEC,10027433,10079504,10074309,10079504
SWALLOWING DISORDER,Swallowing disorder,SWALLOWING DISORDER,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10042646,10013950,10042646
MACROSCOPIC HEMATURIA,macroscopic hematuria,MACROSCOPIC HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10059823,10018867,10059823
NEUROLOGIC DAMAGE,Nervous system disorder,NEUROLOGICAL IMPAIRMENT,NERVOUS SYSTEM DISORDER,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10074237,10029202,10074237
ITCHY AND BURNING AREAS ON THE FACE,Burning sensation in face,BURNING SENSATION IN FACE,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10006787,10006784,10006787
MOTOR AXONAL POLYNEUROPATHY,Polyneuropathy,POLYNEUROPATHY,POLYNEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10036105,10036105,10036105
CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
AST AND PROTHROMBIN PERCENT DID NOT IMPROVE ALLTHOUGH SERUM LEVEL OF T-BIL WAS DECREASED,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
ATYPICAL RIGHT BRONCHOPNEUMONIA,Pneumonia,BRONCHOPNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10006469,10035664,10006469
AGRANULOCYTOSIS DUE TO PNEUMONIA,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
PRIMARY RESISTANCE TO IMATINIB,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
HEMATURIA,Haematuria,HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018867,10018867,10019450
FASTING GLYCAEMIA MEASURED BY THE PATIENT AT HOME VARIED FROM 112 TO 163 MG/DL,Fasting blood glucose increased,FASTING BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10050786,10005557,10050786
BITING OF TOUNGUE,Tongue biting,TONGUE BITING,TONGUE BITING,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10050467,10050467,10050467
LIGHT-HEADEDNESS,light-headedness,LIGHTHEADEDNESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10024492,10013573,10024492
PATIENT COULD NOT TOLERATE A DOSE INCREASE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
DYSPNOEA,dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
SINGLE EROSION DUODENUM,Erosive duodenitis,DUODENAL EROSION,EROSIVE DUODENITIS,GASTROINTESTINAL ULCERATION AND PERFORATION,DUODENAL ULCERS AND PERFORATION,10017947,10013827,10062532,10013826
PRETERM BIRTH (AT 32 WEEK GESTATION),Premature baby,PREMATURE BIRTH,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036590,10036590,10036594
LISTERIAL MENINGOENCEPHALITIS,Listeria monocytogenes infection,LISTERIA MONOCYTOGENES INFECTION,LISTERIOSIS,BACTERIAL INFECTIOUS DISORDERS,LISTERIA INFECTIONS,10021881,10024640,10024641,10024640
ACUTE KIDNEY INJURY,acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
METFORMIN-INDUCED LACTIC ACIDOSIS (LACTATE LEVEL 11.57 MMOL/L),Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
ANAPHYLAXIS,Anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
COMA,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
"HE REMAINED HYPOTENSIVE DESPITE DOPAMINE, EPINEPHRINE, AND NOREPINEPHRINE (LACK OF DRUG EFFECT WITH NO ADR)",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LACTATES AT 11.63 MMOL/L FOLOWING OVERDOSE,Blood lactic acid increased,LACTATE INCREASED,BLOOD LACTIC ACID INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10023660,10005635,10023660
LACK OF SLEEP AFFECTED THE PATIENT'S MOOD,Depressed mood,DEPRESSED MOOD,DEPRESSED MOOD,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10012374,10012374,10012374
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
SEVERE HYPERSENSITIVITY REACTION,Hypersensitivity,HYPERSENSITIVITY REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020756,10020751,10020756
PHILADELPHIA CHROMOSOME (PH) INDEPEDENT CLONAL CHANGES/ABERRATION,Cytogenetic abnormality,CHROMOSOME ABNORMALITY,CYTOGENETIC ABNORMALITY,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,CHROMOSOMAL ABNORMALITIES NEC,10010331,10008815,10067477,10008815
APLASIA,bone marrow depression,BONE MARROW DEPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10005986
LEFT SIDED HEMIPLEGIA,left hemiplegia,LEFT HEMIPLEGIA,HEMIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10024108,10019468,10024108
LOSS OF APPETITE,Appetite lost,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
DUODENAL ULCER HEMORRHAGIC (HEMORRHAGIC ULCER IN THE BULBOUS REGION OF THE DUODENUM),Duodenal ulcer haemorrhage,DUODENAL ULCER HEMORRHAGIC,DUODENAL ULCER HAEMORRHAGE,GASTROINTESTINAL ULCERATION AND PERFORATION,DUODENAL ULCERS AND PERFORATION,10017947,10013839,10013839,10013847
AN INHIBITORY AUTOANTIBODY TO COAGULATION FACTOR VIII,Autoantibody positive,AUTOANTIBODY POSITIVE,AUTOANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10060973,10060973,10060973
UNRESPONSIVENESS,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
IRRITABILITY,Irritability,IRRITABILITY,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10022998,10022998,10022998
ANTIPSYCHOTIC-INDUCED STUTTERING PRIAPISM,priapism,PRIAPISM,PRIAPISM,SEXUAL FUNCTION AND FERTILITY DISORDERS,ERECTION AND EJACULATION CONDITIONS AND DISORDERS,10038604,10036661,10036661,10036661
TOOK 300 TABLETS OF ACETYLSALICYLIC ACID,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
EDEMA NOTED IN THE BILATERAL PARIETAL AND OCCIPITAL LOBES,edema noted in the bilateral parietal and occipital lobes,EDEMA NOS,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014234,10030095,10014234
PULMONARY MICROASPIRATION,Aspiration pleural cavity,ASPIRATION PLEURAL CAVITY,ASPIRATION PLEURAL CAVITY,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC HISTOPATHOLOGY PROCEDURES,10022891,10003522,10003522,10003522
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
HEPATIC CYTOLYSIS FOLLOWING ACUTE RENAL FAILURE RESULTING IN METHOTREXATE OVEREXPOSURE,hepatic cytolysis,HEPATIC CYTOLYSIS,HEPATOCELLULAR INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10049199,10019837,10049199
REOCCURRENCE OF DISORDERS,Muscle stiffness,MUSCLE STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10028339,10052904,10028339
LACK OF DRUG EFFECT IN OFF LABEL TREATMENT OF HEREDITARY ANGIOEDEMA DURING PREGNANCY,Hereditary angioedema,HEREDITARY ANGIOEDEMA,HEREDITARY ANGIOEDEMA,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10019860,10019860,10019860
INABILITY OF SWALLOWING,Unable to swallow,UNABLE TO SWALLOW,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10075917,10013950,10075917
ANGIOEDEMA,Angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
HAEMATEMESIS,Haematemesis,HAEMATEMESIS,HAEMATEMESIS,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018830,10018830,10018830
DRUG INTOXICATION,drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
INTRACEREBRAL HAEMORRHAGE,Cerebral haemorrhage,INTRACEREBRAL HAEMORRHAGE,CEREBRAL HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10022737,10008111,10022753
HYPOGLYCEMIA,hypoglycemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10021005,10020993,10021005
STEROID INDUCED OSTEOPOROSIS,Osteoporosis,OSTEOPOROSIS STEROID-INDUCED,OSTEOPOROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10031287,10031282,10031287
DIPLOPIA,Diplopia,DIPLOPIA,DIPLOPIA,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10013036,10013036,10013036
SIGNIFICANTLY INCREASED AND PROLONGED MENSTRUAL BLEEDING,Menses irregular with excessive bleeding,MENSES IRREGULAR WITH EXCESSIVE BLEEDING,MENOMETRORRHAGIA,MENSTRUAL CYCLE AND UTERINE BLEEDING DISORDERS,MENSTRUATION WITH INCREASED BLEEDING,10038604,10027318,10027295,10027318
HEMODYNAMIC FAILURE FOLLOWING ACUTE ANEMIA,Hemodynamic instability,HEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10058270,10052076,10058270
"AMPICILLIN AND GENTAMICIN WERE PRESCRIBED FOR CHORIOAMNIONITIS (DRUG EXPOSURE DURING PREGNANCY, SECOND TRIMESTER WITH NO ADR)",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, SECOND TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076616,10073513,10076616
SUBCUTANEOUS PHAEOHYPHOMYCOSIS,Fungal infection,MYCOSIS,FUNGAL INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10067330,10017533,10067330
HISTORY OF TONIC-CLONIC SEIZURES AND MIGRAINE HEADACHES ON METOPROLOL FOR PROPHYLAXIS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DISTICHIASIS,distichiasis,DISTICHIASIS,DISTICHIASIS,EYE DISORDERS CONGENITAL,EYELID DISORDERS CONGENITAL,10010331,10066128,10066128,10066128
ANOREXIA,Decreased appetite,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10002646
AMIODARONE-INDUCED THYROTOXICOSIS,Hyperthyroidism,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
"OVERDOSED FROM A COMBINATION OF MULTIPLE MEDICATIONS INCLUDING SALICYLATE, ACETAZOLAMIDE, AND NORTRIPTYLINE",drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
AMIODARONE ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
SEVERE DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
PALLOR,Pallor,PALLOR,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033546,10033546,10033546
"ADMINISTRATION OF INSULIN FROM 7 MONTHS GESTATATION (DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER)-WITH NO ADR",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
COMPLEX FOCAL SEIZURE,Partial seizures,FOCAL SEIZURES,PARTIAL SEIZURES,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10016843,10061334,10016843
ANCA ASSOCIATED VASCULITIS DUE TO ESCHERICHIA COLI INFECTION,Anti-neutrophil cytoplasmic antibody positive vasculitis,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,IMMUNE DISORDERS NEC,VASCULITIDES,10021428,10050894,10050894,10050894
DRY COUGH,Cough,DRY COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10013773,10011224,10013773
PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
IRON DEFICIENCY ANEMIA,Iron deficiency anaemia,IRON DEFICIENCY ANEMIA,IRON DEFICIENCY ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIA DEFICIENCIES,10005329,10022972,10022972,10022974
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
JUVENILE MYELOMONOCYTIC LEUKEMIA,juvenile chronic myelomonocytic leukemia,JUVENILE CHRONIC MYELOMONOCYTIC LEUKEMIA,JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS CHRONIC MYELOID,10029104,10054439,10023249,10054439
WORSENING LEFT SIDED CHEST PAIN,chest pain aggravated,CHEST PAIN AGGRAVATED,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10048413,10008479,10048413
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
BRAIN DEAD,Brain death,BRAIN DEATH,BRAIN DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10049054,10049054,10049054
SUBCONVULSIVE WITH INCREASED MUSCLE TONE IN ALL LIMBS,Hypertonia,INCREASED MUSCLE TONE,HYPERTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10020852,10020852,10021670
CYANOSIS OF BOTH THE UPPER LIMBS,cyanosis of both the upper limbs,CYANOSIS,CYANOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10011703,10011703,10011703
SUICIDE ATTEMPT,Suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
PATIENT HAD NOT BEEN TAKING MEDICATIONS REGULARLY (DRUG MISUSE)/INTENTIONAL DOSE OMISSION,Intentional dose omission,INTENTIONAL DOSE OMISSION,INTENTIONAL DOSE OMISSION,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT USE ISSUES,10022117,10079221,10079221,10079221
FREQUENT MOOD SWINGS,Mood swings,MOOD SWINGS,MOOD SWINGS,MOOD DISORDERS AND DISTURBANCES NEC,FLUCTUATING MOOD SYMPTOMS,10037175,10027951,10027951,10027951
CYTOMEGALOVIRUS INFECTION,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011831,10011831,10011831
"BETTER GLYCEMIC CONTROL, IMPROVEMENT OF LIVER FUNCTION",Therapeutic response unexpected,UNEXPECTED THERAPEUTIC DRUG EFFECT,THERAPEUTIC RESPONSE UNEXPECTED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10052807,10043417,10052807
RENAL FAILURE,renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
PLASMA CREATININE 512 UMO1/1,Blood creatinine increased,PLASMA CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10035278,10005483,10035278
MINERALOCORTICOID-RESPONSIVE HYPONATREMIA OF THE ELDERLY (SODIUM LEVELS 110 MEQ/L),Hyponatraemia,HYPONATREMIA AGGRAVATED,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10048375,10021036,10054430
CNS IMAGING REVEALED AN INFARCT IN LEFT FRONTAL LOBE,infarct cerebral,INFARCT CEREBRAL,CEREBRAL INFARCTION,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10021755,10008118,10021755
SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
KAPOSI SARCOMA- ASSOCIATED HERPESVIRUS 8 WITH GUT INVOLVEMENT,Kaposi's sarcoma,KAPOSI'S SARCOMA,KAPOSI'S SARCOMA,SOFT TISSUE NEOPLASMS MALIGNANT AND UNSPECIFIED,KAPOSI'S SARCOMAS,10029104,10023284,10023284,10023284
TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
ULCERATIVE COLITIS,Ulcerative colitis,ULCERATIVE COLITIS,COLITIS ULCERATIVE,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10045365,10009900,10045365
VISUAL DISTURBANCE,Visual impairment,VISUAL DISTURBANCE,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047543,10047571,10047543
LOW DOSE ASPIRIN GIVEN FOR SLE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NEUROPATHIC PAIN IN LEGS AND FEET,neuropathic pain,NEUROPATHIC PAIN,NEURALGIA,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10054095,10029223,10054095
ANURIA,anuria,ANURIA,ANURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10002847,10002847,10002847
CEFEPIME TROUGH WAS 100.68 MCG/ML,drug trough level,DRUG TROUGH LEVEL,DRUG TROUGH LEVEL,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10080597,10080597,10080597
DRUG INDUCED PANCREATITIS,Pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
NONRESPONSE TO INDUCTION WITH CYCLOPHOSPHAMIDE,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
REBOUND EFFECT,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
NEPHROTOXICITY FOLLOWING INCREASED GENTAMICIN CONCENTRATION IN THE BODY,Nephropathy toxic,NEPHROTOXICITY,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10067571
GENERALIZED TOXICODERMA,Toxic skin eruption,TOXICODERMA,TOXIC SKIN ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10044259,10057970,10044259
ILEUS PARALYTIC,Ileus paralytic,ILEUS PARALYTIC,ILEUS PARALYTIC,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,NON-MECHANICAL ILEUS,10017947,10021333,10021333,10021333
SEVERE HYPONATREMIA ASSOCIATED WITH MOXIFLOXACIN (123-127 MMOL/L),Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
INVASIVE CANDIDIASIS,invasive candidiasis,INVASIVE CANDIDIASIS,SYSTEMIC CANDIDA,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10064954,10042938,10064954
GROUND GLASS OPACITIES IN THE SUPERIOR LOBES OF BOTH LUNGS,ground glass opacities in the superior lobes of both lungs,GROUND GLASS OPACITY IN THORACIC CT,COMPUTERISED TOMOGRAM THORAX ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10072879,10057799,10072879
STILL DEVELOPING NEW BULLAE ON ATTEMPTED PREDNISOLONE REDUCTION (REBOUND EFFECT),Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
COORDINATION DISTURBANCE,Coordination abnormal,COORDINATION DISTURBANCE,COORDINATION ABNORMAL,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10010949,10010947,10010949
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
URINARY RETENTION OF URINARY TRACT,Urinary retention,URINARY RETENTION,URINARY RETENTION,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046555,10046555,10046555
KIDNEY DAMAGE,Renal disorder,KIDNEY DISORDER,RENAL DISORDER,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL DISORDERS NEC,10038359,10038428,10038428,10051052
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
CHOLESTASIS,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
MILD PATCHY TUBULAR ATROPHY,Renal tubular atrophy,RENAL TUBULAR ATROPHY,RENAL TUBULAR ATROPHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10038536,10038536,10038536
BLOOD CLOT ADHERENT TO THE BOWEL,clot blood,CLOT BLOOD,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10009667,10043607,10009667
PILOTâ€™S INABILITY TO MAINTAIN CONTROL OF THE AIRPLANE,Performance status decreased,PERFORMANCE STATUS DECREASED,PERFORMANCE STATUS DECREASED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10048919,10048919,10048919
VERY ANGRY,Anger,ANGER,ANGER,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10002368,10002368,10002368
OMEPRAZOLE GIVEN FOR RECURRENT ABDOMINAL PAIN,Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
DIRECT BILIRUBIN INCREASED (21 MICROMOL/L),Bilirubin conjugated increased,DIRECT BILIRUBIN INCREASED,BILIRUBIN CONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10013038,10004685,10013038
SUSPICIOUS,Suspiciousness,SUSPICIOUSNESS,SUSPICIOUSNESS,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10042635,10042635,10042635
ADRENAL INSUFFICIENCY PRECIPITATED BY ADMINISTRATION OF LEVOTHYROXINE SODIUM LEADING TO METABOLIC ACIDOSIS AND CIRCULATORY COLLAPSE,Adrenal insufficiency,ADRENAL INSUFFICIENCY,ADRENAL INSUFFICIENCY,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001367,10001367,10001367
PATIENT TREATED WITH PREDNISOLONE FOR COXSACKIEVIRUS A4 INFECTION (OFF LABELUSE) WITH NO ADVERSE EVENTS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
IGM LEVEL INCREASED TO 10300 MG/DL,Blood immunoglobulin M increased,IGM INCREASED,BLOOD IMMUNOGLOBULIN M INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10021278,10005601,10021278
DISSEMINATED ZOSTER FOLLOWING PATIENT HAD STOPPED MEDICATION ON HIS OWN (NON COMPLIANCE),Herpes zoster disseminated,HERPES ZOSTER DISSEMINATED,HERPES ZOSTER DISSEMINATED,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10065038,10065038,10065038
ERYTHEMA OF FACE,Erythema,ERYTHEMA FACIAL,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015212,10015150,10015212
BULLAE,Blister,BULLAE,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006554,10005191,10006554
CRUSTED LESIONS ON THE SCALP,crust,CRUST,SCAB,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10011468,10039509,10011468
FETAL VALPROATE SYNDROME,Foetal anticonvulsant syndrome,FETAL VALPROATE SYNDROME,FOETAL ANTICONVULSANT SYNDROME,CONGENITAL AND HEREDITARY DISORDERS NEC,CHEMICALLY-INDUCED CONGENITAL SYNDROMES,10010331,10016870,10066485,10016524
TYPICAL SYMPTOMS OF DEPRESSIVE DISORDER,depressive disorder,DEPRESSIVE DISORDER,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012399,10012378,10012399
SEVERE HYPOGLYCEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
"HER INR THE EVENING PRIOR TO HEMATOMA EVACUATION WAS 1.9,",International normalised ratio increased,INR INCREASED,INTERNATIONAL NORMALISED RATIO INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10022402,10022595,10022402
EDEMA LEGS,Oedema peripheral,EDEMA LEGS,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030109,10030124,10014230
BREATHLESSNESS,Dyspnoea,BREATHLESSNESS,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10006345
SIGNIFICANT LIVER AND SPLEEN ENLARGEMENT,Hepatomegaly,LIVER ENLARGEMENT,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10024676
BRADYCARDIA WAS DEEMED SECONDARY TO DILTIAZEM/SYMPTOMATIC BRADYCARDIA,bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
NON-COMPLIANCE WITH THE POSOLOGY DUE TO ABUNDANT MEDICATION,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
DISEASE PROGRESSION OF PRE-EXISTING CANCER,Malignant neoplasm progression,PROGRESSION OF PRE-EXISTING CANCER,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10057096,10051398,10057096
NECK STIFFNESS,neck stiffness,NECK STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10028843,10052904,10028843
SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
BUN 195 MG/DL,Blood urea increased,BUN INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10006576,10005851,10006576
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
RESPIRATORY DEPRESSION,Respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
HEPATOTOXICITY,hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
BILATERAL PLEURAL EFFUSION,Pleural effusion,BILATERAL PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10078037,10035598,10078037
VOMITTING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
UNABLE TO WALK,Gait inability,UNABLE TO WALK,GAIT INABILITY,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017581,10017581,10049278
GRADE 2 WBC AND PLT DEFICIENCIES,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
EXCESSIVE WEIGHT GAIN (8 KGS IN 12 MONTHS),Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
AUDITORY HALLUCINATION,"Hallucination, auditory","HALLUCINATION, AUDITORY","HALLUCINATION, AUDITORY",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019070,10019070,10019070
UPPER RESPIRATORY INFECTION PROBABLY VIRAL (NOT CONFIRMED),Upper respiratory infection probably viral (not confirmed),VIRAL UPPER RESPIRATORY TRACT INFECTION,VIRAL UPPER RESPIRATORY TRACT INFECTION,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10047482,10047482,10047482
THREAT OF PRETERM BIRTH,Premature birth,PREMATURE BIRTH,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036594,10036590,10036594
 potential,2018-06-21 00:00:00,1,,,,INTERACTIONS,10013710,10013710,
ARCHED EYEBROWS,arched eyebrows,EYE ABNORMALITY,EYE DISORDER,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10015903,10015916,10015903
SEVERE PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
PLATELET COUNT DECREASED (40 X 10E9/L),Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
POOR COMPLIANCE,treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
ELEVATED D-DIMER,Fibrin D dimer increased,FIBRIN D DIMER INCREASED,FIBRIN D DIMER INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10016581,10016581,10016581
ITCHY PALMS AND FEET,Extremities itchy sensation of,EXTREMITIES ITCHY SENSATION OF,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10015886,10037087,10015886
ULCERATIVE COLITIS,Colitis ulcerative,ULCERATIVE COLITIS,COLITIS ULCERATIVE,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009900,10009900,10045365
DM CONTROL WAS POOR (HEMOGLOBIN A1C 9-10%) UNDER INTENSIVE CONVENTIONAL INSULIN THERAPY,Diabetes mellitus inadequate control,DIABETES MELLITUS INADEQUATE CONTROL,DIABETES MELLITUS INADEQUATE CONTROL,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012607,10012607,10012607
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
SEPSIS FROM SKIN AND SOFT TISSUE,sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
FEVER (38.0 DEGREE CELSIUS),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
TREATMENT FAILURE OF TRIPLET THERAPY (WITH NO ADR),Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
CEREBRAL MICRO BLEEDS,Cerebral microbleeding,CEREBRAL MICROBLEEDING,CEREBRAL MICROHAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS NEC,10029205,10071798,10067277,10071798
ECLAMPSIA,Eclampsia,ECLAMPSIA,ECLAMPSIA,MATERNAL COMPLICATIONS OF PREGNANCY,HYPERTENSION ASSOCIATED DISORDERS OF PREGNANCY,10036585,10014129,10014129,10014129
OFTEN LIP SWELLING,Lip swelling,LIP SWELLING,LIP SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10024570,10024570,10024570
ACUTE MUCOSITIS,mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
OXALIPLATIN INDUCED HEPATIC SINUSOIDAL OBSTRUCTION SYNDROME (HSOS),Venoocclusive liver disease,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
LACK OF EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
"DESPITE COMPLETE DISAPPEARANCE OF THE ER PATTERN WITH HYDROQUINIDINE THERAPY (300 MG THRICE DAILY), THE TEENAGER STILL SUFFERED RECURRENT LIFE-THREATENING VENTRICULAR ARRHYTHMIA EPISODES",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
NEUROPATHY,Neuropathy,NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029328,10029331,10029328
POSITIVE KUSSMAUL'S SIGN,positive Kussmaul's sign,POSITIVE KUSSMAUL'S SIGN,BLOOD PRESSURE SYSTOLIC INSPIRATORY DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10036213,10005761,10036213
MALIGNANT NEOPLASM PROGRESSION,Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
MASSIVE INTRACRANIAL HEMORRHAGE,intracranial hemorrhage,INTRACRANIAL HEMORRHAGE,HAEMORRHAGE INTRACRANIAL,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10022763,10018985,10022763
"PAPULOPUSTULAR ERUPTION, PAPULOPUSTULAR RASH",rash pustular,RASH PUSTULAR,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037888,10037888,10037888
POLYDIPSIA,polydipsis,POLYDIPSIA,POLYDIPSIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,FLUID INTAKE INCREASED,10027433,10036067,10036067,10036067
WEIGHT GAIN,Weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
DEVELOPED ANTI-DRUG ANTIBODIES TO CERTOLIZUMAB,Drug specific antibody present,DRUG SPECIFIC ANTIBODY PRESENT,DRUG SPECIFIC ANTIBODY PRESENT,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013745,10013745,10013745
MARKED TREMOR,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
VITAMIN,Vitamin,VITAMIN C,VITAMIN C,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",VITAMIN ANALYSES,10022891,10047620,10047620,10047620
DRESS SYNDROME,Dress syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
HYPOPHOSPHATEMIA,hypophosphatemia,HYPOPHOSPHATEMIA,HYPOPHOSPHATAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",PHOSPHORUS METABOLISM DISORDERS,10027433,10021059,10021058,10021059
TSH VALUES ROSE ERRONEOUSLY DUE TO INTERFERENCE BY EXOGENOUS BIOTIN THUS CONFUSING AND COMPLICATING THE CLINICAL PICTURE,False positive laboratory result,FALSE POSITIVE LABORATORY RESULT,FALSE POSITIVE INVESTIGATION RESULT,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",INVESTIGATIONS NEC,10022891,10056669,10070748,10056669
"BLISTERS OF THE LATERAL TONGUE, ORAL MUCOSA, LIPS AND SCROTUM","blisters of the lateral tongue, oral mucosa, lips and scrotum",BLISTERS,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005216,10005191,10005216
OEDEMA DETEORATED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
SHE CAME TO THE EMERGENCY ROOM COMPLAINING OF MELENA AFTER FOUR DAYS OF TREATMENT WITH ENOXAPARIN,Melaena,MELENA,MELAENA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10027141,10027141,10027162
PATIENT WAS TREATED WITH MYCOPHENOLATE FOR TREATMENT OF AUTOIMMUNE ENCEPHALOPATHY WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
MILD FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
BLOODY DIARRHEA,bloody diarrhea,BLOODY DIARRHEA,DIARRHOEA HAEMORRHAGIC,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10005872,10012741,10005872
MOOD FLUCTUATIONS,Mood swings,MOOD SWINGS,MOOD SWINGS,MOOD DISORDERS AND DISTURBANCES NEC,FLUCTUATING MOOD SYMPTOMS,10037175,10027951,10027951,10027951
HYPOKALEMIA,hypokalemia,HYPOKALEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021018,10021015,10021018
PROLONGED DIARRHEA LASTING FOR ONE MONTH,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
SUPERFICIAL KERATITIS,Keratitis,KERATITIS SUPERFICIAL,KERATITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CORNEAL INFECTIONS, OEDEMAS AND INFLAMMATIONS",10015919,10023341,10023332,10023341
SLIGHT ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
TACHYPNEIC,Tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
MAJOR DISTURBANCE OF CONSCIOUSNESS,Consciousness disturbed,CONSCIOUSNESS DISTURBED,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010770,10001854,10010770
SKIN LESIONS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
HYPOTHERMIA,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
PROGRESSION OF ACUTE MYELOID LEUKEMIA FOLLOWING LACK OF DRUG EFFECT OF FLUDARABINE CYTARABINE AND TOPOTECAN AS INDUCTION THERAPY,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
EYELID AND PERIORAL MYOCLONIA,myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
HYPOCALCEMIA (6 MG/DL),Hypocalcaemia,HYPOCALCEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020947,10020947,10020949
RENAL AGENESIS,Renal agenesis,RENAL AGENESIS,RENAL APLASIA,RENAL AND URINARY TRACT DISORDERS CONGENITAL,RENAL DISORDERS CONGENITAL,10010331,10038354,10064655,10038354
RESISTANCE TO BOTH DABIGATRAN AND WARFARIN,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
CUTANEOUS LESIONS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
SLIGHTLY ELEVATION OF CREATININE,Creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
DISEASE PROGRESSION (PROGRESSION IN LYMPH NODES ON BOTH SIDES - METASTASIS OF LUNG ADENOCARCINOMA),Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
"MICRODONTIA WAS FOUND IN TEETH 34, 35, 37, 44, 45, 47 AND 48",Tooth malformation,ANOMALY TEETH,TOOTH MALFORMATION,DENTAL AND GINGIVAL CONDITIONS,DENTAL DEVELOPMENTAL DISORDERS AND ANOMALIES,10017947,10002636,10044046,10002636
WITNESSED SYNCOPAL EPISODE AT HOME,syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
PERSISTENT THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
BIOLOGICAL INFLAMMATORY SYNDROME,Systemic inflammatory response syndrome,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10051379,10051379,10051379
BLADDER MUCOSA SEVERE INFLAMMATION WITH CYTOPATHIC CHANGES,Mucosal inflammation,MUCOSAL INFLAMMATION,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028116,10028116,10028116
AMYLASE INCREASED (MORE THAN 500U/L),Amylase increased,AMYLASE INCREASED,AMYLASE INCREASED,GASTROINTESTINAL INVESTIGATIONS,DIGESTIVE ENZYMES,10022891,10002016,10002016,10002016
WORSENING WAS PREDOMINANTLY SENSORY AND MOTOR DYSFUNCTION ON THE LEFT SIDE/MARKED SENSORY DYSFUNCTION IN THE LOWER LIMBS,sensory abnormality of lower extremities,SENSORY ABNORMALITY OF LOWER EXTREMITIES,SENSORY DISTURBANCE,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10040022,10040026,10040022
SLIGHT LEUCOCYTOSIS,leucocytosis,LEUCOCYTOSIS NOS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024279,10024378,10024279
CARCINOMA OF DESCENDING COLON,Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
ERYTHEMATOUS TO VIOLACEOUS PLAQUE,erythematous to violaceous plaque,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
CORTICOSUBCORTICAL ATROPHY,atrophy,ATROPHY,ATROPHY,TISSUE DISORDERS NEC,TROPHIC DISORDERS,10018065,10003694,10003694,10003694
CRAMPS IN THE CALF MUSCLES,muscle cramps,MUSCLE CRAMPS,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028295,10028334,10028295
"HEMOSTASIS WAS IMPAIRED, WHICH COULD RESULT FROM THE FACT THAT DUAL ANTIPLATELET THERAPY HAD BEEN IMPLEMENTED",Haemorrhagic disorder,HAEMORRHAGE ABNORMAL,HAEMORRHAGIC DISORDER,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),BLEEDING TENDENCIES,10005329,10018967,10019009,10018967
RESPONSE LOSS/FAILURE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
GENERAL DISCOMFORT,Discomfort,GENERAL DISCOMFORT,DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10018064,10013082,10018064
"ERYTHEMATOUS TO VIOLACEOUS PATCHES AND PLAQUES ON THE FACE, BOTH EARS, RIGHT AXILLA, ABDOMEN, DISTAL FINGERS,",erythematous eruption,ERYTHEMATOUS ERUPTION,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015241,10037855,10015241
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
BILATERAL REFRACTIVE VISUAL ERROR,Visual disturbances,VISUAL DISTURBANCES,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047545,10047571,10047545
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
MULTIPLE BILATERAL PARENCHYMAL HEMORRHAGIC FOCI,Cerebral hemorrhage,CEREBRAL HEMORRHAGE,CEREBRAL HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008114,10008111,10008114
SQUAMOUS CELL CARCINOMA FOLLOWING CHRONIC TOXICITY WITH VORICONAZOLE,Squamous cell carcinoma,SQUAMOUS CELL CARCINOMA,SQUAMOUS CELL CARCINOMA,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10041823,10041823,10041823
"BONE MARROW FAILURE DUE TO METHOTREXATE GIVEN IN ERROR (INSTEAD OF MEDROXYPROGESTERONE ACETATE, DRUG DISPENSING ERROR)",bone marrow failure,BONE MARROW FAILURE,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10065553,10065553,10065553
CHOLESTATIC HEPATITIS,Hepatitis cholestatic,CHOLESTATIC HEPATITIS,HEPATITIS CHOLESTATIC,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10019754,10019754,10008639
HEALING METACARPAL FRACTURES,fractured metacarpal,FRACTURED METACARPAL,HAND FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10017297,10019114,10017297
PSYCHOTROPIC DRUG INTOLERANCE,Drug Intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
MUSCLE CRAMPS,Muscle cramps,MUSCLE CRAMPS,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028295,10028334,10028295
NECK STIFFNESS,neck stiffness,NECK STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10028843,10052904,10028843
IMPETIGO CONTAGIOSA/SKIN SWABS WERE POSITIVE FOR PENICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS,Staphylococcal impetigo,STAPHYLOCOCCUS AUREUS IMPETIGO,STAPHYLOCOCCAL IMPETIGO,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10041939,10041923,10041939
GRADE 3 OESOPHAGITIS,Oesophagitis,OESOPHAGITIS,OESOPHAGITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,OESOPHAGITIS (EXCL INFECTIVE),10017947,10030216,10030216,10030216
SENSORY NEUROPATHY,Sensory neuropathy,SENSORY NEUROPATHY,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10062975,10034620,10062975
TOTAL BILIRUBIN WAS ELEVATED TO 6.1,bilirubin elevated,BILIRUBIN ELEVATED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10004688,10005364,10004688
RUPTURE OF ACHILLES TENDON,Tendon achilles rupture of,TENDON ACHILLES RUPTURE OF,TENDON RUPTURE,INJURIES NEC,"MUSCLE, TENDON AND LIGAMENT INJURIES",10022117,10043236,10043248,10043236
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
"BULLOUS FIXED DRUG ERUPTION FOLLOWING IBUPROFEN INGESTION/ MULTIFOCAL LESIONS IN HIS ORAL MUCOSA, PENIS, AND MULTIPLE SITES OF SKIN FOLLOWING IBUPROFEN INGESTION",Dermatitis bullous,BULLOUS LESIONS,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006565,10012441,10006565
OLIGOHYDRAMNIOS,Oligohydramnios,OLIGOHYDRAMNIOS,OLIGOHYDRAMNIOS,"PLACENTAL, AMNIOTIC AND CAVITY DISORDERS (EXCL HAEMORRHAGES)",AMNIOTIC FLUID AND CAVITY DISORDERS OF PREGNANCY NEC,10036585,10030289,10030289,10030289
LACK OF COMPLIANCE,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
GIDDINESS,Dizziness,GIDDINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10018263,10013573,10018263
OPIOIDS DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
PROGRESSIVE SCLERAL ATROPHY,Atrophy,ATROPHY,ATROPHY,TISSUE DISORDERS NEC,TROPHIC DISORDERS,10018065,10003694,10003694,10003694
ELEVATION IN HER BETAHYDROXYBUTYRATE,Blood ketone body,BETAHYDROXYBUTYRATE,BLOOD KETONE BODY,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10059970,10057593,10059970
MUCOCUTANEOUS BLEEDING DUE TO THROMBOCYTOPENIA,Mucocutaneous haemorrhage,MUCOCUTANEOUS HEMORRHAGE,MUCOCUTANEOUS HAEMORRHAGE,SKIN VASCULAR ABNORMALITIES,SKIN HAEMORRHAGES,10040785,10076048,10076048,10076049
CONGENITAL SCALP DEFECTS FOLLOWING DRUG EXPOSURE IN UTERO,Congenital scalp defects following drug exposure in utero,CONGENITAL SKIN DISORDER,CONGENITAL SKIN DISORDER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL NEC,10010331,10067769,10067769,10067769
SEIZURES,seizures,SEIZURES,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039910,10039906,10039910
ERYTHEMATOUS EROSION ON THE LIPS WITH SORES AND BLISTERS IN THE ORAL MUCOSA,Rash erythematous,ERYTHEMATOUS ERUPTION,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015241
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
BILATERAL PAPILLEDEMA,papilledema,PAPILLEDEMA,PAPILLOEDEMA,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC",OPTIC DISC ABNORMALITIES NEC,10015919,10033703,10033712,10033703
"AFTER 30 MONTHS OF TREATMENT, PROGRESSION OF THE PRIMARY TUMOR AS WELL AS THE LIVER METASTASES WAS SEEN FOLLOWING DRUG RESISTANCE AND LACK OF DRUG EFFECT",Gastrointestinal stromal tumour,GASTROINTESTINAL STROMAL TUMOR,GASTROINTESTINAL STROMAL TUMOUR,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,GASTROINTESTINAL NEOPLASMS MALIGNANCY UNSPECIFIED NEC,10029104,10051066,10051066,10062427
INFECTED HYDRONEPHROSIS SECONDARY TO URETERAL CONCREMENT,infected hydronephrosis,HYDRONEPHROSIS,HYDRONEPHROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL OBSTRUCTIVE DISORDERS,10038359,10020524,10020524,10020524
INCREASED CBF FROM CO-ADMINISTRATION OF KETAMINE AT THE TIME OF MILRINONE INFUSION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
SIGNIFICANT CIRCULATORY INSTABILITY,Cardiovascular disorder,CIRCULATORY INSTABILITY,CARDIOVASCULAR DISORDER,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10009197,10007649,10009197
INDIRECT HYPERBILIRUBINEMIA,Hyperbilirubinaemia,INDIRECT HYPERBILIRUBINEMIA,HYPERBILIRUBINAEMIA,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10075822,10020578,10075817
RECURRENT ASPERGILLUS NIGER OTOMYCOSIS DUE TO INSUFFICIENT ACTIVITY OF NYSTATIN AND WITH THE USE OF TOPICAL AND ORAL ANTIBIOTICS,Otitis media fungal,OTITIS MEDIA FUNGAL,OTITIS MEDIA FUNGAL,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10065175,10065175,10065175
"EAR WAS MODERATELY SWOLLEN, ERYTHEMATOUS, WARM AND TENDER",Skin warm,SKIN WARM,SKIN WARM,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040952,10040952,10040952
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
MYOCARDIUM ENZYME RISING,Myocardial necrosis marker increased,CARDIAC ENZYMES INCREASED,MYOCARDIAL NECROSIS MARKER INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10007548,10075211,10007548
HER ACHILLES TENDONS STARTED TO HURT,Tendon pain,ACHILLES TENDON PAIN,TENDON PAIN,"TENDON, LIGAMENT AND CARTILAGE DISORDERS",TENDON DISORDERS,10028395,10050471,10066371,10050471
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
INVASIVE TEMPERATURE OF 40.1 CELSIUS,Hyperthermia,HYPERTHERMIA,HYPERTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10020843,10020843,10020843
ROTHIA MUCILAGINOSA INFECTION,Stomatococcal infection,ROTHIA MUCILAGINOSA INFECTION,STOMATOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10070993,10068385,10070993
TYPHLITIS FOLLOWING CHEMOTHRAPY-RELATED TOXICITY,Colitis,TYPHLITIS,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10045271,10009887,10045271
"MULTIPLE ULCERS OF THE ORAL MUCOSA, GINGIVA, AND SOFT PALATE",Oral ulceration,ORAL ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10031027,10028034,10031027
DRY COUGH,dry cough,DRY COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10013773,10011224,10013773
SUBSTITUTION ERRORS LEADING TO HYOSCINE HYDROBROMIDE OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
CORNEAL SCAR IN THE RIGHT EYE DUE TO INVASIVE SQUAMOUS CELL CARCINOMA OF THE CONJUNCTIVA,Corneal scar,CORNEAL SCAR,CORNEAL SCAR,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CORNEAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10011044,10011044,10011044
PATIENTâ€™S MOTHER WAS TREATED WITH THIAMAZOLE (10 MG/DAY) DURING THE FIRST TRIMESTER OF PREGNANCY,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
BEDRIDDEN DUE TO HYPOGYLCEMIA,bedridden,BEDRIDDEN,BEDRIDDEN,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10048948,10048948,10048948
DRUG USE IN UNAPPROVED POPULATION,Product use issue,DRUG USE IN UNAPPROVED POPULATION,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10071551,10076309,10071551
SYNCOPE,Syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
CHEMOTHERAPY-INDUCED PERFORATION OF GASTRIC CANCER (PERFORATION MEASURING 25 MM IN SIZE WAS OBSERVED FROM THE LESSER CURVATURE OF THE ANTRUM TO THE POSTERIOR WALL),Gastric perforation,GASTRIC PERFORATION,GASTRIC PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,GASTRIC ULCERS AND PERFORATION,10017947,10017815,10017815,10017815
RIGHT CEREBELLAR LESION,Cerebellar lesion NOS,CEREBELLAR LESION NOS,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10049441,10051290,10049441
G1 PROTEINURIA,Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
BACK PAIN FOLLOWING OFF LABEL USE OF METHOTREXATE IN MORPHOEA PROFUNDA,Back pain,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003988,10003988,10003988
OPIATE DEPENDENCY WAS TREATED BY DIMINISHING DOSAGES OF MORPHINE,Toxicity to various agents,POISONING BY METHADONE,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10035882,10070863,10035882
CONSCIOUSNESS DISTURBED,Altered state of consciousness,CONSCIOUSNESS DISTURBED,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010770,10001854,10010770
"THROMBOSIS FOLLOWING DRUG DRUG INTERACTION BETWEEN CLOPIDOGREL BISULFATE AND DARUNAVIR, EMTRICITABINE/TENOFOVIR, TENOFOVIR, ACETYLSALICYLIC ACID (ASPIRIN) AND RITONAVIR",thrombosis,THROMBOSIS,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10043607,10043607,10043607
STEROID-INDUCED DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
HAPTOGLOBIN INCREASED (LESS THAN 0.5 G/L),Haptoglobin increased,HAPTOGLOBIN INCREASED,HAPTOGLOBIN INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",HAEM METABOLISM ANALYSES,10022891,10019152,10019152,10019152
AMINOPHYLLINE INDUCED HYPONATREMIA,Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
INTRAVASCULAR IMMUNE HAEMOLYTIC ANAEMIA,immune haemolytic anaemia drug-induced,IMMUNE HAEMOLYTIC ANAEMIA DRUG-INDUCED,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10053591,10018916,10053591
"POSITIVE RESULT AFTER 14 H, WITH A PRURITIC RASH ON THE FOREARMS AND ANTERIOR CHEST",Rash pruritic,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10037085
"DESPITE ADDITION OF DIURETIC DRUG, CARDIAC FAILURE FURTHER AGGRAVATED",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
DIARRHEA,Diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
SEVERE EPIDERMAL NECROLYSIS ON 100 PERCENT OF THE BODY SURFACE AREA WITH SEVERE MUCOSAL INVOLVEMENT,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
SEVERE PAIN AT INJECTION SITE,Injection site pain,INJECTION SITE PAIN,INJECTION SITE PAIN,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022086,10022086,10022086
LESIONS RAPIDLY BECAME GENERALIZED,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
ZOLPIDEM DEPENDENCE,Drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
INSOMNIA,insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
RESPIRATORY DISTRESS AND PROGRESSIVE AXIAL HYPOTONIA WHICH MOTIVE HIS TRANSFER TO NEONATAL INTENSIVE CARE UNIT,Hypotonia neonatal,HYPOTONIA NEONATAL,HYPOTONIA NEONATAL,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10021119,10021119,10021119
ISONIAZID INDUCED RHABDOMYOLYSIS,Isoniazid induced rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
DROP IN HER URINE VOLUME,Oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
FLUCTUATING MOOD CHANGES,Mood altered,MOOD CHANGE,MOOD ALTERED,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10027940,10027940,10027941
HE WAS FEBRILE (39.3 DEGREE CELSIUS),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PROGRESSIVE CHANGE IN HER MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
DIED DESPITE OPTIMAL INTENSIVE CARE SUPPORT/DEVELOPED MULTIPLE COMPLICATIONS DESPITE ANTIMICROBIAL TREATMENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
EDEMA GENITAL,Edema genital,EDEMA GENITAL,OEDEMA GENITAL,REPRODUCTIVE TRACT DISORDERS NEC,REPRODUCTIVE TRACT SIGNS AND SYMPTOMS NEC,10038604,10014224,10030104,10014224
SEVERE MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
MALAISE (GRADE 1),Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
RELAPSE OF TDT-NEGATIVE T-CELL LYMPHOBLASTIC LYMPHOMA FOLLOWING LACK OF DRUG EFFECT,lymphoblastic lymphoma,LYMPHOBLASTIC LYMPHOMA,NON-HODGKIN'S LYMPHOMA,LYMPHOMAS NON-HODGKIN'S UNSPECIFIED HISTOLOGY,NON-HODGKIN'S LYMPHOMAS NEC,10029104,10065923,10029547,10065923
HIGH PHOSPHATE 2.51 MMOL/L,Blood phosphorus increased,PHOSPHATE HIGH,BLOOD PHOSPHORUS INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10034931,10050196,10034931
NEUROLOGICAL DEFICIT,Nervous system disorder,CENTRAL NERVOUS SYSTEM DISORDER,NERVOUS SYSTEM DISORDER,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10007943,10029202,10007943
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
"CREATINE KINASE (CK) LEVEL WAS 49,146 U/L",Creatine kinase high,CREATINE KINASE HIGH,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011335,10005470,10011335
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
NEUTROPENIA (2ND EPISODE),Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
METHOTREXATE AND MYCOPHENOLATE MOFETIL USED FOR CHRONIC IDIOPATHIC INTERMEDIATE UVEITIS (OFF LABEL USE WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BILATERAL INGUINAL HERNIAS,Inguinal hernia,BILATERAL INGUINAL HERNIA,INGUINAL HERNIA,ABDOMINAL HERNIAS AND OTHER ABDOMINAL WALL CONDITIONS,INGUINAL HERNIAS,10017947,10067165,10022016,10067165
RASH,rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
GREENISH DIARRHEA/CLOSTRIDIUM DIFFICILE A AND B TOXIN WAS FOUND IN THE STOOL CULTURE,Clostridium difficile colitis,"DIARRHEA, CLOSTRIDIUM DIFFICILE",CLOSTRIDIUM DIFFICILE COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10006835,10009657,10012734
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
HEART RATE INCREASED FROM 120-160 TO 150-170 BEATS PER MIN,Heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
CIRCULATORY COLLAPSE INDUCED BY ADRENAL INSUFFICIENCY CAUSED BY LEVOTHYROXINE SODIUM,Circulatory collapse,CIRCULATORY COLLAPSE,CIRCULATORY COLLAPSE,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10009192,10009192,10009192
OFF-LABEL USE OF PROPRANOLOL IN INFANTILE HEMANGIOMA WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
POSSIBLE SECONDARY DRUG INDUCED THROMBOCYTOSIS,Thrombocytosis,THROMBOCYTOSIS,THROMBOCYTOSIS,PLATELET DISORDERS,THROMBOCYTOSES,10005329,10043563,10043563,10043563
ELEVATED INFLAMMATORY MARKERS,Inflammatory marker increased,INFLAMMATORY MARKER INCREASED,INFLAMMATORY MARKER INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,CHEMISTRY ANALYSES NEC,10022891,10069826,10069826,10069826
DRUG INDUCED LONG QT SYNDROME,QT interval prolonged,QT INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037703,10014387,10037703
PATIENT TREATED WITH HYDROXYCHLOROQUINE FOR VASCULAR INFECTION WITH C. BURNETII (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
OSTEOPOROTIC LUMBAR SPINE FRACTURE,Lumbar vertebral fracture,LUMBAR VERTEBRAL FRACTURE,LUMBAR VERTEBRAL FRACTURE,BONE AND JOINT INJURIES,SPINAL FRACTURES AND DISLOCATIONS,10022117,10049947,10049947,10049947
NON-ACCIDENTAL OVERDOSE OF QUININE (19.5 G),overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
ATRIAL FIBRILLATION DUE TO HYPOKALEMIA,atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
RISING SERUM CREATININE (106 MOL/L),Blood creatinine increased,BLOOD CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005483,10005483,10005483
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
SIALORRHOEA,Salivary hypersecretion,SIALORRHOEA,SALIVARY HYPERSECRETION,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10059812,10039424,10059812
OROPHARYNGEAL BLEEDING\ HEMATHEMESIS,Oropharyngeal hemorrhage,OROPHARYNGEAL HEMORRHAGE,PHARYNGEAL HAEMORRHAGE,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),PHARYNGEAL DISORDERS (EXCL INFECTIONS AND NEOPLASMS),10038738,10060843,10034827,10060843
DRUG ALLERGY,Drug hypersensitivity,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
HYPERSENSITIVITY TO RISPERIDONE,drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
THE TUMOUR HAD NO RESPONSE TO INITIAL ADJUVANT SYSTEMIC CHEMOTHERAPY,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
"SEVERAL DOZEN ROUND, PINK, SCALY PAPULES AND PLAQUES WITH PERPHERAL COLLARETTES OF SCALE",Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
OFF LABEL USE OF IMIQUIMOD FOR GIANT FACIAL INVASIVE SQUAMOUS CELL CARCINOMA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
COAGULOPATHY,Coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
MYALGIA AFFECTING THE CALF MUSCLES AND TO A LESSER EXTENT THE DISTAL QUADRICEPS AND PROXIMAL FOREARM MUSCLES,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
BUPRENORPHINE IN THE SETTING OF A NEWLY DIAGNOSED PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
INCREASED CREATININE CLEARANCE,Creatinine renal clearance increased,CREATININE RENAL CLEARANCE INCREASED,CREATININE RENAL CLEARANCE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011364,10011364,10011364
ACUTE DRUG-INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
DRUG HYPERSENSITIVITY REACTIONS,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
URINE JCPYV HAD BEEN CONSECUTIVELY POSITIVE WITH VIRAL LOAD OF >106 COPIES/ML,JC virus infection,JC VIRUS INFECTION,JC VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10023163,10023163,10023163
DRUG EXPOSURE DURING PREGNANCY,DRUG EXPOSURE DURING PREGNANCY,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ALANINE AMINOTRANSFERASE INCREASED (385 U/L),Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
PURPURIC NODULE ON THE ANTIHELIX OF THE RIGHT EAR,purpuric nodule on the antihelix of the right ear,NODULE ON EXTREMITY,NODULE,TISSUE DISORDERS NEC,MASS CONDITIONS NEC,10018065,10050690,10054107,10050690
INAPPETENCE (GRADE3),Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
QUALITY OF LIFE HAD SIGNIFICANTLY DETERIORATED,Quality of life decreased,QUALITY OF LIFE DECREASED,QUALITY OF LIFE DECREASED,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",INVESTIGATIONS NEC,10022891,10067620,10067620,10067620
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
SINUSOIDAL OBSTRUCTION SYNDROME,Venoocclusive liver disease,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
MULTI ORGAN FAILURE DUE TO SEPSIS,Multiple organ dysfunction syndrome,MULTI ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028151
MILD WORSENING OF KIDNEY FUNCTION THAT WAS ATTRIBUTED TO DEHYDRATION,Kidney function abnormal,KIDNEY FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10023422,10062237,10023422
PORTAL VEIN THROMBOSIS FOLLOWING WORSENING OF SLE,Portal vein thrombosis,PORTAL VEIN THROMBOSIS,PORTAL VEIN THROMBOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10036206,10036206,10036206
ESOPHAGEAL SUBMUCOSAL HEMATOMA,Oesophageal intramural haematoma,ESOPHAGEAL INTRAMURAL HEMATOMA,OESOPHAGEAL INTRAMURAL HAEMATOMA,GASTROINTESTINAL HAEMORRHAGES NEC,GASTRIC AND OESOPHAGEAL HAEMORRHAGES,10017947,10077486,10077486,10077490
CISPLATIN-RESISTANT NON-SEMINOMATOUS TESTICULAR GERM CELL TUMOR,Testicular germ cell cancer metastatic,TESTICULAR GERM CELL CANCER METASTATIC,TESTICULAR GERM CELL CANCER METASTATIC,REPRODUCTIVE NEOPLASMS MALE MALIGNANT AND UNSPECIFIED,TESTICULAR NEOPLASMS MALIGNANT,10029104,10068694,10068694,10068694
SPO2 DECREASED 80% IMMEDIATELY AFTER THE COMPLETION,Oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
HEMORRHAGIC BULLAE,bullae,BULLAE,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006554,10005191,10006554
INSULIN RESISTANCE,Insulin resistance,INSULIN RESISTANCE,INSULIN RESISTANCE,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10022489,10022489,10022489
I-II DEGREE ANEMIA,anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
CEREBROSPINAL VIRAL ESCAPE [VIRAL LOAD INCREASED],Viral load increased,VIRAL LOAD INCREASED,VIRAL LOAD INCREASED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10062180,10062180,10062180
6-METHYLMERCAPTOPURINE -INDUCED LEUCOCYTOPENIA,Leucocytopenia,LEUCOCYTOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10068178,10024384,10068178
ABNORMAL SERUM BIOCHEMISTRY RESULTS INCLUDED ERYTHROCYTE SEDIMENTATION RATE 145 MM/H,Red blood cell sedimentation rate increased,ERYTHROCYTE SEDIMENTATION RATE INCREASED,RED BLOOD CELL SEDIMENTATION RATE INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),HAEMATOLOGICAL ANALYSES NEC,10022891,10049187,10049187,10015264
KLEBESIELLA PNEUMONIAE,Klebsiella infection,KLEBSIELLA PNEUMONIAE INFECTION,KLEBSIELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10052209,10061259,10052209
CORONARY THROMBOSIS FOLLOWING TEN /SJS,Coronary thrombosis,CORONARY THROMBOSIS,CORONARY ARTERY THROMBOSIS,CORONARY ARTERY DISORDERS,CORONARY ARTERY DISORDERS NEC,10007541,10011108,10011091,10011108
LUNG ABSCESS,Lung abscess,LUNG ABSCESS,LUNG ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10025028,10025028,10025028
LACK OF EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
BILATERAL HAND AND WRIST ARTHRITIS,Arthritis,ARTHRITIS,ARTHRITIS,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10003246,10003246,10003246
GLIOBLASTOMA,Glioblastoma,GLIOBLASTOMA,GLIOBLASTOMA,NERVOUS SYSTEM NEOPLASMS MALIGNANT AND UNSPECIFIED NEC,GLIAL TUMOURS MALIGNANT,10029104,10018336,10018336,10018336
DECREASED MOBILITY,Mobility decreased,MOBILITY DECREASED,MOBILITY DECREASED,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10048334,10048334,10048334
MULTIPLE ULCER,Ulcer,ULCER,ULCER,TISSUE DISORDERS NEC,ULCERS NEC,10018065,10045285,10045285,10045285
IRRITABLE,Irritability,IRRITABLE,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10023000,10022998,10023000
AMANTADINE AUGMENTED TO 100 MG TID,Overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
FINE CRACKLES AT BOTH LUNG BASES,Rales,CRACKLES LUNG,RALES,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10054910,10037833,10054910
RENAL TOXICITY,toxicity renal,TOXICITY RENAL,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10044258,10029155,10044258
GRADE 1 ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
ANION GAP,Anion gap,ANION GAP,ANION GAP,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10002522,10002522,10002522
VASCULITIS,Vasculitis,VASCULITIS,VASCULITIS,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10047115,10047115,10047115
PERSISTENT RENAL FAILURE/POLYURIC RENAL FAILURE PHASE,Renal failure neonatal,RENAL FAILURE NEONATAL,RENAL FAILURE NEONATAL,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038447,10038447,10038447
GRADE 4 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
SEPSIS DUE TO PNEUMOCYSTIS JIROVECI PNEUMONIA,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
CONFLUENT LIVID-ERYTHEMATOUS EXANTHEMA,Rash,EXANTHEMA,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10015587
TOXIC BONE MARROW DAMAGE,Bone marrow toxicity,BONE MARROW TOXICITY,BONE MARROW TOXICITY,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10051779,10051779,10051779
ABDOMINAL DISORDER WAS GETTING WORSE DESPITE THERAPY,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
WEIGHT LOSS OF 22 POUNDS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
LEFT-SIDED FOCAL SEIZURES,left-sided focal seizures,FOCAL SEIZURES,PARTIAL SEIZURES,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10016843,10061334,10016843
LEUKOPENIA,Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
DRY COUGH,dry cough,DRY COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10013773,10011224,10013773
WORSENING SHORTNESS OF BREATH,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
1ST MTP JOINT SWELLING,Joint swelling,JOINT SWELLING,JOINT SWELLING,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023232,10023232,10023232
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SEVERE GRANULOCYTOPENIA,Granulocytopenia,GRANULOCYTOPENIA,GRANULOCYTOPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10018687,10018687,10018687
ACUTE RENAL FAILURE IN THE COURSE OF RHABDOMYOLYSIS/ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
RIGHT BUTTOCK DISCOMFORT,Musculoskeletal discomfort,HIP DISCOMFORT,MUSCULOSKELETAL DISCOMFORT,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10054245,10053156,10054245
CHOLESTASIS,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
CALCIFICATION/POST-CORTICOSTEROID INJECTION CALCIFICATION,Injection site calcification,INJECTION SITE CALCIFICATION,INJECTION SITE CALCIFICATION,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10054812,10054812,10054812
PALMOPLANTAR EXANTHEMA,Rash,PALMOPLANTAR RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10068748,10037844,10068748
EXCESSIVE SEDATION IN THE MORNING,sedation excessive,SEDATION EXCESSIVE,SEDATION COMPLICATION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,ANAESTHETIC AND ALLIED PROCEDURAL COMPLICATIONS,10022117,10039898,10079741,10039898
"TEMPERATURE ELEVATION, FIRST DAY AFTER APPLICATION UP TO 39C, SECOND DAY UP TO 37C",Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
OROPHARYNGEAL MUCOSITIS,Oropharyngeal mucositis,MUCOSITIS ORAL,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028130,10042128,10028130
SEVERE HEMATOCHEZIA,severe hematochezia,HEMATOCHEZIA,HAEMATOCHEZIA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10060544,10018836,10060544
MILD MENTAL DISTURBANCES WITH HYPONATREMIA (126MMOL/L),mild mental disturbances with hyponatremia,MENTAL STATE ABNORMAL,MENTAL DISORDER,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10027381,10061284,10027381
VERTIGO,Vertigo,VERTIGO,VERTIGO,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10047340,10047340,10047340
LIMITED PLANTAR AND DORSIFLEXION OF BILATERAL ANKLES,Movements reduced,MOVEMENTS REDUCED,HYPOKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028045,10021021,10028045
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"SYMPTOMS WAS NOT RELIEVED AFTER 10 DAYS OF TREATMENT, AND THE SKIN LESIONS STILL PROGRESSED QUICKLY",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ST-LINE DEPLETION,electrocardiogram ST segment depression,ST SEGMENT DEPRESSED,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041892,10014391,10041891
ESCHERICHIA COLI INFECTION/ESCHERICHIA COLI BACTERAEMIA,Escherichia bacteraemia,ESCHERICHIA COLI BACTERAEMIA,ESCHERICHIA BACTERAEMIA,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10054258,10054258,10054280
NECROTIZING GRANULOMATOUS INFLAMMATION,Granuloma,NECROTISING GRANULOMA,GRANULOMA,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10072175,10018691,10072175
NEUROGENIC BLADDER DUE TO MYELOPATHY FOLLOWING INTRATHECAL CHEMOTHERAPY,Neurogenic bladder,NEUROGENIC BLADDER,NEUROGENIC BLADDER,BLADDER AND BLADDER NECK DISORDERS (EXCL CALCULI),MYONEUROGENIC BLADDER DISORDERS,10038359,10029279,10029279,10029279
PERFORATION IN THE SMALL BOWEL,Intestinal perforation,BOWEL PERFORATION,INTESTINAL PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,INTESTINAL ULCERS AND PERFORATION NEC,10017947,10006056,10022694,10006056
LITHIUM TOXICITY,Toxicity to various agents,LITHIUM TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10050501,10070863,10050501
RIGIDITY OF LIMBS,Limb discomfort,LIMB DISCOMFORT,LIMB DISCOMFORT,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10061224,10061224,10061224
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HIGH ANIONIC GAP METABOLIC ACIDOSIS,High anion gap metabolic acidosis,HIGH ANION GAP METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10069033,10027417,10069033
DISTAL STENOSIS OF THE BASILAR ARTERY WITH THROMBUS,Arterial stenosis,ARTERIAL STENOSIS,ARTERIAL STENOSIS,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10060965,10060965,10060965
LOMENTOSPORA PROLIFICANS PLEUROPNEUMONIA,pleuropneumonia,PLEUROPNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10059406,10035664,10059406
CHRONIC ALLOGRAFT DYSFUNCTION FOLLOWING BK VIRUS NEPHROPATHY,Complications of transplanted kidney,KIDNEY GRAFT DYSFUNCTION,COMPLICATIONS OF TRANSPLANTED KIDNEY,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10051366,10010185,10051366
EXTREME HYPERCALCEMIA DUE TO VITAMIN D INTOXICATION,extreme hypercalcemia due to vitamin D intoxication,HYPERCALCEMIA,HYPERCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020587,10020583,10020587
THERE WAS NO IMPROVEMENT,No therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
IMPULSIVE BEHAVIOUR,Impulsive behaviour,IMPULSIVE BEHAVIOUR,IMPULSIVE BEHAVIOUR,IMPULSE CONTROL DISORDERS NEC,IMPULSE CONTROL DISORDERS,10037175,10021567,10021567,10021567
PROGRESSIVE WORSENING DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
HYPOESTHESIA OVER C4 TO T1 REGIONS,Hypoaesthesia,HYPOESTHESIA,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10020937,10020937,10020976
INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
MUCOSAL SURFACES OF THE LIPS AND EYES DEMONSTRATED HEMORRHAGIC CRUSTING,mucosal surfaces of the lips and eyes demonstrated hemorrhagic crusting,SKIN ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10040842,10015150,10040842
ALANINE AMINOTRANSFERASE INCREASED- 53 U/L (NORMAL 10-40),Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
ZOLPIDEM DEPENDENCE,Drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
WORSENING OF HER CHRONIC LOWER BACK PAIN,Back pain,LOW BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10024891,10003988,10024891
IRRESISTIBLE URGE TO MOVE HIS LEGS,Restlessness,RESTLESSNESS (DRUG RELATED),RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038744,10038743,10038744
DECREASED MOTOR FUNCTIONING IN BOTH ARMS AND LEGS (EDSS 6.0),Motor dysfunction,MOTOR DYSFUNCTION,MOTOR DYSFUNCTION,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10061296,10061296,10061296
ANGIOEDEMA,angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
LOSS OF MUSCLE MASS,Muscle disorder,MUSCLE DISORDER,MUSCLE DISORDER,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028300,10028300,10028300
DISEASE PROGRESSION,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
LISINOPRIL INDUCED SMALL BOWEL ANGIOEDEMA,Intestinal angioedema,SMALL BOWEL ANGIOEDEMA,INTESTINAL ANGIOEDEMA,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10051401,10076229,10051401
PHOTOSENSITIVE LICHENOID DRUG ERUPTION,Eruption lichenoid,ERUPTION LICHENOID,LICHENOID KERATOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,HYPERKERATOSES,10040785,10015141,10064000,10015141
GENERALIZED RASH,Generalized rash,GENERALIZED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10049201,10037858,10049201
PYREXIA,pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
AGGRESSIVITY,Aggressiveness,AGGRESSIVENESS,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001494,10001488,10001494
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
BLOOD UREA INCREASED,Blood urea increased,BLOOD UREA INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005851,10005851,10005851
PAPULES ON THE TRUNK AND UPPER LIMBS (MULTIPLE LIGHT-BROWN PAPULES UP TO 7 MM IN DIAMETER DISSEMINATED ON THE TRUNK AND UPPER EXTREMITIES),Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
PANCYTOPENIA FOLLOWING INTOXICATION OF METHOTREXATE DUE TO INAPPROPRIATE DRUG ADMINISTRATION,pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
BAD RESPONSE TO TREATMENT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HIRSUTISM,Hirsutism,HIRSUTISM,HIRSUTISM,SKIN APPENDAGE CONDITIONS,HYPERTRICHOSES,10040785,10020112,10020112,10020112
PEDAL EDEMA,Oedema peripheral,PEDAL EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10055950,10030124,10034206
PNEUMOCYSTIS JIROVECII PNEUMONIA,Pneumocystis jirovecii pneumonia,PNEUMOCYSTIS JIROVECII PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10073755,10073755,10073755
PREMATURE SEPSIS,Sepsis neonatal,SEPSIS NEONATAL,SEPSIS NEONATAL,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040049,10040049,10040049
PAIN OF MODERATE INTENSITY (VAS 5) IN THE LEFT LOWER LIMB WITH PARESTHESIA/PARESTHESIAS,paresthesia,PARESTHESIA,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10033987,10033775,10033987
PERMEABILITY OF THE FORAMEN OVALE,Foramen ovale patent,FORAMEN OVALE PATENT,ATRIAL SEPTAL DEFECT,CARDIAC AND VASCULAR DISORDERS CONGENITAL,CARDIAC SEPTAL DEFECTS CONGENITAL,10010331,10016982,10003664,10016982
PITTING EDEMA OF LEGS,Oedema,PITTING EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10035076,10030095,10054547
ORIENTATION,Disorientation,ORIENTATION DISTURBED,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10031087,10013395,10031087
INJECTION SITE HEMORRHAGE,Injection site hemorrhage,INJECTION SITE HEMORRHAGE,INJECTION SITE HAEMORRHAGE,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022068,10022067,10022068
CRP INCREASED (4),CRP increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
"ESPITE THESE IMPROVEMENTS, THE PATIENT REPORTED PERSISTENT FATIGUE, MYALGIAS, AND ARTHRALGIAS",subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
SOFT TISSUE EDEMA LOCALIZED IN FRONT OF TRAGUS,Localised oedema,LOCALIZED EDEMA,LOCALISED OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10048961,10048961,10062466
TENOFOVIR-INDUCED PROXIMAL RTA WITH FANCONI SYNDROME,Fanconi syndrome,FANCONI SYNDROME,FANCONI SYNDROME,RENAL AND URINARY TRACT DISORDERS CONGENITAL,RENAL DISORDERS CONGENITAL,10010331,10016219,10016219,10016219
TREATMENT WITH VALACICLOVIR AT THE RECOMMENDED DOSES WAS INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
LOW POTASSIUM LEVELS,Potassium low,POTASSIUM LOW,BLOOD POTASSIUM DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10036452,10005724,10036452
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
GBS,Guillain-Barre syndrome,GUILLAIN BARRE SYNDROME,GUILLAIN-BARRE SYNDROME,PERIPHERAL NEUROPATHIES,ACUTE POLYNEUROPATHIES,10029205,10018767,10018767,10018766
ELEVATION OF THE INFLAMMATORY PARAMETERS (CRP 480 NG/L),Inflammatory marker increased,INFLAMMATORY MARKER INCREASED,INFLAMMATORY MARKER INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,CHEMISTRY ANALYSES NEC,10022891,10069826,10069826,10069826
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
TENDENCY OF AST / ALT TO INCREASE,Hepatic enzyme increased,HEPATIC ENZYMES INCREASED,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10060795,10060795,10019662
"DISSEMINATED MUCORMYCOSIS DUE TO CUNNINGHAMELLA BERTHOLLETIAE, WITH LUNG, SKIN, RENAL, AND CENTRAL NERVOUS SYSTEM INVOLVEMENT",Disseminated mucormycosis,DISSEMINATED MUCORMYCOSIS,MUCORMYCOSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10073239,10028098,10073239
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
"HE COULD NOT GET UP BY HIMSELF AND REPORTED FEELING ""FROZEN""",Musculoskeletal stiffness,STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10042045,10052904,10042045
CHRONIC GVHD IN EYES,Graft versus host disease in eye,GRAFT VERSUS HOST DISEASE IN EYE,GRAFT VERSUS HOST DISEASE IN EYE,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10074563,10074563,10074563
HAD PARTIAL MYOCLONIC SEIZURES RESISTANT TO PHENOBARBITAL AND LEVETIRACETAM,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
STARTED HAVING BILATERAL HIP PAIN,Arthralgia,PAIN IN HIP,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10011249,10003239,10033432
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
DISSEMINATED NOCARDIA NOVA INFECTION,Nocardiosis,NOCARDIA INFECTION,NOCARDIOSIS,BACTERIAL INFECTIOUS DISORDERS,NOCARDIA INFECTIONS,10021881,10064083,10029444,10064083
WATER INTOXICATION INDUCED BY LOW-DOSE CYCLOPHOSPHAMIDE,Water intoxication,WATER INTOXICATION,WATER INTOXICATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME INCREASED,10027433,10047837,10047837,10047837
CHRONIC GVHD IN LIVER,Chronic graft versus host disease in liver,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10072160,10072160,10072160
SUDDEN HYPOTHYROIDISM AND AMIODARONE-LITHIUM COMBINATION,Hypothyroidism,HYPOTHYROIDISM,HYPOTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPOFUNCTION DISORDERS,10014698,10021114,10021114,10021114
DRUG EXPOSURE VIA PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ACUTE MID CIRCUMFLEX ARTERY OCCLUSION,Arterial occlusion,ARTERIAL OCCLUSION,ARTERIAL OCCLUSIVE DISEASE,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10058475,10062599,10058475
HIGH LEVELS OF TROPONIN I,Troponin I increased,TROPONIN I INCREASED,TROPONIN I INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10058268,10058268,10058268
ADMINISTRATION OF MYCOPHENOLATE AND METHYLPREDNISOLONE WAS INEFFECTIVE IN INCREASING THE PLATELET COUNT (LACK OF DRUG EFFECT WITH NO ADVERSE EVENT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
NO POSITIVE CLINICAL EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SERUM BICARBONATE DECREASED (LESS THAN 10 MEQ/L),Blood bicarbonate decreased,BICARBONATE DECREASED SERUM,BLOOD BICARBONATE DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10004545,10005359,10004545
CONTINUED PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
DIFFUSE ERYTHEMATOUS MACULES ON HER TRUNK AFTER AMOXICILLIN TREATMENT,Macule,DARK REDDISH MACULE,MACULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10011862,10025421,10011862
PERIPHERAL NERVE DISORDER,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
PROBABLY TOXIC SERUM CONCENTRATIONS OF AMIODARONE AND DULOXETINE,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
PAINFUL ULCERATIONS,Ulceration,ULCERATION,ULCER,TISSUE DISORDERS NEC,ULCERS NEC,10018065,10080913,10045285,10080913
BROAD FOREHEAD,head Deformity,HEAD DEFORMITY,HEAD DEFORMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES (INCL INTERVERTEBRAL DISC DISORDERS),"MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES OF SKULL, FACE AND BUCCAL CAVITY",10028395,10061199,10061199,10061199
THROMBOTIC MICROANGIOPATHY (TMA),Thrombotic microangiopathy,THROMBOTIC MICROANGIOPATHY,THROMBOTIC MICROANGIOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10043645,10043645,10043645
ABSCESS ON BUTTOCK,Subcutaneous abscess,ABSCESS ON BUTTOCK,SUBCUTANEOUS ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10000309,10042343,10000309
RIGHT LOWER QUADRANT ABDOMINAL PAIN,Abdominal pain lower,RIGHT LOWER QUADRANT PAIN,ABDOMINAL PAIN LOWER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10058051,10000084,10058051
ELEVATED FERRITIN 705NG/ML,Ferritin increased,FERRITIN INCREASED,SERUM FERRITIN INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10016459,10040250,10016459
SWEATING,sweating,SWEATING,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042661,10020642,10042661
PROVISIONAL DIAGNOSIS OF ACUTE CHOLINERGIC SYNDROME CAUSED BY GALANTAMINE,Cholinergic syndrome,CHOLINERGIC SYNDROME,CHOLINERGIC SYNDROME,NEUROMUSCULAR DISORDERS,AUTONOMIC NERVOUS SYSTEM DISORDERS,10029205,10008674,10008674,10008674
ANAPHYLACTIC REACTION TO INDOMETHACIN,Anaphylactic reaction to drug,ANAPHYLACTIC REACTION TO DRUG,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10054844,10002198,10054844
AMNESIA,amnesia,AMNESIA,AMNESIA,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10001949,10001949,10001949
PHOTOSENSITIVITY,Photosensitivity reaction,PHOTOSENSITIVITY,PHOTOSENSITIVITY REACTION,EPIDERMAL AND DERMAL CONDITIONS,PHOTOSENSITIVITY AND PHOTODERMATOSIS CONDITIONS,10040785,10034966,10034972,10034966
BILATERAL BAND KERAOPATHY,Band keratopathy,BAND KERATOPATHY,KERATOPATHY,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CORNEAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10004086,10023365,10004086
APHASIA,Aphasia,APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002948,10002948,10002948
GENERALIZED FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
MUCOUS MEMBRANE DISORDER SUCH AS STOMATITIS,Mucous membrane disorder,MUCOUS MEMBRANE DISORDER,MUCOUS MEMBRANE DISORDER,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028133,10028133,10028133
PATIENT ADMINISTERED HYDROXYCHLOROQUINE FOR CLIPEERS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LIP SWELLING,Lip swelling,LIP SWELLING,LIP SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10024570,10024570,10024570
MASSIVE PROGRESSION OF CEREBRAL LESION LOAD INCLUDING NEW T2W-HYPERINTENSE LESIONS WITH GADOLINIUM RING ENHANCEMENT,Nuclear magnetic resonance imaging abnormal,NUCLEAR MAGNETIC RESONANCE IMAGING GADOLINIUM-ENHANCED ABNORMAL,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",IMAGING PROCEDURES NEC,10022891,10029821,10029816,10029821
ABDOMINAL PAIN LOWER,Abdominal pain lower,ABDOMINAL PAIN LOWER,ABDOMINAL PAIN LOWER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000084,10000084,10000084
RIFAMPICIN INDUCED SEVERE THROMBOCYTOPENIA (PLATELET COUNT 0.3 Ã— 10 4 / L),Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
ESPECIALLY THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
ACUTE TARDIVE DYSKINESIA SYMPTOMS,Tardive dyskinesia,TARDIVE DYSKINESIA,TARDIVE DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10043118,10043118,10043118
COMBINED CENTRAL NERVOUS SYSTEM DEPRESSION,Central nervous system depression NOS,CENTRAL NERVOUS SYSTEM DEPRESSION NOS,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10007941,10012373,10007941
TEMPERATURE ELEVATION UP TO 38-38.5 C,Body temperature increased,TEMPERATURE ELEVATION,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10043204
EBV INFECTION,Epstein-Barr virus infection,EBV INFECTION,EPSTEIN-BARR VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,EPSTEIN-BARR VIRAL INFECTIONS,10021881,10015108,10015108,10014077
QRS 162,Electrocardiogram QRS complex prolonged,QRS PROLONGED,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037697,10014380,10037697
ADMINISTRATION OF ACETAZOLAMIDE FOR IDIOPATHIC BILATERAL VESTIBULOPATHY(UNAPPROVED INDICATION)-OFF LABEL USE WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NEUROTOXICITY DUE TO CISPLATIN MAY ALSO CONTRIBUTE TO THE DEVELOPMENT OF SIADH,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
DIFFUSE ERYTHEMATOUS RASH ON THE EXTREMITIES AND TRUNK,Rash erythematous,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10037855
GASTROINTESTINAL ADR,Gastrointestinal disorder,REACTION GASTROINTESTINAL,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10037947,10017944,10037947
HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"USE OF CAPECITABINE AND TEMOZOLOMIDE FOR NEUROENDOCRINE TUMOR OF UNKNOWN ORIGIN, OSTEOBLASTIC BONE METASTASES AND LIVE METASTASES (OFF LABEL USE) WITH NO ADVERSE EVENT",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
OPIUM ADDICTION,Drug dependence,OPIUM ADDICTION,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10030900,10013663,10030900
EVENTUALLY STOPPED RESPONDING TO PROMPTS,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
CHOREIC MOVEMENTS OF THE LEFT HEMIBODY/ HEMICHOREA,hemichorea,HEMICHOREA,CHOREA,MOVEMENT DISORDERS (INCL PARKINSONISM),CHOREIFORM MOVEMENTS,10029205,10062587,10008748,10062587
DRUG LEVEL INCREASED,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
CLUSTERED PERIORAL 1 - 2 MM NON-FOLLICULAR PUSTULES,Pustule,PUSTULE,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037578,10037888,10037578
LETHARGIC,Lethargy,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024262
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
DRUG INTERACTION/SUSPECTED DRUG INTERACTION BETWEEN QUETIAPINE/METOPROLOL/CIPROFLOXACIN AND DULOXETINE/METABOLISM OF METOPROLOL INHIBITED BY DULOXETINE,Drug-drug pharmacokinetic interaction,DRUG-DRUG PHARMACOKINETIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10065994,10013710,10065994
DRUG EXPOSURE DURING PREGNANCY,"Drug exposure during pregnancy, first trimester","DRUG EXPOSURE DURING PREGNANCY, FIRST TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076617,10073513,10076617
RADIOLOGICAL PROGRESSION OCCURRED,Rectal adenocarcinoma,RECTAL ADENOCARCINOMA,RECTAL ADENOCARCINOMA,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,COLORECTAL NEOPLASMS MALIGNANT,10029104,10038019,10038019,10038019
OBSTIPATION,Constipation,OBSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10029932
ALT INCREASED (269 U/L),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
DRUG ERUPTION,Drug eruption,DRUG ERUPTION,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10013687,10013687,10013687
ACUTE HEPATITIS,Hepatitis acute,HEPATITIS ACUTE,HEPATITIS ACUTE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019727,10019727,10019727
MULTIPLE CHOLELITHIASIS,Cholelithiasis,CHOLELITHIASIS,CHOLELITHIASIS,GALLBLADDER DISORDERS,CHOLECYSTITIS AND CHOLELITHIASIS,10019805,10008629,10008629,10008629
GENERAL FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
NORMAL NEWBORN,Normal newborn,NORMAL NEWBORN,NORMAL NEWBORN,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS",NORMAL NEWBORN STATUS,10036585,10029769,10029769,10029769
SHE WAS AWAKE BUT DISORIENTED,disorientation,DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013395
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
A PRODUCTIVE COUGH,productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
ACUTE RENAL FAILURE DUE TO SEVERE METFORMIN-ASSOCIATED LACTIC ACIDOSIS,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
ORTHOPNEA,orthopnea,ORTHOPNEA,ORTHOPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10031122,10031123,10031122
GRADE 3 LEUKOPENIA,Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
"ACUTE FLUVOXAMINE, OXYCODONE, AND OLANZAPINE INTOXICTION",Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
COUGH,cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
FLACCID PARAPLEGIA FOLLOWING LUMBOSACRAL POLYRADICULOPATHY DUE TO INTRATHECAL DRUG TOXICITY,paraplegia,PARAPLEGIA,PARAPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10033892,10033892,10033892
PATIENT WAS TREATED WITH MYCOPHENOLATE MOFETIL FOR FOCAL SEGMENTAL GLOMERULOSCLEROSIS ( OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PNEUMOCYSTIS JIROVECI PNEUMONIA AND ITS WORSENING,Pneumocystis jirovecii pneumonia,PNEUMOCYSTIS JIROVECI PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10073755,10073755,10064108
PULSE INCREASED,Heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
VIRAL LOAD REBOUND (LACK OF DRUG EFFECT WITH NO ADR),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
"RADIATION TOXICITY GRADING (RTOG) GRADE 1 TOXICITIES TO THE SKIN, SALIVA, AND MUCOUS MEMBRANES",Radiotoxicity,RADIOTOXICITY,RADIATION INJURY,INJURIES BY PHYSICAL AGENTS,RADIATION INJURIES,10022117,10069763,10037760,10069763
VLDV CHOLESTEROL INCREASED (38 MG/DL),Very low density lipoprotein increased,VERY LOW DENSITY LIPOPROTEIN INCREASED,VERY LOW DENSITY LIPOPROTEIN INCREASED,LIPID ANALYSES,CHOLESTEROL ANALYSES,10022891,10047361,10047361,10047361
DRUG-INDUCED LIVER INJURY (DILI),Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
INCREASED FASTING BLOOD GLUCOSE AND HBA1C LEVELS,Fasting blood glucose increased,FASTING BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10050786,10005557,10050786
HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
FACIAL EDEMA,Face oedema,EDEMA FACE,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10016029,10016029,10014222
NAUSEOUS,Nausea,NAUSEOUS,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028823
3 RARE STOOLS,Frequent bowel movements,INCREASED STOOL FREQUENCY,FREQUENT BOWEL MOVEMENTS,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL SPASTIC AND HYPERMOTILITY DISORDERS,10017947,10017367,10017367,10048456
APGAR-MIN 1 SCORE WAS 6,Apgar score abnormal,APGAR SCORE ABNORMAL,APGAR SCORE ABNORMAL,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10056850,10056850,10056850
SEPTIC SHOCK DUE TO SEPSIS,septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
LIVER IMPAIRMENT,Liver disorder,LIVER DISORDER,LIVER DISORDER,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10024670,10024670,10024670
REDUCED TACROLIMUS LEVEL FOLLOWING RIBAVIRIN INDUCED ANAEMIA (1.0 NG/ML AND DROPPED TO UNDETECTABLE LEVEL),Drug level decreased,DRUG LEVEL DECREASED,DRUG LEVEL DECREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013718,10013718,10013718
GALACTORRHOEA,Galactorrhoea,GALACTORRHOEA,GALACTORRHOEA,BREAST DISORDERS,LACTATION DISORDERS,10038604,10017600,10017600,10017600
"SKIN LESIONS HAD PROGRESSED TO EXTENSIVE ERYTHEMATOUS PLAQUES AND YELLOW/BLACK CRUST COVERING THE FOREHEAD, CHEEKS, BOTH ARMS, AND THIGHS",Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
DRUG EXPOSURE VIA PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
PATIENT DID NOT RESPOND TO THE TREATMENT OF AMOXICILLIN/CLAVULANIC ACID AND FUSIDIC ACID (LACK OF DRUG EFFECT) WITH NO ADVERSE EVENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CONSCIOUSNESS LOSS,Loss of consciousness,CONSCIOUSNESS LOSS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10010771
HYPOMAGNESEMIA,hypomagnesemia,HYPOMAGNESEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021028,10021027,10021028
RETAINED PLACENTA,Retained placenta,RETAINED PLACENTA,RETAINED PLACENTA OR MEMBRANES,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,MATERNAL COMPLICATIONS OF DELIVERY NEC,10036585,10038757,10038758,10038757
RESPIRATORY DEPRESSION,respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
LINEZOLID-ASSOCIATED LACTIC ACIDOSIS FOLLOWING SUPRATHERAPEUTIC LINEZOLID LEVELS/ HIGH LINEZOLID TROUGH CONCENTRATION 49 MG/L,Drug level above therapeutic,DRUG LEVEL ABOVE THERAPEUTIC,DRUG LEVEL ABOVE THERAPEUTIC,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10061132,10061132,10061132
POOR SUCKING,Poor sucking reflex,POOR SUCKING REFLEX,POOR SUCKING REFLEX,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10058605,10058605,10058605
NON-SUSTAINED VENTRICULAR TACHYCARDIA PERSISTED,non-sustained ventricular tachycardia,NON-SUSTAINED VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10060731,10047302,10060731
"WORSENING OF DECOMPENSATION OF LIVER DISEASE DUE TO TENOFOVIR DISOPROXIL FUMARATE, SOFOSBUVIR AND SIMEPREVIR",Hepatic failure,HEPATIC DECOMPENSATION,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10076894,10019663,10076894
ALTERED SENSORIUM AND MYOCLUNUS WERE FELT TO BE SECONDARY TO GABAPENTIN TOXICITY,myoclunus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
GRADE 3 DECREASED HB,Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
DYSPHAGIA FOLLOWING STOMATITIS/ESOPHAGITIS GRADE 3,Dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
PAIN CONTROL WAS UNSATISFACTORY WITH CELECOXIB AND COMBINATION OF CODEINE AND PARACETAMOL,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
ESOPHAGEAL VARICES,Varices oesophageal,ESOPHAGEAL VARICES,VARICES OESOPHAGEAL,GASTROINTESTINAL VASCULAR CONDITIONS,OESOPHAGEAL VARICES,10017947,10056091,10056091,10015452
"PRO
GRESSIVE FATIGUE",Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
SKIN ERYTHEMA,skin erythema,SKIN ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10040842,10015150,10040842
EXERTION INTOLERANCE,Dyspnea exertional,DYSPNEA EXERTIONAL,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013966,10013971,10013966
CARBIMAZOLE IN UTERO,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
EDEMATOUS FLUSHED FACE,face edema,FACE EDEMA,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10016025,10016029,10016025
QT PROLONGATION,QT prolonged,QT PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037705,10014387,10037705
REPEATED TONIC-CLONIC SEIZURES,Generalised tonic-clonic seizure,TONIC-CLONIC SEIZURES,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10044000,10018100,10044000
DRUG-INDUCED KIDNEY INJURY,Renal injury,RENAL INJURY,RENAL INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10061481,10061481,10061481
HYPOVOLEMIC HYPONATREMIA,hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
HAEMORRHAGE,Haematuria,HAEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018867,10018867,10018867
CSF PROTEIN INCREASED (VALUE NOS),CSF protein increased,CSF PROTEIN INCREASED,CSF PROTEIN INCREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10011575,10011575,10011575
HOARSENMESS,Dysphonia,HOARSENESS,DYSPHONIA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10020201,10013952,10020201
PRURITUS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
GENERALIZED PRURITUS,Pruritus generalised,GENERALIZED PRURITUS,PRURITUS GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10052576,10052576,10018123
SEVERE HYPERTROPHIC LEFT VENTRICLE,Ventricular hypertrophy,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10047295,10047295,10047295
TREATMENT WITHOUT EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DEATH,Death,DEATH,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10011906,10011906,10011906
PROGRESSION OF METASTATIC GASTROINTESTINAL STROMAL TUMOR,Progression of pre-existing cancer,PROGRESSION OF PRE-EXISTING CANCER,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10057096,10051398,10057096
LOCAL SWELLING,Swelling,LOCAL SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10024770,10042674,10024770
JITTERY,Feeling jittery,JITTERINESS,FEELING JITTERY,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10023191,10016338,10023191
NEUTROPENIA   GRADE 3,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
TARGET VALUE OF LDL-CHOLESTEROL NOT ATTAINED,ldl cholesterol increased,LDL CHOLESTEROL INCREASED,LOW DENSITY LIPOPROTEIN INCREASED,LIPID ANALYSES,CHOLESTEROL ANALYSES,10022891,10024055,10024910,10024055
MORPHINE INTOXICATION,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
UNINTENTIONAL 10-POUND WEIGHT LOSS,weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,Immune reconstitution inflammatory syndrome associated tuberculosis,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10072797,10072797,10072797
BONE INFECTION (BACTERIAL),bone infection,BONE INFECTION,OSTEOMYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,BONE AND JOINT INFECTIONS,10021881,10061017,10031252,10061017
CLOZAPINE-ASSOCIATED MYOCARDITIS,myocarditis,MYOCARDITIS,MYOCARDITIS,MYOCARDIAL DISORDERS,NONINFECTIOUS MYOCARDITIS,10007541,10028606,10028606,10028606
ANEMIA,anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
INCREASED CREATININE,Creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
LETHARGY,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
HEMATOLOGICAL TOXICITY (GRADE 3),Haematotoxicity,HEMATOTOXICITY,HAEMATOTOXICITY,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10061188,10061188,10061196
THROMBOCYTOPENIA CAUSED BY MULTIPLE DRUG-DEPENDENT ANTIBODIES,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
CRP WAS 271 MG/L,C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
MILD HYPEREMIA OF PHARYNX WITH CLEAR NOSE SECRETION,Pharyngeal erythema,PHARYNGEAL HYPEREMIA,PHARYNGEAL ERYTHEMA,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),PHARYNGEAL DISORDERS (EXCL INFECTIONS AND NEOPLASMS),10038738,10074994,10057009,10075001
FACIAL DEVIATION WITH DROOLING OF SALIVA FROM THE ANGLE OF THE MOUTH,drooling,DROOLING,DROOLING,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013642,10013642,10013642
OLANZAPINE AND RISPERIDONE WERE FOUND TO BE INEFFECTIVE IN MANAGING HIS SYMPTOMS,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
NAIL TOXICITY,Nail toxicity,NAIL TOXICITY,NAIL TOXICITY,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10059206,10059206,10059206
RENAL FAILURE,renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
EPISODE OF SUSTAINED VENTRICULAR TACHYCARDIA DEGENERATING INTO VENTRICULAR FIBRILLATION,Sustained ventricular tachycardia,SUSTAINED VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10060730,10047302,10060730
OBSTRUCTION/ OBSTRUCTING THE OUTLET OF THE PYLORUS/GASTRIC OUTLET OBSTRUCTION,Obstruction,OBSTRUCTION,OBSTRUCTION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061876,10061876,10061876
COAGULATION DISORDER AND PROLONGED ACT,Coagulopathy,COAGULATION DISORDER,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009731,10009802,10009731
DRUG-INDUCED IMMUNE HEMOLYTIC ANEMIA DUE TO IMATINIB,Immune hemolytic anemia drug-induced,IMMUNE HEMOLYTIC ANEMIA DRUG-INDUCED,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10055213,10018916,10055213
TACHYCARDIA (115 BPM) DUE TO CMV INFECTION,tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
DEVELOPMENT OF PHATIC DISORDER MAILY OF EXPRESSIVE TYPE,Language disorder,EXPRESSIVE LANGUAGE DISORDER,LANGUAGE DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10015715,10074869,10015715
ERYTHROVIRUS MYOCARDITIS (1ST RECURRENCE),Viral myocarditis,VIRAL MYOCARDITIS,VIRAL MYOCARDITIS,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10047470,10047470,10047470
NECROTIZING FASCIITIS WITH LEG EFFUSION (CULTURE POSITIVE FOR GROUP A STREPTOCOCCUS),Necrotising fasciitis streptococcal,NECROTISING FASCIITIS STREPTOCOCCAL,NECROTISING FASCIITIS STREPTOCOCCAL,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10028888,10028888,10028888
REFUSAL TO TAKE ORAL MEDICATION,Refusal of treatment by patient,REFUSAL OF TREATMENT BY PATIENT,REFUSAL OF TREATMENT BY PATIENT,LIFESTYLE ISSUES,SOCIAL ISSUES NEC,10041244,10056407,10056407,10056407
LACK OF RESPONSE,No drug effect ,NO DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10029437,10013709,10029437
"DESPITE CHEMOTHERAPY FOR 20 MONTHS, PERITONEAL DISSEMINATION PROGRESSED",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
JAUNDICE,jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
EEG REVEALED DIFFUSE SLOWING OF BACKGROUND ACTIVITY WITH MULTIFOCAL BIHEMISPHERIC SHARP WAVE,Electroencephalogram abnormal,EEG GROUND ACTIVITY DECREASED,ELECTROENCEPHALOGRAM ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10066976,10014408,10066976
"2 ROUND, RED, FIRM NICKEL-SIZED PLAQUES WITH A CENTRAL VIOLACEOUS","2 round, red, firm nickel-sized plaques with a central violaceous",SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
LOSS OF MUSCLE STRENGTH,Muscular weakness,MUSCLE WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028372,10028372,10028350
LEUKOCYTOPENIA (1.4X10E9/L),Leukopenia,LEUKOCYTOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10068177
WITHDRAWAL SYMPTOMS,Withdrawal syndrome,WITHDRAWAL SYNDROME,WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10048010,10048010,10048010
HR 150 BPM,Heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
DISSEMINATED INTERSTITIAL CONSOLIDATIONS ABOVE BOTH LUNG FIELDS. / INTERSTITIAL PULMONARYFIBROSIS LESIONS,Interstitial pulmonary fibrosis,INTERSTITIAL PULMONARY FIBROSIS,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022619,10022611,10022619
SUFFOCATION,Suffocation,SUFFOCATION,ASPHYXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10042443,10003497,10042443
THE PATIENT'S ANGIOEDEMA CONTINUED TO PROGRESS,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
DROWSY,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
WRITHING-LIKE MOVEMENTS,involuntary movement,INVOLUNTARY MOVEMENT (NOS),DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10022895,10013916,10022895
WOMAN WHO DID NOT DECLARED TAKING PREGABALIN BUT SOME EVIDENCE SUPPORTED ADDICTION.,Drug dependence,DRUG ADDICTION,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013658,10013663,10013658
CHANGE IN MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
APHASIA,Aphasia,APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002948,10002948,10002948
MYOGLOBINURIA,Myoglobinuria,MYOGLOBINURIA,MYOGLOBINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10028629,10028629,10028629
CHEST PAIN,chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
GENERALISED URTICARIA,Urticaria,GENERALISED URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10074035,10046735,10074035
ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
PLATELET DYSFUNCTION,Platelet dysfunction,PLATELET DYSFUNCTION,PLATELET DYSFUNCTION,PLATELET DISORDERS,PLATELET DISORDERS NEC,10005329,10073391,10073391,10073391
VENTRICULAR TACHYCARDIA,ventricular tachycardia,VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047302,10047302,10047302
PROLONGED PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME,Activated partial thromboplastin time prolonged,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10000636,10000636,10000636
PROCTITIS,proctitis,PROCTITIS,PROCTITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,RECTAL INFLAMMATIONS NEC,10017947,10036774,10036774,10036774
"MUSCLE WEAKNESS MAINLY IN THE UPPER LIMBS, AFFECTING BOTH PROXIMAL AND DISTAL MUSCLE GROUPS, SHE WAS UNABLE TO LIFT HER HANDS ABOVE HER HEAD",Muscular weakness,MUSCLE WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028372,10028372,10028350
SEPTIC SHOCK FOLLOWING TOPICAL CLOBETASOL INDUCED NECROTIZING FASCIITIS OF THE LEFT UPPER LIMB,septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
FETAL VALPROATE SYNDROME,Fetal valproate syndrome,FETAL VALPROATE SYNDROME,FOETAL ANTICONVULSANT SYNDROME,CONGENITAL AND HEREDITARY DISORDERS NEC,CHEMICALLY-INDUCED CONGENITAL SYNDROMES,10010331,10016524,10066485,10016524
MILD PARESIS OF THE PLANTAR FLEXORS AND DORSIFLEXORS (MRC LEVEL 4/5),Monoparesis,LEG PARESIS,MONOPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10065013,10027925,10065013
"PRESENCE OF ROUND-SHAPED PSEUDO-FILAMENTOUS OR FILAMENTOUS PIGMENTED FUNGI (UP TO 20 MCM OF DIAMETER),INDICATIVE OF CEREBRAL PHAEOHYPHOMYCOSIS",phaeohyphomycosis,PHAEOHYPHOMYCOSIS,PHAEOHYPHOMYCOSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10080815,10080815,10080815
THALAMOMESENCEPHALIC ABSCESS WITH PERIPHERAL EDEMA AND CEREBRITIS,Cerebritis,CEREBRITIS,ENCEPHALITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10054860,10014581,10054860
SYSTEMIC IONIZED CALCIUM FELL (0.8 MMOL/L) DUE TO PERSISTENT CHELATION OF CALCIUM FOLLOWING INTERFERENCE OF CITRATE METABOLISM BY CYCLOPHOSPHAMIDE (DRUG INTERACTION),Calcium ionised decreased,CALCIUM IONISED DECREASED,CALCIUM IONISED DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10060898,10060898,10060898
HYPONATREMIA/SERUM SODIUM DECREASED (124 MEQ PER L),Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
BULLSEYE APPEARANCE ON RETINAL PHOTOGRAPHY,Maculopathy,BULL'S EYE MACULOPATHY,MACULOPATHY,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10068902,10025425,10068902
DYSPHAGIA,Dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
ALLERGY TO RIFAMPICIN,Drug hypersensitivity,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
AMAUROSIS OF THE AFFECTED EYE,amaurosis,AMAUROSIS,AMAUROSIS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10001902,10001902,10001902
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
KERATIC PRECIPITATES,keratic precipitates,KERATIC PRECIPITATES,KERATIC PRECIPITATES,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CORNEAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10053703,10053703,10053703
HYPOGAMMAGLOBULINEMIA,hypogammaglobulinemia,HYPOGAMMAGLOBULINEMIA,HYPOGAMMAGLOBULINAEMIA,IMMUNODEFICIENCY SYNDROMES,PRIMARY IMMUNODEFICIENCY SYNDROMES,10021428,10054427,10020983,10054427
OEDEMA TO FACE,Face oedema,OEDEMA FACE,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10016029,10016029,10030101
ACUTE NEUTROPHILIC FOLLICULITIS,neutrophilic folliculitis,NEUTROPHILIC FOLLICULITIS,NEUTROPHILIC DERMATOSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10073673,10058105,10073673
MISUSE,Intentional product misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
ENHANCED COMPUTED TOMOGRAPHY SHOWED MULTIPLE NODULES AND LYMPHADENOPATHIES AT THE AXILLAE,lymphadenopathy axillary,LYMPHADENOPATHY AXILLARY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10049109,10025197,10049109
ITCH,Itch,ITCH,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023082,10037087,10023082
"MULTIPLE TREATMENTS WERE ATTEMPTED INCLUDING OPIOIDS, STEROIDS, MUSCLE RELAXERS, GABAPENTIN, VENLAFAXINE, STRETCHING, TENS, MASSAGE, ICE/HEAT. UNFORTUNATELY, THE PATIENT'S PAIN CONTINUED TO WORSEN",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PATIENT WAS EXPERIENCING AN UNREPORTED ADVERSE REACTION WHICH WAS PROBABLY PROVOKING OEDEMA,Oedema,OEDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10030095
ORTHOPNOEA,orthopnoea,ORTHOPNOEA,ORTHOPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10031123,10031123,10031123
RASH,rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
VERTIGO,Vertigo,VERTIGO,VERTIGO,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10047340,10047340,10047340
HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
"DESPITE INITIAL RELIEF, THE PAIN NOT ONLY RECURRED, BUT ALSO BEGAN TO WORSEN, EVEN AS HER CARBAMAZEPINE DOSE WAS INCREASED SUBSTANTIALLY.",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
CONTINUING PAIN AND THE LACK OF COMPLETE HEALING OF THE POST-EXTRACTIVE SITES,Procedural pain,POSTOPERATIVE PAIN,PROCEDURAL PAIN,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10054711,10064882,10054711
PATIENT RECEIVED MOXIFLOXACIN MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PLEURAL EFFUSION,Pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
HYPOXEMIA,Hypoxia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021141,10021143,10021142
INCREASED PERVAGINAL BLEEDING,increased pervaginal bleeding,VAGINAL BLEEDING,VAGINAL HAEMORRHAGE,VULVOVAGINAL DISORDERS (EXCL INFECTIONS AND INFLAMMATIONS),VULVOVAGINAL DISORDERS NEC,10038604,10046883,10046910,10046883
SEVERE ALLERGY TO PREDNISONE ALLERGY,Drug hypersensitivity,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
ABNORMAL SERUM BIOCHEMISTRY RESULTS INCLUDED ALANINE AMINOTRANSFERASE 288 U/L,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
WHEAL,Urticaria,WHEALS,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10047918,10046735,10047918
PATERNAL DRUG EXPOSURE BEFORE PREGNANCY,Paternal exposure before pregnancy,PATERNAL DRUG EXPOSURE BEFORE PREGNANCY,PATERNAL EXPOSURE BEFORE PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10068414,10080093,10068414
DISEASE WAS STILL ACTIVE WITH 3 NEW GADOLIUM ENHANCING LESIONS ON MRI,Nuclear magnetic resonance imaging gadolinium-enhanced abnormal,NUCLEAR MAGNETIC RESONANCE IMAGING GADOLINIUM-ENHANCED ABNORMAL,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",IMAGING PROCEDURES NEC,10022891,10029821,10029816,10029821
LEFT UPPER JAW AND IN ASCENDING BRANCH OF THE LEFT MANDIBLE WITH SECONDARY ARTERIAL OCCLUSION,Arterial occlusion,ARTERIAL OCCLUSION,ARTERIAL OCCLUSIVE DISEASE,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10058475,10062599,10058475
MILD LEFT VENTRICULAR HYPERTROPHY,Left ventricular hypertrophy,LEFT VENTRICULAR HYPERTROPHY,LEFT VENTRICULAR HYPERTROPHY,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10049773,10049773,10049773
EXTENSIVE LEFT CORTICAL AND SUBCORTICAL ISCHAEMIC INFARCTS/INFARCTS IN THE IPSILATERAL ACA TERRITORY,cerebral infarction,CEREBRAL INFARCTION,CEREBRAL INFARCTION,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008118,10008118,10008118
DECLINE IN EXERCISE TOLERANCE,Exercise tolerance decreased,EXERCISE TOLERANCE DECREASED,EXERCISE TOLERANCE DECREASED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10051301,10051301,10051301
PROGRESSIVE SHORTNESS OF BREATH,shortness of breath,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
ERYTHROCYTURIA,Haematuria,ERYTHROCYTURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10050784,10018867,10050784
INSUFFICIENT PAIN RELIEF,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
GENERALIZED CUTANEOUS PRURITUS,Pruritus cutaneous,PRURITUS CUTANEOUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037090,10037087,10037090
WORSENING OF ODONTOGENIC INFECTION FOLLOWING MULTIDRUG RESISTANCE,Pathogen resistance,MULTI-ANTIBIOTIC RESISTANCE,PATHOGEN RESISTANCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10028152,10034133,10028152
FIBRIN DEGRADATION PRODUCTS ABOVE 40 MCG/ML,Fibrin degradation products increased,FIBRIN DEGRADATION PRODUCTS HIGH,FIBRIN DEGRADATION PRODUCTS INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10016587,10016588,10016587
ANION GAP,Anion gap,ANION GAP,ANION GAP,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10002522,10002522,10002522
PARKINSONISM WORSENED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
PALLOR,Pallor,PALLOR,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033546,10033546,10033546
BIMODAL HALLUCINATORY PSYCHOSIS (TACTILE AND VISUAL HALLUCINATIONS) AFTER OFLOXACIN THERAPY,"Hallucination, tactile","HALLUCINATION, TACTILE","HALLUCINATION, TACTILE",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019074,10019074,10019074
LOST CONSCIOUSNESS,Consciousness loss,CONSCIOUSNESS LOSS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010771,10024855,10010771
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
CITROBACTER FREUNDII INFECTION,Citrobacter infection,CITROBACTER FREUNDII INFECTION,CITROBACTER INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10054234,10051904,10054234
PULMONARY EDEMA,Pulmonary oedema,PULMONARY EDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037423,10037423,10037375
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
ACUTE HAEMOLYTIC ANAEMIA,Haemolytic anaemia,ACUTE HAEMOLYTIC ANAEMIA,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10066625,10018916,10066625
METHYLPREDNISOLONE INDUCED DIABETES,Diabetes mellitus,DIABETES STEROID-INDUCED,DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012628,10012601,10012628
GRADE-2 URINARY TRACT INFECTION,Urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
PATIENT'S PRESENTATION WAS EXACERBATED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
CSF ANALYSIS SHOWED PROTEIN 2.32  G/L,CSF protein increased,CSF PROTEIN INCREASED,CSF PROTEIN INCREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10011575,10011575,10011575
INTERSTITIAL PNEUMONIA,Interstitial lung disease,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
RESPIRATORY FAILURE,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
"MALIGNANT INTERTRIGO, THE INTERTRIGINOUS PATTERN OF TOXIC ERYTHEMA CAUSED BY CHEMOTHERAPY",Intertrigo,INTERTRIGO,INTERTRIGO,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10022622,10022622,10022622
TONSILLAR SWELLING WITH ULCERATIONS,ulceration,ULCERATION,ULCER,TISSUE DISORDERS NEC,ULCERS NEC,10018065,10080913,10045285,10080913
CHEMOTHERAPY INDUCED NAUSEA AND VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
MYONECROSIS,Muscle necrosis,MYONECROSIS,MUSCLE NECROSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10028320,10028320,10028636
LOSS OF CONCIOUSNESS/ FAINT,Fainting ,FAINTING,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10016169,10042772,10016169
SYMMETRICAL PERIPHERAL GANGRENE,Gangrene,PERIPHERAL GANGRENE,GANGRENE,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10034574,10017711,10034574
RASBURICASE-INDUCED METHEMOGLOBINEMIA (METHEMOGLOBIN-5.8%),Methaemoglobinaemia,ACQUIRED METHEMOGLOBINEMIA,METHAEMOGLOBINAEMIA,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10000570,10027496,10054290
ARDS,ARDS,ARDS,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10003083,10001052,10003083
FULL BODY RASH (DIFFUSED RASH COVERING 60-70% OF BODY SURFACE AREA),Rash generalised,GENERALIZED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037858,10037858,10049201
HEART RATE INCREASED (117/MIN),Heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
GRADE 2 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
HYPERCAPNIA,Hypercapnia,HYPERCAPNIA,HYPERCAPNIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10020591,10020591,10020591
CAUSING HER TO AWAKEN FROM SLEEP,Nocturnal awakening,NOCTURNAL AWAKENING,MIDDLE INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10029448,10027590,10029448
PULMONARY ASPERGILLOMA,Bronchopulmonary aspergillosis,BRONCHOPULMONARY ASPERGILLOSIS,BRONCHOPULMONARY ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10006473,10006473,10006473
SPINAL SUBDURAL AND SUBARACHNOID HEMORRHAGE,Spinal subdural haemorrhage,SPINAL SUBDURAL HEMORRHAGE,SPINAL SUBDURAL HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10073563,10073563,10073567
UNABLE TO EAT WELL,unable to eat,UNABLE TO EAT,FEEDING DISORDER,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10069830,10061148,10069830
APNEA,Apnoea,APNEA,APNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10002974,10002974,10002972
WEIGHT GAIN,Weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
MILD TRANSIENT MACROSCOPIC HEMATURIA,macroscopic hematuria,MACROSCOPIC HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10059823,10018867,10059823
WORSENING OF LESIONS WITH INCREASING PAIN,Pain,PAIN AGGRAVATED,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033396,10033371,10033376
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
PAPULONODULAR LESIONS,Nodule,NODULE,NODULE,TISSUE DISORDERS NEC,MASS CONDITIONS NEC,10018065,10054107,10054107,10054107
ACUTE LIVER FAILURE,acute liver failure,ACUTE LIVER FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10049844,10000804,10049844
HYPERSENSITIVITY REACTION,Hypersensitivity,HYPERSENSITIVITY REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020756,10020751,10020756
CLOSTRIDIAL COLITIS,Clostridium colitis,CLOSTRIDIUM COLITIS,CLOSTRIDIUM COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10058305,10058305,10058305
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
CENTRAL PLEURITIC,Pleuritic pain,PLEURITIC PAIN,PLEURITIC PAIN,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10035623,10035623,10035623
FLUSHING,Flushing,FLUSHING,FLUSHING,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10016825,10016825,10016825
MILD MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
FACIAL SWELLING,Swelling face,FACIAL SWELLING,SWELLING FACE,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10042682,10042682,10016065
HEMATEMESIS,Hematemesis,HEMATEMESIS,HAEMATEMESIS,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10019418,10018830,10019418
SUICIDALITY,Suicidal ideation,SUICIDAL IDEATION,SUICIDAL IDEATION,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042458,10042458,10042458
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
LEUCOPENIA,Leucopenia,LEUCOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024283,10024384,10024283
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
CPK INCREASE,CPK increase,CPK INCREASE,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011267,10005470,10011267
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
ATTEMPTED SUICIDE WITH MEDICATION,attempted suicide,ATTEMPTED SUICIDE,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10003728,10042464,10003728
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
DIVALPROEX HAD DEMONSTRATED A RAPID EFFECT IN REDUCING SCHOOL ANXIETY AND IMPROVING SCHOOL ATTENDANCE,Drug effective for unapproved indication,DRUG EFFECTIVE FOR UNAPPROVED INDICATION,DRUG EFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10079317,10079317,10079317
"INTERACTION BETWEEN IVERMECTIN, HALOPERIDOL AND RISPERIDONE/DRUG-DRUG INTERACTION",Drug-drug pharmacokinetic interaction,DRUG-DRUG PHARMACOKINETIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10065994,10013710,10065994
DRUG-INDUCED HAEMOLYTIC ANAEMIA,Haemolytic anaemia,HAEMOLYTIC ANAEMIA DRUG-INDUCED,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10018918,10018916,10018918
MULTIPLE BRUISING ON LEGS AND ARMS,Bruising of arm,BRUISING OF ARM,CONTUSION,INJURIES NEC,SKIN INJURIES NEC,10022117,10006505,10050584,10006505
MESENTRIC VASCULITIS FOLLOWING PROGRESSING HENOCH-SCHONLEIN PURPURA FOLLOWING STEROID RESISTANCE,Vasculitis,VASCULITIS,VASCULITIS,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10047115,10047115,10047115
HYPERGLYCAEMIA,Hyperglycaemia,HYPERGLYCAEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020635
"PATIENT WAS TREATED WITH TRAMADOL AND GABAPENTIN FOR PAIN, HER NRS PAIN SCORE WAS AT THAT TIME 7 DESPITE MEDICATION WITH GABAPENTIN AND DESPITE MEDICATION (LACK OF DRUG EFFECT) WITH NO ADR",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HEMATOLOGIC INTOLERANCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
PERTUSSIS,Pertussis,PERTUSSIS,PERTUSSIS,BACTERIAL INFECTIOUS DISORDERS,BORDETELLA INFECTIONS,10021881,10034738,10034738,10034738
EXACERBATION OF COPD,Chronic obstructive pulmonary disease,COPD EXACERBATION,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10010953,10009033,10010953
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
ELEVATED JVP,Venous pressure jugular increased,JUGULAR VENOUS PRESSURE RAISED,VENOUS PRESSURE JUGULAR INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10047240,10047240,10023242
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ACUTE SKIN GRADE 1GVHD (DUE TO LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
FAILING OUTPATIENT TREATMENT FOR COMMUNITY ACQUIRED PNEUMONIA WITH LEVOFLOXACIN (TREATMENT FAILURE WITH NO ADR),Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
EDEMA,Edema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014210,10030095,10014210
NAPROXEN-INDUCED PHOTOSENSITIVITY,Photosensitivity reaction,PHOTOSENSITIVITY,PHOTOSENSITIVITY REACTION,EPIDERMAL AND DERMAL CONDITIONS,PHOTOSENSITIVITY AND PHOTODERMATOSIS CONDITIONS,10040785,10034966,10034972,10034966
EXTRAPYRAMIDAL SIDE EFFECTS APPEARED,drug-induced extrapyramidal side effects,DRUG-INDUCED EXTRAPYRAMIDAL SIDE EFFECTS,EXTRAPYRAMIDAL DISORDER,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10013760,10015832,10013760
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
HYPERKERATOTIC LESIONS,Hyperkeratosis,HYPERKERATOSIS,HYPERKERATOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,HYPERKERATOSES,10040785,10020649,10020649,10020649
LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
CONDITION WORSENED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
SIGNIFICANTLY HYPOTENSIVE,hypotensive,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021107,10021097,10021107
GRADE 2 PHARYNGEAL MUCOUS MEMBRANE DISORDER,Pharyngeal inflammation,PHARYNGEAL MUCOSITIS,PHARYNGEAL INFLAMMATION,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),PHARYNGEAL DISORDERS (EXCL INFECTIONS AND NEOPLASMS),10038738,10065881,10065716,10065881
IMMEDIATE-TYPE HYPERSENSITIVITY REACTIONS,Type I hypersensitivity,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
LEFT LOWER EXTREMITY PAIN,pain in lower extremity,PAIN OF LOWER EXTREMITIES,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033473,10033425,10033473
INFECTION,infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
DECREASED APPETITE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER WITH NO ADR",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
C-REACTIVE PROTEIN MILDLY ELEVATED AT 33.0 MG/L,C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
METASTASES TO BONE,Metastases to bone,METASTASES TO BONE,METASTASES TO BONE,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027452,10027452,10027452
INCONSISTENCY OF BIOAVAILABILITY,drug level altered,DRUG LEVEL ALTERED,DRUG LEVEL CHANGED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013715,10013717,10013715
BACTERAEMIA FROM ESCHERICHIA COLI,Escherichia coli bacteraemia,ESCHERICHIA COLI BACTERAEMIA,ESCHERICHIA BACTERAEMIA,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10054280,10054258,10054280
PREDNISONE INDUCED OSTEOPOROSIS/ ON THE FEMORAL NECKTHERE IS A FINDING OF BMD IN THE OSTEOPOROSIS BAND AND ALSO ON THE FOREARM,Osteoporosis,OSTEOPOROSIS,OSTEOPOROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10031282,10031282,10031282
"SERUM AMYLASE AND LIPASE WERE SIGNIFICANTLY ELEVATED AT 1040 U/L (10 3 NORMAL [N]) AND 8417 U/L (42 N), RESPECTIVELY",Amylase increased,SERUM AMYLASE INCREASED,AMYLASE INCREASED,GASTROINTESTINAL INVESTIGATIONS,DIGESTIVE ENZYMES,10022891,10040139,10002016,10040139
STEROID ACNE,Acne,STEROID ACNE,ACNE,SKIN APPENDAGE CONDITIONS,ACNES,10040785,10000517,10000496,10042023
PNEUMONIA (PSEUDOMONAS AERUGINOSA) PROGRESSION DUE TO TREATMENT FAILURE,pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
"BLOTCHY, ITCHY RASH THAT APPEARED ON HER HANDS, NECK, AND STOMACH",itchy rash,ITCHY RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023092,10037884,10023092
DRUG INTOLERANCE,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
SECONDARY ISCHEMIC HEPATITIS,Ischemic hepatitis,ISCHEMIC HEPATITIS,ISCHAEMIC HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10023040,10023025,10023040
ELEVATED TRANSAMINASES,Transaminases increased,TRANSAMINASES INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054889,10054889,10054889
REPEATED EPISODES OF CMV AND HHV6 REACTIVATIONS,human herpesvirus 6 infection reactivation,HUMAN HERPESVIRUS 6 INFECTION REACTIVATION,HUMAN HERPESVIRUS 6 INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10066845,10020431,10066845
SWELLING IN RIGHT DELTOID WITHIN A DAY OF HAVING IMMUNIZATIONS,Vaccination site swelling,VACCINATION SITE SWELLING,VACCINATION SITE SWELLING,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10069620,10069620,10069620
PARADOXICAL EFFECT ON HER PUPIL,Paradoxical drug reaction,PARADOXICAL DRUG REACTION,PARADOXICAL DRUG REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048958,10048958,10048958
SERUM CREATININE INCREASED (145 MUCROMOL/L),Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
"MASSIVE HYPERTRIGLYCERIDEMIA TRIGLYCERIDE (TG) VALUE =*3,500MG/DL), DESPITE ONGOING THERAPY WITH MICRONIZED FENOFIBRATE (160 MG/DAY), OMEGA-3-FATTY-ACIDS (6,000 MG/DAY),",Hypertriglyceridaemia,HYPERTRIGLYCERIDEMIA,HYPERTRIGLYCERIDAEMIA,LIPID METABOLISM DISORDERS,ELEVATED TRIGLYCERIDES,10027433,10020869,10020869,10020870
SEPTIC-TOXIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
HYPOCHONDRIAC FEARS,Hypochondriacal personality,HYPOCHONDRIACAL PERSONALITY,ILLNESS ANXIETY DISORDER,SOMATIC SYMPTOM AND RELATED DISORDERS,SOMATIC SYMPTOM DISORDERS,10037175,10020963,10078077,10020963
DRY TONGUE,dry tongue,TONGUE DRY,TONGUE DRY,TONGUE CONDITIONS,TONGUE SIGNS AND SYMPTOMS,10017947,10049713,10049713,10049713
TINGLING AND PAIN LOCATED IN HER THIGHS/LEG PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
ELEVATED KIDNEY FUNCTION PARAMETERS,Renal impairment,RENAL FUNCTION AGGRAVATED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038453,10062237,10038453
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
CHEST TIGHTNESS,chest tightness,CHEST TIGHTNESS,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008492,10008469,10008492
NOCTURNAL DISRUPTIVE BEHAVIORS,Behavior disorder,BEHAVIOR DISORDER,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004204,10061422,10004204
IMPAIRED QOL,Quality of life decreased,QUALITY OF LIFE DECREASED,QUALITY OF LIFE DECREASED,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",INVESTIGATIONS NEC,10022891,10067620,10067620,10067620
2-DAY OLD INFANT GIRL WITH AN AORTIC THROMBUS THAT HAD PROGRESSED TO OCCLUDE THE ILIAC ARTERIES BILATERALLY ON ANTICOAGULATION,Thrombosis,THROMBUS,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10080924,10043607,10080924
PATIENT WAS TAKING MYCOPHENOLATE MOFETIL FOR THE GIVEN INDICATION (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
FEBRILE,febrile reaction,FEBRILE REACTION,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016289,10037660,10016289
ACUTE DISSEMINATED ENCEPHALOMYELITIS,Acute disseminated encephalomyelitis,ACUTE DISSEMINATED ENCEPHALOMYELITIS,ACUTE DISSEMINATED ENCEPHALOMYELITIS,DEMYELINATING DISORDERS,DEMYELINATING DISORDERS NEC,10029205,10000709,10000709,10000709
PATIENT WAS TREATED WITH AZITHROMYCIN FOR CRYPTOSPORIDIOSIS ( OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LACK OF DRUG EFFECT WITH NO ADR,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SEVERE RELAPSING BACTERIAL PYELONEPHRITIS,Bacterial pyelonephritis,BACTERIAL PYELONEPHRITIS,BACTERIAL PYELONEPHRITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10059517,10059517,10059517
WBC INCREASED (14000 PER MCL),White blood cell count increased,WBC INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056739,10047943,10056739
"AMPHOTERICIN B, LIPOSOMAL USED FOR FUNGAL INFECTION FOR RHIZOPUS ARRHIZUS WITH NO CLINICAL IMPROVEMENT [DRUG INEFFECTIVE]",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
HYPOVOLEMIC SHOCK,hypovolemic shock,HYPOVOLEMIC SHOCK,HYPOVOLAEMIC SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10021140,10021138,10021140
LACK OF EFFECT,lack of effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
MULTIPLE ELECTROLYTE DEFICIENCY DUE TO RABEPRAZOLE SODIUM,electrolyte depletion,ELECTROLYTE DEPLETION,ELECTROLYTE DEPLETION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10014415,10014415,10014415
SLIT LAMP EXAM SHOWED KERATIC PRECIPITATES AND SEVERE IRITIS,Keratic precipitates,KERATIC PRECIPITATES,KERATIC PRECIPITATES,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CORNEAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10053703,10053703,10053703
MALIGNANT ASCITES FOLLOWING POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,Malignant ascites,MALIGNANT ASCITES,MALIGNANT ASCITES,NEOPLASM RELATED MORBIDITIES,ONCOLOGIC COMPLICATIONS AND EMERGENCIES,10029104,10025538,10025538,10025538
IMMUNE-MEDIATED NECROTIZING MYOPATHY,Immune-mediated necrotising myopathy,IMMUNE-MEDIATED NECROTIZING MYOPATHY,IMMUNE-MEDIATED NECROTISING MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10072155,10072155,10072156
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
TIREDNESS AND DYSPNOEA FOR MINOR EXERCISE ASSOCIATED WITH ORTHOPNOEA,Orthopnoea,ORTHOPNEA,ORTHOPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10031123,10031123,10031122
"DURING THE TREATMENT WITH ACYCLOVIR FOR 5 MONTHS, BUT WITHOUT EFFECT.",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LOST HIS WAY AND WANTS TO FINISH,psychiatric symptoms,PSYCHIATRIC SYMPTOM,PSYCHIATRIC SYMPTOM,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,PSYCHIATRIC SYMPTOMS NEC,10037175,10061472,10061472,10061472
RESTLESS,restless,RESTLESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038740,10038743,10038740
CYSTOID MACULAR EDEMA,cystoid macular edema,CYSTOID MACULAR EDEMA,CYSTOID MACULAR OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","RETINAL, CHOROID AND VITREOUS INFECTIONS AND INFLAMMATIONS",10015919,10051240,10058202,10051240
RIFAMPICIN INDUCED THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
SUDDEN DESATURATION,Oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
URINE ANALYSIS REVEALED NUMEROUS PUS CELLS,Pyuria,URINE CONTAINING PUS,PYURIA,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10037686,10037686,10046621
PULMONARY EDEMA,Pulmonary oedema,PULMONARY EDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037423,10037423,10037375
DISEASE RELAPSE,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
TENDENCY FOR RETROPULSION,Fall,LOSS OF POSTURE,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10024873,10016173,10024873
TWO WEEKS HISTORY OF PRODUCTIVE COUGH,Productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
POTASSIUM IODIDE IN TREATMENT OF SWEET'S SYNDROME (DRUG USE FOR UNAPPROVED INDICATION WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MYELOTOXICITY,Bone marrow toxicity,BONE MARROW TOXICITY,BONE MARROW TOXICITY,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10051779,10051779,10051779
PLASMA OSMOLALITY 255 MOSM/KG,Blood osmolarity decreased,PLASMA OSMOLALITY DECREASED,BLOOD OSMOLARITY DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",WATER AND ELECTROLYTE ANALYSES NEC,10022891,10035385,10005696,10035385
SPHINCTER OF ODDI DYSFUNCTION AGGRAVATION/HYPERTONIC,Sphincter of Oddi dysfunction,SPHINCTER OF ODDI DYSFUNCTION,SPHINCTER OF ODDI DYSFUNCTION,BILE DUCT DISORDERS,OBSTRUCTIVE BILE DUCT DISORDERS (EXCL NEOPLASMS),10019805,10066424,10066424,10066424
LYMPH FLOW DISORDER IN THE UPPER ARM,Lymphoedema,LYMPHOEDEMA,LYMPHOEDEMA,LYMPHATIC VESSEL DISORDERS,LYMPHOEDEMAS,10047065,10025282,10025282,10025282
SEVERE LIVER DAMAGE,Liver injury,LIVER DAMAGE,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067125,10067125,10024668
"MACULAR EDEMA SEEMED TO BE RESISTANT IN RESPONSE TO MULTIPLE BEVACIZUMAB INJECTIONS (OVERALL, 12 IN 16 MONTHS) AND INTRAVIFREAL TRIAMCINOLONE INJECTION/SATISFACTORY TREATMENT RESPONSE WAS NOT OBTAINED",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
PATIENT WAS STARTED ON INDOMETACIN 50 MG THRICE A DAY,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BOTH ARM PITS HAD HYPERPIGMENTATION,both arm pits had hyperpigmentation,HYPERPIGMENTATION SKIN,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10020715,10040865,10020715
LYELL'S SYNDROME,Toxic epidermal necrolysis,LYELL'S SYNDROME,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10025166,10044223,10025168
UNDERWENT FALL DUE TO HYPOGLYCEMIA,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
RESIDUAL BROWN PIGMENTATION,Pigmentation disorder,SKIN PIGMENTATION,PIGMENTATION DISORDER,PIGMENTATION DISORDERS,PIGMENTATION CHANGES NEC,10040785,10040910,10062080,10040910
MEDICATION ERROR,Medication error,MEDICATION ERROR,MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10027091,10027091,10027091
AUDITORY HALLUCINATIONS,"Hallucination, auditory",AUDITORY HALLUCINATIONS,"HALLUCINATION, AUDITORY",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019070,10019070,10003785
BLISTERING,blistering,BLISTERING,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005214,10005191,10005214
TREMOR IN THE EXTREMITIES,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
AMOXICILLIN-CLAVULANIC ACID-INDUCED LIVER INJURY,drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
DEHYDRATION FOLLOWING CYSTOISOSPORIASIS (CYSTOISOSPORA BELLI),Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
PARTIAL RESPONSE WITH NO ADR,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
HIRSUITISM,Hirsutism,HIRSUTISM,HIRSUTISM,SKIN APPENDAGE CONDITIONS,HYPERTRICHOSES,10040785,10020112,10020112,10020112
MEDICATION ERROR,Medication error,MEDICATION ERROR,MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10027091,10027091,10027091
DRESSLER'S SYNDROME/LARGE POST-INFARCTION PERICARDIAL EFFUSION,Dressler's syndrome,DRESSLER'S SYNDROME,DRESSLER'S SYNDROME,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10013637,10013637,10013637
HEPATITIS E VIRUS INFECTION,Hepatitis E,HEPATITIS E,HEPATITIS E,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10019768,10019768,10019768
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
INTENTIONAL SUSPECTED SUICIDE,Completed suicide,COMPLETED SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10010144,10010144,10010144
DRUG TOXICITY,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
CENTRAL NERVOUS SYSTEM DEPRESSION FOLLOWING ACCIDENTAL ONDANSETRON OVERDOSE,Depressed level of consciousness,DEPRESSION CENTRAL NERVOUS SYSTEM,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10012383,10012373,10012383
DECREASED PULSE OXIMETRIC SATURATION (89 PERCENT),Oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
PSYCHOMOTOR RETARDATION,psychomotor retardation,PSYCHOMOTOR RETARDATION,PSYCHOMOTOR RETARDATION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10037213,10037213,10037213
USE OF LEVETIRACETAM AT DOSES HIGHER THAN THE MAXIMUM RECOMMENDED,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
VENTILATORY IMPAIRMENT,Hypoventilation,VENTILATION DIFFICULT,HYPOVENTILATION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10047262,10021133,10047262
ECHOCARDIOGRAM DOCUMENTED A MODERATE LEFT VENTRICULAR (LV) SYSTOLIC DISFUNCTION,Left ventricular dysfunction,LEFT VENTRICULAR SYSTOLIC DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10069501,10049694,10069501
EMESIS,Vomiting,EMESIS,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10014542
GENERALIZED ITCHING/ GENERALISED PRURITUS,Pruritus generalised,GENERALISED PRURITUS,PRURITUS GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10052576,10052576,10074033
OFF LABEL USE,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INTOLERANCE TO NEUROLEPTICS AND SUSCEPTIBILITY FOR MALIGNANT HYPERTHERMIA,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
INEFFECTIVE DUAL ANTIPLATELET THERAPY,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
MULTIPLE AXILLARY LYMPHADENOPATHY,Lymphadenopathy,LYMPHADENOPATHY AXILLARY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10049109,10025197,10049109
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
NO LONGER ABLE TO SIT INDEPENDENT OF SUPPORT OR TO ASSIST WITH TRANSFERS.,loss of personal independence in daily activities,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10079487,10079487,10079487
SPORADIC INCLUSION BODY MYOSITIS,Inclusion body myositis,SPORADIC INCLUSION BODY MYOSITIS,INCLUSION BODY MYOSITIS,MUSCLE DISORDERS,MUSCLE INFECTIONS AND INFLAMMATIONS,10028395,10075052,10066407,10075052
VERAPAMIL INTOXICATION,Poisoning,INTOXICATION,POISONING,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10061355,10061355,10022727
NEUTROPHIL COUNT OF 390/ÎœL,Neutrophil count decreased,NEUTROPHIL COUNT LOW,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029369,10029366,10029369
DISEASE PROGRESSION,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
CK CONTINUED TO BE ABOVE THE NORMAL LIMIT / CK WAS FOUND TO BE OVER 11 TIMES THE NORMAL UPPER LIMIT,CK increased,CK INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10009219,10005470,10009219
INCOMPLETE EFFECT FOR HIEPRECHOLESTEROLEMIA,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
ARTHRALGIA,arthralgia,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
UREMIA (21.4MICROMOL/L),Azotaemia,UREMIA,AZOTAEMIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE COMPLICATIONS,10038359,10046320,10003885,10046369
CYTOTOXIC CHEMOTHERAPY,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
LOPERAMIDE INDUCED BRUGADA PATTERN (TYPE 1 BRUGADA PATTERN ON LEADS V1-V2),Electrocardiogram abnormal,BRUGADA-TYPE ECG,ELECTROCARDIOGRAM ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10069779,10014363,10069779
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
RETINAL DYSFUNCTION,Retinal function test abnormal,RETINAL FUNCTION TEST ABNORMAL,RETINAL FUNCTION TEST ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",OPHTHALMIC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10038866,10038866,10038866
LEFT VENTRICULAR EJECTION FRACTION OF 30%,Ejection fraction decreased,LEFT VENTRICULAR EJECTION FRACTION DECREASED,EJECTION FRACTION DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10053222,10050528,10053222
BILIRUBIN TOTAL INCREASED (4.57 MG/DL),Blood bilirubin increased,BILIRUBIN TOTAL INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056806,10005364,10056806
LATE CHRONIC ANEMIA/RELAPSED,chronic anaemia,CHRONIC ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10072868,10002034,10072868
MENSTRUAL CYCLE IS IRREGULAR,Irregular menstrual cycle,IRREGULAR MENSTRUAL CYCLE,MENSTRUATION IRREGULAR,MENSTRUAL CYCLE AND UTERINE BLEEDING DISORDERS,MENSTRUATION AND UTERINE BLEEDING NEC,10038604,10022991,10027339,10022991
PATIENT TREATED WITH METAMIZOLE AND AMOXICILLIN DESPITE PREVIOUSLY NOTED HISTORY OF DRUG ALLERGY (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ENTERITIS,Enteritis,ENTERITIS,ENTERITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10014866,10014866,10014866
ANOREXIA,Decreased appetite,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10002646
TACHYPNOEIC,tachypnoea,TACHYPNOEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043089
KLEBSIELLA PNEUMONIAE INFECTION,Klebsiella pneumoniae infection,KLEBSIELLA PNEUMONIAE INFECTION,KLEBSIELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10052209,10061259,10052209
ASCITES INCREASED,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
"COMBINED THERAPY OF LACOSAMIDE 100 MG/12 HOURS, CARBAMAZEPINE 200 MG/24 HOURS/ USED CONCOMITANTLY",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
VERTIGO,Vertigo,VERTIGO,VERTIGO,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10047340,10047340,10047340
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
PULMONARY SARCOIDOSIS DETERIORATION FOLLOWING REBOUND EFFECT OF PREDNISONE,Pulmonary sarcoidosis,PULMONARY SARCOIDOSIS,PULMONARY SARCOIDOSIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10037430,10037430,10037430
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
CRP WAS 32 MG/L,C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
EXTREMITIES WITH ELASTIC EDEMA,Oedema extremities,OEDEMA EXTREMITIES,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10055917,10030124,10055917
SWELLING ON LIPS AND TONGUE,swelling of lips and tongue,SWELLING OF LIPS,LIP SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10042703,10024570,10042703
REPEATED MYELOSUPPRESSION (CTCAE GRADE 1-3),Bone marrow failure,MYELOSUPPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10028584
DROPING OF HEAD,Dropped head syndrome,DROPPED HEAD SYNDROME,DROPPED HEAD SYNDROME,NEUROMUSCULAR DISORDERS,NEUROMUSCULAR DISORDERS NEC,10029205,10072442,10072442,10072442
BILATERAL IRIDOCYCLITIS,Iridocyclitis,IRIDOCYCLITIS,IRIDOCYCLITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10022941,10022941,10022941
MALABSORPTION,Malabsorption,MALABSORPTION,MALABSORPTION,MALABSORPTION CONDITIONS,MALABSORPTION SYNDROMES,10017947,10025476,10025476,10025476
ANTI YELLOW FEVER VIRUS IMMUNOGLOBULIN G ANTIBODY NEGATIVE,antibody test negative,ANTIBODY TEST NEGATIVE,ANTIBODY TEST NEGATIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOLOGY ANALYSES NEC,10022891,10061426,10061426,10061426
CEREBRAL TOXOPLASMOSIS,Cerebral toxoplasmosis,CEREBRAL TOXOPLASMOSIS,CEREBRAL TOXOPLASMOSIS,PROTOZOAL INFECTIOUS DISORDERS,TOXOPLASMA INFECTIONS,10021881,10057854,10057854,10057854
"INTRAOCULAR PRESSURE REMAINED HIGH DESPITE FULL MEDICAL THERAPY WITH DORZOLAMIDE, TIMOLOL, BRIMONIDINE, AND ORAL ACETAZOLAMIDE (LACK OF DRUG EFFECT).",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
BILATERAL SUBEPENDYMAL HAEMORRHAGES,Cerebral haemorrhage,SUBEPENDYMAL HEMORRHAGE,CEREBRAL HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10063734,10008111,10063736
APHASIA,Aphasia,APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002948,10002948,10002948
CARDIAC INSUFFICIENCY,Cardiac failure,CARDIAC INSUFFICIENCY,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10007554,10007554,10007582
LARGE HEMATOMA ON HER LEFT SHIN,Haematoma,HEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10019428
"TREATED WITH PROPOFOL, MIDAZOLAM, LEVETIRACETAM AND FINALLY PHENOBARBITAL BUT SEIZURES REMAINED UNABATED (LACK OF DRUG EFFECT)",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
VENLAFAXINE IV SELF-ADMINISTRATION,treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
LACK OF CONCENTRATION,poor concentration,POOR CONCENTRATION,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10036149,10013496,10036149
30 MONTH OLD PATIENT TREATED WITH SALBUTAMOL (DRUG USE FOR UNAPPROVED POPULATION) OFF LABEL USE WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RPR POSITIVE (1:32),Treponema test positive,RPR SYPHILIS TEST POSITIVE,TREPONEMA TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,BACTERIA IDENTIFICATION AND SEROLOGY (EXCL MYCOBACTERIA),10022891,10052519,10070158,10052519
INCOMPLETE IMPROVEMENT OF THE CLINICAL CONDITION,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
FEVER (40 DEGREE CELSIUS),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PUNCH BIOPSY FROM THE PERIPHERY OF ONE OF THE LESIONS REVEALED A DIFFUSE DERMAL PROLIFERATION OF LARGE ATYPICAL LYMPHOCYTES,Lymphocytic infiltration,LYMPHOCYTIC INFILTRATION,LYMPHOCYTIC INFILTRATION,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10062049,10062049,10062049
"ERYTHEMATOUS PRURITIC LESIONS IN THE FEET WITH PROGRESSION TO UPPER LIMBS,LOWER LIMBS AND TRUNK",Pruritus generalised,GENERALISED PRURITUS,PRURITUS GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10052576,10052576,10074033
CHILLS,chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
LOW VOLUME ASCITES,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
ABDOMINAL CRAMPS,Abdominal pain,ABDOMINAL CRAMPS,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000055,10000081,10000057
FEVERISH,feverish,FEVERISH,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10073718,10037660,10073718
SUICIDE ATTEMPT,suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
LOSS OF CYTOGENETIC RESPONSE,No therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
"MINOR HAEMORRHAGE, DARK RED DEPOSITION IN THE DRAINAGE ROUTE",Bloody discharge,BLOODY DISCHARGE,BLOODY DISCHARGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10057687,10057687,10057687
ITCHY SKIN AFFECTIONS,Pruritus,ITCHY SKIN,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023094,10037087,10023094
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
CHEST PAIN,chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
NECROSIS OF THE MANDIBLE AFTER BISPHOSPHONATES,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
HEPATIC PAIN,Hepatic pain,HEPATIC PAIN,HEPATIC PAIN,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019705,10019705,10019705
CELLULITIS,Cellulitis,CELLULITIS,CELLULITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10007882,10007882,10007882
DETORIOTING CONDITION,Condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
CRYPTOCOCCUS NEOFORMANS INFECTION,Cryptococcus neoformans,CRYPTOCOCCUS NEOFORMANS,CRYPTOCOCCOSIS,FUNGAL INFECTIOUS DISORDERS,CRYPTOCOCCAL INFECTIONS,10021881,10011491,10011490,10011491
INTERSTITIAL FIBROSIS,interstitial fibrosis,FIBROSIS KIDNEY,KIDNEY FIBROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL DISORDERS NEC,10038359,10016647,10023421,10016647
GRADE 3 ATRIAL FIBRILLATION,Atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
SLURRED SPEECH FOLLOWING MULTIPLE DRUG POISONING,Dysarthria,SLURRED SPEECH,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041053,10013887,10041053
SUBARACHNOID HEMORRHAGE/ INTRAPARENCHYMAL HEMORRHAGE,Subarachnoid hemorrhage,SUBARACHNOID HEMORRHAGE,SUBARACHNOID HAEMORRHAGE,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10042320,10042316,10042320
POOR RESPONSE TO IMATINIB,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PARESTHESIA,Paraesthesia,PARESTHESIA,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10033775,10033775,10033987
PLEURAL EFFUSION,pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
PATIENT RECEIVED METHOTREXATE DURING PREGNANCY (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ANTICOAGULANTS APPEAR TO MAGNIFY EACH OTHER'S EFFECTS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
WORSENING HYPOXIA,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
SUBOPTIMAL RESPONSE OF IMATINIB DUE TO DRUG INTERACTION BETWEEN IMATINIB AND PHENYTOIN,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
HYPOPROTEINAEMIA,Hypoproteinaemia,HYPOPROTEINAEMIA,HYPOPROTEINAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10021083,10021083,10021083
GENERALIZED RASH,generalized rash,GENERALIZED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10049201,10037858,10049201
ADENOVIRUS REACTIVATION,Adenovirus infection,ADENOVIRUS INFECTION,ADENOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,ADENOVIRAL INFECTIONS,10021881,10060931,10060931,10060931
BRADYKINESIA,bradykinesia,BRADYKINESIA,BRADYKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10006100,10006100,10006100
CARDIOTOXICITY,cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
CHRONIC WATERY DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
DETERIORATION OF EGFR IS STRONGLY LINKED TO ENHANCED PLATELET ACTIVITY DURING DAPT,Renal impairment,RENAL FUNCTION AGGRAVATED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038453,10062237,10038453
DEHYDRATION,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
DRUG RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
NO ADVERSE DRUG REACTION,no adverse drug reaction,NO ADVERSE DRUG REACTION,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067481,10067482,10067481
BLEEDING AND THROMBOTIC COMPLICATIONS,Gastrointestinal haemorrhage,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017936
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
SEVERE INTERSTITIAL PNEUMONIA,Interstitial lung disease,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
GRADE 4 TRANSAMINITIS,Transaminases increased,TRANSAMINITIS,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054969,10054889,10054969
NEONATAL HAEMORRHAGIC DISEASE FOLLOWING DRUG EXPOSURE IN UTERO,Haemorrhagic disease of newborn,HEMORRHAGIC DISEASE OF NEWBORN,HAEMORRHAGIC DISEASE OF NEWBORN,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),BLEEDING TENDENCIES,10005329,10019008,10019008,10019601
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
MUCOSITIS,mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
NEUTROPENIA DURING FAMILIAL MEDITERRANEAN FEVER ATTACKS FOLLOWING NON COMPLIANCE TO COLCHICINE,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
EPHEDRINE OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
SEVERE ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
INVOLUNTARY BOWEL AND BLADDER HABIT,Anal incontinence,INVOLUNTARY BOWEL MOVEMENT,ANAL INCONTINENCE,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10065601,10077605,10065601
HYPOESTHESIA,Hypoesthesia,HYPOESTHESIA,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10020976,10020937,10020976
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
ANTI YELLOW FEVER VIRUS IMMUNOGLOBULIN G ANTIBODY NEGATIVE,antibody test negative,ANTIBODY TEST NEGATIVE,ANTIBODY TEST NEGATIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOLOGY ANALYSES NEC,10022891,10061426,10061426,10061426
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
"ADDITIVE EFFECTS OF HALOPERIDOL, AND INCREASING CLOZAPINE AND VALPROATE DOSES",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
NODULE ON THE LEFT FOOT,Skin mass,SUBCUTANEOUS NODULE,SKIN MASS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS CONDITIONS NEC,10040785,10042348,10067868,10042348
PIGMENT DISPERSION IN THE IRIDOCORNEAL ANGLE DUE TO BILATERAL ACUTE IRIS TRANSILLUMINATION,Pigment dispersion syndrome,PIGMENT DISPERSION SYNDROME,PIGMENT DISPERSION SYNDROME,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","IRIS AND CILIARY BODY STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10052134,10052134,10052134
ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,Acute generalised exanthematous pustulosis,ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10062372
INCREASED 25-HYDROXYCHOLECALCIFEROL (555 NG/DL),Blood 25-hydroxycholecalciferol increased,BLOOD 25-HYDROXYCHOLECALCIFEROL INCREASED,BLOOD 25-HYDROXYCHOLECALCIFEROL INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",VITAMIN ANALYSES,10022891,10053812,10053812,10053812
OCCASIONAL REDNESS OF EYES,Ocular hyperaemia,REDNESS OF EYES,OCULAR HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10015963,10030041,10038205
AST INCREASED (169.1 U/L),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
ELATED MOOD,Mood elevated,MOOD ELEVATED,EUPHORIC MOOD,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10027949,10015535,10027949
"MULTIPLE ULCERATED PALQUES ON LEFT HAND, WRIST AND LEFT FOOT",Ulcer,ULCER,ULCER,TISSUE DISORDERS NEC,ULCERS NEC,10018065,10045285,10045285,10045285
DRUG INTERACTION,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
TREATMENT WAS INEFFECTIVE/USE OF AN ANTIDEPRESSANT WAS NOT EFFECTIVE/TREATMENT DID NOT WORK,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
VANISHING BILE DUCT SYNDROME (SIGNIFICANT DUCTOPENIA (>50% DECREASE IN THE BILE DUCTS)),Vanishing bile duct syndrome,VANISHING BILE DUCT SYNDROME,VANISHING BILE DUCT SYNDROME,BILE DUCT DISORDERS,STRUCTURAL AND OTHER BILE DUCT DISORDERS,10019805,10054753,10054753,10054753
UNABLE TO TOLERATE ORAL INTAKE,Oral intake reduced,ORAL INTAKE REDUCED,HYPOPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10063889,10063743,10063889
ENLARGED PANNUS WITH INTERNAL UMBILICUS,Abdominal fat apron,ABDOMINAL FAT APRON,ABDOMINAL FAT APRON,ABDOMINAL HERNIAS AND OTHER ABDOMINAL WALL CONDITIONS,ABDOMINAL WALL CONDITIONS NEC,10017947,10077983,10077983,10077983
ACTUTE INFECTIOUS ENDOCARDITIS DUE  TO CLOSTRIDIUM SEPTICUM INFECTION FOLLOWING CONDITION AGGRAVATED,Acute endocarditis,ACUTE ENDOCARDITIS,ACUTE ENDOCARDITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CARDIAC INFECTIONS,10021881,10049001,10049001,10049001
RENAL DYSFUNCTION,Renal impairment,KIDNEY DYSFUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10023417
THE PATIENT WAS TREATED WITH IMIQUIMOD FOR LENTIGO MALIGNA (OFF-LABEL),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MULTIPLE ORGAN FAILURE,Multiple organ dysfunction syndrome,MULTIPLE ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028237
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
ANGULAR CHEILITIS,Angular cheilitis,ANGULAR CHEILITIS,ANGULAR CHEILITIS,INFECTIONS - PATHOGEN UNSPECIFIED,DENTAL AND ORAL SOFT TISSUE INFECTIONS,10021881,10002509,10002509,10002509
"BLISTERS APPEARED ON NECK, BACK,ABDOMEN,LOWER ARMS, LEGS AND FEET",Blister,BLISTERS,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005216
RAPID AGGRAVATION OF INTERSTITIAL PNEUMONITIS AND PH,Pulmonary hypertension,PULMONARY HYPERTENSION,PULMONARY HYPERTENSION,PULMONARY VASCULAR DISORDERS,PULMONARY HYPERTENSIONS,10038738,10037400,10037400,10037400
RIGHT EYE PAIN,eye pain,EYE PAIN,EYE PAIN,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10015958,10015958,10015958
HYPERSALIVATION,hypersalivation,HYPERSALIVATION,SALIVARY HYPERSECRETION,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10020746,10039424,10020746
SIGNIFICANT GINGIVAL HYPERPLASIA,Gingival hypertrophy,GINGIVAL HYPERPLASIA,GINGIVAL HYPERTROPHY,DENTAL AND GINGIVAL CONDITIONS,GINGIVAL DISORDERS NEC,10017947,10018283,10018284,10018283
EDEMA,Injection site oedema,INJECTION SITE EDEMA,INJECTION SITE OEDEMA,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022085,10022085,10022058
ACUTE CHLOROQUINE POISONING,Drug poisoning,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
ANAEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
TONIC-CLONIC SEIZURE,tonic-clonic seizure,TONIC-CLONIC SEIZURES,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10044000,10018100,10044000
MILD SYMPTOMATIC NEPHROLITHIASIS/RENAL STONE WAS RECOVERED FROM THE URINE,Nephrolithiasis,NEPHROLITHIASIS RECURRENT,NEPHROLITHIASIS,UROLITHIASES,RENAL LITHIASIS,10038359,10066652,10029148,10066652
SEIZURE-LIKELY ACTIVITY AT HOME DUE TO LOPERAMIDE TOXICITY FOLLOWING DRUG MISUSE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
"WHITE BLOOD CELL COUNT 6,200 WITH 58% POLYMORPHONUCLEAR LEUKOCYTES AND 38% LYMPHOCYTES",Lymphocyte percentage increased,LYMPHOCYTE PERCENTAGE INCREASED,LYMPHOCYTE PERCENTAGE INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10052232,10052232,10052232
INFECTION,infection NOS,INFECTION NOS,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021842,10021789,10021842
SD-OCT SHOWED DEFECT IN THE PARACENTRAL PHOTORECEPTOR LAYER WITH THE FIELD TEST REVEALING DENSE PARACENTRAL RING SCOTOMA WITH DECREASED FOVEAL SENSITIVITY IN BOTH EYES,Visual field defect,CENTRAL SCOTOMA,VISUAL FIELD DEFECT,NEUROLOGICAL DISORDERS OF THE EYE,NEUROLOGIC VISUAL PROBLEMS NEC,10029205,10007973,10047555,10007973
NEOSTIGMINE WAS USED FOR THYROID STORM INDUCED SEVERE TACHYCARDIA WITH NO ADR (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"EXTREMELY PAINFUL ECCHYMOTIC AREA, HARD ON PALPITATION AT THE SITE OF INJECTION",Injection site haemorrhage,ECCHYMOSIS INJECTION SITE,INJECTION SITE HAEMORRHAGE,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022057,10022067,10014081
DRUG-ALCOHOL INTERACTION,Alcohol interaction,ALCOHOL INTERACTION,ALCOHOL INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10001597,10001597,10001597
DRUG TOXICITY,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
CHILLS,chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
DRUG INTERACTION BETWEEN ENZALUTAMIDE AND DIGOXIN,Drug Interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
BLOODY STOOL WITH MAJOR BLEEDING,Haematochezia,BLOODY STOOL,HAEMATOCHEZIA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10005873,10018836,10005873
HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
RESPIRATORY FAILURE,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
SYMPTOMS OF LEFT VENTRICULAR FAILURE,left ventricular failure,LEFT VENTRICULAR FAILURE,LEFT VENTRICULAR FAILURE,HEART FAILURES,LEFT VENTRICULAR FAILURES,10007541,10024119,10024119,10024119
ALL LESIONS REMITTED WITH THE EXCEPTION OF THE ULCER IN THE UPPER SURFACE OF THE LEFT FOOT (POSSIBLE LACK OF EFFICACY),Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
"ABDOMEN WAS DIFFUSELY TENDER, MOST MARKEDLY IN THE EPIGASTRIUM",Tenderness epigastric,TENDERNESS EPIGASTRIC,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10043227,10000097,10043227
BLOOD GLUCOSE LEVEL BEFORE SLEEP INCREASED TO 503 MG/DL,Blood glucose increased,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10005557,10005557,10005557
VALPROATE-INDUCED COMA DUE TO WORSENING OF CARNITINE INSUFFICIENCY AND KETOSIS,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
INVOLUNTARY JERKS THROUGH HIS WHOLE BODY,Jerkiness,JERKINESS,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10023188,10013916,10023188
CARDIAC FAILURE DUE TO THROMBOTIC THROMBOCYTOPAENIC PURPURA,Cardiac failure,CARDIAC FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10007554,10007554,10007554
PRESERVED BIVENTRICULAR SYSTOLIC FUNCTION,ventricular dysfunction,VENTRICULAR DYSFUNCTION,VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10059056,10059056,10059056
"COLD EXTREMITIES WITH ACROCYANOSIS OF THE RIGHT HAND AND BOTH FEET, ALTHOUGH WITH AUDIBLE PULSE",Acrocyanosis,ACROCYANOSIS,CYANOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10000592,10011703,10000592
MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
RASH,rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
"ABSENCE OF RESPONSE ON TREATMENTS WITH HYDROXYCHLOROQUINE, RITUXIMAB AND CYCLOSPORINE",No therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
NO POSITIVE EFFECT WAS IDENTIFIED (LACK OF EFFICACY),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
COAGULOPATHY,Coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FOCAL LEFT ARM MOTOR SEIZURE,Partial seizures,FOCAL SEIZURES,PARTIAL SEIZURES,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10016843,10061334,10016843
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
SHOULDER HAD NO MOTOR FUNCTION,shoulder,MOTOR ACTIVITY RETARDED,HYPOKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10027992,10021021,10027992
FALL/COLLAPSE DUE TO RIVASTIGMINE INDUCED HEART BLOCK,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
ATRIAL FIBRILLATION AND RAPID VENTRICULAR RATE WAS REFRACTORY TO HER USUAL COMBINATION DOSES OF 'PILLIN-IN-POCKET' METOPROLOL (25 MG) AND FLECAINIDE (100 MG),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ACUTE SKIN AND ORAL GVHD,GvHD,GVHD,GRAFT VERSUS HOST DISEASE,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10018799,10018651,10018799
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
SERUM BETA-D-GLUCAN LEVEL 76.1 PG/ML (NORMAL RANGE <20 PG/ML),Blood beta-D-glucan increased,BLOOD BETA-D-GLUCAN INCREASED,BLOOD BETA-D-GLUCAN INCREASED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,FUNGUS IDENTIFICATION AND SEROLOGY,10022891,10051793,10051793,10051793
LEUCOPENIA,leucopenia,LEUCOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024283,10024384,10024283
AGGRESSIVE BEHAVIOR,Aggression,AGGRESSIVE BEHAVIOR,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001490,10001488,10062375
SHOCK,Shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
TOXICITY,toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
DIARRHEA,Diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BULLOUS LESION ON THE DORSUM OF HIS NOSE,Dermatitis bullous,BULLOUS LESIONS,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006565,10012441,10006565
AGGRESSIVE EPISODE AT HOME/AGGRESSIVE EPISODE TOWARDS HIS MOTHER AND HOME APPLIANCES,Aggression,AGGRESSION,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001488,10001488,10001488
EYE PAIN,Eye pain,EYE PAIN,EYE PAIN,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10015958,10015958,10015958
VENTRICULAR TRIGEMINY,ventricular trigeminy,VENTRICULAR TRIGEMINY,VENTRICULAR EXTRASYSTOLES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10050780,10047289,10050780
LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
THE PLASMA GLUCOSE LEVEL OF 70 MG/DL ON FREESTYLE LIBRE WHICH IS NOT THE ACTUAL BLOOD SUGAR LEVEL(SUSPECTED HYPOGLYCAEMIA),Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
SIGNIFICANT RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
HEPATOTOXICITY,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
OFF LABEL USE,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CRP WAS ELEVATED AT 16.2 MG/DL,CRP increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
STEVENS-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEDATIVE EFFECT INCLUDING THE RESPIRATORY CENTER EFFECT,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
SHE DEVELOPED SHOOTING PAINS IN HER LEGS AND FEET,Pain in extremity,LEG PAIN,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033473,10033425,10024130
INTERMITTENT EPISODES OF BLOODY STOOLS,Haematochezia,BLOODY STOOL,HAEMATOCHEZIA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10005873,10018836,10005873
REMITTING SERONEGATIVE SYMMETRICAL SYNOVITIS WITH PITTING EDEMA,Seronegative arthritis,REMITTING SERONEGATIVE SYMMETRICAL SYNOVITIS WITH PITTING OEDEMA SYNDROME,SERONEGATIVE ARTHRITIS,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10065225,10062164,10065225
CELLULITIS,Cellulitis,CELLULITIS,CELLULITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10007882,10007882,10007882
SWEATING,hyperhidrosis,SWEATING,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042670,10020642,10042661
CEREBRAL ASPERGILLOSIS (ASPERGILLUS WAS CULTURED FROM CENTRAL LINE TIP),Cerebral aspergillosis,CEREBRAL ASPERGILLOSIS,CEREBRAL ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10051597,10051597,10051597
DEHYDRATED APPEARANCE,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
DESQUAMATIVE ERYTHTRODERMA,skin erythema desquamative,SKIN ERYTHEMA DESQUAMATIVE,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040843,10040844,10040843
INCREASE IN CREATINE PHOSPHOKINASE (CPK),Blood creatine phosphokinase increased,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10005470,10005470,10005470
DRUG INTOLERANCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
PAIN INCREASED AT PALPATION,Pain,PAIN AGGRAVATED,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033396,10033371,10033376
METASTATIC WILMS TUMOR RELAPSE,Nephroblastoma,WILMS TUMOR,NEPHROBLASTOMA,RENAL AND URINARY TRACT NEOPLASMS MALIGNANT AND UNSPECIFIED,RENAL NEOPLASMS MALIGNANT,10029104,10047986,10029145,10047985
BETA-HCG LEVEL RAPIDLY ELEVATED TO 15000IU/ML,beta-HCG level rapidly elevated to 15000IU/mL,BLOOD BETA HUMAN CHORIONIC GONADOTROPIN INCREASED,HUMAN CHORIONIC GONADOTROPIN INCREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),REPRODUCTIVE HORMONE ANALYSES,10022891,10066033,10071332,10066033
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
BAD MOOD,Mood altered,BAD MOOD,MOOD ALTERED,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10004064,10027940,10004064
"BOWEL WALL THICKENING OF THE CECUM, ASCENDING, AND PROXIMAL TRANSVERSE COLON WITH PNEUMATOSIS OF CECUM AND PORTAL VENOUS GAS",Pneumatosis,PNEUMATOSIS,PNEUMATOSIS,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10051986,10051986,10051986
PROFOUND ACIDEMIA ( PH 7),Acidosis,ACIDEMIA,ACIDOSIS,ACID-BASE DISORDERS,MIXED ACID-BASE DISORDERS,10027433,10060699,10000486,10060694
EYE INFECTION,Eye Infection ,EYE INFECTION,EYE INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10015929,10015929,10015929
RUBELLA INFECTION IN THE NEONATE/ CONGENITAL RUBELLA SYNDROME,Congenital rubella infection,CONGENITAL RUBELLA INFECTION,CONGENITAL RUBELLA INFECTION,INFECTIONS AND INFESTATIONS CONGENITAL,VIRAL INFECTIONS CONGENITAL,10010331,10010619,10010619,10010619
AMIODARONE-INDUCED PULMONARY TOXICITY,Pulmonary toxicity,PULMONARY TOXICITY,PULMONARY TOXICITY,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10061924,10061924,10061924
MUCOUS MEMBRANE DISORDER SUCH AS STOMATITIS,Mucous membrane disorder,MUCOUS MEMBRANE DISORDER,MUCOUS MEMBRANE DISORDER,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028133,10028133,10028133
FOCAL LESIONS IN THE RIGHT TEMPORAL REGION,Brain lesion,BRAIN LESION,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10067294,10051290,10067294
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
DELIBERATE OVERDOSE OF LAMOTRIGINE,Intentional overdose,DELIBERATE OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10012211,10022523,10012211
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
MYALGIA,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
NO ADVERSE REACTION,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
INDIRECT HYPERBILIRUBINAEMIA (90.29UMOL/L),Hyperbilirubinaemia,INDIRECT HYPERBILIRUBINAEMIA,HYPERBILIRUBINAEMIA,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10075822,10020578,10075822
TUBULOPATHY,Renal tubular disorder,RENAL TUBULAR DISORDER,RENAL TUBULAR DISORDER,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10038537,10038537,10038537
FOAMING AT THE MOUTH,Foaming at mouth,FOAMING AT MOUTH,FOAMING AT MOUTH,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10062654,10062654,10062654
STAGE 1A ENDOMETRIOID OVARIAN CANCER,Ovarian endometrioid carcinoma,OVARIAN ENDOMETRIOID CARCINOMA,OVARIAN ENDOMETRIOID CARCINOMA,REPRODUCTIVE NEOPLASMS FEMALE MALIGNANT AND UNSPECIFIED,OVARIAN NEOPLASMS MALIGNANT (EXCL GERM CELL),10029104,10073269,10073269,10073269
UNSTABLE ARTERIAL HYPERTENSION MAX. 190/110 MMHG (PRIMARY ARTERIAL HYPERTENSION OF GRADE 3),labile hypertension,LABILE HYPERTENSION,LABILE HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10049079,10049079,10049079
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
MASTALGIA,Breast pain,MASTALGIA,BREAST PAIN,BREAST DISORDERS,BREAST SIGNS AND SYMPTOMS,10038604,10006298,10006298,10026876
ESCHERICHIA COLI INFECTION,Escherichia infection,ESCHERICHIA COLI INFECTION,ESCHERICHIA INFECTION,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10061126,10061126,10054242
LUNG MASS PROGRESSED,lung mass,LUNG MASS,PULMONARY MASS,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10056355,10056342,10056355
WHITE BLOOD CELL INCREASED (16.2 X10E9),White blood cell count increased,WHITE BLOOD CELL INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10049183,10047943,10049183
CHEST PAIN,chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
HEMOGLOBIN 10.5G/DL,Haemoglobin decreased,HEMOGLOBIN LOW,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018889,10018884,10055600
RESPIRATORY DISTRESS WITH NEUROLOGIC DEPRESSION,respiratory distress with neurologic depression,RESPIRATORY DISTRESS NEONATAL,NEONATAL RESPIRATORY DISTRESS,NEONATAL RESPIRATORY DISORDERS,NEONATAL HYPOXIC CONDITIONS,10038738,10038688,10028973,10038688
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS FLARED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
BACTERIAL BRONCHO-PNEUMONIA,Pneumonia,BRONCHOPNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10006469,10035664,10006469
DARK URINE,Chromaturia,URINE DISCOLORATION,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10046629,10008796,10046628
PROGRESSION OF LUNG CANCER WITH THE DEVELOPMENT OF BRAIN METASTASIS DESPITE 5 CYCLES OF TREATMENT (LACK OF DRUG EFFECT),Lung cancer metastatic,LUNG CANCER METASTATIC,LUNG CANCER METASTATIC,RESPIRATORY AND MEDIASTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,RESPIRATORY TRACT AND PLEURAL NEOPLASMS MALIGNANT CELL TYPE UNSPECIFIED NEC,10029104,10050017,10050017,10050017
CARDIAC SOUNDS DIFFERED FROM THE PREVIOUS ONES / SEPARATE HEART SOUND WAS HEARD,Heart sound abnormal,HEART SOUND ABNORMAL,HEART SOUNDS ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC AUSCULTATORY INVESTIGATIONS,10022891,10019309,10019311,10019309
SHOWED NO SIGNS OF IMPROVEMENT,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
SHE HAD AN UNEXPECTED CARDIOPULMONARY ARREST DUE TO ANOTHER SUICIDE ATTEMPT BY TAKING A BOX OF WARFARIN SODIUM,Suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
10 EPISODES OF FEVER IN NEUTROPENIA,Neutropenic fever,NEUTROPENIC FEVER,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10051312,10016288,10051312
PERIPHERAL NERVE DISORDER,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
REBOUND EFFECT,rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
ABASIA,Abasia,ABASIA,GAIT INABILITY,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10049460,10017581,10049460
WEAKNESS OF THE PROXIMAL MUSCLES OF BOTH ARMS AND LEGS/ WEAKNESS OF SHOULDER AND PELVIC GIRDLES,Muscular weakness,MUSCLE WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028372,10028372,10028350
PATIENT HAD DIARRHEA WITH UNRESPONDING METRONIDAZOL TREATMENT FOR 10 DAYS ( LACK OF DRUG EFFECT) WITH NO ADVERSE DRUG REACTION,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
WEIGHT LOSS,Weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
INFILTRATION,Hepatic steatosis,FATTY LIVER INFILTRATION,HEPATIC STEATOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10024685,10019708,10016263
TRACHEOESOPHAGEAL FISTULA,Tracheo-oesophageal fistula,TRACHEOESOPHAGEAL FISTULA,TRACHEO-OESOPHAGEAL FISTULA,RESPIRATORY DISORDERS CONGENITAL,LARYNGEAL AND TRACHEAL DISORDERS CONGENITAL,10010331,10044310,10044310,10044317
"WITH SURFACE OOZING, CRUSTING AND BLEEDING POINTS OVER",wound secretion,WOUND OOZING,WOUND SECRETION,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10058997,10048629,10058997
SEVERE VENO-OCCLUSIVE DISEASE,Venoocclusive disease,VENOOCCLUSIVE DISEASE,VENOOCCLUSIVE DISEASE,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10062173,10062173,10062173
TOXICITY UP TO GRADE III,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
WORSENING NON PRODUCTIVE COUGH,Cough,COUGH NONPRODUCTIVE,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10013773,10011224,10011229
GENERALIZED ERYTHEMATOUS ANNULAR LESIONS AND PLAQUES,Generalized rash,GENERALIZED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10049201,10037858,10049201
PNEUMOCYSTIS JIROVECI PNEUMONIA FOLLOWING LYMPHOPENIA,Pneumocystis jirovecii pneumonia,PNEUMOCYSTIS JIROVECI PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10073755,10073755,10064108
DRUG EXPOSURE DURING PREGNANCY WITH NO ADR,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
INCREASED DEPRESSION SYMTOMS,Depression,DEPRESSION NOS,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012387,10012378,10012387
TENESMUS,Rectal tenesmus,RECTAL TENESMUS,RECTAL TENESMUS,ANAL AND RECTAL CONDITIONS NEC,ANAL AND RECTAL SIGNS AND SYMPTOMS,10017947,10057071,10057071,10057071
LACK OF DRUG EFFECT,LACK OF DRUG EFFECT,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
"PATIENT WAS INITIALLY PLACED ON AMIODARONE HYDROCHLORIDE, HOWEVER NSVT PERSISTED",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
COMPLICATIONS ASSOCIATED WITH LEG VARICOSE VEINS,COMPLICATIONS ASSOCIATED WITH LEG VARICOSE VEINS,PERIPHERAL VASCULAR DISORDER NOS,PERIPHERAL VASCULAR DISORDER,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10034637,10034636,10034637
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
DIFFUSE BILATERAL ACUTE INTERSTITIAL PNEUMONITIS ASSOCIATED WITH MOPP CHEMOTHERAPY,Acute interstitial pneumonitis,ACUTE INTERSTITIAL PNEUMONITIS,ACUTE INTERSTITIAL PNEUMONITIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10066728,10066728,10066728
GFR DECREASED (15-29 ML/MIN),Glomerular filtration rate decreased,GFR DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018214,10018358,10018214
SUSPECTED FLUPIRTINE-INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
METHOTREXATE PRESCRIBED FOR INFLAMMATORY BOWEL DISEASE,methotrexate prescribed for inflammatory bowel disease,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LACK OF EFFICACY,Lack of efficacy,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
STERILE ABSCESS VACCINE REACTION,Abscess sterile,ABSCESS STERILE,ABSCESS STERILE,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10000317,10000317,10000317
DRAMATIC MINOCYCLINE PIGMENTATION,Hyperpigmentation skin,HYPERPIGMENTATION SKIN,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10020715,10040865,10020715
POLYARTHRALGIA,polyarthralgia,POLYARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10036029,10003239,10036029
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
UNRESPONSIVE/DECREASING RESPONSIVENESS/UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
PAIN LOCALIZED TO THE GROIN AREA,Groin pain,GROIN PAIN,GROIN PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,SOFT TISSUE DISORDERS NEC,10028395,10018735,10018735,10018735
BLOOD PRESSURE INCREASED (175/100 MMHG),Blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
AMIODARONE-INDUCED THYROTOXICOSIS,Hyperthyroidism,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RECURRENCE OF URTICARIA SYMPTOMS AFTER PREDNISOLONE TAPER(REBOUND EFFECT),rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
BREATHING RATE WAS 36/MIN,Respiratory rate decreased,BREATHING RATE SLOWED,RESPIRATORY RATE DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10038710,10038710,10006341
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
BRONCHOSPASM,bronchospasm,BRONCHOSPASM,BRONCHOSPASM,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10006482,10006482,10006482
RISE IN TROPONIN LEVELS,Troponin increased,TROPONIN INCREASED,TROPONIN INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10058267,10058267,10058267
NON EXERTIONAL SHORTNESS OF BREATH OF FEW DAYS DURATION,Shortness of breath,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
MILD THROMBOCYTOPENIA/CLOZAPINE INDUCED THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
PANCYTOPENIA,pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
HEMOLYTIC ANEMIA,hemolytic anemia,HEMOLYTIC ANEMIA,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10019493,10018916,10019493
APIDLY COALESCED AND PRESENTED AS ERYTHRODERMA,apidly coalesced and presented as erythroderma,DERMATITIS EXFOLIATIVE,DERMATITIS EXFOLIATIVE,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10012455,10012455,10012455
TREATMENT-RESISTANT HYPERTENSION,Hypertension aggravated,HYPERTENSION AGGRAVATED,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020773,10020772,10020773
AGITATION,agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
CARDIOGENIC SHOCK,Cardiogenic shock,CARDIOGENIC SHOCK,CARDIOGENIC SHOCK,HEART FAILURES,HEART FAILURES NEC,10007541,10007625,10007625,10007625
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
MULTIPLE RASHES,Multiple rashes,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
"STIGMAS OF PARKINSONISM (TREMORS, APATHY, HYPOPHONY)",Parkinsonism,PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034010,10034010,10034010
PURULENT DISCHARGE,Purulent discharge,PURULENT DISCHARGE,PURULENT DISCHARGE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10037569,10037569,10037569
DRUG-INDUCED IDIOPATHIC THROMBOCYTOPENIC PURPURA,drug-induced idiopathic thrombocytopenic purpura,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IMMUNE THROMBOCYTOPENIC PURPURA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10021245,10074667,10021245
MOTOR AND SENSORY LOSS OF BOTH LOWER EXTREMITIES/PARAPLEGIA DUE TO ACUTE SPINAL SUBDURAL HEMORRHAGE,motor and sensory loss of both lower extremities/paraplegia due to acute spinal subdural hemorrhage,PARAPLEGIA,PARAPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10033892,10033892,10033892
"THROMBOCYTOPENIA (PLATELET COUNT 58,000/MM3) FOLLOWING METHOTREXATE OVERDOSE DUE TO DRUG DISPENSING ERROR FOLLOWING INAPPROPRIATE SELF MEDICATION",Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
MODERATE HEPATIC IMPAIRMENT,hepatic impairment,HEPATIC IMPAIRMENT,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10052254,10019670,10052254
DIARRHOEA,diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
IMPAIRMENT OF CONSCIOUSNESS GCS 7,Altered state of consciousness,ALTERED STATE OF CONSCIOUSNESS,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10001854,10001854,10001854
HEPARIN-INDUCED HAEMORRHAGIC BULLOUS DERMATOSES ON THE LEG,Dermatitis bullous,BULLOUS DERMATITIS,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10012441,10012441,10006556
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
VARICELLA ZOSTER REACTIVATION,varicella zoster reactivation,VARICELLA ZOSTER VIRUS INFECTION,VARICELLA ZOSTER VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10075611,10075611,10075611
ACUTE ARTERIAL ISCHEMIA IN THE LEFT LEG SECONDARY TO A POPLITEAL ARTERIAL THROMBOSIS,Acute limb ischaemia,ACUTE LIMB ISCHAEMIA,PERIPHERAL ISCHAEMIA,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10077113,10034576,10077113
GRADE 1-2 ACNEIFORM RASH,Rash acneiform,RASH ACNEIFORM,DERMATITIS ACNEIFORM,SKIN APPENDAGE CONDITIONS,ACNES,10040785,10037847,10012432,10037847
TUBERCULOSIS ABSCESS FOLLOWING CEREBRAL TUBERCULOSIS,Tuberculosis,TUBERCULOUS ABSCESS,TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10056684,10044755,10056684
ACUTE RENAL FAILURE,acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
POOR CLINICAL RESPONSE FOLLOWIMG TREATMENT WITH CYCLOPHOSPHAMIDE FOR CEREBRAL AMYLOID ANGIOPATHY (CAA-I) (OFF LABEL USE WITH NO ADR)),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG EXPOSURE VIA BREAST MILK,Drug exposure via breast milk,DRUG EXPOSURE VIA BREAST MILK,EXPOSURE VIA BREAST MILK,"EXPOSURES, CHEMICAL INJURIES AND POISONING",PATHWAYS AND SOURCES OF EXPOSURE,10022117,10051075,10080751,10051075
PROGRESSIVE NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ACUTE PANCREATITIS,Pancreatitis acute,ACUTE PANCREATITIS,PANCREATITIS ACUTE,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033647,10033647,10000971
ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
"ANTISEIZURE DRUG TRIALS OF LAMOTRIGINE, LEVETIRACETAM, PHENYTOIN AND OXCARBAZEPINE WERE LARGELY UNSUCCESSFUL IN CONTROLLING HIS SEIZURES (LACK OF DRUG EFFECT )",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
RESTLESSNESS,restlessness,RESTLESSNESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038743,10038743,10038743
METFORMIN INTOXICATION,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
GENERALISED PRURITIC RASH,rash genaralised,RASH GENERALISED,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037858,10037858,10037858
DIAGNOSED WITH DEMENTIA,Dementia,DEMENTIA,DEMENTIA,MENTAL IMPAIRMENT DISORDERS,DEMENTIA (EXCL ALZHEIMER'S TYPE),10029205,10012267,10012267,10012267
MULTIPLE SYMPTOMATIC SEIZURE,multiple symptomatic seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
GENERALIZED RASH,Rash generalised,GENERALIZED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037858,10037858,10049201
CYTOMEGALOVIRUS COLITIS,Cytomegalovirus colitis,CYTOMEGALOVIRUS COLITIS,CYTOMEGALOVIRUS COLITIS,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10048983,10048983,10048983
SERUM CONCENTRATION OF VALPROIC ACID/SERUM VPA CONCENTRATIONS WERE UNEXPECTEDLY FOUND TO BE SUBTHERAPEUTIC (14.1 MCG/ML),Anticonvulsant drug level decreased,ANTICONVULSANT DRUG LEVEL DECREASED,ANTICONVULSANT DRUG LEVEL DECREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10057857,10057857,10057857
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
GRADE 1 HEPATIC ENCEPHALOPATHY,Hepatic encephalopathy,HEPATIC ENCEPHALOPATHY,HEPATIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10019660,10019660,10019660
OLMESARTAN INDUCED ENTEROPATHY,Gastrointestinal disorder,GASTROENTEROPATHY NOS,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017945,10017944,10017922
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
RESPIRATORY DEPRESSION,Respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
PAIN (PAIN SCORE 5),Pain in jaw,JAW PAIN,PAIN IN JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10033433,10033433,10023157
REBOUND OF AUTOIMMUNE MENINGOENCEPHALO-MYELONEURITIS DUE TO PREDNISONE TAPER,Autoimmune encephalopathy,AUTOIMMUNE ENCEPHALOPATHY,AUTOIMMUNE ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10075691,10075691,10075691
ECTROPION OF LOWER EYELIDS AND LID MARGIN HYPERAEMIA OF BOTH EYES,Ectropion,ECTROPION,ECTROPION,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","LID, LASH AND LACRIMAL STRUCTURAL DISORDERS",10015919,10014179,10014179,10014179
MEDICATION RELATED OSTEONECROSIS OF THE JAW INDUCED SINUSITIS,Sinusitis,SINUSITIS,SINUSITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10040753,10040753,10040753
VERTIGO,Vertigo,VERTIGO,VERTIGO,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10047340,10047340,10047340
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
ADENOVIREMIA,adenoviremia,ADENOVIRUS INFECTION,ADENOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,ADENOVIRAL INFECTIONS,10021881,10060931,10060931,10060931
UREA INCREASED (92 MG/DL),Blood urea increased,UREA INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10046353,10005851,10046353
HIP ARTHROPLASTY,hip arthroplasty,HIP ARTHROPLASTY,HIP ARTHROPLASTY,BONE AND JOINT THERAPEUTIC PROCEDURES,JOINT THERAPEUTIC PROCEDURES,10042613,10020096,10020096,10020096
GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED,Gamma-glutamyltransferase increased,GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10017668,10017693,10017668
LETHARGIC,lethargic,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024262,10024264,10024262
REDUCED URINE OUTPUT,urine output decreased,URINE OUTPUT DECREASED,URINE OUTPUT DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059895,10059895,10059895
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
INTRAUTERINE GROWTH RESTRICTION,Foetal growth restriction,INTRAUTERINE GROWTH RETARDATION,FOETAL GROWTH RESTRICTION,FOETAL COMPLICATIONS,FOETAL GROWTH COMPLICATIONS,10036585,10022819,10070531,10022819
POST INFLAMMATORY HYPERPIGMENTATION,Post inflammatory pigmentation change,POST INFLAMMATORY HYPERPIGMENTATION,POST INFLAMMATORY PIGMENTATION CHANGE,PIGMENTATION DISORDERS,PIGMENTATION CHANGES NEC,10040785,10036260,10036229,10036260
MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,Acute generalised exanthematous pustulosis,ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10062372
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
JOINT PAINS,joint pains,JOINT PAIN,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023222,10003239,10023222
INFLAMMATORY LYMPHOPLASMOCYTIC INFILTRATE,Lymphocytic infiltration,LYMPHOCYTIC INFILTRATION,LYMPHOCYTIC INFILTRATION,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10062049,10062049,10062049
STUPOR,Stupor,STUPOR,STUPOR,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042264,10042264,10042264
CHEST CT SCAN CONFIRMED THE CONSOLIDATION WITH CAVITATION AND SIGNS OF NECROSIS,Pulmonary necrosis,PULMONARY NECROSIS,PULMONARY NECROSIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10058824,10058824,10058824
URIC ACID INCREASED (1293 MICROMOL/L),Blood uric acid increased,URIC ACID INCREASED,BLOOD URIC ACID INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10066980,10005861,10066980
ACUTE RENAL FAILURE,Acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
"ERYTHEMATOUS SKIN LESIONS SPREAD ON THE BACK, LOWER LIMBS AND FACE ASSOCIATED WITH FEVER, CONJUNCTIVITIS AND GINGIVOSTOMATITIS",Generalised erythema,GENERALIZED ERYTHEMA,GENERALISED ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10051576,10051576,10062433
"GAMMA-GLUTAMYLTRANSPEPTIDASE [GGT; 63.6 U/L (RANGE, 0-55 U/L)]",Gamma glutamyl transpeptidase increased,GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10017668,10017693,10017668
HYPOMANIA,Hypomania,HYPOMANIA,HYPOMANIA,MANIC AND BIPOLAR MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH MANIC SYMPTOMS,10037175,10021030,10021030,10021030
FORGETFULNESS,forgetfulness,FORGETFULNESS,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10017060,10027175,10017060
RESTRICTIVE PULMONARY DISEASE,Restrictive pulmonary disease,RESTRICTIVE PULMONARY DISEASE,RESTRICTIVE PULMONARY DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10048667,10048667,10048667
FALLS,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
HEAVY BRUISING,Contusion,BRUISING,CONTUSION,INJURIES NEC,SKIN INJURIES NEC,10022117,10050584,10050584,10006504
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
COORDINATION ABNORMAL,Coordination abnormal,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10010947,10010947,10010947
IJC SITE WAS STILL OOZING,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
INTRA-ABDOMINAL ABSCESS,Abdominal abscess,INTRA-ABDOMINAL ABSCESS,ABDOMINAL ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10059621,10060921,10059621
ALANINE AMINOTRANSFERASE ELEVATED (73 U/L) FOLLOWING ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
CARDIAC COMPLICATION,Cardiac disorder,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10061024,10061024,10061024
CEREBRAL HEMORRHAGE,Cerebral haemorrhage,CEREBRAL HEMORRHAGE,CEREBRAL HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008111,10008111,10008114
DRY COUGH,dry cough,DRY COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10013773,10011224,10013773
SEPSIS (GRAM NEGATIVE),Bacterial sepsis,SEPTICEMIA GRAM-NEGATIVE,BACTERIAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10074047,10053840,10054611
VINCRISTINE INDUCED LEFT VOCAL CORD PARALYSIS,Vocal cord paralysis,VOCAL CORD PARALYSIS,VOCAL CORD PARALYSIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),VAGUS NERVE DISORDERS,10029205,10047674,10047674,10047674
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
CRYPTOCOCCAL MENINGITIS/ LUMBAR PUNCTURE SHOWED LYMPHOCYTIC MENINGITIS WITH NUMEROUS COLONIES OF CRYPTOCOCCUS NEOFORMANS,Meningitis cryptococcal,CRYPTOCOCCUS NEOFORMANS MENINGITIS,MENINGITIS CRYPTOCOCCAL,FUNGAL INFECTIOUS DISORDERS,CRYPTOCOCCAL INFECTIONS,10021881,10011488,10027209,10011488
ACUTE OTITIS MEDIA (AOM) STAGE III,Otitis media acute,OTITIS MEDIA ACUTE,OTITIS MEDIA ACUTE,INFECTIONS - PATHOGEN UNSPECIFIED,EAR INFECTIONS,10021881,10033079,10033079,10033079
HEPATOMEGALY,Hepatomegaly,HEPATOMEGALY,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10019842
CREATINE KINASE INCREASED (CK 1882 U/L),Blood creatine phosphokinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
RETROPHARYNGEAL ABSCESS AGGRAVATION,Retropharyngeal abscess aggravation,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
EDEMATOUS ITCHING AND CONFLUENT RASH ON THE MASTECTOMY SCAR,Itching,ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023084,10037087,10023084
MULTIPLE NODULE IN BOTH LUNGS,Pulmonary mass,LUNG NODULE,PULMONARY MASS,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10049498,10056342,10049498
INTERACTION BETWEEN LITHIUM AND PARACETAMOL-CODEINE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
ANGINA SYNDROME,Angina pectoris,ANGINA SYNDROME,ANGINA PECTORIS,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10002393,10002383,10002387
ALLERGY,Hypersensitivity,ALLERGY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001738,10020751,10001738
RELATIVE HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
THE PERIOD WAS USUALLY MUCH LONGER DUE TO HORMONAL IUD,Menorrhagia,PROLONGED PERIODS,MENORRHAGIA,MENSTRUAL CYCLE AND UTERINE BLEEDING DISORDERS,MENSTRUATION WITH INCREASED BLEEDING,10038604,10036875,10027313,10036875
CYTOMEGALOVIRUS ESOPHAGITIS,Cytomegalovirus oesophagitis,CYTOMEGALOVIRUS ESOPHAGITIS,CYTOMEGALOVIRUS OESOPHAGITIS,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10049018,10049018,10062415
DEATH,Death,DEATH,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10011906,10011906,10011906
CANDIDIASIS IN THE OESOPHAGUS,Candidiasis of the oesophagus,CANDIDIASIS OF THE OESOPHAGUS,OESOPHAGEAL CANDIDIASIS,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10056094,10030154,10056094
HOARSENESS OF VOICE,hoarseness of voice,HOARSENESS OF VOICE,DYSPHONIA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10020202,10013952,10020202
THE NEUROLOGICAL CONDITION OF THE PATIENT WAS NOT CHANGED,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SKIN BIOPSY REVEALED NON-INFLAMMATORY SUBEPIDERMAL BULLOUS DERMATOSIS,Dermatitis bullous,DERMATOSIS BULLOUS,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10012519,10012441,10012519
VENTRICULAR DYSRHYTHMIA,Ventricular arrhythmia,VENTRICULAR ARRHYTHMIA,VENTRICULAR ARRHYTHMIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047281,10047281,10047281
"COUGH, PRODUCTIVE COUGH",Productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
SEVERE FRONTAL HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
RASH EVOLVED FROM PAINFUL ERYTHRODERMA,Dermatitis exfoliative generalised,ERYTHRODERMA,DERMATITIS EXFOLIATIVE GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10015277,10012456,10015277
FEVER/ BODY TEMPERATURE ELEVATION UP TO 39 C,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
"VISUAL HALLUCINATIONS, NAUSEA, VOMITING, CONSTIPATION, FLATULENCE, DIARRHEA, ABDOMINAL SWELLING, TREMORS, INCREASED PULSE RATE, DECREASED URINATION AND WEIGHT LOSS (+/- 6 KG)",tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
CERVICAL LYMPHODENOPATHY INCREASED,Lymphadenopathy cervical,LYMPHADENOPATHY CERVICAL,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025200,10025197,10025200
SLIGHT EYELID EDEMA,Eyelid oedema,EYELID EDEMA,EYELID OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","LID, LASH AND LACRIMAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10015993,10015993,10015985
HYPERSENSITIVITY REACTION,Hypersensitivity,HYPERSENSITIVITY REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020756,10020751,10020756
VENLAFAXINE OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS POSITIVE ABSCESS,Staphylococcal infection,METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10027508,10058080,10027508
DISSEMINATED INTRAVASCULAR COAGULATION (DIC) WITH ACUTE KIDNEY INJURY FOLLOWING RIFAMPICIN INDUCED IMMUNE-ALLERGIC REACTION,Disseminated intravascular coagulation,DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10013442,10013442,10013442
BULL'S EYE MACULOPATHY,Maculopathy,BULL'S EYE MACULOPATHY,MACULOPATHY,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10068902,10025425,10068902
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
WITHDRAWAL SYNDROME,Withdrawal syndrome,WITHDRAWAL SYNDROME,WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10048010,10048010,10048010
CONJUNCTIVITIS,Conjunctivitis,CONJUNCTIVITIS,CONJUNCTIVITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10010741,10010741,10010741
RIGHT LUMBAR REGION TENDERNESS,Back pain,LUMBAR PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10024891,10003988,10024998
"INFLAMMATION OF THE VESSELS GRADUALLY NARROWED THE ARTERIES, WHICH  BECAME OCCLUDED",Arterial occlusive disease,ARTERIAL OCCLUSION,ARTERIAL OCCLUSIVE DISEASE,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10058475,10062599,10058475
OXALIPLATIN BASED CHEMOTHERAPY INDUCED SINUSOIDAL OBSTRUCTIVE SYNDROME,Venoocclusive liver disease,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
IMPAIRED VISION,Vision abnormal,VISION ABNORMAL,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047508,10047571,10047508
IT CAN BE ASSUMED THAT THE DECEASED STOLE THE SYRINGES WITH ROCURONIUM FROM THE HOSPITAL,Intentional drug misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
SCAR,Scar,SCAR,SCAR,INJURIES NEC,SKIN INJURIES NEC,10022117,10039580,10039580,10039580
USE OF CISPLATIN AND OXALIPLATIN FOR RELAPSED ENTEROPATHY ASSCOIATED/MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA AND MYCOPHENOLATE MOFETIL FOR GVHD PROPHYLAXIS (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CHOLESTASIS,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
SLIGHT DROP IN POSTURAL BLOOD PRESSURE FROM SBP 136MMHG TO 105MMHG,Orthostatic hypotension,POSTURAL HYPOTENSION,ORTHOSTATIC HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10036433,10031127,10036433
DECREASED DIURESIS/ REDUCED DIURESIS,antidiuresis,ANTIDIURESIS,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10002774,10030302,10002774
DRIVING UNDER INFLUENCE (DUI),Impaired driving ability,IMPAIRED DRIVING ABILITY,IMPAIRED DRIVING ABILITY,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10049564,10049564,10049564
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
DRUG-INDUCED CHOLESTATIC LIVER INJURY (CHOLESTASIS) DUE TO DRUG-INDUCED VANISHING BILE DUCT SYNDROME,Cholestatic liver injury,CHOLESTATIC LIVER INJURY,CHOLESTATIC LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067969,10067969,10067969
EROSIVE GASTRITIS,Gastritis erosive,GASTRITIS EROSIVE,GASTRITIS EROSIVE,GASTROINTESTINAL ULCERATION AND PERFORATION,GASTRIC ULCERS AND PERFORATION,10017947,10017865,10017865,10017865
DRESS SYNDROME INDUCED BY RANITIDINE/ DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS),DRESS syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
MALIGNANT NEOPLASM PROGRESSION,Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PRURITUS,pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
INJECTED > 300 UNITS OF SHORT ACTING INSULIN ANALOGUE,intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
MILD ENCEPHALOPATHY WITH A REVERSIBLE SPLENIAL LESION,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
PATIENT WAS TREATED WITH MISOPROSTOL FOR INDUCTION OF LABOUR (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HBA1C: 8.4%,Haemoglobin A1C increased,HAEMOGLOBIN A1C INCREASED,GLYCOSYLATED HAEMOGLOBIN INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10056186,10018484,10056186
DIFFUSE MALAISE,malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
ADVANCED BRAIN AND PULMONARY EDEMA,Brain edema,BRAIN EDEMA,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10006121,10048962,10006121
DEVELOPED SEVERE TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
LIGHT HYPERTENSION FOLLOWING OFF LABEL USE OF DRUG,hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
THE PATIENT WAS TREATED WITH METHYLPREDNISOLONE FOR HAEMOLYTIC URAEMIC SYNDROME ENCEPHALOPATHY (OFF-LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HYPERTHYROIDISM,hyperthyroidism,HYPERTHYROIDISM,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10020850,10020850,10020850
CARDIOGENIC SHOCK FOLLOWING MYOCARDIAL ISCHEMIA,Cardiogenic shock,CARDIOGENIC SHOCK,CARDIOGENIC SHOCK,HEART FAILURES,HEART FAILURES NEC,10007541,10007625,10007625,10007625
ALEMTUZUMAB ADMINISTERED FOR PRE-BMT CONDITIONING,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HIGH FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
CYTOGENETIC RELAPSE,Cytogenetic abnormality,CYTOGENETIC ABNORMALITY,CYTOGENETIC ABNORMALITY,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,CHROMOSOMAL ABNORMALITIES NEC,10010331,10067477,10067477,10067477
ABDOMINAL PAIN,abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
KNEE PAIN,Knee pain,KNEE PAIN,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023477,10003239,10023477
IT WAS DIFFICULT TO OPEN THE PATIENT'S MOUTH,Dyskinesia,MOUTH MOVEMENT IMPAIRED,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028027,10013916,10028027
GENERALIZED BODY WEAKNESS,Asthenia,WEAKNESS GENERALIZED,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047864,10003549,10047865
SEVERE MITRAL REGURGITATION,Mitral valve incompetence,MITRAL REGURGITATION,MITRAL VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,MITRAL VALVULAR DISORDERS,10007541,10027718,10027727,10027718
RIGHT PRETIBIAL SWELLING,swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
"CYTOMEGALOVIRUS INFECTION REACTIVATION (CMV VIRAL LOAD-77,826 COPIES/ML)",Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION REACTIVATION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10058666,10011831,10058666
NUMBNESS OF PERIPHERAL LIMBS,Hypoaesthesia,HYPOAESTHESIA,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10020937,10020937,10020937
ACUTE NEPHRITIS WITH SEPSIS,Acute nephritis,ACUTE NEPHRITIS,NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10000940,10029117,10000940
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
IJC SITE WAS STILL OOZING,catheter site bleeding,CATHETER SITE BLEEDING,CATHETER SITE HAEMORRHAGE,ADMINISTRATION SITE REACTIONS,IMPLANT AND CATHETER SITE REACTIONS,10018065,10051109,10051099,10051109
FACTITIOUS HYPOGLYCEMIA (18 MG/DL) FOLLOWING DRUG ABUSE OF GLYBURIDE,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
HIT WITH THROMBOSIS,heparin-induced thrombosis,HEPARIN-INDUCED THROMBOSIS,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10063492,10062506,10063492
DISSEMINATED INTRAVASCULAR COAGULATION,Disseminated intravascular coagulation,DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10013442,10013442,10013442
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
WHEN A PAINLESS BLUISH-GRAY HYPERPIGMENTATION OF HER HARD PALATE WAS OBSERVED,Oral pigmentation,PALATAL PIGMENTATION,ORAL PIGMENTATION,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SIGNS AND SYMPTOMS,10017947,10077553,10077552,10077553
MYOCARDITIS,Myocarditis,MYOCARDITIS,MYOCARDITIS,MYOCARDIAL DISORDERS,NONINFECTIOUS MYOCARDITIS,10007541,10028606,10028606,10028606
MICROSCOPIC HEMATURIA,Haematuria,MICROSCOPIC HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018869,10018867,10059824
PATIENT TREATED WITH IVIG AND METHYLPREDNISOLONE FOLLOWED BY RITUXIMAB AND CYCLOPHOSPHAMIDE WITH NO IMPROVEMENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
POSITIVE CHVOSTEK'S SIGN,positive Chvostek's sign,CHVOSTEK'S SIGN,CHVOSTEK'S SIGN,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10051518,10051518,10051518
CONDITION WORSENED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
OBSTRUCTING THE UPPER AIRWAY,upper airway obstruction,UPPER AIRWAY OBSTRUCTION,UPPER AIRWAY OBSTRUCTION,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10067775,10067775,10067775
TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
"PATIENT STILL RATIONALIZED HIS SOCIAL ANXIETY, AVOIDANT BEHAVIOR AND SYMPTOMS OF SELECTIVE MUTISM.",social anxiety disorder,SOCIAL ANXIETY DISORDER,SOCIAL ANXIETY DISORDER,ANXIETY DISORDERS AND SYMPTOMS,FEAR SYMPTOMS AND PHOBIC DISORDERS (INCL SOCIAL PHOBIA),10037175,10041242,10041242,10041242
DRUG INTERACTION,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
CEREBRAL INFARCTION IN LEFT FRONTAL LOBE,Cerebral infarction,CEREBRAL INFARCTION,CEREBRAL INFARCTION,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008118,10008118,10008118
DESCENDING NECROTIZING MEDIASTINITIS DUE TO WORSENING OF ODONTOGENIC INFECTION FOLLOWING MULTIDRUG RESISTANCE,Mediastinitis,NECROTIZING MEDIASTINITIS,MEDIASTINITIS,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10069399,10027082,10069401
MIXED APHASIA,Mixed aphasia,MIXED APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10077688,10002948,10077688
MICROSCOPIC COLITIS,Colitis microscopic,COLITIS MICROSCOPIC,COLITIS MICROSCOPIC,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10056979,10056979,10056979
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
RECOVERY IN NEUTROPHIL COUNT FROM 0.3 Ã— 10^9/L TO 1.2 Ã— 10^9/L,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ACUTE RENAL FAILURE,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
MACULOPAPULAR EXANTHEMA PLUS OEDEMA,Maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
"ANXIETY SYMPTOMS (WORRYING ABOUT EVERYTHING, TENSION INTERNAL, PREDICTION OF FAILURES)",Condition aggravated,DISEASE AGGRAVATION,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10013097,10010264,10013097
REPEATED ATTEMPTED HOMICIDE BY ADMINISTRATION OF DRUGS,Physical assault,HOMICIDAL ATTEMPT,PHYSICAL ASSAULT,LEGAL ISSUES,CRIMINAL ACTIVITY,10041244,10064160,10034983,10064160
HYPOPYON,Hypopyon,HYPOPYON,HYPOPYON,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10021086,10021086,10021086
THYROTOXICOSIS,Hyperthyroidism,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
CHEMOTHERAPY-RELATED COGNITIVE IMPAIRMENT,Chemotherapy-related cognitive impairment,COGNITIVE IMPAIRMENT,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10009846,10057668,10009846
CREATININE 880 MICROMOL/L,Raised serum creatinine,RAISED SERUM CREATININE,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10037825,10005483,10037825
NO ADVERSE EVENT,Tachycardia,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
PATIENT TREATED WITH HYDROXYCHLOROQUINE FOR FRONTAL FIBROSING ALOPECIA (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PATIENT WAS TREATED WITH CETIRIZINE HYDROCHLORIDE FOR NEUROPATHIC BREASTFEEDING PAIN (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PATIENT WAS ADMINISTERED ORAL RIBAVIRIN FOR CRIMEAN-CONGO HEMORRHAGIC FEVER(UNAPPROVED INDICATION FOR DRUG) OFF LABEL USE WITH NO ADVERSE DRUG REACTION.,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DYSPNOEA AT REST,Dyspnoea at rest,DYSPNOEA AT REST,DYSPNOEA AT REST,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013969,10013969,10013969
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
BILATERAL LARGE PNEUMOTHORAX DUE TO PNEUMOCYSTIS JIROVECII PNEUMONIA INSPITE OF SULFAMETHOXAZOLE/TRIMETHOPRIM,Pneumothorax,PNEUMOTHORAX,PNEUMOTHORAX,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035759,10035759,10035759
EPISODES OF LIGHT HEADEDNESS AND PASSING OUT LIKE SENSATION,Light headedness,LIGHT HEADEDNESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10024461,10013573,10024461
SHOCK,Shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
CARDIOMEGALY,Cardiomegaly,CARDIOMEGALY,CARDIOMEGALY,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10007632,10007632,10007632
LOSS OF APPETITE,Appetite lost,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
DIFFUSE HYPOKINESIA,Ventricular hypokinesia,DIFFUSE VENTRICULAR HYPOKINESIA,VENTRICULAR HYPOKINESIA,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10058180,10050510,10058180
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
HYPERKALAEMIC PERIODIC PARALYSIS,hyperkalaemic periodic paralysis,HYPERKALAEMIC PERIODIC PARALYSIS,FAMILIAL PERIODIC PARALYSIS,NEUROLOGICAL DISORDERS CONGENITAL,NEUROLOGICAL DISORDERS CONGENITAL NEC,10010331,10076439,10016208,10076439
DIFFICULTIES FALLING ASLEEP,difficulty sleeping,DIFFICULTY SLEEPING,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10012804,10022437,10012804
CEFTRIAXONE-INDUCED IMMUNE HEMOLYSIS,hemolysis intravascular,HEMOLYSIS INTRAVASCULAR,INTRAVASCULAR HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10019492,10022822,10019492
ANAEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
NEUROGENIC BOWEL DUE TO MYELOPATHY FOLLOWING INTRATHECAL CHEMOTHERAPY,Neurogenic bowel,NEUROGENIC BOWEL,NEUROGENIC BOWEL,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10048657,10048657,10048657
ACUTE RENAL IMPAIRMENT,Renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
ALANINE TRANSAMINASE ELEVATED AT 74 IU/L,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
SERUM CREATININE INCREASED (3.0825 MG/DL),Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
SWELLING OF THE EYELIDS AND LIPS,Lip swelling,LIP SWELLING,LIP SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10024570,10024570,10024570
SODIUM VALPROATE INDUCED HYPERAMMONAEMIA,Hyperammonaemia,HYPERAMMONAEMIA,HYPERAMMONAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020575,10020575,10020575
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
"ON THE MAXIMUM RECOMMENDED DOSE OF CARBIMAZOLE, SHE FELT NO BETTER",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
CONFUSION DURING THE NIGHT,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
ARRHYTHMIA,arrhythmia,ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10003119
OFF-LABEL USE FOR FLUDARABINE PHOSPHATE AND ALEMTUZUMAB AS THEY WERE ADMINISTERED AS PART OF BONE MARROW CONDITIONING REGIMEN FOR STEM CELL TRANSPLANT,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
SENSORY AND MOTOR DEFICIT OF ONE LIMB,Sensory loss,SENSORY DEFICIT,SENSORY LOSS,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10040030,10040030,10061563
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
MUSCLE STIFFNESS,Musculoskeletal stiffness,MUSCLE STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10028339,10052904,10028339
NEPHROTIC SYNDROME WORSENING / RENAL FUNCTION DETERIORATED,Nephrotic syndrome worsened,NEPHROTIC SYNDROME WORSENED,NEPHROTIC SYNDROME,NEPHROPATHIES,GLOMERULONEPHRITIS AND NEPHROTIC SYNDROME,10038359,10066701,10029164,10066701
DOCETAXEL RESISTANCE/DRUG RESISTANCE,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
HYPOGONADISM,Hypogonadism,HYPOGONADISM,HYPOGONADISM,ENDOCRINE DISORDERS OF GONADAL FUNCTION,ENDOCRINE ABNORMALITIES OF GONADAL FUNCTION NEC,10014698,10058359,10058359,10058359
PATIENT TREATED WITH METHOTREXATE FOR INTERSTITIAL ECTOPIC PREGNANCY (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RELAPSE OF CHRONIC EOSINOPHILIC LEUKEMIA,relapse of chronic eosinophilic leukemia,CHRONIC EOSINOPHILIC LEUKEMIA,CHRONIC EOSINOPHILIC LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS CHRONIC MYELOID,10029104,10065872,10065854,10065872
DRUG EXPOSURE DURING PREGNANCY WITH NO REPORTED ADVERSE EVENT,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
WITHDRAWAL SYMPTOMS,Withdrawal symptom,WITHDRAWAL SYMPTOM,WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10073281,10048010,10073281
HYPOTENSION GRADE 3,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
"OVER MEDICATION-SOMNOLENCE, UNDER DOSING- CONTINUOUS SPASMS. TEMPORAL STROKE",somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
SEVERE COLICKY LIKE BACK PAINS THAT RADIATED TOWARDS HIS ABDOMEN,Back pain,BACK PAIN (WITH RADIATION),BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003989,10003988,10003989
PARKINSONIAN GAIT,Parkinsonian gait,PARKINSONIAN GAIT,PARKINSONIAN GAIT,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10056242,10056242,10056242
HEPATOBILIARY DISEASE,Hepatobiliary disease,HEPATOBILIARY DISEASE,HEPATOBILIARY DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10062000,10062000,10062000
PALPITATION,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
UNINTENTIONAL WEIGHT LOSS,Abnormal loss of weight,UNINTENTIONAL WEIGHT LOSS,ABNORMAL LOSS OF WEIGHT,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10068329,10000159,10068329
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
RENAL IMPAIRMENT,Renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
RESISTANCE GENE DFRA12 SHOWED TRIMETHOPRIM RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
GASTROINTESTINAL DISCOMFORT,Abdominal discomfort,GASTROINTESTINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10054209,10000059,10054209
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
RENAL IMPAIRMENT,Hepatic function abnormal,FUNCTION LIVER ABNORMAL,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019670,10019670,10017475
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
RECTAL CARCINOMA,Rectal carcinoma,RECTAL CARCINOMA,RECTAL CANCER,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,COLORECTAL NEOPLASMS MALIGNANT,10029104,10038052,10038038,10038052
CONVULSIONS,Seizure,CONVULSIONS,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10010904,10039906,10010914
RECURRENCE OF MYELITIS,disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
RENAL INSUFFIENCY,Renal insufficiency,RENAL INSUFFICIENCY,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038474,10038435,10038474
GRADE 3 ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
"MINOR HAEMORRHAGE, HAEMATURIA",Haematuria,HAEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018867,10018867,10018867
RESPIRATORY DISCOMFORT,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
HYPERSENSITIVITY,hypersensitivity,HYPERSENSITIVITY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020751,10020751,10020751
"MINIMAL RESPONSE WITH FLUDARABINE, CHLORAMBUCIL AND RITUXIMAB","minimal response with fludarabine, chlorambucil and rituximab",SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
CARDIOTOXICITY,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
HYPERKALEMIA,Hyperkalaemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020646,10020646,10020647
EPISODIC USE OF TRAMADOL,Intentional product misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
VENTRICULAR ARRHYTHMIAS,Ventricular arrhythmia,VENTRICULAR ARRHYTHMIA,VENTRICULAR ARRHYTHMIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047281,10047281,10047281
BACLOFEN OVERDOSE,drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
DISEASE REFRACTORY,Epilepsy,REFRACTORY EPILEPSY,EPILEPSY,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10053551,10015037,10077953
HYPERTENSIVE EMERGENCY,Hypertensive emergency,HYPERTENSIVE EMERGENCY,HYPERTENSIVE EMERGENCY,VASCULAR HYPERTENSIVE DISORDERS,ACCELERATED AND MALIGNANT HYPERTENSION,10047065,10058179,10058179,10058179
MULTIPLE ITCHY AND PAINFUL ERYTHEMATOUS PATCHES,multiple itchy and painful erythematous patches,PAINFUL RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10074762,10037844,10074762
LACK OF EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
TOTAL EXTENT OF EXFOLIATION WAS EVALUATED AS 33% (TOTAL BODY SURFACE AREA),Skin exfoliation,SKIN EXFOLIATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040844,10040844,10040844
CIRCUMSTANCES OF DEATH: SUICIDE,Completed suicide,SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042462,10010144,10042462
DOSE 2 ADMINISTERED ON 17-NOV-2015 AND DOSE 3 ADMINISTERED ON 14 JUN 2016,Inappropriate schedule of vaccine administered,INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTERED,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10063976,10021597,10063976
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
METHOTREXATE USED FOR LUPUS ERYTHEMATODES,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
HYPEREOSINOPHILIA,Eosinophilia,HYPEREOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10064890,10014950,10064890
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NODULE OF 3 CM IN DIAMETER WITH A PSEUDOCAPSULE WAS FOUND CENTRALLY IN THE LIVER,Hepatic mass,LIVER NODULE,HEPATIC MASS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10049578,10057110,10049578
INTRAVENTRICULAR HEMORRHAGE FOLLOWING DISSEMINATED MUCORMYCOSIS,Intraventricular haemorrhage,INTRAVENTRICULAR HEMORRHAGE,INTRAVENTRICULAR HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10022840,10022840,10055299
EXTRAPYRAMIDAL DISORDER,Extrapyramidal disorder,EXTRAPYRAMIDAL DISORDER,EXTRAPYRAMIDAL DISORDER,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10015832,10015832,10015832
PERSISTENT ACTIVE DISEASE,Hematological malignancy,HEMATOLOGICAL MALIGNANCY,HAEMATOLOGICAL MALIGNANCY,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),HAEMATOLOGIC NEOPLASMS NEC,10029104,10066481,10066476,10066481
TYPE 1 HYPERSENSITIVITY,Type I hypersensitivity,TYPE I HYPERSENSITIVITY,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10045240,10045240,10045240
LARGE B CELL LYMPHOMA WITH EPSTEIN-BARR VIRUS,epstein-barr virus associated lymphoma,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,B-CELL LYMPHOMAS NEC,10029104,10071441,10071441,10071441
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FALL FROM LADDER,faal from ladder,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
GLOMERULAR FILTRATION RATE (EGFR) OF 29 ML/MIN,Glomerular filtration rate decreased,GLOMERULAR FILTRATION RATE LOW,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018360,10018358,10018360
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
TEN DAYS OF FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PURPURIC SKIN RASH FOLLOWING RIFAMPICIN INDUCED THROMBOCYTOPENIA,Purpura,PURPURIC RASH,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037566,10037549,10037566
"DIFFUSE, PRURITIC, MACULOPAPULAR RASH",Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
PREMATURE BIRTH,Premature birth,PREMATURE BIRTH,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036594,10036590,10036594
SHOULDER GIRDLE PAIN,Musculoskeletal pain,SHOULDER PAIN,MUSCULOSKELETAL PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10040617,10028391,10040617
INCREASED RIGHT UPPER LOBE OPACIFICATION,Lung consolidation,LUNG CONSOLIDATION,LUNG CONSOLIDATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025080,10025080,10025080
MEMORY PROBLEMS,Memory impairment,MEMORY DISTURBANCE,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027175,10027175,10027172
NEUROTOXIC EFFECTS CAUSE CYTOTOXIC EDEMA,Cytotoxic oedema,CYTOTOXIC EDEMA,CYTOTOXIC OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10067276,10067276,10067279
BICLONAL BLAST CRISIS,Blast crisis in myelogenous leukaemia,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS MYELOID NEC,10029104,10050282,10050282,10050282
HYPERKALAEMIA,Hyperkalaemia,HYPERKALAEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020646,10020646,10020646
ANEMIA,anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
HYPOGLYCEMIA EPISODES,Hypoglycemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10021005,10020993,10021005
MUTENESS,Mutism,MUTISM,MUTISM,COMMUNICATION DISORDERS AND DISTURBANCES,COMMUNICATIONS DISORDERS,10037175,10028403,10028403,10028403
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
NEUTROPENIC FEVER FOLLOWING POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,Febrile neutropenia,NEUTROPENIC FEVER,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10051312,10016288,10051312
OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
COMPLEMENT FACTOR C4 DECREASED (10.2 MG/DL),Complement factor C4 decreased,COMPLEMENT FACTOR C4 DECREASED,COMPLEMENT FACTOR C4 DECREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNE RESPONSE PROTEIN ANALYSES NEC,10022891,10050983,10050983,10050983
OXALIPLATIN IMMUNE-INDUCED SYNDROME/ DRUG-INDUCED IMMUNE THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
UNMEASURABLE BLOOD PRESSURE,Blood pressure immeasurable,BLOOD PRESSURE IMMEASURABLE,BLOOD PRESSURE IMMEASURABLE,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005748,10005748,10005748
SUBEPIDERMAL BLISTER FORMATION,blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
DRUG-INDUCED INTERSTITIAL PNEUMONIA,Interstitial lung disease,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
ESCHERICHIA COLI SEPTICEMIA,Escherichia sepsis,SEPTICAEMIA DUE TO ESCHERICHIA COLI (E. COLI),ESCHERICHIA SEPSIS,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10015296,10015296,10060412
ACUTE RENAL INSUFFICIENCY,Acute renal insufficiency,ACUTE RENAL INSUFFICIENCY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10050440,10069339,10050440
AUTOIMMUNE NEUTROPENIA,Autoimmune neutropenia,AUTOIMMUNE NEUTROPENIA,AUTOIMMUNE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10055128,10055128,10055128
SINUSOIDAL OBSTRUCTION SYNDROME/VENOOCCLUSIVE DISEASE (SOS),Venoocclusive liver disease,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
PATCHY BRONCHIOLITIS,Bronchiolitis,BRONCHIOLITIS,BRONCHIOLITIS,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10006448,10006448,10006448
STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
RHABDOMYOLYSIS WITH MYOGLOBINURIA,Myoglobinuria,MYOGLOBINURIA,MYOGLOBINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10028629,10028629,10028629
UREA 53 MG/DL,Blood urea increased,UREA INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10046353,10005851,10046353
PATIENT BECAME INCREASINGLY WEAK,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
DYSTONIC POSTURE/DYSTONIA OF HEAD,Dystonia,DYSTONIA,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10013983,10013983,10013983
FEELING OF BLOATING,bloating,BLOATING,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10005265,10000060,10005265
LOW BLOOD PRESSURE (NOS),Hypotension,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10024895
HEADACHE/BROMOCRIPTINE- ASSOCIATED HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
RECTUS ABDOMINIS MUSCLE HAEMATOMA,Abdominal wall haematoma,RECTUS ABDOMINIS MUSCLE HAEMATOMA,ABDOMINAL WALL HAEMATOMA,ABDOMINAL HERNIAS AND OTHER ABDOMINAL WALL CONDITIONS,ABDOMINAL WALL CONDITIONS NEC,10017947,10071748,10067383,10071748
ERYTHEMATOUS PLAQUES ALL OVER THE BODY,Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
PERITONITIS FOLLOWING INTESTINAL PERFORATION,acute peritonitis,ACUTE PERITONITIS,PERITONITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10066720,10034674,10066720
PATIENT WAS TREATED WITH CISPLATIN FOR SMALL CELL LUNG CANCER WITH NO ADR (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEPATIC IMPAIRMENT,hepatic impairment,HEPATIC IMPAIRMENT,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10052254,10019670,10052254
MILD METABOLIC ACIDOSIS DUE TO ACUTE KIDNEY FAILURE,Mild metabolic acidosis due to acute kidney failure,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
SEVERAL MILD GASTRIC EROSIONS/SEVERE EROSIONS FOUND IN THE ESOPHAGUS AND THE PYLORUS,Gastritis erosive,GASTRIC EROSIONS,GASTRITIS EROSIVE,GASTROINTESTINAL ULCERATION AND PERFORATION,GASTRIC ULCERS AND PERFORATION,10017947,10017783,10017865,10017783
ABNORMAL SWELLING OF THE ABDOMEN,Abdominal distension,ABDOMINAL DISTENSION,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10000060
CLARITHROMYCIN WAS SHIFTED BECAUSE OF INTOLERANCE (DRUG INTOLERANCE),drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
WHEEZE,Wheezing,WHEEZE,WHEEZING,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10047924,10047924,10047921
PARADOXICAL EMBOLISM FOLLOWINMG COAGLUAPATHY,Paradoxical embolism,PARADOXICAL EMBOLISM,PARADOXICAL EMBOLISM,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10066059,10066059,10066059
SMALL CELL LUNG CANCER TRANSFORMATION FROM EGFR-MUTANT LUNG ADENOCARCINOMA,Small cell lung cancer,SMALL CELL LUNG CANCER,SMALL CELL LUNG CANCER,RESPIRATORY AND MEDIASTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,RESPIRATORY TRACT SMALL CELL CARCINOMAS,10029104,10041067,10041067,10041067
ACUTE RENAL FAILURE,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
WITH NO BENEFIT,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
HOT FLASHES,Hot flush,HOT FLASHES,HOT FLUSH,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10060800,10060800,10020407
BACK PAIN,Back pain,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003988,10003988,10003988
INTERMITTENT DIARRHEA,Diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
PERIPHERAL EOSINOPHILIA RECURRED,Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
DROPPED OXYGEN SATURATION TO 88 PER CENT,Oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
BILATERAL CONJUNCTIVITIS,bilateral conjunctivitis,CONJUNCTIVITIS,CONJUNCTIVITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10010741,10010741,10010741
HIGH GRADE TEMPERATURE OF 39.9 DEGREE C,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
HEMATEMESIS,Haematemesis,HEMATEMESIS,HAEMATEMESIS,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018830,10018830,10019418
ESTIMATED GLOMERULAR FILTRATION RATE DECREASED (24 ML/MIN/1.73 M2),Glomerular filtration rate decreased,GLOMERULAR FILTRATION RATE DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018358,10018358,10018358
LETHARGY,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
MILD TRANSAMINITIS,Transaminases increased,TRANSAMINITIS,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054969,10054889,10054969
STEATOHEPATITIS,Hepatic steatosis,HEPATIC STEATOSIS,HEPATIC STEATOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019708,10019708,10019708
STEVENS-JOHNSON SYNDROME,stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
BABOON SYNDROME,baboon syndrome,BABOON SYNDROME,SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10051993,10078325,10051993
LOQUACIOUS FOLLOWING MULTIPLE DRUG POISONING,Logorrhoea,TALKATIVENESS,LOGORRHOEA,COMMUNICATION DISORDERS AND DISTURBANCES,SPEECH AND LANGUAGE USAGE DISTURBANCES,10037175,10043111,10024796,10043111
PRODUCTIVE COUGH,Productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
VENTRICULITIS,ventriculitis,VENTRICULITIS,CNS VENTRICULITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10047303,10009719,10047303
NO AMELIORATION OF PAIN SYMPTOMS WAS OBSERVED,Drug ineffective,DRUG EFFECT LACK OF,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013684
DRUG EXPOSURE IN UTERO,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
LIVER DAMAGE,Liver injury,LIVER DAMAGE,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067125,10067125,10024668
DELIRIUM DUE TO VALPROATE ASSOCIATED  HYPERAMMONEMIA,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
"FAILED TREATMENT WITH CONVENTIONAL, BIOLOGICAL THERAPY DRUGS AND PHOTOTHERAPY (LACK OF DRUG EFFECT WITH NO ADR)",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
RAPID WORSENING OF RENAL PARAMETERS OF IGA NEPRHOPATHY DESPITE 4 MONTHS OF IMMUNOSUPPRESION FOLLOWING LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
UNINTENTIONAL INTOXICATION,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
INFECTION REACTIVATION,Infection reactivation,INFECTION REACTIVATION,INFECTION REACTIVATION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10070891,10070891,10070891
METRONIDAZOLE-INDUCED ENCEPHALOPATHY,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
GENERAL MALAISE,general malaise,GENERAL MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10018066,10025482,10018066
ALT INCREASED (379U/L),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
CHRONIC HEPATITIS B REACTIVATION,Hepatitis B reactivation,HEPATITIS B REACTIVATION,HEPATITIS B REACTIVATION,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10058827,10058827,10058827
HEPATIC DAMAGE FOLLOWING INTENTIONAL OVERDOSE,Liver injury,HEPATIC DAMAGE,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067125,10067125,10019648
PANCREATITIS,Pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
BILATERAL LOWER EXTREMITY EDEMA,Oedema peripheral,EDEMA OF LOWER EXTREMITIES,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030109,10030124,10054498
SEVERE LACTIC ACIDOSIS,lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
DYSPNEA THAT WORSENED WITH EXERTION,Dyspnea exertional,DYSPNEA EXERTIONAL,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013966,10013971,10013966
SEVERE BURNING,Pain,PAIN BURNING,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033386,10033371,10033386
POOR ORAL INTAKE,Hypophagia,ORAL INTAKE REDUCED,HYPOPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10063889,10063743,10063889
GENERALIZED TONIC-CLONIC SEIZURE,Generalized tonic-clonic seizure,GENERALIZED TONIC-CLONIC SEIZURE,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10062448,10018100,10062448
WORSENING OF CONGENITAL METHEMOGLOBINEMIA DUE TO PROVOCATION BY IMATINIB,Congenital methaemoglobinaemia,CONGENITAL METHEMOGLOBINEMIA,CONGENITAL METHAEMOGLOBINAEMIA,BLOOD AND LYMPHATIC SYSTEM DISORDERS CONGENITAL,HAEMOGLOBINOPATHIES CONGENITAL,10010331,10010543,10010543,10062832
DISSEMINATED STERCORALIS STRONGYLOIDIASIS,Strongyloides stercoralis infection,STRONGYLOIDES STERCORALIS INFECTION,STRONGYLOIDIASIS,HELMINTHIC DISORDERS,NEMATODE INFECTIONS,10021881,10042253,10042254,10042253
EXTENSIVE COLONIC ULCERATIONS/ULCERATIONS SCATTERED THROUGHOUT THE RIGHT COLON,Gastrointestinal ulcer,GASTROINTESTINAL ULCER,GASTROINTESTINAL ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,"GASTROINTESTINAL ULCERS AND PERFORATION, SITE UNSPECIFIED",10017947,10061459,10061459,10061459
PROTEINURIA (660 MG/GCR),Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
POSTERIORLY ROTATED LOW SET EARS,Low set ears,LOW SET EARS,LOW SET EARS,EAR AND LABYRINTHINE DISORDERS CONGENITAL,EXTERNAL EAR DISORDERS CONGENITAL,10010331,10024929,10024929,10024929
INCREASED PAIN,increased pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
HYPONATREMIA,Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
ASPERGILLUS FUMIGATUS PNEUMONIA,Bronchopulmonary aspergillosis,PNEUMONIA ASPERGILLUS,BRONCHOPULMONARY ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10048385,10006473,10048385
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
ORAL ULCERATION,oral ulceration,ORAL ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10031027,10028034,10031027
DIAPHORESIS,Hyperhidrosis,HYPERHIDROSIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10020642,10020642,10020642
PULMONARY ARTERIAL HYPERTENSION,Pulmonary arterial hypertension,PULMONARY ARTERIAL HYPERTENSION,PULMONARY ARTERIAL HYPERTENSION,PULMONARY VASCULAR DISORDERS,PULMONARY HYPERTENSIONS,10038738,10064911,10064911,10064911
INFECTION,Infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
GROANING NOISE,Groaning,GROANING,MOANING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10080985,10027783,10080985
DUCTUS ARTERIOSUS PREMATURE CLOSURE,Ductus arteriosus premature closure,DUCTUS ARTERIOSUS PREMATURE CLOSURE,DUCTUS ARTERIOSUS PREMATURE CLOSURE,CARDIAC AND VASCULAR DISORDERS CONGENITAL,ARTERIAL DISORDERS CONGENITAL,10010331,10049996,10049996,10049996
ASPARTATE AMINOTRANSFERASE INCREASED (399),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
GENERALIZED ABDOMINAL DISTENSION,Abdominal distension,ABDOMINAL DISTENSION,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10000060
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LOW BLOOD PRESSURE,Low blood pressure,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10024895,10021097,10024895
PATIENT STARTED COUGHING 20 MINS AFTER THE PROCEDURE WITH EVOLVED OR MILD HEMOPTYSIS,Haemoptysis,HEMOPTYSIS,HAEMOPTYSIS,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10018964,10018964,10019523
MULTIPLE SEPTIC EMBOLI OF BRAIN FOLLOWING ENTEROCOCCUS FAECALIS INFECTION,Septic embolus,SEPTIC EMBOLI,SEPTIC EMBOLUS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040067,10040067,10040066
GENERALISED ERYTHEMA,Generalised erythema,GENERALISED ERYTHEMA,GENERALISED ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10051576,10051576,10051576
ALTERED MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
THE PATIENT DEVELOPED SEPTICEMIA AND DIED FROM SEPTIC DEATH DESPITE INTENSIVE ANTIBIOTIC AND ANTIMYCOTIC TREATMENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
LEUKOCYTOSIS,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
VIRAL INFECTION (INFLUENZA A VIRUS SUBTYPE H1N1 TEST POSITIVE),Influenza A virus test positive,INFLUENZA A VIRUS SUBTYPE H1N1 TEST POSITIVE,INFLUENZA A VIRUS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10070222,10070215,10070222
ORAL BLISTERING,oral blistering,BLISTERS,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005216,10005191,10005216
MILD BLEEDING,Haemorrhage,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10005103
DIFFUSE RIGHT UPPER LOBE AND LEFT LOWER LOBE INFILTRATES,Lung infiltration,BILATERAL PULMONARY INFILTRATES,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10070790,10025102,10070790
DETERIORATING LFTS,Liver function test abnormal,LIVER FUNCTION TEST ABNORMAL,LIVER FUNCTION TEST ABNORMAL,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10024690,10024690,10024690
DRUG USE FOR UNAPPROVED INDICATION,drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
DETERIORATION IN RENAL FUNCTION,Renal impairment,RENAL FUNCTION AGGRAVATED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038453,10062237,10038453
CESAREAN IN WEEK 31 AND DELIVERED TWIN BABIES,Premature baby,PREMATURE BABY 26 TO 32 WEEKS,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10053593,10036590,10053593
ACUTE KIDNEY INJURY (AKI)/ PROGRESSIVE AKI,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
DISEASE PROGRESSION OF PRE-EXSISTING CANCER,Malignant neoplasm progression,PROGRESSION OF PRE-EXISTING CANCER,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10057096,10051398,10057096
ASPIRIN-EXACERBATED RESPIRATORY DISEASE (AERD),Aspirin-exacerbated respiratory disease,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10075084,10075084,10075084
WORSENING OF GLYCATED HEMOGLOBIN,Glycosylated haemoglobin increased,GLYCOSYLATED HEMOGLOBIN INCREASED,GLYCOSYLATED HAEMOGLOBIN INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10018484,10018484,10055590
LOCAL LYMPHADENOPATHY,Lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
"TWO DOSES OF PARACETAMOL 500 MG WERE ADMINISTERED BY MISTAKE, WITHOUT ANY REACTIVATION OF THE CLINICAL PRESENTATION",Drug administration error,DRUG ADMINISTRATION ERROR,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064295,10064295,10064295
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
EXPERIENCING TOXICITIES OF LETHARGY AND MILD DIARRHOEA,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
THYROTOXICOSIS,thyrotoxicosis,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
LEUKEMOID REACTION,Leukaemoid reaction,LEUKEMOID REACTION,LEUKAEMOID REACTION,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024328,10024328,10024373
BENDAMUSTINE HYDROCHLORIDE USED FOR HODGKIN LYMPHOMA,bendamustine hydrochloride used for Hodgkin lymphoma,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
INAPPROPRIATE CONFUSING SPEECH,Inappropriate speech,INAPPROPRIATE SPEECH,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10059488,10041466,10059488
LACTIC ACIDOSIS,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
INABILITY TO HEAR BILATERALLY/ HEARING LOSS BILATERALLY,Deafness,HEARING LOSS,DEAFNESS,HEARING DISORDERS,HEARING LOSSES,10013993,10011878,10011878,10019246
PLATELET COUNT DECREASED (36 X 10E^3 PER MICROLITER),Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
SEVERE LIGHT HEADEDNESS/DIZZINESS,Dizziness,LIGHT HEADEDNESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10024461,10013573,10024461
BILIARY SLUDGE,Cholelithiasis,BILIARY SLUDGE,CHOLELITHIASIS,GALLBLADDER DISORDERS,CHOLECYSTITIS AND CHOLELITHIASIS,10019805,10004671,10008629,10004671
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
"COGNITION IS KNOWN TO BE IMPAIRED AT ALTITUDE, AND IT SEEMS UNWISE TO USE MEDICATION THAT CAN POTENTIALLY ALTER MOOD AND ADVERSELY INFLUENCE DECISION MAKING",Cognitive impairment,COGNITIVE IMPAIRMENT,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10009846,10057668,10009846
ANXIETY,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
ESCHERICHIA COLI BACTEREMIA,Escherichia bacteraemia,ESCHERICHIA COLI BACTEREMIA,ESCHERICHIA BACTERAEMIA,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10054258,10054258,10054279
ACUTE RESPIRATORY DISTRESS SYNDROME,Acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
HYPOTENSIVE,Hypotension,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021107
WHITE BLOOD CELL COUNT DECREASED,White blood cell count decreased,WHITE BLOOD CELL COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10047942
RESPIRATORY FAILURE WORSENED FOLLOWING HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS WORSENING,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
DRY MOUTH FOLLOWING OFF LABEL USE,dry mouth,DRY MOUTH,DRY MOUTH,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10013781,10013781,10013781
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
"DROWSINESS AND CEREBELLAR SYMPTOMS (NYSTAGMUS, BALANCE PROBLEMS)",Nystagmus,NYSTAGMUS,NYSTAGMUS,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10029864,10029864,10029864
HEPATITIS C REACTIVATION,Hepatitis C,HEPATITIS C,HEPATITIS C,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10019744,10019744,10019744
ADMINISTRATION OF METHOTREXATE AND MYCOPHENOLATE MOFETIL (OFF LABEL USE) FOR THE TREATMENT OF IGG4-RELATED DISEASE (OFF LABEL USE) WITH NO REPORTED ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SUSPECTED PLEURAL EMPYEMA,Infectious pleural effusion,PULMONARY EMPYEMA,INFECTIOUS PLEURAL EFFUSION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10037658,10071699,10037381
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
MILD ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
OLANZAPINE OVERDOSAGE/INTOXICATING THEMSELVES,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
"PREGNANT PATIENT TREATED WITH LEVOTHYROXINE, DESMOPRESSIN AND HYDROCORTISONE (DRUG EXPOSURE DURING PREGNANCY WITH NO ADR)",Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
GOODPASTURE'S SYNDROME,Goodpasture's syndrome,GOODPASTURE'S SYNDROME,GOODPASTURE'S SYNDROME,NEPHROPATHIES,GLOMERULONEPHRITIS AND NEPHROTIC SYNDROME,10038359,10018620,10018620,10018620
INABILITY TO BEND OVER WITHOUT DEVELOPING FLUSH AND HEADACHE,Movement disorder,MOVEMENT DISORDER,MOVEMENT DISORDER,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028035,10028035,10028035
TREMOR,tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
HYPONATREMIA,Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
LESION EXTENDING TO EXTENSIVE SKIN LOOKING LIKE VZV INFECTION IDENTIFIED AS FUSARIUM INFECTION (DISEASE PROGRESSION FOLLOWING LACK OF DRUG EFFECT),Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
ITCHING,Pruritus,ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023084,10037087,10023084
STEVENS-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
DIARRHOEA DUE TO HYPERTHYROIDISM,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
HAD DIFFUSE BILATERAL UPPER AND LOWER EXTREMITY RIGIDITY WITH GLOBAL HYPER-REFLEXIA,rigidity,RIGIDITY,MUSCLE RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10039168,10028330,10039168
SERUM CALCIUM LEVELS WAS MARKEDLY ELEVATED (4.1 MMOL/L),Hypercalcaemia,HYPERCALCEMIA,HYPERCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020583,10020583,10020587
VENTRICULAR FIBRILLATION,Ventricular fibrillation,VENTRICULAR FIBRILLATION,VENTRICULAR FIBRILLATION,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047290,10047290,10047290
"HYPERPIGMENTED MACULAR LESIONS OF 0.5 CM IN DIAMETER WERE PRESENT IN BOTH LOWER EXTREMITIES, PARTICULARLY ON ANTERIOR OF TIBIAS",Skin hyperpigmentation,SKIN HYPERPIGMENTATION,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10040865,10040865,10040865
HAEMORRHAGE INTRACRANIAL,Haemorrhage intracranial,INTRACRANIAL HAEMORRHAGE,HAEMORRHAGE INTRACRANIAL,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10018985,10018985,10073792
THROMBUS IN VENA CAVA INFERIOR,Vena cava thrombosis,VENA CAVA THROMBOSIS,VENA CAVA THROMBOSIS,EMBOLISM AND THROMBOSIS,VENA CAVAL EMBOLISM AND THROMBOSIS,10047065,10047195,10047195,10047195
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
G2 MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
GENERAL CONDITION FURTHER DETERIORATED,Condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
EYELID ERYTHEMA,Erythema eyelid,ERYTHEMA EYELID,ERYTHEMA OF EYELID,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","LID, LASH AND LACRIMAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10051630,10015237,10051630
COAGULOPATHY,Coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
DISTURBED CONSCIOUSNESS ACCOMPANYING HYPOGLYCAEMIA,Altered state of consciousness,CONSCIOUSNESS DISTURBED,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010770,10001854,10010770
NIFEDIPINE GIVEN FOR THREATENED PRETERM LABOR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
INAPPETENCE (GRADE3),Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
CONJUNCTIVAL SECRETION,Conjunctival disorder,CONJUNCTIVAL DISORDER,CONJUNCTIVAL DISORDER,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CONJUNCTIVAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10061446,10061446,10061446
LOSING POINT IN CLOCK DRAWING,Dementia,DEMENTIA,DEMENTIA,MENTAL IMPAIRMENT DISORDERS,DEMENTIA (EXCL ALZHEIMER'S TYPE),10029205,10012267,10012267,10012267
DRUG INDUCED SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,Lupus-like syndrome,DRUG-INDUCED CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS-LIKE SYNDROME,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),LUPUS ERYTHEMATOSUS (INCL SUBTYPES),10028395,10074893,10050551,10074893
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
FAINTING/COLLAPSED,fainting,FAINTING,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10016169,10042772,10016169
ATAXIA,ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
CERTAIN DRUGS (NOT SPECIFIED) WERE CAUSING ADVERSE REACTIONS/ PATIENT WAS EXPERIENCING AN UNREPORTED ADVERSE REACTION WHICH WAS PROBABLY PROVOKING OEDEMA,Adverse drug reaction,ADVERSE DRUG REACTION,ADVERSE DRUG REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061623,10061623,10061623
INCREASED MICTURITION FREQUENCY (BY LOCAL COMPRESSION/INFILTRATION OF THE URINARY BLADDER),Micturition frequency increased,MICTURITION FREQUENCY INCREASED,POLLAKIURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10071065,10036018,10071065
CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
COLD SWEAT,Cold sweat,COLD SWEAT,COLD SWEAT,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10009866,10009866,10009866
"D-DIMER 1,235 MCG/ML",Fibrin D dimer increased,FIBRIN D DIMER HIGH,FIBRIN D DIMER INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10016580,10016581,10016580
BRIEFLY UNCONSCIOUS FOLLOWING SEVERE HYPOTENSION FOLLOWING SEVERE BRADYCARDIA,unconscious,UNCONSCIOUS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10045479,10024855,10045479
DYSURIA,dysuria,DYSURIA,DYSURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10013990,10013990,10013990
IMMEDIATE ALLERGIC REACTION TO AMOXICILLIN,Immediate hypersensitivity reaction,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
CLOSTRIDIUM DIFFICILE-ASSOCIATED ENTEROCOLITIS,Enterocolitis,ENTEROCOLITIS,ENTEROCOLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10014893,10014893,10014893
INTENTIONAL PARACETAMOL AND CODEINE OVERDOSE,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
INCREASE IN THE LOCALIZED SCLERODERMA ACTIVITY INDEX/DISEASE ACTIVITY INCREASED,Morphea,MORPHEA,MORPHOEA,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),CONNECTIVE TISSUE DISORDERS NEC,10028395,10027979,10027982,10027979
ORAL INTAKE REDUCED,Hypophagia,HYPOPHAGIA,HYPOPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10063743,10063743,10063743
ACUTE INFARCTS IN BILATERAL FRONTO-PARIETAL AREAS,Infarction,INFARCTION,INFARCTION,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10061216,10061216,10061216
MINOR HAEMORRHAGE (GENITAL HAEMORRHAGE),Genital haemorrhage,GENITAL HAEMORRHAGE,GENITAL HAEMORRHAGE,REPRODUCTIVE TRACT DISORDERS NEC,REPRODUCTIVE TRACT DISORDERS NEC (EXCL NEOPLASMS),10038604,10061178,10061178,10061178
PATIENT WAS ADMINISTERED MYCOPHENOLATE FOR UNAPPROVED INDICATION PEMPHIGUS VULGARIS (OFF LABEL USE FOR MYCOPHENOLATE MOFETIL),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CHRONIC GVHD (EXTENSIVE DISEASE),GVHD,GVHD,GRAFT VERSUS HOST DISEASE,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10018799,10018651,10018799
CMV INFECTION,Cytomegalovirus infection,CMV INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011831,10011831,10009703
TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDINE WAS GIVEN BY CRUSHING THE TABLET OR ORAL SUSPENSION (WRONG TECHNIQUE IN PRODUCT USAGE PROCESS) WITH NO ADR,Wrong technique in product usage process,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076573,10076573,10076573
POLYMORPHIC VENTRICULAR TACHYCARDIA,Ventricular tachycardia,POLYMORPHIC VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10028158,10047302,10036095
REVERSIBLE HYPEROXALURIA NEPHROPATHY (URINE OXALATE 80 MG/24 HR) FOLLOWING INTENTIONAL HIGH DOSE OF ASCORBIC ACID AND AGGRAVATED DUE TO IBUPROFEN,Hyperoxaluria,HYPEROXALURIA,HYPEROXALURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10020703,10020703,10020703
LIVER FAILURE,liver failure,LIVER FAILURE,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10024678,10019663,10024678
FEVER (38.6 DEGREE C),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
CARDIAC ARREST DUE TO PNEUMONIA AND SEPTIC SHOCK,cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
DECREASING CENTRAL VISION IN HER LEFT EYE,Vision loss,VISION LOSS,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047522,10005169,10047522
ANGIOEDEMA,Angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
OFF LABEL USE,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
IMBALANCE,imbalance,BALANCE DIFFICULTY,BALANCE DISORDER,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10004070,10049848,10004070
THICKENING AND TIGHTENING OF THE SKIN,Skin hypertrophy,SKIN THICKENING,SKIN HYPERTROPHY,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,SKIN HYPERPLASIAS AND HYPERTROPHIES,10040785,10040867,10040867,10040936
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
PERSISTENT AQUEOUS DIARRHOEA FOLLOWING OFF LABEL USE OF MYCOPHENOLATE MOFETIL FOR ISN/RPS CLASS IV-G (A) LUPUS NEPHRITIS,Diarrhoea,WATERY DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10047849,10012735,10055422
IMMUNE RECONSTITUTION SYNDROME,Immune reconstitution inflammatory syndrome,IMMUNE RECONSTITUTION SYNDROME,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10054014,10065042,10054014
"AST INCREASED (1,498 U/L)",Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
SLURRING OF SPEECH,Dysarthria,SPEECH SLURRED,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041053,10013887,10041472
ESCERICHIA COLI INFECTION,Escerichia coli infection,ESCHERICHIA COLI INFECTION,ESCHERICHIA INFECTION,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10054242,10061126,10054242
PROGRESSION OF METASTATIC TESTICULAR CHORIOCARCINOMA,progression of metastatic testicular choriocarcinoma,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
INTRAABDOMINAL HEMORRHAGE/ OTHER SITES OF INTRA-ABDOMINAL HEMORRHAGE,Hemorrhage intraabdominal,HEMORRHAGE INTRAABDOMINAL,INTRA-ABDOMINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10055268,10061249,10055268
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
RICHTER TRANSFORMATION DRIVEN BY EPSTEIN-BARR VIRUS REACTIVATION,Richter's syndrome,RICHTER'S SYNDROME,RICHTER'S SYNDROME,LYMPHOMAS NON-HODGKIN'S B-CELL,DIFFUSE LARGE B-CELL LYMPHOMAS,10029104,10058728,10058728,10058728
PATIENT TREATED WITH HYDROXYCHLOROQUINE AND IMIQUIMOD FOR MORPHOEA PROFUNDA (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HE CANNOT WALK,unable to walk,UNABLE TO WALK,GAIT INABILITY,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10049278,10017581,10049278
MILD ACUTE EPIDERMAL SPONGIOSIS,Eczema,EPIDERMA SPONGIOSIS,ECZEMA,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10062582,10014184,10062582
RESPIRATORY FAILURE FOLLOWING KAPOSI 'S SARCOMA,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
COLONOSCOPY WAS NOTABLE FOR MILD COLITIS IN THE TRANSVERSE AND DESCENDING COLON WITH A MILD NODULAR APPEARANCE AND FRIABILITY,Endoscopy large bowel abnormal,ENDOSCOPY LARGE BOWEL ABNORMAL,ENDOSCOPY LARGE BOWEL ABNORMAL,GASTROINTESTINAL INVESTIGATIONS,GASTROINTESTINAL AND ABDOMINAL IMAGING PROCEDURES,10022891,10014810,10014810,10014810
CHOLESTASIS,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
FEVER OF 39Â°C,Fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
MULTIPLE DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
OCULAR HYPERTENSIONS FOLLOWING OFF LABEL USE OF MYCOPHENOLATE FOR BLAU-JABS SYNDROME,Ocular hypertension,OCULAR HYPERTENSION,OCULAR HYPERTENSION,GLAUCOMA AND OCULAR HYPERTENSION,GLAUCOMAS (EXCL CONGENITAL),10015919,10030043,10030043,10030043
STENOTROPHOMONAS MALTOPHILIA PNEUMONIA IN TRACHEA (>100000 COLONIES/ML),Pneumonia bacterial,PNEUMONIA BACTERIAL,PNEUMONIA BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10060946,10060946,10060946
CARDIAC ARREST FOLLOWING HEMOLYSIS,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
FEBRILE NEUTROPENIA GRADE 3,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
PLEURAL EFFUSION,Pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
CORONARY ENDOTHELIAL DYSFUNCTION,Endothelial dysfunction,ENDOTHELIAL DYSFUNCTION,ENDOTHELIAL DYSFUNCTION,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10048554,10048554,10048554
TUMOR LYSIS SYNDROME,Tumor lysis syndrome,TUMOR LYSIS SYNDROME,TUMOUR LYSIS SYNDROME,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10045152,10045170,10045152
BREATH SOUNDS DECREASED,Breath sounds abnormal,BREATH SOUNDS DECREASED,BREATH SOUNDS ABNORMAL,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10006333,10064780,10006333
THESE MEDICATIONS WERE POORLY TOLERATED DUE TO NAUSEA AND FLUID RETENTION,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
CONFUSED,Confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
REPORTED A PARADOXICAL EFFECT OF THIS DRUG ON HER VOICE,Paradoxical drug reaction,PARADOXICAL DRUG REACTION,PARADOXICAL DRUG REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048958,10048958,10048958
HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
"INTERNATIONAL NORMALIZED RATIO OF 2 (NORMAL 0.9-1.2),",International normalised ratio increased,INTERNATIONAL NORMALIZED RATIO INCREASED,INTERNATIONAL NORMALISED RATIO INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10022595,10022595,10062459
PARKINSONISM WORSENED,Parkinsonism aggravated,PARKINSONISM AGGRAVATED,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034011,10034010,10034011
"RECURRENT RESPIRATORY INFECTIONS WITH PSEUDOMONAS AERUGINOSA, NOCARDIA NOVA AND ESCHERICHIA COLI",Respiratory tract infection,RESPIRATORY INFECTION,RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10038700,10062352,10038700
PERMANENT INSULIN-DEPENDENT DIABETES,insulin-dependent diabetes mellitus,INSULIN-DEPENDENT DIABETES MELLITUS,TYPE 1 DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10022497,10067584,10022497
URINE RBC GREATER THAN 720/HPF (0-5/HPF) WITHOUT CASTS,urine RBC increased,URINE RBC INCREASED,RED BLOOD CELLS URINE POSITIVE,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINALYSIS NEC,10022891,10046668,10038182,10046668
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
CONSTRICTIVE CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
"CLEARANCE DECREASED AT 59 ML/ MN/ 1,73 M2",creatinine clearance decreased,CREATININE CLEARANCE DECREASED,CREATININE RENAL CLEARANCE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011363,10011372,10011363
CHILLS,chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
"DESPITE ADEQUATE TREATMENT, THE CLINICAL CONDITION AGGRAVATED",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
SUSPICION OF THROMBOCYTOPENIA (BLOOD PLATELET COUNT DECREASED (20X10E9/L)),Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
GENERALIZED ERYTHEMATOUS MACULOPAPULAR RASH,Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
MACULOPAPULAR RASH OVER TRUNK AND EXTREMITIES,Maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PULSELESS ELECTRICAL ACTIVITY,pulseless electrical activity,PULSELESS ELECTRICAL ACTIVITY,PULSELESS ELECTRICAL ACTIVITY,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10058151,10058151,10058151
INDIRECT BILIRUBIN INCREASED (82.59 MICMOL/L),Blood bilirubin unconjugated increased,INDIRECT BILIRUBIN INCREASED,BLOOD BILIRUBIN UNCONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10021709,10005370,10021709
POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE,post transplant lymphoproliferative disease,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10051358,10051358,10051358
BONE EXPOSURE IN JAW,bone exposure in jaw,EXPOSED BONE IN JAW,EXPOSED BONE IN JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10071014,10071014,10071014
NEUTROPENIA,neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
SPONTANEOUS RIGHT KIDNEY RUPTURE,Kidney rupture,KIDNEY RUPTURE,KIDNEY RUPTURE,INJURIES NEC,RENAL AND URINARY TRACT INJURIES NEC,10022117,10023434,10023434,10023434
SHORTNESS OF BREATH,shortness of breath,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
MILD MUCOSITIS ORAL/STOMATITIS,Stomatitis,MUCOSITIS ORAL,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028130,10042128,10028130
PESSIMISTIC THOUGHT,Thinking abnormal,ABNORMAL THINKING,THINKING ABNORMAL,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10000182,10043431,10000182
LEUKOCYTOSIS,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
WORSENED THE AGITATION AND AGGRESSION,Aggression,AGGRESSION AGGRAVATED,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001489,10001488,10001489
BRADYKINESIA,Bradykinesia,BRADYKINESIA,BRADYKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10006100,10006100,10006100
PROMINENT SWELLING OF LOWER EYELIDS,Eyelid oedema,SWELLING OF EYELID,EYELID OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","LID, LASH AND LACRIMAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10042690,10015993,10042690
TRANSAMINASE ELEVATION OF MORE THAN 5 TIMES THE UPPER LIMIT OF NORMAL,Transaminases increased,TRANSAMINASES INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054889,10054889,10054889
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
AGGRESSION,Aggression,AGGRESSIVENESS,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001488,10001488,10001494
DRUG INTERACTION BETWEEN PIPERACILLIN/TAZOBACTAM AND VANCOMYCIN,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
SEROLOGY WAS POSITIVE FOR COXSACKIE PCR,Coxsackie virus test positive,COXSACKIE VIRUS SEROLOGY TEST POSITIVE,COXSACKIE VIRUS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10058574,10070384,10058574
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
PULMONARY OEDEMA,Pulmonary oedema,PULMONARY OEDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037423,10037423,10037423
THE SKIN LESIONS DID NOT IMPROVE WITH PREDNISONE TREATMENT WITH NO ADR,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HE SHOWED GLASGOW COMA SCORE OF 7,Comatose,COMATOSE,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10058472,10010071,10058472
RELAPSE OF ADULT STILL'S DISEASE FOLLOWING LACK OF DRUG EFFECT,Still's disease,ADULT ONSET STILL'S DISEASE,STILL'S DISEASE,JOINT DISORDERS,RHEUMATOID ARTHROPATHIES,10028395,10079456,10042061,10079456
WIDESPREAD URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
DISCOMFORT,discomfort,DISCOMFORT,DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10013082,10013082,10013082
METFORMIN TOXICITY,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
ORBITAL MASS,Mass,MASS,MASS,TISSUE DISORDERS NEC,MASS CONDITIONS NEC,10018065,10026865,10026865,10026865
PATIENT WAS TREATED WITH SULFASALAZINE FOR SACROLITIS AND SPONDYLOARTHRITIS ( OFF LABEL USE) WITH NO ADVERSE DRUG REACTION.,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DUCTUS ARTERIOSUS CLOSURE IN MIDGESTATION FETUS,Ductus arteriosus premature closure,DUCTUS ARTERIOSUS PREMATURE CLOSURE,DUCTUS ARTERIOSUS PREMATURE CLOSURE,CARDIAC AND VASCULAR DISORDERS CONGENITAL,ARTERIAL DISORDERS CONGENITAL,10010331,10049996,10049996,10049996
SEVERE BONE MARROW SUPRESSION DUE FOLLOWING DRUG INTOLERANCE AND LACK OF DRUG EFFECT,Bone marrow failure,MYELOSUPPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10028584
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
MENINGOCOCCAL GROUP W (MENW) SEPTICEMIA,Meningococcal sepsis,MENINGOCOCCAL SEPSIS,MENINGOCOCCAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,NEISSERIA INFECTIONS,10021881,10027280,10027280,10027280
DRUG EXPOSURE DURING PREGNANCY WITH NO ADR,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
STAPHYLOCCOCUS AUREUS INFECTION,Staphylococcal infection,STAPHYLOCOCCUS AUREUS INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10075981,10058080,10075981
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
POOR QUALITY SLEEP,Poor quality sleep,POOR QUALITY SLEEP,POOR QUALITY SLEEP,SLEEP DISTURBANCES (INCL SUBTYPES),SLEEP DISTURBANCES NEC,10029205,10062519,10062519,10062519
GRADUAL INCREASE IN WEIGHT,Weight increased,WEIGHT INCREASED,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047899
PALPITATION,Palpitations,PALPITATION,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033556
ANTIPEROXIDASE ANTIBODIES (ATPO) ELEVATED,Anti-thyroid antibody,ANTI-THYROID ANTIBODIES,ANTI-THYROID ANTIBODY,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),THYROID ANALYSES,10022891,10060325,10060325,10048437
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
NECROTIC CORE AND COLLARETTE OF SCALE ON THE RIGHT LATERAL LOWER LEG AND RIGHT MEDIAL ANKLE,necrotic core and collarette of scale on the right lateral lower leg and right medial ankle,NECROSIS SKIN,SKIN NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10028879,10040893,10028879
PAIN IN RIGHT HIP,Arthralgia,PAIN IN HIP,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10011249,10003239,10033432
DRUG DEPENDENCE TO MEPHENESIN AND ALPRAZOLAM,drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
UNREST,Restlessness,UNREST,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10045556,10038743,10045556
NONBLOODY DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
ADRENAL SUPPRESSION,Adrenal suppression,ADRENAL SUPPRESSION,ADRENAL SUPPRESSION,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001382,10001382,10001382
PATIENT WAS ADMINISTEED METHOTREXATE FOR THE TREATMENT OF RIGHT UNRUPTURED TUBAL PREGNANCY (OFF LABEL USE) WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
INTRAPERITONEAL DISSEMINATION OF GASTRIC CANCER,Gastric cancer,GASTRIC CANCER,GASTRIC CANCER,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,GASTRIC NEOPLASMS MALIGNANT,10029104,10017758,10017758,10017758
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
DRUG INEFFECTIVE,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
DRY GANGRENE,dry gangrene,DRY GANGRENE,DRY GANGRENE,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10049927,10049927,10049927
FEBRILE,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
"CONICAL INVERSION OF THE ST-T SEGMENT IN LEADS I, II, AVF AND V2â€“V6",ST segment depression,ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041892,10014391,10041892
SYMPTOMS WORSENED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
INADVERTENT METHOTREXATE EXPOSURE IN PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
POISONING DELIBERATE,Poisoning deliberate,POISONING DELIBERATE,POISONING DELIBERATE,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10036000,10036000,10036000
ARRHYTHMIA VENTRICULAR,Arrhythmia ventricular,ARRHYTHMIA VENTRICULAR,VENTRICULAR ARRHYTHMIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10003131,10047281,10003131
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
CLUBBING,clubbing,CLUBBING,CLUBBING,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,SOFT TISSUE DISORDERS NEC,10028395,10009691,10009691,10009691
MILD PULMONARY INFILTRATION,Lung infiltration,PULMONARY INFILTRATION,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025102,10025102,10037411
"SHE RECIEVED DIAZEPAM 10MG IVX2 ON HOSPITAL DAY 1 AND 2 SHE REPORTED ANXIETY, RESTLESSNESS, NAUSEA, ABDOMINAL PAIN, AND DIARRHEA",Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
PATIENTâ€™S RASH PERSISTED AND WAS PAINFUL WITH ERYTHEMA,painful rash,PAINFUL RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10074762,10037844,10074762
IMIPRAMINE COULD POTENTIALLY ENHANCE THE DOPAMINE EFFECTS OF AMISULPRIDE/ OTHER NEUROLEPTICS COULD HAVE HAD AN ADDITIVE EFFECT TOGETHER WITH AMISULPRIDE,Potentiating drug interaction,POTENTIATING DRUG INTERACTION,POTENTIATING DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10068072,10068072,10068072
ABDOMINAL DISTENSION,abdominal distension,ABDOMINAL DISTENSION,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10000060
LYMPHOCYTOSIS (71%),Lymphocytosis,LYMPHOCYTOSIS,LYMPHOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10025280,10025280,10025280
QUALITATIVE PLATELET DEFECTS,Platelet abnormalities,PLATELET ABNORMALITIES,PLATELET DISORDER,PLATELET DISORDERS,PLATELET DISORDERS NEC,10005329,10035511,10035532,10035511
RIGORING,Rigoring,RIGORING,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10039176,10008531,10039176
BILATERAL RUPTURE OF THE ACHILLES TENDONS,Achilles tendon rupture,ACHILLES TENDON RUPTURE,TENDON RUPTURE,INJURIES NEC,"MUSCLE, TENDON AND LIGAMENT INJURIES",10022117,10000439,10043248,10000439
ENLARGEMENT OF THE BILATERAL EXTRAOCULAR MUSCLE BELLIES AND BILATERAL EXOPHTHALMOS,Extraocular muscle disorder,EXTRAOCULAR MUSCLE DISORDER,EXTRAOCULAR MUSCLE DISORDER,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10053635,10053635,10053635
NAIL CHANGES,Nail disorder,NAIL CHANGES,NAIL DISORDER,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10028689,10028694,10028689
HAPTOGLOBIN DECREASED (32 MG/DL),Haptoglobin decreased,HAPTOGLOBIN DECREASED,HAPTOGLOBIN DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",HAEM METABOLISM ANALYSES,10022891,10019150,10019150,10019150
"ACUTE PANCYTOPENIA (HEMOGLOBIN 8MG/DL, WBC 3000/CUMM, PLATELET COUNT 19000)",Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
GRADE 3/4 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
HAD TRIED TRANEXEMIC ACID WITH POOR RESPONSE,subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
ANEMIA,Anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
METABOLIC ACIDOSIS,metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
"THE RISK OF FALL WAS CONSIDERED TO BE INCREASED BY THE USE OF PAROXETINE, BUPROPION AND QUETIAPINE",Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
CONDITION WORSENED,CONDITION WORSENED,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
DIARRHEA ASSOCIATED WITH TREATMENT,Diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
ITCHY RASH,Rash pruritic,ITCHY RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10023092
GASTROINTESTINAL BLEEDING/ HEMATEMESIS/VOMIT COFFEE-GROUND APPEARING MATERIAL WHICH WAS HEME POSITIVE,gastrointestinal bleeding,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017936,10017955,10017936
BK VIRUS CYSTITIS,BK virus infection,BK VIRUS INFECTION,BK VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10055181,10055181,10055181
TOXICITY IN FORM OF DIGESTIVE SYNDROME,Gastrointestinal toxicity,GASTROINTESTINAL TOXICITY,GASTROINTESTINAL TOXICITY,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10059024,10059024,10059024
SEVERE WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
MILD ANKLE EDEMA,Oedema peripheral,ANKLE EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10002546,10030124,10002542
SEVERE HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
PATIENT TREATED WITH IFOSFAMIDE FOR MALIGNANT NEURILEMOMMA (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEVERE PRURITUS OF THE ENTIRE BODY,Pruritus generalised,PRURITUS GENERALIZED,PRURITUS GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10052576,10052576,10037092
DRESS SYNDROME,DRESS syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
"ERYTHEMATOUS, LACY RASH ON HER CHEST, COMBINED WITH PERIORBITAL SWELLING AND SIGNIFICANT DYSPNEA",Eye swelling,PERIORBITAL SWELLING,EYE SWELLING,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10056647,10015967,10056647
"COULD BARELY WALK, AND HAD TO CLIMB THE STAIRS ON ALL FOURS",Gait inability,UNABLE TO WALK,GAIT INABILITY,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017581,10017581,10049278
LOW BIRTH WEIGHT BABY,Low birth weight baby,LOW BIRTH WEIGHT BABY,LOW BIRTH WEIGHT BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10067508,10067508,10067508
IRREGULAR ERYTHEMATOUS MACULOPAPULAR ZONES,Rash erythematous,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015243
PALPITATION,palpitation,PALPITATION,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033556,10033557,10033556
"OCCULAR IRRITATION FOLLOWING DRUG INTOLERANCE WITH BRIMONIDINE, TIMOLOL, BRIMONIDINE/TIMOLOL COMBINATION, AND TRAVOPROST",Irritation eye,IRRITATION EYE,EYE IRRITATION,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10023013,10015946,10023013
VERTEBROGENIC PAIN SYNDROME,Spinal pain,VERTEBROGENIC PAIN SYNDROME,SPINAL PAIN,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10066999,10072005,10066999
MESENTERIC ISCHEMIA,Mesenteric ischaemia,MESENTERIC ISCHAEMIA,INTESTINAL ISCHAEMIA,GASTROINTESTINAL VASCULAR CONDITIONS,GASTROINTESTINAL VASCULAR OCCLUSION AND INFARCTION,10017947,10051022,10022680,10051022
INTERSTITIAL PNEUMONIA,interstitial pneumonia,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
ELIZABETHKINGIA MENINGOSEPTICA INFECTION,Bacterial infection,BACTERIAL INFECTION,BACTERIAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10060945,10060945,10060945
"LEFT VENTRICULAR THROMBOSIS, EMBOLIC STROKE, INTRACRANIAL HEMORRHAGE, HEADACHE, MACROSCOPIC HAEMATURIA AND REPORTED SUBTHERAPEUTIC RESPONSE TO CLOPIDOGREL",Haemorrhage intracranial,INTRACRANIAL HEMORRHAGE,HAEMORRHAGE INTRACRANIAL,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10018985,10018985,10022763
HYPERSOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
LEVETIRACETAM WAS WITHOUT EFFECT AND THEREFORE DISCONTINUED,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DISORIENTED,Disorientation,DISORIENTATED,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013394
BULLOUS DRUG ERUPTION,Drug eruption,DRUG ERUPTION,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10013687,10013687,10013687
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ELEVATED C REACTIVE PROTEIN (162 MG/L),C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
AMIODARONE ASSOCIATED LIVER TOXICITY,Drug-induced hepatotoxicity,DRUG-INDUCED HEPATOTOXICITY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072937,10072268,10072937
INR DECREASED,International normalised ratio decreased,INR DECREASED,INTERNATIONAL NORMALISED RATIO DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10022401,10022594,10022401
SUBTOTAL LOSS OF VISION FOLLOWING CHEMOTHERAPY-INDUCED EXACERBATIONS OF THYROID ORBITOPATHY,Blindness,LOSS OF VISION,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047522,10005169,10024881
HAEMOGLOBIN DECREASED (5.8 G/DL),Haemoglobin decreased,HAEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10018884
PROFOUND HYPOTHERMIA,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
NEUROLOGICAL SYMPTOM,Neurological symptom,NEUROLOGICAL SYMPTOM,NEUROLOGICAL SYMPTOM,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10060860,10060860,10060860
"NO IMPROVEMENT IN TREATMENT FOR UPPER ABDOMINAL DISCOMFORT (NAUSEA, ABDOMINAL DISTENSION
AND SLOW DIGESTIONS) (UNAPPROVED INDICATION)",Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
PROGRESSIVE ANEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
GRANULOMATOUS BALANOPOSTHITIS,Balanoposthitis infective,BALANOPOSTHITIS INFECTIVE,BALANOPOSTHITIS INFECTIVE,INFECTIONS - PATHOGEN UNSPECIFIED,MALE REPRODUCTIVE TRACT INFECTIONS,10021881,10067741,10067741,10067741
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
FALLS,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
SYSTEMIC LUPUS ERYTHEMATOSUS CONDITION DETERIORATED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
HEMOPTYSIS,Haemoptysis,HAEMOPTYSIS,HAEMOPTYSIS,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10018964,10018964,10018964
PRO-COLLAGEN 3 N-PEPTIDE (P3NP) RAISED,Serum procollagen type III N-terminal propeptide increased,SERUM PROCOLLAGEN TYPE III N-TERMINAL PROPEPTIDE INCREASED,SERUM PROCOLLAGEN TYPE III N-TERMINAL PROPEPTIDE INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10064803,10064803,10064803
HEPARIN INDUCED THROMBOCYTOPENIA,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
DISTURBED CONSCIOUSNESS,Consciousness disturbed,CONSCIOUSNESS DISTURBED,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010770,10001854,10010770
GRADE 1 NEPHROCALCINOSIS,Nephrocalcinosis,NEPHROCALCINOSIS,NEPHROCALCINOSIS,UROLITHIASES,RENAL LITHIASIS,10038359,10029146,10029146,10029146
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
EMOTIONAL LABILITY,Emotional lability,EMOTIONAL LABILITY,AFFECT LABILITY,MOOD DISORDERS AND DISTURBANCES NEC,AFFECT ALTERATIONS NEC,10037175,10014555,10054196,10014555
OVERDOSE,Overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
ATRIAL FIBRILLATION,Atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
DRUG INDUCED AND COGESTIVE HEPATOPATHY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
WEIGHT GAIN,weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
PATIENT WAS TREATED WITH ISONIAZID AND RIFAPENTINE FOR ATOPIC DERMATITIS ( OFF LABEL USE FOR INDICATION) WITH NO ADVERSE DRUG REACTION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PANCYTOPENIA,pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
CHILLINESS,Feeling cold,CHILLINESS,FEELING COLD,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008530,10016326,10008530
STREPTOCOCCUS ORALIS INFECTION,Streptococcal infection,STREPTOCOCCAL INFECTION,STREPTOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10061372,10061372,10061372
MYALGIA IN THE ARMS AND LEGS,myalgia in the arms and legs,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
GASTROINTESTINAL SIDE EFFECTS,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
PNEUMONIA FOLLOWING HYPOGAMMAGLOBULINAEMIA,pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
NSTEMI,Non STEMI,NON STEMI,ACUTE MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10064348,10000891,10064348
DRUG-INDUCED HEPATOTOXICITY,Drug-induced hepatotoxicity,DRUG-INDUCED HEPATOTOXICITY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072937,10072268,10072937
OTITIS MEDIA,otitis media,OTITIS MEDIA,OTITIS MEDIA,INFECTIONS - PATHOGEN UNSPECIFIED,EAR INFECTIONS,10021881,10033078,10033078,10033078
ASCITES,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
PERSISTENT MEMORY PROBLEMS,Memory impairment,MEMORY IMPAIRMENT,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027175,10027175,10027175
EXTRAPULMONARY TUBERCULOSIS,extrapulmonary tuberculosis,EXTRAPULMONARY TUBERCULOSIS,EXTRAPULMONARY TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10064445,10064445,10064445
LACK OF SLEEP AFFECTED THE PATIENT'S MOOD / SLEEPING BADLY POSSIBLY CAUSED ALSO DEPRESSEDMOOD,Depressed mood,DEPRESSED MOOD,DEPRESSED MOOD,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10012374,10012374,10012374
A URINALYSIS WAS SIGNIFICANT FOR >10 HYALINE CASTS WITH PROTEINURIA,Casts urinary hyaline,CASTS URINARY HYALINE,URINARY CASTS,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINALYSIS NEC,10022891,10007718,10046533,10007718
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
SHORT FOCAL SEIZURE AND EXHIBITED POSTURING WITH AUTONOMIC CHANGES,Partial seizures,FOCAL SEIZURES,PARTIAL SEIZURES,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10016843,10061334,10016843
LIVER FUNCTION CONTINUED TO WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
BILIRUBIN ELEVATED 102 MICROMOL/L,Blood bilirubin increased,BILIRUBIN ELEVATED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10004690,10005364,10004688
OPSOCLONUS,Eye movement disorder,EYE MOVEMENT DISORDER,EYE MOVEMENT DISORDER,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10061129,10061129,10061129
DISORIENTATION,disorientation,DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013395
CARDIAC ARRHYTHMIA,Arrhythmia,CARDIAC ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10007518
EOSINOPHILIC PNEUMONIA,Eosinophilic pneumonia,EOSINOPHILIC PNEUMONIA,EOSINOPHILIC PNEUMONIA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10014962,10014962,10014962
THYROGEN ADMISTERED AT FREQUENCTY OF BID,Inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
CYANOSIS NEONATAL,Cyanosis neonatal,CYANOSIS NEONATAL,CYANOSIS NEONATAL,NEONATAL RESPIRATORY DISORDERS,NEONATAL HYPOXIC CONDITIONS,10038738,10011705,10011705,10011705
HEPATOSTEATOSIS,Hepatosis ,HEPATOSIS,LIVER DISORDER,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10048682,10024670,10048682
ACUTE ONSET AGITATION,acute onset agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
PATIENT TREATED WITH MYCOPHENOLATE MOEFTIL FOR BILATERAL CENTRAL RETINAL ARTERY OCCLUSION (OFF LABEL FOR INDICATION WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
WEIGHT LOSS,weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
DISCONTINUED MEDICATION WITH BOSENTAN AT HER OWN BECAUSE OF PREPARATION FOR PREGNANCY IN 2016,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
ELEVATED LIVER ENZYMES,Elevated liver enzymes,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
POLYDIPSIA,Polydipsia,POLYDIPSIA,POLYDIPSIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,FLUID INTAKE INCREASED,10027433,10036067,10036067,10036067
BILATERAL PARAESTHESIA OF LOWER LIMBS ASCENDING TO PELVIS,Paraesthesia,PARESTHESIA LOWER LIMB,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10052409,10033775,10054531
OLANZAPINE-INDUCED PARKINSONISM,Drug-induced parkinsonism,DRUG-INDUCED PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10013707,10034010,10013707
"WBC INCREASED (10,000/CUMM)",White blood cell count increased,WBC INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056739,10047943,10056739
DEPRESSIVE STATE,Depression,DEPRESSIVE STATE,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012377,10012378,10049709
PULMONARY CONGESTION,Pulmonary congestion,PULMONARY CONGESTION,PULMONARY CONGESTION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037368,10037368,10037368
RASH,RASH,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
WEIGHT GAIN,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
DYSMORPHIA,Dysmorphism,DYSMORPHISM,DYSMORPHISM,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL DISORDERS CONGENITAL NEC,10010331,10066054,10066054,10066054
PRESENCE IN URINE OF OPIATES AND CANNABIS,urine drug screen positive,URINE DRUG SCREEN POSITIVE,DRUG SCREEN POSITIVE,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,TOXICOLOGY LABORATORY ANALYSES,10022891,10051105,10049177,10051105
POOR APPETITE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
TRANSIENT AGAMMAGLOBULINEMIA,Hypogammaglobulinaemia,AGAMMAGLOBULINEMIA,HYPOGAMMAGLOBULINAEMIA,IMMUNODEFICIENCY SYNDROMES,PRIMARY IMMUNODEFICIENCY SYNDROMES,10021428,10001470,10020983,10001471
SWELLING,swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
DISTURBING BUT PAINFUL DISCOMFORT,Leg  discomfort,LEG DISCOMFORT,LIMB DISCOMFORT,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10054246,10061224,10054246
PATIENT TREATED WITH DEXTROMETHORPHAN HYDROBROMIDE FOR ENCEPHALOPATHY (OFF LABEL USE FOR INDICATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MENTAL STATUS DETERIORATED,Mental impairment,MENTAL DETERIORATION,MENTAL IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10027352,10027374,10027352
LOSS OF STRENGTH OF LOWER RIGHT AND UPPER LIMB,Asthenia,STRENGTH LOSS OF,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10042174,10003549,10042174
PATHOGEN RESISTANCE,Pathogen resistance,PATHOGEN RESISTANCE,PATHOGEN RESISTANCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10034133,10034133,10034133
ASPIRATION PNEUMONIA,aspiration pneumonia,ASPIRATION PNEUMONIA,PNEUMONIA ASPIRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10003525,10035669,10003525
SEROUS DISCHARGE,serous discharge,SEROUS DISCHARGE,SECRETION DISCHARGE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10053530,10053459,10053530
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
PLATELET COUNT DECREASED/THROMBOCYTOPENIA G3,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
OLIGURIC,Oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
MAJOR CONGENITAL MALFORMATIONS,Congenital anomaly,CONGENITAL ANOMALY NOS,CONGENITAL ANOMALY,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10010357,10010356,10010357
PROGRESSIVE PARALYSIS IN LOWER EXTREMITIES,paralysis legs,PARALYSIS LEGS,DIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10050045,10013033,10050045
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
MYDRIASIS,Mydriasis,MYDRIASIS,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10028521,10028521,10028521
SCLERODERMA RENAL CRISIS,Scleroderma renal crisis,SCLERODERMA RENAL CRISIS,SCLERODERMA RENAL CRISIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062553,10062553,10062553
"PATIENT TREATED WITH ILOPROST TROMETAMOL FOR SYSTEMIC SCLEROSIS WITH PULMONARY, ESOPHAGEAL, CUTANEOUS, AND VASCULAR INVOLVEMENT (OFF LABEL USE)",off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TENDON RUPTURE,Achilles tendon rupture,ACHILLES TENDON RUPTURE,TENDON RUPTURE,INJURIES NEC,"MUSCLE, TENDON AND LIGAMENT INJURIES",10022117,10000439,10043248,10000439
LIGHTHEADEDNESS,Dizziness,LIGHTHEADEDNESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10024461,10013573,10024492
WIDESPREAD RASH,widespread rash,WIDESPREAD RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10047984,10037858,10047984
INTRAEPIDERMAL PUSTULES AND SPONGIFORM PUSTULES OF KOGOJ,Pustule,PUSTULE,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037578,10037888,10037578
AN ATYPICAL FRACTURE OF THE LEFT FEMORAL SHAFT,Atypical femur fracture,ATYPICAL FEMUR FRACTURE,ATYPICAL FEMUR FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10070884,10070884,10070884
BIG CO2 AMOUNT WAS OBSERVED IN EXHALATION,CO2 total abnormal NOS,CO2 TOTAL ABNORMAL NOS,CARBON DIOXIDE ABNORMAL,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10009724,10064156,10009724
MILD ASCITES,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
FACIAL EDEMA,Face oedema,EDEMA FACE,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10016029,10016029,10014222
HEMOPHAGOCYTOSIS IN THE BONE MARROW,phagocytosis,PHAGOCYTOSIS,PHAGOCYTOSIS,METABOLISM DISORDERS NEC,CELL METABOLISM DISORDERS NEC,10027433,10057249,10057249,10057249
DISEASE PROGRESSION/STAGE IV PERIPHERAL CD30+ T-CELL LYMPHOMA (NOT OTHERWISE SPECIFIED),Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
FIBRINOID IRITIS WITH A 1.00 MM HYPOPYON IN THE LEFT EYE AND 1.5 MM HYPOPYON AND 360 DEGREE OF POSTERIOR SYNECHIAE IN THE LEFT EYE,Hypopyon,HYPOPYON,HYPOPYON,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10021086,10021086,10021086
KETOCONAZOLE AND FLUCONAZOLE INDUCED CHEMICAL SENSITIVITY,Multiple chemical sensitivity,MULTIPLE CHEMICAL SENSITIVITY,MULTIPLE CHEMICAL SENSITIVITY,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10057865,10057865,10057865
MUSCLE PAIN,Muscle pain,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028322,10028411,10028322
BRONCHOSPASM,Bronchospasm,BRONCHOSPASM,BRONCHOSPASM,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10006482,10006482,10006482
POOR RESPONSE TO STEROIDS AND CYCLOPHOSPHAMIDE,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
MOTOR APHASIA,motor aphasia,APHASIA MOTOR,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002949,10002948,10002949
FOETAL DISTRESS,Foetal distress,FOETAL DISTRESS,FOETAL DISTRESS SYNDROME,FOETAL COMPLICATIONS,FOETAL COMPLICATIONS NEC,10036585,10016854,10016855,10016854
LOW-RISK HUMAN PAPILLOMAVIRUS TYPE 11,Papilloma viral infection,HUMAN PAPILLOMA VIRUS INFECTION,PAPILLOMA VIRAL INFECTION,VIRAL INFECTIOUS DISORDERS,PAPILLOMA VIRAL INFECTIONS,10021881,10063001,10061331,10063001
SEVERE MYALGIA,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
 warm at touching,2018-05-23 00:00:00,1,,16-OCT-2014,,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10037855,10037855,172800
ANAPHYLAXIS (GRADE 4),Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
INCREASED BILIRUBIN (3.11 MG/DL),Blood bilirubin increased,BILIRUBIN INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10004690,10005364,10004690
 vn 1.7-23.3),2018-04-02 00:00:00,1,,,,ADRENAL CORTICAL HYPERFUNCTIONS,10075916,10020571,
ACUTE LYMPHOBLASTIC LEUKEMIA RELAPSE FOLLOWING TREATMENT FAILURE,Acute lymphoblastic leukaemia recurrent,ACUTE LYMPHOBLASTIC LEUKAEMIA RECURRENT,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,LEUKAEMIAS,LEUKAEMIAS ACUTE LYMPHOCYTIC,10029104,10063621,10063620,10063621
TACHYCARDIAC,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
LACTATE DEHYDROGENASE ELEVATED (1806 U/L),Blood lactate dehydrogenase increased,LACTATE DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10023654,10005630,10023654
PERIPHERAL NEUROPATHY,Neuropathy peripheral,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10080342
ALTERNARIA INFECTION,alternaria infection,ALTERNARIA INFECTION,ALTERNARIA INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10054207,10054207,10054207
FLECAINIDE INDUCED TYPE 1 BRUGADA PATTERN,Brugada syndrome,BRUGADA SYNDROME,BRUGADA SYNDROME,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10059027,10059027,10059027
LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
 on both sides the inferior nasal artery is threadlike and almost invisible,2018-08-02 00:00:00,1,,,,RETINAL BLEEDING AND VASCULAR DISORDERS (EXCL RETINOPATHY),10079723,10038830,
ACUTE CORONARY SYNDROME,Acute coronary syndrome,ACUTE CORONARY SYNDROME,ACUTE CORONARY SYNDROME,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10051592,10051592,10051592
LYELL'S SYNDROME,Lyell's syndrome,LYELL'S SYNDROME,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10025168,10044223,10025168
KAPOSI'S SARCOMA,Kaposi's sarcoma,KAPOSI'S SARCOMA,KAPOSI'S SARCOMA,SOFT TISSUE NEOPLASMS MALIGNANT AND UNSPECIFIED,KAPOSI'S SARCOMAS,10029104,10023284,10023284,10023284
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
EOSINOPHILIA (EOSINOPHIL COUNT 4.68 K/ML),Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
LEFT VENTRICULAR DYSFUNCTION,Left ventricular dysfunction,LEFT VENTRICULAR DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10049694,10049694,10049694
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
ACUTE MENTAL STATUS CHANGE,Mental status changes,ACUTE MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10066632,10048294,10066632
ALANINE AMINOTRANSFERASE (AROUND 400U/L) INCREASED,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
EDEMA OF LOWER LIMBS,Edema lower limb,EDEMA LOWER LIMB,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014232,10030124,10014232
DECREASED CORTISOL LEVELS: 2.8 ÎœG/DL,Cortisol decreased,CORTISOL DECREASED,CORTISOL DECREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),ADRENAL CORTEX TESTS,10022891,10011198,10011198,10011198
LACK OF DRUG EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LOW HEMOGLOBIN (109 G/L),Haemoglobin decreased,HEMOGLOBIN LOW,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018889,10018884,10055600
SENSORY FUNCTION LOSS OF EXTREMITIES,Sensory loss,SENSORY LOSS,SENSORY LOSS,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10040030,10040030,10040030
LUNG INFECTION,Lung infection,LUNG INFECTION,LUNG INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10061229,10061229,10061229
ANION GAP,Anion gap,ANION GAP,ANION GAP,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10002522,10002522,10002522
RETINAL THICKNESS AND VOLUMES WERE REDUCED/RETINAL DYSFUNCTION,Retinal disorder,RETINAL DISORDER,RETINAL DISORDER,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10038853,10038853,10038853
CT THORAX SHOWED ONE SMALL NON-SPECIFIC PULMONARY NODULE,Pulmonary mass,LUNG NODULE,PULMONARY MASS,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10049498,10056342,10049498
ACUTE RENAL INJURY,Acute renal injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
TREATED WITH METHIMAZOLE FOR AMIODARONE-INDUCED THYROTOXICOSIS,Hyperthyroidism,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
ABDOMINAL DISTENSION,abdominal distension,ABDOMINAL DISTENSION,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10000060
ABDOMINAL LYMPHADENOPATHY DUE TO KAPOSIâ€™S SARCOMA,abdominal lymphadenopathy,ABDOMINAL LYMPHADENOPATHY,ABDOMINAL LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10073485,10073485,10073485
GRADE 2 DIARRHEA,Diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
EPISODE OF BRADYCARDIA FOLLOWING LACK OF DRUG EFFECT,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
RAISED CRP (73 MG/DL),C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
WARFARIN NONCOMPLIANCE LEADING UPTO STROKE,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
INCREASING CALCIFICATION IN PERITONEAL IMPLANTS ON CT,Computerised tomogram abnormal,CT SCAN ABNORMAL,COMPUTERISED TOMOGRAM ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",IMAGING PROCEDURES NEC,10022891,10011604,10010235,10011604
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
PALPITATION,Palpitations,PALPITATION,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033556
PHARMACOLOGICAL ANAMNESIS,anamnestic reaction,ANAMNESTIC REACTION,ANAMNESTIC REACTION,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10078965,10078965,10078965
SKIN FIBROSIS,skin fibrosis,SKIN FIBROSIS,SKIN FIBROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10050207,10050207,10050207
PARTIALLY RESISTANT TO IMATINIB MESILATE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
SECONDARY GENERALIZED BRACHIORADIAL PRURITUS SUCCESSFULLY TREATED WITH GABAPENTIN,Drug effective for unapproved indication,DRUG EFFECTIVE FOR UNAPPROVED INDICATION,DRUG EFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10079317,10079317,10079317
INTRACTABLE NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
OPTIC NEURITIS,Optic neuritis,OPTIC NEURITIS,OPTIC NEURITIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OPTIC NERVE DISORDERS NEC,10029205,10030942,10030942,10030942
POOR PAIN MANAGEMENT,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
DYSGEUSIA,Dysgeusia,DYSGEUSIA,DYSGEUSIA,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10013911,10013911,10013911
EMESIS,Vomiting,EMESIS,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10014542
BISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAW (MAXILLA (MEDIAL)),Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
ANTINUCLEAR ANTIBODIES,antinuclear antibodies,ANTINUCLEAR ANTIBODIES PRESENT,ANTINUCLEAR ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10002806,10060055,10002806
ORAL INFECTION WITH CULTURE POSITIVE FOR  RAOULTELLA PLANTICOLA FOLLOWING FEBRILE NEUTROPENIA,Oral bacterial infection,ORAL BACTERIAL INFECTION,ORAL BACTERIAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10065233,10065233,10065233
SEVERE THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
OCULOGYRIC CRISIS,Oculogyric crisis,OCULOGYRIC CRISIS,OCULOGYRIC CRISIS,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10030071,10030071,10030071
DEXAMETHASONE WAS USED FOR OCULAR ROSACEA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
AMIODARONE-INDUCED ACUTE LIVER FAILURE/ INTRAVENOUS AMIODARONE-INDUCED ACUTE LIVER FAILURE IN CARDIAC SURGERY,Acute hepatic failure,ACUTE LIVER FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10049844
CHEMOTHERAPY RELATED ACUTE ERYTHROLEUKEMIA,Erythroleukaemia,ERYTHROLEUKEMIA,ERYTHROLEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10015281,10015281,10015282
HEPATITIS,Hepatitis,HEPATITIS,HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019717,10019717,10019717
DIARRHEA / DIARRHOEIC CONTENTS IN THE INTESTINES,Diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
VENO-OCCLUSIVE DISEASE,Venoocclusive disease,VENOOCCLUSIVE DISEASE,VENOOCCLUSIVE DISEASE,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10062173,10062173,10062173
"BURNING SENSATION IN HER SKIN, EYES, MOUTH AND GENITAL AREA",Burning sensation,BURNING SENSATION,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10006784,10006784,10006784
"MUCOSAL EROSIONS AFFECTING MOUTH, URETHRAL MEATUS AND PERIANAL REGION, CONJUCTIVAL ERYTHEMA, EXTENSIVE ERYTHEMA AND LOCAL SUPERFICIAL EROSIONS AFFECTING FACE, NECK,AREAS OF HAIRY SKIN,UPPER HALF OF TORSO AND ARMS/OROPHARYNGEAL EROSIONS",mucosal erosion,MUCOSAL EROSION,MUCOSAL EROSION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10061297,10061297,10061297
SPRUE-LIKE ENTEROPATHY,Sprue-like enteropathy,SPRUE-LIKE ENTEROPATHY,SPRUE-LIKE ENTEROPATHY,MALABSORPTION CONDITIONS,MALABSORPTION SYNDROMES,10017947,10079622,10079622,10079622
THE PATIENT IS UNCOMPLIANT TO THE DOUBLE ANTIPLATELET THERAPY (BOTH CLOPIDOGREL AND ASPIRINE),Intentional dose omission,INTENTIONAL DOSE OMISSION,INTENTIONAL DOSE OMISSION,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT USE ISSUES,10022117,10079221,10079221,10079221
ANEMIA (HEMOGLOBIN 6.8 G/DL),Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
FLACCID PARAPARESIS,Paraparesis,FLACCID PARAPARESIS,PARAPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10070828,10033885,10070828
SWELLING,swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HODGKIN'S DISEASE STAGE II IN PARTIAL RESPONSE,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
"PERIPHERAL NERVE DISORDER, GRADE 1 PERIPHERAL NEUROPATHY",Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
PATIENT BECAME FEVERISH AGAIN,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
LEFT ECTOPIC PREGNANCY / RUPTURED ECTOPIC PREGNANCY,Ruptured ectopic pregnancy,RUPTURED ECTOPIC PREGNANCY,RUPTURED ECTOPIC PREGNANCY,MATERNAL COMPLICATIONS OF PREGNANCY,MATERNAL COMPLICATIONS OF PREGNANCY NEC,10036585,10048407,10048407,10048407
HSV PNEUMONIA,Pneumonia viral,VIRAL PNEUMONIA,PNEUMONIA VIRAL,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10047474,10035737,10047474
"OPIOID SWITCHING TO INTRAVENOUS FENTANYL WAS INITIATED, BUT IT WAS NOT EFFECTIVE",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
TOOK DULOXETINE 90 MG DAILY AND METHYLPHENIDATE 36 MG DAILY DURING PREGNANCY AND BREAST FEEDING,Foetal exposure during pregnancy,FETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071404,10071404,10071421
DECREASED APETITE/LOSS OF APPETITE AS A RESULT OF ANTIBIOTIC THERAPY,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
GENERAL AGITATION,general agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
MYCOBACTERIUM HECKESHORNENSE LUNG INFECTION,Mycobacterial infection,MYCOBACTERIAL INFECTION,MYCOBACTERIAL INFECTION,MYCOBACTERIAL INFECTIOUS DISORDERS,ATYPICAL MYCOBACTERIAL INFECTIONS,10021881,10062207,10062207,10062207
SHORT LOSS OF CONSCIOUSNESS WITH SPASMS OF MIMIC MUSCLES,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
INCREASED AGITATION,Agitation,INCREASED AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001498,10001497,10021651
TACHYPNEA,tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
"CHRONIC PLAQUES OF ECZEMA ON THE DORSA OF HANDS, FOREARMS, CHIN, LIPS AND FACE",Eczema,ECZEMA FACIAL,ECZEMA,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10014195,10014184,10014195
PATIENTS HAD NO CHANGE WITH MYCOPHENOLATE MOFETIL,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
FLU-LIKE FEBRILE PROCESS,Febrile cold (excl flu like illness),FEBRILE COLD (EXCL FLU LIKE ILLNESS),NASOPHARYNGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10016283,10028810,10016283
ONLY THROMBUS WAS IDENTIFIED,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SERUM CREATININE (4.36 MG/DL- 16.2 MG/DL),Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
SEVERE HYPOGLYCEMIA,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
TREATED WITH ALEMTUZUMAB/T-CELL PROLYMPHOCYTIC LEUKEMIA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BLURRING OF VISION IN BOTH EYES,blurring of vision in both eyes,BLURRING OF VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10005888,10047513,10005888
BROAD COMPLEX TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
METRONIDAZOLE ASSOCIATED ENCEPHALOPATHY,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
PAIN,pain ,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
VISUAL HALLUCINATIONS,visual hallucinations,VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10047570,10019075,10047570
SUICIDAL ATTEMPT (HIGH-DOSE ALPRAZOLAM),Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
MACULAR OEDEMA FOLLOWING GENTAMICIN-INDUCED MACULAR INFARCTION,Macular oedema,MACULAR OEDEMA,MACULAR OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","RETINAL, CHOROID AND VITREOUS INFECTIONS AND INFLAMMATIONS",10015919,10025415,10025415,10025415
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
COLDNESS IN RIGHT LEG,Peripheral coldness,COLD FEET,PERIPHERAL COLDNESS,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10009859,10034568,10009859
PATIENT'S PAIN CONTINUED TO WORSEN,Pain aggravated,PAIN AGGRAVATED,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033376,10033371,10033376
CLOZAPINE INDUCED MYOCARDITIS,Myocarditis,MYOCARDITIS,MYOCARDITIS,MYOCARDIAL DISORDERS,NONINFECTIOUS MYOCARDITIS,10007541,10028606,10028606,10028606
HER BLOOD PRESSURE WAS 152/96 MM HG,Hypertension aggravated,HYPERTENSION AGGRAVATED,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020773,10020772,10020773
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
SUFFOCATION,suffocation,SUFFOCATION,ASPHYXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10042443,10003497,10042443
DECREASED APPETITE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
GRADE II AND GRADE III GRANULOCYTOPENIA,Granulocytopenia,GRANULOCYTOPENIA,GRANULOCYTOPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10018687,10018687,10018687
LARYNGEAL EDEMA,Laryngeal oedema,LARYNGEAL EDEMA,LARYNGEAL OEDEMA,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),"LARYNGEAL SPASM, OEDEMA AND OBSTRUCTION",10038738,10023845,10023845,10023838
"ACUTE COLITIS DUE TO WORSENING OF SLE AND LACK OF DRUG EFFECT OF HYDROCORTISONE, VANCOMYCIN, CIPROFLOXACIN, MEROPENEM AND METRONIDAZOLE",Colitis,COLITIS,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009887,10009887,10009887
REBOUND EFFECT,rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
DARK-COLORED EMESIS,emesis,EMESIS,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10014542,10047700,10014542
IMMEDIATE ALLERGIC REACTION TO AMOXICILLIN,Immediate hypersensitivity reaction,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
ALTERED MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
OLIGURIA,Oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
SLIGHT ELEVATION OF NEUTROPHILS,Neutrophils increased,NEUTROPHILS INCREASED,NEUTROPHIL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029381,10029368,10029381
SUICIDE ATTEMPT,Suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
DEVELOPED REFRACTORY ARDS,Acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
THEOPHYLLINE-ASSOCIATED SEIZURES,Seizure,SEIZURES,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039910
POLYRADICULOPATHY DUE TO EBV ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,Radiculopathy,POLYRADICULOPATHY,RADICULOPATHY,SPINAL CORD AND NERVE ROOT DISORDERS,SPINAL CORD AND NERVE ROOT DISORDERS NEC,10029205,10036140,10037779,10036140
SEVEN KG WEIGHT LOSS IN 20 DAYS FOLLOWING MAGNESIUM LEVELS DECREASE,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
THROAT WAS RED,Pharyngeal erythema,PHARYNX REDNESS OF,PHARYNGEAL ERYTHEMA,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),PHARYNGEAL DISORDERS (EXCL INFECTIONS AND NEOPLASMS),10038738,10034863,10057009,10034863
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
PARVOVIRUS B19 INFECTION,Viral infection,VIRAL INFECTION,VIRAL INFECTION,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10047461,10047461,10047461
HYPOCHLORAEMIA,Hypomagnesaemia,HYPOMAGNESAEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021027,10021027,10021027
REM SLEEP REBOUND/WITHDRAWAL EFFECT,Withdrawal syndrome,WITHDRAWAL REACTION,WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10048008,10048010,10048008
PATIENT STARTED TREATMENT WITH TOPICAL FUSIDIC ACID TWO TIMES DAILY WITH LITTLE IMPROVEMENT WITH NO ADR,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
DISORIENTATION,Disorientation,DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013395
TREATMENT WAS NOT TAKEN REGULARLY,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
EBV-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,Histiocytosis haematophagic,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,HISTIOCYTOSIS HAEMATOPHAGIC,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10071583,10048595,10071580
RENAL FUNCTION DETERIORATED,Renal function abnormal,RENAL FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038451,10062237,10038451
PATIENT WAS EXPOSED WITH CARBIMAZOLE THROUGHOUT PREGNANCY,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
MUSCLE DAMAGE,Muscle injury,MUSCLE DAMAGE,MUSCLE INJURY,INJURIES NEC,"MUSCLE, TENDON AND LIGAMENT INJURIES",10022117,10028314,10028314,10028297
PURULENT PERITONITIS,Peritonitis,PERITONITIS,PERITONITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10034674,10034674,10034674
SWELLING OF HER TONGUE,Swollen tongue,SWELLING OF TONGUE,SWOLLEN TONGUE,TONGUE CONDITIONS,TONGUE SIGNS AND SYMPTOMS,10017947,10042727,10042727,10042706
A RING SCOTOMA WITH INFERIOR SPARING,Visual field defect,SCOTOMA ANNULAR,VISUAL FIELD DEFECT,NEUROLOGICAL DISORDERS OF THE EYE,NEUROLOGIC VISUAL PROBLEMS NEC,10029205,10039730,10047555,10039730
ACUTE ADRENAL CRISIS FOLLOWING INADEQUATE ADAPTATION OF GLUCOCORTICOID DOSASE TO THE ACUTE STRESS SITUATION,adrenal crisis,ADRENAL CRISIS,ADRENOCORTICAL INSUFFICIENCY ACUTE,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001346,10001389,10001346
BASILAR THROMBOSIS,Thrombosis,THROMBOSIS,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10043607,10043607,10043607
NONALLERGIC ASTHMA DEPENDENT ON CORTICOSTEROID (REBOUND EFFECT),Asthma,ASTHMA,ASTHMA,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10003553,10003553,10003553
VALPROATE-INDUCED COMA DUE TO WORSENING OF CARNITINE INSUFFICIENCY AND KETOSIS,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
FEVER,fever,HYPERTHERMIA,HYPERTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10020843,10020843,10020843
SLIGHT FEVER (38 Â°C),fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
LOST HIS ABILITY TO WALK,Difficulty in walking,DIFFICULTY IN WALKING,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10012794,10017577,10012794
IMMUNOSUPPRESSIVE TREATMENT PREDISPOSED THE CHILD TO CLINICALLY MASKED BACTERIAL ENDOCARDITIS AND PULMONARY EMBOLISM,Infection masked,INFECTION MASKED,INFECTION MASKED,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021836,10021836,10021836
JAUNDICE,jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
DRUG ERUPTION,Drug eruption,DRUG ERUPTION,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10013687,10013687,10013687
DEATH BY CAFFEINE OVERDOSE,Blood caffeine increased,CAFFEINE HIGH,BLOOD CAFFEINE INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,TOXICOLOGY LABORATORY ANALYSES,10022891,10006929,10005384,10006929
TENDERNESS,Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
MARKED BONE MARROW DEPRESSION,Bone marrow failure,BONE MARROW DEPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10005986
TREATMENT FAILURE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
CORONARY ARTERIAL ECTASIA FOLLOWING BOSENTAN ADMINISTRATION AND OFF LABEL USE OF SILDENAFIL CITRATE,Coronary artery dilatation,CORONARY ARTERY DILATATION,CORONARY ARTERY DILATATION,CORONARY ARTERY DISORDERS,CORONARY ARTERY DISORDERS NEC,10007541,10065420,10065420,10065420
NEPHROTOXICITY,nephrotoxicity,NEPHROTOXICITY,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10067571
MALNUTRITION,Malnutrition,MALNUTRITION,MALNUTRITION,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10061273,10061273,10061273
"POOR SLEEP, BAD DREAMS, FEELING LIKE A ZOMBIE",Insomnia,DIFFICULTY SLEEPING,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10012804,10022437,10012804
RAPID ATRIAL FIBRILLATION,atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,Progressive multifocal leukoencephalopathy,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10036807,10036807,10036807
GASTROINTESTINAL DISEASE,gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
TRANSIENT CHEST TIGHTNESS,Chest discomfort,CHEST TIGHTNESS,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008492,10008469,10008492
UNREST,Restlessness,UNREST,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10045556,10038743,10045556
FIRST-DEGREE ATRIOVENTRICULAR BLOCK,atrioventricular block first degree,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10003674,10003674,10003674
LETHARGY FOLLOWING ACCIDENTAL OVERDOSE WITH 60 MG OF CETIRIZINE (12-FOLD OVERDOSE OF CETIRIZINE),lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
UNABLE TO SWALLOW,unable to swallow,UNABLE TO SWALLOW,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10075917,10013950,10075917
DOCETAXEL INDUCED SCLERODERMA (EXACERBATION),Scleroderma,SCLERODERMA,SCLERODERMA,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),CONNECTIVE TISSUE DISORDERS NEC,10028395,10039710,10039710,10039710
HYPOGLYCAEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
ACUTE COMPLETE BILATERAL LOSS OF VISION DUE TO CINCHONISM FOLLOWING INTENTIONAL DRUG ABUSE,Blindness,BILATERAL BLINDNESS,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10004556,10005169,10004556
ANTI-HMGCR-ASSOCIATED IMMUNE-MEDIATED NECROTISING MYOPATHY,immune-mediated necrotising myopathy,IMMUNE-MEDIATED NECROTISING MYOPATHY,IMMUNE-MEDIATED NECROTISING MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10072155,10072155,10072155
INSOMNIA,insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
PARENCHYMAL HAEMORRHAGE TYPE 2,haemorrhage,HAEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10055798
LEG STIFFNESS,leg stiffness,STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10042045,10052904,10042045
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
INABILITY TO EITHER STAND OR WALK,difficulty in standing,DIFFICULTY IN STANDING,DYSSTASIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10050218,10050256,10050218
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
LIGHT-COLOR AND ENLARGED TONGUE,Tongue discolouration,TONGUE DISCOLOURATION,TONGUE DISCOLOURATION,TONGUE CONDITIONS,TONGUE SIGNS AND SYMPTOMS,10017947,10043949,10043949,10043949
CHEMOTHERAPY INDUCED ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
GRADE II ANAPHYLAXIS TO METAMIZOLE AND GRADE III ANAPHYLAXIS TO AMOXICILLIN,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
ENERGY LEVELS INCREASED,Energy increased,ENERGY INCREASED,ENERGY INCREASED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10048779,10048779,10048779
PARTIAL REGRESSION OF HYPERTENSION AND CARDIAC FAILURE WAS NOTED WITH THE PRESERVATION OF A HIGH LEVEL OF CREATININE,subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
LITHIUM TOXICITY,Toxicity to various agents,LITHIUM TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10050501,10070863,10050501
"LACK OF THERAPEUTIC COMPLIANCE, CHAOTIC TREATMENT",Intentional drug misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
SYPHILIDS,syphilis,SYPHILIS,SYPHILIS,BACTERIAL INFECTIOUS DISORDERS,TREPONEMA INFECTIONS,10021881,10062120,10062120,10062120
"PATIENT WAS TREATED WITH IMATINIB FOR GASTROINTESTINAL STROMAL TUMOUR, BUT TUMOUR SHOWS NO RESPONSE TO THERAPY (LACK OF DRUG EFFECT) WITH NO ADVERSE EVENTS",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SERUM CREATINE KINASE INCREASED,Blood creatine phosphokinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
PROGRESSION OF PANCREATIC CARCINOSARCOMA FOLLOWING FAILING THESE TWO LINES OF CHEMOTHERAPY,Pancreatic carcinoma,PANCREATIC CARCINOMA,PANCREATIC CARCINOMA,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,PANCREATIC NEOPLASMS MALIGNANT (EXCL ISLET CELL AND CARCINOID),10029104,10033609,10033609,10033609
PUSTULES,Rash pustular,PUSTULE,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037578,10037888,10037578
CHRONIC ALLOGRAFT DYSFUNCTION FOLLOWING BK VIRUS NEPHROPATHY,Complications of transplanted kidney,KIDNEY GRAFT DYSFUNCTION,COMPLICATIONS OF TRANSPLANTED KIDNEY,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10051366,10010185,10051366
CYTOMEGALOVIRUS INFECTION FOLLOWING CHEMOTHERAPY,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011831,10011831,10011831
ACUTE LYMPHOBLASTIC LEUKAEMIA RELAPSE,acute lymphoblastic leukaemia,ACUTE LYMPHOBLASTIC LEUKAEMIA,ACUTE LYMPHOCYTIC LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE LYMPHOCYTIC,10029104,10000844,10000846,10000844
CISPLATIN WAS USED FOR JAW OSTEOSARCOMA (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LACTATE DEHYDROGENASE (336 U PER L),Blood lactate dehydrogenase increased,LACTATE DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10023654,10005630,10023654
PROGRESSION OF PNEUMONIA TO LEFT LOWER BACTERIAL LOBE PNEUMONIA WITH PARAPNEUMONIC EFFUSION DUE TO LACK OF EFFECT OF ANTIBIOTIC TREATMENT,Pneumonia bacterial,PNEUMONIA BACTERIAL,PNEUMONIA BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10060946,10060946,10060946
IMMEDIATE SYSTEMIC HYPERSENSITIVITY REACTION,Immediate hypersensitivity reaction,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
RESPIRATORY FAILURE,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
FACIAL SWELLING,Swelling face,FACIAL SWELLING,SWELLING FACE,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10042682,10042682,10016065
"SEVERE, SYMPTOMATIC AND PROLONGED HYPOCALCEMIA (5.3 MG/DL)",Hypocalcaemia,HYPOCALCEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020947,10020947,10020949
SWOLLEN FACE,Swelling face,SWELLING OF FACE,SWELLING FACE,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10042682,10042682,10042691
PTOSIS,ptosis,PTOSIS,EYELID PTOSIS,OCULAR NEUROMUSCULAR DISORDERS,EYELID MOVEMENT DISORDERS,10015919,10037272,10015995,10037272
INTENSE PAIN IN THE HIPS,Pain in hip,PAIN IN HIP,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10033432,10003239,10033432
PRIAPISM,priapism,PRIAPISM,PRIAPISM,SEXUAL FUNCTION AND FERTILITY DISORDERS,ERECTION AND EJACULATION CONDITIONS AND DISORDERS,10038604,10036661,10036661,10036661
HYPERSIALOSIS,Hypersialosis,HYPERSIALOSIS,SALIVARY HYPERSECRETION,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10077370,10039424,10077370
SEVERE DROWSINESS,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
SECOND RELAPSE WITH ATYPICAL CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
"HERPES ZOSTER LESIONS ALONG A LEFT THORACIC DERMATOME, BACK AND LOWER LIMBS DUE TO VARICELLA-ZOSTER VIRUS REACTIVATION",Herpes zoster,SHINGLES,HERPES ZOSTER,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10019974,10019974,10040555
SCLERODERMA RENAL CRISIS,Scleroderma renal crisis,SCLERODERMA RENAL CRISIS,SCLERODERMA RENAL CRISIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062553,10062553,10062553
AUTONOMIC DYSFUNCTION,Autonomic Dysfunction,AUTONOMIC DYSFUNCTION,AUTONOMIC NERVOUS SYSTEM IMBALANCE,NEUROMUSCULAR DISORDERS,AUTONOMIC NERVOUS SYSTEM DISORDERS,10029205,10049559,10003840,10049559
DUODENAL ULCER/ ULCER IN BACK WALL OF BULBUS DUODENI (FORREST IIA BLEEDING),Duodenal ulcer,DUODENAL ULCER,DUODENAL ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,DUODENAL ULCERS AND PERFORATION,10017947,10013836,10013836,10013836
PATIENT WAS ADMINISTERED ASPIRIN IN THIRD TRIMESTER (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEVERE PAIN RESULTING FROM BONE METASTASES OF THE CERVICAL SPINE,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
CONFLUENT BLISTERING OF HER ARMS AND LEGS,Blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
EMESIS,Vomiting,EMESIS,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10014542
PATIENT USED MYCOPHENOLATE MOFETIL FOR IMMNUNOSUPPRESSION FOR RELAPSE OF MICROSCOPIC POLYANGIITIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PATIENT GAINED WEIGHT (+4 KILOGRAMS),Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
DEVELOPMENT OF NEW METASTASIS\ NEW METASTASES IN LUNG,Metastases to lung,METASTASES TO LUNG,METASTASES TO LUNG,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027458,10027458,10027458
PERIPHERAL NERVE DISORDER NOS,Neuropathy peripheral,PERIPHERAL NERVE DISORDER NOS,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10051174,10029331,10051174
SEPTIC SHOCK DUE TO TOXIC EPIDERMAL NECROLYSIS,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
ASSOCIATED TRANSIENT ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
SKIN RASH,Rash,SKIN RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040913
THINKING ABNORMAL,Thinking abnormal,THINKING ABNORMAL,THINKING ABNORMAL,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10043431,10043431,10043431
COLLAGENOUS COLITIS,colitis collagenous,COLITIS COLLAGENOUS,COLITIS MICROSCOPIC,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10048928,10056979,10048928
POOR RENAL CLEARANCE,Renal clearances low,RENAL CLEARANCES LOW,RENAL FUNCTION TEST ABNORMAL,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10038418,10061480,10038418
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
DELUSION OF PERSECUTION,Persecutory delusion,DELUSION OF PERSECUTION,PERSECUTORY DELUSION,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10034702,10034702,10012243
SPONTANEOUS MISCARRIAGE FOLLOWING OFF LABEL USE OF MYCOPHENOLATE MOFETIL DURING PREGNANCY,Miscarriage of pregnancy,MISCARRIAGE OF PREGNANCY,ABORTION SPONTANEOUS,ABORTIONS AND STILLBIRTH,ABORTIONS SPONTANEOUS,10036585,10027650,10000234,10027650
LEFT SIDED WEAKNESS,Hemiparesis,WEAKNESS LEFT OR RIGHT SIDE,HEMIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10047866,10019465,10047866
ASPIRIN-EXACERBATED RESPIRATORY DISEASE,Aspirin-exacerbated respiratory disease,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10075084,10075084,10075084
GAIN IN WEIGHT,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
LOSS OF APPETITE,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
LACK OF DRUG EFFECT (ST ELEVATION MYOCARDIAL INFARCTION DESPITE THE TREATMENT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
MIRTAZAPINE IN THE TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A YOUNG HIV-POSITIVE PATIENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
COMPLETE CESSATION OF HER MIGRAINES AFTER THE USE OF LATANOPROST/FAVOURABLE SIDE EFFECT,Therapeutic response unexpected,UNEXPECTED THERAPEUTIC BENEFIT,THERAPEUTIC RESPONSE UNEXPECTED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10076884,10043417,10076884
"THE TREATMENT WITH DEXKETOPROFEN, NAPROXEN AND KETOPROFEN WAS INEFFECTIVE AND PAIN",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
TENDERNESS ON PALPATION,Myalgia,TENDERNESS MUSCLE,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10043230,10028411,10043230
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
HYPOTHERMIA,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
NEUTROPHILIA,Neutrophilia,NEUTROPHILIA,NEUTROPHILIA,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10029379,10029379,10029379
NO IMPROVEMENT IN SYMPTOMS WAS SEEN,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,Drug rash,DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058919,10073508,10058919
ASPIRIN USED FOR HYPERTENSION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CHEST PAIN REFRACTORY,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
FALLS,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
MATERNAL EXPOSURE DURING PREGNANCY,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
AMIODARONE INDUCED THYROIDITIS TYPE 2,Thyroiditis,THYROIDITIS,THYROIDITIS,THYROID GLAND DISORDERS,ACUTE AND CHRONIC THYROIDITIS,10014698,10043778,10043778,10043778
PROGRESSIVE SPLENOMEGALY,Splenomegaly,SPLENOMEGALY,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041660,10041660,10041660
SECONDARILY GENERALISED TONIC-CLONIC SEIZURE,Generalised tonic-clonic seizure,GENERALISED TONIC-CLONIC SEIZURE,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10018100,10018100,10018100
DISSEMINATED INTRAVASCULAR COAGULATION DUE TO SEPSIS,disseminated intravascular coagulation,DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10013442,10013442,10013442
CEREBRAL OEDEMA,Brain oedema,CEREBRAL OEDEMA,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10048962,10048962,10008127
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ATAXIA/CEREBELLAR ATAXIA,ataxia,ATAXIA CEREBELLAR,CEREBELLAR ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003592,10008025,10003592
DISSEMINATED INTRAVASCULAR COAGULATION (JAPANESE ASSOCIATION FOR ACUTE MEDICINE DISSEMINATEDINTRAVASCULAR COAGULATION (DIC) SCORE OF 6) DUE TO SPETIC SHOCK FOLLOWING SEPSIS,Disseminated intravascular coagulation,DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10013442,10013442,10013442
SLURRED SPEECH,Dysarthria,SLURRED SPEECH,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041053,10013887,10041053
LEUKOCYTOSIS WITH NEUTROPHILIA AND A HIGH CRP LEVEL,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
"HER ACHILLES TENDONS STARTED TO HURT, THEN HER KNEES AND SHOULDERS",Joint pain,JOINT PAIN,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023222,10003239,10023222
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
DYSPNEA ON EXERTION,Dyspnea exertional,DYSPNEA EXERTIONAL,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013966,10013971,10013966
INDOLENT INFECTION,Infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SUBACUTE ISCHEMIC INFARCTION,Ischemic cerebral infarction,ISCHEMIC CEREBRAL INFARCTION,ISCHAEMIC CEREBRAL INFARCTION,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10060848,10060840,10060848
EBV REACTIVATION,EBV infection reactivation,EBV INFECTION REACTIVATION,EPSTEIN-BARR VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,EPSTEIN-BARR VIRAL INFECTIONS,10021881,10014078,10015108,10014078
HEPATOSPLENOMEGALY,Hepatosplenomegaly,HEPATOSPLENOMEGALY,HEPATOSPLENOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019847,10019847,10019847
PATIENT WAS TREATED WITH MYCOPHENOLATE MOFETIL FOR INTERSTITIAL PNEUMONITIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRY SKIN,Dry skin,DRY SKIN,DRY SKIN,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10013786,10013786,10013786
ANKLE CLONUS,ankle clonus,CLONUS,CLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10009346,10009346,10009346
VARICELLA-ZOSTER VIRUS INFECTION (INVOLVED DERMATOMA D8),Varicella zoster virus infection,VARICELLA ZOSTER VIRUS INFECTION,VARICELLA ZOSTER VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10075611,10075611,10075611
HD MTX AND HD ARA-C DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
REDDISH SKIN LESIONS ON FACE AND ABDOMEN,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
DESTRUCTIVE THYROIDITIS CAUSED BY AMIODARONE,Thyroiditis,DESTRUCTIVE THYROIDITIS,THYROIDITIS,THYROID GLAND DISORDERS,ACUTE AND CHRONIC THYROIDITIS,10014698,10069885,10043778,10069885
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
DROWSY WITH A WEAK PULSE,drowsy with a weak pulse,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
DRUG INDUCED GINGIVAL HYPERPLASIA,gingival hyperplasia,GINGIVAL HYPERPLASIA,GINGIVAL HYPERTROPHY,DENTAL AND GINGIVAL CONDITIONS,GINGIVAL DISORDERS NEC,10017947,10018283,10018284,10018283
"EDEMA WAS MANIFESTED IN HIS LOWER EXTREMITIES/THEN, EDEMA WAS EVIDENT ON BOTH HANDS AND THE LEG.",Oedema peripheral,EDEMA LOWER LIMB,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030109,10030124,10014232
SHORT-TERM AMNESIA,Amnesia,SHORT-TERM MEMORY LOSS,AMNESIA,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10040602,10001949,10040602
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DIFFUSE STENOSIS WITH CALCIFICATION IN THE LEFT ANTERIOR DESCENDING CORONARY ARTERY,Coronary artery stenosis,CORONARY ARTERY STENOSIS,CORONARY ARTERY STENOSIS,CORONARY ARTERY DISORDERS,CORONARY ARTERY DISORDERS NEC,10007541,10011089,10011089,10011089
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
ATELECTASIS,Atelectasis,ATELECTASIS,ATELECTASIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10003598,10003598,10003598
SYMPTOM AGGRAVATION AND APPEARANCE OF COUGH WITH HEMOPTYSIS EXPECTORATION,Haemoptysis,HAEMOPTYSIS,HAEMOPTYSIS,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10018964,10018964,10018964
TACHYPNEA,tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
PATIENT WAS ADMINISTERED RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS E (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SWEATING,Hyperhidrosis,SWEATING,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042670,10020642,10042661
ANOREXIA,Decreased appetite,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10002646
MODERATE ITCHING,Pruritus,ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023084,10037087,10023084
OLMESARTAN INDUCED SPRUE-LIKE ENTEROPATHY,Sprue-like enteropathy,SPRUE-LIKE ENTEROPATHY,SPRUE-LIKE ENTEROPATHY,MALABSORPTION CONDITIONS,MALABSORPTION SYNDROMES,10017947,10079622,10079622,10079622
ADVERSE REACTIONS FROM GASTROINTESTINAL TRACT OCCURED,Gastrointestinal disorder,GASTROINTESTINAL DISORDER NOS,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017945,10017944,10017945
SEVERE DEPRESSION,depression,DEPRESSION,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012378,10012378,10012378
SERUM CONTAINED CEFOTAXIME DEPENDENT ANTIBODIES AGAINST NEUTROPHILS,Drug specific antibody present,DRUG SPECIFIC ANTIBODY PRESENT,DRUG SPECIFIC ANTIBODY PRESENT,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013745,10013745,10013745
WHITE PATCHES IN ORAL CAVITY,Oral disorder,ORAL DISORDER,ORAL DISORDER,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE DISORDERS NEC,10017947,10067621,10067621,10067621
PATIENT TREATED WITH METHYLPREDNISOLONE AND PREDNISONE FOR ANCA GLOMERULONEPHRITIS AND  GLOMERULONEPHROPATHY (SUBTHERAPEUTIC RESPONSE) BUT HER RENAL DYSFUNCTION AND PROTEINURIA WERE SUSTAINED,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CULTURES GREW CANDIDA GLABRATA,candida infection,CANDIDA INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10074170,10074170,10074170
HALLUCINATION,Hallucination,HALLUCINATION,HALLUCINATION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019063,10019063,10019063
FELL TWICE,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
GRADE B OESOPHAGITIS,Oesophagitis,OESOPHAGITIS,OESOPHAGITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,OESOPHAGITIS (EXCL INFECTIVE),10017947,10030216,10030216,10030216
ACUTE SALICYLATE INGESTION,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
NO PAIN RELIEF,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
"RITUXIMAB,PREDNISONE AND CICLOSPORIN USED FOR CHRONIC GRAFT VERSUS HOST DISEASE (CGVHD)",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ACUTE VESICO-BULLOUS ERUPTIONS FROM METHOTREXATE IN A PATIENT OF PSORIASIS WHO INDULGED IN SELF-MEDICATION AND WAS WRONGFULLY DISPENSED HIGHER DOSES OF METHOTREXATE,Dermatitis bullous,VESICULO-BULLOUS ERUPTION,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10037899,10012441,10047378
HYPOGLYCEMIA,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
G3/4 TOXICITIES WERE OBSERVED EXCEPT 2 CASES OF G3 NEUTROPENIA AND THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
LARYNGOMALACIA WITH TRACHEOMALACIA,Laryngomalacia,LARYNGOMALACIA,LARYNGOMALACIA,RESPIRATORY DISORDERS CONGENITAL,LARYNGEAL AND TRACHEAL DISORDERS CONGENITAL,10010331,10060786,10060786,10060786
FUNGAL URINARY TRACT INFECTION,Urinary tract infection fungal,URINARY TRACT INFECTION FUNGAL,URINARY TRACT INFECTION FUNGAL,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10049059,10049059,10049059
RESTLESSNESS,Restlessness,RESTLESSNESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038743,10038743,10038743
WORSENING LEUCOPENIA WITH EVENTUAL AGRANULOCYTOSIS,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
CNS TOXICITY SECONDARY TO ELEVATED LEVELS OF VORICONAZOLE.,CNS toxicity,CNS TOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10071215,10029350,10071215
HAEMATOLOGICAL TOXICITY,Haematotoxicity,HAEMATOTOXICITY,HAEMATOTOXICITY,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10061188,10061188,10061188
HEMODYNAMIC INSTABILITY,hemodynamic instability,HEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10058270,10052076,10058270
DROWSINESS,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
DRY COUGH,dry cough,DRY COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10013773,10011224,10013773
EPSTEIN-BARR-VIRUS -ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM (DLBCL),Diffuse large B-cell lymphoma,DIFFUSE LARGE B-CELL LYMPHOMA,DIFFUSE LARGE B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,DIFFUSE LARGE B-CELL LYMPHOMAS,10029104,10012818,10012818,10012818
GRADE 3 ASPARTATE AMINOTRANSFERASE ELEVATION,Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASE,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003480
VENTRICULAR TACHYCARDIA,ventricular tachycardia,VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047302,10047302,10047302
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
PAIN UNRESPONSIVE TO CONVENTIONAL DRUG TREATMENT (LACK OF DRUG EFFECT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SKIN WAS VERY PALE THEN TURNED YELLOW-GREEN,Pallor,PALE SKIN,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033550,10033546,10033533
BISPHOSPHONATEâ€‘INDUCED OSTEONECROSIS OF THE JAW,bisphosphonateâ€‘induced osteonecrosis of the jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
PROGRESSIVE LOWER LIMB WEAKNESS,Muscle weakness lower limb,MUSCLE WEAKNESS LOWER LIMB,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10065776,10028372,10065776
BOTH PUPILS WERE DILATED WITH CONJUGATE DEVIATION FROM LOWER SIDE SLIGHTLY TO THE RIGHT,Mydriasis,DILATED PUPILS,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10013014,10028521,10013014
DISTURBANCES OF ORIENTATION,Disorientation,DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013395
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
VOMITING CHYME,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PRODUCT ADMINISTERED TO 13-YEAR-OLD BOY,Drug administered to patient of inappropriate age,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10071062,10071062,10071062
GENERALISED RASH,Rash generalised,GENERALISED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037858,10037858,10018095
ASPARTATE AMINOTRANSFERASE INCREASED (55 IU/L),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
NECROSIS ON  THE DISTAL PHALANGE OF THE THIRD FINGER ON THE RIGHT HAND DUE TO THROMBOTIC VASCULITIS,necrosis,NECROSIS,NECROSIS,TISSUE DISORDERS NEC,NECROSIS NEC,10018065,10028851,10028851,10028851
DISTURBED SLEEP,Sleep disturbance,SLEEP DISTURBANCE,SLEEP DISORDER,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10040995,10040984,10040995
FEVER (BODY TEMPERATURE 38 DEGREE C),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
NEUTROPHIL COUNT LOW (1500/L),Neutrophil count decreased,NEUTROPHIL COUNT LOW,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029369,10029366,10029369
DIARRHEA,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
FUNGAL INFECTION REACTIVATION,Infection reactivation,INFECTION REACTIVATION,INFECTION REACTIVATION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10070891,10070891,10070891
HERPES ZOSTER INFECTION,Herpes zoster,HERPES ZOSTER,HERPES ZOSTER,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10019974,10019974,10019974
GRADE 3 INAPPETENCE,Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
NONCONVULSIVE STATUS EPILEPTICUS,Status epilepticus,NONCONVULSIVE STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10057769,10041962,10057769
RED PURPURITIC MACULES,purpura,PURPURA,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037549,10037549,10037549
TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
STREPTOCOCCUS CONSTELLATUS DUE TO WORSENING OF RIGHT EMPYEMA,Streptococcal infection,STREPTOCOCCAL INFECTION,STREPTOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10061372,10061372,10061372
LEFT VENTRICULAR OUTFOW TRACT(LVOT) OBSTRUCTION,Left ventricle outflow tract obstruction,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,CARDIAC AND VASCULAR DISORDERS CONGENITAL,CARDIOVASCULAR DISORDERS CONGENITAL NEC,10010331,10065930,10065930,10065930
MEMORY LAPSES THAT ARE GRADUALLY GETTING WORSE,Memory deficit,MEMORY DEFICIT,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027171,10027175,10027171
DYSPEPSIA,Dyspepsia,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,DYSPEPTIC SIGNS AND SYMPTOMS,10017947,10013946,10013946,10013946
GENERALIZED PUSTULAR PSORIASIS OMPLICATED WITH SEVERE ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,Acute generalised exanthematous pustulosis,ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10062372
SEPTICEMIA FOLLOWING LACK OF DRUG EFFECT,Sepsis,SEPTICEMIA,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040089
GRADE 1 VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
MIXED HEARING LOSS RIGHT EAR AND HIGH FREQUENCY HEARING LOSS OF LEFT EAR,Deafness bilateral,HEARING LOSS BILATERAL,DEAFNESS BILATERAL,HEARING DISORDERS,HEARING LOSSES,10013993,10052556,10052556,10057844
OPIUM ABUSE,Drug abuse,OPIOID ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10030887,10013654,10030887
ANAPHYLACTIC SHOCK,anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
GRADE 1 NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ELEVATED CREATINE KINASE OF 5932 UNITS/L,Blood creatine phosphokinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
MISCARRIAGE,Miscarriage,MISCARRIAGE,ABORTION SPONTANEOUS,ABORTIONS AND STILLBIRTH,ABORTIONS SPONTANEOUS,10036585,10027649,10000234,10027649
SUBSEQUENT AGGRAVATION OF THE KALIEMIA (MAXIMUM OF 6.9MMOL/L),Hyperkalemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020647,10020646,10020647
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
INCREASED THIRST,increased thirst,INCREASED THIRST,THIRST,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10021689,10043458,10021689
ARRHYTHMIC TONES,Arrhythmia,ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10003119
GRADE 2 HYPERTENSION,hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
EPISTAXIS,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
ACUTE DYSTONIA,Dystonia,ACUTE DYSTONIA,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10066608,10013983,10066608
OLIGURIA,oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
ANAPHYLACTOID REACTION,Anaphylactoid reaction,ANAPHYLACTOID REACTION,ANAPHYLACTOID REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002216,10002216,10002216
BLOOD PRESSURE DECREASED TO 70/50 MMHG,blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
CLOSTRIDIUM INFECTION,clostridial infection,CLOSTRIDIAL INFECTION,CLOSTRIDIAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10061043,10061043,10061043
DIFFICULTIES IN READING AND WRITING,Reading disorder,READING DISORDER,READING DISORDER,COGNITIVE AND ATTENTION DISORDERS AND DISTURBANCES,LEARNING DISORDERS,10037175,10037999,10037999,10037999
METHICILLIN RESISTANT STREPTOCOCCUS ANGIONOSUS,Streptococcal infection,STREPTOCOCCAL INFECTION,STREPTOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10061372,10061372,10061372
PREGABALIN TOXICITY,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
REFRACTORY DISLIPIDAEMIA/ MARKED DETORIORATION IN THE PARAMETERS OF THE LIPID PROFILE,Dyslipidaemia,DYSLIPIDEMIA,DYSLIPIDAEMIA,LIPID METABOLISM DISORDERS,LIPID METABOLISM AND DEPOSIT DISORDERS NEC,10027433,10058108,10058108,10058110
PYOGENIC SPONDYLITIS FOLLOWING NECROTIZING FASCIITIS OF THE LOWER LEG CAUSED BY ESCHERICHIA COLI,Infective spondylitis,INFECTIVE SPONDYLITIS,INFECTIVE SPONDYLITIS,INFECTIONS - PATHOGEN UNSPECIFIED,BONE AND JOINT INFECTIONS,10021881,10062960,10062960,10062960
PERSISTANT GASTROINTESTINAL SIDE EFFECTS,gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
LEFT EYE PAIN,left eye pain,EYE PAIN,EYE PAIN,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10015958,10015958,10015958
PULMONARY EMBOLISM FOLLOWING WOUND DEHISCENCE AND SUBTHERAPEUTIC EFFECT OF LINEZOLID AND MEROPENEM,Pulmonary embolism,PULMONARY EMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037377,10037377,10037377
GRADE 2 CYSTITIS,Cystitis,CYSTITIS,CYSTITIS,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10011781,10011781,10011781
G3 OR ABOVE PROTEINURIA,Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
BASAL CELL SKIN CANCER,Basal cell carcinoma,BASAL CELL CARCINOMA,BASAL CELL CARCINOMA,SKIN NEOPLASMS MALIGNANT AND UNSPECIFIED,SKIN NEOPLASMS MALIGNANT AND UNSPECIFIED (EXCL MELANOMA),10029104,10004146,10004146,10004146
DRUG-INDUCED PNEUMONIA CAUSED BY CLOPIDOGREL WAS STRONGLY SUSPECTED.,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
DUODENAL ULCER WITH EDEMATOUS AND ERYTHEMATOUS BORDERS,Duodenal ulcer,DUODENAL ULCER,DUODENAL ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,DUODENAL ULCERS AND PERFORATION,10017947,10013836,10013836,10013836
"PATIENT REQUIRED REOPERATION FOR BLEEDING, SINCE HE WAS MAKING USE OF CLOPIDOGREL PREOPERATIVELY",Haemorrhagic diathesis,BLEEDING TENDENCY,HAEMORRHAGIC DIATHESIS,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),BLEEDING TENDENCIES,10005329,10005134,10062713,10005134
HALLUCINATIONS,hallucinations,HALLUCINATIONS,HALLUCINATION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019077,10019063,10019077
ABNORMALITIES OF VENTRICULAR REPOLARIZATION,Electrocardiogram repolarisation abnormality,ELECTROCARDIOGRAM REPOLARIZATION ABNORMALITY,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10052464,10052464,10052509
EMOTIONAL LIABILITY,Emotional disorder,EMOTIONAL DISORDER,EMOTIONAL DISORDER,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10014551,10014551,10014551
BACK MYALGIA,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
INTESTINAL PERFORATION,Intestinal perforation,INTESTINAL PERFORATION,INTESTINAL PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,INTESTINAL ULCERS AND PERFORATION NEC,10017947,10022694,10022694,10022694
ERYTHRODERMA AROUND THE MOUTH AND ON THE ORAL MUCOSA,Erythroderma,ERYTHRODERMA,DERMATITIS EXFOLIATIVE GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10015277,10012456,10015277
PRIMARY RESISTANCE TO IMATINIB  (NO CYTOGENETIC RESPONSE),drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
SENSORY-MOTOR DEFICIT IN THE UPPER AND LOWER LIMBS,motor deficit,MOTOR DEFICIT,MOTOR DYSFUNCTION,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10079471,10061296,10079471
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CANDIDIASIS,Candida infection,CANDIDIASIS,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10007152,10074170,10007152
ANAPHYLACTIC REACTION,Anaphylactic reaction,ANAPHYLACTIC REACTION,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002198,10002198,10002198
GRADE 3 PYROGENIC NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
WORSENING OF ODONTOGENIC INFECTION FOLLOWING MULTIDRUG RESISTANCE,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
APHASIA,aphasia,APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002948,10002948,10002948
CNS COMA/CNS DEPRESSION FOLLOWING EXPOSURE TO TOXIC AGENT,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
RELAPSE OF DISEASE,Prostate cancer recurrent,PROSTATE CANCER RECURRENT,PROSTATE CANCER RECURRENT,REPRODUCTIVE NEOPLASMS MALE MALIGNANT AND UNSPECIFIED,PROSTATIC NEOPLASMS MALIGNANT,10029104,10036911,10036911,10036911
BLOOD PRESSURE DID NOT DECREASE,Blood pressure high,BLOOD PRESSURE HIGH,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10005747,10020772,10005747
"POLYARTICULAR PAIN, WITH SWELLING OF HANDS, ELBOWS, KNEES, AND ANKLES AND FEET THAT HAD NOT IMPROVED ON NAPROXEN TREATMENT",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
GRADE 3 MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
SLEEPING DIFFICULTY,Insomnia,DIFFICULTY SLEEPING,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10012804,10022437,10012804
ACUTE KIDNEY INJURY FOLLOWING STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
ACUTE RESPIRATORY DISTRESS SYNDROME,Acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
PROGRESSION OF INTERSTITIAL PNEUMONIA AND FLUIDOTHORAX,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
CREATININE CLEARANCE 70ML/MIN,Creatinine renal clearance decreased,CREATININE CLEARANCE DECREASED,CREATININE RENAL CLEARANCE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011363,10011372,10011363
PROTEINURIA,Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
"ACYCLOVIR IMPROVED MOST SYMPTOMS, BUT HEADACHES AND DECREASED CONCENTRATION PERSIST  (SUBTHERAPEUTIC RESPONSE)","Acyclovir improved most symptoms, but headaches and decreased concentration persist  (subtherapeutic response)",SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
MALIGNANT CORONARY VASOSPASM,Arteriospasm coronary,CORONARY VASOSPASM,ARTERIOSPASM CORONARY,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10011107,10003225,10011110
MEAN ARTERIAL PRESSURE 50MMHG,Mean arterial pressure decreased,MEAN ARTERIAL PRESSURE DECREASED,MEAN ARTERIAL PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10026983,10026983,10026983
DRUG TOXICITY DUE TO INTERACTION BETWEEN CLARITHROMYCIN AND TACROLIMUS,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
LATERAL FLEXION OF BODY TRUNK AND HEAD ON RIGHT SIDE,Muscle stiffness,MUSCLE STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10028339,10052904,10028339
CLOBAZAM INDUCED EDEMA/EDEMA WAS EVIDENT ON BOTH HANDS AND THE LEG.,Oedema peripheral,OEDEMA HANDS,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10058204,10030124,10058204
REBLEEDING,Haemorrhage,HAEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10055798
FLUSHING SENSATION,Flushing,FLUSHING,FLUSHING,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10016825,10016825,10016825
NEUTROPENIA,neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
CSF ANALYSIS SHOWED ELEVATED GLUCOSE,CSF glucose increased,CSF GLUCOSE INCREASED,CSF GLUCOSE INCREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10050763,10050763,10050763
LEISHMANIASIS AND PROGRESSION FOLLOWING TREATMENT WITH PREDNISONE AND AZATHIOPRINE,Leishmaniasis,LEISHMANIASIS,LEISHMANIASIS,PROTOZOAL INFECTIOUS DISORDERS,LEISHMANIA INFECTIONS,10021881,10024198,10024198,10024198
QTC OF 816 MS,Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
FLUCTUATIONS IN HIS BLOOD PRESSURE,Blood pressure fluctuation,BLOOD PRESSURE FLUCTUATION,BLOOD PRESSURE FLUCTUATION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,BLOOD PRESSURE DISORDERS NEC,10047065,10005746,10005746,10005746
PROTEUS INFECTION,Proteus infection,PROTEUS INFECTION,PROTEUS INFECTION,BACTERIAL INFECTIOUS DISORDERS,PROTEUS INFECTIONS,10021881,10061470,10061470,10061470
A SUPRACLAVICULAR LYMPH NODE BIOPSY SHOWED NECROTISING GRANULOMAS,Granuloma,NECROTISING GRANULOMA,GRANULOMA,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10072175,10018691,10072175
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY,Dentatorubral-pallidoluysian atrophy,DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY,DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY,NEUROLOGICAL DISORDERS CONGENITAL,CEREBELLAR DISORDERS CONGENITAL,10010331,10075298,10075298,10075298
METFORMIN LEVEL OF PLASMA WAS 128 MG/L,Drug level in blood increased,DRUG LEVEL IN BLOOD INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013721,10013722,10013721
DIABETIC KETOACIDOSIS,Diabetic ketoacidosis,DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEC,10027433,10012671,10012671,10012671
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
MELENA,Melaena,MELENA,MELAENA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10027141,10027141,10027162
MYCOPHENOLATE MOFETIL USED FOR ALLO-HSCT,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
SEIZURES FOLLOWING EXPOSURE TO TOXIC AGENT,Seizure,SEIZURES,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039910
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
DRUG-INDUCED HEPATIC FUNCTION DISORDER,Hepatic function abnormal,HEPATIC FUNCTION DISORDER,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019674,10019670,10019674
MYCOBACTERIUM ABSCESSUS FOLLOWING INTENTIONAL MISUSE OF INSULIN,Mycobacterium abscessus infection,MYCOBACTERIUM ABSCESSUS INFECTION,MYCOBACTERIUM ABSCESSUS INFECTION,MYCOBACTERIAL INFECTIOUS DISORDERS,ATYPICAL MYCOBACTERIAL INFECTIONS,10021881,10064789,10064789,10064789
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"INCREASED LEVEL OF ALT, AST, GGT",hepatic enzymes increased,HEPATIC ENZYMES INCREASED,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10019662,10060795,10019662
GAS GANGRENE,Gas gangrene,GAS GANGRENE,GAS GANGRENE,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10017737,10017737,10017737
"HE WAS STARTED ON METHIMAZOLE 30 MG/DAY AND PROPRANOLOL 60 MG/DAY. AFTER A MONTH OF TREATMENT, SYMPTOMS PERSIST,",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
"REFRACTORY SHOCK REQUIRED EPINEPHRINE INFUSION, TITRATED TO 1 MCG/KG/MIN/DESPITE THERAPY, SBP (MEASURED USING A RADIAL ARTERY CATHETER WITH AN EXCELLENT WAVEFORM) REMAINED BELOW 80 MM HG",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
ATYPICAL NODULAR INFILTRATIVE PROCESS IN THE RIGHT LOWER LOBE,Pulmonary mass,LUNG NODULE,PULMONARY MASS,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10049498,10056342,10049498
DEFICIENCY OF VITAMIN B12,Vitamin B12 deficiency,VITAMIN B12 DEFICIENCY,VITAMIN B12 DEFICIENCY,VITAMIN RELATED DISORDERS,WATER SOLUBLE VITAMIN DEFICIENCIES,10027433,10047609,10047609,10047609
ELEVATED CREATININE,Blood creatinine increased,CREATININE HIGH,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011367,10005483,10011367
PHARYNGITIS,Pharyngitis,PHARYNGITIS,PHARYNGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10034835,10034835,10034835
ANEMIA (HB:10.3 G/DL),Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
HE HAD ACCIDENTALLY STOPPED TAKING LEVOTHYROXINE,Inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
RENAL FAILURE,Renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
SEIZURES,Seizure,SEIZURES,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039910
DRUG EFFECT LACK OF,drug effect lack of,DRUG EFFECT LACK OF,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013684,10013709,10013684
COLLAPSED ON STREET,Circulatory collapse,COLLAPSE CIRCULATORY,CIRCULATORY COLLAPSE,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10009192,10009192,10009909
DETERIORATION OF GENERAL CONDITION,General physical health deterioration,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10049438,10049438,10049438
DISCOMFORT OF THE LEFT EYE FOR 5 DAYS,Ocular discomfort,OCULAR DISCOMFORT,OCULAR DISCOMFORT,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10052143,10052143,10052143
CRYOGLOBULINAEMIC VASCULITIS DUE TO TREATMENT RESISTANT HCV INFECTION,Cryoglobulinaemic vasculitis due to treatment resistant HCV infection,CRYOGLOBULINAEMIC VASCULITIS,CRYOGLOBULINAEMIA,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10075624,10011474,10075624
3.1 CM RIGHT ADRENAL MASS WITH 67% ENHANCEMENT,Adrenal mass,ADRENAL MASS,ADRENAL MASS,ADRENAL GLAND DISORDERS,ADRENAL GLAND DISORDERS NEC,10014698,10053235,10053235,10053235
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
LOSS OF APPETITE,loss of appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
URINE KETONES,Urine ketone body present,KETONE BODIES URINE POSITIVE,URINE KETONE BODY PRESENT,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10057597,10057597,10023384
CONJUNCTIVAL HYPEREMIA,Conjunctival hyperaemia,CONJUNCTIVAL HYPEREMIA,CONJUNCTIVAL HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CONJUNCTIVAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10051625,10051625,10054364
MYOCARDIAL CELLS DEATH,Cell death,CELL DEATH,CELL DEATH,METABOLISM DISORDERS NEC,CELL METABOLISM DISORDERS NEC,10027433,10057248,10057248,10057248
"ERYTHEMATOUS, SCALY PSORIATIC PLAQUES ON SHOULDERS, ALL EXTREMITIES, DORSUM OF HANDS AND FEET AT THE INTERTRIGINOUS AREAS",Psoriasis,PSORIATIC PLAQUE,PSORIASIS,EPIDERMAL AND DERMAL CONDITIONS,PSORIATIC CONDITIONS,10040785,10050577,10037153,10050577
"DESPITE BEING ON METHYLPREDNISOLONE AND  IMMUNOGLOBULIN, ULCERS WERE REFRACTORY TO HEALING (LACK OF DRUG EFFECT)",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SMALL GASTRIC ULCER,Gastric ulcer,GASTRIC ULCER,GASTRIC ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,GASTRIC ULCERS AND PERFORATION,10017947,10017822,10017822,10017822
VAGINAL BLEEDING,Vaginal haemorrhage,VAGINAL BLEEDING,VAGINAL HAEMORRHAGE,VULVOVAGINAL DISORDERS (EXCL INFECTIONS AND INFLAMMATIONS),VULVOVAGINAL DISORDERS NEC,10038604,10046910,10046910,10046883
QUETIAPINE 200 MG/DAY FOR 1 YEAR WHICH WAS REPLACED WITH CLOZAPINE DUE TO PARTIAL RESPONSE,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
ATYPICAL FEMUR FRACTURE/UNILATERAL FRACTURES,Atypical femur fracture,ATYPICAL FEMUR FRACTURE,ATYPICAL FEMUR FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10070884,10070884,10070884
ZOLPIDEM DEPENDENCE,Drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
CHRONIC LOPERAMIDE ABUSE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
LOWER ABDOMEN TENDERNESS,Abdominal tenderness,LOWER ABDOMINAL TENDERNESS,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10069063,10000097,10069063
TREATMENT FAILURE,treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
A HIGH ANION GAP METABOLIC ACIDOSIS,High anion gap metabolic acidosis,HIGH ANION GAP METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10069033,10027417,10069033
PERIPHERAL NERVE DISORDER NOS,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
BACK MYALGIA ON EZETIMIBE TREATMENT,myalgia,LOCALISED MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10063543,10028411,10063543
DRUG INDUCED ACUTE RENAL INSUFFICIENCY/NON-OLIGURIC ACUTE RENAL INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
PERIPHERAL NERVE DISORDER NOS,Neuropathy peripheral,PERIPHERAL NERVE DISORDER NOS,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10051174,10029331,10051174
GENERALIZED ERYTHEMATOUS PAPULOSQUAMOUS ERUPTION,Rash generalised,GENERALIZED ERUPTION,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037858,10037858,10062432
ABDOMINAL DISCOMFORT,Abdominal discomfort,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10000059,10000059,10000059
SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
SEVERE MORBILLIFORM DRUG ERUPTION,Rash morbilliform,MORBILLIFORM ERUPTION,RASH MORBILLIFORM,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037870,10037870,10027967
"DESPITE INITIATION OF INTRAVENOUS HEPARIN DRIP, THE PATIENT'S OVERALL STATUS DECLINED",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
NYSTAGMUS/ HORIZONTAL AND NON-RHYTHMIC VERTICAL NYSTAGMUS,Nystagmus,NYSTAGMUS,NYSTAGMUS,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10029864,10029864,10029864
PATIENT HAD 3 MONTHS PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
RIGORS,rigors,RIGORS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10039177,10008531,10039177
BLOOD PRESSURE FLUCTUATION,Blood pressure fluctuation,BLOOD PRESSURE FLUCTUATION,BLOOD PRESSURE FLUCTUATION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,BLOOD PRESSURE DISORDERS NEC,10047065,10005746,10005746,10005746
AST INCREASED (1419 IU/L),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
FAILED RESPONSE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PLATELET COUNT NORMAL,platelet count normal,PLATELET COUNT NORMAL,PLATELET COUNT NORMAL,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035530,10035530,10035530
UNILATERAL RIGHT-HANDED TREMOR/NEUROLEPTIC PARKINSONISM~,Parkinsonism,DRUG-INDUCED PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10013707,10034010,10013707
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
PAIN AND TENDERNESS OF THE BREAST,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
MELAENA,Melaena,MELAENA,MELAENA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10027141,10027141,10027141
SEVERELY ELEVATED CRP,C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
ALKALINE PHOSPHATASE LEVELS LOW,Blood alkaline phosphatase decreased,BONE ALKALINE PHOSPHATASE DECREASED,BLOOD ALKALINE PHOSPHATASE DECREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10066808,10059569,10066808
PYROGENIC NEUTROPENIA,Neutropenic fever,NEUTROPENIC FEVER,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10051312,10016288,10051312
BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
"RELAPSE OF IGG4 RELATED LUNG DISEASE FOLLOWING SUBTHERAPEUTIC RESPONSE OF IMMUNOSUPPRESSIVE AGENTS, INCLUDING GLUCOCORTICOIDS",sub therapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
"ESCALATION IN PACING BEHAVIOUR, AGITATION AND ALSO REPORTED; WORSENING OF AGITATION",condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
PARONYCHIA,Paronychia,PARONYCHIA,PARONYCHIA,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10034016,10034016,10034016
METRONIDAZOLE-INDUCED CENTRAL NERVOUS SYSTEM TOXICITY,central nervous system toxicity,CENTRAL NERVOUS SYSTEM TOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10071216,10029350,10071216
SEVERE LACTIC ACIDOSIS (25 MMOL/L) FOLLOWING DRUG OVERDOSE,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
SKIN LESION,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
SEVERE BONE MARROW SUPPRESSION,Bone marrow failure,MYELOSUPPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10028584
INTENSE PRURITUS,pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
"MASSIVE, FATAL HEMOLYTIC REACTION AFTER ADMINISTRATION OF CEFTRIAXONE",Haemolysis,HEMOLYTIC REACTION,HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10018930,10018910,10019514
EXTRAORAL EXAMINATION REVEALED EDEMATOUS LIPS WITH HEMORRHAGIC CRUSTS AND PURULENT DISCHARGE,,,3 days,,INFECTIONS - PATHOGEN UNSPECIFIED,10021879,10037569,10037569,
"RAPID DETERIORATION, WITH ENCEPHALOPATHY, ATAXIA, AND DYSARTHRIA AND RECURRENT STATUS",Status epilepticus,STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10041962,10041962,10041962
LACTIC ACIDOSIS,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
METFORMIN ASSOCIATED LACTIC ACIDOSIS,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
WARFARIN WAS CHANGED TO HEPARIN AT 22ND WEEK OF GESTA,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
"THE PATIENT WAS TREATED WITH SERTRALINE 50 MG DAILY, IN A CONTINUOUS SCHEME/SERTRALINE USED TO TREAT PREMENSTRUAL DYSPHORIC DISORDER",Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
OBSTRUCTIVE UROPATHY,Urinary tract obstruction,OBSTRUCTIVE UROPATHY,URINARY TRACT OBSTRUCTION,GENITOURINARY TRACT DISORDERS NEC,GENITAL AND URINARY TRACT DISORDERS NEC,10038359,10029984,10061574,10029984
GRADE 2 HAND FOOT SYNDROME ASSOCIATED WITH DOCETAXEL TREATMENT,Palmar-plantar erythrodysaesthesia syndrome,HAND AND FOOT SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10019111,10033553,10019111
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
CHRONIC ALLOGRAFT DYSFUNCTION DUE TO BK VIRUS NEPHROPATHY,Complications of transplanted kidney,KIDNEY GRAFT DYSFUNCTION,COMPLICATIONS OF TRANSPLANTED KIDNEY,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10051366,10010185,10051366
TACHYPNEA,Tachypnoea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043088
MACULAR RASH ON THE TRUNK,macular rash,MACULAR RASH,RASH MACULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025418,10037867,10025418
GASTROINTESTINAL BLEEDING,Gastrointestinal haemorrhage,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017936
GLOMERULAR FILTRATION RATE PROGRESSIVELY DETERIORATED,Glomerular filtration rate abnormal,GLOMERULAR FILTRATION RATE ABNORMAL,GLOMERULAR FILTRATION RATE ABNORMAL,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018356,10018356,10018356
CHOLESTASTIC,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
USE OF STEROID WITH UNCONTROLLED HYPERTENSION MAY HAVE AGGRAVATED THE DISSECTION INTO MULTIPLE,Use of steroid with uncontrolled hypertension may have aggravated the dissection into multiple,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
EXERTIONAL DYSPNOEA,exertional dyspnoea,EXERTIONAL DYSPNOEA,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10015656,10013971,10015656
HUNDREDS OF PUSTULES ON ERYTHEMATOUS AND OEDEMATOUS SKIN ON TRUNK/PERIPHERAL OEDEMA,Skin oedema,SKIN EDEMA,SKIN OEDEMA,SKIN VASCULAR ABNORMALITIES,SKIN VASCULAR CONDITIONS NEC,10040785,10058679,10058679,10058724
SERUM CARCINOEMBRYONIC ANTIGEN (CEA) LEVELS DECLINED TO 9.4 NG/ML (NOVEMBER 2012)/THE SERUM CEA LEVEL FELL TO 36.01 NG/ML,Carcinoembryonic antigen decreased,CARCINOEMBRYONIC ANTIGEN DECREASED,CARCINOEMBRYONIC ANTIGEN DECREASED,CYTOGENETIC INVESTIGATIONS,CELL MARKER ANALYSES,10022891,10074847,10074847,10074847
POOR APPETITE FOR 5 MONTHS,Appetite suppressed,APPETITE SUPPRESSED,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003030,10061428,10003030
SEVERE ENCEPHALITIS ATTRIBUTED TO DRUG TOXICITY,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
RENAL INTERSTITIUM DISPLAYED FOCAL MILD LYMPHOPLASMACYTIC INFILTRATION AND MILD FIBROSIS,Kidney fibrosis,RENAL INTERSTITIAL FIBROSIS,KIDNEY FIBROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL DISORDERS NEC,10038359,10038475,10023421,10038475
ABNORMAL LIVER ENZYMES,Hepatic enzyme abnormal,HEPATIC ENZYME ABNORMAL,HEPATIC ENZYME ABNORMAL,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10062685,10062685,10062685
HYPOKALEMIA,Hypokalaemia,HYPOKALEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021018
PUPIL DIFFERENCE,Pupils unequal,PUPIL UNEQUAL,PUPILS UNEQUAL,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10037538,10037538,10037517
DRUG-INDUCED HEPATITIS,Drug-induced liver injury,DRUG-INDUCED HEPATITIS,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10013762,10072268,10013762
CENTRAL CYANOSIS,Cyanosis central,CYANOSIS CENTRAL,CYANOSIS CENTRAL,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10011704,10011704,10011704
CRUSTS,crusts,CRUST,SCAB,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10011468,10039509,10011468
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
HALLUCINATIONS,Hallucination,HALLUCINATIONS,HALLUCINATION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019063,10019063,10019077
BLOOD PRESSURE DECREASED (BP 90/60 MMHG),Blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
SUSPECTED MEDICATION INDUCED LIVER- AND PANCREAS TOXICITY,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
DECREASED URINE OUTPUT,Urine output decreased,URINE OUTPUT DECREASED,URINE OUTPUT DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059895,10059895,10059895
ACUTE POISONING FOLLOWING OFF LABEL WITH METHOTREXATE,Acute poisoning following off label with methotrexate,POISONING,POISONING,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10061355,10061355,10061355
PATIENT SHOWED PARTIAL RESPONSIVENESS WHILE BEING TREATED WITH PREDNISONE FOR IGG4 RELATED DISEASE (SUBTHERAPEUTIC RESPONSE) WITH NO ADR,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
STEVENS-JOHNSONS SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
NEW SKIN NODULES,skin nodule,SKIN NODULE,SKIN MASS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS CONDITIONS NEC,10040785,10040902,10067868,10040902
FATAL POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
HISTOPATHOLOGICAL EXAMINATION REVEALED SPONGIOSIS IN THE EPIDERMIS ACCOMPANIED BY SOME FOCAL KERATINOCYTE NECROSIS,Epidermal necrosis,KERATINOCYTE NECROSIS,EPIDERMAL NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10059292,10059284,10059292
ABSCESS IN THE RIGHT FRONTAL LOBE DUE TO NOCARDIA SPP.,Brain abscess,BRAIN ABSCESS,BRAIN ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10006105,10006105,10006105
TREATMENT WITH ETANERCEPT TERMINATED DUE TO ACUTE HAEMOLYTIC ANEAMIA,Acute hemolytic anemia,ACUTE HEMOLYTIC ANEMIA,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10066624,10018916,10066624
RESPIRATORY FAILURE,respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
"PERSISTENT FEVER AND, EVENTUALLY, NEUTROPENIA",Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
TROPONIN T INCREASED (0.340 UG/L),Troponin T increased,TROPONIN T INCREASED,TROPONIN T INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10058269,10058269,10058269
DRUG INDUCED LIVER INJURY (DILI),drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
HYPOKALEMIC ACIDOSIS,acidosis,ACIDOSIS,ACIDOSIS,ACID-BASE DISORDERS,MIXED ACID-BASE DISORDERS,10027433,10000486,10000486,10000486
ACUTE HEART FAILURE,Cardiac failure acute,ACUTE HEART FAILURE,CARDIAC FAILURE ACUTE,HEART FAILURES,HEART FAILURES NEC,10007541,10007556,10007556,10000803
SPONTANEOUS PNEUMOTHORAX,Pneumothorax spontaneous,PNEUMOTHORAX SPONTANEOUS,PNEUMOTHORAX SPONTANEOUS,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035763,10035763,10035763
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HYPOCALCEMIA,Hypocalcaemia,HYPOCALCEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020947,10020947,10020949
BECAUSE OF CLINICAL WORSENING DESPITE THE 2ND DOSE OF 2-PAM GIVEN ON SECOND DAY,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
NON-CONVULSIVE STATUS EPILEPTICUS,Status epilepticus,NONCONVULSIVE STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10057769,10041962,10057769
CUTANEOUS LESION,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
LIVER TOXICITY,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
RECURRENT KIKUCHI-FUJIMOTO DISEASE FOLLOWING PREDNISOLONE DISCONTIUATION/REDUCTION,Histiocytic necrotising lymphadenitis,KIKUCHI DISEASE,HISTIOCYTIC NECROTISING LYMPHADENITIS,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10069071,10069070,10069071
ADHESIONS OF THE RIGHT OCULAR PLICA,adhesion,ADHESION,ADHESION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10059837,10059837,10059837
KIKUCHIS ADENITIS,Histiocytic necrotising lymphadenitis,KIKUCHI DISEASE,HISTIOCYTIC NECROTISING LYMPHADENITIS,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10069071,10069070,10069071
POLYDIPSIA,polydipsia,POLYDIPSIA,POLYDIPSIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,FLUID INTAKE INCREASED,10027433,10036067,10036067,10036067
PRURITUS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
SEVERE LOWER GASTROINTESTINAL ARTERIAL BLEEDING,Gastrointestinal haemorrhage,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017936
FLATULENCES/TYMPANITES,Flatulence,FLATULENCE,FLATULENCE,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10016766,10016766,10016766
INFLAMMATION DUE TO OXCARBAZEPINE,Colitis microscopic,COLITIS MICROSCOPIC,COLITIS MICROSCOPIC,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10056979,10056979,10056979
ADMINISTRATION OF INSULIN DURING PREGNANCY(DRUG EXPOSURE DURING PREGNANCY) WITH NO ADVERSE DRUG REACTION,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
BLOOD PRESSURE INCREASED- 130/80 MMHG,Blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
ERYTHEMATOUS ITCHING,Rash pruritic,ITCHY RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10023092
SEVERE STENOSIS,Aortic stenosis,AORTIC STENOSIS,AORTIC STENOSIS,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",AORTIC NECROSIS AND VASCULAR INSUFFICIENCY,10047065,10002906,10002906,10002906
ABILIFY 15 MG AND 7.5 MG GIVEN TWICE DAILY,Inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
ALTERED MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
ACUTE DEEP VEIN THROMBOSIS IN THE UPPER-LEFT LIMB,deep vein thrombosis,DEEP VEIN THROMBOSIS,DEEP VEIN THROMBOSIS,EMBOLISM AND THROMBOSIS,PERIPHERAL EMBOLISM AND THROMBOSIS,10047065,10051055,10051055,10051055
SEVERE SINUSOIDAL PORTAL HYPERTENSION FOLLOWING VENOOCCLUSIVE LIVER DISEASE,Portal hypertension,PORTAL HYPERTENSION,PORTAL HYPERTENSION,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10036200,10036200,10036200
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ASA WAS DISCONTINUED AFTER LESS THAN A MONTH DUE TO INCREASED BRUISING AND BLEEDING,Contusion,BRUISING,CONTUSION,INJURIES NEC,SKIN INJURIES NEC,10022117,10050584,10050584,10006504
LACTIC ACIDOSIS,lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
CHEST RADIOGRAPH SHOWED DIFFUSE BILATERAL INTERSTITIAL INFILTRATES,Lung infiltration,BILATERAL PULMONARY INFILTRATES,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10070790,10025102,10070790
SHAKING OF HANDS,Tremor,SHAKING OF HANDS,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10040530,10044565,10040530
PUSTULE,Rash pustular,PUSTULE,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037578,10037888,10037578
HYPERGLYCAEMIC HYPEROSMOLAR SYNDROME,Hyperglycaemic hyperosmolar nonketotic syndrome,HYPEROSMOLAR HYPERGLYCAEMIC SYNDROME,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEUROLOGICAL,10027433,10078893,10063554,10078893
RENAL DYSFUNCTION FOLLOWING ACUTE MUCOCUTANEOUS METHOTREXATE TOXICITY,Renal impairment,RENAL FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038451,10062237,10038451
STEROID INDUCED DIABETES MELLITUS,Diabetes steroid-induced,DIABETES STEROID-INDUCED,DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012628,10012601,10012628
APATHY,Apathy,APATHY,APATHY,MOOD DISORDERS AND DISTURBANCES NEC,MOOD DISORDERS NEC,10037175,10002942,10002942,10002942
"RUBOR, CALOR, TUMOUR",redness,REDNESS,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10038198,10015150,10038198
ESTRIOL IN 24 HOUR URINE WAS LOW (70/24 HOURS),Oestriol decreased,ESTRIOL LOW,OESTRIOL DECREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),REPRODUCTIVE HORMONE ANALYSES,10022891,10073892,10030236,10015507
PANCYTOPENIA,pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
PALPITATION,Palpitation,PALPITATION,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033556,10033557,10033556
ACETAMENOPHEN TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
DRUG INEFFECTIVE WITH IPRATROPIUM BROMIDE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
WHO ADMINISTERED ADENOSINE UNSUCCESSFULLY,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
PATHOGEN RESISTANCE,Pathogen resistance,PATHOGEN RESISTANCE,PATHOGEN RESISTANCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10034133,10034133,10034133
OFF LABEL USE FOR POPULATION AND INDICATION FOR LEVETIRACETAM AND LACOSAMIDE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INTERMITTENT PARALYSIS IN BOTH LOWER EXTREMITIES,Paralysis,PARALYSIS,PARALYSIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10033799,10033799,10033799
IRRITABILITY,Irritability,IRRITABILITY,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10022998,10022998,10022998
PALPITATION,palpitation,PALPITATION,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033556,10033557,10033556
ROENTGENOGRAM OF THE ABDOMEN REVEALED DISTENDED BOWEL LOOPS,Intestinal dilatation,DISTENDED BOWEL,INTESTINAL DILATATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10069736,10022642,10069736
SEVERELY IMPAIRED VENTILATION,Hypoventilation,VENTILATION DIFFICULT,HYPOVENTILATION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10047262,10021133,10047262
REBOUND EFFECT,rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
MULTIPLE CONCOMITANT MEDICATIONS CAN ALTER THE PHARMACOKINETICS OF ANTI-TUBERCULOUS MEDICATIONS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
EOSINOPHILIA (2.2X10E9/L),Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
INCREASED APPETITE,Increased appetite,INCREASED APPETITE,INCREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10021654,10021654,10021654
NIGHT SWEATS,Night sweats,NIGHT SWEATS,NIGHT SWEATS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10029410,10029410,10029410
DRUG-INDUCED IDIOSYNCRATIC LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
WHEEZING,Wheezing,WHEEZING,WHEEZING,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10047924,10047924,10047924
MYELOPATHY FOLLOWING INTRATHECAL CHEMOTHERAPY,Myelopathy,MYELOPATHY,MYELOPATHY,SPINAL CORD AND NERVE ROOT DISORDERS,SPINAL CORD AND NERVE ROOT DISORDERS NEC,10029205,10028570,10028570,10028570
LYMPHADENITIS,Lymphadenitis,LYMPHADENITIS,LYMPHADENITIS,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025188,10025188,10025188
EXACERBATION OF CHRONIC HEART FAILURE,Cardiac failure chronic,CARDIAC FAILURE CHRONIC AGGRAVATED,CARDIAC FAILURE CHRONIC,HEART FAILURES,HEART FAILURES NEC,10007541,10066498,10007558,10066498
CMV REACTIVATION,cytomegalovirus reactivation,CYTOMEGALOVIRUS INFECTION REACTIVATION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10058666,10011831,10058666
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
POLYNEUROPATHY,polyneuropathy,POLYNEUROPATHY,POLYNEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10036105,10036105,10036105
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
INCESSENT TACHCARDIA ATTACKS REPEATED,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
LETHARGIC,Lethargy,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024262
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
GRADUAL DECREASE IN ALBUMIN LEVELS FROM 38.5 G/L IN THE FIRST TRIMESTER,Gradual decrease in albumin levels from 38.5 g/l in the first trimester,ALBUMIN DECREASED,BLOOD ALBUMIN DECREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10001561,10005287,10001561
HYPOGLYCEMIA,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
HYDROCEPHALUS,Hydrocephalus,HYDROCEPHALUS,HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,HYDROCEPHALIC CONDITIONS,10029205,10020508,10020508,10020508
BONE MARROW HYPOCELLULARITY FOLLOWING AGRANULOCYTOSIS,hypocellular marrow,HYPOCELLULAR MARROW,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10020954,10065553,10020954
"CROSS REACTIVITY TO CEFADROXIL, CEFACLOR AND CEFALEXIN",Drug cross-reactivity,DRUG CROSS-REACTIVITY,THERAPEUTIC PRODUCT CROSS-REACTIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10076743,10079645,10076743
EXTRAPYRAMIDAL SIDE EFFECTS EXACERBATIONS FOLLOWED EACH TIME THAT CLOZAPINE WAS INCREASED,Extrapyramidal disorder,EXTRAPYRAMIDAL DISORDER AGGRAVATED,EXTRAPYRAMIDAL DISORDER,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10058837,10015832,10058837
ANTIPSYCHOTIC-INDUCED HYPERPROLACTINEMIA,Hyperprolactinaemia,HYPERPROLACTINEMIA,HYPERPROLACTINAEMIA,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPERFUNCTION,10014698,10020737,10020737,10020739
INCREASED LIBIDO,Libido increased,INCREASED LIBIDO,LIBIDO INCREASED,"SEXUAL DYSFUNCTIONS, DISTURBANCES AND GENDER IDENTITY DISORDERS",SEXUAL DESIRE DISORDERS,10037175,10024421,10024421,10021669
DROP IN BLOOD PRESSURE 80/40 MMHG,blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
ONDANSETRON OVERDOSE,accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
PERSISTENT OBSTIPATION,Constipation,OBSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10029932
MASSIVE CISPLATIN OVERDOSE OF 500 MG/M2,Overdose,ACUTE OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067695,10033295,10067695
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
FREQUENT URINATION OF SMALL AMOUNT,frequency urinary,FREQUENCY URINARY,POLLAKIURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10017366,10036018,10017366
LIVE BIRTH,Live birth,LIVE BIRTH,LIVE BIRTH,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS","NORMAL PREGNANCY, LABOUR AND DELIVERY",10036585,10049550,10049550,10049550
"GASTROINTESTINAL BLEEDING/ VOMITTED HEME POSITIVE, BROWN MATERIAL",gastrointestinal bleeding,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017936,10017955,10017936
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
PLAQUE,Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
SEVERE PAIN IN UPPER ABDOMEN,Abdominal pain upper,ABDOMINAL PAIN UPPER,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000087,10000087,10000087
LDH INCREASED (314 U/L),Blood lactate dehydrogenase increased,BLOOD LACTATE DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10005630,10005630,10005630
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
FATAL HEMOLYSIS CAUSED BY CEFTRIAXONE,Haemolysis,HEMOLYSIS,HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10018910,10018910,10019491
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
FETAL DISTRESS,fetal distress,FETAL DISTRESS,FOETAL DISTRESS SYNDROME,FOETAL COMPLICATIONS,FOETAL COMPLICATIONS NEC,10036585,10016486,10016855,10016486
BILIRUBIN TOTAL INCREASED (7.9 MG/DL),Blood bilirubin increased,BILIRUBIN TOTAL INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056806,10005364,10056806
DRUG INEFFECTIVE,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
SKIN TENDERNESS FOLLOWING DRUG TOXICITY DUE TO DRUG INTERACTION,skin tenderness,SKIN TENDERNESS,PAIN OF SKIN,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10051797,10033474,10051797
PULMONARY EDEMA,Pulmonary oedema,PULMONARY EDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037423,10037423,10037375
PARONYCHIA,Paronychia,PARONYCHIA,PARONYCHIA,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10034016,10034016,10034016
HIVES,Hives,HIVES,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10020197,10046735,10020197
CHRONIC KIDNEY DISEASE,Chronic kidney disease,CHRONIC KIDNEY DISEASE,CHRONIC KIDNEY DISEASE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10064848,10064848,10064848
CUTANEOUS ERUPTION,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
PATIENT WAS ADMINISTERED MYCOPHENOLATE FOR THE TREATMENT OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS RELAPSE (OFF LABEL USE) WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ABNORMALLLY ELEVATED LDH (800IU/L),Blood lactate dehydrogenase increased,LDH INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10024051,10005630,10024051
SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
CREATINPHOSPHOKINASE ELEVATION,Blood creatine phosphokinase increased,CPK INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011268,10005470,10011268
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
LESION DID NOT IMPROVE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DROWSINESS,drowsiness,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
COMPLETE LEFT HEMIPLAGIA WITH APHASIA,Aphasia,APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002948,10002948,10002948
CONJUNCTIVAL HEMORRHAGE,Conjunctival haemorrhage,CONJUNCTIVAL HEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,OCULAR HAEMORRHAGES AND VASCULAR DISORDERS NEC,CONJUNCTIVAL AND CORNEAL BLEEDING AND VASCULAR DISORDERS,10015919,10010720,10010719,10010720
TENDERNESS,Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
HEPATOSPLENOMEGALY,hepatosplenomegaly,HEPATOSPLENOMEGALY,HEPATOSPLENOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019847,10019847,10019847
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
UNABLE TO ROUSE,Loss of consciousness,UNCONSCIOUS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10045479
ADMINISTRATION OF VINCRISTINE AND CYCLOPHOSPHAMIDE FOR PRIMITIVE NEUROECTODERMAL TUMOUR OF THE PROSTATE(UNAPPROVED INDICATION FOR BOTH)-OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DECREASED WHITE BLOOD CELL OF   GRADE 3,White blood cell count decreased,WHITE BLOOD CELL COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10047942
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
MULTIPLE NEW ISCHEMIC STROKES,Ischaemic stroke,ISCHEMIC STROKE,ISCHAEMIC STROKE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10061256,10061256,10055221
MULTIPLE DRUG POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
"SEVERE HYPONATREMIA (104 MEQ/L),",Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
HEPATITIS,hepatitis,HEPATITIS,HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019717,10019717,10019717
A PROLONGED QTC INTERVAL,Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
LYMPHOCYTES DECREASED (30%),lymphocytes decreased (30%),LYMPHOCYTE COUNT DECREASED,LYMPHOCYTE COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10025256,10025256,10025256
IMMUNE RECONSTITUTION SYNDROME,Immune reconstitution syndrome,IMMUNE RECONSTITUTION SYNDROME,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10054014,10065042,10054014
TREATMENT INDUCED MODERATE NEUROPATHIC FOOT PAIN,treatment induced moderate neuropathic foot pain,NEUROPATHIC PAIN,NEURALGIA,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10054095,10029223,10054095
MILD PTOSIS FOLLOWING DRUG EXPOSURE IN UTERO,Eyelid ptosis,PTOSIS,EYELID PTOSIS,OCULAR NEUROMUSCULAR DISORDERS,EYELID MOVEMENT DISORDERS,10015919,10015995,10015995,10037272
LEFT INGUINAL HERNIA,Inguinal hernia,INGUINAL HERNIA,INGUINAL HERNIA,ABDOMINAL HERNIAS AND OTHER ABDOMINAL WALL CONDITIONS,INGUINAL HERNIAS,10017947,10022016,10022016,10022016
LOEFFLER ENDOCARDITIS FOLLOWING HEART FAILURE,Loefï¬‚er endocarditis,LOEFFLER'S ENDOCARDITIS,ENDOCARDITIS FIBROPLASTICA,ENDOCARDIAL DISORDERS,ENDOCARDITIS NEC,10007541,10052841,10052837,10052841
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
DIARRHEA PERSISTING FOR SIX MONTHS,chronic diarrhea,CHRONIC DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10066556,10012735,10066556
ZONISAMIDE PROVED AN INEFFECTIVE ANTIEPILEPTIC DRUG,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DELIRIUM,delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
SINUS BRADYCARDIA,sinus bradycardia,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040741,10040741,10040741
THE LEFT UPPER LIMB IS STRONGLY SWOLLEN AND ITS MOBILITY IS SIGNIFICANTLY REDUCED,Peripheral swelling,SWELLING OF LIMB,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042702,10048959,10042701
SPLENOMEGALY,Splenomegaly,SPLENOMEGALY,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041660,10041660,10041660
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
RENAL FUNCTION DETERIORATED DESPITE IMMNUOSUPPRESSANTS,Renal impairment,RENAL FUNCTION AGGRAVATED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038453,10062237,10038453
BLACKOUT/ALREADY OUT OF YOUR HEAD/END UP DOING A HIT,blackout,BLACKOUT,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10004982,10024855,10004982
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
TREMOR,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
SLEEP DISTURBANCE,Sleep disturbance,SLEEP DISTURBANCE,SLEEP DISORDER,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10040995,10040984,10040995
DRY COUGH,dry cough,DRY COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10013773,10011224,10013773
CORTICOTROPIC DEFICIENCY,Adrenocorticotropic hormone deficiency,CORTICOTROPHIN DEFICIENCY,ADRENOCORTICOTROPIC HORMONE DEFICIENCY,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPOFUNCTION,10014698,10078569,10073179,10078569
QUADRIPARESIS,Quadriparesis,QUADRIPARESIS,QUADRIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10049680,10049680,10049680
PROGRESSIVE TACHYPNEA,Tachypnoea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043088
"OCCURRENCE OF LOOSE, NONBLOODY STOOLS",loose stools,LOOSE STOOLS,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10024840,10012735,10024840
ANXIETY,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
"DOCETAXEL HYPERSENSITIVITY REACTION/ HYPERSENSITIVITY REACTION, ITCHING, GENERALIZED WEAKNESS, THORACIC OPPRESSION AND NEUTROPENIA",drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
EXPECTORATION WITH BLOOD-STAINED SPUTUM,Haemoptysis,SPUTUM BLOODY,HAEMOPTYSIS,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10041804,10018964,10041804
PROTEUS MIRABILIS INFECTION,Proteus infection,PROTEUS INFECTION,PROTEUS INFECTION,BACTERIAL INFECTIOUS DISORDERS,PROTEUS INFECTIONS,10021881,10061470,10061470,10061470
BENZODIAZEPINE ABUSE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
DISSEMINATED FUNGAL INFECTION BY EXOPHIALA SPP. DESPITE EARLY BROAD SPECTRUM ANTI FUNGAL COVERAGE (VORICONAZOLE AND AMPHOTERICIN B),Fungal infection,FUNGAL INFECTION,FUNGAL INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017533,10017533,10017533
 ref less than 40),2018-05-31 00:00:00,1,,,,LIVER FUNCTION ANALYSES,10001946,10001946,
RENAL INSUFFICIENCY,Renal failure,RENAL INSUFFICIENCY,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038474,10038435,10038474
CORNEAL BAND KERATOPATHY,Keratopathy,BAND KERATOPATHY,KERATOPATHY,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CORNEAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10023366,10023365,10004086
VARICES OESOPHAGEAL,Varices oesophageal,VARICES OESOPHAGEAL,VARICES OESOPHAGEAL,GASTROINTESTINAL VASCULAR CONDITIONS,OESOPHAGEAL VARICES,10017947,10056091,10056091,10056091
PARACETAMOL AND CODEINE ABUSE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
GRAFT LOSS DUE TO CHRONIC ALLOGRAFT DYSFUNCTION FOLLOWING BK VIRUS NEPHROPATHY,Renal transplant failure,RENAL GRAFT LOSS,RENAL TRANSPLANT FAILURE,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10048749,10074495,10048749
RETINOPATHY FOLLOWING DRUG INTERACTION BETWEEN METHOTREXATE AND HYDROXYCHLOROQUINE SULFATE,Retinopathy,RETINOPATHY,RETINOPATHY,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINOPATHIES NEC,10015919,10038923,10038923,10038923
SHE FELL DOWN FROM A STANDING POSITION DUE TO INCOMPLETE ATYPICAL FEMUR FRACTURE,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
TICS,Tic,TICS,TIC,CHANGES IN PHYSICAL ACTIVITY,TIC DISORDERS,10037175,10043833,10043833,10043849
FREE SERUM THYROXINE (T4) INCREASED (1.56 NG/DL),Thyroxine free decreased,FREE T4 DECREASED,THYROXINE FREE DECREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),THYROID ANALYSES,10022891,10051884,10055162,10051884
HYDROXYCHLOROQUINE TOXICITY-INDUCED CARDIOMYOPATHY,Cardiomyopathy,CARDIOMYOPATHY,CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10007636,10007636,10007636
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
NO RESPONSE,Therapy non-responder,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
BAL CULTURE GREW KLEBSIELLA,Klebsiella infection,KLEBSIELLA INFECTION,KLEBSIELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10061259,10061259,10061259
ADMINISTRATION OF ACETAZOLAMIDE FOR IDIOPATHIC BILATERAL VESTIBULOPATHY(UNAPPROVED INDICATION)-OFF LABEL USE WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
IGG DECREASED (5.1 G/L),IgG decreased,IGG DECREASED,BLOOD IMMUNOGLOBULIN G DECREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10021271,10005595,10021271
INFLAMMATORY SIGNS MARKED AT THE LEVEL OF THE PERINEUM,Genital tract inflammation,GENITAL TRACT INFLAMMATION,GENITAL TRACT INFLAMMATION,REPRODUCTIVE TRACT DISORDERS NEC,REPRODUCTIVE TRACT INFECTIONS AND INFLAMMATIONS NEC,10038604,10058821,10058821,10058821
ASPIRIN ADMINISTERED WITH LOW MOLECULAR WEIGHT HEPARIN,Drug administration error,DRUG ADMINISTRATION ERROR,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064295,10064295,10064295
VORICONAZOLE-INDUCED LIVER INJURY,Drug-induced hepatotoxicity,DRUG-INDUCED HEPATOTOXICITY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072937,10072268,10072937
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
LICHEN SCLEROSUS,lichen sclerosus,LICHEN SCLEROSUS,LICHEN SCLEROSUS,EPIDERMAL AND DERMAL CONDITIONS,PAPULOSQUAMOUS CONDITIONS,10040785,10024434,10024434,10024434
"SLIGHTLY CLOUDY, RED-COLORED URINE",red urine,RED URINE,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10038197,10008796,10038197
"AMIODARONE-INDUCED KERATOPATHY/AMIODARONE KERATOPATHY GRADE III (RIGHT), GRADE II (LEFT)",Keratopathy,KERATOPATHY,KERATOPATHY,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CORNEAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10023365,10023365,10023365
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
2 CHEMOTHERAPY-INDUCED REVERSIBLE GRADE 4 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
HEMATEMESIS,Haematemesis,HEMATEMESIS,HAEMATEMESIS,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018830,10018830,10019418
OCCUPATIONAL EXPOSURE TO CHLORHEXIDINE,Occupational exposure to drug,OCCUPATIONAL EXPOSURE TO DRUG,OCCUPATIONAL EXPOSURE TO PRODUCT,"EXPOSURES, CHEMICAL INJURIES AND POISONING",OCCUPATIONAL EXPOSURES,10022117,10068469,10073311,10068469
BULL'S EYE MACULOPATHY,Maculopathy,BULL'S EYE MACULOPATHY,MACULOPATHY,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10068902,10025425,10068902
HENOCH-SCHOENLEIN PURPURA CAUSED BY CEFUROXIME AND EXACERBATED BY CEFTRIAXONE AND AMOXICILLIN,Henoch-Schonlein purpura,HENOCH-SCHONLEIN PURPURA,HENOCH-SCHONLEIN PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10019617,10019617,10019617
ELEVATION OF MYELOPEROXIDASE ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (18.7 U/ML),Antineutrophil cytoplasmic antibody positive,MYELOPEROXIDASE ANTIBODY TEST POSITIVE,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10060156,10060136,10060156
MYCOPHENOLATE MOFETIL PRESCRIBED FOR GRANULOMATOSIS WITH POLYANGIITIS,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
INSULIN ANTIBODY WAS 46.1 U/ML,Anti-insulin antibody increased,ANTI-INSULIN ANTIBODY INCREASED,ANTI-INSULIN ANTIBODY INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10053815,10053815,10053815
HYPERPROLACTINAEMIA,Hyperprolactinaemia,HYPERPROLACTINAEMIA,HYPERPROLACTINAEMIA,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPERFUNCTION,10014698,10020737,10020737,10020737
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
PREMATURE DUCTUS ARTERIOSUS CLOSURE/CLOSED DUCTUS ARTERIOSUS,Ductus arteriosus premature closure,DUCTUS ARTERIOSUS PREMATURE CLOSURE,DUCTUS ARTERIOSUS PREMATURE CLOSURE,CARDIAC AND VASCULAR DISORDERS CONGENITAL,ARTERIAL DISORDERS CONGENITAL,10010331,10049996,10049996,10049996
MULTIPLE MESENTERIC AND INTESTINAL PARIETAL ABSCESSES,Abscess intestinal,ABSCESS INTESTINAL,ABSCESS INTESTINAL,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10000285,10000285,10000285
INCREASED CPK,Blood creatine phosphokinase increased,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10005470,10005470,10005470
PYRAZINAMIDE INDUCED THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
PRERENAL ACUTE RENAL FAILURE,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
IRRITABLE,irritable,IRRITABLE,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10023000,10022998,10023000
ECG REVEALED PROLONGED QRS OF 170 MS DUE TO LOPERAMIDE CHRONIC ABUSE FOLLOWING CHRONIC OVERDOSE,Electrocardiogram QRS complex prolonged,QRS PROLONGED,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037697,10014380,10037697
SEVERE DRY COUGH,Dry cough,DRY COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10013773,10011224,10013773
GRADE 1 BILATERAL NEPHROCALCINOSIS,Nephrocalcinosis,NEPHROCALCINOSIS,NEPHROCALCINOSIS,UROLITHIASES,RENAL LITHIASIS,10038359,10029146,10029146,10029146
ANEMIA (HB LEVEL 80 G/L),Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
IPSILATERAL PLEURAL EFFUSION AGAIN/ MULTILOCULATED EFFUSION,Pleural effusion,PLEURAL EFFUSION RECURRENT,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10066721,10035598,10066721
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
LIVER DYSFUNCTION,Hepatic dysfunction NOS,HEPATIC DYSFUNCTION NOS,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019657,10019670,10019657
RIGHT EYE DEVELOPED RECURRENT EPITHELIAL DEFECT,disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
INCREASE IN MODIFIED LOCALIZED SCLERODERMA ACTIVITY INDEX,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
SIGNS OF RENAL INSUFFICIENCY FOLLOWING PORTAL HYPERTENSION,Renal failure,RENAL INSUFFICIENCY,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038474,10038435,10038474
MULTIPLE ORAL ULCERS,multiple oral ulcers,ULCERS APHTHOUS ORAL,APHTHOUS ULCER,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10045372,10002959,10045372
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
LOW BIRTH WEIGHT BABY,Low birth weight baby,BIRTHWEIGHT LOW,LOW BIRTH WEIGHT BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10004961,10067508,10004961
DRUGS INEFFECTIVE (THE PATIENT MAINTAINED PERIPHERAL OEDEMA ASSOCIATED WITH HEAVY PROTEINURIA AND HYPOALBUMINAEMIA),Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
HEPATIC ENCEPHALOPATHY,hepatic encephalopathy,HEPATIC ENCEPHALOPATHY,HEPATIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10019660,10019660,10019660
MYOGLOBINURIA,Myoglobinuria,MYOGLOBINURIA,MYOGLOBINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10028629,10028629,10028629
SERUM LEVEL OF LACTIC DEHYDROGENASE ELEVATED FOLLOWING ACCIDENTAL INGESTION OF METHOTREXATE,serum lactic dehydrogenase increased,SERUM LACTIC DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10040320,10005630,10040320
TEMPERATURE OF 39Â°C,temperature increased,TEMPERATURE ELEVATION,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10043204,10005911,10043204
ACUTE CORONARY VASOSPASM INDUCED BY OXALIPLATIN,Arteriospasm coronary,CORONARY VASOSPASM,ARTERIOSPASM CORONARY,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10011107,10003225,10011110
HIGH-GRADE FEVER,pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
ABNORMAL FETAL HEART RHYTHM,Foetal heart rate abnormal,FETAL HEART RATE ABNORMAL,FOETAL HEART RATE ABNORMAL,FOETAL AND NEONATAL INVESTIGATIONS,FOETAL AND NEONATAL DIAGNOSTIC PROCEDURES,10022891,10051139,10051139,10054384
PERIPHERAL NERVE DISORDER,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
HAEMATEMESIS,Haematemesis,HAEMATEMESIS,HAEMATEMESIS,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018830,10018830,10018830
"PREVIOUS TREATMENT WITH METOPROLOL TARTRATE FAILED TO RELEASE THE SYMPTOMS, SO HE WAS REFERRED
FOR CATHETER ABLATION",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ACUTE RENAL FAILURE,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
"EAR WAS MODERATELY SWOLLEN, ERYTHEMATOUS, WARM AND TENDER",Ear swelling,EAR SWELLING,EAR SWELLING,AURAL DISORDERS NEC,EAR DISORDERS NEC,10013993,10014025,10014025,10014025
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
NORMAL BABY,Normal baby,NORMAL BABY,NORMAL NEWBORN,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS",NORMAL NEWBORN STATUS,10036585,10029757,10029769,10029757
TROPONIN T WAS POSITIVE,Troponin T increased,CARDIAC TROPONIN T INCREASED,TROPONIN T INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10007613,10058269,10007613
INAPPROPRIATE DOSING AND DRUG-DRUG INTERACTIONS,Incorrect dose administered,WRONG DOSE ADMINISTERED,INCORRECT DOSE ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10048054,10064355,10048054
HYPERTRIGLYCERIDEMIA,Hypertriglyceridaemia,HYPERTRIGLYCERIDEMIA,HYPERTRIGLYCERIDAEMIA,LIPID METABOLISM DISORDERS,ELEVATED TRIGLYCERIDES,10027433,10020869,10020869,10020870
CARBAMAZEPINE-INDUCED TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
ODYNOPHAGIA,Odynophagia,ODYNOPHAGIA,ODYNOPHAGIA,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE PAIN AND PARAESTHESIA,10017947,10030094,10030094,10030094
WHITE DOTS SYNDROME,Retinal white dots syndrome,RETINAL WHITE DOTS SYNDROME,RETINAL EXUDATES,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINOPATHIES NEC,10015919,10059081,10038862,10059081
APPLICATION SITE ERYTHEMA IN DIAMETER OF 15 MM X 12 MM WITH OEDEMA AND LOCAL HYPERTHERMIA,Vaccination site inflammation,VACCINATION SITE INFLAMMATION,VACCINATION SITE INFLAMMATION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10068878,10068878,10068878
STOMATITIS,stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
SEVERE BACK PAIN AS WELL AS THE HIP JOINT AND HEEL PAIN,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
MELENA,Melena,MELENA,MELAENA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10027162,10027141,10027162
RIGHT HEMIPLEGIA ON AMIODARONE BOLUS ADMINISTRATION,Hemiplegia,RIGHT HEMIPLEGIA,HEMIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10039154,10019468,10039154
AZOOSPERMIA LEADING TO TRANSIENT INFERTILITY,Infertility,INFERTILITY,INFERTILITY,SEXUAL FUNCTION AND FERTILITY DISORDERS,SEXUAL FUNCTION AND FERTILITY DISORDERS NEC,10038604,10021926,10021926,10021926
LANGUAGE WAS ABSENT,language was absent,LANGUAGE DISORDER,LANGUAGE DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10074869,10074869,10074869
MILD RESTRICTIVE IMPAIRMENT,Restrictive pulmonary disease,RESTRICTIVE PULMONARY DISEASE,RESTRICTIVE PULMONARY DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10048667,10048667,10048667
ACUTE RESPIRATORY DISTRESS SYNDROME FOLLOWING METOCLOPRAMIDE INDUCED PHEOCHROMOCYTOMA CRISIS,Acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
BODY TEMPERATURE INCREASED (39.9 DEGREE CELSIUS),Body temperature increased,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10005911
INFILTRATION IN HER LEFT EYE,Corneal disorder,CORNEAL DISORDER,CORNEAL DISORDER,EYE DISORDERS NEC,CORNEAL DISORDERS NEC,10015919,10061453,10061453,10061453
HAEMOPTYSIS,Haemoptysis,HAEMOPTYSIS,HAEMOPTYSIS,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10018964,10018964,10018964
HYPERTROPHIC OSTEOARTHROPATHYFOLLOWING SENNA MISUSE,Hypertrophic osteoarthropathy,HYPERTROPHIC OSTEOARTHROPATHY,HYPERTROPHIC OSTEOARTHROPATHY,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10020877,10020877,10020877
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
CARDIAC ARREST/ACUTE HEART FAILURE,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
HYPERSENSITIVITY,hypersensitivity,HYPERSENSITIVITY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020751,10020751,10020751
RASH,rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
NEUROTOXICITY,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION,Methicillin-resistant Staphylococcus aureus infection,METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10027508,10058080,10027508
HER EXTERNAL VENTRICULAR DEVICES REPEATEDLY CLOGGED,Complication associated with device,COMPLICATION ASSOCIATED WITH DEVICE,COMPLICATION ASSOCIATED WITH DEVICE,COMPLICATIONS ASSOCIATED WITH DEVICE,COMPLICATIONS ASSOCIATED WITH DEVICE NEC,10018065,10077107,10077107,10077107
VISUAL HALLUCINATIONS,"Hallucination, visual",VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019075,10019075,10047570
GRADE 2 ACUTE GVHD,Acute graft versus host disease,ACUTE GRAFT VERSUS HOST DISEASE,ACUTE GRAFT VERSUS HOST DISEASE,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10066260,10066260,10066260
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
LEFT VENTRICULAR SYSTOLIC DYSFUNCTION,left ventricular systolic dysfunction,LEFT VENTRICULAR SYSTOLIC DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10069501,10049694,10069501
STOPPED EATING,Decreased appetite,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10002646
SHORT OF BREATH,short of breath,SHORT OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040596,10013968,10040596
HYPERGLYCEMIA,Hyperglycemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020639,10020635,10020639
METHOTREXATE AND PREDNISONE USED FOR TREATMENT OF SARCOIDOSIS,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
JCV INFECTION,JC virus infection,JC VIRUS INFECTION,JC VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10023163,10023163,10023163
PROTEINURIA,proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
DECREASED MUSCLE STRENGTH,Muscle weakness,MUSCLE WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028350,10028372,10028350
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
DRUG-INDUCED INTERSTITIAL PNEUMONIA,Interstitial pneumonia,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
CIRCULATORY FAILURE,Circulatory collapse,CIRCULATORY FAILURE,CIRCULATORY COLLAPSE,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10009195,10009192,10009195
"IN PATIENT INTRAVENOUS HEPARIN, DESPITE THE ABOVE MEASURES THE PATIENT DIED",Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE EVENT,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HIGH MTX ANAEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
EGFR DECREASED (62 ML/MIN),Glomerular filtration rate decreased,GLOMERULAR FILTRATION RATE DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018358,10018358,10018358
SEPTIC INTRAVASCULAR PULMONARY EMBOLISM FOLLOWING TREATMENT NON-COMPLIANCE,Pulmonary embolism,EMBOLISM LUNG,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037377,10037377,10050071
DRUG DEPENDENT ANTIBODIES PRESENT,Drug specific antibody present,DRUG SPECIFIC ANTIBODY PRESENT,DRUG SPECIFIC ANTIBODY PRESENT,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013745,10013745,10013745
PULSE IRREGULAR (88/MIN),Heart rate irregular,PULSE IRREGULAR,HEART RATE IRREGULAR,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10037475,10019304,10037475
LITHIUM INDUCED THYROTOXICOSIS,Thyrotoxicosis,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
CONSTIPATION,Constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
PHARYNGO-TONSILITIS,Pharyngitis,PHARYNGITIS,PHARYNGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10034835,10034835,10034835
SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
CYTOMEGALOVIRUS (CMV) PNEUMONIA,Pneumonia cytomegaloviral,PNEUMONIA CYTOMEGALOVIRAL,PNEUMONIA CYTOMEGALOVIRAL,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10035676,10035676,10035676
RASH WORSENED,Rash,RASH AGGRAVATED,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10048332,10037844,10048332
10-CM SUBCUTANEOUS INDURATION DUE TO INSULIN WAS FOUND IN THE LEFT HYPOCHONDRIUM,Injection site induration,INJECTION SITE INDURATION,INJECTION SITE INDURATION,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022075,10022075,10022075
E. COLI WORSENING DUE TO LACK OF EFFECT OF ANTIBIOTICS,Escherichia infection,ESCHERICHIA COLI INFECTION,ESCHERICHIA INFECTION,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10061126,10061126,10054242
HYPERINTENSITY IN THE CORTEX AND SUBCORTICAL WHITE MATTER OF THE OCCIPITAL LOBES BILATERALLY,Hyperintensity in brain deep nuclei,HYPERINTENSITY IN BRAIN DEEP NUCLEI,HYPERINTENSITY IN BRAIN DEEP NUCLEI,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10079392,10079392,10079392
TOOK 0.4 MG OF ABILIFY,Prescribed underdose,PRESCRIBED UNDERDOSE,PRESCRIBED UNDERDOSE,OVERDOSES AND UNDERDOSES NEC,UNDERDOSES NEC,10022117,10073085,10073085,10073085
LUNG HYPOPLASIA,pulmonary hypoplasia,PULMONARY HYPOPLASIA,PULMONARY HYPOPLASIA,RESPIRATORY DISORDERS CONGENITAL,PULMONARY AND BRONCHIAL DISORDERS CONGENITAL,10010331,10037407,10037407,10037407
CL CREATININE =39 ML/MIN,Creatinine renal clearance decreased,CLEARANCE CREATININE DECREASED,CREATININE RENAL CLEARANCE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011363,10011372,10009255
PEAK-DOSE DYSKINESIA,Dyskinesia,DYSKINESIA,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10013916,10013916,10013916
"AT 35 WEEKS OF GESTATION, SHE UNDERWENT A CESAREAN SECTION",premature birth,PREMATURE BIRTH,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036594,10036590,10036594
POSSIBILITY OF AN ADVERSE DRUG REACTION BETWEEN TOPIRAMATE AND PHENOBARBITAL CONTRIBUTING TO HYPOTHERMIA,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
DIARRHEAS,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
CONCOMITANT JOINT PAIN,joint pain,JOINT PAIN,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023222,10003239,10023222
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
HEART BEAT INCREASED (VALUE- 80 BPM),Heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
RHEUMATOID ARTHRITIS REMAINED ACTIVE DESPITE TREATMENT (NO ADVERSE EVENT),drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
NIFEDIPINE GIVEN FOR THREATENED PRETERM LABOR,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
IMPAIRED RENAL FUNCTION,Renal impairment,IMPAIRED RENAL FUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10021523
FELL SEVERAL TIMES/FELL,fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
BONE MARROW APLASIA,Bone marrow failure,APLASIA BONE MARROW,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10002962,10065553,10002962
MATERNAL EXPOSURE (DEP),Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
MILD HEPATOMEGALY WITH FREE SUBHEPATIC FLUID,Hepatomegaly,HEPATOMEGALY,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10019842
CLONAZEPAM AND QUETIAPINE WERE ADMINISTERED WITHOUT RESPONSE,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
MIDAZOLAM INDUCED MYOCLONIC SEIZURE,Myoclonic epilepsy,MYOCLONIC SEIZURE NOS,MYOCLONIC EPILEPSY,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10049588,10054859,10049588
EXOPHTHALMOS,exophthalmos,EXOPHTHALMOS,EXOPHTHALMOS,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION OF EYE NEC",10015919,10015683,10015683,10015683
DILATED PUPILS FOLLOWING ACCIDENTAL ONDANSETRON OVERDOSE,Mydriasis,DILATED PUPILS,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10013014,10028521,10013014
HYPERLORDOSIS IN THE REGION OF THE LUMBAR SPINE,hyperlordosis,HYPERLORDOSIS,LORDOSIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES (INCL INTERVERTEBRAL DISC DISORDERS),SPINE AND NECK DEFORMITIES,10028395,10078166,10024842,10078166
PROGRESSIVE DISEASE,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
RESPIRATORY DEPRESSION,Respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
WORSENING DYSPNEA ON EXERTION,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
"ERYTHEMATOUS/ERYTHEMATOUS PUSTULAR RASH INCREASING IN SIZE OVER HIS HANDS, BACK, CHEST AND FACE",erythematous rash,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015243,10037855,10015243
BLOOD PRESSURE 82/46 MM HG,Blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
CARDIAC ARREST,cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
OFF LABEL USE (STEROID-DEPENDENT IDIOPATHIC NEPHROTIC SYNDROME),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HYPOTENSIVE (BLOOD PRESSURE: 60-70/30-50 MMHG) AND COLLPASED,Hypotension,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021107
ACIDOTIC/METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
"DARK-REDDISH, SLIGHTLY ITCHING RASH ON HER UPPER CHEST",Rash pruritic,ITCHY RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10023092
BLOOD PRESSURE INCREASED (230/120 MMHG),Blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY,Peripheral neuropathy,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10080342,10029331,10080342
LETHARGIC,Lethargy,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024262
EPSTEIN-BARR VIRUS POLYMERASE CHAIN REACTION POSITIVE,Polymerase chain reaction positive,POLYMERASE CHAIN REACTION POSITIVE,POLYMERASE CHAIN REACTION POSITIVE,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",INVESTIGATIONS NEC,10022891,10075628,10075628,10075628
THERAPEUTIC DISCONTINUITY,Product use issue,PRODUCT USE ISSUE,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076309,10076309,10076309
VANCOMYCIN-ASSOCIATED ACUTE KIDNEY INJURY WITH A STEEP RISE IN SERUM CREATININE,acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
PROTHROMBIN TIME INCREASED (AROUND 150 SECONDS),Prothrombin time prolonged,PROTHROMBIN TIME INCREASED,PROTHROMBIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037063,10037063,10037061
GRAVES' DISEASE,Graves' disease,GRAVES' DISEASE,BASEDOW'S DISEASE,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10018706,10004161,10018706
HIGH ANION GAP METABOLIC ACIDOSIS,Metabolic acidosis,HIGH ANION GAP METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10069033,10027417,10069033
HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
ACUTE FLACCID PARALYSIS,Paralysis,FLACCID PARALYSIS,PARALYSIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10033809,10033799,10016744
EXERCISE TOLERANCE DECREASED,Exercise tolerance decreased,EXERCISE TOLERANCE DECREASED,EXERCISE TOLERANCE DECREASED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10051301,10051301,10051301
MULTIPLE ORGAN FAILURE,Multiple organ failure,MULTIPLE ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028237,10077361,10028237
WHEALS OF BOTH EXTREMITIES AND THORACOABDOMINAL REGION,Wheals,WHEALS,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10047918,10046735,10047918
RESPIRATORY FAILURE,respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
"INTERACTION BETWEEN VALPROIC ACID, QUETIAPINE AND PALIPERIDONE",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
ANTITHROMBOTIC PROPHYLAXIS FROM THE FIRST TRIMESTER (LOW MOLECULAR WEIGHT HEPARIN AT APROPHYLACTIC DOSE OF 4000 IU/DAY + ACETYLSALICYLIC ACID 100 MG/DAY),Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
ITCHY PATCH OF ERYTHEMA ON THE BACK,Localised erythema,LOCALISED ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10064351,10015150,10064351
ABDOMINAL PAIN FOLLOWING OPIOID WITHDRAWAL,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
DIARRHEA,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
ACUTE MACULAR NEURORETINOPATHY,acute macular outer retinopathy,ACUTE MACULAR OUTER RETINOPATHY,ACUTE MACULAR OUTER RETINOPATHY,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINOPATHIES NEC,10015919,10079367,10079367,10079367
ONE MALE PATIENT WAS ADMITTED TO INTENSIVE CARE UNIT BECAUSE OF MULTI ORGAN FAILURE DUE TO PARACETAMOL ANAPHYLAXIS (CLAVIEN IV - LIFE THREATENING),Anaphylactic reaction to drug,ANAPHYLACTIC REACTION TO DRUG,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10054844,10002198,10054844
SOMNOLENCE DURING THE DAY/DIZZINESS AND SLEEPINESS,Somnolence,SLEEPINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041014,10041349,10041014
ATROPHIC LESION OF CHEEKS,Oral mucosa atrophy,ORAL MUCOSA ATROPHY,ORAL MUCOSA ATROPHY,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE DISORDERS NEC,10017947,10050172,10050172,10050172
PULMONARY INFECTION,Lung infection,LUNG INFECTION,LUNG INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10061229,10061229,10061229
SWELLING PAIN OF THE LEFT GREAT TOE,swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
POSSIBLY BILATERAL INFLAMMATORY CHANGES OF THE LUNGS,Pneumonitis,LUNG INFLAMMATION,PNEUMONITIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10077942,10035742,10077942
DRUG EXPOSURE VIA PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
GRADE-4 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
APICAL THROMBUS/LV THROMBUS,Thrombosis,THROMBOSIS,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10043607,10043607,10043607
DRUG RESISTANCE TO MULTIPLE COURSES OF METRONIDAZOLE AND VANCOMYCIN,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
STROKE,stroke,STROKE,CEREBROVASCULAR ACCIDENT,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10042244,10008190,10042244
BLOOD GLUCOSE ABNORMAL,blood glucose abnormal,BLOOD GLUCOSE ABNORMAL,BLOOD GLUCOSE ABNORMAL,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10005554,10005554,10005554
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
PAO2 35MMHG,PO2 decreased,PAO2 DECREASED,PO2 DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10068439,10035768,10068439
ZOLEDRONIC ACID-RELATED OSTEONECROSIS OF THE RIGHT MANDIBLE,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
CIRCUMFERENTIAL CONFLUENT RED PLAQUE WITH SEROUS CRUST AND SCALE ON THE CIRCUMCISED GLANS PENIS EXTENDING OVER THE CORONA AND ONTO THE DISTAL PENILE SHAFT,Penile plaque,PENILE PLAQUE,PENILE PLAQUE,PENILE AND SCROTAL DISORDERS (EXCL INFECTIONS AND INFLAMMATIONS),PENILE DISORDERS NEC (EXCL ERECTION AND EJACULATION),10038604,10070652,10070652,10070652
MEDICATION-RELATED OSTEONECROSIS OF THE JAW STAGE 3 [MAXILLA (QUADRANT II) AND MANDIBLE (QUADRANT IV)],Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
EXACERBATION OF DYSARTHRIA FOLLOWING PARTIAL RESPONSE,exacerbation of dysarthria,DYSARTHRIA,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10013887,10013887,10013887
SEPSIS OF URINARY ORIGIN,Urosepsis,UROSEPSIS,UROSEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10048709,10048709,10048709
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
SUBMANDIBULAR LYMPHADENOPATHY,Lymphadenopathy,SUBMANDIBULAR LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10063531,10025197,10063531
VOGT-KOYANAGI-HARADA DISEASE,Vogt-Koyanagi-Harada syndrome,VOGT-KOYANAGI-HARADA SYNDROME,VOGT-KOYANAGI-HARADA SYNDROME,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10047680,10047680,10047680
UNRESPONSIVE TO STIMULI,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
DRUG EXPOSURE DURING LACTATION,Exposure via breast milk,DRUG EXPOSURE VIA BREAST MILK,EXPOSURE VIA BREAST MILK,"EXPOSURES, CHEMICAL INJURIES AND POISONING",PATHWAYS AND SOURCES OF EXPOSURE,10022117,10051075,10080751,10051075
TONIC-CLONIC SEIZURES,Tonic-clonic seizures,TONIC-CLONIC SEIZURES,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10044000,10018100,10044000
SLUGGISH GAIT,Gait disturbance,GAIT DISTURBANCE,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017577,10017577,10017577
ANTERIOR UVEITIS FLARE DURING PREDNISONE TAPER( REBOUND EFFECT),Uveitis,UVEITIS FLARE UP,UVEITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10075797,10046851,10075797
GASTRIC MUCOSAL TEAR AND DIRECT MUCOSAL INJURY,Gastrointestinal injury,GASTROINTESTINAL INJURY,GASTROINTESTINAL INJURY,INJURIES NEC,ABDOMINAL INJURIES NEC,10022117,10061172,10061172,10061172
LYMPHOCYTOSIS PROGRESSION,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
MUSCLE WEAKNESS REMAINED/STENOSIS OF THE LEFT RENAL ARTERY AND INTERSTITIAL LUNG DISEASE WERE NOT CHANGED,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
LITTLE RESPONSE TO VERBAL COMMANDS,Hyporesponsive to stimuli,HYPORESPONSIVE TO VERBAL STIMULI,HYPORESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10077714,10071552,10077714
DYSARTHRIA,Dysarthria,DYSARTHRIA,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10013887,10013887,10013887
360-DEGREE CHOROIDAL DETACHMENT,Choroidal detachment,CHOROIDAL DETACHMENT,CHOROIDAL DETACHMENT,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","CHOROID AND VITREOUS STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10008783,10008783,10008783
INTERMITTENT DECEREBRATE POSTURING WITH HORIZONTAL ROVING EYE MOVEMENTS,Decerebrate posture,DECEREBRATE POSTURE,DECEREBRATE POSTURE,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10073346,10073346,10073346
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
BACK MYALGIA ON EZETIMIBE TREATMENT,Myalgia,LOCALISED MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10063543,10028411,10063543
ENLARGED HEART,Cardiomegaly,HEART ENLARGED,CARDIOMEGALY,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10007632,10007632,10019278
ABDOMINAL PAIN,abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
ACETYLSALICYLIC ACID USED FOR SECONDARY POLYCYTHEMIA,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
HSV TYPE 2,HSV infection,HSV INFECTION,HERPES SIMPLEX,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10063570,10019948,10063570
OFF LABEL USE OF METHOTREXATE FOR CROHN'S DISEASE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
GRADE 3 NEUTROPENIA (ANC 0.3 G/I),Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
MYALGIA,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
TOXIC BLOOD METFORMIN LEVELS WERE CONFIRMED (51.45 MICROGRAM/ML),Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
CONCENTRATION DISTURBANCES,Disturbance in attention,CONCENTRATION IMPAIRED,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10010248,10013496,10010249
PSYCHOTIC SYMPTOMS,psychotic symptom,PSYCHOTIC SYMPTOM,PSYCHOTIC SYMPTOM,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10079254,10079254,10079254
COUGH,cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
BRADYCARDIA,bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
DECREASED VISION (20/400),Visual impairment,VISION DECREASED,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047516,10047571,10047516
LIPASE INCREASED (1211 IU/L),Lipase increased,LIPASE INCREASED,LIPASE INCREASED,GASTROINTESTINAL INVESTIGATIONS,DIGESTIVE ENZYMES,10022891,10024574,10024574,10024574
ST-SEGMENT ELEVATION,ST-segment elevation,ST SEGMENT ELEVATION,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041894,10014392,10041894
PATIENT WAS ADMINISTERED MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF RECALCITRANT PERISTOMAL PYODERMA GANGRENOSUM (OFF LABEL USE) WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MYCOPHENOLATE MOFETIL USED FOR THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (OFF LABEL USE WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TOXIC BLOOD METFORMIN LEVELS WERE CONFIRMED (49.30 ÎœG/ML),Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
LACK OF DRUG EFFECT/ BOTH ESOPHAGEAL AND EXTRAESOPHAGEAL CONTINUED TO OCCUR WITH VARYING FREQUENCY,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SEVERE PANCYTOPENIA AND MUCOSITIS INDUCED BY LOW DOSE METHOTREXATE FOLLOWING DRUG DISPENSING ERROR,mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
METHOTREXATE RELATED LYMPHOMATOID GRANULOMATOSIS WITH MULTIPLE PULMONARY SITES/ PULMONARY LYMPHOMATOID GRANULOMATOSIS SECONDARY TO METHOTREXATE AND AZATHIOPRINE THERAPY,pulmonary granulomatosis,PULMONARY GRANULOMATOSIS,PULMONARY GRANULOMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10037393,10037391,10037393
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
CHEMOTHERAPY WAS STOPPED AFTER TWO CYCLES BECAUSE OF LIVER CONDITION,Liver disorder,LIVER DISORDER,LIVER DISORDER,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10024670,10024670,10024670
"LARGE LYMPHOID CELLS WITH LOBULATED NUCLEI DIFFUSELY INFILTRATED, CONSISTENT WITH DIFFUSE LARGE B CELL LYMPHOMA",Diffuse large B-cell lymphoma,DIFFUSE LARGE B-CELL LYMPHOMA,DIFFUSE LARGE B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,DIFFUSE LARGE B-CELL LYMPHOMAS,10029104,10012818,10012818,10012818
DABIGATRAN PLASMA OVERDOSE/ OVER DOSE,Overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
ANGIOEDEMA,Angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
IRRITABLE,Irritability,IRRITABLE,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10023000,10022998,10023000
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN BONE MARROW,Haemophagocytic lymphohistiocytosis,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,HISTIOCYTOSIS HAEMATOPHAGIC,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10071583,10048595,10071583
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
BRAIN EDEMA,Brain oedema,BRAIN EDEMA,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10048962,10048962,10006121
INCREASED HBV DNA VIRAL LOAD DUE TO LAMIVUDINE RESISTANCE FOLLOWING ACQUIRED GENE MUTATION,Hepatitis B DNA increased,HBV VIRAL LOAD INCREASED,HEPATITIS B DNA INCREASED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10068375,10068379,10068375
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
ERYTHEMATOUS PLAQUES ON BOTH LOWER LIMBS,erythematous eruption,ERYTHEMATOUS ERUPTION,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015241,10037855,10015241
INSOMNIA,insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
SEVERE RECURRENT RESPIRATORY TRACT INFECTIONS DUE TO HYPOGAMMAGLOBULINEMIA AND LYMPHOPENIA,Respiratory tract infection,RECURRENT RESPIRATORY TRACT INFECTIONS,RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10038133,10062352,10038133
DISEASE PROGRESSION FOLLOWING OFF-LABEL USE OF TEMOZOLOMIDE IN METASTATIC MELANOMA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PURPURIC PAPULES,purpuric papules,PURPURA,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037549,10037549,10037549
VOCAL TIC (SNIFFING),Vocal tic,VOCAL TIC,TIC,CHANGES IN PHYSICAL ACTIVITY,TIC DISORDERS,10037175,10066771,10043833,10066771
ASPARTATE AMINOTRANSFERASE INCREASED (AROUND 600U/L),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
"PAPULAR RASH, CONFINED TO THE EXTREMITIES, BUTTOCKS AND FACE, MONOMORPHIC SKIN-COLOURED PAPULES ON THE EXTENSOR SURFACES, FEW CRUSTED EXCORIATIONS",papular rash,PAPULAR RASH,RASH PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10033726,10037876,10033726
ABORTED CARDIAC ARREST,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
GLUTEAL COMPARTMENT SYNDROME (GCS) IN THE CONTEXT OF DRUG OVERDOSE,Compartment syndrome,COMPARTMENT SYNDROME,COMPARTMENT SYNDROME,MUSCLE DISORDERS,MYOPATHIES,10028395,10010121,10010121,10010121
EXTENSIVE BILATERAL ANGIOINVASIVE FUNGAL PNEUMONIA WITH GROSS NECROSIS (FULMINANT PNEUMONIA),Pneumonia fungal,PNEUMONIA FUNGAL,PNEUMONIA FUNGAL,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10061354,10061354,10061354
32 YRS OLD FEMALE RECEIVED ASPIRIN DURING PREGNANCY AND DELIVERED LOW WEIGHT BABY,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
TRANSIENT SEVERE IMMUNODEFICIENCY SECONDARY TO CHEMOTHERAPY,Immunodeficiency secondary to chemotherapy,IMMUNODEFICIENCY SECONDARY TO CHEMOTHERAPY,SECONDARY IMMUNODEFICIENCY,IMMUNODEFICIENCY SYNDROMES,ACQUIRED IMMUNODEFICIENCY SYNDROMES,10021428,10056376,10054979,10056376
ENCEPHALITIS AGGRAVATED,encephalitis,ENCEPHALITIS,ENCEPHALITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10014581,10014581,10014581
HEPATIC CANCER,Hepatic cancer,ANAPLASTIC CARCINOMA OF LIVER,HEPATIC CANCER,HEPATOBILIARY NEOPLASMS MALIGNANT AND UNSPECIFIED,HEPATIC NEOPLASMS MALIGNANT,10029104,10078345,10073069,10078345
ASTHENIA GRADE 2,ASTHENIA,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
DRESS SYNDROME,Drug reaction with eosinophilia and systemic symptoms,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
PATIENT WAS TREATED WITH FLUDARABINE FOR BONE MARROW CONDITIONING REGIMEN FOR DONOR TYPE APLASIA (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
EOSINOPHILIC PNEUMONIA,eosinophilic pneumonia,EOSINOPHILIC PNEUMONIA,EOSINOPHILIC PNEUMONIA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10014962,10014962,10014962
"BEGAN TO HAVE REDNESS, SWELLING, AND PAIN AT THE EXTRAVASATION SITE",Injection site erythema,INJECTION SITE REDNESS,INJECTION SITE ERYTHEMA,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022098,10022061,10022098
PRURITIC RASH,Rash pruritic,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10037085
ELECTROCARDIOGRAM SHOWED SINUS BRADYCARDIA WITH LONG QT INTERVAL,QT interval prolonged,QT INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037703,10014387,10037703
DELIRIOUS,Delirium,DELIRIOUS,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012217
PAIN AND HURDLES ASSOCIATED WITH ADMINISTRATION OF INSULIN,Administration site pain,ADMINISTRATION SITE PAIN,ADMINISTRATION SITE PAIN,ADMINISTRATION SITE REACTIONS,ADMINISTRATION SITE REACTIONS NEC,10018065,10058049,10058049,10058049
BLOODY DIARRHEA (7-9 BLOODY STOOLS PER DAY),Diarrhoea haemorrhagic,BLOODY DIARRHEA,DIARRHOEA HAEMORRHAGIC,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012741,10012741,10005872
RECURRENT NEUTROPENIA,neutropenia aggravated,NEUTROPENIA AGGRAVATED,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029356,10029354,10029356
INFLAMMATION OF THE MECKEL'S DIVERTICULUM,Diverticulitis Meckel's,DIVERTICULITIS MECKEL'S,DIVERTICULITIS MECKEL'S,GASTROINTESTINAL TRACT DISORDERS CONGENITAL,GASTROINTESTINAL TRACT DISORDERS CONGENITAL NEC,10010331,10013542,10013542,10013542
INTOLERABLE GASTROINTESTINAL ADVERSE EFFECTS,Gastrointestinal disorder,GASTROINTESTINAL DISORDER NOS,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017945,10017944,10017945
NECK PAIN,Neck pain,NECK PAIN,NECK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10028836,10028836,10028836
ANALGESIC EFFECT DECREASED,Analgesic effect decreased,ANALGESIC EFFECT DECREASED,INADEQUATE ANALGESIA,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049504,10021576,10049504
GENERALIZED ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
STRESS-INDUCED CARDIOMYOPATHY,Stress cardiomyopathy,STRESS CARDIOMYOPATHY,STRESS CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10066286,10066286,10066286
LIVER DAMAGE,Liver injury,LIVER DAMAGE,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067125,10067125,10024668
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
HEPARIN INDUCED  THROMBOCYTOPENIA,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
FEVER,Chronic fever,CHRONIC FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10066565,10037660,10066565
ACUTE PULMONARY THROMBOEMBOLISM,Acute pulmonary thromboembolism,PULMONARY THROMBOEMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037436,10037377,10037436
INTERSTITIAL FIBROSIS,pulmonary fibrosis,INTERSTITIAL PULMONARY FIBROSIS,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022619,10022611,10022619
SIGNIFICANT LESIONS CAUSED BY PRESSURE-RELATED HYPERKERATOSIS ON  THE  LEFT  SOLE UNDER  THE  PROMINENT  HEADS  OF THE  THIRD  AND  FOURTH  METATARSAL  BONES,Hyperkeratosis,HYPERKERATOSIS,HYPERKERATOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,HYPERKERATOSES,10040785,10020649,10020649,10020649
FINE CRACKLES AT BOTH LUNG BASES, fine crackles at both lung bases ,CRACKLES LUNG,RALES,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10054910,10037833,10054910
"PITUITARY ASSESSMENT SHOWED A NORMAL MRI, SUBSTITUTED GONADOTROPIC FUNCTION AND HYPOCORTISOLISM WHICH REQUIRED INCREASED HYDROCORTISONE TREATMENT",Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
GASTRIC ADENOCANCER (STAGE IV),Adenocarcinoma gastric,ADENOCARCINOMA GASTRIC STAGE IV NOS,ADENOCARCINOMA GASTRIC,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,GASTRIC NEOPLASMS MALIGNANT,10029104,10001157,10001150,10001157
BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
MULTIPLE DRUG RESISTANCE,multiple-drug resistance,MULTIPLE-DRUG RESISTANCE,MULTIPLE-DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048723,10048723,10048723
HYPOTHYROIDISM,Hypothyroidism,HYPOTHYROIDISM,HYPOTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPOFUNCTION DISORDERS,10014698,10021114,10021114,10021114
PROGRESSION OF GLUCOCORTICOSTEROID-RESISTANT PEMPHIGOID GESTATIONIS FOLLOWING LACK OF DRUG EFFECT WITH PREDNISOLONE AND CLASS IV CORTICOSTEROIDS,Herpes gestationis,PEMPHIGOID GESTATIONIS,HERPES GESTATIONIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10052801,10019939,10052801
STAPHYLOCOCCUS AUREUS BACTEREMIA,Staphylococcal bacteraemia,STAPHYLOCOCCUS AUREUS BACTEREMIA,STAPHYLOCOCCAL BACTERAEMIA,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10058863,10051017,10058887
EXERTIONAL DYSPNEA,exertional dyspnea,EXERTIONAL DYSPNEA,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10055548,10013971,10055548
PANCYTOPENIA,pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
TERMINATION OF PREGNANCY,Termination of pregnancy,TERMINATION OF PREGNANCY,ABORTION INDUCED,OBSTETRIC AND GYNAECOLOGICAL THERAPEUTIC PROCEDURES,INDUCED ABORTIONS,10042613,10043281,10000220,10043281
FLECAINIDE INDUCED TYPE 1 BRUGADA PATTERN,Brugada syndrome,BRUGADA SYNDROME,BRUGADA SYNDROME,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10059027,10059027,10059027
PATIENT RECEIVED MOXIFLOXACIN MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS,Patient received moxifloxacin multidrug-resistant pulmonary tuberculosis,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
FETAL VALPROATE SYNDROME,Foetal anticonvulsant syndrome,FETAL VALPROATE SYNDROME,FOETAL ANTICONVULSANT SYNDROME,CONGENITAL AND HEREDITARY DISORDERS NEC,CHEMICALLY-INDUCED CONGENITAL SYNDROMES,10010331,10016524,10066485,10016524
DICLOFENAC-INDUCED ACUTE RHABDOMYOLYSIS,rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
VISUAL HALLUCINATIONS,"Hallucination, visual",VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019075,10019075,10047570
INDIRECT BILIRUBIN INCREASED - 99.18 MICROMOL/L,Blood bilirubin unconjugated increased,INDIRECT BILIRUBIN INCREASED,BLOOD BILIRUBIN UNCONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10021709,10005370,10021709
LEFT ANTERIOR FASCICULAR BLOCK,Bifascicular block,BIFASCICULAR BLOCK,BIFASCICULAR BLOCK,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10057393,10057393,10057393
PREMATURE 1700 G HEALTHY BOY WAS DELIVERED,Low birth weight baby,LOW BIRTH WEIGHT BABY,LOW BIRTH WEIGHT BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10067508,10067508,10067508
"BUPROPION, DULOXETINE AND QUETIAPINE WERE USED AS PSYCHOTROPIC MEDICATION AND THEN DISCONTINUED DUE TO POOR RESPONSE",Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
SEVERE HYPOKALEMIA (1.7 MEQ/L),Hypokalaemia,HYPOKALEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021018
ANAPHYLAXIS,ANAPHYLAXIS,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
PULMONARY MOIST RALES WERE HEARD,Rales,CRACKLES LUNG,RALES,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10054910,10037833,10054910
INTOLERANT DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
MULTIORGAN SYSTEM FAILURE DUE TO HERPES SIMPLEX VIRUS HEPATITIS,Multiple organ dysfunction syndrome,MULTIORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028162
SWELLING OF LEFT AND RIGHT AURICULE,Swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
COAGULOPATHY,Coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
"DESPITE SUBSEQUENT EPINEPHRINE INJECTION FOR MASSIVE HEMATEMESIS, THE MASS CONTINUED TO OOZE",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
QUETIAPINE (12.5 MG) AT NIGHT (OFF LABEL),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEMATOMA'S EXPANSION LEADING TO IRREVERSIBLE HEART FAILURE,Haematoma,HEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10019428
PURULENT DISCHARGE,PURULENT DISCHARGE,PURULENT DISCHARGE,PURULENT DISCHARGE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10037569,10037569,10037569
CEREBROVASCULAR ACCIDENT,Cerebrovascular accident,CEREBROVASCULAR ACCIDENT,CEREBROVASCULAR ACCIDENT,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008190,10008190,10008190
CARDIOVASCULAR INSUFFICIENCY,circulatory depression,CIRCULATORY DEPRESSION,CARDIOVASCULAR INSUFFICIENCY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10064995,10065929,10064995
WHITE CELL COUNT WAS 12.4 X 10E9/ L,White blood cell count increased,INCREASED WHITE CELL COUNT,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047943,10047943,10021695
AMIODARONE INFLUENCED DIGOXIN CLEARANCE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
CHILD WAS TREATED WITH INDOMETACIN,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
AST INCREASED,Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
PERIPHERAL NERVE DISORDER/GRADE 3 PERIPHERAL NEUROPATHY,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
"THE PATIENT WAS VACCINATED WITH ACT HIB ON 28-SEP-2015, 23-NOV-2015 AND 29-JUN-2016",Inappropriate schedule of vaccine administered,INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTERED,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10063976,10021597,10063976
HYDROXYCHLOROQUINE-INDUCED RESTRICTIVE CARDIOMYOPATHY FOLLOWING DRUG TOXICITY,Restrictive cardiomyopathy,RESTRICTIVE CARDIOMYOPATHY,RESTRICTIVE CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10038748,10038748,10038748
WEIGHT LOSS,weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
ACUTE OR SUBACUTE MYOCARDIAL INFARCTION,Acute myocardial infarction,ACUTE MYOCARDIAL INFARCTION,ACUTE MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10000891,10000891,10000891
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
REPEATED EPISODES OF LEUKOENCEPHALOPATHY,Leukoencephalopathy,LEUKOENCEPHALOPATHY,LEUKOENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10024382,10024382,10024382
RESPIRATORY ARREST,Respiratory arrest,RESPIRATORY ARREST,RESPIRATORY ARREST,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038669,10038669,10038669
ABDOMINAL DISCOMFORT,Abdominal discomfort,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10000059,10000059,10000059
DETERIORATION OF CONSCIOUS LEVEL,Condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
MACULOPAPULAR EXANTHEMA,Rash maculo-papular,MACULO-PAPULAR EXANTHEMA,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10049195,10037868,10049195
DRUG RESISTANCE TO ISONIAZID AS TUBERCULOSIS GREW IN LYMPH NODE CULTURE,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
COLON CANCER,colon cancer,COLON CANCER,COLON CANCER,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,COLORECTAL NEOPLASMS MALIGNANT,10029104,10009944,10009944,10009944
MUCOCUTANEOUS TOXICITY INDUCED BY LOW-DOSE METHOTREXATE THERAPY,Mucocutaneous ulceration,MUCOCUTANEOUS ULCERATION,MUCOCUTANEOUS ULCERATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10028084,10028084,10028084
BRONCHOSPASM,bronchospasm,BRONCHOSPASM,BRONCHOSPASM,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10006482,10006482,10006482
METHYLPREDNISOLONE INDUCED ACUTE LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
LACTIC ACIDOSIS WITH A LACTATE LEVEL OF 5.6 MMOL/L,lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
ACCIDENTALLY WAS TREATED WITH CANDESARTAN,Accidental exposure to product,ACCIDENTAL EXPOSURE TO PRODUCT,ACCIDENTAL EXPOSURE TO PRODUCT,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,ACCIDENTAL EXPOSURES TO PRODUCT,10022117,10073317,10073317,10073317
"PATIENT WITH DISSEMINATED CMV INFECTION TREATED WITH CYCLOPHOSPHAMIDE (UNAPPROVED POPULATION, OFF LABEL USE)",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RADIOGRAPHS REVEALED SOFT TISSUE LUCENCIES CONSISTENT WITH AIR,Soft tissue disorder,SOFT TISSUE DISORDER,SOFT TISSUE DISORDER,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,SOFT TISSUE DISORDERS NEC,10028395,10061366,10061366,10061366
DRUG EXPOSURE IN UTERO,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
PHOTOTOXIC AMIODARONE HYPERPIGMENTATION ON LIGHT-EXPOSED AREAS,Photosensitivity reaction,PHOTOTOXICITY,PHOTOSENSITIVITY REACTION,EPIDERMAL AND DERMAL CONDITIONS,PHOTOSENSITIVITY AND PHOTODERMATOSIS CONDITIONS,10040785,10034977,10034972,10034977
TREATED WITH ASPIRIN FOR ESSENTIAL THROMBOCYTEMIA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
NEUROLEPTIC MALIGNANT SYNDROME,neuroleptic malignant syndrome,NEUROLEPTIC MALIGNANT SYNDROME,NEUROLEPTIC MALIGNANT SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10029282,10029282,10029282
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
CLONUS,clonus,CLONUS,CLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10009346,10009346,10009346
"TREATMENT WAS LIMITED BY INTOLERANCE FOR ADEQUATE DOSES OF METOPROLOL, RAMIPRIL AND CANDESARTAN",drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
LACRIMATION,lacrimation,LACRIMATION,LACRIMATION INCREASED,EYE DISORDERS NEC,LACRIMATION DISORDERS,10015919,10023639,10023644,10023639
CALCIFICATION OF BASAL GANGLIA,Cerebral calcification,CEREBRAL CALCIFICATION,CEREBRAL CALCIFICATION,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10066296,10066296,10066296
HEMATOCRIT DECREASED (35.2 PERCENT),Haematocrit decreased,HEMATOCRIT DECREASED,HAEMATOCRIT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018838,10018838,10019423
HEPATIC NECROSIS,hepatic necrosis,HEPATIC NECROSIS,HEPATIC NECROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019692,10019692,10019692
CORNEAL DAMAGE DUE TO TOXIC EPIDERMAL NECROLYSIS FOLLOWING STEVENS JOHNSON SYNDROME,Corneal disorder,CORNEAL DISORDER,CORNEAL DISORDER,EYE DISORDERS NEC,CORNEAL DISORDERS NEC,10015919,10061453,10061453,10061453
SUDDEN UTERINE CONTRACTILE FUNCTION,Uterine contractions during pregnancy,UTERINE CONTRACTIONS DURING PREGNANCY,UTERINE CONTRACTIONS DURING PREGNANCY,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS","NORMAL PREGNANCY, LABOUR AND DELIVERY",10036585,10049975,10049975,10049975
PATHOGEN RESISTANCE,Pathogen resistance,PATHOGEN RESISTANCE,PATHOGEN RESISTANCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10034133,10034133,10034133
ALTERED MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
ACUTE DRUG OVERDOSE,acute overdose,ACUTE OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067695,10033295,10067695
DONE GRIEVOUS BODILY HARM,Intentional self-injury,DELIBERATE SELF-INJURY,INTENTIONAL SELF-INJURY,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10022524,10022524,10012214
HAEMORRHAGE,Haemorrhage,HAEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10055798
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
TENDERNESS IN THE HYPOGASTRIC REGION,Abdominal tenderness,LOWER ABDOMINAL TENDERNESS,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10069063,10000097,10069063
ERYTHEMA,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ANTIBIOTIC TREATMENT WAS COMPLETED WITHOUT EVIDENT CLINICAL IMPROVEMENT OF THE INFECTIOUS SYMPTOMS/ DRUG INEFFECTIVE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
URINE SEDIMENT MICROSCOPY DEMONSTRATED 5-10 ISOMORPHIC RED BLOOD CELLS PER HIGH POWER FIELD (HPF),Red blood cells urine,RED BLOOD CELLS URINE,RED BLOOD CELLS URINE,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINALYSIS NEC,10022891,10050676,10050676,10050676
BURNING IN THE TIPS OF HER EXTREMITIES,extremities burning sensation of,EXTREMITIES BURNING SENSATION OF,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10015884,10006784,10015884
INCREASED INFLAMMATION MARKERS,Inflammatory marker increased,INFLAMMATORY MARKER INCREASED,INFLAMMATORY MARKER INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,CHEMISTRY ANALYSES NEC,10022891,10069826,10069826,10069826
TRANSPLANT REJECTION,Transplant rejection,TRANSPLANT REJECTION,TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10044439,10044439,10044439
OPIOID OVERDOSE,drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
CLONAL CHROMOSOME ABNORMALITIES,clonal chromosome abnormalities,CHROMOSOME ABNORMALITY,CYTOGENETIC ABNORMALITY,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,CHROMOSOMAL ABNORMALITIES NEC,10010331,10008815,10067477,10008815
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
DRY SKIN,Dry skin,DRY SKIN,DRY SKIN,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10013786,10013786,10013786
ACUTE RENAL FAILURE/ RHABDOMYOLYSIS-INDUCED RENAL FAILURE/ ACUTE KIDNEY INJURY,acute kidney injury,RHABDOMYOLYSIS-INDUCED RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10050996,10069339,10050996
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
CLOSTRIDIUM DIFFICILE COLITIS,Clostridium difficile colitis,CLOSTRIDIUM DIFFICILE COLITIS,CLOSTRIDIUM DIFFICILE COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10009657,10009657,10009657
NEUTROPENIC,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
POSSIBLE CONNECTIVE TISSUE DISEASE,Connective tissue disorder,CONNECTIVE TISSUE DISORDER,CONNECTIVE TISSUE DISORDER,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),CONNECTIVE TISSUE DISORDERS NEC,10028395,10061087,10061087,10061087
E. COLI URINE INFECTION,Escherichia urinary tract infection,ESCHERICHIA URINARY TRACT INFECTION,ESCHERICHIA URINARY TRACT INFECTION,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10052238,10052238,10052238
MEDICATION-INDUCED CENTRAL ANTICHOLINERGIC SYNDROME,Anticholinergic syndrome,ANTICHOLINERGIC SYNDROME,ANTICHOLINERGIC SYNDROME,NEUROMUSCULAR DISORDERS,AUTONOMIC NERVOUS SYSTEM DISORDERS,10029205,10002757,10002757,10002757
HYPERSENSITIVITY PNEUMONITIS,hypersensitivity pneumonitis,PNEUMONITIS HYPERSENSITIVITY,ALVEOLITIS ALLERGIC,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10035754,10001890,10035754
RELAPSE OF LYMPHOCYTIC HYPOPHYSITIS REBOUND AFTER PREDNISOLONE DOSE TAPERING,Lymphocytic hypophysitis,LYMPHOCYTIC HYPOPHYSITIS,LYMPHOCYTIC HYPOPHYSITIS,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,HYPOTHALAMIC AND PITUITARY DISORDERS NEC,10014698,10063685,10063685,10063685
BACK PAIN,Back pain,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003988,10003988,10003988
SUICIDE ATTEMPT,suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
INTERMITTENT RHYTHMIC JERKING OF THE RIGHT LOWER LIMB AND KICKING OUT OF BOTH LEGS,Jerkiness,JERKINESS,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10023188,10013916,10023188
"EVEN AFTER INCREASING THE DOSE OF TRANSDERMAL FENTANYL TO 75 MG PER HOUR, THESE INTERVENTIONS WERE UNSUCCESSFUL",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
KNEE AND BACK PAIN,back pain,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003988,10003988,10003988
HYPEREOSINOPHILIA ASSOCIATED WITH HEPATIC CYTOLYSIS THAT COULD SUGGEST ASSOCIATED VISCERAL INVOLVEMENT,hepatic cytolysis,HEPATIC CYTOLYSIS,HEPATOCELLULAR INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10049199,10019837,10049199
RE ACCUMULATION OF PSEUDOMENINGOCELE,Pseudomeningocele,PSEUDOMENINGOCELE,PSEUDOMENINGOCELE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NEUROLOGICAL AND PSYCHIATRIC PROCEDURAL COMPLICATIONS,10022117,10059599,10059599,10059599
LABIAL EDEMA,edema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014210,10030095,10014210
ACYCLOVIR-INDUCED THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
PERSISTENT SINUS TACHYCARDIA,Sinus tachycardia,SINUS TACHYCARDIA,SINUS TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040752,10040752,10040752
RHEUMATOID FACTOR INCREASED (MORE THAN 600 IU/ML),Rheumatoid factor increased,RHEUMATOID FACTOR INCREASED,RHEUMATOID FACTOR INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10057962,10057962,10057962
GENERALIZED SEIZURE DUE TO DRUG WITHDRAWAL SYNDROME,generalized seizure due to drug withdrawal syndrome,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
LACK OF EFFICACY,lack of efficacy,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
"DRUG INEFFECTIVE/ CLINICALLY, THE CONDITION DID NOT IMPROVE",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
DIABETIC NEPHROPATHY FOLLOWING WORSENING DIABETIC CONTROL,Diabetic nephropathy,DIABETIC NEPHROPATHY,DIABETIC NEPHROPATHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10061835,10061835,10061835
PANCYTOPENIA,pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
2 SMALL ESCHARS APPEARED IN THE DORSAL AND LATERAL REGION OF THE FOOT FOLLOWING CALCIUM GLUCONATE EXTRAVASATION,Eschars,ESCHAR,ESCHAR,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10051814,10051814,10051814
EUTHYROID,Euthyroid goiter ,EUTHYROID GOITER,GOITRE,THYROID GLAND DISORDERS,THYROID DISORDERS NEC,10014698,10059187,10018498,10059187
POSTOPERATIVE WOUND INFECTION,postoperative wound infection,POSTOPERATIVE WOUND INFECTION,POSTOPERATIVE WOUND INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10036410,10036410,10036410
IATROGENIC ADRENAL INSUFFICIENCY SECONDARY TO COMBINATION THERAPY WITH ELVITEGRAVIR/COBICISTAT/TENOFOVIR DISOPROXIL FUMARATE/EMTRICITABINE AND INTERLAMINAR TRIAMCINOLONE INJECTION,Adrenal insufficiency,ADRENAL INSUFFICIENCY,ADRENAL INSUFFICIENCY,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001367,10001367,10001367
ISCHAEMIC STROKE,Ischaemic stroke,ISCHAEMIC STROKE,ISCHAEMIC STROKE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10061256,10061256,10061256
SEVERE UNCONTROLLED SYSTEMIC INFLAMMATORY RESPONSE,Inflammation,INFLAMMATION,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10061218,10061218,10061218
EXTREMITY SWELLING,Peripheral swelling,PERIPHERAL SWELLING,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10048959,10048959,10048959
ADYNAMIA,Adynamia,ADYNAMIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10001425,10003549,10001425
BRADYCARDIA (44 BPM),Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
SHE ILLICITLY PURCHASED AND CONSUMED BUPRENORPHINE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
DEPRESSION,depression,DEPRESSION,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012378,10012378,10012378
DIFFUSE THIGH PAIN,Pain in thigh,PAIN IN THIGH,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10048973,10033425,10048973
FEVER (BODY TEMPERATURE NOS),fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
UNCONSCIOUS,Loss of consciousness,UNCONSCIOUS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10045479
BILATERAL PLEURAL EFFUSION,bilateral pleural effusion,BILATERAL PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10078037,10035598,10078037
TEMPERATURE ELEVATION UP TO 38.5 C,Body temperature increased,TEMPERATURE ELEVATION,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10043204
REDUCED LYMPHOCYTE COUNT,Reduced Lymphocyte count,LYMPHOCYTE COUNT DECREASED,LYMPHOCYTE COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10025256,10025256,10025256
EROSIVE LESIONS AROUND THE MOUTH,skin erosion,SKIN EROSION,SKIN EROSION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040840,10040840,10040840
GENERALIZED PSORIASIS TO PASI 19.6,Psoriasis,PSORIASIS AGGRAVATED,PSORIASIS,EPIDERMAL AND DERMAL CONDITIONS,PSORIATIC CONDITIONS,10040785,10037154,10037153,10037154
PATIENT DID NOT IMPROVE WITH TWO INTRAVITREAL AMPHOTERICIN B INJECTIONS ALONG SIDE SYSTEMIC ANTIFUNGAL FLUCONAZOLE (LACK OF DRUG EFFECT) WITH NO ADR,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
HEMOLYTIC UREMIC SYNDROME RECURRENCE,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
MULTIORGAN FAILURE,Multiple organ dysfunction syndrome,MULTIORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028162
SUICIDE ATTEMPT,suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
NO RESPONSE TO THERAPY,Therapy non-responder,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
SUFFOCATION,Suffocation,SUFFOCATION,ASPHYXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10042443,10003497,10042443
PREGNANCY INDUCED HYPERTENSION,Pregnancy induced hypertension,PREGNANCY INDUCED HYPERTENSION,GESTATIONAL HYPERTENSION,MATERNAL COMPLICATIONS OF PREGNANCY,HYPERTENSION ASSOCIATED DISORDERS OF PREGNANCY,10036585,10036563,10070538,10036563
SUBCUTANEOUS SITE REACTIONS IN HER ARMS.,Administration site reaction,ADMINISTRATION SITE REACTION,ADMINISTRATION SITE REACTION,ADMINISTRATION SITE REACTIONS,ADMINISTRATION SITE REACTIONS NEC,10018065,10001315,10001315,10001315
CYTOMEGALOVIRUS HEPATITIS,Cytomegalovirus hepatitis,CYTOMEGALOVIRUS HEPATITIS,CYTOMEGALOVIRUS HEPATITIS,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011830,10011830,10011830
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
GRADE 2 HAND FOOT SYNDROME,Hand and foot syndrome,HAND AND FOOT SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10019111,10033553,10019111
"PURPURA ALL OVER BODY FOLLOWING THROMBOCYTOPENIA INDUCED BY RIFAMPICIN, PYRAZINAMIDE AND CIPROFLOXACIN",Purpura,PURPURA,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037549,10037549,10037549
ACUTE BACLOFEN WITHDRAWAL SYNDROME,drug withdrawal syndrome neonatal,DRUG WITHDRAWAL SYNDROME NEONATAL,DRUG WITHDRAWAL SYNDROME NEONATAL,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10013756,10013756,10013756
EVIDENCE OF SIADH,Inappropriate antidiuretic hormone secretion,SIADH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,POSTERIOR PITUITARY DISORDERS,10014698,10040626,10053198,10040626
PURPLE SUBCUTANEOUS HARD NODULES,subcutaneous nodule,SUBCUTANEOUS NODULE,SKIN MASS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS CONDITIONS NEC,10040785,10042348,10067868,10042348
MRONJ (MEDICATION-RELATED OSTEONECROSIS OF THE JAW)(MANDIBLE)(STAGE 1),Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
SEVERE INFLAMMATION IN THE ANTERIOR CHAMBER,Eye inflammation,EYE INFLAMMATION,EYE INFLAMMATION,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10015943,10015943,10015943
ASYMPTOMATIC FRECKLE-LIKE HYPERPIGMENTED LESIONS ON HIS NECK AND CHEEKS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
HEMOGLOBIN 7.2 G/DL,Haemoglobin decreased,HEMOGLOBIN LOW,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018889,10018884,10055600
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
REPORTEDLY EXPERIENCED NO BENEFIT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
FOGGINESS OF THOUGHT,Foggy feeling in head,FOGGY FEELING IN HEAD,FEELING ABNORMAL,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10016876,10016322,10016876
MULTIPLE FACIAL DYSMORPHIAS,Facial dysmorphism,FACIAL DYSMORPHISM,DYSMORPHISM,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL DISORDERS CONGENITAL NEC,10010331,10016045,10066054,10016045
CANNOT READ PROPERLY,Visual impairment,ABNORMAL VISION,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10000186,10047571,10000186
BLOOD IN THE FECES,Haematochezia,BLOODY STOOL,HAEMATOCHEZIA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10005873,10018836,10005873
MULTI ORGAN FAILURE FOLLOWING RESPIRATORY INFECTION DUE TO KLEBSIELLA PNEUMONIAE CARBAPENEMASE,Multiple organ dysfunction syndrome,MULTI ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028151
AGGRAVATION OF IDIOPATHIC HYPERTROPHIC CRANIAL PACHYMENINGITIS,Pachymeningitis,HYPERTROPHIC PACHYMENINGITIS,PACHYMENINGITIS,CENTRAL NERVOUS SYSTEM INFECTIONS AND INFLAMMATIONS,MENINGITIS NEC,10029205,10052436,10053658,10052436
DIFFUSE EDEMA INVOLVING THE SIGMOID COLON AND RECTUM,intestinal edema,INTESTINAL EDEMA,GASTROINTESTINAL OEDEMA,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10058065,10058061,10058065
HSV-1-POSITIVE ORAL MUCOSITIS,Stomatitis,MUCOSITIS ORAL,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028130,10042128,10028130
12-YEARS-OLD PATIENT WHO WAS ADMINISTERED FLUDARABINE PHOSPHATE (DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE) WITHOUT ADVERSE REACTION,12-Years-old patient who was administered fludarabine phosphate (drug administered to patient of inappropriate age) without adverse reaction,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10071062,10071062,10071062
MACULAR PIGMENTARY CHANGES WITH MOTTLING WAS FOUND,macular pigmentary changes with mottling was found,MACULAR PIGMENTATION,MACULAR PIGMENTATION,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10071041,10071041,10071041
MAINTAINED DAILY AND NOCTURNAL SYMPTOMS,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SEVERE PAIN IN THE LEFT LUMBAR FOSSA,Iliac fossa pain,ILIAC FOSSA PAIN,ABDOMINAL PAIN LOWER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10021341,10000084,10021341
HYPERURICEMIA,Hyperuricemia,HYPERURICEMIA,HYPERURICAEMIA,PURINE AND PYRIMIDINE METABOLISM DISORDERS,DISORDERS OF PURINE METABOLISM,10027433,10020907,10020903,10020907
NEUTROPHILIA (94%),Neutrophil count increased,NEUTROPHILS INCREASED,NEUTROPHIL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029381,10029368,10029381
NEPHROTOXICITY,Nephrotoxicity,NEPHROTOXICITY,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10067571
EXCESSIVE DROWSINESS IN THE MORNING,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
HYPOXEMIA,Hypoxia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021141,10021143,10021142
ABSOLUTE NEUTROPHIL COUNT (ANC) DECREASED (0.32/NL),Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
GRAFT-VERSUS-HOST DISEASE,Graft versus host disease in skin,GRAFT VERSUS HOST DISEASE IN SKIN,GRAFT VERSUS HOST DISEASE IN SKIN,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10064675,10064675,10064675
BILIRUBIN INCREASED,bilirubin increased,BILIRUBIN INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10004690,10005364,10004690
BP DROPPED TO 60/40 MMHG,Blood pressure decreased,BLOOD PRESSURE DROPPED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005744
DISSEMINATED INTRAVASCULAR COAGULATION,disseminated intravascular coagulation,DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10013442,10013442,10013442
EPSTEIN-BARR VIRUS IN SITU HYBRIDIZATION SHOWED A POSITIVE RESULT,Epstein-Barr virus test positive,EPSTEIN-BARR VIRUS TEST POSITIVE,EPSTEIN-BARR VIRUS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10064545,10064545,10064545
LEUKOCYTOSIS,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
ALKALINE PHOSPHATASE-269 U/L (NORMAL 35-105 U/L),Blood alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
AGITATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
MILD GRAFT TENDERNESS,Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY (AADCD),Inborn error of metabolism,INBORN ERROR OF METABOLISM,INBORN ERROR OF METABOLISM,METABOLIC AND NUTRITIONAL DISORDERS CONGENITAL,INBORN ERRORS OF METABOLISM NEC,10010331,10062018,10062018,10062018
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
LEFT VENTRICULAR THROMBOSIS,Cardiac ventricular thrombosis,LEFT VENTRICULAR THROMBOSIS,CARDIAC VENTRICULAR THROMBOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10080067,10053994,10080067
HOSPITAL ADMISSION FOR HEART FAILURE,Cardiac failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10007554,10007554,10019279
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
EXTREME DIFFICULTY IN CHEWING AND SWALLOWING FOOD,Dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
E HAD TO SWITCH OFF HIS IPHONE TOUCH ID BECAUSE IT WOULD NOT RESPOND/PAPILLARY RIDGE DAMAGE,fingerprint loss,FINGERPRINT LOSS,FINGERPRINT LOSS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10069686,10069686,10069686
ENCEPHALOPATHY,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
VOMITED SEVERAL TIMES WITHOUT BLOOD,Vomiting,VOMITED,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047699
ANAPLASTIC EVOLUTION OF KAPOSI'S SARCOMA,Kaposi's sarcoma,KAPOSI'S SARCOMA,KAPOSI'S SARCOMA,SOFT TISSUE NEOPLASMS MALIGNANT AND UNSPECIFIED,KAPOSI'S SARCOMAS,10029104,10023284,10023284,10023284
URINE ANALYSIS SHOWED KETONE 2+,Urine ketone body present,URINE KETONE BODY PRESENT,URINE KETONE BODY PRESENT,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10057597,10057597,10057597
"SIGNIFICANT FACIAL OEDEMA (LIP AND EYES), SPORADICALLY, FACIAL ANGIOEDEMA (OF EYES, LIPS), BEING PARADOXICALLY AGGRAVATED",angioedema aggravated,ANGIOEDEMA AGGRAVATED,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10048331,10002424,10048331
LOWER LIMB EDEMA,Oedema peripheral,EDEMA LOWER LIMB,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030109,10030124,10014232
PYOGENIC SPONDYLITIS AND ILIOPSOAS MUSCLE ABSCESS,psoas abscess,PSOAS ABSCESS,PSOAS ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,MUSCLE AND SOFT TISSUE INFECTIONS,10021881,10056517,10056517,10056517
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
"ALTHOUGH 3 CYCLES OF G-SOX WERE ADMINISTERED, HIS DYSPHAGIA WORSENED",Dysphagia,DYSPHAGIA AGGRAVATED,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10048359,10013950,10048359
HHV-6 VIREMIA,Viremia,VIREMIA,VIRAEMIA,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10054688,10058874,10054688
CORONARY ANEURYSM WAS OBSERVED IN CONTEXT OF INADEQUATE EFFECT/ CORONARY ANEURYSM WAS OBSERVED 20 DAYS AFTER THE INITIAL SYMPTOMS.,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HEPARIN INDUCED INTRAPERITONEAL BLEEDING,peritoneal bleeding,PERITONEAL BLEEDING,PERITONEAL HAEMORRHAGE,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL HAEMORRHAGES,10017947,10071861,10034666,10071861
DRUG INTERACTION BETWEEN CITALOPRAM AND ONDANSETRON,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
BILATERAL CHOANAL ATRESIA,choanal atresia,CHOANAL ATRESIA,CHOANAL ATRESIA,RESPIRATORY DISORDERS CONGENITAL,PHARYNGEAL DISORDERS CONGENITAL,10010331,10008587,10008587,10008587
ACUTE OXYGEN DEFICIENCY,Hypoxia,HYPOXIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021143,10021143,10021143
GENERALISED EPILEPTIC INSULT,Generalised tonic-clonic seizure,GENERALISED TONIC-CLONIC SEIZURE,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10018100,10018100,10018100
KLEBSIELLA FOLLICULITIS,Klebsiella infection,KLEBSIELLA INFECTION,KLEBSIELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10061259,10061259,10061259
SINUS TACHYCARDIA,sinus tachycardia,SINUS TACHYCARDIA,SINUS TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040752,10040752,10040752
INADEQUATE ADMINISTRATION OF STRESS DOSES OF HYDROCORTISONE,inappropriate dose of drug administered,INAPPROPRIATE DOSE OF DRUG ADMINISTERED,INCORRECT DOSE ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021590,10064355,10021590
LOW LEUKOCYTE COUNT (3.3 THOUSAND/ML),White blood cell count decreased,WHITE BLOOD CELL COUNT LOW,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10051617,10047942,10051617
"TREATMENT FAILURE IN A RETROSPECTIVE, MULTI-CENTER COHORT STUDY OF 310 PATIENTS, ONE ADULT PATIENT WAS DESCRIBED,",Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
CREATININE INCREASED (6.9 MG/DL),Blood creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
GRADE 1 BILATERAL NEPHROCALCINOSIS,Nephrocalcinosis,NEPHROCALCINOSIS,NEPHROCALCINOSIS,UROLITHIASES,RENAL LITHIASIS,10038359,10029146,10029146,10029146
DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION,Disseminated Bacillus Calmette-Guerin infection,DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION,DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10076666,10076666,10076666
VACCINATION FAILURE LEADING TO INFLUENZA INFECTION,Vaccination failure leading to influenza infection,VACCINATION FAILURE,VACCINATION FAILURE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,VACCINATION RELATED COMPLICATIONS,10022117,10046862,10046862,10046862
"APATIC HYPOBULIC SYNDROME WITH HYPODYNAMOGENIA, BRADYPSYCHISM, SOCIAL FUNCTION IMPAIREMENT, ANHEDONIA AND HYPOENERGY/APATHETIC-HYPOBULIC SYNDROME",Mental function decreased,MENTAL FUNCTION DECREASED,MENTAL IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10027372,10027374,10027372
EDEMA,edema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014210,10030095,10014210
PRESSURED SPEECH,Pressure of speech,PRESSURE OF SPEECH,PRESSURE OF SPEECH,COMMUNICATION DISORDERS AND DISTURBANCES,SPEECH ARTICULATION AND RHYTHM DISTURBANCES,10037175,10036649,10036649,10036649
ANOREXIA,anorexia nervosa,ANOREXIA NERVOSA,ANOREXIA NERVOSA,EATING DISORDERS AND DISTURBANCES,EATING DISORDERS NEC,10037175,10002649,10002649,10002649
BILATERAL HYDRONEPHROSIS,Bilateral hydronephrosis,BILATERAL HYDRONEPHROSIS,HYDRONEPHROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL OBSTRUCTIVE DISORDERS,10038359,10004564,10020524,10004564
REDUCTION IN SERUM CONCENTRATION OF CLOZAPINE FOLLOWING COADMINISTRATION,Antipsychotic drug level decreased,ANTIPSYCHOTIC DRUG LEVEL DECREASED,ANTIPSYCHOTIC DRUG LEVEL DECREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10072426,10072426,10072426
RASH ON FACE AND BODY,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
NEUROLOGIC EXAMINATION WAS NOTABLE FOR ASTERIXIS AND BRISK REFLEXES,Neurologic examination was notable for asterixis and brisk reflexes,REFLEX TEST ABNORMAL,REFLEX TEST ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10068273,10068273,10068273
EROSION OF THE UVULA,Uvulitis,UVULITIS,UVULITIS,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE DISORDERS NEC,10017947,10051962,10051962,10051962
PREMATURE BIRTH,Premature birth,PREMATURE BIRTH,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036594,10036590,10036594
"DRUG EXPOSURE DURING PREGNANCY,IMMUNOSUPPRESSIVE TREATMENT OF PREDNISONE 10 MG AND TACROLIMUS 6 MG DAILY WAS NOT MODIFIED THROUGH PREGNANCY",Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
LOWER LEG OEDEMA,lower leg oedema,LOWER LEG OEDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10078346,10030124,10078346
AGGRESSIVE EBV POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCLS) NON-GERMINAL CENTRE DUE TO RICHTER TRANSFORMATION DRIVEN BY EPSTEIN-BARR VIRUS REACTIVATION,Diffuse large B-cell lymphoma,DIFFUSE LARGE B-CELL LYMPHOMA,DIFFUSE LARGE B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,DIFFUSE LARGE B-CELL LYMPHOMAS,10029104,10012818,10012818,10012818
SEVERAL BLEEDING EPISODES,Bleeding,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10005103,10055798,10005103
LOQUACIOUS FOLLOWING DRUG POISOINING,Logorrhoea,TALKATIVENESS,LOGORRHOEA,COMMUNICATION DISORDERS AND DISTURBANCES,SPEECH AND LANGUAGE USAGE DISTURBANCES,10037175,10043111,10024796,10043111
CHAGASIC HYPODERMITIS DUE TO REACTIVATION OF CHAGAS DISEASE,American trypanosomiasis,CHAGAS DISEASE RECURRENT,AMERICAN TRYPANOSOMIASIS,PROTOZOAL INFECTIOUS DISORDERS,TRYPANOSOMAL INFECTIONS,10021881,10066500,10001935,10066500
NON-PRODUCTIVE COUGH,Cough nonproductive,COUGH NONPRODUCTIVE,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011229,10011224,10011229
DECREASED ORAL INTAKE,Hypophagia,ORAL INTAKE REDUCED,HYPOPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10063889,10063743,10063889
DRUG INTOLERANCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
TEMPERATURE ELEVATION UP TO UNTIL 39 C,Body temperature increased,TEMPERATURE ELEVATION,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10043204
TWO PHARMACOLOGICAL TRIALS HAD FAILED OWING TO SEVERE EXTRAPYRAMIDAL EFFECTS,Drug-induced extrapyramidal side effects,DRUG-INDUCED EXTRAPYRAMIDAL SIDE EFFECTS,EXTRAPYRAMIDAL DISORDER,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10013760,10015832,10013760
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
ELEVATED D-DIMER AT >10000 NG/ML,Fibrin D dimer increased,FIBRIN D DIMER INCREASED,FIBRIN D DIMER INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10016581,10016581,10016581
SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME,severe acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
HIS WEIGHT AND LENGTH PERCENTILES WAS LOW,Body height below normal,BODY HEIGHT BELOW NORMAL,BODY HEIGHT BELOW NORMAL,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10056811,10056811,10056811
REFRACTORY TO AEDS,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
SERUM TROPONIN WAS ELEVATED,Troponin increased,TROPONIN INCREASED,TROPONIN INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10058267,10058267,10058267
IMMEDIATE ALLERGIC REACTION TO AMOXICILLIN/CLAVULANIC ACID,Immediate hypersensitivity reaction,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
RESPIRATORY DISTRESS SYNDROME,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
BLEEDING,Haemorrhage,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10005103
RAPIDLY PROGRESSIVE OPTIC NEURITIS FOLLOWING LACK OF DRUG EFFECT,Optic neuritis,OPTIC NEURITIS,OPTIC NEURITIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OPTIC NERVE DISORDERS NEC,10029205,10030942,10030942,10030942
MUSCLE PAIN,Myalgia,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028322
TRANSIENT LEUKOPENIA (LEUKOCYTE COUNT NOS) FOLLOWING OFF LABEL USE,Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
PETECHIAE  IN  THE  LOWER  EXTREMITIES,Petechiae,PETECHIAE,PETECHIAE,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10034754,10034754,10034754
KETOSIS,Ketosis,KETOSIS,KETOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023391,10023391,10023391
RBBB,RBBB,RBBB,BUNDLE BRANCH BLOCK RIGHT,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10037920,10006582,10037920
RED SKIN LESIONS LOCALISED IN THE ARMS AND LEGS WITH NECROTIC CENTRAL AREA,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
SELF HARMING BEHAVIOUR,Intentional self-injury,DELIBERATE SELF-HARM,INTENTIONAL SELF-INJURY,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10022524,10022524,10012213
MILD HYPEREMIA OF PHARYNX WITH CLEAR NOSE SECRETION,Rhinorrhoea,NASAL DISCHARGE,RHINORRHOEA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10028737,10039101,10028737
MILD RASH,mild rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
HYPERGLYCAEMIA (IN THE 300 MG/DL RANGE),Hyperglycaemia,HYPERGLYCAEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020635
IGE-MEDIATED HYPERSENSITIVITY,Type I hypersensitivity,TYPE I HYPERSENSITIVITY,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10045240,10045240,10045240
SCARS AND PSEUDOPOLYPS ON THE TRANSVERSE AND LEFT COLON FOLLOWING CLOSTRIDIUM DIFFICILE INFECTION,Pseudopolyp,PSEUDOPOLYP,PSEUDOPOLYP,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10056626,10056626,10056626
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
HAEMORRHAGIC LIVER NECROSIS,Haemorrhage,HAEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10055798
AGGRAVATION OF THYROID FUNCTION,Hypothyroidism,THYROID FUNCTION DECREASED,HYPOTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPOFUNCTION DISORDERS,10014698,10043727,10021114,10043727
HEMOGLOBINURIA,Haemoglobinuria,HEMOGLOBINURIA,HAEMOGLOBINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018906,10018906,10019489
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
EMOTIONAL ADR,Emotional disorder,EMOTIONAL DISORDER,EMOTIONAL DISORDER,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10014551,10014551,10014551
CEFUROXIME-INDUCED LUPUS ERYTHEMATOSUS (DILE),Lupus-like syndrome,DRUG-INDUCED LUPUS ERYTHEMATOSUS,LUPUS-LIKE SYNDROME,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),LUPUS ERYTHEMATOSUS (INCL SUBTYPES),10028395,10013706,10050551,10013706
BENZODIAZEPINE WITHDRAWAL MAY HAVE BEEN CONTRIBUTING TO THE PATIENT'S DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
LACK OF DRUG EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
ACUTE KIDNEY INJURY DUE TO ACUTE URINARY RETENTION,acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
DRUG-INDUCED HYPERSENSITIVITY,hypersensitivity,HYPERSENSITIVITY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020751,10020751,10020751
FREQUENCY WEIGHT LOSS,weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
SEVERE CLOSTRIDIUM DIFFICILE ENTEROCOLITIS,Clostridium difficile colitis,CLOSTRIDIUM DIFFICILE COLITIS,CLOSTRIDIUM DIFFICILE COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10009657,10009657,10009657
METHEMOGLOBINEMIA,methemoglobinemia,METHEMOGLOBINEMIA,METHAEMOGLOBINAEMIA,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10027506,10027496,10027506
METASTASES TO CENTRAL NERVOUS SYSTEM,Metastases to central nervous system,METASTASES TO CENTRAL NERVOUS SYSTEM,METASTASES TO CENTRAL NERVOUS SYSTEM,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10059282,10059282,10059282
HYPOGAMMAGLOBULINEMIA,Hypogammaglobulinaemia,HYPOGAMMAGLOBULINEMIA,HYPOGAMMAGLOBULINAEMIA,IMMUNODEFICIENCY SYNDROMES,PRIMARY IMMUNODEFICIENCY SYNDROMES,10021428,10020983,10020983,10054427
HYPOKALEMIC QUADRIPLEGIA,quadriplegia,QUADRIPLEGIA,QUADRIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10037714,10037714,10037714
DE NOVO HEPATOCELLULAR CARCINOMA,Hepatocellular carcinoma,HEPATOCELLULAR CARCINOMA,HEPATOCELLULAR CARCINOMA,HEPATOBILIARY NEOPLASMS MALIGNANT AND UNSPECIFIED,HEPATIC NEOPLASMS MALIGNANT,10029104,10073071,10073071,10073071
BONE EXPOSURE,Exposed bone in jaw,EXPOSED BONE IN JAW,EXPOSED BONE IN JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10071014,10071014,10071014
POST INFLAMMATORY HYPERPIGMENTATION,Post inflammatory pigmentation change,POST INFLAMMATORY HYPERPIGMENTATION,POST INFLAMMATORY PIGMENTATION CHANGE,PIGMENTATION DISORDERS,PIGMENTATION CHANGES NEC,10040785,10036260,10036229,10036260
DEVELOPED ANTI-DRUG ANTIBODIES TO ADALIMUMAB,Drug specific antibody present,DRUG SPECIFIC ANTIBODY PRESENT,DRUG SPECIFIC ANTIBODY PRESENT,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013745,10013745,10013745
HYPOGLYCAMIEA WITH UNCONSCIOUSNESS/ LOSS OF CONSCIOUSNESS,Loss of consciousness,UNCONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10045481
DECOMPENSATION OF DIABETES MELLITUS WITH OCCASIONAL BLOOD GLUCOSE LEVELS OF > 20 MMOL/L,Diabetic metabolic decompensation,DIABETIC METABOLIC DECOMPENSATION,DIABETIC METABOLIC DECOMPENSATION,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEC,10027433,10074309,10074309,10074309
MARKEDLY TORPID PERISTALSIS,bowel peristalsis decreased,BOWEL PERISTALSIS DECREASED,GASTROINTESTINAL HYPOMOTILITY,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10052537,10052105,10052537
FLUCONAZOLE USED FOR TREATMENT OF ESOPHAGEAL CANDIDIASIS,Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
PAIN AND BLURRY VISION IN THE RIGHT EYE,Vision blurred,VISION BLURRED,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047513,10047513,10047513
EPISODES OF BLANK STARING/ STARE OFF WITH HER EYES HALF-CLOSED,Staring,STARING,STARING,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10041953,10041953,10041953
PAIN,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
OLMESARTAN-INDUCED ENTEROPATHY,sprue-like enteropathy,SPRUE-LIKE ENTEROPATHY,SPRUE-LIKE ENTEROPATHY,MALABSORPTION CONDITIONS,MALABSORPTION SYNDROMES,10017947,10079622,10079622,10079622
MALNUTRITION,malnutrition,MALNUTRITION,MALNUTRITION,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10061273,10061273,10061273
DIZZINESS ON STANDING,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
TRICUSPID (GRADE2) VALVE INSUFFICIENCY,Tricuspid valve incompetence,TRICUSPID INSUFFICIENCY,TRICUSPID VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,TRICUSPID VALVULAR DISORDERS,10007541,10044640,10044640,10044635
"TWO MONTHS LATER, THE PATIENT ALSO REPORTED PAIN WITH SIMILAR CHARACTERISTICS IN HIS LEFT HAND","Two months later, the patient also reported pain with similar characteristics in his left hand",PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
"IN CHEST COMPUTED TOMOGRAPHY (CT) SCAN, MULTIPLE FOCAL AREA IN BILATERAL PARENCHYMAL CONSOLIDATION WITH SURROUNDING GROUND GLASS OPACITY WERE SEEN",Ground glass opacity in thoracic CT,GROUND GLASS OPACITY IN THORACIC CT,COMPUTERISED TOMOGRAM THORAX ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10072879,10057799,10072879
DRUG INTERACTION OF ANTIRETROVIRAL DRUGS WITH FLUTICASONE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
HEADACHES,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
LETHARGIC,Lethargic,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024262,10024264,10024262
HYPERTENSION/SEVERE RIGHT VENTRICULAR HYPERTENSION,Right ventricular hypertension,RIGHT VENTRICULAR HYPERTENSION,RIGHT VENTRICULAR HYPERTENSION,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10074301,10074301,10074301
ACUTE KIDNEY INJURY,Acute Kidney Injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
INTERACTION OF STATINS WITH ANTIPSYCHOTIC DRUGS AND BENZODIAZEPINES,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
LEFT BUNDLE BRANCH BLOCK,Bundle branch block left,LEFT BUNDLE BRANCH BLOCK,BUNDLE BRANCH BLOCK LEFT,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10006580,10006580,10024100
LETHARGY,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
YAWNING,Yawning,YAWNING,YAWNING,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10048232,10048232,10048232
BRONCHOALVEOLAR LAVAGE FLUID CULTURES WERE POSITIVE FOR ESCHERICHIA COLI AND CANDIDA ALBICANS,Escherichia coli infection,ESCHERICHIA COLI INFECTION,ESCHERICHIA INFECTION,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10054242,10061126,10054242
MYALGIA IN RIGHT THIGH REGION,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
"MINIMAL EROSIONS ON THE BUCCAL MUCOSA, SOFT PALATE AND LIPS WITH ATROPHIC GLOSSITIS",atrophic glossitis,ATROPHIC GLOSSITIS,ATROPHIC GLOSSITIS,TONGUE CONDITIONS,TONGUE DISORDERS,10017947,10069085,10069085,10069085
ELEVATED BLOOD PRESSURE (180/110 MMHG),blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
METASTASES TO THE LEFT LUNG WITH INVOLVEMENT OF THE SUPRACLAVICULAR LYMPH NODES ON THE LEFT SIDE,Metastases to lung,METASTASES TO LUNG,METASTASES TO LUNG,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027458,10027458,10027458
FASCICULAR VENTRICULAR TACHYCARDIA DUE TO DIGITALIS TOXICITY,ventricular tachycardia,VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047302,10047302,10047302
HEMORRHAGIC NECROSIS OF THE ADRENAL GLANDS,Adrenal cortical necrosis,ADRENAL CORTICAL NECROSIS,ADRENAL CORTEX NECROSIS,ADRENAL GLAND DISORDERS,ADRENAL GLAND DISORDERS NEC,10014698,10001345,10001337,10001345
CLOZAPINE-INDUCED RESTLESS LEGS SYNDROME,Restless legs syndrome,RESTLESS LEGS SYNDROME,RESTLESS LEGS SYNDROME,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10058920,10058920,10058920
DOMPERIDONE WAS NOT EFFECTIVE IN CONTROLLING THE NAUSEA,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
SEVERE POSTERIOR NECK PAIN,neck pain,NECK PAIN,NECK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10028836,10028836,10028836
BREATHLESSNESS,breathlessness,BREATHLESSNESS,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10006345,10013968,10006345
ISOLATION,Loneliness,LONELINESS,PSYCHIATRIC SYMPTOM,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,PSYCHIATRIC SYMPTOMS NEC,10037175,10024799,10061472,10024799
GASTROINTESTINAL DISORDER,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
DEPRESSED MOOD,Depressed mood,DEPRESSED MOOD,DEPRESSED MOOD,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10012374,10012374,10012374
MULTIPLE OPEN AREAS OF DESQUAMATION/SLOUGHING,Skin exfoliation,DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10012528,10040844,10012528
ATAXIC,ataxic,ATAXIC,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003596,10003591,10003596
HYPONATREMIA,hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
AGRANULOCYTOSIS,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
HAND ANGIOEDEMA,Angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
BLOOD PRESSURE INCREASED (220/45 MMHG),Blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
PATIENT TREATED WITH FLUDARABINE AS LYMPHODEPLETING CONDITIONING REGIMEN WITH NO ADR (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"DISHEVELED, AND ORIENTED ONLY TO SELF",Disorientation,DISORIENTATED,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013394
TYPE I HYPERSENSITIVITY REACTION,Type I hypersensitivity,TYPE I HYPERSENSITIVITY,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10045240,10045240,10045240
MYALGIA,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
PROGRESSION OF GASTROINTESTINAL SYMPTOMS TO ACUTE HEPATIC FAILURE,acute hepatic failure,ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10000804
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
RESIDUAL NEUROMUSCULAR BLOCKADE,Neuromuscular blockade,NEUROMUSCULAR BLOCKADE,NEUROMUSCULAR BLOCKADE,NEUROMUSCULAR DISORDERS,NEUROMUSCULAR JUNCTION DYSFUNCTION,10029205,10029315,10029315,10029315
MORBILLIFORM DRUG ERUPTION,Rash morbilliform,MORBILLIFORM ERUPTION,RASH MORBILLIFORM,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037870,10037870,10027967
ERYTHEMATOUS OEDEMATOUS PLAQUE,Erythema,ERYTHEMA OEDEMATOUS,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015236,10015150,10015236
"WE ASSOCIATED CLOPIDOGREL 0.2 MG/KG/DAY TO ASPIRIN, WITH NO RESULT, ANEURYSM AND THROMBUS INCREASING/ DEVELOPED SEVERE CORONARY COMPLICATIONS DESPITE IGIV",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
ATRIAL FIBRILLATION PAROXYSMAL,atrial fibrillation paroxysmal,ATRIAL FIBRILLATION PAROXYSMAL,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003661,10003658,10003661
PAINFUL RASH ON PALMS AND SOLES,Rash,PAINFUL RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10074762,10037844,10074762
ABNORMAL MOVEMENTS WITH DONEPEZIL IN ALZHEIMER DISEASE/ABNORMAL MOVEMENTS OF THE LOWER LIMBS,Dyskinesia,MOVEMENTS ABNORMAL,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028039,10013916,10028039
APPETITE INCREASED,Increased appetite,INCREASED APPETITE,INCREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10021654,10021654,10021654
ESOPHAGITIS,Esophagitis,ESOPHAGITIS,OESOPHAGITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,OESOPHAGITIS (EXCL INFECTIVE),10017947,10015461,10030216,10015461
RETROBULBAR OPTIC NEURITIS,Optic neuritis,OPTIC NEURITIS RETROBULBAR,OPTIC NEURITIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OPTIC NERVE DISORDERS NEC,10029205,10030945,10030942,10030945
ELECTROLYTE ABNORMALITIES,electrolyte abnormalities,BLOOD ELECTROLYTES ABNORMAL,BLOOD ELECTROLYTES ABNORMAL,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",WATER AND ELECTROLYTE ANALYSES NEC,10022891,10061014,10061014,10061014
CYTOKINE RELEASE SYNDROME,Cytokine release syndrome,CYTOKINE RELEASE SYNDROME,CYTOKINE RELEASE SYNDROME,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10052015,10052015,10052015
LATE-ONSET NON-INFECTIOUS PULMONARY COMPLICATIONS,Lung disorder,LUNG DISORDER,LUNG DISORDER,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10025082,10025082,10025082
NEUTROPHIL COUNT INCREASED (160%),Neutrophil count increased,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029368,10029368,10029368
CREATININE INCREASED (4.92 MG/DL),Blood creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
ALUMINUM TOXICITY FOLLOWING SUCRALFATE ADMINISTRATION,Metal poisoning,METAL POISONING,METAL POISONING,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10027439,10027439,10027439
PARTIAL HYDATIDIFORM MOLE FOLLOWING DRUG EXPOSURE IN UTERO,Benign hydatidiform mole,HYDATIDIFORM MOLE,BENIGN HYDATIDIFORM MOLE,REPRODUCTIVE NEOPLASMS FEMALE BENIGN,REPRODUCTIVE NEOPLASMS FEMALE BENIGN NEC,10029104,10020481,10004272,10020481
TRANSAMINASES INCREASED,Transaminases increased,TRANSAMINASES INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054889,10054889,10054889
BREAKTHROUGH DISEASE ACTIVITY,breakthrough disease activity,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
CANDIDA ALBICANS INFECTION,candida albicans infection,CANDIDA ALBICANS INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10054230,10074170,10054230
EXPRESSIVE APHASIA,Aphasia,EXPRESSIVE APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10015713,10002948,10015713
TRANSITORY MILD LOSS OF APPETITE,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
SEVERE MS,severe multiple sclerosis,MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,DEMYELINATING DISORDERS,MULTIPLE SCLEROSIS ACUTE AND PROGRESSIVE,10029205,10028245,10028245,10028245
QUEASY,Nausea,QUEASY,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10037730,10028813,10037730
DEATH,death,DEATH,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10011906,10011906,10011906
HEART RATE 120 BEATS/MIN,Heart rate increased,HEART RATE HIGH,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019302,10019303,10019302
BODY WEIGHT INCREASE,Weight increased,WEIGHT INCREASED,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047899
ALANINE AMINOTRANSFERASE INCREASED ( 88.6 U/L),Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
FATAL THROMBOEMBOLIC EVENTS,Embolism,THROMBOEMBOLIC EVENT,EMBOLISM,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10043566,10061169,10043565
SEVERE ACUTE AXONAL NEUROPATHY INDUCED BY CIPROFLOXACIN (GBS PHENOTYPE),axonal neuropathy,AXONAL NEUROPATHY,AXONAL NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10003882,10003882,10003882
PRONOUNCED DECREASE IN WBC COUNT (0.48 Ã— 109/L,White blood cell count decreased,WBC DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056731,10047942,10056731
WRIST PAIN,Arthralgia,WRIST PAIN,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10048692,10003239,10048692
DYSMICROBISM,Dysbacteriosis,INTESTINAL BACTERIA FLORA DISTURBANCE,DYSBACTERIOSIS,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10066382,10064389,10066382
CONGESTION,Congestion pulmonary,CONGESTION PULMONARY,PULMONARY CONGESTION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10010680,10037368,10010680
BILIARY PANCREATITIS DUE TO REVERSIBLE SYMPTOMATIC BILIARY OBSTRUCTION ASSOCIATED WITH CEFTRIAXONE PSEUDOLITHIASIS,Pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
SKIN SWELLING,Skin swelling,SKIN SWELLING,SKIN SWELLING,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10053262,10053262,10053262
GROUND GLASS OPACITIES,Chest X-ray abnormal,GROUND GLASS OPACITY ON CHEST X-RAY,CHEST X-RAY ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10072880,10008499,10072880
AN ELEVATED SERUM LEVEL CREATININE,Blood creatinine increased,CREATININE HIGH,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011367,10005483,10011367
SYSTEMIC CHEMOTHERAPY WAS STARTED ON THE 27TH WEEK OF GESTATION,Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
PATIENT TREATED WITH RIBAVIRIN FOR HEPATITIS E (OFF LABEL USE FOR INDICATION) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FACE PAIN,Facial pain,FACIAL PAIN,FACIAL PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10016059,10016059,10016059
HYPERVIGILANT,hypervigilant,HYPERVIGILANCE,HYPERVIGILANCE,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,PSYCHIATRIC SYMPTOMS NEC,10037175,10048533,10048533,10048533
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
TRANSIENT MODERATELY ELEVATED LEVELS OF LIVER ENZYMES,Hepatic enzyme increased,ELEVATED LIVER ENZYME LEVELS,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014480,10060795,10014480
PRIAPISM,Priapism,PRIAPISM,PRIAPISM,SEXUAL FUNCTION AND FERTILITY DISORDERS,ERECTION AND EJACULATION CONDITIONS AND DISORDERS,10038604,10036661,10036661,10036661
ANXIETY,anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
PREDIABETES,Glucose tolerance impaired,PREDIABETES,GLUCOSE TOLERANCE IMPAIRED,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10065542,10018429,10065542
"DESPITE INTENSIVE CONSERVATIVE TREATMENT, THE FULMINANT SEPTIC PROCESS COULD NOT BE STOPP",Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
DIFFICULTRY WITH ABILITY TO MULTITASK,difficultry with ability to multitask,INABILITY TO WORK,IMPAIRED WORK ABILITY,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10076939,10052302,10076939
 normal(155-357 umol/L),2018-03-27 00:00:00,1,,,,METABOLISM TESTS NEC,10050450,10005861,
"A WIDESPREAD MUCOSAL DEFECT, ULCERATION WITH A WHITE COAT",Mucosal ulceration,MUCOSAL ULCERATION,MUCOSAL ULCERATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028124,10028124,10028124
HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
MILD ACUTE PANCREATITIS,Pancreatitis acute,ACUTE PANCREATITIS,PANCREATITIS ACUTE,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033647,10033647,10000971
IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY,Idiosyncratic drug-induced liver Injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
INTRACRANIAL BLEED,Haemorrhage intracranial,INTRACRANIAL HEMORRHAGE,HAEMORRHAGE INTRACRANIAL,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10018985,10018985,10022763
BREATHING PROBLEMS DUE TO SPINE DEFROMATION,Dyspnoea,DIFFICULTY BREATHING,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10012791
MUSCLE NECROSIS,muscle necrosis,MUSCLE NECROSIS,MUSCLE NECROSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10028320,10028320,10028320
ABDOMINAL PAIN,abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
METEORISM,Flatulence,METEORISM,FLATULENCE,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10016766,10016766,10027493
RAYNAUD'S PHENOMENON ON HER HANDS WAS OBSERVED,Raynaud's phenomenon,RAYNAUD'S PHENOMENON,RAYNAUD'S PHENOMENON,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10037912,10037912,10037912
CELLULITIS IN THE FOOT  FOLLOWING SECONDARY HYPOGAMMAGLOBULINEMIA DUE TO RECEIVING IMMUNOSUPPRESSANTS,Cellulitis,CELLULITIS OF FOOT,CELLULITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10007911,10007882,10007911
PATIENT UNDERWENT EMERGENCY CESAREAN SECTION AT 34 WEEKS BECAUSE OF NON-REASSURING FETAL STATUS,Premature delivery,PREMATURE DELIVERY,PREMATURE DELIVERY,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036595,10036595,10036595
ASCITES,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
RECURRENT MINIMAL CHANGE DISEASE AND ACUTE TUBULAR NECROSIS FROM NSAID USE,Renal tubular necrosis,ACUTE TUBULAR NECROSIS,RENAL TUBULAR NECROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL VASCULAR AND ISCHAEMIC CONDITIONS,10038359,10001099,10038540,10001099
ANTI YELLOW FEVER VIRUS IMMUNOGLOBULIN G ANTIBODY NEGATIVE,antibody test negative,ANTIBODY TEST NEGATIVE,ANTIBODY TEST NEGATIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOLOGY ANALYSES NEC,10022891,10061426,10061426,10061426
INAPPROPRIATE DOSING AND DRUG-DRUG INTERACTIONS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
DIGOXIN TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE (SIADH),Inappropriate antidiuretic hormone secretion,SIADH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,POSTERIOR PITUITARY DISORDERS,10014698,10040626,10053198,10040626
DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,Systemic inflammatory response syndrome,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10051379,10051379,10051379
SIMVASTATIN WAS INVOLVED IN THE HIGHEST NUMBER OF POTENTIAL DDIS WITH WARFARIN,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
SINUS TACHYCARDIA,SINUS TACHYCARDIA,SINUS TACHYCARDIA,SINUS TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040752,10040752,10040752
ANAEMIA,anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
SEVERE FLUPIRTINE-INDUCED LIVER INJURY/ SEVERE IDIOSYNCRATIC DRUG INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
INCREASED GAMMA-GLUTAMYLTRANSFERASE,Gamma-glutamyltransferase increased,GAMMA-GLUTAMYLTRANSFERASE INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10017693,10017693,10017693
TOTAL BILIRUBIN (370.3 MICROMOL/L),Blood bilirubin increased,BILIRUBIN TOTAL INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056806,10005364,10056806
POSTOPERATIVE NAUSEA,Procedural nausea,POSTOPERATIVE NAUSEA,PROCEDURAL NAUSEA,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,GASTROINTESTINAL AND HEPATOBILIARY PROCEDURAL COMPLICATIONS,10022117,10028818,10066962,10036285
BACLOFEN WITHDRAWAL,Drug withdrawal syndrome,DRUG WITHDRAWAL SYNDROME,DRUG WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10013754,10013754,10013754
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
AGRANULOCYTOSIS,Agranulocytosis,ANGINA AGRANULOCYTIC,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10002374,10001507,10002374
PUPILS SLUGGISH TO REACT/PUPILS WERE DILATED AND SLUGGISH TO REACT,Pupillary reflex impaired,LIGHT REFLEX SLUGGISH,PUPILLARY REFLEX IMPAIRED,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10024463,10037532,10024463
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
LEUKEMIA SECONDARY TO ONCOLOGY CHEMOTHERAPY,Leukaemia,LEUKEMIA SECONDARY TO ONCOLOGY CHEMOTHERAPY,LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS NEC,10029104,10060395,10024288,10048293
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
ACUTE TOXIC PSYCHOSIS,Substance-induced psychotic disorder,DRUG-INDUCED PSYCHOSIS,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10013708,10072388,10013708
ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
HYPONATREMIA,Hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
DYSMORPHIC FEATURES,dysmorphism,DYSMORPHISM,DYSMORPHISM,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL DISORDERS CONGENITAL NEC,10010331,10066054,10066054,10066054
MYCOPHENOLATE MOFETIL AND HYDROXYCHLOROQUINE USED TO TREAT ANTI-MDA5-POSITIVE AMYOPATHIC DERMATOMYOSITIS (OFF LABEL USE WITH NO ADVERSE EVENT),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
NO ADVERSE EVENT,HIV viraemia,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
PANCYTOPENIA,pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
PATHOLOGICAL FRACTURE IN THE AREA OF THE LEFT FEMORAL BONE,Pathological fracture,PATHOLOGIC FRACTURE OF FEMUR,PATHOLOGICAL FRACTURE,FRACTURES,FRACTURES NEC,10028395,10070180,10034156,10070180
ACUTE ESOPHAGEAL NECROSIS/ULCERO-NECROTIC ASPECT OF ESOPHAGEAL MUCOSA SLIGHT REDUCTION OF FLOGOSIS,Necrotising oesophagitis,ESOPHAGEAL NECROSIS,NECROTISING OESOPHAGITIS,GASTROINTESTINAL ULCERATION AND PERFORATION,OESOPHAGEAL ULCERS AND PERFORATION,10017947,10065737,10055668,10065727
HEMORRHAGIC CRUSTS,Scab,CRUST,SCAB,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10039509,10039509,10011468
TACHYPNEA,tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
LETHARGIC,Lethargy,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024262
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,Palmar-plantar erythrodysaesthesia syndrome,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10033553,10033553,10033553
OLIGURIA,Oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
MYCOPHENOLATE MOFETIL USED IN STEROID-DEPENDENT IDIOPATHIC NEPHROTIC SYNDROME,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
SYMPTOMATIC ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
"HEADACHE RE-OCCURED INSPITE OF TAKING VERAPAMIL, METHYLPREDNISOLONE AND PREGABALIN",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
DRUG-INDUCED KIDNEY INJURY,Renal injury,INJURY TO KIDNEY,RENAL INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10022221,10061481,10022221
WIDESPREAD SKIN ERUPTION FOLLOWING INITIATION OF HYDROXYCHLOROQUINE/ VAGUELY TARGETOID ANNULAR AREAS ON ULNAR SURFACE OF FOREARMS,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
OVERDOSE OF PROPRANOLOL,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
HEMATURIA,Haematuria,HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018867,10018867,10019450
PERSISTENT INCREASED VASOPRESSOR REQUIREMENT,Blood pressure abnormal,BLOOD PRESSURE ABNORMAL,BLOOD PRESSURE ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005728,10005728,10005728
DISEASE PROGRESSION,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
RECURRENT MINIMAL CHANGE DISEASE AND ACUTE TUBULAR NECROSIS FROM NSAID USE,Glomerulonephritis minimal lesion,MINIMAL CHANGE DISEASE,GLOMERULONEPHRITIS MINIMAL LESION,NEPHROPATHIES,GLOMERULONEPHRITIS AND NEPHROTIC SYNDROME,10038359,10058326,10018374,10058326
OXALIPLATIN-INDUCED ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
ACUTE QUININE POISONING,acute quinine poisoning,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
"PATIENT DEVELOPED A PERSISTENT RASH UNRESPONSIVE TO MULTIPLE TREATMENTS THAT INCLUDED BARRIER CREAMS, TOPICAL ANTIBIOTICS AND ANTIFUNGAL AGENTS, AND VARIOUS TOPICAL CORTICOSTEROIDS",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
SENSORY-MOTOR DEFICIT IN THE UPPER AND LOWER LIMBS,sensory deficit,SENSORY DEFICIT,SENSORY LOSS,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10061563,10040030,10061563
DISSEMINATED INTRAVASCULAR COAGULATION,Disseminated intravascular coagulation,DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10013442,10013442,10013442
NEUROPHYSIOLOGICAL CHANGES,Neurologic changes,NEUROLOGIC CHANGES,NEUROLOGICAL SYMPTOM,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10029283,10060860,10029283
ANOREXIA,ANOREXIA,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10002646,10061428,10002646
"APATIC HYPOBULIC SYNDROME WITH HYPODYNAMOGENIA, BRADYPSYCHISM, SOCIAL FUNCTION IMPAIREMENT, ANHEDONIA AND HYPOENERGY/APATHETIC-HYPOBULIC SYNDROME",Social irresponsibility,SOCIAL IRRESPONSIBILITY,ANTISOCIAL BEHAVIOUR,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10041248,10002820,10041248
DRUG RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
PALLOR,pallor,PALLOR,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033546,10033546,10033546
SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
MIXED ANION GAP FOLLOWING HIGH DOSE OF SODIUM CHLORIDE,Anion gap abnormal,ANION GAP ABNORMAL,ANION GAP ABNORMAL,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10002523,10002523,10002523
CHRONIC PRODUCTIVE COUGH,Productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
PATIENT DEVELOPED MIXED ACUTE CARDIAC ALLOGRAFT REJECTION DUE TO LACK OF DRUG EFFECT (LACK OF DRUG EFFECT),Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
VISUAL HALLUCINATIONS,"Hallucination, visual",VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019075,10019075,10047570
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
OPIOID TYPE WITHDRAWL FOLLOWING CESSATION OF EXCESSIVE LOPERAMIDE MISUSE,Intentional product misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
SWEET'S SYNDROME WORSENED DUE TO REBOUND EFFECT FOLLOWING INITIAL TAPERING OF CORTICOSTEROIDS AND LACK OF EFFECT OF INCREASED METHYLPREDNISOLONE DOSE AND CYCLOSPORINE,Acute febrile neutrophilic dermatosis,SWEET'S SYNDROME,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10042673,10000748,10042673
VASO-OCCLUSIVE CRISIS,Sickle cell anaemia with crisis,VASO-OCCLUSIVE CRISIS,SICKLE CELL ANAEMIA WITH CRISIS,HAEMOGLOBINOPATHIES,SICKLE CELL TRAIT AND DISORDERS,10005329,10072397,10040642,10072397
CEREBRAL INFARCTION,Cerebral infarction,CEREBRAL INFARCTION,CEREBRAL INFARCTION,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008118,10008118,10008118
DRUG RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
MOTHER HAD BEEN TREATED THROUGHOUT PREGNANCY WITH VALPROIC ACID AND PHENYTOIN,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
BALANCE DISORDER,balance disorder,BALANCE DISORDER,BALANCE DISORDER,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10049848,10049848,10049848
"HYPERGLYCAEMIA (183-208 MG/DL, 10.2-11.6 MMOL/L)/INCREASED GLYCEMIA BEFORE BEDTIME",Hyperglycaemia,HYPERGLYCAEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020635
OCCASIONAL CHEST PAIN BY EXERTION,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
METHOTREXATE ADMINISTERED FOR CESAREAN SCAR PREGNANCY (UNAPPROVED INDICATION)-OFF LABEL USE WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PALE SKIN,Pallor,PALE SKIN,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033550,10033546,10033533
PERSISTENT BACTERAEMIA BACTERAEMIA DESPITE TREATMENT WITH ANTIBIOTICS (DRUG INEFFECTIVE) WITH NO ADR,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
"PATIENT WAS TREATED WITH CYCLIN, AMOXICILLIN, DISULONE, RIFAMPICIN, ZINC, ISOTRETINOIN, TACROLIMUS WITHOUT ANY SUCCESS (LACK OF DRUG EFFECT)",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
INTERMITTENT ANTERIOR CHEST PAIN WITH ACUTE DYSPNEA,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
"PERCEPTUAL ABNORMALITIES-NAMELY, VISUAL, AUDITORY",visual disturbances,VISUAL DISTURBANCES,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047545,10047571,10047545
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
HYPERPOTASSEMIA,Hyperkalaemia,HYPERPOTASSEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020646,10020646,10020736
RESPIRATORY INSUFFICIENCY (TYPE 2),Respiratory insufficiency,RESPIRATORY INSUFFICIENCY,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038701,10038695,10038701
DIFFUSE TENDERNESS,Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
DID NOT HAVE DEEP SLEEP WOKE UP MANY TIMES,Sleep disorder,SLEEP DISTURBED,SLEEP DISORDER,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10040984,10040984,10040999
INAPPETENCE,Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
DRUG EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
DRUG-INDUCED PARKINSONISM,Parkinsonism,DRUG-INDUCED PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10013707,10034010,10013707
MULTIRESISTANT PSEUDOMONAS AERUGINOSA ISOLATED IN THE UROCULTURE,Urinary tract infection pseudomonal,URINARY TRACT INFECTION PSEUDOMONAL,URINARY TRACT INFECTION PSEUDOMONAL,BACTERIAL INFECTIOUS DISORDERS,PSEUDOMONAL INFECTIONS,10021881,10062279,10062279,10062279
PATIENT WAS TREATED WITH METHOTREXATE FOR MUCOPOLYSACCHARIDOSIS IVA (OFF LABEL USE FOR INDICATION WITH NO ADR),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG RESISTANCE,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
"NUMEROUS ERYTHEMATOUS, FLATTOPPED PAPULES ON THE INGUINAL FOLDS EXTENDING TO THE UPPER THIGHS, BUT NOT EXTENDING TO THE VULVA",Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
COAGULOPATHY,coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
PROTHROMBIN TIME INCREASED,Prothrombin time,PROTHROMBIN TIME,PROTHROMBIN TIME,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037056,10037056,10037056
SEPTIC SHOCK SECONDARY TO FEBRILE NEUTROPENIA,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
OROPHARYNGEAL ANGIOEDEMA,Angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
SEVERE STRICTUIRING TERMINAL ILEUM CROHN'S DISEASE,Stricture of ileum,STRICTURE OF ILEUM,ILEAL STENOSIS,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,DUODENAL AND SMALL INTESTINAL STENOSIS AND OBSTRUCTION,10017947,10042236,10021307,10042236
LACK OF DRUG EFFECT WITH LETROZOLE,lack of drug effect with letrozole,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
SEPTICEMIA FOLLOWING DESCENDING NECROTIZING MEDIASTINITIS,septicemia following descending necrotizing mediastinitis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
APLASIA CUTIS FOLLOWING DRUG EXPOSURE IN UTERO,Aplasia cutis congenita,APLASIA CUTIS CONGENITA,APLASIA CUTIS CONGENITA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL NEC,10010331,10002963,10002963,10002963
GLOBAL HYOKINETIC,Hypokinesia,HYPOKINESIA,HYPOKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10021021,10021021,10021021
EOSINOPHILIA,Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
GENERALIZED LYMPHADENOPATHY,Lymphadenopathy,GENERALIZED LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10069548,10025197,10069549
PATHOGEN RESISTANCE,Pathogen resistance,PATHOGEN RESISTANCE,PATHOGEN RESISTANCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10034133,10034133,10034133
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
"ATRIAL TACHYCARDIA AND ATRIAL FLUTTER APPEAR IN THE OPERATION. THE PACEMAKER CANNOT START NORMALLY. AFTER A SMALL DOSE OF AMIODARONE HYDROCHLORIDE IS INJECTED INTO THE VEIN, THE CARDIAC FUNCTION IS SLIGHTLY IMPROVED",off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEPATITIS CMV,Cytomegalovirus hepatitis,HEPATITIS CMV,CYTOMEGALOVIRUS HEPATITIS,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011830,10011830,10019760
LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
NSAIDS COLOPAHTY IS THE REASON FOR POSITIVE IFOBT(477.173 NG/ ML),Occult blood positive,FAECAL OCCULT BLOOD POSITIVE,OCCULT BLOOD POSITIVE,GASTROINTESTINAL INVESTIGATIONS,FAECAL ANALYSES NEC,10022891,10061880,10061880,10016095
BLOOD IN HER STOOL,blood in her stool,BLOOD IN STOOL,HAEMATOCHEZIA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10005603,10018836,10005603
AMMONIA INCREASED (216 MCG/ML),Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
MUTLIORGAN BLEEDING,Internal bleeding,INTERNAL BLEEDING,INTERNAL HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10075196,10075192,10075196
LONG Q-T INTERVAL,QT interval prolonged,QT INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037703,10014387,10037703
SIGNIFICANT FACIAL SWELLING,Facial swelling,FACIAL SWELLING,SWELLING FACE,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10016065,10042682,10016065
MELANOMA LOCALISED AT THE NECK,Malignant melanoma,MELANOMA SKIN,MALIGNANT MELANOMA,SKIN NEOPLASMS MALIGNANT AND UNSPECIFIED,SKIN MELANOMAS (EXCL OCULAR),10029104,10027155,10025650,10027155
ACUTE LIVER FAILURE,Acute liver failure,ACUTE LIVER FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10049844,10000804,10049844
THROMBOCYTOPENIA (PLATELETS 93 G/L),thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
SERUM LEVELS OLANZAPINE SHOWED A SUPRA THERAPEUTIC LEVEL,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
TENOFOVIR DRUG TROUGH CONCENTRATION BELOW THERAPEUTIC [ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC],Antiviral drug level below therapeutic,ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC,ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10059975,10059975,10059975
LARGE RETROPERITONEAL HEMATOMA,Retroperitoneal hematoma,RETROPERITONEAL HEMATOMA,RETROPERITONEAL HAEMATOMA,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL HAEMORRHAGES,10017947,10058361,10058360,10058361
DIED DUE TO A METASTATIC BLADDER CANCER,Metastatic carcinoma of the bladder,METASTATIC CARCINOMA OF THE BLADDER,METASTATIC CARCINOMA OF THE BLADDER,RENAL AND URINARY TRACT NEOPLASMS MALIGNANT AND UNSPECIFIED,BLADDER NEOPLASMS MALIGNANT,10029104,10057352,10057352,10057352
"SEIZURES CONTINUED DESPITE OF LEVETIRACETAM, PHENOBARBITAL AND MIDAZOLAM INFUSION",Therapy non-responder,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
LEFT VENTRICULAR EJECTION FRACTION DECREASED,Ejection fraction decreased,LEFT VENTRICULAR EJECTION FRACTION DECREASED,EJECTION FRACTION DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10053222,10050528,10053222
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
REDUCED ORAL INTAKE,Hypophagia,ORAL INTAKE REDUCED,HYPOPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10063889,10063743,10063889
LUNG INFECTIONS RECURRENT,Lung infection,LUNG INFECTION,LUNG INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10061229,10061229,10061229
HAVING A HIGH RISK OF GASTROINTESTINAL TRACT BLEEDING/ GASTROINTESTINAL BLEEDING,Gastrointestinal haemorrhage,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017936
LIVER ENLARGEMENT,Hepatomegaly,LIVER ENLARGEMENT,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10024676
POLYCYTHEMIA VERA TREATED WITH ASPIRIN,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CHOREATIC HYPERKINESIA,Hyperkinesia,HYPERKINESIA,HYPERKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10020651,10020651,10020651
"EPILEPTIC CRISIS/SHE WAS TREATED WITH LAMOTRIGINE, CLONAZEPAM AND LEVOMEPROMAZINA MALEATO",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
GRADE 4 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
OPPORTUNISTIC INFECTIONS FOLLOWING IMMUNOSUPPRESSIVE THERAPIES,Opportunistic infection,OPPORTUNISTIC INFECTION,OPPORTUNISTIC INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10030901,10030901,10030901
PRURITIC RASH,pruritic rash,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037085,10037884,10037085
CONSCIOUSNESS SUDDENLY CHANGED INTO STUPOR (GLASGOW COMA SCALE: E2M1V1),Stupor,STUPOR,STUPOR,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042264,10042264,10042264
ILEAL OBSTRUCTION,Small intestinal obstruction,ILEAL OBSTRUCTION,SMALL INTESTINAL OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,DUODENAL AND SMALL INTESTINAL STENOSIS AND OBSTRUCTION,10017947,10065730,10041101,10065730
MATERNAL EXPOSURE DURING PREGNANCY,maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
DESQUAMATIVE LESIONS WERE NOTED ON ALL MUCOSAL SURFACES,Skin exfoliation,SKIN DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040826,10040844,10040826
AKINESIA OF THE APICAL REGION,Akinesia,AKINESIA,AKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10001541,10001541,10001541
PROGRESSION OF SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
DISTURBANCE OF CONSCIOUSNESS,Consciousness disturbed,CONSCIOUSNESS DISTURBED,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010770,10001854,10010770
ADRENAL INSUFFICIENCY FOLLOWING DRUG INTERACTION,Adrenal insufficiency,ADRENAL INSUFFICIENCY,ADRENAL INSUFFICIENCY,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001367,10001367,10001367
COLCHICINE-INDUCED MYOPATHY,Myopathy,MYOPATHY,MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10028641,10028641,10028641
5-HYDROXYTRYPTAMINE3-RECEPTOR ANTAGONIST IGE-MEDIATED REACTION,hypersensitivity type I,HYPERSENSITIVITY TYPE I,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020762,10045240,10020762
PATIENT RECEIVED ASPIRIN AND CLOPIDOGREL TOGETHER,Labelled drug-drug interaction medication error,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT MONITORING ERRORS AND ISSUES,10022117,10064373,10064373,10064373
GRADE 4 ADRENAL FAILURE,adrenal failure,DYSFUNCTION ADRENAL,ADRENAL DISORDER,ADRENAL GLAND DISORDERS,ADRENAL GLAND DISORDERS NEC,10014698,10013900,10001347,10013900
PATIENT WAS INFECTED WITH AN H. PYLORI STRAIN RESISTANT TO CLARITHROMYCIN,Pathogen resistance,PATHOGEN RESISTANCE,PATHOGEN RESISTANCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10034133,10034133,10034133
ATTRIBUTED TO THE SUPRATHERAPEUTIC VALPROIC ACID LEVEL,subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
ANAPHYLACTIC SHOCK,anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
"FEELING OF BEING ""MUDDIED-UP""/FEELING OF SUPPRESSION/PERSISTENT FEELING OF SUPPRESSION",Sluggishness,SLUGGISHNESS,SLUGGISHNESS,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10041052,10041052,10041052
ELEVATED TRIGLYCERIDES,Triglycerides high,TRIGLYCERIDES HIGH,BLOOD TRIGLYCERIDES INCREASED,LIPID ANALYSES,TRIGLYCERIDE ANALYSES,10022891,10052373,10005839,10052373
INTERMITTENT EPISODES OF MILD CHOKING,choking,CHOKING,CHOKING,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10008589,10008589,10008589
SERUM CREATININE ELEVATED (2.6 MG/DL),Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
PROGRESSIVE WORSENING OF RENAL FUNCTION,Renal impairment,RENAL FUNCTION AGGRAVATED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038453,10062237,10038453
INCREASING CONFUSION,Confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
MULTIFOCAL CONFLUENT MYOCARDIAL INFARCTION WITH LEFT VENTRICULAR DYSFUNCTION AND ACUTE ISCHEMIC LESIONS,Left ventricular dysfunction,LEFT VENTRICULAR DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10049694,10049694,10049694
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
SERIAL TRYPTASE LEVELS INCREASED (46UG/L),Tryptase increased,TRYPTASE INCREASED,TRYPTASE INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOLOGY ANALYSES NEC,10022891,10063342,10063342,10063342
VERBAL ABILITY BEING SIGNIFICANTLY BELOW HIS NON-VERBAL ACTIVITY,verbal ability being significantly below his non-verbal activity,SLOW SPEECH DEVELOPMENT,SPEECH DISORDER DEVELOPMENTAL,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041046,10041467,10041046
NON SPECIFIC T WAVE CHANGES DUE TO CINCHONISM FOLLOWING INTENTIONAL DRUG ABUSE,Electrocardiogram T wave abnormal,ELECTROCARDIOGRAM T WAVE ABNORMAL,ELECTROCARDIOGRAM T WAVE ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10050380,10050380,10050380
SEVERE THROMBOCYTOPENIA (PLATELET COUNT WAS 22 X 10E9/L),thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CONGENITAL CMV INFECTION FOLLOWING DRUG EXPOSURE IN UTERO,Congenital cytomegalovirus infection,CONGENITAL CMV INFECTION,CONGENITAL CYTOMEGALOVIRUS INFECTION,INFECTIONS AND INFESTATIONS CONGENITAL,VIRAL INFECTIONS CONGENITAL,10010331,10010430,10010430,10010420
UNPRESCRIBED USAGE OF A TOPICAL STEROID,Prescription drug used without a prescription,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076639,10076639,10076639
RECEIVED DIGOXIN AND FLECAINIDE/ THE FETUS WAS EXPOSED TO FLECAINIDE AND DIGOXIN IN-UTERO DURING THE THIRD TRIMESTER OF,Foetal exposure during pregnancy,"FOETAL EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071426,10071404,10071426
CAFFEINE INTOXICATION FOR SUICIDE ATTEMPT,Suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
REDNESS AT THE INJECTION SITE,Injection site erythema,INJECTION SITE REDNESS,INJECTION SITE ERYTHEMA,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022098,10022061,10022098
PURPURA VASCULAR,Purpura vascular,PURPURA VASCULAR,VASCULAR PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037564,10047097,10037564
BASE EXCESS DECREASED (-13.4 MMOL/L),Base excess decreased,BASE EXCESS DECREASED,BASE EXCESS DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10059994,10059994,10059994
HYPOXIA,hypoxia,HYPOXIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021143,10021143,10021143
THROMBOCYTOPENIA (19 X10E3/ MICRO L),Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
ADENOVIRUS REACTIVATION,Adenovirus infection,ADENOVIRUS INFECTION,ADENOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,ADENOVIRAL INFECTIONS,10021881,10060931,10060931,10060931
"ANAEMIA, FAECAL SAMPLES WERE POSITIVE FOR HAEMOGLOBIN, AND GASTROINTESTINAL BLEEDING WAS CONSIDERED THE CAUSE OF ANAEMIA",Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
METABOLIC ALKALOSIS,Metabolic alkalosis,METABOLIC ALKALOSIS,METABOLIC ALKALOSIS,ACID-BASE DISORDERS,METABOLIC ALKALOSES,10027433,10027423,10027423,10027423
IN-STENT THROMBOSIS,stent thrombosis,STENT THROMBOSIS,VASCULAR STENT THROMBOSIS,COMPLICATIONS ASSOCIATED WITH DEVICE,VASCULAR COMPLICATIONS ASSOCIATED WITH DEVICE,10018065,10076859,10063934,10076859
ERYTHEMATOUS GASTROJEJUNAL ANASTOMOSIS WITH BILE POOLING IN THE GASTRIC REMNANT,Remnant gastritis,REMNANT GASTRITIS,REMNANT GASTRITIS,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,GASTROINTESTINAL AND HEPATOBILIARY PROCEDURAL COMPLICATIONS,10022117,10069433,10069433,10069433
POLYOMAVIRUS NEPHROPATHY,Polyomavirus-associated nephropathy,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065381,10065381,10065381
PLEURAL EFFUSION,pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
TRAMODOL ABOVE THE THERAPEUTIC RANGE ENOUGH IN THE YOUNG WOMEN'S SYSTEM TO KILL,Overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
CSF ANALYSIS SHOWED PREDOMINANT LYMPHOCYTES,CSF lymphocyte count abnormal,CSF LYMPHOCYTE COUNT ABNORMAL,CSF LYMPHOCYTE COUNT ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10011548,10011548,10011548
MILD LEUKOCYTOSIS (WHITE BLOOD CELL COUNT 10.9 K/ML),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
ELEVATED JUGULAR VENOUS PRESSURE,Venous pressure jugular increased,JUGULAR VENOUS PRESSURE RAISED,VENOUS PRESSURE JUGULAR INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10047240,10047240,10023242
INTERFACE DERMATITIS WITH NECROTIC KERATINOCYTES,Dermatitis,INTERFACE DERMATITIS,DERMATITIS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10072824,10012431,10072824
LETHARGY,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
OFF LABEL USE,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
POOR CONTROL,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ALKALINE PHOSPHATASE 207 U/L,Blood alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
GRADE 3 DIARRHEA(NON-HEMATOLOGICAL TOXICITY),diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
OSTEOPENIA,Osteopenia,OSTEOPENIA,OSTEOPENIA,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10049088,10049088,10049088
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
FLUID RETENTION,Fluid retention,FLUID RETENTION,FLUID RETENTION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME INCREASED,10027433,10016807,10016807,10016807
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HYPOXAEMIA,Hypoxia,HYPOXAEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021141,10021143,10021141
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
LEUKOCYTOSIS (16.8X10E9/L),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
"EROSIONS ESPECIALLY ON THE TRUNK AND EXTREMITIES, AS WELL AS IN THE GENITAL UND PERIANAL REGION WITH SCARRING",Skin erosion,SKIN EROSION,SKIN EROSION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040840,10040840,10040840
HEPATOCELLULAR NECROSIS,Hepatic necrosis,NECROSIS HEPATOCELLULAR,HEPATIC NECROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10028859,10019692,10028859
UNRESPONSIVE PATIENT,unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
ALP INCREASED (2000 IU/L),Blood alkaline phosphatase increased,ALP INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001771,10059570,10001771
SERUM CREATININE INCREASED (13.1 MG/DL),Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
BRADYCARDIC(55BPM),Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
ACUTE RENAL FAILURE DUE TO METFORMIN INTOXICATION,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
POSTPRANDIAL ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
PYODERMA GANGRENOSUM,Pyoderma gangrenosum,PYODERMA GANGRENOSUM,PYODERMA GANGRENOSUM,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10037635,10037635,10037635
ACUTE BACTERIAL MENINGITIS FOLLOWING DRUG USE WITHOUT PRESCRIPTION FOR UNAPPROVED INDICATION AND POPULATION,Meningitis bacterial,BACTERIAL MENINGITIS,MENINGITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10027202,10027202,10004049
SIGNIFICANT WEIGHT LOSS (15.5% FROM BASELINE BODY WEIGHT),Weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
AUTOIMMUNE NEUTROPENIA,Autoimmune neutropenia,AUTOIMMUNE NEUTROPENIA,AUTOIMMUNE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10055128,10055128,10055128
WORSENING OF INTERSTITIAL PNEUMONIA FOLLOWING LACK OF DRUG EFFECT,Interstitial lung disease,INTERSTITIAL PNEUMONIA AGGRAVATED,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10066726,10022611,10066726
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
SOME VESICLES COALESCED WITH THE CENTRAL NECROTIC PLAQUES,Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
SERUM ALANINE AMINOTRANSFERASE 99 IU/L,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
SMALL BRUISES ON HER BODY,Contusion,BRUISE,CONTUSION,INJURIES NEC,SKIN INJURIES NEC,10022117,10050584,10050584,10006502
PARKINSONISM-LIKE MOVEMENTS,Parkinsonism,PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034010,10034010,10034010
DROP IN MOOD,Mood altered,MOOD ALTERED,MOOD ALTERED,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10027940,10027940,10027940
MILDLY INCREASED AST/ALT,Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
"LOW-GRADE FEVER ((MAXIMUM TEMPERATURE, 38.2Â°C)",fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PLEURAL EFFUSION FOLLOWING CAMPYLOBACTER INFECTION,Pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
MYOSITIS INVOLVING THE VASTUS MEDIALIS VASTUS INTERMEDIUS AND VASTUS LATERALIS MUSCLES WITH EDEMA AND A CENTRAL SERPIGENOUS COLLECTION OF FLUID,Myositis,MYOSITIS,MYOSITIS,MUSCLE DISORDERS,MUSCLE INFECTIONS AND INFLAMMATIONS,10028395,10028653,10028653,10028653
"PARADOXICAL REACTION OF AGITATION WITH AGGRESSIVENESS, ANXIETY AND SCARIFICATION",paradoxical drug reaction,PARADOXICAL DRUG REACTION,PARADOXICAL DRUG REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048958,10048958,10048958
CHEST TIGHTNESS,Chest tightness,CHEST TIGHTNESS,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008492,10008469,10008492
WORSENING OF ADULT ONSET ASTHMA DUE TO STRONGYLOIDIASIS,Asthma late onset,ADULT ONSET ASTHMA,ASTHMA LATE ONSET,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10079507,10003559,10079507
PSYCHOMOTOR INHIBITION,Psychomotor skills impaired,PSYCHOMOTOR SKILLS IMPAIRED,PSYCHOMOTOR SKILLS IMPAIRED,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10049215,10049215,10049215
"A SWELLING OF THE FOREARM, WRIST, AND BACK OF THE RIGHT HAND, AND A SWELLING OF THE PROXIMAL INTERPHALANGEAL JOINT OF THE MIDDLE FINGER",Peripheral swelling,HAND SWELLING,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10019121,10048959,10019121
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
ECG SHOWED ST DEPRESSION IN LATERAL LEADS,Electrocardiogram ST segment depression,ST DEPRESSED,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041886,10014391,10041886
SEQUELAE OF CALCIPHYLAXIS/ADVANCEMENT OF THE ISCHEMIC ULCERATIONS,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
SEVERE COMBIINES IMMUNODEFICIENCY (SCID),Severe combined immunodeficiency syndrome,SEVERE COMBINED IMMUNODEFICIENCY SYNDROME,COMBINED IMMUNODEFICIENCY,IMMUNE SYSTEM DISORDERS CONGENITAL,IMMUNE SYSTEM ABNORMALITIES CONGENITAL,10010331,10069566,10010099,10069566
ANTHRACYCLINE-INDUCED CARDIOTOXICITY,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
ACUTE PROMYELOCYTIC LEUKEMIA,acute promyelocytic leukemia,ACUTE PROMYELOCYTIC LEUKEMIA,ACUTE PROMYELOCYTIC LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10001020,10001019,10001020
STAGE 5 CHRONIC RENAL INSUFFICIENCY,Chronic kidney disease,CHRONIC RENAL INSUFFICIENCY,CHRONIC KIDNEY DISEASE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10050441,10064848,10050441
DETERIORATION OF PARANEOPLASTIC JAUNDICE,CHOLESTATIC JAUNDICE,CHOLESTATIC JAUNDICE,JAUNDICE CHOLESTATIC,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008640,10023129,10008640
SERPENTINE SUPRAVENOUS HYPERPIGMENTATION,Infusion site hyperpigmentation,INFUSION SITE HYPERPIGMENTATION,INFUSION SITE DISCOLOURATION,ADMINISTRATION SITE REACTIONS,INFUSION SITE REACTIONS,10018065,10065480,10065460,10065480
ASCITES,ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
TENDER,Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
OVERDOSE,overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
CEREBRAL VENOUS THROMBOSIS,Cerebral venous thrombosis,CEREBRAL VENOUS THROMBOSIS,CEREBRAL VENOUS THROMBOSIS,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CEREBROVASCULAR VENOUS AND SINUS THROMBOSIS,10029205,10008138,10008138,10008138
URINARY TRACT INFECTION,urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
GRADE 2-3 HAEMATOLOGICAL TOXICITY DURING TREATMENT WITH DOXORUBICIN LIPOSOMAL [PEGYLATED LIPOSOMAL DOXORUBICIN],Haematotoxicity,HAEMATOTOXICITY,HAEMATOTOXICITY,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10061188,10061188,10061188
PERIPHERAL NEUROPATHY,peripheral neuropathy,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10080342,10029331,10080342
RESPIRATORY DISTRESS INCREASED (LACK OF DRUG EFFECT),Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
IRREGULAR VENOUS WALL STRUCTURES,vein disorder,INDURATION OF VENOUS WALL,VEIN DISORDER,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10021726,10047184,10021726
"PAINFUL, ULCERATED, TUMOUR-LIKE LESION ON THE LAST PHALANX OF THE FIFTH DIGIT OF HER LEFT HAND",Skin ulcer,ULCER OF UPPER EXTREMITY,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10072131,10040943,10072131
CYTOMEGALOVIRUS REACTIVATION INFECTION,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011831,10011831,10011831
HEPATOTOXICITY,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"TOXICOLOGICAL ANALYSIS SUGGESTED THAT MIDAZOLAM, TOGETHER WITH AIR, WAS ALSO INJECTED INTO THE CIRCULATION USING THE SAME BOTTLE AND INFUSION SET",Completed suicide,SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042462,10010144,10042462
ABDOMINAL RIGIDITY,Abdominal rigidity,ABDOMINAL RIGIDITY,ABDOMINAL RIGIDITY,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000090,10000090,10000090
C-PEPTIDE INCREASE,Insulin C-peptide increased,INSULIN C-PEPTIDE INCREASED,INSULIN C-PEPTIDE INCREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),"GASTROINTESTINAL, PANCREATIC AND APUD HORMONE ANALYSES",10022891,10022478,10022478,10022478
PROLONGATION OF QT AND PR INTERVALS,QT prolonged,QT PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037705,10014387,10037705
EXTRAPYRAMIDAL SIDE EFFECTS,Drug-induced extrapyramidal side effects,DRUG-INDUCED EXTRAPYRAMIDAL SIDE EFFECTS,EXTRAPYRAMIDAL DISORDER,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10013760,10015832,10013760
GENERALISED ERYTHEMATOUS LESIONS,Rash erythematous,ERYTHEMATOUS ERUPTION,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015241
CARDIAC ARREST,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
EPSTEIN-BARR VIRUS,epstein-Barr Virus,EPSTEIN-BARR VIRUS INFECTION,EPSTEIN-BARR VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,EPSTEIN-BARR VIRAL INFECTIONS,10021881,10015108,10015108,10015108
METHOTREXATE INDUCED ACUTE PNEUMONITIS,Pneumonitis,PNEUMONITIS,PNEUMONITIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10035742,10035742,10035742
PATENT DUCTUS ARTERIOSUS,Patent ductus arteriosus,PATENT DUCTUS ARTERIOSUS,PATENT DUCTUS ARTERIOSUS,CARDIAC AND VASCULAR DISORDERS CONGENITAL,PERSISTENT FOETAL CIRCULATION DISORDERS,10010331,10034130,10034130,10034130
BILATERAL MILD NUCLEAR CATARACTS,Cataract,CATARACT,CATARACT,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",CATARACT CONDITIONS,10015919,10007739,10007739,10007739
WHITE GINGIVAL LESIONS FOLLOWING HYPERCALCEMIA,white gingival lesions following hypercalcemia,GINGIVAL EROSION,GINGIVAL EROSION,DENTAL AND GINGIVAL CONDITIONS,GINGIVAL DISORDERS NEC,10017947,10018282,10018282,10018282
"OCCASIONAL BURNING, PINPRICKS, AND SWELLING OF THE CLITORIS",Burning sensation,BURNING SENSATION,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10006784,10006784,10006784
ABNORMALITIES IN LIVER FUNCTION,Hepatic function abnormal,FUNCTION LIVER ABNORMAL,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019670,10019670,10017475
UPPER RESPIRATORY INFECTION,Upper respiratory tract infection,UPPER RESPIRATORY INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10046306,10046306,10046300
NECROTIC NODULES OVER THE LEFT TEMPLE AND RIGHT INDEX FINGER,necrosis,NECROSIS,NECROSIS,TISSUE DISORDERS NEC,NECROSIS NEC,10018065,10028851,10028851,10028851
DYSPNEA,Dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
"HEROIN, FENTANYL AND 3-MF INTOXICATION",intentional drug misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
PUNCH BIOPSY REVEALED BASAL VACUOLAR CHANGE WITH EPIDERMAL APOPTOSIS,Apoptosis,APOPTOSIS,APOPTOSIS,METABOLISM DISORDERS NEC,CELL METABOLISM DISORDERS NEC,10027433,10059512,10059512,10059512
JARISCH-HERXHEIMER REACTION,Jarisch-Herxheimer reaction,JARISCH-HERXHEIMER REACTION,JARISCH-HERXHEIMER REACTION,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10023125,10023125,10023125
MYELOPATHY,Myelopathy,MYELOPATHY,MYELOPATHY,SPINAL CORD AND NERVE ROOT DISORDERS,SPINAL CORD AND NERVE ROOT DISORDERS NEC,10029205,10028570,10028570,10028570
THROMBOSIS OF THE SUPERIOR MESENTERIC VEIN / PARTIAL RECANALIZATION OF THROMBOSIS,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
CONGENITAL HEMANGIOMA/BUT PPL TREATMENT STARTED 5 DAYS AFTER BIRTH RESULTED IN RAPID RESOLUTION THE CH GRADUALLY DECREASED IN SIZE,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
SIGNIFICANT INCREASE IN THE TRYPTASE LEVELS,Tryptase increased,TRYPTASE INCREASED,TRYPTASE INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOLOGY ANALYSES NEC,10022891,10063342,10063342,10063342
ARTHRALGIA,Arthralgia,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
"VACCINATION SITE ERYTHEMA/ VACCINATION SITE PAIN/ APPLICATION SITE ERYTHEMA, THE SIZE OF THE CHILDS PALM, APPLICATION SITE WAS WARM WITH PAIN",Vaccination site inflammation,VACCINATION SITE INFLAMMATION,VACCINATION SITE INFLAMMATION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10068878,10068878,10068878
CHEST PAIN,chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
DRUG-DRUG INTERACTIONS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
PERSISTENT AND SEVERE HYPOGLYCEMIA (GLUCOSE VALUE OF 35 MG/DL) ASSOCIATED WITH TRIMETHOPRIM-SULFAMETHOXAZOLE,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
QRS WAS NOW PROLONGED/QRS PROLONGATION,QRS prolonged,QRS PROLONGED,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037697,10014380,10037697
SQUAMOUS CELL CARCINOMA OF THE TONGUE,Squamous cell carcinoma of the tongue,SQUAMOUS CELL CARCINOMA OF THE TONGUE,SQUAMOUS CELL CARCINOMA OF THE TONGUE,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,LIP AND ORAL CAVITY NEOPLASMS MALIGNANT,10029104,10041865,10041865,10041865
DIARRHEA INDUCED DUE BY ANTIBIOTICS,Diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
POTENTIAL CONTRIBUTION TO HEPATOPATHY,Liver disorder,HEPATOPATHY,LIVER DISORDER,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10024670,10024670,10059616
HYPOXEMIA,hypoxemia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021142,10021143,10021142
LYMPHOCYTIC INFILTRATION,Lymphocytic infiltration,LYMPHOCYTIC INFILTRATION,LYMPHOCYTIC INFILTRATION,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10062049,10062049,10062049
INCOHERENT,incoherent,INCOHERENT,INCOHERENT,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10021630,10021630,10021630
ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
THYROID DISORDER,Thyroid disorder,DYSFUNCTION THYROID,THYROID DISORDER,THYROID GLAND DISORDERS,THYROID DISORDERS NEC,10014698,10013907,10043709,10013907
PURPLISH-RED MACULE AND MASS IN THE PARIETAL REGION OF THE HEAD,Mass,MASS,MASS,TISSUE DISORDERS NEC,MASS CONDITIONS NEC,10018065,10026865,10026865,10026865
AXILLARY LYMPHADENOPATHY,Lymphadenopathy,LYMPHADENOPATHY AXILLARY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10049109,10025197,10049109
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
GENERALISED TONIC-CLONIC SEIZURES,Generalised tonic-clonic seizure,GENERALISED TONIC-CLONIC SEIZURE,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10018100,10018100,10018100
COGNITIVE DECLINE,Cognitive disorder,COGNITIVE IMPAIRMENT,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10057668,10057668,10009846
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
TRANSIENT CORONARY SPASM,Arteriospasm coronary,CORONARY SPASM,ARTERIOSPASM CORONARY,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10011107,10003225,10011107
HAEMOGLOBIN DECREASED (10.5 G/DL),haemoglobin decreased,HAEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10018884
INTOLERABLE TOXICITY,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,hemophagocytic lymphohistiocytosis,LYMPHOHISTIOCYTOSIS,LYMPHOHISTIOCYTOSIS,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),HISTIOCYTOSES,10029104,10049646,10049646,10049646
GRADE 2 NEUROPATHY,neuropathy,NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029328,10029331,10029328
HYPOMAGNESAEMIA,Hypomagnesaemia,HYPOMAGNESAEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021027,10021027,10021027
CLOSTRIDIUM DIFFICILE INFECTION,Clostridium difficile infection,CLOSTRIDIUM DIFFICILE INFECTION,CLOSTRIDIUM DIFFICILE INFECTION,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10054236,10054236,10054236
SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
DECOMPENSATED HEART FAILURE AND CARDIAC ARRHYTHMIA,Cardiac failure,DECOMPENSATED HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10066159,10007554,10066159
"ABDOMINAL MUSCLE DYSKINESIA (""BELLY DANCER SYNDROME"")",Dyskinesia,DYSKINESIA,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10013916,10013916,10013916
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
IDIOPATHIC PANCREATITIS,Pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
GRADE 3 NON-OLIGURIC ACUTE RENAL FAILURE,Acute nonoliguric renal failure,ACUTE NONOLIGURIC RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10080530,10069339,10080530
HYPOXEMIA,hypoxemia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021142,10021143,10021142
PERICENTRAL HEPATOCELLULAR NECROSIS,Hepatic necrosis,HEPATIC NECROSIS,HEPATIC NECROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019692,10019692,10019692
INEFFECTIVE TREATMENT WITH PARACETAMOL,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
CONFUSED,confused,CONFUSED,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010298,10010305,10010298
INR INCREASED (10.3),International normalised ratio increased,INR INCREASED,INTERNATIONAL NORMALISED RATIO INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10022402,10022595,10022402
DRUG EXPOSURE VIA PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
PATIENT COULD NOT TOLERATE AMOXICILLIN WITH CLAVULANIC ACID,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
BROMOCRIPTINE RESISTANCE,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
LOSS OF APPETITE,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
OPPORTUNISTIC INFECTION,Opportunistic infection,OPPORTUNISTIC INFECTION,OPPORTUNISTIC INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10030901,10030901,10030901
ESOPHAGEAL CANDIDIASIS,Esophageal candidiasis,ESOPHAGEAL CANDIDIASIS,OESOPHAGEAL CANDIDIASIS,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10015365,10030154,10015365
REBOUND EFFECT,rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
SWELLING,swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
GRADE 3 FEBRILE NEUTROPENIA,febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
GENERALIZED CUTANEOUS RASH,Rash generalised,RASH GENERALISED,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037858,10037858,10037858
SEVERE MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
ASCITES INFECTION,ascites infection,ASCITES INFECTION,PERITONITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10051156,10034674,10051156
LEFT VENTRICULAR DYSFUNCTION,left ventricular dysfunction,LEFT VENTRICULAR DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10049694,10049694,10049694
MULTI ORGAN FAILURE,Multiple organ dysfunction syndrome,MULTI ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028151
HIGH LEVELS OF GAMMA GLOBULIN (39.5 %),Immunoglobulins increased,GAMMA GLOBULIN INCREASED,IMMUNOGLOBULINS INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10017666,10021500,10017662
PRETERM DELIVERY (CESARIA SECTION AT 35 WEEKS OF GESTATION),Premature delivery,PREMATURE DELIVERY,PREMATURE DELIVERY,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036595,10036595,10036595
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
MULTIPLE DRUG POISONING,Drug poisoning,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
SEPSIS CAUSED BY PSEUDOMONAS DUE TO PERSISTENT SEVERE BONE MARROW APLASIA,Pseudomonal sepsis,PSEUDOMONAL SEPSIS,PSEUDOMONAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,PSEUDOMONAL INFECTIONS,10021881,10058877,10058877,10058877
DRUG INDUCED NECROTIZING PANCREATITIS,Pancreatitis necrotising,NECROTIZING PANCREATITIS,PANCREATITIS NECROTISING,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033654,10033654,10028891
"GLUTAMICPYRUBIC TRANSAMINASE/GPT ELEVATIONS OF 4,506 U/L",glutamicpyrubic transaminase,GLUTAMIC-PYRUVIC TRANSAMINASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10018457,10001551,10018457
GLUCOCORTICOID INDUCED OSTEOPOROSIS,Osteoporosis,OSTEOPOROSIS STEROID-INDUCED,OSTEOPOROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10031287,10031282,10031287
HER LEVEL OF COUNSCIOUSNESS VARIED,Altered state of consciousness,ALTERED STATE OF CONSCIOUSNESS,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10001854,10001854,10001854
NORMAL NEWBORN,Normal newborn,NORMAL NEWBORN,NORMAL NEWBORN,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS",NORMAL NEWBORN STATUS,10036585,10029769,10029769,10029769
PATIENT HAD PERSISTENT HYPOTENSION AND WORSENING ST ELEVATION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
THROAT TIGHTNESS,Throat tightness,THROAT TIGHTNESS,THROAT TIGHTNESS,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10043528,10043528,10043528
THE PATIENT NOTED IMPAIREMENT IN THE NIGHT VISION,Night blindness,DECREASED NIGHT VISION,NIGHT BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10011974,10029404,10011974
USE OF FLUOROURACIL AND OXALIPLATIN FOR METASTATIC UROTHELIAL CARCINOMA WITH PERITONEAL METASTASES (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CONJUNCTIVITIS WAS PRESENT IN THE EYES BILATERALLY,Conjunctivitis,CONJUNCTIVITIS,CONJUNCTIVITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10010741,10010741,10010741
BILATERAL VESTIBULOPATHY SECONDARY TO GENTAMICIN TOXICITY,Vestibular toxicity,VESTIBULAR DISORDER,VESTIBULAR DISORDER,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR DISORDERS NEC,10013993,10047386,10047386,10047386
OFF LABEL USE,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ANOREXIA,Decreased appetite,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10002646
ANXIOUS,Anxiety,FEELING ANXIOUS,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10016323,10002855,10016323
PROGRESSIVE ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
HYPOXIC ENCEPHALOPATHY,hypoxic encephalopathy,HYPOXIC ENCEPHALOPATHY,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10021147,10070511,10021147
PROGRESSIVELY AGGRAVATED HEART FAILURE FOLLOWING DISEASE PROGRESSION DUE TO LACK OF DRUG EFFECT OF PIPERACILLIN-TAZOBATAM,heart failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10019279,10007554,10019279
DERANGED LIVER FUNCTION,Function liver abnormal,FUNCTION LIVER ABNORMAL,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10017475,10019670,10017475
IATROGENIC CUSHING SYNDROME,Cushing's syndrome,CUSHING'S SYNDROME,CUSHING'S SYNDROME,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011652,10011652,10011652
TRUNCAL ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
INSOMNIA,Insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
DISSEMINATED CRYPTOCOCCEMIA FOLLOWING PANCYTOPENIA,Disseminated cryptococcosis,DISSEMINATED CRYPTOCOCCOSIS,DISSEMINATED CRYPTOCOCCOSIS,FUNGAL INFECTIOUS DISORDERS,CRYPTOCOCCAL INFECTIONS,10021881,10013439,10013439,10013439
GLUCOSE LEVEL DECREASES AT 15 MG/DL,glucose decreased,GLUCOSE DECREASED,BLOOD GLUCOSE DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10018419,10005555,10018419
HYPERACUSIS,Hyperacusis,HYPERACUSIS,HYPERACUSIS,HEARING DISORDERS,HYPERACUSIA,10013993,10020559,10020559,10020559
TYPE 1 AUTOIMMUNE PANCREATITIS (AIP) WITH EXOCRINE INSUFFICIENCY,Autoimmune pancreatitis,AUTOIMMUNE PANCREATITIS,AUTOIMMUNE PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10069002,10069002,10069002
"MATERNAL EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",Maternal exposure during pregnancy,"MATERNAL EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10074500,10071408,10074500
MUCOSAL MEMBRANE DISORDER SUCH AS STOMATITIS,Mucous membrane disorder,MUCOUS MEMBRANE DISORDER,MUCOUS MEMBRANE DISORDER,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028133,10028133,10028133
OCULAR DISCOMFORT,Ocular discomfort,OCULAR DISCOMFORT,OCULAR DISCOMFORT,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10052143,10052143,10052143
RIGHT FLACCID HEMIPARESIS/MOTOR DEFICIT OF THE RIGHT HEMI BODY,Hemiparesis,HEMIPARESIS (RIGHT),HEMIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019467,10019465,10019467
OXALIPLATIN BASED CHEMOTHERAPY INDUCED SINUSOIDAL OBSTRUCTIVE SYNDROME,Venoocclusive liver disease,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
DROWSINESS,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
PROLONGED QT INTERVAL,QT interval prolonged,QT INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037703,10014387,10037703
DRUG TOXICITY,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
FIBRINOGEN LEVEL OF 5 G/L,Blood fibrinogen increased,FIBRINOGEN INCREASED,BLOOD FIBRINOGEN INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10016597,10005521,10016597
TOOK AN UNKNOWN QUANTITY TO INCREASE EFFECTS TO ALCOHOL,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
"TREATED WITH 2MG OF ORAL DIAZEPAM, WITH LITTLE EFFECT.",Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
INTENTIONAL LIDOCAINE INHALATION,Intentional product misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
METHOTREXATE WAS NOT TOLERATED,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
BREATHING PATTERN DISORDER,Respiratory disorder,RESPIRATORY DISORDER,RESPIRATORY DISORDER,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10038683,10038683,10038683
REPORTED THE INTAKE OF ABOUT 4 DL GRAPEFRUIT JUICE BEFORE PALPITATION STARTED,Labelled drug-food interaction medication error,LABELED DRUG-FOOD INTERACTION MEDICATION ERROR,LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT MONITORING ERRORS AND ISSUES,10022117,10064374,10064374,10064379
RIBAVARIN-INDUCED ANAEMIA (HEMOGLOBIN 3.7 G/DL),Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
GRADE 4 HYPOKALEMIA,Hypokalaemia,HYPOKALAEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021015
DIED,Death,DEATH,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10011906,10011906,10011906
PATIENT TREATED WITH METHOTREXATE FOR DERMATOMYOSITIS (DRUG USE FOR UNAPPROVED INDICATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HYPOXIC,hypoxic,HYPOXIC,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021144,10021143,10021144
ABDOMINAL DISCOMFORT,Abdominal discomfort,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10000059,10000059,10000059
"MULTIPLE ABSCESSES IN THE LUNG, LIVER AND SPLEEN",Splenic abscess,SPLENIC ABSCESS,SPLENIC ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,HEPATOBILIARY AND SPLEEN INFECTIONS,10021881,10041643,10041643,10041643
MYCOBACTERIUM TUBERCULOSIS INFECTION,Mycobacterium tuberculosis NOS,MYCOBACTERIUM TUBERCULOSIS NOS,TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10028461,10044755,10028461
MALE BREAST CANCER (MBC)/FINASTERIDE TREATMENT AND MALE BREAST CANCER,Breast cancer male,BREAST CANCER MALE,BREAST CANCER MALE,BREAST NEOPLASMS MALIGNANT AND UNSPECIFIED (INCL NIPPLE),BREAST AND NIPPLE NEOPLASMS MALIGNANT,10029104,10061020,10061020,10061020
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
"NEUTROPAENIA [GRADE 4 ACCORDING TO CTCAE],  REOCCURRED ON A REGULAR BASIS",Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
DRUG POISONING,Drug poisoning,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
SYSTOLIC BLOOD PRESSURE DECRESED,Blood pressure systolic decreased,BLOOD PRESSURE SYSTOLIC DECREASED,BLOOD PRESSURE SYSTOLIC DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005758,10005758,10005758
PATIENT WAS TREATED WITH MYCOPHENOLATE MOFETIL FOR GRANULOMATOSIS WITH POLYANGIITIS (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
WORSENING OF HIS HYPERKINETIC MOVEMENTS,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE),Systemic lupus erythematosus,SYSTEMIC LUPUS ERYTHEMATOSUS,SYSTEMIC LUPUS ERYTHEMATOSUS,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),LUPUS ERYTHEMATOSUS (INCL SUBTYPES),10028395,10042945,10042945,10042945
ABNORMAL FETAL HEART RHYTHM,Fetal heart rate abnormal,FETAL HEART RATE ABNORMAL,FOETAL HEART RATE ABNORMAL,FOETAL AND NEONATAL INVESTIGATIONS,FOETAL AND NEONATAL DIAGNOSTIC PROCEDURES,10022891,10054384,10051139,10054384
NEURO-REGRESSION,Neurodevelopmental disorder,NEURODEVELOPMENTAL DISORDER,NEURODEVELOPMENTAL DISORDER,DEVELOPMENTAL DISORDERS NEC,PERVASIVE DEVELOPMENTAL DISORDERS NEC,10037175,10064062,10064062,10064062
DUCTUS ARTERIOSUS PREMATURE CLOSURE,Ductus arteriosus premature closure,DUCTUS ARTERIOSUS PREMATURE CLOSURE,DUCTUS ARTERIOSUS PREMATURE CLOSURE,CARDIAC AND VASCULAR DISORDERS CONGENITAL,ARTERIAL DISORDERS CONGENITAL,10010331,10049996,10049996,10049996
PARTIAL THROMBOPLASTIN TIME (62.4 SECONDS),Activated partial thromboplastin time prolonged,PARTIAL THROMBOPLASTIN TIME PROLONGED,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10034094,10000636,10034094
BLOODY DIARRHEA FOLLOWING LACK OF DRUG EFFECT WITH METHYLPREDNISOLONE,bloody diarrhea,BLOODY DIARRHEA,DIARRHOEA HAEMORRHAGIC,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10005872,10012741,10005872
GRADE 3-4 INFECTION,Infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
DEHYDRATION,dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
MORE PROSTRATED,prostration,PROSTRATION,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10036985,10016256,10036985
BLEEDING POINTS SCATTERED ON LOWER LIMBS,Petechia,PETECHIA,PETECHIAE,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10034752,10034754,10034752
PROBLEMS WITH CONCENTRATION,Disturbance in attention,CONCENTRATION ABILITY IMPAIRED,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10010248,10013496,10010248
DIFFUSE ABDOMINAL TENDERNESS,diffuse abdominal tenderness,ABDOMINAL TENDERNESS,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000097,10000097,10000097
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
HE CONTINUED TO HAVE EPISODES OF HYPERGLYCEMIA IN THE HIGH 400S,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
TREATMENT CONTINUED THOUGHOUT HER BREASTFEEDING WITH GOOD EFFECT,Exposure via breast milk,DRUG EXPOSURE VIA BREAST MILK,EXPOSURE VIA BREAST MILK,"EXPOSURES, CHEMICAL INJURIES AND POISONING",PATHWAYS AND SOURCES OF EXPOSURE,10022117,10051075,10080751,10051075
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,Acute generalised exanthematous pustulosis,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10048799
SINUS RHYTHM,Sinus rhythm,SINUS RHYTHM,SINUS RHYTHM,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10048815,10048815,10048815
"COMPULSIVE CLEANING AND WASHING OF EYELIDS, IRRITABILITY AND REDUCED SLEEP; ON TABLET RISPERIDONE 3MG/DAY, THE BEHAVIORAL SYMPTOMS OTHER THAN HALLUCINATIONS WORSENED",Obsessive-compulsive symptom,OBSESSIVE-COMPULSIVE SYMPTOM,OBSESSIVE-COMPULSIVE SYMPTOM,ANXIETY DISORDERS AND SYMPTOMS,OBSESSIVE-COMPULSIVE DISORDERS AND SYMPTOMS,10037175,10077894,10077894,10077894
MULTI-ORGAN FAILURE,Multiple organ dysfunction syndrome,MULTI-ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028154
MALAISE WORSENED/SYSTOLIC BLOOD PRESSURE SUDDENLY DECREASED TO 50 MMHG,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
PATIENT WAS TREATED WITH ACYLOVIR BUT HAD PERSISTENT LANGUAGE AND COGNITIVE DIFFICULTIES (LACK OF DRUG EVENT WITH NO ADVERSE EVENT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
MALAISE,malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
ERYTHEMATOUS PAPULOSQUAMOUS ERUPTION,Erythematous eruption,ERYTHEMATOUS ERUPTION,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015241,10037855,10015241
AGGRAVATED BY REDUCTION OF QUETIAPINE FUMARATE,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
POST-LT MYCOTIC ANEURYSM OF THE HEPATIC ARTERY,Mycotic aneurysm,MYCOTIC ANEURYSM,INFECTIVE ANEURYSM,INFECTIONS - PATHOGEN UNSPECIFIED,VASCULAR INFECTIONS,10021881,10028517,10058017,10028517
PAIN IN AND AROUND THE ABDOMINAL SCARING,Scar pain,SCAR PAIN,SCAR PAIN,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10049002,10049002,10049002
PSEUDOMONAS SEPTICEMIA FOLLOWING PSEUDOMONAS AERUGINOSA,Pseudomonas infection,PSEUDOMONAS INFECTION,PSEUDOMONAS INFECTION,BACTERIAL INFECTIOUS DISORDERS,PSEUDOMONAL INFECTIONS,10021881,10061471,10061471,10061471
GAPS IN MEMORY,Memory impairment,MEMORY IMPAIRED,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027175,10027175,10027174
PROGRESSIVE ST-DEPRESSION,ST segment depression,ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041892,10014391,10041892
OPTICAL COHERENCE TOMOGRAPHY SHOWED PARAFOVEAL THINNING IN BOTH EYES,Optical coherence tomography abnormal,OPTICAL COHERENCE TOMOGRAPHY ABNORMAL,OPTICAL COHERENCE TOMOGRAPHY ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",IMAGING PROCEDURES NEC,10022891,10073561,10073561,10073561
NO RESPONSE,Therapy non-responder,THERAPY NON-RESPONDER,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051082,10051082,10051082
TINNITUS,Tinnitus,TINNITUS,TINNITUS,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10043882,10043882,10043882
NUMBNESS ALONG THE MEDIAL ASPECT OF HIS LEFT LEG/DECREASED SENSATION IN THE MEDICAL ASPECT OF THE THIGH,numbness in leg,NUMBNESS IN LEG,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10029839,10020937,10029839
GENERALIZED ERYTHEMATOUS AND PUSTULOUS DERMATITIS,Dermatitis,DERMATITIS,DERMATITIS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10012431,10012431,10012431
LIFE THREATENING IDIOPATIC REACTION TO HYDROCHLOROTHIAZIDE/ SHE MAY HAVE HAD ALLERGIC REACTION,Allergic reaction,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
THE CHILD UNDERGOES THERAPY WITH CORTICOSTEROIDS (PREDNISONE 15 MG 4 TIMES A DAY) WITHOUT ANY IMPROVEMENT,no therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
FEVER >39.5 DEGREE CENTIGRADE/FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
LEVOFLOXACIN-INDUCED PSYCHOSIS,psychosis,PSYCHOSIS,PSYCHOTIC DISORDER,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10037234,10061920,10037234
PATIENT SELF-ADMINISTERED ACETAMINOPHEN,self-medication,SELF-MEDICATION,SELF-MEDICATION,THERAPEUTIC PROCEDURES AND SUPPORTIVE CARE NEC,THERAPEUTIC PROCEDURES NEC,10042613,10050729,10050729,10050729
EDEMA,Oedema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10014210
EPISTAXIS,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
IMMUNE MEDIATED NECTROTISING MYOPATHY,Immune-mediated necrotising myopathy,IMMUNE-MEDIATED NECROTIZING MYOPATHY,IMMUNE-MEDIATED NECROTISING MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10072155,10072155,10072156
PERTUSSIS,Pertussis,PERTUSSIS,PERTUSSIS,BACTERIAL INFECTIOUS DISORDERS,BORDETELLA INFECTIONS,10021881,10034738,10034738,10034738
"PAINFUL WITH BRUISING LARGE LESION 5"" X 5"" STERILE ABSCESS",Injection site pain,INJECTION SITE PAIN,INJECTION SITE PAIN,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022086,10022086,10022086
FEBRILE,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
FEVER,Fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
"DESPITE ADMINISTRATION OF PREGABALIN, THE PATIENTâ€™S NEURALGIA PERSISTED (LACK OF DRUG EFFECT WITH NO ADVERSE EVENT REACTION)",lack of drug effect,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
AGGRAVATION OF BULLOUS PEMPHIGOID FOLLOWING TREATMENT FAILURE,Pemphigoid,BULLOUS PEMPHIGOID,PEMPHIGOID,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006567,10034277,10006567
UNRESPONSIVE,unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
HANDS EDEMA,Edema hands,EDEMA HANDS,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10050065,10030124,10050065
RENAL FUNGAL BALLS CAUSED BY CANDIDA ALBICANS,Candida albicans infection,CANDIDA ALBICANS INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10054230,10074170,10054230
EXPERIENCING FREQUENT BEHAVIOURAL OUTBURTS,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
MASSIVE HEPATOTOXIC REACTION,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
RELAPSE OF NEPHRITIS WITH NEPHRITIC TYPE ALBUMINURIA,Nephritis,NEPHRITIS,NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029117,10029117,10029117
LISTERIAL MENINGOENCEPHALITIS DUE TO LISTERIA MONOCYTOGENS INFECTION,Meningoencephalitis bacterial,MENINGOENCEPHALITIS BACTERIAL,MENINGOENCEPHALITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10051256,10051256,10051256
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
DIARRHEA,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
VENTRICULAR TACHYCARDIA,ventricular tachycardia,VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047302,10047302,10047302
SLIGHT HYPERTRICHOSIS OF BOTH MALAR AREAS,Hypertrichosis,HYPERTRICHOSIS,HYPERTRICHOSIS,SKIN APPENDAGE CONDITIONS,HYPERTRICHOSES,10040785,10020864,10020864,10020864
NECROTIZING MICROASCUS TRACHEOBRONCHITIS/MICROASCUS CIRROSUS INFECTION,Respiratory tract infection fungal,RESPIRATORY TRACT INFECTION FUNGAL,RESPIRATORY TRACT INFECTION FUNGAL,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10060692,10060692,10060692
DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE DRUG REACTION,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
LEUKOPENIA,leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
ASYSTOLE FOLLOWING CARDIAC ARREST FOLLOWING DRUG OVERDOSE,asystole,ASYSTOLE,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10003586,10007515,10003586
PERIHILAR LYMPHADENOPATHY,Perihilar Lymphadenopathy,HILAR LYMPHADENOPATHY,HILAR LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10020094,10020094,10020094
POLYOMAVIRUS NEPHROPATHY/ BK VIRUS NEPHROPATHY (VIREMIA >104 COPIES/ML),Polyomavirus-associated nephropathy,BK VIRUS NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065333,10065381,10065333
ASPARTATE AMINOTRANSFERASE INCREASED (6170 IU/L),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
LETHARGY,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
MODERATE ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
WORSENING OF STRIDOR,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
AT A TEMP OF 40C / FEBRILE ILLNESS,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
OUR PATIENT HAD POOR PREDNISONE RESPONSE (LACK OF DRUG EFFECT WITH NO ADR),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
INCREASED LETHARGY,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
GRADE 4 DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
PROPRANOLOL USED IN 68-YEAR-OLD PATIENT,Drug use in unapproved age group,DRUG USE IN UNAPPROVED AGE GROUP,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10076467,10071062,10076467
ACUTE RENAL FAILURE,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
SEVERE MYELODYSPLASIA,myelodysplasia,MYELODYSPLASIA,MYELODYSPLASTIC SYNDROME,LEUKAEMIAS,MYELODYSPLASTIC SYNDROMES,10029104,10028532,10028533,10028532
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
GRADE II HYPERSENSITIVITY REACTION,Hypersensitivity,HYPERSENSITIVITY REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020756,10020751,10020756
RIGHT WRIST AND LEFT HIP JOINTS PAIN,Arthralgia,JOINT PAIN,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10023222
JAW PAIN,jaw pain,JAW PAIN,PAIN IN JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10023157,10033433,10023157
HEPARIN INDUCED THROMBOCYTOPENIA,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
GASTRIC INTOLERANCE,Gastric disorder,GASTRIC DISORDER,GASTRIC DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10056819,10056819,10056819
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
HYPERMAGNESAEMIA,Hypermagnesaemia,HYPERMAGNESAEMIA,HYPERMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10020669,10020669,10020669
"SEVERAL LUPUS FLARES SINCE,PRIMARILY DUE TO POOR DRUG COMPLIANCE",SLE flare,SLE FLARE,SYSTEMIC LUPUS ERYTHEMATOSUS,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),LUPUS ERYTHEMATOSUS (INCL SUBTYPES),10028395,10065992,10042945,10065992
"BIOPSY OF THE RASH CONFIRMED A PROMINENT LYMPHOHISTIOCYTIC INFILTRATE WITHIN THE PAPILLARY DERMIS, FOCALLY OBSCURING THE DERMO-EPIDERMAL JUNCTION",Lymphocytic infiltration,LYMPHOCYTIC INFILTRATION,LYMPHOCYTIC INFILTRATION,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10062049,10062049,10062049
CUTANEOUS ICTERUS,Jaundice,ICTERUS,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10021207
FEVERISH ERYTHEMA,fever,FEVERISH,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10073718,10037660,10073718
ASTHMA SYMPTOMS,Asthma,ASTHMA NOS,ASTHMA,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10003560,10003553,10003560
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
HEPATIC DYSFUNCTION,Hepatic function abnormal,HEPATIC DYSFUNCTION NOS,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019657,10019670,10019657
HEPARIN INDUCED THROMBOCYTOPENIA WAS CONFIRMED,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
DIZZINESS DUE TO POISONING ASSOCIATED WITH INAPPROPRIATE USE OF A EUTECTIC MIXTURE OF LIDOCAINE AND PRILOCAINE,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
 also on palms and soles,2018-08-10 00:00:00,1,,,,DERMAL AND EPIDERMAL CONDITIONS NEC,10033733,10033733,
SWELLING AT INJECTION SITE,Injection site swelling,INJECTION SITE SWELLING,INJECTION SITE SWELLING,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10053425,10053425,10053425
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
TACHYPNEA,Tachypnoea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043088
SEVERE TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
EXFOLIATION OF THE SKIN LESION ALL OVER THE BODY (TOTAL BODY SURFACE AREA INVOLVED 50-60 %),Exfoliation of skin,EXFOLIATION OF SKIN,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10015661,10040844,10015661
REDUCED APPETITE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
STAGE 1 OSTEONECROSIS OF THE JAW,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
CHEST TIGHTNESS,Chest tightness,CHEST TIGHTNESS,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008492,10008469,10008492
APHAGIA,Dysphagia,APHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10049866,10013950,10049866
TEMPERATURE INCREASED TO 41Â°C,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
USE OF HYDROXYCHLOROQUINE FOR SNITZLER'S SYNDROME (OFF LABEL USE ) WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BLOATING,Abdominal distension,BLOATING,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10005265,10000060,10005265
ASPERGILLUS SPP,Aspergillus infection,ASPERGILLUS INFECTION,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10074171,10074171,10074171
OIDIODENDRON CEREALIS INFECTION,fungal infection,FUNGAL INFECTION,FUNGAL INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017533,10017533,10017533
ALT INCREASED 250 IU/L,Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
COUGH,cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
INTRAUTERINE GROWTH RETARDATION,Foetal growth restriction,INTRAUTERINE GROWTH RETARDATION,FOETAL GROWTH RESTRICTION,FOETAL COMPLICATIONS,FOETAL GROWTH COMPLICATIONS,10036585,10022819,10070531,10022819
FEBRILE,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
EXERTION DYSPNOE PERSISTED DESPITE THE TREATMENT,Dyspnoea exertional,DYSPNEA EXERTIONAL,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013971,10013971,10013966
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
2+ EDEMA IN LOWER EXTREMETIES,Oedema peripheral,EDEMA OF LOWER EXTREMITIES,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030109,10030124,10054498
DISEASE PROGRESSION,diseae progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
PROGRESSING EMESIS,emesis,EMESIS,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10014542,10047700,10014542
DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
"WHEN CALCULATING THE INITIAL BOLUS DOSE OF 150 MG/KG A DECIMAL POINT ERROR WAS MADE, RESULTING IN A 10-FOLD HIGHER DOSE THAN INTENDED (160 G INSTEAD OF 16 G)",Dose calculation error,DOSE CALCULATION ERROR,DOSE CALCULATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076874,10076874,10076874
AMIODARONE-INDUCED THYROTOXICOSIS,Hyperthyroidism,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
OXYGEN SATURATION DECREASED,Oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
TRANSFORMATION OF CHRONIC MYELOPROLIFERATIVE DISEASE,Chronic myeloid leukaemia transformation,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,LEUKAEMIAS,LEUKAEMIAS CHRONIC MYELOID,10029104,10068232,10068232,10068232
PATIENT RECEIVED MOXIFLOXACIN MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS,Patient received moxifloxacin multidrug-resistant pulmonary tuberculosis,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
OEDEMATOUS FACE,face oedematous,FACE OEDEMATOUS,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10016030,10016029,10016030
BLEEDING FROM PORT-A-CATH SITE,bleeding,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10005103,10055798,10005103
ALANINE AMINOTRANSFERASE INCREASED (153 IU/L),Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
HEMATOCHEZIA,Haematochezia,HEMATOCHEZIA,HAEMATOCHEZIA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018836,10018836,10060544
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
LEUKOPENIA WITH FEBRILE NEUTROPENIA,Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
RENAL ATROPHY,Renal atrophy,RENAL ATROPHY,RENAL ATROPHY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL STRUCTURAL ABNORMALITIES AND TRAUMA,10038359,10038381,10038381,10038381
BILATERAL LUNG INFILTRATES,Bilateral pulmonary infiltrates,BILATERAL PULMONARY INFILTRATES,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10070790,10025102,10070790
HALLUCINATIONS OF FLASHING LIGHTS AND ANIMALS SCURRYING ACROSS THE FLOOR,"Hallucinations, mixed","HALLUCINATIONS, MIXED","HALLUCINATIONS, MIXED",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019079,10019079,10019079
MACROSCOPIC HEMATURIA,macroscopic hematuria,MACROSCOPIC HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10059823,10018867,10059823
SWELLING OF RIGHT PAROTID GLAND,Parotid gland enlargement,PAROTID SWELLING,PAROTID GLAND ENLARGEMENT,SALIVARY GLAND CONDITIONS,SALIVARY GLAND ENLARGEMENTS,10017947,10034028,10034023,10034028
COMBINED CENTRAL NERVOUS SYSTEM DEPRESSION,Central nervous system depression NOS,CENTRAL NERVOUS SYSTEM DEPRESSION NOS,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10007941,10012373,10007941
ABSOLUTE CD8+ T-LYMPHOCYTE COUNT 70/UL,CD8 lymphocytes decreased,CD8 LYMPHOCYTES DECREASED,CD8 LYMPHOCYTES DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056283,10056283,10056283
EJECTION FRACTION 35 %,Ejection fraction decreased,EJECTION FRACTION DECREASED,EJECTION FRACTION DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10050528,10050528,10050528
CARBAMAZEPINE LEVEL WAS SUB THERAPEUTIC,Drug level decreased,DRUG LEVEL DECREASED,DRUG LEVEL DECREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013718,10013718,10013718
HYPERTENSIVE,Hypertension,HYPERTENSIVE,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020800
GENITAL LESIONS,Genital lesion,GENITAL LESION,GENITAL LESION,REPRODUCTIVE TRACT DISORDERS NEC,REPRODUCTIVE TRACT DISORDERS NEC (EXCL NEOPLASMS),10038604,10061978,10061978,10061978
REACTIVATION OF HBV DURING POSTOPERATIVE ADJUVANT CHEMOTHERAPY WITH CAPECITABINE,Hepatitis B reactivation,HEPATITIS B REACTIVATION,HEPATITIS B REACTIVATION,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10058827,10058827,10058827
FLATULENCE,Flatulence,FLATULENCE,FLATULENCE,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10016766,10016766,10016766
PERIPHERAL EDEMA FOLOWING DRUG EXPOSURE DURING PREGNANCY WITH DEXAMETHASONE,Oedema peripheral,PERIPHERAL EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030124,10030124,10034570
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
THICKNESS OF SUBCUTANEOUS ADIPOSE TISSUE AT INJECTION SITE (LEFT SIDE OF THE ABDOMINAL REGION) INCREASED (17 MM),Injection site hypertrophy,INJECTION SITE SUBCUTANEOUS FATTY HYPERTROPHY,INJECTION SITE HYPERTROPHY,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022101,10022072,10022101
MAJOR BLEEDING,Haemorrhage,MAJOR BLEED,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10070921,10055798,10070921
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
MULTIPLE BRANCHING SEPTATE FUNGAL HYPHAE AT ALL LEVELS AND POSTERIOR TO DESCEMET'S MEMBRANE,Fungal infection,FUNGAL INFECTION,FUNGAL INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017533,10017533,10017533
DIFFICULTY BREATHING,Dyspnoea,DIFFICULTY BREATHING,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10012791
HIS PENIS HAS A SMALL EROSION,Penile erosion,PENILE EROSION,PENILE ULCERATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10064061,10034322,10064061
"PROTRACTED NEUTROPENIA GRADE 4 AND RECURRENT NEUTROPENIA FOLLOWING FCR (1ST, 2ND AN 3RD  ADMINISTRATION)",Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
PATIENT TREATED WITH TRAMADOL FOR INJECTION SITE PAIN REVEALED NO IMPROVEMENT OF THE SYMPTOMS (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
TRUNK AND UPPER AND LOWER LIMB BRUISING,bruising,BRUISING,CONTUSION,INJURIES NEC,SKIN INJURIES NEC,10022117,10006504,10050584,10006504
CONDITION WORSENED (HAND SHAKE GET WORSENED)/PATIENT'S HAND TREMORS WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
POST-CHEMOTHERAPY NEUTROPENIC SEPSIS,Neutropenic sepsis,NEUTROPENIC SEPSIS,NEUTROPENIC SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10049151,10049151,10049151
CALCIUM DEPOSITS IN SMALL,Calcium deposits,CALCIUM DEPOSITS,CALCINOSIS,TISSUE DISORDERS NEC,TROPHIC DISORDERS,10018065,10006958,10006938,10006958
MARKED LYMPHOTIC COLITIS,Colitis microscopic,LYMPHOCYTIC COLITIS,COLITIS MICROSCOPIC,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10025268,10056979,10025268
SEVERE HEART FAILURE FOLLOWING CARDIOMYOPATHY DUE TO OFF LABEL USE OF CHLOROQUINE,heart failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10019279,10007554,10019279
PATIENT HAD BEEN BROKEN MENTALLY,mental disorder,MENTAL DISORDER,MENTAL DISORDER,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10061284,10061284,10061284
GLYCATED HAEMOGLOBIN (HBA1C) 12 %,Glycosylated haemoglobin increased,HBA1C INCREASED,GLYCOSYLATED HAEMOGLOBIN INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10056186,10018484,10052424
ABDOMINAL PAIN,abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
ACUTE RENAL FAILURE DUE TO UNINTENTIONAL OVERDOSE OF VALACICLOVIR,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
RESPIRATORY INFECTION,Respiratory tract infection,RESPIRATORY INFECTION,RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10038700,10062352,10038700
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
HEPATIC CYTOLYSIS,hepatic cytolysis,HEPATIC CYTOLYSIS,HEPATOCELLULAR INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10049199,10019837,10049199
URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
PSEUDO-NIKOLSKY SIGN POSITIVE,Nikolsky's sign,NIKOLSKY'S SIGN,NIKOLSKY'S SIGN,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10029415,10029415,10029415
IGG INCREASED (VALUE-13.2),Blood immunoglobulin G increased,IGG INCREASED,BLOOD IMMUNOGLOBULIN G INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10021272,10005596,10021272
CATHETER SEPSIS,Catheter sepsis,CATHETER SEPSIS,DEVICE RELATED SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10053212,10069802,10053212
HEMATOCHEZIA AND HEMODYNAMIC INSTABILITY,Haemodynamic instability,HEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10052076,10052076,10058270
HYPOXEMIA,Hypoxia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021141,10021143,10021142
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
ANOREXIA,Decreased appetite,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10002646
BROMOCRIPTINE-RESISTANT INVASIVE GIANT PROLACTINOMAS,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
ATROPHIC LESIONS OF THE CHEEKS,Mucosal atrophy,MUCOSAL ATROPHY,MUCOSAL ATROPHY,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10067994,10067994,10067994
"ASSUMING A POSTSTREPTOCOCCAL NEUROPSYCHIATRIC DISORDER, THE PATIENT WAS TREATED WITH HIGH-DOSE PENICILLIN (3 X 1 MIO. L.E./ D) FOR THREE DAYS WITHOUT ANY CLINICAL EFFECT",Lack of drug effect ,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PACO2 DECREASED (28 TORR),Pulmonary arterial pressure decreased,PULMONARY ARTERIAL PRESSURE DECREASED,PULMONARY ARTERIAL PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10060231,10060231,10060231
"TENSE, SOMETIMES HEMORRHAGIC BLISTERS",Blood blister,BLOOD BLISTER,BLOOD BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005372,10005372,10005372
PUSTULAR SKIN ERUPTION,pustular skin eruption,PUSTULAR SKIN ERUPTION,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037577,10037888,10037577
SOBOE,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
"THE PATIENT USED METHOTREXATE AND HYDROXYCHLOROQUINE, BOTH FOR MORPHEA PROFUNDAL (OFF LABEL).",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
PARTIAL PRESSURE OF CARBON DIOXIDE OF 3.4 KPA,PCO2 decreased,PARTIAL PRESSURE CO2 DECREASED,PCO2 DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10034181,10034181,10034078
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ISCHEMIA,Ischaemia,ISCHEMIA,ISCHAEMIA,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10061255,10061255,10054438
HEPATITIS C RELAPSE,Hepatitis C,HEPATITIS C RELAPSE,HEPATITIS C,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10070678,10019744,10071127
LOADING CAPACITY REDUCTION,Decreased ventricular preload,DECREASED VENTRICULAR PRELOAD,DECREASED VENTRICULAR PRELOAD,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10050905,10050905,10050905
ABSENT TENDON REFLEXES IN THE LOWER LIMBS,Areflexia,TENDON REFLEX ABSENT,AREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10067218,10003084,10067218
RIGHT SIDED HEMIPLEGIA FOLLOWING HEMOPHAGOCYTIC LYMPHOPHAGOCYTOSIS DUE TO MYCOBACTERIAL INFECTION,Hemiplegia (right),HEMIPLEGIA (RIGHT),HEMIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019470,10019468,10019470
ANION GAP,Anion gap,ANION GAP,ANION GAP,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10002522,10002522,10002522
SMALL PLAQUES OVER ELBOW AND PERIORBITAL REGION,Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
HALLUCINATING,Hallucination,HALLUCINATING,HALLUCINATION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019063,10019063,10019062
MULTIPLE ORGAN DYSFUNCTION,Multiple organ dysfunction syndrome,MULTIPLE ORGAN DYSFUNCTION SYNDROME,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10077361,10077361,10077361
LOSS OF APPETITE,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
"PRANDIAL, NONSPECIFIC THORACALGIA",Thoracalgia,THORACALGIA,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10067524,10008479,10067524
LOW BLOOD PRESSURE,Hypotension,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10024895
NO EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
COMA,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
HYPOXIA,hypoxia,HYPOXIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021143,10021143,10021143
APNEA DUE TO RESPIRATORY DISTRESS FOLLOWING OPIUM POISONING,Apnoea,APNEA,APNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10002974,10002974,10002972
SUICIDE,suicide,SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042462,10010144,10042462
WORSENING OF THE CLINICAL PICTURE,General physical health deterioration,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10049438,10049438,10049438
LATE HYPOXIC CARDIAC ARREST SECONDARY TO CRITICAL ILLNESS POLYNEUROMYOPATHY,cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
DRUG-INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
RAW EYELIDS,Blepharitis,INFLAMMATION OF EYELIDS,BLEPHARITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","LID, LASH AND LACRIMAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10021962,10005148,10021962
NON-IMMEDIATE URTICARIA,urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
SEVERE ALLERGIC REACTION,Allergic reaction,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
SYSTEMIC ASPERGILLOSIS,Aspergillus infection,ASPERGILLOSIS,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003488,10074171,10003488
GROUP WITH HISTORY OF TDP,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
THROMBUS OF THE RIGHT COMMON FEMORAL VEIN,Venous thrombosis,VENOUS THROMBOSIS,VENOUS THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10047249,10047249,10047249
ANAPHYLACTIC SHOCK,Anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
OFF LABEL USE (MANTLE CELL LYMPHOMA),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PATIENT WAS TREATED WITH INSULIN LISPRO AND INSULIN GLARGINE HOWEVER HYPERGLYCAEMIA (IN THE 300 MG/DL RANGE) PERSISTED,Diabetes mellitus inadequate control,TYPE I DIABETES MELLITUS INADEQUATE CONTROL,DIABETES MELLITUS INADEQUATE CONTROL,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10063623,10012607,10063623
INCREASE IN HEPATIC CYTOLYSIS ENZYMES AND INCREASE IN BILIRUBIN,Hepatocellular injury,HEPATIC CYTOLYSIS,HEPATOCELLULAR INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10049199,10019837,10049199
THE PATIENT WAS TREATED WITH METHOTREXATE FOR ECTOPIC PREGNANCY (OFF LABEL USE) WITH NO ADVERSE DRUG REACTION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PRIMAQUINE INDUCED SEVERE ACUTE HAEMOLYTIC ANAEMIA,Haemolytic anaemia,ACUTE HAEMOLYTIC ANAEMIA,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10066625,10018916,10066625
DRESS SYNDROME,dress syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
TRANSIENT FLUSHING OF THE CHEST AND FACE,transient flushing of the chest and face,FLUSHING,FLUSHING,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10016825,10016825,10016825
SEPSIS,sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
SERIOUS LACTATE ACIDOSIS DURING METFORMIN ADMINISTRATION,Acidosis lactic,ACIDOSIS LACTIC,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10000491,10023676,10000491
MOON FACIES,moon facies,MOON FACE,CUSHINGOID,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10027953,10011655,10027953
PRURITUS OCCURRED 1 DAY AFTER WITHDRAWAL,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
TEMPERATURE ELEVATION/FEBRILITY,Body temperature increased,TEMPERATURE ELEVATION,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10043204
"INTERACTION BETWEEN CODEINE, METHADONE AND CLONAZEPAM/ INTERACTION- ADR TO PRESCRIBED MEDICINES/INTERACTION BETWEEN",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
RECURRENT GENERALIZED BULLOUS FIXED DRUG ERUPTION,fixed drug eruption,FIXED DRUG ERUPTION,FIXED ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10016740,10016741,10016740
RETICULOCYTE COUNT OF 0.2 %,Reticulocyte count decreased,RETICULOCYTE COUNT LOW,RETICULOCYTE COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10038793,10038790,10038793
PARKINSONâ€™S FEATURES,Parkinson's disease,PARKINSON'S DISEASE,PARKINSON'S DISEASE,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10061536,10061536,10061536
ACCIDENTAL DRUG OVERDOSE,Accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
QRS COMPLEXES AT 160MSEC,Electrocardiogram QRS complex prolonged,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10014380,10014380,10014380
BLEEDING FROM THE STOMA,Stoma site haemorrhage,STOMA SITE BLEEDING,STOMA SITE HAEMORRHAGE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,STOMA COMPLICATIONS,10022117,10074508,10074508,10059020
DYSPHAGIA,Dysphagia,DYSPHAGIA AGGRAVATED,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10048359,10013950,10048359
EXACERBATION OF GLAUCOMA/ EXACERBATION OF GLAUCOMA RIGHT EYE,Glaucoma aggravated,GLAUCOMA AGGRAVATED,GLAUCOMA,GLAUCOMA AND OCULAR HYPERTENSION,GLAUCOMAS (EXCL CONGENITAL),10015919,10048354,10018304,10048354
"BICARBONATE: 8.1 MMOL/L, SODIUM: 141 MMOL/L, POTASSIUM: 3.9 MMOL/L, CHLORINE: 100 MMOL/L (ANION GAP 36.8 MMOL/L)",Anion gap increased,ANION GAP INCREASED,ANION GAP INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10002528,10002528,10002528
10 EOSINOPHILS,Eosinophil count high,EOSINOPHIL COUNT HIGH,EOSINOPHIL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10014944,10014945,10014944
HEPATIC FUNCTION ABNORMAL,Hepatic function abnormal,HEPATIC FUNCTION ABNORMAL,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019670,10019670,10019670
NAUSEA (GRADE 2),Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
INVASIVE SQUAMOUS CELL CARCINOMA OF THE CONJUNCTIVA WITH LYMPH NODE METASTASES,Malignant neoplasm of conjunctiva,SQUAMOUS CELL CARCINOMA OF CONJUNCTIVA,MALIGNANT NEOPLASM OF CONJUNCTIVA,OCULAR NEOPLASMS,OCULAR NEOPLASMS MALIGNANT (EXCL MELANOMAS),10029104,10079644,10025861,10079644
PULMONARY HYPERTENSION,pulmonary hypertension,PULMONARY HYPERTENSION,PULMONARY HYPERTENSION,PULMONARY VASCULAR DISORDERS,PULMONARY HYPERTENSIONS,10038738,10037400,10037400,10037400
"MULTIPLE CRANIAL NERVE PALSIES FOLLOWING ACUTE LYMPHOBLASTIC LEUKEMIA RELAPSE(BILATERAL OPTIC NERVE, LEFT TRIGEMINAL NERVE PALSY, LEFT FACIAL NERVE-LOWER MOTOR NEURON-TYPE PALSY)",multiple cranial nerve palsies,MULTIPLE CRANIAL NERVE PALSIES,CRANIAL NERVE PALSIES MULTIPLE,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),CRANIAL NERVE DISORDERS NEC,10029205,10028186,10011314,10028186
CHEST CT AND CHEST X RAY SHOWED CONSOLIDATION OF UPPER LOBES DUE TO DISSEMINATED NOCARDIOSIS,Lung consolidation,LUNG CONSOLIDATION,LUNG CONSOLIDATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025080,10025080,10025080
TOTAL T3 OF 297.8 NG/DL,total T3 of 297.8 ng/dL,T3 INCREASED,TRI-IODOTHYRONINE INCREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),THYROID ANALYSES,10022891,10043053,10044596,10043053
BACTERAEMIA CAUSED BY HELICOBACTER CINAEDI,Bacteraemia,BACTERAEMIA,BACTERAEMIA,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10003997,10003997,10003997
ARTHRALGIAS,arthralgia,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
PATIENT ADMITTED TO HAVE INGESTED 12 TABLETS CONTAINING 25 MG DEM/TOTAL DOSE: 600 M DAY,intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
LACTIC ACID INCREASED (2.4MMOL/L),Blood lactic acid increased,BLOOD LACTIC ACID INCREASED,BLOOD LACTIC ACID INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10005635,10005635,10005635
VASOPLEGIC SYNDROME,Vasoplegia syndrome,VASOPLEGIC SYNDROME,VASOPLEGIA SYNDROME,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,CARDIAC AND VASCULAR PROCEDURAL COMPLICATIONS,10022117,10067080,10067080,10067654
MINIMAL IMPROVEMENT IN SYMPTOMS (SUBTHERAPEUTIC RESPONSE WITH NO ADR),subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
CREPITATION ON BOTH THE LUNGS,Rales,LUNG CREPITATION,RALES,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10050052,10037833,10050052
HYPERGLYCAEMIA/ SUGAR LEVEL WAS ABOUT 400MG/DL / SUGARS UP TO 200-250 MG/DL,Hyperglycaemia,HYPERGLYCAEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020635
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HYPERLACTATAEMIA DUE TO ACUTE KIDNEY FAILURE,Hyperlactacidaemia,HYPERLACTATAEMIA,HYPERLACTACIDAEMIA,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10058603,10020660,10058603
MINOR BLEEDING AT THE SITE OF DRAIN REMOVAL,Post procedural haemorrhage,POST PROCEDURAL HAEMORRHAGE,POST PROCEDURAL HAEMORRHAGE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10051077,10051077,10051077
ATROPINISM FOLLOWING INTENTIONAL DRUG OVERDOSE,intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
HIGH GRADE FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
HYPOTHERMIC,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
PYREXIA,pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
DISTAL RENAL TUBULAR ACIDOSIS,Renal tubular acidosis,RENAL TUBULAR ACIDOSIS,RENAL TUBULAR ACIDOSIS,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10038535,10038535,10038535
SOMATOSENSORY EVOKED POTENTIALS ABNORMAL,Somatosensory evoked potentials abnormal,SOMATOSENSORY EVOKED POTENTIALS ABNORMAL,SOMATOSENSORY EVOKED POTENTIALS ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10049464,10049464,10049464
LACK OF THERAPEUTIC EFFECT/ MYELOMA PROGRESSION,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LYMPHOPENIA,Lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
TOXICODERMA-LIKE SKIN ERUPTION OF THE TRUNK,Toxicoderma,TOXICODERMA,TOXIC SKIN ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10044259,10057970,10044259
AUDITORY HULLICINATIONS,auditory hullicinations,HALLUCINATION AUDITORY,"HALLUCINATION, AUDITORY",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019064,10019070,10019064
CLOSTRIDIUM DIFFICILE DIARRHEA,Clostridium difficile colitis,C.DIFFICILE DIARRHEA,CLOSTRIDIUM DIFFICILE COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10006835,10009657,10006834
DYSPNOE,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
LIGHTHEADEDNESS,Dizziness,LIGHTHEADEDNESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10024461,10013573,10024492
DRUG EXPOSURE DURING PREGNANCY WITH NO ADR,"drug exposure during pregnancy, third trimester","DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
SINUS TACHYCARDIA,Sinus tachycardia,SINUS TACHYCARDIA,SINUS TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040752,10040752,10040752
CHILLS,chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
GENERAL PATIENT NON COMFORT,Discomfort,DISCOMFORT,DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10013082,10013082,10013082
A DEPRESSED LV EJECTION FRACTION OF 20%,Ejection fraction decreased,LEFT VENTRICULAR EJECTION FRACTION DECREASED,EJECTION FRACTION DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10053222,10050528,10053222
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
INTERSTITIAL PNEUMONIA,Interstitial lung disease,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
"COUGHING OCCURRED ABOUT A MONTH AGO, AND GRADUALLY BECAME WORSE",Cough aggravated,COUGH AGGRAVATED,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10048381,10011224,10048381
IBUPROFEN USED FOR COXITE,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
INCREASED ALKALINE PHOSPHATASE (179 U/L),Blood alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
HYPOXEMIA,Hypoxia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021141,10021143,10021142
ANAPHYLACTIC SHOCK,anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
HYPOURICAEMIA,Hypouricaemia,HYPOURICAEMIA,HYPOURICAEMIA,PURINE AND PYRIMIDINE METABOLISM DISORDERS,DISORDERS OF PURINE METABOLISM,10027433,10021131,10021131,10021131
SWELLING ABOUT THE SIZE OF A BASEBALL AT THE INJECTION SITE,vaccination site swelling,VACCINATION SITE SWELLING,VACCINATION SITE SWELLING,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10069620,10069620,10069620
FLUSHED FACE,Flushing,FLUSHING,FLUSHING,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10016825,10016825,10016825
"MULTIPLE LESIONS, IN RIGHT FRONTAL LOBE, LEFT PARIETAL LOBE, LEFT TEMPORAL LOBE, LEFT INSULAR LOBE AND ON THE MENINGEAL LAYER OF LEFT TEMPORAL REGION",Central nervous system lesion,BRAIN LESION,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10067294,10051290,10067294
PREDNISONE USED FOR ACQUIRED HEMOPHILIA A,Prednisone used for acquired hemophilia A,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
CONTINUED DULOXETINE THROUGHOUT PREGNANCY AND LACTATION,Exposure via breast milk,DRUG EXPOSURE VIA BREAST MILK,EXPOSURE VIA BREAST MILK,"EXPOSURES, CHEMICAL INJURIES AND POISONING",PATHWAYS AND SOURCES OF EXPOSURE,10022117,10051075,10080751,10051075
INCREASE IN FREQUENCY AND INTENSITY OF SEIZURES,Convulsions aggravated,CONVULSIONS AGGRAVATED,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10010915,10039906,10010915
"CT OF ABDOMEN AND PELVIS REVEALED DILATED AND FLUID FILLED CECUM, ASCENDING,TRANSVERSE AND DESCENDING COLON AND TINY LOCULES OF GAS IN SPLENIC FLEXURE AND DESCENDING COLON",Computerised tomogram abnormal,CT ABNORMAL,COMPUTERISED TOMOGRAM ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",IMAGING PROCEDURES NEC,10022891,10011600,10010235,10011600
PUPILS UNEQUAL,Pupils unequal,PUPILS UNEQUAL,PUPILS UNEQUAL,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10037538,10037538,10037538
RENAL FUNCTION IMPAIRMENT,impaired renal function,IMPAIRED RENAL FUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10021523,10062237,10021523
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
SHE BECAME CUSHINGOID,cushingoid,CUSHINGOID,CUSHINGOID,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011655,10011655,10011655
BLADDER PERFORATION,Bladder perforation,BLADDER PERFORATION,BLADDER PERFORATION,BLADDER AND BLADDER NECK DISORDERS (EXCL CALCULI),BLADDER DISORDERS NEC,10038359,10063575,10063575,10063575
SECONDARY WOUND INFECTION DUE TO MYCOBACTERIUM HAEMOPHILUM,wound infection bacterial,WOUND INFECTION BACTERIAL,WOUND INFECTION BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10065240,10065240,10065240
ATTEMPTED HOMICIDE,Victim of crime,VICTIM OF CRIME,VICTIM OF CRIME,LEGAL ISSUES,CRIME VICTIMS,10041244,10061409,10061409,10061409
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SEVERE PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
LACTIC ACIDOSIS (PH-7.28) FOLLOWING HYPOGLYCEMIA,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
BRISK REFLEXES IN LOWER LEGS,Hyperreflexia,INCREASED REFLEXES,HYPERREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10020745,10020745,10021676
MUCOCUTANEOUS TOXICITY INDUCED BY LOW DOSE METHOTREXATE,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
CYTOMEGALOVIRUS INFECTION,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011831,10011831,10011831
HYPOTENSION FOLLOWING EXPOSURE TO TOXIC AGENTS,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
SODIUM VALPROATE-INDUCED ENCEPHALOPATHY,encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
CENTRAL PLEURITIC CHEST PAIN,Pleuritic pain,PLEURITIC PAIN,PLEURITIC PAIN,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10035623,10035623,10035623
ASYMMETRIC WEAKNESS FOLLOWING A POLYSUBSTANCE OVERDOSE/ LEFT SHOULDER WEAKNESS/RIGHT KNEE EXTENSION WEAKNESS,Weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
LOW PLASMA SODIUM CONCENTRATION (105 MMOL/ LITRE),Hyponatraemia,HYPONATRAEMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021036
LOSS OF COLLAGEN IV  IN VACUOLES AT THE DEJ.,Collagen disorder,COLLAGEN DISORDER,COLLAGEN DISORDER,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),CONNECTIVE TISSUE DISORDERS NEC,10028395,10009903,10009903,10009903
PROGRESSIVE DISEASE,Chronic lymphocytic leukemia,CHRONIC LYMPHOCYTIC LEUKEMIA,CHRONIC LYMPHOCYTIC LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS CHRONIC LYMPHOCYTIC,10029104,10008976,10008958,10008976
PURPLE BRUISING RASH UNDER HER RIGHT BREAST AND SIX TO SEVEN REDDISH SPOTS ON TEH LEFT HIP,Contusion,BRUISE,CONTUSION,INJURIES NEC,SKIN INJURIES NEC,10022117,10050584,10050584,10006502
POOR PO INTAKE,Hypophagia,ORAL INTAKE REDUCED,HYPOPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10063889,10063743,10063889
VIRAL INFECTION,Viral infection,VIRAL INFECTION,VIRAL INFECTION,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10047461,10047461,10047461
FLORID ULCERATIVE COLITIS/ INFLAMMATORY BOWEL DISEASE,Colitis ulcerative,ULCERATIVE COLITIS,COLITIS ULCERATIVE,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009900,10009900,10045365
"UNILATERAL INVOLUNTARY MOVEMENTS OF RIGHT HAND AND FOOT AROSE THAT BECOME MORE EVIDENT ON NEXT DAY,INVOLVING UPPER AND LOWER EXTREMETIES AND VERLAPPING WITH PROXIMAL BALISTIC MOVEMENTS",involuntry muscle movement,INVOLUNTARY MUSCLE MOVEMENT,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10022898,10013916,10022898
CAMPTOCORMIA,Camptocormia,CAMPTOCORMIA,CAMPTOCORMIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10069646,10069646,10069646
SEGMENTED NEUTROPHILS DECREASED (4%),Neutrophil count decreased,SEGMENTED NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10071074,10029366,10071074
EMOTIONAL LABILITY,Affect lability,EMOTIONAL LABILITY,AFFECT LABILITY,MOOD DISORDERS AND DISTURBANCES NEC,AFFECT ALTERATIONS NEC,10037175,10014554,10054196,10014555
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
ENTEROCOCCUS FECALIS INFECTION,Enterococcal infection,ENTEROCOCCUS FAECIUM INFECTION,ENTEROCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,ENTEROCOCCAL INFECTIONS,10021881,10054241,10061124,10054241
RIGHT UPPER QUADRANT ABDOMINAL TENDERNESS,Abdominal tenderness,UPPER ABDOMINAL TENDERNESS,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10069064,10000097,10069064
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
DRUG USE FOR UNAPPROVED INDICATION (OFF LABEL USE WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
IMATINIB MESILATE USED FOR TREATMENT OF SCLERODERMATOUS GRAFT VERSUS HOST DISEASE (OFF LABEL USE WITH NO ADR),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HYPOTONIC,Hypotonia,HYPOTONIA,HYPOTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10021118,10021118,10021118
OFF LABEL-DOSE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
"PRESENCE OF BUPRENORPHINE, 3,4-METHYLENEDIOXYPYROVALERONE, MORPHINE, NORDAZEPAM,MIDAZOLAM AND SUFENTANIL",Drug screen positive,DRUG SCREEN POSITIVE,DRUG SCREEN POSITIVE,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,TOXICOLOGY LABORATORY ANALYSES,10022891,10049177,10049177,10049177
ANAPHYLACTOID SYMPTOMS ON CESSATION OF RANITIDINE,Withdrawal syndrome,WITHDRAWAL SYMPTOM,WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10073281,10048010,10073281
LACK OF EFFICACY,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
GALLBLADDER HAEMORRHAGE,Haemobilia,GALLBLADDER HAEMORRHAGE,HAEMOBILIA,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10058950,10058947,10058950
SYSTEMIC CONTACT DERMATITIS FROM PREDNISOLONE,Dermatitis contact,CONTACT DERMATITIS,DERMATITIS CONTACT,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10012442,10012442,10010790
THE PATIENT DEVELOPED BILATERAL HYPOACUSIA DUE TO ANTIBIOTIC TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
PREMATURE BABY,Premature baby,PREMATURE BABY,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036590,10036590,10036590
LOE IN AN UNAPPROVED INDICATION (CUTANEOUS LEISHMANIASIS),Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
WORSENING OF DESCENDING NECROTIZING MEDIASTINITIS,Necrotizing mediastinitis,NECROTIZING MEDIASTINITIS,MEDIASTINITIS,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10069401,10027082,10069401
CANDIDIASIS,Candida infection,CANDIDIASIS,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10007152,10074170,10007152
CHRONIC MYELOID LEUKEMIA-BLAST CRISIS DUE TO IMATINIB RESISTANCE,Blast crisis in myelogenous leukemia,BLAST CRISIS IN MYELOGENOUS LEUKEMIA,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS MYELOID NEC,10029104,10060564,10050282,10060564
BRONCHOSPASM (SAO2 86% WITH LOSS OF END-TIDAL CO2 TRACING),Bronchospasm,BRONCHOSPASM,BRONCHOSPASM,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10006482,10006482,10006482
"FALLING DOWN FROM A CHAIR, FALLING OVER A COUPLE OF TIMES",falling down,FALLING DOWN,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016178,10016173,10016178
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
URINARY TRACT INFECTION,urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
DRUG EXPOSURE IN UTERO,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
"DRUG INDUCED NON-BLANCHABLE, NON-PRURITIC ,ERYTHEMATOUS, MACULAR RASH INVOLVING THE EXTENSOR ASPECTS OF BOTH LEGS",Rash erythematous,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015243
INCREASE OF SERUM CREATININE LEVEL FROM 1.8 TO 4.2 MG/DL,Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
CRP INCREASE (158 MG/L),C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
ANTI YELLOW FEVER VIRUS IMMUNOGLOBULIN G ANTIBODY NEGATIVE,antibody test negative,ANTIBODY TEST NEGATIVE,ANTIBODY TEST NEGATIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOLOGY ANALYSES NEC,10022891,10061426,10061426,10061426
HEMATURIA,Haematuria,HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018867,10018867,10019450
DIFFUSE DRUG ERUPTION,Drug eruption,DRUG ERUPTION,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10013687,10013687,10013687
CELLULITIS,cellulitis,CELLULITIS,CELLULITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10007882,10007882,10007882
LEG SWOLLEN,Injection site swelling,INJECTION SITE SWELLING,INJECTION SITE SWELLING,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10053425,10053425,10053425
HYPOTHERMIA,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
HUMAN ORF DISEASE DUE TO PARAPOX VIRUS,Parapox virus infection,PARAPOX VIRUS INFECTION,PARAPOX VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,PARAPOX VIRAL INFECTIONS,10021881,10072078,10072078,10072078
BLURRY VISION IN BOTH EYE,blurry vision,BLURRY VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10005889,10047513,10005889
"RASH ON HER TRUNK AND SPREAD TO HER NECK, ARMS, AND LEGS",generalized rash,GENERALIZED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10049201,10037858,10049201
TORSADES DE POINTES TACHYCARDIA,Torsade de pointes,TORSADES DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044067
SEVERE MYELOSUPPRESSION,Severe myelosuppression,MYELOSUPPRESSION ADULT,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10028585,10065553,10028585
SEVERE MOTOR WEAKNESS,Muscular weakness,MUSCLE WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028372,10028372,10028350
ULCER AND SUBCUTANEOUS NODULE WHERE HE WAS RECEIVING LEUPRORELIN ACCETATE INJECTIONS,application site nodule,APPLICATION SITE NODULE,APPLICATION SITE NODULE,ADMINISTRATION SITE REACTIONS,APPLICATION AND INSTILLATION SITE REACTIONS,10018065,10050101,10050101,10050101
LATE PHASE REACTION,Type IV hypersensitivity reaction,DELAYED TYPE HYPERSENSITIVITY,TYPE IV HYPERSENSITIVITY REACTION,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10012210,10053613,10012210
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,Posterior reversible encephalopathy syndrome,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10071066,10071066,10071066
MACULOPAPULAR ERUPTION,Rash maculo-papular,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10037868
DRUG EXPOSURE IN UTERO,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
MARKED BONE MARROW TRILINEAGE DYSPLASIA/MYELODYSPLASTIC SYNDROME,Myelodysplastic syndrome,MYELODYSPLASTIC SYNDROME,MYELODYSPLASTIC SYNDROME,LEUKAEMIAS,MYELODYSPLASTIC SYNDROMES,10029104,10028533,10028533,10028533
SKIN LESIONS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
PERSISTENCE OF INTRACTABLE DIGITAL ULCER ON RIGHT TOE DUE TO A CONTACT ALLERGY CAUSED BY POVIDONE-IODINE AND CHLORHEXIDINE DIGLUCONATE,Skin ulcer,DIGITAL ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10072119,10040943,10072119
HEPATITIS,Hepatitis,HEPATITIS,HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019717,10019717,10019717
CIPROFLOXACIN INDUCED TONIC-CLONIC SEIZURES,tonic-clonic seizures,TONIC-CLONIC SEIZURES,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10044000,10018100,10044000
FELT TIRED IN THE MORNING,Fatigue,TIREDNESS,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10043890
AMMONIA INCREASED,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
"THE PATIENT RECEIVED CHEMOTHERAPY  WITH  CISPLATIN  PLUS  PEMETREXED TO TREAT MALIGNANT PLEURAL MESOTHELIOMA,  TO WHICH HE SHOWED A PARTIAL RESPONSE (SUBTHERAPEUTIC RESPONSE)",subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
RHABDOMYOLYSIS,rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
OCCASIONAL SWELLING OF THE CLITORIS,genital swelling,GENITAL SWELLING,GENITAL SWELLING,REPRODUCTIVE TRACT DISORDERS NEC,REPRODUCTIVE TRACT SIGNS AND SYMPTOMS NEC,10038604,10067639,10067639,10067639
LACK OF DRIUG EFFECT,LACK OF DRIUG EFFECT,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
16 YEAR OLD BOY CONDITIONING WITH FLUDARABINE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"LIVER WAS CONSIDERABLY FIRM, SWOLLEN, AND CONTAINED PATCHY NECROTIC AREAS",Liver inflammation,LIVER INFLAMMATION,HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10078239,10019717,10078239
"INTENSELY PRURITIC RASH ON HIS HANDS, LEGS, AND TRUNK",Rash pruritic,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10037085
ANAPLASTIC EVOLUTION,Neoplasm malignant,ANAPLASTIC CARCINOMA,NEOPLASM MALIGNANT,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10072461,10028997,10072461
ANAEMIA WAS AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
"HALLUCINATIONS, NON COMPLIANCE","HALLUCINATIONS, NON COMPLIANCE","HALLUCINATIONS, MIXED","HALLUCINATIONS, MIXED",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019079,10019079,10019079
WEAKNESS,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
ASSOCIATED PAINFUL CERVICAL ADENOPATHIES,associated painful cervical adenopathies,LYMPHADENOPATHY CERVICAL,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025200,10025197,10025200
LOST SPONTANEOUS RESPIRATION,Respiration spontaneous decreased,RESPIRATION SPONTANEOUS DECREASED,HYPOPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038657,10021079,10038657
DYSPHAGIA,Dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
CONVEXAL SUBARACHNOID HAEMORRHAGE,Subarachnoid haemorrhage,SUBARACHNOID HAEMORRHAGE,SUBARACHNOID HAEMORRHAGE,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10042316,10042316,10042316
PHOTOPHOBIA,Photophobia,PHOTOPHOBIA,PHOTOPHOBIA,OCULAR SENSORY SYMPTOMS NEC,OCULAR SENSATION DISORDERS,10015919,10034960,10034960,10034960
COLOR VISION ABNORMALITY,Colour blindness,DEFECTIVE COLOR VISION,COLOUR BLINDNESS,EYE DISORDERS CONGENITAL,OCULAR DISORDERS CONGENITAL NEC,10010331,10010050,10010050,10055520
ACUTE CEREBRAL ISCHEMIA,Cerebral ischaemia,CEREBRAL ISCHEMIA,CEREBRAL ISCHAEMIA,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008120,10008120,10008121
VISUAL HALLUCINATIONS/HALLUCINATIONS/FIGURE DRESSED IN BLACK COAT AND HAT/SAW SPIDERS ON,"hallucination, visual",HALLUCINATION VISUAL,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019075,10019075,10019068
VIREMIA,Viraemia,VIREMIA,VIRAEMIA,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10058874,10058874,10054688
DELUSIONAL MOOD/RELIGIOUS DELUSION,delusion,DELUSION,DELUSION,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10012239,10012239,10012239
ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY-MEDIATED RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS,Glomerulonephritis rapidly progressive,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,NEPHROPATHIES,GLOMERULONEPHRITIS AND NEPHROTIC SYNDROME,10038359,10018378,10018378,10018378
MYCOPHENOLATE MOFETIL USE FOR SYSTEMIC LUPUS ERYTHEMATOSUS,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
RHINORRHOEA,rhinorrhoea,RHINORRHOEA,RHINORRHOEA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10039101,10039101,10039101
ERYTHEMA MULTIFORME,Erythema multiforme,ERYTHEMA MULTIFORME,ERYTHEMA MULTIFORME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10015218,10015218,10015218
SEPSIS DUE TO STAPHYLOCOCCUS HOMINIS,Staphylococcal infection,STAPHYLOCOCCAL INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10058080,10058080,10058080
PLAQUE ON THE RIGHT FOREARM,Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
INFLAMMATORY INFILTRATION,Lung infiltration,PULMONARY INFILTRATION,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025102,10025102,10037411
LEFT KNEE ARTHRITIS FOLLOWING IMMUNE RECONSTITUTION INFLAMMATORY (IRIS) SYNDROME,Arthritis,KNEE ARTHRITIS,ARTHRITIS,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10056617,10003246,10067624
DEVELOPMENT OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA,Acute lymphoblastic leukemia,ACUTE LYMPHOBLASTIC LEUKEMIA,ACUTE LYMPHOCYTIC LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE LYMPHOCYTIC,10029104,10000845,10000846,10000845
RESPIRATORY FAILURE,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
AMISULPRIDE TOXICITY,Toxicity to various agents,TOXICITY TO VARIOUS AGENTS,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10070863,10070863,10070863
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
SPEECH IMPAIRMENT,Speech disorder,SPEECH IMPAIRMENT NOS,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041469,10041466,10041469
HYPERMAGNESEMIA AT BIRTH FOLLOWING DRUG EXPOSURE IN UTERO,Hypermagnesaemia,HYPERMAGNESEMIA,HYPERMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10020669,10020669,10020670
SEVERE NECROSIS,Necrosis,NECROSIS,NECROSIS,TISSUE DISORDERS NEC,NECROSIS NEC,10018065,10028851,10028851,10028851
PROGRESS AND RELAPSE OF THE DISEASE MALIGNANT NEOPLASM,metastases to heart,METASTASES TO HEART,METASTASES TO HEART,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10049717,10049717,10049717
IMATINIB-RESISTANT METASTATIC LESIONS IN THE REMNANT LIVER,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
PULMONARY ARTERIAL HYPERTENSION TYPE III DUE TO LUNG FIBROSIS,Pulmonary arterial hypertension,PULMONARY ARTERIAL HYPERTENSION,PULMONARY ARTERIAL HYPERTENSION,PULMONARY VASCULAR DISORDERS,PULMONARY HYPERTENSIONS,10038738,10064911,10064911,10064911
TENDERNESS IN UPPER ABDOMEN,Abdominal tenderness,ABDOMINAL TENDERNESS,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000097,10000097,10000097
ACYCLOVIR RESISTANCE TO VARICELLA ZOSTER VIRUS,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
DRUG INEFFECTIVE,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
RIGHT BUNDLE BRANCH BLOCK,right bundle branch block,RIGHT BUNDLE BRANCH BLOCK,BUNDLE BRANCH BLOCK RIGHT,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10039147,10006582,10039147
RESPIRATORY INSUFFICIENCY,Respiratory failure,RESPIRATORY INSUFFICIENCY,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038701
METHOTREXATE AND IMATINIB MESILATE USED FOR TREATMENT OF SCLERODERMATOUS GRAFT VERSUS HOST DISEASE (OFF LABEL USE WITH NO ADR),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA,refractory cytopenia with multilineage dysplasia,REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA,REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA,LEUKAEMIAS,MYELODYSPLASTIC SYNDROMES,10029104,10067959,10067959,10067959
"IMMEDIATE, NON-ANAPHYLAXIS HYPERSENSITIVITY",Hypersensitivity,HYPERSENSITIVITY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020751,10020751,10020751
MARKED TINNITUS,tinnitus,TINNITUS,TINNITUS,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10043882,10043882,10043882
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
PATIENT TREATED WITH CYCLOPHOSPHAMIDE FOR PURE RBC APLASIA (OFF LABEL USE) WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ELECTRIC SHOCK SENSATION,Electric shock sensation,ELECTRIC SHOCK SENSATION,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10014358,10033775,10014358
BRONCHOPNEUMONIA OF THE LUNGS,Pneumonia,BRONCHOPNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10006469,10035664,10006469
NEONATAL HYPOCALCAEMIA FOLLOWING DRUG EXPOSURE IN UTERO,Neonatal hypocalcaemia,NEONATAL HYPOCALCAEMIA,NEONATAL HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10079306,10079306,10079306
"DRUG INTERACTION BETWEEN RIFAMPICIN, VORICONAZOLE, CICLOSPORIN AND METHYLPREDNISOLONE",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
LACK OF EFFICACY/SHOWED A PARTIAL REMISSION,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
PSYCHOTIC MANIA,Psychosis manic,PSYCHOSIS MANIC,MANIA,MANIC AND BIPOLAR MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH MANIC SYMPTOMS,10037175,10037239,10026749,10037239
PANCYTOPENIA,pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
MULTIORGAN FAILURE FOLLOWING HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS SECONDARY TO DISSEMINATED HISTOPLASMOSIS,Multiple organ dysfunction syndrome,MULTIORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028162
MUEHRCKEâ€™S LINES,Leukonychia,LEUKONYCHIA,NAIL DISCOLOURATION,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10050658,10028692,10050658
DIPLOPIA,Diplopia,DIPLOPIA,DIPLOPIA,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10013036,10013036,10013036
FLARE UP OF ADULT STILL'S DISEASE,Still's disease,ADULT ONSET STILL'S DISEASE,STILL'S DISEASE,JOINT DISORDERS,RHEUMATOID ARTHROPATHIES,10028395,10079456,10042061,10079456
RENAL FAILURE,Renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
WEIGHT LOSS OF 12 KG DURING LAST  4 MONTHS FOLLOWING LOSS OF APPETITE,weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
RIGHT LEG SUBCUTANEOUS PHAEOHYPHOMYCOSIS (EXOPHIALA JEANSELMEI),Phaehyphomycosis,PHAEHYPHOMYCOSIS,PHAEHYPHOMYCOSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10034799,10034799,10034799
DARK URINE,Chromaturia,URINE DISCOLORATION,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10046629,10008796,10046628
ELEVATED C-REACTIVE PROTEIN (43MG/L),C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
EPISODIC TREMOR,tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
HEAD HURT,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
PATIENT WAS ADMINISTERED LEVOTHYROXINE SODIUM FOR FETAL GOITROUS HYPOTHYROIDISM (DRUG EXPOSURE DURING PREGNANCY) WITH NO ADVERSE DRUG REACTION,"Drug exposure during pregnancy, third trimester","DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
BUT LED TO HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
GRADE 3 MUCOSITIS,mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
JAUNDICED,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
INGESTION OF TWO TABLETS OF OLANZAPINE (15 MG EACH) WHICH FATHER WAS TAKING FOR PSYCHIATRIC ILLNESS,accidental drug intake by child,ACCIDENTAL DRUG INTAKE BY CHILD,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,ACCIDENTAL EXPOSURES TO PRODUCT,10022117,10064368,10073318,10064368
STOPPED DEVELOPING,Development psychomotor impaired,DEVELOPMENT PSYCHOMOTOR IMPAIRED,PSYCHOMOTOR SKILLS IMPAIRED,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10012554,10049215,10012554
PSOAS HEMATOMA,psoas hematoma,HEMATOMA MUSCLE,MUSCLE HAEMORRHAGE,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10019433,10028309,10019433
REITER'S SYNDROME,Reiter's syndrome,REITER'S SYNDROME,REITER'S SYNDROME,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10038294,10038294,10038294
INTRA AND SUBRETINAL HAEMORRHAGE,Retinal haemorrhage,RETINAL HAEMORRHAGE,RETINAL HAEMORRHAGE,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINAL BLEEDING AND VASCULAR DISORDERS (EXCL RETINOPATHY),10015919,10038867,10038867,10038867
ADRENAL SUPPRESSION,Adrenal suppression,ADRENAL SUPPRESSION,ADRENAL SUPPRESSION,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001382,10001382,10001382
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
THE IMMUNIZATION WITH BCG VACCINEWAS ACCIDENTALLY PERFORMED INSTEAD OF MEASLES-MUMPS-RUBELLA (MMR) VACCINE,Wrong drug administered,WRONG VACCINE ADMINISTERED,WRONG DRUG ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10063978,10048055,10063978
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DELUSION OF GRANDIOSITY,Delusion of grandeur,GRANDIOSE DELUSION,DELUSION OF GRANDEUR,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10012241,10012241,10018669
"RESISTANCE TO IMATINIB, DASATINIB AND NILOTINIB",Multiple-drug resistance,MULTIPLE-DRUG RESISTANCE,MULTIPLE-DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048723,10048723,10048723
ANAPHYLACTIC REACTION WITH FIRST DOSE OF RANITIDINE,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
HE INADVERTENTLY RECEIVED ORAL ACETAMINOPHEN SUSPENSION BY PERIPHERAL INTRAVENOUS LINE,Incorrect route of drug administration,WRONG ROUTE OF ADMINISTRATION,INCORRECT ROUTE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10048057,10064304,10048057
MULTIORGAN NECROTIZING GRANULOMATOUS VASCULITIS,necrotizing granulomatous vasculitis,NECROTIZING GRANULOMATOUS VASCULITIS,GRANULOMATOSIS WITH POLYANGIITIS,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10028890,10072579,10028890
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
VISUAL HALLUCINATIONS,"Hallucination, visual",VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019075,10019075,10047570
FEBRILE NEUTROPENIA/GRADE 4 NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
DIRECT BILIRUBIN (295.6 MICROMOL/L),Bilirubin conjugated increased,DIRECT BILIRUBIN INCREASED,BILIRUBIN CONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10013038,10004685,10013038
SEVERE PERIPHERAL NEUROTOXICITY,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
SEVERE ELECTROLYTE IMBALANCE,Electrolyte imbalance,ELECTROLYTE IMBALANCE,ELECTROLYTE IMBALANCE,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10014418,10014418,10014418
ALLERGIC REACTIONS,allergic reactions,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
FREE T4 ABNORMAL,Thyroxine free abnormal,FREE T4 ABNORMAL,THYROXINE FREE ABNORMAL,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),THYROID ANALYSES,10022891,10017356,10055158,10017356
DECLINE IN COGNITION,Cognitive disorder,COGNITIVE DISORDER,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10057668,10057668,10057668
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
ACIDEMIA,acidemia,ACIDEMIA,ACIDOSIS,ACID-BASE DISORDERS,MIXED ACID-BASE DISORDERS,10027433,10060694,10000486,10060694
"BLOOD SMEAR SHOWED HYPERSEGMENTED NEUTROPHILS, SMALL PLATELETS, MILD HYPOREGENERATIVE PANCYTOPENIA AND MORPHOLOGICAL DATA SUGGESTIVE OF DRUG TOXICITY",Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
MYELOSUPPRESSION FOLLOWING METHOTREXATE POISONING,myelosuppression following methotrexate poisoning,BONE MARROW DEPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10005986
EMPHYSEMA,Emphysema,EMPHYSEMA,EMPHYSEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10014561,10014561,10014561
DIARRHEA,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
LEUKOCYTOSIS (11800/MM3),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
HAEMATOMA/EXTENSIVE HEMATOMA IN THIGH AND SHIN AREA,Haematoma,HAEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10018852
APHASIA,aphasia,APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002948,10002948,10002948
DECREASED ACUITY,Visual acuity decreased,VISUAL ACUITY DECREASED,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10049061,10047531,10049061
"WORSENED WITH VISCERAL, AUDITORY AND VISUAL HALLUCINATION",Hallucination,HALLUCINATION,HALLUCINATION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019063,10019063,10019063
MATERNAL DRUG EXPOSURE DURING DELIVERY,Maternal exposure during delivery,MATERNAL EXPOSURE DURING DELIVERY,MATERNAL EXPOSURE DURING DELIVERY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071407,10071407,10071407
ERYTHEMA MULTIFORME-TYPE DRUG ERUPTION,Erythema multiforme,ERYTHEMA MULTIFORME,ERYTHEMA MULTIFORME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10015218,10015218,10015218
LACK OF IMPROVEMENT AFTER 18 MONTHS OF TREATMENT/ LACK OF DRUG EFFECT (PRIMARY RESISTANCE TO IMATINIB),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
INCREASED BLEEDING SYMPTOM FOLLOWING PLATELET DYSFUNCTION,Haemorrhagic diathesis,AGGRAVATED BLEEDING TENDENCY,HAEMORRHAGIC DIATHESIS,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),BLEEDING TENDENCIES,10005329,10066486,10062713,10066486
METHOTREXATE ENCEPHALOPATHY,Toxic encephalopathy,DRUG-INDUCED ENCEPHALOPATHY,TOXIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10049035,10044221,10049035
ACUTE ANTIBODY-MEDIATED LIVER TRANSPLANT REJECTION,acute antibody-mediated liver transplant rejection,LIVER TRANSPLANT REJECTION,LIVER TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10024715,10024715,10024715
ACUTE MYOCARDIAL INFARCTION WITH ST ELEVATION,Acute myocardial infarction,ACUTE MYOCARDIAL INFARCTION,ACUTE MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10000891,10000891,10000891
E.FAECALIS MENINGITIS,Meningitis enterococcal,ENTEROCOCCAL MENINGITIS,MENINGITIS ENTEROCOCCAL,BACTERIAL INFECTIOUS DISORDERS,ENTEROCOCCAL INFECTIONS,10021881,10027232,10027232,10014890
HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
GENERALIZEDD UPPER ABDOMINAL PAIN NOT RESTRICTED TO THE EPIGASTRIUM,Abdominal pain upper,UPPER ABDOMINAL PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000087,10000087,10046272
AMMONIA INCREASED,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
DECREASED GLUCOSE LEVEL IN CSF (2 MMOL/L),CSF glucose decreased,CSF GLUCOSE DECREASED,CSF GLUCOSE DECREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10011537,10011537,10011537
TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
HYPERKALEMIA,hyperkalemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020647,10020646,10020647
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
COAGULOPATHY FOLLOWING SALICYIC ACID INTOXICATION,coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
DRUG POISONING,drug poisoning,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
NO BENEFIT,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
AGGRAVATION OF POLLAKIURIA SYMPTOM,Pollakiuria,POLLAKIURIA,POLLAKIURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10036018,10036018,10036018
DEEP TENDON REFLEX WAS SLUGGISH,tendon reflex decreased,TENDON REFLEX DECREASED,HYPOREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10043245,10021089,10043245
LIGHTHEADED WITH ASSOCIATED NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
"DESPITE THIS, HE REMAINED PERSISTENTLY VASOPLEGIC (SVR 440 DYNE/S/CM5)",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
RESPIRATORY DETERIORATION,respiratory insufficency,RESPIRATORY INSUFFICIENCY,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038701,10038695,10038701
"APPLICATION SITE OEDEMA, ERYTHEMA",Vaccination site inflammation,VACCINATION SITE INFLAMMATION,VACCINATION SITE INFLAMMATION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10068878,10068878,10068878
THESE MEDICATIONS WERE POORLY TOLERATED DUE TO NAUSEA AND FLUID RETENTION,Fluid retention,FLUID RETENTION,FLUID RETENTION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME INCREASED,10027433,10016807,10016807,10016807
TACHYCARDIC,Tachycardic,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
BONE EXPOSURE IN JAW AFTER 1 WEEK,Exposed bone in jaw,EXPOSED BONE IN JAW,EXPOSED BONE IN JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10071014,10071014,10071014
OSTEOPOROTIC LUMBAR VERTEBRAL FRACTURES,Osteoporosis steroid-induced,OSTEOPOROSIS STEROID-INDUCED,OSTEOPOROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10031287,10031282,10031287
C-REACTIVE PROTEIN (CRP) INCREASED (6 MG/DL),C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
ANTIBIOTIC-ASSOCIATED DIARRHEA,Antibiotic-associated diarrhea,ANTIBIOTIC-ASSOCIATED DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10002739,10012735,10002739
SNEEZING,Sneezing,SNEEZING,SNEEZING,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10041232,10041232,10041232
SIGNS OF INFLAMMATION AND INFECTION,Infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
PREGNANT WOMAN WAS ADMINISTERED MESALAZINE FOR THE TREATMENT OF ULCERATIVE COLITIS (DRUG EXPOSURE DURING PREGNANCY) WITH NO ADVERSE EVENT,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
APPLICATION SWELLING OF THE RIGHT SHOULDER IN DIAMETER 3X3CM AND HYPEREMIA 1CM,Vaccination site inflammation,VACCINATION SITE INFLAMMATION,VACCINATION SITE INFLAMMATION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10068878,10068878,10068878
PERIPHERAL EOSINOPHILIA,EOSINOPHILIA,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
ABDOMEN WAS SOFT WITH MILD TENDERNESS FOLLOWING MULTIPLE DRUG OVERDOSE DUE TO SUICIDAL INTENT,Abdominal tenderness,ABDOMINAL TENDERNESS,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000097,10000097,10000097
PATIENT TREATED WITH MYCOPHENOLATE MOFETIL FOR LUPUS (OFF-LABEL USE) WITH NO ADVERSE EVENTS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
"PATIENT HAD PARTIAL RESPONSE TO CHOP CHEMOTHERAPY AFTER BEING TREATED FOR PERIPHERAL T-CELL LYMPHOMA , NOT OTHERWISE SPECIFIED (SUBTHERAPEUTIC RESPONSE)",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
AMIODARONE LUNG,Interstitial lung disease,INTERSTITIAL LUNG DISEASE,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022611,10022611,10022611
:SINUSOIDAL OBSTRUCTION SYNDROME/VENO-OCCLUSIVE DISEASE,Venoocclusive liver disease,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
MUSCLE PAIN,Myalgia,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028322
TENDER HEPATOMEGALY,Liver tenderness,HEPATOMEGALY TENDERNESS,LIVER TENDERNESS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019843,10024712,10019843
BLOOD PRESSURE OF 145/62 MMHG,Hypertension,BLOOD PRESSURE HIGH,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10005747
EXTENSIVE ERUPTIVE SYRINGOMA,Sweat gland tumour,SYRINGOMA,SWEAT GLAND TUMOUR,CUTANEOUS NEOPLASMS BENIGN,SKIN NEOPLASMS BENIGN,10029104,10042927,10042658,10042927
"SHE WAS  TREATED WITH MTX, HCQ, ADALIMUMAB AND ETANERCEPT FOR RHEUMATOID ARTHRITIS WHICH WERE DISCONTINUED BECAUSE OF LACK OF EFFICACY",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PO2 147 MM HG,PO2 increased,PARTIAL PRESSURE O2 INCREASED,PO2 INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10034083,10035769,10034083
MUCOSAL ATROPHY,Mucosal atrophy,MUCOSAL ATROPHY,MUCOSAL ATROPHY,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10067994,10067994,10067994
ELEVATED BUN,Blood urea increased,BUN INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10006576,10005851,10006576
LIMITATION IN THE RANGE OF MOTION OF MAJOR JOINTS,Limitation in the range of motion of major joints,JOINT RANGE OF MOTION DECREASED,JOINT RANGE OF MOTION DECREASED,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10048706,10048706,10048706
MALIGNANT HYPERTHERMIA,malignant hyperthermia,MALIGNANT HYPERTHERMIA,HYPERTHERMIA MALIGNANT,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10025607,10020844,10025607
SMALL OESOPHAGEAL VARICES,Varices oesophageal,VARICES OESOPHAGEAL,VARICES OESOPHAGEAL,GASTROINTESTINAL VASCULAR CONDITIONS,OESOPHAGEAL VARICES,10017947,10056091,10056091,10056091
FLUID LOSSES VIA LARGE SKIN DEFECTS IMPOSSIBLE TO MEASURE,Fluid loss,FLUID LOSS,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10016802,10012174,10016802
"HIS VISUAL ACUITY WAS COUNTING FINGERS AT 15 CM IN THE RIGHT EYE, AND 0.1 (1.2) IN THE LEFT EYE",Visual acuity reduced,VISUAL ACUITY REDUCED,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047531,10047531,10047531
VESICULOBULLOUS ERUPTIONS,Vesiculobullous rash,VESICULOBULLOUS RASH,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10047381,10012441,10047381
"SKIN WAS DRY, COOL AND SLIGHTLY MOTTLED",mottled skin,MOTTLED SKIN,LIVEDO RETICULARIS,SKIN VASCULAR ABNORMALITIES,SKIN VASOMOTOR CONDITIONS,10040785,10028010,10024648,10028010
STOMAL VARICES,Stomal varices,STOMAL VARICES,STOMAL VARICES,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,STOMA COMPLICATIONS,10022117,10075186,10075186,10075186
GRADE 2 VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
GRAFT FUNCTION WAS DELAYED [DELAYED GRAFT FUNCTION],Graft function was delayed [Delayed graft function],DELAYED GRAFT FUNCTION,DELAYED GRAFT FUNCTION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10076664,10076664,10076664
COMBATIVENESS,Aggression,COMBATIVE REACTION,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10010085,10001488,10010085
INTOXICATION,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
COAGULATION DISORDER,coagulation disorder,COAGULATION DISORDER,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009731,10009802,10009731
COMA/CNS DEPRESSION,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
SWELLING FACE,Swelling face,SWELLING FACE,SWELLING FACE,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10042682,10042682,10042682
GENERALIZED FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
TWO WEEKS LATER (HBD 35 + 6),Premature baby,PREMATURE BABY 33 TO 36 WEEKS,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10053594,10036590,10053594
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
PALLOR OF THE SKIN AND MUCOSA,Pallor of skin,PALLOR OF SKIN,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033550,10033546,10033550
EXTRAVASATION IN THE DORSUM OF LEFT FOOT,extravasation,EXTRAVASATION,EXTRAVASATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10015866,10015866,10015866
PATIENT DID NOT ADHERE WITH THE INTRAVENOUS ANTIMICROBIAL THERAPY AND REPEATEDLY WITHDREW FROM MEDICAL THERAPY DUE TO HER HEROIN ADDICTION (NON-COMPLIANCE),Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
SOPOR,Sopor,SOPOR,SOPOR,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10058709,10058709,10058709
RENAL INSUFFICIENCY,renal insufficiency,RENAL INSUFFICIENCY,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038474,10038435,10038474
ALT INCREASED (98 U),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
SIGNIFICANT DROP IN MEAN ARTERIAL PRESSURE (LESS THAN 55 MMHG),Mean arterial pressure decreased,MEAN ARTERIAL PRESSURE DECREASED,MEAN ARTERIAL PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10026983,10026983,10026983
"SHE DEVELOPED SEVERE THROMBOCYTOPENIA (15,000UL) WITHIN 48 HOURS/HEPARIN INDUCED THROMBOCYTOPENIA",Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
IMMUNE HEMOLYTIC ANEMIA DRUG-INDUCED,Haemolytic anaemia,IMMUNE HEMOLYTIC ANEMIA DRUG-INDUCED,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10053591,10018916,10055213
WAKE UP DISTURBINGLY OFTEN DURING THE NIGHT AND SOMETIMES TOO EARLY IN THE MORNING,Nocturnal awakening,NOCTURNAL AWAKENING,MIDDLE INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10029448,10027590,10029448
BLEEDING OESOPHAGEAL VARICES,bleeding oesophageal varices,BLEEDING OESOPHAGEAL VARICES,OESOPHAGEAL VARICES HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,GASTRIC AND OESOPHAGEAL HAEMORRHAGES,10017947,10055968,10030210,10055968
ERYTHEMATOUS SCALY ERUPTION WITH PLAQUES OF VARIOUS SIZES ON HER TRUNK AND EXTREMITIES,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
LDH INCREASED (334 U PER L),Blood lactate dehydrogenase increased,LDH INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10024051,10005630,10024051
ANISOCORIA,anisocoria,ANISOCORIA,PUPILS UNEQUAL,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10002535,10037538,10002535
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
GENERALISED RASH,generalised rash,GENERALISED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10018095,10037858,10018095
PNEUMOCYSTIS PNEUMONIA,Pneumocystis pneumonia,PNEUMOCYSTIS PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10035661,10073755,10035661
BILATERAL CRACKLES,Crepitations,CRACKLES,CREPITATIONS,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10011283,10011376,10011283
IMPAIRED COORDINATION/COORDINATION DISORDER,Coordination impaired,COORDINATION IMPAIRED,COORDINATION ABNORMAL,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10010950,10010947,10010950
"ATYPICAL RASH WITH MACULES ON CHEST, THE LIMBS AND THE FACE",Rash macular,RASH MACULAR,RASH MACULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037867,10037867,10037867
DIARRHEA,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
RV THROMBUS DUE TO HYPERCOAGULABLE STATE,Cardiac ventricular thrombosis,CARDIAC VENTRICULAR THROMBOSIS,CARDIAC VENTRICULAR THROMBOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10053994,10053994,10053994
AN AXIS FRACTURE CAUSED BY A FALL,fractured vertebra,FRACTURED VERTEBRA,SPINAL FRACTURE,BONE AND JOINT INJURIES,SPINAL FRACTURES AND DISLOCATIONS,10022117,10017317,10041569,10017317
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
HEPATIC FUNCTION DISORDER,Hepatic function abnormal,HEPATIC FUNCTION DISORDER,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019674,10019670,10019674
TYPE-B LACTIC ACIDOSIS DUE TO METFORMIN ACUTE OVERDOSE,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
TENOFOVIR DISOPROXIL FUMARATE-ASSOCIATED RENAL TUBULAR DYSFUNCTION,Renal tubular dysfunction,RENAL TUBULAR DYSFUNCTION,RENAL TUBULAR DYSFUNCTION,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10050335,10050335,10050335
MEDICATION-RELATED OSTEONECROSIS OF THE JAW STAGE 2 ([MAXILLA (QUADRANT I)],osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
CONJOINT JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
ST SEGMENT ELEVATION,Electrocardiogram ST segment elevation,ST SEGMENT ELEVATION,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041893,10014392,10041894
IDIOPATHIC NEPHROTIC SYNDROME (REBOUND EFFECT),Nephrotic syndrome,NEPHROTIC SYNDROME,NEPHROTIC SYNDROME,NEPHROPATHIES,GLOMERULONEPHRITIS AND NEPHROTIC SYNDROME,10038359,10029164,10029164,10029164
ABDOMINAL DISCOMFORT,abdominal discomfort,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10000059,10000059,10000059
"UNDERLYING ERYTHEMATOUS AND EDEMATOUS BASE, AFFECTING FACE, NECK, AND TRUNK","underlying erythematous and edematous base, affecting face, neck, and trunk",ERYTHEMATOUS ERUPTION,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015241,10037855,10015241
REFRACTORY WOUND DEHISCENCE,Wound dehiscence,WOUND DEHISCENCE,WOUND DEHISCENCE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10048031,10048031,10048031
GRADE 1 IMMEDIATE HYPERSENSITIVITY REACTION,Type I hypersensitivity,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
ERYTHEMATOUS RASH OVER HER TRUNK AND LIMBS,rash erythematous,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10037855
HYPERACTIVE,Hyperactive,HYPERACTIVE,PSYCHOMOTOR HYPERACTIVITY,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10020554,10037211,10020554
MUCOUS MEMBRANE DISORDER SUCH AS STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
MICRO HEMATOCRIT DECREASED (30 PERCENT),Haematocrit decreased,HEMATOCRIT DECREASED,HAEMATOCRIT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018838,10018838,10019423
SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
BLISTERS,Blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
OVERDOSE OF CAFFEINE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
PROGRESSION OF TOXIC CONTACT DERMATITIS FOLLOWING TREATMENT WITH LINEZOLID,toxic contact dermatitis,CONTACT DERMATITIS,DERMATITIS CONTACT,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10010790,10012442,10010790
FACIAL EDEMA,Face oedema,EDEMA FACE,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10016029,10016029,10014222
HYPERFERRITINAEMIA,Hyperferritinaemia,HYPERFERRITINAEMIA,HYPERFERRITINAEMIA,IRON AND TRACE METAL METABOLISM DISORDERS,IRON EXCESS,10027433,10075046,10075046,10075046
GASTROINTESTINAL MOTILITY DISORDER,Gastrointestinal motility disorder,GASTROINTESTINAL MOTILITY DISORDER,GASTROINTESTINAL MOTILITY DISORDER,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL DYSKINETIC DISORDERS,10017947,10061173,10061173,10061173
EXERTIONAL DYSPNOEA,Dyspnoea exertional,EXERTIONAL DYSPNOEA,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013971,10013971,10015656
TRANSAMINITIS,Transaminases increased,TRANSAMINITIS,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054969,10054889,10054969
ENTEROCOCCUS (CAUSED BY ENTEROCOCCUS FAECIUM),Enterococcal sepsis,ENTEROCOCCAL SEPSIS,ENTEROCOCCAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,ENTEROCOCCAL INFECTIONS,10021881,10054221,10054221,10054221
BREATHLESSNESS ON EXERTION,breathlessness on exertion,BREATHLESSNESS,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10006345,10013968,10006345
HYPOXIA (OXYGEN SATURATION IN ROOM AIR WAS 70%),hypoxia,HYPOXIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021143,10021143,10021143
PRURITIC CUTANEOUS RASH ON THE UPPER LIMBS,Pruritic rash,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037085,10037884,10037085
LOW COMPLIANCE TO ART,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
GRADUAL DECLINE OF SERUM SODIUM LEVELS,Blood sodium decreased,SERUM SODIUM DECREASED,BLOOD SODIUM DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10054863,10005802,10054863
OPIUM ABUSE,Drug abuse,OPIOID ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10030887,10013654,10030887
INTENTIONAL SUSPECTED SUICIDE,Completed suicide,COMPLETED SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10010144,10010144,10010144
PRODUCT DID NOT RELIEVE HER SYMPTOMS,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
"SMALL, VIMETIN POSITIVE, ROUND BLUE CELL TUMOUR SUGGESTIVE OF EWING'S SARCOMA COMPRESSING THE BRAINSTEM",Ewing's sarcoma,EWING'S SARCOMA,EWING'S SARCOMA,SKELETAL NEOPLASMS MALIGNANT AND UNSPECIFIED,BONE SARCOMAS,10029104,10015560,10015560,10015560
DEATH FROM FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
HAPTOGLOBIN LOW,Haptoglobin decreased,HAPTOGLOBIN LOW,HAPTOGLOBIN DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",HAEM METABOLISM ANALYSES,10022891,10019153,10019150,10019153
CEFTAZIDIM (ADMINISTERED FOR 8 DAYS) THAT CAN DETERMINE THE INCREASE OF THE LDH VALUES,LDH increased,LDH INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10024051,10005630,10024051
LOCALIZED PRURITIC EXANTHEMA ABOUT 12-15 CM IN SIZE IN THE AREA OF SC ADMINISTRATION,exanthema,EXANTHEMA,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015587,10037844,10015587
GASTRIC JUICE WAS POSITIVE FOR MYCOBACTERIUM TUBERCULOSIS COMPLEX DNA,Mycobacterium tuberculosis complex test positive,MYCOBACTERIUM TUBERCULOSIS TEST POSITIVE,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,MYCOBACTERIA IDENTIFICATION AND SEROLOGY,10022891,10066074,10070325,10070329
SWELLING OF HIS TONGUE,Swollen tongue,SWELLING OF TONGUE,SWOLLEN TONGUE,TONGUE CONDITIONS,TONGUE SIGNS AND SYMPTOMS,10017947,10042727,10042727,10042706
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
HEMOLYSIS FROM CEFTRIAXONE ADMINISTRATION (HB OF LESS THAN 2 G),Haemolysis,HEMOLYSIS,HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10018910,10018910,10019491
FEVER (102 DEGREE FAHRENHEIT),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
HAIR LOSS,hair loss,HAIR LOSS,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10019045,10001760,10019045
FEEDING INTOLERANCE,Feeding intolerance,FEEDING INTOLERANCE,FEEDING INTOLERANCE,FOOD INTOLERANCE SYNDROMES,FOOD MALABSORPTION AND INTOLERANCE SYNDROMES (EXCL SUGAR INTOLERANCE),10027433,10076042,10076042,10076042
LEFT RADIAL ARTERY THROMBOSIS,Thrombosis,THROMBOSIS,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10043607,10043607,10043607
SEVERE METABOLIC ALKALOSIS,Metabolic alkalosis,METABOLIC ALKALOSIS,METABOLIC ALKALOSIS,ACID-BASE DISORDERS,METABOLIC ALKALOSES,10027433,10027423,10027423,10027423
IMMEDIATE ALLERGIC REACTION TO AMOXICILLIN,Immediate hypersensitivity reaction,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
DIARRHOEA,diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
BLEEDING,Bleeding,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10005103,10055798,10005103
LIVER DAMAGE,Liver injury,LIVER DAMAGE,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067125,10067125,10024668
DESPITE TOPICAL TREATMENT WITH BETASONE A NEW FLARE APPEARED,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HSV SUPERINFECTION,Superinfection viral,SUPERINFECTION VIRAL,SUPERINFECTION VIRAL,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10066983,10066983,10066983
PNEUMONITIS,Pneumonitis,PNEUMONITIS,PNEUMONITIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10035742,10035742,10035742
"GRADE 3, HORIZONTAL ROTATORY, RIGHT BEATING NYSTAGMUS",Nystagmus,NYSTAGMUS,NYSTAGMUS,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10029864,10029864,10029864
ACUTE GENERALIZED EXANTHEMATIC PUSTULOSIS INDUCED BY CEFACLOR AND ACETAZOLAMIDE,Acute generalised exanthematous pustulosis,ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10062372
ATYPICAL FEMORAL FRACTURE,Atypical femur fracture,ATYPICAL FEMUR FRACTURE,ATYPICAL FEMUR FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10070884,10070884,10070884
BEHAVIORAL CHANGES CONSISTENT WITH AUDITORY HALLUCINATIONS,auditory hallucinations,AUDITORY HALLUCINATIONS,"HALLUCINATION, AUDITORY",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10003785,10019070,10003785
SHAKING,Shaking,SHAKING,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10040528,10044565,10040528
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
GASTROINTESTINAL TUBERCULOSIS,Tuberculosis gastrointestinal,TUBERCULOSIS GASTROINTESTINAL,TUBERCULOSIS GASTROINTESTINAL,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10061390,10061390,10061390
REFRACTORY GRAFT-VERSUS-HOST DISEASE,no therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
"AT 17 WEEKS, THE MALE FOETUS DIED (FOETAL DEATH)/ DELIVERED A DEAD MALE FOETUS (FOETAL DEATH)",Foetal death,FOETAL DEATH,FOETAL DEATH,ABORTIONS AND STILLBIRTH,STILLBIRTH AND FOETAL DEATH,10036585,10055690,10055690,10055690
THICK RALES,Rales,RALES,RALES,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10037833,10037833,10037833
"INTERMITTENT, SUBSTERNAL, 8 OUT OF 10, CRUSHING LEFT-SIDED CHEST PAIN RADIATING TO HIS LEFT MANDIBLE AND LEFT UPPER EXTREMITY",Chest pain,SUBSTERNAL CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10042427,10008479,10042427
SEVERE NEUTROPENIA/CTCAE GRADE 4 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
INCONTINENCE FOLLOWING INTENTIONAL LOPERAMIDE ABUSE,Incontinence,INCONTINENCE,INCONTINENCE,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10021639,10021639,10021639
RECURRENT URINARY TRACT INFECTION,Urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
LESIONS COVERED WITH PEARLSCENT SQUAMOUS FEATURES CHARACTERIZED BY AN ABRUPT MARGIN OF ERYTHEMATOUS PLAQUES AND PAPULES,Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
CASE OF SEVERE IBUPROFEN MONO-INTOXICATION,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
HEARING LOSS ON THE RIGHT SIDE FOLLOWING ADMINISTRATION OF VALGANCICLOVIR IN UTERO,Hearing loss unilateral,HEARING LOSS UNILATERAL,DEAFNESS UNILATERAL,HEARING DISORDERS,HEARING LOSSES,10013993,10057845,10048812,10057845
DYSPNOEA UPON FATIGUE,Dyspnoea exertional,DYSPNOEA ON EFFORT,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013971,10013971,10013973
LOSS OF VISUAL ACUITY,Visual acuity reduced,VISUAL ACUITY LOST,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047531,10047531,10047530
DIARRHOEA,diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
LIVER TOXICITY,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
STELLATE ULCERATIONS,Ulcer,ULCER,ULCER,TISSUE DISORDERS NEC,ULCERS NEC,10018065,10045285,10045285,10045285
FEELING WOOZY,Woozy,WOOZY,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10048019,10013573,10048019
SERUM CPK PEAKING AT 6380 IU/L,Blood creatine phosphokinase increased,CPK INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011268,10005470,10011268
DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
POINT OF CARE TROPONIN T LEVEL INCREASED (0.03 MCG/L),Troponin T increased,TROPONIN T INCREASED,TROPONIN T INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10058269,10058269,10058269
HYPOKALAEMIA (SEVERELY HYPOKALEMIC),hypokalaemia,HYPOKALAEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021015
PRURITUS OCCURRED 1-3 DAYS AFTER WITHDRAWAL OF CETTIRIZINE,Drug withdrawal syndrome,DRUG WITHDRAWAL SYNDROME,DRUG WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10013754,10013754,10013754
PREMATURE RUPTURE OF THE MEMBRANES,Premature rupture of the membranes,PREMATURE RUPTURE OF MEMBRANES,PREMATURE RUPTURE OF MEMBRANES,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036603,10036603,10036603
ALKALINE PHOSPHATASE INCREASED (201 IU/L),Blood alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
REPEATING COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
HEPATIC ARTERY ANEURYSM,Hepatic artery aneurysm,HEPATIC ARTERY ANEURYSM,HEPATIC ARTERY ANEURYSM,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10019634,10019634,10019634
SIROLIMUS TROUGH LEVEL INCREASED (10.5 MICG/L) FOLLOWING INTERACTION WITH FLUCONAZOLE,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
EATING EXCESSIVELY,Excessive eating,EXCESSIVE EATING,HYPERPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10015598,10020710,10015598
"WITH MARKS LOST IN MEMORY, FLUENCY AND ATTENTION ONLY",Disturbance in attention,ATTENTION IMPAIRED,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10013496,10013496,10003738
UTERUS ENLARGED,Uterine enlargement,UTERUS ENLARGED,UTERINE ENLARGEMENT,"UTERINE, PELVIC AND BROAD LIGAMENT DISORDERS",UTERINE DISORDERS NEC,10038604,10046838,10046782,10046838
DRUG EXPOSURE VIA PREGNANCY,Drug Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ACUTE PANCREATITIS FOLLOWING LINEZOLID INDUCED TOXICITY,pancreatitis acute,PANCREATITIS ACUTE,PANCREATITIS ACUTE,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033647,10033647,10033647
ADRENAL B-CELL LYMPHOMA WORSENING DESPITE ONGOING CHEMOTHERAPY,Diffuse large B-cell lymphoma,DIFFUSE LARGE B-CELL LYMPHOMA,DIFFUSE LARGE B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,DIFFUSE LARGE B-CELL LYMPHOMAS,10029104,10012818,10012818,10012818
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
MIRTAZAPINE 15 MG THAT HE DID NOT TOLERATE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
JAUNDICE AND ABNORMAL HEPATIC FUNCTION SHOWED A TENDENCY TOWARD EXACERBATION,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
FELT DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
PARADOXICAL EMBOLISM FOLLOWING COAGULOPATHY,Paradoxical embolism,PARADOXICAL EMBOLISM,PARADOXICAL EMBOLISM,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10066059,10066059,10066059
QUETIAPINE WHICH CAUSED HYPOTENSION AND FALLS,fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
SECONDARY GLOMERULOSCLEROSIS LEADING TO STAGE 5 CHRONIC RENAL INSUFFICIENCY,glomerulosclerosis,GLOMERULOSCLEROSIS,GLOMERULOSCLEROSIS,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10061989,10061989,10061989
HYPERACUTE LEUCOPENIA ASSOCIATED WITH FUROSEMIDE,Leukopenia,LEUCOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024283
ALLERGY TO AMOXICLLIN,Drug hypersensitivity,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
TACHYARRHYTHMIA,Tachyarrhythmia,TACHYARRHYTHMIA,TACHYARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10049447,10049447,10049447
HAEMOGLOBIN DROP TO 3GM,Haemoglobin decreased,HAEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10018884
DRUG RELATED DEATH,Death,DEATH,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10011906,10011906,10011906
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
HEPATOCELLULAR CARCINOMA FOLLOWING HBV INFECTION,hepatocellular carcinoma following HBV infection,HEPATOCELLULAR CARCINOMA,HEPATOCELLULAR CARCINOMA,HEPATOBILIARY NEOPLASMS MALIGNANT AND UNSPECIFIED,HEPATIC NEOPLASMS MALIGNANT,10029104,10073071,10073071,10073071
ACUTE PANCREATITIS,acute pancreatitis,ACUTE PANCREATITIS,PANCREATITIS ACUTE,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10000971,10033647,10000971
LEVAMISOLE-INDUCED RETIFORM PURPURA,purpura,PURPURA,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037549,10037549,10037549
ECLAMPSIA,Eclampsia,ECLAMPSIA,ECLAMPSIA,MATERNAL COMPLICATIONS OF PREGNANCY,HYPERTENSION ASSOCIATED DISORDERS OF PREGNANCY,10036585,10014129,10014129,10014129
MEMORY LOSS FOLLOWING MANIC EPISODE,Amnesia,MEMORY LOSS,AMNESIA,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027176,10001949,10027176
ENTEROCOCCUS FAECALIS INFECTION,Enterococcus faecalis infection,ENTEROCOCCUS FAECALIS INFECTION,ENTEROCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,ENTEROCOCCAL INFECTIONS,10021881,10051978,10061124,10051978
VITAMIN D DEFICIENCY,Vitamin D deficiency,VITAMIN D DEFICIENCY,VITAMIN D DEFICIENCY,VITAMIN RELATED DISORDERS,FAT SOLUBLE VITAMIN DEFICIENCIES AND DISORDERS,10027433,10047626,10047626,10047626
APPLICATION SITE HYPEREMIA WITH DIAMETER 10X10CM,Hyperaemia,HYPEREMIA,HYPERAEMIA,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10020565,10020565,10020619
MRONJ (MEDICATION-RELATED OSTEONECROSIS OF THE JAW) (STAGE 2),Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
DUODENAL VILLIOUS ATROPHY,Histology abnormal,HISTOLOGY ABNORMAL,HISTOLOGY ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",HISTOPATHOLOGY PROCEDURES NEC,10022891,10062059,10062059,10062059
PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY,Progressive multifocal leukoencephalopathy,PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10036807,10036807,10036806
POSTURING,Posturing,POSTURING,POSTURING,CHANGES IN PHYSICAL ACTIVITY,STEREOTYPIES AND AUTOMATISMS,10037175,10036437,10036437,10036437
PAIN AND SWELLING OF RIGHT BUTTOCK/DIFFUSE SWELLING INVOLVING RIGHT GLUTEUS MEDIUS AND PIRIFORMIS MUSCLE,Joint swelling,HIP SWELLING,JOINT SWELLING,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10054941,10023232,10054941
ATRIAL FIBRILLATION,Atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
DISCOLORATION OF THE OUTER SKIN WITH A CENTRAL EROSION OF THE SKIN,Skin discolouration,SKIN DISCOLOURATION,SKIN DISCOLOURATION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040829,10040829,10040829
NIPPLE SEPERATION FOLLOWING DRUG EXPOSURE IN UTERO,Nipple disorder,NIPPLE DISORDER,NIPPLE DISORDER,BREAST DISORDERS,BREAST DISORDERS NEC,10038604,10029417,10029417,10029417
SEVERE RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
SWELLING AND ERYTHEMA OF PERIORBITAL TISSUES,Eye swelling,PERIORBITAL SWELLING,EYE SWELLING,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10056647,10015967,10056647
OCCASIONAL BURNING OF THE CLITORIS,burning sensation,BURNING SENSATION,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10006784,10006784,10006784
MULTIORGAN FAILURE DUE TO POLYMICROBIAL NEUTROPENIC SEPSIS,multiorgan failure,MULTIORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028162,10077361,10028162
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
VIRAL (CORONAVIRUS) BRONCHIOLITIS DUE TO TRANSIENT SEVERE IMMUNODEFICIENCY SECONDARY TO CHEMOTHERAPY,bronchiolitis,BRONCHIOLITIS,BRONCHIOLITIS,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10006448,10006448,10006448
MILD SELF-LIMITED BRUISING,Contusion,BRUISING,CONTUSION,INJURIES NEC,SKIN INJURIES NEC,10022117,10050584,10050584,10006504
DICLOFENAC OVERUSE,drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
TOTAL LUEKOCYTE COUNT DECREASED (2600 CELLS/UL),total luekocyte count decreased (2600 cells/ul),LEUKOCYTE COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10048552,10047942,10048552
FREQUENT FALLS,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
SLUGGISH,Sluggishness,SLUGGISHNESS,SLUGGISHNESS,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10041052,10041052,10041052
PNEUMONIA WAS SUSPECTED,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
BLLATERAL CONJUNCTIVITIS WITH ULCERATION,Conjunctival ulcer,CONJUNCTIVAL ULCERATION,CONJUNCTIVAL ULCER,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CONJUNCTIVAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10010737,10010736,10010737
RENAL FUNCTION ONLY PARTIALLY IMPROVED (SUBTHERAPEUTIC RESPONSE WITH NO ADVERSE EVENT),Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
SHE DELIVERED PREMATURELY IN THE 6TH MONTH OF PREGNANCY,Premature baby,PREMATURE BABY,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036590,10036590,10036590
WHITE BLOOD CELL COUNT DECREASED,White blood cell count decreased,WHITE BLOOD CELL COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10047942
BOTH CONJUCTIVAS WERE YELLOW,Ocular icterus,CONJUNCTIVA COLORING YELLOW,OCULAR ICTERUS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10010693,10058117,10062414
CHURG STRAUSS SYNDROME,Churg Strauss syndrome,CHURG STRAUSS SYNDROME,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,IMMUNE DISORDERS NEC,VASCULITIDES,10021428,10009164,10078117,10009164
HYPERSENSITIVITY REACTIONS,Hypersensitivity,HYPERSENSITIVITY REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020756,10020751,10020756
HALLUCINATORY BEHAVIOUR,Abnormal behaviour,HALLUCINATION-LIKE ABNORMAL BEHAVIOR,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10019076,10061422,10062453
MALE BREAST CANCER (MBC)/FINASTERIDE TREATMENT AND MALE BREAST CANCER,Breast cancer male,BREAST CANCER MALE,BREAST CANCER MALE,BREAST NEOPLASMS MALIGNANT AND UNSPECIFIED (INCL NIPPLE),BREAST AND NIPPLE NEOPLASMS MALIGNANT,10029104,10061020,10061020,10061020
MISCARRIAGE FOLLOWING INADVERTENT DRUG EXPOSURE TO METHOTREXATE DURING PREGNANCY,Abortion spontaneous,MISCARRIAGE,ABORTION SPONTANEOUS,ABORTIONS AND STILLBIRTH,ABORTIONS SPONTANEOUS,10036585,10000234,10000234,10027649
ELEVATED WHITE BLOOD COUNT WITH NEUTROPHILIA,White blood cell count increased,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047943,10047943,10047943
BEP REGIMEN RESISTANCE,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
POSTURAL INSTABILITY,Postural tremor,POSTURAL TREMOR,POSTURAL TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10073211,10073211,10073211
"ANTIRETROVIRAL (LAMIVUDINE, NEVIRAPINE) RESISTANCE VIRAL MUTATION",Viral mutation identified,VIRAL MUTATION IDENTIFIED,VIRAL MUTATION IDENTIFIED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10063111,10063111,10063111
ACUTE KIDNEY INJURY FOLLOWING DIC,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
VARICES OESOPHAGEAL,Varices oesophageal,VARICES OESOPHAGEAL,VARICES OESOPHAGEAL,GASTROINTESTINAL VASCULAR CONDITIONS,OESOPHAGEAL VARICES,10017947,10056091,10056091,10056091
"COMPULSIVE CLEANING AND WASHING OF EYELIDS, IRRITABILITY AND REDUCED SLEEP; ON TABLET RISPERIDONE 3MG/DAY, THE BEHAVIORAL SYMPTOMS OTHER THAN HALLUCINATIONS WORSENED",Sleep decreased,SLEEP DECREASED,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10040982,10022437,10040982
EROSIONS OF THE LIPS,Lip erosion,LIP EROSION,LIP EROSION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10051992,10051992,10051992
RIGORS,Rigors,RIGORS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10039177,10008531,10039177
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
"EIKENELLA CORRODENS, PREVOTELLA ORALIS, ENTEROCOCCUS FAECALIS, ESCHERICHIA COLI AND BACTEROIDES MERDAE ASSOCIATED PERITONITIS",Peritonitis bacterial,PERITONITIS BACTERIAL,PERITONITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10062070,10062070,10062070
LOSS OF APPETITE,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
GLASGOW COMA SCALE ABNORMAL (7/15),Coma scale abnormal,GLASGOW COMA SCALE ABNORMAL,COMA SCALE ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10058466,10069709,10058466
HER THROAT WAS ERYTHEMATOUS,Pharyngeal erythema,RED THROAT,PHARYNGEAL ERYTHEMA,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),PHARYNGEAL DISORDERS (EXCL INFECTIONS AND NEOPLASMS),10038738,10038196,10057009,10038196
DIFFUSE OOZING WAS NOTED THROUGHOUT VISUALIZED SMALL BOWEL WITH INFLAMED MUCOSA,Mucosal inflammation,MUCOSAL INFLAMMATION,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028116,10028116,10028116
TRIGLYCERIDE INCREASED,Triglyceride increased,TRIGLYCERIDE INCREASED,BLOOD TRIGLYCERIDES INCREASED,LIPID ANALYSES,TRIGLYCERIDE ANALYSES,10022891,10044659,10005839,10044659
DRESS SYNDROME,DRESS syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
DRUG INTOXICATION,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
HYPERSENSITIVITY,Hypersensitivity,HYPERSENSITIVITY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020751,10020751,10020751
"STENT THROMBOSIS IS A MULTIFACTORIAL PHENOMENON, WHICH WAS CLEARLY NOT ONLY DRIVEN BY THE LACK OF CLOPIDOGREL EFFICACY DURING MTH",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ACUTE POSTERNAL FAILURE,acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
DIABETIC KETOACIDOSIS,diabetic ketoacidosis,DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEC,10027433,10012671,10012671,10012671
INADVERTENT ACETAMINOPHEN OVERDOSE,Accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
FETAL TACHYCARDIA,Fetal tachycardia,FETAL TACHYCARDIA,TACHYCARDIA FOETAL,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10054725,10043074,10054725
"IMATINIB BLUNTS TUBULAR SECRETION OF CREATININE, PLASMA CREATININE CONCENTRATION WAS FOUND TO BE ELEVATED, INDEPENDENTLY OF ANY RENAL  DYSFUNCTION",Blood creatinine increased,PLASMA CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10035278,10005483,10035278
ENLARGED BREASTS,Breast enlargement,BREAST ENLARGEMENT,BREAST ENLARGEMENT,BREAST DISORDERS,BREAST DISORDERS NEC,10038604,10006242,10006242,10006242
PAINFUL NECROTIC WOUNDS ON BOTH UPPER LEGS,Wound necrosis,WOUND NECROSIS,WOUND NECROSIS,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10053716,10053716,10053716
"LEUKOPENIA, STOMATITIS, MTX FOR ECTOPIC PREGNANCY, DRUG USE VIA UNAPPROVED ADMINISTRATION ROUTE (MTX VIA INTRA-AMNIOTIC ROUTE)",Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
ELEVATED LACTATE DEHYDROGENASE,Blood lactate dehydrogenase increased,LACTATE DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10023654,10005630,10023654
PERSISTENT FDG-AVID DISEASE AND ELEVATED LDH (DRUG INEFFECTIVE),drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
NON-ST-SEGMENT ELEVATED MYOCARDIAL INFARCTION,non-ST-segment elevated myocardial infarction,NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION,ACUTE MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10064347,10000891,10064347
QT PROLONGATION,QT prolonged,QT PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037705,10014387,10037705
DESQUAMATION FOLLOWING ACUTE LOCALISED EXANTHEMATOUS PUSTULOSIS,desquamation,DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10012528,10040844,10012528
EXFOLIATION ENCOMPASSING HIS ENTIRE BODY FROM HIS FACE TO THE SOLES OF HIS FEET AND MULTIPLE BROWN PLATE-LIKE SCALES COVERING HIS FACE,Skin exfoliation,SKIN EXFOLIATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040844,10040844,10040844
WEAKENED BREATHING AND DULLNESS OVER THE LUNGS,Respiratory rate decreased,BREATHING SLOWED,RESPIRATORY RATE DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10006343,10038710,10006343
RIGHT SEGMENTAL SPINAL MYOCLONUS,Myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
ALT INCREASED (80 U/L),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
ACUTE OCCLUSION OF HIS INNOMINATE ARTERY (IA) ACCOMPANIED BY SUBCLAVIAN STEAL SYNDROME,Arterial occlusive disease,ARTERIAL OCCLUSION,ARTERIAL OCCLUSIVE DISEASE,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10058475,10062599,10058475
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
"COLON CANCER PRESENTING AS PSEUDO-OBSTRUCTION DURING PREGNANCY/BEGAN ADJUVANT CHEMOTHERAPY CONSISTING OF 5-FLUOROURACIL, LEUCOVORIN AND OXALOPLATIN FOUR WEEKS POST-OPERATIVELY",Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
REVERSIBLE PARKINSONISM,parkinsonism,PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034010,10034010,10034010
[THALAMUS HEMORRHAGE WITH] INTRAVENTRICULAR HEMORRHAGE,Intraventricular haemorrhage,INTRAVENTRICULAR HEMORRHAGE,INTRAVENTRICULAR HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10022840,10022840,10055299
RECURRENT EPISODES OF ANAPHYLAXIS AND GRADE III ANAPHYLAXIS FOLLOWING IBUPROFEN AND OCCUPASIONAL EXPOSURE TO CEFUROXIME,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
IBUPROFEN INTOXICATION,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
UPPER RESPIRATORY INFECTIONS FOLLOWING OFF LABEL USE OF MYCOPHENOLATE MOFETIL,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ADRENAL SUPPRESSION,Adrenal suppression,ADRENAL SUPPRESSION,ADRENAL SUPPRESSION,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001382,10001382,10001382
DISTENDED ABDOMEN,Abdominal distension,DISTENDED ABDOMEN,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10013480
DRUG ABUSE,drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
RENAL FAILURE,Renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
METFORMIN TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
IRRITABILITY,Irritability,IRRITABILITY,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10022998,10022998,10022998
DEEP NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE EVENT,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
REDNESS ON THE RIGHT PATELLA AND CHEEK,Erythema,REDNESS,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10038198,10015150,10038198
COLLAGENOUS COLITIS,Colitis microscopic,COLITIS MICROSCOPIC,COLITIS MICROSCOPIC,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10056979,10056979,10056979
WBC INCREASED (9570 CELLS/MM3),White blood cell count increased,WBC INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056739,10047943,10056739
PRESSURED SPEECH,Speech disorder,SPEECH DISORDER,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041466,10041466,10041466
DUPILUMAB INDUCED CONJUCTIVITIS IN BOTH EYES (MODERATE PALPEBRAL),Conjunctivitis,CONJUNCTIVITIS,CONJUNCTIVITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10010741,10010741,10010741
LOSARTAN-INDUCED ENTEROPATHY,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
UNSATISFACTORY RESPONSE WITH CAPTEM AND FOLFOX,subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
HYPOGLYCAEMIA NIGHT (BLOOD GLUCOSE NOS),Hypoglycaemia,HYPOGLYCAEMIA NIGHT,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020995,10020993,10020995
"ACUTE SHARP ABDOMINAL PAIN IN THE EPIGASTRIC AREA WITH A SEVERITY OF 8/10, NON RADIATING WHICH WORSENS WITH MOVEMENT",Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
LIVER FUNCTION ABNORMALITIES SUGGESTIVE OF HEPATITIS,Hepatitis,HEPATITIS,HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019717,10019717,10019717
INTENTIONAL OVERDOSE,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
DISORIENTATION,Disorientation,DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013395
DIAPHORETIC STATE,diaphoretic state,DIAPHORESIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10012703,10020642,10012703
"BLUISH DISCOLORATION THAT HAD STARTED 1 YEAR BEFORE AS A SMALL AREA BUT HAD SPREAD TO INVOLVE THE ENTIRE FACE, FINGERS, GUMS, TEETH, AND SCLERA, AND INCLUDED A DARK DISCOLORATION OF THE NECK AND UPPER CHEST",Discoloration skin,DISCOLORATION SKIN,SKIN DISCOLOURATION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10013076,10040829,10013076
RECURRENT VITREOUS HEMORRHAGE,Vitreous haemorrhage,VITREOUS HEMORRHAGE,VITREOUS HAEMORRHAGE,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS,10015919,10047655,10047655,10047656
HERPES SIMPLEX VIRUS (HSV) ASSOCIATED FULMINANT HEPATITIS/HERPETIC HEPATITIS,Hepatitis fulminant,HEPATITIS FULMINANT,HEPATITIS FULMINANT,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019772,10019772,10019772
RIGHT ATRIAL THROMBUS FOLLOWING HEART FAILURE,right atrial thrombus,INTRACARDIAC THROMBUS,INTRACARDIAC THROMBUS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048620,10048620,10048620
SIMVASTATIN ASSOCIATED WITH ADVERSE DRUG REACTION,Adverse drug reaction,ADVERSE DRUG REACTION,ADVERSE DRUG REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061623,10061623,10061623
SERUM POTASSIUM OF 2.18 MMOL/L WAS DETECTED,serum potassium increased,SERUM POTASSIUM INCREASED,BLOOD POTASSIUM INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10040379,10005725,10040379
ACUTE MYOCARDIAL INFARCTION WITH ST ELEVATION (STEMI),Electrocardiogram ST segment elevation,ST ELEVATED,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041887,10014392,10041887
PNEUMOCOCCAL PNEUMONIA,Pneumonia pneumococcal,PNEUMOCOCCAL PNEUMONIA,PNEUMONIA PNEUMOCOCCAL,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10035728,10035728,10035647
PAIN,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
CARBIMAZOLE-INDUCED EOSINOPHILIC PLEURAL EFFUSION,eosinophilic pleural effusion,EOSINOPHILIC PLEURAL EFFUSION,EOSINOPHILIC PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10080148,10080148,10080148
"PATIENT HAD A SYMPTOMATOLOGY GASTROESOPHAGEAL REFLUX DISEASE (GERD), GASTRIC DISCOMFORT",Gastrooesophageal reflux disease,GASTROESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10017885,10017885,10066874
"CLOZAPINE INDUCED ENURESIS/ENURESIS NOCTURNA/IN THE FOURTH WEEK OF CLOZAPINE TREATMENT, THE PATIENT BEGAN TO HAVE COMPLAINTS OF ENURESIS",Enuresis,NOCTURNAL ENURESIS,ENURESIS,PSYCHIATRIC DISORDERS NEC,PSYCHIATRIC ELIMINATION DISORDERS,10037175,10029453,10014928,10029453
PORTAL HYPERTENSION FOLLOWING LATE ONSET HEPATIC VENO-OCCLUSIVE DISEASE,Portal hypertension,PORTAL HYPERTENSION,PORTAL HYPERTENSION,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10036200,10036200,10036200
MULTIPLE MACULOPAPULAR LESIONS ON LEGS AND ARMS,Rash maculo-papular,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10037868
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
GRAM-POSITIVE COCCI INFECTION,Bacterial infection,GRAM-POSITIVE COCCI INFECTION,BACTERIAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10054276,10060945,10054276
"INSULIN ANTIBODY (HUMAN INSULIN-SPECIFIC IGE ANTIBODY TITRE: 8.32 IU/ML, TESTED POSITIVELY FOR ANTI-INSULIN ANTIBODY, ANTI-INSULIN ANTIBODY TITRE  50.0 AND INSULIN-ANTIBODY BINDING RATE OF 78.2%)",Anti-insulin antibody positive,ANTI-INSULIN ANTIBODY POSITIVE,ANTI-INSULIN ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10053814,10053814,10053814
FOCAL EPILEPSY,focal epilepsy,FOCAL EPILEPSY,PARTIAL SEIZURES,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10065337,10061334,10065337
CEREBRAL INFARCTION,cerebral infarction,CEREBRAL INFARCTION,CEREBRAL INFARCTION,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008118,10008118,10008118
COLD,Nasopharyngitis,COLD,NASOPHARYNGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10010106,10028810,10009851
RIGHT PEDAL EDEMA WITH CYANOSIS,Cyanosis,CYANOSIS,CYANOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10011703,10011703,10011703
"TOXICOLOGICAL ANALYSIS SUGGESTED THAT MIDAZOLAM, TOGETHER WITH AIR, WAS ALSO INJECTED INTO THE CIRCULATION USING THE SAME BOTTLE AND INFUSION SET",Intentional product misuse,INTENTIONAL MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10058995,10074903,10058995
RESPIRATORY INFECTION,Respiratory tract infection,RESPIRATORY INFECTION,RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10038700,10062352,10038700
THE TREATMENT WAS NOT SUFFICIENT TO CONTROL THE SYMPTOMS (LACK OF DRUG EFFECT WITRH NO ADVERSE EVENT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DRUG OVERDOSE DEATHS/ACCIDENTAL,Accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
DRESS SYNDROME,Drug reaction with eosinophilia and systemic symptoms,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
DIFFUSE OSTEOPENIA,osteopenia,OSTEOPENIA,OSTEOPENIA,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10049088,10049088,10049088
LACK OF SLEEP,Insomnia,SLEEP LOSS,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10041017,10022437,10041001
LIMITED MOVEMENT OF UPPER LIMBS,limb discomfort,LIMB DISCOMFORT,LIMB DISCOMFORT,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10061224,10061224,10061224
"LEUKOCYTES 22,100/ÎœL",White blood cell count increased,LEUKOCYTE COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047943,10047943,10048553
HEPATOMEGALY,hepatomegaly,HEPATOMEGALY,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10019842
INTENTIONAL SUSPECTED SUICIDE,Completed suicide,COMPLETED SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10010144,10010144,10010144
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
"PROGRESSION OF SYSTEMIC SARCOIDOSIS (TO LYMPH NODES,MAXILLARY SINUSES AND GI TRACT) FOLLOWING POOR COMPLIANCE OF DRUGS",Sarcoidosis,SARCOIDOSIS,SARCOIDOSIS,IMMUNE DISORDERS NEC,ACUTE AND CHRONIC SARCOIDOSIS,10021428,10039486,10039486,10039486
LYMPHOPENIA,Lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
MUCOSAL INFLAMMATION,Mucosal inflammation,MUCOSAL INFLAMMATION,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028116,10028116,10028116
MILD FACIAL EDEMA,mild facial edema,OEDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10030095
ASCITES,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
ENCEPHALOPATHY,encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
CELLULITIS OF THE LEFT LOWER LIMB REFRACTORY TO FLUCLOXACILLIN THERAPY,Cellulitis of the left lower limb refractory to flucloxacillin therapy,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
"REDUCED GENERAL FUNCTION, SUCH THAT HE WAS VIRTUALLY BED-BOUND",Bedridden,BEDRIDDEN,BEDRIDDEN,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10048948,10048948,10048948
ACNEIFORM RASH GRADE 1 (FIRST DEGREE ACNEIFORM ERUPTION OF FACE AND UPPER ABDOMEN),Rash acneiform,RASH ACNEIFORM,DERMATITIS ACNEIFORM,SKIN APPENDAGE CONDITIONS,ACNES,10040785,10037847,10012432,10037847
SHORTNESS OF BREATH,shortness of breath,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
GRADE 4 THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
IDIOPATHIC INTRACRANIAL HYPERTENSION (300 MM OF H2O) ASSOCIATED WITH ANEMIA WHICH WAS SECONDARY TO ZIDOVUDINE THERAPY,Idiopathic intracranial hypertension,IDIOPATHIC INTRACRANIAL HYPERTENSION,IDIOPATHIC INTRACRANIAL HYPERTENSION,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10078904,10078904,10078904
SEVERE DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
30 MONTH OLD PATIENT WAS VACCINATED WITH PENTAXIM,Drug administered to patient of inappropriate age,INAPPROPRIATE AGE AT VACCINE ADMINISTRATION,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10067927,10071062,10067927
MACULOPAPULAR RASH ON CHEST,Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
RECURRENT EPISODES OF ANAPHYLAXIS TO HD-MTX,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
HYPONATREMIA (115 MMOL/L),Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
ANGINA PECTORIS-LIKE CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
COMA VIGIL FOLLOWING SEROTONIN SYNDROME,Depressed level of consciousness,COMA VIGIL,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10063030,10012373,10063030
CONDITION AGGRAVATED,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
THERAPY OF CHRONIC GVHD AFTER ALLOGENIC STEM CELL TRANSPLANT WAS MYCOPHENOLATE MOFETIL (OFF LABEL USE FOR INDICATION WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INCREASED DIFFICULTY TO MOVE,Movements reduced,MOVEMENTS REDUCED,HYPOKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028045,10021021,10028045
BILATERAL THIGH AND KNEE PAIN,Arthralgia,PAIN IN KNEE,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023477,10003239,10033445
POLYMORPHIC VENTRICULAR TACHYCARDIA,Ventricular tachycardia,POLYMORPHIC VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10028158,10047302,10036095
URINARY TRACT INFECTIONS,urinary tract infections,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
GRADE 3 THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
BRONCHOALVEOLAR LAVAGE DISCLOSED ASPERGILLUS FUMIGATUS,Aspergillus fumigatus bronchopulmonary infection,ASPERGILLUS FUMIGATUS BRONCHOPULMONARY INFECTION,BRONCHOPULMONARY ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003493,10006473,10003493
PULMONARY EMBOLISM,Pulmonary embolism,PULMONARY EMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037377,10037377,10037377
SUBARACHNOID HEMORRHAGE,Subarachnoid haemorrhage,SUBARACHNOID HEMORRHAGE,SUBARACHNOID HAEMORRHAGE,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10042316,10042316,10042320
A RASH ON HIS UPPER AND LOWER EXTREMITIES DEVELOPED,rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
EXTENSIVE HEMORRHAGIC ULCER WITH UNDERMINED VIOLACEOUS BORDERS,Ulcer haemorrhage,HEMORRHAGIC ULCER,ULCER HAEMORRHAGE,TISSUE DISORDERS NEC,ULCERS NEC,10018065,10019017,10061577,10055285
VIRAL HEPATITIS C INFECTION,Hepatitis C,HEPATITIS C,HEPATITIS C,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10019744,10019744,10019744
REBOUND OF VANCOMYCIN-RESISTANT ENTEROCOCCI BACTEREMIA (VRE) FOLLOWING DISCONTINUATION OF LINEZOLID,Enterococcal bacteraemia,ENTEROCOCCAL BACTEREMIA,ENTEROCOCCAL BACTERAEMIA,BACTERIAL INFECTIOUS DISORDERS,ENTEROCOCCAL INFECTIONS,10021881,10014885,10014885,10014886
NECROTIC MUCOSA,Mucosal necrosis,MUCOSAL NECROSIS,MUCOSAL NECROSIS,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10067993,10067993,10067993
GRAND MAL CONVULSION,Generalised tonic-clonic seizure,GRAND MAL CONVULSION,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10018659,10018100,10018659
UPPER RESPIRATORY INFECTION,Upper respiratory infection,UPPER RESPIRATORY INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10046300,10046306,10046300
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
VESICOBULLOUS LESIONS ON PALM,Dermatitis bullous,BULLOUS LESIONS,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006565,10012441,10006565
ACUTE EXACERBATION OF HYPOXAEMIA AND INTERSTITIAL OPACITIES DEVELOPED IN ALMOST ALL LUNG FIELDS,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
LACK OF THERAPEUTIC EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PROPHYLAXES WITH ASPIRIN WAS GIVEN UNTIL DELIVERY AT 38 WEEKS,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
CLINICAL HYPERTHYROSIS/THYROTOXICOSIS,thyrotoxicosis,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
PATIENT HAD DIFFICULITY STANDING ON HIS TOES,Difficulty in standing,DIFFICULTY IN STANDING,DYSSTASIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10050218,10050256,10050218
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
"DESPITE IV FLUID INFUSION OF 2000 ML OF 0.9% NS, THE MEAN ARTERIAL PRESSURE (MAP) REMAINED BELOW 55 MMHG",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DEEP VEIN THROMBOSIS IN THE LEFT SIDED FEMORAL VEIN,Deep vein thrombosis,DEEP VEIN THROMBOSIS,DEEP VEIN THROMBOSIS,EMBOLISM AND THROMBOSIS,PERIPHERAL EMBOLISM AND THROMBOSIS,10047065,10051055,10051055,10051055
PROGRESSIVE MUSCLE WEAKNESS/ WEAKNESS INITIALLY AFFECTED THE PROXIMAL UPPER LIMBS AND PROGRESSED TO THE PROXIMAL LOWER LIMBS,Muscle weakness aggravated,MUSCLE WEAKNESS AGGRAVATED,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10048391,10028372,10048391
MULTIPLE PARENCHYMAL AND SUBPLEURAL NODULES,Nodule,NODULE,NODULE,TISSUE DISORDERS NEC,MASS CONDITIONS NEC,10018065,10054107,10054107,10054107
MACULOPAPULAR RASH,Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
CONCENTRATION PROBLEMS,Concentration impaired,CONCENTRATION IMPAIRED,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10010249,10013496,10010249
DYSPNEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
MILD ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
NEED TO INCREASE METHADONE [OPIOID MAINTENANCE TREATMENT ],Drug withdrawal maintenance therapy,OPIOID MAINTENANCE TREATMENT,DRUG WITHDRAWAL MAINTENANCE THERAPY,THERAPEUTIC PROCEDURES AND SUPPORTIVE CARE NEC,DRUG WITHDRAWAL THERAPIES,10042613,10071103,10052970,10071103
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
MUSCULAR CRAMPS (CRAMPS IN HIS CALVES),Muscle spasms,MUSCLE CRAMPS,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028294,10028334,10028295
COLONIC PERFORATION FOLLOWING CMV RELATED COLITIS,Colonic perforation,COLONIC PERFORATION,LARGE INTESTINE PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,INTESTINAL ULCERS AND PERFORATION NEC,10017947,10010001,10023804,10010001
CENTRIOLOBULAR EMPHYSEMA,Emphysema,EMPHYSEMA,EMPHYSEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10014561,10014561,10014561
REDNESS ON LEFT LOWER LEG/ DIFFUSE REDNESS OF LEFT LOWER LEG,Erythema,REDNESS OF LEGS,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10038207,10015150,10038207
RENAL DISORDER,Renal disorder,RENAL DISORDER,RENAL DISORDER,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL DISORDERS NEC,10038359,10038428,10038428,10038428
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
VISUAL HALLUCINATIONS,"Hallucination, visual",VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019075,10019075,10047570
OVARIAN SUPPRESSION FAILURE DUE TO THE TREATMENT FAILURE,Ovarian failure,OVARIAN FAILURE,OVARIAN FAILURE,OVARIAN AND FALLOPIAN TUBE DISORDERS,OVARIAN AND FALLOPIAN TUBE DISORDERS NEC,10038604,10033165,10033165,10033165
SEIZURES,seizures,SEIZURES,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039910,10039906,10039910
COMPENSATION OF DIABETES AGGRAVATED AGAIN/INSUFFICIENT COMPENSATION OF DIABETES MELLITUS,Diabetes mellitus inadequate control,DIABETES MELLITUS INADEQUATE CONTROL,DIABETES MELLITUS INADEQUATE CONTROL,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012607,10012607,10012607
DRUG VACCINE INTERACTION,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
ADMINISTERED AMPICILLIN FOR PYOGENIC SPONDYLITIS CAUSED BY E. FAECALIS BUT BACILLEMIA PERSISTED (LACK OF DRUG EFFECT) WITH NO ADVERSE DRUG REACTION,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
ORAL MUCOSA EROSION,Oral mucosa erosion,ORAL MUCOSA EROSION,ORAL MUCOSA EROSION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10064594,10064594,10064594
ESCHERICHIA COLI AT SIGNIFICANT TITRES WAS CULTURED FROM URINE/RECURRENT E. COLI URINARY SYSTEM INFECTIONS WERE FOUND ON URINE CULTURES,Escherichia urinary tract infection,ESCHERICHIA URINARY TRACT INFECTION,ESCHERICHIA URINARY TRACT INFECTION,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10052238,10052238,10052238
NEUTROPHILS 80%,Neutrophil count increased,NEUTROPHIL COUNT HIGH,NEUTROPHIL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029367,10029368,10029367
SEIZURES RELAPSED,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
PYURIA,pyuria,PYURIA,PYURIA,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10037686,10037686,10037686
JOINT EFFUSION,Joint effusion,JOINT EFFUSION,JOINT EFFUSION,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023215,10023215,10023215
INFANTILE HEMANGIOMAS TREATED WITH ORAL PROPRANOLOL,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CHERRY CONSUMPTION MAY CAUSE UNEXPECTEDLY HIGH INR,Food interaction,FOOD INTERACTION,FOOD INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10016948,10016948,10016948
TUMOR,gum swelling,GUM SWELLING,GINGIVAL SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10018789,10018291,10018789
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
SEVERE DIARRHEA- GRADE III,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
OFF LABEL USE FOR LIP INFANTILE HAEMANGIOMA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
ERYTHEMATOUS RASH WITH RAISED VESICLES ON THE LEFT THIGH,Thigh abscess,THIGH ABSCESS,ABSCESS LIMB,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10078806,10050473,10078806
UNSTEADINESS/ LOST BALANCE AFTER CLOSING EYES/ IMBALANCE,unsteadiness,UNSTEADINESS,BALANCE DISORDER,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10046260,10049848,10046260
OSTEOCALCIN LEVEL WAS 7.9 NG/ML (24-70),Osteocalcin decreased,OSTEOCALCIN DECREASED,OSTEOCALCIN DECREASED,MUSCULOSKELETAL AND SOFT TISSUE INVESTIGATIONS (EXCL ENZYME TESTS),BIOCHEMICAL MARKERS OF BONE METABOLISM,10022891,10050940,10050940,10050940
PERSISTENT LDL-C ELEVATION,Low density lipoprotein increased,LOW DENSITY LIPOPROTEIN INCREASED,LOW DENSITY LIPOPROTEIN INCREASED,LIPID ANALYSES,CHOLESTEROL ANALYSES,10022891,10024910,10024910,10024910
ANASARCA,Generalised oedema,ANASARCA,GENERALISED OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10002241,10018092,10002241
"MOTTLING AND CYANOSIS AFFECTED HIS FINGERS, TOES, NOSE AND GENITALIA WITHIN ONE WEEK",Livedo reticularis,MOTTLED SKIN,LIVEDO RETICULARIS,SKIN VASCULAR ABNORMALITIES,SKIN VASOMOTOR CONDITIONS,10040785,10028010,10024648,10028010
THERAPY-RELATED ACUTE MYELOGENOUS LEUKEMIA WITH CHARACTERISTIC DEL5Q AND DEL7Q CHROMOSOMAL ABNORMALITIES,Treatment related acute myeloid leukemia,TREATMENT RELATED ACUTE MYELOID LEUKEMIA,ACUTE MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10066353,10000880,10066353
PAINFUL LESIONS ON THE SKIN OF HIS LOWER LIMBS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
PRURITUS,pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
BEHAVIORAL MISCONCEPTIONS,Behavior disorder,BEHAVIOR DISORDER,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004204,10061422,10004204
SWELLING OF LEFT PAROTID GLAND,Parotid gland enlargement,PAROTID SWELLING,PAROTID GLAND ENLARGEMENT,SALIVARY GLAND CONDITIONS,SALIVARY GLAND ENLARGEMENTS,10017947,10034028,10034023,10034028
ELECTROCARDIOGRAM QT PROLONGED,Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QT PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10014387,10014387,10014387
BLUISH DISCOLORATION WITH MULTIPLE BLISTERS AND LESIONS OVER HIS RIGHT CALF AND THIGH,Blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
PULMONARY EDEMA DUE TO METHOTREXATE INTOXICATION BECAUSE OF DRUG PRESCRIBING ERROR,pulmonary edema,PULMONARY EDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037375,10037423,10037375
HYPONATREMIA,Hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
ALLERGIC REACTION,allergic reaction,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
HYDROCEPHALUS,hydrocephalus,HYDROCEPHALUS,HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,HYDROCEPHALIC CONDITIONS,10029205,10020508,10020508,10020508
SCROTAL ULCER NECROTIC WITH A BLACK ESCHAR,eschar,ESCHAR,ESCHAR,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10051814,10051814,10051814
ACUTE ENCEPHALOPATHY DURING A POST-ICTAL PERIOD,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
FETAL TACHYCARDIA,Fetal tachycardia,FETAL TACHYCARDIA,TACHYCARDIA FOETAL,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10054725,10043074,10054725
INCREASED LEVEL OF NEUTROPHILS,increased level of neutrophils,NEUTROPHILS INCREASED,NEUTROPHIL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029381,10029368,10029381
BACK AND LIMB FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
DRIED ESCHARS OVER PREVIOUS BLISTER SITES,eschar,ESCHAR,ESCHAR,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10051814,10051814,10051814
MUSCLE WEAKNESS,Muscular weakness,MUSCLE WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028372,10028372,10028350
ADENOVIRAL GASTROENTERITIS,gastroenteritis viral,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10017918,10017918,10017918
SYNCOPE NECESSITATING PACEMAKER IMPLANTATION,Syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
COMMMAND AUDITORY HALLUCINATIONS,"Hallucination, auditory",AUDITORY HALLUCINATIONS,"HALLUCINATION, AUDITORY",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019070,10019070,10003785
"GENERALIZED ERYTHEMATOUS, BLANCHEABLE, CONFLUENT, MACULOPAPULAR RASH",Rash erythematous,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015243
"DRUG EXPOSURE DURING PREGNANCY, SECOND TRIMESTER",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, SECOND TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076616,10073513,10076616
PATIENT RESPONDED PARTLY TO PREDNISOLONE,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
HEPATITIS B VIRUS GENOTYPE WAS DETERMINED,Hepatitis B,HEPATITIS B,HEPATITIS B,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10019731,10019731,10019731
TRICHOPHYTON RUBRUM,Trichophyton infection,TRICHOPHYTON INFECTION,TRICHOPHYTOSIS,FUNGAL INFECTIOUS DISORDERS,TINEA INFECTIONS,10021881,10061388,10067409,10061388
PATIENT WAS TREATED WITH CYCLOPHOSPHAMIDE AND METHYLPREDNISOLONE WITH MINIMAL BENEFIT,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
HYPOOSMOLAR HYPONATREMIA,Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
WHEEZING,Wheezing,WHEEZING,WHEEZING,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10047924,10047924,10047924
ABDOMINAL LYMPHADENOPATHY,Abdominal lymphadenopathy,ABDOMINAL LYMPHADENOPATHY,ABDOMINAL LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10073485,10073485,10073485
PEAK VANCOMYCIN LEVEL 35 (1G/ML) FOLLOWING DRUG INTERACTION,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
INAPPETENCE,Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
BILATERAL LUNG CRACKLES,Rales,CRACKLES LUNG,RALES,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10054910,10037833,10054910
DRUG-INDUCED HAEMOLYTIC ANAEMIA,Haemolytic anaemia,HEMOLYTIC ANEMIA DRUG-INDUCED,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10018918,10018916,10055208
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
EOSINOPHILIA,eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
FIXED POSTURING,posture abnormal,POSTURE ABNORMAL,POSTURE ABNORMAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10036436,10036436,10036436
HEPARIN-INDUCED THROMBOCYTOPENIA THROMBOSIS,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOSIS,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10063492,10062506,10063492
WBC COUNT INCREASED (55.3X10E3/MICROL),White blood cell count increased,WBC INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056739,10047943,10056739
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
RECEIVED OVERDOSE OF PARACETAMOL AND PREGABALIN (NOT PRESCRIBED),Overdose,MULTIPLE DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10057867,10033295,10057867
"DEVELOPED SCALY, CENTRALLY CLEARING, ANNULAR ERYTHEMATOUS LESIONS ON HIS FACE, TORSO AND LIMBS (FIG. 1), WITH NAILFOLD ERYTHEMA",Nail fold inflammation,NAIL FOLD INFLAMMATION,NAIL FOLD INFLAMMATION,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10074978,10074978,10074978
PULMONARY FIBROSIS SECONDARY TO AMIODARONE,Pulmonary fibrosis,PULMONARY FIBROSIS,PULMONARY FIBROSIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10037383,10037383,10037383
WORSENED MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
EXPERIENCED RECURRENT ARRHYTHMIC EVENTS AT EXCERCISE OR EMOTIONAL STRESS,Arrhythmia,ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10003119
HIGH FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
MARKED MALAISE DUE TO ANTIHYPERTENSIVE MEDICATION,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
TREMOR,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
BLOOD PRESSURE OF 90/40 MMHG,Hypotension,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10024895
CONFUSION,confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
ORAL INTAKE BECAME IMPOSSIBLE,Feeding disorder,UNABLE TO EAT,FEEDING DISORDER,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10069830,10061148,10069830
"ERYTHEMATOUS AND SCALY RASH AFFECTING THE FACE, TRUNK, AND EXTREMITIES",erythematous and scaly rash,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015243,10037855,10015243
ERYTHEMA NODOSUM,Erythema nodosum,ERYTHEMA NODOSUM,ERYTHEMA NODOSUM,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,PANNICULITIDES,10040785,10015226,10015226,10015226
"SEVERE LACTIC ACIDOSIS FOLLOWING METFORMIN OVERDOSE, CATECHOLAMINES REFRACTIVE VASODILATORY SHOCK AND INTENTIONAL DRUG MISUSE",Intentional product use issue,INTENTIONAL PRODUCT USE ISSUE,INTENTIONAL PRODUCT USE ISSUE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT USE ISSUES,10022117,10076308,10076308,10076308
COMPRESSIVE OPTIC NEUROPATHY,Optic neuropathy,OPTIC NEUROPATHY,OPTIC NEUROPATHY,VISION DISORDERS,VISUAL PATHWAY DISORDERS,10015919,10061323,10061323,10061323
MULTIFOCAL CUTANEOUS KAPOSI SARCOMA,Kaposi's sarcoma,KAPOSI'S SARCOMA,KAPOSI'S SARCOMA,SOFT TISSUE NEOPLASMS MALIGNANT AND UNSPECIFIED,KAPOSI'S SARCOMAS,10029104,10023284,10023284,10023284
SERUM ALBUMIN DECREASED (30.6 G/L) DUE TO STEVENS JOHNSON SYNDROME,Blood albumin decreased,SERUM ALBUMIN DECREASED,BLOOD ALBUMIN DECREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10040123,10005287,10040123
UNABLE TO WALK,walking disability,WALKING DISABILITY,WALKING DISABILITY,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10053204,10053204,10053204
MILD CREATININE ELEVATION,Creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
"RASH CHARACTERISED BY URTICARIAL PLAQUES ON HER BACK, UPPER LIMBS, AND ANTERIOR SURFACES OF HER THIGHS.",rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
FLUDARABINE PHOSPHATE USED IN CHILD BELOW AGE 18,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PAINFUL ULCERS NONHEALING,painful ulcers nonhealing,ULCER,ULCER,TISSUE DISORDERS NEC,ULCERS NEC,10018065,10045285,10045285,10045285
OXALIPLATIN BASED CHEMOTHERAPY INDUCED SINUSOIDAL OBSTRUCTIVE SYNDROME,Venoocclusive liver disease,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
CARDIORESPIRATORY ARREST FOLLOWING DRUG INDUCED LONG QT SYNDROME SECONDARY TO TOXICITY FROM MEGLUMINE ANTIMONIATE,Cardio-respiratory arrest,CARDIO-RESPIRATORY ARREST,CARDIO-RESPIRATORY ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007617,10007617,10007617
LACK OF RESPONSE,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
CONFUSION,confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
BILATERAL PLEURAL EFFUSION,Pleural effusion,BILATERAL PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10078037,10035598,10078037
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
AST INCREASED (13794 UNITS/L),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
MILD RIGHT UPPER QUADRANT TENDERNESS ON DEEP PALPITAION IN THE RENAL FLANK AREAS BILATERALLY,Upper abdominal tenderness,UPPER ABDOMINAL TENDERNESS,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10069064,10000097,10069064
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
URINE DIPSTIX TESTING DEMOSTRATED++ BILIRUBIN,Bilirubin urine present,BILIRUBIN URINE PRESENT,BILIRUBIN URINE PRESENT,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10077356,10077356,10077356
HYPERSENSITIVITY,Hypersensitivity,HYPERSENSITIVITY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020751,10020751,10020751
DRUG MISUSE,Intentional product misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
MILD PROTEINURIA,mild proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
LEFT ACUTE NONCARDIOGENIC PULMONARY EDEMA INDUCED BY HIGH DOSE OF NEOSTIGMINE,Non-cardiogenic pulmonary edema,NON-CARDIOGENIC PULMONARY EDEMA,NON-CARDIOGENIC PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10029537,10029538,10029537
DISSEMINATED NECROTIZING LEUKOENCEPHALOPATHY,Disseminated necrotizing leukoencephalopathy,DISSEMINATED NECROTIZING LEUKOENCEPHALOPATHY,LEUKOENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10067605,10024382,10067605
RIVAROXABAN USED FOR SPLANCHNIC VEIN THROMBOSIS,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
ASPARTATE TRANSAMINASE INCREASED (2729 IU/L),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
THALAMOMESENCEPHALIC ABSCESS FOLLOWING LISTERIAL MENINGOENCEPHALITIS,Brain abscess,BRAIN ABSCESS,BRAIN ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10006105,10006105,10006105
"STAPHYLOCOCCUS SPP., INCLUDING STAPHYLOCOCCUS EPIDERMIDIS AND STAPHYLOCOCCUS HOMINIS",Staphylococcal infection,STAPHYLOCOCCAL INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10058080,10058080,10058080
RELAPSE OF LUPUS NEPHRITIS WITH CYCLOPHOSPHAMIDE/DISEASE RECURRENCE,Lupus nephritis,LUPUS NEPHRITIS,LUPUS NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10025140,10025140,10025140
LYMPHOPENIA,Lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
DRUG-INDUCED IMMUNE THROMBOCYTOPENIA OF RAPID-ONSET (PLATELET COUNT FELL TO 5X10^9/L OVER 4 DAYS)/RAPID-ONSET LEVOFLOXACIN-INDUCED D-ITP,Immune thrombocytopenic purpura,AUTOIMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10050245,10074667,10050245
HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
HYPERNATREMIA (160 MMOL/L),Hypernatraemia,HYPERNATREMIA,HYPERNATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10020679,10020679,10020680
NODE ESCAPE RHYTHM WITH RETROGRADE ATRIAL ACTIVATION,Escape nodal,ESCAPE NODAL,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10015291,10042602,10015291
MONOSOMY 7 IN PH-NEGATIVE CELLS ASSOCIATED SEVERE MYELODYSPLASIA,Chromosomal mutation,CHROMOSOMAL MUTATION,CHROMOSOMAL MUTATION,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,CHROMOSOMAL ABNORMALITIES NEC,10010331,10061765,10061765,10061765
LACK OF DRUG EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
RETAIN OF PAIN (POSSIBLE LACK OF EFFICACY),pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
PATIENT TREATED WITH METHOTREXATE FOR ECTOPIC PREGNANCY (OFF LABEL USE FOR INDICATION) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MS RELAPSE,ms relapse,MULTIPLE SCLEROSIS RELAPSE,MULTIPLE SCLEROSIS RELAPSE,DEMYELINATING DISORDERS,MULTIPLE SCLEROSIS ACUTE AND PROGRESSIVE,10029205,10048393,10048393,10048393
"DELAYED, CELL-MEDIATED, ALLERGY TO ISONIAZID",Type IV hypersensitivity reaction,DELAYED TYPE HYPERSENSITIVITY,TYPE IV HYPERSENSITIVITY REACTION,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10012210,10053613,10012210
SEPSIS,sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
MILD THRUSH,Thrush,THRUSH,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10043649,10074170,10043649
"RAPID,SHALLOW BREATHING PATTERN",shallow breathing,SHALLOW BREATHING,HYPOPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040533,10021079,10040533
HYPONATREMIA,Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
LOW COPPER SERUM LEVEL,Blood copper decreased,COPPER LOW,BLOOD COPPER DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10010960,10005442,10010960
DEPRESSION,depression,DEPRESSION,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012378,10012378,10012378
BLINDNESS,Blindness,VISION LOSS,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047522,10005169,10047522
PAPULES AND SUBCUTANEOUS NODULES ON HER ANTERIOR UPPER CHEST AND ARMS,Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
NO ADVERSE EVENT,NO ADVERSE EVENT,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
PRODUCTIVE COUGH,Productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
LIVER DYSFUNCTION/PROGRESSIVE KIDNEY AND LIVER DYSFUNCTION,Hepatic function abnormal,HEPATIC DYSFUNCTION NOS,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019657,10019670,10019657
ASPIRIN SEEMS TO BE THE MOST CONSENSUAL PROPHYLACTIC OPTION/PLATELET COUNTS CONTINUED TO RISE UNTIL DAY 14,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SERTRALINE INDUCED CERVICAL DYSTONIA,Torticollis,CERVICAL DYSTONIA,TORTICOLLIS,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10064124,10044074,10064124
RETICULOCYTE COUNT INCREASED (13 PER CENT),Reticulocyte count increased,RETICULOCYTE COUNT INCREASED,RETICULOCYTE COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10038792,10038792,10038792
"WE STOPPED HER ANTICOAGULANT BECAUSE HER PLATELET COUNT WAS 30,000",Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
AN URGENT SKIN BIOPSY SHOWED PROMINENT NEUTROPHILIC DERMAL INFILTRATES FORMING OCCASIONAL MICROABSCESSES AROUND ECCRINE GLANDS,Subcutaneous abscess,ABSCESSES OF SKIN,SUBCUTANEOUS ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10000320,10042343,10000320
LICHENOID LESIONS,Rash papular,LICHEN,RASH PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10024426,10037876,10024426
DECLINE IN FUNCTIONS,Social anxiety disorder,SOCIAL ANXIETY DISORDER,SOCIAL ANXIETY DISORDER,ANXIETY DISORDERS AND SYMPTOMS,FEAR SYMPTOMS AND PHOBIC DISORDERS (INCL SOCIAL PHOBIA),10037175,10041242,10041242,10041242
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
QTC PROLONGATION AND TORSADES DE POINTES DUE TO A COADMINISTRATION OF FLUOXETINE AND AMIODARONE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
REFRACTORY TO TREATMENT WITH THE FIRST DOSE OF IMMUNOGLOBULIN AND ACETYLSALICYLIC ACID,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
STATE OF SHOCK DUE TO METFORMIN-INDUCED LACTIC ACIDOSIS,Shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
ACUTE RENAL INSUFFICIENCY,Acute kidney injury,ACUTE RENAL INSUFFICIENCY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10050440,10069339,10050440
ANXIETY,anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
ARTERIAL HYPOTENSION,Arterial hypotension,ARTERIAL HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10066331,10021097,10066331
WBC'S 0.3 X 10^9 / L,White blood cell count decreased,WBC DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056731,10047942,10056731
DRUG-DRUG INTERACTIONS,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
RIGHT OPTIC NEURITIS,optic neuritis,OPTIC NEURITIS,OPTIC NEURITIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OPTIC NERVE DISORDERS NEC,10029205,10030942,10030942,10030942
PROTEIN 370 MG/L,CSF protein increased,CSF PROTEIN INCREASED,CSF PROTEIN INCREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10011575,10011575,10011575
THE PATIENT WAS ADMINISTERED METHOTREXATE FOR IDYOPATHIC POLYMYOSITIS (OFF LABEL OF METHOTREXATE FOR INDICATION),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PROGRESSIVE DYSPNOEA,progressive dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
ORANGE-RED DISCOLORATION OF THE BODY,Skin discolouration,SKIN DISCOLORATION,SKIN DISCOLOURATION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040829,10040829,10040828
SUSPECTED FLUPIRTINE-INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
DISCRETE EYELIDS ERYTHEMA,Erythema of eyelid,ERYTHEMA EYELID,ERYTHEMA OF EYELID,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","LID, LASH AND LACRIMAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10015237,10015237,10051630
POLYMORPHIC AND PRURITIC CUTANEOUS ERUPTION LIMITED IN EXTREMITIES,pruritic rash,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037085,10037884,10037085
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
INTOLERABLE SEXUAL SIDE EFFECTS,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
UPPER RESPIRATORY TRACT INFECTIONS,Upper respiratory tract infection,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10046306,10046306,10046306
SYSTOLIC BLOOD PRESSURE DIFFERENCE BETWEEN LEFT AND RIGHT ARMS,Blood pressure difference of arms,BLOOD PRESSURE DIFFERENCE OF ARMS,BLOOD PRESSURE DIFFERENCE OF EXTREMITIES,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10071055,10071052,10071055
SCARRING FOLLOWING VIRAL INFECTION OR REACTIVATION,Scar,SKIN SCARRING,SCAR,INJURIES NEC,SKIN INJURIES NEC,10022117,10070845,10039580,10070845
COMMENCED TREATMENT WITH ACETAZOLAMIDE FOR IDIOPATHIC INTRACRANIAL HYPERTENSION (OFF LABEL USE WITH NO ADR),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RED AND PAINFUL EYES,Eye pain,PAINFUL RED EYES,EYE PAIN,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10033516,10015958,10033516
CMV INFECTION,Cytomegalovirus infection,CMV INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011831,10011831,10009703
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
NAUSEA AND VOMITING,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ANAPHYLACTIC REACTION,Anaphylactic reaction,ANAPHYLACTIC REACTION,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002198,10002198,10002198
SILDENAFIL ADMINISTERED IN CHILD (OFF LABEL USE IN POPULATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"SKIN OF BOTH THE UPPER AND LOWER EXTREMITIES OF THE PATIENT WAS BLACK AND HAD SEVERE PIGMENTATION,PROMINENT ON THE SHANKS AND DORSUM PEDIS (CUTANEOUS HYPERPIGMENTATION) FOLLOWING OFF LABEL USE",Skin hyperpigmentation,SKIN HYPERPIGMENTATION,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10040865,10040865,10040865
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PLASMA CREATININE INCREASED (4.8 MG/DL),Blood creatinine increased,PLASMA CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10035278,10005483,10035278
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
TOXIC METABOLIC ENCEPHALOPATHY DUE TO SUPRATHERAPEUTIC VORICONAZOLE FOLLOWING DRUG INTERACTION WITH POSACONAZOLE,Metabolic encephalopathy,METABOLIC ENCEPHALOPATHY,METABOLIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10062190,10062190,10062190
"POLYCLONAL HYPERGAMMAGLOBULINEMIA (IGG 3140MG/DL, IGA 424MG/DL AND IGM 340MG/DL),",Hypergammaglobulinaemia,POLYCLONAL HYPERGAMMAGLOBULINEMIA,HYPERGAMMAGLOBULINAEMIA,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10036041,10020630,10036042
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
PERIPHERAL NERVE DISORDER,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
PAIN,pain in jaw,PAIN IN JAW,PAIN IN JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10033433,10033433,10033433
RESULTANT HYPERPIGMENTATION,Hyperpigmentation skin,HYPERPIGMENTATION SKIN,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10020715,10040865,10020715
PULMONARY HYPERTENSION KEPT PROGRESSING FOLLOWING LACK OF DRUG EFFECT OF SILDENAFIL,Pulmonary hypertension,PULMONARY HYPERTENSION,PULMONARY HYPERTENSION,PULMONARY VASCULAR DISORDERS,PULMONARY HYPERTENSIONS,10038738,10037400,10037400,10037400
LEFT-VENTRICULAR (LV) DILATATION,Dilatation ventricular,DILATATION VENTRICULAR,DILATATION VENTRICULAR,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10013012,10013012,10013012
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HOARSENESS,Dysphonia,HOARSENESS,DYSPHONIA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10020201,10013952,10020201
RENAL FAILURE,Renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
EXTRAPYRAMIDAL EFFECTS,Extrapyramidal disorder,EXTRAPYRAMIDAL DISORDER,EXTRAPYRAMIDAL DISORDER,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10015832,10015832,10015832
RETICULOCYTE COUNT DECREASED (LESS THAN 20X10E9/L),Reticulocyte count decreased,RETICULOCYTE COUNT DECREASED,RETICULOCYTE COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10038790,10038790,10038790
GRADE 1 FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
MYOCARDIAL DISORDER,Cardiomyopathy,MYOCARDIAL DISORDER,CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10028591,10007636,10028591
SEVERE IRRITABILITY,Irritability,IRRITABILITY,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10022998,10022998,10022998
"WHITE BLOOD CELL COUNT INCREASED 13,800/MCL",White blood cell count increased,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047943,10047943,10047943
TREATMENT WITH IMATINIB RESULTED IN PARTIAL RESPONSE,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
"SHE HAD BEEN TREATED WITH LITHIUM, SERTRALINE, AND MIRTAZAPINE DURING THE SECOND TRIMESTER OF PREGNANCY, WITHOUT MUCH IMPROVEMENT.",Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HYPOGLYCEMIC EPISODES,Hypoglycaemia,HYPOGLYCEMIC EPISODE,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10060385,10020993,10049635
HYPOKALAEMIA DUE TO OLMESARTAN INDUCED SPRUE-LIKE ENTEROPATHY,Hypokalaemia,HYPOKALAEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021015
AST INCREASED (179),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
PHENOMENON OF MONONEUROPATHY MULTIPLEX,Mononeuropathy multiplex,MONONEUROPATHY MULTIPLEX,MONONEUROPATHY MULTIPLEX,PERIPHERAL NEUROPATHIES,MONONEUROPATHIES,10029205,10027918,10027918,10027918
INTERSTITIAL PNEUMONIA,Interstitial lung disease,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
TIREDNESS,Fatigue,TIREDNESS,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10043890
ADVERSE DRUG REACTIONS WERE SERIOUS IN ONLY TWO CASES,Adverse event,ADVERSE EVENT,ADVERSE EVENT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10060933,10060933,10060933
RENAL DYSFUNCTION,renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
RHEUMATOID NODULES IN LUNGS,Rheumatoid nodule,RHEUMATOID NODULE,RHEUMATOID NODULE,JOINT DISORDERS,RHEUMATOID ARTHROPATHIES,10028395,10048694,10048694,10048694
HEPATOTOXICITY,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
PERSISTENT HIGH GRADE FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
DIFFUSE PIGMENTATION IN DUODENUM,Mucosal pigmentation,MUCOSAL PIGMENTATION,MUCOSAL PIGMENTATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10067724,10067724,10067724
OFF LABEL USE OF ANTITHROMBOTIC THERAPY (LOW MOLECULAR WEIGHT HEPARIN AT DOSE OF 4000 IU/DAY +ACETYLSALICYLIC ACID 100 MG/DAY) AS A PROPHYLAXIS OF PLACENTAL OBSTETRIC COMPLICATIONS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
OCCUPATIONAL EXPOSURE TO DRUG (PREPARATION OF INTRAVENOUS DRUGS),Occupational exposure to product,OCCUPATIONAL EXPOSURE TO DRUG,OCCUPATIONAL EXPOSURE TO PRODUCT,"EXPOSURES, CHEMICAL INJURIES AND POISONING",OCCUPATIONAL EXPOSURES,10022117,10068469,10073311,10068469
BACK MYALGIA ON EZETIMIBE TREATMENT,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
CARDIOTOXICITY,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
PATIENT TREATED WITH CYCLOPHOSPHAMIDE AS CONDITIONING THERAPY (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INSUFFICIENT CONTROL OF SYMPTOMS OF PSORIASIS WITH TOPICAL CALCIPOTRIENE AND BETAMTHASONE (SUBTHERAPEUTIC EFFECT) WITH NO ADR,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
FIBRINOGEN LEVEL OF 0.63 G/L,Blood fibrinogen increased,FIBRINOGEN INCREASED,BLOOD FIBRINOGEN INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10016597,10005521,10016597
ASYSTOLE  ( SEVERE NON ALLERGIC REACTION),Cardiac arrest,ASYSTOLE,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10003586,10007515,10003586
"HYPERSENSITIVITY REACTION, ITCHING, GENERALIZED WEAKNESS, THORACIC OPPRESSION AND NEUTROPENIA",weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
DISEASE PROGRESSION,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
SECONDARY MYELODYSPLASTIC SYNDROME,Myelodysplastic syndrome,MYELODYSPLASTIC SYNDROME,MYELODYSPLASTIC SYNDROME,LEUKAEMIAS,MYELODYSPLASTIC SYNDROMES,10029104,10028533,10028533,10028533
LOWMOLECULAR WEIGHT PROTEINURIA,proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
WORSENED DROWSINESS,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
EPSTEIN-BARR VIRUS ASSOCIATED B-CELL LYMPHOMA,B-cell lymphoma,B-CELL LYMPHOMA,B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,B-CELL LYMPHOMAS NEC,10029104,10003899,10003899,10003899
TACHYPHYLAXIS,Tachyphylaxis,TACHYPHYLAXIS,TACHYPHYLAXIS,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10043087,10043087,10043087
CERVICAL LYMPHADENOPATHY,Lymphadenopathy,LYMPHADENOPATHY CERVICAL,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025200,10025197,10025200
LIVER INJURY,Liver injury,LIVER INJURY,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067125,10067125,10067125
MAGNESIUM DECREASED (1.3 MG/DL),Blood magnesium decreased,MAGNESIUM DECREASED,BLOOD MAGNESIUM DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10025432,10005654,10025432
CELLS AND DEBRIS IN VITREOUS OF LEFT EYE,Vitreous floaters,VITREOUS DEBRIS,VITREOUS FLOATERS,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","CHOROID AND VITREOUS STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10047654,10047654,10072356
WORSENING OF VERTEBRAL OSTEOMYELITIS/ VERTEBRAL OSTEOMYELITIS,Osteomyelitis,OSTEOMYELITIS AGGRAVATED,OSTEOMYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,BONE AND JOINT INFECTIONS,10021881,10066711,10031252,10066711
TRANSIENT ISCHEMIC ATTACK,Transient ischaemic attack,TRANSIENT ISCHEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,TRANSIENT CEREBROVASCULAR EVENTS,10029205,10044390,10044390,10072760
OCCASIONAL INTRA-EPIDERMAL VESICLES HARBOURING LANGERHANS CELLS,vesicles ,VESICLES,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10047368,10005191,10047368
MASSIVE INTRAVASCULAR HEMOLYSIS,Haemolysis,HEMOLYSIS,HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10018910,10018910,10019491
THE PATIENT INITIALLY TREATED WITH METHOTREXATE BUT IT DID NOT RESPOND TO THE TREATMENT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
"A BLOOD SMEAR SHOWED ANISOPOIKILOCYTOSIS, TEAR DROP FORMS, HEMIGHOST RED CELLS, MATURE LYMPHOCYTES AND SMUDGE CELLS",Poikilocytosis,POIKILOCYTOSIS,POIKILOCYTOSIS,RED BLOOD CELL DISORDERS,RED BLOOD CELL ABNORMAL FINDINGS NEC,10005329,10035774,10035774,10035774
MYCOPHENOLATE MOFETIL USED FOR TREATMENT OF SARCOIDOSIS,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
JAUNDICE,jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
DIARRHEAS,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
FACIAL TWITCHING,twitching facial,TWITCHING FACIAL,MUSCLE TWITCHING,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10045200,10028347,10045200
EPSTEIN-BARR VIRUS-ASSOCIATED POLYMORPHIC POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER,Post transplant Epstein-Barr virus associated lymphoproliferative disorder,POST TRANSPLANT EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10075146,10051358,10075146
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
SEROTONIN SYNDROME,Serotonin syndrome,SEROTONIN SYNDROME,SEROTONIN SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10040108,10040108,10040108
IMMEDIATE-TYPE HYPERSENSITIVITY REACTIONS,Type I hypersensitivity,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
ANOTHER ARRHYTHMIA ATTACK DESPITE THE TREATMENT,Arrhythmia,ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10003119
SOMNOLENCE,somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
MARKED SINUS BRADYCARDIA AND SINUS ARRHYTHMIA ALONG WITH SECOND-DEGREE HEART BLOCK,Sinus arrhythmia,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040739,10040739,10040739
PATIENT TREATED WITH HYDROXYCHLOROQUINE FOR AUTOIMMUNE FEMALE INFERTILITY WITH NO ADR (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BODY WEIGHT 1525G,Low birth weight baby,BIRTH WEIGHT LOW,LOW BIRTH WEIGHT BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10004961,10067508,10004958
ADMINISTRATION OF FUROSEMIDE DURING PREGNANCY,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
CUTANEOUS ULCERATION ON FEET,Skin ulceration,SKIN ULCERATION,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040947,10040943,10040947
VALPROIC ACID TOXICITY,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
NEWLY DIAGNOSED CIRRHOSIS,Hepatic cirrhosis,CIRRHOSIS LIVER,HEPATIC CIRRHOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10019641,10019641,10009211
FLUID RETENTION,fluid retention,FLUID RETENTION,FLUID RETENTION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME INCREASED,10027433,10016807,10016807,10016807
DRUG INTERACTION/OLANZAPINE WAS ALSO DISCONTINUED DUE TO INTERACTION WITH CARBAMAZEPINE,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
OFF LABEL USE (GI STROMAL TUMOUR WITH METASTASES TO LIVER),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ALP INCREASED (946 MG/DL),Blood alkaline phosphatase increased,ALP INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001771,10059570,10001771
INGESTION OF 30 500 MG TABLETS OF PARACETAMOL,Overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
CHRONIC HEV INFECTION,Hepatitis E,HEPATITIS E,HEPATITIS E,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10019768,10019768,10019768
LACK OF EFFICACY,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
INCREASED PROTEINURIA,proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
BACTERIAL CONJUNCTIVITIS,Conjunctivitis bacterial,CONJUNCTIVITIS BACTERIAL,CONJUNCTIVITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10061784,10061784,10061784
RIGHT PYRAMIDIC,Neurological symptom,NEUROLOGICAL SYMPTOM,NEUROLOGICAL SYMPTOM,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10060860,10060860,10060860
SHE DID NOT TAKE HER MEDICATION REGULARLY,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
BLURRED VISION,Vision blurred,BLURRED VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047513,10047513,10005886
PRESCRIBED UNDERDOSE,Prescribed underdose,PRESCRIBED UNDERDOSE,PRESCRIBED UNDERDOSE,OVERDOSES AND UNDERDOSES NEC,UNDERDOSES NEC,10022117,10073085,10073085,10073085
ALT INCREASED (245 U/L),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
TREATMENT ALLOWED PARTIAL REGRESSION OF INFILTRATED LESIONS,subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
GRADE 2 PAPULOPUSTULAR RASH,Rash pustular,RASH PUSTULAR,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037888,10037888,10037888
OPIUM ADDICTION,Drug dependence,OPIUM ADDICTION,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10030900,10013663,10030900
HEPATOBILIARY ABNORMALITIES,Hepatobiliary disease,HEPATOBILIARY DISEASE NOS,HEPATOBILIARY DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10051306,10062000,10051306
DRUG INDUCED LUNG INJURY CAUSED BY LEVOFLOXACIN EYE DROPS FOLLOWING DELAYED HYPERSENSITIVITY,Traumatic lung injury,LUNG INJURY,TRAUMATIC LUNG INJURY,INJURIES NEC,CHEST AND RESPIRATORY TRACT INJURIES NEC,10022117,10061230,10069363,10061230
SINUSOIDAL OBSTRUCTION SYNDROME/VENO-OCCLUSIVE DISEASE,Venoocclusive liver disease,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
ALLERGY TO ACETYLSALICYLIC ACID,Allergic reaction to analgesics,ALLERGIC REACTION TO ANALGESICS,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10072246,10013700,10072246
PATIENT WAS TREATED WITH ASPIRIN AND ATORVASTATIN FOR LIMBSHAKING TRANSIENT ISCHEMIC ATTACK BUT SHE CONTINUED TO HAVE SYMPTOMS WITH NO IMPROVEMENT OVER A PERIOD OF 3 MONTHS WITH NO ADVERSE EVENT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SPONTANEOUS BACTERIAL PERITONITIS,Peritonitis bacterial,SPONTANEOUS BACTERIAL PERITONITIS,PERITONITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10061135,10062070,10061135
REBOUND OF NEPHROTIC SYNDROME FOLLOWING PREDNISONE TAPER,rebound of nephrotic syndrome following prednisone taper,NEPHROTIC SYNDROME,NEPHROTIC SYNDROME,NEPHROPATHIES,GLOMERULONEPHRITIS AND NEPHROTIC SYNDROME,10038359,10029164,10029164,10029164
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
EPSTEIN-BARR VIRUS REACTIVATION,Epstein-Barr virus infection reactivation,EPSTEIN-BARR VIRUS INFECTION REACTIVATION,EPSTEIN-BARR VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,EPSTEIN-BARR VIRAL INFECTIONS,10021881,10015109,10015108,10015109
ULCER IN THE RIGHT EYE,Corneal ulcer,CORNEAL ULCER,ULCERATIVE KERATITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CORNEAL INFECTIONS, OEDEMAS AND INFLAMMATIONS",10015919,10048492,10064996,10048492
RECURRENT SINUS AND LUNG INFECTIONS,Lung infection,LUNG INFECTION,LUNG INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10061229,10061229,10061229
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
SEVERE HEADACHE,severe headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
SEVERE LEFT VENTRICULAR SYSTOLIC DISFUNCTION WITH A CALCULATED LEFT VENTRICULAR EJECTION FRACTION (LVEF) OF 27%,left ventricular systolic disfunction,LEFT VENTRICULAR SYSTOLIC DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10069501,10049694,10069501
"CROSS REACTIVITY TO CEFACLOR, CEFADROXIL AND CEFALEXIN",Drug cross-reactivity,DRUG CROSS-REACTIVITY,THERAPEUTIC PRODUCT CROSS-REACTIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10076743,10079645,10076743
BRAIN METASTSIS ACCOMPANIED BY BRAIN EDEMA,Metastases to central nervous system,METASTASES TO BRAIN,METASTASES TO CENTRAL NERVOUS SYSTEM,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027453,10059282,10027453
DRUG NONCOMPLIANCE,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
HIP PAIN,Arthralgia,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
BASAL CRACKLES ON BOTH LUNGS- INFLAMMATORY INFILTRATES,Rales,CRACKLES LUNG,RALES,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10054910,10037833,10054910
BLURRED RIGHT OPTIC DISC[OPTIC DISCS BLURRED],Optic discs blurred,OPTIC DISCS BLURRED,OPTIC DISCS BLURRED,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC",OPTIC DISC ABNORMALITIES NEC,10015919,10030923,10030923,10030923
LEFT HEEL CELLULITIS,Cellulitis,CELLULITIS OF FOOT,CELLULITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10007911,10007882,10007911
"BLOODY DIARRHOEA (ON DAY SIX, WHICH BECAME PROFUSE ON DAY EIGHT)",Diarrhoea haemorrhagic,BLOODY DIARRHOEA,DIARRHOEA HAEMORRHAGIC,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012741,10012741,10055957
FRACTURED ROOTS IN THE UPPER AND LOWER ARCH WITH TEETH DISLOCATION AND PERIODENTAL DISRUPTION,Tooth dislocation,TOOTH DISLOCATION,TOOTH DISLOCATION,INJURIES NEC,SITE SPECIFIC INJURIES NEC,10022117,10079745,10079745,10079745
NEUTROPENIC (NOS),Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
INVASIVE BRONCHOPULMONARY ASPERGILLOSIS,Aspergillus fumigatus bronchopulmonary infection,ASPERGILLUS FUMIGATUS BRONCHOPULMONARY INFECTION,BRONCHOPULMONARY ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003493,10006473,10003493
ELEVATED CREATININE,Blood creatinine increased,CREATININE HIGH,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011367,10005483,10011367
OCCASIONAL VISUAL HALLUCINATIONS,Visual hallucinations,VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10047570,10019075,10047570
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
CEREBELLAR ATAXIA,Cerebellar ataxia,CEREBELLAR ATAXIA,CEREBELLAR ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10008025,10008025,10008025
PROGRESSION (NECROTIC AREAS INSIDE THE ISCHEMIC LESION),Necrosis,NECROSIS,NECROSIS,TISSUE DISORDERS NEC,NECROSIS NEC,10018065,10028851,10028851,10028851
PATIENT WAS GIVEN MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF LUPUS NEPHRITIS ( OFF LABEL USE OF THE DRUG) WITH NO ADVERSE DRUG REACTION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"AFTER 10 DAYS IN THE CICU ON HEPARIN, THE PATIENT'S PLATELET COUNT DROPPED TO 22,000 ÎœL-1",Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
HYPOKINESIA,hypokinesia,HYPOKINESIA,HYPOKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10021021,10021021,10021021
HUNGRY BONE SYNDROME,hungry bone syndrome,HUNGRY BONE SYNDROME,HUNGRY BONE SYNDROME,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10062623,10062623,10062623
COMATOSE,comatose,COMATOSE,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10058472,10010071,10058472
INTERACTION WITH CHLORAMPHENICOL/ PHENYTOIN TOXICITY RESULTING FROM DRUG INTERACTION WITH CHLORAMPHENICOL,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
"MALE PATIENT SELF ADMINISTERED SCOPOLAMINE, BUPRENORPHINE, QUETIAPINE, METHADONE, DIAZEPAM, PREGABALIN AND GABAPENTIN",Prescription drug used without a prescription,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076639,10076639,10076639
ALT INCREASED (8098 U/L),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
"DIFFUSE ABDOMINAL PAIN, ESPECIALLY IN THE EPIGASTRIC AREA",Abdominal pain upper,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
ENCEPHALOPATHY DUE TO ACCIDENTAL INTRATHECAL METHOTREXATE OVERDOSE FOLLOWING PRODUCT LABEL CONFUSION AND INTRAVENOUS FORMULATION ADMINISTERED BY OTHER ROUTE(ADMINISTRATION OF HIGHER INTRAVENOUS DOSE VIAL IN SMALL VOLUME WHICH RESULTED FROM THE RESEMB,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
CARDIAC ARREST,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
PATIENT TREATED WITH DEXAMETHASONE FOR FETAL LUNGS MATURATION (DRUG EXPOSURE DURING PREGNANCY) WITH NO ADR,Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
TACHYCARDIA,tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
FULMINANT HEPATIC FAILURE,Fulminant hepatic failure,FULMINANT HEPATIC FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10017469,10000804,10017469
FERRITIN INCREASED (15655 NG/ML),Serum ferritin increased,FERRITIN INCREASED,SERUM FERRITIN INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10016459,10040250,10016459
RECURRENT FEVER,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
HEMOGLOBIN 65 G/L,Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
NO SIGNIFICANT RADIOLOGICAL CHANGE,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
VOMITUS,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
"LEVELS OF SODIUM, CHLORIDE, AND POTASSIUM WERE LOW",Blood potassium decreased,POTASSIUM LOW,BLOOD POTASSIUM DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10036452,10005724,10036452
DISSEMINATED CUTANEOUS LEISHMANIASIS WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
"DESPITE THE ADMINISTRATION OF 102 UNITS OF SUBCUTANEOUS INSULIN ON THAT DAY, HER BLOOD GLUCOSE REMAINED ELEVATED CONSISTENTLY, PERSISTENT HYPERGLYCEMIA",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
FAILED TREATMENT WITH METHOTREXATE FOR ACPA POSITIVE RHEUMATOID ARTHRITIS,treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
PERSISTENT ISOLATION OF CANDIDA GLABRATA FROM BLOOD SPECIMENS (TREATMENT FAILURE),Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
AGGRAVATION UPON RESUMING PRESCRIBED REGIMEN,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
RISUS SARDONICUS FACIES,Risus sardonicus,RISUS SARDONICUS,RISUS SARDONICUS,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10039198,10039198,10039198
POOR ORAL INTAKE,oral intake reduced,ORAL INTAKE REDUCED,HYPOPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10063889,10063743,10063889
WEAKNESS,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
GOT INCREASED (898 UI/L),Aspartate aminotransferase increased,GOT INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10018624,10003481,10018624
"DESPITE LORAZEPAM AND LEVETIRACETAM ADMINISTRATION, THE PATIENT DID NOT RETURN TO BASELINE AND WAS TRANSFERRED TO OUR UNIT",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
WORSENING OF NEUROSARCOIDOSIS,Neurosarcoidosis,NEUROSARCOIDOSIS,NEUROSARCOIDOSIS,CENTRAL NERVOUS SYSTEM INFECTIONS AND INFLAMMATIONS,CENTRAL NERVOUS SYSTEM INFLAMMATORY DISORDERS NEC,10029205,10078011,10078011,10078011
FEBRILE,febrile,FEBRILE REACTION,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016289,10037660,10016289
RIGHT ILIAC MUSCLE HAEMATOMA,Muscle haemorrhage,HAEMATOMA MUSCLE,MUSCLE HAEMORRHAGE,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10055890,10028309,10055890
POSTPUSTULAR DESQUAMATION,Exfoliative rash,RASH DESQUAMATING,EXFOLIATIVE RASH,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10037853,10064579,10037853
EXHAUSTION,Exhaustion,EXHAUSTION,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10015667,10016256,10015667
AMOXICILLIN ALLERGY,Drug allergy,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
HYPERTHERMIA,Hyperthermia,HYPERTHERMIA,HYPERTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10020843,10020843,10020843
"THERAPY WITH HEPARIN AND PENTOXIFYLLIN DID NOT PREVENT THE PROGRESSIVE, NECROTIZING AND SUPPURATIVE EVOLUTION OF THE DISEASE (LACK OF DRUG EFFECT)",Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
NEUROTOXICITY,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
DARK BROWN URINE,myoglobinuria,MYOGLOBINURIA,MYOGLOBINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10028629,10028629,10028629
HYPERAMMONAEMIA,Hyperammonaemia,HYPERAMMONAEMIA,HYPERAMMONAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020575,10020575,10020575
PAIN ON SWALLOWING,Odynophagia,ODYNOPHAGIA,ODYNOPHAGIA,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE PAIN AND PARAESTHESIA,10017947,10030094,10030094,10030094
"FEELING OF BEING ""MUDDIED-UP""/FEELING OF SUPPRESSION/PERSISTENT FEELING OF SUPPRESSION",feeling abnormal,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10016322,10016322,10016322
THROMBOPHLEBITIS DUE TO CAMPYLOBACTER  FETUS SSP.FETUS,Thrombophlebitis,THROMBOPHLEBITIS,THROMBOPHLEBITIS,EMBOLISM AND THROMBOSIS,PERIPHERAL EMBOLISM AND THROMBOSIS,10047065,10043570,10043570,10043570
INTERACTION BETWEEN ITRACONAZOLE AND SIMVASTATIN,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
ANKYLOSING SPONDYLITIS,ankylosing spondylitis,ANKYLOSING SPONDYLITIS,ANKYLOSING SPONDYLITIS,JOINT DISORDERS,SPONDYLOARTHROPATHIES,10028395,10002556,10002556,10002556
APPLICATION SITE HYPEREMIA WITH DIAMETER 6X6CM,Hyperaemia,HYPEREMIA,HYPERAEMIA,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10020565,10020565,10020619
THROMBEX AND ASPIRIN PROTECT WERE STARTED RIGHT BEFORE HEMORRHAGIC EVENT OCCURED,Labelled drug-drug interaction medication error,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT MONITORING ERRORS AND ISSUES,10022117,10064373,10064373,10064373
ELEVATED  PROTEINASE 3 (PR3) ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) TITER WAS FOUND TO BE 65.8 U/ML,Antineutrophil cytoplasmic antibody positive,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10060136,10060136,10060136
SEVERE EXACERBATION OF LEFT-SIDE COLITIS DUE TO ADMINISTRATION OF MESALAZINE,Colitis ulcerative aggravated,COLITIS ULCERATIVE AGGRAVATED,COLITIS ULCERATIVE,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009901,10009900,10009901
SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
FEELING WEAK,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
LACK OF EFFICACY,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CHOLESTASIS,cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
"NEW BONE METASTASIS: 3RD, 6TH, 7TH, AND 11TH RIGHT COSTAL RIBS",Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
GASTRIC VARICEAL BLEEDING,Gastric varices haemorrhage,GASTRIC VARICES BLEEDING,GASTRIC VARICES HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,GASTRIC AND OESOPHAGEAL HAEMORRHAGES,10017947,10057572,10057572,10057577
1-YEAR OLD GIRL ADMINISTERED WITH BORTEZOMIB FOR RELAPSED KMT2A (MLL)-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA (OFF LABEL FOR AGE AND INDICATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PERIPHERAL NEUROPATHY FOLLOWING DRUG TOXICITY,peripheral neuropathy,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10080342,10029331,10080342
PROPAFENONE INTOXICATION,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
HEADACHE ASSOCIATED WITH GAGGING,Retching,GAGGING,RETCHING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10072124,10038776,10017572
WEAKNESS,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
PLEURITIC CHEST PAIN,Pleuritic pain,PLEURITIC PAIN,PLEURITIC PAIN,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10035623,10035623,10035623
ANOREXIA,Decreased appetite,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10002646
THROMBOCYTOPENIA AND LEFT FEMORAL VEIN THROMBOSIS AND PULMONARY EMBOLISM,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
APPROX. 25 ML OF LEMTRADA SOLUTION LEFT IN THE INFUSION SYSTEM AFTER EACH INFUSION/ALEMTUZUMAB PRESUMABLY ONLY 9MG/D WERE APPLIED,Underdose,UNDERDOSE,UNDERDOSE,OVERDOSES AND UNDERDOSES NEC,UNDERDOSES NEC,10022117,10057362,10057362,10057362
STAPHYLOCOCCUS AUREUS INFECTION,Staphylococcal infection,STAPHYLOCOCCUS AUREUS INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10075981,10058080,10075981
RELAPSE OF DISEASE,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
REDNESS OCCURRED ON THE WHOLE UPPER ARM,Erythema,LOCALIZED ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10064351,10015150,10024781
HAD NO WITHDRAWAL REFLEXES AND WAS UNRESPONSIVE TO PAIN,unresponsive to pain,UNRESPONSIVE TO PAIN STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10062495,10045555,10062495
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TENOFOVIR-INDUCED FANCONI SYNDROME,Fanconi syndrome acquired,FANCONI SYNDROME ACQUIRED,FANCONI SYNDROME ACQUIRED,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10052607,10052607,10052607
"I HAVE HAD 2 EPISODES OF WHERE ALL I CAN DESCRIBE IS THAT A LARGE WAVE WAHES OVER ME, I FEEL NAUSEOUS, I AM VIOLENTLY, SICK, I LOOSE MY ABILITY TO SPEACH, BECOME DISORIENTATED, I CANNOT STAND UNAIDES.",Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
QTC PROLONGATION,Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
LOST CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
IMMEDIATE HYPERSENSITIVITY REACTION TO CYCLOPHOSPHAMIDE/ ACUTE ANAPHYLACTIC REACTION,Anaphylactic reaction,ACUTE ANAPHYLACTIC REACTION,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10000663,10002198,10000663
INFECTIONS GRADE 3-4,Infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
DRUG EXPOSURE DURING PREGNANCY WITH NO ADR,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
SLIPPED CAPITAL FEMORAL EPIPHYSIS,Slipped capital femoral epiphysis,SLIPPED FEMORAL CAPITAL EPIPHYSIS,EPIPHYSIOLYSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),EPIPHYSEAL DISORDERS,10028395,10041027,10015079,10041027
MACULOPAPULAR RASH,Maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
CRUSTS IN THE NOSE,Nasal crusting,NASAL CRUSTING,NASAL CRUSTING,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10076524,10076524,10076524
PATIENT TREATED WITH METHOTREXATE AND MYCOPHENOLATE MOFETIL FOR UVEITIS (UNAPPROVED INDICATION FOR BOTH DRUGS)- OFF LABEL USE WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG OVERDOSE DELIBERATE SELF-INFLICTED,Drug overdose deliberate self-inflicted,DRUG OVERDOSE DELIBERATE SELF-INFLICTED,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10013738,10022523,10013738
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
MEDULLARY APLASIA,Aplasia,APLASIA,APLASIA,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10002961,10002961,10002961
SYNCOPAL EPISODE,syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
GAS-CONTAINING CERVICAL AND THORACIC SPINAL EPIDURAL ABSCESS SECONDARY TO KLEBSIELLA PNEUMONIA INFECTION,klebsiella pneumonia infection,PNEUMONIA KLEBSIELLA,PNEUMONIA KLEBSIELLA,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10035717,10035717,10035717
SLIGHT DYSARTHRIA,Dysarthria,DYSARTHRIA,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10013887,10013887,10013887
A SIGNIFICANT PATENT DUCTUS ARTERIOSUS (PDA) OF 4 MM,Patent ductus arteriosus,PATENT DUCTUS ARTERIOSUS,PATENT DUCTUS ARTERIOSUS,CARDIAC AND VASCULAR DISORDERS CONGENITAL,PERSISTENT FOETAL CIRCULATION DISORDERS,10010331,10034130,10034130,10034130
CREATININE CLEARANCE OF 37.1 ML/MIN,Creatinine clearance decreased,CREATININE CLEARANCE DECREASED,CREATININE RENAL CLEARANCE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011363,10011372,10011363
ISOLATED EOSINOPHILIA (4.6 X 10^9 /L),Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
ANAEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
PERSISTENT ABDOMINAL PAIN,abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
NO AMELIORATION OF PAIN SYMPTOMS WAS OBSERVED,Drug ineffective,DRUG EFFECT LACK OF,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013684
THROMBOTIC MICROANGIOPATHYES(TMA),Thrombotic microangiopathy,THROMBOTIC MICROANGIOPATHY,THROMBOTIC MICROANGIOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10043645,10043645,10043645
"INTRAUTERINE GROWTH RESTRICTION (IUGR)/ GROWTH RESTRICTION (SKELETAL PARAMETERS CONSISTENT WITH A FOETAL AGE OF 17 WEEKS, 5",Foetal growth restriction,INTRAUTERINE GROWTH RETARDATION,FOETAL GROWTH RESTRICTION,FOETAL COMPLICATIONS,FOETAL GROWTH COMPLICATIONS,10036585,10022819,10070531,10022819
ALLERGY TO ALUMINIUM,Allergy to aluminium,ALLERGY TO ALUMINIUM,ALLERGY TO METALS,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10077091,10066414,10077091
METHOTREXATE WAS DISPENSED INSTEAD OF METOLAZONE ( DRUG DISPENSING ERORR),Drug dispensing error,DRUG DISPENSING ERROR,DRUG DISPENSING ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT DISPENSING ERRORS AND ISSUES,10022117,10064354,10064354,10064354
METASTASES TO BONE,Metastases to bone,METASTASES TO BONE,METASTASES TO BONE,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027452,10027452,10027452
CEREBRAL ANGIOGRAPHY DEMONSTRATED A 1MM M4 SEGMENT MYCOTIC ANEURYSM,Mycotic aneurysm,MYCOTIC ANEURYSM,INFECTIVE ANEURYSM,INFECTIONS - PATHOGEN UNSPECIFIED,VASCULAR INFECTIONS,10021881,10028517,10058017,10028517
EXTENSIVE FIBROSIS,Fibrosis,FIBROSIS,FIBROSIS,TISSUE DISORDERS NEC,FIBROSIS NEC,10018065,10016642,10016642,10016642
WORSENING OF FIXED DRUG REACTION WITH MULTIPLE MOUTH ULCERATIONS,mouth ulcerations,MOUTH ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028034,10028034,10028034
THE PATIENT WAS TAKING THE MAXIMUM DAILY DOSE REGULARLY FOR SEVERAL YEARS AND DEVELOPED A DYSTONIC REACTION PROBABLY AS A RESULT OF THE ANTIHISTAMINE OVERUSE,Incorrect drug administration duration,DRUG ADMINISTRATION DURATION TOO LONG,INCORRECT DRUG ADMINISTRATION DURATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064312,10064307,10064312
COMATOSE FOLLOWING PROGRESSION OF POSTINFECTIOUS ACUTE DEMYELINATING ENCEPHALOMYELITIS DESPITE STEROID PULSE THERAPY,Coma,COMATOSE,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10058472,10010071,10058472
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
"THE PATIENT DEVELOPED VENTRICULAR FIBRILLATION. HE DID NOT RESPOND TO AMIODARONE INFUSION, FOLLOWED BY 4 TIMES OF DEFIBRILLATION AND CARDIOVERSION",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
NON-BLOODY DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
"MASSIVE WITHDRAWAL SYMPTOMS WITH NAUSEA, VOMITING, DIARHEA AND WITH PAIN",Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HEPATIC AND PERITONEAL METASTASIS,Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
GLOBALLY DEVELOPMENTALLY DELAYED,developmental delay,DEVELOPMENTAL DELAY,DEVELOPMENTAL DELAY,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10012559,10012559,10012559
ODYNOPHAGIA WORSENING FOLLOWING PATIENT SHOWED NONRESPONSIVENSS TO TREATMENT WITH METHYLPREDNISOLONE FOR ERYTHEMA MULTIFOME LEADING TO ITS WORSENING,Odynophagia,ODYNOPHAGIA,ODYNOPHAGIA,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE PAIN AND PARAESTHESIA,10017947,10030094,10030094,10030094
EXCESSIVE DROWSINESS,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
ANGIOEDEMA,Angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
CORTICOSTEROID-INDUCED HYPOMANIC EPISODE,Hypomania,HYPOMANIA,HYPOMANIA,MANIC AND BIPOLAR MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH MANIC SYMPTOMS,10037175,10021030,10021030,10021030
PATIENT WAS GIVEN HEPARIN AND ENOXAPARIN DURING PREGNANCY (DRUG EXPOSURE DURING PREGNANCY),drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
SEVERE HYPOCALCAEMIA DUE TO PPI-INDUCED FUNCTIONAL HYPOPARATHYROIDISM,hypoparathyroidism,HYPOPARATHYROIDISM,HYPOPARATHYROIDISM,PARATHYROID GLAND DISORDERS,HYPOPARATHYROID DISORDERS,10014698,10021041,10021041,10021041
DECREASED RESPIRATORY SOUNDS,Breath sounds abnormal,RESPIRATORY SOUNDS DECREASED,BREATH SOUNDS ABNORMAL,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10006333,10064780,10038715
APLASIA CUTIS CONGENITA FOLLOWING EXPOSURE TO THIAMAZOLE IN UTERO,Aplasia cutis congenita,APLASIA CUTIS CONGENITA,APLASIA CUTIS CONGENITA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL NEC,10010331,10002963,10002963,10002963
MULTIORGAN FAILURE,Multiple organ dysfunction syndrome,MULTIORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028162
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
MILD REDNESS,Redness mouth,REDNESS MOUTH,ORAL MUCOSAL ERYTHEMA,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SIGNS AND SYMPTOMS,10017947,10049321,10067418,10049321
HYPERTHERMIA AT 38.2Â°C,hyperthermia,HYPERTHERMIA,HYPERTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10020843,10020843,10020843
ABDOMINAL TENDERNESS,abdominal tenderness,ABDOMINAL TENDERNESS,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000097,10000097,10000097
WORSENED HYPERTENSION (160/100 MMHG G3),Hypertension,HYPERTENSION WORSENED,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020773,10020772,10020799
ACUTE DRUG-INDUCED AUTOIMMUNE HEPATITIS,Drug-induced hepatitis,DRUG-INDUCED HEPATITIS,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10013762,10072268,10013762
POSTBULBAR DUODENAL ULCER,Duodenal ulcer,DUODENAL ULCER,DUODENAL ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,DUODENAL ULCERS AND PERFORATION,10017947,10013836,10013836,10013836
SERUM BPN LEVELS WERE ABNORMALLY HIGH,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
HYPOALBUMINEMIA (2.4 G/DL),Hypoalbuminaemia,HYPOALBUMINEMIA,HYPOALBUMINAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020942,10020942,10020943
PROGRESSION OF CHRONIC IDIOPATHIC MYELOFIBROSIS FOLLOWING LACK OF DRUG EFFECT,myelofibrosis,MYELOFIBROSIS,MYELOFIBROSIS,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),MYELOPROLIFERATIVE DISORDERS (EXCL LEUKAEMIAS),10029104,10028537,10028537,10028537
MULTIPLE SMALL BLISTERS,Blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
TOENAILS WERE NOTED TO BE DYSTROPHIC,Nail dystrophy,NAIL DYSTROPHY,NAIL DYSTROPHY,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10028698,10028698,10028698
CONCENTRATION PROBLEMS,Disturbance in attention,DISTURBANCE IN ATTENTION,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10013496,10013496,10013496
UROSEPSIS,Urosepsis,UROSEPSIS,UROSEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10048709,10048709,10048709
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
MYOPATHY APPARENTLY PRECIPITATED BY FENOFIBRATES IN PATIENTS ALREADY TAKING LOW DOSES OF STATINS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
SEVERE WEAKNESS,Asthenia ,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
SGOT INCREASED (100 IU/L),Aspartate aminotransferase increased,SGOT INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10040524,10003481,10040524
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
DRUGS USED IN ASTHMA AND ANGIOEDEMA,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
GASTROINTESTINAL SIDE EFFECTS,Gastrointestinal disorder,GASTROINTESTINAL DISORDER NOS,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017945,10017944,10017945
TWO PARTIAL SEIZURES ASSOCIATED WITH AURA,Partial seizures,PARTIAL SEIZURES,PARTIAL SEIZURES,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10061334,10061334,10061334
ELEVATED LIVER ENZYMES,Hepatic enzyme increased,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
ASCITES,ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
ANOREXIA,anorexia,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10002646,10061428,10002646
URSODEOXYCHOLIC ACID USED FOR INTRAHEPATIC CHOLESTASIS OF PREGNANCY WITHOUT SYMPTOMATIC BENEFIT (LACK OF DRUG EFFECT),Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
LETHARGY,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
MULTIPLE CEREBRAL ABSCESSES,Cerebral abscess,CEREBRAL ABSCESS,BRAIN ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10075341,10006105,10075341
"FATIGUE FOLLOWING EXPOSURE OF DACARBAZINE, BLEOMYCIN, DOXORUBICIN AND VINBLASTIN DURING PREGNANCY",Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
EPIGASTRIC PAIN,Abdominal pain upper,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
MESALAZINE INDUCED ACUTE MYOCARDITIS,Myocarditis,ACUTE MYOCARDITIS,MYOCARDITIS,MYOCARDIAL DISORDERS,NONINFECTIOUS MYOCARDITIS,10007541,10000932,10028606,10000932
ENCEPHALITIS AND THALAMIC INJURY FROM NEUROINVASIVE WEST NILE VIRUS,encephalitis and thalamic injury from neuroinvasive West Nile virus,ENCEPHALITIS VIRAL,ENCEPHALITIS VIRAL,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10014612,10014612,10014612
RESTLESSNESS,restlessness,RESTLESSNESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038743,10038743,10038743
GENERALIZED PRURITUS OF SKIN,Pruritus generalised,PRURITUS GENERALISED,PRURITUS GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10052576,10052576,10052576
PAIN IN THE JOINTS AND MUSCLES,joint pain,JOINT PAIN,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023222,10003239,10023222
AST INCREASED (671 U/L),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
YELLOW-BROWN PURULENT ASCITES FOLLOWING SPONTANEOUS ACALCULOUS GALLBLADDER PERFORATION,ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
FEBRILE,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PARTIAL RESPONSE,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
"INTRACTABLE VOMITING CONTINUED, DESPITE TAKING ONDANSETRON",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
EPISODIC BLEEDING FOLLOWING DRUG-INDUCED IMMUNE THROMBOCYTOPENIA,Haemorrhage,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10005103
WEIGHT GAIN,Weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
OVERDOSE OF 10 G OF PARACETAMOL,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
INJECTION SITE PAIN,Injection site pain,INJECTION SITE PAIN,INJECTION SITE PAIN,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022086,10022086,10022086
INTENSE PAIN IN THE HIPS,intense pain in the hips,PAIN IN HIP,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10033432,10003239,10033432
HYPERTENSIVE WITH BLOOD PRESSURES RANGING FROM 160/100 TO 200/115 MM HG,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
MULTIPLE ASYMPTOMATIC BROWN MACULES ON THE PALMS AND SOLES WITH A DIAMETER BETWEEN 1 AND 5 MM,Macule,MACULE,MACULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10025421,10025421,10025421
"BILATERAL, SYMMETRICAL MEDIAL THALAMIC INFARCTS",Thalamic infarction,THALAMIC INFARCTION,THALAMIC INFARCTION,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10064961,10064961,10064961
LIVER TOXICITY FOLLOWING ACCIDENTAL INGESTION OF METHOTREXATE,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
VISUAL AND AUDITORY HALLUCINATIONS,"Hallucinations, mixed",AUDITORY AND VISUAL HALLUCINATIONS,"HALLUCINATIONS, MIXED",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10003776,10019079,10003777
REVERSIBLE PURE-WORD DEAFNESS,deafness,DEAFNESS,DEAFNESS,HEARING DISORDERS,HEARING LOSSES,10013993,10011878,10011878,10011878
INCREASE IN SERUM CREATININE,Serum creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
MALIGNANT CATATONIA,Malignant catatonia,MALIGNANT CATATONIA,MALIGNANT CATATONIA,CHANGES IN PHYSICAL ACTIVITY,DECREASED PHYSICAL ACTIVITY LEVELS,10037175,10080149,10080149,10080149
ANAPHYLAXIS,Anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
CONDITION AGGRAVATED,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DECREASED PCO2 (18 MMHG),PCO2 decreased,PCO2 DECREASED,PCO2 DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10034181,10034181,10034181
SUICIDAL THOUGHTS,Suicidal ideation,SUICIDAL IDEATION,SUICIDAL IDEATION,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042458,10042458,10042458
SEVERE CYSTITIS,Cystitis,CYSTITIS,CYSTITIS,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10011781,10011781,10011781
VESICULAR SLIGHTLY BLISTERING RASH,Vesicular rash,VESICULAR RASH,RASH VESICULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10047377,10037898,10047377
BLOATING,Abdominal distension,BLOATING,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10005265,10000060,10005265
CHRONIC ALLOGRAFT DYSFUNCTION FOLLOWING BK VIRUS NEPHROPATHY,Transplant dysfunction,GRAFT DYSFUNCTION,TRANSPLANT DYSFUNCTION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10074860,10074860,10059677
AREFLEXIA,Areflexia,AREFLEXIA,AREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10003084,10003084,10003084
RECURRENT TRANSIENT ISCHEMIC ATTACKS,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HYPERREFLEXIA,Hyperreflexia,HYPERREFLEXIA,HYPERREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10020745,10020745,10020745
CONFUSED FOLLOWING ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,Confusional state,CONFUSED,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010298
ALT ELEVATED,Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
VIGILANCE DISTURBANCE/ATTENTION DISORDER,disturbance in attention,DISTURBANCE IN ATTENTION,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10013496,10013496,10013496
FENOFIBRATE ASSOCIATED ACUTE LIVER INJURY,Liver injury,ACUTE LIVER INJURY,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067970,10067125,10067970
PULMONARY HYPERTENSION KEPT PROGRESSING FOLLOWING LACK OF DRUG EFFECT OF SILDENAFIL,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
ACHILLES TENDONS STARTED TO HURT,Achilles tendon pain,ACHILLES TENDON PAIN,TENDON PAIN,"TENDON, LIGAMENT AND CARTILAGE DISORDERS",TENDON DISORDERS,10028395,10050471,10066371,10050471
"LIVER ENZYMES (AST, ALT) REMAINED SLIGHTLY ELEVATED",Hepatic enzyme increased,HEPATIC ENZYME INCREASED,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10060795,10060795,10060795
RHABDOMYOLYSIS,rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
STAGE IV PROSTATE ADENOCARCINOMA GLEASON 3+4,Adenocarcinoma of prostate,ADENOCARCINOMA OF PROSTATE,PROSTATE CANCER,REPRODUCTIVE NEOPLASMS MALE MALIGNANT AND UNSPECIFIED,PROSTATIC NEOPLASMS MALIGNANT,10029104,10001186,10060862,10001186
METFORMIN CAUSING THAIMINE DEFICIENCY,Vitamin B1 decreased,THIAMINE DECREASED,VITAMIN B1 DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",VITAMIN ANALYSES,10022891,10058788,10058740,10058788
THE FETUS WAS EVALUATED AND NOTED TO HAVE BRADYCARDIA,Fetal bradycardia,FETAL BRADYCARDIA,BRADYCARDIA FOETAL,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10054724,10006094,10054724
PERIPHERAL FACIAL NERVE PALSY FOLLOWING REBOUND EFFECT ON TAPERING OF PREDNISOLONE,peripheral facial nerve palsy,PALSY,PARALYSIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10033558,10033799,10033558
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
THICKNESS OF SUBCUTANEOUS ADIPOSE TISSUE AT LOWER ABDOMINAL REGION (17 MM),Injection site hypertrophy,INJECTION SITE SUBCUTANEOUS FATTY HYPERTROPHY,INJECTION SITE HYPERTROPHY,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022101,10022072,10022101
DEPRESSED LEVEL OF CONSCIOUSNESS,Depressed level of consciousness,DEPRESSED LEVEL OF CONSCIOUSNESS,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10012373,10012373,10012373
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
MYALGIA IN THE BACK,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
DECREASED CONSCIOUSNESS,Depressed level of consciousness,CONSCIOUSNESS DECREASED,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010768,10012373,10010768
LETHARGY,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
SEPSIS FOLLOWING NEUTROPENIC FEVER DUE TO CHEMOTHERAPY AND DRUG INTERACTION OF VORINOSTAT AND BORTEZOMIB,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
INTOXICATION WITH UNCONSCIOUSNESS / POISONING,intoxication,INTOXICATION,POISONING,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10022727,10061355,10022727
CT SHOWED BRONCHIAL WALL THICKENING,Bronchial wall thickening,BRONCHIAL WALL THICKENING,BRONCHIAL WALL THICKENING,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHIAL CONDITIONS NEC,10038738,10067182,10067182,10067182
CHAGASIC HYPODERMITIS,Dermo-hypodermitis,DERMO-HYPODERMITIS,DERMO-HYPODERMITIS,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10065259,10065259,10065259
WORSENING OF DIABETES COMPENSATION,Diabetes mellitus,DIABETES,DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012601,10012601,10012594
PATIENT TREATED WITH MYCOPHENOLATE MOFETIL FOR IGA NEPHROPATHY (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SYMPTOMS WERE EXACERBATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SLEEPY,Somnolence,SLEEPY,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041018,10041349,10041018
EFFORT DYSPNEA,Dyspnea on effort,DYSPNEA ON EFFORT,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10055546,10013971,10055546
PATIENT EXPERIENCED A PARTIAL AND NON PERMANENT PAIN CONTROL DURING THE THERAPY WITH ETORICOXIB TAKEN FOR THE TREATMENT OF SPONDYARTHROSIS WITH BILATERAL PAINFUL SHOULDER AND MULTIPLE DISC HERNIA,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
LEUKOCYTOSIS,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
CARDIAC DYSFUNCTION,Cardiac dysfunction,CARDIAC DYSFUNCTION,CARDIAC DYSFUNCTION,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10079751,10079751,10079751
CORNEAL NEOVASCULARIZATION,Corneal neovascularisation,CORNEAL NEOVASCULARIZATION,CORNEAL NEOVASCULARISATION,OCULAR HAEMORRHAGES AND VASCULAR DISORDERS NEC,CONJUNCTIVAL AND CORNEAL BLEEDING AND VASCULAR DISORDERS,10015919,10055665,10055665,10011031
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
"MILD, ASYMPTOMATIC HYPOKALEMIA",Hypokalaemia,HYPOKALEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021018
CORTICOSTEROID DOSE REQUIRED TO BE MAINTAINED HIGHER THAN 10MG/DAY FOR BIRDSHOT CHORIORETINOPATHY FOLLOWING REBOUND EFFECT,Birdshot chorioretinopathy,BIRDSHOT CHORIORETINOPATHY,BIRDSHOT CHORIORETINOPATHY,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","RETINAL, CHOROID AND VITREOUS INFECTIONS AND INFLAMMATIONS",10015919,10072959,10072959,10072959
ANOREXIA,Decreased appetite,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10002646
ASPIRATION PNEUMONIA,aspiration pneumonia,ASPIRATION PNEUMONIA,PNEUMONIA ASPIRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10003525,10035669,10003525
FULMINANT SEPTICEMIA,Sepsis,SEPTICEMIA,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040089
PERSISTENT LACTIC ACIDOSIS,lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
CLUBFOOT,Talipes,CLUBFOOT,TALIPES,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS OF LIMBS CONGENITAL,10010331,10009694,10043101,10009694
PATIENT SHOWED PERSISTENT ELECTROGRAPHIC SPASM COMPLEXES WITH ELECTRODECREMENTAL RESPONSE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SEVERE DIARRHEA/ WATERY STOOLS,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
TACHYCARDIA,tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
PERSISITNG SIGNIFICANT HYPERCHOLESTEROLAEMIA/NO SIGNIFICANT CHANGES IN LIPIDAL SPECTRUM/EXPECTED VALUES OF BLOOD CHOLESTEROL HAS NOT YET BEEN REACHED,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
ERYTHEMA,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
"ALTHOUGH RECEIVED A COMBINATION THERAPY OF PREDNISOLONE CYCLOPHOSPHAMIDE, HER CLINICAL SYMPTOMS AND PULMONARY FUNCTION DETERIORATED GRADUALLY",drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
ENCEPHALOPATHY,encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
HEPARIN-INDUCED THROMBOCYTOPENIA WITH TROMBOSIS,Heparin-induced thrombosis,HEPARIN-INDUCED THROMBOSIS,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10063492,10062506,10063492
MULTIPLE CALCIUM OXALATE RENAL STONES INVOLVING BOTH KIDNEYS FOLLOWING HYPERCALCAEMIA,Renal stone,RENAL STONE,NEPHROLITHIASIS,UROLITHIASES,RENAL LITHIASIS,10038359,10038527,10029148,10038527
EXTREME FATIGUE,Fatigue,FATIGUE EXTREME,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016257,10016256,10016257
SIGNS OF NEUROLOGICAL DYSFUNCTION,Neurological symptom,NEUROLOGICAL SYMPTOMS NOS,NEUROLOGICAL SYMPTOM,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10029307,10060860,10029307
DESCEMET'S FOLD,Corneal disorder,FOLDS IN DESCEMET'S MEMBRANE,CORNEAL DISORDER,EYE DISORDERS NEC,CORNEAL DISORDERS NEC,10015919,10016891,10061453,10016891
PROTUBERANT FONTANELLE,PROTUBERANT FONTANELLE,FONTANELLE BULGING,FONTANELLE BULGING,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10016945,10016945,10016945
"PROGRESSIVE WORSENING OF THE AUTOIMMUNE ENTEROPATHY DESPITE MANAGEMENT WITH CHRONIC STEROIDS, COMBINATION RITUXIMAB/MYCOPHENOLATE MOFETIL",autoimmune disorder nos,AUTOIMMUNE DISORDER NOS,AUTOIMMUNE DISORDER,AUTOIMMUNE DISORDERS,AUTOIMMUNE DISORDERS NEC,10021428,10003815,10061664,10003815
RELAPSING FOCAL SEIZURES OF HIS RIGHT ARM,Partial seizures,FOCAL SEIZURES,PARTIAL SEIZURES,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10016843,10061334,10016843
CIRCUMFERENTIAL ULCER IN THE LOWER ESOPHAGUS,Oesophageal ulcer,ULCER OF ESOPHAGUS,OESOPHAGEAL ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,OESOPHAGEAL ULCERS AND PERFORATION,10017947,10030201,10030201,10045323
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
WORSENING METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
FIXED DRUG ERUPTION,Fixed drug eruption,FIXED DRUG ERUPTION,FIXED ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10016740,10016741,10016740
STEROID RESISTANT IGG4 RELATED PACHYMENINGITIS,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
GLOBAL CARDIAC HYPOKINESIA WITH A SYSTOLIC EJECTION FRACTION ASSESSED AT 35% IN THE ELECTROCARDIOGRAM FOLLOWING SEVERE HYPOKALEMIA (1.5 MMOL/L) FOLLOWING ACUTE OVERDOSE,Ventricular hypokinesia,GLOBAL VENTRICULAR HYPOKINESIA,VENTRICULAR HYPOKINESIA,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10073234,10050510,10073234
PATIENT APPEARED TO BE 18 WEEKS PREGNANT,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
"FIBROSIS, WITH INCREASED NUMBERS OF FIBROBLASTS AND A MILD LYMPHOHISTIOCYTIC INFILTRATE",Fibrosis,FIBROSIS,FIBROSIS,TISSUE DISORDERS NEC,FIBROSIS NEC,10018065,10016642,10016642,10016642
HIGH LEUCOCYTE COUNT WITH NEUTROPHIL PREDOMINANCE IN BLOOD SMEAR/LEUKOCYTOSIS,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
RIGHT EAR FULLNESS,Fullness head,FULLNESS HEAD,HEAD DISCOMFORT,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10017468,10019194,10017468
CALCULUS BILIARY,calculus biliary,CALCULUS BILIARY,CHOLELITHIASIS,GALLBLADDER DISORDERS,CHOLECYSTITIS AND CHOLELITHIASIS,10019805,10006986,10008629,10006986
UNCONSCIOUSNESS,Loss of consciousness,UNCONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10045481
RED SPOTS WITH HYPERAESTHESIA AND INDUCING BURNING SENSATION,Burning sensation,BURNING SENSATION,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10006784,10006784,10006784
TINY NODULE IN THE POSTERIOR SEGMENT OF RIGHT UPPER LUNG,lung nodule,LUNG NODULE,PULMONARY MASS,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10049498,10056342,10049498
SHORTLY AFTER DISCONTINUATION OF PREDNISONE LUPUS SYMPTOMS APPEARED,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
FEMALE INFANT WEIGHING 2470 G,Low birth weight baby,LOW BIRTH WEIGHT BABY,LOW BIRTH WEIGHT BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10067508,10067508,10067508
SEVERE VILLOUS ATROPHY,intestinal villi atrophy,INTESTINAL VILLI ATROPHY,INTESTINAL VILLI ATROPHY,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL MUCOSAL DYSTROPHIES AND SECRETION DISORDERS,10017947,10049443,10049443,10049443
LIGHTHEADEDNESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
PATIENT WAS ADMINISTERED METHOTREXATE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (OFF LABEL USE) WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DESATURATION DETERIORATION,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
NO ADVERSE EFFECTS,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
DRUG-DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
GENERALIZED ERYTHEMATOUS ANNULAR LESIONS AND PLAQUES,Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
PERSISTENT THIRD-DEGREE ATRIOVENTRICULAR BLOCK,Atrioventricular block complete,ATRIOVENTRICULAR BLOCK THIRD DEGREE,ATRIOVENTRICULAR BLOCK COMPLETE,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10065659,10003673,10065659
DEATH,Death,DEATH,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10011906,10011906,10011906
INCREASE OF QTC FROM 423 TO 490 MSEC UNDER 5-DAYS THERAPY WITH CLARITHROMYCIN 250 MG,Electrocardiogram QTc interval prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
ELEVATED BETA-D-GLUCAN,Blood beta-D-glucan increased,BLOOD BETA-D-GLUCAN INCREASED,BLOOD BETA-D-GLUCAN INCREASED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,FUNGUS IDENTIFICATION AND SEROLOGY,10022891,10051793,10051793,10051793
TRIGGER FINGER,trigger finger,TRIGGER FINGER,TRIGGER FINGER,"TENDON, LIGAMENT AND CARTILAGE DISORDERS",TENDON DISORDERS,10028395,10044654,10044654,10044654
AKÃšTNEJ KARDIÃLNEJ INSUFICIENCIE / ACUTE CARDIAC INSUFFICIENCY,Cardiac failure acute,ACUTE CARDIAC INSUFFICIENCY,CARDIAC FAILURE ACUTE,HEART FAILURES,HEART FAILURES NEC,10007541,10066332,10007556,10066332
MID-DILATED PUPIL,dilated pupils,DILATED PUPILS,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10013014,10028521,10013014
TREATED WITH 600 MG FLUCONAZOLE TWICE DAILY,Incorrect dosage administered,INCORRECT DOSAGE ADMINISTERED,INCORRECT DOSAGE ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10073768,10073768,10073768
IN THE BRONCHUS INTERMEDIUS THERE WAS PRONOUNCED CHANGES WITH BROWNISH COATING AND ULCERATION,bronchial ulceration,BRONCHIAL ULCERATION,BRONCHIAL ULCERATION,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHIAL CONDITIONS NEC,10038738,10051547,10051547,10051547
CLOZAPINE -INDUCED AGRANULOCYTOSIS,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
ARTERIAL HYPOTENSION,Arterial hypotension,ARTERIAL HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10066331,10021097,10066331
JAW OSTEONECROSIS ASSOCIATED WITH THE USE OF BISPHOSPHONATES,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
PATIENT WAS EXPOSED METFORMIN AND INSULIN DURING PREGNANCY,Foetal exposure during pregnancy,FETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071404,10071404,10071421
ERUPTIVE DISSEMINATED POROKERATOSIS,Porokeratosis,POROKERATOSIS,POROKERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL NEC,10010331,10036175,10036175,10036175
DROWSY,Drowsiness,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
QUEASY,Nausea,QUEASY,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10037730,10028813,10037730
DIARRHEA,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
"ARTERIAL HYPERTENSION, FAILURE TO ACHIEVE THE THERAPEUTIC TARGET",No therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
LOSS OF VISION (LEFT EYE AND RIGHT) DUE TO UVEITIS,Blindness,LOSS OF VISION,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047522,10005169,10024881
STANDARD RESTRICTION OF VIBRATION SENSATION (6/8),Decreased vibratory sense,DECREASED VIBRATORY SENSE,DECREASED VIBRATORY SENSE,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10067502,10067502,10067502
PRESSURED SPEECH AND CONVERSATION DERAILMENTS,Disorganised speech,DISORGANISED SPEECH,DISORGANISED SPEECH,COMMUNICATION DISORDERS AND DISTURBANCES,SPEECH AND LANGUAGE USAGE DISTURBANCES,10037175,10076227,10076227,10076227
UNCONTROLLED TYPE 2 DM/UNCONTROLLED DYSLIPIDEMIA,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
RESPONDED TO COMBINATION WITH MMF FOR 15 MONTHS,Therapeutic response shortened,THERAPEUTIC RESPONSE SHORTENED,THERAPEUTIC RESPONSE SHORTENED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10078575,10078575,10078575
"DESPITE THESE THERAPIES, HYPERCAPNIA AND DECREASED BREATH",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
IBUPROFEN-INDUCED ACUTE LIVER FAILURES (ALF),acute liver failure,ACUTE LIVER FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10049844,10000804,10049844
ACUTE HYDROCORTISONE MYOPATHY,Myopathy,STEROID MYOPATHY,MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10028646,10028641,10042024
CYTOMEGALOVIRUS INFECTION,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011831,10011831,10011831
CORTISONE-INDUCED OSTEOPOROSIS,Osteoporosis,OSTEOPOROSIS STEROID-INDUCED,OSTEOPOROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10031287,10031282,10031287
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
PUSTULAR ERUPTIONS,Pustular skin eruption,PUSTULAR SKIN ERUPTION,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037577,10037888,10037577
LIVER WAS PALPABLE TWO TO THREE CENTIMETERS BELOW THE BORDER OF THE RIB,Liver palpable,LIVER PALPABLE,LIVER PALPABLE,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10075895,10075895,10075895
INCREASED LEVELS OF KREBS VON DEN LUNGEN 6 (2947 U PER ML),Cell marker increased,KL-6 INCREASED,CELL MARKER INCREASED,CYTOGENETIC INVESTIGATIONS,CELL MARKER ANALYSES,10022891,10064498,10064095,10064498
MITOCHONDRIAL DAMAGE FOLLOWING USE OF LEVOFLOXACIN,Mitochondrial cytopathy,MITOCHONDRIAL CYTOPATHY,MITOCHONDRIAL CYTOPATHY,METABOLISM DISORDERS NEC,CELL METABOLISM DISORDERS NEC,10027433,10050029,10050029,10050029
CARDIAC EMBOLISM (EMBOLISM),Embolism,EMBOLISM,EMBOLISM,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10061169,10061169,10061169
VISUAL AURA,visual disturbances,VISUAL DISTURBANCES,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047545,10047571,10047545
SERIOUSLY INJURED,Injury,INJURY,INJURY,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10022116,10022116,10022116
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
THERE WERE MARKED POSITIONAL DEFORMITIES OF BOTH HANDS,Hand deformity,HAND DEFORMITY,HAND DEFORMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES (INCL INTERVERTEBRAL DISC DISORDERS),EXTREMITY DEFORMITIES,10028395,10061194,10061194,10061194
TRANSIENT IMPAIRMENT OF THE SENSORY AND MOTORIC CRANIAL NERVES V AND VII,Trigeminal nerve disorder,TRIGEMINAL NERVE DISORDER,TRIGEMINAL NERVE DISORDER,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),TRIGEMINAL DISORDERS,10029205,10060890,10060890,10060890
FAILURE OF MEDICAL TREATMENT WITH ATROPINE AND OXIMES,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
BORTEZOMIB AND CYCLOPHOSPHAMIDE USED IN THE TREATMENT OF REFRACTORY N-METHYL-D-ASPARTATE RECEPTOR ANTIBODY ENCEPHALITIS (OFF LABEL USE FOR UNAPPROVED INDICATION WITH NO ADR),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RENAL GRAFT LOSS FOLLOWING CHRONIC ALLOGRAFT DYSFUNCTION DUE TO  BK VIRUS NEPHROPATHY,Renal transplant failure,RENAL GRAFT LOSS,RENAL TRANSPLANT FAILURE,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10048749,10074495,10048749
BILATERAL PLEURAL EFFUSION,Pleural effusion,BILATERAL PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10078037,10035598,10078037
URTICARIAL-LIKE MACULOPAPULAR RASH AROUND HIS WAIST AND BILATERAL UPPER LIMBS,Maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
PATIENT WITH PREVIOUS INFECTION WAS TREATED WITH PREDNISONE (DRUG USED IN UNAPPROVED POPULATION),Product use issue,DRUG USE IN UNAPPROVED POPULATION,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10071551,10076309,10071551
SSRI-ASSOCIATED BRUXISM,Bruxism,BRUXISM,BRUXISM,CHANGES IN PHYSICAL ACTIVITY,STEREOTYPIES AND AUTOMATISMS,10037175,10006514,10006514,10006514
IMMEDIATE-TYPE ALLERGIC REACTIONS TO OMEPRAZOLE,immediate hypersensitivity reaction,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
TETANY DUE TO HYPOCALCEMIA (1.64 MMOL/L),Tetany,TETANY,TETANY,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10043380,10043380,10043380
ELEVATED C REACTIVE PROTEIN,C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY RELAPSE FOLLOWING ACUTE PHASE REACTION,Chronic inflammatory demyelinating polyradiculoneuropathy,CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,PERIPHERAL NEUROPATHIES,CHRONIC POLYNEUROPATHIES,10029205,10077384,10057645,10077384
HIV 1 PERSISTENT VIREMIA,HIV viraemia,HIV VIRAEMIA,HIV VIRAEMIA,VIRAL INFECTIOUS DISORDERS,RETROVIRAL INFECTIONS,10021881,10077716,10077716,10077716
PRETIBIAL EDEMA,Oedema peripheral,PRETIBIAL EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10059825,10030124,10059808
HE WAS USING IBUPROFEN AT HOME FOR THE PAIN WHICH DID NOT CONTROL HIS SYMPTOMS,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
GRADE 2 ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
RESPIRATORY VIRAL PANEL WAS POSITIVE FOR RHINOVIRUS,Rhinovirus infection,RHINOVIRUS INFECTION,RHINOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,RHINOVIRAL INFECTIONS,10021881,10061494,10061494,10061494
SKIN LESIONS AROUND THE MOUTH AND THE THIGHS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
NEPHROPATHY,nephropathy,NEPHROPATHY,NEPHROPATHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10029151,10029151,10029151
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
HYPOTONIC-HYPORESPONSIVE EPISODE,Hypotonic-hyporesponsive episode,HYPOTONIC-HYPORESPONSIVE EPISODE,HYPOTONIC-HYPORESPONSIVE EPISODE,NEUROMUSCULAR DISORDERS,NEUROMUSCULAR DISORDERS NEC,10029205,10021121,10021121,10021121
"ILL-DEFINED ACUTE-ONSET, PAINFUL,VIOLACEOUS INDURATED PLAQUES WITH CENTRAL EROSION AND SURROUNDING SCALE INVOLVING THE MEDIAL THIGHS AND INGUINAL FOLDS",Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
WHEEZES AT THE RIGHT SIDE,Wheezing,WHEEZES,WHEEZING,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10047924,10047924,10047923
DRUG INTERACTION BETWEEN ATAZANAVIR AND DOLUTEGRAVIR,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
INTENTIONAL SUSPECTED SUICIDE,Completed suicide,COMPLETED SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10010144,10010144,10010144
LISTERIA MONOCYTOGENES MENINGOENCEPHALITIS,meningoencephalitis bacterial,MENINGOENCEPHALITIS BACTERIAL,MENINGOENCEPHALITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10051256,10051256,10051256
SPIRITUAL/EXISTENTIAL DISTRESS,Emotional distress,EMOTIONAL DISTRESS,EMOTIONAL DISTRESS,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10049119,10049119,10049119
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
NEONATAL ABSTINENCE SYNDROME,Neonatal abstinence syndrome,NEONATAL ABSTINENCE SYNDROME,DRUG WITHDRAWAL SYNDROME NEONATAL,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10074192,10013756,10074192
RIBAVIRIN-INDUCED/EXACERBATED ANEMIA (SERUM HEMOGLOBIN CONCENTRATION TO 8.3 G/DL),Anemia aggravated,ANEMIA AGGRAVATED,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10054309,10002034,10054309
WAS POORLY TOLERATED,Was poorly tolerated,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
SCLERAL ICTERUS,Ocular icterus,SCLERAL ICTERUS,OCULAR ICTERUS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10057488,10058117,10057488
BLUNT-EDGED HEPATOMEGALY,Hepatomegaly,HEPATOMEGALY,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10019842
REDUCED VISUAL ACUITY FOR 2 WEEKS,Visual acuity reduced,VISUAL ACUITY REDUCED,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047531,10047531,10047531
ERYTHEMA,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
FURTHER DEVELOPED INTO IN TO A BLOOD STREAM INFECTION,Bacteraemia,BACTERAEMIA,BACTERAEMIA,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10003997,10003997,10003997
ABORTION,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
CARDIAC ARREST,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
DAMAGED PATCH,Product physical issue,PRODUCT PHYSICAL ISSUE,PRODUCT PHYSICAL ISSUE,"PRODUCT QUALITY, SUPPLY, DISTRIBUTION, MANUFACTURING AND QUALITY SYSTEM ISSUES",PRODUCT PHYSICAL ISSUES,10077536,10071134,10071134,10071134
IMATINIB INDUCED DIFFUSED BLUE-GRAY HYPERPIGMENTATION INVOLVING THE HARD PALATE,Mucosal pigmentation,MUCOSAL PIGMENTATION,MUCOSAL PIGMENTATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10067724,10067724,10067724
ROUGH RESPIRATORY SOUND,Respiratory disorder,RESPIRATORY DISORDER,RESPIRATORY DISORDER,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10038683,10038683,10038683
IRRITABILITY,irritability,IRRITABILITY,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10022998,10022998,10022998
EXACERBATION OF GRANULOMATOSIS WITH POLYANGIITIS,Granulomatosis with polyangiitis,GRANULOMATOSIS WITH POLYANGIITIS,GRANULOMATOSIS WITH POLYANGIITIS,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10072579,10072579,10072579
MOTOR VEHICLE COLLISION (MVC) WITH SKULL BASE FRACTURES,Skull fracture,SKULL FRACTURE,SKULL FRACTURE,BONE AND JOINT INJURIES,"SKULL FRACTURES, FACIAL BONE FRACTURES AND DISLOCATIONS",10022117,10061365,10061365,10061365
DURING APLASIA THE PATIENT DEVELOPED A PSEUDOMONAS AERUGINOSA SEPTICEMIA AND DESPITE AGGRESSIVE ANTIBIOTIC AND SUPPORTIVE TREATMENT HE DIED FROM SEPTICEMIA,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PATIENT TREATED WITH HYDROXYCHLOROQUINE SULFATE FOR SJOGRENâ€™S SYNDROME (DRUG USED FOR UNAPPROVED INDICATION),Product used for unknown indication,PRODUCT USED FOR UNKNOWN INDICATION,PRODUCT USED FOR UNKNOWN INDICATION,THERAPEUTIC PROCEDURES AND SUPPORTIVE CARE NEC,THERAPEUTIC PROCEDURES NEC,10042613,10070592,10070592,10070592
SKIN ULCER,Skin ulcer,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040943,10040943,10040943
NEUROTOXICITY,neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
BULLAE,Blister,BULLAE,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006554,10005191,10006554
END-GAZE NYSTAGMUS CONSISTENT WITH THE USE OF ANTI-SEIZURE MEDICATION,Nystagmus,NYSTAGMUS,NYSTAGMUS,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10029864,10029864,10029864
OFF LABEL USE OF METHOTREXATE,Off Label Use of Methotrexate,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SECOND RELAPSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS,Acute disseminated encephalomyelitis,ACUTE DISSEMINATED ENCEPHALOMYELITIS,ACUTE DISSEMINATED ENCEPHALOMYELITIS,DEMYELINATING DISORDERS,DEMYELINATING DISORDERS NEC,10029205,10000709,10000709,10000709
STEVENS JOHNSON SYNDROME,STEVENS JOHNSON SYNDROME,STEVENS JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042030,10042033,10042030
STEROID INDUCED DIABETES MELLITUS,Diabetes mellitus,DIABETES STEROID-INDUCED,DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012628,10012601,10012628
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
UNDESCENDED TESTES,Cryptorchism,UNDESCENDED TESTIS,CRYPTORCHISM,REPRODUCTIVE TRACT AND BREAST DISORDERS CONGENITAL,MALE REPRODUCTIVE TRACT DISORDERS CONGENITAL,10010331,10011498,10011498,10045506
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
PERSISTENT NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
PATIENT WAS ADMINISTERED MYCOPHENOLATE FOR THE TREATMENT OF STIFF PERSON SYNDROME (OFF LABEL USE) WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"SEPTICAEMIA (G-NEGATIVE ESCHERICHIA COLI, G-POSITIVE STAPHYLOCOCCUS EPIDERMIS) WITH CIRCULAR INSTABILITY","Septicemia (G-negative rods- Escherichia coli, G-positive cocci - Staphylococcusm",SEPTICEMIA,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040089,10040047,10040089
LYMPHADENOPATHY,Lymphadenopathy,LYMPH NODES ENLARGED,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025186,10025197,10025186
ACUTE PISA SYNDROME SECONDARY TO BETAHISTINE TREATMENT,Pisa syndrome,PISA SYNDROME,PLEUROTHOTONUS,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10050511,10035628,10050511
METABOLIC ASIDOSIS DUE TO REPEATED EPILEPTIC SEIZURES,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
ARTHRALGIA,Arthralgia,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
ALLERGY,allergy,ALLERGY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001738,10020751,10001738
SEVERE GASTRO-INTESTINAL SIDE EFFECTS FOLLOWING OFF LABEL USE OF HYDROXYCHLOROQUINE,gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
NO ADVERSE DRUG REACTION,no adverse drug reaction,NO ADVERSE DRUG REACTION,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067481,10067482,10067481
"ABNORMAL LAB VALUES OF TSH, PTH AND T4 DUE TO HIGH AMOUNTS OF BIOTIN",abnormal lab tests,LAB TEST ABNORMAL,LABORATORY TEST ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",INVESTIGATIONS NEC,10022891,10023524,10023547,10023524
STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY KLEBSIELLA PNEUMONIAE FOLLOWING VENTILATOR-ASSOCIATED TRACHEOBRONCHITIS PROGRESSION,Ventilator associated pneumonia,VENTILATOR ASSOCIATED PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10065153,10035664,10065153
GYNECOMASTIA,Gynecomastia,GYNECOMASTIA,GYNAECOMASTIA,BREAST DISORDERS,BREAST DISORDERS NEC,10038604,10018801,10018800,10018801
PAIN,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
DRUG-INDUCED INTERSTITIAL PNEUMONIA,Interstitial lung disease,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
PARADOXICAL HYPERTENSION (BLOOD PRESSURE PEAKED AT 209/110 MM HG)/LIDOCAINE INDUCED PARADOXICAL HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
SEVERE PERSONALITY CHANGES,personality change,PERSONALITY CHANGE,PERSONALITY CHANGE,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10034719,10034719,10034719
NO ADVERSE DRUG REACTION,No adverse drug reaction,NO ADVERSE DRUG REACTION,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067481,10067482,10067481
FREQUENT YAWNING,Yawning,YAWNING,YAWNING,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10048232,10048232,10048232
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
DEATH,Death,DEATH,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10011906,10011906,10011906
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
RETINOPATHY IN BOTH EYES,Retinopathy,RETINOPATHY,RETINOPATHY,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINOPATHIES NEC,10015919,10038923,10038923,10038923
DECREASED VISUAL ACUITY OF THE RIGHT EYE (0.05),Visual acuity reduced,VISUAL ACUITY DECREASED,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047531,10047531,10049061
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
7 POUND WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
PLATELET COUNT DROPPED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
RECURRENT EPISODIC PULSELESS ELECTRICAL ACTIVITY,Pulseless electrical activity,PULSELESS ELECTRICAL ACTIVITY,PULSELESS ELECTRICAL ACTIVITY,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10058151,10058151,10058151
"NAUSEA FOLLOWING ADMINISTRATION OF HYDROXYCHLOROQUINE, AZATHIOPRINE AND DAPSONE",Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
CEREBRAL OEDEMA,Brain oedema,CEREBRAL OEDEMA,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10048962,10048962,10008127
ENTEROBACTER INFECTION,Enterobacter infection,ENTEROBACTER INFECTION,ENTEROBACTER INFECTION,BACTERIAL INFECTIOUS DISORDERS,ENTEROBACTER INFECTIONS,10021881,10051910,10051910,10051910
COGNITIVE DETERIORATION,Cognitive disorder,COGNITIVE DETERIORATION,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10009843,10057668,10009843
EXCITABLE AGITATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
CHEST COMPUTED TOMOGRAPHY SHOWING DI USE ALVEOLAR IN LTRATES,Lung infiltration,LUNG INFILTRATION,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025102,10025102,10025102
SPONTANEOUS ACALCULOUS GALLBLADDER PERFORATION AND NECROSIS,gallbladder necrosis,GALLBLADDER NECROSIS,GALLBLADDER NECROSIS,GALLBLADDER DISORDERS,GALLBLADDER DISORDERS NEC,10019805,10059446,10059446,10059446
VERY ANXIOUS,Anxious mood,ANXIOUS MOOD,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002875,10002855,10002875
FUNCTIONAL STENOSIS OF PULMONARY ARTERIES,Pulmonary artery stenosis,PULMONARY ARTERY STENOSIS,PULMONARY ARTERY STENOSIS,PULMONARY VASCULAR DISORDERS,VASCULAR PULMONARY DISORDERS NEC,10038738,10037338,10037338,10037338
OCCUPATIONAL ALLERGIC CONTACT DERMATITIS FOLLOWING CROSS REACTIVITY,Dermatitis contact,ALLERGIC CONTACT DERMATITIS,DERMATITIS CONTACT,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10056265,10012442,10056265
BIBASAF PULMONARY CREPITATION,Rales,LUNG CREPITATION,RALES,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10050052,10037833,10050052
UNRESPONSIVE STATE AT HOME,unresponsive state at home,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
FUNGAL SEPSIS WITH CANDIDA ALBICANS DESPITE ANTIFUMGAL PROPHYLAXIS WITH FLUCONAZOLE,fungal sepsis,FUNGAL SEPSIS,FUNGAL SEPSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10058872,10058872,10058872
ALTERED MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
MULTIPLE SYSTEM ORGAN FAILURE,Multiple organ dysfunction syndrome,MULTI ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028151
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
ACUTE ACALCULOUS CHOLECYSTITIS,Cholecystitis acute,ACUTE ACALCULOUS CHOLECYSTITIS,CHOLECYSTITIS ACUTE,GALLBLADDER DISORDERS,CHOLECYSTITIS AND CHOLELITHIASIS,10019805,10000648,10008614,10000648
PROTHROMBIN TIME RATIO DECREASED,Prothrombin time ratio decreased,PROTHROMBIN TIME RATIO DECREASED,PROTHROMBIN TIME RATIO DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037066,10037066,10037066
MARIOTTE BLIND SPOT,Scotoma of blind spot,SCOTOMA OF BLIND SPOT AREA,VISUAL FIELD DEFECT,NEUROLOGICAL DISORDERS OF THE EYE,NEUROLOGIC VISUAL PROBLEMS NEC,10029205,10039733,10047555,10039733
PATIENT TREATED WITH CELECOXIB FOR METASTATIC INFLAMMATORY MYOFIBROBLASTIC TUMOR (OFF LABEL USE) WITH NO ADVERSE EVENTS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRY MUCOUS MEMBRANE,mucosal dryness,MUCOSAL DRYNESS,MUCOSAL DRYNESS,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028111,10028111,10028111
ANTERIOR UVEITIS,Iridocyclitis,ANTERIOR UVEITIS,IRIDOCYCLITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10002709,10022941,10002709
PERSISTENT DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
THYROTOXICOSIS LEADING TO ADRENAL CRISIS,Adrenocortical insufficiency acute,ADRENAL CRISIS,ADRENOCORTICAL INSUFFICIENCY ACUTE,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001346,10001389,10001346
"RASHES ON FACE WERE ITCHY, SCALY AND EXTENDING TOWARDS HAIRLINE",Exfoliative rash,RASH SCALY,EXFOLIATIVE RASH,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10037889,10064579,10037889
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
VACCINE FAILURE LEADING TO HAEMOPHILUS INFLUENZAE INFECTION,Haemophilus infection,HAEMOPHILUS INFLUENZAE INFECTION,HAEMOPHILUS INFECTION,BACTERIAL INFECTIOUS DISORDERS,HAEMOPHILUS INFECTIONS,10021881,10018952,10061190,10018952
INTENTIONAL DRUG USE FOR UNAPPROVED INDICATION,Intentional use for unlabeled indication,INTENTIONAL USE FOR UNLABELED INDICATION,INTENTIONAL PRODUCT USE ISSUE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT USE ISSUES,10022117,10058999,10076308,10058999
METABOLIC ACIDOSIS FOLLOWING WORSENING OF P.FALCIPARUM MALARIA,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
VISIBLY IN DISTRESS,Emotional distress,EMOTIONAL DISTRESS,EMOTIONAL DISTRESS,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10049119,10049119,10049119
CHEMOTHERAPY-INDUCED PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
HYPERKALAEMIA,Hyperkalaemia,HYPERKALAEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020646,10020646,10020646
AUTISM,Autism spectrum disorder,AUTISM,AUTISM SPECTRUM DISORDER,DEVELOPMENTAL DISORDERS NEC,PERVASIVE DEVELOPMENTAL DISORDERS NEC,10037175,10003805,10063844,10003805
ALLERGIC TO 5-ASA,drug allergy,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
PAIN IN EXTREMITY,Pain in extremity,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033425,10033425,10033425
CHOLESTATIC AND LIVER DAMAGE,Cholestatic liver injury,CHOLESTATIC LIVER INJURY,CHOLESTATIC LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067969,10067969,10067969
TOXICODERMA ON THE TRUNK,Toxic skin eruption,TOXICODERMA,TOXIC SKIN ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10044259,10057970,10044259
GRADE 3 NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
DEPIGMENTATION AROUND THE INJECTED AREA,Injection site discolouration,INJECTION SITE PIGMENTATION CHANGES,INJECTION SITE DISCOLOURATION,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022091,10051572,10022091
COMA,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
PATIENT TREATED WITH MYCOPHENOLATE MOFETIL FOR ULCERATIVE COLITIS RELATED INTERSTITIAL LUNG DISEASE (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
ACNEIFORM RASH (GRADE 2),Rash acneiform,RASH ACNEIFORM,DERMATITIS ACNEIFORM,SKIN APPENDAGE CONDITIONS,ACNES,10040785,10037847,10012432,10037847
MYOCLONUS,Myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
PROCALCITONIN INCREASED (0.56 NG/ML),Procalcitonin increased,PROCALCITONIN INCREASED,PROCALCITONIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10067081,10067081,10067081
PAINLESS SWELLING AT HIS LEFT FLANK,swelling abdomen,SWELLING ABDOMEN,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10042679,10000060,10042679
ELEVATION OF ASPARTATE AMINOTRANSFERASE,Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
STICKY AND SLOW THINKING,sticky and slow thinking,SLOWED THINKING,BRADYPHRENIA,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10041049,10050012,10041049
ALT INCREASED (221 IU/L) FOLLOWING DRUG INTERACTION,Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
DISTENDED NECK VEINS,Vasodilatation,VEIN DISTENDED,VASODILATATION,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047186,10047141,10047186
DRUG-INDUCED ALLERGIC NEPHRITIS (DIAN) ACUTE INTERSTITIAL NEPHRITIS,Tubulointerstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029135,10048302,10000819
SALIVARY GLAND MASS,Salivary gland mass,SUBMANDIBULAR GLAND NODULE,SALIVARY GLAND MASS,SALIVARY GLAND CONDITIONS,SALIVARY GLAND DISORDERS NEC,10017947,10054840,10057002,10054840
FLUID RETENTION,Fluid retention,FLUID RETENTION,FLUID RETENTION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME INCREASED,10027433,10016807,10016807,10016807
BLOOD PRESSURE INCREASED (138/72MMHG),blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
ANAPHYLACTIC REACTION,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
PATIENT WAS TREATED WITH MYCOPHENOLATE MOFETIL FOR OESOPHAGEAL PEMPHIGOID (OFF LABEL USE) WITH NO ADVERSE EVENTS,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HAIR LOSS,Alopecia,HAIR LOSS,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10019045,10001760,10019045
PHARYNGEAL INFLAMMATION,Pharyngeal inflammation,PHARYNGEAL INFLAMMATION,PHARYNGEAL INFLAMMATION,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),PHARYNGEAL DISORDERS (EXCL INFECTIONS AND NEOPLASMS),10038738,10065716,10065716,10065716
VERBETRAL OSTEOMYELITIS DUE TO MYCOBACTERIUM AVIUM INFECTION,verbetral osteomyelitis due to mycobacterium avium infection,OSTEOMYELITIS,OSTEOMYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,BONE AND JOINT INFECTIONS,10021881,10031252,10031252,10031252
INCREASE IN HBA1C,HbA1C increased,HBA1C INCREASED,GLYCOSYLATED HAEMOGLOBIN INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10052424,10018484,10052424
PRURITIS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
HYPERKALEMIA,hyperkalemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020647,10020646,10020647
MEMORY DISORDERS,Memory impairment,MEMORY DISTURBANCE,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027175,10027175,10027172
TREATMENT NON-COMPLIANCE,treatment non-compliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
BK VIRUS NEPHROPATHY DUE TO BK VIREMIA,BK virus nephropathy,BK VIRUS NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065333,10065381,10065333
RAPIDLY DEVELOPING BLISTERING EXANTHEMA OF PURPURIC MACULES,Blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
ANOREXIA,anorexia,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10002646,10061428,10002646
PSYCHOGENIC HYPERTENSION,hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
ARTHRALGIA,Arthralgia,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
SEVERE ARTERIOSCLEROSIS,Arteriosclerosis,ARTERIOSCLEROSIS,ARTERIOSCLEROSIS,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10003210,10003210,10003210
ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
CEFTRIAXONE-INDUCED HAEMOLYTIC ANAEMIA,Haemolytic anaemia,HEMOLYTIC ANEMIA DRUG-INDUCED,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10018918,10018916,10055208
MYOCARDIAL ISCHEMIA,Myocardial ischaemia,MYOCARDIAL ISCHEMIA,MYOCARDIAL ISCHAEMIA,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10028600,10028600,10028601
LIVER METASTASES,liver metastases,LIVER METASTASES,METASTASES TO LIVER,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10024700,10027457,10024700
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
ACCELERATED THE COURSE OF ARRHYTHMIA/POLYMORPHIC PVCS,Condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
QT-INTERVAL PROLONGATION,QT interval prolonged,QT INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037703,10014387,10037703
HERBAL INTERACTION,Herbal interaction,HERBAL INTERACTION,HERBAL INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10070493,10070493,10070493
INVASION  TO  THE  BOTALLO LIGAMENT ON THE LEFT SIDE OF THE TUMOR WAS OBSERVED.,Tumor invasion,TUMOUR LOCAL INVASION,TUMOUR INVASION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10068679,10064390,10068679
IGG4 RELATED DISEASE DETERIORATED LEADING TO HER DEATH,IgG4 related disease,IGG4 RELATED SCLEROSING DISEASE,IMMUNOGLOBULIN G4 RELATED DISEASE,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),CONNECTIVE TISSUE DISORDERS NEC,10028395,10071581,10077271,10071581
SCLERAL ICTERUS,scleral icterus,SCLERAL ICTERUS,OCULAR ICTERUS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10057488,10058117,10057488
NOSOCOMIAL RESPIRATORY INFECTION,Respiratory infection,RESPIRATORY INFECTION,RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10038700,10062352,10038700
EJECTION FRACTION DECREASED,ejection fraction decreased,EJECTION FRACTION DECREASED,EJECTION FRACTION DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10050528,10050528,10050528
LACK OF DRUG EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
H. CAPSULATUM DISSEMINATED HISTOPLASMOSIS,Histoplasmosis disseminated,HISTOPLASMA CAPSULATUM INFECTION DISSEMINATED,HISTOPLASMOSIS DISSEMINATED,FUNGAL INFECTIOUS DISORDERS,HISTOPLASMA INFECTIONS,10021881,10020128,10020144,10020128
"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER (WITH NO ADVERSE EVENT)",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
HYPER-RESONANCE ON PERCUSSION,hyper-resonance on percussion,PERCUSSION TEST ABNORMAL,PERCUSSION TEST ABNORMAL,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10051721,10051721,10051721
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ISCHEMIC HEPATIC INSULT,Hepatic ischaemia,HEPATIC ISCHAEMIA,HEPATIC ISCHAEMIA,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10056328,10056328,10056328
ALT INCREASED (130U/L),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
THICK YELLOW HYPERKERATOSIS MOSTLY SPARED HER TRUNK,hyperkeratosis,HYPERKERATOSIS,HYPERKERATOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,HYPERKERATOSES,10040785,10020649,10020649,10020649
STUPOR,Stupor,STUPOR,STUPOR,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042264,10042264,10042264
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
"WITHDRAWAL SYNDROME MANIFESTING IN A CHILD AFTER MIDAZOLAM, PROPOFOL, AND FENTANYL DISCONTINUATION",Drug withdrawal syndrome,DRUG WITHDRAWAL SYNDROME,DRUG WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10013754,10013754,10013754
GRAND-MAL CONVULSION,Grand mal convulsion,GRAND MAL CONVULSION,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10018659,10018100,10018659
OPPORTUNISTIC INFECTION,opportunistic infection,OPPORTUNISTIC INFECTION,OPPORTUNISTIC INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10030901,10030901,10030901
LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
ECG SHOWED TALL T,Electrocardiogram T wave abnormal,ELECTROCARDIOGRAM T WAVE ABNORMAL,ELECTROCARDIOGRAM T WAVE ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10050380,10050380,10050380
BLOOD BILIRUBIN INCREASED,Blood bilirubin increased,BLOOD BILIRUBIN INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10005364,10005364,10005364
DIFFUSE ALVEOLAR HEMORRHAGE SECONDARY TO COMBINATION OF AMIODARONE AND FLUCONAZOLE,pulmonary alveolar hemorrhage,PULMONARY ALVEOLAR HEMORRHAGE,PULMONARY ALVEOLAR HAEMORRHAGE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10037314,10037313,10037314
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
SEVERE PANCYTOPENIA DUE TO GRAFT VERSUS HOST DISEASE,severe pancytopenia due to graft versus host disease,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
DRUG OVERDOSE (CUMULATIVE DOSE WAS GREATER THAN 1160 G),Overdose,CHRONIC OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067696,10033295,10067696
VENTRICULAR TACHYCARDIA,ventricular tachycardia,VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047302,10047302,10047302
FREQUENT PREMATURE VENTRICULAR COMPLEXES FOLLOWING HYDROXYCHLOROQUINE TOXICITY AND INTERACTION WITH ONDANSETRON,Ventricular extrasystoles,PREMATURE VENTRICULAR ECTOPIC BEATS,VENTRICULAR EXTRASYSTOLES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047289,10047289,10058292
HB DROP TO 7.2 G/DL,Haemoglobin decreased,HB DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10019171,10018884,10019171
VENTRICULAR FIBRILLATION,ventricular fibrillation,VENTRICULAR FIBRILLATION,VENTRICULAR FIBRILLATION,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047290,10047290,10047290
PROGRESSIVE PULMONARY METASTASES FOLLOWING LACK OF DRUG EFFECT OF CAPECITABINE AND BEVACIZUMAB,pulmonary metastases,PULMONARY METASTASES,METASTASES TO LUNG,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10037420,10027458,10037420
TOPIRAMATE WAS INEFFECTIVE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
"MACULOPAPULAR, ERYTHEMATOUS, SQUAMOUS SKIN LESIONS, WHICH DISAPPEARED WHEN PRESSED DOWN, LOCATED ON THE UPPER AND LOWER LIMBS",Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
ULCERATION OF COLONIC MUCOSA,Mucosal ulceration,MUCOSAL ULCERATION,MUCOSAL ULCERATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028124,10028124,10028124
VITAMIN C-ASSOCIATED HEMOLYSIS,Hemolysis,HEMOLYSIS,HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10019491,10018910,10019491
SYMMETRICAL PERIPHERAL GANGRENE,Gangrene,PERIPHERAL GANGRENE,GANGRENE,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10034574,10017711,10034574
ALANINE AMINOTRANSFERASE INCREASED (98.7 U/I),Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
THYROID DISEASE INDUCED BY AMIODARONE,Thyroid disorder,THYROID DISORDER,THYROID DISORDER,THYROID GLAND DISORDERS,THYROID DISORDERS NEC,10014698,10043709,10043709,10043709
DISCOLORATION OF THE LEFT GLUTEAL REGION,Skin discolouration,SKIN DISCOLORATION,SKIN DISCOLOURATION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040829,10040829,10040828
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NASAL SECRETION,nasal secretion,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10053459,10053459,10053459
MODERATE SINUSOIDAL OBSTRUCTION SYNDROME,Sinusoidal obstruction syndrome,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
FACIAL REDNESS AND HEATING,Feeling of warmth facial,FEELING OF WARMTH FACIAL,FEELING HOT,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10016359,10016334,10016359
PAIN OVER LEFT HIP,pain over left hip,PAIN IN HIP,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10033432,10003239,10033432
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
HEMOGLOBIN DECREASE/HEMOGLOBIN 69 G / L,Hemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10019483,10018884,10019483
IRIS TRANSILLUMINATION PIGMENT DISPERSION IN THE IRIDOCORNEAL ANGLE,Iris transillumination defect,IRIS TRANSILLUMINATION DEFECT,IRIS TRANSILLUMINATION DEFECT,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","IRIS AND CILIARY BODY STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10053677,10053677,10053677
HYPERAEMIC PAPULES AND NODULES WITH CENTRAL NECROSIS ON BOTH ELBOWS AND KNEES,Skin necrosis,SKIN NECROSIS,SKIN NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040893,10040893,10040893
HEART RATE (135 BEATS/MIN),Heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
FLUSHING,Flushing,FLUSHING,FLUSHING,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10016825,10016825,10016825
"A 62 YEARS-OLD FEMALE PATIENT EXPERIENCED IATROGENIC KAPOSI'S SARCOMA DURING TACROLIMUS, MYCOPHENOLATE MOFETIL AND PREDNISONE TREATMENT",Kaposi's sarcoma,KAPOSI'S SARCOMA,KAPOSI'S SARCOMA,SOFT TISSUE NEOPLASMS MALIGNANT AND UNSPECIFIED,KAPOSI'S SARCOMAS,10029104,10023284,10023284,10023284
RELAPSE OF CDI DUE TO DEVELOPMENT OF CDI RESISTANCE STRAIN DUE TO ANTIBIOTIC PRESSURE,Relapse of CDI due to development of CDI resistance strain due to antibiotic pressure,CLOSTRIDIUM DIFFICILE INFECTION RECURRENCE,CLOSTRIDIUM DIFFICILE INFECTION,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10072994,10054236,10072994
PERIPHERAL EOSINOPHIL COUNT WAS 2408 ÎœL,Eosinophil count increased,EOSINOPHIL COUNT INCREASED,EOSINOPHIL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10014945,10014945,10014945
HYPONATREMIA (127 MMOL/L),Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
SEVERE HYPOMAGNESAEMIA,Hypomagnesaemia,HYPOMAGNESAEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021027,10021027,10021027
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
ANOMALY CONGENITAL,Congenital anomaly,ANOMALY CONGENITAL,CONGENITAL ANOMALY,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10010356,10010356,10002617
ELEVATED SERUM PROCALCITONIN,Procalcitonin increased,PROCALCITONIN INCREASED,PROCALCITONIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10067081,10067081,10067081
OVERDOSE,overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
PORTAL VEIN TRUNK ANEURYSM,Aneurysm,ANEURYSM,ANEURYSM,ANEURYSMS AND ARTERY DISSECTIONS,ANEURYSMS AND DISSECTIONS NON-SITE SPECIFIC,10047065,10002329,10002329,10002329
HYPONATREMIA,Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
PERIPHERAL NEUROPATHY,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
ACQUIRED VON WILLEBRAND SYNDROME,Acquired Von Willebrand's disease,ACQUIRED VON WILLEBRAND'S DISEASE,ACQUIRED VON WILLEBRAND'S DISEASE,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULATION FACTOR DEFICIENCIES,10005329,10069495,10069495,10069495
CARBAPENUM-RESISTANT KLEBSIELLA PNEUMONIAE BLOOD STREAM INFECTION,Klebsiella sepsis,KLEBSIELLA SEPSIS,KLEBSIELLA SEPSIS,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10054160,10054160,10054160
INGESTING A PACKAGE (30 TABLETS 400 MG EACH) OF CARBAMAZEPINE FOR SUICIDE ATTEMPT,Intentional overdose,DRUG OVERDOSE DELIBERATE SELF-INFLICTED,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033298,10022523,10013738
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
COLON DIVERTICULITIS PERFORATION,Large intestine perforation,COLONIC PERFORATION,LARGE INTESTINE PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,INTESTINAL ULCERS AND PERFORATION NEC,10017947,10010001,10023804,10010001
ALKALINE PHOSPHATASE INCREASED (152 IU/L),Blood alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
ABDOMINAL STRIAE,Striae,STRIAE,SKIN STRIAE,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,SKIN HYPOPLASIAS AND ATROPHIES,10040785,10042223,10040925,10042223
PERICARDIAL EFFUSION,Pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
PREMATURE BIRTH,Premature baby,PREMATURE BIRTH,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036590,10036590,10036594
AREFLEXIA,areflexia,AREFLEXIA,AREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10003084,10003084,10003084
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
ANGINA BULLOSA HEMORRHAGICA,Angina bullosa hemorrhagica,ANGINA BULLOSA HEMORRHAGICA,ANGINA BULLOSA HAEMORRHAGICA,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE DISORDERS NEC,10017947,10064225,10064223,10064225
INTENTIONAL DRUG MISUSE,INTENTIONAL DRUG MISUSE,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
PROLONGED LIVER DYSFUNCTION,Hepatic function disorder,HEPATIC FUNCTION DISORDER,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019674,10019670,10019674
IMPORTANT AGITATION WITH DELIRIOUS REMARKS AND DISORGANIZATION 18 DAYS AFTER THE LAST INCREASE OF THE DOSE/ PARADOXICAL REACTION OF AGITATION WITH DELUSIONAL DISORDER AND DISORGANISATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
PNEUMONIA WITHIN 1 YEAR AFTER VACCINATION,Vaccination failure,VACCINATION FAILURE,VACCINATION FAILURE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,VACCINATION RELATED COMPLICATIONS,10022117,10046862,10046862,10046862
VERTEBRAL FRACTURE,Spinal fracture,VERTEBRAL FRACTURE,SPINAL FRACTURE,BONE AND JOINT INJURIES,SPINAL FRACTURES AND DISLOCATIONS,10022117,10047333,10041569,10047333
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
VERTIGO,vertigo,VERTIGO,VERTIGO,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10047340,10047340,10047340
STAGGERING GAIT (GAIT INSATBILITY),Gait disturbance,GAIT DISTURBANCE,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017577,10017577,10017577
SYMPTOMATIC HYPOTENSION,Hypotension symptomatic,HYPOTENSION SYMPTOMATIC,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021105,10021097,10021105
OBNUBILATION,Depressed level of consciousness,OBNUBILATION,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10049219,10012373,10049219
PSORIASIFORM DERMATITIS (SKIN FINDINGS ON BOTH KNEES AND ELBOW JOINTS),Dermatitis psoriasiform,DERMATITIS PSORIASIFORM,DERMATITIS PSORIASIFORM,EPIDERMAL AND DERMAL CONDITIONS,PSORIATIC CONDITIONS,10040785,10058675,10058675,10058675
EBV ASSOCIATED STAGE IE PLL-PTLD OF KIDNEY,Plasmacytoma,PLASMACYTOMA,PLASMACYTOMA,PLASMA CELL NEOPLASMS,PLASMA CELL MYELOMAS,10029104,10035484,10035484,10035484
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
DYSPNOEA ON EXERTION,Dyspnoea exertional,DYSPNOEA EXERTIONAL,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013971,10013971,10013971
LOCAL SKIN IRRITATION WITH FAST DETERIORATION TOWARDS URTICARIA,urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
VISUAL DISTURBANCES,Visual impairment,VISUAL DISTURBANCES,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047543,10047571,10047545
HEART RATE INCREASED,Heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
OEDEMA WITH DIAMETER 10X5CM,Localised oedema,LOCALIZED EDEMA,LOCALISED OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10048961,10048961,10062466
CHRONIC NOROVIRUS GASTROENTERITIS,Gastroenteritis norovirus,GASTROENTERITIS NOROVIRUS,GASTROENTERITIS NOROVIRUS,VIRAL INFECTIOUS DISORDERS,CALICIVIRAL INFECTIONS,10021881,10068189,10068189,10068189
ACCELERATED SUBCUTANEOUS NODULOSIS IN A PATIENTS WITH RHEUMATOID ARTHRITIS,progression of rheumatoid arthritis,PROGRESSION OF RHEUMATOID ARTHRITIS,RHEUMATOID ARTHRITIS,JOINT DISORDERS,RHEUMATOID ARTHROPATHIES,10028395,10066578,10039073,10066578
ONYCHOLYSIS,onycholysis,ONYCHOLYSIS,ONYCHOLYSIS,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10030337,10030337,10030337
HEPATOMEGALY,Hepatomegaly,HEPATOMEGALY,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10019842
COLLAPSE WITH FALL/LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
MILD DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
RESIDUAL HYPERPIGMENTATION (AS A SEQUEAL OF PHOTOSENSITIVE RASH),Skin hyperpigmentation,SKIN HYPERPIGMENTATION,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10040865,10040865,10040865
FIRST LINE ANTIBIOTICS - PENICILLIN,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
DEVELOPED RESISTANT TO CLAVULANIC ACID,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
DECOMPENSATIO CORDIS,decompensation cardiac,DECOMPENSATION CARDIAC,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10011949,10007554,10011949
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
GENERALIZED WEAKNESS,Weakness generalized,WEAKNESS GENERALIZED,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047865,10003549,10047865
FLUOXETINE AND OLANZAPINE INTOXICATION,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
MULTIPLE LARGE ERYTHEMATOUS SKIN LESION/ RASH,Rash erythematous,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10037855
HYPERTROPHY OF THE OUTER CORTEX,bone hypertrophy,BONE HYPERTROPHY,EXOSTOSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10005973,10015688,10005973
SEVERE LIVER TOXICITY/HEPATOTOXICITY,hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
HALLUCINATIONS UPON AWEKENING,Hallucinations upon awekening,HALLUCINATIONS,HALLUCINATION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019077,10019063,10019077
"PURGATIVE ABUSE ASSOCIATED WITH REVERSIBLE CACHEXIA, HYPOGAMMAGLOBULINAEMIA, AND FINGER CLUBBING",Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
DEVELOPMENT OF ULCER WITH NECROSIS,Skin necrosis,ULCERO-NECROTIC SKIN LESION,SKIN NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10048839,10040893,10048839
RED BLOTCHY RASH ON HER ARMS AND FELT SOMEWHAT ITCHY,Rash erythematous,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10037855
ERYTHEMATOUS RASH,Rash erythematous,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10037855
"GUY HAD TAKEN 13G OF DOLIPRANE, HE ALMOST LEFT HIS LIFE",Overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
LIPID DISORDERS,dyslipidaemia,DYSLIPIDEMIA,DYSLIPIDAEMIA,LIPID METABOLISM DISORDERS,LIPID METABOLISM AND DEPOSIT DISORDERS NEC,10027433,10058108,10058108,10058110
BLISTERS AND EROSIONS OCCURRED ON SITES OF PREVIOUSLY UNINVOLVED SKIN,Skin erosion,SKIN EROSION,SKIN EROSION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040840,10040840,10040840
SLEEPLESSNESS,Sleeplessness,SLEEPLESSNESS,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10041017,10022437,10041017
HOARSENESS,Dysphonia,HOARSENESS,DYSPHONIA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10020201,10013952,10020201
DISSEMINATED INFECTION DUE TO MYCOBACTERIUM BOVIS,Disseminated Bacillus Calmette-Guerin infection,DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION,DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10076666,10076666,10076666
INVOLUNTARY MOVEMENTS OF UPPER LEFT EXTREMITY,Body movements involuntary,BODY MOVEMENTS INVOLUNTARY,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10005899,10013916,10005899
ORAL ULCERATION,Mouth ulceration,ORAL ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028034,10028034,10031027
NIFEDIPINE WAS USED TO ATTENUATE UTERINE CONTRACTIONS/ MEDICATION DURING STUDY PERIOD,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
DRUG EXPOSURE IN UTERO/MOTHER USED NIFEDIPINE DURING PREGNANCY,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
MASSIVE LEFT MIDDLE CEREBRAL ARTERY STROKE DUE TO DISSEMINATED INTRA-VASCULAR COAGULOPATHY,ischemic stroke,ISCHEMIC STROKE,ISCHAEMIC STROKE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10055221,10061256,10055221
"COMPUTED TOMOGRAPHY (CT) SCAN OF THE CHEST REVEALED A RIGHT UPPER LOBE LUNG LESION, MEASURING 2.1 CM IN ITS LONGEST DIMENSION, ASSOCIATED WITH GROUND-GLASS OPACITY",Computerised tomogram thorax abnormal,GROUND GLASS OPACITY IN THORACIC CT,COMPUTERISED TOMOGRAM THORAX ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10072879,10057799,10072879
MORNING DULLNESS,Feeling abnormal,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10016322,10016322,10016322
SKIN ERUPTION,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
ACUTE GRAFT VERSUS HOST DISEASE,acute graft versus host disease,ACUTE GRAFT VERSUS HOST DISEASE,ACUTE GRAFT VERSUS HOST DISEASE,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10066260,10066260,10066260
SEPTIC SHOCK,septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
DYSPNEA,Dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
DELIVERY OF THE INFANT AT 26 WEEKS OF GESTATION,Premature baby,PREMATURE BABY,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036590,10036590,10036590
PROGRESSIVE WORSENING OF SWELLING OF LIPS,Lip swelling,SWELLING OF LIPS,LIP SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10024570,10024570,10042703
DRUG-INDUCED INTERSTITIAL PNEUMONIA,Interstitial lung disease,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
USE OF METHOTREXATE FOR INDUCED ABORTION IN CESAREAN SCAR PREGNANCY (ECTOPIC PREGNANCY) (OFF LABEL USE FOR INDICATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
GRADE 3 MUCOSITIS FOLLOWING ACUTE RENAL FAILURE RESULTING IN METHOTREXATE OVEREXPOSURE,grade 3 mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
CONGESTED LIVER,Hepatic congestion,HEPATIC CONGESTION,HEPATIC CONGESTION,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019645,10019645,10019645
STAPHYLOCOCCUS HOMINIS DUE TO FEBRILE NEUTROPENIA,Staphylococcal infection,STAPHYLOCOCCAL INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10058080,10058080,10058080
ANURIA,Anuria,ANURIA,ANURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10002847,10002847,10002847
OCCUPATIONAL CONTACT DERMATITIS CAUSED BY HYDROXYCHLOROQUINE SULFATE,Dermatitis contact,ALLERGIC CONTACT DERMATITIS,DERMATITIS CONTACT,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10056265,10012442,10056265
NOCARDIOSIS,Nocardiosis,NOCARDIOSIS,NOCARDIOSIS,BACTERIAL INFECTIOUS DISORDERS,NOCARDIA INFECTIONS,10021881,10029444,10029444,10029444
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
HEMOGLOBIN 11.9 G/DL,Haemoglobin decreased,HEMOGLOBIN LOW,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018889,10018884,10055600
MULTIFOCAL MYOCLONUS,Myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
BRONCHOSPASM,bronchospasm,BRONCHOSPASM,BRONCHOSPASM,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10006482,10006482,10006482
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
DISSEMINATED PETECHIAE,Petechiae,PETECHIAE,PETECHIAE,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10034754,10034754,10034754
WORSENING PAIN,Pain,PAIN WORSENED,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033396,10033371,10033499
WORSENED HYPERTENSION (BLOOD PRESSURE-140/90) (G2),Hypertension,HYPERTENSION WORSENED,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020773,10020772,10020799
MENINGITIS,Meningitis,MENINGITIS,MENINGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10027199,10027199,10027199
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
EPISODE OF DROP ATTACK/FALL ATTACK,Drop attacks,DROP ATTACKS,DROP ATTACKS,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10013643,10013643,10013643
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
IRRITABILITY,irritability,IRRITABILITY,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10022998,10022998,10022998
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CHRONIC TYPE ADULT T-CELL LEUKAEMIA-LYMPHOMA (ATL),adult T-cell lymphoma/leukaemia,ADULT T-CELL LYMPHOMA/LEUKAEMIA,ADULT T-CELL LYMPHOMA/LEUKAEMIA,LYMPHOMAS NON-HODGKIN'S T-CELL,ADULT T-CELL LYMPHOMAS/LEUKAEMIAS,10029104,10001413,10001413,10001413
LEFT SUBDIAPHRAGMATIC ABSCESS,subdiaphragmatic abscess,SUBDIAPHRAGMATIC ABSCESS,SUBDIAPHRAGMATIC ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10056349,10056349,10056349
SUBARACHNOIDAL HEMORRHAGE,Subarachnoid haemorrhage,SUBARACHNOID HEMORRHAGE,SUBARACHNOID HAEMORRHAGE,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10042316,10042316,10042320
PULMONARY TALCOSIS,Lung disorder,LUNG DISORDER,LUNG DISORDER,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10025082,10025082,10025082
APATHY,apathy,APATHY,APATHY,MOOD DISORDERS AND DISTURBANCES NEC,MOOD DISORDERS NEC,10037175,10002942,10002942,10002942
DEPRESSION,depression,DEPRESSION,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012378,10012378,10012378
SUB CONJUCTIVAL HAEMORRHAGE,eye haemorrhage,EYE HAEMORRHAGE,EYE HAEMORRHAGE,OCULAR HAEMORRHAGES AND VASCULAR DISORDERS NEC,OCULAR BLEEDING AND VASCULAR DISORDERS NEC,10015919,10015926,10015926,10015926
DEGENERATIVE AORTIC VALVE DISEASE,Degenerative aortic valve disease,DEGENERATIVE AORTIC VALVE DISEASE,DEGENERATIVE AORTIC VALVE DISEASE,CARDIAC VALVE DISORDERS,AORTIC VALVULAR DISORDERS,10007541,10075846,10075846,10075846
SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
RECURRENT THROMBOSES,Thrombosis,THROMBOSIS,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10043607,10043607,10043607
HYPEREOSINOPHILIA AT 1400 CELLS/MM3,hypereosinophilia at 1400 cells/mm3,HYPEREOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10064890,10014950,10064890
BK VIRUS NEPHROPATHY (VIREMIA >104 COPIES/ML),Polyomavirus-associated nephropathy,BK VIRUS NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065333,10065381,10065333
FEELING ABNORMAL,Feeling abnormal,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10016322,10016322,10016322
PATIENT WAS TREATED WITH  MYCOPHENOLATE MOFETIL FOR AUTOIMMUNE ENCEPHALITIS ( OFF LABEL USE) WITH NO ADVERSE DRUG REACTION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CEFEPIME NEUROTOXICITY,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
NO ADVERSE EVENT,No Adverse Event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
STATIN MYOPATHY DUE TO THE INTERACTION BETWEEN CYCLOSPORINE AND ATORVASTATIN,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
"MUCOUS MEMBRANE EROSIONS OF OCULAR,ORAL AND GENITAL MUCOSA",Mucosal erosion,MUCOSAL EROSION,MUCOSAL EROSION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10061297,10061297,10061297
LOWER EXTREMITY TARGET LESION,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
TRIVIAL LANGUAGE,Language disorder,LANGUAGE DISORDER,LANGUAGE DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10074869,10074869,10074869
FEBRILE PROTEINURIA,Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
"C-REACTIVE PROTEIN INCREASED-61.57 MG/L (REFERENCE VALUE, <5.00 MG/L)",C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
HER WEIGHT WAS 49 KG AT FIRST PRESENTATION AND 53 KG WHEN HER MEDICATIONS WERE STOPPED AFTER TWO YEARS DUE TO A POSSIBLE SIDE EFFECT,weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
AGGRAVATION OF DYSPNEA/ PROGRESSIVE DYSPNEA,Dyspnea exacerbated,DYSPNEA EXACERBATED,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013965,10013968,10013965
RIVASTIGMINE-INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
LOW BIRTH WEIGHT,Low birth weight baby,LOW BIRTH WEIGHT BABY,LOW BIRTH WEIGHT BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10067508,10067508,10067508
SEVERELY DECREASED OF LV FUNCTION,Left ventricular ejection decreased,LEFT VENTRICULAR EJECTION DECREASED,EJECTION FRACTION DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10024118,10050528,10024118
SCARCE EFFECTIVENESS,Drug effect decreased,DRUG EFFECT DECREASED,DRUG EFFECT DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013678,10013678,10013678
HEPATITIS B,Hepatitis B,HEPATITIS B,HEPATITIS B,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10019731,10019731,10019731
CONCENTRATION AND COORDINATION DISTURBANCES/ INSTRUCTIONS MUST BE REPEATED SEVERAL TIMES/DELAYED RESPONSE,Coordination disturbance,COORDINATION DISTURBANCE,COORDINATION ABNORMAL,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10010949,10010947,10010949
BLOOD GLUCOSE ON ADMISSION WAS 52.2MMOL/L,Blood glucose increased,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10005557,10005557,10005557
IMMUNE MEDIATED NECROTIZING MYOPATHY,Immune-mediated necrotising myopathy,IMMUNE-MEDIATED NECROTIZING MYOPATHY,IMMUNE-MEDIATED NECROTISING MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10072155,10072155,10072156
OSTEOPOROSIS,Osteoporosis,OSTEOPOROSIS,OSTEOPOROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10031282,10031282,10031282
CLOSTRIDIUM DIFFICILE INFECTION,Clostridium difficile infection,CLOSTRIDIUM DIFFICILE INFECTION,CLOSTRIDIUM DIFFICILE INFECTION,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10054236,10054236,10054236
ASPIRIN TREATMENT WAS INITIATED IN ORDER TO CONTROL THROMBOCYTOPENIA,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
"A RELAPSE OCCURRED AND THE FINDING AT THE NECK/THROAT DID NOT RESPOND TO 2 CYCLES OF D-DHAP REGIMEN, NEITHER TO 2 CYCLES OF R-GEMOX",Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
SUBTHERAPEUTIC EFFECT OF CYCLOPHOSPHOMIDE AND MYCOPHENOLATE MOFETIL,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PROGRESSION OF PLEURAL ALVEOLAR RHABDOMYOSARCOMA FOLLOWING PARTIAL RESPONSE OF DACARBAZINE AND EPIRUBICIN,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
PATIENT TREATED WITH SULFASALAZINE FOR FAMILIAL MEDITERRANEAN FEVER (OFF LABEL USE) WITH NO ADRS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INVASIVE PULMONARY ASPERGILLUS FUMIGATUS INFECTION,Bronchopulmonary aspergillosis,ASPERGILLUS FUMIGATUS BRONCHOPULMONARY INFECTION,BRONCHOPULMONARY ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003493,10006473,10003493
ERYTHEMATOUS ERUPTION,Rash erythematous,ERYTHEMATOUS ERUPTION,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015241
CARDIAC FAILURE,Cardiac failure,CARDIAC FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10007554,10007554,10007554
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
MEMORY FLASHES OF SODOMY,Memory blackout,MEMORY BLACKOUT,AMNESIA,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10079176,10001949,10079176
DRUG INTOLERANCE,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE REACTION,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
FEBRILE,febrile,FEBRILE REACTION,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016289,10037660,10016289
PROTEIN URINE,Protein urine,PROTEIN URINE,PROTEIN URINE,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINALYSIS NEC,10022891,10037018,10037018,10037018
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
ATRIAL FIBRILLATION CAUSING ST ELEVATION MYOCARDIAL INFARCTION DUE TO CORONARY EMBOLISM,Atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
DELAYED MUCOCUTANEOUS REACTION,Hypersensitivity,HYPERSENSITIVITY REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020756,10020751,10020756
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
"WARFARIN AT A CONCENTRATION OF 8.4 MG/L IN PERIPHERAL BLOOD, WHICH SUPPOSES AN INR WELL ABOVE 4.5/ ""SUDDEN DEATH"" WITH SPONTANEOUS EPIGLOTTIC HEMATOMA SECONDARY TO HIGH BLOOD CONCENTRATION OF WARFARIN",Anticoagulation drug level increased,ANTICOAGULATION DRUG LEVEL INCREASED,ANTICOAGULATION DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10074528,10074528,10074528
CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
MUTE PLANTAR RESPONSE,plantar response extensor,PLANTAR RESPONSE EXTENSOR,EXTENSOR PLANTAR RESPONSE,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10035157,10015727,10035157
DIFFUSE MUSCLE TENDERNESS,Myalgia,TENDERNESS MUSCLE,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10043230,10028411,10043230
OLIGOHYDRAMNIOS,Oligohydramnios,OLIGOHYDRAMNIOS,OLIGOHYDRAMNIOS,"PLACENTAL, AMNIOTIC AND CAVITY DISORDERS (EXCL HAEMORRHAGES)",AMNIOTIC FLUID AND CAVITY DISORDERS OF PREGNANCY NEC,10036585,10030289,10030289,10030289
"-BLOCKER THERAPY IS CONTRAINDICATED, AND ITS ADMINISTRATION CONTRIBUTED TO THE DEVELOPMENT OF CARDIOGENIC SHOCK",Contraindicated product administered,CONTRAINDICATED DRUG ADMINISTERED,CONTRAINDICATED PRODUCT ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10074899,10078504,10074899
HAD A DECREASE IN PLATELETS,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
RESPIRATORY DIFFICULTY,Respiration labored,RESPIRATION LABORED,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038653,10013968,10038653
LIVER DYSFUNCTION FOLLOWING DRUG OVERDOSE,Hepatic dysfunction NOS,HEPATIC DYSFUNCTION NOS,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019657,10019670,10019657
"WARM, SWOLLEN, EXTREMELY TENDER RIGHT ELBOW OF ONE DAY'S DURATION",Swollen elbows,SWOLLEN ELBOWS,JOINT SWELLING,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10042717,10023232,10042717
LATE ONSET OF PNEUMOCYSTIS JIROVECII PNEUMONIA,Pneumocystis jirovecii pneumonia,PNEUMOCYSTIS JIROVECII PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10073755,10073755,10073755
HEPARIN-INDUCED THROMBOCYTOPENIA,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
INCREASE IN C REACTIVE PROTEIN,C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
SIGNIFICANT DROP IN HEMOGLOBIN (3 G),Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
ADMINISTRATION OF METHOTREXATE FOR CROHN'S DISEASE AND MYCOPHENOLATE MOFETIL FOR GVHD PROPHYLAXIS (UNAPPROVED INDICATION FOR BOTH)-OFF LABEL USE WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
GRADE 1 FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
RENAL FUNCTION PROGRESSIVELY DETERIORATED,Renal impairment,RENAL FUNCTION AGGRAVATED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038453,10062237,10038453
WEAKNESS DUE TO SPINAL CORD COMPRESSION,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
METHOTREXATE AND HYDROXYCHLOROQUINE SULFATE USED FOR TREATMENT OF DERMATOMYOSITIS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
KIDNEY FAILURE DUE TO HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,kidney failure,KIDNEY FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10023418,10038435,10023418
LICHEN PLANUS,Lichen planus,LICHEN PLANUS,LICHEN PLANUS,EPIDERMAL AND DERMAL CONDITIONS,PAPULOSQUAMOUS CONDITIONS,10040785,10024429,10024429,10024429
GRADE 4 ANEMIA,Anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
DIABETIC FOOT,Diabetic foot infection,DIABETIC FOOT INFECTION,DIABETIC FOOT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10060803,10060803,10060803
PATIENT TREATED WITH ZOLEDRONIC ACID FOR NON-INFECTIOUS OSTEOMYELITIS OF JAW (OFF LABEL USE) WITH NO ADVERSE EVENTS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
CORTICOSTEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE (LACK OF DRUG EFFECT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
ORO-NASAL FISTULA DUE TO ORAL MUCOSITIS,Fistula,FISTULA,FISTULA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,SOFT TISSUE DISORDERS NEC,10028395,10016717,10016717,10016717
HYPONATREMIA,Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
PLEURITIC CHEST PAIN,pleuritic pain,PLEURITIC PAIN,PLEURITIC PAIN,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10035623,10035623,10035623
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
GUT SYMPTOMS DID NOT IMPROVE EVEN AFTER 14 DAYS OF CORTICOSTEROID TREATMENT/ EFFUSIONS DID NOT IMPROVE,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LAMOTRIGINE BLOOD LEVELS ALSO FELL DURING THE CYCLE WITH ESTRADIOL VALERATE,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
INCREASE IN MLOSSI/INCREASED CENTRAL NERVOUS SYSTEM ACTIVITY,Morphoea,MORPHOEA,MORPHOEA,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),CONNECTIVE TISSUE DISORDERS NEC,10028395,10027982,10027982,10027982
ANEURYSMAL DILATATION OF THE ABDOMINAL AORTA,Aortic aneurysm,ABDOMINAL ANEURYSM,AORTIC ANEURYSM,ANEURYSMS AND ARTERY DISSECTIONS,AORTIC ANEURYSMS AND DISSECTIONS,10047065,10000054,10002882,10000051
HEPATOMEGALY,Hepatomegaly,HEPATOMEGALY,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10019842
ANOREXIA,Anorexia nervosa,ANOREXIA NERVOSA,ANOREXIA NERVOSA,EATING DISORDERS AND DISTURBANCES,EATING DISORDERS NEC,10037175,10002649,10002649,10002649
CHEST X-RAY REVEALED A LARGE RIGHT UPPER LOBE OPACITY,Chest X-ray abnormal,CHEST X-RAY ABNORMAL,CHEST X-RAY ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10008499,10008499,10008499
COLD AND CLAMMY EXTREMITIES,Peripheral coldness,COLD EXTREMITIES,PERIPHERAL COLDNESS,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10009857,10034568,10009857
"PATHOLOGICAL EXAMINATION OF ESOPHAGEAL BIOPSIES REVEALED MILD CHRONIC GASTRITIS AT THE GASTROESOPHAGEAL JUNCTION, WITH CYTOTOXIC COLCHICINE EFFECT",Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
METABOLIC ALKALOSIS,metabolic alkalosis,METABOLIC ALKALOSIS,METABOLIC ALKALOSIS,ACID-BASE DISORDERS,METABOLIC ALKALOSES,10027433,10027423,10027423,10027423
MEDICATION OVERUSE HEADACHE WITH EPISODIC MEGRAINE,Intentional product misuse,INTENTIONAL PRODUCT MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10074903,10074903,10074903
HYPOTENSION FOLLOWING EXPOSURE TO MORPHINE (TOXIC AGENT),Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
GASTROINTESTINAL EVENTS,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
CONFUSION,confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
ACUTE REJECTION,Kidney transplant rejection,REJECTION ACUTE RENAL,KIDNEY TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10038297,10023439,10038297
DERMATITIS BULLOUS,Dermatitis bullous,BULLOUS LESIONS,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006565,10012441,10006565
INTENTIONAL DRUG INTOXICATION,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
MYALGIA,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
HEMATOLOGICAL ABNORMALITIES,Haematology test abnormal,HAEMATOLOGY TEST ABNORMAL,HAEMATOLOGY TEST ABNORMAL,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),HAEMATOLOGICAL ANALYSES NEC,10022891,10057755,10057755,10057755
MYCOBACTERIUM BOVIS OSTEOMYELITIS/ TUBERCULOUS OSTEOMYELITIS/ MULTIPLE BONE MARROW LESIONS,Bone tuberculosis,MYCOBACTERIUM TUBERCULOSIS INFECTION OSTEOMYELITIS,BONE TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10028457,10056377,10028457
COLLAGENOUS COLITIS,Colitis microscopic,COLITIS COLLAGENOUS,COLITIS MICROSCOPIC,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10048928,10056979,10048928
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ACUTE-ONSET AMIODARONE-INDUCED PULMONARY TOXICITY,Pulmonary toxicity,PULMONARY TOXICITY,PULMONARY TOXICITY,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10061924,10061924,10061924
PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
MEGALOMANIA DELUSIONS,Delusion of grandeur,DELUSIONS OF GRANDEUR,DELUSION OF GRANDEUR,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10012241,10012241,10012261
TO BE IN ATRIAL FIBRILLATION WITH FAST VENTRICULAR RESPONSE,Atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
SEVERAL FILLING DEFECTS INVOLVING THE RADIAL AND ULNAR ARTERIAL DISTRIBUTIONS,arterial disorder,ARTERIAL DISORDER,ARTERIAL DISORDER,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10060963,10060963,10060963
SEVERE HYPSENSITIVITY REACTION,severe hypsensitivity reaction,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
HIGH FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
INFECTION IN CYST OF RIGHT UPPER LOBE,Lung infection,LUNG INFECTION,LUNG INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10061229,10061229,10061229
PARENCHYMAL NECROSIS ON THE LEFT LATERAL SEGMENT OF THE LIVER,Hepatic necrosis,LIVER NECROSIS,HEPATIC NECROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019692,10019692,10024701
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
ACUTE MYELOID LEUKEMIA,acute myeloid leukemia,ACUTE MYELOID LEUKEMIA,ACUTE MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10000886,10000880,10000886
WORSENING OF CONDITION,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
SINUS TACHYCARDIA,Sinus tachycardia,SINUS TACHYCARDIA,SINUS TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040752,10040752,10040752
FEBRILE,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
HEPATIC ENCEPHALOPATHY DUE TO REACTIVATION OF HEPATITIS B,hepatic encephalopathy,HEPATIC ENCEPHALOPATHY,HEPATIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10019660,10019660,10019660
INVASIVE PULMONARY MYCOSIS,pulmonary mycosis,PULMONARY MYCOSIS,PULMONARY MYCOSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10037422,10037422,10037422
"STREPTOCOCCUS SALIVARIUS, S.SANGUINIS, S. GORDONII AND S. ORALIS INFECTION",Streptococcal infection,STREPTOCOCCAL INFECTION,STREPTOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10061372,10061372,10061372
HYPOTONIA,hypotonia,HYPOTONIA,HYPOTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10021118,10021118,10021118
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
LEFT PERIPHERAL FACIAL PALSY ASSOCIATED WITH LOWER LIP EDEMA,Facial paralysis,FACIAL PALSY,FACIAL PARALYSIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),FACIAL CRANIAL NERVE DISORDERS,10029205,10016060,10016062,10016060
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
NEUTROPHILIA,neutrophilia,NEUTROPHILIA,NEUTROPHILIA,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10029379,10029379,10029379
NEUTROPENIA,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
TOXIC EPIDERMAL NECROLYSIS (TEN),Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
WHINY,Moaning,MOANING,MOANING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10027783,10027783,10027783
ACUTE RESPIRATORY DISTRESS SYNDROME SECONDARY TO DIFFUSE ALVEOLAR HEMORRHAGE,Acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
PEMPHIGOID GESTATIONIS RECURRENCE AFTER USE OF A CONTRACEPTIVE PATCH/PEMPHIGOID GESTATIONIS RECURRENCE A FEW WEEKS AFTER THE START OF A MINIPILL,Pemphigoid gestationis,PEMPHIGOID GESTATIONIS,HERPES GESTATIONIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10052801,10019939,10052801
STAPHYLOCOCCUS LUGDUNENSIS AND STAPHYLOCOCCUS EPIDERMIDIS INFECTION,Staphylococcus lugdunensis infection,STAPHYLOCOCCUS LUGDUNENSIS INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10078704,10058080,10078704
"SPASM HIS RIGHT HAND, LEG AND RIGHT SIDE OF THE FACE",Muscle spasms,SPASMS,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10041408,10028334,10041408
ACUTE OVERDOSE,Overdose,ACUTE OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067695,10033295,10067695
LARGE SEQUESTRUM,Primary sequestrum,PRIMARY SEQUESTRUM,PRIMARY SEQUESTRUM,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10052460,10052460,10052460
CLOSTRIDIUM DIFFICILE ENTEROCOLITIS,Clostridium difficile colitis,CLOSTRIDIUM DIFFICILE COLITIS,CLOSTRIDIUM DIFFICILE COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10009657,10009657,10009657
COMPLICATED ACUTE PERICARDITIS FOLLOWING MYOCARDIAL INFARCTION,Pericarditis,ACUTE PERICARDITIS,PERICARDITIS,PERICARDIAL DISORDERS,NONINFECTIOUS PERICARDITIS,10007541,10000996,10034484,10000996
SEVERE GASTROINTESTINAL TOXICITY,Gastrointestinal toxicity,GASTROINTESTINAL TOXICITY,GASTROINTESTINAL TOXICITY,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10059024,10059024,10059024
"PATIENT WITH SEVERE APLASTIC ANEMIA WHO WAS TREATED WITH FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE AND ALEMTUZUMAB AS CONDITIONING REGIMEN FOR ALLOGENEIC STEM CELL TRANSPLANTATION (OFF LABEL USE) WITH NO ADVERSE DRUG REACTION",Off-label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PANCREATITIS,Pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
ATOPIC ECZEMA ON THE LIMBS OF THE FOLDS,Eczema atopic,ECZEMA ATOPIC,DERMATITIS ATOPIC,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10014191,10012438,10014191
BASE EXCESS(18MMOL/L),Base excess,BASE EXCESS,BASE EXCESS,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10059961,10059961,10059961
BREAST WAS EDEMATOUS,Breast oedema,BREAST EDEMA,BREAST OEDEMA,BREAST DISORDERS,BREAST SIGNS AND SYMPTOMS,10038604,10006294,10006294,10054340
LIVER INJURY INDUCED BY CLOMIPHENE CITRATE FOLLOWING OFF LABEL USE,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
SEVERE NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
SEVERE ALLERGY,Allergy,ALLERGY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001738,10020751,10001738
STEVENS- JOHNSON SYNDROME (SJS),Stevens-Johnson syndrome,STEVENS JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042030
FEELING UNWELL,Malaise,FEELING UNWELL,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016365,10025482,10016370
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
NO CLINICAL IMPROVEMENT,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
BILLIRUBIN-230 MICROMOL/L (NORMAL 5-25 MICROMOL/L),Blood bilirubin increased,BILIRUBIN INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10004690,10005364,10004690
MENTAL STATUS INITIALLY CHANGED,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
BACK PAIN EXTENDING TO THE RIGHT LATERAL AND ANTERIOR THORACIC REGION,back pain,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003988,10003988,10003988
PATIENT'S MOTHER RECEIVED ACETYLSALICYLIC ACID DURING PREGNANCY,Foetal exposure during pregnancy,FOETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071404,10071404,10071404
CHOLESTATIC AND LIVER DAMAGE,Cholestatic liver injury,CHOLESTATIC LIVER INJURY,CHOLESTATIC LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067969,10067969,10067969
"FIVEFIRMRED-PURPLE PLAQUES ON THE MEDIAL ASPECT OF THE LEFT KNEE, FOREARM AND HIP, AND RIGHT LEG AND THIGH",Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
SWALLOWED 30 CAPSULES OF RIFAMPIN (300MG PER CAPSULE),intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
SOCIALLY VERY WITHDRAWN,Disturbance in social behaviour,DISTURBANCE IN SOCIAL BEHAVIOUR,DISTURBANCE IN SOCIAL BEHAVIOUR,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10061108,10061108,10061108
MYCOPLASMA GENITALIUM URETHRITIS,Mycoplasma genitalium urethritis,MYCOPLASMA GENITALIUM URETHRITIS,URETHRITIS MYCOPLASMAL,MYCOPLASMAL INFECTIOUS DISORDERS,MYCOPLASMA INFECTIONS,10021881,10075067,10075063,10075067
PROPRANOLOL ADMINISTERED TO 90-YEAR-OLD PATIENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MUSCLE STIFFNESS,muscle stiffness,MUSCLE STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10028339,10052904,10028339
"HIGH HECTIC FEVER, UP TO 40 DEGREE CELSIUS",Fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
HICCUPS,Hiccups,HICCUPS,HICCUPS,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10020039,10020039,10020039
RESPIRATORY DISTRESS AND PROGRESSIVE AXIAL HYPOTONIAWHICH MOTIVE HIS TRANSFER TO NEONATAL INTENSIVE CARE UNIT,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
SLOW THINKING,Bradyphrenia,THINKING SLOW,BRADYPHRENIA,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10043437,10050012,10043437
"PRURITIC ERUPTION ON THE UPPER AND LOWER LIMBS, NECK AND TRUNK",Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
INTESTINAL MUCOSAL DISORDER,Gastrointestinal mucosal disorder,GASTROINTESTINAL MUCOSAL DISORDER,GASTROINTESTINAL MUCOSAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL MUCOSAL DYSTROPHIES AND SECRETION DISORDERS,10017947,10056995,10056995,10056995
"NONBILIOUS, NONBLOODY VOMITING",Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
GRANULOMATOSIS WITH POLYANGITIIS REFRACTORY TO TREATMENT (LACK OF DRUG EFFECT) WITH NO ADR,Lack of drug effect,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
EQUIVOCAL JC VIRUS POLYMERASE CHAIN REACTION (PCR),equivocal JC virus polymerase chain reaction (PCR),JC VIRUS DNA PCR,JC POLYOMAVIRUS TEST,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10075615,10080768,10075615
PYREXIAL,Pyrexia,PYREXIAL,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037668
SERUM BACLOFEN CONCENTRATIONS,Drug level in blood increased,DRUG LEVEL IN BLOOD INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013721,10013722,10013721
BILATERAL SHOULDER PAIN ESPECIALLY ON THE LEFT SIDE,Musculoskeletal pain,SHOULDER PAIN,MUSCULOSKELETAL PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10040617,10028391,10040617
LINEZOLID-INDUCED GLAUCOMATOUS TOXIC OPTIC NEUROPATHY,Linezolid-induced toxic optic neuropathy,TOXIC OPTIC NEUROPATHY,TOXIC OPTIC NEUROPATHY,VISION DISORDERS,VISUAL PATHWAY DISORDERS,10015919,10044245,10044245,10044245
FREQUENT RELAPSES OF CROHN'S DISEASE DESPITE MEDICATIONS (LACK OF DRUG EFFECT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
IMMEDIATE TYPE HYPERSENSITIVITY,Type I hypersensitivity,IMMEDIATE HYPERSENSITIVITY,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021413,10045240,10021413
RESPIRATORY FAILURE,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
PATIENT WAS ADMINISTERED METHOTREXATE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (OFF LABEL USE) WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HYPOPLASTIC NIPPLES/HYPOTHELIA,breast hypoplasia,BREAST HYPOPLASIA,BREAST HYPOPLASIA,BREAST DISORDERS,BREAST DISORDERS NEC,10038604,10049070,10049070,10049070
UNEXPECTED THERAPEUTIC BENEFIT,Therapeutic effect unexpected,THERAPEUTIC EFFECT UNEXPECTED,THERAPEUTIC RESPONSE UNEXPECTED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10043412,10043417,10043412
LACK OF DRUG EFFECT /THERAPY FAILURE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CARBON DIOXIDE PRESSURE DECREASED (3.2 KPA),PCO2,PARTIAL ARTERIAL PRESSURE OF CARBON DIOXIDE,PCO2,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10059944,10034180,10059944
PERIPHERAL EDEMA,Oedema peripheral,PERIPHERAL EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030124,10030124,10034570
"THE ARRHYTHMIA DID NOT RESPOND TO INTRAVENOUS ADENOSINE, METOPROLOL AND DIGOXIN THERAPY",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PARKINSONISM,Parkinsonism,PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034010,10034010,10034010
ECZEMATOUS RASH,Eczema,ECZEMATOUS RASH,ECZEMA,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10014209,10014184,10014209
COAGULASE NEGATIVE STAPHYLOCOCCUS,coagulase negative,COAGULASE NEGATIVE STAPHYLOCOCCAL INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10054273,10058080,10054273
SHORT BREATH,Dyspnoea,SHORT OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040596
PREMACULAR SUBHYALOID HAEMORRHAGE FOLLOWING POST-CHEMOTHERAPY PANCYTOPENIA,Subhyaloid haemorrhage,SUBHYALOID HAEMORRHAGE,RETINAL HAEMORRHAGE,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINAL BLEEDING AND VASCULAR DISORDERS (EXCL RETINOPATHY),10015919,10059288,10038867,10059288
MYXEDEMA,Myxoedema,MYXEDEMA,MYXOEDEMA,THYROID GLAND DISORDERS,THYROID HYPOFUNCTION DISORDERS,10014698,10028665,10028665,10028663
ACUTE RENAL IMPAIRMENT,Renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
HEART FAILURE,heart failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10019279,10007554,10019279
LACK OF EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PSEUDOMONAS AERUGINOSA SEPSIS,Infection Pseudomonas aeruginosa,INFECTION PSEUDOMONAS AERUGINOSA,PSEUDOMONAS INFECTION,BACTERIAL INFECTIOUS DISORDERS,PSEUDOMONAL INFECTIONS,10021881,10021860,10061471,10021860
STIFFENING AND VERSION OF THE HEAD TO THE LEFT,Musculoskeletal stiffness,STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10042045,10052904,10042045
SKIN LESIONS/ASYMPTOMATIC CUTANEOUS LESIONS CONSISTING OF TENSE BLISTERS ON THE HANDS AND SKIN,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
RESTLESS,Restlessness,RESTLESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038743,10038743,10038740
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
T-CELL MEDIATED HYPERSENSITIVITY,Delayed type hypersensitivity,DELAYED TYPE HYPERSENSITIVITY,TYPE IV HYPERSENSITIVITY REACTION,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10012210,10053613,10012210
INCREASED HUMAN INSULIN-SPECIFIC IGE ANTIBODY AND ANTI-INSULIN IGG ANTIBODY (IA) LEVELS,Blood immunoglobulin G increased,IGG INCREASED,BLOOD IMMUNOGLOBULIN G INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10021272,10005596,10021272
DILATED CARDIOMYOPATHY FOLLOWING CARDIOTOXICITY,Congestive cardiomyopathy,DILATED CARDIOMYOPATHY,CONGESTIVE CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10056419,10056370,10056419
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
HAD REDUCED PLATELET AGGREGATION,Platelet aggregation decreased,PLATELET AGGREGATION DECREASED,PLATELET AGGREGATION DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035517,10035517,10035517
FEVER (38 DEGREE CELCIUS),fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
REPETITIVE HEART FAILURE EPISODES,Cardiac failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10007554,10007554,10019279
LANGUAGE DEFICITS,LANGUAGE DEFICITS,LANGUAGE DISORDER,LANGUAGE DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10074869,10074869,10074869
RESPIRATORY VIRAL INFECTION,respiratory viral infection,RESPIRATORY INFECTION,RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10038700,10062352,10038700
GRADUAL DESQUAMATION OF THE RASH (SKIN DESQUAMATION),Skin exfoliation,SKIN DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040826,10040844,10040826
HYPOCALCAEMIA AFFECTING BONES,Hypocalcaemia,HYPOCALCAEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020947,10020947,10020947
METHOTREXATE INDUCED LYMPHOPROLIFERATIVE DISORDER,methotrexate induced lymphoproliferative disorder,LYMPHOPROLIFERATIVE DISORDER,LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10061232,10061232,10061232
ENTEROVIRAL CNS INFECTION DUE TO HYPOGAMMAGLOBULINEMIA (IG G LEVEL-310MG/DL),Central nervous system enteroviral infection,CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION,CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION,VIRAL INFECTIOUS DISORDERS,ENTEROVIRAL INFECTIONS NEC,10021881,10061035,10061035,10061035
HYPOXEMIA,Hypoxia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021141,10021143,10021142
ANTIEPILEPTIC DRUG HYPERSENSITIVITY,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
GASTRIC PAIN,gastric pain,GASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10017814,10000087,10017814
LIVEDO RETICULARIS,Livedo reticularis,LIVEDO RETICULARIS,LIVEDO RETICULARIS,SKIN VASCULAR ABNORMALITIES,SKIN VASOMOTOR CONDITIONS,10040785,10024648,10024648,10024648
SEPSIS SECONDARY TO PNEUMONIA,sepsis ,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
PATIENT WITH SKIN PICKING DISORDER TREATED WITH N-ACETYLCYSTEINE (OFF LABEL USE) WITH NO ADR.,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
STEROID-INDUCED DIABETES MELLITUS,Diabetes mellitus,DIABETES STEROID-INDUCED,DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012628,10012601,10012628
PATIENT DEVELOPED DEVELOPED THREE NEW BRAIN METASTASES DESPITE TREATMENT WITH CARBOPLATIN AND PEMETREXED WITH NO REPORTED ADR (LACK OF DRUG EFFECT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
TWO WEEKS AFTER THE COMPLETION OF TREATMENT THE PATEINT DEVELOPED RECURRENCE OF DIARRHEA CAUSED BY CLOSTRIDIUM DIFFICILE COLITIS (REBOUND EFFECT),Clostridium difficile colitis,CLOSTRIDIUM DIFFICILE COLITIS,CLOSTRIDIUM DIFFICILE COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10009657,10009657,10009657
EPILEPTIC PAROXYSM,Epileptic seizure,EPILEPTIC SEIZURE,EPILEPSY,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10015052,10015037,10015052
CLINICAL CONDITION RAPIDLY DETERIORATED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
THE PATIENT DEVELOPED COMA FOLLOWING HYPERAMMONEMIC ENCEPHALOPATHY,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
REBOUND EFFECT,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
COMPLAINTS OF WORSENING SHORTNESS OF BREATH,complaints of worsening shortness of breath,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
SLIGHT RIGIDITY IN ALL FOUR EXTREMITIES,Muscle rigidity,RIGIDITY,MUSCLE RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10039168,10028330,10039168
CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
NULLISOMY Y,Chromosome analysis abnormal,CHROMOSOMAL ANALYSIS ABNORMAL,CHROMOSOME ANALYSIS ABNORMAL,CYTOGENETIC INVESTIGATIONS,CHROMOSOME ANALYSES,10022891,10008817,10008817,10008812
HYPOTENSIVE,Hypotension,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021107
CLINDAMYCIN INDUCED ANAPHYLACTOID REACTION,Anaphylactoid reaction,ANAPHYLACTOID REACTION,ANAPHYLACTOID REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002216,10002216,10002216
IGE-MEDIATED HYPERSENSITIVITY,Type I hypersensitivity,TYPE I HYPERSENSITIVITY,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10045240,10045240,10045240
EXTREME HYPERCALCAEMIA,Extreme hypercalcaemia ,HYPERCALCAEMIA,HYPERCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020583,10020583,10020583
PATIENT WAS TREATED WITH DIAZOXIDE FOR INSULINOMA WITH NO ADR (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
EMBOLIA CUTIS MEDICAMENTOSA,Embolia cutis medicamentosa,NICOLAU SYNDROME,EMBOLIA CUTIS MEDICAMENTOSA,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10058731,10058729,10058731
RETICULOCYTE COUNT INCREASED (8.4%),Reticulocyte count increased,RETICULOCYTE COUNT INCREASED,RETICULOCYTE COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10038792,10038792,10038792
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
THROMBIN TIME INCREASED (18),Blood thrombin increased,THROMBIN INCREASED,BLOOD THROMBIN INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10043537,10005821,10043537
REDUCED BONE DENSITY,Bone density decreased,BONE DENSITY DECREASED,BONE DENSITY DECREASED,MUSCULOSKELETAL AND SOFT TISSUE INVESTIGATIONS (EXCL ENZYME TESTS),MUSCULOSKELETAL AND SOFT TISSUE IMAGING PROCEDURES,10022891,10049470,10049470,10049470
HEMATURIA,Haematuria,HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018867,10018867,10019450
POSTOPERATIVE HAEMORRHAGE,Post procedural haemorrhage,POSTOPERATIVE HAEMORRHAGE,POST PROCEDURAL HAEMORRHAGE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10054709,10051077,10054709
SYMPTOMS DID NOT RESPOND TO THERAPY,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
DELAYED TOXICITY,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
"COMPANY DIAGNOSIS: HYPERSENSITIVITY WITH EXPIRATORY WHEEZING AND RALES, ERYTHEMA LEFT UPPER LIMB, FACIAL FLUSH",Hypersensitivity,HYPERSENSITIVITY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020751,10020751,10020751
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
THE PATIENT HAD BEEN GIVEN IM DEXAMETHASONE ON HOUR PRIOR TO DELIVERY (DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE EVENT REACTION),"drug exposure during pregnancy, third trimester","DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
THE PATIENT EXPERIENCED RECURRENT PSYCHOTIC SYMPTOMS/CATATONIA/BIZARRE BEHAVIOR/GELASMUS,Schizophrenia relapse,SCHIZOPHRENIA RELAPSE,SCHIZOPHRENIA,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,SCHIZOPHRENIA NEC,10037175,10064337,10039626,10064337
ASEPTIC MENINGITIS,Meningitis aseptic,ASEPTIC MENINGITIS,MENINGITIS ASEPTIC,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10027201,10027201,10003458
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
DISCOMFORT,Oral discomfort,DISCOMFORT IN MOUTH,ORAL DISCOMFORT,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SIGNS AND SYMPTOMS,10017947,10030973,10030973,10013089
VISUAL ACUITY DECREASED (6/9),Visual acuity reduced,VISUAL ACUITY DECREASED,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047531,10047531,10049061
PATIENT TREATED WITH MEROPENEM AND TEICOPLANIN DURING PREGNANCY WITH NO ADVERSE EVENTS (DRUG EXPOSURE DURING PREGNANCY),Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
SCOTOMA ANNULAR,Visual field defect,SCOTOMA ANNULAR,VISUAL FIELD DEFECT,NEUROLOGICAL DISORDERS OF THE EYE,NEUROLOGIC VISUAL PROBLEMS NEC,10029205,10039730,10047555,10039730
DRUG REACTION SYNDROME WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,Drug reaction with eosinophilia and systemic symptoms,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10073508,10073508,10073508
PROGRESSIVE DISEASE,Chronic lymphocytic leukemia,CHRONIC LYMPHOCYTIC LEUKEMIA,CHRONIC LYMPHOCYTIC LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS CHRONIC LYMPHOCYTIC,10029104,10008976,10008958,10008976
CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
"DESPITE TREATING WITH DOXYCYCLINE, RIFAMPIN AND ETHAMBUTOL, THE SKIN LESIONS IMPROVED ONLY SLIGHTLY",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
ACUTE OCCLUSION OF HIS INNOMINATE ARTERY (IA) ACCOMPANIED BY SUBCLAVIAN STEAL SYNDROME,Subclavian steal syndrome,SUBCLAVIAN STEAL SYNDROME,SUBCLAVIAN STEAL SYNDROME,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10042335,10042335,10042335
RESPIRATORY FAILURE,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
AGITATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
LABOURED BREATHING,Dyspnoea,LABOURED BREATHING,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10023557,10013968,10023556
EXCESSIVE SWEATING,Hyperhidrosis,EXCESS SWEATING,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10015590,10020642,10015590
EPISODE OF FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
RENAL FAILURE,Renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
ALBUMIN DECREASED,Blood albumin decreased,ALBUMIN DECREASED,BLOOD ALBUMIN DECREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10001561,10005287,10001561
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
POLYOMA VIRUS CYSTITIS,Cystitis viral,CYSTITIS VIRAL,CYSTITIS VIRAL,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10065197,10065197,10065197
ACUTE TUBULAR NECROSIS,acute tubular necrosis,ACUTE TUBULAR NECROSIS,RENAL TUBULAR NECROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL VASCULAR AND ISCHAEMIC CONDITIONS,10038359,10001099,10038540,10001099
METHICILLIN SENSITIVE STAPHYLOCOCCUS AURES SUPERINFECTION SECONDARY TO ERLOTINIB,Superinfection bacterial,SUPERINFECTION BACTERIAL,SUPERINFECTION BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10066972,10066972,10066972
LATE ONSET PNEUMOCYSTIS JIROVECII PNEUMONIA (OF LUNGS),Pneumocystis jirovecii pneumonia,PNEUMOCYSTIS JIROVECII PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10073755,10073755,10073755
LOSS OF THE ABILITY TO WALK,Gait inability,UNABLE TO WALK,GAIT INABILITY,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017581,10017581,10049278
SYSTEMIC HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
SWELLING OVER THE WHOLE BODY,swelling over the whole body,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
COMATOSE,comatose,COMATOSE,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10058472,10010071,10058472
ERYTHEMATOUS-EDEMATOUS MACULES AND PLAQUES,erythema oedematous,ERYTHEMA OEDEMATOUS,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015236,10015150,10015236
ANAPHYLAXIS GRADE 1,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
CARVEDILOL THERAPY FOR PRIMARY PROPHYLAXIS OF VARICEAL BLEEDING,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
SEVERE SALICYLATE INTOXICATION/SALICYLATE POISONING,Poisoning by salicylates,POISONING BY SALICYLATES,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10035963,10070863,10035963
MULTISYSTEM ORGAN FAILURE,Multiple organ dysfunction syndrome,MULTIPLE ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028237
ACUTE MYOCARDIAL INFARCTION ASSOCIATED WITH CLOMIPHENE CITRATE,Acute myocardial infarction,ACUTE MYOCARDIAL INFARCTION,ACUTE MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10000891,10000891,10000891
DRUG INTOLERANCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
TRICHOPHYTON RUBRUM RESISTANT TO TERBINAFINE/T. RUBRUM ISOLATE WAS FOUND SENSITIVE TO BOTH THE DRUGS,fungal resistance,FUNGAL RESISTANCE,PATHOGEN RESISTANCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10077713,10034133,10077713
"ERYTHEMATOUS AND EDEMATOUS PAPULES, INCLUDING TARGET PAPULAE",Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
PRURITIC HIVES,pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
DEVELOPED MULTIPLE SOFT TISSUE ABSCESSES INCLUDING SOLEAL ABSCESS DUE TO WORSENING OF MELIOIDOSIS FOLLOWING LACK OF DRUG EFFECT,Abscess soft tissue,ABSCESS SOFT TISSUE,ABSCESS SOFT TISSUE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10050474,10050474,10050474
"VISUAL HALLUCINATIONS, NAUSEA, VOMITING, CONSTIPATION, FLATULENCE, DIARRHEA, ABDOMINAL SWELLING, TREMORS, INCREASED PULSE RATE, DECREASED URINATION AND WEIGHT LOSS (+/- 6 KG)",vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
FLUSHED SKIN FOLLOWING ACCIDENTAL ONDANSETRON OVERDOSE,Flushing,FLUSHED SKIN,FLUSHING,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10016824,10016825,10016824
SUSPICION OF INTERSTITIAL PNEUMONIA RELATED TO IMMUNOSUPPRESION/SUSPECTED INTERSTITIAL LUNG DISEASE DUE TO AMYOPATHICDM,Interstitial pneumonia,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
AMIODARONE-INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
REDUCTION OF IMMUNOSUPPRESSION (PREDNISOLONE AND TACROLIMUS) DUE TO RENAL FUNCTION IMPAIRMENT,Renal impairment,IMPAIRED RENAL FUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10021523
PURULENT SPUTUM,Sputum purulent,SPUTUM PURULENT,SPUTUM PURULENT,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10050090,10050090,10050090
SCOPULARIOPSIS,Scopulariopsis,SCOPULARIOPSIS INFECTION,SCOPULARIOPSIS INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10079529,10079529,10079529
DIARRHOEA,Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
HYPOGLYCAEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
TRANSAMINITIS,transaminitis,TRANSAMINITIS,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054969,10054889,10054969
"PATIENT HAD SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND SLE-RELATED ANTIPHOSPHOLIPID SYNDROME, FOR WHICH SHE RECEIVED MYCOPHENOLATE (OFF LABEL USE)",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
CUTANEOUS LESION KAPOSI'S SARCOMA,Kaposi's sarcoma,"KAPOSI'S SARCOMA, SKIN",KAPOSI'S SARCOMA,SOFT TISSUE NEOPLASMS MALIGNANT AND UNSPECIFIED,KAPOSI'S SARCOMAS,10029104,10023296,10023284,10023296
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
PROGRESSIVE DIFFUSE ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
DISSEMINATED MACULO-PAPULAR EXANTHEMA,maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
NEAR FATAL ANAPHYLACTIC REACTION TO CHLORHEXIDINE,anaphylactic reaction,ANAPHYLACTIC REACTION,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002198,10002198,10002198
GENERALIZED ACUTE URTICARIA,Acute urticaria,ACUTE URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10001106,10046735,10001106
PRE-AURICAL AND RETROPHARYNGEAL ABSCESS,Abscess of external ear,ABSCESS OF EXTERNAL EAR,SUBCUTANEOUS ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10000296,10042343,10000296
MICROCEPHALY,Microcephalic,MICROCEPHALIC,MICROCEPHALY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS OF SKULL CONGENITAL,10010331,10027532,10027534,10027532
FEBRILE (38.1 C),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
OFF LABEL USE WITH NO ADR,OFF LABEL USE,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ACICLOVIR-INDUCED NEPHROPATHY,nephropathy,NEPHROPATHY,NEPHROPATHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10029151,10029151,10029151
"TWO EPISODES OF MACRO-HAEMATURIA/LEFT VENTRICULAR THROMBOSIS, EMBOLIC STROKE, INTRACRANIAL HEMORRHAGE, HEADACHE, MACROSCOPIC HAEMATURIA AND REPORTED SUBTHERAPEUTIC RESPONSE TO CLOPIDOGREL",Macroscopic haematuria,MACROSCOPIC HAEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10059802,10018867,10059802
SYSTEMIC CORTICOSTEROID WITHDRAWAL,Drug withdrawal syndrome,DRUG WITHDRAWAL SYNDROME,DRUG WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10013754,10013754,10013754
RENAL IMPAIRMENT,renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
URINE CONTAINED HAEMOGLOBIN,Haemoglobin urine present,HAEMOGLOBIN URINE PRESENT,HAEMOGLOBIN URINE PRESENT,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINALYSIS NEC,10022891,10018909,10018909,10018909
"DESPITE PROMPT MANAGEMENT INCLUDING SURGICAL DEBRIDEMENT AND APPROPRIATE ANTIBIOTICS, DEATH OCCURRED 36 HOURS AFTER INTENSIVE CARE ADMISSION",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SCLERODERMATOUS CGVHD/PROGRESSIVE DISEASE/CHRONIC GVHD IN SKIN,Chronic graft versus host disease in skin,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10072159,10072159,10072159
DILATED VENTRICLES IN HEAD CT,Cerebral ventricle dilatation,CEREBRAL VENTRICULOMEGALY,CEREBRAL VENTRICLE DILATATION,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10068352,10048824,10068352
BLOOD PRESSURE READING LOW,Blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
DESQUAMATION OF THE DORSAL ASPECTS OF THE HANDS AND FEET,desquamation,DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10012528,10040844,10012528
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
LINEAR FISSURES WITH DRY LIPS,Skin fissures,SKIN FISSURE,SKIN FISSURES,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040849,10040849,10040848
LIVE BIRTH,Live birth,LIVE BIRTH,LIVE BIRTH,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS","NORMAL PREGNANCY, LABOUR AND DELIVERY",10036585,10049550,10049550,10049550
BLUE-GREY PIGMENTATION IN THE FOREHEAD,Pigmentation disorder,SKIN PIGMENTATION,PIGMENTATION DISORDER,PIGMENTATION DISORDERS,PIGMENTATION CHANGES NEC,10040785,10040910,10062080,10040910
TACHYCARDIC TO 135,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
HYDROXYCHLOROQUINE CARDIOMYOPATHY,Cardiomyopathy,CARDIOMYOPATHY,CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10007636,10007636,10007636
HYPOTHERMIA,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
5-FU-RELATED CARDIOTOXICITY,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
DUODENITIS,Duodenitis,DUODENITIS,DUODENITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10013864,10013864,10013864
ORGANIC CATATONIA,Catatonia,CATATONIA,CATATONIA,CHANGES IN PHYSICAL ACTIVITY,DECREASED PHYSICAL ACTIVITY LEVELS,10037175,10007776,10007776,10007776
PARANEOPLASTIC LIMBIC ENCEPHALITIS,Limbic encephalitis,PARANEOPLASTIC LIMBIC ENCEPHALITIS,LIMBIC ENCEPHALITIS,CENTRAL NERVOUS SYSTEM INFECTIONS AND INFLAMMATIONS,ENCEPHALITIS NEC,10029205,10078013,10078012,10078013
FACIAL DYSKINETIC,Dyskinesia,DYSKINESIA,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10013916,10013916,10013916
CASE OF DEPENDENCE SYNDROME TO BACLOFEN FOLLOWING HIGH DOSE THERAPY,drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
ACUTE TOXIC HEPATITIS,Hepatitis toxic,HEPATITIS ACUTE TOXIC,HEPATITIS TOXIC,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10052553,10019795,10052553
CLOSTRIDIUM DIFFICILE INFECTION,Clostridium difficile infection,CLOSTRIDIUM DIFFICILE INFECTION,CLOSTRIDIUM DIFFICILE INFECTION,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10054236,10054236,10054236
SEVERE PNEUMONIA/CLINICALLY SUSPECTED PNEUMONIA,pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
DYSTROPHIC KERATINOCYTES,Skin dystrophy,SKIN DYSTROPHY,SKIN DYSTROPHY,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,SKIN DYSTROPHIES,10040785,10040836,10040836,10040836
MULTIPLE DRUG OVERDOSE,Overdose,MULTIPLE DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10057867,10033295,10057867
NEONATAL ABSTINENCE SYNDROME FOLLOWING DRUG EXPOSURE IN UTERO,Drug withdrawal syndrome neonatal,NEONATAL ABSTINENCE SYNDROME,DRUG WITHDRAWAL SYNDROME NEONATAL,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10074192,10013756,10074192
GENERALISED PETECHIAL RASH WITH ROSETTES,Petechiae,PETECHIAL RASH,PETECHIAE,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10034756,10034754,10034756
EXANTHEMA WAS DOCUMENTED ON BOTH ARMS AND HANDS WITH CONFLATING PLAQUES,Rash,EXANTHEMA,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10015587
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEPATOMEGALY,Hepatomegaly,HEPATOMEGALY,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10019842
CUTANEOUS ERUPTION WITH MILITARY PATTERNS,Drug eruption,DRUG ERUPTION,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10013687,10013687,10013687
MYELOBLASTS INCREASED,Myeloblast count increased,MYELOBLAST COUNT INCREASED,MYELOBLAST COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10050766,10050766,10050766
RARS (REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS),Refractory anemia with ringed sideroblasts,REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS,REFRACTORY ANAEMIA WITH RINGED SIDEROBLASTS,LEUKAEMIAS,MYELODYSPLASTIC SYNDROMES,10029104,10054594,10038272,10054594
"THE LESIONS HEALED , FOLLOWING WHICHTHE FREQUENCY OF PENTOXIFYLLINE WAS DECREASED TO ONCE DAILY AND SHE HAD REMAINED FREE OF LESIONS FOR THE PAST 4 MONTHS AT THE TIME OF REPORTING THIS STUDY.",Drug effective for unapproved indication,DRUG EFFECTIVE FOR UNAPPROVED INDICATION,DRUG EFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10079317,10079317,10079317
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
ACUTE DILI WITH PREDOMINANT HEPATOCYTE NECROSIS,drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
ALKALINE PHOSPHATASE INCREASED (299 IU/L),Blood alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
PROGRESSIVE WEAKNESS AND AREFLEXIA,Asthenia,WEAKNESS WORSENED,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10066688,10003549,10066688
CHRONIC PAIN/TENDON PAIN,Tendon pain,TENDON PAIN,TENDON PAIN,"TENDON, LIGAMENT AND CARTILAGE DISORDERS",TENDON DISORDERS,10028395,10066371,10066371,10066371
DRUG USED FOR UNAPPROVED INDICATION,drug used for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
ACUTE NEUTROPHILIC SUPPURATIVE FOLLICULITIS/ACUTE NEUTROPHILIC FOLLICULITIS,neutrophilic folliculitis,NEUTROPHILIC FOLLICULITIS,NEUTROPHILIC DERMATOSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10073673,10058105,10073673
ALTERED MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
ON THE SECOND DAY OF HOSPITALIZATION INCREASED LEVEL OF HS TROPONIN UP TO 139 NG/ML,troponin increased,TROPONIN INCREASED,TROPONIN INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10058267,10058267,10058267
"TOE WAS HOT, ERYTHEMATOUS, AND TENDER",Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
ASYSTOLIC ARREST,Cardiac arrest,ASYSTOLIC,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10003586,10007515,10003589
URTICARIA,Nettle rash,NETTLE RASH,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10029220,10046735,10029220
UNINTENTIONAL WEIGHT LOSS,unintentional weight loss,UNINTENTIONAL WEIGHT LOSS,ABNORMAL LOSS OF WEIGHT,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10068329,10000159,10068329
OLMESARTAN INDUCED SPRUE-LIKE ENTEROPATHY,sprue-like enteropathy,SPRUE-LIKE ENTEROPATHY,SPRUE-LIKE ENTEROPATHY,MALABSORPTION CONDITIONS,MALABSORPTION SYNDROMES,10017947,10079622,10079622,10079622
METHOTREXATE TOXICITY FOLLOWING ACECLOFENAC-INDUCED ACUTE KIDNEY INJURY,methotrexate toxicity following aceclofenac-induced acute kidney injury,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
ASTHENIA,asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
MANIC EPISODE,Mania,MANIC EPISODE,MANIA,MANIC AND BIPOLAR MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH MANIC SYMPTOMS,10037175,10026778,10026749,10026778
OPIOID INDUCED HYPERALGESIA,Hyperaesthesia,HYPERALGESIA,HYPERAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10020573,10020568,10020573
PARTIAL RESPONSE,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
NON-RESPONSE TO RITUXIMAB,No therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
FOUR MONTHS OF OMEPRAZOLE HAD NO EFFECT (LACK OF DRUG EFECT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PATIENT WAS ADMINISTERED MYCOPHENOLATE AND CYCLOPHOSPHAMIDE FOR UNAPPROVED INDICATION PEMPHIGUS VULGARIS (OFF LABEL USE FOR INDICATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ORAL ULCERATION,oral ulceration,ORAL ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10031027,10028034,10031027
ACUTELY WORSENING DYSPNEA,Dyspnoea,DYSPNOEA EXACERBATED,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013970,10013968,10013970
MASSIVE PULMONARY EMBOLISM,Acute massive pulmonary embolism,ACUTE MASSIVE PULMONARY EMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10000853,10037377,10000853
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
METFORMIN -INDUCED LACTIC ACIDOSIS/HYPERLACTATAEMIC HIGH ANION GAP METABOLIC ACIDOSIS,lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
SLIGHT INCREASE IN SERUM IGE,Blood immunoglobulin E increased,IGE INCREASED,BLOOD IMMUNOGLOBULIN E INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10021267,10005591,10021267
DESQUAMATION,Skin exfoliation,DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10012528,10040844,10012528
SEVERE STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
FACIAL FLUSHING,facial flushing,FACIAL FLUSHING,FLUSHING,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10016046,10016825,10016046
CESAREAN SECTION WAS CARRIED OUT AT 31 WEEKS AND 4 DAYS,Premature delivery,PREMATURE DELIVERY,PREMATURE DELIVERY,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036595,10036595,10036595
"ITCHY, SPREADING BUMPS ON HIS UPPER TORSO, BACK, AND ARMS",itchy,ITCHY,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023089,10037087,10023089
MARKED ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
IRRITABILITY,Irritability,IRRITABILITY,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10022998,10022998,10022998
PERIPHERAL NEUROPATHY NOS,Neuropathy peripheral,PERIPHERAL NEUROPATHY NOS,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10034610,10029331,10034610
ERYTHEMATOUS SKIN LESION,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
TABLETS HAD GONE DOWN THE WRONG PASSAGE/ASPIRATION OF MEDICINE,aspiration,ASPIRATION,ASPIRATION,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10003504,10003504,10003504
DRUG INDUCED HEMOLYTIC ANEMIA (HEMOGLOBIN 4.9 G/DL AND RBC 160X10E4 PER MICROL) ASSOCIATED WITH AGRANULOCYTOSIS,Haemolytic anaemia,HEMOLYTIC ANEMIA DRUG-INDUCED,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10018918,10018916,10055208
SPLENOMEGALY,Splenomegaly,SPLENOMEGALY,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041660,10041660,10041660
UVEITIS,uveitis,UVEITIS,UVEITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10046851,10046851,10046851
ABNORMALITY IN LIVER FUNCTION,Hepatic function abnormal,FUNCTION LIVER ABNORMAL,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019670,10019670,10017475
IDIOPATHIC THROMBOCYTOPENIC PURPURA RELAPSE AFTER THE COMPLETION OF METHYLPREDNISOLONE THERAPY (REBOUND EFFECT),Immune thrombocytopenic purpura,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IMMUNE THROMBOCYTOPENIC PURPURA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10021245,10074667,10021245
ACUTE HEMORRHAGIC PANCREATITIS,Pancreatitis haemorrhagic,PANCREATITIS HAEMORRHAGIC,PANCREATITIS HAEMORRHAGIC,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033650,10033650,10033650
"THIS DUAL THERAPY (PREDNISONE AND HYDROXYCHLOROQUINE) WAS STARTED 1 MONTH PRIOR TO IVF, AND WAS STOPPED WHEN THE MISCARRIAGE WAS DIAGNOSED",Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HAEMORRHAGIC ANAEMIA,haemorrhagic anaemia,HAEMORRHAGIC ANAEMIA,HAEMORRHAGIC ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10052293,10052293,10052293
CISPALTIN ASSOCIATED SUDDEN CARDIAC ARREST AND HEMODYNAMIC COLLAPSE,Circulatory collapse,CIRCULATORY COLLAPSE,CIRCULATORY COLLAPSE,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10009192,10009192,10009192
DRUG EXPOSURE DURING PREGNANCY,DRUG EXPOSURE DURING PREGNANCY,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
DRUG ABUSE,drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
ANAL PAIN,anal pain,ANAL PAIN,PROCTALGIA,ANAL AND RECTAL CONDITIONS NEC,ANAL AND RECTAL PAINS,10017947,10002167,10036772,10002167
PATIENTS TREATED WITH OMEPRAZOLE/EXCEPTIONAL CASES OF TREATMENT FAILURE/ PATIENT WITH NON-EROSIVE GERD AND TREATMENT FAILURE TO OMEPRAZOLE/CLINICAL FAILURE WITH OMEPRAZOLE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
LIMB MALFORMATION FOLLOWING DRUG EXPOSURE IN UTERO,limb malformation,LIMB MALFORMATION,LIMB MALFORMATION,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS OF LIMBS CONGENITAL,10010331,10024500,10024500,10024500
FEVER,Fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
INCREASED FLUCTUATION IN DRUG THERAPY'S EFFECT,Drug effect variable,DRUG EFFECT VARIABLE,DRUG EFFECT VARIABLE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10074541,10074541,10074541
CYTOMEGALOVIRUS INFECTION,cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011831,10011831,10011831
NEUTROPHILIA (11.0X10 E9 //L),Neutrophilia,NEUTROPHILIA,NEUTROPHILIA,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10029379,10029379,10029379
PATIENT DIED 20 DAYS LATER FROM REFRACTORY RIGH-TSIDED HEART FAILURE,Right ventricular failure,RIGHT HEART FAILURE,RIGHT VENTRICULAR FAILURE,HEART FAILURES,RIGHT VENTRICULAR FAILURES,10007541,10039152,10039163,10039152
PULMONARY EMBOLISM,Pulmonary embolism,PULMONARY EMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037377,10037377,10037377
SHE PERSPIRES,perspiration excessive,PERSPIRATION EXCESSIVE,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10034734,10020642,10034734
BORTEZOMIB USED FOR PRIMARY SYSTEMIC AMYLOIDOSIS (OFF LABEL USE),bortezomib used for primary systemic amyloidosis (off label use),OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CISPLATIN-RELATED KIDNEY TOXICITY,Nephropathy toxic,TOXICITY RENAL,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10044258
INFUSION REACTIONS,infusion reactions,INFUSION RELATED REACTION,INFUSION RELATED REACTION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10051792,10051792,10051792
CLUMSINESS,Clumsiness,CLUMSINESS,CLUMSINESS,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10009696,10009696,10009696
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
ANGULATED RETIFORM PURPURA,purpura,PURPURA,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037549,10037549,10037549
WHITE BLOOD CELL COUNT 16500/MM3,White blood cell count increased,WHITE BLOOD CELL INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10049183,10047943,10049183
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
DRUG EXPOSURE VIA PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
LOWER LIMB EDEMA,Edema lower limb,EDEMA LOWER LIMB,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014232,10030124,10014232
"CHILDREN WERE NON INFECTED AND NON-PROTECTED, DESPITE COMPLETE PASSIVE-ACTIVE IMMUNIZATION",Hepatitis B antibody negative,HEPATITIS B ANTIBODY NEGATIVE,HEPATITIS B ANTIBODY NEGATIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10019734,10019734,10019734
PANCYTOPENIA WITH GRADE 4 THROMBOCYTOPENIA (MINIMAL PLATELETS 4000/MCL) AND GRADE 3 LEUKOPENIA (MINIMAL WBC 1170/MCL),Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
MILD INTERSTITIAL PNEUMONIA/INTERSTITIAL PNEUMONIA WITH MILD GROUND-GLASS OPACITIES IN HER LUNG,Interstitial lung disease,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
EDEMA,Oedema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10014210
GENERAL WEAKNESS,general weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
PETECHIAL HAEMORRHAGES ON THE LUNGS,Pulmonary haemorrhage,PULMONARY HAEMORRHAGE,PULMONARY HAEMORRHAGE,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10037394,10037394,10037394
WHITE BLOOD CELL COUNT DECREASED,white blood cell count decreased,WHITE BLOOD CELL COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10047942
BIHEMISPHERIC MULTIFOCAL SHARP WAVE EEG,Electroencephalogram abnormal,EEG ABNORMAL,ELECTROENCEPHALOGRAM ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10000127,10014408,10014276
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
PAINFUL   LEFT   POPLITEAL   FOSSA ABSCESS,abscesses of skin,ABSCESS,ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10000269,10000269,10000269
GESTATION PERIOD,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
NON-ADHERENT WITH HER PRESCRIBED RISPERIDONE,treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
PANCOLITIS,Colitis,PANCOLITIS,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10033573,10009887,10033573
COAGULOPATHY,Coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
PERSISTENT METHEMOGLOBINEMIA (9.5%),Methaemoglobinaemia,METHEMOGLOBINEMIA,METHAEMOGLOBINAEMIA,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10027496,10027496,10027506
SUBTHERAPEUTIC RESPONSE,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
INTERACTION BETWEEN RIFAMPICIN AND VORICONAZOLE,Drug interaction,DRUG-DRUG PHARMACOKINETIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10065994,10013710,10065994
SMALL BOWEL STENOSIS AS A MANIFESTATION OF CHRONIC INTESTINAL GRAFT VERSUS HOST DISEASE,Chronic graft versus host disease in intestine,CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE,CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10072158,10072158,10072158
ALKALINE PHOSPHATASE INCREASED (307UI/L),Blood alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
PULMONARY ARTERIAL HYPERTENSION,Pulmonary arterial hypertension,PULMONARY ARTERIAL HYPERTENSION,PULMONARY ARTERIAL HYPERTENSION,PULMONARY VASCULAR DISORDERS,PULMONARY HYPERTENSIONS,10038738,10064911,10064911,10064911
SEROTONIN SYNDROME,Serotonin syndrome,SEROTONIN SYNDROME,SEROTONIN SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10040108,10040108,10040108
DISSEMINATED COCCIDIOIDOMYCOSIS,Coccidioidomycosis,COCCIDIOIDOMYCOSIS,COCCIDIOIDOMYCOSIS,FUNGAL INFECTIOUS DISORDERS,COCCIDIOIDES INFECTIONS,10021881,10009825,10009825,10009825
BRONCHOPNEUMONIA,Bronchopneumonia,BRONCHOPNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10006469,10035664,10006469
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
HERPES SIMPLEX I OF THE MOUTH AND NOSE,Herpes virus infection,HERPES VIRUS INFECTION,HERPES VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10019973,10019973,10019973
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
DIFFUSE MUSCLE ACHES,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
SUICIDAL IDEATION,Suicidal ideation,SUICIDAL IDEATION,SUICIDAL IDEATION,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042458,10042458,10042458
DISEASE RECURRENCE,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
GALACTORRHOEA,Galactorrhoea,GALACTORRHOEA,GALACTORRHOEA,BREAST DISORDERS,LACTATION DISORDERS,10038604,10017600,10017600,10017600
ALT INCREASED 215 U/L,Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
JAUNDICE FOLLOWING INTENTIONAL OVERDOSE,jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
CT SCAN OF THE BRAIN AND VISCERAL SKULL REVEALED LEFT SINUSITIS,Sinusitis,SINUSITIS,SINUSITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10040753,10040753,10040753
EXANTHEMA,Rash,EXANTHEMA,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10015587
LOW BACK PAIN,LOW BACK PAIN,LOW BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10024891,10003988,10024891
RESPIRATORY DEPRESSION FOLLOWING METABOLIC ACIDOSIS,Respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
ACUTE-ONSET CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
ACUTE LIVER FAILURE,Acute hepatic failure,ACUTE LIVER FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10049844
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
DYSKINESIA,Dyskinesia,DYSKINESIA,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10013916,10013916,10013916
MOTOR UNREST,Akathisia,MOTOR UNREST COMPULSIVE,AKATHISIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028007,10001540,10028007
BODY CORE TEMPERATURE (RECTAL TEMPERATURE) WAS ABOVE 42 Â°C,Body temperature increased,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10005911
THROMBOCYTOPENIA (PLATELET COUNT 128 K/ML),Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
CHARGE SYNDROME FOLLOWING DRUG EXPOSURE IN UTERO OF METHIMAZOLE,CHARGE syndrome,CHARGE SYNDROME,CHARGE SYNDROME,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10064063,10064063,10064063
PREGABALIN CAUSES BLACKOUTS/LOSS OF CONTROL,Blackout,BLACKOUT,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10004982,10024855,10004982
MUSCULAR PAIN,Myalgia,MUSCULAR PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028361
CHRONIC THROMBOCYTOPENIA (GRADE-II),Thrombocytopenia,CHRONIC THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10066667,10043554,10066667
BLEOMYCIN USED FOR PERSISTENT PLANTAR VIRAL WARTS WITH NO ADR,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
CREAMY WHITE CHORIORETINAL LESIONS SPARING THE MACULLA,Chorioretinal disorder,CHORIORETINAL DISORDER,CHORIORETINAL DISORDER,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10061763,10061763,10061763
SKIN LESIONS WERE THE MOST SIGNIFICANT SIGNS IN THESE INFANT CASES,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
ONGOING AND SEVERE 10/10 LEG PAIN,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
GASTROINTESTINAL BLEEDING FOLLOWING DEVELOPMENT OF FACTOR 8 INHIBITOR AND IMMUNE THROMBOCYTOPENIA,Gastrointestinal haemorrhage,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017936
CHILLS,chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
DRUG ERUPTION,DRUG ERUPTION,DRUG ERUPTION,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10013687,10013687,10013687
HYPONATREMIA,Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
AGITATED,Agitation,AGITATED,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001495
INTRAOCULAR PRESSURE WAS CONSISTENTLY IN THE HIGH 30 TO LOW 40 RANGE DESPITE TREATMENT WITH ACETAZOLAMIDE (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
MEGALOBLASTIC ANEMIA DUE TO VITAMIN B12 DEFICIENCY IN TOTALLY GASTRECTOMIZED TYPE 2 DIABETIC PATIENT,Anaemia megaloblastic,MEGALOBLASTIC ANEMIA,ANAEMIA MEGALOBLASTIC,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002065,10002065,10027129
COGNITIVE DYSFUNCTION,Cognitive disorder,COGNITIVE FUNCTION ABNORMAL,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10048599,10057668,10048599
CHILLS,chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
HER CAREGIVER WAS UNABLE TO PROVIDE DETAILS WITH REGARD TO WHICH MEDICINES AND HOW MANY TOTAL DOSES WERE MISSED,drug dose omission,DRUG DOSE OMISSION,DRUG DOSE OMISSION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064294,10064294,10064294
METABOLIC ACIDOSIS,metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
DYSTONIC POSTURINGOF THE LIMBS,dystonia,DYSTONIA,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10013983,10013983,10013983
RESULTED IN ONLY A SHORT-TERM IMPROVEMENT,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
RESISTANT HYPERTENSION,Resistant hypertension,REFRACTORY HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10038274,10020772,10038274
ACCESS IN DEPARTMENT OF EMERGENCY AND ACCEPTANCE (DEA) FOR INGESTION AND VOLUNTARY OF STIOLNOX - ABUSE (17 TABLETS) PATIENT NOT VERY RESPONSIVE AND EXTREMELY SOMNOLENT.,Overdose intentional,OVERDOSE INTENTIONAL,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033300,10022523,10033300
COLLAPSE AT SCHOOL,Syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
METFORMIN-INDUCED LACTIC ACIDOSIS FOLLOWING ACCIDENTAL OVERDOSE DUE TO INAPPROPRIATE DOSE OF DRUG ADMINISTRATION FOLLOWING WRONG DRUG ADMINISTRATION,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
TACHYCARDIA (105 BEATS PER MINUTE),Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
FAILURE OF IMPLANON IN A WOMAN ON ANTICONVULSANT THERAPY WITH CARBAMAZEPINE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
ASPARTATE TRANSAMINASE INCREASED (4650 INTERNATIONAL UNITS),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
OPT WAS POSITIVE FOR AMOXICILLIN/ ALLERGY,Drug hypersensitivity,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
PUSTULAR DRUG ERUPTIONS (1-3 MM IN DIAMETER ON TOP OF ERYTHEMA),pustular skin eruption,PUSTULAR SKIN ERUPTION,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037577,10037888,10037577
GRAVES-BASEDOW DISEASE,Graves-Basedow disease ,GRAVES-BASEDOW DISEASE,BASEDOW'S DISEASE,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10065624,10004161,10065624
APPLICATION SITE OEDEMA IN DIAMETER OF 12 MM X 12 MM,Vaccination site oedema,VACCINATION SITE OEDEMA,VACCINATION SITE OEDEMA,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10069617,10069617,10069617
AGITATED/ PRAYING LOUD/ CONTINUE TO BE AGITATED AND BROKE HER GLASSES,agitated,AGITATED,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001495,10001497,10001495
TONGUE LACERATIONS,tongue lacerations,TONGUE INJURY,TONGUE INJURY,INJURIES NEC,SITE SPECIFIC INJURIES NEC,10022117,10059924,10059924,10059924
URTICARIA,urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
CUSHING'S SYNDROME,Cushing's syndrome,CUSHING'S SYNDROME,CUSHING'S SYNDROME,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011652,10011652,10011652
PARTIAL REMISSION OF THEIR SYMPTOMATOLOGY,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
BRADYCARDIA DUE TO DRUG INTERACTION,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
OTOTOXICITY,Ototoxicity,OTOTOXICITY,OTOTOXICITY,AURAL DISORDERS NEC,EAR DISORDERS NEC,10013993,10033109,10033109,10033109
PRURITUS,pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
LOSS OF VISION,Blindness,LOSS OF VISION,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047522,10005169,10024881
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
SOMNOLENT,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
"OVARIAN SIZE > 8 CM, <12 CM",Ovarian enlargement,OVARY ENLARGED,OVARIAN ENLARGEMENT,OVARIAN AND FALLOPIAN TUBE DISORDERS,OVARIAN AND FALLOPIAN TUBE DISORDERS NEC,10038604,10033157,10033157,10033285
LYMPHADENOPATHY,Lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
HAEMOPHILUS INFLUENZAE INFECTION,Haemophilus infection,HAEMOPHILUS INFLUENZAE INFECTION,HAEMOPHILUS INFECTION,BACTERIAL INFECTIOUS DISORDERS,HAEMOPHILUS INFECTIONS,10021881,10018952,10061190,10018952
BILATERAL PULMONARY INFILTRATES,Lung infiltration,BILATERAL PULMONARY INFILTRATES,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10070790,10025102,10070790
PH 7.5,Blood pH increased,PH INCREASED,BLOOD PH INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10034780,10005708,10034780
OVERDOSE,Overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
CRP WAS 16.7  MG/DL,C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
DRUG INTOXICATION,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
SEVERE DYSTONIC REACTION,Dystonia,DYSTONIC REACTION,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10013986,10013983,10013986
"PATIENT WAS EXPOSED TO RANITIDINE HYDROCHLORIDE, ERYTHROMYCIN, ENOXAPARIN SODIUM AND PIPERACILLIN SODIUM/TAZOBACTAM SODIUM DURING PREGNANCY",Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
MILD NORMOCYTIC ANAEMIA,normocytic anaemia,NORMOCYTIC ANAEMIA,NORMOCYTIC ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10029784,10029784,10029784
WORSENING OF THROMBOCYTOPENIA,Thrombocytopenia aggravated,THROMBOCYTOPENIA AGGRAVATED,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043556,10043554,10043556
MATERNAL EXPOSURE BEFORE PREGNANCY,Maternal exposure before pregnancy,MATERNAL EXPOSURE BEFORE PREGNANCY,MATERNAL EXPOSURE BEFORE PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071406,10071406,10071406
HYPOCALCEMIA - CALCIUM LEVEL (1.28 MMOL/L),Hypocalcaemia,HYPOCALCEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020947,10020947,10020949
POOR RESPONSE TO HIGH DOSE METHYLPREDNISOLONE (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SUPRACHOROIDAL HAEMORRHAGE,haemorrhage eye,HAEMORRHAGE EYE,EYE HAEMORRHAGE,OCULAR HAEMORRHAGES AND VASCULAR DISORDERS NEC,OCULAR BLEEDING AND VASCULAR DISORDERS NEC,10015919,10055805,10015926,10055805
HEPATITIS ACUTE,Hepatitis acute,HEPATITIS ACUTE,HEPATITIS ACUTE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019727,10019727,10019727
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
AMYLOIDOSIS DUE TO RELAPSE OF FAMILIAL MEDITERRANEAN FEVER,Amyloidosis,AMYLOIDOSIS,AMYLOIDOSIS,IMMUNE DISORDERS NEC,AMYLOIDOSES,10021428,10002022,10002022,10002022
PATIENT WAS TREATED WITH METHYLPREDNISOLONE WITH NO RESPONSE TO TREATMENT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
GRADE II ANAPHYLAXIS DURING A DRUG  CHALLENGE TEST WITH ETORICOXIB,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
INAPPROPRIATE ROUTE OF DRUG ADMINISTRATION,Drug administered via inappropriate route ,DRUG ADMINISTERED VIA INAPPROPRIATE ROUTE,INCORRECT ROUTE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10013660,10064304,10013660
ASTHMA LIKE SYMPTOMS AFTER TAKING ASPIRIN,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
MICROALBUMINURIA,Microalbuminuria,MICROALBUMINURIA,MICROALBUMINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10027525,10027525,10027525
POLYURIC ACUTE RENAL FAILURE FOLLOWING CEPHALEXIN INDUCED TOXIC EPIDEMAL NECROLYSIS,acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
DISEASE PROGRESSION,DISEASE PROGRESSION,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
ABSCESS OF ILIOPSOAS MUSCLE,Muscle abscess,MUSCLE ABSCESS,MUSCLE ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,MUSCLE AND SOFT TISSUE INFECTIONS,10021881,10049206,10049206,10049206
PHYSICAL EXAMINATION WAS REMARKABLE FOR A GRADE 2/6 HOLOSYSTOLIC MURMUR,Cardiac murmur,HOLOSYSTOLIC MURMUR,CARDIAC MURMUR,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC AUSCULTATORY INVESTIGATIONS,10022891,10050566,10007586,10050566
WORSENING BLISTERING,Blister,BLISTERING,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005214,10005191,10005214
SEIZURES,seizure,SEIZURES,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039910
DECREASED URINE OUTPUT (700ML),Urine output decreased,URINE OUTPUT DECREASED,URINE OUTPUT DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059895,10059895,10059895
STUMBLED DUE TO ACHILLES TENDON RUPTURE,stumbling,STUMBLING,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10042262,10017577,10042262
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
HIGH DOSE OF SLEEPINESS-PREVENTING MEDICINE (ESTARON MOCHAÂ®) FOR SUICIDE ATTEMPT,Suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
HAND TREMOR AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
COMA/ CNS DEPRESSION,Depressed level of consciousness,CNS DEPRESSION,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10012383,10012373,10009710
GEN,Nystagmus,GAZE-EVOKED NYSTAGMUS,NYSTAGMUS,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10077413,10029864,10077413
OCCASIONAL PROBLEMS WITH FALLING ASLEEP,Insomnia,DIFFICULTY SLEEPING,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10012804,10022437,10012804
BACK PAIN,Back pain,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003988,10003988,10003988
INSOMNIA,Insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
INAPPETENCE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
FEBRILE,febrile,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
PERIPHERAL NERVE DISORDER,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
PRURITUS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
ELECTROCARDIOGRAM ST ELEVATION,Electrocardiogram ST segment elevation,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10014392,10014392,10014392
FEVER (102.2 DEGREE F),fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
POLYSEROSITIS,polyserositis,POLYSEROSITIS,POLYSEROSITIS,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10036141,10036141,10036141
"FLORID EUPTION ON PHOTO-EXPOSED AREAS OF FACE, NECK AND LOWER LIMBS (MARKED ERYTHEMA ON FACE, NECK AND UPPER CHEST WITH CRUSTING ON LIPS)",Erythema,SKIN ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10040842,10015150,10040842
MYELOSUPPRESSION SECONDARY TO LINEZOLID,Bone marrow failure,MYELOSUPPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10028584
POOR MEMORY,Memory impairment,MEMORY IMPAIRMENT,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027175,10027175,10027175
TREATMENT WITHOUT CLINICAL RESPONSE,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
NO WET NAPPIES,Anuria,ANURIA,ANURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10002847,10002847,10002847
DRUG INDUCED ANAPHYLACTIC SHOCK,Anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
INCOMPLETE BONE REMODELLING OF THE MANDIBULAR LEFT FIRST MOLAR SOCKET,Bone disorder,BONE DISORDER,BONE DISORDER,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10005956,10005956,10005956
ACUTE REJECTION DUE TO BK VIRUS INFECTION,Rejection acute renal,REJECTION ACUTE RENAL,KIDNEY TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10038297,10023439,10038297
SKIN ERUPTION AGGRAVATED,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
"AMIODARONE, A STRONG P-GLYCOPROTEIN INHIBITOR WITH A LONG T HALF (3-4 WEEKS), MIGHT HAVE CONTRIBUTED TO THE TOXICITY OF DABIGATRAN, SEVERE HAEMATURIA",Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
UPPER LEG CALCIPHYLAXIS,calciphylaxis,CALCIPHYLAXIS,CALCIPHYLAXIS,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10051714,10051714,10051714
PANCYTOPENIA FOLLOWING HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
WORSENING OF ODONTOGENIC INFECTION FOLLOWING MULTIDRUG RESISTANCE,Tooth infection,TOOTH INFECTION,TOOTH INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,DENTAL AND ORAL SOFT TISSUE INFECTIONS,10021881,10048762,10048762,10048762
BILATERAL RED SORE EYES/ BILATERAL CONJUNCTIVITIS,Conjunctivitis,CONJUNCTIVITIS,CONJUNCTIVITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10010741,10010741,10010741
PERIPHERAL NERVE DISORDER,Peripheral nerve disorder,PERIPHERAL NERVE DISORDER NOS,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10051174,10029331,10051174
RHABDOMYOLYSIS FOLLOWING OFF LABEL USE OF COLCHICINE FOR PERICARDITIS AND DRUG INTERACTION BETWEEN COLCHICINE AND AMLODIPINE,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
SPONGIOSIS,spongiosis,EPIDERMA SPONGIOSIS,ECZEMA,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10062582,10014184,10062582
ASYMPTOMATIC MACROSCOPIC CRYSTALLURIA,Crystalluria,CRYSTALLURIA,CRYSTALLURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10011509,10011509,10011509
THROMBUS WAS DESCRIBED AT THE END OF THE VENOUS CATHETER IN THE UPPER VENA CAVA,Vena cava thrombosis,SUPERIOR VENACAVAL THROMBOSIS,VENA CAVA THROMBOSIS,EMBOLISM AND THROMBOSIS,VENA CAVAL EMBOLISM AND THROMBOSIS,10047065,10042570,10047195,10042570
TOXIC OPTIC NEUROPATHY,toxic optic neuropathy,TOXIC OPTIC NEUROPATHY,TOXIC OPTIC NEUROPATHY,VISION DISORDERS,VISUAL PATHWAY DISORDERS,10015919,10044245,10044245,10044245
THYROTOXICOSIS FAILED TO RESPOND TO CONVENTIONAL TREATMENT WITH CARBIMAZOLE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
CHRONIC ENTERITIS DUE TO SAPOVIRUS,Gastroenteritis sapovirus,GASTROENTERITIS SAPOVIRUS,GASTROENTERITIS SAPOVIRUS,VIRAL INFECTIOUS DISORDERS,CALICIVIRAL INFECTIONS,10021881,10068190,10068190,10068190
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
DISTURBED CONSCIOUSNESS FOLLOWING HYPOGLYCEMIA,Altered state of consciousness,CONSCIOUSNESS DISTURBED,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010770,10001854,10010770
COMA/CNS DEPRESSION,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
ACANTHOSIS OF EPIDERMIS,acanthosis,ACANTHOSIS,ACANTHOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,SKIN HYPERPLASIAS AND HYPERTROPHIES,10040785,10000349,10000349,10000349
INDIRECT BILIRUBIN (13.68 LMOL/L),Blood bilirubin unconjugated increased,BILIRUBIN INDIRECT INCREASED,BLOOD BILIRUBIN UNCONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10021709,10005370,10004691
SEVERE PAIN,severe pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
PROTEINURIA,Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
WORSENING OF THE CHEST PAIN,chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
CATASTROPHIC COMPLICATIONS POSTOPERATIVELY RELATED TO HER ANTICOAGULATION MANAGEMENT,Post procedural complication,POSTOPERATIVE COMPLICATION,POST PROCEDURAL COMPLICATION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10058018,10058046,10058018
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
PELVIC LYMPHADENOPATHY FOLLOWING LACK OF DRUG EFFECT OF CAPECITABINE AND BEVACIZUMAB,Lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
"MINOR HAEMORRHAGE, HAEMORRHAGE FROM PENIS TUMOR",Tumour haemorrhage,TUMOUR HAEMORRHAGE,TUMOUR HAEMORRHAGE,NEOPLASM RELATED MORBIDITIES,ONCOLOGIC COMPLICATIONS AND EMERGENCIES,10029104,10049750,10049750,10049750
DRY SKIN (CTCAE GRADE 1),Dry skin,DRY SKIN,DRY SKIN,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10013786,10013786,10013786
PURULENCE,Purulence,PURULENCE,PURULENCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10061926,10061926,10061926
HYPOTHERMIA/HER RECTAL TEMPERATURE WAS 28Â°C,hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
PHYSICAL AND INTELLECTUAL FATIGUABILITY,Fatigue,FATIGUABILITY,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016259,10016256,10016259
DRUG RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
HIGH TRYPTASE VALUE,Tryptase increased,TRYPTASE INCREASED,TRYPTASE INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOLOGY ANALYSES NEC,10022891,10063342,10063342,10063342
SKIN ERUPTION,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
SEVERE PERITONEAL SCLEROSIS,Encapsulating peritoneal sclerosis,PERITONITIS SCLEROSING,ENCAPSULATING PERITONEAL SCLEROSIS,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL FIBROSIS AND ADHESIONS,10017947,10034682,10075012,10034682
GFR OF 20 ML/MIN/1.73 M^2,Glomerular filtration rate decreased,GLOMERULAR FILTRATION RATE DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018358,10018358,10018358
NEUTROPENIC FEVER,Neutropenic fever,NEUTROPENIC FEVER,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10051312,10016288,10051312
DIFFICULTY WITH ACTIVITIES OF DAILY LIVING BECAUSE OF SEVERE ITCHING,Loss of personal independence in daily activities,ACTIVITIES OF DAILY LIVING IMPAIRED,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10050954,10079487,10050954
INTENTIONAL SUSPECTED SUICIDE,Completed suicide,COMPLETED SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10010144,10010144,10010144
ZOSTER INFECTION (GRADE 3),Viral infection,VIRAL INFECTION,VIRAL INFECTION,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10047461,10047461,10047461
NIGHT IS MIALGIA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
CONFUSED,Confused,CONFUSED,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010298,10010305,10010298
"VERY SOFT, LOW PITCHED BIBASILAR WHEEZING",Wheezing,WHEEZING,WHEEZING,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10047924,10047924,10047924
MULTIDRUG ABUSE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
NUMEROUS COALESCENT SKIN DEFECTS ON THE BACK AND DORSAL PARTS OF BOTH ARMS AND LEGS,Skin disorder,SKIN DISORDER,SKIN DISORDER,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040831,10040831,10040831
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
NYSTAGMUS,Nystagmus,NYSTAGMUS,NYSTAGMUS,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10029864,10029864,10029864
PAIN DURING THE NIGHT,Pain in extremity,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033425,10033425,10033425
BLURRED VISION,Vision blurred,BLURRED VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047513,10047513,10005886
STATUS POST COLLAPSE WITH FALL ON FACE,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
QUININE TOXICITY,quinine toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
DIABETIC KETOACIDOSIS,Diabetic ketoacidosis,DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEC,10027433,10012671,10012671,10012671
ABERRANT OPIOID-INDUCED BEHAVIOUR (BODY DEPENDENCE),Drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
ABDOMINAL PAIN INTENSIFIED 2 WEEKS AFTER PIPAC 4,Pain,PAIN AGGRAVATED,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033396,10033371,10033376
INABILITY TO TOLERATE ORAL INTAKE,Hypophagia,ORAL INTAKE REDUCED,HYPOPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10063889,10063743,10063889
ASPIRIN-EXACERABATED RESPIRATORY DISEASE,aspirin-exacerabated respiratory disease,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10075084,10075084,10075084
ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,Acute generalised exanthematous pustulosis,ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10062372
IRREVERSIBLE LUNG DAMAGE,Lung disorder,LUNG DISORDER,LUNG DISORDER,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10025082,10025082,10025082
DRUG EXPOSURE IN UTERO,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
ACUTE RENAL FAILURE,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
USE OF FLUDARABINE PHOSPHATE IN A CHILD (OFF LABEL USE) AND USE OF METHOTREXATE FOR GVHD PROPHYLAXIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PIGMENTED SPOTS DUE TO MAJOCCHI'S GRANULOMA FOLLOWING IMMUNOSUPPRESSION CAUSED BY TREATMENT WITH CORTICOSTEROIDS AND MYCOPHENOLATE MOFETIL,Pigmentation disorder,SKIN PIGMENTATION,PIGMENTATION DISORDER,PIGMENTATION DISORDERS,PIGMENTATION CHANGES NEC,10040785,10040910,10062080,10040910
BILATERAL FEET BURNING PAIN,Pain,PAIN BURNING,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033386,10033371,10033386
GENERALIZED EXANTHEMA,Rash generalised,EXANTHEMA GENERALIZED,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10058693,10037858,10058721
MASSIVE GLIBENCLAMIDE OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
CRAMPING IN THE CALF,Muscle spasms,CRAMPS CALF,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10011294,10028334,10011294
CEFEPIME HYDROCHLORIDE NEUROTOXICITY,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
NERVOUS SYSTEM DISORDER,Nervous system disorder,NERVOUS SYSTEM DISORDER,NERVOUS SYSTEM DISORDER,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029202,10029202,10029202
MASSIVE THROMBOSIS,Thrombosis,THROMBOSIS,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10043607,10043607,10043607
LEUKOPENIA FOLLOWING TREATMENT WITH CYCLOPHOSPHAMIDE,leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
CARDIAC ARRHYTHMIAS OCCURRED,arrhythmia,ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10003119
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
NOCTURIA,Nocturia,NOCTURIA,NOCTURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY TRACT SIGNS AND SYMPTOMS NEC,10038359,10029446,10029446,10029446
LEUKOCYTOSIS (30X10E3/ MICRO LITRE),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
HYPERTRICHOSIS OVER THE FOREHEAD,Hypertrichosis,HYPERTRICHOSIS,HYPERTRICHOSIS,SKIN APPENDAGE CONDITIONS,HYPERTRICHOSES,10040785,10020864,10020864,10020864
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
ALLERGIC INTERSTITIAL NEPHRITIS,Nephritis interstitial,NEPHRITIS INTERSTITIAL,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029134,10048302,10029134
DRUG INTOLERANCE,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
PATIENT TREATED WITH OMEPRAZOLE FOR INTERSTITIAL PULMONARY FIBROSIS (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
WORSENING FACIAL SWELLING,Swelling face,FACIAL SWELLING,SWELLING FACE,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10042682,10042682,10016065
NEUTROPENIA,neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
LOSS OF APPETITE,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
COMA/CNS DEPRESSION,Depressed level of consciousness,CNS DEPRESSION,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10012383,10012373,10009710
ACUTE RESPIRATORY DISTRESS SYNDROME,Acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
LOOSE STOOLS,Diarrhoea,LOOSE STOOLS,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10024840,10012735,10024840
JAUNDICE,jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
"TWO FOCAL LIVER METASTASES/ POSSIBILITY OF ANOTHER SECONDARY PROCESS IN THE LIVER, WHICH WAS CONFIRMED WITH A PET/CT SCAN",Liver metastases,LIVER METASTASES,METASTASES TO LIVER,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10024700,10027457,10024700
PATIENT SHORTLY COLLAPSED AND WETTED HIMSELF,Cardiovascular disorder,UNSPECIFIED CIRCULATORY SYSTEM DISORDER,CARDIOVASCULAR DISORDER,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10045663,10007649,10045663
PRURITUS,pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
ATTEMPT TO COMMIT SUICIDE,Suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
DRUG EXPOSURE DURING ECTOPIC ABDOMINAL PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
METHOTREXATE USED FOR PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE (OFF LABEL USE FOR INDICATION),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG WITHDRAWAL INDUCED REDUPLICATIVE PARAMNESIA,withdrawal syndrome,WITHDRAWAL SYMPTOM,WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10073281,10048010,10073281
BREATHING HARDER,Hyperventilation,HYPERPNEA,HYPERVENTILATION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10020734,10020910,10020733
PARACETAMOL SELF-POISONING,Poisoning deliberate,POISONING DELIBERATE SELF-INFLICTED,POISONING DELIBERATE,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10036001,10036000,10036001
RHINORRHOEA AND NASAL DRIPPING,rhinorrhoea,RHINORRHOEA,RHINORRHOEA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10039101,10039101,10039101
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
DRONEDARONE-INDUCED PHOTOSENSITIVITY,Photosensitivity reaction,PHOTOSENSITIVITY,PHOTOSENSITIVITY REACTION,EPIDERMAL AND DERMAL CONDITIONS,PHOTOSENSITIVITY AND PHOTODERMATOSIS CONDITIONS,10040785,10034966,10034972,10034966
HYPNAGOGIC HALLUCINATIONS,Hypnagogic hallucination,HYPNAGOGIC HALLUCINATION,HYPNAGOGIC HALLUCINATION,SLEEP DISORDERS AND DISTURBANCES,NARCOLEPSY AND ASSOCIATED CONDITIONS,10037175,10020927,10020927,10020927
DIFFUSE AND SEVERE MUSCLE WASTING AND WEAKNESS,muscle wasting,MUSCLE WASTING,MUSCLE ATROPHY,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028348,10028289,10028348
SERUM CREATININE INCREASED (3.04 MG/DL),Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
PHILADELPHIA CHROMOSOME (PH) INDEPENDENT CLONAL CHANGES/ABERRATION (MONOSOMY 7),Cytogenetic abnormality,CYTOGENETIC ABNORMALITY,CYTOGENETIC ABNORMALITY,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,CHROMOSOMAL ABNORMALITIES NEC,10010331,10067477,10067477,10067477
OXCARBAZEPINE- INDUCED DRESS/DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,Drug reaction with eosinophilia and systemic symptoms,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
GENERALIZED PRURITUS WITH SKIN RASH,skin rash,SKIN RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040913,10037844,10040913
MULTIFOCAL LESIONS IN THE LEFT HEMISPHERE,multifocal lesions in the left hemisphere,BRAIN LESION,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10067294,10051290,10067294
ACQUIRED HYPOTHYROIDISM IN A NEWBORN TREATED WITH AMIODARONE IN THE FIRST WEEK OF LIFE,Hypothyroidism,ACQUIRED HYPOTHYROIDISM,HYPOTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPOFUNCTION DISORDERS,10014698,10000559,10021114,10000559
FAILURE OF BONE MARROW,Bone marrow failure,BONE MARROW FAILURE,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10065553,10065553,10065553
THE PATIENT WAS TREATED WITH PYRIDOXINE HYDROCHLORIDE FOR PERIPHERAL NEURITIS (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"MAINTAINED DEPRESSIVE MOOD, ADYNAMIA, ANHEDONIA, ANOREXIA, ISOLATION",Anorexia,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10002646,10061428,10002646
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
LYMPHADENOPATHIES IN RIGHT CERVICAL IA AND IB LEVELS,Lymphadenopathy cervical,LYMPHADENOPATHY CERVICAL,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025200,10025197,10025200
HEMORRHAGE,Haemorrhage,HEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10019524
HE BECOMES RESTLESS,Restlessness,RESTLESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038743,10038743,10038740
ELEVATED PROCALCITONIN (2.6 NG/DL),Procalcitonin increased,PROCALCITONIN INCREASED,PROCALCITONIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10067081,10067081,10067081
PARALYSIS,Paralysis,PARALYSIS,PARALYSIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10033799,10033799,10033799
CARDIAC ARREST FOLLOWING ANAPHLACTIC SHOCK,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
INTOLERABILITY TO METHOTREXATE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
TEN,TEN,TEN,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10043221,10044223,10043221
HEMATOLOGICAL TOXICITIES,Haematotoxicity,HEMATOTOXICITY,HAEMATOTOXICITY,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10061188,10061188,10061196
BRADYCARDIA AND A WIDENED SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
MORNING BASAL CORTISOL LEVEL DECREASED (3.83 MG/DL),Cortisol decreased,CORTISOL DECREASED,CORTISOL DECREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),ADRENAL CORTEX TESTS,10022891,10011198,10011198,10011198
FEVER UP TO 39.5 Â° C,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
MILD CELLULAR REJECTION,Transplant rejection,ACUTE CELLULAR REJECTION,TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10049237,10044439,10049237
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
LOSS OF CONSCIOUSNESS,loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
ELEVATED TRIGLYCERIDES (580 MG/DL),Blood triglycerides increased,TRIGLYCERIDES HIGH,BLOOD TRIGLYCERIDES INCREASED,LIPID ANALYSES,TRIGLYCERIDE ANALYSES,10022891,10052373,10005839,10052373
"MULTIPLE DRUG HYPERSENSTIVITY SYNDROME TO ANTIHISTAMINES,CORTICOSTEROIDS AND NON STERIIDAL ANTIINFLAMMATORIES",Drug reaction with eosinophilia and systemic symptoms,DRUG-INDUCED HYPERSENSITIVITY SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10059724,10073508,10059724
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PROPRANOLOL USED FOR HEPATIC CIRRHOSIS,Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
ABDOMINAL DISTENSION,Abdominal distension,ABDOMINAL DISTENSION,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10000060
BILATERAL ASYMMETRIC OPTIC NEURITIS,Optic neuritis,BILATERAL OPTIC NEURITIS,OPTIC NEURITIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OPTIC NERVE DISORDERS NEC,10029205,10004571,10030942,10004571
STEVENS-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
FOOT PAIN,Pain in extremity,FOOT PAIN,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033429,10033425,10016974
CREATINE KINASE LEVEL INCREASED TO 29998 U/L,Blood creatine phosphokinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
PERMANENTLY STOP DONEPEZIL ONE DRUG ON THE QT LIST) DUE TO LACK OF RESPONSE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
CYTOPENIAS,Cytopenia,CYTOPENIA,CYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10066274,10066274,10066274
"XEROSIS WITH CRUSTING, WAXING, AND WANING PRURITIC ERYTHEMATOUS MACULOPAPULAR RASH OVER CHEEKS, NECK, TRUNK, CHEST, AND LIMBS",xerosis,XEROSIS,XEROSIS,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10048222,10048222,10048222
CARDIO-RESPIRATORY ARREST,Cardio-respiratory arrest,CARDIO-RESPIRATORY ARREST,CARDIO-RESPIRATORY ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007617,10007617,10007617
PSEUDOANEURYSM AT THE SUPERIOR ANTERIOR WALL OF PETROUS SEGMENT,Vascular pseudoaneurysm,PSEUDOANEURYSM,VASCULAR PSEUDOANEURYSM,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,CARDIAC AND VASCULAR PROCEDURAL COMPLICATIONS,10022117,10048977,10048975,10048977
SEIZURES,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
FEW TENSE 2-8 MM BLISTERS,Blister,BLISTERS,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005216
VISCERAL LEISHMANIASIS DUE TO IMMUNOSUPPRESSION,Visceral leishmaniasis,VISCERAL LEISHMANIASIS,VISCERAL LEISHMANIASIS,PROTOZOAL INFECTIOUS DISORDERS,LEISHMANIA INFECTIONS,10021881,10047505,10047505,10047505
METABOLIC ALKALOSIS,metabolic alkalosis,METABOLIC ALKALOSIS,METABOLIC ALKALOSIS,ACID-BASE DISORDERS,METABOLIC ALKALOSES,10027433,10027423,10027423,10027423
SYSTOLIC BLOOD PRESSURE RANGING BETWEEN 90-100,systolic blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
DEPENDENCE ON EXTREMELY HIGH DOSE OF ZOLPIDEM,Drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
LIVER FUNCTION TESTS RAISED,Liver function test increased,LIVER FUNCTION TESTS RAISED,LIVER FUNCTION TEST INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10077692,10077692,10048556
PARKINSONISM WORSENED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
WORSENING LYMPHOPENIA,Lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
PALE SKIN,pale skin,PALE SKIN,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033533,10033546,10033533
TREMOR FOLLOWING METRONIDAZOLE TOXICITY AND OFF LABEL USE,tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
EOSINOPHILIA,Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
SYMPHISITIS,Osteitis,BONE INFLAMMATION,OSTEITIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10063913,10031149,10063913
HYPOKALAEMIA,Hypokalaemia,HYPOKALAEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021015
SHORTNESS OF BREATH,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
STOMATITIS AND OTHER MUCOSAL MEMBRANE DISORDERS,Mucous membrane disorder,MUCOUS MEMBRANE DISORDER,MUCOUS MEMBRANE DISORDER,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028133,10028133,10028133
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
OMEPRAZOLE USED IN PATIENT WEIGHING 8.8 KG (UNAPPROVED POPULATION),drug use in unapproved population,DRUG USE IN UNAPPROVED POPULATION,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10071551,10076309,10071551
LOSS OF ENERGY,Asthenia,LOSS OF ENERGY,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10024862,10003549,10024862
ATYPICAL LYMPHOCYTES,Lymphocyte morphology abnormal,ATYPICAL LYMPHOCYTES,LYMPHOCYTE MORPHOLOGY ABNORMAL,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10003751,10062047,10003751
GLUCOSE INTOLERANCE,Glucose tolerance impaired,GLUCOSE INTOLERANCE,GLUCOSE TOLERANCE IMPAIRED,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10052426,10018429,10052426
DEHYDRATED,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
ALANINE AMINOTRANSFERASE INCREASED,Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
"TINGLING SPORADICALLY IN HER FINGERTIPS, KNEES AND ANKLES BILATERALLY",Paraesthesia,TINGLING SENSATION,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10043880,10033775,10043880
IMATINIB RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
"THE GIRL DEVELOPED ACUTE LYMPHOBLASTIC LEUKAEMIA FOLLOWING IN UTERO EXPOSURE TO TENOFOVIR,EMTRICITABINE, ATAZANAVIR, RITONAVIR AND RALTEGRAVIR",Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
INCREASED QUININE LEVEL IN BLOOD FOLLOWING ADMINISTRATION OF INCORRECTLY DILUTED QUININE,Inappropriate dilution of medication,INAPPROPRIATE DILUTION OF MEDICATION,PRODUCT PREPARATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT PREPARATION ERRORS AND ISSUES,10022117,10057387,10076869,10057387
PARADOXICAL REACTION,Paradoxical drug reaction,PARADOXICAL DRUG REACTION,PARADOXICAL DRUG REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048958,10048958,10048958
TRANSVERSE MYELITIS FOLLOWING OFF LABEL USE,Myelitis transverse,MYELITIS TRANSVERSE,MYELITIS TRANSVERSE,CENTRAL NERVOUS SYSTEM INFECTIONS AND INFLAMMATIONS,MYELITIS (INCL INFECTIVE),10029205,10028527,10028527,10028527
OSTEOPENIA,Osteopenia,OSTEOPENIA,OSTEOPENIA,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10049088,10049088,10049088
POSTPARTUM BILATERAL FEMORAL NECK FRACTURE DUE TO EXCESSIVE CORTICOSTEROID CONSUMPTION DURING PREGNANCY,Femoral neck fracture,FEMORAL NECK FRACTURE,FEMORAL NECK FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10016450,10016450,10016450
INVASIVE FUNGAL INFECTION,Systemic mycosis,INVASIVE MYCOSIS,SYSTEMIC MYCOSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10062642,10052366,10062642
UPPER GASTROINTESTINAL BLEED,Upper gastrointestinal haemorrhage,UPPER GASTROINTESTINAL HEMORRHAGE,UPPER GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10046274,10046274,10055356
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
MUSCLE PAIN,Myalgia,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028322
PAPILLEDEMA,papilledema,PAPILLEDEMA,PAPILLOEDEMA,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC",OPTIC DISC ABNORMALITIES NEC,10015919,10033703,10033712,10033703
PROTRACTED SEVERE SYSTEMIC MULTIORGAN CYTOMEGALOVIRUS DISEASE DUE TO BONE MARROW SUPPRESSION,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011831,10011831,10011831
DIAPHORESIS,diaphoresis,DIAPHORESIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10012703,10020642,10012703
LEVAMISOLE INDUCED AGRANULOCYTOSIS,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
NEUTROPENIC FEVER (40.1 DEGREE CELSIUS),Febrile neutropenia,NEUTROPENIC FEVER,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10051312,10016288,10051312
MOOD CHANGES,Mood change,MOOD CHANGE,MOOD ALTERED,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10027941,10027940,10027941
FALL,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
ACUTE RESPIRATORY FAILURE/ACUTE RESPIRATORY INSUFFICIENCY FOLLOWING PNEUMOCYSTIS PNEUMONIA,Acute respiratory failure,ACUTE RESPIRATORY INSUFFICIENCY,ACUTE RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10001053,10001053,10069144
WEIGHT LOSS,weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
OCTREOTIDE FAILED TO CONTROL THE BLEEDING,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PHARYNGODYNIA,Oropharyngeal pain,PHARYNGODYNIA,OROPHARYNGEAL PAIN,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10074930,10068319,10074930
MILD BURNING SENSATION IN HIS CHEST.,Burning sensation,BURNING SENSATION,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10006784,10006784,10006784
BODY TEMPERATURE > 39Â°C,Body temperature increased,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10005911
HYPOGLYCAEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
MYALGIA/BACK MYALGIA ON EZETIMIBE TREATMENT,Myalgia,LOCALISED MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10063543,10028411,10063543
NAUSEES,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
RADIAL FISSURES AROUND THE MOUTH,Skin fissures,SKIN FISSURES,SKIN FISSURES,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040849,10040849,10040849
VERTIGO,vertigo,VERTIGO,VERTIGO,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10047340,10047340,10047340
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
LOSS OF CONSCIOUSNESS OCCURRED 1 HOUR AFTER LUNCH FOLLOWING HYPOGLYCAEMIC ATTACK,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
ACETAMINOPHEN WAS PARTIALLY EFFECTIVE IN TERMINATING THESE HEADACHES,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
SHOCK DUE TO METFORMIN-ASSOCIATED LACTIC ACIDOSIS,Shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
VISCERAL LEISHMANIASIS,Visceral leishmaniasis,VISCERAL LEISHMANIASIS,VISCERAL LEISHMANIASIS,PROTOZOAL INFECTIOUS DISORDERS,LEISHMANIA INFECTIONS,10021881,10047505,10047505,10047505
HE HAD CONTINUALY BLOODY URINE,blood urine present,BLOOD URINE PRESENT,BLOOD URINE PRESENT,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINALYSIS NEC,10022891,10018870,10018870,10018870
WIDESPREAD PAINFUL PRURITIC SKIN ERUPTIONS,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
AGITATION,agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
AXONAL NEUROPATHY,Axonal neuropathy,AXONAL NEUROPATHY,AXONAL NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10003882,10003882,10003882
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CUTANEOUS ULCERATION IN LEGS/ NICORANDIL AND CUTANEOUS ULCERATION,leg ulcer,LEG ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10068310,10040943,10068310
INTESTINAL DISTENSION,Abdominal distension,ABDOMINAL DISTENSION,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10000060
HAIR LOSS,Alopecia,HAIR LOSS,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10019045,10001760,10019045
PATIENT WAS ADMINISTERED DEXAMETHASONE FOR FETAL LUNG MATURITY (OFF LABEL FOR INDICATION) AND MISOPROSTOL WAS USED FOR LABOUR INDUCTION IN PREGNANCY (OFF LABEL USE FOR INDICATION AND POPULATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ADMINISTRATION TO THE PREGNANT PATIENT,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
CYANOSIS,Cyanosis,CYANOSIS,CYANOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10011703,10011703,10011703
MASSIVE CEREBRAL HEMORRHAGE/LARGE LEFT HEMISPHERE INTRAPARENCHYMAL HEMORRHAGE WITH MIDLINE SHIFT TO THE RIGHT,Cerebral haemorrhage,CEREBRAL HEMORRHAGE,CEREBRAL HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008111,10008111,10008114
ASPERGILLUS TERREUS INFECTION,Aspergillus infection,ASPERGILLUS INFECTION,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10074171,10074171,10074171
WIDESPREAD RASH,Rash generalised,WIDESPREAD RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10047984,10037858,10047984
TACHYARRHYTHMIA COULD HAVE BEEN EXACERBATED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
CENTRAL NECROSIS FOLLOWING CEREBRAL PHAEOHYPHOMYCOSIS CAUSED BY CLADOPHIALOPHORA BANTIANA,Central nervous system necrosis,CENTRAL NERVOUS SYSTEM NECROSIS,CENTRAL NERVOUS SYSTEM NECROSIS,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10065784,10065784,10065784
ALANINE AMINOTRANSFERASE LEVEL INCREASED (90 IU/L),Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
FUNGAL MYOCARDITIS WITH FIBRINOUS FUNGAL PERICARDITIS,Pericarditis fungal,PERICARDITIS FUNGAL,PERICARDITIS FUNGAL,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10065220,10065220,10065220
GAIT IMBALANCE FOLLOWING METRONIDAZOLE TOXICITY AND OFF LABEL USE,gait abnormal,GAIT ABNORMAL,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017573,10017577,10017573
ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
SMALL LEFT PLEURAL EFFUSION AND ASSOCIATED COLLAPSE/CONSOLIDATION,Pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
INCREASING PAIN,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
DIAPHORESIS,Hyperhidrosis,DIAPHORESIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042670,10020642,10012703
USE OF KETOCONAZOLE FOR TESTOSTOXICOSIS,Use of ketoconazole for testostoxicosis,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
IMPAIRED LIVER FUNCTION,impaired liver function,IMPAIRED LIVER FUNCTION,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10021520,10019670,10021520
IMATINIB-RESISTANT CML,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
MALLORY-WEISS SYNDROME,Mallory-Weiss syndrome,MALLORY-WEISS SYNDROME,MALLORY-WEISS SYNDROME,GASTROINTESTINAL HAEMORRHAGES NEC,GASTRIC AND OESOPHAGEAL HAEMORRHAGES,10017947,10026712,10026712,10026712
PURPURIC RASH,Purpuric rash,PURPURIC RASH,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037566,10037549,10037566
B CELL COUNT DECREASED,B-lymphocyte count decreased,B-LYMPHOCYTE COUNT DECREASED,B-LYMPHOCYTE COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10051313,10051313,10051313
SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
IATROGENIC METRORRHAGIA DUE TO CONCOMITANT USE OF ITRACONAZOLE AND SIMVASTATIN,Metrorrhagia,METRORRHAGIA,METRORRHAGIA,MENSTRUAL CYCLE AND UTERINE BLEEDING DISORDERS,MENSTRUATION AND UTERINE BLEEDING NEC,10038604,10027514,10027514,10027514
REFRACTORY ACUTE GOUT WAS INEFFECTIVE TO COLCHICINE TREATMENT (LACK OF DRUG EFFECT WITH NO ADR),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
URINARY RETENTION,Urinary retention,URINARY RETENTION,URINARY RETENTION,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046555,10046555,10046555
AST INCREASED -1066 U/ L,Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
MEDICATION-RELATED OSTEONECROSIS OF THE JAW STAGE 3 ([MANDIBLE (QUADRANT III)],osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
USE OF INTRAVENOUS DHE EXACERBATED THE CEREBRAL VASOCONSTRICTION THAT WAS ALREADY PRESENT/DEVELOPING MULTIFOCAL CEREBRAL HEMORRHAGES AND DIFFUSE CEREBRAL VASCULOPATHY RELATED TO WORSENING RCVS,Reversible cerebral vasoconstriction syndrome,REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME,REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS NEC,10029205,10073240,10073240,10073240
PARAPLEGIC DUE TO INTRATHECAL SPINAL ABSCESSES DUE TO CANDIDA ALBICANS,Paraplegia,PARAPLEGIA,PARAPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10033892,10033892,10033892
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HAD FLU ANYWAY AND EVEN WORSE (REFERENCE TO DEGREE OF FLU),Influenza like illness,FLU LIKE SYMPTOMS,INFLUENZA LIKE ILLNESS,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10016791,10022004,10016791
DIFFUSE ERYTHEMA,Erythema,ERYTHEMA DIFFUSE,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015159,10015150,10015159
ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
FLUCTUATING CONSCIOUSNESS,Consciousness fluctuating,CONSCIOUSNESS FLUCTUATING,CONSCIOUSNESS FLUCTUATING,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10050093,10050093,10050093
HIGH FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
"DRY, NONPRODUCTIVE COUGH",cough,DRY COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10013773,10011224,10013773
ANION GAP INCREASED,Anion gap increased,ANION GAP INCREASED,ANION GAP INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10002528,10002528,10002528
TOXIC PERIPHERAL POLYNEUROPATHY,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
FINE TREMOR OF BILATERAL UPPER EXTREMITIES BOTH AT REST,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
SWELLING OF HER FACE AND LIMBS,Peripheral swelling,SWELLING OF LIMBS,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042702,10048959,10042702
ULCERS,Ulcer,ULCER,ULCER,TISSUE DISORDERS NEC,ULCERS NEC,10018065,10045285,10045285,10045285
INCOMPLETE EFFECT (LACK OF COOPERATION),Therapeutic response decreased,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10043414,10043414,10043414
PALE,Pallor,PALE,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033546,10033546,10033532
TORSADE DE POINTES FOLLOWING HYDROXYCHLOROQUINE TOXICITY AND INTERACTION WITH ONDANSETRON,Torsade de pointes,TORSADE DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044066
HYPERPHAGIA,Hyperphagia,HYPERPHAGIA,HYPERPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10020710,10020710,10020710
VITAMIN D DEFICIENCY,Vitamin D deficiency,VITAMIN D DEFICIENCY,VITAMIN D DEFICIENCY,VITAMIN RELATED DISORDERS,FAT SOLUBLE VITAMIN DEFICIENCIES AND DISORDERS,10027433,10047626,10047626,10047626
MILD ANEMIA,anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
ECHOCARDIOGRAPHY DEMONSTRATED  THROMBI ENLARGEMENT INVOLVING MORE THAN 50% OF LV CAVITY DUE TO HYPERCOAGULATION BY DESMOPRESSIN AND LACK OF EFFECT OF HEPARIN AND WARFARIN,Cardiac ventricular thrombosis,CARDIAC VENTRICULAR THROMBOSIS,CARDIAC VENTRICULAR THROMBOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10053994,10053994,10053994
MOUTH ULCERS,mouth ulcer,MOUTH ULCER,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028033,10028034,10028033
"THE PATIENT CONTINUED TO HAVE CHEST DISCOMFORT DESPITE INTRAVENOUS NITROGLYCERIN, INTRAVENOUS HEPARIN, AND EPTIFIBATIDE BOLUS",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HYPONATREMIA (125 MEQ/L) FOLLOWING CAPILLARY LEAK SYNDROME,Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
PRODUCTIVE COUGH,Productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
"IMATINIB-INDUCED PSEUDOPORPHYRIA (ON THE DORSA OF BOTH HANDS AND, ON TWO OCCASIONS, ON HER LEGS)",Pseudoporphyria,PSEUDOPORPHYRIA,PSEUDOPORPHYRIA,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10037145,10037145,10037145
HYPONATRAEMIA ASSOCIATED WITH TRAMADOL,Hyponatraemia,HYPONATRAEMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021036
ACTIVITIES OF DAILY LIVING IMPAIRED,Activities of daily living impaired,ACTIVITIES OF DAILY LIVING IMPAIRED,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10050954,10079487,10050954
ASYSTOLE,Cardiac arrest,ASYSTOLE,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10003586,10007515,10003586
CREATININE 2.49 MG/DL,Blood creatine increased,CREATINE INCREASED,BLOOD CREATINE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011333,10005464,10011333
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
HYPOTHYROIDISM,Hypothyroidism,HYPOTHYROIDISM,HYPOTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPOFUNCTION DISORDERS,10014698,10021114,10021114,10021114
MARKED PERIFOCAL EDEMA,brain edema,BRAIN EDEMA,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10006121,10048962,10006121
DRUG RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
EXTREME FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
NONBLEEDING SMALL GASTRIC ULCERS DUE TO CHRONIC GASTRITIS,Gastric ulcer,GASTRIC ULCER,GASTRIC ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,GASTRIC ULCERS AND PERFORATION,10017947,10017822,10017822,10017822
GAINED 8.6KG IN BODY WEIGHT,Weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
HEMOGLOBIN LOW,Haemoglobin decreased,HEMOGLOBIN LOW,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018889,10018884,10055600
RESPONDED POORLY TO QUESTIONS,Unresponsive to stimuli,UNRESPONSIVE TO VERBAL STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10063552,10045555,10063552
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SUSPECTED GI BLEEDING,Gastrointestinal haemorrhage,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017936
IMPAIRED GENERAL STATUS,Reduced general condition,REDUCED GENERAL CONDITION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10057364,10049438,10057364
KINASE DOMAIN MUTATION IN PDGFRALPHA CAUSING IMATINIB RESISTANCE,Chromosome analysis abnormal,CHROMOSOME ANALYSIS ABNORMAL,CHROMOSOME ANALYSIS ABNORMAL,CYTOGENETIC INVESTIGATIONS,CHROMOSOME ANALYSES,10022891,10008817,10008817,10008817
GRADE III IMMEDIATE-TYPE REACTION TO PROTON PUMP INHIBITORS,Immediate hypersensitivity reaction,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
ACUTE LIVER FAILURE,Acute hepatic failure,ACUTE LIVER FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10049844
HB LEVEL DECREASED TO 5.3 G/DL,Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
LABILE GLYCEMIC CONTROL,Blood glucose abnormal,BLOOD GLUCOSE ABNORMAL,BLOOD GLUCOSE ABNORMAL,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10005554,10005554,10005554
UNRESPONSIVE TO STANDARD IMMUNOMODULATORY TREATMENT (LACK OF DRUG EFFECT WITH NO ADVERSE REACTION),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
COMA,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
ELEVATED LACTATE DEHYDROGENASE LEVEL AT 458UL/L,Blood lactate dehydrogenase increased,LACTATE DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10023654,10005630,10023654
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
LACK OF EFFICACY (METFORMIN),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
EOSINOPHILIC GASTROENTERITIS,Gastroenteritis eosinophilic,GASTROENTERITIS EOSINOPHILIC,GASTROENTERITIS EOSINOPHILIC,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10017902,10017902,10017902
BACK PAIN,Back pain,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003988,10003988,10003988
MYCOPHENOLATE MOFETIL FOR SYSTEMIC LUPUS ERYTHEMATOSIS AND LUPUS CYSTITIS (OFF LABEL USE FOR INDICATION WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TRANSIENT RIGHT UPPER QUADRANT TENDERNESS TWO DAYS POST-INGESTION,Abdominal tenderness,ABDOMINAL TENDERNESS,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000097,10000097,10000097
INTOLERANCE TO HIGHER DOSE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
ANTICHOLINERGIC SIDE EFFECTS,Anticholinergic syndrome,ANTICHOLINERGIC SYNDROME,ANTICHOLINERGIC SYNDROME,NEUROMUSCULAR DISORDERS,AUTONOMIC NERVOUS SYSTEM DISORDERS,10029205,10002757,10002757,10002757
"SCALY PLAQUE LOCATED WITHIN THE FACE,UPPER CHEST, UPPER NECK, UPPER BACK AND ENTIRE UPPER LIMB",scales,SCALES,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10039518,10040844,10039518
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
ENDOCARDITIS,endocarditis,ENDOCARDITIS,ENDOCARDITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CARDIAC INFECTIONS,10021881,10014665,10014665,10014665
FEBRILE DYSPNEA,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
STOMATITIS,stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
BLOOD CREATININE INCREASED,Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
CONFUSION,confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
CEREBRAL OEDEMA,cerebral oedema,CEREBRAL OEDEMA,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10008127,10048962,10008127
MYOPATHIC SYMPTOMS/IMMUNE-MEDIATED NECROTISING MYOPATHY,Immune-mediated necrotising myopathy,IMMUNE-MEDIATED NECROTISING MYOPATHY,IMMUNE-MEDIATED NECROTISING MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10072155,10072155,10072155
EAR INFECTION,Ear Infection ,EAR INFECTION,EAR INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,EAR INFECTIONS,10021881,10014011,10014011,10014011
STATUS EPILEPTICUS FOLLOWING REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME,status epilepticus,STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10041962,10041962,10041962
GUILLAIN-BARRE SYNDROME,Guillain-Barre syndrome,GUILLAIN-BARRE SYNDROME,GUILLAIN-BARRE SYNDROME,PERIPHERAL NEUROPATHIES,ACUTE POLYNEUROPATHIES,10029205,10018767,10018767,10018767
GRADE 1 NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ELEVATED CRP,C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
RESPIRATORY INFECTIONS PERSISTED,Respiratory tract infection,RESPIRATORY INFECTION,RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10038700,10062352,10038700
"(WEEK 31 OF GESTATION),SHE WAS STARTED ON ENOXAPARIN AND ASPIRIN",Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
"CUTANEOUS ULCERATION ON FINGERS, TOES AND EAR",Skin ulcer,DIGITAL ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10072119,10040943,10072119
PALPITATION DUE TO POISONING ASSOCIATED WITH INAPPROPRIATE USE OF A EUTECTIC MIXTURE OF LIDOCAINE AND PRILOCAINE,Palpitation,PALPITATION,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033556,10033557,10033556
6 BOTTLES/DAY OF CODEINE COUGH SYRUP,chronic overdose,CHRONIC OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067696,10033295,10067696
"HARDENING AND FIBROSIS OF TISSUES SURROUNDING NECROTIC ULCERS THAT LATER EXTENDED UPTO EXTIRE RIGHT ARM, DISTAL HALF OF LEFT LEG, DORSAL PART OF ANKLE AND FOOT",Skin fibrosis,SKIN FIBROSIS,SKIN FIBROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10050207,10050207,10050207
PROSTATE ADENOCARCINOMA,Prostate cancer,ADENOCARCINOMA OF PROSTATE,PROSTATE CANCER,REPRODUCTIVE NEOPLASMS MALE MALIGNANT AND UNSPECIFIED,PROSTATIC NEOPLASMS MALIGNANT,10029104,10001186,10060862,10001186
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
CHRONIC HEPATITIS CAUSED BY HEPATITIS E VIRUS,Chronic hepatitis,CHRONIC HEPATITIS,CHRONIC HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10008909,10008909,10008909
HYPONATRAEMIA,hyponatraemia,HYPONATRAEMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021036
OFLOXACIN PHOTOSENSITIVITY,Photosensitivity,PHOTOSENSITIVITY,PHOTOSENSITIVITY REACTION,EPIDERMAL AND DERMAL CONDITIONS,PHOTOSENSITIVITY AND PHOTODERMATOSIS CONDITIONS,10040785,10034966,10034972,10034966
NEUTROPHILS DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
MARKED ANAEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
CONDITIONS WORSENED DUE TO ONSET OF CHEST PAIN AND DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
CARDIOEMBOLIC STROKE/ SECOND CARDIOEMBOLIC STROKE,Cardioembolic stroke,CARDIOEMBOLIC STROKE,EMBOLIC STROKE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10067816,10014498,10067816
PERSONALITY CHANGES,Personality change,PERSONALITY CHANGE,PERSONALITY CHANGE,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10034719,10034719,10034719
NT-PROBNP MARGINALLY RAISED AT 401NG/L,BNP increased,BNP INCREASED,BRAIN NATRIURETIC PEPTIDE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10068001,10053405,10068001
HIGH-LEVEL VIREMIA,BK virus infection,BK VIRUS INFECTION,BK VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10055181,10055181,10055181
LACK OF EFFICACY- PERSISTING SIGNIFICANT HYPERCHOLESTEROLAEMIA,Familial hypercholesterolemia,FAMILIAL HYPERCHOLESTEROLEMIA,TYPE IIA HYPERLIPIDAEMIA,METABOLIC AND NUTRITIONAL DISORDERS CONGENITAL,INBORN ERRORS OF LIPID METABOLISM,10010331,10054380,10045261,10054380
SUBJECTIVE FIDGETINESS WITH OBSERVABLE FINE TREMORS OF HANDS,Tremor of hands,TREMOR OF HANDS,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044577,10044565,10044577
UNABLE TO TOLERATE THE ERYTHROMYCIN,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
EMESIS,Vomiting,EMESIS,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10014542
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
LDH INCREASED (369 UNITS PER LITRE) DUE TO STEVENS JOHNSON SYNDROME,Blood lactate dehydrogenase increased,LDH INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10024051,10005630,10024051
GENERALIZED FLUSHING,Flushing,GENERALIZED FLUSHING,FLUSHING,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10018083,10016825,10062435
INCREASING WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
CAPECITABINE-INDUCED PARALYTIC ILEUS,capecitabine-induced paralytic ileus,PARALYTIC ILEUS,ILEUS PARALYTIC,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,NON-MECHANICAL ILEUS,10017947,10033841,10021333,10033841
HEART FAILURE,heart failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10019279,10007554,10019279
ACUTE AORTIC REGURGITATION,Aortic regurgitation,AORTIC REGURGITATION,AORTIC VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,AORTIC VALVULAR DISORDERS,10007541,10002904,10002915,10002904
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
TRANSIENT VISUAL DISTURBANCES,Visual impairment,VISUAL DISTURBANCES,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047543,10047571,10047545
PREGNANCY,Pregnancy,PREGNANCY,PREGNANCY,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS","NORMAL PREGNANCY, LABOUR AND DELIVERY",10036585,10036556,10036556,10036556
ELEVATED LIVER ENZYMES,Hepatic enzyme increased,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
STROKE,stroke,STROKE,CEREBROVASCULAR ACCIDENT,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10042244,10008190,10042244
EOSINOPHILS INCREASED (1.4 X 10E9/L),Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
POSTERIOR SYNECHIAE,Iris adhesions,SYNECHIAE POSTERIOR,IRIS ADHESIONS,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","IRIS AND CILIARY BODY STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10036367,10022945,10062785
HEMATOCRIT DECREASED (16.4%),Haematocrit decreased,HEMATOCRIT DECREASED,HAEMATOCRIT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018838,10018838,10019423
GCS DECREASED (11/15),Coma scale abnormal,GLASGOW COMA SCALE ABNORMAL,COMA SCALE ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10058466,10069709,10058466
PULSELESS ELECTRICAL ACTIVITY ARREST,Pulseless electrical activity,PULSELESS ELECTRICAL ACTIVITY,PULSELESS ELECTRICAL ACTIVITY,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10058151,10058151,10058151
OBLITERATIVE BRONCHIOLITIS,Obliterative bronchiolitis,OBLITERATIVE BRONCHIOLITIS,OBLITERATIVE BRONCHIOLITIS,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10029888,10029888,10029888
ABDOMINAL DISTENSION WORSENED,abdominal distension,ABDOMINAL DISTENSION,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10000060
CONDITION AGGRAVATED,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DIFFUSE ADENOVIRUS ENDOTHELIITIS IN ALL ORGANS,Adenovirus infection,ADENOVIRUS INFECTION,ADENOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,ADENOVIRAL INFECTIONS,10021881,10060931,10060931,10060931
MYCOTIC ANEURYSM OF THE ABDOMINAL AORTA,mycotic aneurysm of the abdominal aorta,MYCOTIC ANEURYSM,INFECTIVE ANEURYSM,INFECTIONS - PATHOGEN UNSPECIFIED,VASCULAR INFECTIONS,10021881,10028517,10058017,10028517
EGD REVEALED AN ESOPHAGEAL ULCER AT THE UPPER THORACIC ESOPHAGUS,Oesophageal ulcer,ESOPHAGEAL ULCER,OESOPHAGEAL ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,OESOPHAGEAL ULCERS AND PERFORATION,10017947,10030201,10030201,10015451
PROPRANOLOL USED IN ADULT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CERVICAL EDEMA,Edema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014210,10030095,10014210
INSOMNIA,Insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
RENAL INSUFFICIENCY,renal insufficiency,RENAL INSUFFICIENCY,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038474,10038435,10038474
SPLENOMEGALY,Splenomegaly,SPLENOMEGALY,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041660,10041660,10041660
DIFFICULTY IN WALKING,Difficulty in walking,DIFFICULTY IN WALKING,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10012794,10017577,10012794
ALT INCREASED (152 IU/L),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
ATRIAL FIBRILLATION,Atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
PATIENT WAS MILDLY RESPONSIVE TO THERAPY,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
ABSCESS IN HIS ANTERIOR MEDIASTINUM THAT EXTENDED FROM MEDIAN TO LEFT PARAMEDIAN AREA,Mediastinal abscess,ABSCESS OF MEDIASTINUM,MEDIASTINAL ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10027070,10027070,10000303
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
"ASYMPTOMATIC HYPERKALEMIA CAUSED BY DRUG-DRUG INTERACTION BETWEEN CO-TRIMOXAZOLE AND SACUBITRIL/VALSARTAN AND COMBINED EFFECT OF IBUPROFEN, EPLERENONE AND CARVEDILOL",Hyperkalaemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020646,10020646,10020647
INCREASED SKIN SENSITIVITY,Increased skin sensitivity,INCREASED SKIN SENSITIVITY,HYPERAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10021681,10020568,10021681
SERUM CREATININE INCREASED (13.2 MG/DL),Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
D-PACE WAS INITIATED WITH PARTIAL RESPONSE,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PROPRANOLOL USED FOR ATRIAL FIBRILLATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS CAUSED BY CARBAMAZEPINE/SYNDROME OF INAPPROPRIATE ANTIDIURESIS,SIADH,SIADH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,POSTERIOR PITUITARY DISORDERS,10014698,10040626,10053198,10040626
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
FEVER OF 37.7Â° C,fever chills,FEVER CHILLS,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016559,10037660,10016559
SYMPTOMATIC HYPOTENSION,Hypotension symptomatic,HYPOTENSION SYMPTOMATIC,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021105,10021097,10021105
FONSECAEA PEDROSOI CUTANEOUS INFECTION,Fungal skin infection,FUNGAL SKIN INFECTION,FUNGAL SKIN INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017543,10017543,10017543
WEAKNESS,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
DECUBITUS OF LOWER EXTREMITIES AND OS SACRUM,Decubitus ulcer,DECUBITUS,DECUBITUS ULCER,EPIDERMAL AND DERMAL CONDITIONS,SKIN INJURIES AND MECHANICAL DERMATOSES,10040785,10036651,10011985,10011983
SMALL FOR GESTATIONAL AGE,Small for gestational age,SMALL FOR GESTATIONAL AGE,SMALL FOR DATES BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10041093,10041092,10041093
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DIRECT BILIRUBIN 0.3 TO 4.5 MG/DL,Bilirubin conjugated increased,DIRECT BILIRUBIN INCREASED,BILIRUBIN CONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10013038,10004685,10013038
REVERSIBLE EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,Epstein-Barr virus associated lymphoproliferative disorder,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10068349,10068349,10068349
BLOOD PRESSURE HIGH,Hypertension,BLOOD PRESSURE HIGH,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10005747
DEPIGMENTATION OF FUNDI,retinal depigmentation,RETINAL DEPIGMENTATION,RETINAL DEPIGMENTATION,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10038846,10038846,10038846
GRADUALLY INCREASING RIGHT HIP/GROIN PAIN,Pain in hip,PAIN IN HIP,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10033432,10003239,10033432
HALLUCINATIONS,Hallucination,HALLUCINATIONS,HALLUCINATION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019063,10019063,10019077
ACUTE INFLAMMATORY SYNDROME WITH ELEVATED PROCALCITONIN,Systemic inflammatory response syndrome,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10051379,10051379,10051379
POLYURIA,Polyuria,POLYURIA,POLYURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY TRACT SIGNS AND SYMPTOMS NEC,10038359,10036142,10036142,10036142
ANEMIC WITH A HAEMOGLOBIN OF 62,Anaemia,ANEMIC,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002088,10002034,10060559
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ANGIOEDEMA,angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
MUSCLE WEAKNESS,Muscle weakness,MUSCLE WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028350,10028372,10028350
OLANZAPINE-INDUCED PHOTOALLERGIC REACTION,photosensitivity reaction,PHOTOSENSITIVITY ALLERGIC REACTION,PHOTOSENSITIVITY REACTION,EPIDERMAL AND DERMAL CONDITIONS,PHOTOSENSITIVITY AND PHOTODERMATOSIS CONDITIONS,10040785,10034970,10034972,10034970
DYSPNEA,Dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
ERYTHEMA,erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
FIXED THROMBUS MEASURING 1.8 Ã— 1.12 CM2 IN THE APICAL PART OF THE LEFT VENTRICLE,Thrombus,THROMBUS,THROMBOSIS,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10080924,10043607,10080924
LICHENOID DRUG ERUPTION,drug eruption,DRUG ERUPTION,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10013687,10013687,10013687
CUSHING'S SYNDROME,Cushing's syndrome,CUSHING'S SYNDROME,CUSHING'S SYNDROME,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011652,10011652,10011652
TONSILLITIS,tonsillitis,TONSILLITIS,TONSILLITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10044008,10044008,10044008
SOPOR,Sopor,SOPOR,SOPOR,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10058709,10058709,10058709
HYPOMAGNAESAEMIC,Hypomagnesaemia,HYPOMAGNESAEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021027,10021027,10021027
"THE PATIENT WAS EXPOSED TO PREDNISOLONE, DILTIAZEM HYDROCHLORIDE, ACETYLSALICYLIC ACID, LISINOPRIL DURING PREGNANCY (DRUG EXPOSURE DURING PREGNANCY) WITH NO ADR",Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
LOW BACKACHE,Back pain,LOW BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10024891,10003988,10024891
"FACIAL DYSMORPHISM WAS NOTED INCLUDING NASAL HYPOPLASIA, A DEPRESSED DEPRESSED NASAL BRIDGE WITH A DEEP GROOVE BETWEEN THE ALAE NASI AND NASAL TIP",Dysmorphism,FACIAL DYSMORPHISM,DYSMORPHISM,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL DISORDERS CONGENITAL NEC,10010331,10016045,10066054,10016045
"APPLICATION SITE OEDEMA (UPPER LEG) WHICH EXPANDED UP TO KNEE DURING THE NEXT DAY. THE SKIN WAS WARM, PARTIALLY RED.",Vaccination site reaction,VACCINATION SITE REACTION,VACCINATION SITE REACTION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10059080,10059080,10059080
VENTRICULAR ARRHYTHMIA,ventricular arrhythmia,VENTRICULAR ARRHYTHMIA,VENTRICULAR ARRHYTHMIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047281,10047281,10047281
DRUG INTERACTIONS MAY HAVE CONTRIBUTED TOWARDS THE SUSPECTED TOXICITY OF ACYCLOVIR BECAUSE OF INTERACTION OF ACYCLOVIR WITH MYCOPHENOLATE MOFETIL AND TACROLIMUS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
NEUROLEPTIC MALIGNANT SYNDROME DEVELOPING AFTER 6 MONTHS OF TREATMENT INITIATION,Neuroleptic malignant syndrome,NEUROLEPTIC MALIGNANT SYNDROME,NEUROLEPTIC MALIGNANT SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10029282,10029282,10029282
UREMIA,uremia,UREMIA,AZOTAEMIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE COMPLICATIONS,10038359,10046369,10003885,10046369
BK VIRUS NEPHROPATHY,Polyomavirus-associated nephropathy,BK VIRUS NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065333,10065381,10065333
NO CLINICAL RESPONSE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ABDOMINAL DISTENSION,Abdominal distension,ABDOMINAL DISTENSION,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10000060
PROGRESSIVE WORSENING IN ABSENCE OF BENEFICAL EFFECT - PATIENT DIED DUE TO RESPIIRATORY,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
HUMAN POISON EXPOSURE CASE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
CHROMOBACTERIUM VIOLACEUM /DISEASE PROGRESSED,Bacterial infection,BACTERIAL INFECTION,BACTERIAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10060945,10060945,10060945
CYANOCOBALAMIN ADMINISTERED FOR VASOPLEGIC SYNDROME (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RESPIRATORY COMPENSATED METABOLIC ACIDOSIS WITH HYPOXEMIA,Hypoxia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021141,10021143,10021142
SEVERE HEPARIN-INDUCED THROMBOCYTOPENIA (HIT),Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
ELEVATED LIVER ENZYMES,Hepatic enzyme increased,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
ABSENT COUGH REFLEX WITH A GCS OF 3,Areflexia,ABSENT REFLEX,AREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10003084,10003084,10000338
SGOT (109U/L),Aspartate aminotransferase increased,SGOT INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10040524,10003481,10040524
THROMBUS IN THE APEX OF THE LEFT VENTRICLE FORMED DESPITE DUAL ANTIPLATELET THERAPY AND LMWH TREATMENT (LACK OF DRUG EFFECT) WITH NO REPORTED ADR,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HYPERAMMONAEMIA,Hyperammonaemia,HYPERAMMONAEMIA,HYPERAMMONAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020575,10020575,10020575
"PYODERMA GANGRENOSUM TREATED WITH PREDNISOLONE, CYCLOSPORINE, DAPSONE, INTRAVENOUS IMMUNOGLOBULIN AND CLOBETASOL AND THERE WAS NO BENEFIT AFTER TREATMENT FOR 4 MONTHS (LACK OF DRUG EFFECT WITH NO ADR)",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
"OFF LABEL USE (MYOPHENOLATE MOFETIL, METHOTREXATE AND ANTITHUMOGLOBULIN FOR INDICATION, FLUDARABINE FOR AGE AND INDICATION)",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BLOOD PRESSURE DROPPED TO 90/50 MMHG,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
EPISODE OF GASTROINTESTINAL BLEEDING,gastrointestinal bleeding,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017936,10017955,10017936
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
CERVICAL LYMPH NODES WERE STILL FOUND,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
GENERAL MALAISE,general malaise,GENERAL MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10018066,10025482,10018066
QTC PROLONGATION/ PROLONGATION OF THE CORRECTED QT (QTC) INTERVAL,Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10014383,10014387,10014383
PATIENT HAD A SYMPTOMATIC IMPROVEMENT BUT FAILED TO TOLERATE TREATMENT,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
TORSADE DE POINTES,torsade de pointes,TORSADE DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044066
AF REFRACTORY TO AMIODARONE,Atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
CONDITION WORSENED FOLLOWING LACK OF DRUG EFFECT,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
BULLAE ON RIGHT LEG,Blister,BULLAE,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006554,10005191,10006554
ANAEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
LEFT MORE THAN RIGHT APPENDICULAR ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
"AT 48 HOURS, 96 HOURS AND 1 WEEK READINGS INTRADERMAL TEST FOR DALTEPARIN, NADROPARIN, BEMIPARIN AND ENOXAPARIN WER POSITIVE",allergy test positive,ALLERGY TEST POSITIVE,ALLERGY TEST POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOLOGY ANALYSES NEC,10022891,10056352,10056352,10056352
COMPLEMENT FACTOR C4 DECREASED (4 MG PER DL),Complement factor C4 decreased,COMPLEMENT FACTOR C4 DECREASED,COMPLEMENT FACTOR C4 DECREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNE RESPONSE PROTEIN ANALYSES NEC,10022891,10050983,10050983,10050983
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
SLEEPINESS,Sleepiness,SLEEPINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041014,10041349,10041014
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
ERYTHEMATOVESICULAR RASH -- PHOTOSENSITIVITY,Solar dermatitis,SOLAR ERYTHEMA,SOLAR DERMATITIS,EPIDERMAL AND DERMAL CONDITIONS,PHOTOSENSITIVITY AND PHOTODERMATOSIS CONDITIONS,10040785,10072196,10041303,10072196
DRUG HYPERSENSITIVITY REACTIONS,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
HYPOTENSION FOLLOWING EXPOSURE TO TOXIC AGENT,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
DIABETIC KETOACIDOSIS FOLLOWING PANCREATIC INSUFFICIENCY,diabetic ketoacidosis,DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEC,10027433,10012671,10012671,10012671
BLEEDING OESOPHAGEAL ULCER,Oesophageal ulcer haemorrhage,BLEEDING OESOPHAGEAL ULCER,OESOPHAGEAL ULCER HAEMORRHAGE,GASTROINTESTINAL ULCERATION AND PERFORATION,OESOPHAGEAL ULCERS AND PERFORATION,10017947,10030202,10030202,10055967
CLINICAL SIGNS OF PREMATURE AGING,Premature ageing,PREMATURE AGING,PREMATURE AGEING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10063493,10063493,10054804
CRYPTOGENIC ORGANISING PNEUMONIA,cryptogenic organising pneumonia,CRYPTOGENIC ORGANISING PNEUMONIA,ORGANISING PNEUMONIA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10066396,10067472,10066396
BROMOCRIPTINE-RESISTANT PROLACTINOMAS,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
DIARRHEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
GASTRIC FISTULA,Gastric fistula,GASTRIC FISTULA,GASTRIC FISTULA,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL FISTULAE,10017947,10065713,10065713,10065713
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
BLOOD PRESSURE DECREASED,Blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
"SEVERE ANXIETY,DELUSIONS, HALLUCINATIONS",Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
PARACETAMOL OVER DOSAGE IN THIRD TRIMESTER OF PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HEPATIC BLEEDING FOLLOWING SUBCAPSULAR HAEMATOMA/LARGE LIVER HAEMATOMA,Hepatic bleeding,HEPATIC BLEEDING,HEPATIC HAEMORRHAGE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10071821,10019677,10071821
"PANCYTOPENIA (NEUTOPHILS 0.10 X 10E09/L, PLATELETS OF 55 X 10E09/L AND SEVERE ANEMIA AT 8.9 G/DL)",Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
DIFFUSE DEPOSITION OF INTRATUBULAR CALCIUM OXALATES,Calcinosis,DEPOSIT CALCIUM,CALCINOSIS,TISSUE DISORDERS NEC,TROPHIC DISORDERS,10018065,10006958,10006938,10012367
PROPRANOLOL USED FOR ATRIAL FIBRILLATION,Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
PATIENT WITH ANTI-P200 BULLOUS PEMPHIGOID HAD A NEW EPISODE OF BLISTERING ON REDUCING THE DOSE PREDNISONE,Pemphigoid,BULLOUS PEMPHIGOID,PEMPHIGOID,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006567,10034277,10006567
DIABETIC KETOACIDOSIS,Diabetic ketoacidosis,DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEC,10027433,10012671,10012671,10012671
"MINOR HAEMORRHAGE, HAEMATOMA AND ECCHYMOSIS ON THE LEFT ABDOMINAL WALL",Intra-abdominal haemorrhage,INTRA-ABDOMINAL HAEMORRHAGE,INTRA-ABDOMINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10061249,10061249,10061249
RECURRENT EPISODES OF BILATERAL IRITIS,iritis,IRITIS,IRITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10022955,10022955,10022955
CHEST TIGHTNESS,Chest discomfort,CHEST TIGHTNESS,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008492,10008469,10008492
DECREASE IN HBA1C FROM THE PREVIOUS YEAR WITH A MINIMUM VALUE OF 6.7% WAS FOLLOWED BY REPEATED PROGRESSION UP TO 8.4,HbA1C decreased,HBA1C DECREASED,GLYCOSYLATED HAEMOGLOBIN DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10052425,10018482,10052425
MILD TENDERNESS IN THE TIPS OF FINGERS AND TOES,Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
HAEMATOMA OF LEFT FOREARM,haematoma of left forearm,HAEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10018852
FRECKLE LIKE HYPERPIGMENTED LESIONS ON NECK AND CHEEKS,Ephelides,FRECKLES,EPHELIDES,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10017338,10014970,10017338
DROWSINESS,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
MILD BUT PAINFUL SWELLING WAS NOTED IN THE RIGHT KNEE JOINT,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
CONDYLOMA EXCISION,condyloma excision,CONDYLOMA EXCISION,PAPILLOMA EXCISION,SKIN AND SUBCUTANEOUS TISSUE THERAPEUTIC PROCEDURES,SKIN LESION EXCISIONS,10042613,10058447,10033714,10058447
GENERAL MALAISE,general malaise,GENERAL MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10018066,10025482,10018066
CARDIAC FAILURE CHRONIC AGGRAVATED,Cardiac failure chronic,CARDIAC FAILURE CHRONIC AGGRAVATED,CARDIAC FAILURE CHRONIC,HEART FAILURES,HEART FAILURES NEC,10007541,10066498,10007558,10066498
WORSENING OF COCCIDIOIDAL INFECTION/COCCIDIOIDOMYCOSIS DUE TO ART INDUCED INFLAMMATORY REACTION LEADING TO IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,Coccidioidomycosis,COCCIDIOIDOMYCOSIS,COCCIDIOIDOMYCOSIS,FUNGAL INFECTIOUS DISORDERS,COCCIDIOIDES INFECTIONS,10021881,10009825,10009825,10009825
CONDITION WORSENED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
MACULOPATHY,Maculopathy,MACULA ABNORMALITY,MACULOPATHY,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10025397,10025425,10025397
"LEFT RENAL, SUPERIOR MESENTERIC AND SPLENIC ARTERIAL OCCLUSIONS",Splenic infarction,SPLENIC INFARCTION,SPLENIC INFARCTION,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041648,10041648,10041648
STAPHYLOCOCCUS EPIDERMIDIS INFECTION,Staphylococcus epidermidis infection,STAPHYLOCOCCUS EPIDERMIDIS INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10054154,10058080,10054154
HEPATITIS E VIRUS INFECTION (GENOTYPE 3C),Hepatitis E,HEPATITIS E,HEPATITIS E,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10019768,10019768,10019768
COLOURFUL VIVID TIRING AND UNPLEASANT DREAMS/ VIVID DREAMS,Vivid dreams,VIVID DREAMS,ABNORMAL DREAMS,SLEEP DISORDERS AND DISTURBANCES,PARASOMNIAS,10037175,10047666,10000125,10047666
MACROPROTEINURIA,Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
HAEMATEMESIS,Haematemesis,HAEMATEMESIS,HAEMATEMESIS,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018830,10018830,10018830
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
GRADE 3 FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
ANTIBIOTIC DRUG SHOWED TO BE WITHOUT EFFECT,Therapy non-responder,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
GLOMERULAR FUNCTION DECREASED,Glomerular filtration rate decreased,GLOMERULAR FILTRATION RATE DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018358,10018358,10018358
EOSINOPHILIA,Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
OFF-LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CONDITION AGGRAVATED,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
CUSHINGOID FEATURES,Cushingoid,CUSHINGOID,CUSHINGOID,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011655,10011655,10011655
VORICONAZOLE-INDUCED SEVERE PERIOSTITIS DEFORMANS,Periostitis Deformans,PERIOSTITIS,PERIOSTITIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10034551,10034551,10034551
PROGRESSIVE SYMMETRIC PERIPHERAL EDEMA OF BOTH LOWER AND UPPER EXTREMITIES,peripheral oedema,PERIPHERAL OEDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10034611,10030124,10034611
EMBOLIC STROKE,embolic stroke,EMBOLIC STROKE,EMBOLIC STROKE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10014498,10014498,10014498
HAEMATEMESIS,Haematemesis,HAEMATEMESIS,HAEMATEMESIS,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018830,10018830,10018830
"HYPERLEUKOCYTOSIS WITH 12,300/MM3",hyperleukocytosis,HYPERLEUKOCYTOSIS,HYPERLEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10078862,10078862,10078862
"I HAD, YOU KNOW, GRUMBLING PAINS ALL THE TIME IN YOUR STOMACH.",stomach pain,STOMACH PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10042112,10000087,10042112
CUNNINGHAMELLA PULMONARY MUCORMYCOSIS,Cunninghamella pulmonary mucormycosis,PULMONARY MUCORMYCOSIS,MUCORMYCOSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10078354,10028098,10078354
SERUM CREATININE INCREASED TO 0.9 MG/DL,Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
LACK OF DRUG EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
BLOOD PRESSURE WAS 142/90 MMHG/ DECLINED TO 132/84 MMHG,Blood pressure was 142/90 mmHg/ declined to 132/84 mmHg,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
RELAPSE OF WILM'S TUMOR,Nephroblastoma,WILMS TUMOR,NEPHROBLASTOMA,RENAL AND URINARY TRACT NEOPLASMS MALIGNANT AND UNSPECIFIED,RENAL NEOPLASMS MALIGNANT,10029104,10047986,10029145,10047985
COLLAPSED/UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
CYTOMEGALOVIRUS INFECTION,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011831,10011831,10011831
PERFORATION OF THE JEJUNUM FOLLOWING NECROSIS OF THE JEJUNUM,Intestinal perforation,INTESTINAL PERFORATION,INTESTINAL PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,INTESTINAL ULCERS AND PERFORATION NEC,10017947,10022694,10022694,10022694
DRUG ERUPTION,Drug eruption,DRUG ERUPTION,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10013687,10013687,10013687
LUNG CARCINOMA,Lung neoplasm malignant,LUNG CARCINOMA,LUNG NEOPLASM MALIGNANT,RESPIRATORY AND MEDIASTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,RESPIRATORY TRACT AND PLEURAL NEOPLASMS MALIGNANT CELL TYPE UNSPECIFIED NEC,10029104,10025044,10058467,10025064
FEBRILE,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
SEVERE SEPSIS WAS SUSPECTED,severe sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
CRYPTOCOCCAL INFECTION IN TRANSPLANT KIDNEY MANIFESTING AS CHRONIC ALLOGRAFT DYSFUNCTION,Transplant dysfunction,GRAFT DYSFUNCTION,TRANSPLANT DYSFUNCTION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10074860,10074860,10059677
AXONAL POLYNEUROPATHY FOLLOWING ENTEROVIRAL CNS INFECTION,Axonal neuropathy,AXONAL NEUROPATHY,AXONAL NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10003882,10003882,10003882
MONOGENIC AUTOINFLAMMATORY DISEASE,Autoinflammatory disease,AUTOINFLAMMATORY DISEASE,AUTOINFLAMMATORY DISEASE,IMMUNE DISORDERS NEC,AUTOINFLAMMATORY DISEASES,10021428,10072220,10072220,10072220
THE BABY HAD LOW BIRTH WEIGHT WHICH MIGHT BE ATTRIBUTED TO INTRAUTERINE PROPRANOLOL EXPOSURE,Low birth weight baby,LOW BIRTH WEIGHT BABY,LOW BIRTH WEIGHT BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10067508,10067508,10067508
ADJUSTMENT DISORDER,adjustment disorder,ADJUSTMENT DISORDER,ADJUSTMENT DISORDER,ADJUSTMENT DISORDERS (INCL SUBTYPES),ADJUSTMENT DISORDERS,10037175,10061621,10061621,10061621
SYMPTOMATIC HEPATITIS B VIRUS INFECTION,Acute hepatitis B,ACUTE HEPATITIS B,ACUTE HEPATITIS B,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10059193,10059193,10059193
MYOPATHY,Myopathy,MYOPATHY,MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10028641,10028641,10028641
THIGH PAIN,Pain in thigh,PAIN IN THIGH,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10048973,10033425,10048973
TOXIC LITHIUM LEVEL,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
HAEMORRHAGIC CYSTITIS,Haemorrhagic cystitis,HAEMORRHAGIC CYSTITIS,CYSTITIS HAEMORRHAGIC,BLADDER AND BLADDER NECK DISORDERS (EXCL CALCULI),BLADDER INFECTIONS AND INFLAMMATIONS,10038359,10055853,10011793,10055853
EATING LESS,Appetite impaired,APPETITE IMPAIRED,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003025,10061428,10003025
PRODUCT USE IN UNAPPROVED INDICATION,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
ECG ABNORMALITIES,ECG abnormalities non-specific,ECG ABNORMALITIES NON-SPECIFIC,ELECTROCARDIOGRAM ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10014090,10014363,10014090
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
STAGE 3 MEDICATION-RELATED OSTEONECROSIS OF THE JAW,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
ERYTHEMA,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
BRADY-ARRHYTHMIA,Bradyarrhythmia,BRADYARRHYTHMIA,BRADYARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10049765,10049765,10049765
FEVER (38.5 DEGREE CELSIUS),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PATIENT TAKES SEROPLEX FOR DORMANT BIPOLARITY,Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
ASCITES,ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
FAST DYSTONIAS ON HIS FACE (FACIAL GRIMACING),fast dystonias on his face (facial grimacing),GRIMACING,GRIMACING,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10061991,10061991,10061991
INAPPETENCE,Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
MOZOBIL WAS USED IN A HEALTHY DONOR (ALLOGENIC TRANSPLANTATION) INSTEAD OF FOR AUTOLOGOUS TRANSPLANTATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MUSCULOSKELETAL DISCOMFORT,Musculoskeletal discomfort,MUSCULOSKELETAL DISCOMFORT,MUSCULOSKELETAL DISCOMFORT,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10053156,10053156,10053156
ATYPICAL HEMOLYTIC UREMIC SYNDROME/ DRUG-INDUCED AHUS,Atypical haemolytic uraemic syndrome,ATYPICAL HEMOLYTIC UREMIC SYNDROME,ATYPICAL HAEMOLYTIC URAEMIC SYNDROME,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC MECHANICAL FACTOR,10005329,10079840,10079840,10079841
THE LESIONS HAD BEEN TREATED UNSUCCESSFULLY WITH MOMETASONE FUROATE CREAM/ LITTLE IMPROVEMENT HAD BEEN OBTAINED WITH MOMETASONE FUROATE CREAM,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
TROPONIN I 4.6 NG/ML (NORMAL <0.1),Troponin T increased,TROPONIN T INCREASED,TROPONIN T INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10058269,10058269,10058269
SMALL RIGHT PLEURAL EFFUSION,Pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
ABDOMINAL PAIN,abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
"DICLOFENAC USED FOR HEART FAILURE ALONG WITH DIURETICS, ANTIHYPERTENSIVES",Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
MUCOSITIS FOLLOWING METHOTREXATE INTOXICATION BECAUSE OF DRUG PRESCRIBING ERROR,mucositis following methotrexate intoxication because of drug prescribing error,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
FOCAL PARESIS,Paresis,PARESIS,PARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10033985,10033985,10033985
FEEDING DIFFICULTY,feeding difficulty,FEEDING DISORDER,FEEDING DISORDER,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10061148,10061148,10061148
DETERIORATION OF HEALTH,General physical health deterioration,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10049438,10049438,10049438
HYPERKALEMIA (6.3 MMOL/L),Potassium increased,POTASSIUM INCREASED,BLOOD POTASSIUM INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10036450,10005725,10036450
PERITONITIS FROM CORYNEBACTERIUM JEIKEIUM,Peritonitis,PERITONITIS,PERITONITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10034674,10034674,10034674
SLIGHT BONE MARROW SUPRESSION,Bone marrow disorder,BONE MARROW DISORDER,BONE MARROW DISORDER,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10061729,10061729,10061729
ALBUMINURIA (78.9 MG/GCR),Albuminuria,ALBUMINURIA,ALBUMINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10001580,10001580,10001580
CONFUSED,Confusional state,CONFUSED,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010298
ERYTHROCYTE SEDIMENTATION RATE MORE THANN 120 MM/H,Red blood cell sedimentation rate increased,ERYTHROCYTE SEDIMENTATION RATE HIGH,RED BLOOD CELL SEDIMENTATION RATE INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),HAEMATOLOGICAL ANALYSES NEC,10022891,10015262,10049187,10015262
LOST CONCIOUSNESS FOR FEW MINUTES,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
PATIENT DEVELOPED MYALGIA,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
"AFTER INITIAL IMPROVEMENT CASPOFUNGIN AND POSACONAZOLE WERE UNSUCCESSFUL IN IMPROVING SYMPTOMATOLOGY, LUNG FUNCTION AND DECREASING EXACERBATION FREQUENCY",Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
LEUCOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
DRUG-RESISTANT MULTIFOCAL EPILEPSY/CARBAMAZEPINE AND CLOBAZAM GAVE POOR RESULTS AND THE GIRL CONTINUED TO PRESENT VERY FREQUENT SEIZURES,Partial seizures,FOCAL SEIZURES,PARTIAL SEIZURES,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10016843,10061334,10016843
PNEUMOCYSTIS JIROVECI PNEUMONIA DUE TO LYMPHOPENIA,Pneumocystis jirovecii pneumonia,PNEUMOCYSTIS JIROVECI PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10073755,10073755,10064108
"ELEVATED AST (1284 U/L)/ AST 750 U/L, ALT 453 U/L/ ELEVATION OF TRANSAMINASES",Transaminases increased,TRANSAMINASE VALUE INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10044347,10054889,10044347
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
INSOMNIA,Insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
GRADE 2 MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
FLUDARABINE PHOSPHATE USED FOR 15-MONTH-BOY (OFF LABEL USE FOR UNAPPROVED INDICATION) LEADING TO GASTROPARESIS,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
CD44+/CD24 OR ALDH-1 EXPRESSION IN PRIMARY OR CUTANEOUS METASTATIC BREAST CANCER MAY BE ASSOCIATED WITH RAPID ONSET CHEMORESISTANCE,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
HYPERKALAEMIA,Hyperkalaemia,HYPERKALAEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020646,10020646,10020646
DUODENAL STRICTURE,Duodenal stricture,DUODENAL STRICTURE,DUODENAL STENOSIS,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,DUODENAL AND SMALL INTESTINAL STENOSIS AND OBSTRUCTION,10017947,10013834,10050094,10013834
ELEVATED AMINOTRANSFERASE LEVELS,Elevated Aminotransferase Levels,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
DIFFUSE LARGE B CELL NON-HODGKIN LYMPHOMA,Non-Hodgkin's lymphoma,NON-HODGKIN'S LYMPHOMA,NON-HODGKIN'S LYMPHOMA,LYMPHOMAS NON-HODGKIN'S UNSPECIFIED HISTOLOGY,NON-HODGKIN'S LYMPHOMAS NEC,10029104,10029547,10029547,10029547
MILD FORGETFULNESS,Memory impairment,FORGETFULNESS,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10017060,10027175,10017060
RHEUMATOID ARTHRITIS FLARE,Rheumatoid arthritis,RHEUMATOID ARTHRITIS FLARE UP,RHEUMATOID ARTHRITIS,JOINT DISORDERS,RHEUMATOID ARTHROPATHIES,10028395,10060732,10039073,10060732
PLACENTAL ABRUPTION AT 31 WEEKS OF GESTATIONAL AGE,Premature placental detachment,PREMATURE PLACENTAL DETACHMENT,PREMATURE SEPARATION OF PLACENTA,MATERNAL COMPLICATIONS OF PREGNANCY,HAEMORRHAGIC COMPLICATIONS OF PREGNANCY,10036585,10053595,10036608,10053595
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
"SERUM CREATININE CONCENTRATION WAS ELEVATED AT 1.2 MG/DL, UP FROMTHE BASELINE OF 0.4 MG/DL",Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
SOFT TISSUE DEBRIDEMENT,Debridement,DEBRIDEMENT,DEBRIDEMENT,THERAPEUTIC PROCEDURES AND SUPPORTIVE CARE NEC,THERAPEUTIC PROCEDURES NEC,10042613,10067806,10067806,10067806
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
"HOWEVER, MODERATE IMPROVEMENT OF SYMPTOMS WAS NOTICEABLE IN THE FOURTH WEEK",Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
ACUTE MUCOSITIS,mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
IDIOPATHIC THROMBOCYTOPENIC PURPURA,Idiopathic Thrombocytopenic Purpura,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IMMUNE THROMBOCYTOPENIC PURPURA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10021245,10074667,10021245
TACHYCARDIAC  (HEART RATE 115 BEATS/MIN),tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
GENERALISED MACULOPAPULAR RASH,Rash maculo-papular,GENERALISED MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10077181,10037868,10077181
INFECTIONS GRADE 3-4,Infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
FOCAL NODULAR HYPERPLASIA AFTER TREATMENT WITH OXALIPLATIN,Focal nodular hyperplasia,FOCAL NODULAR HYPERPLASIA,FOCAL NODULAR HYPERPLASIA,HEPATIC AND BILIARY NEOPLASMS BENIGN,HEPATOBILIARY NEOPLASMS BENIGN,10029104,10052285,10052285,10052285
REPEATED INFECTIONS,Infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
"NAUSEA, VOMITING, AGITATION",Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
UNRESPONSIVENESS,no therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
RACING THOUGHTS,Tachyphrenia,RACING THOUGHTS,TACHYPHRENIA,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10067192,10064805,10067192
MACULAR RASH,Rash macular,MACULAR RASH,RASH MACULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037867,10037867,10025418
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
PRETIBIAL OEDEMA,pretibial oedema,PRETIBIAL OEDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10059825,10030124,10059825
EXPERIENCED MORBILLIFORM ERUPTION WORSENING WITH EDEMA OF THE FACE AND NECK,Face edema,FACE EDEMA,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10016025,10016029,10016025
GRADE 2 HERPES ZOSTER,Herpes zoster,HERPES ZOSTER,HERPES ZOSTER,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10019974,10019974,10019974
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
"DESPITE ANTIFUNGAL COMBINATION THERAPY WITH VORICONAZOLE AND CASPOFUNGIN, THE PATIENT DIED 4 WEEKS AFTER TRANSPLANTATION",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
TRICHODYSPLASIA SPINULOSA-ASSOCIATED POLYOMAVIRUS INFECTION,Human polyomavirus infection,HUMAN POLYOMAVIRUS INFECTION,HUMAN POLYOMAVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10057366,10057366,10057366
GFR DECREASED (15-29 ML/MIN),Glomerular filtration rate decreased,GFR DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018214,10018358,10018214
ADMINISTRATION OF DUPILUMAB FOR EOSINOPHILIC ANNULAR ERYTHEMA (UNAPPROVED INDICATION)-OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PATIENT WAS TREATED WITH METHOTREXATE FOR ATOPIC DERMATITIS AND CONTACT DERMATITIS AND DUPILUMAB FOR CONTACT DERMATITIS (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CORTICO-INDUCED DIABETES,Diabetes mellitus,DIABETES STEROID-INDUCED,DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012628,10012601,10012628
HYPONATRAEMIA,Hyponatraemia,HYPONATRAEMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021036
RECEIVED OVERDOSE OF PARACETAMOL AND PREGABALIN (NOT PRESCRIBED),Intentional product misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
CARDIOTOXICITY OF IMMUNOSUPPRESSANTS,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
POSITIVE ANTI-NUCLEAR ANTIBODIES AT A TITRE OF 1 IN 640,Antinuclear antibody positive,ANTINUCLEAR ANTIBODY PRESENT,ANTINUCLEAR ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10060055,10060055,10002810
SHE WAS BED-RIDDEN,Bedridden,BEDRIDDEN,BEDRIDDEN,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10048948,10048948,10048948
"SHE DEVELOPED PALE STOOLS, WHICH PERSISTED FOR FOUR DAYS",Faeces pale,ACHOLIC STOOL,FAECES PALE,GASTROINTESTINAL SIGNS AND SYMPTOMS,FAECAL ABNORMALITIES NEC,10017947,10057077,10016102,10057077
PATIENT TREATED WITH IFOSFAMIDE FOR MALIGNANT METASTATIC RHABDOID TUMOR IN THE CRANIOVERTEBRAL JUNCTION (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG INTERACTION BETWEEN ASPIRIN AND PRASUGREL,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
LEFT VISION LOSS DUE TO CMV RETINITIS,Blindness unilateral,UNILATERAL BLINDNESS,BLINDNESS UNILATERAL,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10005186,10005186,10045528
"REFRACTORY TO MULTIPLE INCLUDING PHENYTOIN, CARBAMAZEPINE, VALPROATE, AND CLOBAZAM",Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
"KAPOSI'S SARCOMA/ HUMAN HERPESVIRUS 8 TUMOUR WITH VISCERAL INVOLVEMENT (GUT, PULMONARY AND UROGENITAL)",Kaposi's sarcoma,KAPOSI'S SARCOMA,KAPOSI'S SARCOMA,SOFT TISSUE NEOPLASMS MALIGNANT AND UNSPECIFIED,KAPOSI'S SARCOMAS,10029104,10023284,10023284,10023284
ON/ OPTIC NEURITIS,optic neuritis,OPTIC NEURITIS,OPTIC NEURITIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OPTIC NERVE DISORDERS NEC,10029205,10030942,10030942,10030942
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
THERAPY RELATED MYELODYSPLASIA,Myelodysplastic syndrome,MYELODYSPLASIA,MYELODYSPLASTIC SYNDROME,LEUKAEMIAS,MYELODYSPLASTIC SYNDROMES,10029104,10056275,10028533,10028532
HYPERCALCEMIA FOLLOWING PNEUMOCYSTIS JIROVECII PNEUMONIA,hypercalcemia following Pneumocystis jirovecii pneumonia,HYPERCALCEMIA,HYPERCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020587,10020583,10020587
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
INCREASED FATIGUE,fatigue aggravated,FATIGUE AGGRAVATED,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10048415,10016256,10048415
PANUVEITIS,panuveitis,PANUVEITIS,UVEITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10033687,10046851,10033687
HYPEREMIA,Hyperemia,HYPEREMIA,HYPERAEMIA,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10020619,10020565,10020619
CEREBRAL OEDEMA,Brain oedema,CEREBRAL OEDEMA,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10048962,10048962,10008127
MYOCLONUS,myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
PARATRACHEAL OEDEMA,Oedema,OEDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10030095
GRADE 1 HEPATIC DISORDER,Liver disorder,DISORDER HEPATIC,LIVER DISORDER,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10024670,10024670,10013228
LIMB THREATENING ARTERIAL THROMBOSIS DUE TO PROGRESSION OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS FOLLOWING INADEQUATE TREATMENT,Peripheral artery thrombosis,ARTERIAL THROMBOSIS LIMB,PERIPHERAL ARTERY THROMBOSIS,EMBOLISM AND THROMBOSIS,PERIPHERAL EMBOLISM AND THROMBOSIS,10047065,10003180,10072564,10003180
BRAIN ABSCESS,Brain abscess,BRAIN ABSCESS,BRAIN ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10006105,10006105,10006105
RED RASHES AROUND ABDOMEN AND BACK (WAIST AREA),Rash erythematous,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10037855
GENERALIZED WEAKNESS,weakness generalized,WEAKNESS GENERALIZED,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047865,10003549,10047865
SKIN LESION APPEARED ON THE RIGHT ARM,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
ACUTE ABDOMEN,Acute abdomen,ACUTE ABDOMEN,ACUTE ABDOMEN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10000647,10000647,10000647
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
LIMB PAIN/LEG PAIN,Pain in limb,PAIN IN LIMB,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033447,10033425,10033447
SIGNIFICANT WEIGHT GAIN,weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
ADMINISTRATION TO PREGNANT FEMALE,Exposure during pregnancy,EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10073513,10073513,10073513
GRADUAL DEVELOPMENT OF REDNESS AND BULLOUS FORMATION IN THE TRUNK AREA AND THE PROXIMAL PARTS OF THE UPPER AND LOWER EXTREMITIES,Dermatitis bullous,BULLOUS DISORDER,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006558,10012441,10006558
PARAESTHESIA,Paraesthesia,PARAESTHESIA,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10033775,10033775,10033775
LIVER FUNCTION DISORDER,Hepatic function abnormal,HEPATIC FUNCTION ABNORMAL,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019670,10019670,10019670
INTERMEDIATE RESISTANCE TO VANCOMYCIN,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
PAIN AND BLURRY VISION IN THE RIGHT EYE,Eye pain,EYE PAIN,EYE PAIN,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10015958,10015958,10015958
AN IRREGULAR PULSE,an irregular pulse,IRREGULAR PULSE,HEART RATE IRREGULAR,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10022994,10019304,10022994
PERIFOCAL EDEMA,Brain oedema,BRAIN EDEMA,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10048962,10048962,10006121
SHOCK,shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
REBOUND EFFECT OF PREDNISOLONE,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
DEVELOPED LEFT SIDED OTALGIA,otalgia,OTALGIA,EAR PAIN,AURAL DISORDERS NEC,EAR DISORDERS NEC,10013993,10031304,10014020,10031304
"WHEN CALCULATING THE INITIAL BOLUS DOSE OF 150 MG/KG A DECIMAL POINT ERROR WAS MADE, RESULTING IN A 10-FOLD HIGHER DOSE THAN INTENDED (160 G INSTEAD OF 16 G)",drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
INCONSOLABLE BEHAVIOUR WITH ABNORMAL BEHAVIOUR,Abnormal behaviour,ABNORMAL BEHAVIOUR,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10061422,10061422,10061422
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
QUINCKE'S OEDEMA,Quincke's edema,QUINCKE'S EDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10037734,10002424,10037734
HYDROCHLOROTHIAZIDE SENSITIZED ACETAZOLAMIDE INDUCED BILATERAL ANGLE CLOSURE GLAUCOMA WITH CHOROIDAL DETACHMENT,Angle closure glaucoma,ANGLE CLOSURE GLAUCOMA,ANGLE CLOSURE GLAUCOMA,GLAUCOMA AND OCULAR HYPERTENSION,GLAUCOMAS (EXCL CONGENITAL),10015919,10002500,10002500,10002500
SERUM LACTATE 8.5MMOL/L/SERUM LACTATE REMAINED IMMEASURABLY HIGH/SERUM LACTATE ABOVE THE UPPER MEASURING LIMIT OF 30MMOL/L,lactate blood increased,LACTATE BLOOD INCREASED,BLOOD LACTIC ACID INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10023651,10005635,10023651
LOW-GRADE FEVER,pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
CHEMOTHERAPY-RELATED MULTI DRUG-RESISTANT,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
PATIENT WAS ADMINISTERED CISPLATIN AND METHOTREXATE FOR THE TREATMENT OF OLECRANON OSTEOSARCOMA (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NO AMELIORATION OF PAIN SYMPTOMS WAS OBSERVED,Drug ineffective,DRUG EFFECT LACK OF,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013684
TYPE 2 RENAL TUBULAR ACIDOSIS,renal tubular acidosis,RENAL TUBULAR ACIDOSIS,RENAL TUBULAR ACIDOSIS,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10038535,10038535,10038535
BRAIN DEATH FOLLOWING UNCAL HERNIATION,brain death,BRAIN DEATH,BRAIN DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10049054,10049054,10049054
EXACERBATION OF URTICARIA,Urticaria,URTICARIA AGGRAVATED,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046738,10046735,10046738
CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
RIGHT UPPER QUADRANT (RUQ) PAIN,Abdominal pain upper,RIGHT UPPER QUADRANT PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10039162,10000087,10039162
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
PATIENT TREATED WITH HYDROCORTISONE FOR HYPOTENSION (OFF LABEL USE FOR INDICATION) WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEPTIC SHOCK FOLLOWING ACUTE RENAL FAILURE DUE TO STAPHYLOCOCCAL SCALDED SKIN SYNDROME,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
INTOLERANCE OF HIGHER GABAPENTIN DOSES,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
METASTASES TO BONE,Metastases to bone,METASTASES TO BONE,METASTASES TO BONE,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027452,10027452,10027452
ANGINA,Angina pectoris,ANGINA PECTORIS,ANGINA PECTORIS,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10002383,10002383,10002383
PAIN IN LUMBAR SPINE,Pain in lumbar spine,PAIN IN LUMBAR SPINE,SPINAL PAIN,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10072009,10072005,10072009
SKIN RASH,rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
DRUG USE FOR UNAPPROVED INDICATION WITH NO ADR,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
SEVERE AND RECURRENT PROPRANOLOL-INDUCED HYPOGLYCAEMIA/HER SERUM GLUCOSE WAS 23MG/DL.,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
METABOLIC ENCEPHALOPATHY,metabolic encephalopathy,METABOLIC ENCEPHALOPATHY,METABOLIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10062190,10062190,10062190
PROGRESSIVELY EXTENSIVE MACULOPAPULAR EXANTHEMA,Maculo-papular exanthema,MACULO-PAPULAR EXANTHEMA,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10049195,10037868,10049195
ACUTE MYOCARDITIS,Acute myocarditis,ACUTE MYOCARDITIS,MYOCARDITIS,MYOCARDIAL DISORDERS,NONINFECTIOUS MYOCARDITIS,10007541,10000932,10028606,10000932
"PAIN,EPIPHORA AND PHOTOPHOBIA IN BOTH EYES SUGGESTING DEVELOPMENT OF CONJUCTIVTIS",Lacrimation increased,EPIPHORA,LACRIMATION INCREASED,EYE DISORDERS NEC,LACRIMATION DISORDERS,10015919,10015068,10023644,10015068
AMBLYOPIA IN LEFT EYE,amblyopia unilateral,AMBLYOPIA UNILATERAL,AMBLYOPIA,VISION DISORDERS,AMBLYOPIC VISION IMPAIRMENT,10015919,10065008,10001906,10065008
RECTAL HAEMORRHAGE,Rectal haemorrhage,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,INTESTINAL HAEMORRHAGES,10017947,10038063,10038063,10038063
ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
ARTERIAL BLOOD PRESSURE DECREASE/BLOOD PRESSURE DROPS TO 75/45 MM HG,Hypotension,BLOOD PRESSURE LOW,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10005753
SPONTANEOUS ERECTION AND EJACULATION,Spontaneous ejaculation,SPONTANEOUS EJACULATION,SPONTANEOUS EJACULATION,SEXUAL FUNCTION AND FERTILITY DISORDERS,ERECTION AND EJACULATION CONDITIONS AND DISORDERS,10038604,10074267,10074267,10074267
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
HYPERTONICITY,Hypertonia,HYPERTONICITY,HYPERTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10020859,10020852,10020859
AMNIOTIC FLUID VOLUME DECREASED,Amniotic fluid volume decreased,AMNIOTIC FLUID VOLUME DECREASED,AMNIOTIC FLUID VOLUME DECREASED,FOETAL AND NEONATAL INVESTIGATIONS,FOETAL AND NEONATAL DIAGNOSTIC PROCEDURES,10022891,10063356,10063356,10063356
GRADE 2 HYPERTENSIVE ANGIOPATHY,Grade 2 hypertensive angiopathy,HYPERTENSIVE ANGIOPATHY,HYPERTENSIVE ANGIOPATHY,VASCULAR HYPERTENSIVE DISORDERS,HYPERTENSION COMPLICATIONS,10047065,10059238,10059238,10059238
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEVERE DIARRHEAL EPISODES,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
SEIZURE,seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
HODGKIN-LIKE IMMUNOBLAST PROLIFERATION IN LYMH NODE,chronic lymphocytic leukemia transformation,CHRONIC LYMPHOCYTIC LEUKEMIA TRANSFORMATION,CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION,LEUKAEMIAS,LEUKAEMIAS CHRONIC LYMPHOCYTIC,10029104,10058723,10058717,10058723
HEART PALPITATION SENSATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
ELEVATED ESTRADIOL E2 (101 PG/ML),Oestradiol increased,ESTRADIOL INCREASED,OESTRADIOL INCREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),REPRODUCTIVE HORMONE ANALYSES,10022891,10030231,10030231,10015500
HEMODYNAMICALLY UNSTABLE,Hemodynamic instability,HEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10058270,10052076,10058270
SEIZURES,Seizures,SEIZURES,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039910,10039906,10039910
OJ-AUTOANTIBODY JUVENILE DERMATOMYOSITIS TREATED WITH METHOTREXATE (OFF LABEL USE WITH NO ADVERSE EVENT),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"PRURITIC, WIDESPREAD ERUPTION",Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
HYPONATREMIA,Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
SUSPECTED GUILLAIN-BARRE SYNDROME,Guillain Barre syndrome,GUILLAIN BARRE SYNDROME,GUILLAIN-BARRE SYNDROME,PERIPHERAL NEUROPATHIES,ACUTE POLYNEUROPATHIES,10029205,10018766,10018767,10018766
LEUCOCYTOSIS IN HEMOGRAM,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
"DESPITE INITIAL RELIEF, THE PAIN NOT ONLY RECURRED, BUT ALSO BEGAN TO WORSEN, EVEN AS HER CARBAMAZEPINE DOSE WAS INCREASED SUBSTANTIALLY.",Pain,PAIN AGGRAVATED,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033396,10033371,10033376
PATIENT TREATD WITH MYCOPHENOLATE MOFETIL FOR ANTI-PD CHECKPOINT INHIBITOR-INDUCED HEPATOTOXICITY (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LIMITATION IN THE RANGE OF MOTION OF MAJOR JOINTS,Limitation in the range of motion of major joints,JOINT RANGE OF MOTION DECREASED,JOINT RANGE OF MOTION DECREASED,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10048706,10048706,10048706
PSORIASIS AND PEMPHIGUS FOLIACEUS AGGRAVATED BY ENALAPRIL AND AMLODIPINE INTAKE,Pemphigus,PEMPHIGUS FOLIACEUS,PEMPHIGUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10057069,10034280,10057069
BRADYPNEA,Bradypnoea,BRADYPNEA,BRADYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10006102,10006102,10006101
DRUG INDUCED PARKINSONISM,DRUG INDUCED PARKINSONISM,PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034010,10034010,10034010
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
PROGRESSIVE SWELLING AND DISCOLORATION OF HIS LLE,Oedema peripheral,LEG EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030109,10030124,10024127
SEVERELY AFFECTING HIS SPEECH,Speech disorder,SPEECH DISORDER,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041466,10041466,10041466
"PAINFUL WITH BRUISING LARGE LESION 5"" X 5"" STERILE ABSCESS",Injection site abscess sterile,INJECTION SITE ABSCESS STERILE,INJECTION SITE ABSCESS STERILE,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022045,10022045,10022045
NODULAR REGENERATIVE HYPERPLASIA (NRH),Nodular regenerative hyperplasia,NODULAR REGENERATIVE HYPERPLASIA,NODULAR REGENERATIVE HYPERPLASIA,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10051081,10051081,10051081
HE RECEIVED IAI WITH HYALURONIC ACID AND DID NOT BRING MUCH RELIEF,subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
CMV REACTIVATION,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION REACTIVATION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10058666,10011831,10058666
SUFFUSIONS AFTER SUBCONJUNCTIVAL APPLICATION,Hemorrhagic suffusion,HEMORRHAGIC SUFFUSION,EXTRAVASATION BLOOD,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10070284,10015867,10070284
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
CEREBRAL LESIONS,Central nervous system lesion,BRAIN LESION,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10067294,10051290,10067294
SEPTICEMIA,Septicemia,SEPTICEMIA,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040089,10040047,10040089
PROGRESSIVE RENAL FAILURE DUE TO METHOTREXATE TOXICITY,Renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) PNEUMONIA,methicillin-resistant Staphylococcus aureus (MRSA) pneumonia,METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS PNEUMONIA,PNEUMONIA STAPHYLOCOCCAL,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10058931,10035734,10058931
LIVER DISEASE,Liver disorder,HEPATIC DISEASE,LIVER DISORDER,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10019650,10024670,10019650
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
DRUG-INDUCED GINGIVAL OVERGROWTH,Gingival hypertrophy,GINGIVAL HYPERTROPHY,GINGIVAL HYPERTROPHY,DENTAL AND GINGIVAL CONDITIONS,GINGIVAL DISORDERS NEC,10017947,10018284,10018284,10018284
HAND/FOOT SYNDROME,Palmar-plantar erythrodysaesthesia syndrome,HAND AND FOOT SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10019111,10033553,10019111
DRUG ADDICTION,drug addiction,DRUG ADDICTION,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013658,10013663,10013658
HEPATOTOXICITY,hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
TOXIC VASODILATION,Vasodilatation,VASODILATATION,VASODILATATION,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047141,10047141,10047141
SEVERE HEPATITIS FOLLOWING HEMOPHAGOCYTIC SYNDROME DUE TO HERPES VIRUS INFECTION,Hepatitis,HEPATITIS,HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019717,10019717,10019717
PARACETAMOL AND OXYCODONE WAS NOT SUFFICIENT TO CONTROL HER ISCHEMIC AND NEUROPATHIC PAIN,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
DIFFICULTY SWALLOWING,Dysphagia,SWALLOWING DIFFICULT,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10042645,10013950,10042645
ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
"GENERALIZED ABDOMINAL PAIN, AND REBOUND AND TENDERNESS PREDOMINANTLY LOCATED AT THE RIGHT LOWER QUADRANT",Abdominal pain,ABDOMINAL PAIN GENERALISED,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000082,10000081,10000082
PRODUCT SUBSTITUTION ISSUE GENERIC TO BRAND,Product substitution issue generic to brand,PRODUCT SUBSTITUTION ISSUE GENERIC TO BRAND,PRODUCT SUBSTITUTION ISSUE,"PRODUCT QUALITY, SUPPLY, DISTRIBUTION, MANUFACTURING AND QUALITY SYSTEM ISSUES",PRODUCT QUALITY ISSUES NEC,10077536,10069337,10069326,10069337
HYPERTRIGLYCERIDEMIA,Hypertriglyceridaemia,HYPERTRIGLYCERIDEMIA,HYPERTRIGLYCERIDAEMIA,LIPID METABOLISM DISORDERS,ELEVATED TRIGLYCERIDES,10027433,10020869,10020869,10020870
DYSARTHRIA,Dysarthria,DYSARTHRIA,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10013887,10013887,10013887
CARDIAC ANEURYSM,Cardiac aneurysm,VENTRICULAR ANEURYSM,CARDIAC ANEURYSM,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10047280,10007513,10047280
A WIDESPREAD ITCHY MACULOPAPULAR RASH,Rash pruritic,ITCHY RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10023092
PAINFULL STIFFNESS IN THE NECK,Musculoskeletal stiffness,NECK STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10028843,10052904,10028843
INFLAMMATORY INFILTRATION CONSISTED PRIMARILY OF LYMPHOCYTES WITH A FEW SCATTERED EOSINOPHILS,Hepatic lymphocytic infiltration,HEPATIC LYMPHOCYTIC INFILTRATION,HEPATIC LYMPHOCYTIC INFILTRATION,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10079686,10079686,10079686
HYPOXEMIA,hypoxemia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021142,10021143,10021142
PULSUS ALTERNANS WAS OBSERVED IN RADIAL ARTERIAL PRESSURE,Pulse abnormal,PULSUS ALTERNANS,PULSE ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10037498,10037466,10037498
PATIENT RECEIVED HIGH-DOSE METHYLPREDNISOLONE AGAIN WITHOUT IMPROVEMENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
OLMESARTAN MEDOXOMIL-INDUCED PHOTOSENSITIVITY,photosensitivity,PHOTOSENSITIVITY,PHOTOSENSITIVITY REACTION,EPIDERMAL AND DERMAL CONDITIONS,PHOTOSENSITIVITY AND PHOTODERMATOSIS CONDITIONS,10040785,10034966,10034972,10034966
NASOPHARYNGITIS,nasopharyngitis,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10028810,10028810,10028810
BLOODSHOT EYES,bloodshot eyes,BLOODSHOT EYE,OCULAR HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10005871,10030041,10005871
INTENTIONALLY INGESTED 90 TABLETS IBUPROFEN/ PATIENT WAS ADMITTED TO ICU 3.5 H AFTER SUICIDAL INGESTION OF 90 ABLETS IBUPROFEN 800MG PER TABLET,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
OFF LABEL USE,OFF LABEL USE,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NONHEALING PAINFUL ULCERS,Ulceration tongue,ULCERATION TONGUE,TONGUE ULCERATION,TONGUE CONDITIONS,TONGUE DISORDERS,10017947,10045358,10043991,10045358
"PARTIAL RESPONSE TO CLOBETASOL PROPIONATE, DOXYCYCLINE AND PREDNISONE",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
LACK OF CLINICAL RESPONSE TO NSAIDS,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
REFRACTORY GRAFT VERSUS HOST DISEASE,No therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
PARESTHESIA,Paraesthesia,PARESTHESIA,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10033775,10033775,10033987
REPORTEDLY EXPERIENCED NO BENEFIT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
"ADMISSIONS WITH VENTRICULAR TACHYCARDIA REQUIRING DC CARDIOVERSION DESPITE THE EMPIRICAL USE OF AMIODARONE, SOTALOL, DISOPYRAMIDE AND PROCAINAMIDE",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HEALTH DETERIORATION,General physical health deterioration,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10049438,10049438,10049438
"HOMOGENEOUS, DIFFUSE, BLUE-BROWN PIGMENTATION ON THE HARD PALATE","homogeneous, diffuse, blue-brown pigmentation on the hard palate",PALATAL PIGMENTATION,ORAL PIGMENTATION,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SIGNS AND SYMPTOMS,10017947,10077553,10077552,10077553
NO ADVERSE DRUG REACTION,no adverse drug reaction,NO ADVERSE DRUG REACTION,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067481,10067482,10067481
ELEVATED TOTAL BILIRUBIN LEVELS (38.4 MICRO MOL/L),Blood bilirubin increased,BILIRUBIN TOTAL INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056806,10005364,10056806
DRUG EXPOSURE IN UTERO,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
CARDIAC FAILURE,Cardiac failure,CARDIAC FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10007554,10007554,10007554
SELF MEDICATION AND DRUG ABUSE,drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
ITCHING,Pruritus,ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023084,10037087,10023084
DEHYDRATION,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
SECONDARY ACUTE MYELOID LEUKEMIA,Treatment related acute myeloid leukemia,TREATMENT RELATED ACUTE MYELOID LEUKEMIA,ACUTE MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10066353,10000880,10066353
"NON-HIV, NON-NATALIZUMAB, PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY",Progressive multifocal leukoencephalopathy,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10036807,10036807,10036807
HEPATIC CYTOLYSIS,Hepatic cytolysis,HEPATIC CYTOLYSIS,HEPATOCELLULAR INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10049199,10019837,10049199
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PANCOLITIS TYPE ACUTE ULCERATIVE COLITIS,Colitis ulcerative,ACUTE ULCERATIVE COLITIS,COLITIS ULCERATIVE,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10066678,10009900,10066678
CARDIAC ARREST,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
INTRACRANIAL HEMORRHAGE/INTRACEREBRAL HEMORRHAGE,Cerebral haemorrhage,INTRACEREBRAL HEMORRHAGE,CEREBRAL HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10022737,10008111,10022754
OLIGURIA,Oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
BLURRY VISION,blurry vision,BLURRY VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10005889,10047513,10005889
SEIZURE,seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
E. COLI BACTEREMIA,Escherichia bacteraemia,ESCHERICHIA COLI BACTEREMIA,ESCHERICHIA BACTERAEMIA,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10054258,10054258,10054279
ELECTROLYTE ABNORMALITY,Electrolyte imbalance,ELECTROLYTE ABNORMALITY,ELECTROLYTE IMBALANCE,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10014410,10014418,10014410
ULCER WITH ENTIRE CIRCUMFERENCE OF STENOSIS IN TERMINAL ILEUM,Rectal stenosis,RECTAL STENOSIS,RECTAL STENOSIS,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,ANAL AND RECTAL STENOSIS AND OBSTRUCTION,10017947,10038079,10038079,10038079
DRUG RESISTANCE,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
GASTRIC PERFORATION INDUCED BY NAPROXEN USE FOLLOWED BY SHORT TERM HIGH DOSE DEXAMETHASONE,gastric perforation,GASTRIC PERFORATION,GASTRIC PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,GASTRIC ULCERS AND PERFORATION,10017947,10017815,10017815,10017815
PROXIMAL MYOPATHY,Myopathy,PROXIMAL MYOPATHY,MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10037078,10028641,10037078
DIFFICULTY IN SWALLOWING,Dysphagia,SWALLOWING DIFFICULT,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10042645,10013950,10042645
WRONG PATIENT RECEIVED MEDICATION,Wrong patient received medication,WRONG PATIENT RECEIVED MEDICATION,WRONG PATIENT RECEIVED MEDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10048056,10048056,10048056
PROSTATITIS (ELEVATED PROSTATE-SPECIFIC ANTIGEN [PSA] AND A FIRM NODULE),Prostatitis,PROSTATITIS,PROSTATITIS,MALE REPRODUCTIVE TRACT INFECTIONS AND INFLAMMATIONS,PROSTATE AND SEMINAL VESICLES INFECTIONS AND INFLAMMATIONS,10038604,10036978,10036978,10036978
MATERNAL EXPOSURE TO THE ANTIHYPERTENSIVE DRUG LOSARTAN DURING WEEKS 20-31 OF PREGNANCY,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
PH DECREASED (6.8),pH decreased ,PH DECREASED,BLOOD PH DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10034778,10005706,10034778
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
POSITIVITY OF LUPUS ANTI NUCLEAR ANTIBODY (ANA) TEST,Antinuclear antibody positive,ANA POSITIVE,ANTINUCLEAR ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10002031,10060055,10060060
LESIONS ON HIS HEAD AND CHEST,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
SEDATION EXCESSIVE,Sedation excessive,SEDATION EXCESSIVE,SEDATION COMPLICATION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,ANAESTHETIC AND ALLIED PROCEDURAL COMPLICATIONS,10022117,10039898,10079741,10039898
VISUAL HALLUCINATIONS,visual hallucinations,VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10047570,10019075,10047570
DIGESTIVE INTOLERANCE,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
MYELITIS,myelitis,MYELITIS,MYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10028524,10028524,10028524
GRADE 3 OR SEVERER NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ABNORMAL BEHAVIOUR,Abnormal behaviour,ABNORMAL BEHAVIOUR,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10061422,10061422,10061422
INCREASED HEART RATE,Heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
FEBRILE,Febrile reaction,FEBRILE REACTION,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016289,10037660,10016289
UNRESPONSIVE TO EPINEPHRINE AND PHENYLEPHRINE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
VERY INTENSIVE YAWNING/INTENSE YAWNING,yawning excessive,YAWNING EXCESSIVE,YAWNING,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10048233,10048232,10048233
CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
PESISTENT DECREASE IN MAGNESIUM LEVEL TO AS LOW AS 0.8MG/DL,Hypomagnesaemia,HYPOMAGNESEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021027,10021027,10021028
BLEEDING,Haemorrhage,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10005103
GENERAL FATIGUE,Fatigue,FATIGABILITY GENERALIZED,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10073917,10016256,10016253
HEAD TRAUMA,Head injury,HEAD INJURY,HEAD INJURY,INJURIES NEC,SITE SPECIFIC INJURIES NEC,10022117,10019196,10019196,10019196
SUSTAINED VENTRICULAR TACHYCARDIA,sustained ventricular tachycardia,SUSTAINED VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10060730,10047302,10060730
MULTIFOCAL CONFLUENT MYOCARDIAL INFARCTION WITH LEFT VENTRICULAR DYSFUNCTION AND ACUTE ISCHEMIC LESIONS,Myocardial infarction,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10028596,10028596,10028596
LIVE BIRTH,Live birth,LIVE BIRTH,LIVE BIRTH,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS","NORMAL PREGNANCY, LABOUR AND DELIVERY",10036585,10049550,10049550,10049550
CUSHING'S DISEASE,Pituitary-dependent Cushing's syndrome,CUSHING'S DISEASE,PITUITARY-DEPENDENT CUSHING'S SYNDROME,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPERFUNCTION,10014698,10011651,10035109,10011651
ACUTE LEG PAIN/ ACUTE PAIN IN RIGHT LEG,Pain in extremity,LEG PAIN,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033473,10033425,10024130
PATIENT TREATED WITH CYCLOPHOSPHAMIDE AND METHOTREXATE FOR ANTERIOR UVEITIS DUE TO SARCOIDOSIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SPLENOMEGALY (MAXIMUM DIAMETER OF 16 CM),Splenomegaly,SPLENOMEGALY,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041660,10041660,10041660
UNDERWENT UNNECESSARY MEDICATION ADMINISTRATION,Medication error,MEDICATION ERROR,MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10027091,10027091,10027091
LABORATORY TEST ABNORMAL,Laboratory test abnormal,LABORATORY TEST ABNORMAL,LABORATORY TEST ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",INVESTIGATIONS NEC,10022891,10023547,10023547,10023547
ELEVATED LIVER FUNCTION TESTS,Hepatic enzyme increased,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
COMMUNITY ACQUIRED CLOSTRIDIUM DIFFICILE INFECTION,Clostridium difficile infection,CLOSTRIDIUM DIFFICILE INFECTION,CLOSTRIDIUM DIFFICILE INFECTION,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10054236,10054236,10054236
COGNITIVE IMPAIRMENT INDUCED BY BENZODIAZEPINE USE DISORDER,Cognitive disorder,COGNITIVE IMPAIRMENT,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10057668,10057668,10009846
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
SECONDARY MALIGNANCY (OROPHARYNGEAL),Oropharyngeal cancer,OROPHARYNGEAL CANCER,OROPHARYNGEAL CANCER,RESPIRATORY AND MEDIASTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,"OROPHARYNGEAL, NASOPHARYNGEAL AND TONSILLAR NEOPLASMS MALIGNANT AND UNSPECIFIED",10029104,10031096,10031096,10031096
AFTER VOLUNTARILY INGESTING 3000MG OF PROPAFENONE,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
INTERMINTTENT PARESTHESIA,Paraesthesia,PARESTHESIA,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10033775,10033775,10033987
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
RECTUS SHEATH HEMATOMA/ RECTUS SHEATH HEMATOMA (BERNU TYPE I),Abdominal wall haematoma,RECTUS SHEATH HEMATOMA,ABDOMINAL WALL HAEMATOMA,ABDOMINAL HERNIAS AND OTHER ABDOMINAL WALL CONDITIONS,ABDOMINAL WALL CONDITIONS NEC,10017947,10071751,10067383,10071749
LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
HYPERALGESIA,Hyperalgesia,HYPERALGESIA,HYPERAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10020573,10020568,10020573
LEFT LEG WEAKNESS AND NUMBNESS,Hypoaesthesia,NUMBNESS,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10029829,10020937,10029829
VENTRICULAR FIBRILLATION FOLLOWED BY BRADYCARDIA,bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
DAILY BLOOD GLUCOSE FLUCTUATIONS,Blood glucose fluctuation,BLOOD GLUCOSE FLUCTUATION,BLOOD GLUCOSE FLUCTUATION,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10049803,10049803,10049803
TRICHOPHYTON,Trichophytosis,TRICHOPHYTON INFECTION,TRICHOPHYTOSIS,FUNGAL INFECTIOUS DISORDERS,TINEA INFECTIONS,10021881,10061388,10067409,10061388
KLEBSIELLA PNEUMONIA FOLLOWING MULTI-DRUG RESISTANCE,Klebsiella pneumoniae infection,KLEBSIELLA PNEUMONIAE INFECTION,KLEBSIELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10052209,10061259,10052209
ERYSIPELAS,Erysipelas,ERYSIPELAS,ERYSIPELAS,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10015145,10015145,10015145
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SUICIDE ATTEMPT,Suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
RESPIRATORY DISTRESS DURING SLEEP,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
METRONIDAZOLE-INDUCED ENCEPHALOPATHY,Toxic encephalopathy,DRUG-INDUCED ENCEPHALOPATHY,TOXIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10049035,10044221,10049035
DELAYED-ONSET HEPARIN-INDUCED THROMBOCYTOPENIA,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
MICROGRAPHIA,micrographia,MICROGRAPHIA,MICROGRAPHIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10057333,10057333,10057333
MILD ANEMIA,Anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
BEHAVIORAL CHANGES,Abnormal behaviour ,ABNORMAL BEHAVIOUR,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10061422,10061422,10061422
ATRIAL SEPTAL DEFECT,Atrial septal defect,ATRIAL SEPTAL DEFECT,ATRIAL SEPTAL DEFECT,CARDIAC AND VASCULAR DISORDERS CONGENITAL,CARDIAC SEPTAL DEFECTS CONGENITAL,10010331,10003664,10003664,10003664
APLASIA CUTIS CONGENITA FOLLOWING EXPOSURE TO METHIMAZOLE IN UTERO,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
BRAIN WEIGHED 1220 G AND WAS SLIGHTLY EDEMATOUS,Brain oedema,BRAIN OEDEMA,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10048962,10048962,10048962
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
OVERT OBSCURE GASTROINTESTINAL BLEEDING (OGIB),Gastrointestinal haemorrhage,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017936
SEVERE AZOTEMIA,azotemia,AZOTEMIA,AZOTAEMIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE COMPLICATIONS,10038359,10003886,10003885,10003886
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
IT WAS NOT HELPING/OCCASIONAL ORBICULAR TWITCHING,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
LEFT ANKLE PAIN,Arthralgia,PAIN ANKLE,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10033420,10003239,10033379
SEROMA CLASSIFIED SURGICAL WOUND INFECTION WITH ESCHERICHIA COLI,Surgical wound infection,SURGICAL WOUND INFECTION,POSTOPERATIVE WOUND INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10053562,10036410,10053562
PHONOPHOBIA,Phonophobia,PHONOPHOBIA,PHONOPHOBIA,ANXIETY DISORDERS AND SYMPTOMS,FEAR SYMPTOMS AND PHOBIC DISORDERS (INCL SOCIAL PHOBIA),10037175,10054956,10054956,10054956
UNABLE TO WALK AND PRESENTED IN A WHEELCHAIR,unable to walk,UNABLE TO WALK,GAIT INABILITY,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10049278,10017581,10049278
RESTLESSNESS,restlessness,RESTLESSNESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038743,10038743,10038743
DRUG ADMINISTRATION ERROR,Drug administration error,DRUG ADMINISTRATION ERROR,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064295,10064295,10064295
CARDIAC MUSCLE REPOLARIZATION DISORDER,electrocardiogram repolarisation abnormality,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10052464,10052464,10052464
ACUTE HYPOXIC RESPIRATORY FAILURE SECONDARY TO SEVERE PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN,hypoxic respiratory failure,HYPOXIC RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10074615,10038695,10074615
CYCLOPHOSPHAMIDE USED FOR TREATMENT OF SARCOIDOSIS,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
PNEUMOPERITONEUM FOLLOWING HSV COLITIS AND INTESTINAL PERFORATION,pneumoperitoneum,PNEUMOPERITONEUM,PNEUMOPERITONEUM,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10048299,10048299,10048299
FULL-BODY RASH,Rash generalised,RASH ALL OVER,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037858,10037858,10037848
POSSIBLE SEPTIC SHOCK AS PER MAH'S ASSESSMENT,Possible septic shock as per MAH's assessment,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
OVERALL EFFECT OF CIA ON QUALITY OF LIFE IS PRESUMED TO BE NEGATIVE,Impaired quality of life,IMPAIRED QUALITY OF LIFE,IMPAIRED QUALITY OF LIFE,LIFESTYLE ISSUES,SOCIAL ISSUES NEC,10041244,10076936,10076936,10076936
TRAUMA,Trauma,TRAUMA,INJURY,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10044461,10022116,10044461
WRIST TENOSYNOVITIS CAUSED BY MYCOBACTERIUM KANSASII,Mycobacterium kansasii infection,MYCOBACTERIUM KANSASII INFECTION,MYCOBACTERIUM KANSASII INFECTION,MYCOBACTERIAL INFECTIOUS DISORDERS,ATYPICAL MYCOBACTERIAL INFECTIONS,10021881,10028447,10028447,10028447
RENAL FAILURE ACUTE ON CHRONIC,Acute kidney injury,RENAL FAILURE ACUTE ON CHRONIC,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038440,10069339,10038440
PATIENT WAS TREATED WITH ACETAZOLAMIDE FOR HEADACHE (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ACUTE MYELOID LEUKEMIA,Acute myeloid leukaemia,ACUTE MYELOID LEUKEMIA,ACUTE MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10000880,10000880,10000886
ALPRAZOLAM ABUSE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
OSTEOMYELITIS,Osteomyelitis,OSTEOMYELITIS,OSTEOMYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,BONE AND JOINT INFECTIONS,10021881,10031252,10031252,10031252
IMMEDIATE ALLERGIC REACTION TO AMOXICILLIN,Immediate hypersensitivity reaction,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
DRUG INDUCED CHOLESTASIS AND CVM INFECTION,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
CONFUSION FOLLOWING BISMUTH SUBSALICYLATE OVERDOSE,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
DECREASED SLEEP,Insomnia,SLEEP DECREASED,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10040982,10022437,10040982
LIVER DECOMPENSATION,Hepatic failure,HEPATIC DECOMPENSATION,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10076894,10019663,10076894
DISEASE RELAPSE,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
LEVOFLOXACIN-INDUCED COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome,COMPLEX REGIONAL PAIN SYNDROME,COMPLEX REGIONAL PAIN SYNDROME,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10064332,10064332,10064332
ST ELEVATIONS,Electrocardiogram ST segment elevation,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10014392,10014392,10014392
ACUTE CARDIAC FAILURE DUE TO STEVENS-JOHNSON SYNDROME,cardiac failure acute,CARDIAC FAILURE ACUTE,CARDIAC FAILURE ACUTE,HEART FAILURES,HEART FAILURES NEC,10007541,10007556,10007556,10007556
CONJUNCTIVA HYPEREMIA FOLLOWING NEVIRAPINE INDUCED TOXIC EPIDERMAL NECROLYSIS,Conjunctival hyperaemia,HYPEREMIA OF CONJUNCTIVA,CONJUNCTIVAL HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CONJUNCTIVAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10051625,10051625,10020621
QUETIAPINE INDUCED CATATONIA,Catatonia,CATATONIA,CATATONIA,CHANGES IN PHYSICAL ACTIVITY,DECREASED PHYSICAL ACTIVITY LEVELS,10037175,10007776,10007776,10007776
"PATIENT TREATED WITH URSODEOXYCHOLIC ACID,  WHICH DID NOT LED TO SUSTAINED IMPROVEMENT OF PRURITUS",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
"FACIAL, PERIORBITAL, UPPER AND LOWER LIMB OEDEMA",edema limbs,EDEMA LIMBS,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10050068,10030124,10050068
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ALKALINE PHOSPHATASE INCREASED,Blood alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
SEVERE HYPERNATREMIA,Hypokalaemia,HYPOKALAEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021015
CHRONIC LOPERAMIDE OVERDOSE OF 200 TO 400 MG PER DAY,Overdose,CHRONIC OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067696,10033295,10067696
ITCHY EYES,Eye pruritus,ITCHY EYES,EYE PRURITUS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10015947,10052140,10023090
INTERACTION BETWEEN AMIODARONE AND DIGOXIN,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
GRADE 3 ENCEPHALOPATHY,encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
OLIGURIA,Oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
"THE PRESCRIPTION, WHICH SHOULD HAVE BEEN ENTERED AS 1 TABLET OF FUROSEMIDE 40 MG, WAS ERRONEOUSLY ENTERED AS 4 TABLETS OF FUROSEMIDE 40 MG, AND THE PATIENT TOOK 4 TABLETS.",Drug prescribing error,DRUG PRESCRIBING ERROR,DRUG PRESCRIBING ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT PRESCRIBING ERRORS AND ISSUES,10022117,10064296,10064296,10064296
SEVERE HEPATITIS,Hepatitis,HEPATITIS,HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019717,10019717,10019717
VERY EARLY LOSS OF AMBULATION IN SPITE OF THE USE OF STEROID,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
INTRAOCULAR PRESSURE WAS 9 MM HG IN THE RIGHT EYE AND 10 MM HG IN THE LEFT EYE,Intraocular pressure decreased,INTRAOCULAR PRESSURE DECREASED,INTRAOCULAR PRESSURE DECREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",OPHTHALMIC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10022804,10022804,10022804
AGRANULOCYTOPENIA,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
PEPTIC ULCER,Peptic ulcer,PEPTIC ULCER,PEPTIC ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,PEPTIC ULCERS AND PERFORATION,10017947,10034341,10034341,10034341
SBP IN THE 40'S,Blood pressure systolic decreased,BLOOD PRESSURE SYSTOLIC LOW,BLOOD PRESSURE SYSTOLIC DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005763,10005758,10005763
HYPERTENSIVE CRISIS,Hypertensive crisis,HYPERTENSIVE CRISIS,HYPERTENSIVE CRISIS,VASCULAR HYPERTENSIVE DISORDERS,ACCELERATED AND MALIGNANT HYPERTENSION,10047065,10020802,10020802,10020802
OLIGURIA,Oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
SYMPTOMS OF DEPRESSIVE DISORDER WITH LOW SELF-ESTEEM,Depressive disorder,DEPRESSIVE DISORDER,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012399,10012378,10012399
GENERALISED TONIC CLONIC SEIZURE FOLLOWING DRUG OVERDOSE,generalised tonic clonic seizure,GENERALISED TONIC-CLONIC SEIZURE,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10018100,10018100,10018100
MILD DIVERTICULOSIS,Mild diverticulosis,DIVERTICULOSIS,DIVERTICULUM,DIVERTICULAR DISORDERS,DIVERTICULA,10017947,10013549,10013554,10013549
HBA1C LEVELS WORSENED (116 MMOL/MOL) FOLLOWING WORSENING DIABETES CONTROL,Glycosylated haemoglobin increased,HBA1C INCREASED,GLYCOSYLATED HAEMOGLOBIN INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10056186,10018484,10052424
GENE MUTATION,gene mutation,GENE MUTATION,GENE MUTATION,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,CHROMOSOMAL ABNORMALITIES NEC,10010331,10064571,10064571,10064571
DISSEMINATED NOCARDIA INFECTION,disseminated nocardia infection,NOCARDIA INFECTION,NOCARDIOSIS,BACTERIAL INFECTIOUS DISORDERS,NOCARDIA INFECTIONS,10021881,10064083,10029444,10064083
THORACIC RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
DROWSINESS,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
INAPPROPRIATE DOSING AND DRUG-DRUG INTERACTIONS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
BACTEREMIA FOLLOWING CMV ENCEPHALITIS,Bacteraemia,BACTEREMIA,BACTERAEMIA,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10003997,10003997,10003999
METHOTREXATE WAS NOT TOLERATED BY PATIENT DUE TO LIVER TOXICITY,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
ACUTE LIVER FAILURE,Acute hepatic failure,ACUTE LIVER FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10049844
TACHYPNOEA,Tachypnoea,TACHYPNOEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043089
SPO2 OF 93% ON 40% OXYGEN,Oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
PERSECUTION MANIA FOLLOWING MULTIPLE DRUG POISONING,Mania,MANIA,MANIA,MANIC AND BIPOLAR MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH MANIC SYMPTOMS,10037175,10026749,10026749,10026749
DRUG TOLERANCE,drug tolerance,DRUG TOLERANCE,DRUG TOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10052804,10052804,10052804
LACK OF EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
TRUNCAL ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
FOLLICULAR BRONCHIOLITIS,Interstitial lung disease,FOLLICULAR BRONCHIOLITIS,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10068805,10022611,10068805
LOSS OF SENSATION BELOW SIXTH THORACIC DERMATOME DUE TO INTRATHECAL SPINAL ABSCESSES DUE TO CANDIDA ALBICANS,Sensory loss,LOSS OF SENSATION,SENSORY LOSS,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10040030,10040030,10024874
HYPOKALEMIA,hypokalemia,HYPOKALEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021018,10021015,10021018
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
MYCOPHENOLATE MOFETIL USED FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE SECONDARY TO JUVENILE DERMATOMYOSITIS (OFF LABEL USE WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
EDEMA AND INTENSE PAIN AT THE LEVEL OF LARGE AND SMALL LABIA SUDDEN ONSET AND PROGRESSIVE AGGRAVATION,Aggravation of existing disorder,AGGRAVATION OF EXISTING DISORDER,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10001484,10010264,10001484
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
MOOD DISORDER,Affective disorder,MOOD DISORDER,AFFECTIVE DISORDER,MOOD DISORDERS AND DISTURBANCES NEC,MOOD DISORDERS NEC,10037175,10079614,10001443,10079614
PATIENT WAS TREATED WITH FLUOROURACIL FOR HIGH-GRADE PANCREATIC NEUROENDOCRINE NEOPLASMS WITH LIVER METASTASIS (DRUG USE FOR UNAPPROVED INDICATION) WITH NO ADVERSE EVENT,patient was treated with fluorouracil for high-grade pancreatic neuroendocrine neoplasms with liver metastasis (drug use for unapproved indication) with no adverse event,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
OFF LABEL USE (PROPOFOL AND REMIFENTANIL),Off label use (propofol and remifentanil),OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FLANK PAIN,flank pain,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10016750,10016750,10016750
"UNSATISFACTORY RESPONSE TO TETRACYCLINES (UNSPECIFIED), RIFAMPICIN, CLINDAMYCIN, TRIMETHOPRIM-COTRIMOXAZOLE, ERTAPENEM, LINEZOLID, ISOTRETINOIN AND ACITRETIN (SUB-THERAPEUTIC EFFECT WITHOUT ADVERSE EVENT REACTION)",Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
"IMPROVEMENTS IN WHITE BLOOD CELL COUNT TO 7850 ( 20,278)/ÎœL, CRP 5.7 ( 20. 3), BODY TEMPERATURE 37.0 ( 39.5)ÂºC, BUN 13.2 ( 28.7), AND CRE 0.94 ( 1.87) MG/DL",Blood creatine increased,CREATINE INCREASED,BLOOD CREATINE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011333,10005464,10011333
PARAOXYSMAL DIZZINESS,paraoxysmal dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
VIRAL INFECTION OR REACTIVATION,Infection reactivation,INFECTION REACTIVATION,INFECTION REACTIVATION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10070891,10070891,10070891
SIGNIFICANTLY WORSENING PANCYTOPENIA DUE TO MYELODYSPLASTIC SYNDROME,Pancytopenia,PANCYTOPENIA AGGRAVATED,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10048432,10033661,10048432
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
NO LONGER ABLE TO WALK DUE TO ESCALATING PAIN FROM THE SOLES OF HIS FEET,Walking difficulty,WALKING DIFFICULTY,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10047810,10017577,10047810
HYPERGLYCEMIA,Hyperglycaemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020639
95% OF DONOR CHIMERISM,Chimerism,CHIMERISM,CHIMERISM,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,CHROMOSOMAL ABNORMALITIES NEC,10010331,10068051,10068051,10068051
"BONE MARROW ASPIRATE AND BIOPSY DEMONSTRATED MEGALOBLASTOID MATURATION OF MYELOID SERIES, COMPATIBLE WITH THE HISTORY OF METHOTREXATE THERAPY AND NUMEROUS POLYCLONAL LYMPHOID AGGREGATES",Lymphadenopathy,LYMPHOID NODULE,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10063166,10025197,10063166
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PRESENTED WITH BILATERAL PHOTOPHOBIA,photophobia,PHOTOPHOBIA,PHOTOPHOBIA,OCULAR SENSORY SYMPTOMS NEC,OCULAR SENSATION DISORDERS,10015919,10034960,10034960,10034960
SKIN ERUPTION,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
PROGRESSIVE FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
PERIPHERAL SENSORY NEUROPATHY,Peripheral sensory neuropathy,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10034620,10034620,10034620
FEBRILE,febrile reaction,FEBRILE REACTION,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016289,10037660,10016289
LYMPHOCYTES 89.6%,Lymphocyte percentage increased,LYMPHOCYTE PERCENTAGE INCREASED,LYMPHOCYTE PERCENTAGE INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10052232,10052232,10052232
HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
AFEBRILE NEUROLEPTIC MALIGNANT SYNDROME,Neuroleptic malignant syndrome,NEUROLEPTIC MALIGNANT SYNDROME,NEUROLEPTIC MALIGNANT SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10029282,10029282,10029282
GRADE 1 PROTEINURIA 1+,Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
DISEASE PROGRESSION,DISEASE PROGRESSION,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
HUNDREDS OF PUSTULES ON ERYTHEMATOUS AND OEDEMATOUS SKIN ON TRUNK,Rash pustular,PUSTULE,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037578,10037888,10037578
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
24 YRS OLD FEMALE RECEIVED ASPIRIN FOR ANTITHROMBIN DEFICIENCYAND CONCEIVED SHORTLY AFTER,C-section,C-SECTION,CAESAREAN SECTION,OBSTETRIC AND GYNAECOLOGICAL THERAPEUTIC PROCEDURES,OBSTETRIC THERAPEUTIC PROCEDURES,10042613,10006832,10006924,10006832
CARDIO-RESPIRATORY FAILURE FOLLOWING TEN /SJS,Cardio-respiratory failure,CARDIO-RESPIRATORY FAILURE,CARDIOPULMONARY FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10049125,10051093,10049125
SECONDARY ANEMIA,Anaemia,SECONDARY ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10039812,10002034,10054606
GASTROINTESTINAL STROMAL  TUMOR PROGRESSION DUE TO SECONDARY RESISTANCE OF IMATINIB,Gastrointestinal stromal tumour,GASTROINTESTINAL STROMAL TUMOR,GASTROINTESTINAL STROMAL TUMOUR,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,GASTROINTESTINAL NEOPLASMS MALIGNANCY UNSPECIFIED NEC,10029104,10051066,10051066,10062427
ASYMPTOMATIC HYPOCALCEMIA,hypocalcemia,HYPOCALCEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020949,10020947,10020949
SEVERE HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
NON-PERSISTENT RENAL IMPAIRMENT,Renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
ACUTE KIDNEY INJURY AND DIABETIC KETOACIDOSIS,acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
QT INTERVAL PROLONGED,Electrocardiogram QT prolonged,QT INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037703,10014387,10037703
ULCERATIONS OF THE ORAL MUCOSA FOLLOWING ACUTE METHOTREXATE TOXICITY IN THE SETTING OF CONCOMITANT USE OF IBUPROFEN AND AMOXICILLIN/CLAVULANIC ACID,Mucosal ulceration,MUCOSAL ULCERATION,MUCOSAL ULCERATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028124,10028124,10028124
SYNCOPE,syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
OCULAR CANDIDIASIS (CANDIDA ALBICANS),Candida infection,CANDIDA ALBICANS INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10054230,10074170,10054230
PULMONARY CONGESTION,Pulmonary congestion,PULMONARY CONGESTION,PULMONARY CONGESTION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037368,10037368,10037368
ELECTROLYTE ABNORMALITIES,electrolyte abnormalities,ELECTROLYTE ABNORMALITY,ELECTROLYTE IMBALANCE,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10014410,10014418,10014410
HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
"HALLUCINATIONS, MIXED",Hallucination,HALLUCINATION,HALLUCINATION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019063,10019063,10019063
CENTRAL CRUSHING CHEST PAIN/ CHEST PAIN,Angina pectoris,CHEST PAIN - CARDIAC,ANGINA PECTORIS,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10008481,10002383,10008481
OVER REPLACEMENT OF HYDROCORTISONE,intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
ELEVATED EOSINOPHIL COUNT OF 16.3 PERCENT,Eosinophil count increased,EOSINOPHIL COUNT INCREASED,EOSINOPHIL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10014945,10014945,10014945
TUMOR LYSIS SYNDROME,tumor lysis syndrome,TUMOR LYSIS SYNDROME,TUMOUR LYSIS SYNDROME,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10045152,10045170,10045152
PRESSURE IN CHEST,Chest pressure,CHEST PRESSURE,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008486,10008469,10008486
MISERABLE AND MILDLY UNWELL,Malaise,UNWELL,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10040658,10025482,10046268
CHRONIC ALLOGRAFT DYSFUNCTION FOLLOWING BK VIRUS NEPHROPATHY,Complications of transplanted kidney,KIDNEY GRAFT DYSFUNCTION,COMPLICATIONS OF TRANSPLANTED KIDNEY,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10051366,10010185,10051366
PURULENT SPUTUM,Sputum purulent,SPUTUM PURULENT,SPUTUM PURULENT,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10050090,10050090,10050090
SEVERE PARKINSONISM WITH RESPIRATORY INSUFFICIENCY SECONDARY TO SULPIRIDE,Parkinsonism,PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034010,10034010,10034010
POST-TRANSPLANT DIABETES,Diabetes mellitus,POST TRANSPLANT DIABETES MELLITUS,DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10063634,10012601,10063634
PERIPHERAL EOSINOPHILIA FOLLOWING REBOUND EFFECT,Eosinophil percentage abnormal,EOSINOPHIL PERCENTAGE ABNORMAL,EOSINOPHIL PERCENTAGE ABNORMAL,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10058133,10058133,10058133
SINUS RHYTHM WAS FOUND AT THE FREQUENCY OF 61 TO 108 BPM (MEAN 82 BPM),Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
"ITCHY RED SKIN RASH SPREAD ALL OVER THE SKIN (FACE, NECK, FOREARMS, LOWER LEGS)",Rash pruritic,ITCHY RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10023092
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
PROGRESSING HENOCH-SCHONLEIN PURPURA FOLLOWING STEROID RESISTANCE,Henoch-Schonlein purpura,HENOCH-SCHONLEIN PURPURA,HENOCH-SCHONLEIN PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10019617,10019617,10019617
DEEP DERMAL DERMATOPHYTOSIS (GROIN) CAUSED BY TRICHOPHYTON RUBRUM,Tinea cruris,DERMATOPHYTOSIS OF GROIN,TINEA CRURIS,FUNGAL INFECTIOUS DISORDERS,TINEA INFECTIONS,10021881,10012508,10043868,10012508
EXTENSIVE LIVER FIBROSIS,Hepatic fibrosis,FIBROSIS LIVER,HEPATIC FIBROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10019668,10019668,10016648
SORE THROAT,sore throat,SORE THROAT,OROPHARYNGEAL PAIN,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10041367,10068319,10041367
ALKALINE PHOSPHATASE INCREASED (502 IU/L),Blood alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
INCREASING FORMICATION,Formication,FORMICATION,FORMICATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10017062,10017062,10017062
APRAXIA,Apraxia,APRAXIA,APRAXIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10003062,10003062,10003062
PROLONGED PROTHROMBIN TIME,Prothrombin time increased,PROTHROMBIN TIME INCREASED,PROTHROMBIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037061,10037063,10037061
BURNING SENSATION,Burning sensation,BURNING SENSATION,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10006784,10006784,10006784
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
PULMONARY OEDEMA,Pulmonary oedema,PULMONARY OEDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037423,10037423,10037423
ACUTELY HYPOTENSIVE,Hypotension,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021107
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
PARTIAL RESPONSE WAS OBSERVED,subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
APPENDICITIS,Appendicitis perforated,APPENDICITIS PERFORATED,APPENDICITIS PERFORATED,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10003012,10003012,10003012
GENERALIZED WEAKNESS,asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
HER PAIN IN THE LUMBAR REGION WORSENED,Lumbar pain,LUMBAR PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10024998,10003988,10024998
ALANINE AMINOTRANSFERASE INCREASED (113 IU/L),Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
MEDICATION-RELATED OSTEONECROSIS OF THE JAW STAGE 1 ([MANDIBLE (QUADRANT IV)],Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
ECCHYMOSIS,ecchymosis,ECCHYMOSIS,ECCHYMOSIS,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10014080,10014080,10014080
NORMOCHROMIC NORMOCYTIC RED BLOOD CELLS (ANEMIA),Normochromic normocytic anaemia,NORMOCHROMIC NORMOCYTIC ANEMIA,NORMOCHROMIC NORMOCYTIC ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10029783,10029783,10054485
DIFFUSE WEAKNESS,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
ACUTE INTERSTITIAL NEPHRITIS,Tubulointerstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029135,10048302,10000819
HYPERVOLEMIC HYPONATREMIA OF MULTIPLE ETIOLOGY (NA=124 MMOL/L),Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
MELENA,Faeces discoloured,BLACK STOOLS,FAECES DISCOLOURED,GASTROINTESTINAL SIGNS AND SYMPTOMS,FAECAL ABNORMALITIES NEC,10017947,10004977,10016100,10004977
TLC 1000 CELLS/CMM,Total lung capacity decreased,TLC DECREASED,TOTAL LUNG CAPACITY DECREASED,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY AND PULMONARY FUNCTION DIAGNOSTIC PROCEDURES,10022891,10043898,10044100,10043898
PHILADELPHIA CHROMOSOME (PH) INDEPENDENT CLONAL CHANGES/ ABERRATION-MONOSOMY 7,Cytogenetic abnormality,CYTOGENETIC ABNORMALITY,CYTOGENETIC ABNORMALITY,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,CHROMOSOMAL ABNORMALITIES NEC,10010331,10067477,10067477,10067477
COMMUNITY-ACQUIRED PNEUMONIA/SEVERE PNEUMONIA,community-acquired pneumonia,COMMUNITY ACQUIRED PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10010120,10035664,10010120
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
ALKALINE PHOSPHATASE LEVEL OF 179 U/L,Blood alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
LDH 710 U/L,Blood lactate dehydrogenase increased,LDH INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10024051,10005630,10024051
PRURITIC PHOTODISTRIBUTED ANNULAR PLAQUES OVER THE BILATERAL EXTENSOR,pruritic photodistributed annular plaques over the bilateral extensor,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
COFFEE GROUND VOMITING,Haematemesis,COFFEE GROUND VOMITING,HAEMATEMESIS,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10009840,10018830,10009840
SEVERE ATAXIA AT THE LEFT SIDE,severe ataxia at the left side,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
PREMATURE BABY,Premature baby,PREMATURE BABY,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036590,10036590,10036590
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
SOMNOLENCE,somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
MYDRIASIS,Mydriasis,MYDRIASIS,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10028521,10028521,10028521
"INVASIVE SINUS, TRACHEOBRONCHEAL, PULMONARY AND INTRACEREBRAL ASPERGILLUS FUMIGATUS INFECTION",Aspergillus infection,ASPERGILLUS FUMIGATUS INFECTION,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003494,10074171,10003494
INABILITY TO PERFORM DAILY ACTIVITIES,Loss of personal independence in daily activities,ACTIVITIES OF DAILY LIVING IMPAIRED,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10050954,10079487,10050954
VARICOSE ULCER,Varicose ulceration,VARICOSE ULCERATION,VARICOSE ULCERATION,VENOUS VARICES,VARICOSE VEINS NEC,10047065,10046995,10046995,10046995
WARFARIN-INDUCED SKIN NECROSIS,Skin necrosis,SKIN NECROSIS,SKIN NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040893,10040893,10040893
PAIN,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
INCREASED DURATION TONIC SEIZURES,Seizure,PROLONGED SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10076333,10039906,10076333
HEADACHE DUE TO CINCHONISM FOLLOWING INTENTIONAL DRUG ABUSE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
CHRONIC DIARRHEA/NOCTURNAL SYMPTOMS OF DIARRHEA,Diarrhoea,NOCTURNAL DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10055959,10012735,10029451
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
VOMITED,Vomiting,VOMITED,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047699
SLEEP DISTURBANCES,Sleep disorder,SLEEP DISORDER,SLEEP DISORDER,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10040984,10040984,10040984
DROWSINESS,drowsiness,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
DELUSIONS,Delusion,DELUSIONS,DELUSION,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10012239,10012239,10012260
BOY'S VERY HEAVY SLEEPINESS,Sleeplessness,SLEEPLESSNESS,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10041017,10022437,10041017
SINGLE DOSE OF 75 MG/ KG INTRAVENOUS PARACETAMOL / INTRAVENOUS PARACETAMOL OVERDOSE,Accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
GFR DECREASED (45-59 ML PER MIN),Glomerular filtration rate decreased,GFR DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018214,10018358,10018214
NEUTROPHIL COUNT OF 0.04 Ã— 109/L,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
49 YRS OLD MAN HAD SEVERE GASTRITIS PRECIPITATING AN ACUTE GASTROINTESTINAL BLEED AND A SEVERE ANAPHYLACTIC REACTION TO ASPIRIN,Anaphylactic reaction,ANAPHYLACTIC REACTION,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002198,10002198,10002198
NON-SEMINOMA TESTICULAR CANCER,non-seminoma testicular cancer,NON-SEMINOMA TESTICULAR CANCER,TESTIS CANCER,REPRODUCTIVE NEOPLASMS MALE MALIGNANT AND UNSPECIFIED,TESTICULAR NEOPLASMS MALIGNANT,10029104,10029557,10057644,10029557
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
ANTINUCLEAR ANTIBODY POSITIVE (GREATER THAN 1:300),Antinuclear antibody positive,ANTINUCLEAR ANTIBODY POSITIVE,ANTINUCLEAR ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10060055,10060055,10060055
PERTUSSIS,Pertussis,PERTUSSIS,PERTUSSIS,BACTERIAL INFECTIOUS DISORDERS,BORDETELLA INFECTIONS,10021881,10034738,10034738,10034738
ACETAMINOPHEN-INDUCED HEPATOCELLULAR INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
SUPERIMPOSED DRUG-INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
ABDOMEN WAS GENERALLY SOFT WITH MILD TENDERNESS ON DEEP PALPATION OF THE LOWER ABDOMEN,Abdominal tenderness,ABDOMINAL TENDERNESS,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000097,10000097,10000097
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
BRONCHOSPASM,bronchospasm,BRONCHOSPASM,BRONCHOSPASM,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10006482,10006482,10006482
ABNORMAL TIBIAL SOMATOSENSORY-EVOKED POTENTIALS (SSEP) RESPONSES ON THE LEFT AND SEVERELY DELAYED CORTICAL RESPONSES ON THE RIGHT,Somatosensory evoked potentials abnormal,SOMATOSENSORY EVOKED POTENTIALS ABNORMAL,SOMATOSENSORY EVOKED POTENTIALS ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10049464,10049464,10049464
INEFFECTIVENESS OF TREATMENT/INCREASED PAIN,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
UNREMITTING VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
BLOOD WAS DRAINING FROM HIS LEFT EAR,Ear haemorrhage,EAR BLEEDING,EAR HAEMORRHAGE,AURAL DISORDERS NEC,EAR DISORDERS NEC,10013993,10014009,10014009,10071803
RIGHT LUNG COLLAPSE FOLLOWING RIGHT LUNG PNEUMPTHORAX,right lung collapse,COLLAPSE OF LUNG,PNEUMOTHORAX,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10009913,10035759,10009913
"BLURRED VISION IN BOTH OF HIS EYES, WHICH WAS MORE INTENSE IN HIS RIGHT EYE","blurred vision in both of his eyes, which was more intense in his right eye",BLURRED VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10005886,10047513,10005886
SYSTEMIC ONSET JUVENILE IDIOPATHIC ARTHRITIS REFRACTORY TO THERAPY WITH METHOTREXATE (LACK OF DRUG EFFECT WITH NO ADR),drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
IMATINIB FAILURE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
MAJOR DEPRESSIVE DISORDER,Major depression,MAJOR DEPRESSIVE DISORDER NOS,MAJOR DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10025453,10057840,10025453
LIMITED SUCCESS,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
SWEATING,sweating,SWEATING,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042661,10020642,10042661
NASAL OBSTRUCTION,Nasal obstruction,NASAL OBSTRUCTION,NASAL OBSTRUCTION,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10028748,10028748,10028748
METABOLIC ACIDOSIS ON ARTERIAL BLOOD GAS ANALYSIS (PH 7.20),Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
DYSPNEA AT REST,dyspnea at rest,DYSPNEA AT REST,DYSPNOEA AT REST,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10079027,10013969,10079027
GASTROINTESTINAL HISTOPLASMOSIS (ILEO-COLONIC HISTOPLASMOSIS),Histoplasmosis,INFECTION BY HISTOPLASMA CAPSULATUM,HISTOPLASMOSIS,FUNGAL INFECTIOUS DISORDERS,HISTOPLASMA INFECTIONS,10021881,10021808,10020141,10021808
WITHDRAWAL REACTION,WITHDRAWAL REACTION,WITHDRAWAL REACTION,WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10048008,10048010,10048008
FETAL BRADYCARDIA,Bradycardia foetal,FETAL BRADYCARDIA,BRADYCARDIA FOETAL,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006094,10006094,10054724
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HILAR NODE,Pulmonary hilum mass,HILAR MASS,PULMONARY HILUM MASS,THORACIC DISORDERS (EXCL LUNG AND PLEURA),MEDIASTINAL DISORDERS,10038738,10058563,10058563,10053637
PATIENT'S CONDITION PROGRESSED INSPITE OF TREATMENT WITH METHYLPREDNISOLONE AND IMMUNOGLOBULIN,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
PARTIAL REMISSION WAS OBTAINED ON FLAG-IDA,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
OCCIPITAL ASPERGILLOSIS ABSCESS,Aspergillus infection,ASPERGILLOSIS,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003488,10074171,10003488
ACUTE GRANULOMATOUS INTERSTITIAL NEPHRITIS DUE TO CO-TRIMOXAZOLE,Tubulointerstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029135,10048302,10000819
ACUTE RESPIRATORY DISTRESS SYNDROME,Acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
AMIODARONE-ASSOCIATED SIADH,Inappropriate antidiuretic hormone secretion,SIADH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,POSTERIOR PITUITARY DISORDERS,10014698,10040626,10053198,10040626
ALPHA-FETOPROTEIN INCREASED (36.5 G/L),Alpha 1 foetoprotein increased,ALPHA-FETOPROTEIN INCREASED,ALPHA 1 FOETOPROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10001835,10001781,10001816
HYPERMAGNESEMIA INDUCED HYPERKALEMIA,Hyperkalaemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020646,10020646,10020647
NO  ADVERSE DRUG REACTION,no  adverse drug reaction,NO ADVERSE DRUG REACTION,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067481,10067482,10067481
NONHEALING PAINFUL ULCER,Ulceration tongue,ULCERATION TONGUE,TONGUE ULCERATION,TONGUE CONDITIONS,TONGUE DISORDERS,10017947,10045358,10043991,10045358
EBV ASSOCIATED STAGE IE PLL-PTLD OF KIDNEY,Plasmacytoma,PLASMACYTOMA,PLASMACYTOMA,PLASMA CELL NEOPLASMS,PLASMA CELL MYELOMAS,10029104,10035484,10035484,10035484
CONJUNCTIVAL EDEMA DUE TO STEVENS-JOHNSON SYNDROME,Conjunctival oedema,CONJUNCTIVAL EDEMA,CONJUNCTIVAL OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CONJUNCTIVAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10010726,10010726,10010715
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
AGITATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
ELECTROLYTE DISTURBANCES,Electrolyte imbalance,ELECTROLYTE DISTURBANCE,ELECTROLYTE IMBALANCE,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10014417,10014418,10014417
ANXIETY,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
AGGRESSIVENESS,aggression,AGGRESSION,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001488,10001488,10001488
RECURRENT FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
DRUG INTOXICATION,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
PULSE INCREASED (102 BEATS/MIN) FOLLOWING CINCHONISM,Heart rate increased,PULSE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10037474,10019303,10037474
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
DEPRESSED THE NERVOUS SYSTEM INHIBITING BREATHING,Dyspnoea,DIFFICULTY BREATHING,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10012791
MULTIPLE ABSCESSES IN THE LIVER,liver abscess,LIVER ABSCESS,LIVER ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,HEPATOBILIARY AND SPLEEN INFECTIONS,10021881,10024652,10024652,10024652
CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
MISSUSE,intentional drug misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
SIGNIFICANT POST-INDUCTION HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
PREGNANCY COMPLICATION,Complication of pregnancy,COMPLICATION OF PREGNANCY,COMPLICATION OF PREGNANCY,MATERNAL COMPLICATIONS OF PREGNANCY,MATERNAL COMPLICATIONS OF PREGNANCY NEC,10036585,10061452,10061452,10061452
PULMONARY OEDEMA,Pulmonary oedema,PULMONARY OEDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037423,10037423,10037423
FEVER (38.5 DEGREE CELSIUS),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
ORAL INTAKE AND ENEMA WITH LACTULOSE WERE INEFFECTIVE,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LEUKOCYTOSIS (12.3X 10E9/L),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
OCCULT FECAL BLOOD,Occult blood,FECAL OCCULT BLOOD,OCCULT BLOOD,GASTROINTESTINAL INVESTIGATIONS,FAECAL ANALYSES NEC,10022891,10061878,10061878,10016297
DISEASE PROGRESSION,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
METHOTREXATE ASSOCIATED EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER RESEMBLING ADVANCED GASTRIC CANCER (TUMOR),Epstein-Barr virus associated lymphoproliferative disorder,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10068349,10068349,10068349
PANCYTOPENIA FOLLOWING ACUTE ACCIDENTAL METHOTREXATE OVERDOSE,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
SIGNIFICANT IRON OVERLOAD,Iron overload,IRON OVERLOAD,IRON OVERLOAD,IRON AND TRACE METAL METABOLISM DISORDERS,IRON EXCESS,10027433,10065973,10065973,10065973
INTAKE OF 40-60 TABLETS,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
BULBAR CONJUNCTIVAL HYPERAEMIA,Conjunctival hyperaemia,BULBAR CONJUNCTIVA HYPERAEMIA,CONJUNCTIVAL HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CONJUNCTIVAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10056649,10051625,10056649
SEVERE METABOLIC ACIDOSIS,metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
DEVELOPMENT OF RIGHT-SIDED HEMIPARESIS,Hemiparesis,HEMIPARESIS (RIGHT),HEMIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019467,10019465,10019467
COOMB TEST POSITIVE,Coombs test positive,COOMBS TEST POSITIVE,COOMBS TEST POSITIVE,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),BLOOD GROUPING AND CROSS-MATCHING ANALYSES,10022891,10061090,10061090,10061090
DIFFICULT TO REMEMBER WHAT SHE HAD BEEN TOLD OR READ SHORTLY BEFORE,Memory disturbance,MEMORY DISTURBANCE,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027172,10027175,10027172
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
PERIMEMBRANOUS VENTRAL SEPTAL DEFECT,Septal defect interatrial,SEPTAL DEFECT INTERATRIAL,ATRIAL SEPTAL DEFECT,CARDIAC AND VASCULAR DISORDERS CONGENITAL,CARDIAC SEPTAL DEFECTS CONGENITAL,10010331,10040055,10003664,10040055
AGGREGATED PRURITIC FOLLICULAR PAPULOPUSTULES ON FOREARMS AND THIGH,Rash pustular,PUSTULE,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037578,10037888,10037578
"OUR PATIENT COLLECTED 11 BUPRENORPHINE TABLETS MG EACH), WHICH HE TOOK IN ONE DAY.",Intentional product misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
CLOUDED MIND,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
ATTEMPTED HOMICIDE (VICTIM),Victim of crime,VICTIM OF CRIME,VICTIM OF CRIME,LEGAL ISSUES,CRIME VICTIMS,10041244,10061409,10061409,10061409
GRAVES' DISEASE,Basedow's disease,GRAVES' DISEASE,BASEDOW'S DISEASE,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10018706,10004161,10018706
AOREXIA,Anorexia post chemotherapy,ANOREXIA POST CHEMOTHERAPY,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10066197,10061428,10066197
"DESPITE THIS REGIMEN, SHE CONTINUED TO HAVE PAIN FROM TRIGEMINAL NEURALGIA, SYMPTOMS OF ANXIETY INTERMITTENTLY SELF-TREATED WITH ALCOHOL, AND NO IMPROVEMENT IN SERUM SODIUM DESPITE THE HIGH SALT INTAKE",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
REVEALED MODERATE LEFT VENTRICLE ENLARGEMENT,ventricular enlargement,VENTRICULAR ENLARGEMENT,VENTRICULAR ENLARGEMENT,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10079339,10079339,10079339
DEPIGMENTATION AROUND THE INJECTED AREA,Skin depigmentation,DEPIGMENTATION SKIN,SKIN DEPIGMENTATION,PIGMENTATION DISORDERS,HYPOPIGMENTATION DISORDERS,10040785,10040825,10040825,10012362
PERIVALVULAR LEAK,Aortic valve incompetence,AORTIC VALVE INCOMPETENCE,AORTIC VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,AORTIC VALVULAR DISORDERS,10007541,10002915,10002915,10002915
PROGRESSIVE FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
FAILED TO RESPOND DURING THE TREATMENT PERIOD,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
SEVERE HYPERKALEMIA ASSOCIATED TO THE USE OF LOSARTAN AND SPIRONOLACTONE,Hyperkalaemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020646,10020646,10020647
AGRANULOCYTOSIS,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
FLEXURAL ERYTHEMA,erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
GENERALIZED ERYTHEMATOUS PATCHES WHICH WERE ATTRIBUTED TO SULFAMETHOXAZOLE/TRIMETHOPRIM OR NEVIRAPINE,Skin erythema,SKIN ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10040842,10015150,10040842
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
EOSINOPHILIA (3300 CELLS/MICRO LITRE),Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
CHROMATURIA,Chromaturia,CHROMATURIA,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10008796,10008796,10008796
LACK OF DRUG EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
BILATERAL ANKLE SWELLING,ankle swelling,ANKLE SWELLING,JOINT SWELLING,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10002553,10023232,10002553
"HYDROCHLOROTHIAZIDE WAS INTRODUCED/IN 1963 AS BLOOD PRESSURE CONTROL WAS STILL POOR,",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
DIZZINESS SYMPTOM,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
FOETAL HYDROPS INCREASED,Hydrops foetalis,HYDROPS FETALIS,HYDROPS FOETALIS,FOETAL COMPLICATIONS,FOETAL COMPLICATIONS NEC,10036585,10020529,10020529,10020526
HIGH BLOOD PRESSURE,blood pressure high,BLOOD PRESSURE HIGH,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10005747,10020772,10005747
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
WITHOUT ADEQUETE RELIEF FOR POST MASTECTOMY PAIN,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
MEXILETINE DRUG-DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
MACULAR AND VESICULAR EXANTHEMA OF THE HANDS AND FEET,exanthema,EXANTHEMA,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015587,10037844,10015587
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
LIVER DYSFUNCTION,Liver disorder,LIVER DISORDER,LIVER DISORDER,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10024670,10024670,10024670
BIOCHEMICAL ABNORMALITIES,Lab test abnormal,LAB TEST ABNORMAL,LABORATORY TEST ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",INVESTIGATIONS NEC,10022891,10023524,10023547,10023524
VITILIGO,Vitiligo,VITILIGO,VITILIGO,PIGMENTATION DISORDERS,HYPOPIGMENTATION DISORDERS,10040785,10047642,10047642,10047642
"SEPTIC SHOCK WITH MULTIPLE PUTATIVE ORIGINS (COLITIS, PNEUMONIA, CATHETER-RELATED BACTEREMIA)",Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
"VOMITING FOLLOWING ADMINISTRATION OF HYDROXYCHLOROQUINE, AZATHIOPRINE AND DAPSONE",Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
LOST CONSCIOUSNESS,Loss of consciousness,LOST CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024885
NEPHROTOXICITY,Nephropathy toxic,NEPHROTOXICITY,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10067571
SUBTHERAPEUTIC RESPONSE,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,Labelled drug-drug interaction medication error,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT MONITORING ERRORS AND ISSUES,10022117,10064373,10064373,10064373
ACQUIRE RESISTANCE TO TREATMENT PROBABLY DUE TO THE GROWTH OF MUTATED CLONES,kras mutation,KRAS MUTATION,K-RAS GENE MUTATION,GENERAL SYSTEM DISORDERS NEC,ACQUIRED GENE MUTATIONS AND OTHER ALTERATIONS,10018065,10069759,10069755,10069759
PERSISTENT ORAL ULCERS AND MOBILE TEETH.,Loose tooth,LOOSE TOOTH,LOOSE TOOTH,DENTAL AND GINGIVAL CONDITIONS,DENTAL DISORDERS NEC,10017947,10065612,10065612,10065612
DISEASE PROGRESSION ( DECOMPENSATION OF DIABETES AFTER 7 YEARS OF THERAPY DUE TO WEIGHT GAIN),Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
HASHIMOTO'S THYROIDITIS,Hashimoto's thyroiditis,HASHIMOTO'S THYROIDITIS,AUTOIMMUNE THYROIDITIS,THYROID GLAND DISORDERS,ACUTE AND CHRONIC THYROIDITIS,10014698,10019167,10049046,10019167
FIXED DRUG ERUPTIONS,Fixed eruption,FIXED DRUG ERUPTION,FIXED ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10016740,10016741,10016740
CLOSTRIDIUM DIFFICILE COLITIS,Clostridium difficile colitis,CLOSTRIDIUM DIFFICILE COLITIS,CLOSTRIDIUM DIFFICILE COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10009657,10009657,10009657
REACTIVE MYDRIATIC PUPILS,Mydriasis,MYDRIASIS,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10028521,10028521,10028521
"THE DOSAGE OF BRC WAS PROGRESSIVELY INCREASED TO 25 MG DAILY, BUT WAS OF NO AVAIL WITH RESPECT TO THE SERUM PRL LEVEL",Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
FELT INCREASINGLY TIRED,Fatigue,TIREDNESS,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10043890
PRECORDIAL PAIN,precordial pain,PRECORDIAL PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10036522,10008479,10036522
SUBCAPSULAR HEMATOMA,Splenic hematoma,SPLENIC HEMATOMA,SPLENIC HAEMATOMA,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10055384,10041646,10055384
LEFT EYELID EDEMA,Eyelid edema,EYELID EDEMA,EYELID OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","LID, LASH AND LACRIMAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10015985,10015993,10015985
HE TRIGEMINAL NEURALGIA HAD WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
"THERAPY RELATED ACUTE MYELOID LEUKEMIA (AML), M1SUBTYPE",Acute myeloid leukemia,ACUTE MYELOID LEUKEMIA,ACUTE MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10000886,10000880,10000886
POTENTIAL PARACETAMOL OVERDOSE,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
ADRENAL INSUFFICIENCY,adrenal insufficiency,ADRENAL INSUFFICIENCY,ADRENAL INSUFFICIENCY,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001367,10001367,10001367
LOW-GRADE GVHD,low-grade GvHD,GVHD,GRAFT VERSUS HOST DISEASE,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10018799,10018651,10018799
DISORIENTED,Disorientation,DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013395
WITH POOR RESULTS,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
MASSIVE WATERY STOOLS (3000 ML/DAY),Diarrhoea,STOOLS WATERY,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10042157,10012735,10042157
MULTIPLE BRIEF EPISODES OF LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
ABDOMINAL COMPLAINTS,Abdominal discomfort,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10000059,10000059,10000059
RECURRENCE OF BURKITT'S LYMPHOMA,Non-Hodgkin's lymphoma,NON-HODGKIN'S LYMPHOMA,NON-HODGKIN'S LYMPHOMA,LYMPHOMAS NON-HODGKIN'S UNSPECIFIED HISTOLOGY,NON-HODGKIN'S LYMPHOMAS NEC,10029104,10029547,10029547,10029547
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
DARK URINE,Chromaturia,URINE DISCOLORATION,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10046629,10008796,10046628
GENERALIZED SKIN LESIONS ASSOCIATED WITH MYALGIA AND FEVER,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
DISSEMINATED INTRAVASCULAR COAGULATION,Disseminated intravascular coagulation,DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10013442,10013442,10013442
NEUROPSYCHIATRIC ADVERSE EFFECTS,Neuropsychiatric symptoms,NEUROPSYCHIATRIC SYMPTOMS,NEUROPSYCHIATRIC SYMPTOMS,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS DUE TO A GENERAL MEDICAL CONDITION NEC,10037175,10078497,10078497,10078497
HYPONATREMIA,Hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
PATIENT EXPERIENCED INTENSIFIED PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
VIVID AND INDESCRIBABLE DREAMS,Abnormal dreams,VIVID DREAMS,ABNORMAL DREAMS,SLEEP DISORDERS AND DISTURBANCES,PARASOMNIAS,10037175,10047666,10000125,10047666
"FOR MAINTENANCE OF SYMPTOMS, WAS ADMITTED",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
GRADE II FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
MOON FACE,Cushingoid,MOON FACE,CUSHINGOID,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10027953,10011655,10027953
INCREASED HEPATOBILIARY ENZYME LEVELS,Hepatic enzyme increased,HEPATIC ENZYMES INCREASED,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10060795,10060795,10019662
MILK-ALKALI SYNDROME FOLLOWING OFF LABEL USE OF CALCIUM CARBONATE FOR SEVERE HEART BURN,milk-alkali syndrome,MILK-ALKALI SYNDROME,MILK-ALKALI SYNDROME,ACID-BASE DISORDERS,METABOLIC ALKALOSES,10027433,10027635,10027635,10027635
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
UNCONTROLLABLE LOW SYSTEMIC BLOOD PRESSURE,Hypotension,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10024895
PAPULES OVER ABDOMEN AND LOWER EXTREMITIES,papules over abdomen and lower extremities,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
BULLAE,bullae,BULLAE,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006554,10005191,10006554
FEVER (40 C),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
SMOOTH PHILTRUM,Dysmorphism,FLAT PHILTRUM,DYSMORPHISM,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL DISORDERS CONGENITAL NEC,10010331,10058844,10066054,10058844
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
A TONIC-CLONIC SEIZURE,tonic-clonic seizures,TONIC-CLONIC SEIZURES,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10044000,10018100,10044000
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
DIARRHOEA/ ACUTE DIARRHEA,Acute diarrhea ,ACUTE DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10000706,10012735,10000706
A RARE CASE OF GASTROINTESTINAL HISTOPLASMOSIS IN AN IMMUNOCOMPROMISED HOST,Histoplasmosis,HISTOPLASMOSIS,HISTOPLASMOSIS,FUNGAL INFECTIOUS DISORDERS,HISTOPLASMA INFECTIONS,10021881,10020141,10020141,10020141
SCHISTOCYTES PRESENT,Red blood cell schistocytes present,RED BLOOD CELL SCHISTOCYTES PRESENT,RED BLOOD CELL SCHISTOCYTES PRESENT,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10038169,10038169,10038169
DRUG EXPOSURE IN UTERO,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
ACUTE LIDOCAINE TOXICITY,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
DIABETIC KETOACIDOSIS,diabetic ketoacidosis,DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEC,10027433,10012671,10012671,10012671
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
PHASES OF SLEEP NOT NORMAL / AMOUNT OF REM SLEEP LOW,Irregular sleep phase,IRREGULAR SLEEP PHASE,IRREGULAR SLEEP PHASE,SLEEP DISTURBANCES (INCL SUBTYPES),DISTURBANCES IN SLEEP PHASE RHYTHM,10029205,10022995,10022995,10022995
VENTRICULAR TACHYCARDIA,Ventricular tachycardia,VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047302,10047302,10047302
NEAR-FATAL FLECAINIDE OVERDOSE/ WHO TOOK APPROXIMATELY 4 GRAMS OF FLECAININDE AND A SMALL AMOUNT OFPARACETAMOL AS AN IMPULSIVE GESTURE,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
RED COLOURED STOOL,Red coloured stool,RED COLOURED STOOLS,FAECES DISCOLOURED,GASTROINTESTINAL SIGNS AND SYMPTOMS,FAECAL ABNORMALITIES NEC,10017947,10058608,10016100,10058608
PROGRESSION OF THE MENINGEAL CARCINOMATOSIS,Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
GRADUALLY WORSENING OF LIPID PROFILE,Lipids abnormal,LIPIDS ABNORMAL,LIPIDS ABNORMAL,LIPID ANALYSES,LIPOPROTEIN AND LIPID TESTS NEC,10022891,10024588,10024588,10024588
NEUROMUSCULAR IRRITABILITY,Neuromyopathy,NEUROMUSCULAR DISORDER NOS,NEUROMYOPATHY,NEUROMUSCULAR DISORDERS,NEUROMUSCULAR DISORDERS NEC,10029205,10029316,10029323,10029316
LYMPHOPENIA,lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PSYCHOTIC FEATURES,Psychotic behaviour,PSYCHOTIC BEHAVIOR,PSYCHOTIC BEHAVIOUR,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10037249,10037249,10067568
LOSS IN INTESTINAL BARRIER INTEGRITY MAY HAVE ALLOWED A GIT-BORNE E. COLI TO CAUSE A PARAVERTEBRAL ABSCESS.,Abscess,ABSCESS,ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10000269,10000269,10000269
METRONIDAZOLE INDUCED ENCEPHALOPATHY,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
ACUTE RENAL FAILURE DUE TO CAST NEPHROPATHY,Acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
SEVERE WEIGHT LOSS (30 KG),Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
"EXTENSIVE VASCULITIS INVOLVING INTERNAL CAROTIDS, ANTERIOR, PROXIMAL,AND POSTERIOR CEREBRAL ARTERIES",Vasculitis,VASCULITIS,VASCULITIS,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10047115,10047115,10047115
FEELS POORLY,Feeling abnormal,FEELS POORLY,FEELING ABNORMAL,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10016377,10016322,10016377
DILATED PUPILS,Mydriasis,DILATED PUPILS,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10013014,10028521,10013014
OROPHARYNGEAL DISCOMFORT,Oropharyngeal discomfort,PHARYNX STRANGE SENSATION OF,OROPHARYNGEAL DISCOMFORT,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10034864,10068318,10034864
"DRUG-INDUCED SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS/CONFLUENT, SHARPLY MARGINATED, INFILTRATED ERYTHEMATOUS LESIONS WITH AN ANNULAR PATTERN LOCATED ON DORSAL HANDS, EXTENSOR SURFACES OF THE UPPER EXTR",drug-induced cutaneous lupus erythematosus,DRUG-INDUCED CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS-LIKE SYNDROME,CONNECTIVE TISSUE DISORDERS (EXCL CONGENITAL),LUPUS ERYTHEMATOSUS (INCL SUBTYPES),10028395,10074893,10050551,10074893
SUBTLE ERYTHEMATOUS THIN PLANAR PLAQUE,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
BILATERAL PLEURAL HEMATOMA,Pulmonary haematoma,PULMONARY HAEMATOMA,PULMONARY HAEMATOMA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10054991,10054991,10054991
HEMIPLEGIA,Hemiplegia,HEMIPLEGIA,HEMIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019468,10019468,10019468
SERUM CREATINE LEVEL WAS ELEVATED TO 164 ÎœMOL/L,serum creatine phosphokinase increased,SERUM CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10040224,10005470,10040224
SUBFOVEAL ATROPHY/LEFT EYE MACULAR DYSFUNCTION/ CLOZAPINE INDUCED MACULOPATHY,Maculopathy,MACULOPATHY,MACULOPATHY,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10025425,10025425,10025425
FOLLICULAR ERYTHEMATOUS SHINY PAPULES,Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
CARDIAC DECOMPENSATION,Cardiac decompensation,DECOMPENSATION CARDIAC,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10011949,10007554,10011949
COUGH WORSENED,Cough aggravated,COUGH AGGRAVATED,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10048381,10011224,10048381
AKI,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
ACUTE ISCHEMIC LESION OBSERVED AT LEFT POSTERIOR INFERIOR CEREBELLAR ARTERY AT CEREBELLUM WITH LESION AT LEFT LATERAL MEDULLA DUE TO CERVICAL ARTERY DISSECTION & VERTEBRAL ARTERY DISSECTION,Central nervous system lesion ,CENTRAL NERVOUS SYSTEM LESION,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10051290,10051290,10051290
"TRAMADOL TREATMENT PROVED TO BE INEFFECTIVE; LACK OF DRUG EFFECT: FLUROURACIL,METHOTREXATE,CYCLOPHOSPHAMIDE,LETROZOLE,ZOLEDRONIC ACID, MORPHINE, FENTANYL.",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
TOPICAL CLOBETASOL INDUCED NECROTIZING FASCIITIS OF THE LEFT UPPER LIMB (GROUP A STREPTOCOCCUS),Necrotizing fasciitis streptococcal,NECROTIZING FASCIITIS STREPTOCOCCAL,NECROTISING FASCIITIS STREPTOCOCCAL,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10055650,10028888,10055650
"SEVERE GVHD OF THE SKIN, LIVER AND INTESTINE",Graft versus host disease in liver,GRAFT VERSUS HOST DISEASE IN LIVER,GRAFT VERSUS HOST DISEASE IN LIVER,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10064676,10064676,10064676
PROGRESSION OF CHRONIC RELAPSING INFLAMMATORY OPTIC NEUROPATHY FOLLOWING LACK OF DRUG EFFECT,progression of chronic relapsing inflammatory optic neuropathy following lack of drug effect,OPTIC NEUROPATHY,OPTIC NEUROPATHY,VISION DISORDERS,VISUAL PATHWAY DISORDERS,10015919,10061323,10061323,10061323
ANURIC,Anuria,ANURIA,ANURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10002847,10002847,10002847
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS,Staphylococcal infection,METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10027508,10058080,10027508
DRUG USE FOR UNAPPROVED INDICATION,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
PROTEINURIA (184 MG/24 HOURS),Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
URINARY OCCULT BLOOD POSITIVE,Blood urine present,URINARY OCCULT BLOOD POSITIVE,BLOOD URINE PRESENT,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINALYSIS NEC,10022891,10052287,10018870,10052287
SKIN REACTION,Skin reaction,SKIN REACTION,SKIN REACTION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040914,10040914,10040914
LEUKOPENIA WITH NEUTROPENIA AND EOSINOPHILIA,Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
ATAXIA FOLLOWING ACCIDENTAL ONDANSETRON OVERDOSE,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
ASPIRIN USED AS ANTIPLATELET AGENT AS PROPHYLAXIS FOR CORONARY ARTERY,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
EDEMA,Oedema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10014210
MILD ACUTE KIDNEY INJURY,acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HYPERGLYCAEMIA,Hyperglycaemia,HYPERGLYCAEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020635
CREATINE PHOSPHOKINASE INCREASED (1050U/L),Blood creatine phosphokinase increased,CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011349,10005470,10011349
TOLERANCE/SEVERE MISUSE OF PREGABALIN (UP TO 1800 MG/DAY) ASSOCIATED WITH CRAVING AND TOLERANCE,Drug tolerance,DRUG TOLERANCE,DRUG TOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10052804,10052804,10052804
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
MARKEDLY PROLONGED QTC,Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
LIVER DAMAGE,liver damage,LIVER DAMAGE,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10024668,10067125,10024668
ACUTE DERMATITIS,acute dermatitis,DERMATITIS,DERMATITIS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10012431,10012431,10012431
"IMPROVEMENTS IN WHITE BLOOD CELL COUNT TO 7850 ( 20,278)/ÎœL, CRP 5.7 ( 20. 3), BODY TEMPERATURE 37.0 ( 39.5)ÂºC, BUN 13.2 ( 28.7), AND CRE 0.94 ( 1.87) MG/DL",C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
PARAESTHESIA IN BOTH HIS UPPER AND LOWER LIMBS,Paraesthesia of limbs,PARAESTHESIA OF LIMBS,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10033784,10033775,10033784
DRUG EXPOSURE DURING PREGNANCY WITH NO ADR,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
NECK REDNESS,Erythema,RED NECK,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10038194,10015150,10038194
ANURIA,Anuria,ANURIA,ANURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10002847,10002847,10002847
HYPOCHONDRIA/HYPOCHONDRIACAL PERSONALITY,hypochondriasis,HYPOCHONDRIASIS,ILLNESS ANXIETY DISORDER,SOMATIC SYMPTOM AND RELATED DISORDERS,SOMATIC SYMPTOM DISORDERS,10037175,10020965,10078077,10020965
HER PERIPHERAL BLOOD SMEAR RESULTS ALSO SHOWED INCREASED NUMBERS OF MONOCYTES,Monocyte count increased,MONOCYTES INCREASED,MONOCYTE COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10027887,10027880,10027887
LOPERAMIDE ABUSE CARDIOTOXICITY,substance abuse,SUBSTANCE ABUSE,SUBSTANCE ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10066169,10066169,10066169
"BULLOUS IMPETIGO (MULTIPLE TENSE BULLAE ON BACK OF HANDS, ELBOWS, KNEES, ANKLES WITHIN NORMAL SKIN, FLANKS, TOP OF THIGHS, CHEST AND ABDOMEN)",Bullous impetigo,BULLOUS IMPETIGO,BULLOUS IMPETIGO,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10006563,10006563,10006563
RIGHT ATRIAL APPENDAGE THROMBUS AND PULMONARY EMBOLISM DUE TO THE INSUFFICIENT ANTICOAGULATION,Atrial thrombosis,ATRIAL THROMBOSIS,ATRIAL THROMBOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048632,10048632,10048632
CNS DEPRESSION,Depressed level of consciousness,CNS DEPRESSION,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10012383,10012373,10009710
UNCONSCIOUSNESS,Unconsciousness,UNCONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10045481,10024855,10045481
CHEMOSIS,chemosis,CHEMOSIS,CONJUNCTIVAL OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CONJUNCTIVAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10008435,10010726,10008435
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
COMPARTMENT SYNDROME OF RIGHT FOREARM,Compartment syndrome,COMPARTMENT SYNDROME,COMPARTMENT SYNDROME,MUSCLE DISORDERS,MYOPATHIES,10028395,10010121,10010121,10010121
"GENERALISED MALAISE, FEVER AND POLYARTHRITIS DESPITE THE TREATMENT",Polyarthritis,POLYARTHRITIS,POLYARTHRITIS,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10036030,10036030,10036030
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME,Posterior reversible encephalopathy syndrome,REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10071066,10071066,10063761
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
"SYMPTOMS ACUTELY WORSENED, WITH INTERMITTENT SHARP ABDOMINAL PAIN, BLOATING, AND DIARRHEA OCCURRING UP TO EIGHT TIMES PER DAY",Symptom recurrence,SYMPTOM RECURRENCE,SYMPTOM RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10080080,10080080,10080080
CUTANEOUS ULCERATION ON LEFT LEG AND FOREHEAD,Skin ulcer,SKIN ULCERATION,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040947,10040943,10040947
ONDANSETRON INDUCED CORONARY ARTERY SPASM,Arteriospasm coronary,CORONARY ARTERY SPASM,ARTERIOSPASM CORONARY,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10003225,10003225,10011088
ULCERATION,ulceration,ULCERATION,ULCER,TISSUE DISORDERS NEC,ULCERS NEC,10018065,10080913,10045285,10080913
"VIOLACEOUS, FLAT-TOPPED, 3- TO 6-MM DISCRETE AND COALESCING PAPULES ON HIS DORSAL HANDS, BACK, CHEST, ABDOMEN, BUTTOCKS, AND LOWER EXTREMITIES",Rash papular,PAPULAR RASH,RASH PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037876,10037876,10033726
LOW ADHERENCE,inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
EXCESSIVE DAYTIME SOMNOLENCE,Excessive daytime sleepiness,EXCESSIVE DAYTIME SLEEPINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10015595,10041349,10015595
COMATOSE FOLLOWING DIFFUSE ADENOVIRUS ENDOTHELIITIS IN ALL ORGANS,Coma,COMATOSE,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10058472,10010071,10058472
PATIENT BECAME GLOBALLY SPASTIC,Muscle spasms,SPASMS,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10041408,10028334,10041408
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
CONDITION AGGRAVATED,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
ACUTE RESPIRATORY DISTRESS SYNDROME FOLLOWING ASPIRATION PNEUMONIA,Acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
"THE SEIZURES PERSISTED DESPITE THE ADMINISTRATION OF VALPROATE, LEVETIRACETAM AND CLONAZEPAM",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
STEROID RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
SEXUAL DYSFUNCTION,sexual dysfunction,SEXUAL DYSFUNCTION,SEXUAL DYSFUNCTION,SEXUAL FUNCTION AND FERTILITY DISORDERS,SEXUAL FUNCTION AND FERTILITY DISORDERS NEC,10038604,10040477,10040477,10040477
TACHYCARDIA (105 BEATS PER MINUTE),Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
RESPIRATORY DISTRESS FOLLOWING OPIUM POISONING,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
"PINPOINT ERYTHEMATOUS, PAPULAR LESIONS",Rash erythematous,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015243
BREATHLESSNESS,Dyspnoea,BREATHLESSNESS,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10006345
NEPHRITIS,nephritis,NEPHRITIS,NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029117,10029117,10029117
POSTURAL HYPOTENSION (90/65 MMHG) FOLLOWING CAPILLARY LEAK SYNDROME,Orthostatic hypotension,POSTURAL HYPOTENSION,ORTHOSTATIC HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10036433,10031127,10036433
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
GRADE III DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
HYPERSENSITIVITY,Hypersensitivity,HYPERSENSITIVITY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020751,10020751,10020751
MULTIPLE DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
EDEMA OF THE HANDS AND FINGERS,Edema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014210,10030095,10014210
"INSULIN-DEPENDENT DIABETES MELLITUS,LIKELY STEROID INDUCED",Type 1 diabetes mellitus,INSULIN-DEPENDENT DIABETES MELLITUS,TYPE 1 DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012608,10067584,10022497
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
METHYLPHENIDATE ABUSE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
SEVERE METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
BUFFALO HUMP,Lipohypertrophy,BUFFALO HUMP,LIPOHYPERTROPHY,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,LIPODYSTROPHIES,10040785,10006539,10062315,10006539
HYPOTHERMIA,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
HEMORRHAGIC CYSTITIS,hemorrhagic cystitis,HEMORRHAGIC CYSTITIS,CYSTITIS HAEMORRHAGIC,BLADDER AND BLADDER NECK DISORDERS (EXCL CALCULI),BLADDER INFECTIONS AND INFLAMMATIONS,10038359,10019598,10011793,10019598
PATIENT RECEIVED CONDITIONING REGIMEN OF FLUDARABINE IN ALL WITH NO ADVERSE EVENT (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SERUM GALACTOMANNAN POSITIVE,Aspergillus test,GALACTOMANNAN ANTIGEN,ASPERGILLUS TEST,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,FUNGUS IDENTIFICATION AND SEROLOGY,10022891,10075170,10070450,10075170
HYPOGLYCEMIA (BLOOD GLUCOSE 19 MG/DL),Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
SLOUGHING ESOPHAGITIS,esophagitis,ESOPHAGITIS,OESOPHAGITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,OESOPHAGITIS (EXCL INFECTIVE),10017947,10015461,10030216,10015461
MYALGIA IN THE BACK/BACK MYALGIA ON EZETIMIBE TREATMENT,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
CANCER DOWNSTAGED TO YCT2N0M0YC STAGE IB AFTER NAC AND WAS DETERMINED AS A PARTIAL RESPONSE (SUB THERAPEUTIC EFFECT) WITH NO ADR.,sub therapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PATINET HAD BEEN PLACED ON RILUZOLE BUT CONTINUED TO PROGRESS,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
"IN HER FIFTH PREGNANCY, SHE SELF-DISCONTINUED AMITRIPTYLINE",Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
INTOXICATION,Poisoning,INTOXICATION,POISONING,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10061355,10061355,10022727
FREEZING OF GAIT,Gait disturbance,GAIT DISTURBANCE,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017577,10017577,10017577
THROMBOCYTES COUNT DECREASED (69X10E3 PER MICROLITRE),Platelet count decreased,THROMBOCYTE COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10043546
METABOLIC BONE DISORDER/SEVERE DEMINERALIZATION,Bone disorder,BONE DISORDER,BONE DISORDER,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10005956,10005956,10005956
LEFT-SIDED HEMIPARESIS,left-sided hemiparesis,HEMIPARESIS,HEMIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019465,10019465,10019465
VOMIT (CTCAE GRADE 2),Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
MULTIPLE DRUG-RESISTANT EPILEPSY,Multiple-drug resistance,MULTIPLE-DRUG RESISTANCE,MULTIPLE-DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048723,10048723,10048723
UNSUCCESSFUL TREATMENT OF ENTERITIS DUE TO ISOSPORA BELLI WITH SPIRAMYCIN (TREATMENT FAILURE),treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
TREATED WITH 600 MG FLUCONAZOLE TWICE DAILY,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
STILLBIRTH,Stillbirth,STILLBIRTH,STILLBIRTH,ABORTIONS AND STILLBIRTH,STILLBIRTH AND FOETAL DEATH,10036585,10042062,10042062,10042062
FATAL FLECAINIDE INTOXICATION,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
MACROVASICULAR STEATOSIS,Steatosis hepatic,STEATOSIS HEPATIC,HEPATIC STEATOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10041970,10019708,10041970
NET IMPAIRED QUALITY OF LIFE,Impaired quality of life,IMPAIRED QUALITY OF LIFE,IMPAIRED QUALITY OF LIFE,LIFESTYLE ISSUES,SOCIAL ISSUES NEC,10041244,10076936,10076936,10076936
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
CONDITION  DETERIORATED,Condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
ABUSE AND FATALITIES,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
VAGINITIS,vaginitis,VAGINITIS,VAGINAL INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,FEMALE REPRODUCTIVE TRACT INFECTIONS,10021881,10046950,10046914,10046950
ACUTE RENAL FAILURE RESULTING IN METHOTREXATE OVEREXPOSURE,acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
CEFTRIOXONE INDUCED HEMOLYTIC ANEMIA/ ACUTE HEMOLYTIC REACTION,Haemolytic anaemia,HEMOLYTIC ANEMIA DRUG-INDUCED,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10018918,10018916,10055208
ALTERED MENTATION,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
1ST DEGREE AV-BLOCKAGE DUE TO HYPERKALEMIA,Heart block AV first degree,HEART BLOCK AV FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10019258,10003674,10019258
DRUG INTERACTION BETWEEN PIPERACILLIN/TAZOBACTAM AND VANCOMYCIN,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
PROLONGED NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
TENDINITIS,tendinitis,TENDINITIS,TENDONITIS,"TENDON, LIGAMENT AND CARTILAGE DISORDERS",TENDON DISORDERS,10028395,10043232,10043255,10043232
"PATIENT DID NOT BENEFIT FROM TREATMENT OF PROPRANOLOL, PRIMIDONE AND GABAPENTIN",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
ERYTHEMATOUS RASH ON HIS FACE AND UPPER TORSO WITH SOME TENDENCY TO INVOLVE THE LOWER TORSO AND THE LOWER EXTREMITIES AS WELL,Rash erythematous,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015243
MILD HYPERGLYCEMIA,Hyperglycaemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020639
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
INTENTIONAL INGESTION OF 65 G PARACETAMOL EACH TIME.,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
RECURRENT PURPURIC RASH CONSISTENT ON SKIN BIOPSY WITH LEUKOCYTOCLASTIC VASCULITIS,Purpura,PURPURIC RASH,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037566,10037549,10037566
ALLERGY,Hypersensitivity,ALLERGY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001738,10020751,10001738
ONE PATIENT PRESENTED A POST-COLONOSCOPY FLARE OF UC,Colitis ulcerative,COLITIS ULCERATIVE AGGRAVATED,COLITIS ULCERATIVE,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009901,10009900,10009901
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
DRUG INTERACTION WITH CARBAMAZEPINE,drug interaction ,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
BABY SHOWED SIGNS OF WITHDRAWAL,Drug withdrawal syndrome neonatal,WITHDRAWAL SYNDROME NEONATAL,DRUG WITHDRAWAL SYNDROME NEONATAL,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10013756,10013756,10048012
ASCITES,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
"IN THE PRESENCE OF STIGMAS OF PARKINSONISM (TREMORS, APATHY, HYPOPHONY, ETC.) OF NEUROLOGY.""",Parkinsonism,PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034010,10034010,10034010
PERSISTENT AND RECURRENT HIP JOINT INFECTION CAUSED BY STAPHYLOCOCCUS ARGENTEUS DEVELOPING INTO SMALL COLONY VARIANTS INDUCED BY AMIKACIN DUE TO GENE MUTATION,Staphylococcal infection,STAPHYLOCOCCAL INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10058080,10058080,10058080
GENERALIZED MALAISE,generalized malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
DIFFICULITY VOIDING,Dysuria,DIFFICULTY VOIDING,DYSURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10013990,10013990,10012806
DARK URINE,Chromaturia,URINE DISCOLOURATION,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10046629,10008796,10046629
HEMOPTYSIS/ STREAKS OF BLOOD IN HIS SPUTUM/ MASSIVE HEMOPTYSIS,Haemoptysis,HEMOPTYSIS,HAEMOPTYSIS,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10018964,10018964,10019523
MIOSIS,Miosis,MIOSIS,MIOSIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10027646,10027646,10027646
NON-IMMUNOLOGICAL HEMOLYTIC ANEMIA/ ANEMIZATION,Haemolytic anaemia,HEMOLYTIC ANEMIA,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10018916,10018916,10019493
BETA-HCG INCREASED,Human chorionic gonadotropin increased,HUMAN CHORIONIC GONADOTROPIN INCREASED,HUMAN CHORIONIC GONADOTROPIN INCREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),REPRODUCTIVE HORMONE ANALYSES,10022891,10071332,10071332,10071332
"WATERY DIARRHEA,WHICH OCCURRED 5-6 TIMES A DAY ( HOWEVER, THE FREQUENCY OF HIS DIARRHEA EPISODES HAD INCREASED TO >10 TIMES/DAY LATER ON)",Diarrhoea,WATERY DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10047849,10012735,10055422
BURNING,burning sensation,BURNING SENSATION,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10006784,10006784,10006784
DRUG RESISTANCE,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
MASSIVE HAEMOLYSIS IN SEVERE SEPSIS,Haemolysis,HAEMOLYSIS,HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10018910,10018910,10018910
MAJOR TOXICITIES,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
HEMOLYTIC UREMIC SYNDROME,Haemolytic uraemic syndrome,HEMOLYTIC UREMIC SYNDROME,HAEMOLYTIC URAEMIC SYNDROME,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC MECHANICAL FACTOR,10005329,10018932,10018932,10019515
MODERATE PROXIMAL LEFT ANTERIOR DESCENDENT CORONARY ARTERY STENOSIS,Coronary artery stenosis,LEFT ANTERIOR DESCENDING CORONARY ARTERY STENOSIS,CORONARY ARTERY STENOSIS,CORONARY ARTERY DISORDERS,CORONARY ARTERY DISORDERS NEC,10007541,10072048,10011089,10072048
DROWSINESS/ INCREASING DROWSINESS REQUIRED ENDOTRACHEAL INTUBATION,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
ABNORMAL FINDINGS ON MRI,MRI brain abnormal,MRI BRAIN ABNORMAL,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CENTRAL NERVOUS SYSTEM IMAGING PROCEDURES,10022891,10056922,10029818,10056922
POTENTIAL DRUG INTERACTIONS BETWEEN ANTIRETROVIRAL AND ANTIPLATELET DRUGS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
SINUSOIDAL OBSTRUCTION SYNDROME,Venoocclusive liver disease,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
GGT INCREASED (2000 IU/L),Gamma-glutamyltransferase increased,GGT INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056910,10017693,10056910
MUCOSITIS,mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
CENTRAL OBESITY ASSOCIATED WITH CHRONIC USE OF STEROID,Central obesity,CENTRAL OBESITY,CENTRAL OBESITY,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10065941,10065941,10065941
BLOOD UREA NITROGEN INCREASED (84 MG/DL),Blood urea increased,BLOOD UREA NITROGEN INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005855,10005851,10005855
DIABETIC NEPHROPATHY,Diabetic nephropathy,DIABETIC NEPHROPATHY,DIABETIC NEPHROPATHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10061835,10061835,10061835
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
DIRECT ANTIGLOBU-LIN TEST (DAT) WAS NEGATIVE,Coombs direct test negative,COOMBS DIRECT TEST NEGATIVE,COOMBS DIRECT TEST NEGATIVE,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),BLOOD GROUPING AND CROSS-MATCHING ANALYSES,10022891,10010931,10010931,10010931
MATERNAL TACHYCARDIA OF 130/MIN PERSISTED,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
HAND TREMOR AGGRAVATED,Tremor,TREMOR OF HANDS,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10040530,10044565,10044577
DIFFUSE LARGE B CELL LYMPHOMA,B-cell lymphoma,B-CELL LYMPHOMA,B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,B-CELL LYMPHOMAS NEC,10029104,10003899,10003899,10003899
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
MOOD SWING,mood swing,MOOD SWINGS,MOOD SWINGS,MOOD DISORDERS AND DISTURBANCES NEC,FLUCTUATING MOOD SYMPTOMS,10037175,10027951,10027951,10027951
HYPOKALEMIA AND METABOLIC ACIDOSIS.,Hypokalaemia,HYPOKALEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021018
METFORMIN ASSOCIATED LACTIC ACIDOSIS,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
DRUG ALLERGY,Drug hypersensitivity,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
VIRAL RESISTANCE,Viral resistance,VIRAL RESISTANCE,PATHOGEN RESISTANCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10068750,10034133,10068750
SKIN ITCHING,Pruritus,ITCHY SKIN,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023094,10037087,10023094
TONIC-CLONIC SEIZURES,Generalised tonic-clonic seizure,TONIC-CLONIC SEIZURES,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10044000,10018100,10044000
PYRAZINAMIDE-INDUCED PHOTOTOXICITY,phototoxicity,PHOTOTOXICITY,PHOTOSENSITIVITY REACTION,EPIDERMAL AND DERMAL CONDITIONS,PHOTOSENSITIVITY AND PHOTODERMATOSIS CONDITIONS,10040785,10034977,10034972,10034977
INVERSION OF SLEEP-WAKING CYCLE,Sleep disorder,SLEEP PROBLEM,SLEEP DISORDER,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10040984,10040984,10041005
ACHIEVING BLOOD LEVELS >500 NG/ML (THERAPEUTIC BENCHMARK: 400 NG/ML),drug level above therapeutic,DRUG LEVEL ABOVE THERAPEUTIC,DRUG LEVEL ABOVE THERAPEUTIC,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10061132,10061132,10061132
VZV AND HSV ASSOCIATED BELL'S PALSY,Bell's palsy,BELL'S PALSY,FACIAL PARALYSIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),FACIAL CRANIAL NERVE DISORDERS,10029205,10004223,10016062,10004223
ANTERIOR SEGMENT INFLAMMATION,Eye inflammation,EYE INFLAMMATION,EYE INFLAMMATION,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10015943,10015943,10015943
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
HYPERPROLACTINEMIA,hyperprolactinemia,HYPERPROLACTINEMIA,HYPERPROLACTINAEMIA,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPERFUNCTION,10014698,10020739,10020737,10020739
ZOLPIDEM DEPENDENCE,Drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
INJURED RENAL TUBULES WITH MILD ATROPHIC,Renal tubular atrophy,RENAL TUBULAR ATROPHY,RENAL TUBULAR ATROPHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10038536,10038536,10038536
ABDOMINAL CRAMPING,Abdominal pain,ABDOMINAL CRAMPS,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000055,10000081,10000057
ASPIRATION PNEUMONIA,Pneumonia aspiration,ASPIRATION PNEUMONIA,PNEUMONIA ASPIRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10035669,10035669,10003525
HYPOGLYCAEMIA,hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
40 DEGREE CELCIUS FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
INCREASING NUMBNESS AND TINGLING IN HER DISTAL LOWER EXTREMETIES,Paraesthesia,TINGLING OF EXTREMITY,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10063451,10033775,10063451
FEVER (38.2 C),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,Acute generalised exanthematous pustulosis,ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10062372
ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,Acute generalised exanthematous pustulosis,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10048799
TAKAYASU'S ARTERITIS SUSPECTED,Takayasu's arteritis,TAKAYASU'S ARTERITIS,TAKAYASU'S ARTERITIS,VASCULAR INFLAMMATIONS,ARTERIAL INFLAMMATIONS,10047065,10043097,10043097,10043097
SLIGHT CONJUNCTIVITIS,slight conjunctivitis,CONJUNCTIVITIS,CONJUNCTIVITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10010741,10010741,10010741
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
DRY MOUTH,Dry mouth,DRY MOUTH,DRY MOUTH,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10013781,10013781,10013781
INABILITY TO PERFORM TANDEM GAIT,Gait disturbance,GAIT DISORDER,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017577,10017577,10017576
GGT INCREASED,Gamma-glutamyltransferase increased,GGT INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056910,10017693,10056910
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
IRON DEFICIENCY,iron deficiency,IRON DEFICIENCY,IRON DEFICIENCY,IRON AND TRACE METAL METABOLISM DISORDERS,IRON DEFICIENCIES,10027433,10022970,10022970,10022970
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PANCYTOPENIA,pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
"FIRST LINE TREATMENT FOR CP-CML FOR 2 YERAS, UNTIL RESISTANCE DEVELOPED.",Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
"TREATMENT WITH PERINDOPRIL, INDAPAMIDE AND METOPROLOL HAD NO EFFECT WITH NO REPORTED ADR (LACK OF DRUG EFFECT)",Lack of Efficacy,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PROTRACTED LEUKOPENIA,Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
CONFUSION,confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
DIFFUSE PAINFUL DERMAL AND SUBCUTANEOUS NODULES,Skin mass,SKIN NODULE,SKIN MASS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS CONDITIONS NEC,10040785,10040902,10067868,10040902
PERICARDIAL EFFUSION,pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
HAND TREMORS,Tremor of hands,TREMOR OF HANDS,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044577,10044565,10044577
BULLOUS PEMPHIGOID,bullous pemphigoid,BULLOUS PEMPHIGOID,PEMPHIGOID,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006567,10034277,10006567
AMIODARONE INDUCED THYROTOXICOSIS,Thyrotoxicosis,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
RESCUE THERAPY WITH ALEMTUZUMAB IN MULTIPLE SCLEROSIS POST-NATALIZUMAB PUERPERIUM REACTIVATION/ALEMTUZUMAB ADMINISTERED FOR HIGH POSTPARTUM MS INFLAMMATORY ACTIVITY,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MYALGIA,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
BILATERAL HIPPOCAMPAL SCLEROSIS,hippocampal sclerosis,HIPPOCAMPAL SCLEROSIS,HIPPOCAMPAL SCLEROSIS,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10063629,10063629,10063629
BLOOD UREA NITROGEN (BUN 123 MG/DL),Blood urea increased,BUN INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10006576,10005851,10006576
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
LESION WAS INDURATED AND MILDLY INFILTRATED,Injection site extravasation,INJECTION SITE INFILTRATION,INJECTION SITE EXTRAVASATION,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022077,10022062,10022077
MULTIPLE DRUG TOXICITY/ MIXED DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
ASPIRATION PNEUMONIA,Pneumonia aspiration,ASPIRATION PNEUMONIA,PNEUMONIA ASPIRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10035669,10035669,10003525
PORTAL HYPERTENSION,Portal hypertension,PORTAL HYPERTENSION,PORTAL HYPERTENSION,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10036200,10036200,10036200
MYCOBACTERIUM TUBERCULOSIS,Mycobacterium tuberculosis complex test positive,MYCOBACTERIUM TUBERCULOSIS TEST POSITIVE,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,MYCOBACTERIA IDENTIFICATION AND SEROLOGY,10022891,10066074,10070325,10070329
GINGIVAL OVERGROWTH,Gingival hypertrophy,GINGIVAL HYPERTROPHY,GINGIVAL HYPERTROPHY,DENTAL AND GINGIVAL CONDITIONS,GINGIVAL DISORDERS NEC,10017947,10018284,10018284,10018284
"SCALY LESIONS ON AN ERYTHEMATOSUS BASE ON CHEEKS, NOSE AND FOREHEAD",Exfoliative rash,RASH SCALY,EXFOLIATIVE RASH,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10037889,10064579,10037889
STUPOROUS,Stupor,STUPOR,STUPOR,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042264,10042264,10042264
HEART FAILURE FOLLOWING ANAPHYLACTIC SHOCK,heart failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10019279,10007554,10019279
SWELLING,swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
ACUTE OVERDOSE,Overdose,ACUTE OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067695,10033295,10067695
SLIGHT COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
GFR GROUP AT DIAGNOSIS (15-29 ML/MIN),Glomerular filtration rate decreased,GFR DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018214,10018358,10018214
DROWSINESS,drowsiness,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
CUTANEOUS HYPERPIGMENTATION,Skin hyperpigmentation,SKIN HYPERPIGMENTATION,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10040865,10040865,10040865
"REDUCED INTENSITY CONDITIONING WITH ALEMTUZUMAB, TARGETED BUSULFAN AND FLUDARABINE",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FOLLICULAR KERATOTIC PLUGS DUE TO MAJOCCHI'S GRANULOMA FOLLOWING IMMUNOSUPPRESSION CAUSED BY TREATMENT WITH CORTICOSTEROIDS AND MYCOPHENOLATE MOFETIL,Keratosis follicular,KERATOSIS FOLLICULAR,KERATOSIS FOLLICULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL NEC,10010331,10023369,10023369,10023369
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DRUG INTERACTION,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
SCIATICA,sciatica,SCIATICA,SCIATICA,SPINAL CORD AND NERVE ROOT DISORDERS,LUMBAR SPINAL CORD AND NERVE ROOT DISORDERS,10029205,10039674,10039674,10039674
ALLERGY,Hypersensitivity,ALLERGY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001738,10020751,10001738
TRANSIENT ERYTHEMA,transient erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
GRADE 3 PERIPHERAL NEUROPATHY,Peripheral neuropathy,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10080342,10029331,10080342
INFLAMMATION IN MESENTERY AND WALLS OF INTESTINAL LOOPS,Inflammation,INFLAMMATION,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10061218,10061218,10061218
PAIN WAS NOT RELIEVED AFTER ORAL ADMINISTRATION OF CARBAMAZEPINE/ LACK OF EFFICACY,Lack of drug,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PLEOCYTOSIS,Pleocytosis,PLEOCYTOSIS,PLEOCYTOSIS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10035551,10035551,10035551
MEDIAL MECHANICAL ECTROPION,Ectropion,MECHANICAL ECTROPION,ECTROPION,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","LID, LASH AND LACRIMAL STRUCTURAL DISORDERS",10015919,10027047,10014179,10027047
TIGHTNESS IN THE THROAT,Throat tightness,THROAT TIGHTNESS,THROAT TIGHTNESS,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10043528,10043528,10043528
TINNITUS,tinnitus,TINNITUS,TINNITUS,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10043882,10043882,10043882
MXD (DIFFERENTIAL WHITE BLOOD CELL) COUNT RAISED AT 1.8 AND 1.7 X10E9/L,Differential white blood cell count abnormal,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10012785,10012785,10012785
RED AND WATERING EYES,red and watering eyes,WATERING EYES,LACRIMATION INCREASED,EYE DISORDERS NEC,LACRIMATION DISORDERS,10015919,10047848,10023644,10047848
GENERALISED ERYTHEMATOUS PLAQUES ON SCALP,skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
PERSISTENT BRONCHITIS,Bronchitis,BRONCHITIS,BRONCHITIS,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10006451,10006451,10006451
AN AUDIOGRAM SHOWED A UNILATERAL 25 DB HIGH FREQUENCY LOSS,hearing loss,HEARING LOSS,DEAFNESS,HEARING DISORDERS,HEARING LOSSES,10013993,10019246,10011878,10019246
IMATINIB WAS SUSPENDED FOR DRUG RESISTANCE ONSET,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
PATIENT TREATED WITH HYDROXYCHLOROQUINE FOR LICHEN SCLEROSUS (UNAPPROVED INDICATION) AND HYDROXYCHLOROQUINE RE-ADMINISTERED AFTER MACULOPATHY DIAGNOSIS (UNAPPROVED POPULATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DISORIENTATED,Disorientation,DISORIENTATED,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013394
HIGH SERUM CREATININE KINASE,Blood creatine phosphokinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
PROGRESSION OF LUNG IN FILTRATES,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
LEG STRENGTH REDUCED,Asthenia,STRENGTH LOSS OF,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10042174,10003549,10042174
ENDOCARDITIS,Endocarditis,ENDOCARDITIS,ENDOCARDITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CARDIAC INFECTIONS,10021881,10014665,10014665,10014665
MULTIPLE ORGAN DYSFUNCTION SYNDROME FOLLOWING PROGRESSION OF METASTATIC TESTICULAR CHORIOCARCINOMA,multiple organ dysfunction syndrome following progression of metastatic testicular choriocarcinoma,MULTIPLE ORGAN DYSFUNCTION SYNDROME,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10077361,10077361,10077361
DESPITE TREATMENT THE PATIENT CONTINUED TO DETERIORATE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
RIGIDITY,Muscle rigidity,RIGIDITY,MUSCLE RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10039168,10028330,10039168
KIDNEY FUNCTION LOSS,Function kidney decreased,FUNCTION KIDNEY DECREASED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10017474,10062237,10017474
TAXANE-INDUCED CUTANEOUS TOXICITY (GRADE 2),Skin toxicity,SKIN TOXICITY,SKIN TOXICITY,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10059516,10059516,10059516
CHRONIC DIARRHOEA,chronic diarrhoea,CHRONIC DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10066557,10012735,10066557
QT/QTC INTERVALS PROLONGED 586/724 MS,QT prolonged,QT PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037705,10014387,10037705
GRADE I ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
THALAMIC PAIN SYNDROME,Thalamic pain,THALAMIC PAIN,CENTRAL PAIN SYNDROME,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10065533,10064012,10065533
DISORGANIZED BEHAVIOR,Abnormal behaviour,BEHAVIOR ABNORMAL,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10061422,10061422,10004203
INTERSTITIAL LUNG DISEASE,Interstitial lung disease,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
GENERALISED BRADYKINESIA,Bradykinesia,BRADYKINESIA,BRADYKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10006100,10006100,10006100
CEPHALEA,cephalgia,CEPHALGIA,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10008013,10019211,10008013
ALP INCREASED (395 IU/L),Blood alkaline phosphatase increased,ALP INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001771,10059570,10001771
BK VIREMIA,BK Viremia,BK VIRUS INFECTION,BK VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10055181,10055181,10055181
SEROTONIN SYNDROME,Serotonin syndrome,SEROTONIN SYNDROME,SEROTONIN SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10040108,10040108,10040108
HYPOGLYCAEMIA/SYMPTOMATIC HYPOGLYCAEMIA ACCOMPANYING INCREASED PHYSICAL EXERTION/NOCTURNAL HYPOGLYCAEMIA,Hypoglycemia night,HYPOGLYCEMIA NIGHT,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10060490,10020993,10060490
ANISOCORIA,anisocoria,ANISOCORIA,PUPILS UNEQUAL,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10002535,10037538,10002535
URINE PROTEIN/CREATININE RATIO INCREASED (10.2 G/DAY),Urine protein/creatinine ratio increased,URINE PROTEIN/CREATININE RATIO INCREASED,URINE PROTEIN/CREATININE RATIO INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10053538,10053538,10053538
INTRAVENOUS MISUSE OF ORAL DRUGS (METHADONE SYRUP DIRECTLY INTO BR...,Wrong route of administration,WRONG ROUTE OF ADMINISTRATION,INCORRECT ROUTE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10048057,10064304,10048057
VRE BACTEREMIA PERSISITED DESPITE CONCURRENT DAPTOMYCIN AND GENTAMICIN USE (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
MYOCARDIAL INFARCTION AND LEFT VENTRICULAR DYSFUNCTION.,Myocardial infarction,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10028596,10028596,10028596
DRUG INTERACTION BETWEEN ATAZANAVIR AND DOLUTEGRAVIR,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
CENTRAL AND PERIPHERAL NEUROTOXICITY CAUSED BY METRONIDAZOLE,Nervous system disorder,CENTRAL NERVOUS SYSTEM DISORDER,NERVOUS SYSTEM DISORDER,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10007943,10029202,10007943
"ACUTE TOXIC HEPATITIS/NECROTIZING HEPATOPATHY, WHICH WAS INTERPRETED AS TOXIC HEPATITIS",Hepatitis toxic,HEPATITIS TOXIC,HEPATITIS TOXIC,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019795,10019795,10019795
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
ANXIETY,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
MONONEUROPATHY,Mononeuropathy,MONONEUROPATHY,MONONEUROPATHY,PERIPHERAL NEUROPATHIES,MONONEUROPATHIES,10029205,10062203,10062203,10062203
REVERSIBLE NEUTROPENIA (NEUTROPHIL GRANULOCYTE <5 PERCENT),Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
HYPERAMMONAEMIC ENCEPHALOPATHY DURING TREATMENT WITH SODIUM VALPROATE,Hyperammonaemic encephalopathy,HYPERAMMONAEMIC ENCEPHALOPATHY,HYPERAMMONAEMIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10067327,10067327,10067327
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
SENNA MISUSE,Intentional product misuse,INTENTIONAL PRODUCT MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10074903,10074903,10074903
LOMENTOSPORA PROLIFICANS INFECTION,Scedosporium prolificans infection,SCEDOSPORIUM PROLIFICANS INFECTION,SCEDOSPORIUM INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10076592,10059045,10076592
LEUKOPENIA,Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
DRUG USE FOR UNAPPROVED POPULATION (OFF LABEL USE WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HYPOTENSIVE,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
A MODERATELY SEVERE CORTICOSUBCORTICAL BRAIN ATROPHY,cerebral atrophy,CEREBRAL ATROPHY,CEREBRAL ATROPHY,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10008096,10008096,10008096
HYPERSENSITIVITY REACTION,hypersensitivity reaction,HYPERSENSITIVITY REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020756,10020751,10020756
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
CHRONIC HEPATITIS C,Chronic hepatitis C,CHRONIC HEPATITIS C,CHRONIC HEPATITIS C,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10008912,10008912,10008912
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
MUCOSITIS,mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
VANDETANIB-INDUCED GRADE 2 CORNEA VERTICILLATA,cornea verticillata,CORNEA VERTICILLATA,CORNEA VERTICILLATA,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CORNEAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10077604,10077604,10077604
PATIENT RECEIVED HYDROXYCHLOROQUINE BEFORE 16 WEEKS GESTATION,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
PHYSICAL EXAMINATION REVEALED TREMORS,tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
LEFT SIDED HEMIPLEGIA FOLLOWING CENTRAL NERVOUS SYSTEM NEUROTOXICITY,Hemiplegia,HEMIPLEGIA (LEFT),HEMIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019469,10019468,10019469
WORSENING OF SCEDOSPORIUM APIOSPERMUM INFECTION DESPITE SYSTEMIC COMBINED TREATMENT AND APPROPRIATE POSACONAZOLE LEVELS,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
METAMIZOLE-INDUCED AGRANULOCYTOSIS,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
"LYMPHADENOPATHY IN THE NECK, THORAX AND ABDOMEN",Lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
STAGE 3 MEDICATION-RELATED OSTEONECROSIS OF THE JAW (SUB-TOTAL MANDIBLE),Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
WORSENING OF PULMONARY NODULES,Pulmonary mass,LUNG NODULE,PULMONARY MASS,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10049498,10056342,10049498
CIRCULATORY ARREST,Circulatory collapse,CIRCULATORY COLLAPSE,CIRCULATORY COLLAPSE,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10009192,10009192,10009192
ACCIDENTAL INGESTION OF DRUG,Accidental ingestion of drug,ACCIDENTAL INGESTION OF DRUG,ACCIDENTAL EXPOSURE TO PRODUCT,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,ACCIDENTAL EXPOSURES TO PRODUCT,10022117,10073319,10073317,10073319
CONFUSED CONVERSATION,Confusional state,CONFUSED,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010298
PSORIASIS AND PEMPHIGUS FOLIACEUS AGGRAVATED BY ENALAPRIL AND AMLODIPINE INTAKE,Psoriasis,PSORIASIS AGGRAVATED,PSORIASIS,EPIDERMAL AND DERMAL CONDITIONS,PSORIATIC CONDITIONS,10040785,10037154,10037153,10037154
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
SEVERE ACTIVATION OF DISEASE DURING IMMUNOTHERAPY,Multiple sclerosis relapse,MULTIPLE SCLEROSIS RELAPSE,MULTIPLE SCLEROSIS RELAPSE,DEMYELINATING DISORDERS,MULTIPLE SCLEROSIS ACUTE AND PROGRESSIVE,10029205,10048393,10048393,10048393
ELEVATED PSA LEVEL,PSA increased,PSA INCREASED,PROSTATIC SPECIFIC ANTIGEN INCREASED,CYTOGENETIC INVESTIGATIONS,CELL MARKER ANALYSES,10022891,10037102,10036975,10037102
AURICULAR SWELLING,Auricular swelling,AURICULAR SWELLING,AURICULAR SWELLING,EXTERNAL EAR DISORDERS (EXCL CONGENITAL),EXTERNAL EAR DISORDERS NEC,10013993,10003800,10003800,10003800
ANEMIA PROGRESSED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) SYNDROME,drug reaction with eosinophilia and systemic symptoms,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
LOWER DOSES OF PREDNISONE RESULTED IN WORSENING URTICARIA FOLLOWING REBOUND EFFECT,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
LITHIUM TREATMENT DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
DRUG ABUSE,drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
VALVULAR REGURGITATION,Heart valve incompetence,HEART VALVE REGURGITATION,HEART VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,CARDIAC VALVE DISORDERS NEC,10007541,10067673,10067660,10067673
MACRO-HAEMATURIA,Haematuria,MACROSCOPIC HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10017332,10018867,10059823
LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
LOW PLASMA UREA (0.9 IU/L),Blood urea decreased,PLASMA UREA DECREASED,BLOOD UREA DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10035463,10005850,10035463
INCREASING RESTING HEART RATE,heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
DRUG USE FOR UNAPPROVED INDICATION/OFF LABEL USE,drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
SYNCOPE,Syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
PREGNANT PATIENT TREATED WITH TRIAMCINOLONE ACETONIDE WITH NO ADR (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PNEUMONITIS WORSENED FOLLOWING LACK OF DRUG EFFECT,Pneumonitis,PNEUMONITIS,PNEUMONITIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10035742,10035742,10035742
DARK URINE,Chromaturia,URINE COLOURING BLACK,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10046618,10008796,10046618
"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER WITH NO ADR","Drug exposure during pregnancy, third trimester","DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
SKIN DETACHMENT (50%TBSA,,,,,EPIDERMAL AND DERMAL CONDITIONS,10014982,10034218,10040844,
"DESPITE METHYLPREDNISOLONE, CYCLOPHOSHAMIDE AND RITUXIMAB, HIS CONDITION DETERIORATED AND INTERSTITIAL LUNG DISEASE PROGRESSED (LACK OF DRUG EFFECT) AND HE DIED",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PALPITATION,Palpitations,PALPITATION,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033556
SEVERE COUGH,severe cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
RENAL TRANSPLANT FAILURE,Renal transplant failure,RENAL GRAFT LOSS,RENAL TRANSPLANT FAILURE,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10048749,10074495,10048749
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
NEUTROPENIC FEVER,Febrile neutropenia,NEUTROPENIC FEVER,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10051312,10016288,10051312
GENERAL MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
"METHOTREXATE, CLINDAMYCIN, ISOTRETINOIN, ACITRETIN USED FOR FOLLICULITIS DECALVANS",Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
OSTEONECROSIS OF JAW,Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
ATTENTION DEFICIT DISORDER,attention deficit disorder,ATTENTION DEFICIT DISORDER,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,COGNITIVE AND ATTENTION DISORDERS AND DISTURBANCES,ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOUR DISORDERS,10037175,10003731,10003736,10003731
APPETITE LOSS,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
DIFFUSE ITCHY XEROTIC SCALING MACULES,Macule,MACULE,MACULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10025421,10025421,10025421
TRANSIENT EXPRESSIVE APHASIA,Transient aphasia,TRANSIENT APHASIA,TRANSIENT APHASIA,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,TRANSIENT CEREBROVASCULAR EVENTS,10029205,10080106,10080106,10080106
MILD LOWER ABDOMINAL TENDERNESS TO PALPATION,Abdominal tenderness,TENDERNESS EPIGASTRIC,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10043227,10000097,10043227
VISUAL CHANGES,Visual impairment,VISUAL DISTURBANCE,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047543,10047571,10047543
HYPERCALCEMIA (16.1 MG/DL),Hypercalcaemia,HYPERCALCEMIA,HYPERCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020583,10020583,10020587
ESCHERICHIA COLI INFECTION,Escherichia coli infection,ESCHERICHIA COLI INFECTION,ESCHERICHIA INFECTION,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10054242,10061126,10054242
BLURRING OF VISION ASSOCIATED WITH PAIN AND ANXIETY,Vision blurred,BLURRING OF VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047513,10047513,10005888
ANXIOUSNESS,feeling anxious,FEELING ANXIOUS,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10016323,10002855,10016323
BLOOD UREA NITROGEN OF 26 (REF: 6-20 MG/DL),Blood urea nitrogen increased,BLOOD UREA NITROGEN INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005855,10005851,10005855
LEVAMISOLE-INDUCED VASCULITIS,vasculitis,VASCULITIS,VASCULITIS,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10047115,10047115,10047115
JAW PAIN,Jaw pain,JAW PAIN,PAIN IN JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10023157,10033433,10023157
MULTIORGAN FAILURE DUE TO SEPSIS,Multiple organ dysfunction syndrome,MULTIORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028162
ACUTE CELLULAR REJECTION DUE TO BK ALLOGRAFT NEPHROPATHY,acute cellular rejection,ACUTE CELLULAR REJECTION,TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10049237,10044439,10049237
ERYTHEMATOUS ERUPTION,Rash erythematous,ERYTHEMATOUS ERUPTION,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015241
RAISED CRP (UNKNOWN CAUSE),C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
MASSIVE GPT INCREASE,Alanine aminotransferase increased,GPT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10018644,10001551,10018644
SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
NASALã€€BLEEDING,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
SERUM SICKNESS-LIKE REACTION,Serum sickness-like reaction,SERUM SICKNESS-LIKE REACTION,SERUM SICKNESS-LIKE REACTION,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10040402,10040402,10040402
PATIENT WAS TREATED WITH NOREPINEPHRINE AND PENTAGLOBIN/ NO CLINICAL IMPROVEMENTS WERE OBSERVED BUT A PREGRESSIVE SERIOUS AND CONTINOUS WORSENING OF CLINICAL PICTURE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
3 MM PUNCH BOPSY OF THE SKIN REVEALED FULL-THICKNESS EPIDERMAL NECROSIS,Epidermal necrosis,EPIDERMAL NECROSIS,EPIDERMAL NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10059284,10059284,10059284
RELAPSE OF P.OVALE MALARIA FOLLOWING TREATMENT FAILURE OF PRIMAQUINNE FOR P.OVALE MALARIA,Plasmodium ovale infection,OVALE MALARIA,PLASMODIUM OVALE INFECTION,PROTOZOAL INFECTIOUS DISORDERS,PLASMODIA INFECTIONS,10021881,10033117,10035502,10033117
CLINDAMYCIN-INDUCED MACULOPAPULAR EXANTHEMA,maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
HEMOLYSIS,Haemolysis,HEMOLYSIS,HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10018910,10018910,10019491
TOBACCO ADDICTION SYNDROME,nicotine addiction,NICOTINE ADDICTION,NICOTINE DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10056478,10057852,10056478
NEW INTRACRANIAL LESIONS,Brain lesion,BRAIN LESION,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10067294,10051290,10067294
PERIVASCULAR INFILTRATION OF INFLAMMATORY CELLS,Vasculitis,VASCULITIS,VASCULITIS,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10047115,10047115,10047115
MUSCLE RIGIDITY,Muscle rigidity,MUSCLE RIGIDITY,MUSCLE RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10028330,10028330,10028330
HYPOXIA,Hypoxia,HYPOXIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021143,10021143,10021143
ASPARTATE AMINOTRANSFERASE (AST) WERE ELEVATED UP TO 39 U/L,Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
PERFORATED DUODENAL ULCER,Duodenal ulcer perforation,DUODENAL ULCER PERFORATED,DUODENAL ULCER PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,DUODENAL ULCERS AND PERFORATION,10017947,10013849,10013849,10013848
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
ABSENCE OF RESPONSE,No therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
CAESAREAN SECTION,caesarean section,CAESAREAN SECTION,CAESAREAN SECTION,OBSTETRIC AND GYNAECOLOGICAL THERAPEUTIC PROCEDURES,OBSTETRIC THERAPEUTIC PROCEDURES,10042613,10006924,10006924,10006924
ELEVATED WHITE BLOOD CELL COUNT,White blood cell count increased,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047943,10047943,10047943
ELEVATED AMINOTRANSFERASE VALUES,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASE,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001550
ARTERIO-VENOUS MALFORMATIONS,Arteriovenous malformation,ARTERIOVENOUS MALFORMATION,ARTERIOVENOUS MALFORMATION,CARDIAC AND VASCULAR DISORDERS CONGENITAL,VASCULAR ANOMALIES CONGENITAL NEC,10010331,10003193,10003193,10003193
COUGH,cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
PAIN IN 5.5X6.6 CM AREA OF INJECTION SITE,Injection site pain,INJECTION SITE PAIN,INJECTION SITE PAIN,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022086,10022086,10022086
HEAVINESS AND NUMBNESS MIGRATING UP TO THE SHIN AND THIGHS OF BOTH LEGS,Numbness of lower extremities,NUMBNESS OF LOWER EXTREMITIES,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10029850,10020937,10029850
LIPODYSTROPHY (GRADE 2),Lipodystrophy,LIPODYSTROPHY,LIPODYSTROPHY ACQUIRED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,LIPODYSTROPHIES,10040785,10024608,10049287,10024608
FULL THICKNESS EPIDERMIS WITH PARTIAL NECROSIS,Epidermal necrosis,EPIDERMAL NECROSIS,EPIDERMAL NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10059284,10059284,10059284
MILD FETAL ACIDOSIS,Foetal acidosis,FETAL ACIDOSIS,FOETAL ACIDOSIS,FOETAL COMPLICATIONS,FOETAL COMPLICATIONS NEC,10036585,10050347,10050347,10054742
PHOTOPHOBIA,Photophobia,PHOTOPHOBIA,PHOTOPHOBIA,OCULAR SENSORY SYMPTOMS NEC,OCULAR SENSATION DISORDERS,10015919,10034960,10034960,10034960
SEVERE ANAEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
NON SMALL CELL LUNG CARCINOMA,Non-small cell lung cancer,NON-SMALL CELL LUNG CANCER,NON-SMALL CELL LUNG CANCER,RESPIRATORY AND MEDIASTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,NON-SMALL CELL NEOPLASMS MALIGNANT OF THE RESPIRATORY TRACT CELL TYPE SPECIFIED,10029104,10061873,10061873,10061873
PATIENT FELL FACE-FIRST ONTO THE PAVEMENT FOLLOWING LOSS OF CONSCIOUSNESS DUE TO CARDIAC SYNCOPE,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
WORSENING MALAISE,worsening malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
TUBERCULOSIS TREATMENT DURATION EXTENDED,Tuberculosis,TUBERCULOSIS,TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10044755,10044755,10044755
ALOPECIA GRADE 2,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
HEMODYNAMIC INSTABILITY,Haemodynamic instability,HEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10052076,10052076,10058270
SUICIDE,Completed suicide,SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042462,10010144,10042462
BRONCHOSPASM,Bronchospasm,BRONCHOSPASM,BRONCHOSPASM,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10006482,10006482,10006482
UPPER AIRWAY OBSTRUCTION,Upper airway obstruction,UPPER AIRWAY OBSTRUCTION,UPPER AIRWAY OBSTRUCTION,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10067775,10067775,10067775
DEATH,DEATH,DEATH,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10011906,10011906,10011906
"MRI  OF  CHEST,  ABDOMEN  AND  PELVIS  DEMONSTRATED  BILATERAL  ADRENAL  MASSES  MEASURING  18  AND  30 MM  ON  THE  RIGHT  AND  LEFT  ADRENAL  GLANDS",Adrenal mass,ADRENAL MASS,ADRENAL MASS,ADRENAL GLAND DISORDERS,ADRENAL GLAND DISORDERS NEC,10014698,10053235,10053235,10053235
DISSEMINATED DEMYELINATING LEUKOENCEPHALOPATHY,Leukoencephalopathy,LEUKOENCEPHALOPATHY,LEUKOENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10024382,10024382,10024382
CLAMMY SKIN FOLLOWING OPIOID WITHDRAWAL,Cold sweat,CLAMMINESS,COLD SWEAT,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10009230,10009866,10009230
COLD SHIVERS,Chills,SHIVERS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10040558,10008531,10040559
OTHELLO SYNDROME,Othello syndrome,OTHELLO SYNDROME,JEALOUS DELUSION,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10073241,10023164,10073241
"COLON CANCER, STAGE III",Colon cancer stage III,COLON CANCER STAGE III,COLON CANCER STAGE III,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,COLORECTAL NEOPLASMS MALIGNANT,10029104,10009955,10009955,10009955
PUPILARY DILATION,Mydriasis,DILATATION PUPILLARY,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10013014,10028521,10013007
BRAIN LESION,brain lesion,BRAIN LESION,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10067294,10051290,10067294
VENTILATOR-ASSOCIATED PNEUMONIA,Pneumonia,VENTILATOR ASSOCIATED PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10065153,10035664,10065153
"IN AN ATTEMPT TO HAVE VISUAL IMPROVEMENT, THE PATIENT TOOK ACETAZOLAMIDE AGAIN (INTENTIONAL DRUG MISUSE)",Intentional product misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
ANAPHYLACTIC SHOCK FOLLOWING ADMINISTRATION OF CEFUROXIME,Anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
APATHETIC,Apathy,APATHY,APATHY,MOOD DISORDERS AND DISTURBANCES NEC,MOOD DISORDERS NEC,10037175,10002942,10002942,10002942
RIGHT FOOT GANGRENE,Gangrene,GANGRENE,GANGRENE,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10017711,10017711,10017711
CIRCULATORY DEPRESSION,Cardiovascular insufficiency,CIRCULATORY DEPRESSION,CARDIOVASCULAR INSUFFICIENCY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10064995,10065929,10064995
MINOR HAEMORRHAGE (INTERNAL HAEMORRHAGE AT THE SITE OF  IV LINE REMOVAL),Injection site bruising,INJECTION SITE BRUISING,INJECTION SITE BRUISING,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022052,10022052,10022052
HIS ADDICTION SLIPPED BY EVERYONE,Drug addiction,DRUG ADDICTION,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013658,10013663,10013658
PANCREATIC AMYLASE INCREASED (509 U/L),Blood pancreatic amylase increased,BLOOD PANCREATIC AMYLASE INCREASED,AMYLASE INCREASED,GASTROINTESTINAL INVESTIGATIONS,DIGESTIVE ENZYMES,10022891,10053880,10002016,10053880
REDUCED APPETITE,reduced appetite,APPETITE DECREASED NOS,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003020,10061428,10003020
 Loss of nails,2018-03-19,0,,,,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10028694,10028694,
ANTIHYPERTENSIVE THERAPY WITH ALISKIREN FOR 5-YEAR OLD GIRL,drug use in unapproved age group,DRUG USE IN UNAPPROVED AGE GROUP,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10076467,10071062,10076467
INCONTINENCE,incontinence,INCONTINENCE,INCONTINENCE,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10021639,10021639,10021639
FLUDARABINE PHOSPHATE USED IN CHILD BELOW AGE 18,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEMIPARESIS,Hemiparesis,HEMIPARESIS,HEMIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019465,10019465,10019465
COMPLIANCE TO THE TREATMENT WAS IRREGULAR (INAPPOROPRIATE SCHEDULE OF DRUG ADMINISTRATION),Inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
PARTIAL REMISSION,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
"FATAL DOSE OF METHADONE, AND DEATH IS CONSIDERED AN ACCIDENT",Accidental overdose,DRUG OVERDOSE ACCIDENTAL,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10013737
THE FACE AND EXTREMITIES WERE EDEMATOUS,Edema face,EDEMA FACE,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014222,10016029,10014222
CMV-RELATED HEPATITIS,Cytomegalovirus hepatitis,CYTOMEGALOVIRUS HEPATITIS,CYTOMEGALOVIRUS HEPATITIS,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011830,10011830,10011830
HAIR LOSS,Alopecia,HAIR LOSS,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10019045,10001760,10019045
AGITATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
DETERIORATION OF ATTENTION,Disturbance in attention,DISTURBANCE IN ATTENTION,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10013496,10013496,10013496
PRODUCT USE IN UNAPPROVED INDICATION,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
SKIN RASH,Rash,SKIN RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040913
SIGNIFICANT ERYTHROPHAGOCYTOSIS,significant erythrophagocytosis,ERYTHROPHAGOCYTOSIS,ERYTHROPHAGOCYTOSIS,WHITE BLOOD CELL DISORDERS,WHITE BLOOD CELL ABNORMAL FINDINGS NEC,10005329,10053430,10053430,10053430
OVERDOSE,Overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
SENSORY AXONAL POLYNEUROPATHY,Sensory polyneuropathy axonal,SENSORY POLYNEUROPATHY AXONAL,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10040040,10034620,10040040
TACHYCARDIA,tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
ASPARTATE AMINOTRANSFERASE ELEVATED (541 U/L),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
"FACIAL ANGIOEDEMA (EYES, LIPS)",lip edema,LIP EDEMA,LIP OEDEMA,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10024553,10024558,10024553
FULMINANT ISOLATED ADENOVIRUS HEPATITIS,Hepatitis fulminant,HEPATITIS FULMINANT,HEPATITIS FULMINANT,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019772,10019772,10019772
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,Progressive multifocal leukoencephalopathy,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10036807,10036807,10036807
AMBLYOPIA,Amblyopia,AMBLYOPIA,AMBLYOPIA,VISION DISORDERS,AMBLYOPIC VISION IMPAIRMENT,10015919,10001906,10001906,10001906
DRUG ALLERGY,drug allergy,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
HIGH FREQUENCY ARRHYTHMIA,ventricular arrhythmia,VENTRICULAR ARRHYTHMIA,VENTRICULAR ARRHYTHMIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047281,10047281,10047281
INCREASING BREATHLESSNESS,Dyspnoea,BREATHLESSNESS,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10006345
MULTIPLE CEREBRAL INFARCTION,Cerebral infarction,CEREBRAL INFARCTION,CEREBRAL INFARCTION,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008118,10008118,10008118
PARADOXICAL CHEST MOVEMENT IMPEDED HER VENTILATION,paradoxical chest movement,PARADOXICAL CHEST MOVEMENT,FLAIL CHEST,BONE AND JOINT INJURIES,THORACIC CAGE FRACTURES AND DISLOCATIONS,10022117,10063696,10016747,10063696
MEDICATION-RELATED OSTEONECROSIS OF THE JAW STAGE 3 ([MANDIBLE (QUADRANT III)],osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
NONGAP ACIDOSIS,Acidosis hyperchloraemic,ACIDOSIS HYPERCHLORAEMIC,ACIDOSIS HYPERCHLORAEMIC,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10000489,10000489,10000489
CHLORPROMAZINE AGRANULOCYTOSIS,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
PARONYCHIA,Paronychia,PARONYCHIA,PARONYCHIA,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10034016,10034016,10034016
DEPRESSED MOOD FOLLOWING OFF LABEL USE OF METHOTREXATE FOR GENERALIZED LICHEN SCLEROSUS,Depressed mood,DEPRESSED MOOD,DEPRESSED MOOD,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10012374,10012374,10012374
"ON PATHOLOGY OF THE UPPER LIMBS, OCCLUSIVE THROMBI WERE IDENTIFIED IN THE VEINS AND ARTERIES.",Arterial thrombosis limb,ARTERIAL THROMBOSIS LIMB,PERIPHERAL ARTERY THROMBOSIS,EMBOLISM AND THROMBOSIS,PERIPHERAL EMBOLISM AND THROMBOSIS,10047065,10003180,10072564,10003180
SUDDEN COMA,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
GENERAL EDEMATOUS FACE APPEARANCE,Face oedema,EDEMA FACE,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10016029,10016029,10014222
DEHYDRATED,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
"WRISTS, HANDS AND FINGERS WERE SWOLLEN AND TENDER",Swelling of hands,SWELLING OF HANDS,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042695,10048959,10042695
ACUTE LIVER INJURY FOLLOWING  DRUG OVERDOSE AND DRUG POISONING,Liver injury,ACUTE LIVER INJURY,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067970,10067125,10067970
SKIN ERUPTION,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
CT CHEST REVEALED BILATERAL ASYMMETRIC GROUND GLASS OPACITIES,Computerised tomogram thorax abnormal,GROUND GLASS OPACITY IN THORACIC CT,COMPUTERISED TOMOGRAM THORAX ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10072879,10057799,10072879
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
ATYPICAL DIFFUSE EMPHYSEMA FOLLOWING PNEUMOCYSTIS PNEUMONIA,Emphysema,EMPHYSEMA,EMPHYSEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10014561,10014561,10014561
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
TYPE 2 HYPERSENSITIVITY REACTION,Type II hypersensitivity,TYPE II HYPERSENSITIVITY,TYPE II HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10054000,10054000,10054000
P. AERUGINOSA SEPTICAEMIA,Pseudomonal sepsis,SEPTICAEMIA DUE TO PSEUDOMONAS,PSEUDOMONAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,PSEUDOMONAL INFECTIONS,10021881,10040083,10058877,10060410
MULTIPLE DRUG POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
GLU 22,Blood glucose abnormal,GLUCOSE ABNORMAL,BLOOD GLUCOSE ABNORMAL,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10018415,10005554,10018415
PERIPHERAL EDEMA,peripheral edema,PERIPHERAL EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10034570,10030124,10034570
DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE EVENT,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
EXAMINATION SHOWED HYPOXIA,Hypoxia,HYPOXIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021143,10021143,10021143
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
CHRONIC  OVERDOSE,chronic  overdose,CHRONIC OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067696,10033295,10067696
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,Peripheral arterial occlusive disease,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10062585,10062585,10062585
ALT INCREASED (667 U/L),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
LAMIVUDINE THERAPY FOR HEPATITIS B VIRUS (OFF-LABEL USE FOR INDICATION WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG INTERACTION BETWEEN VANDETANIB AND MITOTANE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
"GEMCITABINE AND DOCETAXEL WERE ADMINISTERED AS INITIAL TREATMENT, BUT THE DISEASE PROGRESSED",disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
ANTI YELLOW FEVER VIRUS IMMUNOGLOBULIN G ANTIBODY NEGATIVE,antibody test negative,ANTIBODY TEST NEGATIVE,ANTIBODY TEST NEGATIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOLOGY ANALYSES NEC,10022891,10061426,10061426,10061426
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
DRUG EXPOSURE VIA PREGNANCY,DRUG EXPOSURE,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
DRUG INDUCED THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
POSITIVE HHV-8 (HUMAN HERPES VIRUS-8),Human herpes virus 8 test positive,HUMAN HERPES VIRUS 8 TEST POSITIVE,HUMAN HERPES VIRUS 8 TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10071210,10071210,10071210
PROLONGED SEPTIC-HAEMORRHAGIC-HYPOVOLAEMIC SHOCK,Hypovolaemic shock,HYPOVOLAEMIC SHOCK,HYPOVOLAEMIC SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10021138,10021138,10021138
STAPHYLOCOCCUS AUREUS SEPTICEMIA,Staphylococcus Aureus septicemia,STAPHYLOCOCCUS AUREUS SEPTICEMIA,STAPHYLOCOCCAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10054638,10056430,10054638
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
SIGNIFICANT TRANSHEPATIC/CAVAL GRADIENT,Hepatic venous pressure gradient,HEPATIC VENOUS PRESSURE GRADIENT,HEPATIC VENOUS PRESSURE GRADIENT,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10076951,10076951,10076951
HORIZONTAL BINOCULAR DIPLOPIA DUE TO INFARCT OF THE OCULOMOTOR NERVE NUCLEUS FOLLOWING ANTIPHOSPHOLIPID SYNDROME,Diplopia,BINOCULAR DIPLOPIA,DIPLOPIA,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10076680,10013036,10076680
FEVER (BODY TEMPERATURE NOS),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
DECREASED LVEF (34%),Ejection fraction decreased,LEFT VENTRICULAR EJECTION FRACTION DECREASED,EJECTION FRACTION DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10053222,10050528,10053222
NON-OCCLUSIVE MESENTERIC ISCHEMIA,Non-occlusive mesenteric ischaemia,NON-OCCLUSIVE MESENTERIC ISCHAEMIA,INTESTINAL ISCHAEMIA,GASTROINTESTINAL VASCULAR CONDITIONS,GASTROINTESTINAL VASCULAR OCCLUSION AND INFARCTION,10017947,10077836,10022680,10077836
RECURRENCE OF SKIN ERUPTIONS,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
TRANSIENT ISCHEMIC ATTACK,Transient ischaemic attack,TRANSIENT ISCHEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,TRANSIENT CEREBROVASCULAR EVENTS,10029205,10044390,10044390,10072760
TIBOLONE USED FOR TREATMENT OF DEEP ENDOMETRIOSIS,Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
GALLBLADDER WALL THICKENING,Gallbladder enlargement,GALLBLADDER WALL THICKENING,GALLBLADDER ENLARGEMENT,GALLBLADDER DISORDERS,GALLBLADDER DISORDERS NEC,10019805,10064076,10062693,10064076
ATTEMPTED SUICIDE WITH MEDICATION,suicide attempt,ATTEMPTED SUICIDE,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10046262,10042464,10003728
ACUTE KIDNEY INJURY,acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
RIGHT CENTRAL FACIAL PARALYSIS FOLLOWING LISTERIAL MENINGOENCEPHALITIS,Facial paralysis,FACIAL PARALYSIS,FACIAL PARALYSIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),FACIAL CRANIAL NERVE DISORDERS,10029205,10016062,10016062,10016062
DETERIORATED TO FUNCTIONAL CLASS III,Condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
HIGH-GRADE FEVER (40-41 DEGREE C),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
IMATINIB RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
GENERALIZED SKIN RASH,Rash generalised,GENERALIZED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037858,10037858,10049201
SEPTIC STATUS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
HYPOTENSIVE,Hypotension,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021107
ACUTE ADRENAL CRISIS FOLLOWING INADEQUATE ADAPTATION OF GLUCOCORTICOID DOSAGE TO THE ACUTE STRESS SITUATION,adrenal crisis,ADRENAL CRISIS,ADRENOCORTICAL INSUFFICIENCY ACUTE,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001346,10001389,10001346
ASPARTATE TRANSAMINASE (AST) 245 IU/L,Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
VERTIGO,vertigo,VERTIGO,VERTIGO,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10047340,10047340,10047340
ERYTHEMATOUS MACULE,erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
COMPLETE HEART BLOCK,complete heart block,COMPLETE HEART BLOCK,ATRIOVENTRICULAR BLOCK COMPLETE,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10010141,10003673,10010141
BULLOUS SKIN LESION,Dermatitis bullous,BULLOUS LESIONS,DERMATITIS BULLOUS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006565,10012441,10006565
ACUTE POISONING WITH METHOTREXATE,Acute poisoning with methotrexate,POISONING,POISONING,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10061355,10061355,10061355
PARACETAMOL OVERDOSAGE/ 8 TABLETS OF PARALEN 500MG GRADUALLY WITHIN THE DAY 6,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
SMALL BOWEL OBSTRUCTION,Small intestinal obstruction,SMALL BOWEL OBSTRUCTION,SMALL INTESTINAL OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,DUODENAL AND SMALL INTESTINAL STENOSIS AND OBSTRUCTION,10017947,10041101,10041101,10041055
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
TYPE 1 ALLERGIC HYPERSENSITIVITY,Type I hypersensitivity,TYPE I HYPERSENSITIVITY,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10045240,10045240,10045240
BIOLOGICAL INFLAMMATORY SYNDROME,Inflammation,INFLAMMATION,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10061218,10061218,10061218
"PATIENT WAS ADMINISTERED PERINDOPRIL, CARVEDILOL AND DESMOPRESSIN DURING PREGNANCY (DRUG EXPOSURE DURING PREGNANCY)",Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
"VINCRISTINE,MELPHALANE,CARNADINE,CYCLOPHOSPHAMIDE,PREDNISONE WERE ADMINISTERED BUT WITHOUT THERAPEUTIC EFFECT,PROGRESSION OF PLASMA CELL MYELOMA WAS OBSERVED",plasma cell myeloma,PLASMA CELL MYELOMA,PLASMA CELL MYELOMA,PLASMA CELL NEOPLASMS,PLASMA CELL MYELOMAS,10029104,10035226,10035226,10035226
METHOTREXATE-ASSOCIATED MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
REPEATED RECURRENCE OF SEIZURES,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
"LOW 25-HYDROXY AND 24,25-DIHYDROXY VITAMIN D LEVELS",Vitamin D decreased,VITAMIN D LOW,VITAMIN D DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",VITAMIN ANALYSES,10022891,10078111,10062189,10078111
PREDNISONE TREATMENT FAILURE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ASYSTOLE,asystole,ASYSTOLE,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10003586,10007515,10003586
ACUTE ST AT THE OSTIUM OF THE LAD/ RECURRENT ST PROTRUDING INTO THE DISTAL LM BIFURCATION WITH THE LCX,Vascular stent thrombosis,STENT THROMBOSIS,VASCULAR STENT THROMBOSIS,COMPLICATIONS ASSOCIATED WITH DEVICE,VASCULAR COMPLICATIONS ASSOCIATED WITH DEVICE,10018065,10076859,10063934,10076859
PARADOXICAL REACTION TO MIDAZOLAM IN PRETERM NEONATES,Paradoxical drug reaction,PARADOXICAL DRUG REACTION,PARADOXICAL DRUG REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048958,10048958,10048958
CREATININE INCREASED 12MG/DL,Creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
NOT GETTING BETTER,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
IMPAIRED INGESTION,Hypophagia,ORAL INTAKE REDUCED,HYPOPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10063889,10063743,10063889
GRADE 4 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
SEVERE CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
FAILED TO RESPOND TO MEGLUMINE ANTIMONATE AND AMPHOTERICIN B LIPID COMPLEX (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
LETHARGIC,Lethargic,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024262,10024264,10024262
ACUTE LEFT-SIDED ABDOMINAL AND LOWER BACK PAIN,Back pain,LOW BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10024891,10003988,10024891
ACIDOSIS,Acidosis,ACIDOSIS,ACIDOSIS,ACID-BASE DISORDERS,MIXED ACID-BASE DISORDERS,10027433,10000486,10000486,10000486
SYNCOPE,Syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
MITRAL REGURGITATION (MR) SEVERE,Mitral regurgitation,MITRAL REGURGITATION,MITRAL VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,MITRAL VALVULAR DISORDERS,10007541,10027718,10027727,10027718
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
METHOTREXATE WAS ADMINISTERED FOR THE MANAGEMENT OF INTERSTITIAL ECTOPIC PREGNANCY (OFF-LABEL USE).,off-label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEPATOTOXICITY,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
AMMONIA INCREASED,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
GLYCAEMIC DISORDER/GLYCAEMIA/DESPITE THE INCREASE IN BASAL INSULIN DOSE THE PATIENT DID NOT ACHIEVE SATISFACTORY METABOLIC CONTROL,Type I diabetes mellitus inadequate control,TYPE I DIABETES MELLITUS INADEQUATE CONTROL,DIABETES MELLITUS INADEQUATE CONTROL,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10063623,10012607,10063623
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
TREATMENT FAILURE,TREATMENT FAILURE,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
EPIDURAL HEMATOMA,epidural hematoma,EPIDURAL HEMATOMA,EXTRADURAL HAEMATOMA,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10015013,10015769,10015013
SLUGGISH GAIT FOLLOWING MULTIPLE DRUG POISONING,Gait disturbance,GAIT DISTURBANCE,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017577,10017577,10017577
FULMINANT HEPATIC FAILURE,Acute hepatic failure,ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10000804
BEING WITHOUT TAMSULOSIN FOR THREE DAYS,treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
DIFFUSE HYPOKINESIS,ventricular hypokinesia,VENTRICULAR HYPOKINESIA,VENTRICULAR HYPOKINESIA,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10050510,10050510,10050510
NEPHROTOXICITY,nephrotoxicity,NEPHROTOXICITY,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10067571
RAVING AND LETHARGIC,Lethargy,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024262
MIOTIC AND NONREACTIVE PUPILS,Pupils fixed,PUPILS FIXED,PUPIL FIXED,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10037536,10037515,10037536
METHOTREXATE OVERDOSE,methotrexate overdose,OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033295,10033295,10033295
INTENTIONAL SUSPECTED SUICIDE,Completed suicide,COMPLETED SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10010144,10010144,10010144
MULTIPLE CAVITATING LUNG LESIONS,pulmonary cavitation,PULMONARY CAVITATION,PULMONARY CAVITATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10051738,10051738,10051738
ALANINE AMINOTRANSFERASE INCREASED (65 IU/L),Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
ACUTE TUBULAR NECROSIS,acute tubular necrosis,ACUTE TUBULAR NECROSIS,RENAL TUBULAR NECROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL VASCULAR AND ISCHAEMIC CONDITIONS,10038359,10001099,10038540,10001099
GRADE 1 VENTRICULR ARRHYTHMIA,grade 1 ventriculr arrhythmia,ARRHYTHMIA VENTRICULAR (NOS),VENTRICULAR ARRHYTHMIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10003132,10047281,10003132
RUPTURE WITH GENERALIZED DESQUAMATION,rupture with generalized desquamation,DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10012528,10040844,10012528
PROGRESSIVE ABDOMINAL PAIN/STOMACH ACHE,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
GRADE II CHOLANGITIS DUE TO CTRX-INDUCED BILIARY PSEUDOLITHIASIS,Cholangitis,CHOLANGITIS,CHOLANGITIS,BILE DUCT DISORDERS,BILE DUCT INFECTIONS AND INFLAMMATIONS,10019805,10008604,10008604,10008604
BROMOCRIPTINE SENSITIVE,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
TUBULAR NECROSIS,Renal tubular necrosis,TUBULAR NECROSIS,RENAL TUBULAR NECROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL VASCULAR AND ISCHAEMIC CONDITIONS,10038359,10045144,10038540,10045144
ARTHRALGIAS,arthralgias,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
DRUG INTERACTION BETWEEN SERTRALINE AND PHENYTOIN,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
NEUROLOGICAL REGRESSION,Neurological impairment,NEUROLOGICAL IMPAIRMENT,NERVOUS SYSTEM DISORDER,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10074237,10029202,10074237
DEPIGMENTATION AT THE SITES OF INJECTION,Injection site discolouration,INJECTION SITE DISCOLOURATION,INJECTION SITE DISCOLOURATION,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10051572,10051572,10051572
RESPIRATORY DEPRESSION,Respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
PARACETAMOL ALLERGY,Drug hypersensitivity,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
HALLUCINATIONS,Hallucination,HALLUCINATIONS,HALLUCINATION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019063,10019063,10019077
HYPOTENSIVE,hypotensive,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021107,10021097,10021107
PERITONEAL INFLAMMATION,Peritonitis bacterial,PERITONITIS BACTERIAL,PERITONITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10062070,10062070,10062070
CMV COLITIS,CMV colitis,CMV COLITIS,CYTOMEGALOVIRUS COLITIS,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10051359,10048983,10051359
METHOTREXATE INDUCED-LYMPHOPROLIFERATIVE DISORDER,Epstein-Barr virus associated lymphoproliferative disorder,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10068349,10068349,10068349
BILATERAL ILIOPSOAS HEMORRHAGE,Haemorrhage,HAEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10055798
RESTING DYSPNEA,Dyspnoea at rest,DYSPNEA AT REST,DYSPNOEA AT REST,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013969,10013969,10079027
LEUKOCYTOSIS,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
ITCHING MACULOPAPULAR RASH ON THE WHOLE BODY,Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
ALLERGY TO ASPIRIN,Drug hypersensitivity,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
DRUG INTERACTION,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
PERSISITNG SIGNIFICANT HYPERCHOLESTEROLAEMIA/NO SIGNIFICANT CHANGES IN LIPIDAL SPECTRUM/EXPECTED VALUES OF BLOOD CHOLESTEROL HAS NOT YET BEEN REACHED,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
WORSENING HEADACHES,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
SEVERE HEMATOCHEZIA,Severe hematochezia,HEMATOCHEZIA,HAEMATOCHEZIA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10060544,10018836,10060544
"PRURITUS ON THE PALMS AND SOLES OF THE FEET THAT PROGRESSED TO MACULES, ERYTHEMATOUS PAPULES, VESICLES AND, FINALLY, BLISTERS",Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
PRURITIC ERYTHEMATOUS RASH ON TRUNK AND EXTREMITIES,Rash erythematous,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015243
SUSPECTED ANAPHYLAXIS,Anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
HEMATOMA,Haematoma,HEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10019428
PATIENT WAS EXPOSED TO MISOPROSTOL FOR INDUCTION OF LABOR TO TERMINATE THE PREGNANCY(OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
AGITATED,Agitation,AGITATED,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001495
TONIC-CLONIC SEIZURE ASSOCIATED WITH LOSS OF CONSCIOUSNESS AND APNEA,loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
FLUSHING,Flushing,FLUSHING,FLUSHING,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10016825,10016825,10016825
MYOCARDITIS,Myocarditis,MYOCARDITIS,MYOCARDITIS,MYOCARDIAL DISORDERS,NONINFECTIOUS MYOCARDITIS,10007541,10028606,10028606,10028606
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SCATTERED SKIN RASH WITH MILD ITCHING,Rash pruritic,ITCHY RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10023092
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
KIDNEY FAILURE,Kidney failure,KIDNEY FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10023418,10038435,10023418
PARADOXICAL ABSCESS FORMATION DURING ANTITUBERCULOSIS THERAPY,abscess,ABSCESS,ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10000269,10000269,10000269
CHOREA,chorea,CHOREA,CHOREA,MOVEMENT DISORDERS (INCL PARKINSONISM),CHOREIFORM MOVEMENTS,10029205,10008748,10008748,10008748
HYPOGLYCAEMIC EPISODES FOLLOWING INFUSION OF INSULIN,Hypoglycaemia,HYPOGLYCAEMIC EPISODE,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10060385,10020993,10060385
PATIENT WAS TREATED WITH IMIQUIMOD FOR HECK'S DISEASE (OFF LABEL USE) WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"PREGNANT WOMEN WAS TREATED WITH ASPIRIN AND CLOPIDOGREL, WITHOUT COMPLICATIONS",Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
LOCAL REACTION,Local reaction,LOCAL REACTION,LOCAL REACTION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10024769,10024769,10024769
ATRIAL FIBRILLATION,Atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
HOT,feeling hot,FEELING HOT,FEELING HOT,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10016334,10016334,10016334
ASYSTOLE,asystole,ASYSTOLE,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10003586,10007515,10003586
RHABDOMYOLYSIS/SERTRALINE INDUCED REVERSIBLE MYOPATHY WITH RHABDOMYOLYSIS AND TRISMUS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
TAKOTSUBO CARDIOMYOPATHY,Takotsubo cardiomyopathy,CARDIOMYOPATHY,CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10007636,10007636,10007636
PATIENT WAS FOUND TO BE NOT RESPONSIVE TO STEROIDS,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DELAYED METHOTREXATE CLEARANCE,Drug clearance decreased,DRUG CLEARANCE DECREASED,DRUG CLEARANCE DECREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10049463,10049463,10049463
MODERATE AXIAL HYPOTONIA,Hypotonia,HYPOTONIA,HYPOTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10021118,10021118,10021118
DRUG FEVER,Pyrexia,DRUG FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037662,10037660,10013697
LEMIERRE SYNDROME DUE TO CELLULITIS AGGRAVATED,Lemierre syndrome,LEMIERRE SYNDROME,LEMIERRE SYNDROME,BACTERIAL INFECTIOUS DISORDERS,FUSOBACTERIUM INFECTIONS,10021881,10065552,10065552,10065552
SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
OCCASIONALLY DEVELOPED EPIGASTRALGIA DUE TO CORTICOSTEROID THERAPY,epigastralgia,EPIGASTRALGIA,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10048944,10000087,10048944
FAILED TO RESPOND DURING THE TREATMENT PERIOD,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
THERMOPHOBIA,Thermophobia,THERMOPHOBIA,THERMOPHOBIA,ANXIETY DISORDERS AND SYMPTOMS,FEAR SYMPTOMS AND PHOBIC DISORDERS (INCL SOCIAL PHOBIA),10037175,10075147,10075147,10075147
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
TREATMENT FAILURE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
"PATIENT EXPERIENCED TRANSIENT HEPATIC TOXICITIES, HAEMATOLOGICAL TOXICITY AND DIARRHOEA WHICH ALLRECOVERED WITHIN TWO TO THREE WEEKS AND TRANSAMINITIS GRADE 4 (OUTCOME NOT REPORTED). SUDDENDEATH OCC",off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INTRAUTERINE GROWTH RESTRICTION,Foetal growth restriction,INTRAUTERINE GROWTH RETARDATION,FOETAL GROWTH RESTRICTION,FOETAL COMPLICATIONS,FOETAL GROWTH COMPLICATIONS,10036585,10022819,10070531,10022819
SEVERE COGNITIVE AND BEHAVIORAL DETERIORATION SUGGESTIVE OF A DEGENERATIVE DISEASE WHILE BEING TREATED WITH SODIUM VALPROATE,Cognitive disorder,COGNITIVE DETERIORATION,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10009843,10057668,10009843
KAWASAKI DISEASE,Kawasaki's disease,KAWASAKI'S DISEASE,KAWASAKI'S DISEASE,VASCULAR INFLAMMATIONS,ARTERIAL INFLAMMATIONS,10047065,10023320,10023320,10023320
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
NEGATIVE MYOCLONUS (ASTERIXIS),negative myoclonus,NEGATIVE MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10063953,10028622,10063953
HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
BLOOD INSULIN,Blood insulin,INSULIN,BLOOD INSULIN,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),"GASTROINTESTINAL, PANCREATIC AND APUD HORMONE ANALYSES",10022891,10022468,10005605,10022468
A PRURITIC LACY RED RASH ON ENTIRE BODY,Rash pruritic,RASH PRURITIC,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10037884
ABSENT-MINDED,absent-minded,ABSENT-MINDED,DAYDREAMING,COGNITIVE AND ATTENTION DISORDERS AND DISTURBANCES,COGNITIVE AND ATTENTION DISORDERS AND DISTURBANCES NEC,10037175,10067170,10057315,10067170
INJURY,Injury,INJURY,INJURY,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10022116,10022116,10022116
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
RIVAROXABAN NON-RESPONSE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PULSELESS DUE TO EXTENDED-SPECTRUM-BETA-LACTAMASE KLEBSIELLA PNEUMONIAE BACTEREMIA,Pulse absent,PULSELESS,PULSE ABSENT,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10037497,10037469,10037495
"PATIENT WAS NOTED TO HAVE A FOCAL MOTOR SEIZURE IN HER LEFT LEG, ARM, AND FACE LASTING ABOUT 20 MINUTES DESPITE THE ADMINISTRATION LORAZEPAM AND INCREASING HER PROPOFOL",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SEMINAL VESICULITIS,seminal vesiculitis,SEMINAL VESICULITIS,SEMINAL VESICULITIS,MALE REPRODUCTIVE TRACT INFECTIONS AND INFLAMMATIONS,PROSTATE AND SEMINAL VESICLES INFECTIONS AND INFLAMMATIONS,10038604,10039954,10039954,10039954
"AFTER COMPLETION OF NARANJO'S ALGORITHM,OBTAINED A TOTAL SCORE OF 7.INDICATING, IN CONJUNCTION WITH CLINICAL ASSESSMENT AND LABORATORY TESTS OF PLATELET COUNT, THE PRESENCE OF A PROBABLE INTERACTION",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
FAILED TO RESPOND DURING THE TREATMENT PERIOD,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
DRUG-INDUCED LIVER INJURY/ DRONEDARONE-INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
RIGHT SIDE EMPHYSEMATOUS PYELONEPHRITIS (CLASS 1) AND IMAGING WITH NCCT KUB REVEALED AIR POCKETS IN COLLECTIVE SYSTEM,Emphysematous pyelonephritis,EMPHYSEMATOUS PYELONEPHRITIS,EMPHYSEMATOUS PYELONEPHRITIS,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10068822,10068822,10068822
INTESTINAL HEMORRHAGE FOLLOWED BY GASTROINTESTINAL TUBERCULOSIS (GITB),Intestinal haemorrhage,INTESTINAL HEMORRHAGE,INTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,INTESTINAL HAEMORRHAGES,10017947,10059175,10059175,10059178
ACUTE BUCCAL DYSTONIA/ ACUTE DYSTONIC REACTION,acute dystonia,ACUTE DYSTONIA,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10066608,10013983,10066608
"SEVERE ALLERGIC ASTHMA THAT PROGRESSIVELY WORSENED OVER THE YEARS DESPITE THE BEST THERAPY. SHE HAD BEEN HOSPITALIZED 35 TIMES, INCLUDING NINE ADMISSIONS TO THE RESPIRATORY INTENSIVE CARE",Asthma aggravated,ASTHMA AGGRAVATED,ASTHMA,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10003554,10003553,10003554
SALLOW COMPLEXATION,Swallowing difficult,SWALLOWING DIFFICULT,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10042645,10013950,10042645
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
"THERE WAS WORSENING OF FATIGUE, WHICH IMPROVED WITH REDUCTION OF BETABLOCKER USAGE(METOPROLOL)",Fatigue,FATIGUE AGGRAVATED,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10048415,10016256,10048415
GABAPENTIN TOXICITY,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
"BECAUSE OF PERSISTENT SEPSIS, MEROPENEM WAS INTRODUCED",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PATIENT ACCIDENTALLY EXPOSED TO METHOTREXATE,Accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
PROTHROMBIN TIME SHORTENED,Prothrombin time shortened,PROTHROMBIN TIME SHORTENED,PROTHROMBIN TIME SHORTENED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037070,10037070,10037070
ACUTE DYSTONIA,Dystonia,ACUTE DYSTONIA,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10066608,10013983,10066608
RESISTANT TO FRONTLINE IMATINIB,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
DECREASED OXYGEN SATURATION,Oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
"CHRONIC RENAL, CARDIAC AND PULMONARY INSUFFICIENCY CONTRIBUTED TO ACETAMINOPHEN TOXICITY IN THIS PATIENT",Respiratory failure,RESPIRATORY INSUFFICIENCY,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038701
HEADACHE DUE TO IMMUNE THROMBOCYTOPENIA,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
CEFTRIAXONE INDUCED NON-CONVULSIVE STATUS EPILEPTICUS,Status epilepticus,NONCONVULSIVE STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10057769,10041962,10057769
SWOLLEN TONGUE,Swollen tongue,SWOLLEN TONGUE,SWOLLEN TONGUE,TONGUE CONDITIONS,TONGUE SIGNS AND SYMPTOMS,10017947,10042727,10042727,10042727
THE CLIENT HAD ABRUPTLY STOPPED BUPRENORPHINE 7 DAYS AFTER/SIGNIFICANT CHANGE IN HIS BEHAVIOR,Drug withdrawal syndrome,DRUG WITHDRAWAL SYNDROME,DRUG WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10013754,10013754,10013754
GRADE 1 PAPULOPUSTULAR RASH THAT PROGRESSED TO GRADE 2 RASH,Papulopustular rash,PAPULOPUSTULAR RASH,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10069138,10037888,10069138
MULTI-ORGAN FAILURE,Multiple organ dysfunction syndrome,MULTI-ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028154
PANOPHTHALMITIS,panophthalmitis,PANOPHTHALMITIS,PANOPHTHALMITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10033683,10033683,10033683
INCREASED IRON STORES (GRADE3-4),Iron increased,IRON INCREASED,BLOOD IRON INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10022981,10005620,10022981
SEVERE RENAL FAILURE,Renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
DISSEMINATED STRONGYLOIDIASIS HYPERINFECTION,Strongyloidiasis,STRONGYLODIASIS HYPERINFECTION,STRONGYLOIDIASIS,HELMINTHIC DISORDERS,NEMATODE INFECTIONS,10021881,10080246,10042254,10080246
DRUG DEPENDENT ANTIBODY WAS POSITIVE,Drug specific antibody present,DRUG SPECIFIC ANTIBODY PRESENT,DRUG SPECIFIC ANTIBODY PRESENT,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013745,10013745,10013745
NO IMPROVEMENT AFTER STEROID THERAPY FOR A MONTH,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
MOTOR SYMPTOMS WERE NOT SIGNIFICANTLY AMELIORATED BY THESE DRUGS IN EITHER PATIENT/BEING OF NO,drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
OCCASIONAL PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
PERIORBITAL OEDEMA,periorbital oedema,PERIORBITAL OEDEMA,PERIORBITAL OEDEMA,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10034545,10034545,10034545
REDUCTION OF APPROXIMATELY 5MG/DL OF THE HAEMOGLOBIN LEVEL.,Haemoglobin decreased,HAEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10018884
DYSTONIC MOVEMENTS/ GENERALISED DYSTONIA WITH PREDOMINANTLY CERVICOFACIAL INVOLVEMENT,Dystonia,DYSTONIA,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10013983,10013983,10013983
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
SINUSOIDAL OBSTRUCTION SYNDROME,Venoocclusive liver disease,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
HYPEREOSINOPHILIA ASSOCIATED WITH HEPATIC CYTOLYSIS THAT COULD SUGGEST ASSOCIATED VISCERAL INVOLVEMENT,hypereosinophilia,HYPEREOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10064890,10014950,10064890
HEADACHE AGGRAVATED,headache aggravated,HEADACHE AGGRAVATED,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10048567,10019211,10048567
USED ACETYLSALICYLIC ACID ALONG WITH RTPA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SHORTNESS OF BREATH,shortness of breath,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
INTENTIONAL SUSPECTED SUICIDE,Completed suicide,COMPLETED SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10010144,10010144,10010144
MELENA,Melaena,MELENA,MELAENA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10027141,10027141,10027162
RIGHT LOWER LIMB HYPOTONIA,Hypotonia,HYPOTONIA,HYPOTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10021118,10021118,10021118
POLYURIA,polyuria,POLYURIA,POLYURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY TRACT SIGNS AND SYMPTOMS NEC,10038359,10036142,10036142,10036142
C-REACTIVE PROTEIN LEVEL OF 20 MG/DL,C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
ACUTE RENAL FAILURE DUE TO DRUG INTERACTION,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
UNABLE TO HOLD HEAD UPRIGHT OR SIT UNASSISTED/MOVEMENTS WERE SYMMETRICAL BUT WEAK,unable to hold head upright or sit unassisted/movements were symmetrical but weak,WEAKNESS GENERALISED,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047864,10003549,10047864
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
DIARRHOEA,diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
FLAT AFFECT,Flat affect,FLAT AFFECT,FLAT AFFECT,MOOD DISORDERS AND DISTURBANCES NEC,AFFECT ALTERATIONS NEC,10037175,10016759,10016759,10016759
INCREASE OF C3-MEDICATED EXTRAVASCULAR HEMOLYSIS,hemolysis,HEMOLYSIS,HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10019491,10018910,10019491
DYSPHAGIA,Dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
ALLERGIC TO METAMIZOLE,Drug hypersensitivity,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
SKIN PEELING,Skin peeling,SKIN PEELING,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040908,10040844,10040908
LYMPHOID BLAST CRISIS,Blast crisis in myelogenous leukaemia,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS MYELOID NEC,10029104,10050282,10050282,10050282
MYCOPHENOLATE MOFETIL USED IN UNAPPROVED INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PULMONARY MYCOBACTERIOSIS DUE TO M. SIMIAE AND M. INTRACELLULARE,Mycobacterial infection,MYCOBACTERIAL INFECTION,MYCOBACTERIAL INFECTION,MYCOBACTERIAL INFECTIOUS DISORDERS,ATYPICAL MYCOBACTERIAL INFECTIONS,10021881,10062207,10062207,10062207
RASH,rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
SYMPTOMATIC HYPOGLYCAEMIA ACCOMPANYING INCREASED PHYSICAL EXERTION,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
DYSARTHRIA,Dysarthria,DYSARTHRIA,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10013887,10013887,10013887
LARGE INFECTED PSEUDOANEURYSM OF 115MM,Pseudoaneurysm,PSEUDOANEURYSM,VASCULAR PSEUDOANEURYSM,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,CARDIAC AND VASCULAR PROCEDURAL COMPLICATIONS,10022117,10048977,10048975,10048977
ALKALINE PHOSPHATASE INCREASED (131 U/L),Blood alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
RISPERIDONE INDUCED HYPERPROLACTINEMIA,Hyperprolactinaemia,HYPERPROLACTINEMIA,HYPERPROLACTINAEMIA,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPERFUNCTION,10014698,10020737,10020737,10020739
SUICIDE POISONING,suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
FACIAL PAIN/PRESSURE,Facial pain,FACIAL PAIN,FACIAL PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10016059,10016059,10016059
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
WORSENING OF DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
HYPOPLASIA OF THE RIGHT TIBIA AND FIBULA FOLLOWING DRUG EXPOSURE IN UTERO,Limb hypoplasia congenital,LIMB HYPOPLASIA CONGENITAL,LIMB HYPOPLASIA CONGENITAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS OF LIMBS CONGENITAL,10010331,10048575,10048575,10048575
CIPROFLOXACIN-INDUCED STEVENSâ€“JOHNSON SYNDROME,Stevens Johnson syndrome,STEVENS JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042030,10042033,10042030
NEUROLOGICAL TOXICITY,neurological toxicity,CENTRAL NERVOUS SYSTEM TOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10071216,10029350,10071216
"EXTENSIVE INVASIVE MUCORMYCOSIS A ECTING  THE  VASCULATURE AS WELL  AS PARENCHYMA OF HER LUNGS, BRAIN HEART AND LIVER",mucormycosis,MUCORMYCOSIS,MUCORMYCOSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10028098,10028098,10028098
DRUG INTOLERANCE,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
THIGH SWELLING,swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
ADVERSE EFFECT,Adverse event NOS,ADVERSE EVENT NOS,ADVERSE EVENT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049535,10060933,10049535
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
PROTRACTED NAUSEA/EMESIS (GRADE 3),Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
MULTIPLE TENSE HAEMORRHAGIC BULLAE/ SUBCORNEAL BLISTER FILLED WITH ERYTHROCYTES,Blood blister,BLOOD BLISTER,BLOOD BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005372,10005372,10005372
SEVERE SELECTIVE CELECOXIB HYPERSENSITIVITY,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
CIPROFLOXACIN AND ENALAPRIL AS SUSPECT OR INTERACTING MEDICINES/ USE OF ENALAPRIL MAY LEAD TO RENAL IMPAIRMENT DUE TO OTHER MEDICINES THAT AFFECT RENAL GLOMERULAR FILTRATION,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
DRUG ALLERGY (GRADE I),Drug allergy,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
ACUTE PYELONEPHRITIS DUE TO RECURRENT URINARY TRACT INFECTIONS WITH PSEUDOMONAS AERUGINOSA,Pyelonephritis acute,ACUTE PYELONEPHRITIS,PYELONEPHRITIS ACUTE,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10037597,10037597,10001032
MACULOPAPULAR EXANTHEMA,Maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
"SEPTIC SHOCK WITH ORGAN FAILURE (KIDNEY, LIVER, RESPIRATORY INSUFFICIENCY WITHOUT PNEUMONIA,CIRCULATION)",Respiratory failure,RESPIRATORY INSUFFICIENCY,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038701
RECURRENT INSULIN HYPERSENSITIVITY,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
AGITATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
HEPATOTOXICITY,hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
TREATMENT FAILURE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
STOMATITIS AND OTHER MUCOSAL MEMBRANE DISORDERS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
TYPE 2 RESPIRATORY FAILURE FOLLOWING HOSPITAL ACQUIRED PNEUMONIA,Hypercapnic respiratory failure,HYPERCAPNIC RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10060842,10038695,10060842
BEING EMOTIONALLY DULLED,Emotional disorder,EMOTIONAL DISORDER,EMOTIONAL DISORDER,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10014551,10014551,10014551
MILD PARTIAL PTOSIS OF LEFT EYE,Eyelid ptosis,PTOSIS,EYELID PTOSIS,OCULAR NEUROMUSCULAR DISORDERS,EYELID MOVEMENT DISORDERS,10015919,10015995,10015995,10037272
GASTROINTESTINAL SYMPTOMS,Gastrointestinal symptom NOS,GASTROINTESTINAL SYMPTOM NOS,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10018011,10017944,10018011
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
 magnetic gait,2018-05-19,,,,,GAIT DISTURBANCES,10017589,10017577,
HYPERBILIRUBINEMIA (95.59 MICMOL/L),Hyperbilirubinaemia,HYPERBILIRUBINEMIA,HYPERBILIRUBINAEMIA,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10020578,10020578,10020582
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
"TREATED WITH PROPOFOL, MIDAZOLAM, LEVETIRACETAM AND FINALLY PHENOBARBITAL BUT SEIZURES REMAINED UNABATED (OFFLABEL USE OF MIDAZOLAM FOR EPILEPTIC SEIZURE)",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TREMULOUSNESS,Tremor,TREMULOUSNESS,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044580,10044565,10044580
SERUM CONJUGATED BILIRUBIN INCREASED (134 MICMOL/L),Bilirubin conjugated increased,CONJUGATED BILIRUBIN LEVEL INCREASED,BILIRUBIN CONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10010689,10004685,10010689
PALLOR,Pallor,PALLOR,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033546,10033546,10033546
NASAL BLEEDING,nasal bleeding,NASAL BLEEDING,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10028723,10015090,10028723
TUMOR LYSIS SYNDROME,Tumour lysis syndrome,TUMOR LYSIS SYNDROME,TUMOUR LYSIS SYNDROME,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10045170,10045170,10045152
ALEMTUZUMAB AND FLUDARABINE FOR CONDITIONING REGIMEN,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HYPERTENSION (BLOOD PRESSURE NOS),Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
EXACERBATION OF PLASMA CELL VULVITIS FOLLOWING SUBTHERAPEUTIC EFFECT,Plasma cell vulvitis,PLASMA CELL VULVITIS,PLASMA CELL VULVITIS,FEMALE REPRODUCTIVE TRACT INFECTIONS AND INFLAMMATIONS,VAGINAL AND VULVAL INFECTIONS AND INFLAMMATIONS,10038604,10079057,10079057,10079057
BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
PAIN IN THE LOWER EXTREMITIES FOR 2 MONTHS,Pain in extremity,PAIN OF LOWER EXTREMITIES,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033473,10033425,10033473
DEPRESSION DUE TO SPINE DEFROMATION,Depression,DEPRESSION,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012378,10012378,10012378
GRADE 1 BILATERAL NEPHROCALCINOSIS,Nephrocalcinosis,NEPHROCALCINOSIS,NEPHROCALCINOSIS,UROLITHIASES,RENAL LITHIASIS,10038359,10029146,10029146,10029146
RHABDOMYOLYSIS FOLLOWING DIPHENHYDRAMINE OVERDOSE,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
CARDIO-RESPIRATORY ARREST,Cardio-respiratory arrest,CARDIO-RESPIRATORY ARREST,CARDIO-RESPIRATORY ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007617,10007617,10007617
COLONOSCOPIC EXAMINATION REVEALED ERYTHEMA,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
ERYTHEMA ON PALM AND SOLES,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
PNEUMOPERITONEUM FOLLOWING ILEAL PERFORATION,Pneumoperitoneum,PNEUMOPERITONEUM,PNEUMOPERITONEUM,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10048299,10048299,10048299
DISEASE PROGRESSION WITH AN INCREASE IN PYLORIC ANTRUM-MASS,Malignant neoplasm progression,PROGRESSION OF PRE-EXISTING CANCER,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10057096,10051398,10057096
AST INCREASED (80 IU/L),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
PATIENT TREATED WITH METHOTREXATE AND MYCOPHENOLATE FOR UVEITIS (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RESPIRATORY FAILURE,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
HEMATOTOXICITY,Hematotoxicity,HEMATOTOXICITY,HAEMATOTOXICITY,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10061196,10061188,10061196
FEELING OF TONGUE SWELLING,Tongue swelling non-specific,TONGUE SWELLING NON-SPECIFIC,SWOLLEN TONGUE,TONGUE CONDITIONS,TONGUE SIGNS AND SYMPTOMS,10017947,10043984,10042727,10043984
NEUTROPENIA,neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
INCREASED AVERAGE 24H BLOOD PRESSURE/ THE PATIENTâ€™S BLOOD PRESSURE 140-15/80-90 HGMM/ BLOOD PRESSURE ABOVE NORMAL VALUES,blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
UNCONSCIOUS/FOUND UNCONSCIOUS AT THE DESK/FOUND AT HOME UNCONCIOUS,Unconscious,UNCONSCIOUS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10045479,10024855,10045479
PORPHYRIA NON-ACUTE,Porphyria non-acute,PORPHYRIA NON-ACUTE,PORPHYRIA NON-ACUTE,METABOLIC AND NUTRITIONAL DISORDERS CONGENITAL,INBORN ERRORS OF PORPHYRIN METABOLISM,10010331,10036186,10036186,10036186
ACUTE RENAL FAILURE,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
INADEQUATE THERAPEUTIC EFFECT,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
BACK MYALGIA,Myalgia,LOCALISED MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10063543,10028411,10063543
WESTÂ´S SYNDROME,West's syndrome,WEST'S SYNDROME,INFANTILE SPASMS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10058893,10021750,10058893
LUNG FUNCTION ESTIMATION DEMONSTRATED MILD IMPAIRMENT OF GAS EXCHANGE,Respiratory gas exchange disorder,RESPIRATORY GAS EXCHANGE DISORDER,RESPIRATORY GAS EXCHANGE DISORDER,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10062105,10062105,10062105
SUICIDAL BEHAVIOUR,Suicidal behaviour,SUICIDAL BEHAVIOUR,SUICIDAL BEHAVIOUR,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10065604,10065604,10065604
TIGHTENING OF THE NECK MUSCLES WITH BACKWARD AND RIGHT SIDED DEVIATION OF HEAD,Muscle tightness,NECK TIGHTNESS,MUSCLE TIGHTNESS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028845,10049816,10028845
THE INFECTION COULD NOT BE CONTROLLED DESPITE EFFECTIVE ANTIBIOTIC THERAPY,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
MICROVESICULAR CIRRHOSIS,Hepatic cirrhosis,HEPATIC CIRRHOSIS,HEPATIC CIRRHOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10019641,10019641,10019641
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
SEVERE DIABETIC KETOACIDOSIS FOLLOWING LIPOHYPERTROPHY,Diabetic ketoacidosis,DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEC,10027433,10012671,10012671,10012671
ANTERIOR UVEITIS,anterior uveitis,ANTERIOR UVEITIS,IRIDOCYCLITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10002709,10022941,10002709
EMESIS,Vomiting,EMESIS,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10014542
MACROHEMATURIA,Haematuria,MACROSCOPIC HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10017332,10018867,10059823
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
GELASMUS/LAUGHING FIT/ GIGGLING,Inappropriate affect,INAPPROPRIATE LAUGHTER,INAPPROPRIATE AFFECT,MOOD DISORDERS AND DISTURBANCES NEC,AFFECT ALTERATIONS NEC,10037175,10021595,10021588,10021595
MEDICATION NON-ADHERENCE,treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
SERUM ALBUMIN  DECREASED (2.7 MG/DL),Blood albumin decreased,SERUM ALBUMIN DECREASED,BLOOD ALBUMIN DECREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10040123,10005287,10040123
USE OF MYCOPHENOLATE MOFETIL IN THROMBOTIC THROMBOCYTOPENIC PURPURA (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
OVERDOSED ON FENTANYL,Overdose intentional,OVERDOSE INTENTIONAL,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033300,10022523,10033300
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
COUGH WITH EXPECTORATION,Productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
EARLY ALLERGIC REACTION CAUSED BY RIFAMPICIN,allergic reaction,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
CSF GLUCOSE 1.5 MMOL/L,CSF glucose decreased,CSF GLUCOSE DECREASED,CSF GLUCOSE DECREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10011537,10011537,10011537
HYPERCALCIURIA (UR CA:CR 2.05MMOL/MMOL),Hypercalciuria,HYPERCALCIURIA,HYPERCALCIURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10020590,10020590,10020590
MYALGIA,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
DRUG INTERACTIONS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
RESPIRATORY DISTRESS,respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
SEPSIS,sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
TACHYPNEA,Tachypnoea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043088
ORCHITIS/ BCG-RELATED ORCHITIS,Orchitis,ORCHITIS,ORCHITIS,INFECTIONS - PATHOGEN UNSPECIFIED,MALE REPRODUCTIVE TRACT INFECTIONS,10021881,10031064,10031064,10031064
STEROID HYPERTENSION,Secondary hypertension,SECONDARY HYPERTENSION,SECONDARY HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10039834,10039834,10039834
PATIENT ADMINISTERED HYDROXYCHLOROQUINE FOR THE TREATMENT OF AUTOIMMUNE FEMALE INFERTILITY (OFF LABEL USE) WITH NO ADVERSE EVENT,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FACIAL ERYTHEMA,erythema facial,ERYTHEMA FACIAL,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015212,10015150,10015212
GRADE 1 INCREASE IN ALT,Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
HEPATITIS B VIRUS REACTIVATION (PEAK HBV DNA 3.7 LOG IU PER ML),Hepatitis B reactivation,HEPATITIS B REACTIVATION,HEPATITIS B REACTIVATION,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10058827,10058827,10058827
COMPUTED TOMOGRAPHY SCAN OF THE CHEST DEMONSTRATED SEVERAL BILATERAL SUBCENTIMETER PULMONARY NODULES IN THE LOWER LOBES AND LINGULA,Pulmonary mass,LUNG NODULE,PULMONARY MASS,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10049498,10056342,10049498
ACUTE LIVER FAILURE,Acute hepatic failure,ACUTE LIVER FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10049844,10000804,10049844
CHANGED THE ANTIBIOTIC THERAPY TO MEROPENEM DUE TO CLINICAL WORSENING,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
DISORIENTATED,Disorientated,DISORIENTATED,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013394,10013395,10013394
MILD HEPATOMEGALY,Hepatomegaly,HEPATOMEGALY,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10019842
TRILINEAGE DYSPLASIA,Myelodysplastic syndrome,MARROW DYSPLASIA,MYELODYSPLASTIC SYNDROME,LEUKAEMIAS,MYELODYSPLASTIC SYNDROMES,10029104,10026849,10028533,10026849
DISEASE RECURRENCE,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
WORSENING LEFT VENTRICULAR OUTFLOW OBSTURCTION,left ventricle outflow tract obstruction,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,CARDIAC AND VASCULAR DISORDERS CONGENITAL,CARDIOVASCULAR DISORDERS CONGENITAL NEC,10010331,10065930,10065930,10065930
AMMONIA LEVEL WAS 120 UMOL/L (NORMAL RANGE 12-47 UMOL/L),ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
GRADE 4 ANXIETY,anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
FEEL SO BAD,Feeling abnormal,FEELING BAD,FEELING ABNORMAL,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10016377,10016322,10016324
SEVERE ITCHING,Pruritus,ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023084,10037087,10023084
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
LOPERAMIDE NO RESOLUTION OF DIARRHEA (LACK OF DRUG EFFECT WITH NO ADVERSE EVENT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
INCREASE IN THE FREQUENCY AND NUMBER OF VENTRICULAR ARRHYTHMIAS/ HAD 17 EPISODES OF POLYMORPHIC VTAND 9 EPISODES OF MONOMORPHIC VT AFTER STUDY DRUG AND AMIODARONE ADMINISTRATION.,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
DRUG ADDICTION,Drug addiction,DRUG ADDICTION,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013658,10013663,10013658
HYPOGLYCAEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
NON-SUSTAINED VENTRICULAR TACHYCARDIA,Ventricular tachycardia,NON-SUSTAINED VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10060731,10047302,10060731
ERECTILE DYSFUNCTION,Erectile dysfunction,ERECTILE DYSFUNCTION,ERECTILE DYSFUNCTION,SEXUAL FUNCTION AND FERTILITY DISORDERS,ERECTION AND EJACULATION CONDITIONS AND DISORDERS,10038604,10061461,10061461,10061461
LACK OF EFFICACY LEADING TO INFLUENZA TYPE A MYOCARDITIS,Viral myocarditis,VIRAL MYOCARDITIS,VIRAL MYOCARDITIS,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10047470,10047470,10047470
ENDOCARDIAL FIBROSIS,Endocardial fibrosis,ENDOCARDIAL FIBROSIS,ENDOCARDIAL FIBROSIS,ENDOCARDIAL DISORDERS,ENDOCARDIAL DISORDERS NEC,10007541,10014664,10014664,10014664
REFERRED TO US WITH A LDL CHOLESTEROL CONCENTRATION OF 4.8 MMOL/L (185 MG/DL)/LIPOPROTEIN(A) OF 173 NMOL/L WAS MEASURED,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SMALL ERYTHEMATOUS RASH ON THE LIMBS,erythematous rash,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015243,10037855,10015243
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
NON-OCCLUSIVE MESENTERIC ISCHEMIA (NOMI)),Intestinal ischaemia,NON-OCCLUSIVE MESENTERIC ISCHEMIA,INTESTINAL ISCHAEMIA,GASTROINTESTINAL VASCULAR CONDITIONS,GASTROINTESTINAL VASCULAR OCCLUSION AND INFARCTION,10017947,10077836,10022680,10077815
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
IGM DECREASED (LESS THAN 0.17 G/L),IgM decreased,IGM DECREASED,BLOOD IMMUNOGLOBULIN M DECREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10021277,10005600,10021277
CARDIAC OUTPUT 2.1 L/MINUTE DUE TO SEPTIC SHOCK FOLLOWING DESCENDING NECROTIZING MEDIASTINITIS DUE TO WORSENING OF ODONTOGENIC INFECTION FOLLOWING MULTIDRUG RESISTANCE,Cardiac output decreased,CARDIAC OUTPUT DECREASED,CARDIAC OUTPUT DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10007595,10007595,10007595
ONYCHOLYSIS,Onycholysis,ONYCHOLYSIS,ONYCHOLYSIS,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10030337,10030337,10030337
PERIPHERAL NEUROPATHY,Neuropathy peripheral,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10080342
LACK OF IMPROVEMENT AFTER THE ANTIBIOTIC USED FOR 2 DAYS/SWELLING OF THE NECK DID NOT DIMINISH,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
CUTANEOUS ULCERATIONS,skin ulcer,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040943,10040943,10040943
LOW ALBUMIN,Albumin decreased,ALBUMIN DECREASED,BLOOD ALBUMIN DECREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10001561,10005287,10001561
PERSISTING LOWER BACK PAIN,Low back pain,LOW BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10024891,10003988,10024891
OCCASIONAL CONSTIPATION,Constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
PATIENT HAD PARTIAL RESPONSE TO THE CHEMOTHERAPY (SUBTHERAPEUTIC RESPONSE),Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
CONGESTIVE HEART FAILURE,Cardiac failure congestive,CONGESTIVE HEART FAILURE,CARDIAC FAILURE CONGESTIVE,HEART FAILURES,HEART FAILURES NEC,10007541,10007559,10007559,10010684
"CENTRAL CHEST PAIN, PLEURITIC IN NATURE AND ASSOCIATED WITH SEVERE DYSPNEA",Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
BLEEDING FOLLOWING TONGUE CANCER,Haemorrhage,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10005103
URINARY INCONTINENCE,Urinary incontinence,URINARY INCONTINENCE,URINARY INCONTINENCE,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046543,10046543,10046543
FETAL EXPOSURE DURING PREGNANCY,Fetal exposure during pregnancy,FETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071421,10071404,10071421
GROUND GLASS OPACITY,ground glass opacity,GROUND GLASS OPACITY IN THORACIC CT,COMPUTERISED TOMOGRAM THORAX ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10072879,10057799,10072879
ACUTE HEPATIC FAILURE IN AN INFANT CAUSED BY ACETAMINOPHEN TOXICITY/ DEVELOPED ACUTE FATAL HEPATIC FAILURE,Acute hepatic failure,ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10000804
OLIGURIA (0.0 ML/KG/L),Oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
NORMOCYTIC AND NORMOCHROMIC ANEMIA,Normocytic anaemia,NORMOCYTIC ANEMIA,NORMOCYTIC ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10029784,10029784,10029785
MECHANICAL SMALL-BOWEL OBSTRUCTION RESULTING FROM ADHESIVE BANDS,Small bowel obstruction,SMALL BOWEL OBSTRUCTION,SMALL INTESTINAL OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,DUODENAL AND SMALL INTESTINAL STENOSIS AND OBSTRUCTION,10017947,10041055,10041101,10041055
A 15-POUND WEIGHT GAIN,weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
FLARE-UP,Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
INTRAVENTRICULAR HEMORRHAGE DUE TO DRUG INDUCED IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AND WORSENING OF COCCIDIOIDES IMMITIS INFECTION,Intraventricular haemorrhage,INTRAVENTRICULAR HEMORRHAGE,INTRAVENTRICULAR HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10022840,10022840,10055299
SINUS TACHYCARDIA (VALUE- 160/MIN),Sinus tachycardia,SINUS TACHYCARDIA,SINUS TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040752,10040752,10040752
"INJECTION SITE A VIOLET COLORATION INDURATION AND A LOT OF PAIN,",Injection site induration,INJECTION SITE INDURATION,INJECTION SITE INDURATION,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022075,10022075,10022075
REBOUND OF CHRONIC BULLOUS DISEASE OF CHILDHOOD FOLLOWING PREDNISOLONE DOSE REDUCTIONS,Chronic bullous disease of childhood,CHRONIC BULLOUS DISEASE OF CHILDHOOD,LINEAR IGA DISEASE,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10056539,10024515,10056539
DRUG EXPOSURE IN UTERO,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
ASPARTATE AMINOTRANSFERASE SIGNIFICANTLY INCREASED,aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
RESPIRATORY SYNDROME,Respiratory distress syndrome (neonatal),RESPIRATORY DISTRESS SYNDROME (NEONATAL),NEONATAL RESPIRATORY DISTRESS SYNDROME,NEONATAL RESPIRATORY DISORDERS,NEONATAL HYPOXIC CONDITIONS,10038738,10038690,10028974,10038690
MODERATE-TO-MARKED ACUTE HUMORAL REJECTION,moderate-to-marked acute humoral rejection,HUMORAL REJECTION,TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10064682,10044439,10064682
DIFFUSE RIGIDITY,Muscle rigidity,RIGIDITY,MUSCLE RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10039168,10028330,10039168
INCOMPLETE BISPHOSPHONATE ATYPICAL FEMORAL FRACTURE,Atypical femur fracture,ATYPICAL FEMUR FRACTURE,ATYPICAL FEMUR FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10070884,10070884,10070884
LACTATION EXPOSURE,Exposure via breast milk,DRUG EXPOSURE VIA BREAST MILK,EXPOSURE VIA BREAST MILK,"EXPOSURES, CHEMICAL INJURIES AND POISONING",PATHWAYS AND SOURCES OF EXPOSURE,10022117,10051075,10080751,10051075
SLIGHT VISUAL DISTURBANCES,Visual impairment,VISUAL DISTURBANCES,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047543,10047571,10047545
TREATMENT FAILURE  OF TRIPLE THERAPY (WITH NO ADR),Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
HYPOTENSIVE,Hypotension,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021107
HALLUCINATION,hallucination,HALLUCINATION,HALLUCINATION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019063,10019063,10019063
WORSENING OF THE IMAGING ALTERATIONS EVEN AFTER TWO CYCLES OF ANTIBIOTIC THERAPY,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PULMONARY EMBOLISM,Pulmonary Embolism,PULMONARY EMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037377,10037377,10037377
OVERT HALITOSIS,Halitosis,HALITOSIS,BREATH ODOUR,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10019058,10006326,10019058
"MULTIPLE ERYTHEMATOUS, INDURATED PAPULES AND PLAQUES WITH NO MUCOSAL INVOLVEMENT",Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
MENTAL DETERIORATION,mental impairment,MENTAL DETERIORATION,MENTAL IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10027352,10027374,10027352
AMNIOTIC FLUID VOLUME DECREASED,Amniotic fluid volume decreased,AMNIOTIC FLUID VOLUME DECREASED,AMNIOTIC FLUID VOLUME DECREASED,FOETAL AND NEONATAL INVESTIGATIONS,FOETAL AND NEONATAL DIAGNOSTIC PROCEDURES,10022891,10063356,10063356,10063356
NEUROLOGICAL TOXICITY,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
"10 MONTH OLD MALE WAS ADMINISTERED FLUDARABINE (UNAPPROVED USE FOR CHILDREN BELOW 18, OFF LABEL USE WITH NO ADVERSE EVENT)",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HAND STIFFNESS,Stiffness,STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10042045,10052904,10042045
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
LIVER DYSFUNCTION,Liver disorder,LIVER DISORDER,LIVER DISORDER,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10024670,10024670,10024670
WORSENING OF PULMONARY LESIONS,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
TACHYPNEIC,Tachypnoea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043088
INCREASED PROTHROMBIN TIME (61.2 S),Prothrombin time prolonged,PROTHROMBIN TIME INCREASED,PROTHROMBIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037063,10037063,10037061
RESPIRATORY RATE INCREASED- 20 BREATHS/MIN,Respiratory rate increased,RESPIRATORY RATE INCREASED,RESPIRATORY RATE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10038712,10038712,10038712
TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
GRADE 4 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
HYPERLACTATEMIA,Hyperlactacidaemia,HYPERLACTATEMIA,HYPERLACTACIDAEMIA,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10058603,10020660,10058601
PLEURAL EFFUSION,Pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
TYPE 2 DIABETES MELLITUS,Type 2 diabetes mellitus,TYPE 2 DIABETES MELLITUS,TYPE 2 DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10067585,10067585,10067585
TEMPERATURE SPIKES OF 38 DEGREE C,Body temperature increased,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10005911
HYDROXYCHLOROQUINE USED FOR IMMUNE THROMBOCYTOPENIA,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
BRAIN DEATH,brain death,BRAIN DEATH,BRAIN DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10049054,10049054,10049054
LIVER FIBROSIS,Hepatic fibrosis,FIBROSIS LIVER,HEPATIC FIBROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10019668,10019668,10016648
EPILEPTIFORM,Epilepsy,EPILEPTIFORM MOVEMENT,EPILEPSY,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10015056,10015037,10015056
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
THE PATIENT RECEIVED MISOPROSTOL FOR POSTPARTUM HAEMORRHAGE (OFFLABEL USE) NO ADR,OFF LABEL USE,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"SEATED WITH ELBOWS FLEXED, FISTS CLENCHED, AND NECK FLEXED AND STIFF",musculoskeletal stiffness,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10052904,10052904,10052904
HYPOTENSIVE,Hypotensive,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021107,10021097,10021107
CRYPTOCOCCUS NEOFORMANS INFECTION,Cryptococcosis,CRYPTOCOCCUS NEOFORMANS INFECTION,CRYPTOCOCCOSIS,FUNGAL INFECTIOUS DISORDERS,CRYPTOCOCCAL INFECTIONS,10021881,10011493,10011490,10011493
INJECTION SITE SUBCUTANEOUS TISSUE CHANGE (INDURATED),Injection site induration,INJECTION SITE INDURATION,INJECTION SITE INDURATION,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022075,10022075,10022075
HYPOXIC RESPIRATORY FAILURE DUE TO STRONGYLOIDIASIS,Respiratory failure,HYPOXIC RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10074615,10038695,10074615
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
GENITAL ITCHING,Pruritus genital,GENITAL ITCHING,PRURITUS GENITAL,REPRODUCTIVE TRACT DISORDERS NEC,REPRODUCTIVE TRACT SIGNS AND SYMPTOMS NEC,10038604,10018154,10037093,10018154
MULTIPLE ILL-DEFINED 2-3-MM LIGHT BROWN MACULES ON PALMS AND SOLES,Macule,MACULE,MACULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10025421,10025421,10025421
BENDAMUSTINE USED FOR HODGKIN'S LYMPHOMA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PROTHROMBIN TIME INCREASED (100 UNITS NOS),Prothrombin time prolonged,PROTHROMBIN TIME INCREASED,PROTHROMBIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037063,10037063,10037061
TIREDNESS,Fatigue,TIREDNESS,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10043890
HAEMATOMA,Haematoma,HAEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10018852
SOMNOLENT,somnolent,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
WATERY DIARRHEA,watery diarrhea,WATERY DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10055422,10012735,10055422
MORNING STIFFNESS,Musculoskeletal stiffness,EARLY MORNING STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10014048,10052904,10014048
ANAPHYLAXIS,Anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
VOMIT,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
MISCARRIAGE,Abortion spontaneous,MISCARRIAGE,ABORTION SPONTANEOUS,ABORTIONS AND STILLBIRTH,ABORTIONS SPONTANEOUS,10036585,10000234,10000234,10027649
ASPIRATION PNEUMONIA FOLLOWING TEN /SJS,Aspiration pneumonia,ASPIRATION PNEUMONIA,PNEUMONIA ASPIRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10003525,10035669,10003525
VITAMIN B12 DEFICIENCY,vitamin B12 deficiency,VITAMIN B12 DEFICIENCY,VITAMIN B12 DEFICIENCY,VITAMIN RELATED DISORDERS,WATER SOLUBLE VITAMIN DEFICIENCIES,10027433,10047609,10047609,10047609
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
WIDESPREAD EROSIONS AND CRUSTED LESIONS ON ERYTHEMATOUS BACKGROUND LOCATED ON THE DORSAL SURFACE OF BOTH HANDS AND FORARMS,Skin erosion,SKIN EROSION,SKIN EROSION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040840,10040840,10040840
TINY PUSTULES,Rash pustular,PUSTULE,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037578,10037888,10037578
COMPLETE RECOVERY AFTER ACUTE ZONISAMIDE OVERDOSE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
SCROTAL ABSCESS,Scrotal abscess,SCROTAL ABSCESS,SCROTAL ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,MALE REPRODUCTIVE TRACT INFECTIONS,10021881,10049571,10049571,10049571
GRADUAL SWELLING,Swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
CELLULITIS DUE TO CAMPYLOBACTER FETUS SSP.FETUS,Cellulitis,CELLULITIS,CELLULITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10007882,10007882,10007882
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
IRRITABLE MOOD,Irritability,IRRITABLE MOOD,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10074694,10022998,10074694
MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
INCREASED SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
TACHYPNEA,Tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
"ABNORMAL AST/ALT DUE TO OLANZAPINE, HALOPERIDOL AND QUETIAPINE",Transaminases increased,TRANSAMINASES INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054889,10054889,10054889
DRUG-INDUCED ASEPTIC MENINGITIS,aseptic meningitis,ASEPTIC MENINGITIS,MENINGITIS ASEPTIC,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10003458,10027201,10003458
PLEURITIS,Pleurisy,PLEURITIS,PLEURISY,PLEURAL DISORDERS,PLEURAL INFECTIONS AND INFLAMMATIONS,10038738,10035618,10035618,10035624
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
AKATHISIA,Akathisia,AKATHISIA,AKATHISIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10001540,10001540,10001540
ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
SUICIDE,Completed suicide,SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042462,10010144,10042462
MOTOR DIFFICULTIES,Motor dysfunction,MOTOR DYSFUNCTION,MOTOR DYSFUNCTION,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10061296,10061296,10061296
BEING LOQUACIOUS,Logorrhoea,TALKATIVENESS,LOGORRHOEA,COMMUNICATION DISORDERS AND DISTURBANCES,SPEECH AND LANGUAGE USAGE DISTURBANCES,10037175,10043111,10024796,10043111
HOMOLATERAL PTOSIS,Eyelid ptosis,PTOSIS,EYELID PTOSIS,OCULAR NEUROMUSCULAR DISORDERS,EYELID MOVEMENT DISORDERS,10015919,10015995,10015995,10037272
RENAL FUNCTION WORSENED,renal function aggravated,RENAL FUNCTION AGGRAVATED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038453,10062237,10038453
ORAL HEMORRHAGIC BLISTERS FOLLOWING THROMBOCYTOPENIA,hemorrhagic blisters,BLISTERS,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005216,10005191,10005216
RESPIRATORY ACIDOSIS,Respiratory acidosis,RESPIRATORY ACIDOSIS,RESPIRATORY ACIDOSIS,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10038661,10038661,10038661
TEMPERATURE OF 100.2,Pyrexia,HIGH TEMPERATURE,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10020083,10037660,10020083
IVCD/ SEVERE INTRA-VENTRICULAR CONDUCTION DELAY,Defect conduction intraventricular,DEFECT CONDUCTION INTRAVENTRICULAR,DEFECT CONDUCTION INTRAVENTRICULAR,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10012118,10012118,10012118
HAEMORRHAGIC INFLAMMATION OF STOMACH MUCOSA,Mucosal inflammation,MUCOSAL INFLAMMATION,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028116,10028116,10028116
NO ADVERSE EVENT,No Adverse Event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
PATIENT WAS TREATED WITH MYCOPHENOLATE MOFETIL FOR ERROSIVE ORAL LICHEN PLANUS (OFF LABEL USE OF DRUG FOR INDICATION)-WITH NO ADVERSE DRUG REACTION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LEUKOCYTOSIS,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
WARFARIN AND CLOPIDOGREL HAD BEEN HELD DUE TO GASTROINTESTINAL BLEEDING,Gastrointestinal haemorrhage,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017936
INAPPETENCE,Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
NODULES OVER LOWER AND UPPER LIMBS,Nodule skin,NODULE SKIN,SKIN MASS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS CONDITIONS NEC,10040785,10029494,10067868,10029494
MEDIASTINAL LYMPHADENOPATHY,Mediastinal lymphadenopathy,MEDIASTINAL LYMPHADENOPATHY,LYMPHADENOPATHY MEDIASTINAL,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10027075,10025205,10027075
HYPERREFLEXIA,Hyperreflexia,HYPERREFLEXIA,HYPERREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10020745,10020745,10020745
DRUG USE IN UNAPPROVED POPULATION WITH NO REPORTED ADR,Product use issue,DRUG USE IN UNAPPROVED POPULATION,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10071551,10076309,10071551
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,Posterior reversible encephalopathy syndrome,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10071066,10071066,10071066
"WEEPING FACIAL EROSIONS, INCLUDING THE LIPS, EROSIONS ON THE NECK, AND ORAL MUCOSA",Lip erosion,LIP EROSION,LIP EROSION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10051992,10051992,10051992
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
OLIGURIC RENAL FAILURE FOLLOWING HEMOLYTIC-UREMIC SYNDROME,Renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
PARTIAL VIROLOGIC RESPONSE,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
RENAL FAILURE (SERUM CREATININE 430 LMOL/L),renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
TOXIC MEGACOLON DUE TO ASPERGILLOSIS,Megacolon toxic,MEGACOLON TOXIC,MEGACOLON,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,NON-MECHANICAL ILEUS,10017947,10027115,10027110,10027115
COLITIS,Colitis,COLITIS,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009887,10009887,10009887
LOSS OF WEIGHT,Weight decreased,LOSS OF WEIGHT,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10024883
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
MULTIPLE SHOCKS DESPITE TREATMENT WITH AMIODARONE AND/OR BETA BLOCKER (BB),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
INTERSTITIAL PNEUMONIA,Interstitial lung disease,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
TREATMENT FRELATED COMPLICATIONS,Death unexplained,DEATH UNEXPLAINED,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10052809,10011906,10052809
WORSENING OF FATIGUE,Fatigue aggravated,FATIGUE AGGRAVATED,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10048415,10016256,10048415
IMATINIB RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
FAILED THERAPY WITH AZATHIOPRINE AND MYCOPHENOLATE MOFETIL,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SOLITARY RIGHT UPPER LOBE NODULE,Pulmonary mass,LUNG NODULE,PULMONARY MASS,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10049498,10056342,10049498
SEVERE MUCOSITIS,mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
RECURRENT NIGHTMARES,nightmares,NIGHTMARES,NIGHTMARE,SLEEP DISORDERS AND DISTURBANCES,PARASOMNIAS,10037175,10029414,10029412,10029414
EPITHELIOID GRANULOMA,granuloma,GRANULOMA,GRANULOMA,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10018691,10018691,10018691
PROLONGED PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
SUDDEN COLLAPSE OF VITAL FUNCTIONS,Vital functions abnormal,VITAL FUNCTIONS ABNORMAL,VITAL FUNCTIONS ABNORMAL,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10063644,10063644,10063644
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
TEMPERATURE ELEVATION UP TO 38C,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PANIC ATTACKS,Panic attack,PANIC ATTACKS,PANIC ATTACK,ANXIETY DISORDERS AND SYMPTOMS,PANIC ATTACKS AND DISORDERS,10037175,10033664,10033664,10033665
DEVELOPED ANAPHYLAXIS SECONDARY TO CLAVULANIC ACID,Anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
EXACERBATION OF CHARCOT MARIE TOOTH DISEASE (1A DEMYELINATING TYPE),Hereditary motor and sensory neuropathy,CHARCOT-MARIE-TOOTH DISEASE,HEREDITARY MOTOR AND SENSORY NEUROPATHY,NEUROLOGICAL DISORDERS CONGENITAL,PERIPHERAL NERVOUS SYSTEM DISORDERS CONGENITAL NEC,10010331,10008414,10077306,10008414
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
LOSS OF HAIR,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV) INFECTION,Middle East respiratory syndrome,MIDDLE EAST RESPIRATORY SYNDROME,MIDDLE EAST RESPIRATORY SYNDROME,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10075271,10075271,10075271
BLINDNESS,Blindness,BLINDNESS,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10005169,10005169,10005169
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
LEFT AMBLYOPIA,left amblyopia,AMBLYOPIA,AMBLYOPIA,VISION DISORDERS,AMBLYOPIC VISION IMPAIRMENT,10015919,10001906,10001906,10001906
"DRUG EXPOSURE DURING PREGNANCY, SECOND TRIMESTER",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, SECOND TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076616,10073513,10076616
TRANSAMINITIS IN THE THOUSANDS,Transaminases increased,TRANSAMINITIS,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054969,10054889,10054969
AGITATION,agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
ACUTE RENAL FAILURE,acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
TEARING,tearing eyes,TEARING EYES,LACRIMATION INCREASED,EYE DISORDERS NEC,LACRIMATION DISORDERS,10015919,10043171,10023644,10043171
WHITE BLOOD CELL COUNT DECREASED,White blood cell count decreased,WHITE BLOOD CELL COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10047942
ASPERGILLUS INFECTION,Aspergillus infection,ASPERGILLUS INFECTION,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10074171,10074171,10074171
GAMMA-GLUTAMYLTRANSFERASE INCREASED (33XULN),Gamma-glutamyltransferase increased,GAMMA-GLUTAMYLTRANSFERASE INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10017693,10017693,10017693
NORMAL NEWBORN,Normal newborn,NORMAL NEWBORN,NORMAL NEWBORN,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS",NORMAL NEWBORN STATUS,10036585,10029769,10029769,10029769
REBOUND EFFECT OF METHYLPREDNISOLONE AND DEXAMETHASONE,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
FANCONI SYNDROME ACQUIRED,Fanconi syndrome acquired,FANCONI SYNDROME ACQUIRED,FANCONI SYNDROME ACQUIRED,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10052607,10052607,10052607
HEMORRHAGIC SHOCK DUE TO GASTRIC ULCER,Shock haemorrhagic,HEMORRHAGIC SHOCK,SHOCK HAEMORRHAGIC,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10049771,10049771,10050841
VITAMIN D INTOXICATION,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
AMIODARONE-INDUCED HYPERTHYROIDISM/SEVERE HYPERTHYROIDISM/ AMIODARONE-INDUCED DESTRUCTIVE THYROIDITIS,Thyrotoxicosis,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
METHOTREXATE TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
SEVERE INTESTINAL ISCHEMIA (TRANSMURAL ISCHEMIA OF ENTIRE LARGE INTESTINE),Intestinal ischaemia,INTESTINAL ISCHEMIA,INTESTINAL ISCHAEMIA,GASTROINTESTINAL VASCULAR CONDITIONS,GASTROINTESTINAL VASCULAR OCCLUSION AND INFARCTION,10017947,10022680,10022680,10022681
ANAEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
RIGHT UPPER QUADRANT ABDOMINAL PAIN,Abdominal pain upper,RIGHT UPPER QUADRANT PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10039162,10000087,10039162
RECURRENT PYREXIA UP TO 39Â° C,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
TEMOZOLOMIDE (TMZ)-INDUCED INFLAMMATION OF DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS (DSAP) ON BILATERAL FOREARMS,Actinic keratosis,ACTINIC KERATOSIS,ACTINIC KERATOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,SKIN PRENEOPLASTIC CONDITIONS NEC,10040785,10000614,10000614,10000614
ANAPHYLACTIC REACTION,Anaphylactic reaction,ANAPHYLACTIC REACTION,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002198,10002198,10002198
PALMAR AND PLANTAR ERYTHEMA AND SWELLING,Palmar-plantar erythrodysaesthesia syndrome,PALMAR-PLANTAR ERYTHEMA,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10063069,10033553,10063069
CEREBRAL ISCHAEMIA,Cerebral ischaemia,CEREBRAL ISCHAEMIA,CEREBRAL ISCHAEMIA,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008120,10008120,10008120
ELEVATION OF LIVER ENZYME,Hepatic enzyme increased,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
HYPERPIGMENTATION OF SUN-EXPOSED AREAS OF HER SKIN,Photosensitivity reaction,PHOTOSENSITIVITY REACTION,PHOTOSENSITIVITY REACTION,EPIDERMAL AND DERMAL CONDITIONS,PHOTOSENSITIVITY AND PHOTODERMATOSIS CONDITIONS,10040785,10034972,10034972,10034972
HER PAIN IS CONSTANT DESPITE MORPHINE AND VENLAFAXINE (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SLIGHTLY PRODUCTIVE COUGH,Productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
1.5 MM ST ELEVATION IN V1-4,ST elevated,ST ELEVATED,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041887,10014392,10041887
QT PROLONGED,QT prolonged,QT PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037705,10014387,10037705
NEW RELAPSE OF MULTIPLE MYELOMA AND CRYOGLOBULINAEMIC VASCULITIS FOLLOWING BENDAMUSTINE CHEMOTHERAPY FAILURE,Cryoglobulinaemic vasculitis,CRYOGLOBULINAEMIC VASCULITIS,CRYOGLOBULINAEMIA,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10075624,10011474,10075624
SELF-MEDICATION WITH NO ADR,Self-medication,SELF-MEDICATION,SELF-MEDICATION,THERAPEUTIC PROCEDURES AND SUPPORTIVE CARE NEC,THERAPEUTIC PROCEDURES NEC,10042613,10050729,10050729,10050729
CHOLESTASIS,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
DRESS SYNDROME,Dress syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
MUSCULAR RIGIDITY,Muscle rigidity,MUSCLE RIGIDITY,MUSCLE RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10028330,10028330,10028330
COMA/CNS DEPRESSION,Depressed level of consciousness,CNS DEPRESSION,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10012383,10012373,10009710
SPONTANEOUS BACTERIAL PERITONITIS CAUSED BY LISTERIA MONOCYTOGENES,Peritonitis bacterial,PERITONITIS BACTERIAL,PERITONITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10062070,10062070,10062070
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
DIABETES INSIPIDUS,Diabetes insipidus,DIABETES INSIPIDUS,DIABETES INSIPIDUS,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,POSTERIOR PITUITARY DISORDERS,10014698,10012599,10012599,10012599
"BLOOD PRESSURE - 155/70 MMHG, PATHOLOGICAL ECG FINDINGS, LEFT VENTRICULAR HYPERTROPHY, DIASTOLIC DYSFUNCTION",ECG abnormal,ECG ABNORMAL,ELECTROCARDIOGRAM ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10014085,10014363,10014085
PERSISTENT DIARRHEA,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
EASILY HEMORRHAGIC MUCOSAL EROSION IN THE DUODENUM TO THE UPPER JEJUNUM,Haemorrhagic erosive gastritis,HAEMORRHAGIC EROSIVE GASTRITIS,HAEMORRHAGIC EROSIVE GASTRITIS,GASTROINTESTINAL ULCERATION AND PERFORATION,GASTRIC ULCERS AND PERFORATION,10017947,10067786,10067786,10067786
RESPIRATORY RATE INCREASED (47/MIN),Respiratory rate increased,RESPIRATORY RATE INCREASED,RESPIRATORY RATE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10038712,10038712,10038712
"PATIENT WITH STAGE III NON SEMINOMA GERM CELL TUMOR RECEIVED 2 CYCLES OF BLEOMYCIN, ETOPOSIDE, CISPLATIN BECAUSE OF TOXICITY",Toxicity to various agents,DRUG TOXICITY NOS,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013751,10070863,10013751
ABORTION,Aborted pregnancy,ABORTED PREGNANCY,ABORTED PREGNANCY,GENDER RELATED FACTORS,PREGNANCY RELATED CIRCUMSTANCES,10041244,10000209,10000209,10000209
HYPOAUTOFLUORESCENCE (FIRST RING) AND HYPERAUTOFLUORESCENCE (SECOND RING) AROUND FOVEA CREATING A BULLâ€™S EYE PATTERN,Bull's eye maculopathy,BULL'S EYE MACULOPATHY,MACULOPATHY,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10068902,10025425,10068902
UNCONTROLLABLE LOW SYSTEMIC BLOOD PRESSURE,Hypotension,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10024895
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
NON-TRAUMATIC UNILATERAL ADRENAL HEMORRHAGE,adrenal hemorrhage,ADRENAL HEMORRHAGE,ADRENAL HAEMORRHAGE,ADRENAL GLAND DISORDERS,ADRENAL GLAND DISORDERS NEC,10014698,10001363,10001361,10001363
LISTERIA MONOCYTOGENES,Listeria monocytogenes,LISTERIA MONOCYTOGENES INFECTION,LISTERIOSIS,BACTERIAL INFECTIOUS DISORDERS,LISTERIA INFECTIONS,10021881,10024640,10024641,10024640
HEPATIC INVOLVEMENT,Liver disorder,LIVER DISORDER,LIVER DISORDER,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10024670,10024670,10024670
OPIOID USE DISORDER FOLLOWING OPIOID ABUSE,opioid use disorder,OPIOID USE DISORDER,DRUG USE DISORDER,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10079385,10079381,10079385
MUSCLE PAIN IN BOTH LEGS,Pain in extremity,PAIN LEGS,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033459,10033425,10033459
"MOSTLY EMPTY BOTTLES OF HIGH-DOSE CHLORAL HYDRATE, PHENOBARBITAL, AND MORPHINE, CONSISTENT WITH A PHYSICIAN-ASSISTED DYING REGIMEN",Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
"NUCLEAR MEDICINE GASTRIC EMPTYING STUDY DID NOT SHOW ANY EMPTYING AT 90 MINUTES. NASO-GASTRIC LAVAGE WITH NORMAL SALINE, AND LATER WITH ACETYLCYSTEINE DID NOT DISSOLVE THE BEZOAR",Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
GIANT CELL ARTERITIS,giant cell arteritis,GIANT CELL ARTERITIS,TEMPORAL ARTERITIS,VASCULAR INFLAMMATIONS,ARTERIAL INFLAMMATIONS,10047065,10018250,10043207,10018250
MELAENA,melaena,MELAENA,MELAENA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10027141,10027141,10027141
DIAPHORESIS,Hyperhidrosis,DIAPHORESIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042670,10020642,10012703
PERIPHERAL EDEMA,Oedema peripheral,PERIPHERAL EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030124,10030124,10034570
BILATERAL NON-REACTIVE MYDRIASIS DUE TO DRUG INTERACTION,mydriasis,MYDRIASIS,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10028521,10028521,10028521
DEPRESSION PROCEED AGAIN,Depression,DEPRESSION,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012378,10012378,10012378
PROLONGED PT (PROLOBGED BY > 3 S AT BASELINE),prolonged PT (prolobged by > 3 s at baseline),PROTHROMBIN TIME PROLONGED,PROTHROMBIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037063,10037063,10037063
"LACK OF DRUG EFFECT/DESPITE BEING STARTED ON METHYLPREDNISOLONE AND ANTIBIOTICS, SHE CONTINUED TO HAVE WORSENING HYPOXA AND RENAL FAILURE",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
THE MOTHER RECEIVED PREDNISONE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
DEVELOPED A CUTANEOUS PAPULAR RED NODULE ON THE LEFT LEG AND SCROTUM,Skin mass,NODULE SKIN,SKIN MASS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS CONDITIONS NEC,10040785,10040902,10067868,10029494
RECURRENT SPASM,Facial spasm,ORO-FACIAL SPASM,FACIAL SPASM,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),FACIAL CRANIAL NERVE DISORDERS,10029205,10031093,10063006,10031093
INTRA OCULAR PRESSURE WAS INADEQUATELY CONTROLLED ON DORZOALMIDE- LACK OF DRUG EFFECT WITH NO ADVERSE EVENT,Lack of drug efficacy,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
GENERAL WEAKNESS,Asthenia,WEAKNESS GENERALISED,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047864,10003549,10047864
PROGRESSIVE SPLENOMEGALY,Splenomegaly,SPLENOMEGALY,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041660,10041660,10041660
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
SUICIDE ATTEMPT,suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
OSTEALGIA,Bone pain,OSTEALGIA,BONE PAIN,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10006002,10006002,10070685
NEUROPATHIC FOOT PAIN,neuralgia,NEURALGIA,NEURALGIA,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10029223,10029223,10029223
REMITTENT 2-PEAK FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PRIMARY CUTANEOUS POST LIVER TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD),Post transplant lymphoproliferative disorder,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10051358,10051358,10051358
MUCOCUTANEOUS TOXICITY INDUCED BY LOW-DOSE METHOTREXATE THERAPY,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
PCO2 24.5 MM/HG,PCO2 decreased,PARTIAL PRESSURE CO2 DECREASED,PCO2 DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10034181,10034181,10034078
ANEURYSM ATRIAL,Aneurysm atrial,ANEURYSM ATRIAL,CARDIAC ANEURYSM,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10002332,10007513,10002332
DISSOCIATIVE MENTAL STATE,mental state abnormal,MENTAL STATE ABNORMAL,MENTAL DISORDER,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10027381,10061284,10027381
"SKIN OF THE FACE, TRUNK AND EXTREMITIES SHOWED LESIONS SUGGESTIVE OF ERYTHEMATOUS RASH AND SCALLING",Erythematous rash,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015243,10037855,10015243
DRUG OVERDOSE / ACCIDENTAL,Accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
SENSORINEURAL HEARING LOSS THAT WAS LIKELY CAUSED BY CISPLATIN-RELATED TOXICITY,Deafness neurosensory,SENSORINEURAL HEARING LOSS,DEAFNESS NEUROSENSORY,HEARING DISORDERS,HEARING LOSSES,10013993,10040016,10011891,10040016
PATIENT ADMINISTERED METFORMIN AT 4 YEARS OF AGE (UNAPPROVED POPULATION)- OFF LABEL USE FOR POPULATION WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
KOUNIS SYNDROME,Kounis syndrome,KOUNIS SYNDROME,KOUNIS SYNDROME,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10069167,10069167,10069167
TACHYARRHYTHMIA,Tachyarrhythmia,TACHYARRHYTHMIA,TACHYARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10049447,10049447,10049447
DETERIORATING GRAFT FUNCTION [TRANSPLANT DYSFUNCTION],Deteriorating graft function [Transplant dysfunction],TRANSPLANT DYSFUNCTION,TRANSPLANT DYSFUNCTION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10074860,10074860,10074860
"AAOX0 (PATIENT IS ALERT AWAKE BUT NOT ORIENTED TO PERSON,PLACE OR TIME)",Disorientation,DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013395
ANOREXIA,anorexia,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10002646,10061428,10002646
PATHOLOGICAL HIP FRACTURE,Pathological fracture,PATHOLOGICAL FRACTURE OF HIP,PATHOLOGICAL FRACTURE,FRACTURES,FRACTURES NEC,10028395,10054866,10034156,10054866
ANGIOEDEMA,Angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
PRURITUS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
PRURITIS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
EFFECTS OF TREATMENTS ON MUSCLE CRAMPS/NO IMPROVEMENT WITH NIFEDIPINE,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
INFECTED WITH IVDPV3,Poliomyelitis,POLIOMYELITIS,POLIOMYELITIS,VIRAL INFECTIOUS DISORDERS,POLIOMYELITIS VIRAL INFECTIONS,10021881,10036012,10036012,10036012
ABNORMAL SERUM BIOCHEMISTRY RESULTS INCLUDED BLOOD UREA NITROGEN 10.8 MMOL/L,Blood urea increased,BLOOD UREA NITROGEN INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005855,10005851,10005855
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
MORPHINE INTOXICATION,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
TREMOR,tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
DARK TARRY FECES/DARK STOOL,Dark tarry feces/dark stool,FECES DISCOLORED,FAECES DISCOLOURED,GASTROINTESTINAL SIGNS AND SYMPTOMS,FAECAL ABNORMALITIES NEC,10017947,10016307,10016100,10016307
LOWER EXTREMITY WEAKNESS AND ACHES,Muscular weakness,WEAKNESS IN EXTREMITY,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10047868,10028372,10065702
HYPERHIDROSIS,Hyperhidrosis,HYPERHIDROSIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10020642,10020642,10020642
CREATININE CLEARANCE OF 4 ML/MIN/1.72 METRE SQUARE,Clearance creatinine decreased,CLEARANCE CREATININE DECREASED,CREATININE RENAL CLEARANCE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10009255,10011372,10009255
UNINTENTIONAL WEIGHT LOSS,Abnormal loss of weight,UNINTENTIONAL WEIGHT LOSS,ABNORMAL LOSS OF WEIGHT,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10068329,10000159,10068329
LOSS OF CONSCIOUSNESS/ SWITCH OFF AND AM LOST IN THOUGHT,loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
EARLY CEREBELLAR TONSILLAR HERNIATION DUE TO COMMUNICATING HYDROCEPHALUS DUE TO PARIETO-OCCIPITAL INTRACEREBRAL ABSCESS DUE TO WORSENING OF MELIOIDOSIS FOLLOWING LACK OF DRUG EFFECT,Brain herniation,BRAIN HERNIATION,BRAIN HERNIATION,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10006126,10006126,10006126
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
MILD DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
"WAS TREATED WITH SEVERAL ANTIPSYCHOTIC TREATMENTS (RISPERIDONE,LAI RISPERIDONE 50 MG/MONTH, OLANZAPINE 20 MG/DAY,PALIPERIDONE 9 MG/DAY, AND ARIPIPRAZOL 15 MG/DAY) WITHOUT ACHIEVING CLINICAL STABILITY",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PATIENT TREATED WITH KETOCONAZOLE FOR CUSHINGOID (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SCM SECONDARY TO NMS/ STRESS INDUCED CARDIOMYOPATHY,Stress cardiomyopathy,STRESS CARDIOMYOPATHY,STRESS CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10066286,10066286,10066286
"ERYTHEMATOUS PAPULES ON HER UPPER CHEST, UPPER BACK, AND ARMS",Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
SLIGHT SCALING OF SKIN,Skin exfoliation,SKIN SCALY,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040920,10040844,10040920
CLOSTRIDIUM DIFFICLE INFECTION FOLLOWING NEUTROPENIA,Clostridium difficile infection,CLOSTRIDIUM DIFFICILE INFECTION,CLOSTRIDIUM DIFFICILE INFECTION,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10054236,10054236,10054236
MILD METHOTREXATE ASSOCIATED KERATOPATHY,keratopathy,KERATOPATHY,KERATOPATHY,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CORNEAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10023365,10023365,10023365
WORSENING OF IMMUNE THROMBOCYTOPENIA,Autoimmune thrombocytopenia,AUTOIMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10050245,10074667,10050245
"SEDATED, INTUBATED, ON AMIODARONE, LIDOCAINE, NORADRENALINE AND DOPAMINE INFUSIONS/RECURRENT VF EPISODES OCCURRED",Therapy non-responder,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
REDNESS AND SWELLING RIGHT LATERAL MALLEOLUS,Peripheral swelling,SWELLING OF FEET,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042693,10048959,10042693
ALLERGY TO OMEPRAZOLE,Drug allergy,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
STENOSIS ON THE LEFT SIDE DUE TO ATHEROSCLEROSIS,Stenosis,STENOSIS,STENOSIS,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076711,10076711,10076711
OLANZAPINE INDUCED BLEPHAROSPASM,Blepharospasm,BLEPHAROSPASM,BLEPHAROSPASM,OCULAR NEUROMUSCULAR DISORDERS,EYELID MOVEMENT DISORDERS,10015919,10005159,10005159,10005159
STEROIDS DID NOT RESOLVE TEH BILATERAL CHOROIDAL EFFUSIONS AND CILIARY BODY DETACHMENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
FAILED TREATMENT WITH IBUPROFEN,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
FEBRILE WITH A TEMPERATURE OF 38.2 Â°C,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
NEUTROPENIC ENTEROCOLITIS (TYPHLITIS),Neutropenic colitis,NEUTROPENIC ENTEROCOLITIS,NEUTROPENIC COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10029359,10062959,10029359
"STARTED ON OMEPRAZOLE WITH SOME RELIEF OF HEARTBURN AND VOMITING, BUT HE DEVELOPED SEVERE CONSTIPATION",Constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
WERNICKE ENCEPHALOPATHY DUE TO WORSENING OF VITAMIN B1 DEFICIENCY,Wernicke's encephalopathy,WERNICKE'S ENCEPHALOPATHY,WERNICKE'S ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10047911,10047911,10047911
STREPTOCOCCUS  PNEUMONIAE,Streptococcus  pneumoniae,STREPTOCOCCUS PNEUMONIAE PNEUMONIA,PNEUMONIA PNEUMOCOCCAL,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10042195,10035728,10042195
EYES HAD STICKY SECRETIONS THAT MADE HIS EYELIDS DIFFICULT TO SEPARATE,Eye discharge,STICKY EYES,EYE DISCHARGE,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10042037,10015915,10042037
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
SHOCK FOLLOWING NECROTIZING FASCIITIS,Shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
INTRATHECAL ADMINISTRATION OF ALDURAZYME WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ACCIDENTAL INGESTION OF METHOTREXATE,accidental ingestion of drug,ACCIDENTAL INGESTION OF DRUG,ACCIDENTAL EXPOSURE TO PRODUCT,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,ACCIDENTAL EXPOSURES TO PRODUCT,10022117,10073319,10073317,10073319
SORE THROAT,Oropharyngeal pain,SORE THROAT,OROPHARYNGEAL PAIN,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10041367,10068319,10041367
THE PATIENT HAD NO RESPONSE (LACK OF DRUG EFFECT) WITH NO ADVERSE EVENT,the patient had no response (lack of drug effect),LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PAINFUL SKIN NECROSIS,Skin necrosis,SKIN NECROSIS,SKIN NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040893,10040893,10040893
LIVER DAMAGE,Liver injury,LIVER DAMAGE,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067125,10067125,10024668
IMATINIB MESILATE USE IN REFRACTORY EOSINOPHILIC GRANULOMATOSIS WITH POLYANGITIS (DRUG USE FOR UNAPPROVED INDICATION WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"MASSIVE WITHDRAWAL SYMPTOMS WITH NAUSEA, VOMITING, DIARHEA AND WITH PAIN",Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
HEPATITIS A,hepatitis A,HEPATITIS A,HEPATITIS A,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10019719,10019719,10019719
LACK OF DRUG EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
INTRINSIC RENAL INJURY,Renal injury,RENAL INJURY,RENAL INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10061481,10061481,10061481
PERIUNGUAL PYOGENIC GRANULOMA,Pyogenic granuloma,PYOGENIC GRANULOMA,PYOGENIC GRANULOMA,CUTANEOUS NEOPLASMS BENIGN,SKIN NEOPLASMS BENIGN,10029104,10037649,10037649,10037649
GRADUAL TENDENCY TOWARD WORSENING WITH HBA1C OF 7.4%,Diabetes mellitus inadequate control,LOSS OF CONTROL OF BLOOD SUGAR,DIABETES MELLITUS INADEQUATE CONTROL,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10024858,10012607,10024858
ELEVATED SERUM AMYLASE,Amylase increased,SERUM AMYLASE INCREASED,AMYLASE INCREASED,GASTROINTESTINAL INVESTIGATIONS,DIGESTIVE ENZYMES,10022891,10040139,10002016,10040139
MMF AND TACROLIMUS USED IN BONE MARROW TRANSPLANTATION,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
"SUBSTERNAL, TEARING CHEST PAIN",Chest pain,SUBSTERNAL CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10042427,10008479,10042427
RENAL DISORDER,Renal disorder,RENAL DISORDER,RENAL DISORDER,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL DISORDERS NEC,10038359,10038428,10038428,10038428
CLOZAPINE-INDUCED EOSINOPHILIA,Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
RESPIRATORY DISTRESS SYNDROME,respiratory distress syndrome,RESPIRATORY DISTRESS SYNDROME (NEONATAL),NEONATAL RESPIRATORY DISTRESS SYNDROME,NEONATAL RESPIRATORY DISORDERS,NEONATAL HYPOXIC CONDITIONS,10038738,10038690,10028974,10038690
UNSTIMULATED SALIVARY RATE WAS LOW(0.3 ML/MIN),Aptyalism,SALIVA DECREASED,APTYALISM,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10039380,10003068,10039380
IT WAS CONCLUDED THAT EOSINOPHILIA WAS DUE TO CLOZAPINE/CLOZAPINE INDUCED EOSINOPHILIA,Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
SERUM CREATININE INCREASED (195MICROMOL/L),Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
CHOROIDITIS,Choroiditis,CHOROIDITIS,CHOROIDITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","RETINAL, CHOROID AND VITREOUS INFECTIONS AND INFLAMMATIONS",10015919,10008792,10008792,10008792
INDIRECT HYPERBILIRUBINAEMIA (102.1 MICROMOL/L),Hyperbilirubinaemia,INDIRECT HYPERBILIRUBINAEMIA,HYPERBILIRUBINAEMIA,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10075822,10020578,10075822
WEAKNESS OF THE FOURTH AND FIFTH DIGITS,Muscular weakness,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028372,10028372,10028372
10-POUND WEIGHT LOSS,10-pound weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
THE MANIFESTATIONS OF A DIFFERENT (OTHER THAN CARDIOVASCULAR) TOXICITY OF THE ANTI-CANCER TREATMENT DID NOT EXCEED GRADE 1,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
INTENTIONAL PARACETAMOL AND CODEINE MISUSE,Intentional drug misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
HYPERGLYCAEMIA FOLLOWING LACK OF DRUG EFFECT,Hyperglycaemia,HYPERGLYCAEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020635
ALLERGY,Hypersensitivity,HYPERSENSITIVITY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10020751,10020751,10020751
CLAMMY,Cold sweat,CLAMMY,COLD SWEAT,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10009230,10009866,10009231
USE OF METHOTREXATE FOR GAINT CELL ARTERITIS,use of methotrexate for gaint cell arteritis,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ESCHERICHIA COLI EXTENDED SPECTRUM BETALACTAMASES (ESBL+) PRODUCING STRAIN WAS IDENTIFIED IN THE HEMOCULTURE,Escherichia sepsis,ESCHERICHIA SEPSIS,ESCHERICHIA SEPSIS,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10015296,10015296,10015296
DISSEMINATED NOCARDIOSIS (NOCARDIA FARCINICA),Nocardiosis,NOCARDIOSIS,NOCARDIOSIS,BACTERIAL INFECTIOUS DISORDERS,NOCARDIA INFECTIONS,10021881,10029444,10029444,10029444
DIRECT BILIRUBIN INCREASED (2.1 MG/DL),Bilirubin conjugated increased,DIRECT BILIRUBIN INCREASED,BILIRUBIN CONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10013038,10004685,10013038
BALANCE DIFFICULTY SECONDARY TO GENTAMICIN FOLLOWING OFF LABEL USE OF DRUG,Balance disorder,BALANCE DIFFICULTY,BALANCE DISORDER,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10004070,10049848,10004070
POLYCYTHEMIA VERA TREATED WITH ASPIRIN,Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
CMV DNA POSITIVE,Cytomegalovirus test positive,CYTOMEGALOVIRUS DNA TEST POSITIVE,CYTOMEGALOVIRUS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10063310,10051620,10063310
PARENCHYMAL CONSOLIDATION MEASURING 55 X 28 X 34 MM,Lung consolidation,LUNG CONSOLIDATION,LUNG CONSOLIDATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025080,10025080,10025080
ABDOMINAL HEMATOMA,Intra-abdominal haematoma,ABDOMINAL HEMATOMA,INTRA-ABDOMINAL HAEMATOMA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10054975,10056457,10054988
GENERALIZED WEAKNESS,Asthenia,WEAKNESS GENERALISED,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047864,10003549,10047864
CHOLESTSTIC,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
TRIGEMINO-CARDIAC REFLEX,Trigemino-cardiac reflex,TRIGEMINO-CARDIAC REFLEX,TRIGEMINO-CARDIAC REFLEX,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10069828,10069828,10069828
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,Drug rash with eosinophilia and systemic symptoms,DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058919,10073508,10058919
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
CEREBELLAR GAIT DISORDER/PRE-EXISTING AFFERENT GAIT DISTURBANCE AGGRAVATED,Gait disturbance,GAIT DISTURBANCE,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017577,10017577,10017577
LEFT-SIDED HEMIPLEGIA,Hemiplegia (left),HEMIPLEGIA (LEFT),HEMIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019469,10019468,10019469
ACUTE RESPIRATORY DISTRESS SYNDROME,acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
STEVENS JOHNSON SYNDROME,Stevens Johnson syndrome,STEVENS JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042030,10042033,10042030
EPIDERMAL NECROSIS,Epidermal necrosis,EPIDERMAL NECROSIS,EPIDERMAL NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10059284,10059284,10059284
PERSISTENT LACTATE ELEVATION,persistent lactate elevation,LACTATE INCREASED,BLOOD LACTIC ACID INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10023660,10005635,10023660
WEAKNESS,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
PRESSURED SPEECH,Pressure of speech,PRESSURE OF SPEECH,PRESSURE OF SPEECH,COMMUNICATION DISORDERS AND DISTURBANCES,SPEECH ARTICULATION AND RHYTHM DISTURBANCES,10037175,10036649,10036649,10036649
COULDN'T WAKE HER UP,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
ERYTHEMATOUS ERUPTION,Rash erythematous,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10037855
LAMOTRIGINE-INDUCED DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS),Drug reaction with eosinophilia and systemic symptoms,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
HB DECREASED TO 10 MG/DL,Haemoglobin decreased,HB DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10019171,10018884,10019171
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME PRESENTING AS SECONDARY SYPHILIS WITH POLYMORPHOUS ERYTHEMA AND KNEE ARTHRITIS,Immune reconstitution inflammatory syndrome,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10065042,10065042,10065042
VIBRATORY SENSORY DISTAL DEFICIT,vibratory sensory distal deficit,SENSORY DEFICIT,SENSORY LOSS,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10061563,10040030,10061563
VERTIGO,vertigo,VERTIGO,VERTIGO,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10047340,10047340,10047340
ALKALINE PHOSPHATASE (AP) 4.84 ÎœMOL/SL,Alkaline phosphatase increased,ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001675,10059570,10001675
SLIGHT DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
DIFFUSE ISCHEMIA AND PERFUSIONAL DEFECT IN THE MACULA RESULTING FROM CILIORETINAL ARTERY OCCLUSION,Macular ischaemia,MACULAR ISCHAEMIA,MACULAR ISCHAEMIA,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINAL BLEEDING AND VASCULAR DISORDERS (EXCL RETINOPATHY),10015919,10065534,10065534,10065534
INCREASED BLOOD PRESSURE (BP 150/90),Blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
HEART FAILURE,Heart failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10019279,10007554,10019279
BLOOD PRESSURE DECREASED (93/60 MMHG) FOLLOWING INTENTIONAL LOPERAMIDE ABUSE,Blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
PSYCHOMOTOR SLOWING,Psychomotor retardation,PSYCHOMOTOR RETARDATION,PSYCHOMOTOR RETARDATION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10037213,10037213,10037213
VISUAL ACUITY DECREASED,visual acuity reduced,VISUAL ACUITY REDUCED,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047531,10047531,10047531
MACULOPAPULAR EXANTHEMA PLUS OEDEMA,Oedema,OEDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10030095
CHRONICALLY SLEEP-DEPRIVED,Insomnia,SLEEP LOSS,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10041017,10022437,10041001
WORSENING OF FASCICULAR VENTRICULAR TACHYCARDIA ON METOPROLOL (BETA BLOCKER THERAPY),Ventricular tachycardia,VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047302,10047302,10047302
SEVERE GASTROINTESTINAL SYMPTOMS LIKE VOMITING AND ANOREXIA,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
TOTAL BILIRUBIN INCREASED (3.5 MG/DL),Blood bilirubin increased,BILIRUBIN TOTAL INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056806,10005364,10056806
INFLIXIMAB IS INFUSED OVER 1.5 HOURS AT A DOSE OF 5MG/KG FOR IBD,Product use issue,DRUG USE LESS THAN LABELED ADMINISTRATION DURATION,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10079777,10076309,10079775
RIGHT-SIDED VESICULAR RASH IN A DERMATOMAL DISTRIBUTION ON THE TRUNK,Rash vesicular,VESICULAR RASH,RASH VESICULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037898,10037898,10047377
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
INSULIN DEPENDENT DIABETES MELLITUS,Type 1 diabetes mellitus,INSULIN-DEPENDENT DIABETES MELLITUS,TYPE 1 DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012608,10067584,10022497
DEMYELINATING NEUROPATHY DUE TO INTERACTION BETWEEN MEPACRINE AND CHLOROQUINE,Demyelinating polyneuropathy,DEMYELINATING POLYNEUROPATHY,DEMYELINATING POLYNEUROPATHY,PERIPHERAL NEUROPATHIES,CHRONIC POLYNEUROPATHIES,10029205,10061811,10061811,10061811
HBV REACTIVATION,Hepatitis B reactivation,HEPATITIS B REACTIVATION,HEPATITIS B REACTIVATION,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10058827,10058827,10058827
HYPERKERATOSIS,hyperkeratosis,HYPERKERATOSIS,HYPERKERATOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,HYPERKERATOSES,10040785,10020649,10020649,10020649
SCLEROSIS ON THE RIGHT GREATER LIP OF PUDENDUM,Multiple sclerosis,SCLEROSIS MULTIPLE,MULTIPLE SCLEROSIS,DEMYELINATING DISORDERS,MULTIPLE SCLEROSIS ACUTE AND PROGRESSIVE,10029205,10028245,10028245,10039720
AST INCREASED (1523 U/L),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
BRADYCARDIA,bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
ACUTE APPENDICITIS,Appendicitis,ACUTE APPENDICITIS,APPENDICITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10000677,10003011,10000677
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
PREMATURE BIRTH DUE TO DRUG EXPOSURE IN UTERO,Premature baby,PREMATURE BIRTH,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036590,10036590,10036594
PLEOMORPHIC SARCOMA OF THE BLADDER,Urinary bladder sarcoma,URINARY BLADDER SARCOMA,URINARY BLADDER SARCOMA,SOFT TISSUE NEOPLASMS MALIGNANT AND UNSPECIFIED,SOFT TISSUE SARCOMAS HISTOLOGY UNSPECIFIED,10029104,10051690,10051690,10051690
HEPATIC DYSFUNCTION,Hepatic function abnormal,HEPATIC FUNCTION DISORDER,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019674,10019670,10019674
LEFT CHRONIC SUBDURAL HAEMATOMA INCREASED,Subdural haematoma,CHRONIC SUBDURAL HAEMATOMA,SUBDURAL HAEMATOMA,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10049162,10042361,10049162
POSSIBLE HYPERSENSITIVITY PNEUMONITIS,Alveolitis allergic,PNEUMONITIS HYPERSENSITIVITY,ALVEOLITIS ALLERGIC,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10035754,10001890,10035754
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
"SWOLLEN SOLES, PAINFUL WITH PALPATION",Pain in extremity,PAIN FOOT,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033429,10033425,10033400
PNEUMONIA MAINLY CAUSED BY FUNGAL INFECTION,Pneumonia fungal,PNEUMONIA FUNGAL,PNEUMONIA FUNGAL,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10061354,10061354,10061354
DRUG ABUSE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
RECURRENT PERICARDITIS FOLLOWING ULCERATIVE COLITIS,Pericarditis,PERICARDITIS,PERICARDITIS,PERICARDIAL DISORDERS,NONINFECTIOUS PERICARDITIS,10007541,10034484,10034484,10034484
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
MILD SKIN GVHD (OVERALL GRADE I),Graft versus host disease in skin,GRAFT VERSUS HOST DISEASE IN SKIN,GRAFT VERSUS HOST DISEASE IN SKIN,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10064675,10064675,10064675
BLOOD PRESSURE DECREASED,blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
PATIENT WAS TREATED WITH MYCOPHENOLATE MOFETIL AND HYDROXYCHLOROQUINE FOR GIVEN INDICATION ( OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
ACUTELY EXACERBATED CHRONIC RENAL FAILURE,Acute kidney injury,ACUTE ON CHRONIC RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038440,10069339,10000952
SEPSIS FOLLOWING HEMORRHAGIC ENTEROCOLITIS,sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
WBC AND CRP ALSO SHOWED A TRANSIENT REBOUND,C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
IMMUNE RECONSTITUTION SYNDROME,Immune reconstitution inflammatory syndrome,IMMUNE RECONSTITUTION SYNDROME,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10054014,10065042,10054014
HAIR LOSS,Alopecia,HAIR LOSS,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10019045,10001760,10019045
LARGE VEGETATION EXTENDING FROM THE TRICUSPID VALVE TO PULMONARY VALVE,Cardiac valve vegetation,CARDIAC VALVE VEGETATION,CARDIAC VALVE VEGETATION,INFECTIONS - PATHOGEN UNSPECIFIED,CARDIAC INFECTIONS,10021881,10057651,10057651,10057651
TRAUMATIC SUBDURAL HEMATOMA,subdural hemorrhage,SUBDURAL HEMORRHAGE,SUBDURAL HAEMORRHAGE,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10042384,10042364,10042384
ACUTE RENAL FAILURE,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
ESCHAR COVERED WOUNDS ON BOTH ANKLES AND AURICLES OF EARS,eschar,ESCHAR,ESCHAR,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10051814,10051814,10051814
INTERSTITIAL LUNG DISEASE,Interstitial lung disease,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
RECURRENT EPISODES OF INCREASED BLOOD PRESSURE (UPTO 180/100 MMHG) FOLLOWING LACK OF DRUG EFFECT,increased blood pressure,INCREASED BLOOD PRESSURE,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10021655,10005750,10021655
TRANSAMINITIS,Transaminitis,TRANSAMINITIS,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054969,10054889,10054969
OBTUNDED,obtundation,OBTUNDATION,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10029985,10012373,10029985
"BETTER GLYCEMIC CONTROL, IMPROVEMENT OF LIVER FUNCTION",Unexpected therapeutic drug effect,UNEXPECTED THERAPEUTIC DRUG EFFECT,THERAPEUTIC RESPONSE UNEXPECTED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10052807,10043417,10052807
CREATININE INCREASED (11.8 MG/DL),Blood creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
LACK OF DRUG EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
NONPRODUCTIVE COUGH,cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
ACUTE KIDNEY FAILURE,Acute kidney injury,ACUTE KIDNEY FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10000821
"PHENYTOIN WAS PRESCRIBED, AND ONCE THERAPEUTIC LEVEL WAS ACHIEVED, HIS HALLUCINATIONS AND UNPROVOKED EMOTIONAL RESPONSES RESOLVED",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG EFFECT INCOMPLETE,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
ACUTE RETROSTERNAL PAIN,Pain retrosternal,PAIN RETROSTERNAL,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033488,10008479,10033488
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PREMATURE NEWBORN (35 WEEKS),Premature newborn (35 weeks),PREMATURE BABY 33 TO 36 WEEKS,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10053594,10036590,10053594
HYPERCALCAEMIA,Hypercalcaemia,HYPERCALCAEMIA,HYPERCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020583,10020583,10020583
WEAKNESS AND HYPERALGESIA OF EXTREMITIES/REDUCED MUSCLE STRENGTH OF THE PROXIMAL MUSCLES AND PATELLAR,Muscular weakness,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028372,10028372,10028372
HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
SEIZURE WORSENING/ A SEIZURE RELAPSE AFTER 40 MONTHS OF FREEDOM,Condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
TOTAL PROTEIN 5.1 G/DL,Protein total decreased,TOTAL PROTEIN LOW,PROTEIN TOTAL DECREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10044111,10037014,10044111
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
"PROGRESSION OF THE ERUPTION TO THE INGUINAL REGION, BUTTOCKS, AND ABDOMINAL REGION",Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
HEMOGLOBIN DECREASED (41 G/LITER),Hemoglobin decreased (41 g/liter),HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10019483,10018884,10019483
PATIENT RECEIVED MYCOPHENOLATE MOFETIL MILD PORTAL AND INTERFACE HEPATITIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DISSEMINATED ASPERGILLOSIS,Aspergillus infection,ASPERGILLOSIS,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003488,10074171,10003488
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
FUNGAL INFECTION,Fungal infection,FUNGAL INFECTION,FUNGAL INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017533,10017533,10017533
HAEMOPHTHALMIA/ HEMORRHAGE IN THE AREA OF RIGHT EYE MACULA,Macula lutea hemorrhage,MACULA LUTEA HEMORRHAGE,RETINAL HAEMORRHAGE,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINAL BLEEDING AND VASCULAR DISORDERS (EXCL RETINOPATHY),10015919,10055305,10038867,10055305
FELL DOWN,Falling down,FALLING DOWN,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016178,10016173,10016178
"STILL WAS UNABLE TO WALK UP THE STAIRS AND WAS SEVERELY RESTRICTED BY PAIN DURING HOUSE-HOLD CHORES, WITH LEFT KNEE BEING ESPECIALLY PAINFUL AND STIFF",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
CHRONIC NOROVIRUS INFECTION,Norovirus test positive,NOROVIRUS TEST POSITIVE,NOROVIRUS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10070379,10070379,10070379
ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
MYOCLONIAS,Myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
OTITIS,Otitis,OTITIS,EAR INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,EAR INFECTIONS,10021881,10033071,10014011,10033071
ACUTE LIMB ISCHAEMIA,Acute limb ischaemia,ACUTE LIMB ISCHAEMIA,PERIPHERAL ISCHAEMIA,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10077113,10034576,10077113
PHARYNGEAL MUCOSITIS,Pharyngeal inflammation,PHARYNGEAL MUCOSITIS,PHARYNGEAL INFLAMMATION,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),PHARYNGEAL DISORDERS (EXCL INFECTIONS AND NEOPLASMS),10038738,10065881,10065716,10065881
INFLAMMATION OF THE LUNGS,Pneumonitis,LUNG INFLAMMATION,PNEUMONITIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10077942,10035742,10077942
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
PERSISTENT PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
"ERYTHEMATOUS,ALMOST RECTANGULAR SKIN PATCH",Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
URINALYSIS INDICATED HEMOGLOBINURIA,Haemoglobinuria,HEMOGLOBINURIA,HAEMOGLOBINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018906,10018906,10019489
CHRONIC EXCESSIVE DOSES OF IBUPROFEN,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
PERSISTENT NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
SUSPECTED VACCINATION FAILURE,Vaccination failure,VACCINATION FAILURE,VACCINATION FAILURE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,VACCINATION RELATED COMPLICATIONS,10022117,10046862,10046862,10046862
OPIOID OVERDOSE: SEROTONIN SYNDROME,Serotonin syndrome,SEROTONIN SYNDROME,SEROTONIN SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10040108,10040108,10040108
EXACERBATION OF ASTHMATIC ATTACKS,Asthmatic attack,ASTHMATIC ATTACK,ASTHMA,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10003566,10003553,10003566
SMOOTH PHILTRUM,Dysmorphism,FLAT PHILTRUM,DYSMORPHISM,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL DISORDERS CONGENITAL NEC,10010331,10058844,10066054,10058844
ANAPHYLACTIC SHOCK,Anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
SWELLING OF ORAL MUCOSAE,Mouth swelling,ORAL MUCOSA SWOLLEN,MOUTH SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10030993,10075203,10030993
INCREASINGLY FATIGUED,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
METHOTREXATE-RELATED LYMPHOPROLIFERATIVE DISORDER,Lymphoproliferative disorder,LYMPHOPROLIFERATIVE DISORDER,LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10061232,10061232,10061232
DRUG-INDUCED HYPOGLYCAEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
ALTERED SENSORIUM,Sensorium decreased,SENSORIUM DECREASED,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10040019,10012373,10040019
FEELING DIZZY,Dizziness,DIZZY,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10018263,10013573,10013580
AMIODARONE-INDUCED THYROIDITIS,Thyroiditis,THYROIDITIS,THYROIDITIS,THYROID GLAND DISORDERS,ACUTE AND CHRONIC THYROIDITIS,10014698,10043778,10043778,10043778
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
HEADACHES,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
RECURRENT PYROGLUTAMIC ACIDOSIS,Metabolic acidosis,HIGH ANION GAP METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10069033,10027417,10069033
EXTRASPINAL OSTEOARTICULAR MULTIDRUG-RESISTANT TUBERCULOSIS,Joint tuberculosis,JOINT TUBERCULOSIS,JOINT TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10056367,10056367,10056367
CONFUSED,Confused,CONFUSED,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010298,10010305,10010298
"FEVER, ASTHENIA, BONE PAIN",Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
FREQUENT MOOD SWINGS,Mood swings,MOOD SWINGS,MOOD SWINGS,MOOD DISORDERS AND DISTURBANCES NEC,FLUCTUATING MOOD SYMPTOMS,10037175,10027951,10027951,10027951
HEPARIN-INDUCED THROMBOCYTOPENIA,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
"RECURRENT IN-STENT THROMBOSIS FOLLOWING LOE OF ASPIRIN, CLOPIDOGREL AND TICAGRELOR.",coronary stent thrombosis,CORONARY STENT THROMBOSIS,VASCULAR STENT THROMBOSIS,COMPLICATIONS ASSOCIATED WITH DEVICE,VASCULAR COMPLICATIONS ASSOCIATED WITH DEVICE,10018065,10063933,10063934,10063933
SEVERE MYELOSUPPRESSION FOLLOWING METHOTREXATE POISONING,bone marrow depression,BONE MARROW DEPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10005986
HYPOREFLEXIA,hyporeflexia,HYPOREFLEXIA,HYPOREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10021089,10021089,10021089
ACUTE ENCEPHALOPATHY FOLLOWING MYOPATHY,Encephalopathy,ENCEPHALOPATHY ACUTE,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014626,10014625,10014626
DISSEMINATED STRONGYLOIDES STERCORALIS INFECTION,Strongyloides stercoralis infection,STRONGYLOIDES STERCORALIS INFECTION,STRONGYLOIDIASIS,HELMINTHIC DISORDERS,NEMATODE INFECTIONS,10021881,10042253,10042254,10042253
PRODUCTIVE COUGH,Productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
TOTAL ADRENAL INSUFFICIENCY/ADRENAL INSUFFICIENCY,adrenal insufficiency,ADRENAL INSUFFICIENCY,ADRENAL INSUFFICIENCY,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001367,10001367,10001367
HAD PINPOINT PUPILS,Miosis,PUPILS PINPOINT,MIOSIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10037537,10027646,10037537
URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
RENAL DAMAGES,Renal injury,RENAL INJURY,RENAL INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10061481,10061481,10061481
SECOND THROMBOELASTOMETRY ANALYSIS WAS PERFORMED 30 MINUTES AFTER TRANEXAMIC ACID INFUSION DUE TO CONTINUOUS BLEEDING,Lack of drug effect ,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
STROID-RESISTANT VITREOUS OPACITY,vitreous opacities,VITREOUS OPACITIES,VITREOUS OPACITIES,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","CHOROID AND VITREOUS STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10047658,10047658,10047658
DRUG EXPOSURE IN UTERO,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
DISEASE PROGRESSION WITH LYMPH NODES INVOLVEMENT AND INCREASE OF M-PROTEIN,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
PATIENT EXPERIENCED MILD VIREMIA (743 COPIES/ML) AND RELAPSED RETINITIS DESPITE THE ADMINISTERATION OF ORAL VALGANCICLOVIR,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HAEMATOCHEZIA,Haematochezia,HAEMATOCHEZIA,HAEMATOCHEZIA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018836,10018836,10018836
BILATERAL PLEURAL EFFUSIONS BECAME WORSE.,bilateral pleural effusion,BILATERAL PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10078037,10035598,10078037
PLEURAL EFFUSION FOLLOWING PULMONARY OEDEMA DUE TO DRUG EXPOSURE DURING PREGNANCY,pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
PRESENCE OF GRANULAR AND HYALINE CASTS,Urinary casts,CASTS URINARY GRANULAR,URINARY CASTS,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINALYSIS NEC,10022891,10007717,10046533,10007717
EXTENSIVE ANTERIOR STEMI,Acute myocardial infarction,STEMI,ACUTE MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10064346,10000891,10064346
PANCYTOPENIA,pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
ABNORMALITY IN HER LEFT EYE/ LEFT UPPER LID RETRACTION,Eye disorder,EYE ABNORMALITY,EYE DISORDER,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10015903,10015916,10015903
INGESTED 130 TABLETS OF CARVEDILOL AND 30 TABLETS OF AMLODIPINE OVERNIGHT AFTER AN ARGUMENT,intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
POSTERIOR SYNECHIAE,posterior synechiae of iris,POSTERIOR SYNECHIAE OF IRIS,IRIS ADHESIONS,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","IRIS AND CILIARY BODY STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10036367,10022945,10036367
UNINTENTIONAL WEIGHT LOSS OF 20 KG,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
MEDICATIONINDUCED SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
ACUTE NEUTROPENIA,acute neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
INTRAVENOUS UROGRAM SHOWED BILATERALLY ENLARGED KIDNEYS,Kidney Enlargement,KIDNEY ENLARGEMENT,KIDNEY ENLARGEMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL STRUCTURAL ABNORMALITIES AND TRAUMA,10038359,10048469,10048469,10048469
COLONIC HISTOPLASMOSIS,histoplasmosis,HISTOPLASMOSIS,HISTOPLASMOSIS,FUNGAL INFECTIOUS DISORDERS,HISTOPLASMA INFECTIONS,10021881,10020141,10020141,10020141
DRUG PRESCRIBING ERROR (METHOTREXATE PRESCRIBED 10 MG/DAILY INSTEAD OF WEEKLY),drug prescribing error (methotrexate prescribed 10 mg/daily instead of weekly),DRUG PRESCRIBING ERROR,DRUG PRESCRIBING ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT PRESCRIBING ERRORS AND ISSUES,10022117,10064296,10064296,10064296
UNUSUAL CASE OF IATROGENIC KAPOSI'S SARCOMA,Kaposi's sarcoma,KAPOSI'S SARCOMA,KAPOSI'S SARCOMA,SOFT TISSUE NEOPLASMS MALIGNANT AND UNSPECIFIED,KAPOSI'S SARCOMAS,10029104,10023284,10023284,10023284
MILD LEFT VENTRICLE SYSTOLIC DYSFUNCTION,Left ventricular dysfunction,LEFT VENTRICULAR DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10049694,10049694,10049694
CYSTIC AIR FILLED LUNG LESIONS,Lung cyst,LUNG CYST,LUNG CYST,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10068749,10068749,10068749
SEVERE MOOD CHANGES,Altered mood,ALTERED MOOD,MOOD ALTERED,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10001850,10027940,10001850
ACUTELY DISORIENTED AND COULD NOT RECOGNISE HER FAMILY,Disorientation,DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013395
ALTERED SENSORIUM,Sensorium decreased,SENSORIUM DECREASED,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10040019,10012373,10040019
GENERALIZED WEAKNESS,Asthenia,WEAKNESS GENERALISED,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047864,10003549,10047864
PONCETâ€™S DISEASE SECONDARY TO BCG,Poncet's disease,PONCET'S DISEASE,PONCET'S DISEASE,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10071742,10071742,10071742
HAIR DEPIGMENTATION,Hair colour changes,HAIR DEPIGMENTED,HAIR COLOUR CHANGES,SKIN APPENDAGE CONDITIONS,PILAR DISORDERS NEC,10040785,10019033,10019030,10019033
PULSELESSNESS,Pulse absent,PULSELESSNESS,PULSE ABSENT,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10037497,10037469,10037497
KLEBSIELLA PNEUMONIAE,Klebsiella pneumoniae,KLEBSIELLA PNEUMONIAE PNEUMONIA,PNEUMONIA KLEBSIELLA,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10023458,10035717,10023458
LYMPHOCYTOPENIA,lymphocytopenia,LYMPHOCYTOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025278,10025327,10025278
UTERINE PERFORATION,Uterine perforation,UTERINE PERFORATION,UTERINE PERFORATION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,REPRODUCTIVE TRACT AND BREAST PROCEDURAL COMPLICATIONS,10022117,10046810,10046810,10046810
OXYGEN SATURATION RANGING FROM 60 TO 65%,oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
UNABLE TO TOLERATE ANY OF THE ANTI-INFLAMMATORIES BECAUSE OF ASSOCIATED ABDOMINAL DISCOMFORT,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HEMODYNAMIC COLLAPSE FOLLOWING RENAL DYSFUNCTION,Circulatory collapse,CIRCULATORY COLLAPSE,CIRCULATORY COLLAPSE,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10009192,10009192,10009192
"EXCEEDING THE MAXIMUM DOSE (EVERY 6 HOURS) COMPARED TO REGIMEN APPROVED IN THE SMPC
(ONCE A DAY)",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
EOSINOPHILIA/PRESENCE OF 4% EOSINOPHILS/9% EOSINOPHILS,eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
WORSENING OF PHYSICAL STATUS DUE TO DRUG DEPENDENCE,worsening of physical status due to drug dependence,PHYSICALLY UNWELL,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10078500,10025482,10078500
MULTI DRUG RESISTANT (MDR) E.COLI INFECTION,Multiple-drug resistance,MULTIPLE-DRUG RESISTANCE,MULTIPLE-DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10048723,10048723,10048723
"THE PATIENT SUDDENLY DEVELOPED AN EPISODE OF POLYMORPHIC VENTRICULAR TACHYCARDIA AND SHE
THEN HAD 2 MORE EPISODES OF POLYMORPHIC VENTRICULAR FIBRILLATION",Ventricular tachycardia,POLYMORPHIC VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10028158,10047302,10036095
WEAKNESS DUE TO DRUG INTERACTION,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
DISORIENTED REGARDING TIME AND SPACE,disorientation,DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013395
URINARY INCONTINENCE,Urinary incontinence,URINARY INCONTINENCE,URINARY INCONTINENCE,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046543,10046543,10046543
C-REACTIVE PROTEIN INCREASED (279 MG/L),C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
"ADJUSTED SERUM CALCIUM (CA), INTACT - PARATHYROID HORMONE (I-PTH) INCREASED TO EQUAL TO OR MORE THAN REFERENCE VALUE/ADJUSTED CALCIUM INCREASED/21.0",PTH increased,PTH INCREASED,BLOOD PARATHYROID HORMONE INCREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),PARATHYROID ANALYSES,10022891,10037269,10005703,10037269
HYPOTENSION (SYSTOLIC BLOOD PRESSURE 40 MMHG),Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
AMMONIA INCREASED,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
PROGRESSION OF MULTIPLE MYELOMA FOLLOWING LACK OF DRUG EFFECT,Plasma cell myeloma,MULTIPLE MYELOMA,PLASMA CELL MYELOMA,PLASMA CELL NEOPLASMS,PLASMA CELL MYELOMAS,10029104,10028228,10035226,10028228
RIGHT CAVITY AND TRICUSPID VALVE HYPOPLASIA,congenital heart disease NOS,CONGENITAL HEART DISEASE NOS,HEART DISEASE CONGENITAL,CARDIAC AND VASCULAR DISORDERS CONGENITAL,CARDIAC DISORDERS CONGENITAL NEC,10010331,10010495,10019273,10010495
LOSS OF THE RED REFLEX,Red reflex abnormal,RED REFLEX ABNORMAL,RED REFLEX ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",OPHTHALMIC HISTOPATHOLOGY AND IMAGING PROCEDURES,10022891,10074603,10074603,10074603
HYPONATREMIA,hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
NEUROPSYCHIATRIC LUPUS AGGRAVATED,Neuropsychiatric lupus,NEUROPSYCHIATRIC LUPUS,NEUROPSYCHIATRIC LUPUS,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10063663,10063663,10063663
AFTER WITHDRAWAL OF IMATINIB MESILATE PATIENT QUICKLY LOST THE REMISSION,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
WORSENING OF BACTERIAL PNEUMONIA DUE TO LACK OF DRUG EFFECT OF CILASTATIN SODIUM/IMIPENEM,Pneumonia,PNEUMONIA AGGRAVATED,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10048382,10035664,10048382
GRADE 1 INCREASE IN BOTH AST AND ALP,Blood alkaline phosphatase increased,ALP INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10001771,10059570,10001771
TUMOR LYSIS SYNDROME,Tumour lysis syndrome,TUMOR LYSIS SYNDROME,TUMOUR LYSIS SYNDROME,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10045170,10045170,10045152
WEIGHT GAIN,Weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
REBOUND EFFECT,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
PERITONITIS FOLLOWING NON-NEUTROPENIC TYPHLITIS,peritonitis,PERITONITIS,PERITONITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10034674,10034674,10034674
LETHARGY,lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
73% NEUTROPHILS INCREASED,Neutrophil count increased,NEUTROPHILS INCREASED,NEUTROPHIL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029381,10029368,10029381
COGNITIVE SLOWING,Cognitive disorder,COGNITIVE IMPAIRMENT,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10057668,10057668,10009846
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
DIARRHEA,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
FEBRILE DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
HECTIC FEVER UPTO 40 DEGREE CELSIUS,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
CLINICAL RESPONSE WAS STATIONARY,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
HYPOKALAEMIA,Hypokalaemia,HYPOKALAEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021015
AMIODARONE-INDUCED THYROTOXICOSIS,Hyperthyroidism,THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
MUSCULAR WEAKNESS,Muscular weakness,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028372,10028372,10028372
BRONCHOSPASM,Bronchospasm,BRONCHOSPASM,BRONCHOSPASM,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10006482,10006482,10006482
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
PETECHIAE ON THE DISTAL EXTREMITIES,Petechiae,PETECHIAE,PETECHIAE,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10034754,10034754,10034754
AMIODARONE-INDUCED HYPERTHYROIDISM/THYROTOXICOSIS,Hyperthyroidism,HYPERTHYROIDISM,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10020850,10020850,10020850
SERUM CREATININE ( 2.9MG/DL),Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
JUVENILE DERMATOMYOSTITIS FOLLOWING REBOUND EFFECT OF METHOTREXATE AND PREDNISOLONE,Juvenile Dermatomyositis,JUVENILE DERMATOMYOSITIS,DERMATOMYOSITIS,EPIDERMAL AND DERMAL CONDITIONS,CONNECTIVE TISSUE DISORDERS,10040785,10078425,10012503,10078425
MOOD DISORDER WITH MANIC FEATURES,Mania,MANIA,MANIA,MANIC AND BIPOLAR MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH MANIC SYMPTOMS,10037175,10026749,10026749,10026749
OXYGEN DESATURATIONS,Hypoxia,HYPOXIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021143,10021143,10021143
INFECTIOUS CMV PANUVEITIS,panuveitis,PANUVEITIS,UVEITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10033687,10046851,10033687
SEVERE RHABDOMYOLYSIS,rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
DELIRIUM OCCURRED,delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
OWING TO THE PATIENT ERROR,Drug administration error,DRUG ADMINISTRATION ERROR,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064295,10064295,10064295
SEIZURES,Seizure,SEIZURES,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039910
"INVASIVE VASCULAR GROWTH, AS WELL AS DISSEMINATION TO THE HEART/FATAL INVASIVE ASPERGILLOSIS",Aspergillosis,ASPERGILLOSIS,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003488,10074171,10003488
BILATERAL EXOPHTHALMUS DUE TO GRAVES'S DISEASE,Thyrotoxic exophthalmos,THYROTOXIC EXOPHTHALMOS,ENDOCRINE OPHTHALMOPATHY,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION OF EYE NEC",10015919,10043787,10060742,10043787
CHRONIC INFLAMMATION,inflammation,INFLAMMATION,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10061218,10061218,10061218
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
TRANSIENT ELEVATION IN LIVER ENZYME (AST 54/L),transient elevation in liver enzyme (AST 54/L),AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
LARGE ARES OF PURPURIC PATCHES DORSALLY ON BOTH FEET WITH ASSOCIATED HEMORRHAGIC BULLAE,Haemorrhage purpuric,HAEMORRHAGE PURPURIC,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10018996,10037549,10018996
COLCHICINE TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
ADVANCED MYCOSIS FUNGOIDES/SEZARY SYNDROME TREATED WITH ALEMTUZUMAB (OFF LABEL USE) WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INCREASED C-REACTIVE PROTEIN,c-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
TENOFOVIR INDUCED FANCONI'S SYNDROME,acquired fanconi syndrome,FANCONI SYNDROME ACQUIRED,FANCONI SYNDROME ACQUIRED,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10052607,10052607,10052607
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
PSYCHOLOGICAL SYMPTOMS,Mental disorder,PSYCHOLOGICAL DISORDER NOS,MENTAL DISORDER,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10050222,10061284,10050222
GASTROINTESTINAL BLEED,Gastrointestinal haemorrhage,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017955
ALT 289 TO 4097,Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
MORPHINE INTOXICATION,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
OVERDOSE OF T4,Drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
PROPTOSIS FOLLOWING DRUG EXPOSURE IN UTERO,Exophthalmos,PROPTOSIS,EXOPHTHALMOS,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION OF EYE NEC",10015919,10036905,10015683,10036905
INTRAVENOUS INFUSION OF PIRACETAM./24 G DAILY FOR 2 DAYS. AND THEN 36 G DAILY FOR NEXT 3 DAYS,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
SUICIDE ATTEMPT,Completed suicide,SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042462,10010144,10042462
PULMONARY INFECTION FOLLOWING BY SEVERE MYELOSUPPRESSION,lung infection,LUNG INFECTION,LUNG INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10061229,10061229,10061229
ORTHOPNEA,orthopnea,ORTHOPNEA,ORTHOPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10031122,10031123,10031122
TREATMENT FAILURE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
"THE PATIENT INADVERTENTLY RECEIVED OVERDOSE OF TAPENTADOL, METHADONE, BENZODIAZEPINES,
OPIATES AND TRICYCLIC ANTIDEPRESSANTS AND DEVELOPED MODERATE SOMNOLENCE AND DYSARTHRIA",Dysarthria,DYSARTHRIA,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10013887,10013887,10013887
MILD DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
DECREASED WHITE BLOOD CELL OF   GRADE 3,White blood cell count decreased,WHITE BLOOD CELL COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10047942
A 14.5% WEIGHT GAIN,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
MRONJ-INDUCED SINUSITIS,Maxillary sinusitis,MAXILLARY SINUSITIS,SINUSITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10056475,10040753,10056475
"PATEINT WAS TREATED WITH MELPHALAN, CYCLOPHOSPHAMIDE, DEXAMETHASONE,AND THALIDOMIDE (WHICH WAS DISCONTINUED BECAUSE OFATTAINMENT OF STABLE PARTIAL RESPONSE, WITH NO NEUROPATHIC SYMPTOMS).",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
NO IMPROVEMENT IN SYMPTOMS WITH IBUPROFEN,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HEMORRHAGIC DISORDER/VALPROIC-ACID INDUCED BLEEDING DISORDER,hemorrhagic disorder,HEMORRHAGIC DISORDER,HAEMORRHAGIC DISORDER,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),BLEEDING TENDENCIES,10005329,10055279,10019009,10055279
FIBRINOGEN ACTIVITY <60 MG/DL,Fibrinogen decreased,FIBRINOGEN DECREASED,BLOOD FIBRINOGEN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10016596,10005520,10016596
"A LIVID, DISCOLORED SWELLING IN THE REGION OF THE PROXIMAL TIBIA WAS VISIBLE THAT WAS PAINFUL WHEN PRESSURE WAS APPLIED",Swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HYPOTHYROIDISM-INDUCED REVERSIBLE ENCEPHALOPATHY,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
MYCOPHENOLATE MOFETIL USED FOR TREATMENT OF  BLOOD STEM CELL TRANSPLANT AND PROPHYLAXIS AGAINST GRAFT VERSUS HOST,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LEFT VENTRICULAR HYPERTROPHY/SEVERE LEFT VENTRICULAR HYPERTROPHY,left ventricular hypertrophy,LEFT VENTRICULAR HYPERTROPHY,LEFT VENTRICULAR HYPERTROPHY,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10049773,10049773,10049773
IMMEDIATE-TYPE ALLERGY,Type I hypersensitivity,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
ANASTOMOSIS DEHISCENCE,Anastomotic complication,ANASTOMOTIC COMPLICATION,ANASTOMOTIC COMPLICATION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10058059,10058059,10058059
SUBSTITUTION ERRORS LEADING TO HYOSCINE BUTYLBROMIDE OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
PERSECUTORY IDEAS,Persecutory delusion,PERSECUTORY DELUSION,PERSECUTORY DELUSION,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10034702,10034702,10034702
STICKY EYES FOLLOWING NEVIRAPINE INDUCED TOXIC EPIDERMAL NECROLYSIS,Eye discharge,STICKY EYES,EYE DISCHARGE,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10042037,10015915,10042037
SUSTAINED CARDIAC ARREST FOLLOWING E. MENINGOSEPTICA BACTEREMIA,cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
THE PATIENT WAS TREATED WITH MYCOPHENOLATE MOFETIL FOR PRESUMED SERONEGATIVE NMO,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FUNDUS EXAMINATION SHOWED EXUDATIVE RD IN THE RIGHT EYE,Retinal detachment,RETINAL DETACHMENT,RETINAL DETACHMENT,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10038848,10038848,10038848
METHOTREXATE USED FOR GVHD PROPHYLAXIS LEADING TO EPIDIDYMO-ORCHITIS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DIFFUSE SKIN RASH,Rash,SKIN RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040913
FACE BECAME RED AND SWOLLEN/FACIAL SWELLING,facial swelling,FACIAL SWELLING,SWELLING FACE,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10016065,10042682,10016065
PATIENT HAD AN ASTHMA ATTACK WHICH TRIGGERED A CARDIAC ARREST/PATIENT DIED DUE TO CARDIO RESPIRATORY FAILURE CAUSED BY ASTHMA AND CARDIAC ARREST,cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
RESPIRATORY RATE LOW,Respiratory rate decreased,RESPIRATORY RATE LOW,RESPIRATORY RATE DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10038713,10038710,10038713
ANXIETY,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
NARCOLEPSY RESOLVED AFTER CITALOPRAM TREATMENT,Therapeutic response unexpected,UNEXPECTED THERAPEUTIC BENEFIT,THERAPEUTIC RESPONSE UNEXPECTED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10076884,10043417,10076884
KNEE AND ANKLE ARTHRALGIA THAT LIMITED AMBULATION,Difficulty in walking,DIFFICULTY IN WALKING,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10012794,10017577,10012794
GASTROINTESTINAL SYMPTOMS FOLLOWING COLCHICINE OVERDOSE,gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
VARICELLA ZOSTER REACTIVATION,Varicella zoster virus infection,VARICELLA ZOSTER VIRUS INFECTION,VARICELLA ZOSTER VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10075611,10075611,10075611
DIFFUSE ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN GENERALIZED,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000082,10000081,10058826
NAUSEA/VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
POOR CONCENTRATION,Disturbance in attention,POOR CONCENTRATION,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10027346,10013496,10036149
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
INCREASED INTRAOCULAR PRESSURE,Intraocular pressure increased,INCREASED INTRAOCULAR PRESSURE,INTRAOCULAR PRESSURE INCREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",OPHTHALMIC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10022806,10022806,10021667
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
CENTRAL  RETINAL  PALLOR,central  retinal  pallor,RETINAL PALLOR,RETINAL PALLOR,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10038891,10038891,10038891
PLATELET COUNT DECREASED TO 20000/MM3,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
SWOLLEN ABDOMEN,swollen abdomen,SWOLLEN ABDOMEN,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10042714,10000060,10042714
RENAL FUNCTION WAS WORSE DUE TO CISPLATIN,Renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
"VASOPLEGIA REFRACTORY TO FLUIDS, BLOOD PRODUCTS,VASOPRESSORS AND STEROIDS (LACK OF DRUG EFFECT)",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
MULTIPLE DRUG POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
HYPOXIA,Hypoxia,HYPOXIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021143,10021143,10021143
DEVICE-RELATED THROMBUS,Device related thrombosis,DEVICE RELATED THROMBOSIS,DEVICE RELATED THROMBOSIS,COMPLICATIONS ASSOCIATED WITH DEVICE,VASCULAR COMPLICATIONS ASSOCIATED WITH DEVICE,10018065,10077455,10077455,10077455
DECREASED LYMPHOCYTIC COUNT (8.5%),Lymphocyte count decreased,LYMPHOCYTE COUNT DECREASED,LYMPHOCYTE COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10025256,10025256,10025256
CHRONIC ABUSE OF NASAL NAPHAZOLINE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
AN INCREASING WEAKNESS,Weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
CONDITION DETERIORATED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
AGGRAVATION OF BONE PAIN WITH DISCONTINUATION OF CORTICOSTEROID,Bone pain,BONE PAIN AGGRAVATED,BONE PAIN,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10006003,10006002,10006003
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
PATIENT WAS TREATED WITH EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE DURING PREGNANCY WITH NO ADR,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
BUZZING IN BOTH EARS,ear buzzing,EAR BUZZING,TINNITUS,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10013996,10043882,10013996
PULSE WEAK,Pulse weak,PULSE WEAK,PULSE ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10037494,10037466,10037494
"EXANTHEMA ON SKIN, QUICKLY SPREADS OVER SKIN AND MUCOUS MEMBRANES",exanthema,EXANTHEMA,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015587,10037844,10015587
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
NONCIRRHOTIC PORTAL HYPERTENSION,Non-cirrhotic portal hypertension,NON-CIRRHOTIC PORTAL HYPERTENSION,NON-CIRRHOTIC PORTAL HYPERTENSION,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10077259,10077259,10077259
DYSPNEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
PAINFUL RASH ON HIS PENIS,painful rash,PAINFUL RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10074762,10037844,10074762
RECURRENCE OF SYMPTOMS OF HYPERTHYROIDISM,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
DRY COUGH,Cough,DRY COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10013773,10011224,10013773
HBV (HEPATITIS B VIRUS) REACTIVATION,Hepatitis B reactivation,HEPATITIS B REACTIVATION,HEPATITIS B REACTIVATION,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10058827,10058827,10058827
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
MUCOSITIS,Mucositis ,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
BURNING MOUTH SYNDROME,Burning mouth syndrome,BURNING MOUTH SYNDROME,BURNING MOUTH SYNDROME,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SIGNS AND SYMPTOMS,10017947,10068065,10068065,10068065
AFTER FAILING CARDIOVERSION AND AMIODARONE,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
ASYSTOLE,Asystole,ASYSTOLE,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10003586,10007515,10003586
PERICARDIAL EFFUSION LAMINA,pericardial effusion lamina,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
TRANSIENT HYPOGAMMAGLOBULINEMIA,Transient hypogammaglobulinaemia of infancy,TRANSIENT HYPOGAMMAGLOBULINEMIA,TRANSIENT HYPOGAMMAGLOBULINAEMIA OF INFANCY,IMMUNODEFICIENCY SYNDROMES,PRIMARY IMMUNODEFICIENCY SYNDROMES,10021428,10060426,10044388,10044389
TONIC-CLONIC SEIZURE DUE TO IMMUNE HEMOLYTIC ANEMIA,Generalised tonic-clonic seizure,TONIC-CLONIC SEIZURES,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10044000,10018100,10044000
"PRURIGINOUS RASH, MAINLY ON THE THORAX AND ABDOMEN",Pruritic rash,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037085,10037884,10037085
A LARGE BLISTER OF RECENT ONSET ON HIS LEFT ELBOW,blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
CK INCREASED,CK increased,CK INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10009219,10005470,10009219
CUSHINGOID FEATURES,Cushingoid,CUSHINGOID,CUSHINGOID,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011655,10011655,10011655
INCONSOLABLE CRYING,Crying,INCONSOLABLE CRYING,CRYING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10065283,10011469,10065283
CUTANEOUS ULCERATION ON BREAST,Skin ulcer,SKIN ULCERATION,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040947,10040943,10040947
AKINESIS OF THE BASAL INFERIOR SEPTUM,Ventricular regional akinesia,VENTRICULAR REGIONAL AKINESIA,VENTRICULAR HYPOKINESIA,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10074317,10050510,10074317
DESPITE  TREATMENT  WITH  METHYLPREDNISOLONE  PULSE THERAPY,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
FEBRILE NEUTROPENIA (GRADE 3),Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
EXERTIONAL CHEST,Chest discomfort,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008469,10008469,10008469
LETHARGIC,Lethargy,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024262
BREATHLESSNESS,breathlessness,BREATHLESSNESS,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10006345,10013968,10006345
PHENYTOIN INDUCED PSEUDOLYMPHOMA,Pseudolymphoma,PSEUDOLYMPHOMA,PSEUDOLYMPHOMA,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10037127,10037127,10037127
PATIENT WAS TREATED WITH TIMOLOL MALEATE FOR HAEMANGIOMA ON THE RIGHT NASAL BRIDGE (OFF LABEL USE FOR POPULATION) WITH NO ADVERSE EVENTS,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DIARRHEA,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
SEVERE BILATERAL LOWER LIMB PAIN,pain in limb,PAIN IN LIMB,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033447,10033425,10033447
HEADACHES,headaches,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
DEPRESSED FRACTURE OF THE RIGHT FRONTAL MAXILLARY PROCESS AND ORBITAL FLOOR FRACTURE FOLLOWING FALL,Fracture,FRACTURE,FRACTURE,BONE AND JOINT INJURIES,FRACTURES AND DISLOCATIONS NEC,10022117,10017076,10017076,10017076
COMPLEMENT ACTIVATION TRIGGERED BY ATG,complement factor increased,COMPLEMENT FACTOR INCREASED,COMPLEMENT FACTOR INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNE RESPONSE PROTEIN ANALYSES NEC,10022891,10061049,10061049,10061049
DRUG INDUCED HAEMOLYTIC ANAEMIA,Haemolytic anaemia,HEMOLYTIC ANEMIA DRUG-INDUCED,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10018918,10018916,10055208
HAEMORRHAGIC STORKE,Haemorrhagic stroke,HAEMORRHAGIC STROKE,HAEMORRHAGIC STROKE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10019016,10019016,10019016
CONSTANT FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
ACUTE RENAL FAILURE,acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
AMMONIA INCREASED,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
POLYMORPHIC VENTRICULAR TACHYCARDIA DUE TO LOPERAMIDE TOXICITY FOLLOWING DRUG MISUSE,Ventricular tachycardia,POLYMORPHIC VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10028158,10047302,10036095
CENTRAL SLEEP APNOEA SYNDROME DUE TO CHRONIC BACLOFEN OVERDOSE,Central sleep apnoea syndrome,CENTRAL SLEEP APNOEA SYNDROME,SLEEP APNOEA SYNDROME,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10007975,10040979,10007975
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
PARAPROTIEN DID NOT IMPROVE (PROGRESSION OF MYELOMA) FOLLOWING LACK OF DRUG EFFECT,Plasma cell myeloma,MULTIPLE MYELOMA PROGRESSION,PLASMA CELL MYELOMA,PLASMA CELL NEOPLASMS,PLASMA CELL MYELOMAS,10029104,10067095,10035226,10067095
GENERALISATION OF PSORIASIS,Psoriasis aggravated,PSORIASIS AGGRAVATED,PSORIASIS,EPIDERMAL AND DERMAL CONDITIONS,PSORIATIC CONDITIONS,10040785,10037154,10037153,10037154
DRUG EXPOSURE IN UTERO,drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
STAGE 3 ACUTE KIDNEY INJURY,Acute kidney injury,STAGE 3 ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10080271,10069339,10080271
HEPATIC FAILURE DUE TO ADENOVIRUS HEPATITIS FOLLOWING MYELOTOXICITY,Hepatic failure,HEPATIC FAILURE,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10019663,10019663,10019663
HAIR LOSS,Hair loss,HAIR LOSS,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10019045,10001760,10019045
SKIN RASH,Skin rash,SKIN RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040913,10037844,10040913
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
EYE PAIN,Eye pain,EYE PAIN,EYE PAIN,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10015958,10015958,10015958
LYMPHOCYTE INCREASED FROM 600 T0 1500,Lymphocyte count increased,LYMPHOCYTE COUNT INCREASED,LYMPHOCYTE COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10025258,10025258,10025258
DETERIORATION OF GENERAL HEALTH,General physical health deterioration,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10049438,10049438,10049438
ACUTE NEURITIS RETROBULBARIS,Optic neuritis,OPTIC NEURITIS,OPTIC NEURITIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OPTIC NERVE DISORDERS NEC,10029205,10030942,10030942,10030942
SKIN NECROSIS FOLLOWING EXTRAVASATION OF CALCIUM GLUCONATE,skin necrosis,SKIN NECROSIS,SKIN NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040893,10040893,10040893
WIDESPREAD MUSCULOSKELETAL PAIN/PAIN IN SHOULDER,Musculoskeletal pain,MUSCULOSKELETAL PAIN,MUSCULOSKELETAL PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10028391,10028391,10028391
BILIARY LITHIASIS/ GALL STONE FOLLOWING DRUG INTERACTION WITH ATAZANAVIR/RITONAVIR AND RIBAVIRIN,biliary lithiasis,CALCULUS BILIARY,CHOLELITHIASIS,GALLBLADDER DISORDERS,CHOLECYSTITIS AND CHOLELITHIASIS,10019805,10006986,10008629,10006986
TOXIX LEVEL OF CLOZAPINE,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
"PATIENT STOPPED TAKING OXYBUTYNIN, HOT FLUSHES RETURNED  FOLLOWING REBOUND EFFECT",hot flushes,HOT FLUSHES,HOT FLUSH,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10020408,10060800,10020408
SPONTANEOUS RUPTURE OF MEMBRANES,Premature rupture of membranes,PREMATURE RUPTURE OF MEMBRANES,PREMATURE RUPTURE OF MEMBRANES,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036603,10036603,10036603
CARDIAC ARREST,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
UPPER RESPIRATORY TRACT INFECTION,Upper respiratory tract infection,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10046306,10046306,10046306
BREAST BECAME PAINFUL,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
PROSOPAGNOSIA,Prosopagnosia,PROSOPAGNOSIA,PROSOPAGNOSIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10073980,10073980,10073980
21)(q22,-1,,0,GENE MUTATION,,,10064571,10064571,
SERUM LIPASE INCREASED (414 IU/L),Lipase increased,LIPASE INCREASED,LIPASE INCREASED,GASTROINTESTINAL INVESTIGATIONS,DIGESTIVE ENZYMES,10022891,10024574,10024574,10024574
"CLINICAL RESPONSE WAS NOT COMPLETE WITH OLANZAPINE (20 MG), VALPROATE, GABAPENTIN, AND CLONAZEPAM (SUBTHERAPEUTIC RESPONSE)",subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
LEWY BODY DEMENTIA,Dementia with Lewy bodies,DEMENTIA WITH LEWY BODIES,DEMENTIA WITH LEWY BODIES,MENTAL IMPAIRMENT DISORDERS,DEMENTIA (EXCL ALZHEIMER'S TYPE),10029205,10067889,10067889,10067889
SECOND CARDIAC ARREST FOLLOWING ANAPHYLACTIC SHOCK,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
PREDNISONE WAS USED TO TREAT TRAUMATIC ACUTE SUBDURAL HAEMATOMA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DUODENAL ULCER,Duodenal ulcer,DUODENAL ULCER,DUODENAL ULCER,GASTROINTESTINAL ULCERATION AND PERFORATION,DUODENAL ULCERS AND PERFORATION,10017947,10013836,10013836,10013836
NO RESPONSE ON CMF THERAPY (LACK OF DRUG EFFECT) WITH NO ADVERE EVENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEVERE CARDIOGENIC SHOCK COMPLICATED WITH SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE EVENT,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
MACULO-PAPULAR RASH,Maculo-papular rash,MACULO-PAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025423,10037868,10025423
COMA,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,progressive multifocal leukoencephalopathy,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10036807,10036807,10036807
COMMON VARIABLE IMMUNODEFICIENCY DUE TO ELIZABETHKINGIA MIRICOLA AND ROTHIA MUCILAGINOSA SUPERINFECTION,Immunodeficiency common variable,COMMON VARIABLE IMMUNODEFICIENCY,IMMUNODEFICIENCY COMMON VARIABLE,IMMUNODEFICIENCY SYNDROMES,PRIMARY IMMUNODEFICIENCY SYNDROMES,10021428,10021449,10021449,10010112
PATIENT TREATED WITH METHOTREXATE FOR CESAREAN SECTION SCAR ECTOPIC PREGNANCY ,,,,,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,10079156,10053762,10053762,
ITCHING IN HER RIGHT EYE,Eye pruritus,EYE ITCHING,EYE PRURITUS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10015947,10052140,10015947
WILMS TUMOR (PROGRESSIVE DISEASAE),Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
IUGR,Foetal growth restriction,INTRAUTERINE GROWTH RETARDATION,FOETAL GROWTH RESTRICTION,FOETAL COMPLICATIONS,FOETAL GROWTH COMPLICATIONS,10036585,10022819,10070531,10022819
SCATTERED 1-2 CM WELL-DEMARCATED EDEMATOUS AND ERYTHEMATOUS PLAQUES WITH SOME CENTRAL BLISTERING AND EROSIONS WITH CRUST,Scab,CRUST,SCAB,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10039509,10039509,10011468
ANOREXIA,Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
"LEUKOCYTOSI ' AT 13,500/MM3",Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
EXACERBATION OF LESION,Condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
PATIENT WAS ADMINISTERED WITH METHOTREXATE FOR ILEOCOLONIC CROHN'S DISEASE (OFF LABEL USE FOR INDICATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HYPOGLYCEMIA LATE NIGHT (BLOOD GLUCOSE VALUE NOS),Hypoglycaemia,HYPOGLYCAEMIA NIGHT,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020995,10020993,10020995
NECK AND HEAD SWELLING,Swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
ERYTHEMATOUS RASH WITH RAISED VESICLES ON THE GENITAL REGION,Abscess genital organ (male),ABSCESS GENITAL ORGAN (MALE),PENILE ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,MALE REPRODUCTIVE TRACT INFECTIONS,10021881,10000281,10034294,10000281
SEVERE CIRCULATORY SHOCK FOLLOWING DRUG TOXICITY DUE TO OVERDOSE,Shock circulatory,SHOCK CIRCULATORY,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040564,10040560,10040564
INTERACTION BETWEEN POMEGRANADE JUICE AND WARFARIN,Labelled drug-food interaction medication error,LABELED DRUG-FOOD INTERACTION MEDICATION ERROR,LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT MONITORING ERRORS AND ISSUES,10022117,10064374,10064374,10064379
THE WOMAN RECEIVED DIGOXIN AND SOTALOL FOR FETAL SUPRAVENTRICULAR TACHYCARDIA/ PATIENT RECEIVED DIGOXIN AND SOTALOL DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
MAXIMUM SERUM CREATININE 18.6 MG/DL,Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
RASHES ALL OVER THE BODY,Rash generalised,GENERALISED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037858,10037858,10018095
BOTTLES OF PILLS WITH THE PATIENT AND HER NOTE STATED THAT SHE HAD INGESTED 500 TABS OF IBUPROFEN,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
"BONE METASTASIS WAS FOUND IN THE RIGHT COSTAL BONE 6 MONTHS AFTER THE OPERATION, DESPITE TREATMENT WITH LETROZOLE LACK OF DRUG EFFECT)",drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
PULMONARY COMPLICATIONS,Lung disorder,PULMONARY DISORDER,LUNG DISORDER,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10025082,10025082,10037373
PENILE PAIN DUE TO ERECTION,Penile pain,PENILE PAIN,PENILE PAIN,PENILE AND SCROTAL DISORDERS (EXCL INFECTIONS AND INFLAMMATIONS),PENILE DISORDERS NEC (EXCL ERECTION AND EJACULATION),10038604,10034310,10034310,10034310
SUSPECTED URINE RETENTION,Retention urinary,RETENTION URINARY,URINARY RETENTION,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10038783,10046555,10038783
LACK OF DRUG EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
UNCONTROLLED ON THESE MEDICATIONS,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
STEROID REFRACTORY LYMPHOCYTIC MYOCARDITIS,Myocarditis,MYOCARDITIS,MYOCARDITIS,MYOCARDIAL DISORDERS,NONINFECTIOUS MYOCARDITIS,10007541,10028606,10028606,10028606
SWELLING IN THE GUMS,gum swelling,GUM SWELLING,GINGIVAL SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10018789,10018291,10018789
INTERFACE HEPATITIS (SCATTERED FOCI OF NECROSIS ARE NOTED),Hepatic necrosis,NECROSIS LIVER FOCAL,HEPATIC NECROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10028868,10019692,10028868
"ITCHY RASH (RASH ON THE FACE, NECK, TRUNK AND LIMBS); RASH WAS SWOLLEN AND REDDISH AND HAS INTEGRATED FURTHER; COVER 80 PERCENT OF THE BODY SURFACE",Rash pruritic,ITCHY RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10023092
NIGHT SWEATS,Night sweats,NIGHT SWEATS,NIGHT SWEATS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10029410,10029410,10029410
ALTERED MENTAL STATUS,mental disorder,MENTAL DISORDER,MENTAL DISORDER,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10061284,10061284,10061284
INTRAOCULAR LENS INTO THE LEFT EYE CAPSULAR BAG,Intraocular lens repositioning,DISLOCATED LENS,LENS DISLOCATION,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","LENS STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION (EXCL CATARACTS)",10015919,10013152,10024203,10013152
DRUG INDUCED HYPERSENSITIVITY SYNDROME/DRESS SYNDROME,DRESS syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
PATIENT TREATED WITH FLUDARABINE PHOSPHATE FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION (OFF LABEL USE FOR INDICATION) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MACULOPAPULAR EXANTHEMA,maculo-papular exanthema,MACULO-PAPULAR EXANTHEMA,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10049195,10037868,10049195
PAIN EXTENDED TO INVLOVE HIS THIGHS AND SHOULDERS,Pain in extremity,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033425,10033425,10033425
PERIPANCREATIC MASS IN TOUCH WITH THE TAIL AND BODY OF THE PANCREAS COMPRESSING ADJACENT STRUCTURES,Pancreatic mass,PANCREATIC MASS,PANCREATIC MASS,EXOCRINE PANCREAS CONDITIONS,PANCREATIC DISORDERS NEC,10017947,10049082,10049082,10049082
"ACUTE OUTBREAK OF MULTIPLE SMALL NONFOLLICULAR PUSTULES, SINGLE AND OCCASIONALLY WITH HERPETIFORM DISPOSITION/ FORMATION OF SUBCORNEAL, INTRAEPIDERMAL PUSTULES","acute outbreak of multiple small nonfollicular pustules, single and occasionally with herpetiform disposition",PUSTULE,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037578,10037888,10037578
WITHOUT ACHIEVING ANY DISTINCT NEUROLOGICAL ADJUSTMENT,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
FEELING A BITTER TASTE IN SALIVA,Dysgeusia,TASTE BITTER,DYSGEUSIA,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10043127,10013911,10043127
BK VIREMIA,Viraemia,VIRAEMIA,VIRAEMIA,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10058874,10058874,10058874
MENTAL SLOWNESS,Mental disorder,MENTAL DISORDER,MENTAL DISORDER,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10061284,10061284,10061284
ACUTE PANCREATITIS,acute pancreatitis,ACUTE PANCREATITIS,PANCREATITIS ACUTE,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10000971,10033647,10000971
BNP 688,Brain natriuretic peptide increased,BNP INCREASED,BRAIN NATRIURETIC PEPTIDE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10068001,10053405,10068001
CARBAPENUM-RESISTANT KLEBSIELLA PNEUMONIAE BLOOD STREAM INFECTION,Klebsiella sepsis,KLEBSIELLA SEPSIS,KLEBSIELLA SEPSIS,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10054160,10054160,10054160
WORSENING OF RENAL FUNCTION FOLLOWING CRYPTOSPORIDIOSIS INFECTION,Renal function aggravated,RENAL FUNCTION AGGRAVATED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038453,10062237,10038453
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
REDUCED RENAL FUNCTION,Renal function abnormal,RENAL FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038451,10062237,10038451
SERIOUS HYPOGLYCEMIA LEADING TO CONSCIOUSNESS DISTURBANCE,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
ASYMPTOMATIC HYPONATREMIA,Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
LOW LEVEL OF SERUM POTASSIUM,low level of serum potassium,POTASSIUM SERUM DECREASED,BLOOD POTASSIUM DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10036455,10005724,10036455
RENAL INSUFFICIENCY,renal insufficiency,RENAL INSUFFICIENCY,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038474,10038435,10038474
KOCURIA KRISTINAE ENDOCARDITIS WORSENING DESPITE ADEQUATE ANTIBIOTIC THERAPY,Endocarditis bacterial,BACTERIAL ENDOCARDITIS,ENDOCARDITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10014666,10014666,10004019
GINGIVAL HYPERPLASIA/ MASSIVE GROWTH OF UPPER AND LOWER GINGIVA,Gingival hypertrophy,GINGIVAL HYPERPLASIA,GINGIVAL HYPERTROPHY,DENTAL AND GINGIVAL CONDITIONS,GINGIVAL DISORDERS NEC,10017947,10018283,10018284,10018283
ASCITES,ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ENTEROCOCCUS FAECIUM SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
DELIVERED PREMATURELY IN THE 6TH MONTH OF PREGNANCY,Premature delivery,PREMATURE DELIVERY,PREMATURE DELIVERY,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036595,10036595,10036595
TORSADE DE POINTES CONDITION AGGRAVATED,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
INJURY FROM ACETAMINOPHEN,Injury,INJURY NOS,INJURY,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10022123,10022116,10022123
NEUTROPENIA,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
INFANT DIED SECONDARY TO IN-UTERO,Infant died secondary to in-utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
PATIENT RECEIVED MATERNAL TREATMENT WITH DIGOXIN,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
KIDNEY LITHIASIS,Nephrolithiasis,NEPHROLITHIASIS,NEPHROLITHIASIS,UROLITHIASES,RENAL LITHIASIS,10038359,10029148,10029148,10029148
INTRAVENOUS ITRACONAZOLE FOLLOWED BY ORAL ITRACONAZOLE FAILED TO CONTROL THE PULMONARY INFECTION CAUSED BY S PROLIFICANS,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
FEARFULNESS,fear,FEAR,FEAR,ANXIETY DISORDERS AND SYMPTOMS,FEAR SYMPTOMS AND PHOBIC DISORDERS (INCL SOCIAL PHOBIA),10037175,10016275,10016275,10016275
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) KLEBSIELLA BACTEREMIA,Klebsiella bacteraemia,KLEBSIELLA BACTEREMIA,KLEBSIELLA BACTERAEMIA,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10058856,10058856,10058883
PREGNANCY,Pregnancy,PREGNANCY,PREGNANCY,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS","NORMAL PREGNANCY, LABOUR AND DELIVERY",10036585,10036556,10036556,10036556
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
"SUICIDAL DIGOXIN AND THEOPHYLLINE INTOXICATION/SUICIDAL INTOXICATION WITH DIGOXIN, THEOPHYLLINE AND ZOLPIDEM",drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
DYSPNEA,Dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
DROWSINESS,drowsiness,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
HYPERTRIGLYCERIDEMIA (219 MG/DL),hypertriglyceridemia ,HYPERTRIGLYCERIDEMIA,HYPERTRIGLYCERIDAEMIA,LIPID METABOLISM DISORDERS,ELEVATED TRIGLYCERIDES,10027433,10020870,10020869,10020870
ULCERATION,Ulceration,ULCERATION,ULCER,TISSUE DISORDERS NEC,ULCERS NEC,10018065,10080913,10045285,10080913
CELLULITIS,Cellulitis,CELLULITIS,CELLULITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10007882,10007882,10007882
TACHYPNEA,Tachypnoea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043089,10043089,10043088
AKI ASSOCIATED WITH ENALAPRIL AND CIPROFLOXACIN AS CO-SUSPECT OR INTERACTING MEDICINES,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
ONE OR TWO MICTURITIONS A DAY,Micturition frequency decreased,MICTURITION FREQUENCY DECREASED,MICTURITION FREQUENCY DECREASED,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10059042,10059042,10059042
IMMUNE RECONSTITUTION SYNDROME,Immune reconstitution inflammatory syndrome,IMMUNE RECONSTITUTION SYNDROME,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10054014,10065042,10054014
HEART RATE INCREASED (84 BEATS/MIN),Heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
OPIUM ADDICTION,Drug dependence,OPIUM ADDICTION,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10030900,10013663,10030900
PERITONEAL MESOTHELIOMA,Peritoneal mesothelioma malignant,PERITONEAL MESOTHELIOMA MALIGNANT,PERITONEAL MESOTHELIOMA MALIGNANT,MESOTHELIOMAS,MESOTHELIOMAS MALIGNANT AND UNSPECIFIED,10029104,10056558,10056558,10056558
VERTIGO,Vertigo,VERTIGO,VERTIGO,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10047340,10047340,10047340
SYMPTOMATIC EPISODES OF HYPOGLYCAEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
"PRURITUS ON THE PALMS AND SOLES OF THE FEET THAT PROGRESSED TO MACULES, ERYTHEMATOUS PAPULES, VESICLES AND, FINALLY, BLISTERS",Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
PATIENT HAD A PARTIAL BUT NON-SUSTAINED RESPONSE TO OCCIPITAL NERVE BLOCKS,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
BROAD QRS-COMPLEXES,electrocardiogram QRS complex prolonged,QRS WIDENED,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037699,10014380,10037699
"SEVERE ACTIVE DENERVATION IN FOREARM, HANDS, LOWER LEG MUSCLES AND PROXIMAL LEG MUSCLES",Peripheral nerve destruction,PERIPHERAL NERVE DESTRUCTION,PERIPHERAL NERVE DESTRUCTION,"NERVOUS SYSTEM, SKULL AND SPINE THERAPEUTIC PROCEDURES",PERIPHERAL NERVE THERAPEUTIC PROCEDURES,10042613,10034584,10034584,10034584
"INSPITE OF TREATMENT WITH CALCIUM FOLINATE AND FILGRASTIM, HER CONDITION GOT WORSENED",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
OLMESARTAN-INDUCED ENTEROPATHY,Enterocolitis,ENTEROCOLITIS,ENTEROCOLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10014893,10014893,10014893
MYALGIA,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
ELEVATED C-REACTIVE PROTEIN (161 MG/L),C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
CHRONIC HEART FAILURE,Chronic heart failure,CHRONIC HEART FAILURE,CARDIAC FAILURE CHRONIC,HEART FAILURES,HEART FAILURES NEC,10007541,10008908,10007558,10008908
POTENTIAL DRUG INTERACTIONS BETWEEN ANTIRETROVIRAL AND ANTIPLATELET DRUGS,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
CRUSTING,crust,CRUST,SCAB,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10011468,10039509,10011468
RETROPHARYNGEAL ABSCESS AGGRAVATION,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
USE OF HALOPERIDOL WAS NOT INDICATED,Contraindicated product administered,CONTRAINDICATED DRUG ADMINISTERED,CONTRAINDICATED PRODUCT ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10074899,10078504,10074899
CANDIDA PARAPSILOSIS,Candida infection,CANDIDA INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10074170,10074170,10074170
ROAD TRAFFIC CRASHES,Road traffic accident,MOTOR VEHICLE ACCIDENT,ROAD TRAFFIC ACCIDENT,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10003835,10039203,10028008
PLASMA CK CONCENTRATION INCREASED TO 3880 IU PER LITER,Blood creatine phosphokinase increased,CK INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10009219,10005470,10009219
LIVID ERYTHEMA,Erythema,SKIN ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10040842,10015150,10040842
BILATERAL PLEURAL EFFUSION,Pleural effusion,BILATERAL PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10078037,10035598,10078037
MULTIPLE ASYMPTOMATIC BROWN MACULES ON THE PALMS AND SOLES WITH A DIAMETER BETWEEN 1 AND 5 MM,Skin hyperpigmentation,SKIN HYPERPIGMENTATION,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10040865,10040865,10040865
FACIAL EDEMA,Face oedema,EDEMA FACE,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10016029,10016029,10014222
MENTAL DETERIORATION,mental deterioration,MENTAL DETERIORATION,MENTAL IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10027352,10027374,10027352
PYREXIAL,Pyrexial,PYREXIAL,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037668,10037660,10037668
MULTIDRUG RESISTANT E. MENINGOSEPTICA BACTEREMIA,Bacteremia,BACTEREMIA,BACTERAEMIA,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10003999,10003997,10003999
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
CONTINUOUS PAIN BETWEEN THE SCAPULA,Musculoskeletal pain,SHOULDER PAIN,MUSCULOSKELETAL PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10040617,10028391,10040617
LIMB ATAXIA,limb ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
OEDEMA AT THE SITE OF APPLICATION,Application site oedema,APPLICATION SITE OEDEMA,APPLICATION SITE OEDEMA,ADMINISTRATION SITE REACTIONS,APPLICATION AND INSTILLATION SITE REACTIONS,10018065,10003050,10003050,10003050
ARTERIAL PO2 DECREASED (8.4 KPA),PO2 decreased,ARTERIAL OXYGEN PARTIAL PRESSURE DECREASED,PO2 DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10068435,10035768,10068435
TENDER HEPATOMEGALY,tender hepatomegaly,HEPATOMEGALY TENDERNESS,LIVER TENDERNESS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019843,10024712,10019843
KUSSMAUL BREATHING,Kussmaul respiration,BREATHING KUSSMAUL TYPE,KUSSMAUL RESPIRATION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10006339,10023499,10006339
DERANGED COAGULATION PROFILE,deranged coagulation profile,COAGULATION DISORDER,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009731,10009802,10009731
ANTIASTHMATIC THERAPY FAILED TO BRING SUBSTANTIAL IMPROVEMENT DESPITE SWITCHES,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
AST WAS INCREASED 8.6 TIMES THE ULN,Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
HORIZONTAL AND VERTICAL NYSTAGMUS,Nystagmus,NYSTAGMUS,NYSTAGMUS,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10029864,10029864,10029864
LIVER DYSFUCNTION SECONDARY TO VANCOMYCIN AND CEFEPIME,hepatic dysfunction,HEPATIC DYSFUNCTION NOS,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019657,10019670,10019657
NOCTURIA,Nocturia,NOCTURIA,NOCTURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY TRACT SIGNS AND SYMPTOMS NEC,10038359,10029446,10029446,10029446
INFLAMMATORY LOWER BACK PAIN,inflammatory pain,INFLAMMATORY PAIN,INFLAMMATORY PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10065390,10065390,10065390
SHE HAD POOR CONTROL OF T2DM IN RECENT MONTHS,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PULMONARY EMBOLISIM,Pulmonary embolism,PULMONARY EMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037377,10037377,10037377
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
PAIN,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
OLIGURIA,Oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
"DESPITE TREATMENT WITH ANTIHYPERTENSIVE DRUGS, HYPERTENSION PERSISTED (WITH NO ADR)",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DEVELOPED PAINLESS ERYTHEMATOUS SUBCUTANEOUS NODULES,erythematous eruption,ERYTHEMATOUS ERUPTION,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015241,10037855,10015241
MIXED DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
MODERATE EFFICACY,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
SUSTAINED MULTIPLE FRAGILITY FRACTURE,Pathological fracture,PATHOLOGICAL FRACTURE,PATHOLOGICAL FRACTURE,FRACTURES,FRACTURES NEC,10028395,10034156,10034156,10034156
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
TRUNCAL HYPERPIGMENTATION,Skin hyperpigmentation,HYPERPIGMENTATION SKIN,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10040865,10040865,10020715
CENTRAL AND PERIPHERAL NEUROTOXICITY CAUSED BY METRONIDAZOLE,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
GRADE 2 VENO-OCCLUSIVE DISEASE,Venoocclusive disease,VENOOCCLUSIVE DISEASE,VENOOCCLUSIVE DISEASE,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10062173,10062173,10062173
INCREASED INTERNATIONAL NORMALIZED RATIO (INR) WHICH WAS 4.5,Increased INR,INR INCREASED,INTERNATIONAL NORMALISED RATIO INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10022402,10022595,10022402
TOXICODERMA,Toxic skin eruption,TOXICODERMA,TOXIC SKIN ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10044259,10057970,10044259
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
ULCERATING SKIN LESION (POOR HEALING ULCER),skin ulceration,SKIN ULCERATION,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040947,10040943,10040947
TOXIC EPIDERMAL NECROSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
VENTRICULAR FIBRILLATION,Ventricular fibrillation,VENTRICULAR FIBRILLATION,VENTRICULAR FIBRILLATION,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047290,10047290,10047290
CONFUSIONAL STATE,Confusional state,CONFUSIONAL STATE,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010305,10010305,10010305
DARK URINE,Chromaturia,URINE DISCOLORATION,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10046629,10008796,10046628
GLYCOMETABOLIC DECOMPENSATION,Diabetic metabolic decompensation,DIABETIC METABOLIC DECOMPENSATION,DIABETIC METABOLIC DECOMPENSATION,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEC,10027433,10074309,10074309,10074309
STATUS EPILEPTICUS,Status epilepticus,STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10041962,10041962,10041962
AGITATION,agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
MYCOPHENOLATE INDUCED POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,Posterior reversible encephalopathy syndrome,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10071066,10071066,10071066
GENERAL WEAKNESS,general weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
LOW LEVEL OF HAPTOGLOBIN (0.1 G/L),Haptoglobin decreased,HAPTOGLOBIN DECREASED,HAPTOGLOBIN DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",HAEM METABOLISM ANALYSES,10022891,10019150,10019150,10019150
PULMONARY TUBERCULOSIS RELAPSE,Pulmonary tuberculosis,PULMONARY TUBERCULOSIS,PULMONARY TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10037440,10037440,10037440
SIGNIFICANTLY DECREASED BLOOD PRESSURE,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
LEUKOCYTOCLASTIC VASCULITIS FOLLOWING HD MTX AND HD ARA-C DRUG TOXICITY,Hypersensitivity vasculitis,LEUKOCYTOCLASTIC VASCULITIS,HYPERSENSITIVITY VASCULITIS,SKIN VASCULAR ABNORMALITIES,SKIN VASCULITIDES,10040785,10024377,10020764,10024377
DISEASE WORSENED,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
TRICUSPID REGURGITATION FOLLOWING POST-OP PHT CRISIS,Tricuspid regurgitation,TRICUSPID REGURGITATION,TRICUSPID VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,TRICUSPID VALVULAR DISORDERS,10007541,10049217,10044640,10049217
POSSIBLE DRUG MALADMINISTRATION,Drug maladministration,DRUG MALADMINISTRATION,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10013735,10064295,10013735
SICK SINUS SYNDROME ASSOCIATED WITH TOPICAL TIMOLOL MALEATE INSTILLATION,Sinus node dysfunction,SICK SINUS SYNDROME,SINUS NODE DYSFUNCTION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040639,10075889,10040639
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
WEIGHT GAIN,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
ARTHRALGIA,Arthralgia,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
IMBALANCE ISSUES DESCRIBED AS MILDLY UNSTEADY GAIT SECONDARY TO GENTAMICIN FOLLOWING OFF LABEL USE OF DRUG,Gait disturbance,UNSTEADY GAIT,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017582,10017577,10046261
HEMOPTYSIS,Haemoptysis,HEMOPTYSIS,HAEMOPTYSIS,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10018964,10018964,10019523
PT INCREASED (16.0 SECONDS),Prothrombin time prolonged,PT INCREASED,PROTHROMBIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037063,10037063,10037261
INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTERED,Inappropriate schedule of vaccine administered,INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTERED,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10063976,10021597,10063976
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
MACULAR ERYTHEMA,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
RENAL FUNCTION DECLINED,Renal impairment,RENAL FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038451,10062237,10038451
SKIN EXANTHEMA,Rash,EXANTHEMA,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10015587
CEPHALGIA,Headache,CEPHALGIA,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10008013
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
PHYSICAL PAINS/GASTROINTESTINAL CONDITIONS,gastrointestinal pain,GASTROINTESTINAL PAIN,GASTROINTESTINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10017999,10017999,10017999
PRIMARY HYPERALDOSTERONISM,Connâ€™s syndrome,CONN'S SYNDROME,PRIMARY HYPERALDOSTERONISM,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10010758,10036692,10010758
SENSORY NEUROPATHY,Peripheral sensory neuropathy,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10034620,10034620,10034620
PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
MANIC EPISODE WITH PSYCHOTIC SYMPTOMS,Manic psychosis,MANIC PSYCHOSIS,MANIA,MANIC AND BIPOLAR MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH MANIC SYMPTOMS,10037175,10026780,10026749,10026780
DUODENAL EROSION DUE TO CYTOMEGALOVIRUS DUODENITIS,Erosive duodenitis,DUODENAL EROSION,EROSIVE DUODENITIS,GASTROINTESTINAL ULCERATION AND PERFORATION,DUODENAL ULCERS AND PERFORATION,10017947,10013827,10062532,10013826
DECREASE IN URINE OUTPUT,urine output decreased,URINE OUTPUT DECREASED,URINE OUTPUT DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059895,10059895,10059895
CARBOXYHEMOGLOBIN,carboxyhemoglobin,CARBOXYHEMOGLOBIN,CARBOXYHAEMOGLOBIN,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,TOXICOLOGY LABORATORY ANALYSES,10022891,10055580,10007239,10055580
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
RECURRENT DEPRESSIVE EPISODES OCCURRED/DEPRESSIVE EPISODE,Depression,DEPRESSIVE EPISODE,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012402,10012378,10012402
HEMOGLOBIN DECREASED (3.4 G/DL),Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
PERFORATION IN UNRECOGNIZED SUBMUCOUS CLEFT PALATE (SMCP) FOLLOWING DRUG-INDUCED MUCOSITIS,palatal disorder,PALATAL DISORDER,PALATAL DISORDER,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE DISORDERS NEC,10017947,10052453,10052453,10052453
GENERAL MALAISE,Malaise,GENERAL MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10018066,10025482,10018066
"WARM SWOLLEN, PAINFUL RIGHT WRIST AND THUMB",Swelling of wrists,SWELLING OF WRISTS,JOINT SWELLING,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10042707,10023232,10042707
INCREASED UREA,urea increased,UREA INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10046353,10005851,10046353
QRS PROLONGATION,Electrocardiogram QRS complex prolonged,QRS PROLONGED,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037697,10014380,10037697
ACUTE MUCOSITIS,mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
WORSENING OF RESPIRATORY FAILURE DUE TO WORSENING OF MELIOIDOSIS FOLLOWING LACK OF DRUG EFFECT,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
ACUTE MUCOCUTANEOUS METHOTREXATE TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
WOKE UP IN THE MIDDLE OF THE NIGHT/ LACK OF SLEEP,Middle insomnia,MIDDLE INSOMNIA,MIDDLE INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10027590,10027590,10027590
POLYDIPSIA,Polydipsia,POLYDIPSIA,POLYDIPSIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,FLUID INTAKE INCREASED,10027433,10036067,10036067,10036067
HYPOGLYCAEMIC ATTACKS,Hypoglycaemia,HYPOGLYCAEMIC ATTACK,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020999,10020993,10020999
OFF LABEL USE OF MYCOPHENOLATE AND LISINOPRIL FOR THE INDICATION SLE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
EOSINOPHILIC ENDOMYOCARDIAL DISEASE,Restrictive cardiomyopathy,EOSINOPHILIC ENDOMYOCARDIAL DISEASE,RESTRICTIVE CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10014953,10038748,10014953
SEROUS MACULAR DETACHMENT OD,Serous detachment of the macula,SEROUS DETACHMENT OF THE MACULA,MACULAR DETACHMENT,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10062968,10075873,10062968
"RESPIRATORY FAILURE FOLLOWING DIFFUSE ALVEOLAR HEMORRHAGE DUE TO REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS TO STEROIDS, RITUXIMAB AND CYCLOPHOSPHAMIDE",Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
ASYMPTOMATIC HYPERKALEMIA,Hyperkalaemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020646,10020646,10020647
AST INCREASED 258 IU/L,Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
MULTI-ORGAN FAILURE,multi-organ failure,MULTI-ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028154
PROFOUND SENSORINEURAL HEARING LOSS FOLLOWING SYNERGISTIC EFFECT OF AMINOGLUCOSIDE AND LOOP DIURETICS,Deafness neurosensory,SENSORINEURAL HEARING LOSS,DEAFNESS NEUROSENSORY,HEARING DISORDERS,HEARING LOSSES,10013993,10040016,10011891,10040016
FOURNIER'S GANGRENE DUE TO GAS-FORMING ORGANISMS,Necrotising fasciitis,FOURNIER'S GANGRENE,NECROTISING FASCIITIS,INFECTIONS - PATHOGEN UNSPECIFIED,MUSCLE AND SOFT TISSUE INFECTIONS,10021881,10017068,10028885,10017068
WEIGHT LOSS,weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
THE EKG AT THIS TIME SHOWED A RETURN TO A WIDE COMPLEX TACHYCARDIA WITH A TORSADE DE POINTE LIKE MORPHOLOGY DUE TO MULTIPLE DRUG OVERDOSE,Torsade de pointes,TORSADE DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044066
PATELLAR REFLEX AND ACHILLES REFLEXES WERE ABSENT,Patellar reflex was absent,PATELLAR TENDON REFLEX ABSENT,AREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10067217,10003084,10067217
ATAXIA,ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
CHEST TIGHTNESS,Chest discomfort,CHEST TIGHTNESS,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008492,10008469,10008492
PARTIAL REMISSION,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
REBLEEDING,Haemorrhage,HAEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10055798
PATIENT HAD PARTIAL RESPONSE WITH TREATMENT,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
DETERIORATION IN HAEMODYNAMIC STABILITY,Haemodynamic instability,HAEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10052076,10052076,10052076
PLEURAL THICKENING,Pleural thickening,PLEURAL THICKENING,PLEURAL THICKENING,PLEURAL DISORDERS,PLEURAL CONDITIONS NEC,10038738,10035616,10035616,10035616
LIP HERPES,Oral herpes,HERPES ON LIP,ORAL HERPES,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10019942,10067152,10019946
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
PRURITIC ERUPTIONS,pruritic rash,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037085,10037884,10037085
PATIENT WAS ADMINISTERED CISPLATIN FOR THE TREATMENT OF EPITHELOID PLEURAL MESOTHELIOMA (OFF LABEL USE) WITH NO ADVERSE EVENT,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PATIENT WAS TREATED WITH CLOBETASOL UNDER OCCLUSION FOR HAND ECZEMA WITH NO RESPONSE (LACK OF DRUG EFFECT WITH NO ADR),Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
MACULOPAPULAR RASH,maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
RHABDOMYOLYSIS FOLLOWING DRUG INTERACTION,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
REDNESS AT RIGHT THIGH AND ON THE ONE PART OF THE CHEST,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
ADMINISTRATION OF METHOTREXATE AND POTASSIUM CHLORIDE FOR CERVICAL ECTOPIC PREGNANCY (UNAPPROVED INDICATION)-OFF LABEL USE WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TRACHEOESOPHAGEAL FISTULA,tracheoesophageal fistula,TRACHEOESOPHAGEAL FISTULA,TRACHEO-OESOPHAGEAL FISTULA,RESPIRATORY DISORDERS CONGENITAL,LARYNGEAL AND TRACHEAL DISORDERS CONGENITAL,10010331,10044317,10044310,10044317
RECURRENCE AND WORSENING OF RIGHT UPPER EXTREMITY PAIN AND SWELLING,Pain in extremity,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033425,10033425,10033425
SUSTAINED CLONUS,Clonus,CLONUS,CLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10009346,10009346,10009346
BENDAMUSTINE HYDROCHLORIDE FOR WALDENSTROM'S MACROGLOBULINAEMIA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEVERE PSEUDOMEMBRANOUS COLITIS,Pseudomembranous colitis,PSEUDOMEMBRANOUS COLITIS,PSEUDOMEMBRANOUS COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10037128,10037128,10037128
ORAL DISCOMFORT,Oral discomfort,ORAL DISCOMFORT,ORAL DISCOMFORT,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SIGNS AND SYMPTOMS,10017947,10030973,10030973,10030973
HIGLY COLOURED URINE,Chromaturia,URINE DISCOLORATION,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10046629,10008796,10046628
LACK OF DRUG EFFECT/A LOSS OF HAEMATOLOGICAL RESPONSE,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ERYTHEMATOUS SCALY PAPULE ON THE LEFT TEMPLE,erythematous eruption,ERYTHEMATOUS ERUPTION,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015241,10037855,10015241
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
SEVERE DEXAMETHASONE-INDUCED OCULAR HYPERTENSION,Ocular hypertension,OCULAR HYPERTENSION,OCULAR HYPERTENSION,GLAUCOMA AND OCULAR HYPERTENSION,GLAUCOMAS (EXCL CONGENITAL),10015919,10030043,10030043,10030043
CHEST CT SHOWED REGRESSION OF THE METASTATIC LUNG LESIONS,Therapeutic response unexpected,UNEXPECTED BENEFICIAL THERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE UNEXPECTED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10076884,10043417,10076885
COLITIS,Colitis,COLITIS,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009887,10009887,10009887
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
FRACTURE,fractured spinous process,FRACTURED SPINOUS PROCESS,SPINAL FRACTURE,BONE AND JOINT INJURIES,SPINAL FRACTURES AND DISLOCATIONS,10022117,10068254,10041569,10068254
INJECTION SITE INDURATION/ WITH AN APPROXIMATELY 4 X 4CM INDURATED CENTER,vaccination site induration,VACCINATION SITE INDURATION,VACCINATION SITE INDURATION,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10065117,10065117,10065117
MAGICAL THINKING,Magical thinking,MAGICAL THINKING,MAGICAL THINKING,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10025429,10025429,10025429
INTOLERANCE OF IMATINIB,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
HYPERCALCEMIA (2.82 MMOL/L),Hypercalcemia,HYPERCALCEMIA,HYPERCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020587,10020583,10020587
BROWN PLAQUES COVERED WITH NORMOCHROMIC NODULES WITH SMOOTH SURFACE ON THE ANTERIOR ASPECT OF THE LEGS,Skin mass,SKIN NODULE,SKIN MASS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS CONDITIONS NEC,10040785,10040902,10067868,10040902
NYSTAGMUS/PAROXYSMAL UPWARD DEVIATION OF BOTH EYES,Nystagmus,NYSTAGMUS,NYSTAGMUS,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10029864,10029864,10029864
PELVIC ABSCESS,Pelvic abscess,PELVIC ABSCESS,PELVIC ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10034236,10034236,10034236
"ORAL VALACICLOVIR AT 500MG, 2 TABLETS 3 TIMES PER DAY",Prescribed overdose,PRESCRIBED OVERDOSE,PRESCRIBED OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10051076,10051076,10051076
LOW IONISED CALCIUM-1.14 MMOL/L,,,,,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",10047843,10060898,10060898,
HYPERGLYCEMIA,Hyperglycaemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020639
FOCAL NODULAR HYPERPLASIA AFTER TREATMENT WITH OXALIPLATIN,Focal nodular hyperplasia,FOCAL NODULAR HYPERPLASIA,FOCAL NODULAR HYPERPLASIA,HEPATIC AND BILIARY NEOPLASMS BENIGN,HEPATOBILIARY NEOPLASMS BENIGN,10029104,10052285,10052285,10052285
DYSPNEA,dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
PROGRESSIVE FORWARD AND LEFTWARD FLEXION OF HER BACK,Posture abnormal,POSTURE ABNORMAL,POSTURE ABNORMAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10036436,10036436,10036436
SIGNS OF HEART FAILURE,Cardiac failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10007554,10007554,10019279
AGITATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
WEIGHT LOSS,weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
GROUP B STREPTOCOCCUS VIRIDIANS,Beta haemolytic streptococcal infection,"BACTERIAL INFECTION DUE TO STREPTOCOCCUS, GROUP B",BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10004037,10052100,10004037
POLYPS IN COLON NOT BIGGER THAN 10 MM DUE TO CLOSTRIDIUM SEPTICUM INFECTION,Colon adenomatous polyp,COLON ADENOMATOUS POLYP,COLON ADENOMA,GASTROINTESTINAL NEOPLASMS BENIGN,LOWER GASTROINTESTINAL NEOPLASMS BENIGN,10029104,10069428,10048832,10069428
MESENTERIC AND PARA-AORTIC ADENOPATHIES,Abdominal lymphadenopathy,MESENTERIC LYMPHADENOPATHY,ABDOMINAL LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10071450,10073485,10071450
METHOTREXATE INDUCED EBV ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMA,Diffuse large B-cell lymphoma,DIFFUSE LARGE B-CELL LYMPHOMA,DIFFUSE LARGE B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,DIFFUSE LARGE B-CELL LYMPHOMAS,10029104,10012818,10012818,10012818
CHRONIC SENSORY-MOTOR AXONAL POLYNEUROPATHY OF MODERATE SEVERITY,Polyneuropathy chronic,POLYNEUROPATHY CHRONIC,POLYNEUROPATHY CHRONIC,PERIPHERAL NEUROPATHIES,CHRONIC POLYNEUROPATHIES,10029205,10064135,10064135,10064135
INTRAABDOMINAL AND HYPOGASTRIUM PAIN AILMENTS EXACERBATION,Abdominal pain lower,HYPOGASTRIC PAIN,ABDOMINAL PAIN LOWER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000084,10000084,10020987
CARDIAC FAILURE,Cardiac failure,CARDIAC FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10007554,10007554,10007554
EXPOSED BONE,Exposed bone in jaw,EXPOSED BONE IN JAW,EXPOSED BONE IN JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10071014,10071014,10071014
SEPTIC SHOCK SECONDARY TO PYELONEPHRITIS,Pyelonephritis,PYELONEPHRITIS,PYELONEPHRITIS,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10037596,10037596,10037596
LETHARGIC,Lethargy,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024262
MALOCCLUSION,malocclusion,MALOCCLUSION,MALOCCLUSION,DENTAL AND GINGIVAL CONDITIONS,DENTAL DISORDERS NEC,10017947,10061274,10061274,10061274
ILEAL PERFORATION,Ileal perforation,ILEAL PERFORATION,ILEAL PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,INTESTINAL ULCERS AND PERFORATION NEC,10017947,10021305,10021305,10021305
PARTIAL CLINICAL RESPONSE WITH OLANZAPINE (10 MG) (SUBTHERAPEUTIC RESPONSE),subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
TACHYCARDIC,tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
ALLERGIC REACTION,Hypersensitivity,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
TACHYCARDIA,tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
"LACK OF DRUG EFFECT FOLLOWING METHOTREXATE PLUS HYDROCHLOROQUINE, INFLIXIMAB,GOLIMUMAB,ABATACEPT",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
CEREBRAL TOXOPLASMOSIS,cerebral toxoplasmosis,CEREBRAL TOXOPLASMOSIS,CEREBRAL TOXOPLASMOSIS,PROTOZOAL INFECTIOUS DISORDERS,TOXOPLASMA INFECTIONS,10021881,10057854,10057854,10057854
URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
WRITHING MOVEMENTS WHEN DISTURBED,Dyskinesia,MOVEMENTS ABNORMAL,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028039,10013916,10028039
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
DRUG-DRUG INTERACTION,drug-drug interaction,DRUG-DRUG PHARMACODYNAMIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10065993,10013710,10065993
PLATELET COUNT 0.6*10E4/CUMM,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
AST 467,Aspartate aminotransferase increased,AST HIGH,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10075800,10003481,10075800
AUTOIMMUNE HEPATITIS,Autoimmune hepatitis,AUTOIMMUNE HEPATITIS,AUTOIMMUNE HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10003827,10003827,10003827
REBOUND EFFECT,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
KIDNEY RUPTURE WITH BLEEDING INTO RETROPERITONEUM,retroperitoneal haemorrhage,RETROPERITONEAL BLEEDING,RETROPERITONEAL HAEMORRHAGE,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL HAEMORRHAGES,10017947,10038980,10038980,10071878
DELIBERATELY INGESTED 100 TABLETS OF 500 MG PARACETAMOL EACH (50G).,Intentional overdose,OVERDOSE DELIBERATE SELF-INFLICTED,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10033298,10022523,10033298
VALPROATE-ASSOCIATED INDUCED ENCEPHALOPATHY/ DRUG-INDUCED ENCEPHALOPATHY,Toxic encephalopathy,TOXIC ENCEPHALOPATHY,TOXIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10044221,10044221,10044221
DERMATOLOGIC TOXICITY GRADE-3,Skin toxicity,SKIN TOXICITY,SKIN TOXICITY,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10059516,10059516,10059516
STENOTROPHOMONAS MALTOPHILIA INFECTION,Stenotrophomonas infection,STENOTROPHOMONAS MALTOPHILIA INFECTION,STENOTROPHOMONAS INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10051953,10054138,10051953
"INVOLUNTARY CERVICAL MOVEMENTS/EYEBROW ELEVATION, SHRUG SHOULDERS, MAKING SOUNDS/ABNORMAL",Dyskinesia,INVOLUNTARY MOVEMENT (NOS),DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10022895,10013916,10022895
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
TEMPERATURE WAS 100.2 DEGREE F,Body temperature increased,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10005911
CONDITION WAS MARKEDLY WORSENING,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
CREATININE WAS INCREASED,creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
HIGH-LEVEL VIREMIA/VIRURIA,BK virus infection,BK VIRUS INFECTION,BK VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10055181,10055181,10055181
CHRONIC FECAL SECRETION OF VACCINE-DERIVED POLIOVIRUS,vaccine virus shedding,VACCINE VIRUS SHEDDING,VACCINE VIRUS SHEDDING,ANCILLARY INFECTIOUS TOPICS,INFECTIOUS TRANSMISSIONS,10021881,10070583,10070583,10070583
PATIENT WAS ADMINISTERED METHOTREXATE FOR THE TREATMENT OF PULMONARY SARCOIDOSIS (OFF LABEL USE) WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INADEQUATE ADMINISTRATION OF STRESS DOSE OF HYDROCORTISONE,Inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
SHE ASSUMED ARIPIPRAZOLE IN A VERY IRREGULAR WAY,Inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
PATIENT SHOWED NO RESPONSE TO TREATMENT WITH CINACALCET,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
INAPPETENCE,Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
WORRISOME WEIGHT GAIN,Weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
CLOBETASOL PROPIONATE USE FOR DIAPER RASH IN AN INFANT (DRUG USED FOR UNAPPROVED INDICATION),Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
BAD REACTION,Unevaluable event,UNEVALUABLE REACTION,UNEVALUABLE EVENT,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10045524,10062355,10045524
ALTERED MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
"ARADOXICAL REACTION OF AGITATION WITH AGGRESSIVENESS, ANXIETY AND SCARIFICATION",Self mutilation,SELF MUTILATION,INTENTIONAL SELF-INJURY,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10039926,10022524,10039926
"DESPITE IMMUNOSUPPRESSIVE TREATMENT, NO SUBSTANTIAL CHANGE IN THE NEUROLOGICAL PICTURE OCCURRED AND ONLY A MILD COGNITIVE IMPROVEMENT WAS OBSERVED",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ELATED EFFECT,Inappropriate affect,FEELING HAPPY INAPPROPRIATELY,INAPPROPRIATE AFFECT,MOOD DISORDERS AND DISTURBANCES NEC,AFFECT ALTERATIONS NEC,10037175,10016332,10021588,10016332
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA OF TONGUE AND PROGRESSED TO INVOLVE THE FLOOR OF THE MOUTH AND THE LEFT BORDER OF THE TONGUE FOLLOWING CHEMOTHERAPY-INDUCED IMMUNOSUPPRESSION,Squamous cell carcinoma of the tongue,SQUAMOUS CELL CARCINOMA OF THE TONGUE,SQUAMOUS CELL CARCINOMA OF THE TONGUE,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,LIP AND ORAL CAVITY NEOPLASMS MALIGNANT,10029104,10041865,10041865,10041865
"MYCOPHENOLATE MOFETIL WAS RESTARTED, BUT ADAMTS13 ACTIVITY REMAINED BELOW 5 PERCENT AND THE INHIBITOR PERSISTED",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
FIXED AND PINPOINT PUPILS,pupil fixed,PUPIL FIXED,PUPIL FIXED,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10037515,10037515,10037515
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
LACK OF DRUG EFFECT,lack of effect,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
ELEVATED LIVER ENZYMES/HEPATITIS,Elevated liver enzymes,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
THINKING ABNORMAL,Thinking abnormal,THINKING ABNORMAL,THINKING ABNORMAL,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10043431,10043431,10043431
RHEUMATOID NODULE,rheumatoid nodule,RHEUMATOID NODULE,RHEUMATOID NODULE,JOINT DISORDERS,RHEUMATOID ARTHROPATHIES,10028395,10048694,10048694,10048694
"APPLICATION SITE ERYTHEMA IN DIAMETER OF 3,5 CM X 2.5 CM WITH VESICLES",Vaccination site vesicles,VACCINATION SITE VESICLES,VACCINATION SITE VESICLES,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10069623,10069623,10069623
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
ENDOMYOCARDIAL BIOPSY (EMB) SHOWED MILD MYOCYTE HYPERTROPHY,Cardiac hypertrophy,CARDIAC HYPERTROPHY,CARDIAC HYPERTROPHY,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10007572,10007572,10007572
HYPOGLYCEMIA,Hypoglycemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10021005,10020993,10021005
PATIENT STARTED WITH INTRAMUSCULAR ARIPIPRAZOLE DEPOT 200 MG,Prescribed underdose,PRESCRIBED UNDERDOSE,PRESCRIBED UNDERDOSE,OVERDOSES AND UNDERDOSES NEC,UNDERDOSES NEC,10022117,10073085,10073085,10073085
MONOPLEGIA OF THE RIGHT ARM,Monoplegia,MONOPLEGIA OF UPPER LIMB,MONOPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10027931,10027926,10027931
CONCENTRATION DISORDERS,Disturbance in attention,CONCENTRATION (MENTAL) ABNORMAL,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10010247,10013496,10010247
GRADE 3 HYPERCALCEMIA (MAX 12.4 MG/DL) FOLLOWING DRUG INTERACTION,Hypercalcaemia,HYPERCALCEMIA,HYPERCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020583,10020583,10020587
NECROTIC ESCHAR,necrotic eschar,ESCHAR,ESCHAR,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10051814,10051814,10051814
HAPTOGLOBIN DECREASED (LESS THAN 5 MG/DL),Haptoglobin decreased,HAPTOGLOBIN DECREASED,HAPTOGLOBIN DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",HAEM METABOLISM ANALYSES,10022891,10019150,10019150,10019150
LIGHT HYPOMAGNESEMIA,hypomagnesemia,HYPOMAGNESEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021028,10021027,10021028
SEPTIC SHOCK DUE TO TOXIC EPIDERMAL NECROLYSIS,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
DISAPPEARANCE OF PERISTALSIS,Bowel peristalsis absent,BOWEL PERISTALSIS ABSENT,ILEUS PARALYTIC,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,NON-MECHANICAL ILEUS,10017947,10077939,10021333,10077939
PATIENT TREATED WITH COLCHICINE AND PLAQUENIL FOR URTICARIAL VASCULITIS (OFF LABEL USE FOR INDICATION) WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG INTERACTION BETWEEN VINCRISTINE AND DOXORUBICINE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
WAXY FLEXIBILITY/CATALEPSY,catalepsy,CATALEPSY,WAXY FLEXIBILITY,CHANGES IN PHYSICAL ACTIVITY,STEREOTYPIES AND AUTOMATISMS,10037175,10007736,10047853,10007736
JARISCH-HERXHEIMER REACTION DUE TO OFF LABEL USE OF SULFAMETHOXAZOLE-TRIMETHOPRIM,Jarisch-Herxheimer reaction,JARISCH-HERXHEIMER REACTION,JARISCH-HERXHEIMER REACTION,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10023125,10023125,10023125
HYPERGLYCEMIA (SERUM GLUCOSE 20.5 MMOL/L),Hyperglycaemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020639
ELEVATION OF PROSTATE-SPECIFIC ANTIGEN (PSA) LEVEL (113.3 NG/ML),Prostatic specific antigen decreased,PROSTATIC SPECIFIC ANTIGEN DECREASE,PROSTATIC SPECIFIC ANTIGEN DECREASED,CYTOGENETIC INVESTIGATIONS,CELL MARKER ANALYSES,10022891,10036972,10036972,10036971
OFF LABEL USE WITHOUT AE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CARDIAC DECOMPENSATION,Decompensation cardiac,DECOMPENSATION CARDIAC,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10011949,10007554,10011949
SUDDEN LOSS OF VISION IN HER LEFT EYE,Sudden visual loss,SUDDEN VISUAL LOSS,SUDDEN VISUAL LOSS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10042441,10042441,10042441
PATIENT TREATED WITH HEPARIN FOR DIC WHILE BLEEDING (OFF LABEL USE) WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
VACCINATION FAILURE,vaccination failure,VACCINATION FAILURE,VACCINATION FAILURE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,VACCINATION RELATED COMPLICATIONS,10022117,10046862,10046862,10046862
DRUG RESISTANCE,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
PARANOIA,Paranoia,PARANOIA,PARANOIA,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10033864,10033864,10033864
LEFT-SIDED BABINSKI REFLEX TESTED POSITIVE,Extensor plantar response,REFLEX BABINSKI POSITIVE,EXTENSOR PLANTAR RESPONSE,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10038238,10015727,10038238
PRETERM INFANT WITH SHORT PRENATAL EXPOSURE TO CANDESARTAN IN THE THIRD TRIMESTER OF PREGNANCY,Premature baby 33 to 36 weeks,PREMATURE BABY 33 TO 36 WEEKS,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10053594,10036590,10053594
PSYCHOSIS,Psychosis,PSYCHOSIS,PSYCHOTIC DISORDER,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10037234,10061920,10037234
ANTIBIOTIC ASSOCIATED PSEUDOMENBRANOUS COLITIS (PMC),Pseudomembranous colitis,PSEUDOMEMBRANOUS COLITIS,PSEUDOMEMBRANOUS COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10037128,10037128,10037128
PSEUDOMEMBRANOUS CONJUNCTIVITIS,pseudomembranous conjunctivitis,PSEUDOMEMBRANOUS CONJUNCTIVITIS,CONJUNCTIVITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10037129,10010741,10037129
FAILUE TO TOLERATE BENDAMUSTINE (DRUG INTOLERANCE),drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
H. PYLORI INFECTION,Bacterial infection due to helicobacter pylori (H. pylori),BACTERIAL INFECTION DUE TO HELICOBACTER PYLORI (H. PYLORI),HELICOBACTER INFECTION,BACTERIAL INFECTIOUS DISORDERS,HELICOBACTER INFECTIONS,10021881,10004028,10054263,10004028
QUANTITATIVE DISTURBANCES OF CONSCIOUSNESS,Consciousness disturbed ,CONSCIOUSNESS DISTURBED,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010770,10001854,10010770
PUPILS 2MM,Miosis,CONSTRICTED PUPILS,MIOSIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10010779,10027646,10010779
HIGH DOSES OF VASOACTIVE DRUGS,Multiple drug therapy,MULTIPLE DRUG THERAPY,MULTIPLE DRUG THERAPY,THERAPEUTIC PROCEDURES AND SUPPORTIVE CARE NEC,THERAPEUTIC PROCEDURES NEC,10042613,10074950,10074950,10074950
ERYTHEMA ON THE LEFT THIGH,Erythema,ERYTHEMA OF EXTREMITIES,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10079323,10015150,10079323
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
LEFT HYDRONEPHROSIS,Hydronephrosis,HYDRONEPHROSIS,HYDRONEPHROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL OBSTRUCTIVE DISORDERS,10038359,10020524,10020524,10020524
IMPULSE CONTROL DISORDER,Impulse-control disorder,IMPULSE-CONTROL DISORDER,IMPULSE-CONTROL DISORDER,IMPULSE CONTROL DISORDERS NEC,IMPULSE CONTROL DISORDERS,10037175,10061215,10061215,10061215
OPIUM ABUSE,Drug abuse,OPIOID ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10030887,10013654,10030887
SYMPTOMS OF PULMONARY EDEMA/ PURULENT LUNG INFLAMMATION,Pulmonary oedema,PULMONARY EDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037423,10037423,10037375
GASTROINTESTINAL TRACT (GIT) SYMPTOMS,Gastrointestinal disorder,GASTROINTESTINAL SYMPTOM NOS,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10018011,10017944,10018011
ELEVATED INTERLEUKIN 6 (IL6,,,,,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,10021505,10049805,10063322,
INVASIVE ASPERGILLOSIS LOCALISED TO THE COLON,Aspergillosis,ASPERGILLOSIS,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003488,10074171,10003488
HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
DRUG INEFFECTIVE,DRUG INEFFECTIVE,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
COGNITIVE DECLINE,Cognitive deterioration,COGNITIVE DETERIORATION,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10009843,10057668,10009843
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
NO SYMPTOMS RECESSION,lack of efficacy,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
VARICELLA,Varicella,VARICELLA,VARICELLA,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10046980,10046980,10046980
HIGH FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
SEPSIS WAS HARDLY CONTROLLED,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
CONTRAST-INDUCED NEPHROPATHY,Nephropathy,NEPHROPATHY,NEPHROPATHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10029151,10029151,10029151
APHASIA,Aphasia,APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002948,10002948,10002948
ERYTHEMATOUS MACULOPAPULAR ERUPTIONS,Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
PARTIAL EXFOLIATION WAS SEEN,Skin exfoliation,SKIN EXFOLIATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040844,10040844,10040844
CLINICAL EXAMINATION REVEALED BILATERAL ERYTHEMATOUS RASH OVER MALAR REGION SPARING THE NASOLABIAL FOLD AND NASAL BRIDGE,Butterfly rash,MALAR RASH,BUTTERFLY RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10067983,10067982,10067983
REFRACTORY MASTOCYTIC ENTEROCOLITIS,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SUSPECTED FEBRILE NEUTROPENIA,febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
MYCOPHENOLATE MOFETIL USED TO TREAT EROSIVE ORAL LICHEN PLANUS (OFF LABEL USE WITH NO ADVERSE EVENT),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
STUPOROUSNESSRKED AMBITENDENCY,Stupor,STUPOR,STUPOR,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042264,10042264,10042264
WORSENING OF GENERAL SYMPTOMS,condition worsened,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
HYPONATREMIA,Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
THE FIGURE PROVOKED ANXIETY OF THE PATIENT,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
WEIGHT GAIN,Weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
STEATOHEPATITIS,Hepatitis,HEPATITIS,HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019717,10019717,10019717
DRESS SYNDROME,DRESS syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
NON-NEUTROPAENIC TYPHLITIS,non-neutropenic typhlitis,TYPHLITIS,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10045271,10009887,10045271
GAMMA GLOBULIN LEVEL DECREASED (2.5 G/L),Immunoglobulins decreased,GAMMA GLOBULIN DECREASED,IMMUNOGLOBULINS DECREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10017698,10021499,10017661
INSOMNIA,Insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
HEMODYNAMIC COLLAPSE FOLLOWING ANAPHYLACTIC REACTION DUE TO MULTIPLE DRUG INTERACTION,Circulatory collapse,CIRCULATORY COLLAPSE,CIRCULATORY COLLAPSE,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10009192,10009192,10009192
MYALGIA,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
"ALLERGIC SYMPTOMS WITH USE OF PTX, DTX",Hypersensitivity,ALLERGY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001738,10020751,10001738
APLASIA CUTIS CONGENITA AFTER THIMAZOLE EXPOSURE IN UTERO,aplasia cutis congenita after thimazole exposure in utero,APLASIA CUTIS CONGENITA,APLASIA CUTIS CONGENITA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL NEC,10010331,10002963,10002963,10002963
INSOMNIA,insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
ILLICIT USE OF BUPRENORPHINE,Substance abuse,SUBSTANCE ABUSE,SUBSTANCE ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10066169,10066169,10066169
GAMMA GLUTAMYL TRANSFERASE INCREASED (228 IU/L),Gamma-glutamyltransferase increased,GAMMA-GLUTAMYLTRANSFERASE INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10017693,10017693,10017693
SPREADING PROXIMALLY TO HIS FOREARMS AND LOWER LEGS,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
"GEMCITABINE AND DOCETAXEL WERE ADMINISTERED AS INITIAL TREATMENT, BUT THE DISEASE PROGRESSED",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
SCATTERED 1-2 CM WELL-DEMARCATED EDEMATOUS AND ERYTHEMATOUS PLAQUES WITH SOME CENTRAL BLISTERING AND EROSIONS WITH CRUST,Skin erosion,SKIN EROSION,SKIN EROSION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040840,10040840,10040840
GFR DECREASED (LESS THAN 15 ML/MIN),Glomerular filtration rate decreased,GFR DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018214,10018358,10018214
GAMMA-GLUTAMYL TRANSPEPTIDASE 248 U/L,Gamma-glutamyltransferase increased,GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10017668,10017693,10017668
HEMOLYTIC UREMIC SYNDROME RECURRENCE,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
HALOPERIDOL AND RISPERIDONE WERE INEFFECTIVE FOR HER INVOLUNTARY MOVEMENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
MULTISENSITIVE STAPHYLOCOCCUS AUREUS (MSSA)  SEPSIS,MSSA sepsis,MSSA SEPSIS,STAPHYLOCOCCAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10078706,10056430,10078706
BK VIREMIA,BK virus infection,BK VIRUS INFECTION,BK VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10055181,10055181,10055181
ANXIETY,anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
DRUG-DRUG INTERACTION OF 5F-ADB (SYNTHETIC CANNABINOID) WITH TRIMIPRAMINE AND OLANZAPINE,Drug interaction,INTERACTION WITH ILLICIT DRUG,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10073658,10013710,10073658
AMIODARONE SUSPENDED DUE TO THYROID FUNCTION,Thyroid disorder,THYROID DISORDER,THYROID DISORDER,THYROID GLAND DISORDERS,THYROID DISORDERS NEC,10014698,10043709,10043709,10043709
ZOLEDRONIC ACID WAS USED TO TREAT PROSTATE CANCER (OFF LABEL USE OF DRUG),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"DEHYDRATION SYMPTOMS (DRY ORAL MUCOSA, REDUCED SKIN TURGOR)",Skin turgor decreased,SKIN TURGOR DECREASED,SKIN TURGOR DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10049428,10049428,10049428
ELEVATED LACTATE DEHYDROGENASE LEVEL (1534 U/L),Blood lactate dehydrogenase increased,LACTATE DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10023654,10005630,10023654
MULTIPLE LIVER ABSCESSES FOLLOWING KLEBSIELLA PNEUMONIA AND ENTEROBACTER AEROGENS INFECTION,Liver abscess,LIVER ABSCESS,LIVER ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,HEPATOBILIARY AND SPLEEN INFECTIONS,10021881,10024652,10024652,10024652
OCCLUSION OF PERIFOVEAL CAPILLARIES,Vascular occlusion,VASCULAR OCCLUSION,VASCULAR OCCLUSION,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10053648,10053648,10053648
ERYTHEMATOUS PAPULES ON TRUNK/ARMS/LEGS/COALESCING INTO PLAQUES ON THE BILATERAL INGUINAL FOLDS/AXILLAE AND SITES OF ADHESIVES,Rash papular,ERYTHROPAPULAR RASH,RASH PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015285,10037876,10015285
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
ALTERED BLOOD TEST (GRADE I),Blood test abnormal,BLOOD TEST ABNORMAL,BLOOD TEST ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",INVESTIGATIONS NEC,10022891,10061016,10061016,10061016
PORTAL HYPERTENSION,portal hypertension,PORTAL HYPERTENSION,PORTAL HYPERTENSION,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10036200,10036200,10036200
INTESTINAL ISCHAEMIA,intestinal ischaemia,INTESTINAL ISCHAEMIA,INTESTINAL ISCHAEMIA,GASTROINTESTINAL VASCULAR CONDITIONS,GASTROINTESTINAL VASCULAR OCCLUSION AND INFARCTION,10017947,10022680,10022680,10022680
HYPERFERRITINEMIA,Hyperferritinaemia,HYPERFERRITINAEMIA,HYPERFERRITINAEMIA,IRON AND TRACE METAL METABOLISM DISORDERS,IRON EXCESS,10027433,10075046,10075046,10075046
DIFFUSE MILDLY PRURITIC RASH WITH DESQUAMATION OF PALMS OF THE HANDS,pruritic rash,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037085,10037884,10037085
POSTPRANDIAL GLYCAEMIA OF 67-350 MG/DL VALUES WERE HIGHER AFTER SUPPER/FASTING GLYCAEMIA MEASURED BY THE PATIENT AT HOME VARIED FROM 112 TO 163 MG/DL,blood glucose increased,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10005557,10005557,10005557
ATENOLOL WAS COMMENCED AT 24 WEEKS' GESTATIONS,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HYPERLIPIDEMIA INDUCED BY QUETIAPINE,Hyperlipidaemia,HYPERLIPIDEMIA,HYPERLIPIDAEMIA,LIPID METABOLISM DISORDERS,HYPERLIPIDAEMIAS NEC,10027433,10062060,10062060,10020667
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
ELEVATED FERRITIN (11.350 MICRO GRAM/L),Hyperferritinaemia,HYPERFERRITINAEMIA,HYPERFERRITINAEMIA,IRON AND TRACE METAL METABOLISM DISORDERS,IRON EXCESS,10027433,10075046,10075046,10075046
SMOOTH MUSCLE ANTIBODIES AT A TITRE OF 1 IN 320,Smooth muscle antibody,SMOOTH MUSCLE ANTIBODY,SMOOTH MUSCLE ANTIBODY,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10041227,10041227,10041227
DEHYDRATION,dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
TRANSAMINASES INCREASD,Transaminases increased,TRANSAMINASES INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054889,10054889,10054889
ABDOMINAL PAIN,abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
EXPRESSED PALMAR-PLANTAR ERYTHEMA AND SWELLING,swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
HYPERCAPNIC HYPEROXEMIC RESPIRATORY FAILURE,Hyperoxia,HYPEROXIA,HYPEROXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10058490,10058490,10058490
CAESAREAN SECTION AT 37TH WEEK,caesarean section,CAESAREAN SECTION,CAESAREAN SECTION,OBSTETRIC AND GYNAECOLOGICAL THERAPEUTIC PROCEDURES,OBSTETRIC THERAPEUTIC PROCEDURES,10042613,10006924,10006924,10006924
"VOLUNTARY BENZODIAZEPINE INGESTION, FOR SUICIDAL IDEATION",Completed suicide,SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042462,10010144,10042462
DRUG RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
FATIGUE FOLLOWING DEVP,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
ALVEOLAR HEMORRHAGE,Pulmonary alveolar haemorrhage,PULMONARY ALVEOLAR HEMORRHAGE,PULMONARY ALVEOLAR HAEMORRHAGE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10037313,10037313,10037314
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
FISSURING AT FINGER BASES,Skin fissure,SKIN FISSURE,SKIN FISSURES,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040848,10040849,10040848
UMN FACIAL PARESIS DUE TO  PROGRESSION OF SYSTEMIC LUPUS ERYTHEMATOSUS,Facial paresis,FACIAL PARESIS,FACIAL PARESIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),FACIAL CRANIAL NERVE DISORDERS,10029205,10051267,10051267,10051267
"PAIN WAS STABBING TYPE WITH BURNING SENSATION DESCRIBED IN THE FEET, SHIN AND THIGHS",Burning sensation,BURNING SENSATION,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10006784,10006784,10006784
MYOGENIC FINDING,Myopathy,MYOPATHY,MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10028641,10028641,10028641
PAIN IN THE BONES INCREASED ONCE AGAIN IN THE LEFT SIDE OF THE CHEST AND RIGHT SHOULDER/ STINGING PAIN IN BOTH HANDS (NRSAV = 4-5),Bone pain,BONE PAIN,BONE PAIN,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10006002,10006002,10006002
RISE IN AMMONIA LEVEL,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
PERIODIC DISORDERS OF CONSCIOUSNESS,Consciousness disturbed,CONSCIOUSNESS DISTURBED,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010770,10001854,10010770
FALLS FOLLOWING ENCEPHALOPATHY,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
RIGHT FOOT ISCHAEMIA,Peripheral ischaemia,ISCHEMIC FOOT,PERIPHERAL ISCHAEMIA,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10023023,10034576,10023039
PATIENT WAS TREATED WITH ACYCLOVIR WITHOUT ANY CLINICAL IMPROVEMENT (LACK OF DRUG EFFECT) WITH ANY ADR,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
"COMPULSIVE CLEANING AND WASHING OF EYELIDS, IRRITABILITY AND REDUCED SLEEP; ON TABLET RISPERIDONE 3MG/DAY, THE BEHAVIORAL SYMPTOMS OTHER THAN HALLUCINATIONS WORSENED",condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
TREMOR,tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
ABASIA,Gait inability,ABASIA,GAIT INABILITY,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017581,10017581,10049460
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
11-DAYS OLD PAEDIATRIC PATIENT TREATED WITH MEROPENEM (OFF LABEL USE) WITH NO ADVERSE EVENTS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
RIGHT PROPTOSIS,Exophthalmos,PROPTOSIS,EXOPHTHALMOS,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION OF EYE NEC",10015919,10036905,10015683,10036905
PRO-SYNCOPTIC EPISODE DUE TO HYPOTENSION,Syncope,SYNCOPE HYPOTENSIVE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10060743,10042772,10060743
BIOPSIES SHOWED CHRONIC ACTIVE COLITIS WITH ABUNDANT INTRACELLULAR FUNGAL ELEMENT,Colitis,COLITIS,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009887,10009887,10009887
DYSPHONIA,Dysphonia,DYSPHONIA,DYSPHONIA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10013952,10013952,10013952
PULMONARY HAEMORRHAGE,Pulmonary haemorrhage,PULMONARY HAEMORRHAGE,PULMONARY HAEMORRHAGE,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10037394,10037394,10037394
APHASIA,aphasia,APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002948,10002948,10002948
ANXIOUS,Anxiety,FEELING ANXIOUS,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10016323,10002855,10016323
INHOMOGENEOUS ENLARGED PROSTATE WITH HYPERDENSITY OF RIGHT SEMINAL VESICLE,Enlarged prostate,ENLARGED PROSTATE,PROSTATOMEGALY,PROSTATIC DISORDERS (EXCL INFECTIONS AND INFLAMMATIONS),"PROSTATIC SIGNS, SYMPTOMS AND DISORDERS NEC",10038604,10049240,10051482,10049240
PENTAMIDINE-INDUCED PROLONGED HYPOGLYCAEMIA (FASTING GLUCOSE:53 MG/DL),Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
LEFT CENTRAL RETINAL VEIN THROMBOSIS,Retinal vein thrombosis,RETINAL VEIN THROMBOSIS,RETINAL VEIN THROMBOSIS,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINAL BLEEDING AND VASCULAR DISORDERS (EXCL RETINOPATHY),10015919,10038908,10038908,10038908
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
PATIENT DEVELOPED COLCHICINE-RESISTANCE WHILE BEING TREATED PROPHYLACTICALLY FOR FAMILIAL MEDITERRANEAN FEVER (FMF),Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
16 WEEKS PREGNANT LADY WHO INGESTED APAP TOGETHER WITH ASPIRIN,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
GALLBLADDER WALL THICKENING,Gallbladder enlargement,GALLBLADDER WALL THICKENING,GALLBLADDER ENLARGEMENT,GALLBLADDER DISORDERS,GALLBLADDER DISORDERS NEC,10019805,10064076,10062693,10064076
HYPOMAGNESEMIA,Hypomagnesaemia,HYPOMAGNESEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021027,10021027,10021028
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
VITILIGO,Vitiligo,VITILIGO,VITILIGO,PIGMENTATION DISORDERS,HYPOPIGMENTATION DISORDERS,10040785,10047642,10047642,10047642
HEPATOTOXICITY,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
NEUTROPENIA FOLLOWING SELF-MEDICATION OF METAMIZOLE,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
INAPPETENCE RELAPSED/ANOREXIC RELAPSED,Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
WEIGHT NCREASE FROM 79.5 KG AT THE INITIATION OF LEUPROLIDE TO 85.5 KG,Weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
ORTHOSTATIC HYPOTENSION,Orthostatic hypotension,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10031127,10031127,10031127
RESTLESSNESS,Restlessness,RESTLESSNESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038743,10038743,10038743
INDURATION,Induration,INDURATION,INDURATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10060708,10060708,10060708
USE OF METHOTREXATE FOR RELAPSING POLYCHONDRITIS AND IGG4-RELATED DISEASE (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TREATMENT FAILURE/DID NOT RESPOND TO THE FIRST CYCLE OF RITUXIMAB,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
APNEA,Apnoea,APNEA,APNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10002974,10002974,10002972
DRUG EXPOSURE VIA PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
RESPIRATORY FAILURE FOLLOWING PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML),Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
PRIMARY RESISTANCE TO IMATINIB,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
GRADE 2 ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
SEROLOGIC TESTING CONFIRMED THE PRESENCE OF CEFTRIAXONE ANTIBODIES,Drug specific antibody present,DRUG SPECIFIC ANTIBODY PRESENT,DRUG SPECIFIC ANTIBODY PRESENT,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013745,10013745,10013745
INCRTEASED BOWEL MOVEMENTS,Frequent bowel movements,FREQUENT BOWEL MOVEMENTS,FREQUENT BOWEL MOVEMENTS,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL SPASTIC AND HYPERMOTILITY DISORDERS,10017947,10017367,10017367,10017367
TORSADES DE POINTES AND QT PROLONGATION,Torsade de pointes,TORSADES DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044067
SPLENOMEGALY,splenomegaly,SPLENOMEGALY,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041660,10041660,10041660
"PROMINENT NONTENDER LEFT CERVICAL LYMPHADENOPATHY/MULTISITE LYMPHADENOPATHY (LEFT SUPRACLAVICULAR, 13 X 9 MM; BILATERAL AXILLARY LARGEST, 29 X 6 MM; INGUINAL LARGEST, 25 X 9 MM).",Lymphadenopathy,LYMPHADENOPATHY CERVICAL,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025200,10025197,10025200
BARREL CHEST,Barrel chest,BARREL CHEST,BARREL CHEST,MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES (INCL INTERVERTEBRAL DISC DISORDERS),TRUNK DEFORMITIES,10028395,10004133,10004133,10004133
FIRST-DEGREE ATRIOVENTRICULAR BLOCK,Atrioventricular block first degree,AV BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10003850,10003674,10003850
HYPONATREMIC SEIZURE,Hyponatremic seizure,HYPONATREMIC SEIZURE,HYPONATRAEMIC SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10073204,10073183,10073204
PATIENT BEGAN FLEXION MOVEMENTS AND EXTENSION OF THE TONGUE AND UPPER LIMBS,flexion-extension injury,FLEXION-EXTENSION INJURY,POST-TRAUMATIC NECK SYNDROME,INJURIES NEC,"MUSCLE, TENDON AND LIGAMENT INJURIES",10022117,10063419,10071366,10063419
SKIN RASH,skin rash,SKIN RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040913,10037844,10040913
HE EXHIBITED INCREASED PAIN ALONG HIS LUMBAR SPINE,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
QRS PROLONGATION,Electrocardiogram QRS complex prolonged,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10014380,10014380,10014380
SORE THROAT,Oropharyngeal pain,SORE THROAT,OROPHARYNGEAL PAIN,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10041367,10068319,10041367
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
HE WAS INITIALLY TREATED WITH PHENYTOIN BUT SWITCHED TO CARBAMAZEPINE AND PHENOBARBITAL BECAUSE OF PERSISTENT SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
UNCONTROLLED BLOOD PRESSURE,Uncontrolled hypertension,UNCONTROLLED HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10066860,10020772,10066860
COLISTIN INDUCED ACUTE RENAL FAILURE,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
ONGOING SECOND RELAPSE,B-cell lymphoma,FOLLICULAR B-CELL NON-HODGKIN'S LYMPHOMA,B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,B-CELL LYMPHOMAS NEC,10029104,10067070,10003899,10067070
VIVID DREAMS,Abnormal dreams,VIVID DREAMS,ABNORMAL DREAMS,SLEEP DISORDERS AND DISTURBANCES,PARASOMNIAS,10037175,10047666,10000125,10047666
CONJUNCTIVAL HYPEREMIA,Conjunctival hyperaemia,CONJUNCTIVAL HYPEREMIA,CONJUNCTIVAL HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CONJUNCTIVAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10051625,10051625,10054364
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
WEIGHT LOSS,Weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
GAIT DISTURBANCE,Gait disturbance,GAIT DISTURBANCE,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017577,10017577,10017577
HYPOTENSION FOLLOWING LINEZOLID INDUCED TOXICITY,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
VITREOUS HAZE IN THE RIGHT EYE,Vitreous haze,VITREOUS HAZE,VITREOUS HAZE,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","CHOROID AND VITREOUS STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10077514,10077514,10077514
ANAPHYLACTIC SHOCK,Anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
PATIENT TREATED WITH IVERMECTIN FOR PAPULOPUSTULAR ROSACEA (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CONGESTIVE HEPATOPATHY,Hepatic congestion,HEPATIC CONGESTION,HEPATIC CONGESTION,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019645,10019645,10019645
SYNCOPE,Syncope,SYNCOPE,SYNCOPE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10042772,10042772,10042772
GRADE 2 SKIN ERYTHEMA,Erythema,SKIN ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10040842,10015150,10040842
PATIENT TREATED WITH METHOTREXATE FOR IGG4-RELATED DISEASE AND VASCULITIS (DRUG USE FOR UNAPPROVED INDICATION) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
EPISCLERITIS,Episcleritis,EPISCLERITIS,EPISCLERITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","SCLERAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10015084,10015084,10015084
DILATED PUPILS,dilated pupils,DILATED PUPILS,MYDRIASIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10013014,10028521,10013014
"PAINFUL AND ITCHY RASH ON HIS TRUNK, ABDOMEN, NECK, AND BILATERAL UPPER AND LOWER EXTREMITIES",Rash,PAINFUL RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10074762,10037844,10074762
ALEMTUZUMAB AND FLUDARABINE FOR REDUCED INTENSITY CONDITIONING/ALEMTUZUMAB FOR STEROID-REFRACTORY GVHD AND SUSPICIOUS RELAPSE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INSOMNIA,Insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
HYPOCALCEMIA,Hypocalcemia,HYPOCALCEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020949,10020947,10020949
DECREASED APPETITE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
NAUSEAS,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
STEVENS JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042030
IMPAIRED CONCENTRATION,Disturbance in attention,CONCENTRATION IMPAIRED,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10010248,10013496,10010249
DYSARTHARIA,worsening dysartharia,DYSARTHRIA,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10013887,10013887,10013887
URTICARIAL DISSEMINATED LESION,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
FREQUENT MYOCLONUS,Myoclonus,MYOCLONUS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028622,10028622,10028622
 normal range: 6-16 g/L),2018-05-17 00:00:00,1,,,,IMMUNOGLOBULIN ANALYSES,10005595,10005595,
DIPLOPIA,Diplopia,DIPLOPIA,DIPLOPIA,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10013036,10013036,10013036
ZOLPIDEM OVERDOSE,Zolpidem overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
LEUKOCYTOSIS,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
RASH GENERALISED,Rash generalised,RASH GENERALISED,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037858,10037858,10037858
CLINICAL WORSENING OF SYMPTOMS OF CRYPTOCOCCUS GATII INFECTION (LACK OF DRUG EFFECT),Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
NIGHTLY RESTLESS LEGS SYNDROME,Restless legs syndrome,RESTLESS LEGS SYNDROME,RESTLESS LEGS SYNDROME,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10058920,10058920,10058920
ACUTE ISCHAEMIC HEART DISEASE/ACUTE ISCHAEMIC HEART DISEASE WITH A CARDIOPULMONARY ARREST DUE TO A TORSADES DE POINTES TACHYCARDIA RELATED TO A LONG QT SECONDARY TO HALOPERIDOL AND ESCITALOPRAM,Ischaemic heart disease,ISCHAEMIC HEART DISEASE,MYOCARDIAL ISCHAEMIA,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10023024,10028600,10023024
GRADE 2 STOMATITIS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
DRUG-INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
INTENSE EPIGASTRALGIA PRANDIAL,Epigastralgia,EPIGASTRALGIA,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10048944,10000087,10048944
HYPOMAGNESEMIA (IONIZED MAGNESIUM),Hypomagnesemia,HYPOMAGNESEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021028,10021027,10021028
ALEMTUZUMAB TACROLIMUS AND METHOTREXATE WERE FOR PREVENTION OF GRAFT VERSUS HOST DISEASE (GVHD),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
GRADUALLY DEVELOPED CONFUSION,confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
MOTOR VISION DIFFICULTIES,Visual disturbances,VISUAL DISTURBANCES,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047545,10047571,10047545
RIGORS,Chills,RIGORS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10039177
"MONTHLY HOSPITAL ADMISSIONS WERE RECORDED DESPITE TREATMENT WITH MONTELUKAST SODIUM, SALMETEROL AND FLUTICASONE",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
COMA/CNS DEPRESSION,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
ALLODYNIA,Allodynia,ALLODYNIA,ALLODYNIA,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10053552,10053552,10053552
ELECTROLYTE IMBALANCE,electrolyte imbalance,ELECTROLYTE IMBALANCE,ELECTROLYTE IMBALANCE,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10014418,10014418,10014418
INVASIVE FUNGAL LUNG INFECTION,Lung infection,LUNG INFECTION,LUNG INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10061229,10061229,10061229
INTERMITTENT FEVER,Pyrexia,INTERMITTENT FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10022571,10037660,10058698
LIBIDO REDUCTION,Libido decreased,LIBIDO DECREASED,LIBIDO DECREASED,"SEXUAL DYSFUNCTIONS, DISTURBANCES AND GENDER IDENTITY DISORDERS",SEXUAL DESIRE DISORDERS,10037175,10024419,10024419,10024419
PEN WOULD NOT WORK WITH CUSTOMER'S NEEDLE,Device failure,DEVICE FAILURE,DEVICE FAILURE,DEVICE ISSUES,DEVICE ISSUES NEC,10077536,10056871,10056871,10056871
LIVER ENZYMES BECAME MORE THAN 3.5 TIMES NORMAL,Hepatic enzyme increased,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
ASPARTATE AMINOTRANSFERASE (AST) AT 292 IU/L,Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
EMESIS,Vomiting,EMESIS,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10014542
WORSENING OF DIABETIC KETOACIDOSIS FOLLOWING DRUG EXPOSURE DURING PREGNANCY,Diabetic ketoacidosis,DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEC,10027433,10012671,10012671,10012671
SIGNIFICANT GAPS IN MEMORY PERTAINING TO CONVERSATIONS AND EVENTS,memory impairment,MEMORY IMPAIRMENT,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027175,10027175,10027175
PTOSIS OF THE RIGHT EYE LID,Eyelid ptosis,EYELID PTOSIS,EYELID PTOSIS,OCULAR NEUROMUSCULAR DISORDERS,EYELID MOVEMENT DISORDERS,10015919,10015995,10015995,10015995
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
TOXICOLOGY OF METHADONE-RELATED DEATH IN INFANTS UNDER 1 YEAR/METHADONE-RELATED INFANT DEATHS,Toxicity to various agents,POISONING BY METHADONE,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10035882,10070863,10035882
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
EXAMINATION REVEALED TACHYCARDIA AT 105 BEATS PER MINUTE,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
GRADE 3  AND 4 FEBRILE NEUTROPENIA,"Grade 3 febrile neutropenia, Grade 4 neutropenia",FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
SKIN FOLD AND DRYNESS OF THE MUCOUS MEMBRANES,Mucosal dryness,MUCOSAL DRYNESS,MUCOSAL DRYNESS,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028111,10028111,10028111
GRADE I NEUROPATHY,Neuropathy,NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029328,10029331,10029328
SUB PLEURAL CYSTS,sub pleural cysts,PLEURAL CYST,PLEURAL CYST,PLEURAL DISORDERS,PLEURAL CONDITIONS NEC,10038738,10071257,10071257,10071257
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
SEVERE CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY,Neuropathy peripheral,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10080342
PARESTHESIAS OF THE RIGHT FOOT,Paresthesia of fingers,PARESTHESIA OF FINGERS,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10054532,10033775,10054532
BENDAMUSTINE (90 MG/MQ) ON DAY 1 AND 2,Bendamustine (90 mg/mq) on day 1 and 2,PRESCRIBED UNDERDOSE,PRESCRIBED UNDERDOSE,OVERDOSES AND UNDERDOSES NEC,UNDERDOSES NEC,10022117,10073085,10073085,10073085
INTRACEREBRAL LESIONS,Central nervous system lesion,BRAIN LESION,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10067294,10051290,10067294
DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE EVENT,drug exposure during pregnancy with no adverse event,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
BNP INCREASED (2190 PG/ML),Brain natriuretic peptide increased,BNP INCREASED,BRAIN NATRIURETIC PEPTIDE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10068001,10053405,10068001
G2 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ELEVATED LACTATE LEVELS,Blood lactic acid increased,LACTATE INCREASED,BLOOD LACTIC ACID INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10023660,10005635,10023660
SERUM TRANSAMINASES WERE MARKEDLY ELEVATED WITH AST 1220 U/L (NR <34),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
SEVERE PAIN LOCALISED ON THE LATERAL SIDE OF THE RIGHT THIGH,Pain in extremity,PAIN IN THIGH,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10048973,10033425,10048973
IDIOPATHIC RETROPERITONEAL ABSCESSES (SECONDARY  TO  IMMUNOSUPPRESSION),Retroperitoneal abscess,RETROPERITONEAL ABSCESS,RETROPERITONEAL ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10038975,10038975,10038975
VENTRICULAR TACHYCARDIA,Ventricular tachycardia,VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047302,10047302,10047302
"DESPITE TREATMENT WITH CLASS IV TOPICAL CORTICOSTEROID AND PREDNISOLONE UP TO 60 MG/DAY AND , BOTH SKIN LESIONS AND SEVERE PRURITUS PROGRESSED",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
INCREASED CRP LEVEL,c-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
PROBLEMS WITH CO-ORDINATION/MOBILITY,Coordination abnormal,COORDINATION IMPAIRED,COORDINATION ABNORMAL,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10010949,10010947,10010950
LOW VORICONAZOLE LEVELS SECONDARY TO DRUG INTERACTION,drug level decreased,DRUG LEVEL DECREASED,DRUG LEVEL DECREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013718,10013718,10013718
ALTERATION IN CONSCIOUSNESS,Altered state of consciousness,ALTERED STATE OF CONSCIOUSNESS,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10001854,10001854,10001854
NEURITIS RETROBULBARIS DUE TO ETHAMBUTOL,Optic neuritis retrobulbar,OPTIC NEURITIS RETROBULBAR,OPTIC NEURITIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OPTIC NERVE DISORDERS NEC,10029205,10030945,10030942,10030945
IRRATIONAL BEHAVIOUR,irrational behaviour,BEHAVIOR ABNORMAL,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004203,10061422,10004203
"ORAL TREATMENT WITH FEXOFENADINE HYDROCHLORIDE AND TOPICAL STEROIDS WERE STARTED, BUT THE ERUPTIONS AND ITCHING DID NOT SIGNIFICANTLY IMPROVE",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
IMMUNE-MEDIATED NECROTIZING MYOPATHY,Immune-mediated necrotising myopathy,IMMUNE-MEDIATED NECROTIZING MYOPATHY,IMMUNE-MEDIATED NECROTISING MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10072155,10072155,10072156
AKATHISIA,akathisia,AKATHISIA,AKATHISIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10001540,10001540,10001540
DELIVERED BY CAESAREAN SECTION IN THE 34 WEEK OF PREGNANCY,Premature delivery,PREMATURE DELIVERY,PREMATURE DELIVERY,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036595,10036595,10036595
ALTERATIONS IN THE SLEEP PATTERN,change in sleep pattern,CHANGE IN SLEEP PATTERN,SLEEP DISORDER,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10071729,10040984,10071729
VOMITING DUE TO DRUG OVERDOSE AND ACCIDENTAL OVERDOSE FOLLOWING MEDICATION ERROR,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
DRUG USE FOR UNAPPROVED INDICATION,Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
POLYMYOSITIS WORSENING FOLLOWING LACK OF DRUG EFFECT OF CYCLOPHOSPHAMIDE AND METHOTREXATE,Polymyositis,POLYMYOSITIS,POLYMYOSITIS,MUSCLE DISORDERS,MUSCLE INFECTIONS AND INFLAMMATIONS,10028395,10036102,10036102,10036102
GENERALIZED EXANTHEMA,Exanthema generalized,EXANTHEMA GENERALIZED,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10058721,10037858,10058721
BACTERIAL SINUSITIS,Sinusitis bacterial,SINUSITIS BACTERIAL,SINUSITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10060841,10060841,10060841
ENLARGED CARDIAC SILHOUETTE,Cardiac disorder,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10061024,10061024,10061024
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
"TOOK 30 TABLETS OF DIGOXIN, 30 TABLETS A 150MG THEOPHYLLINE, 20 TABS A 10 MG OF ZOLPIDEM",intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
ABNORMAL PROTRUSION OF THE TONGUE,Protrusion tongue,PROTRUSION TONGUE,PROTRUSION TONGUE,TONGUE CONDITIONS,TONGUE SIGNS AND SYMPTOMS,10017947,10037076,10037076,10037076
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PAIN,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
DRESS SYNDROME INDUCED BY SULFAMETHOXAZOLE/TRIMETHOPRIM,DRESS syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
A RISE IN P-ALANINE AMINOTRANSFERASE FOLLOWING TREATMENT WITH TRIMETHOPRIM/SULFAMETHOXAZOLE FOR MELIOIDOSIS,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
SEPTIC MULTI-ORGAN FAILURE FOLLOWING FULMINANT TUMOR PROGRESSION,Multiorgan failure,MULTIORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028162,10077361,10028162
ACUTE DERMATITIS,dermatitis,DERMATITIS,DERMATITIS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10012431,10012431,10012431
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
INTOLERANCE TO HIGHER DOSE,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
COMA FOLLOWING SEROTONIN SYNDROME,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
IDIOPATHIC GASTROPARESIS,Impaired gastric emptying,IDIOPATHIC GASTROPARESIS,IMPAIRED GASTRIC EMPTYING,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10021227,10021518,10021227
SUBSTANTIAL BILATERAL PLEURITIC CHEST PAIN ON DEEP INSPIRATION,Pleuritic pain,PLEURITIC PAIN,PLEURITIC PAIN,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10035623,10035623,10035623
CHEST PAIN,chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
NAUSEA FOLLOWING OFF LABEL USE OF MYCOPHENOLATE MOFETIL,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
DRESS SYNDROME,dress syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
INVERSION OF THE LEFT NIPPLE,Nipple disorder,NIPPLE DISORDER,NIPPLE DISORDER,BREAST DISORDERS,BREAST DISORDERS NEC,10038604,10029417,10029417,10029417
RETINAL ARTERY THROMBOSIS,Retinal artery thrombosis,RETINAL ARTERY THROMBOSIS,RETINAL ARTERY THROMBOSIS,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINAL BLEEDING AND VASCULAR DISORDERS (EXCL RETINOPATHY),10015919,10038831,10038831,10038831
GRADE 1 MUSCLE CRAMPS,Muscle cramps,MUSCLE CRAMPS,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028295,10028334,10028295
ADENOVIRUS REACTIVATION,Adenovirus infection,ADENOVIRUS INFECTION,ADENOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,ADENOVIRAL INFECTIONS,10021881,10060931,10060931,10060931
PENILE ISCHEMIA/PENILE BLOCK WITH 1% LIDOCAINE/GLANS PENIS ISCHEMIA,Ischaemia,ISCHEMIA,ISCHAEMIA,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",NON-SITE SPECIFIC NECROSIS AND VASCULAR INSUFFICIENCY NEC,10047065,10061255,10061255,10054438
MEDICATION INDUCED AKATHISIA,Akathisia,AKATHISIA,AKATHISIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10001540,10001540,10001540
FEVER WITHOUT STIFFNESS,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
HEPARIN-INDUCED THROMBOCYTOPENIA,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
ELEVATED LIVER ENZYME LEVELS,elevated liver enzyme levels,ELEVATED LIVER ENZYME LEVELS,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014480,10060795,10014480
BILATERAL ILIOPSOAS MUSCLE HAEMATOMA,Muscle haemorrhage,HAEMATOMA MUSCLE,MUSCLE HAEMORRHAGE,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10055890,10028309,10055890
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
NOROVIRUS GENOTYPE 2 PCV WAS SUBSEQUENTLY POSITIVE,Norovirus test positive,NOROVIRUS TEST POSITIVE,NOROVIRUS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10070379,10070379,10070379
PATIENT HAD QUICKLY DEVELOPED TOLERANCE,Drug tolerance,DRUG TOLERANCE,DRUG TOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10052804,10052804,10052804
INFECTION,infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
PARADOXICAL REACTION OF AGITATION WITH DELUSIONAL DISORDER AND DISORGANISATION,Abnormal behaviour,BEHAVIOR ABNORMAL,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10061422,10061422,10004203
ADVANCED EMPD THAT WERE SUCCESSFULLY CONTROLLED BY DOCETAXEL WITH CISPLATIN,Drug effective for unapproved indication,DRUG EFFECTIVE FOR UNAPPROVED INDICATION,DRUG EFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10079317,10079317,10079317
HYPOXEMIC RESPIRATORY FAILURE,respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
DIURESIS,Polyuria,POLYURIA,POLYURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY TRACT SIGNS AND SYMPTOMS NEC,10038359,10036142,10036142,10036142
HEMATOCHEZIA,Haematochezia,HEMATOCHEZIA,HAEMATOCHEZIA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018836,10018836,10060544
OXALIPLATIN BASED CHEMOTHERAPY INDUCED SINUSOIDAL OBSTRUCTIVE SYNDROME,Venoocclusive liver disease,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
TYPE I HYPERSENSITIVITY,Type I hypersensitivity,TYPE I HYPERSENSITIVITY,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10045240,10045240,10045240
PULMONARY INFILTRATION,Lung infiltration,PULMONARY INFILTRATION,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025102,10025102,10037411
LEVEL OF CONSCIOUSNESS DECREASED,Depressed level of consciousness,DEPRESSED LEVEL OF CONSCIOUSNESS,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10012373,10012373,10012373
AGITATED,Agitation,AGITATED,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001495
GLOBALLY DEVELOPMENTALLY DELAYED WITH MARKED SPEECH DISABILITY,developmental delay,DEVELOPMENTAL DELAY,DEVELOPMENTAL DELAY,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10012559,10012559,10012559
DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
PREMATURE DELIVERY,Premature delivery,PREMATURE DELIVERY,PREMATURE DELIVERY,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036595,10036595,10036595
PROLONGED PROTHOROMBIN TIME,Prothrombin time prolonged,PROTHROMBIN TIME PROLONGED,PROTHROMBIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037063,10037063,10037063
HIS SPASTICITY INCREASED EVEN AFTER TAKING ORAL BACLOFEN,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
MILD NECK TENDERNESS,mild neck tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
HIGHLY ELEVATED INFLAMMATION MARKERS,Inflammatory marker increased,INFLAMMATORY MARKER INCREASED,INFLAMMATORY MARKER INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,CHEMISTRY ANALYSES NEC,10022891,10069826,10069826,10069826
EXTRAPYRAMIDAL SYMPTOMS,Extrapyramidal symptoms,EXTRAPYRAMIDAL SYMPTOMS,EXTRAPYRAMIDAL DISORDER,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10015835,10015832,10015835
SPONTANEOUS BRUISING,spontaneous bruising,SPONTANEOUS BRUISING,INCREASED TENDENCY TO BRUISE,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),BLEEDING TENDENCIES,10005329,10041729,10021688,10041729
SEVERE HEADACHE,severe headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
APHASIA,aphasia,APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002948,10002948,10002948
HIGHER GAMMA-GLUTAMYL TRANSFERASE (GGT),Gamma-glutamyltransferase increased,GAMMA-GLUTAMYLTRANSFERASE INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10017693,10017693,10017693
HYPOCHLORAEMIA,Hypochloraemia,HYPOCHLORAEMIA,HYPOCHLORAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,CHLORIDE IMBALANCE,10027433,10020955,10020955,10020955
"DRUG EXPOSURE DURING PREGNANCY, FIRST TRIMESTER (WITH NO ADR)",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, FIRST TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076617,10073513,10076617
DEVP/THE WOMAN RECEIVED DIGOXIN AND FLECAINIDE DURING THE THIRD TRIMESTER OF PREGNANCY,Maternal exposure during pregnancy,"MATERNAL EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10074500,10071408,10074500
SOMATIC DELUSION,Somatic delusion,SOMATIC DELUSION,SOMATIC DELUSION,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10041317,10041317,10041317
BACLOFEN TOXICITY,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
METHOTREXATE-ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,Epstein-Barr virus associated lymphoproliferative disorder,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10068349,10068349,10068349
LEUKOCYTOSIS,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
OPTIMAL PAIN CONTROL,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SEVERE AND INTOLERABLE GASTROINTESTINAL ADVERSE EFFECTS,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
STRONGYLOID HYPERINFECTION (BRONCHOALVEOLAR LAVAGE (BAL) FLUID AND STOOL EXAMINATION SHOWED STRONGYLOID LARVAE),Strongyloidiasis,STRONGYLODIASIS HYPERINFECTION,STRONGYLOIDIASIS,HELMINTHIC DISORDERS,NEMATODE INFECTIONS,10021881,10080246,10042254,10080246
SUBCUTANEOUS NODULE ON RIGHT LEG,Skin mass,SUBCUTANEOUS NODULE,SKIN MASS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS CONDITIONS NEC,10040785,10042348,10067868,10042348
MACULOPAPULAR EXANTHEMA PLUS EDEMA,Maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
RESPIRATORY SYNCYTIAL VIRUS/ RESPIRATORY VIRAL INFECTION,Respiratory syncytial virus infection,RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,RESPIRATORY SYNCYTIAL VIRAL INFECTIONS,10021881,10061603,10061603,10061603
HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
SUBTHERAPEUTIC RESPONSE,subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PARANOID DELUSION,Delusion,PARANOID DELUSIONS,DELUSION,DISTURBANCES IN THINKING AND PERCEPTION,DELUSIONAL SYMPTOMS,10037175,10033867,10012239,10033867
PULMONARY ASPERGILLOMA,Aspergilloma,ASPERGILLOMA,ASPERGILLOMA,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003487,10003487,10003487
INJECTION SITE ERYTHEMA,Injection site redness,INJECTION SITE REDNESS,INJECTION SITE ERYTHEMA,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022098,10022061,10022098
PCR DETECTED PRESENCE OF TYPE 2 VACCINE-DERIVED POLIOVIRUS (VDPV),Poliovirus test positive,POLIOVIRUS TEST POSITIVE,POLIOVIRUS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10070341,10070341,10070341
HYDROXYCHLOROQUINE TOXICITY,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
GROSS HEMATURIA,hematuria,HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10019450,10018867,10019450
UNABLE TO MOVE HER RIGHT HAND WELL AND HER RIGHT ARM SOMETIMES ELEVATED INVOLUNTARILY,Mobility decreased,MOBILITY DECREASED,MOBILITY DECREASED,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10048334,10048334,10048334
HEPATOTOXICITY,hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
JAW TRISMUS,Trismus,TRISMUS,TRISMUS,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10044684,10044684,10044684
ELEVATED CREATININE TO 8.0 MG/DL,Blood creatinine increased,CREATININE HIGH,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011367,10005483,10011367
CREATININE 3.8 MG/DL (0.6-1.30 MG/DL),creatinine,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
OEDEMA,Oedema,OEDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10030095
METHOTREXATE ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,Lymphoproliferative disorder,LYMPHOPROLIFERATIVE DISORDER,LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10061232,10061232,10061232
GI HEMORRHAGE DUE TO PREDNISONE,Gastrointestinal haemorrhage,GI HEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10018233
COUGHING,Cough,COUGHING,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011232
FINASTERIDE FOR PATTERNED HAIR LOSS IN PREMENOPAUSAL WOMEN,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEVERE NEUTROPENIA (ABSOLUTE NEUTROPHIL COUNT 270/MCL,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
CHEST DISCOMFORT,Chest discomfort,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008469,10008469,10008469
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
RIGHT EYE CONJUCTIVA WAS INJECTED WITH NODULAR CONJUNCTIVAL LESIONS,Conjunctival hyperaemia,CONJUNCTIVAL INJECTION,CONJUNCTIVAL HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CONJUNCTIVAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10051625,10051625,10010723
LOWER BACK PAIN,Back pain,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003988,10003988,10003988
CMV INFECTION,CMV infection,CMV INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10009703,10011831,10009703
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
TOTAL BILIRUBIN INCREASED FROM 1.3 TO 27 MG/ML,Blood bilirubin increased,BILIRUBIN TOTAL INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056806,10005364,10056806
G1 MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
PATIENT WAS ADMINISTERED MYCOPHENOLATE FOR UNAPPROVED INDICATION PEMPHIGUS VULGARIS (OFF LABEL USE FOR MYCOPHENOLATE MOFETIL),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SEVERE LEUKOPENIA,Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
CHEST PRESSURE SENSATION,Chest discomfort,CHEST PRESSURE SENSATION,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008487,10008469,10008487
KERATODERMA OF THE PALMS,Hyperkeratosis,KERATODERMA,HYPERKERATOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,HYPERKERATOSES,10040785,10023357,10020649,10023357
P.AERUGINOSA INFECTION IN BAL AND URINE,Pseudomonas infection,INFECTION PSEUDOMONAS AERUGINOSA,PSEUDOMONAS INFECTION,BACTERIAL INFECTIOUS DISORDERS,PSEUDOMONAL INFECTIONS,10021881,10021860,10061471,10021860
OUTCOME WAS TRANSIENT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
MYALGIA,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
TRANSIENT THROMBOCYTOPENIA (PLATELETS 133X09/L),transient,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
COGNITIVE DYSFUNCTION,cognitive dysfunction,COGNITIVE DISORDER,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10057668,10057668,10057668
ADMINISTRATION OF CHLOROQUINE FOR SYSTEMIC LUPUS ERYTHEMATOSUS (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
WORSENING OF COLITIS (GRDAE 3-4) FOLLOWING LACK OF DRUG EFFECT,Colitis,COLITIS AGGRAVATED,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009890,10009887,10009890
HYPERTROPHY IN INTERVENTRICULAR SEPTUM,cardiac disorder,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10061024,10061024,10061024
BURNING SENSATION FOLLOWING DRUG TOXICITY DUE TO DRUG INTERACTION,burning sensation,BURNING SENSATION,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10006784,10006784,10006784
LYMPHOPENIA,Lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
EXPERIENCED DIFFICULTY STANDING AND WALKING,Gait disturbance,DIFFICULTY IN WALKING,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10012794,10017577,10012794
MUSCLE WEAKNESS,muscle weakness,MUSCLE WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028350,10028372,10028350
LACK OF APPETITE,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
COLD,Cold,COLD,NASOPHARYNGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10009851,10028810,10009851
HAS A DEPRESSED NASAL BRIDGE,Congenital nose malformation,CONGENITAL NOSE MALFORMATION,CONGENITAL NOSE MALFORMATION,RESPIRATORY DISORDERS CONGENITAL,NASAL DISORDERS CONGENITAL,10010331,10062347,10062347,10062347
THE CLIENT HAD ABRUPTLY STOPPED BUPRENORPHINE 7 DAYS AFTER,Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
"PATIENT RECEIVED ACT-HIB ON 23-FEB-2016 (FIRST DOSE), 18-APR-2016 (SECOND DOSE) AND THIRD DOSE ON 05-DEC-2016",drug dose administration interval too short,DRUG DOSE ADMINISTRATION INTERVAL TOO SHORT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064319,10021597,10064319
HYPOMAGNESEMIA FOLLOWING RENAL DYSFUNCTION,hypomagnesemia,HYPOMAGNESAEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021027,10021027,10021027
GYNAECOMASTIA,Gynaecomastia,GYNAECOMASTIA,GYNAECOMASTIA,BREAST DISORDERS,BREAST DISORDERS NEC,10038604,10018800,10018800,10018800
SEKUNDARES RAYNAUD-SYNDROM,Raynaud's syndrome,RAYNAUD'S SYNDROME,RAYNAUD'S PHENOMENON,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10037914,10037912,10037914
TACHYCARDIC,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
"INDUCIBLE, (INCOORDINATION) ATAXIA",Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
ALLERGIC TO PARACETAMOL AND FENTANYL,Drug allergy,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
OXALIPLATIN-INDUCED ACUTE ST SEGMENT ELEVATION,Electrocardiogram ST segment elevation,ST SEGMENT ELEVATION,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041893,10014392,10041894
PARTIAL METABOLIC RESPONSE,Therapeutic response decreased,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10043414,10043414,10043414
RENAL IMPAIRMENT/KIDNEY DYSFUNCTION,renal impairment/kidney dysfunction,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
MYOPATHY,Myopathy,MYOPATHY,MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10028641,10028641,10028641
DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
BUT NO IMPROVEMENT OF HALLUCINATIONS,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
BENDING AND STRETCHING AND PRONOSUPINATION OF FOUR LIMBS WITHOUT INTERRUPTION IN THE WAKING STATE,Dyskinesia,MOVEMENTS INVOLUNTARY OF LIMBS,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028043,10013916,10028043
FALL,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
TOXIN-POSITIVE CLOSTRIDIUM DIFFICILE COLITIS,Clostridium difficile colitis,CLOSTRIDIUM DIFFICILE COLITIS,CLOSTRIDIUM DIFFICILE COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10009657,10009657,10009657
WITHOUT REVERSING THE FEBRILE SETTING,No therapeutic response,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
BAD COMPENSATION (BLOOD PRESSURE 220/100 MMHG),Blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
NO SYMPTOM IMPROVEMENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HEPATIC FUNCTION ABNORMAL,Hepatic function abnormal,HEPATIC FUNCTION DISORDER,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019674,10019670,10019674
PAO2 DECREASED (5.18 KPA),PO2 decreased,PARTIAL PRESSURE O2 DECREASED,PO2 DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10034082,10035768,10034082
"PANCYTOPENIA AFTER K1 TREATMENT, WAS COMPLICATED BY BACTEREMIA WITH E.COLI CAPTURE (ESBL EXTENDED-SPECTRUM BETA LACTAMASES) AND STREPTOCOCCUS SALIVARIUS",Escherichia bacteraemia,ESCHERICHIA COLI BACTEREMIA,ESCHERICHIA BACTERAEMIA,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10054258,10054258,10054279
THALAMUS HEMORRHAGE RIGHT [WITH INTRAVENTRICULAR HEMORRHAGE,Thalamus haemorrhage,THALAMUS HAEMORRHAGE,THALAMUS HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10058939,10058939,10058939
DID NOT RESPOND,Therapy non-responder,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
BLOOD GLUCOSE INCREASED,Blood glucose increased,FASTING BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10050786,10005557,10050786
GENERALIZED TONIC-CLONIC MOVEMENTS/TONIC-CLONIC EPISODES,Tonic-clonic seizures,TONIC-CLONIC SEIZURES,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10044000,10018100,10044000
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
REDUCTION IN URINE OUTPUT WITH DARK URINE,urine output decreased,URINE OUTPUT DECREASED,URINE OUTPUT DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059895,10059895,10059895
SKIN LESIONS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
GASTROINTESTINAL REACTION G1,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
ALLERGIC REACTION,Hypersensitivity,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
WORSENING RASH ON HER FACE AND NECK,Facial rash,FACIAL RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10016064,10037844,10016064
PYREXIA OF 38 DEGREES CELSIU,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
SLIGHT FEVER (37.2 C),fever,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
PATIENT HAD TAKEN METHOTREXATE DOSE ON A DAILY BASIS INSTEAD OF WEEKLY DOSE,patient had taken methotrexate dose on a daily basis instead of weekly dose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
ACUTE RENAL FAILURE FOLLOWING ACYCLOVIR-INDUCED NEPHROPATHY (ESTIMATED  GLOMERULAR  FILTRATION  RATE <15 ML/MIN),acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
CREATININE INCREASED - 185 MICROMOL/L,Blood creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
EOSINOPHILIA,Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
PRE RENAL KIDNEY FAILURE/ICU STAY PROLONGED BY TRANSIENT PRERENAL KIDNEY FAILURE,Prerenal failure,PRERENAL FAILURE,PRERENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10072370,10072370,10072370
ANTHRACYCLINE INDUCED CARDIOMYOPATHY,Cardiomyopathy,CARDIOMYOPATHY,CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10007636,10007636,10007636
TMA (THROMBOTIC MICROANGIOPATHY),Thrombotic microangiopathy,THROMBOTIC MICROANGIOPATHY,THROMBOTIC MICROANGIOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10043645,10043645,10043645
ACUTE REJECTION FOLLOWING NON COMPLIANCE OF MEDICATION,Liver transplant rejection,REJECTION ACUTE HEPATIC,LIVER TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10038296,10024715,10038296
TACHYCARDIA (HEART RATE 200 BEATS/MIN),Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
BRUGADA TYPE 1 ECG PATTERN,Brugada-type ECG,BRUGADA-TYPE ECG,ELECTROCARDIOGRAM ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10069779,10014363,10069779
INSOMNIA,Insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
SKIN ERUPTION,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
COMA,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
TYPE 1 DRUG-INDUCED KOUNIS SYNDROME,Kounis syndrome type I,KOUNIS SYNDROME TYPE I,KOUNIS SYNDROME,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10074934,10069167,10074934
INCREASED WHITE BLOOD COUNT (WBC),white blood cell count increased,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047943,10047943,10047943
FATALITIES,Death,DEATH,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10011906,10011906,10011906
SUPPRESSED MARKERS OF OSTEOFORMATION,Bone formation decreased,BONE FORMATION DECREASED,BONE FORMATION DECREASED,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10056809,10056809,10056809
INCREASED CREATININE,Creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
PATIENT HAD RECURRENCE OF SYMPTOMS ON DECREASING DOSE OF PREDNISOLONE BELOW 35 MG (REBOUND EFFECT),adult onset still's disease,ADULT ONSET STILL'S DISEASE,STILL'S DISEASE,JOINT DISORDERS,RHEUMATOID ARTHROPATHIES,10028395,10079456,10042061,10079456
BILATERAL LOWER EXTREMITY RASH,rash on leg,RASH ON LEG,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10079349,10037844,10079349
SMALL AND MEDIUM VESSEL VASCULITIS AND THROMBOSIS,vasculitis,VASCULITIS,VASCULITIS,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10047115,10047115,10047115
INTRAUTERINE GROWTH RESTRICTION,Foetal growth restriction,FETAL GROWTH RESTRICTION,FOETAL GROWTH RESTRICTION,FOETAL COMPLICATIONS,FOETAL GROWTH COMPLICATIONS,10036585,10070531,10070531,10070532
DRUG EXPOSURE DURING PREGNANCY WITH NO ADR,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
ANTERIOR MEDIASTINAL LYMPH NODE CONSISTENT WITH MALIGNANCY,Lymphadenopathy mediastinal,MEDIASTINAL LYMPHADENOPATHY,LYMPHADENOPATHY MEDIASTINAL,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025205,10025205,10027075
IMMUNOLOGICAL VACCINE FAILURE,vaccination failure,VACCINATION FAILURE,VACCINATION FAILURE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,VACCINATION RELATED COMPLICATIONS,10022117,10046862,10046862,10046862
CHEST X-RAY (CXR) SHOWED A RIGHT LOWER LOBE (RLL) INFILTRATE,Lung infiltration,LUNG INFILTRATION,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025102,10025102,10025102
RESTRICTED UPGAZE,Gaze palsy,EYES GAZE UPWARD,GAZE PALSY,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10016007,10056696,10016007
METASTASIS TO THE LIVER,metastasis to the liver,METASTASES TO LIVER,METASTASES TO LIVER,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027457,10027457,10027457
PETECHIAL HAEMORRHAGES IN EYELIDS,Eyelid bleeding,EYELID HAEMORRHAGE,EYELID BLEEDING,OCULAR HAEMORRHAGES AND VASCULAR DISORDERS NEC,LID BLEEDING AND VASCULAR DISORDERS,10015919,10053196,10053196,10015987
PROLONGED NEUTROPENIA/SEVERE NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ACUTE BRONCHOPNEUMONIA FOLLOWING ACUTE COMBINED DRUG TOXICITY,Pneumonia,ACUTE BRONCHOPNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10066692,10035664,10066692
HYPERTENSION,hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
TUBULAR ATROPHY,tubular atrophy,ATROPHY KIDNEY,RENAL ATROPHY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL STRUCTURAL ABNORMALITIES AND TRAUMA,10038359,10003701,10038381,10003701
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
CONDITION WORSENED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
POOR RESPONSE OF R-MINI-CHOP REGIMEN,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PLATELET COUNT 134000/L,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
DISCOMFORT ON MICTURITION,Dysuria,DYSURIA,DYSURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10013990,10013990,10013990
QUALITY OF LIFE DECREASED,Quality of life decreased,QUALITY OF LIFE DECREASED,QUALITY OF LIFE DECREASED,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",INVESTIGATIONS NEC,10022891,10067620,10067620,10067620
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
BONE AND ANKLE PAIN,Bone pain,BONE PAIN,BONE PAIN,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10006002,10006002,10006002
LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
EPSTEIN-BARR VIRUS VIREMIA,Epstein-Barr virus infection,EPSTEIN-BARR VIRUS INFECTION,EPSTEIN-BARR VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,EPSTEIN-BARR VIRAL INFECTIONS,10021881,10015108,10015108,10015108
DRONEDARONE LEADING TO ACUTE LIVER FAILURE,Acute hepatic failure,ACUTE LIVER FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10049844
TOTAL BILIRUBIN OF 138 MMOL/L,Blood bilirubin increased,BILIRUBIN TOTAL INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056806,10005364,10056806
PROSTRATION AND POSTURAL INSTABILITY,Fatigue,PROSTRATION,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10036985,10016256,10036985
FREQUENT FORGETFULNESS,Memory impairment,FORGETFULNESS,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10017060,10027175,10017060
MASSIVE HEPTOCYTE NECROSIS,liver necrosis,LIVER NECROSIS,HEPATIC NECROSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10024701,10019692,10024701
HIGH FEVER,Pyrexia,HIGH TEMPERATURE,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10020083,10037660,10020083
DRUG DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
REFRACTORY ACUTE REJECTION FOLLOWING LACK OF DRUG EFECT,Kidney transplant rejection,REJECTION ACUTE RENAL,KIDNEY TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10038297,10023439,10038297
WEIGHT LOSS,weight decreased,WEIGHT DECREASED,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047895
MACULOPAPULAR RASH,maculopapular rash,MACULO-PAPULAR,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025422,10037868,10025422
ENTEROCOLITIS,Enterocolitis,ENTEROCOLITIS,ENTEROCOLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10014893,10014893,10014893
ACUTE RENAL FAILURE,Acute kidney injury,RENAL FAILURE ACUTE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10038436
FAILED TRIALS OF ORAL OXYCODONE AND ORAL GABAPENTIN SECONDARY TO SIGNIFICANT POSTOPERATIVE ILEUS,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PERITONITIS WITH CULTURE POSITIVE FOR CANDIDA ALBICANS,Fungal peritonitis,FUNGAL PERITONITIS,FUNGAL PERITONITIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10061138,10061138,10061138
GRADE 1 ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
SEIZURE,seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
ACUTE PERITONITIS,Acute peritonitis,ACUTE PERITONITIS,PERITONITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10066720,10034674,10066720
FELT SEVERE PAIN OVER HIS RIGHT BUTTOCK AND LATERAL THIGH,Pain in extremity,PAIN IN THIGH,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10048973,10033425,10048973
RIGHT SIDED PTOSIS,Eyelid ptosis,PTOSIS,EYELID PTOSIS,OCULAR NEUROMUSCULAR DISORDERS,EYELID MOVEMENT DISORDERS,10015919,10015995,10015995,10037272
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PROGRESSION OF ANAEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
BLEEDING PER RECTUM/ PERIANAL BLEEDING,perianal bleeding,PERIANAL BLEEDING,ANAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,INTESTINAL HAEMORRHAGES,10017947,10053165,10049555,10053165
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS PNEUMONIA,Pneumonia staphylococcal,METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS PNEUMONIA,PNEUMONIA STAPHYLOCOCCAL,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10058931,10035734,10058931
METABOLIC SYMPTOMS,Metabolic disorder,METABOLIC DISORDER,METABOLIC DISORDER,METABOLISM DISORDERS NEC,METABOLIC DISORDERS NEC,10027433,10058097,10058097,10058097
MEMORY LOSS,Amnesia,MEMORY LOSS,AMNESIA,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027176,10001949,10027176
GRADE 1 NEUROPATHY,neuropathy,NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029328,10029331,10029328
COAGULOPATHY/CRITICAL COAGULOPATHY,coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
SENSATION OF BLACK DOTS IN FRONT OF HIS FACE AFTER GETTING OUT OF BED,Loss of consciousness,BLACKOUT,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10004979,10024855,10004982
ACUTE RENAL FAILURE,acute renal failure,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
SPEECH PROBLEM,Speech disorder,SPEECH DISORDER,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041466,10041466,10041466
SKIN RASH,skin rash,SKIN RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040913,10037844,10040913
SHE REPORTED THAT SHE LOST CONSCIOUSNESS AND WAS DOWN FOR OVER 8 HOURS/PROLONGED LOSS OF CONSCIOUSNESS,Loss of consciousness,LOSS OF CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024855
SORE THROAT,sore throat,SORE THROAT,OROPHARYNGEAL PAIN,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10041367,10068319,10041367
THROMBOSIS WITHIN THE STENT AND NO FLOW IN THE MIDDLE CEREBRAL ARTERY,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
MDS RELAPSE,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
ANTALGIC GAIT,antalgic gait,ANTALGIC GAIT,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10063359,10017577,10063359
ARTERIAL THROMBOEMBOLISM,Arterial thromboembolism,ARTERIAL THROMBOEMBOLISM,EMBOLISM ARTERIAL,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10073529,10014513,10073529
HYPERTENSION,hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
BLOOD PRESSURE INCREASED,Blood pressure increased,BLOOD PRESSURE INCREASED,BLOOD PRESSURE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005750,10005750,10005750
DIC,Disseminated intravascular coagulation,DIC,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10012769,10013442,10012769
FREQUENT BOWEL MOVEMENTS,Frequent bowel movements,FREQUENT BOWEL MOVEMENTS,FREQUENT BOWEL MOVEMENTS,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL SPASTIC AND HYPERMOTILITY DISORDERS,10017947,10017367,10017367,10017367
RESPIRATORY ALKALOSIS,respiratory alkalosis,RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10038664,10038664,10038664
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
AVASCULAR NECROSIS OF FEMORAL HEADS,Osteonecrosis,AVASCULAR NECROSIS FEMORAL HEAD,OSTEONECROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10003860,10031264,10003860
UNCONSCIOUSNESS,unconsciousness,UNCONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10045481,10024855,10045481
ANEMIA GRADE 3,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
TAKOTSUBO SYNDROME,Stress cardiomyopathy,TAKOTSUBO SYNDROME,STRESS CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10067676,10066286,10067676
PATIENT DIED DUE TO PURPURA FULMINANS DESPITE THE TREATMENT WITH PREDNISOLONE AND PROPRANOLOL,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NEUROLOGIC STATUS DECREASED DUE TO DIABETIC KETOACIDOSIS,Neurological decompensation,NEUROLOGICAL STATUS DETERIORATION,NEUROLOGICAL DECOMPENSATION,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10064098,10068357,10064098
BRONCHIOLITIS OBLITERANS,Bronchiolitis obliterans,BRONCHIOLITIS OBLITERANS,OBLITERATIVE BRONCHIOLITIS,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10049202,10029888,10049202
SEPTIC APPEARANCE,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER WITH NO ADR",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
HYPOTHERMIA (36 DEGREES CELSIUS) FOLLOWING INTENTIONAL LOPERAMIDE ABUSE,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
METHOTREXATE (MTX) 2.5 MG WEEKLY COULD NOT BE TOLERATED BECAUSE OF BACK PAIN AND,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
STOPPED TO BE EFFECTIVE,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
WATERY DIARRHEA,watery diarrhea,WATERY DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10055422,10012735,10055422
ENTEROCOCCI INFECTION,enterococcal infection,ENTEROCOCCAL INFECTION,ENTEROCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,ENTEROCOCCAL INFECTIONS,10021881,10061124,10061124,10061124
MISUSE,Intentional drug misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
INFECTIVE ENDOCARDITIS,Endocarditis infective,ENDOCARDITIS INFECTIVE,ENDOCARDITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CARDIAC INFECTIONS,10021881,10014678,10014665,10014678
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
POSTINFLAMMATORY HYPERPIGMENTATION FOLLOWING KAPOSI SARCOMA,Skin hyperpigmentation,HYPERPIGMENTATION SKIN,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10040865,10040865,10020715
DRUG ALLERGY (GRADE I),Drug allergy,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
CHEMOTHERAPY WAS NOT WELL TOLERATED,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
SWEET'S SYNDROME,Sweet's syndrome,SWEET'S SYNDROME,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10042673,10000748,10042673
EXTRADURAL HAEMATOMA,Extradural haematoma,EXTRADURAL HAEMATOMA,EXTRADURAL HAEMATOMA,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10015769,10015769,10015769
CORONARY VASOSPASM,Arteriospasm coronary,CORONARY VASOSPASM,ARTERIOSPASM CORONARY,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10011107,10003225,10011110
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
MASSIVE HEAMATOMA OF RETROPERITONEUM,Retroperitoneal haematoma,RETROPERITONEAL HEMATOMA,RETROPERITONEAL HAEMATOMA,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL HAEMORRHAGES,10017947,10058360,10058360,10058361
"SEVERAL TUBULES CONTAINED OXALATE CRYSTALS, AND BLOOD VESSELS SHOWED HYPERPLASTIC CHANGE",oxalate nephropathy,OXALATE NEPHROPATHY,CRYSTAL NEPHROPATHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10080893,10071503,10080893
DIAPHORETIC,Hyperhidrosis,DIAPHORESIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042670,10020642,10012703
DISSEMINATED GEOTRICHIUM CLVATUM INFECTION,Geotrichum infection,GEOTRICHUM INFECTION,GEOTRICHUM INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10056660,10056660,10056660
DOLICHOCEPHALY,scaphocephaly,SCAPHOCEPHALY,SCAPHOCEPHALY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS OF SKULL CONGENITAL,10010331,10049426,10049426,10049426
HORIZONTAL DIPLOPIA,Diplopia,DIPLOPIA,DIPLOPIA,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10013036,10013036,10013036
BROWN VOMIT,Discoloured vomit,DISCOLOURED VOMIT,DISCOLOURED VOMIT,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10079120,10079120,10079120
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
PROLONGED THERAPY WITH FLUCONAZOLE 150 MG PER DAY DURING10MONTHS,Inappropriate schedule of drug administration,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021597,10021597,10021597
ATRIOVENTRICULAR DISSOCIATION/ ATRIOVENTRICULAR DYSSYNCHRONY,Ventricular dyssynchrony,ATRIOVENTRICULAR DYSSYNCHRONY,VENTRICULAR DYSSYNCHRONY,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10078240,10071186,10078240
LOW ALBUMIN (1.9 G/DL),Blood albumin decreased,ALBUMIN LOW,BLOOD ALBUMIN DECREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10001572,10005287,10001572
HEART RATE OF 111 BEATS/MIN,heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
MILD HYPOCALCEMIA,hypocalcemia,HYPOCALCEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020949,10020947,10020949
URINARY TRACT INFECTION (UTI),Urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
DEVELOPED  SPINE METASTASIS FROM AN INVASIVE ESTHESIONEUROBLASTOMA FOLLOWING LOE,spine metastasis,METASTASIS,METASTASIS,METASTASES,METASTASES TO UNKNOWN AND UNSPECIFIED SITES,10029104,10062194,10062194,10062194
HYPOCALCEMIA,Hypocalcaemia,HYPOCALCEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020947,10020947,10020949
DIFFUSE GRANULOMATOUS INTERSTITIAL NEPHRITIS INDUCED BY PIPERACILLIN-TAZOBACTAM,Nephritis interstitial,NEPHRITIS INTERSTITIAL,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029134,10048302,10029134
CYTOMEGALOVIRUS REACTIVATION (VIRAL LOAD 7 Ã— 1000 COPIES/ML),Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION REACTIVATION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10058666,10011831,10058666
VENOOCCLUSIVE SYNDROME OF THE LIVER,Venoocclusive liver disease,VENOOCCLUSIVE LIVER DISEASE,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10047216,10047216,10047216
PREMATURE ATRIAL COMPLEXES CONDUCTED,Supraventricular extrasystoles,PREMATURE ATRIAL CONTRACTION,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10056964,10042602,10056964
PATIENT HAD TAKEN METHOTREXATE DOSE ON A DAILY BASIS INSTEAD OF WEEKLY DOSE,chronic overdose,CHRONIC OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067696,10033295,10067696
VISUAL HALLUCINATIONS,"Hallucination, visual",VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019075,10019075,10047570
HEMATURIA,Haematuria,HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018867,10018867,10019450
SEVERE APPETITE LOSS,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
THERAPEUTIC RESPONSE UNEXPECTED,Therapeutic response unexpected,THERAPEUTIC RESPONSE UNEXPECTED,THERAPEUTIC RESPONSE UNEXPECTED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10043417,10043417,10043417
AGGRAVATION OF HIS CHRONIC HEPATOSPLENOMEGALY,Hepatosplenomegaly,HEPATOSPLENOMEGALY,HEPATOSPLENOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019847,10019847,10019847
OSTEOPOROSIS,Osteoporosis,OSTEOPOROSIS,OSTEOPOROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10031282,10031282,10031282
ADMINISTRATION SITE NECROSIS,Administration site necrosis,ADMINISTRATION SITE NECROSIS,ADMINISTRATION SITE NECROSIS,ADMINISTRATION SITE REACTIONS,ADMINISTRATION SITE REACTIONS NEC,10018065,10075956,10075956,10075956
ITCHING ON FOREHEAD,itching,ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023084,10037087,10023084
HRCT REVEALED BILATERAL GGO,Computerised tomogram thorax abnormal,GROUND GLASS OPACITY IN THORACIC CT,COMPUTERISED TOMOGRAM THORAX ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10072879,10057799,10072879
DEMYELINATION FOLLOWING SEVERE AXONAL NEUROPATHY INDUCED BY CIPROFLOXACIN,Demyelination,DEMYELINATION,DEMYELINATION,DEMYELINATING DISORDERS,DEMYELINATING DISORDERS NEC,10029205,10012305,10012305,10012305
HYPERAMMONEMIA,Hyperammonaemia,HYPERAMMONEMIA,HYPERAMMONAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020575,10020575,10020576
MICROSCOPIC HEMATURIA,microscopic hematuria,MICROSCOPIC HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10059824,10018867,10059824
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SEVERE HYPOCHONDRIASIS,Illness anxiety disorder,HYPOCHONDRIASIS,ILLNESS ANXIETY DISORDER,SOMATIC SYMPTOM AND RELATED DISORDERS,SOMATIC SYMPTOM DISORDERS,10037175,10020965,10078077,10020965
PLEURAL EFFUSION FOLLOWING HEART FAILURE,pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
GLYCOSURIA,Glycosuria,GLYCOSURIA,GLYCOSURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018473,10018473,10018473
ELECTROLYTE DEPLETION,ifosfamide induced renal tubulopathy,ELECTROLYTE DEPLETION,ELECTROLYTE DEPLETION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10014415,10014415,10014415
TRIED TAKING METOCLOPRAMIDE 2 WEEKS INTO BREASTFEEDING TO INCREASE HER SUPPLY (PRODUCT USE ISSUE) WITH NO ADR,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
INR INCREASED (3.6),International normalised ratio increased,INR INCREASED,INTERNATIONAL NORMALISED RATIO INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10022402,10022595,10022402
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
WAS ADMITTED TO OUR HOSPITAL 10 WEEKS AFTER HIS FIRST SEIZURE DUE TO CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
INCREASED AST (>21575 IU/L),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
LIMPING GAIT,limping gait,GAIT ABNORMAL,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017573,10017577,10017573
DECREASED NEED FOR SLEEP,Insomnia,SLEEP DECREASED,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10040982,10022437,10040982
SUBCUTANEOUS PHAEOHYPHOMYCOSIS NODULE ON LEFT FOOT,Skin mass,SUBCUTANEOUS NODULE,SKIN MASS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS CONDITIONS NEC,10040785,10042348,10067868,10042348
DIFFUSE LEWYBODY DEMENTIA,Dementia with Lewy bodies,DEMENTIA WITH LEWY BODIES,DEMENTIA WITH LEWY BODIES,MENTAL IMPAIRMENT DISORDERS,DEMENTIA (EXCL ALZHEIMER'S TYPE),10029205,10067889,10067889,10067889
LEUKOCYTE COUNT DECREASED (0.4X10E3/MCL),leukocyte count decreased,LEUKOCYTE COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10048552,10047942,10048552
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
GRADE 4 DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
SERUM CREATININE INCREASED TO 1 MG/DL,Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
OOZING SEROUS DISCHARGE,Wound oozing,WOUND OOZING,WOUND SECRETION,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10058997,10048629,10058997
MISUSE,Intentional product misuse,INTENTIONAL PRODUCT MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10074903,10074903,10074903
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
SCATTERED 1-2 CM WELL-DEMARCATED EDEMATOUS AND ERYTHEMATOUS PLAQUES WITH SOME CENTRAL BLISTERING AND EROSIONS WITH CRUST,Blister,BLISTERING,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005214,10005191,10005214
PHYSICAL DISORDERS,Physical impairment,PHYSICAL IMPAIRMENT,PHYSICAL DISABILITY,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10076322,10048624,10076322
MULTIPLE ORGAN FAILURE DUE TO TOXIC EPIDERMAL NECROLYSIS,Multiple organ dysfunction syndrome,MULTIPLE ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028237
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
"FALLS OF THE PATIENT WERE NOT STUMBLING, BUT MORE LIKELY DUE TO ARRHYTHMIAS RESULTING IN LOSS OF MUSCULAR TENSION AND FALLING WITHOUT LOSS OF CONSCIOUSNESS",Muscle weakness,MUSCLE WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028350,10028372,10028350
GOUT/ PODAGRA,Gout,GOUT,GOUT,PURINE AND PYRIMIDINE METABOLISM DISORDERS,DISORDERS OF PURINE METABOLISM,10027433,10018627,10018627,10018627
"NIFEDIPINE WAS USED TO ATTENUATE UTERINE CONTRACTIONS/ MEDICATION DURING STUDY PERIOD
/NIFEDIPINE GIVEN AT 31 + 1 WEEKS OF GESTATION",Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
"PARTIAL WEAKNESS OF LEVATOR PALPEBRAE MUSCLE POWER/MILD OBJECTIVE WEAKNESS, INTERFERING WITH FUNCTION",Extraocular muscle paresis,EYE MUSCLE WEAKNESS,EXTRAOCULAR MUSCLE PARESIS,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10059456,10015829,10059456
SELF-PRESCRIBED STIMULANT FOR THE PAST 12 YEARS IN  VARIABLE DOSES AND FREQUENCIES,Intentional drug misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
DRY MUCOUS MEMBRANES IN THE ORAL CAVITY,Mucosal dryness,MUCOSAL DRYNESS,MUCOSAL DRYNESS,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028111,10028111,10028111
PERIPHERAL POLYNEUROPATHY,Polyneuropathy,POLYNEUROPATHY,POLYNEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10036105,10036105,10036105
PREMATURE RUPTURE OF MEMBRANES,Premature rupture of membranes,PREMATURE RUPTURE OF MEMBRANES,PREMATURE RUPTURE OF MEMBRANES,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036603,10036603,10036603
CEFTRIAXONE-INDUCED ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS/GENERALIZED PUSTULAR PSORIASIS OVERLAP,Acute generalised exanthematous pustulosis,ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10062372
DISSEMINATED BARTONELLA HENSELAE INFECTION,Cat scratch disease,BARTONELLA HENSALAE INFECTION,CAT SCRATCH DISEASE,BACTERIAL INFECTIOUS DISORDERS,BARTONELLA INFECTIONS,10021881,10004144,10007729,10004144
IMPAIRED GLUCOSE TOLERANCE,glucose intolerance,GLUCOSE INTOLERANCE,GLUCOSE TOLERANCE IMPAIRED,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10052426,10018429,10052426
ADYNAMIA,Adynamia,ADYNAMIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10001425,10003549,10001425
DESATURATION,oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
TRUNCUS ARTERIOSUS COMMUNIS PERSISTENT,Truncus arteriosus communis,TRUNCUS ARTERIOSUS COMMUNIS,TRUNCUS ARTERIOSUS PERSISTENT,CARDIAC AND VASCULAR DISORDERS CONGENITAL,GREAT VESSEL DISORDERS CONGENITAL,10010331,10059207,10044703,10059207
THE ELEVATED CREATININE KINASE WAS A RESULT OF ATORVASTATIN 80 MG,Creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
MINOR INTRACEREBRAL HEMORRHAGE,Intracerebral hemorrhage,INTRACEREBRAL HEMORRHAGE,CEREBRAL HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10022754,10008111,10022754
HB DECREASED TO 4.0 G/DL,Haemoglobin decreased,HAEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10018884
BILIRUBIN LEVEL INCREASED  (1.6 MG/DL),Blood bilirubin increased,BILIRUBIN INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10004690,10005364,10004690
JOINT PAIN,Arthralgia,JOINT PAIN,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10023222
ASTHENIA/ADYNAMIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
DRUG DEPENDENCE,Drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
HIGH LEVELS OF TYPE B N-TERMINAL NATRIURETIC PROPEPTIDE,Brain natriuretic peptide increased,BRAIN NATRIURETIC PEPTIDE INCREASED,BRAIN NATRIURETIC PEPTIDE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10053405,10053405,10053405
RETROBULBAR INFECTION,Optic neuritis,OPTIC NEURITIS RETROBULBAR,OPTIC NEURITIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OPTIC NERVE DISORDERS NEC,10029205,10030945,10030942,10030945
CHRONIC ENTEROVIRAL CNS INFECTION DUE TO CHEMOTHERAPY AND IMMUNOSUPPRESSION,Central nervous system enteroviral infection,CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION,CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION,VIRAL INFECTIOUS DISORDERS,ENTEROVIRAL INFECTIONS NEC,10021881,10061035,10061035,10061035
MIRTAZAPINE ADMINISTERED VIA A NASOGASTRIC TUBE,Incorrect route of drug administration,DRUG ADMINISTERED VIA INAPPROPRIATE ROUTE,INCORRECT ROUTE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10013660,10064304,10013660
"THE PATIENT DID NOT RESPOND TO ORAL VANCOMYCIN, INTRAVENOUS METRONIDAZOLE OR ORAL FIDAXOMICIN",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
FORMATION OF CORNEAL ULCERS,corneal ulcer,CORNEAL ULCER,ULCERATIVE KERATITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CORNEAL INFECTIONS, OEDEMAS AND INFLAMMATIONS",10015919,10048492,10064996,10048492
ARTERIAL BLEEDING FROM THE MUSCLE,Arterial haemorrhage,ARTERIAL HAEMORRHAGE,ARTERIAL HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10060964,10060964,10060964
SEVERELY NEUTROPENIC (NEUTROPHIL COUNT: 0.11 Ã— 10*9/L),Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ACUTE METHOTREXATE INTOXICATION FOLLOWING DRUG USE FOR UNAPPROVED INDICATION (OFF LABEL USE),methotrexate intoxication following drug use for unapproved indication (off label use),ACUTE DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10066766,10070863,10066766
A1C OVER THIS PERIOD WAS 11.4% DESPITE METFORMIN AND INSULIN,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SKIN LESIONS PRESENT IN THE BILATERAL DISTAL UPPER EXTREMITIES,skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
SEVERE EXFOLIATIVE DERMATITIS,exfoliative dermatitis,EXFOLIATIVE DERMATITIS,DERMATITIS EXFOLIATIVE,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10015665,10012455,10015665
INSOMNIA,Insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
LYMPHADENOPATHY,lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
VENTRICULAR TACHYCARDIA (150/MIN) DUE TO  INCREASED DRUG LEVEL OF QUININE IN BLOOD (61MICROMIL/LITRE) FOLLOWING MEDICATION ERROR (INAPPROPRIATE DILUTION OF MEDICATION),ventricular tachycardia,VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047302,10047302,10047302
EDEMAS,Oedema,EDEMA NOS,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030114,10030095,10014234
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
VIRAL SEROLOGY FOR CYTOMEGALOVIRUS POSITIVE,Cytomegalovirus test positive,CYTOMEGALOVIRUS ANTIBODY POSITIVE,CYTOMEGALOVIRUS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10050525,10051620,10050525
VACCINE FAILURE LEADING TO HAEMOPHILUS INFLUENZAE INFECTION/ HIB MENINGITIS,Meningitis haemophilus,HAEMOPHILUS INFLUENZAE MENINGITIS,MENINGITIS HAEMOPHILUS,BACTERIAL INFECTIOUS DISORDERS,HAEMOPHILUS INFECTIONS,10021881,10018953,10027241,10018953
DECREASED VIGILANCE,Disturbance in attention,VIGILANCE DECREASED,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10050400,10013496,10050400
CYCLOPHOSPHAMIDE USE FOR MALIGNANT MS,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DYSRHYTHMIA,Arrhythmia,CARDIAC DYSRHYTHMIAS,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10007545
COUGHING,Cough,COUGHING,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011232
SERUM CREATININE INCREASED-1.6 MG/DL,Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
TACHYPNEA,tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
PROGRESSIVE VISUAL LOSS DUE TO PSEUDOPEMPHIGOID,Blindness,VISION LOSS,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047522,10005169,10047522
PROLONGATION OF PROTHROMBIN TIME,Prothrombin time prolonged,PROTHROMBIN TIME PROLONGED,PROTHROMBIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037063,10037063,10037063
GRAFT REJECTION,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
PERIPHERAL NERVE DISORDER NOS,Neuropathy peripheral,PERIPHERAL NERVE DISORDER NOS,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10051174,10029331,10051174
DRUG INTERACTION,drug Interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
"MULTIPLE MEDICATIONS WERE TRIED, INCLUDING VENLAFAXINE, CITALOPRAM AND SERTRALINE/PATIENT'S ANXIETY WORSENED AS THE PD PROGRESSED",Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
DESQUAMATION AT TIPS,Skin exfoliation,SKIN DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040826,10040844,10040826
POSTURAL INSTABILITY,Gait disturbance,INSTABILITY GAIT,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017582,10017577,10022455
PREMATURE INFANT,Premature birth,PREMATURE BIRTH,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036594,10036590,10036594
THICKNESS OF THE SUBCUTANEOUS TISSUE OF LOWER ABDOMINAL REGION INCREASED (16MM),Injection site hypertrophy,INJECTION SITE SUBCUTANEOUS FATTY HYPERTROPHY,INJECTION SITE HYPERTROPHY,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022101,10022072,10022101
SPONTANEOUS ABORTION,Spontaneous abortion,SPONTANEOUS ABORTION,ABORTION SPONTANEOUS,ABORTIONS AND STILLBIRTH,ABORTIONS SPONTANEOUS,10036585,10041687,10000234,10041687
MARKED IMPAIRMENT OF VISUAL ACUITY,Visual impairment,VISUAL IMPAIRMENT,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047571,10047571,10047571
LYMPHOCYTIC CHOLANGITIS,Cholangitis,CHOLANGITIS,CHOLANGITIS,BILE DUCT DISORDERS,BILE DUCT INFECTIONS AND INFLAMMATIONS,10019805,10008604,10008604,10008604
ELEVATION IN NT-PRO BNP,Brain natriuretic peptide increased,BNP INCREASED,BRAIN NATRIURETIC PEPTIDE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10068001,10053405,10068001
WEIGHT LOSS,Weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
NO RESPONSE TO CHEMOTHERAPY,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
BED BOUND FOLLOWING TUMOUR LYSIS SYNDROME,Bedridden,BEDRIDDEN,BEDRIDDEN,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10048948,10048948,10048948
PANCYTOPENIA FOLLOWING ACUTE METHOTREXATE TOXICITY IN THE SETTING OF CONCOMITANT USE OF IBUPROFEN AND AMOXICILLIN/CLAVULANIC ACID,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
INCREASE RISK OF DEVELOPING CDI DUE TO IMMUNOSUPRESSIVE THERAPY/PSEUDOMEMBRANOUS COLITIS,Clostridium difficile infection,CLOSTRIDIUM DIFFICILE INFECTION,CLOSTRIDIUM DIFFICILE INFECTION,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10054236,10054236,10054236
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
C. DIFFICILE COLITIS,Clostridium difficile colitis,C.DIFFICILE COLITIS,CLOSTRIDIUM DIFFICILE COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10009657,10009657,10006833
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
HYPOKINESIS AT THE POSTERIOR WALL OF THE LEFT VENTRICLE,Ventricular hypokinesia,VENTRICULAR HYPOKINESIA,VENTRICULAR HYPOKINESIA,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10050510,10050510,10050510
ADVERSE DRUG REACTIONS,Adverse drug reaction,ADVERSE DRUG REACTION,ADVERSE DRUG REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061623,10061623,10061623
WEIGHT LOSS,Weight loss,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047900,10047895,10047900
THE PATIENT PAIN DEMONSTRATED LIMITED OPIOID RESPONSIVENESS (LACK OF DRUG EFFECT) WITH NO ADVERSE EVENT,the patient pain demonstrated limited opioid responsiveness (lack of drug effect) with no adverse event,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
MILD CUTANEOUS CHRONIC GVHD,Chronic graft versus host disease in skin,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10072159,10072159,10072159
HYPOTENSION (89/56 MMHG),Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
TACHYCARDIC (HEART RATE 110 BPM),Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
FEVER OF 38 DEGREE  C,fever of 38 degree  C,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
 small vesicles along both helical rims and left palate of oral cavity,2018-08-10 00:00:00,1,,,,DERMAL AND EPIDERMAL CONDITIONS NEC,10067723,10067723,
STEPPAGE GAIT ON THE LEFT,Steppage gait,STEPPAGE GAIT,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10066777,10017577,10066777
SEVERE EPIGASTRIC ABDOMINAL PAIN,epigastric pain,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
SEVERE GRAM-NEGATIVE SEPSIS (ACINETOBACTER BAUMMANNI),Bacterial sepsis,BACTERIAL SEPSIS,BACTERIAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10053840,10053840,10053840
LV DIASTOLIC DYSFUNCTION GRADE II,Left ventricular diastolic dysfunction,LEFT VENTRICULAR DIASTOLIC DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10074568,10049694,10074568
MUSCULOSKELETAL PAIN,Musculoskeletal pain,MUSCULOSKELETAL PAIN,MUSCULOSKELETAL PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10028391,10028391,10028391
TEMPERATURE REGULATION DISORDER,Temperature regulation disorder,TEMPERATURE REGULATION DISORDER,TEMPERATURE REGULATION DISORDER,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10061376,10061376,10061376
INFLAMMATION OF THE SUBCUTANEOUS TISSUE,inflammation NOS,INFLAMMATION NOS,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10021961,10061218,10021961
SEVERE HYPOMAGNESAEMIA,hypomagnesaemia,HYPOMAGNESAEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021027,10021027,10021027
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
"INCOMPLETE ATYPICAL FEMUR FRACTURE WHICH LED COMPLETE SUBTROCHANTERIC TRANSVERSE FRACTURE IN HER RIGHT FEMUR, WHICH EXTENDED THROUGH BOTH CORTICES WITH A MEDIAL SPIKE AFTER FALL",Atypical femur fracture,ATYPICAL FEMUR FRACTURE,ATYPICAL FEMUR FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10070884,10070884,10070884
LEUKOCYTE COUNT OF  13300 /MICROLITER WITH A LEFT SHIFT AND BANDEMIA,bandemia,BANDEMIA,BANDAEMIA,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10072091,10072081,10072091
ANAEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
SWOLLEN JOINTS,swollen joints,SWOLLEN JOINTS,JOINT SWELLING,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10042722,10023232,10042722
GRADE II NEUROPATHY,Neuropathy peripheral,NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029328,10029331,10029328
HYPERGLYCEMIA,Hyperglycaemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020639
STEVENS-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
USE OF HYDROXYCHLOROQUINE FOR LICHEN PLANOPILARIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
RENAL DYSFUNCTION (GRADE 3),Renal impairment,KIDNEY DYSFUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10023417
SEVERE BONE MARROW SUPPRESSION,Bone marrow failure,MYELOSUPPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10028584
PATIENT'S BLOOD PRESSURE DROPPED TO 37/0 MMHG,Blood pressure decreased,BLOOD PRESSURE DROPPED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005744
THREE DAYS OF ANTIBIOTICS AND NO IMPROVEMENTIN THE SYMPTOMS (LACK OF DRUG EFFECT WITH NO ADVERSE EVENT),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SEVERE TOXIC MYOCARDIAL DEPRESSION,myocardial depression,MYOCARDIAL DEPRESSION,MYOCARDIAL DEPRESSION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10069140,10069140,10069140
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ANAEMIA,anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
PAINFUL,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
WORSENING CAS TRIGGERED BY TACROLIMUS,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
HYDROXYCHLOROQUINE-TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
"ERYTHRODERMA OF HER EXTREMITIES, FACE, AND SCALP DUE TO TRANSIENT SEVERE IMMUNODEFICIENCY SECONDARY TO CHEMOTHERAPY",erythroderma,ERYTHRODERMA,DERMATITIS EXFOLIATIVE GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10015277,10012456,10015277
SIGNIFICANT NEUROLOGICAL SIDE EFFECTS,Nervous system disorder,NEUROLOGICAL DISORDER NOS,NERVOUS SYSTEM DISORDER,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029298,10029202,10029298
DYSPNEA AT MINOR PHYSICAL EXERTION,Dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
TONE WAS INCREASED,Hypertonia,TONE INCREASED,HYPERTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10020852,10020852,10043933
APAP TOXICITY WAS ASSOCIATED WITH CONCOMITANT DEXTROPROPOXYPHENE INTAKE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
PALE,pale,PALE,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033532,10033546,10033532
DRUG ADMINISTRATION ERROR,Drug administration error,DRUG ADMINISTRATION ERROR,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064295,10064295,10064295
HIGH FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
INADVERTENT METHOTREXATE EXPOSURE IN PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
CONJUNCTIVAL HYPEREMIA,conjunctival hyperemia,CONJUNCTIVAL HYPEREMIA,CONJUNCTIVAL HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CONJUNCTIVAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10054364,10051625,10054364
PORTAL HYPERTENSION,portal hypertension,PORTAL HYPERTENSION,PORTAL HYPERTENSION,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10036200,10036200,10036200
WAS IN INCIPIENT RENAL FAILURE,renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
NON-BLOODY DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
ABSENT DEEP TENDON REFLEXES IN BOTH UPPER AND LOWER EXTREMITIES,Tendon reflex absent,TENDON REFLEX ABSENT,AREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10067218,10003084,10067218
ALLERGY,Drug allergy,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
INTENSE PAIN,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
RESISTANT GENERALIZED ANXIETY DISORDER DESPITE TREATMENT WITH SSRIS AND SNRIS IN APPROPRIATE DOSE FOR APPROPRIATE TIME (LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
INCOMPLETE RIGHT BUNDLE BRANCH BLOCK ON ELECTROCARDIOGRAM,incomplete right bundle branch block on electrocardiogram,INCOMPLETE RIGHT BUNDLE BRANCH BLOCK,BUNDLE BRANCH BLOCK RIGHT,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10051862,10006582,10051862
DROWSY FOLLOWING MULTIPLE DRUG OVERDOSE DUE TO SUICIDAL INTENT,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
CREATININE INCREASED (3.1 MG/DL),Blood creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
ALOPECIA TOTALIS,Alopecia totalis,ALOPECIA TOTALIS,ALOPECIA TOTALIS,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001766,10001766,10001766
HYPOAESTHESIA,Hypoaesthesia,HYPOAESTHESIA,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10020937,10020937,10020937
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
ALLOGENEIC TRANSPLANT TOXICITY,Toxicity to various agents,TOXICITY TO VARIOUS AGENTS,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10070863,10070863,10070863
NO RESPONSE,Therapy non-responder,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
PERIPHERAL NEUROPATHY FOLLOWING METRONIDAZOLE TOXICITY AND OFF LABEL USE,peripheral neuropathy,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10080342,10029331,10080342
GENERAL MALAISE,general malaise,GENERAL MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10018066,10025482,10018066
SUDDEN HYPOTENSION (BLOOD PRESSURE REDUCED FROM 145/80 MMHG TO 75/46 MMHG)/HYPOTENSIVE,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
PULMONARY HEMOSIDEROSIS RELAPSE (TWO RELAPSE),Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SKIN LESIONS INFECTED WITH STAPHYLOCOCCUS AUREUS DUE TO AGRANULOCYTOSIS,staphylococcus aureus,STAPHYLOCOCCUS AUREUS INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10075981,10058080,10075981
MILD MITRAL REGURGITATION,Mitral valve incompetence,MITRAL REGURGITATION,MITRAL VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,MITRAL VALVULAR DISORDERS,10007541,10027718,10027727,10027718
DRUG-INDUCED PARKINSONISM,Parkinsonism,DRUG-INDUCED PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10013707,10034010,10013707
DESPITE TREATMENT HE REMAINED CONVULSIVE WITH SEIZURES,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
DRUG-INDUCED LIVER INJURY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
LYMPHO-DEPLETION AND RESTITUTION WITH MILD PERSISTING LYMPHOPENIA (0.47-0.94 X109/L),Lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
FEVER/ FEBRILE,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
"THE BUN AND SERUM CREATININE WERE INCREASED, INDICATING RENAL INVOLVEMENT DUE TO METHOTREXATE GIVEN IN ERROR (INSTEAD OF MEDROXYPROGESTERONE ACETATE, DRUG DISPENSING ERROR)",renal function abnormal,RENAL FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038451,10062237,10038451
EPISODES OF WENCKEBACH,Atrioventricular block second degree,WENCKEBACH,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10047908,10003677,10047908
BLOOD LACTATE INCREASED (GREATER THAN 15 MMOL/L) FOLLOWING MULTIPLE DRUG OEVRDOSE,Blood lactic acid increased,LACTATE BLOOD INCREASE,BLOOD LACTIC ACID INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10023651,10005635,10023650
"STIFFNESS, SWELLING, AND CONTRACTURE THEN DEVELOPED IN THE RIGHT HAND/STIFFNESS AND SWELLING DEVELOPED IN THE LEFT HAND",Musculoskeletal stiffness,LIMBS STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10024509,10052904,10024509
PNEUMOCYSTIS PNEUMONIA,Pneumocystis pneumonia,PNEUMOCYSTIS PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10035661,10073755,10035661
PULMONARY TUBERCULOSIS,Pulmonary tuberculosis,PULMONARY TUBERCULOSIS,PULMONARY TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10037440,10037440,10037440
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ACUTE ON CHRONIC RENAL FAILURE,Acute kidney injury,ACUTE ON CHRONIC RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038440,10069339,10000952
DRESS / DIHSS,Drug reaction with eosinophilia and systemic symptoms,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
CREATINE INCREASED (11.1 MG/DL),Blood creatine increased,CREATINE INCREASED,BLOOD CREATINE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011333,10005464,10011333
INFECTION LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
MYELODYSPLASTIC SYNDROME,Myelodysplastic syndrome,MYELODYSPLASTIC SYNDROME,MYELODYSPLASTIC SYNDROME,LEUKAEMIAS,MYELODYSPLASTIC SYNDROMES,10029104,10028533,10028533,10028533
NEUROPATHY,neuropathy,NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029328,10029331,10029328
ASPIRIN USED FOR HYPERTENSION,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
POSITIVE FECAL OCCULT BLOOD STOOL,fecal occult blood positive,FECAL OCCULT BLOOD POSITIVE,OCCULT BLOOD POSITIVE,GASTROINTESTINAL INVESTIGATIONS,FAECAL ANALYSES NEC,10022891,10016299,10061880,10016299
RETROGRADE EJACULATION,retrograde ejaculation,RETROGRADE EJACULATION,RETROGRADE EJACULATION,SEXUAL FUNCTION AND FERTILITY DISORDERS,ERECTION AND EJACULATION CONDITIONS AND DISORDERS,10038604,10038967,10038967,10038967
ANXIETY WITH INSOMNIA AND PALPITATIONS,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
QT INTERVAL PROLONGED (VALUE 0.42 SECONDS) FOLLOWING CINCHONISM,Electrocardiogram QT prolonged,QT INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037703,10014387,10037703
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
WEIGHT INCREASED,Weight increased,WEIGHT INCREASED,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047899
SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
DROOLING,drooling,DROOLING,DROOLING,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013642,10013642,10013642
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
LOW PLASMA RENIN ACTIVITY,Renin decreased,BLOOD RENIN ACTIVITY DECREASED,RENIN DECREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,CHEMISTRY ANALYSES NEC,10022891,10062273,10038557,10062273
"OLANZAPINE INDUCED ERYTHEMATOUS RASHES ON UPPER AND LOWER LIMBS, TRUNK",Rash erythematous,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015243
"PATIENT STOPPED TAKING OXYBUTYNIN, HOT FLASHES RETURNED FOLLOWING REBOUND EFFECT",hot flashes,HOT FLASHES,HOT FLUSH,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10020407,10060800,10020407
GLOSSITIS,Glossitis,GLOSSITIS,GLOSSITIS,TONGUE CONDITIONS,TONGUE DISORDERS,10017947,10018386,10018386,10018386
AMNESIC,Amnesia,AMNESIA,AMNESIA,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10001949,10001949,10001949
BILATERAL PULMONARY INFILTRATES,bilateral pulmonary infiltrates,BILATERAL PULMONARY INFILTRATES,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10070790,10025102,10070790
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
AUDITORY HALLUCINATION,"Hallucination, auditory",AUDITORY HALLUCINATIONS,"HALLUCINATION, AUDITORY",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019070,10019070,10003785
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
GROWTH HORMONE DEFICIENCY DUE TO CHRONIC STEROIDS USE,Growth hormone deficiency,GROWTH HORMONE DEFICIENCY,GROWTH HORMONE DEFICIENCY,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPOFUNCTION,10014698,10056438,10056438,10056438
DIFFUSE LYMPHADENOPATHY,Lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
UVEITIS FOLLOWING DRUG INTERACTION,Uveitis,UVEITIS,UVEITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10046851,10046851,10046851
LATER STATED HE HAD OVERDOSED ON HIS PAROXETINE AND HYDROXYZINE ALONE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
LIVER DYSFUNCTION CAUSED BY SEVERE SOS,Hepatic function abnormal,HEPATIC FUNCTION DISORDER,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019674,10019670,10019674
CLUBBING OF FINGERS AND TOES  SENNA MISUSE,Clubbing of fingers,CLUBBING OF FINGERS,CLUBBING,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,SOFT TISSUE DISORDERS NEC,10028395,10009692,10009691,10009692
MULTIPLE CUTANEOUS NODULAR LESIONS MAINLY LOCATED IN THE LEFT ELBOW AND THE BUTTOCKS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
HEMOGLOBIN A1C 9-10%,Glycosylated haemoglobin increased,HBA1C INCREASED,GLYCOSYLATED HAEMOGLOBIN INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10056186,10018484,10052424
CLOSTRIDIAL INFECTION,Clostridial infection,CLOSTRIDIAL INFECTION,CLOSTRIDIAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10061043,10061043,10061043
GENERALIZED PALLOR DUE TO DRUG INTERACTION,pallor,PALLOR,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033546,10033546,10033546
DULL HEADACHE,headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
LEFT LOWER LEG SQUAMOUS CELL CARCINOMA IN SITU,Squamous cell carcinoma,SQUAMOUS CELL CARCINOMA,SQUAMOUS CELL CARCINOMA,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10041823,10041823,10041823
HIGH URINARY AMYLASE (1856 U/24 HOURS),Amylase increased,URINE AMYLASE INCREASED,AMYLASE INCREASED,GASTROINTESTINAL INVESTIGATIONS,DIGESTIVE ENZYMES,10022891,10046612,10002016,10046612
PATIENT WAS TREATED WITH METHOTREXATE FOR MORPHEA (OFF LABEL USE) WITH NO ADVERSE EVENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CARDIAC ARREST FOLLOWING INTENTIONAL LOPERAMIDE OVERDOSE,cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
LEUKOCYTOSIS(70% EOSINOPHILS),leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
"ON THE PALMS OF THE HANDS, WE SAW ERYTHEMATOUS MACULAE",Rash macular,ERYTHROMACULAR RASH,RASH MACULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015283,10037867,10015283
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
INVOLUNTARY CONTRACTION OF HER RIGHT HIP/INVOLUNTARY FLEXION AND EXTENSION OF THE RIGHT HIP,Muscle spasm,MUSCLE SPASM,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028333,10028334,10028333
DEHYDRATION-INDUCED INTESTINAL NECROSIS,Necrosis bowel,NECROSIS BOWEL,GASTROINTESTINAL NECROSIS,GASTROINTESTINAL VASCULAR CONDITIONS,GASTROINTESTINAL NECROSIS AND GANGRENE (EXCL GANGRENOUS HERNIA),10017947,10028856,10017982,10028856
PATIENT EXPERIENCED OSTEOPENIA,Osteopenia,OSTEOPENIA,OSTEOPENIA,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10049088,10049088,10049088
CONTINUOUS AGGRATION OF URTICARIA RASHES/SYMPTOMS WORSENED/PATIENT WAS TREATED WITH FEXOFENADINE AND PREDNISOLONE WITHOUT ANY RELIEF,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
PULMONARY THROMBOEMBOLISM,Pulmonary embolism,PULMONARY EMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037377,10037377,10037377
SEVERE DEHYDRATION,dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
COMPLICATIONS OF TRACHEAL STENOSIS,Tracheal stenosis,TRACHEAL STENOSIS,TRACHEAL STENOSIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),TRACHEAL DISORDERS (EXCL INFECTIONS AND NEOPLASMS),10038738,10050816,10050816,10050816
"NAUSEA AND DIFFUSE, ACHY, AND CONSTANT ABDOMINAL PAIN (GI SIDE EFFECTS)",abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
CARDIOGENIC SHOCK AFTER ADMINISTRATION OF NIFEDIPINE,cardiogenic shock,CARDIOGENIC SHOCK,CARDIOGENIC SHOCK,HEART FAILURES,HEART FAILURES NEC,10007541,10007625,10007625,10007625
OXALIPLATIN INDUCED NEUROTOXICITY,neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
GRAND IDEAS AND INCOHERENT THOUGHTS,thought disorder,THOUGHT DISORDER,THINKING ABNORMAL,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10079962,10043431,10079962
ERYTHEMA ANNULARE AND ERYTHEMA OEDEMATOUS ON THE TRUNK AND FOUR LIMBS,Erythema annulare,ERYTHEMA ANNULARE,ERYTHEMA ANNULARE,EPIDERMAL AND DERMAL CONDITIONS,PAPULOSQUAMOUS CONDITIONS,10040785,10015153,10015153,10015153
UNEXPLAINED WEIGHT GAIN,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
DIABETIC KETOACIDOSIS FOLLOWING HUGE GLYCEMIC VARIABILITY,Diabetic ketoacidosis,DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEC,10027433,10012671,10012671,10012671
BLOOD PRESSURE DECREASED,Blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
EJECTION FRACTION DECREASED,Ejection fraction decreased,LEFT VENTRICULAR EJECTION FRACTION DECREASED,EJECTION FRACTION DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10053222,10050528,10053222
"RED, SWOLLEN, WARM RIGHT UPPER ARM OVER THE SITE OF INJECTION.",Vaccination site cellulitis,VACCINATION SITE CELLULITIS,VACCINATION SITE CELLULITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10069559,10069559,10069559
NAUSEOUS,Nausea,NAUSEOUS,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028823
"PATIENT WAS MANAGED WITH DEXAMETHASONE, BENZYLPENICILLIN AND MAGNESIUM SULFATE IN ANTICIPATION OF PRETERM DELIVERY IN 29+5 MONTH ( DRUG EXPOSURE DURING THIRD TRIMESTER OF PREGNANCY) WITH NO ADR",drug exposure during third trimester of pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
REDNESS ON ARM,Erythema,REDNESS,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10038198,10015150,10038198
NINP/ NEITHER INFECTED NOR PROTECTED,Hepatitis B antibody negative,HEPATITIS B ANTIBODY NEGATIVE,HEPATITIS B ANTIBODY NEGATIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10019734,10019734,10019734
LOWER PROTHROMBIN LEVELS,Lower prothrombin levels,PROTHROMBIN LEVEL DECREASED,PROTHROMBIN LEVEL DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037050,10037050,10037050
ATHELIA FOLLOWING DRUG EXPOSURE IN UTERO,breast malformation,BREAST MALFORMATION,BREAST MALFORMATION,REPRODUCTIVE TRACT AND BREAST DISORDERS CONGENITAL,BREAST DISORDERS CONGENITAL,10010331,10006271,10006271,10006271
PNEUMONIA,pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
MILD CATARACT,Cataract,CATARACT,CATARACT,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",CATARACT CONDITIONS,10015919,10007739,10007739,10007739
PATIENT HAD FRONTAL/INTRA-ORBITAL INFANTILE HAEMANGIOMA (IH),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DRUG OVERDOSE OF PARACETAMOL,Drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
"NAUSEA G3 PERSISTENTE, PARESTESIE ALLE MANI.",Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
GLOBAL CARDIAC HYPOKINESIA WITH A SYSTOLIC EJECTION FRACTION ASSESSED AT 35% IN THE ELECTROCARDIOGRAM FOLLOWING SEVERE HYPOKALEMIA (1.5 MMOL/L) FOLLOWING ACUTE OVERDOSE,Ejection fraction decreased,EJECTION FRACTION DECREASED,EJECTION FRACTION DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10050528,10050528,10050528
INSULINOMA,insulinoma,INSULINOMA,INSULINOMA,ENDOCRINE NEOPLASMS MALIGNANT AND UNSPECIFIED,ISLET CELL NEOPLASMS AND APUDOMA NEC,10029104,10022498,10022498,10022498
HAD BEEN ON EH SINCE 2004 WITH A SUBOPTIMAL RESPONSE.,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
RIGHT VENTRICULAR DIASTOLIC COLLAPSE FOLLOWING CARDIAC TAMPONADE,Right ventricular diastolic collapse,RIGHT VENTRICULAR DIASTOLIC COLLAPSE,RIGHT VENTRICULAR DIASTOLIC COLLAPSE,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10079613,10079613,10079613
MATERNAL USE OF LEVETIRACETAM DURING PREGNANCY,Foetal exposure during pregnancy,FETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071404,10071404,10071421
NÃUSEAS INTENSAS/INTENSE NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
MELENA,Faeces discoloured,BLACK STOOLS,FAECES DISCOLOURED,GASTROINTESTINAL SIGNS AND SYMPTOMS,FAECAL ABNORMALITIES NEC,10017947,10004977,10016100,10004977
ALEMTUZUMAB HAS BEEN USED TO TREAT REFRACTORY CASES OF SÃ‰ZARY SYNDROME,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
APPEARANCE OF EDEMA (SYSTEMIC EDEMA),Oedema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10014210
BONE MARROW DEPRESSION WITH HYPOCELLULAR BONE MARROW FOLLOWING ACUTE AND ACCIDENTAL METHOTREXATE OVERDOSE DUE TO METHOTREXATE INTOXICATION BECAUSE OF DRUG PRESCRIBING ERROR,bone marrow depression,BONE MARROW DEPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10005986
ENTEROBACTER CLOACAE,Enterobacter cloacae infection,ENTEROBACTER CLOACAE INFECTION,ENTEROBACTER INFECTION,BACTERIAL INFECTIOUS DISORDERS,ENTEROBACTER INFECTIONS,10021881,10054240,10051910,10054240
LYMPHOEDEMA/INTENSE INFLAMMATION FOLLOWING OFF LABEL USE,Lymphoedema,LYMPHOEDEMA,LYMPHOEDEMA,LYMPHATIC VESSEL DISORDERS,LYMPHOEDEMAS,10047065,10025282,10025282,10025282
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
AGGRAVATION OF THYROID ORBITOPATHY DESPITE IMMUNOSUPPRESSION BY PREDNISONE(LACK OF DRUG EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
"DESPITE MEDICAL TREATMENT WITH BETA BLOCKER AND AMIODARONE AND AFTER SUCCESSFUL ABLATION OF DIFFERENT VENTRICULAR TACHYCARDIA MORPHOLOGIES IN COMBINATION WITH SUBSTRATE MODIFICATION,",Labelled drug-drug interaction medication error,LABELED DRUG-DRUG INTERACTION MEDICATION ERROR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT MONITORING ERRORS AND ISSUES,10022117,10064373,10064373,10064378
ITCHING,Pruritus,ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023084,10037087,10023084
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
EYE ANGIOPATHY,angiopathy,ANGIOPATHY,ANGIOPATHY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10059245,10059245,10059245
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
FLACCID PARALYSIS,Paralysis,FLACCID PARALYSIS,PARALYSIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10033809,10033799,10016744
LIVER DYSFUNCTION,Hepatic dysfunction NOS,HEPATIC DYSFUNCTION NOS,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019657,10019670,10019657
SWELLING IN RIGHT LEG,Peripheral swelling,SWELLING OF LIMB,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042702,10048959,10042701
MODERATE BRADYKINESIA,Bradykinesia,BRADYKINESIA,BRADYKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10006100,10006100,10006100
SEVERE PERSISTENT HYPOTHYRODISM,hypothyrodism,HYPOTHYROIDISM,HYPOTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPOFUNCTION DISORDERS,10014698,10021114,10021114,10021114
MULTIPLE FALL,multiple fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
LUNG AND BRAIN ABSCESS DUE TO FUSARIUM INFECTION,Fusarium infection,FUSARIUM INFECTION,FUSARIUM INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10051919,10051919,10051919
MRI SCAN SHOWED 13 NEW T2 LESIONS AT THE SUPRATENTORIAL LEVEL AND 5 ON INFRATENTORIAL STRUCTURE,brain lesion,BRAIN LESION,CENTRAL NERVOUS SYSTEM LESION,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10067294,10051290,10067294
HEPATOTOXICITY,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
SCEDOSPORIUM APIOSPERMUM COMPLEX INFECTION,scedosporium apiospermum infection,SCEDOSPORIUM APIOSPERMUM INFECTION,SCEDOSPORIUM INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10076593,10059045,10076593
PULMONARY PARENCHYMAL INFILTRATES,Lung infiltration,LUNG INFILTRATION,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025102,10025102,10025102
HYPOGAMMAGLOBULINEMIA,Hypogammaglobulinaemia,HYPOGAMMAGLOBULINEMIA,HYPOGAMMAGLOBULINAEMIA,IMMUNODEFICIENCY SYNDROMES,PRIMARY IMMUNODEFICIENCY SYNDROMES,10021428,10020983,10020983,10054427
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
THERAPY DID NOT IMPROVE THE NODULES,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
MUSCULAR WEAKNESS,Muscular weakness,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028372,10028372,10028372
PURPURIC LESIONS,Purpuric rash,PURPURIC RASH,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037566,10037549,10037566
CYTOMEGALOVIRUS INFECTION,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011831,10011831,10011831
SWELLING OF NASAL MUCOSA,Nasal congestion,NASAL MUCOSAL SWELLING,NASAL CONGESTION,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL CONGESTION AND INFLAMMATIONS,10038738,10063455,10028735,10063455
SWELLING,Swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
DEHYDRATION,dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
WAKE UP DISTURBINGLY OFTEN DURING THE NIGHT AND SOMETIMES TOO EARLY IN THE MORNING,Middle insomnia,NOCTURNAL AWAKENING,MIDDLE INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10029448,10027590,10029448
IRBESARTAN (DOSING DETAILS UNKNOWN) FOR HYPERTENSIVE ENCEPHALOPATHY,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
GAIT DISTURBANCE,Gait disturbance,GAIT DISTURBANCE,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017577,10017577,10017577
PATIENT DIED DUE TO PURPURA FULMINANS DESPITE THE TREATMENT WITH PREDNISOLONE AND PROPRANOLOL,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PRURITUS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
ACUTE INTERSTITIAL NEPHRITIS RELAPSE FOLLOWING PREDNISONE TAPER (REBOUND EFFECT),Tubulointerstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029135,10048302,10000819
INJECTION SITE SUBCUTANEOUS TISSUE CHANGE (NON-INDURATED),Injection site reaction,INJECTION SITE REACTION,INJECTION SITE REACTION,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022095,10022095,10022095
"WBC INCREASED (15,800)",White blood cell count increased,WBC INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056739,10047943,10056739
RIGORS,rigors,RIGORS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10039177,10008531,10039177
IMMUNE-MEDIATED PERIPHERAL THROMBOCYTOPENIA,Autoimmune thrombocytopenia,AUTOIMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10050245,10074667,10050245
LOCAL TENDERNESS IN TENDON AROUND 9 CM ABOVE FLOOR LEVEL,Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
GENERAL MALAISE,general malaise,GENERAL MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10018066,10025482,10018066
HOARSE VOICE,hoarse voice,HOARSE VOICE,DYSPHONIA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10020200,10013952,10020200
MEMORY DISORDER,Memory disturbance,MEMORY DISTURBANCE,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027172,10027175,10027172
LOWER EXTREMITY MRI SHOWED MILD ATROPHY IN LOWER EXTREMITY AND INCREASED AIGNAL INTENSITY CONSISTENT WITH MYOPATHY,Myopathy,MYOPATHY,MYOPATHY,MUSCLE DISORDERS,MYOPATHIES,10028395,10028641,10028641,10028641
OLIGOHYDRAMNIOS SEQUENCE,oligohydramnios,OLIGOHYDRAMNIOS,OLIGOHYDRAMNIOS,"PLACENTAL, AMNIOTIC AND CAVITY DISORDERS (EXCL HAEMORRHAGES)",AMNIOTIC FLUID AND CAVITY DISORDERS OF PREGNANCY NEC,10036585,10030289,10030289,10030289
RASH DEVELOPED ON THE DORSAL SURFACE/WAS ERYTHEMATOUS,Rash erythematous,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10037855
CHOREA IN OUR PATIENT WAS MOST LIKELY DUE TO TOXICITY FROM LEVOFLOXACIN IN AN UNDERLYING STRUCTURAL BRAIN LESION,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
ORAL MUCOSAL INFLAMMATION,Stomatitis,MUCOSITIS ORAL,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028130,10042128,10028130
HIVES/RECURRENCE OF URTICARIAL/SPORADIC OUTBREAK OF HIVES,Urticaria,HIVES,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10020197
CARCINOID,Carcinoid syndrome,CARCINOID SYNDROME,CARCINOID SYNDROME,NEOPLASTIC AND ECTOPIC ENDOCRINOPATHIES,ECTOPIC ENDOCRINE DISORDERS,10014698,10007270,10007270,10007270
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
DRUG ALLERGY,Drug hypersensitivity,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
RESPIRATORY DISCOMFORT,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
PROLONGATION OF PROTHROMBIN TIME,Prothrombin time prolonged,PROTHROMBIN TIME PROLONGED,PROTHROMBIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037063,10037063,10037063
"HISTOPATHOLOGIC EXAMINATION SHOWING LYMPHOCYTIC INFILTRATE INCLUDING CD8+ T CELLS AT THE DERMO-EPIDERMAL INTERFACE, EXTENDING INTO THE MID-EPIDERMIS AND UPPER EPIDERMIS WITH NECROSIS OF KERATINOCYTES",Epidermal necrosis,KERATINOCYTE NECROSIS,EPIDERMAL NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10059292,10059284,10059292
BRADYKINESIA,Bradykinesia,BRADYKINESIA,BRADYKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10006100,10006100,10006100
TORSADE DE POINTES,Torsade de pointes,TORSADE DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044066
HCTZ-INDUCED PULMONARY EDEMA,Pulmonary edema,PULMONARY EDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037375,10037423,10037375
BLISTER,Blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
GASTROINTESTINAL DISTURBANCES FOLLOWING INTENTIONAL OVERDOSE,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
"DOSING WAS GRADUALLY INCREASED TO 15 MG SIX TIMES A DAY, ADMINISTERED EVERY 2 HOURS",Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
NECK STIFFNESS,neck stiffness,NECK STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10028843,10052904,10028843
HEMATOMA,hematoma,HEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10019428,10018852,10019428
SENSORY PERIPHERAL NERVE DISORDER,Peripheral sensory neuropathy,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10034620,10034620,10034620
COAGULOPATHY,Coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
DRUG DEPENDENCE TO MEPHENESIN AND ALPRAZOLAM,drug dependence,DRUG DEPENDENCE,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013663,10013663,10013663
SUICIDE,Completed suicide,SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042462,10010144,10042462
ACUTE RESPIRATORY DISTRESS SYNDROME,Acute respiratory distress syndrome,ACUTE RESPIRATORY DISTRESS SYNDROME,ACUTE RESPIRATORY DISTRESS SYNDROME,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10001052,10001052,10001052
DIFFUSE EPIGASTRIC ABDOMINAL PAIN,Abdominal pain upper,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
AGGRAVATION OF EXISTING DISORDER,Condition aggravated,AGGRAVATION OF EXISTING DISORDER,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10001484,10010264,10001484
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
PROGRESSIVE DEEP JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
HYPONATREMIA (SODIUM WAS 119 MMOL/L),Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
GRADE 2 ELEVATION OF ALANINE AMINOTRANSFERASE AND ASPARTATE AMINOTRANSFERASE,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
GRADE 2 BREATHLESSNESS,Dyspnoea,BREATHLESSNESS,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10006345
ANTICHOLINERGIC SYMPTOMS,Anticholinergic syndrome,ANTICHOLINERGIC SYNDROME,ANTICHOLINERGIC SYNDROME,NEUROMUSCULAR DISORDERS,AUTONOMIC NERVOUS SYSTEM DISORDERS,10029205,10002757,10002757,10002757
U WAVES ON ELECTROCARDIOGRAM,Electrocardiogram U wave present,U WAVE APPEARANCE,ELECTROCARDIOGRAM U WAVE PRESENT,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10045279,10057913,10045279
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
GRADE 4 NEUTROPENIA ACCORDING TO THE WORLD HEALTH ORGANISATION (WHO),Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
NEUROLEPTIC MALIGNANT SYNDROME,Neuroleptic malignant syndrome,NEUROLEPTIC MALIGNANT SYNDROME,NEUROLEPTIC MALIGNANT SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10029282,10029282,10029282
TONIC-CLONIC SEIZURES/ GENERALIZED TONIC-CLONIC SEIZURE,Generalised tonic-clonic seizure,GENERALIZED TONIC-CLONIC SEIZURE,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10018100,10018100,10062448
GENERALISED ERYTHEMA/ ERYTHEMA-LIKE LESIONS DISSEMINATED ALL OVER THE BODY,Generalised erythema,GENERALISED ERYTHEMA,GENERALISED ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10051576,10051576,10051576
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
PLATELET COUNT DECREASED ( 132E9/L),platelet count decreased ( 132E9/L),PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
DISORIENTATION LASTING FOR A DAY,Disorientation,DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013395,10013395,10013395
QUEASY,Queasy,QUEASY,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10037730,10028813,10037730
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SUPINE POSITION,Vital capacity abnormal,VITAL CAPACITY ABNORMAL,VITAL CAPACITY ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY AND PULMONARY FUNCTION DIAGNOSTIC PROCEDURES,10022891,10047580,10047580,10047580
CLINICAL WORSENING (MYALGIA AND FATIGABILITY),Fatigue,FATIGABILITY,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016259,10016256,10016252
SUICIDE ATTEMPT,suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
HEMOSIDERIN DEPOSITS (POSITIVE PERLS STAIN),Haemosiderin stain,HEMOSIDERIN STAIN,HAEMOSIDERIN STAIN,PIGMENTATION DISORDERS,PIGMENTATION CHANGES NEC,10040785,10078154,10078154,10077596
GRANULOMATOUS DERMATITIS,Granulomatous dermatitis,GRANULOMATOUS DERMATITIS,GRANULOMATOUS DERMATITIS,EPIDERMAL AND DERMAL CONDITIONS,GRANULOMATOUS AND DEEP CUTANEOUS INFLAMMATORY CONDITIONS,10040785,10074954,10074954,10074954
VASCULAR PAIN,Vascular pain,VASCULAR PAIN,VASCULAR PAIN,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10047095,10047095,10047095
PSEUDOMONAS AERUGINOSA INFECTION,Pseudomonas infection,INFECTION PSEUDOMONAS AERUGINOSA,PSEUDOMONAS INFECTION,BACTERIAL INFECTIOUS DISORDERS,PSEUDOMONAL INFECTIONS,10021881,10021860,10061471,10021860
CERVICAL TARDIVE DYSTONIC MOVEMENTS/ SEVERE UNILATERAL DYSTONIC NECK MOVEMENTS,Tardive dyskinesia,TARDIVE DYSKINESIA,TARDIVE DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10043118,10043118,10043118
PORTAL HYPERTENSION WITH GASTROPATHY,Portal hypertensive gastropathy,PORTAL HYPERTENSIVE GASTROPATHY,PORTAL HYPERTENSIVE GASTROPATHY,GASTROINTESTINAL HAEMORRHAGES NEC,GASTRIC AND OESOPHAGEAL HAEMORRHAGES,10017947,10050897,10050897,10050897
ACUTE KIDNEY FAILURE,Acute kidney injury,ACUTE KIDNEY FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10000821
HIGH LEVELS OF BOTH TOTAL CALCIUM (3.42 MMOL/L) AND FREE CALCIUM (1.68 MMOL/L),Blood calcium increased,CALCIUM TOTAL INCREASED,BLOOD CALCIUM INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10006983,10005396,10006983
"PATIENT WAS TREATED WITH CARBAMAZEPINE, LEVETIRACETAM, LACOSAMIDE AND PHENOBARBITAL DURING PREGNANCY/PATIENT WAS ON ANTIEPILEPTIC POLYTHERAPY/MATERNAL EXPOSURE DURING PREGNANCY",Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
BK POLYOMAVIRUS-ASSOCIATED NEPHROPATHY GRADE A,Polyomavirus-associated nephropathy,BK VIRUS NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065333,10065381,10065333
EPISODES OF BRONCHOSPASM,Bronchospasm,BRONCHOSPASM,BRONCHOSPASM,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10006482,10006482,10006482
VOMITS,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SEVERE NEUTROPENIA (NEUTROPHIL COUNT LESS THAN 100 PER CUBIC MM),Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER AS A CONSEQUENCE OF THERAPEUTIC IMMUNOSUPPRESSION,Post transplant lymphoproliferative disorder,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10051358,10051358,10051358
INR FLUCTUATION,INR fluctuation,INR FLUCTUATION,INTERNATIONAL NORMALISED RATIO FLUCTUATION,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10072751,10063351,10072751
"STIPPLING OF LUMBOSACRAL VERTEBRAE AND EPIPHYSIS OF THE FEMURS, CALCANEUS AND TARSAL BONES",Epiphyseal disorder,EPIPHYSEAL DISORDER,EPIPHYSEAL DISORDER,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),EPIPHYSEAL DISORDERS,10028395,10060825,10060825,10060825
RENAL TUBULAR INHIBITION OF METHOTREXATE EXCRETION BY CIPROFLOXACIN LED TO RENAL FAILURE/ AKI ASSOCIATED WITH ENALAPRIL AND CIPROFLOXACIN AS CO-SUSPECT OR INTERACTING MEDICINES,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
ANAPHYLACTIC SHOCK,anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
CONDITION WORSENED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
FLUOROPYRIMIDINE INDUCED CHEST PAIN FOLLOWING CARDIOTOXICITY,Angina pectoris,CHEST PAIN - CARDIAC,ANGINA PECTORIS,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10008481,10002383,10008481
PNEUMONITIS,Pneumonitis,PNEUMONITIS,PNEUMONITIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10035742,10035742,10035742
ACUTE ANEMIA,Acute anemia,ACUTE ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10066545,10002034,10066545
DEATH FROM FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
RENAL INSUFFICIENCY DUE TO DEHYDRATION FOLLOWING RECURRENCE OF GASTRIC SARCOIDOSIS,Renal failure,RENAL INSUFFICIENCY,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038474,10038435,10038474
ACUTE IGE MEDIATED ALLERGIC REACTION,Hypersensitivity,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
HIV-1 PERSISTENT VIREMIA FOLLOWING DRUG RESISTANCE,HIV viraemia,HIV VIREMIA,HIV VIRAEMIA,VIRAL INFECTIOUS DISORDERS,RETROVIRAL INFECTIONS,10021881,10077716,10077716,10077718
UNABLE TO WALK,unable to walk,UNABLE TO WALK,GAIT INABILITY,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10049278,10017581,10049278
DRUG-INDUCED INTERSTITIAL PNEUMONIA,Interstitial lung disease,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
METABOLIC ACIDOSIS FOLLOWING DRUG EXPOSURE IN UTERO AND DRUG EXPOSURE VIA BREAST MILK,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
PAINFUL ULCER,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
INCREASED CORNEA NEOVASCULARIZATION,Corneal neovascularisation,CORNEAL NEOVASCULARIZATION,CORNEAL NEOVASCULARISATION,OCULAR HAEMORRHAGES AND VASCULAR DISORDERS NEC,CONJUNCTIVAL AND CORNEAL BLEEDING AND VASCULAR DISORDERS,10015919,10055665,10055665,10011031
USE OF BISOPROLOL FOR ATRIAL FIBRILLATION (OFF LABEL USE WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
REPEAT CT SCAN SHOWED THAT THE PELVIC MASS HAD ENLARGED SINCE HER SCAN 7 WEEKS PRIOR,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
"LOW PLASMA CONCENTRATION OF VORICONAZOLE AND CICLOSPORIN FOLLOWING DRUG INTERACTION BETWEEN RIFAMPICIN, VORICONAZOLE, CICLOSPORIN AND METHYLPREDNISOLONE",Drug level decreased,DRUG LEVEL DECREASED,DRUG LEVEL DECREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013718,10013718,10013718
DRUG CROSS-REACTIVITY,Drug cross-reactivity,DRUG CROSS-REACTIVITY,THERAPEUTIC PRODUCT CROSS-REACTIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10076743,10079645,10076743
FACIAL OEDEMA,Face oedema,OEDEMA FACE,FACE OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10016029,10016029,10030101
NODULES IN THE PENIS WERE LARGER AND MORE NUMEROUS WITH NEW NODULES IN THE SUPRAPUBIC REGION,Nodule,NODULE,NODULE,TISSUE DISORDERS NEC,MASS CONDITIONS NEC,10018065,10054107,10054107,10054107
HYPOGLYCEMIA,hypoglycemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10021005,10020993,10021005
SLIGHTLY DISTENDED ABDOMEN/ HYDROAERIC LEVELS AND GASEOUS INTESTINAL DISTENTION,slightly distended abdomen,DISTENDED ABDOMEN,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10013480,10000060,10013480
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
PARAESTHESIA,Paraesthesia,PARAESTHESIA,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10033775,10033775,10033775
CONCENTRATION IMPAIRED,Concentration impaired,CONCENTRATION IMPAIRED,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10010249,10013496,10010249
ANOREXIA,anorexia,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10002646,10061428,10002646
MUCOUS MEMBRANE DISORDER SUCH AS STOMATITIS,Mucous membrane disorder,MUCOUS MEMBRANE DISORDER,MUCOUS MEMBRANE DISORDER,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028133,10028133,10028133
RIGHT-HAND PARESTHESIA,paresthesia,PARESTHESIA,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10033987,10033775,10033987
"BLOOD GLUCOSE CONTROL WAS UNSUCCESSFULLY ACHIEVED WITH DEGLUDEC, GLIMEPIRIDE,SITAGLIPTIN AND METFORMIN  (LACK OF DRUG EFFET) WITH NO ADR",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
JAUNDICED,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
DRUG EXPOSURE IN UTERO,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
NYSTAGMUS IN ALL DIRECTIONS OF GAZE,Nystagmus,NYSTAGMUS,NYSTAGMUS,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10029864,10029864,10029864
DISEASE PROGRESSION,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
ABNORMAL SPEECH FOLLOWING ACCIDENTAL ONDANSETRON OVERDOSE,Speech disorder,SPEECH DISORDER,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041466,10041466,10041466
HYPERGLYCEMIA,Hyperglycaemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020639
VOMIT,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
MYALGIA,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
RESPONSE TO TREATMENT WAS IRREGULAR AND INCOMPLETE,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
IMPAIRED CONSCIOUSNESS (JCS III--300),Consciousness decreased,CONSCIOUSNESS DECREASED,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010768,10012373,10010768
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
FOCAL NECROSIS OF THE KERATINOCYTES,Epidermal necrosis,KERATINOCYTE NECROSIS,EPIDERMAL NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10059292,10059284,10059292
INFERO-LATERAL ACUTE MYOCARDIAL INFARCTION,Myocardial infarction,INFEROLATERAL MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10057551,10028596,10057551
ABSOLUTE NEUTROPHIL COUNT DECREASE,Neutrophil count decreased,ABSOLUTE NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10059234,10029366,10059234
HEMOGLOBIN 10.7 G/DL,Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
STOMATITIS,stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
"BEHAVIOUR PROBLEMS ON SCALES OF SOMATIC COMPLAINTS,COMMUNICATION AND DELINQUENT BEHAVIOUR",Communication disorder,COMMUNICATION DISORDER,COMMUNICATION DISORDER,COMMUNICATION DISORDERS AND DISTURBANCES,COMMUNICATIONS DISORDERS,10037175,10061046,10061046,10061046
NASAL OBSTRUCTION,nasal obstruction,NASAL OBSTRUCTION,NASAL OBSTRUCTION,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10028748,10028748,10028748
DRUG USED FOR THE TREATMENT OF FIBROMYALGIA,Fibromyalgia,FIBROMYALGIA,FIBROMYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10048439,10048439,10048439
INCREASE IN ALANINE AMINOTRANSFERASE,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
INTRACTABLE ASCITES,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
LEUKOCYTOSIS WITH LEFT SHIFT,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
ACUTE OVERDOSE,acute overdose,ACUTE OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067695,10033295,10067695
CARDIOTOXICITY,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
SKIN LESION,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
RINGING IN BOTH EARS,ringing in ears,RINGING IN EARS,TINNITUS,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10039183,10043882,10039183
STAPHYLOCOCCAL BACTEREMIA,Staphylococcal bacteraemia,STAPHYLOCOCCAL BACTEREMIA,STAPHYLOCOCCAL BACTERAEMIA,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10051017,10051017,10054637
RECURRENT GRADE IV NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ACUTE PERICARDITIS,Pericarditis,ACUTE PERICARDITIS,PERICARDITIS,PERICARDIAL DISORDERS,NONINFECTIOUS PERICARDITIS,10007541,10000996,10034484,10000996
UREMIA,Azotaemia,UREMIA,AZOTAEMIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE COMPLICATIONS,10038359,10046320,10003885,10046369
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
CONSTIPATION DUE TO SPINAL CORD COMPRESSION,Constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
"WITH TOPICAL BRIMONIDINE, IN WHICH BOTH THE PERIPAPILLARY AND THE PRELAMINAR AREA MICROCIRCULATION REMAINED UNCHANGED/ LACK OF DRUG EFFECT",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
MOBILIZATION OF A REFRACTORY GERM CELL TUMOR PATIENT,mobilization of a refractory germ cell tumor patient,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SIGNIFICANT INCREASE IN VPA CLEARANCE DUE TO INHIBITION OF VPA-GLUCURONIDE CLEAVAGE IS MOST PROBABLE MECHANISM OF THIS INTERACTION,drug clearance increased,DRUG CLEARANCE INCREASED,DRUG CLEARANCE INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10059641,10059641,10059641
BASOPHILIA,Basophilia,BASOPHILIA,BASOPHILIA,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10004173,10004173,10004173
PNEUMOCYSTIS PNEUMONIA,Pneumocystis jirovecii pneumonia,PNEUMOCYSTIS PNEUMONIA,PNEUMOCYSTIS JIROVECII PNEUMONIA,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10035661,10073755,10035661
PATIENT WAS TREATED WITH OFF-LABEL MARAVIROC AND MIRTAZAPINE,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PULMONARY EMBOLISM,Pulmonary embolism,PULMONARY EMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037377,10037377,10037377
CARDIORESPIRATORY ARREST FOLLOWING QUININE POISOINING,cardio-respiratory arrest,CARDIO-RESPIRATORY ARREST,CARDIO-RESPIRATORY ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007617,10007617,10007617
SHE REPORTED USING IT UP TO 8 TIMES DAILY ON HER NECK AND IN HER MOUTH,Incorrect route of drug administration,DRUG ADMINISTERED VIA INAPPROPRIATE ROUTE,INCORRECT ROUTE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10013660,10064304,10013660
ITCHY,itchy,ITCHY,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023089,10037087,10023089
HIGH PALATE,high palate,HIGH ARCHED PALATE,HIGH ARCHED PALATE,GASTROINTESTINAL TRACT DISORDERS CONGENITAL,PALATE DISORDERS CONGENITAL,10010331,10020046,10020046,10020046
FINASTERIDE FOR PATTERNED HAIR LOSS IN PREMENOPAUSAL WOMEN,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
"PATIENT INCORRECTLY TAKES THE PRESCRIBED THERAPY: 1 TABLET EDOXABAN, 2 TABLETS,BISOPROLOL 2.5 MG, 2 TABLETS DILZENE 60MG , IRBESARTAN 300MG, 3 TABLETS FUROSEMIDE 25MG,MANIFESTED BRADYCARDIA HR 40-42. PATIENT  CLINICALLY ASYMPTOMATIC",Medication error,MEDICATION ERROR,MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10027091,10027091,10027091
TRANSTHORACIC ECHOCARDIOGRAM REVEALED A SMALL RIM OF PERICARDIAL FLUID WITH HYPOKINESIS OF APICAL ANTEROLATERAL AND INFERIOR WALLS WITH LEFT VENTRICULAR EJECTION FRACTION OF 45-50%,Ejection fraction decreased,LEFT VENTRICULAR EJECTION FRACTION DECREASED,EJECTION FRACTION DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10053222,10050528,10053222
NO ADVERSE DRUG REACTION,No adverse drug reaction,NO ADVERSE DRUG REACTION,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067481,10067482,10067481
URATE NEPHROPATHY,Urate nephropathy,URATE NEPHROPATHY,URATE NEPHROPATHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10046337,10046337,10046337
OCCLUSION OF THE AORTIC BIFURCATION,Aortic occlusion,AORTIC OCCLUSION,AORTIC OCCLUSION,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS",AORTIC NECROSIS AND VASCULAR INSUFFICIENCY,10047065,10058178,10058178,10058178
THREE LESIONS OVER MIDLINE SCALP ARRANGED IN A LINEAR FASHION,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
G2 TASTE DISTURBANCE,Dysgeusia,TASTE DISTURBANCE,DYSGEUSIA,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10043132,10013911,10043132
URINARY MAGNESIUM EXCRETION WAS AT THE UPPER LIMIT OF THE REFERENCE RANGE,Urine magnesium increased,URINE MAGNESIUM INCREASED,URINE MAGNESIUM INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10071354,10071354,10071354
HIGH INTENSITY AT THE BILATERAL CEREBELLAR DENTATE NUCLEUS AND MIDBRAIN TEGMENTUM,Hyperintensity in brain deep nuclei,HYPERINTENSITY IN BRAIN DEEP NUCLEI,HYPERINTENSITY IN BRAIN DEEP NUCLEI,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10079392,10079392,10079392
HYPOTHERMIA,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
DISSEMINATED INTRAVASCULAR COAGULATION,Disseminated intravascular coagulation,DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10013442,10013442,10013442
ANXIETY,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
EPIDIDYMITIS,Epididymitis,EPIDIDYMITIS,EPIDIDYMITIS,INFECTIONS - PATHOGEN UNSPECIFIED,MALE REPRODUCTIVE TRACT INFECTIONS,10021881,10015000,10015000,10015000
TINNITUS/BUZZING,Tinnitus,TINNITUS,TINNITUS,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10043882,10043882,10043882
SEVER TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
BRONCHOALVEOLAR LAVAGE FLUID CULTURES WERE POSITIVE FOR ESCHERICHIA COLI AND CANDIDA ALBICANS,Candida albicans infection,CANDIDA ALBICANS INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10054230,10074170,10054230
VIRAL MUTATION IDENTIFIED,Viral mutation identified,VIRAL MUTATION IDENTIFIED,VIRAL MUTATION IDENTIFIED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10063111,10063111,10063111
"WARM SWOLLEN, PAINFUL RIGHT WRIST AND THUMB",Wrist pain,WRIST PAIN,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10048692,10003239,10048692
DUAL ANTIPLATELET THERAPY RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
USE OF COLCHICINE TO TREAT RHEUMATOID ARTHRITIS (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
COLLAPSED,fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
PARAPLEGIA,Paraplegia,PARAPLEGIA,PARAPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10033892,10033892,10033892
PLEURAL EFFUSION,pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
BK POLYOMA VIRUSâ€“ASSOCIATED NEPHROPATHY,BK virus nephropathy,BK VIRUS NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065333,10065381,10065333
ACUTE PANCREATITIS,Pancreatitis acute,ACUTE PANCREATITIS,PANCREATITIS ACUTE,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033647,10033647,10000971
EPSTEIN-BARR VIRUS-ASSOCIATED POLYMORPHIC POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER/ REACTIVATION OF EBV,Epstein-Barr virus infection reactivation,EPSTEIN-BARR VIRUS INFECTION REACTIVATION,EPSTEIN-BARR VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,EPSTEIN-BARR VIRAL INFECTIONS,10021881,10015109,10015108,10015109
POSTURE ANALYSIS REVEALED THAT THE HEAD WAS SLIGHTLY BENT FORWARD,Posture abnormal,HEAD POSTURE ABNORMAL,POSTURE ABNORMAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10064020,10036436,10064020
ORTHOSTATIC HYPOTENSION,Orthostatic hypotension,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10031127,10031127,10031127
MULTIFOCAL VENTRICULAR EXTRASYSTOLES,Ventricular extrasystoles,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047289,10047289,10047289
"DRUG-DRUG INTERACTIONS OF FENTANYL WITH DEXAMETHASONE, ENZALUTAMIDE, AMITRIPTYLINE AND PREGABALIN",Drug-drug pharmacokinetic interaction,DRUG-DRUG PHARMACOKINETIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10065994,10013710,10065994
QTC 573 MS,Electrocardiogram QT prolonged,QT PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037705,10014387,10037705
LOPERAMIDE TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
ANASARCA DUE TO GVHD WORSENED FOLLOWING LACK OF DRUG EFFECT,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
"PATIENT RECEIVED FIRST DOSE OF ACT-HIB ON 19 JAN 2016, SECOND DOSE ON 30 MAR 2016 AND THIRD DOSE ON 10 OCT 2016",Inappropriate schedule of vaccine administered,INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTERED,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10063976,10021597,10063976
DESPITE OF THE PROMPT APPLICATION OF ANTI-INFECTIVE THERAPY,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
DIFFUSE MUSCLE PAIN,muscle pain,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028322,10028411,10028322
BOUTONNIERE DEFORMITY IN HAND PHALANGES,boutonniere deformity,BOUTONNIERE DEFORMITY,FINGER DEFORMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES (INCL INTERVERTEBRAL DISC DISORDERS),EXTREMITY DEFORMITIES,10028395,10006046,10061156,10006046
APLASTIC ANEMIA,Aplastic anaemia,APLASTIC ANEMIA,APLASTIC ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10002967,10002967,10002969
SUDDEN DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
LETHAL ACETYLSALICYLIC ACID POISONING,Poisoning deliberate,POISONING DELIBERATE,POISONING DELIBERATE,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10036000,10036000,10036000
AGITATION FLUCTUATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
DRUG INEFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
LEUKOCYTOSIS,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
FAILED TREATMENT WITH IBUPROFEN,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
ACCIDENTAL OVERDOSE WHICH WAS SUGGESTIVE OF TOXICITY,drug overdose accidental,DRUG OVERDOSE ACCIDENTAL,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10013737,10000381,10013737
PRURITIC HIVES,hives,HIVES,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10020197,10046735,10020197
CEREBRAL EDEMA,Brain oedema,CEREBRAL EDEMA,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10048962,10048962,10008107
ACUTE EXACERBATION OF INTERSTITIAL LUNG DISEASE,Interstitial lung disease,INTERSTITIAL PNEUMONIA AGGRAVATED,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10066726,10022611,10066726
B CELL APLASIA,Aplasia,APLASIA,APLASIA,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10002961,10002961,10002961
GRAM STAIN OF DEBRIDED NECROTIC TISSUE FROM THE RIGHT ARM SHOWED NUMEROUS GRAM-POSITIVE RODS,Soft tissue necrosis,SOFT TISSUE NECROSIS,SOFT TISSUE NECROSIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,SOFT TISSUE DISORDERS NEC,10028395,10065769,10065769,10065769
TACHYCARDIA,tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
NO ADVERSE REACTION,No adverse event,NO ADVERSE REACTION,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067483,10067482,10067483
ACUTE HYPOGLYCEMIA,Hypoglycemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10021005,10020993,10021005
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CEFTRIAXONE-INDUCED DRUG RASH,drug rash,DRUG RASH,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10062948,10013687,10062948
PATIENT RECEIVED PREDNISONE DURING PREGNANCY WITH NO REPORTED ADVERSE DRUG REACTION,Patient received prednisone during pregnancy with no reported adverse drug reaction,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
WORSENING OF HIS DIABETES/WORSENING OF HIS GLYCAEMIC COMPENSATION/DETERIORATION IN HIS DIABETES,Diabetes mellitus aggravated,DIABETES MELLITUS AGGRAVATED,DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012603,10012601,10012603
CAPECITABINE INDUCED CARDIOTOXICITY,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
SEVERE KLEBSIELLA PNEUMONIAE INFECTION,Klebsiella pneumoniae infection,KLEBSIELLA PNEUMONIAE INFECTION,KLEBSIELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10052209,10061259,10052209
LACK OF EFFICACY- PERSISTING SIGNIFICANT HYPERCHOLESTEROLAEMIA,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
MILD EPIGASTRIC TENDERNESS TO PALPATION,Tenderness epigastric,TENDERNESS EPIGASTRIC,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10043227,10000097,10043227
AMMONIA INCREASED,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
PULMONARY TUBERCULOSIS,Pulmonary tuberculosis,PULMONARY TUBERCULOSIS,PULMONARY TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10037440,10037440,10037440
ANOREXIA,Anorexia,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10002646,10061428,10002646
IMATINIB INTOLERANCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
PALPITATION,Palpitations,PALPITATION,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033556
HYPERAMMONIEMIA DURING TREATMENT WITH VALPROIC ACID/ELEVATED BLOOD AMMONIA,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
DEPENDENCE OF TRAMADOL AND FENTANYL PRESCRIBED FOR FIBROMYALGIA,Drug dependence,DEPENDENCE ON OPIATES,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10012346,10013663,10012346
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
SERIOUS ADVERSE EVENT,Adverse event,ADVERSE EVENT,ADVERSE EVENT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10060933,10060933,10060933
DRUG EXPOSURE DURING PREGNANCY (WITH NO ADR),drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
ADMINISTRATION OF TEMOZOLOMIDE FOR SIALOBLASTOMA IN A 1 YEAR OLD PATIENT (UNAPPROVED INDICATION AND POPULATION)-OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
REBOUND HYPERTENSION,Withdrawal hypertension,REBOUND HYPERTENSION,WITHDRAWAL HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10038002,10048007,10038002
MID-EPIGASTRIC TENDERNESS,Abdominal tenderness,TENDERNESS EPIGASTRIC,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10043227,10000097,10043227
GRADE 3 VOMITING,grade 3 vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
MASSIVE HEAMATOMA OF ABDOMINAL WALL,Abdominal wall haematoma,ABDOMINAL WALL HEMATOMA,ABDOMINAL WALL HAEMATOMA,ABDOMINAL HERNIAS AND OTHER ABDOMINAL WALL CONDITIONS,ABDOMINAL WALL CONDITIONS NEC,10017947,10067383,10067383,10067838
ULCERATED MUCOSA THROUGHOUT THE COLON AND RECTUM,Mucosal ulceration,MUCOSAL ULCERATION,MUCOSAL ULCERATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028124,10028124,10028124
MULTIPLE DARK STOOLS,Faeces discoloured,DISCOLOURED STOOLS,FAECES DISCOLOURED,GASTROINTESTINAL SIGNS AND SYMPTOMS,FAECAL ABNORMALITIES NEC,10017947,10016100,10016100,10013081
GASTROINTESTINAL HAEMORRAGE,Gastrointestinal haemorrhage,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10017955
ORTHOPNOEA,Orthopnoea,ORTHOPNOEA,ORTHOPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10031123,10031123,10031123
ASPIRATION PNEUMONNIA DUE TO UNCONTROLLED SIALORRHOEA,Pneumonia aspiration,ASPIRATION PNEUMONIA,PNEUMONIA ASPIRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10035669,10035669,10003525
CONGENITAL LEFT VENTRICULAR (LV) FREE WALL SUBMITRAL ANEURYSM FOLLOWING DRUG EXPOSURE IN UTERO,Cardiac aneurysm,VENTRICULAR ANEURYSM,CARDIAC ANEURYSM,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10047280,10007513,10047280
TOTAL BILIRUBIN INCREASED -63 ÎœMOL/L,Blood bilirubin increased,BILIRUBIN TOTAL INCREASED,BLOOD BILIRUBIN INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056806,10005364,10056806
HYPERPLASIA OF HEPATIC SELLATE CELLS,Hyperplasia,HYPERPLASIA,HYPERPLASIA,TISSUE DISORDERS NEC,TROPHIC DISORDERS,10018065,10020718,10020718,10020718
ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA DUE TO DRESS SYNDROME,Supraventricular tachycardia,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003682,10042604,10003682
GRADE 2 LEUKOPENIA,Leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
EFFORT DYSPNEA,Dyspnea on effort,DYSPNEA ON EFFORT,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10055546,10013971,10055546
NECK PAIN,Neck pain,NECK PAIN,NECK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10028836,10028836,10028836
TOTAL SERUM CALCIUM ELEVATED AT 14.3 MG/DL,Serum calcium increased,SERUM CALCIUM INCREASED,BLOOD CALCIUM INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10040175,10005396,10040175
"PATIENT TREATED WITH KETOCONAZOLE FOR INCREASED 1,25-DIHYDROXY VITAMIN D  LEVEL (OFF LABEL USE FOR INDICATION) WITH NO ADR",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INTERSTITIAL NEPHRITIS,interstitial nephritis,NEPHRITIS INTERSTITIAL,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029134,10048302,10029134
TLC DECREASED (2900 CELLS/MICL),TLC decreased (2900 cells/micL),TLC DECREASED,TOTAL LUNG CAPACITY DECREASED,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY AND PULMONARY FUNCTION DIAGNOSTIC PROCEDURES,10022891,10043898,10044100,10043898
TRANSIENT IMPAIRMENT OF RENAL FUNCTION,transient impairment of renal function,RENAL FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038451,10062237,10038451
FEVER,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
MUCOCUTANEOUS LEISHMANIASIS,Mucocutaneous Leishmaniasis,MUCOCUTANEOUS LEISHMANIASIS,MUCOCUTANEOUS LEISHMANIASIS,PROTOZOAL INFECTIOUS DISORDERS,LEISHMANIA INFECTIONS,10021881,10054165,10054165,10054165
ACUTE LIVER FAILURE,Acute hepatic failure,ACUTE LIVER FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10049844
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
TOXIC EPIDERMAL NECROLYSIS,Toxic Epidermal Necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
SALMONELLOSIS CAUSED BY SECONDARY TRASMISSION OF SALMONELLA ENTERICA SSP. ARIZONAE,Salmonellosis,SALMONELLOSIS,SALMONELLOSIS,BACTERIAL INFECTIOUS DISORDERS,SALMONELLA INFECTIONS,10021881,10039447,10039447,10039447
POORLY CONTROLLED HYPERTENSION,drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
WORSENING ANEMIA,worsening anemia,ANEMIA AGGRAVATED,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10054309,10002034,10054309
PROGRESSIVE DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
HYPERSENSITIVITY REACTIONS/ GRADE 2 HYPERSENSITIVITY REACTION,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
C-REACTIVE PROTEIN INCREASED (59 G/L),C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
ANTINUCLEAR ANTIBODY POSITIVE,Antinuclear antibody positive,ANTINUCLEAR ANTIBODY POSITIVE,ANTINUCLEAR ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10060055,10060055,10060055
PROTHROMBIN TIME INCREASED (28 SECONDS),Prothrombin time prolonged,PROTHROMBIN TIME INCREASED,PROTHROMBIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10037063,10037063,10037061
EOSINOPHILIA,Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
GYNAECOMASTIA,Gynaecomastia,GYNAECOMASTIA,GYNAECOMASTIA,BREAST DISORDERS,BREAST DISORDERS NEC,10038604,10018800,10018800,10018800
POOR APPETITE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
PROCALCITONIN WAS ELEVATED TO 19.3 NG/ML,Procalcitonin increased,PROCALCITONIN INCREASED,PROCALCITONIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10067081,10067081,10067081
ASYMPTOMATIC LEUKOPENIA,asymptomatic leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
SYMMETRICAL ERYTHEMATOUS PATCHES ON BOTH SHINS,Rash,PATCHY RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10034120,10037844,10034120
FOUR MONTH OLD PATIENT RECEIVED LEVETIRACETAM,Drug use in unapproved age group,DRUG USE IN UNAPPROVED AGE GROUP,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10076467,10071062,10076467
"BASAL-CELL CANCER, SKIN",Basal cell carcinoma,BASAL CELL CARCINOMA,BASAL CELL CARCINOMA,SKIN NEOPLASMS MALIGNANT AND UNSPECIFIED,SKIN NEOPLASMS MALIGNANT AND UNSPECIFIED (EXCL MELANOMA),10029104,10004146,10004146,10004146
BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
SUBCUTANEOUS INFECTION ON THE LEFT SIDE OF THE SKULL,Skin infection,SUBCUTANEOUS INFECTION,SKIN INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10067882,10040872,10067882
STRONG PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
THE PATIENT'S HICCUPS RESOLVED AFTER ADMINISTRATION OF CHLORPROMAZINE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PNEUMOPERITONIUM FOLLOWING JEJUNAL PERFORATION,Pneumoperitoneum,PNEUMOPERITONEUM,PNEUMOPERITONEUM,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10048299,10048299,10048299
SCARRING,Scar,SCARRING,SCAR,INJURIES NEC,SKIN INJURIES NEC,10022117,10039580,10039580,10039589
"PATIENT WAS PRESCRIBED PREDNISONE, HYDROCORTISONE CREAM AND CALAMINE LOTION WITHOUT SIGNIFICANT IMPROVEMENT (LACK OF DRUG EFFECT)","patient was prescribed prednisone, hydrocortisone cream and calamine lotion without significant improvement (lack of drug effect)",LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
GENERALIZED ITCHY RASH,Generalized rash,GENERALIZED RASH,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10049201,10037858,10049201
"TACHYCARDIA, PAROXYSMAL HYPERTENSION, AND NAUSEA AND VOMITING AFTER CLOZAPINE INITIATION",Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
DIARRHEA FOLLOWING BISMUTH SUBSALICYLATE OVERDOSE,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
BURNING SENSATIONS IN THE LEGS,Burning sensation,BURNING SENSATION,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10006784,10006784,10006784
TINEA CORPORIS ON THE RIGHT BUTTOCK,tinea corporis,TINEA CORPORIS,BODY TINEA,FUNGAL INFECTIOUS DISORDERS,TINEA INFECTIONS,10021881,10043867,10005913,10043867
PLEURAL EFFUSION,pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
PARTIAL IMPROVEMENT OF THE SYMPTOMS,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
MULTIPLE DRUG HYPERSENSITIVITY SYNDROME,Drug reaction with eosinophilia and systemic symptoms,DRUG-INDUCED HYPERSENSITIVITY SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10059724,10073508,10059724
LYMPHOCYTIC INFILTRATE INCLUDING CD8+ T CELLS,Lymphocytic infiltration,LYMPHOCYTIC INFILTRATION,LYMPHOCYTIC INFILTRATION,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10062049,10062049,10062049
ANEMIA DUE TO PULMONARY HEMORRHAGE,anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
POSTURAL HYPOTENSION,Orthostatic hypotension,POSTURAL HYPOTENSION,ORTHOSTATIC HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10036433,10031127,10036433
FEVER,Fever,FEVERISH,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10073718,10037660,10073718
PROGRESSION OF THE INTRACRANIAL LEUKOENCEPHALOPATHY FOLLOWING PREDNISONE TAPER,progression of the intracranial leukoencephalopathy,LEUKOENCEPHALOPATHY,LEUKOENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10024382,10024382,10024382
SWELLING OF OCCIPITAL GLAND,Lymphadenopathy,GLANDS SWOLLEN,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10067201,10025197,10018299
DRUG INTOLERENCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
LITHIUM-INDUCED END STAGE RENAL DISEASE,end stage renal disease,END STAGE RENAL DISEASE,END STAGE RENAL DISEASE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10077512,10077512,10077512
MODERATE PROXIMAL LEFT ANTERIOR DESCENDENT CORONARY ARTERY STENOSIS,coronary artery stenosis,CORONARY ARTERY STENOSIS,CORONARY ARTERY STENOSIS,CORONARY ARTERY DISORDERS,CORONARY ARTERY DISORDERS NEC,10007541,10011089,10011089,10011089
PROGRESSIVE DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
THE EFFUSION DID NOT RESPOND TO PREDNISOLONE (LACK OF DRUG EFFECT) WITH NO ADR,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
FEBRILE NEUTROPENIA FOLLOWING TREATMENT WITH R-GDP REGIMEN,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
OFF LABEL USE (VENOUS MALFORMATION SCLEROSIS),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
PRODUCTIVE COUGH,productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
MILD PHOTOSENSITIVITY REACTIONS ON THE SUN-EXPOSED AREA DUE TO THE DOXYCYCLINE,Photosensitivity reaction,PHOTOSENSITIVITY REACTION,PHOTOSENSITIVITY REACTION,EPIDERMAL AND DERMAL CONDITIONS,PHOTOSENSITIVITY AND PHOTODERMATOSIS CONDITIONS,10040785,10034972,10034972,10034972
ACUTE PYELONEPHRITIS WITH PROVIDENCIA RETTGERI,Bacterial pyelonephritis,BACTERIAL PYELONEPHRITIS,BACTERIAL PYELONEPHRITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10059517,10059517,10059517
APLASIA CUTIS CONGENITA FOLLOWING DRUG EXPOSURE IN UTERO,Aplasia cutis congenita,APLASIA CUTIS CONGENITA,APLASIA CUTIS CONGENITA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL NEC,10010331,10002963,10002963,10002963
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
HR DROPPED TO 61 BPM,Heart rate decreased,HEART RATE DECREASED,HEART RATE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019301,10019301,10019301
CORONARY VASOSPASM LEADING TO ACUTE MYOCARDIAL INFARCTION/ISCHEMIA,Arteriospasm coronary,CORONARY VASOSPASM,ARTERIOSPASM CORONARY,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10011107,10003225,10011110
PURULENT CONTENT,Purulence,PURULENCE,PURULENCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10061926,10061926,10061926
PROSTHETIC DYSFUNCTION FOLLOWING ENDOCARDITIS DUE TO LISTERIA INFECTION RELAPSE OCCUR AS ANTIBIOTIC TREATMENT AFTER FIRST EPISODE WAS NOT SUCCESSFUL FOLLOWING SUBTHERAPEUTIC RESPONSE,Device malfunction,PROSTHETIC CARDIAC VALVE MALFUNCTION,DEVICE MALFUNCTION,DEVICE ISSUES,DEVICE MALFUNCTION EVENTS NEC,10077536,10073511,10063829,10073511
ENLARGED SPLEEN,Spleen enlarged,SPLEEN ENLARGED,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041637,10041660,10041637
CENTRAL DESQUAMATION,Skin exfoliation,SKIN DESQUAMATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040826,10040844,10040826
SWEATING,sweating,SWEATING,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042661,10020642,10042661
ACUTE PSYCHOTIC SYMPTOMS,Psychotic symptom,PSYCHOTIC SYMPTOM,PSYCHOTIC SYMPTOM,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10079254,10079254,10079254
ABNORMAL POSTURE,Posture abnormal,POSTURE ABNORMAL,POSTURE ABNORMAL,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10036436,10036436,10036436
ASPIRIN TREATMENT WAS INITIATED IN ORDER TO CONTROL THROMBOCYTOPENIA,Drug administration error,DRUG ADMINISTRATION ERROR,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064295,10064295,10064295
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
OPIUM POISONING,Toxicity to various agents,"POISONING BY OPIUM (ALKALOIDS), UNSPECIFIED",TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10035890,10070863,10035890
HYPERKALEMIA,hyperkalemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020647,10020646,10020647
MILD SEROTONIN SYNDROME,serotonin syndrome,SEROTONIN SYNDROME,SEROTONIN SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10040108,10040108,10040108
MYALGIA,myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
INCREASE IN THE LOCALIZED SCLERODERMA ACTIVITY INDEX,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
ESSENTIAL THROMBOCYTHEMIA,Essential thrombocythaemia,ESSENTIAL THROMBOCYTHEMIA,ESSENTIAL THROMBOCYTHAEMIA,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),MYELOPROLIFERATIVE DISORDERS (EXCL LEUKAEMIAS),10029104,10015493,10015493,10015494
EDEMA OF THE LOWER EXTREMITIES,Edema of lower extremities,EDEMA OF LOWER EXTREMITIES,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10054498,10030124,10054498
INTERSTITIAL LUNG DISEASE WORSENED DUE TO PULMONARY BLASTOMYCOSIS (BLASTOMYCOSIS DERMATITIDIS INFECTION),Interstitial lung disease,INTERSTITIAL LUNG DISEASE,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022611,10022611,10022611
"I HAVE HAD 2 EPISODES OF WHERE ALL I CAN DESCRIBE IS THAT A LARGE WAVE WAHES OVER ME, I FEEL NAUSEOUS, I AM VIOLENTLY, SICK, I LOOSE MY ABILITY TO SPEACH, BECOME DISORIENTATED, I CANNOT STAND UNAIDES.",Speech impairment NOS,SPEECH IMPAIRMENT NOS,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041469,10041466,10041469
TINEA CRURIS,Tinea cruris,TINEA CRURIS,TINEA CRURIS,FUNGAL INFECTIOUS DISORDERS,TINEA INFECTIONS,10021881,10043868,10043868,10043868
LISINOPRIL FOR MILD MICROALBUMINURIA,Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
TUMOUR PROGRESSION WITH NEUROAXIS DISSEMINATION,Li-Fraumeni syndrome,LI-FRAUMENI SYNDROME,LI-FRAUMENI SYNDROME,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,ABNORMAL GENE CARRIERS,10010331,10066795,10066795,10066795
INCREASED LUMBAR BMD RESULTING IN ECHINOCOCCAL CYST,Bone density increased,BONE DENSITY INCREASED,BONE DENSITY INCREASED,MUSCULOSKELETAL AND SOFT TISSUE INVESTIGATIONS (EXCL ENZYME TESTS),MUSCULOSKELETAL AND SOFT TISSUE IMAGING PROCEDURES,10022891,10057864,10057864,10057864
HIGH DOSE METHOTREXATE INDUCED ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
ANTEROCOLLIS/ANTEROCOLLIS WORSENED,Torticollis,ANTECOLLIS,TORTICOLLIS,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10065261,10044074,10065261
VULVA GRADUALLY BECAME ULCERATED,Vulval ulceration,ULCERATION OF VULVA,VULVAL ULCERATION,VULVOVAGINAL DISORDERS (EXCL INFECTIONS AND INFLAMMATIONS),VULVOVAGINAL DISORDERS NEC,10038604,10045355,10047768,10045355
LUCID DREAMS,Abnormal dreams,LUCID DREAMS,ABNORMAL DREAMS,SLEEP DISORDERS AND DISTURBANCES,PARASOMNIAS,10037175,10079069,10000125,10079069
BLEED UNCONTROLLABLY,Haemorrhage,HAEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10055798
IRRITABILITY,irritability,IRRITABILITY,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10022998,10022998,10022998
GRADE 3 NEUTROPENIA (COUNT NOS),Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
APICAL THROMBUS INCREASED IN SIZE DESPITE THE ANTICOAGULANT THERAPY,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
INADEQUATE ADAPTATION OF GLUCOCORTICOID DOSAGE TO THE ACUTE STRESS SITUATION,Inappropriate dose of drug administered,INAPPROPRIATE DOSE OF DRUG ADMINISTERED,INCORRECT DOSE ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10021590,10064355,10021590
"BENZOIDIAZEPINE WITHDRAWAL SYMPTOMS/AGGRAVATED WITHDRAWAL SYMPTOMS/ SHOWED A TREMOR, SHIVERING AND MOTOR RESTLESSNESS MOST LIKELY AS PART OF WITHDRAWAL SYMPTOMS FROM DIAZEPAM",Drug withdrawal syndrome,DRUG WITHDRAWAL SYNDROME,DRUG WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10013754,10013754,10013754
ACUTE EDEMATOUS PANCREATITIS,Oedematous pancreatitis,EDEMATOUS PANCREATITIS,OEDEMATOUS PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10052400,10052400,10054706
URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
KIDNEY DYSFUNCTION,kidney dysfunction,KIDNEY DYSFUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10023417,10062237,10023417
ACYCLOVIR AND CIDOFOVIR RESISTANT HSV-2  INFECTION (DRUG RESISTANCE),drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
PATIENT DID NOT SHOW ANY IMPROVEMENT IN HEARING LOSS IN BOTH EARS AFTER 11 MONTHS THIAMINE TREATMENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ACUTE DIVERTICULITIS,Diverticulitis,ACUTE DIVERTICULITIS,DIVERTICULITIS,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10052812,10013538,10052812
PERSISTANT DROWSINESS DUE TO DRUG INTERACTION,drowsiness,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
SEVERE WORSENING OF DYSPNOEA,Dyspnoea,DYSPNOEA EXACERBATED,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013970,10013968,10013970
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TERTIARY ADRENAL INSUFFICIENCY,Adrenal insufficiency,ADRENAL INSUFFICIENCY,ADRENAL INSUFFICIENCY,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001367,10001367,10001367
RESPIRATORY FAILURE DUE TO GOODPASTURE'S DISESE WORSENING,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
DECOUPLING (2.08),"nonspecific abnormal results of function study, cardiovascular","NONSPECIFIC ABNORMAL RESULTS OF FUNCTION STUDY, CARDIOVASCULAR",CARDIOVASCULAR FUNCTION TEST ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10029705,10007651,10029705
NO ADVERSE DRUG REACTION,No adverse drug reaction,NO ADVERSE DRUG REACTION,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067481,10067482,10067481
ANXIETY,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
NEONATAL SEIZURES,Convulsion neonatal,NEONATAL SEIZURES,CONVULSION NEONATAL,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10061197,10010911,10061197
DECEREBRATE POSTURING,Decerebrate posture,DECEREBRATE POSTURE,DECEREBRATE POSTURE,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10073346,10073346,10073346
RENAL IMPAIRMENT,Renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
PULMONARY CRYPTOCOCCUS NEOFORMANS INFECTION COMPLICATED BY EMPYEMA,Empyema,EMPYEMA,EMPYEMA,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10014568,10014568,10014568
LACK OF EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
INVASIVE PULMONARY ASPERGILLUS FUMIGATUS INFECTION,Bronchopulmonary aspergillosis,ASPERGILLUS FUMIGATUS BRONCHOPULMONARY INFECTION,BRONCHOPULMONARY ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003493,10006473,10003493
SKIN FRAGILITY,Skin fragility,SKIN FRAGILITY,SKIN FRAGILITY,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040851,10040851,10040851
"BLOOD PRESSURE - 155/70 MMHG, PATHOLOGICAL ECG FINDINGS, LEFT VENTRICULAR HYPERTROPHY, DIASTOLIC DYSFUNCTION",Diastolic dysfunction,DIASTOLIC DYSFUNCTION,DIASTOLIC DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10052337,10052337,10052337
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
STIFFNESS,Musculoskeletal stiffness,STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10042045,10052904,10042045
IMATINIB RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
PATIENT TREATED WITH CISPLATIN FOR STAGE IV (T4N2M0) PLEURAL MESOTHELIOMA (OFF LABEL USE) WITH NO ADVERSE EVENTS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
REPEATED HYPOGLYCEMIC ATTACK,Hypoglycaemia,HYPOGLYCAEMIC ATTACK,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020999,10020993,10020999
MILD VISUAL DISTURBANCE,mild visual disturbance,VISUAL DISTURBANCE,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047543,10047571,10047543
DISSEMINATED STRONGYLOIDES STERCORALIS INFECTION,Strongyloidiasis,STRONGYLOIDES STERCORALIS INFECTION,STRONGYLOIDIASIS,HELMINTHIC DISORDERS,NEMATODE INFECTIONS,10021881,10042253,10042254,10042253
INCOMPLETE EFFECT (BISOPROLOL) (BP+150/90),Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
CONSTRICTED PUPILS,Miosis,MIOSIS,MIOSIS,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10027646,10027646,10027646
HOT AND TENSE BILATERAL INFLAMMATORY EDEMA OF THE TWO THIGHS AND THE LEFT ARM,Oedema,INFLAMMATORY EDEMA REACTION,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10021993,10030095,10021991
DARK URINE,Chromaturia,URINE DISCOLORATION,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10046629,10008796,10046628
PRODROMAL STAGE OF NEUROLEPTIC MALIGNANT SYNDROME(NMS) APPEARED,Disease prodromal stage,DISEASE PRODROMAL STAGE,DISEASE PRODROMAL STAGE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10069581,10069581,10069581
PERIPHERAL NEUROPATHY,Neuropathy peripheral,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10080342
SHE COULD NOT TOLERATE THE COMBINATION OF 2 OR 3 CHEMOTHERAPY DRUGS,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
METHEMOGLOBINEMIA DUE TO POISONING ASSOCIATED WITH INAPPROPRIATE USE OF A EUTECTIC MIXTURE OF LIDOCAINE AND PRILOCAINE,Methemoglobinemia,METHEMOGLOBINEMIA,METHAEMOGLOBINAEMIA,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10027506,10027496,10027506
ACUTE ACALCULOUS CHOLECYSTITIS,Cholecystitis acute,ACUTE ACALCULOUS CHOLECYSTITIS,CHOLECYSTITIS ACUTE,GALLBLADDER DISORDERS,CHOLECYSTITIS AND CHOLELITHIASIS,10019805,10000648,10008614,10000648
JARISCH HERXHEIMER REACTION,Jarisch Herxheimer reaction,JARISCH-HERXHEIMER REACTION,JARISCH-HERXHEIMER REACTION,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10023125,10023125,10023125
DISTURBED BREATHING,Dyspnoea,BREATHING DIFFICULT,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10006338
HYPOXEMIA,hypoxemia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021142,10021143,10021142
LOCAL ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
DEPRESSION/DEPRESSED,depression,DEPRESSION,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012378,10012378,10012378
RIGHT CENTRAL FACIAL PARESIS,Facial paresis,FACIAL PARESIS,FACIAL PARESIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),FACIAL CRANIAL NERVE DISORDERS,10029205,10051267,10051267,10051267
ELEVATED TRANSAMINASES/INCREASE IN HEPATIC TRANSAMINASES,Transaminases increased,TRANSAMINASES INCREASED,TRANSAMINASES INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10054889,10054889,10054889
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
SEPTIC SHOCK,septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
ATRIAL FIBRILLATION,atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
DRUG EXPOSURE DURING PREGNANCY WITH NO ADR,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
WORSENING NUMBNESS AND PAIN THAT LIMITED HOUSEHOLD TASKS,Numbness,NUMBNESS,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10029829,10020937,10029829
"DURING THE TIME HE WAS TAKING SERTRALINE, THE FIRST PSORIATIC PLAQUES APPEARED/PLAQUE-TYPE PSORIASIS",Psoriasis,PLAQUE PSORIASIS,PSORIASIS,EPIDERMAL AND DERMAL CONDITIONS,PSORIATIC CONDITIONS,10040785,10071117,10037153,10071117
ELEVATION IN ASPARTATE AMINOTRANSFERASE (185 U/L),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
CEREBRAL AMYLOID ANGIOPATHY,cerebral amyloid angiopathy,CEREBRAL AMYLOID ANGIOPATHY,CEREBRAL AMYLOID ANGIOPATHY,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS NEC,10029205,10068044,10068044,10068044
MENINGOENCEPHALITIS DUE TO SCEDOSPORIUM APIOSPERMUM INFECTION,meningoencephalitis,MENINGOENCEPHALITIS,ENCEPHALITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10027282,10014581,10027282
PRIMARY BONE MARROW(PBM) LIMITED DIFFUSE LARGE Bâ€‘CELL LYMPHOMA FOLLOWING PROLONGED IMMUNOSUPPRESSIVE THERAPY,Diffuse large B-cell lymphoma,DIFFUSE LARGE B-CELL LYMPHOMA,DIFFUSE LARGE B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,DIFFUSE LARGE B-CELL LYMPHOMAS,10029104,10012818,10012818,10012818
PAINFUL LESION,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
FEVER OF 38 DEGREE C,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PERSISTENT JOINT INFLAMMATION,Arthritis,JOINT INFLAMMATION,ARTHRITIS,JOINT DISORDERS,ARTHROPATHIES NEC,10028395,10023217,10003246,10023217
LIGHT REFLEX WAS SLUGGISH,light reflex sluggish,LIGHT REFLEX SLUGGISH,PUPILLARY REFLEX IMPAIRED,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10024463,10037532,10024463
DRUG EXPOSURE DURING PREGNANCYWITH NO ADVERSE DRUG REACTION,Drug exposure during pregnancywith no adverse drug reaction,"DRUG EXPOSURE DURING PREGNANCY, SECOND TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076616,10073513,10076616
HYPOKALEMIC,Hypokalaemia,HYPOKALEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021018
DISCOMFORT IN AND AROUND THE ABDOMINAL SCARING,Discomfort,DISCOMFORT,DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10013082,10013082,10013082
INTENSE PAIN IN LEGS AND HANDS,Pain in extremity,PAIN LEGS,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033459,10033425,10033459
"SUBCUTANEOUS METHOTREXATE FAILED TO BRING HER SYMPTOMS UNDER CONTROL; HYDROXYCHLOROQUINE DID NOT CONTROL HER SYMPTOMS; RITUXIMAB, MYCOPHENOLATE MOFETIL AND IV CYCLOPHOSPHAMIDE WAS ALSO UNSUCCESSFUL IN CONTROLLING THE DISEASE (LACK OF DRUG EFFECT)",drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
ERYTHEMA AND CONJUNCTIVAL SECRETION,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
MILD SEPTAL HYPERTROPHY,Cardiac hypertrophy,CARDIAC HYPERTROPHY,CARDIAC HYPERTROPHY,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10007572,10007572,10007572
DELIRIUM,delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
BULBAR SYMPTOMS,Bulbar poliomyelitis,BULBAR POLIOMYELITIS,BULBAR POLIOMYELITIS,VIRAL INFECTIOUS DISORDERS,POLIOMYELITIS VIRAL INFECTIONS,10021881,10006545,10006545,10006545
NOT COMMUNICATING,not communicating,COMMUNICATION DISORDER,COMMUNICATION DISORDER,COMMUNICATION DISORDERS AND DISTURBANCES,COMMUNICATIONS DISORDERS,10037175,10061046,10061046,10061046
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
"HIGH CONCENTRATIONS OF CLOZAPINE AND ORPHENADRINE DETECTED IN BLOOD, URINE AND GASTRIC CONTENT",Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
LESIONS ASSOCIATED WITH PRES,Abrasions,ABRASIONS,SKIN ABRASION,INJURIES NEC,SKIN INJURIES NEC,10022117,10000266,10064990,10000266
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
SLEEP DISORDERS,sleep disorders,DISORDER SLEEP,SLEEP DISORDER,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10013268,10040984,10013268
CEREBRAL OEDEMA DUE TO ADRENAL CRISIS,Cerebral oedema,CEREBRAL OEDEMA,BRAIN OEDEMA,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10008127,10048962,10008127
MUSCLE STIFFNESS,Musculoskeletal stiffness,MUSCLE STIFFNESS,MUSCULOSKELETAL STIFFNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10028339,10052904,10028339
DIRECT BILIRUBIN INCREASED (30 MICROMOL/LITRE),Bilirubin conjugated increased,DIRECT BILIRUBIN INCREASED,BILIRUBIN CONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10013038,10004685,10013038
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
DRUG-DRUG INTERACTION,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
HAEMORRHAGIC ANAEMIA,Haemorrhagic anaemia,HAEMORRHAGIC ANAEMIA,HAEMORRHAGIC ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10052293,10052293,10052293
PRESYNCOPAL EPISODE WITH BRADYCARDIA AFTER ACCIDENTAL OVERDOSE WITH METOPROLOL AND DRUG INTERACTION BETWEEN METOPROLOL TARTRATE AND DILTIAZEMHYDROCHLORIDE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
INTESTINAL OBSTRUCTION,Intestinal obstruction,INTESTINAL OBSTRUCTION,INTESTINAL OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION,GASTROINTESTINAL STENOSIS AND OBSTRUCTION NEC,10017947,10022687,10022687,10022687
QTC OF 529 MS,Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
MUCOCUTANEOUS HYPERPIGMENTATION,Mucosal pigmentation,MUCOSAL PIGMENTATION,MUCOSAL PIGMENTATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10067724,10067724,10067724
GRADE 3 IMMEDIATE HYPERSENSITIVITY REACTION,Type I hypersensitivity,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
INCREASED SKIN SENSITIVITY,increased skin sensitivity,INCREASED SKIN SENSITIVITY,HYPERAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10021681,10020568,10021681
LDL CHOLESTEROL INCREASED (992 MG/DL),LDL cholesterol increased,LDL CHOLESTEROL INCREASED,LOW DENSITY LIPOPROTEIN INCREASED,LIPID ANALYSES,CHOLESTEROL ANALYSES,10022891,10024055,10024910,10024055
MACULAR ERYTHEMA OF THE FACE/TARGET LESION LIKE MACULE,Macule,MACULE,MACULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10025421,10025421,10025421
REDNESS OF CONJUCTIVA IN BOTH EYES,Conjunctival hyperaemia,CONJUNCTIVAL REDNESS,CONJUNCTIVAL HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CONJUNCTIVAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10010731,10051625,10010731
RECURRENT DENTAL INFECTIONS,Tooth infection,TOOTH INFECTION,TOOTH INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,DENTAL AND ORAL SOFT TISSUE INFECTIONS,10021881,10048762,10048762,10048762
URTICARIA,urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
DEATH,Death,UNKNOWN CAUSE OF DEATH,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10063378,10011906,10063378
PROGRESSION OF INTERSTITIAL LUNG DISEASE RAPID AND RESISTANT TO TREATMENT IN A CONTEXT OF AMYOPATHIC DERMATOMYOSITIS,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
ERYTHROVIRUS MYOCARDITIS (2ND RECURRENCE),Viral myocarditis,VIRAL MYOCARDITIS,VIRAL MYOCARDITIS,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10047470,10047470,10047470
APNEA,apnea,APNEA,APNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10002972,10002974,10002972
PROGRESSED RENAL DYSFUNCTION DOLLOWING HYPERAMMONEMIA,Kidney dysfunction,KIDNEY DYSFUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10023417,10062237,10023417
ABDOMINAL BLOATING SENSATION,Bloating,BLOATING,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10005265,10000060,10005265
SLEEP DISTURBANCE,Sleep disorder,SLEEP DISTURBANCE,SLEEP DISORDER,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10040984,10040984,10040995
DRUG INDUCED DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
RAPID WORSENING OF HEPATIC FUNCTION,Hepatic function abnormal,HEPATIC FUNCTION ABNORMAL,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10019670,10019670,10019670
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
DRUG EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
POLYDIPSIA,polydipsia,POLYDIPSIA,POLYDIPSIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,FLUID INTAKE INCREASED,10027433,10036067,10036067,10036067
PARALYSIS OF BOTH LIMBS,Paralysis,PARALYSIS,PARALYSIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10033799,10033799,10033799
HYPOXIA,Hypoxia,HYPOXIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021143,10021143,10021143
STREPTOCOCCUS MILLERI INFECTION WORSENING DESPITE TREATMENT,Streptococcal infection,STREPTOCOCCAL INFECTION,STREPTOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STREPTOCOCCAL INFECTIONS,10021881,10061372,10061372,10061372
HE HAD INCREASED THE DOSE TO 6 TABLETS PER DAY BECAUSE OF HIS FLU SYMPTOMS,Intentional product misuse,INTENTIONAL MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10058995,10074903,10058995
SUBCORTICAL ABSCESSES,Brain abscess,INTRACRANIAL ABSCESS,BRAIN ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10022755,10006105,10022755
ANTINUCLEAR ANTIBODIES PRESENT,Antinuclear antibody positive,ANTINUCLEAR ANTIBODIES PRESENT,ANTINUCLEAR ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10060055,10060055,10002806
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
DRUG EXPOSURE DURING PREGNANCY WITH NO ADR,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
MEDICATION-RELATED OSTEONECROSIS OF THE JAW STAGE 3 [MANDIBLE (QUADRANT III)],Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
PANIC ATTACKS,Panic attack,PANIC ATTACK,PANIC ATTACK,ANXIETY DISORDERS AND SYMPTOMS,PANIC ATTACKS AND DISORDERS,10037175,10033664,10033664,10033664
MUCOCUTANEOUS ORAL ULCERS,Mucocutaneous ulceration,MUCOCUTANEOUS ULCERATION,MUCOCUTANEOUS ULCERATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10028084,10028084,10028084
DRUG INEFFECTIVE,drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
CONTINUOUS BURNING PAIN IN EPIGASTRIUM,Abdominal pain upper,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
EDEMA,edema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014210,10030095,10014210
"TREATED WITH UNSPECIFIED DOSES OF VALPROATE, METHYLPHENIDATE, RISPERIDONE AND BUPROPION, WITH POOR RESPONSE TO MEDICATION AND NON-ADHERENCE TO THERAPEUTIC TREATMENT",Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
URINARY INCONTINENCE,urinary incontinence,URINARY INCONTINENCE,URINARY INCONTINENCE,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046543,10046543,10046543
FETAL GROWTH RETARDATION,Foetal growth restriction,FOETAL GROWTH RETARDATION,FOETAL GROWTH RESTRICTION,FOETAL COMPLICATIONS,FOETAL GROWTH COMPLICATIONS,10036585,10016857,10070531,10016857
ANEMIA,anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
FLARE UP OF NEUROMYELITIS OPTICA ASSOCIATED SPECTRUM DISORDER IN THE LEFT EYE FOLLOWING NON COMPLIANCE,Neuromyelitis optica spectrum disorder,NEUROMYELITIS OPTICA SPECTRUM DISORDER PROGRESSION,NEUROMYELITIS OPTICA SPECTRUM DISORDER,DEMYELINATING DISORDERS,DEMYELINATING DISORDERS NEC,10029205,10077881,10077875,10077881
"CORTICARIAL LESIONS AND, SPORADICALLY, FACIAL ANGIOEDEMA (OF EYES, LIPS), BEING PARADOXICALLY",Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
CHEMOTHERAPY INDUCED CARDIOVASCULAR TOXICITY,cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
ACIDEMIC,Acidosis,ACIDEMIA,ACIDOSIS,ACID-BASE DISORDERS,MIXED ACID-BASE DISORDERS,10027433,10060699,10000486,10060694
INTRAVENOUS FEEDING LINE INFECTION,Device related infection,DEVICE RELATED INFECTION,DEVICE RELATED INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10064687,10064687,10064687
"300 MG, THE PATIENT STARTED TO EXPERIENCE NOCTURNAL ENURESIS",Enuresis,NOCTURNAL ENURESIS,ENURESIS,PSYCHIATRIC DISORDERS NEC,PSYCHIATRIC ELIMINATION DISORDERS,10037175,10029453,10014928,10029453
DROWSINESS,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
PLEURAL EFFUSION,pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
VALPROIC ACID-INDUCED ACUTE LIVER FAILURE,Acute hepatic failure,ACUTE LIVER FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10049844
CMV REACTIVATION,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION REACTIVATION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10058666,10011831,10058666
SLEEP DISORDER WITH AWAKENING EARLY,sleep disorder,SLEEP DISORDER,SLEEP DISORDER,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10040984,10040984,10040984
RENAL IMPAIRMENT,renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
BILATERAL TEARING,Lacrimation increased,TEARING EYES,LACRIMATION INCREASED,EYE DISORDERS NEC,LACRIMATION DISORDERS,10015919,10016015,10023644,10043171
MYOCARDIAL SYSTOLIC DYSFUNCTION (EJECTION FRACTION 33 %),ejection fraction decreased,EJECTION FRACTION DECREASED,EJECTION FRACTION DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10050528,10050528,10050528
SEVERE IMPAIRMENT OF LEFT VENTRICULAR EJECTION FRACTION,Ejection fraction abnormal,EJECTION FRACTION ABNORMAL,EJECTION FRACTION ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10014331,10014331,10014331
KETOCONAZOLE ADMINISTERED FOR TREATMENT OF HYPERCORTISOLISM IN ECTOPIC CUSHING SYNDROME (UNAPPROVED INDICATION)-OFF LABEL USE WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CUTANEOUS ULCERATION ON LEGS,Skin ulcer,LEG ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10068310,10040943,10068310
DRY MUCOUS MEMBRANES OF THE MOUTH,Dry mouth,DRY MOUTH,DRY MOUTH,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10013781,10013781,10013781
CHEMOTHERAPY-INDUCED ASEPTIC NECROSIS OF AURICLE,Osteonecrosis,ASEPTIC NECROSIS,OSTEONECROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10003461,10031264,10003459
SUICIDE ATTEMPT,Suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
HIP PAIN,Arthralgia,PAIN IN HIP,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10011249,10003239,10033432
TENDERNESS OF THE STERNUM ON PERCUSSION,Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
"POLYPHARMACY, CLINICAL DRUG-DRUG INTERACTIONS MAY CONTRIBUTE TO THE DEVELOPMENT OF TDP",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
MINOCYCLINE WAS DISCONTINUED BECAUSE OF HEADACHES,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
DIFFICULTY WRITING WITH THE LEFT HAND,Dysgraphia,WRITING IMPAIRED,DYSGRAPHIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10058319,10058319,10048053
HYPOGLYCEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
COMA,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
ACUTE PROMYELOCYTIC LEUKEMIA (APL),Second primary malignancy,SECOND PRIMARY MALIGNANCY,SECOND PRIMARY MALIGNANCY,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10039801,10039801,10039801
INTENTIONAL DRUG OVERDOSE,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
"ATRIAL FIBRILLATION MIGHT LEAD TO HIS SHOCK STATUS/SHOWED RAPID ATRIAL FIBRILLATION (HEART RATE, 150 BEATS/MIN)",Atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
RECURRENCE MUCO-CUTANEOUS LEISHMANIASIS,mucocutaneous leishmaniasis,MUCOCUTANEOUS LEISHMANIASIS,MUCOCUTANEOUS LEISHMANIASIS,PROTOZOAL INFECTIOUS DISORDERS,LEISHMANIA INFECTIONS,10021881,10054165,10054165,10054165
SEVERE SUICIDE ATTEMPT,suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
PATIENT WAS TREATED WITH PREDNISOLONE AND PYRIDOSTIGMINE  BUT HAD LACK OF IMPROVEMENT (LACK OF DRUG EFFECT) WITH NO ADVERSE EVENT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
CENTRILOBULAR MICRONODULARITY,lung nodule,LUNG NODULE,PULMONARY MASS,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10049498,10056342,10049498
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
BLISTERS,Blisters,BLISTERS,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005216,10005191,10005216
BLACK ESCHAR,Eschar,ESCHAR,ESCHAR,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10051814,10051814,10051814
THERAPY-RELATED ACUTE MYELOID LEUKAEMIA,Acute myeloid leukaemia,ACUTE MYELOID LEUKAEMIA,ACUTE MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10000880,10000880,10000880
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
SGOT INCREASED (108 IU/L),Aspartate aminotransferase increased,SGOT INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10040524,10003481,10040524
GRADE 2 THROMBOPENIA,thrombopenia,THROMBOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043569,10043554,10043569
IMPAIRED RENAL FUNCTION,Renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
BACK MYALGIA ON EZETIMIBE TREATMENT,Myalgia,LOCALISED MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10063543,10028411,10063543
WEAKNESS,Weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
OLMESARTAN-INDUCED ENTEROCOLOPATHY,Sprue-like enteropathy,SPRUE-LIKE ENTEROPATHY,SPRUE-LIKE ENTEROPATHY,MALABSORPTION CONDITIONS,MALABSORPTION SYNDROMES,10017947,10079622,10079622,10079622
MEDICATION-RELATED OSTEONECROSIS OF THE JAW STAGE 2 ([MANDIBLE (QUADRANT IV)],Osteonecrosis of Jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
BONE MARROW DEPRESSION WITH HYPERCELLULAR BONE MARROW FOLLOWING ACUTE METHOTREXATE OVERDOSE DUE TO METHOTREXATE INTOXICATION BECAUSE OF DRUG PRESCRIBING ERROR.,Bone marrow depression,BONE MARROW DEPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10005986
ANXIETY,anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
NEUTROPENIA FOLLOWING TREATMENT WITH CYCLOPHOSPHAMIDE,neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
SYMPTOMS WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
"DUE TO PERSISTENT HEADACHES AND ONLY MILD CHEST PAIN, HER ISOSORBIDE MONONITRATE WAS DISCONTINUED AT 34 WEEKS.",Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
"PATIENT RECEIVED ASPIRIN, WARFARIN AND CLOPIDOGREL",Labelled drug-drug interaction medication error,LABELED DRUG-DRUG INTERACTION MEDICATION ERROR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT MONITORING ERRORS AND ISSUES,10022117,10064373,10064373,10064378
REBOUND EFFECT,rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
LOWER RESPIRATORY TRACT INFECTION,lower respiratory tract infection,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10024968,10024968,10024968
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
DRUG-INDUCED ACUTE INTERSTITIAL NEPHRITIS,Tubulointerstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029135,10048302,10000819
DRUG ASSOCIATED ACUTE INTERSTITIAL NEPHRITIS,Acute interstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10000819,10048302,10000819
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
HEPATOMEGALY,hepatomegaly,HEPATOMEGALY,HEPATOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019842,10019842,10019842
SEVERE PSEUDOMEMBRANOUS COLITIS,Pseudomembranous colitis,PSEUDOMEMBRANOUS COLITIS,PSEUDOMEMBRANOUS COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10037128,10037128,10037128
ESTIMATED GLOMERULAR FILTRATION RATE DECREASED (40.8 ML/MIN/1.73M2),Glomerular filtration rate decreased,GLOMERULAR FILTRATION RATE DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018358,10018358,10018358
SWEATING PROFUSELY,sweating increased,SWEATING INCREASED,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042667,10020642,10042667
INFECTION,infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
HYPOXIC RESPIRATORY FAILURE DUE TO LEMIERRE SYNDROME,Respiratory failure,HYPOXIC RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10074615,10038695,10074615
RASH/EXANTHEMA,rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
GRADE 4 DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
VISUAL DISTURBANCES,Visual impairment,VISUAL DISTURBANCES,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047543,10047571,10047545
HAEMORRHAGE IN THIGH,Haemorrhage,HAEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10055798
ACIDOSIS FOLLOWING SHOCK DUE TO SEPSIS FOLLOWING MULTIPLE INFECTIONS,Acidosis,ACIDOSIS,ACIDOSIS,ACID-BASE DISORDERS,MIXED ACID-BASE DISORDERS,10027433,10000486,10000486,10000486
GRADE 2 DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
POLYDIPSIA,polydipsia,POLYDIPSIA,POLYDIPSIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,FLUID INTAKE INCREASED,10027433,10036067,10036067,10036067
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
SLOW PULSE,slow pulse,SLOW PULSE,HEART RATE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10041044,10019301,10041044
SLIGHT DEGENERATION OF THE MACULA,Macular degeneration,MACULAR DEGENERATION,MACULAR DEGENERATION,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10025409,10025409,10025409
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SHE WAS INTOLERANT OF THIS MEDICATION,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
ETHAMBUTOL-INDUCED HYPERSENSITIVITY LUNG REACTION,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
STAPHYLOCOCCUS HAEMOLYTICUS INFECTION,Staphylococcal infection,STAPHYLOCOCCAL INFECTION,STAPHYLOCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10058080,10058080,10058080
WITHOUT SUFFICIENT EFFECT ON PSORIASIS WITH NO ADR,subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
TACHYCARDIC,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
EPIDERMAL NECROSIS,epidermal necrosis,EPIDERMAL NECROSIS,EPIDERMAL NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10059284,10059284,10059284
LIVER METASTASES,Metastases to liver,LIVER METASTASES,METASTASES TO LIVER,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027457,10027457,10024700
COGNITIVE IMPAIRMENT,cognitive impairment,COGNITIVE IMPAIRMENT,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10009846,10057668,10009846
TENDER LIVER,Liver tenderness,LIVER TENDERNESS,LIVER TENDERNESS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10024712,10024712,10024712
RECURRENT GRADE I/III IMMEDIATE-TYPE REACTION TO PROTON PUMP INHIBITORS/ALLERGIC REACTION OF IMMEDIATY TYPE,Immediate hypersensitivity reaction,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
FEVER (UNITS NOS),fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
TOXIC EPIDERMAL NECROLYSIS FOLLOWING STEVENS JOHNSON SYNDROME,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
STOMATITIS FOLLOWING ACUTE AND ACCIDENTAL METHOTREXATE OVERDOSE DUE TO METHOTREXATE INTOXICATION BECAUSE OF DRUG PRESCRIBING ERROR,stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
LYMPHOPENIA,lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
OFF LABEL USE OF PROPRANOLOL FOR HAEMANGIOMA,Off Label Use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"PARACETAMOL WHEN ASSOCIATED WITH OTHER VASOCONSTRICTORS (SUCH AS POLYPHENOLS), INTERFERES WITH PROSTAGLANDIN METABOLISM",Food interaction,FOOD INTERACTION,FOOD INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10016948,10016948,10016948
DIZZY,dizzy,DIZZY,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013580,10013573,10013580
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
STEROID-INDUCED DIABETES MELLITUS,Diabetes mellitus,DIABETES MELLITUS,DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012601,10012601,10012601
OGNITIVE PERFORMANCE OF THE PATIENT WAS MOST NOTABLY IMPAIRED WHEN MEDICATION FREE,Drug withdrawal syndrome,DRUG WITHDRAWAL SYNDROME,DRUG WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10013754,10013754,10013754
PATIENT TREATED WITH RIBAVIRIN FOR HEPATITIS E VIRUS INFECTION (OFF LABEL USE FOR INDICATION) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PAROXYMAL ATRIAL FIBRILATION,Atrial fibrillation,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10003658,10003658,10003658
FUNCTIONAL DECLINE/ AN INABILITY TO MANAGE ACTIVITIES OF DAILY LIVING AT HOME.,Loss of personal independence in daily activities,ACTIVITIES OF DAILY LIVING IMPAIRED,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10050954,10079487,10050954
OFF LABEL USE OF BORTEZOMIB FOR ANTIBODY-MEDIATED REJECTION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LOW HEMOGLOBIN (10.2 G/DL),Haemoglobin decreased,HEMOGLOBIN LOW,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018889,10018884,10055600
ECZEMA-LIKE RASH,Eczema,ECZEMATOUS RASH,ECZEMA,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10014209,10014184,10014209
IMATINIB RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
PAIN IN RIGHT HYPOCHONDRIUM WITH A FIRM ROUND MASS,pain in right hypochondrium,HYPOCHONDRIUM PAIN RIGHT,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10020966,10000087,10020966
DETERIORATION OF RENAL FUNCTION FOLLOWING RHABDOMYLOSIS DUE TO OFF LABEL USE OF COLCHICINE AND DRUG INTERACTION BETWEEN COLCHICINE AND AMLODIPINE,Impaired renal function,IMPAIRED RENAL FUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10021523,10062237,10021523
GRAFT LOSS FOLLOWING CHRONIC ALLOGRAFT DYSFUNCTION DUE TO BK VIRUS NEPHROPATHY,Renal transplant failure,RENAL GRAFT LOSS,RENAL TRANSPLANT FAILURE,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10048749,10074495,10048749
FOOT SWELLING FOLLOWING OFF LABEL USE OF DRUG,swelling of feet,SWELLING OF FEET,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042693,10048959,10042693
SUBSTANTIAL BLEEDING,bleeding,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10005103,10055798,10005103
INTERACTION BETWEEN VALPROIC ACID AND QUETIAPINE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
CENTRAL HYPOTHYROIDISM,Hypothyroidism,HYPOTHYROIDISM,HYPOTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPOFUNCTION DISORDERS,10014698,10021114,10021114,10021114
CEREBRAL TOXOPLASMOSIS,Cerebral Toxoplasmosis,CEREBRAL TOXOPLASMOSIS,CEREBRAL TOXOPLASMOSIS,PROTOZOAL INFECTIOUS DISORDERS,TOXOPLASMA INFECTIONS,10021881,10057854,10057854,10057854
NEVIRAPINE INDUCED STEVENS-JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS-JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042033
PNEUMONIA ASPIRATION,Pneumonia aspiration,PNEUMONIA ASPIRATION,PNEUMONIA ASPIRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10035669,10035669,10035669
DRUGS USED FOR CROHN'S DISEASE AND HELICOBACTER PYLORI MODERATE ACTIVE CHRONIC GASTRITIS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA (SDRIFE),Symmetrical drug-related intertriginous and flexural exanthema,SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA,SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10078325,10078325,10078325
ANAPHYLACTIC SHOCK,Anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
NON-PTLD MALIGNANCY/RENAL CELL CA,renal cell carcinoma,RENAL CELL CARCINOMA,RENAL CELL CARCINOMA,RENAL AND URINARY TRACT NEOPLASMS MALIGNANT AND UNSPECIFIED,RENAL NEOPLASMS MALIGNANT,10029104,10067946,10067946,10067946
BLOOD UREA NITROGEN INCREASED (33 MG/DL),Blood urea increased,BLOOD UREA NITROGEN INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005855,10005851,10005855
GRADE 1 THROMBOCYTOPENIA,grade 1 thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
TERBINAFINE-INDUCED GENERALIZED PUSTULAR PSORIASIS,Pustular psoriasis,PUSTULAR PSORIASIS,PUSTULAR PSORIASIS,EPIDERMAL AND DERMAL CONDITIONS,PSORIATIC CONDITIONS,10040785,10037575,10037575,10037575
INFECT ASSOCIATED WORSENING OF LDOPA SENSITIVE PARKINSONâ€™S DISEASE,Parkinson's disease aggravated,PARKINSON'S DISEASE AGGRAVATED,PARKINSON'S DISEASE,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034006,10061536,10034006
ACETAMINOPHEN LEVEL WAS 109 LG/ML,Drug level increased,DRUG LEVEL IN BLOOD INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013721,10013722,10013721
PARKINSONISM,parkinsonism ,PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034010,10034010,10034010
POTENTIAL DRUG-DRUG INTERACTION (ENZALUTAMIDE AND OXYCODONE),Potentiating drug interaction,POTENTIATING DRUG INTERACTION,POTENTIATING DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10068072,10068072,10068072
DYSURIA,Dysuria,DYSURIA,DYSURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10013990,10013990,10013990
FLECAINIDE OVERDOSE-INDUCED BRUGADA ELECTROCARDIOGRAM PATTERN,Electrocardiogram abnormal,BRUGADA-TYPE ECG,ELECTROCARDIOGRAM ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10069779,10014363,10069779
SWELLING OF LIPS,Lip swelling,SWELLING OF LIPS,LIP SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10024570,10024570,10042703
ERYTHEMATOUS RASH,erythematous rash,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015243,10037855,10015243
LONG QT SYNDROME TRIGGERED BY DOMPERIDONE USE FOR BREAST FEEDING,Long QT syndrome,LONG QT SYNDROME,LONG QT SYNDROME,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10024803,10024803,10024803
LOUD VENTRICULAR THIRD SOUNDS,Heart sounds abnormal,THIRD CARDIAC SOUND,HEART SOUNDS ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),CARDIAC AUSCULTATORY INVESTIGATIONS,10022891,10050135,10019311,10050135
SWELLING OF LIPS,Lip swelling,SWELLING OF LIPS,LIP SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10024570,10024570,10042703
WORSENING OF THE DISEASE CLINICALLY,disease aggravation,DISEASE AGGRAVATION,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10013097,10010264,10013097
HYPONATREMIA (117MEQ/L),Hyponatraemia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021038
STAGE 4 NON-HODGKIN LYMPHOMA PROGRESSED TO NEUROLYMPHOMATOSIS FOLLOWING AGGRESSIVE CHEMOTHERAPY (LACK OF DRUG EFFECT),Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
COUGH,cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
RELAPSE OF LYMPHOCUTANEOUS NOCARDIOSIS,nocardiosis,NOCARDIOSIS,NOCARDIOSIS,BACTERIAL INFECTIOUS DISORDERS,NOCARDIA INFECTIONS,10021881,10029444,10029444,10029444
HYPERNATRAEMIA,Hypernatraemia,HYPERNATRAEMIA,HYPERNATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10020679,10020679,10020679
OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
INFECTION AGGRAVATED,Infection,INFECTION AGGRAVATED,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021791,10021789,10021791
NEW ONSET ABDOMINAL PAIN ON A BACKGROUND OF REGULAR IBUPROFEN USE POST-OPERATIVELY,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
BLOOD IN MY URINE,blood in urine,BLOOD IN URINE,BLOOD URINE PRESENT,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINALYSIS NEC,10022891,10005604,10018870,10005604
SJS SYMPTOMS WERE MORE AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
DISTAL POLYNEUROPATHY,Polyneuropathy,POLYNEUROPATHY,POLYNEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10036105,10036105,10036105
BECAME TOTALLY WHEELCHAIR BOUND,Wheelchair user,WHEELCHAIR USER,WHEELCHAIR USER,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10047920,10047920,10047920
ASPIRATION,Aspiration,ASPIRATION,ASPIRATION,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10003504,10003504,10003504
FALLING,Falling,FALLING,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016177,10016173,10016177
HYDROXYCHLOROQUINE ASSOCIATED HYPERPIGMENTATION,Skin hyperpigmentation,HYPERPIGMENTATION SKIN,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10040865,10040865,10020715
OSTEOPENIA WHICH EVENTUALLLY PROGRESSED TO OSTEPOROSIS,Osteoporosis,OSTEOPOROSIS,OSTEOPOROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10031282,10031282,10031282
GFR DECREASED (LESS THAN 15 ML/MIN),Glomerular filtration rate decreased,GFR DECREASED,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018214,10018358,10018214
UVEITIS FOLLOWING TREATMENT WITH METHOTREXATE AND TNF-ALPHA INHIBITORS,uveitis,UVEITIS,UVEITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10046851,10046851,10046851
COLD URTICARIA DRAMATICALLY RESOLVED AFTER HYDROXYCHLOROQUINE TREATMENT WAS STARTED FOR FRONTAL FIBROSING ALOPECIA (UNEXPECTED THERAPEUTIC BENEFIT) WITH NO ADR,unexpected therapeutic benefit,UNEXPECTED THERAPEUTIC BENEFIT,THERAPEUTIC RESPONSE UNEXPECTED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10076884,10043417,10076884
ELECTROCARDIOGRAM PR INTERVAL PROLONGED,Electrocardiogram PR prolongation,ELECTROCARDIOGRAM PR INTERVAL PROLONGED,ELECTROCARDIOGRAM PR PROLONGATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053655,10053657,10053655
SUDDEN WEAKNESS OF LEFT LEG,lower extremities weakness of,LOWER EXTREMITIES WEAKNESS OF,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10024947,10028372,10024947
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
SEROTONIN SYNDROME FROM VENLAFAXINE-TRANYLCYPROMINE INTERACTION,serotonin syndrome,SEROTONIN SYNDROME,SEROTONIN SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10040108,10040108,10040108
NEUTROPENIA,neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
NAUSEA/VOMITING,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ALLERGIC REACTION,allergic reaction,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
PATIENT TREATED WITH METHOTREXATE AND HYDROXYCHLOROQUINE FOR MORPHEA PROFUNDA (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
HYPERREFLEXIA/TREMOR,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
SPIKING FEVER,feverish,FEVERISH,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10073718,10037660,10073718
GENERALIZED BODY PAIN,generalized body pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
PARACETAMOL INTOXICATION AS AN AUTOLYTIC ATTEMPT,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
TUBERCULOMA,Tuberculoma of central nervous system,TUBERCULOMA OF CENTRAL NERVOUS SYSTEM,TUBERCULOMA OF CENTRAL NERVOUS SYSTEM,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10052883,10052883,10052883
INTERMITTENT NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ACUTE CORONARY SYNDROME,acute coronary syndrome,ACUTE CORONARY SYNDROME,ACUTE CORONARY SYNDROME,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10051592,10051592,10051592
WILMS' TUMOR PROGRESSION,Nephroblastoma,WILMS' TUMOR,NEPHROBLASTOMA,RENAL AND URINARY TRACT NEOPLASMS MALIGNANT AND UNSPECIFIED,RENAL NEOPLASMS MALIGNANT,10029104,10047986,10029145,10047987
CRYPT ABSCESS,Abscess intestinal,INTESTINAL CRYPT ABSCESS,ABSCESS INTESTINAL,INFECTIONS - PATHOGEN UNSPECIFIED,ABDOMINAL AND GASTROINTESTINAL INFECTIONS,10021881,10067675,10000285,10067675
DRUG ABUSE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
LETHARGIC,Lethargy,LETHARGIC,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024262
"DESPITE TREATMENT, THE WEAKNESS IN BOTH LEGS WORSENED",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DECREASED KIDNEY FUNCTION,Renal impairment,FUNCTION KIDNEY DECREASED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10017474,10062237,10017474
HALLUCINATING,Hallucination,HALLUCINATING,HALLUCINATION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019063,10019063,10019062
ACCIDENTAL DRUG OVERDOSE,Accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
TAPERING OF CORTICOSTEROID DOSE(REBOUND EFFECT OF CORTICOSTEROID DOSE),rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
INTENTIONAL SUSPECTED SUICIDE,Completed suicide,COMPLETED SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10010144,10010144,10010144
INCREASED SEVERITY OF EXTRAPYRAMIDAL SYMPTOMS AND COGNITIVE DETERIORATION,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
URGENT CAESAREAN SECTION,Urgent caesarean section,CAESAREAN SECTION,CAESAREAN SECTION,OBSTETRIC AND GYNAECOLOGICAL THERAPEUTIC PROCEDURES,OBSTETRIC THERAPEUTIC PROCEDURES,10042613,10006924,10006924,10006924
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
MARKED SOCIAL AND OCCUPATIONAL IMPAIRMENT,Mental impairment,MENTAL IMPAIRMENT,MENTAL IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10027374,10027374,10027374
PATIENTâ€™S CONDITION DETERIORATED,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
ERYTHOID HYPERPLASIA,Marrow hyperplasia,HYPERPLASIA ERYTHROID,MARROW HYPERPLASIA,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),HAEMATOLOGIC NEOPLASMS NEC,10029104,10020724,10026851,10020724
HAEMATOCHEZIA,Haematochezia,HAEMATOCHEZIA,HAEMATOCHEZIA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018836,10018836,10018836
PANCYTOPENIA DRAMATICALLY DETERIORATED,Pancytopenia aggravated,PANCYTOPENIA AGGRAVATED,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10048432,10033661,10048432
MILD HEMOLYSIS,Haemolysis,HEMOLYSIS,HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10018910,10018910,10019491
BLISTERS ERUPTED,Blister,BLISTERS,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005216
PHARMACEUTICAL CHOLESTASIS,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
BEGINING OF CARDIOGENIC SHOCK,Cardiogenic shock,CARDIOGENIC SHOCK,CARDIOGENIC SHOCK,HEART FAILURES,HEART FAILURES NEC,10007541,10007625,10007625,10007625
LACTIC ACIDOSIS FOLLOWING MITOCHONDRIAL TOXICITY,lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
SEVERE ANXIETY,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
"PATIENT WAS TREATED WITH PREDNISOLONE AND UDCA FOR VANISHING BILE DUCT SYNDROME, GIVEN NO IMPROVEMENT IN SERUM ALP OR BILIRUBIN WITH CORTICOSTEROIDS AND UDCA (LACK OF DRUG EFFECT)",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
SPLENOMEGALY,splenomegaly,SPLENOMEGALY,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041660,10041660,10041660
ACUTE RESPIRATORY FAILURE FOLLOWING CYTOKINE STORM,Acute respiratory failure,ACUTE RESPIRATORY FAILURE,ACUTE RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10001053,10001053,10001053
LIVE BIRTH,LIVE BIRTH,LIVE BIRTH,LIVE BIRTH,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS","NORMAL PREGNANCY, LABOUR AND DELIVERY",10036585,10049550,10049550,10049550
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
LIPASE INCREASED (MORE THAN 2000/L),Lipase increased,LIPASE INCREASED,LIPASE INCREASED,GASTROINTESTINAL INVESTIGATIONS,DIGESTIVE ENZYMES,10022891,10024574,10024574,10024574
RIGHT AXIS DEVIATION,QRS axis abnormal,"Q AXIS, RIGHT AXIS DEVIATION",QRS AXIS ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10051002,10057624,10051002
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
ACUTE DRUG OVERDOSE,drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
INTERMITTENT FEVER,Pyrexia,INTERMITTENT FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10022571,10037660,10058698
EPISODE OF EPISTAXIS,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
PROLONGED QTC,QT prolonged,QT PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037705,10014387,10037705
LEFT HYDROPNEUMOTHORAX FOLLOWING BRONCHIECTASIS,Pneumothorax,HYDROPNEUMOTHORAX,PNEUMOTHORAX,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10048725,10035759,10048725
SERUM BICARBONATE DECREASED (15 MMOL/L),Blood bicarbonate decreased,BICARBONATE DECREASED SERUM,BLOOD BICARBONATE DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10004545,10005359,10004545
CEFEPIME INDUCED NEUROTOXICITY,neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
PRIMARY RESISTANCE TO IMATINIB,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
SLEEPING MORE HOURS,Somnolence,SLEEPINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041014,10041349,10041014
LOGORRHEIC,Logorrhoea,LOGORRHEA,LOGORRHOEA,COMMUNICATION DISORDERS AND DISTURBANCES,SPEECH AND LANGUAGE USAGE DISTURBANCES,10037175,10024796,10024796,10062848
SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
THERAPY FAILED TO INDUCE REMISSION,treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
LACK OF DRUG EFFECT (NULL RESPONDER TO PEG/RBV),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
WORSENING OF SEIZURES,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
PRURITUS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
ITCHING ERYTHEMA,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
METFORMIN-ASSOCIATED LACTIC ACIDOSIS,lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
GRADE 1 FATIGUE,grade 1 fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
GENERALISED WEAKNESS,Asthenia,WEAKNESS GENERALISED,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047864,10003549,10047864
"ARCUATE HYPOPIGMENTATION AND OVOID APPEARANCE OF FOVEA (FLYING SAUCER SIGN) IN  BOTH EYES,  SPECKLED HYPERREFLECTANCE AT THE CENTER OF MACULA WITH AN ARCUATE ZONE OF HYPOREFLECTANCE (RIGHT EYE), HYPERAUTOFLUORESE AND HYPOAUTOFLUORESCENCE",Retinal fovea disorder,RETINAL FOVEA DISORDER,RETINAL DISORDER,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10048896,10038853,10048896
EXTRAPULMONARY TUBERCULOSIS (LYMPHADENITIS),focal seizure,LYMPHADENITIS BACTERIAL,LYMPHADENITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10065224,10065224,10065224
CARBAMAZEPINE USED FOR MIXED-TYPE SCHIZOAFFECTIVE DISORDER,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
EDEMA,edema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014210,10030095,10014210
DRUG EXPOSURE DURING PREGNANCY,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
ONDANSETRON-HYDROXYCHLOROQUINE INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
TWO EPISODES OF VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
INFANTILE HEMANGIOMAS TREATED WITH ORAL PROPRANOLOL,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
URIC ACID INCREASED (0.53 MMOL/L),Blood uric acid increased,URIC ACID INCREASED,BLOOD URIC ACID INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10066980,10005861,10066980
NECROTIC KERATINOCYTES,keratinocyte necrosis,KERATINOCYTE NECROSIS,EPIDERMAL NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10059292,10059284,10059292
ULTRASONOGRAPHY REVEALED DIFFUSE HYPERECHOGENIC AREA WITH INFLAMMATION INVOLVING SUBCUTIS AND GLUTEAL MUSCLES,Myositis,MUSCLE INFLAMMATION,MYOSITIS,MUSCLE DISORDERS,MUSCLE INFECTIONS AND INFLAMMATIONS,10028395,10028313,10028653,10028313
PATIENT HAD RECURRENCE OF SYMPTOMS OF LUPUS ENTERITIS FOLLWING TAPERING OF STEROIDS ( REBOUND EFFECT),Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
"HODGKIN LYMPHOMA-TYPE, STAGE IVB FOLLOWING LYMPHOPROLIFERATIVE DISORDER DUE TO EBV HEPATITIS",Hodgkin's disease stage IV,HODGKIN'S DISEASE STAGE IV,HODGKIN'S DISEASE STAGE IV,LYMPHOMAS HODGKIN'S DISEASE,HODGKIN'S DISEASE NEC,10029104,10061597,10061597,10061597
METFORMIN POISONING,Drug poisoning,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
RIGHT INGUINAL SWELLING,Swelling,SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10042674,10042674,10042674
DEBILITATING HEADACHES,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
FELL,fell,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
OBESE,Obesity,OBESITY,OBESITY,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10029883,10029883,10029883
CSF STUDY REVEALED THE PRESENCE OF OLIGOCLONAL BANDS,CSF oligoclonal band present,CSF OLIGOCLONAL BAND PRESENT,CSF OLIGOCLONAL BAND PRESENT,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10011562,10011562,10011562
DISTURBANCE OF CONSCIOUSNESS,consciousness disturbed,CONSCIOUSNESS DISTURBED,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010770,10001854,10010770
MODERATE-VOLUME HAEMOPERITONEUM FOLLOWING ACALCULOUS GALLBLADDER PERFORATION,moderate-volume haemoperitoneum following acalculous gallbladder perforation,HAEMOPERITONEUM,PERITONEAL HAEMORRHAGE,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL HAEMORRHAGES,10017947,10018935,10034666,10018935
PRURITUS,pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
BIRTH WEIGHT OF 1720 G,Low birth weight baby,BIRTH WEIGHT LOW,LOW BIRTH WEIGHT BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10004961,10067508,10004958
PAINFUL SWELLING OF THE KNEE,Joint swelling,KNEE SWELLING,JOINT SWELLING,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10077135,10023232,10077135
GLOMERULONEPHRITIS,Glomerulonephritis,GLOMERULONEPHRITIS,GLOMERULONEPHRITIS,NEPHROPATHIES,GLOMERULONEPHRITIS AND NEPHROTIC SYNDROME,10038359,10018364,10018364,10018364
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
LEFT BUTTOCK WAS PAINFUL AND THERE WAS TINGLING OVER THE POSTERIOR LEFT LEG,Paraesthesia,TINGLING,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10043880,10033775,10043876
APNEIC,Apnea,APNEA,APNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10002972,10002974,10002972
HYPOKALEMIA,hypokalemia,HYPOKALEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021018,10021015,10021018
NEUROTOXICITY,neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
"INCREASE IN THE CLAVICLE CAPITATION, RIGHT KNEE AND LEFT ANKLE",bone disorder,BONE DISORDER,BONE DISORDER,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10005956,10005956,10005956
MUSCLE TWITCHING IN UPPER LIMB,Muscle twitching,MUSCLE TWITCHING,MUSCLE TWITCHING,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028347,10028347,10028347
CONSCIOUSNESS DISTURBANCE,consciousness disturbed,CONSCIOUSNESS DISTURBED,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010770,10001854,10010770
RELATIVELY SMALL FINGERNAILS,Congenital nail disorder,CONGENITAL NAIL DISORDER,CONGENITAL NAIL DISORDER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS CONGENITAL,HAIR AND NAIL DISORDERS CONGENITAL,10010331,10010557,10010557,10010557
METABOLIC ACIDOSIS PH 6.877 DUE TO USE OF METFORMIN,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
"METAMIZOLE-INDUCED AGRANULOCYTOSIS PROGRESSED FROM LOCAL TO SYSTEMIC WITH SEPTIC SHOCK AND MULTI-ORGAN FAILURE (RENAL DYSFUNCTION, LIVER DYSFUNCTION, PLATELET DYSFUCTION)",Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
ABNORMAL LOSS OF WEIGHT,Abnormal loss of weight,ABNORMAL LOSS OF WEIGHT,ABNORMAL LOSS OF WEIGHT,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10000159,10000159,10000159
METASTASES TO LIVER,Metastases to liver,METASTASES TO LIVER,METASTASES TO LIVER,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027457,10027457,10027457
CARBAPENUM-RESISTANT KLEBSIELLA PNEUMONIAE BLOOD STREAM INFECTION,Klebsiella sepsis,KLEBSIELLA SEPSIS,KLEBSIELLA SEPSIS,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10054160,10054160,10054160
SERUM CREATININE 501 MMOL/L,Blood creatinine abnormal,SERUM CREATININE ABNORMAL,BLOOD CREATININE ABNORMAL,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040231,10005481,10040231
CUTANEOUS SARCOIDOSIS-LIKE GRANULOMATOUS DISORDER,Granulomatous disease,GRANULOMATOUS DISEASE,GRANULOMA,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10018701,10018691,10018701
WEAKLY POSITIVE LINEAR IGA AND IGG DEPOSITION,Linear IgA disease,LINEAR IGA DISEASE,LINEAR IGA DISEASE,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10024515,10024515,10024515
MULTIPLE DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
"USE OF BUPRENORPHINE, 3,4-METHYLENEDIOXYPYROVALERONE, TETRAZEPAM, MIRTAZAPINE, CITALOPRAM AND QUETIAPINE",Polysubstance abuse,POLYSUBSTANCE ABUSE,SUBSTANCE ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10052459,10066169,10052459
CELLULITIS IN THE LEFT LEG FOLLOWING SECONDARY HYPOGAMMAGLOBULINEMIA DUE TO RECEIVING IMMUNOSUPPRESSANTS,Cellulitis,CELLULITIS OF LEG,CELLULITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10007912,10007882,10007912
PARANEOPLASTIC SERONEGATIVEÂ Â PAUCI-IMMUNE GLOMERULONEPHRITIS ASSOCIATED WITH LUNG ADENOCARCINOMA,Paraneoplastic glomerulonephritis,PARANEOPLASTIC GLOMERULONEPHRITIS,PARANEOPLASTIC GLOMERULONEPHRITIS,NEPHROPATHIES,GLOMERULONEPHRITIS AND NEPHROTIC SYNDROME,10038359,10076749,10076749,10076749
INTOXICATION,drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
BLOOD GLUCOSE LEVEL OF 26 MG/DL,Blood glucose decreased,BLOOD GLUCOSE DECREASED,BLOOD GLUCOSE DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10005555,10005555,10005555
PATIENT TREATED WITH DOCETAXEL AND CISPLATIN FOR OSTEOGENIC SARCOMA (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
LIP OEDEMA,Lip oedema,LIP OEDEMA,LIP OEDEMA,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10024558,10024558,10024558
TUBERCULOSIS,Tuberculosis,TUBERCULOSIS,TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10044755,10044755,10044755
FEBRICULA,Febricula,FEBRICULA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10065377,10037660,10065377
BILATERAL URETERAL OBSTRUCTION,Ureteric obstruction,URETERIC OBSTRUCTION,URETERIC OBSTRUCTION,URETERIC DISORDERS,URETERIC DISORDERS NEC,10038359,10046406,10046406,10046406
INTENTIONAL OVERDOSE,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
OCCASIONALLY STEROID PSYCHOSIS,Psychotic disorder,PSYCHOSIS,PSYCHOTIC DISORDER,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10037234,10061920,10037234
C-REACTIVE PROTEIN INCREASED,C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
ANGINA,Angina pectoris,ANGINA PECTORIS,ANGINA PECTORIS,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10002383,10002383,10002383
PLASMA CONCENTRATION OF CBZ WAS SLIGHTLY ELEVATED,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
LYMPH NODES ENLARGEMENT,Lymphadenopathy,ENLARGEMENT OF LYMPH NODES,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025186,10025197,10014847
WHO WAS TREATED WITH NIVOLUMAB AND ALLOPURINOL FOR LYMPHOMA (OFF LABEL USE).,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
AT HOUR 12-13 LEFT VENTRICULAR FUNCTION WAS IMPAIRED,left ventricular dysfunction,LEFT VENTRICULAR DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10049694,10049694,10049694
MILD DIFFICULTY IN BREATHING AND SWALLOWING,Swallowing difficult,SWALLOWING DIFFICULT,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10042645,10013950,10042645
OCULAR HYPERTENSION,Ocular hypertension,OCULAR HYPERTENSION,OCULAR HYPERTENSION,GLAUCOMA AND OCULAR HYPERTENSION,GLAUCOMAS (EXCL CONGENITAL),10015919,10030043,10030043,10030043
HYPOXIA,Hypoxia,HYPOXIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021143,10021143,10021143
NECROTIZING FASCIITIS OF RIGHT THIGH ASSOCIATED WITH INTRAMUSCULAR INJECTION OF DICLOFENAC,Necrotising fasciitis,NECROTIZING FASCIITIS,NECROTISING FASCIITIS,INFECTIONS - PATHOGEN UNSPECIFIED,MUSCLE AND SOFT TISSUE INFECTIONS,10021881,10028885,10028885,10055647
HER MOUTH WAS DRY,Dry mouth,DRY MOUTH,DRY MOUTH,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10013781,10013781,10013781
WEAKNESS OF THE LEFT ARM,Asthenia,FEELINGS OF WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016373,10003549,10016373
CONDUCTION ABNORMALITIES,Conduction disorder,CONDUCTION DISORDER,CONDUCTION DISORDER,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10010276,10010276,10010276
HYPERTHERMIA,hyperthermia,HYPERTHERMIA,HYPERTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10020843,10020843,10020843
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
RESPIRATORY INSUFFICIENCY,Respiratory insufficiency,RESPIRATORY INSUFFICIENCY,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038701,10038695,10038701
BLOODSHOT EYES,Subconjunctival redness,SUBCONJUNCTIVAL REDNESS,CONJUNCTIVAL HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CONJUNCTIVAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10062962,10051625,10062962
THE PATIENT COULD NOT FUNCTION PROPERLY,Fear-related avoidance of activities,FEAR-RELATED AVOIDANCE OF ACTIVITIES,FEAR-RELATED AVOIDANCE OF ACTIVITIES,ANXIETY DISORDERS AND SYMPTOMS,FEAR SYMPTOMS AND PHOBIC DISORDERS (INCL SOCIAL PHOBIA),10037175,10080136,10080136,10080136
PLEOCYTOSIS,pleocytosis,PLEOCYTOSIS,PLEOCYTOSIS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10035551,10035551,10035551
CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
GRADE 4 NEUTROPHILS DECREASED/ GRADE 3 NEUTROPHILS DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
MYELODYSPLASIA,myelodysplasia,MYELODYSPLASIA,MYELODYSPLASTIC SYNDROME,LEUKAEMIAS,MYELODYSPLASTIC SYNDROMES,10029104,10028532,10028533,10028532
GRADE III IMMEDIATE HYPERSENSITIVITY REACTION,Type I hypersensitivity,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
ASAT INCREASED (120 U/L),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
GAIT INSTABILITY,Gait disturbance,GAIT INSTABILITY,GAIT DISTURBANCE,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017582,10017577,10017582
CESAREAN SECTION WAS CARRIED OUT AT 31 WEEKS AND 4 DAYS,Premature baby,PREMATURE BABY 26 TO 32 WEEKS,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10053593,10036590,10053593
LIVER ENZYMES WERE MILDLY ELEVATED,Hepatic enzyme increased,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
SUSTAINED ARRHYTHMIA,Arrhythmia,ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10003119
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
"SEVERAL PINK, SHINY,ERODED PAPULES ON RIGHT FRONTAL SCALP,LEFT FOREHEAD AND CHEEK,NUMEROUS, CONFLUENT, UMBILICATED PINK PAPULES ON THE LOWER BACK AND BUTTOCKS",Papule,PAPULE,PAPULE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10033733,10033733,10033733
"MILD LEUKOCYTOSIS 11,900K/UL",leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
"CYTOGENETIC ABNORMALITIES (-7, ADD(13)Q31)","cytogenetic abnormalities (-7, add(13)q31)",CYTOGENETIC ABNORMALITY,CYTOGENETIC ABNORMALITY,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,CHROMOSOMAL ABNORMALITIES NEC,10010331,10067477,10067477,10067477
"LACK OF DRUG EFFECT/PARTIAL CONTROL OF MYOCLONIC SEIZURES, GENERALISED TONIC CLONIC SEIZURES, PARTIAL SEIZURE (90%).",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
CONDITION QUICKLY DETERIORATED PROGRESSING TO CARDIOGENIC SHOCK,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
HYPERTROPHIC CARDIOMYOPATHY,Hypertrophic cardiomyopathy,HYPERTROPHIC CARDIOMYOPATHY,HYPERTROPHIC CARDIOMYOPATHY,CARDIAC AND VASCULAR DISORDERS CONGENITAL,CARDIAC SEPTAL DEFECTS CONGENITAL,10010331,10020871,10020871,10020871
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
PROCTITIS,Proctitis,PROCTITIS,PROCTITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,RECTAL INFLAMMATIONS NEC,10017947,10036774,10036774,10036774
LLE WAS SWOLLEN AND TENDER WITH MILD NUMBNESS,Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
SIGNIFICANT SLOWING OF THINKING,Thinking slow,THINKING SLOW,BRADYPHRENIA,DISTURBANCES IN THINKING AND PERCEPTION,THINKING DISTURBANCES,10037175,10043437,10050012,10043437
MYOCLONIC JERKS,Myoclonus,MYOCLONIC JERKS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028621,10028622,10028621
INTELLECTUAL DISABILITY,Intellectual disability,INTELLECTUAL DISABILITY,INTELLECTUAL DISABILITY,MENTAL IMPAIRMENT DISORDERS,INTELLECTUAL DISABILITIES,10029205,10067989,10067989,10067989
DIGOXIN TOXICITY,digoxin toxicity,DIGOXIN TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10012999,10070863,10012999
TRISOMY 8,Trisomy 8,TRISOMY 8,TRISOMY 8,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,AUTOSOMAL CHROMOSOMAL ABNORMALITIES,10010331,10053871,10053871,10053871
HEMODYNAMIC COLLAPSE DUE TO AMLODIPINE TOXICITY,Circulatory collapse,COLLAPSE CIRCULATORY,CIRCULATORY COLLAPSE,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10009192,10009192,10009909
INTERMITTENT BOUTS OF VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
FLATTENED AND BIPHASIC T-WAVES ESPECIALLY IN V4-V6,T wave flattening of,T WAVE FLATTENING OF,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10042965,10014394,10042965
SYMPTOMATIC POLYNEUROPATHY ASSOCIATED WITH OXALIPLATIN,Polyneuropathy,POLYNEUROPATHY,POLYNEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10036105,10036105,10036105
PROFOUND HYPOGLYCEMIA DUE TO CONTINUED  CAMPYLOBACTER BACTEREMIA,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
BULBAR PALSY,Bulbar palsy,BULBAR PALSY,BULBAR PALSY,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),MIXED CRANIAL NERVE DISORDERS,10029205,10006542,10006542,10006542
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
OPTHALMOLOGIC EXAM SHOWED BILATERAL PERIORBIATAL EDEMA,Periorbital oedema,PERIORBITAL EDEMA,PERIORBITAL OEDEMA,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10034545,10034545,10054541
DIFFICULTY IN SPEECH,Speech disorder,SPEECH DISORDER,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041466,10041466,10041466
CEREBELLAR SIGNS LOCALIZED TO THE LEFT,Nervous system disorder,CEREBELLAR DISORDER NOS,NERVOUS SYSTEM DISORDER,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10051087,10029202,10051087
SWEATY,sweaty,SWEATY,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042670,10020642,10042670
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
ITCHING,Pruritus,ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023084,10037087,10023084
HYPERAEMIC PAPULES AND NODULES WITH CENTRAL NECROSIS ON BOTH ELBOWS AND KNEES,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
VERTEBRAL FRACTURE,Spinal fracture,VERTEBRAL FRACTURE,SPINAL FRACTURE,BONE AND JOINT INJURIES,SPINAL FRACTURES AND DISLOCATIONS,10022117,10047333,10041569,10047333
PARTIAL RESPONSE WAS OBSERVED,PARTIAL RESPONSE WAS OBSERVED,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10043414,10043414,10043414
NIGHT SWEATS,night sweats,NIGHT SWEATS,NIGHT SWEATS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10029410,10029410,10029410
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
MYALGIA IN THE BACK/BACK MYALGIA ON EZETIMIBE TREATMENT,Myalgia,LOCALISED MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10063543,10028411,10063543
NEUROTOXICITY,neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
CHEST PAIN,chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
PATIENT WASC MANAGED WITH METHOTREXATE TO TREAT INTERSTITIAL PREGNANCY (OFF LABEL USE OF DRUG FOR INDICATION WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CHEMOTHERAPY-INDUCED HUS,Haemolytic uraemic syndrome,HEMOLYTIC UREMIC SYNDROME,HAEMOLYTIC URAEMIC SYNDROME,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC MECHANICAL FACTOR,10005329,10018932,10018932,10019515
FACIAL DROP,Facial paralysis,FACIAL DROOP,FACIAL PARALYSIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),FACIAL CRANIAL NERVE DISORDERS,10029205,10016062,10016062,10016044
LACTATE DEHYDROGENASE INCREASED (3950 U PER L),Blood lactate dehydrogenase increased,LACTATE DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10023654,10005630,10023654
PANCREATITIS,Pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
HIGH GRADE WEAKNESS IN THE LEFT SIDE OF THE BODY,Hemiparesis,WEAKNESS LEFT OR RIGHT SIDE,HEMIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10047866,10019465,10047866
SEVERE HIGH ANION GAP METABOLIC ACIDOSIS,High anion gap metabolic acidosis,HIGH ANION GAP METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10069033,10027417,10069033
WATERY DIARRHEA,watery diarrhea,WATERY DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10055422,10012735,10055422
TRISOMY 8,trisomy 8,TRISOMY 8,TRISOMY 8,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,AUTOSOMAL CHROMOSOMAL ABNORMALITIES,10010331,10053871,10053871,10053871
DIGOXIN TOXICITY,digoxin toxicity,DIGOXIN TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10012999,10070863,10012999
DISTURBANCE OF CONSCIOUSNESS,Altered state of consciousness,CONSCIOUSNESS DISTURBED,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010770,10001854,10010770
INCREASE IN CPK CONCENTRATION,CPK increased,CPK INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011268,10005470,10011268
ACUTELY DEPRESSED,Depression,DEPRESSION,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012378,10012378,10012378
"NAUSEA, GRADE 2 NAUSEA",Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ADRENOCORTICOTROPIC DEFICIENCY,Adrenocorticotropic hormone deficiency,ADRENOCORTICOTROPIC HORMONE DEFICIENCY,ADRENOCORTICOTROPIC HORMONE DEFICIENCY,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPOFUNCTION,10014698,10073179,10073179,10073179
REDUCED MOBILITY,Mobility decreased,MOBILITY DECREASED,MOBILITY DECREASED,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10048334,10048334,10048334
INTENTIONAL OVERDOSE,intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
HERPES ZOSTER INFECTION,Herpes zoster,HERPES ZOSTER,HERPES ZOSTER,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10019974,10019974,10019974
ABSOLUTE NEUTROPHILS DECREASED (48/MM3),Neutrophil count decreased,ABSOLUTE NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10059234,10029366,10059234
STATIN-ASSOCIATED RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
HAND TREMORS,Tremor of hands,TREMOR OF HANDS,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044577,10044565,10044577
REPEATED APPEARANCE OF ERYTHEMA ON THE NUCHAL,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
"RED, SWOLLEN, WARM RIGHT UPPER ARM OVER THE SITE OF INJECTION.",Vaccination site swelling,VACCINATION SITE SWELLING,VACCINATION SITE SWELLING,ADMINISTRATION SITE REACTIONS,VACCINATION SITE REACTIONS,10018065,10069620,10069620,10069620
SERRATIA MARCESCENS,Serratia marcescens,SERRATIA MARCESCENS INFECTION,SERRATIA INFECTION,BACTERIAL INFECTIOUS DISORDERS,SERRATIA INFECTIONS,10021881,10054151,10061512,10054151
WIDESPREAD ERYTHEMA OF THE GENITALS WITH EXFOLIATION,Skin exfoliation,SKIN EXFOLIATION,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040844,10040844,10040844
LEUCOPENIA,Leukopenia,LEUCOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024283
LEVOFLOXACIN INDUCED NEUROTOXICITY/POTENTIAL NEUROTOXICITY,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
INJECTION SITE EXTRAVASATION,Injection site extravasation,INJECTION SITE EXTRAVASATION,INJECTION SITE EXTRAVASATION,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022062,10022062,10022062
HIGH BLOOD PRESSURE,Blood pressure high,BLOOD PRESSURE HIGH,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10005747,10020772,10005747
LEFLUNOMIDE-INDUCED STEVENS JOHNSON SYNDROME,Stevens-Johnson syndrome,STEVENS JOHNSON SYNDROME,STEVENS-JOHNSON SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10042033,10042033,10042030
HIGH DERMAL PERIVASCULAR AND SPONGIOTIC DERMATITIS WITH MARKED EOSINOPHILIA,Eczema,ACUTE SPONGIOTIC DERMATITIS,ECZEMA,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10072674,10014184,10072674
NEUTROPENIA OF â‰¥GRADE 3,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
PATIENT TREATED WITH TADALAFIL FOR PULMONARY ARTERIAL HYPERTENSION (UNAPPROVED USE FOR INDICATION)-OFF LABEL USE WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TREMORS,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
INTERLEUKIN LEVEL INCREASED,Interleukin level increased,INTERLEUKIN LEVEL INCREASED,INTERLEUKIN LEVEL INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNE RESPONSE PROTEIN ANALYSES NEC,10022891,10063322,10063322,10063322
LOW LEVELS OF BASAL SERUM CORTISOL (0.8 UG/DL),Cortisol decreased,SERUM CORTISOL DECREASED,CORTISOL DECREASED,ENDOCRINE INVESTIGATIONS (INCL SEX HORMONES),ADRENAL CORTEX TESTS,10022891,10040218,10011198,10040218
NEOPLASMA MUND MALIGNE,Oral carcinoma,ORAL CARCINOMA,LIP AND/OR ORAL CAVITY CANCER,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,LIP AND ORAL CAVITY NEOPLASMS MALIGNANT,10029104,10030964,10061523,10030964
IN 23RD WEEK OF PREGNANCY SHE WAS STARTED ON ENOXAPARIN,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
INFARCT IN THE LEFT FRONTAL LOBE,Cerebral infarction,CEREBRAL INFARCTION,CEREBRAL INFARCTION,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008118,10008118,10008118
RESPIRATORY RATE 30/MIN,Respiratory rate increased,RESPIRATORY RATE HIGH,RESPIRATORY RATE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10038711,10038712,10038711
5-FLUOROURACIL TOXICITY,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
BLOOD PRESSURE DECREASED,Blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
COMA,coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
HYPOGLYCAEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
BILATERAL SEGMENTAL POLIOSIS,Achromotrichia acquired,POLIOSIS,ACHROMOTRICHIA ACQUIRED,SKIN APPENDAGE CONDITIONS,PILAR DISORDERS NEC,10040785,10065628,10049865,10065628
INCREASED SERUM CREATININE (1020.1 MCMOL/L),Blood creatinine increased,INCREASED SERUM CREATININE,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10021678
HERPES ZOSTER INFECTION,Herpes zoster,HERPES ZOSTER,HERPES ZOSTER,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10019974,10019974,10019974
OLIGOHYDRAMNIOS,Oligohydramnios,OLIGOHYDRAMNIOS,OLIGOHYDRAMNIOS,"PLACENTAL, AMNIOTIC AND CAVITY DISORDERS (EXCL HAEMORRHAGES)",AMNIOTIC FLUID AND CAVITY DISORDERS OF PREGNANCY NEC,10036585,10030289,10030289,10030289
10 GTCS PER YEAR/SHE EXPERIENCED AN ATTACK AT HER WORKPLACE,Generalised tonic-clonic seizure,GENERALISED TONIC-CLONIC SEIZURE,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10018100,10018100,10018100
CEREBRO-ORGANIC PSYCHOSYNDROME,psychoorganic syndrom,PSYCHOORGANIC SYNDROME,ORGANIC BRAIN SYNDROME,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS DUE TO A GENERAL MEDICAL CONDITION NEC,10037175,10078099,10031077,10078099
ERYTHEMA ANNULAR CENTRIFUGUM,erythema annular centrifugum,ERYTHEMA ANNULARE CENTRIFUGUM,ERYTHEMA ANNULARE,EPIDERMAL AND DERMAL CONDITIONS,PAPULOSQUAMOUS CONDITIONS,10040785,10015154,10015153,10015154
HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
MULTIPLE IMMUNOSUPPRESSIVE THERAPY SCHEMES WERE TRIED BUT WITHOUT SUCCESS,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HEART FAILURE FOLLOWING PULMONARY EMBOLISM,Cardiac failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10007554,10007554,10019279
SYNDROME OF INAPPRORIATE ANTI-DIURETIC HORMONE SECRETION AND FANCONI SYNDROME,Inappropriate antidiuretic hormone secretion,SIADH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,POSTERIOR PITUITARY DISORDERS,10014698,10040626,10053198,10040626
DISRUPTION OF THE PHOTORECEPTOR-RETINAL PIGMENT EPITHELIUM JUNCTION,Retinopathy,RETINOPATHY,RETINOPATHY,"RETINA, CHOROID AND VITREOUS HAEMORRHAGES AND VASCULAR DISORDERS",RETINOPATHIES NEC,10015919,10038923,10038923,10038923
WORSENING OF LIVER FAILURE,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
RESTLESS,Restlessness,RESTLESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038743,10038743,10038740
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
DRUG-INDUCED ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
STATUS EPILEPTICUS,Status epilepticus,STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10041962,10041962,10041962
ICTERUS ON THE SKIN AND SCLERA,Jaundice,ICTERUS,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10021207
PERSISTENSE OF CLL,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
HEART ATTACK,Myocardial infarction,HEART ATTACK,MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10019250,10028596,10019250
FLUID RETENTION,Fluid retention,FLUID RETENTION,FLUID RETENTION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME INCREASED,10027433,10016807,10016807,10016807
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
DECREASED WHITE BLOOD CELL OF   GRADE 3,White blood cell count decreased,WHITE BLOOD CELL COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10047942
FUNGAL THYROIDITIS,Thyroiditis,THYROIDITIS,THYROIDITIS,THYROID GLAND DISORDERS,ACUTE AND CHRONIC THYROIDITIS,10014698,10043778,10043778,10043778
INFLAMMATION AND SWELLING IN THE ANKLES,inflammation and swelling in the ankles,INFLAMMATION,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10061218,10061218,10061218
NEUROLEPTIC MALIGNANT SYNDROME,Neuroleptic malignant syndrome,NEUROLEPTIC MALIGNANT SYNDROME,NEUROLEPTIC MALIGNANT SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10029282,10029282,10029282
MYOCARDIAL INJURY/ISCHEMIA,Myocardial ischaemia,MYOCARDIAL ISCHEMIA,MYOCARDIAL ISCHAEMIA,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10028600,10028600,10028601
MACULOPAPULAR RASH,Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
UPPER RESPIRATORY TRACT INFECTION,Upper respiratory tract infection,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10046306,10046306,10046306
FLUDARADINE ADMINISTERED IN INFANT FOR CONDITIONING REGIMEN/ALEMTUZUMAB ADMINISTERED FOR CONDITIONING REGIMEN,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"SUDDEN ONSET OF PANCYTOPENIA (HB 7.3 G/DL, PLTS 20,000/ÎœL, WBC 100/ÎœL)",Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
QT INTERVAL PROLONGED (0. 470SEC) DUE TO CINCHONISM FOLLOWING INTENTIONAL DRUG ABUSE,Electrocardiogram QT prolonged,QT INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037703,10014387,10037703
LANSOPRAZOLE INCREASING THE BLOOD CONCENTRATION OF PARACETAMOL,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
EXCITATION,Agitation,EXCITABILITY,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10015622,10001497,10015622
STATIN INTOLERANCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
TUBERCULOSIS DISSEMINATION,Tuberculosis,TUBERCULOSIS,TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10044755,10044755,10044755
LACK OF TREATMENT RESPONSE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
PAIN ON WALKING,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
TREATMENT LEAD TO PARTIAL RESPONSE,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
SEVERE CONFUSIONAL EPISODE,confusional state,CONFUSIONAL STATE,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010305,10010305,10010305
CONGENITAL ANOMALY,Congenital anomaly,CONGENITAL ANOMALY,CONGENITAL ANOMALY,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10010356,10010356,10010356
GRADE 2 URINARY TRACT INFECTION,Urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
PARALYTIC ILEUS,ileus paralytic,ILEUS PARALYTIC,ILEUS PARALYTIC,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,NON-MECHANICAL ILEUS,10017947,10021333,10021333,10021333
SEVERE ASEPTIC TEMPORAL LOBE ENCEPHALITIS,Encephalitis,ENCEPHALITIS,ENCEPHALITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10014581,10014581,10014581
CONTINUING TO OOZE FROM THE SITE,Haemorrhage,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10005103
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
"BLISTERS OF THE LATERAL TONGUE, ORAL MUCOSA, LIPS AND SCROTUM",blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
POOR CONCENTRATION,Disturbance in attention,POOR CONCENTRATION,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10027346,10013496,10036149
NUMEROUS EOSINOPHILS,Allergic eosinophilia,ALLERGIC EOSINOPHILIA,ALLERGIC EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10075185,10075185,10075185
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PANCREATIC INFLAMMATION,pancreatic inflammation,PANCREATIC INFLAMMATION,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10076039,10033645,10076039
GROUND GLASS OPACITY IN THORACIC CT,Computerised tomogram thorax abnormal,GROUND GLASS OPACITY IN THORACIC CT,COMPUTERISED TOMOGRAM THORAX ABNORMAL,RESPIRATORY AND PULMONARY INVESTIGATIONS (EXCL BLOOD GASES),RESPIRATORY TRACT AND THORACIC IMAGING PROCEDURES,10022891,10072879,10057799,10072879
THE AREA OF THE LESIONS GRADUALLY ENLARGED AND ADJACENT TISSUE INVASION INCREASED,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
NOCARDIA SPP WAS ISOLATED,Nocardiosis,NOCARDIA INFECTION,NOCARDIOSIS,BACTERIAL INFECTIOUS DISORDERS,NOCARDIA INFECTIONS,10021881,10064083,10029444,10064083
FALL,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
TIP-TOED WHILE WALKING,Toe walking,TOE WALKING,TOE WALKING,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10068872,10068872,10068872
MILD CONJUCTIVITIS,Conjunctivitis,CONJUNCTIVITIS,CONJUNCTIVITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10010741,10010741,10010741
RESPIRATORY FAILURE DUE TO TYPE-B LACTIC ACIDOSIS (NORMOXIC) FOLLOWING DRUG OVERDOSE,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
INADVERTENT OVERDOSE OF 600 MG OF IT ADMINISTERED METHOTREXATE INSTEAD OF THE INTENDED DOSE OF 12 MG,Wrong dose administered,WRONG DOSE ADMINISTERED,INCORRECT DOSE ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10048054,10064355,10048054
GASTROINTESTINAL INTOLERANCE,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
LOSS OF VISUAL ACUITY,loss of visual acuity,VISUAL ACUITY LOST,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047530,10047531,10047530
PATIENT BECAME HEMODYNAMICALLY MINIMALLY UNSTABLE,Haemodynamic instability,HEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10052076,10052076,10058270
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
"PATIENT WAS PRESCRIBED OXYCODONE FOR POSTOPERATIVE PAIN CONTROL. OVER TIME, POST-OP RECREATIONAL USE OF OXYCODONE WAS STARTED WITH NO REPORTED ADR.",Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
TRICUSPID REGURGITATION FOLLOWING HEART FAILURE DUE TO ENDOMYOCARDIAL FIBROSIS,tricuspid regurgitation,TRICUSPID REGURGITATION,TRICUSPID VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,TRICUSPID VALVULAR DISORDERS,10007541,10049217,10044640,10049217
SEVERE PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
RUXOLITINIB AND PREDNISONE FOR TREATMENT OF CORTICOSTEROID REFRACTORY GRAFT VERSUS HOST DISEASE,Drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
INCREASE OF PANCREATIC ENZYMES,increase of pancreatic enzymes,PANCREATIC ENZYMES INCREASED,PANCREATIC ENZYMES INCREASED,GASTROINTESTINAL INVESTIGATIONS,DIGESTIVE ENZYMES,10022891,10061900,10061900,10061900
BACK MYALGIA ON EZETIMIBE TREATMENT,Myalgia,LOCALISED MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10063543,10028411,10063543
SUPERFICIAL ACUTE SUPPURATIVE/PUSTULAR FOLLICULITIS,Pustular folliculitis,PUSTULAR FOLLICULITIS,FOLLICULITIS,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10048635,10016936,10048635
SEPSIS OF URINARY ORIGIN,Urosepsis,UROSEPSIS,UROSEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10048709,10048709,10048709
STEVEN-JOHNSON SYNDROME WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA DID NOT RESPOND TO DAILY ORAL PREDNISOLONE (WITH NO ADR),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DACARBAZINE USED TO TREAT HODGKIN'S LYMPHOMA,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
ALTERED CONSCIOUSNESS,Consciousness abnormal,CONSCIOUSNESS ABNORMAL,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010765,10001854,10010765
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
NON-TRAUMATIC LATERAL ABDOMINAL WALL HERNIA,hernia abdominal wall,HERNIA ABDOMINAL WALL,ABDOMINAL HERNIA,ABDOMINAL HERNIAS AND OTHER ABDOMINAL WALL CONDITIONS,ABDOMINAL HERNIAS NEC,10017947,10019911,10060954,10019911
BENDAMUSTINE HYDROCHLORIDE FOR WALDENSTROM'S MACROGLOBULINAEMIA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MONOMORPHIC POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER  OF T LYMPHOCYTES,Mycosis fungoides,CUTANEOUS T-CELL LYMPHOMA,MYCOSIS FUNGOIDES,LYMPHOMAS NON-HODGKIN'S T-CELL,MYCOSES FUNGOIDES,10029104,10011677,10028483,10011677
ANGIOEDEMA,Angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
APNEA,Apnoea,APNEA,APNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10002974,10002974,10002972
NECROTISING FASCITIS,Necrotising fasciitis,NECROTISING FASCIITIS,NECROTISING FASCIITIS,INFECTIONS - PATHOGEN UNSPECIFIED,MUSCLE AND SOFT TISSUE INFECTIONS,10021881,10028885,10028885,10028885
GRADE 4 DRUG-INDUCED AGRANULOCYTOSIS,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
TREMORS,tremors,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
PREGNANCY INDUCED HYPERTENSION,Gestational hypertension,GESTATIONAL HYPERTENSION,GESTATIONAL HYPERTENSION,MATERNAL COMPLICATIONS OF PREGNANCY,HYPERTENSION ASSOCIATED DISORDERS OF PREGNANCY,10036585,10070538,10070538,10070538
SEPTIC/SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
ANION GAP METABOLIC ACIDOSIS/HIGH ANION GAP METABOLIC ACIDOSIS,High anion gap metabolic acidosis,HIGH ANION GAP METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10069033,10027417,10069033
MILD HYPONATREMIA/ SEVERE HYPOSMOLAR HYPONATREMIA,Hyponatremia aggravated,HYPONATREMIA AGGRAVATED,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10054430,10021036,10054430
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
LIVER WAS PALPABLE 2 CMS BELOW THE RIGHT COASTAL MARGIN WITH A SPAN OF 6 CMS,Liver palpable,LIVER PALPABLE SUBCOSTAL,LIVER PALPABLE,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10024704,10075895,10024704
HYPOGLYCAEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
HEPATOPATHY FOLLOWING LEFLUNOMIDE THERAPY,Liver disorder,HEPATOPATHY,LIVER DISORDER,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC AND HEPATOBILIARY DISORDERS NEC,10019805,10024670,10024670,10059616
FEEDING DIFFICULTIES,Feeding disorder,FEEDING DISORDER,FEEDING DISORDER,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10061148,10061148,10061148
LYMPHOPENIA,Lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
DEEP VEIN THROMBOSIS,deep vein thrombosis,DEEP VEIN THROMBOSIS,DEEP VEIN THROMBOSIS,EMBOLISM AND THROMBOSIS,PERIPHERAL EMBOLISM AND THROMBOSIS,10047065,10051055,10051055,10051055
LYMPHOPENIA,Lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
DRUG ABUSE,drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
METHOTREXATE INDUCED EBV ASSOCIATED LYMPHOPROLIERATIVE DISORDER,Epstein-Barr virus associated lymphoproliferative disorder,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),LYMPHOPROLIFERATIVE DISORDERS NEC (EXCL LEUKAEMIAS AND LYMPHOMAS),10029104,10068349,10068349,10068349
WEAKNESS OF LIMBS,Weakness of limbs,WEAKNESS OF LIMBS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10047868,10028372,10047868
DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
PROLONGED USE OF AMPHOTERICIN B LIPID MAY HAVE BEEN THE CAUSE OF MTX EXCRETION DELAY IN THE PATIENT,Drug clearance decreased,DRUG CLEARANCE DECREASED,DRUG CLEARANCE DECREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10049463,10049463,10049463
PNEUMONIA FOLLOWING INADVERTANT OVERDOSE OF INTRATHECAL METHOTREXATE,pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
SIGNIFICANT ACIDOSIS,Acidosis,ACIDOSIS,ACIDOSIS,ACID-BASE DISORDERS,MIXED ACID-BASE DISORDERS,10027433,10000486,10000486,10000486
PAINFUL UPON PALPATION,Abdominal pain,ABDOMINAL PAIN LOCALIZED,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000083,10000081,10062367
INCREASED GGT,Gamma-glutamyltransferase increased,GGT INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10056910,10017693,10056910
SUSPICION OF HEART FAILURE (HF),Heart failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10019279,10007554,10019279
"PATIENT STILL EXPERIENCED SWELLING, TENDERNESS AND MULTIPLE VESICLE FORMATION ON FACE EVEN AFTER HYALURONIDASE ADMINISTRATION (LACK OF DRUG EFFECT) WITH NO ADVERSE EVENT",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
"PATIENT TREATED WITH METHOTREXATE, DOXYCYCLINE AND HYDROXYCHLOROQUINE SULFATE FOR LICHEN PLANOPILARIS (OFF LABEL USE FOR INDICATION) WITH NO ADR",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
QTC 584MS,Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
IMPAIRED LEFT AND SLIGHTLY IMPAIRED RIGHT SYSTOLIC VENTRICULAR FUNCTION,Left ventricular systolic dysfunction,LEFT VENTRICULAR SYSTOLIC DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10069501,10049694,10069501
RETINAL TOXICITY DUE TO HYDROXYCHLOROQUINE FOLLOWING DRUG INTERACTION,Retinal toxicity,RETINAL TOXICITY,RETINAL TOXICITY,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","RETINAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10048955,10048955,10048955
TACHYCARDIA,tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
ASCITIC FLUID,Ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
HYPOKALEMIA,Hypokalaemia,HYPOKALEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021018
TREATMENT NONCOMPLIENCE,treatment noncomplience,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
CONJUNCTIVA WAS CHEMOSED WITH PAPILLARY HYPERTROPHY,conjunctiva was chemosed with papillary hypertrophy,CONJUNCTIVAL EDEMA,CONJUNCTIVAL OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CONJUNCTIVAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10010715,10010726,10010715
PRODUCT USE IN UNAPPROVED INDICATION,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
FLUDARABINE ADMINSTERED IN INFANT FOR CONDITIONING REGIMEN/ALEMTUZUMAB ADMINISTERED FOR CONDITIONING REGIMEN,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NEUTROPENIC FEVER FOLLOWING CHEMOTHERAPY DRUGS AND INTERACTION BETWEEN BORTEZOMIB AND VORINOSTAT,Febrile neutropenia,NEUTROPENIC FEVER,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10051312,10016288,10051312
URINARY RETENTION,Urinary retention,URINARY RETENTION,URINARY RETENTION,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046555,10046555,10046555
LOW BLOOD PRESSURE,low blood pressure,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10024895,10021097,10024895
SEVERE STAGE III RETINOPATHY OF PREMATURITY IN ZONE I IN BOTH EYES FOLLOWING OFF LABEL USE,Retinopathy of prematurity,RETINOPATHY OF PREMATURITY,RETINOPATHY OF PREMATURITY,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","CHOROID AND VITREOUS STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10038933,10038933,10038933
TONIC CONVULSION,Tonic convulsion,TONIC CONVULSION,TONIC CONVULSION,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10043994,10043994,10043994
DRUG INTERACTION,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
PROSTAGLANDIN ASSOCIATED PERIORBITOPATHY,Prostaglandin analogue periorbitopathy,PROSTAGLANDIN ANALOGUE PERIORBITOPATHY,PROSTAGLANDIN ANALOGUE PERIORBITOPATHY,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10079621,10079621,10079621
NAUSEA/VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PYRAZINAMIDE WAS CEASED DUE TO WIDESPREAD ARTHRALGIAS,pyrazinamide was ceased due to widespread arthralgias,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
OVERALL DECREASE IN MUSCLE STRENGTH DUE TO DRUG INTERACTION,hypotonia,HYPOTONIA,HYPOTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10021118,10021118,10021118
DYSPLASIA DUE TO LACK OF DRUG EFFECT,dysplasia,DYSPLASIA,DYSPLASIA,TISSUE DISORDERS NEC,TROPHIC DISORDERS,10018065,10058314,10058314,10058314
"HISTOLOGY SHOWED REACTIVE CHANGES IN THE EPITHELIAL CELLS, IRREGULARITY OF THE CRYPT, MIXED INFLAMMATORY CELL INFILTERATE WITH NUMEROUS LYMPHOCYES, PLASMA CELLS AND EOSINOPHILS IN THE LAMINA PROPRIA",Biopsy colon abnormal,COLON BIOPSY ABNORMAL,BIOPSY COLON ABNORMAL,GASTROINTESTINAL INVESTIGATIONS,GASTROINTESTINAL HISTOPATHOLOGY PROCEDURES,10022891,10009941,10004760,10009941
EXTREMELY PSYCHOTIC,Psychotic disorder,PSYCHOTIC,PSYCHOTIC DISORDER,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10037248,10061920,10037248
COMBATIVE,Aggression,AGGRESSIVE BEHAVIOR,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001490,10001488,10062375
PROGRESSIVE CONFUSION,confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
CORNEAL OPACITY,Corneal opacity,CORNEAL OPACITY,CORNEAL OPACITY,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CORNEAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10011035,10011035,10011035
WEAKNESS,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
SLIGHT ENLARGEMENT OF THE PAROTID GLANDS,Parotid gland enlargement,ENLARGEMENT PAROTID GLAND,PAROTID GLAND ENLARGEMENT,SALIVARY GLAND CONDITIONS,SALIVARY GLAND ENLARGEMENTS,10017947,10034023,10034023,10014850
BASICERVICAL FRACTURE OF THE PROXIMAL RIGHT FEMUR,Femoral neck fracture,FEMORAL NECK FRACTURE,FEMORAL NECK FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10016450,10016450,10016450
LOCALIZED ITCHY RASH ABOUT 12-15 CM WIDE WAS PRESENT NEXT TO THE AREA OF THE SUBCUTANEOUS ADMINISTRATION,application site pruritus,APPLICATION SITE ITCHING,APPLICATION SITE PRURITUS,ADMINISTRATION SITE REACTIONS,APPLICATION AND INSTILLATION SITE REACTIONS,10018065,10003053,10003053,10003047
CONDITION WORSENED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
SHE WAS TREATED WITH SUSPECTS DURING PREGNANCY (DRUG EXPOSURE DURING PREGNANCY),drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
"PRURITIC MACULOPAPULAR ERUPTION ON THE TRUNK, BACK, AND UPPER LIMBS",Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
BLURRED VISION AND PAIN ON EYE MOVEMENT OF THE RIGHT EYE//THE PATIENTDEVELOPED MILD PAIN AND BLURRED VISION IN THE FELLOW (LEFT) EYE,Eye pain,OCULAR PAIN,EYE PAIN,EYE DISORDERS NEC,OCULAR DISORDERS NEC,10015919,10015958,10015958,10067261
GINGIVORRHAGIA WHEN BRUSHING TEETH AND SOMETIMES EATING,Gingival bleeding,GINGIVAL BLEEDING,GINGIVAL BLEEDING,DENTAL AND GINGIVAL CONDITIONS,GINGIVAL HAEMORRHAGES,10017947,10018276,10018276,10018276
MYCOBACTERIUM HAEMOPHILUM INFECTION,mycobacterium infection,MYCOBACTERIAL INFECTION,MYCOBACTERIAL INFECTION,MYCOBACTERIAL INFECTIOUS DISORDERS,ATYPICAL MYCOBACTERIAL INFECTIONS,10021881,10062207,10062207,10062207
SWELLING OF BILATERAL ANKLES,Joint swelling,ANKLE SWELLING,JOINT SWELLING,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10002553,10023232,10002553
"EPILEPSY WAS UNCONTROLLED DESPITE TRYING VALPROATE, CARBAMAZEPINE, CLOBAZAM, LEVETIRACETAM, OXCARBAMAZEPINE AND PERAMPANEL",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
"OVER 36-48 HOURS, THE INFANT RECIEVED 1565MG PARACETAMOL (233MG/KG)",Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
WEAKNESS,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
POSITIVE RESULT FOR CRYPTOCOCCUS NEOFORMANS INFECTION,Cryptococcosis,CRYPTOCOCCUS NEOFORMANS INFECTION,CRYPTOCOCCOSIS,FUNGAL INFECTIOUS DISORDERS,CRYPTOCOCCAL INFECTIONS,10021881,10011493,10011490,10011493
NEUROPSYCHIATRIC DISTURBANCE,Neuropsychiatric symptoms,NEUROPSYCHIATRIC SYMPTOMS,NEUROPSYCHIATRIC SYMPTOMS,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS DUE TO A GENERAL MEDICAL CONDITION NEC,10037175,10078497,10078497,10078497
PR SEGMENT DEPRESSION,Electrocardiogram ST segment depression,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10014391,10014391,10014391
PRE-MATURE BABY/ HYPOTROPHIC INFANT (34TH WEEK OF PREGNANCY),Premature baby,PREMATURE BABY 33 TO 36 WEEKS,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10053594,10036590,10053594
ABSOLUTE LYMPHOCYTE COUNT DECREASED (800/CMM),absolute lymphocyte count decreased,ABSOLUTE LYMPHOCYTE COUNT DECREASED,LYMPHOCYTE COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10065395,10025256,10065395
REDNESS AND SCALING,redness,REDNESS,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10038198,10015150,10038198
NOCTURNAL SWEATING,Night sweats,NIGHT SWEATS,NIGHT SWEATS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10029410,10029410,10029410
ELEVATION OF CREATININE TO 5.2 MG/DL,Blood creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
NASAL SKIN APPEARED THICKENED,Skin hypertrophy,SKIN THICKENING,SKIN HYPERTROPHY,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,SKIN HYPERPLASIAS AND HYPERTROPHIES,10040785,10040867,10040867,10040936
TOOK PARACETAMOL AND PREGABALIN WITHOUT PRESCRIPTION/ TOOK MOTHER IN LAWS PREGABALIN,Prescription drug used without a prescription,PRESCRIPTION DRUG USED FROM ANOTHER PATIENT,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10079231,10076639,10079231
PROGRESSIVE SEPSIS DUE TO BREAST CALCIPHYLAXIS,sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
GRADE 4 CARDIAC TOXICITY,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
ELEVATED LEVELS OF ALANINE,Alanine aminotransferase increased,ALANINE AMINOTRANSFERASE INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001551,10001551,10001551
PUPIL REFLEXES ARE QUITE LOW AND RATHER SLOW,Pupillary reflex impaired,PUPILLARY REFLEX IMPAIRED,PUPILLARY REFLEX IMPAIRED,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10037532,10037532,10037532
BLOOD LEVELS OF TACROLIMUS EXCEEDED,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
"POTENTIAL DRUG-DRUG INTERACTION (FENTANYL, ENZALUTAMIDE AND DEXAMETHASONE)",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
DEATH,Death,DEATH UNEXPLAINED,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10063378,10011906,10052809
FN,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
DRUG INDUCED COLITIS/ SEVERE CHEMOTHERAPY INDUCED COLITIS,colitis,COLITIS,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009887,10009887,10009887
BLOOD LOSS DURING SURGERY REACHED 2500 ML,Haemorrhage,HAEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10055798
PROSTRATED,Fatigue,PROSTRATION,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10036985,10016256,10036985
ESR INCREASED (24 MM/HR),Red blood cell sedimentation rate increased,ESR INCREASED,RED BLOOD CELL SEDIMENTATION RATE INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),HAEMATOLOGICAL ANALYSES NEC,10022891,10015480,10049187,10015480
ACUTE TUMOR LYSIS SYNDROME,Tumour lysis syndrome,TUMOR LYSIS SYNDROME,TUMOUR LYSIS SYNDROME,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10045170,10045170,10045152
DUPILUMAB INDUCED CONJUCTIVITIS IN BOTH EYES (MILD PALPEBRAL),Conjunctivitis,CONJUNCTIVITIS,CONJUNCTIVITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10010741,10010741,10010741
"PATIENT BECAME PREGNANT WHILE ON VALPROATES, CARBAMAZEPINE (DRUG EXPOSURE DURING PREGNANCY)",Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
LACK OF DRUG EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
MULTIPLE DRUG POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
HEPATOCELLULAR DAMAGE,Hepatocellular injury,HEPATOCELLULAR DAMAGE,HEPATOCELLULAR INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019837,10019837,10019831
RECURRENCE OF LUNG SQUAMOUS CELL CARCINOMA FOLLOWING LACK OF DRUG EFFECT,Lung squamous cell carcinoma recurrent,LUNG SQUAMOUS CELL CARCINOMA RECURRENT,LUNG SQUAMOUS CELL CARCINOMA RECURRENT,RESPIRATORY AND MEDIASTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,NON-SMALL CELL NEOPLASMS MALIGNANT OF THE RESPIRATORY TRACT CELL TYPE SPECIFIED,10029104,10025120,10025120,10025120
TRICUSPID VALVE LACK OF PERMEABILITY,congenital tricuspid insufficiency,CONGENITAL TRICUSPID INSUFFICIENCY,CONGENITAL TRICUSPID VALVE INCOMPETENCE,CARDIAC AND VASCULAR DISORDERS CONGENITAL,CARDIAC VALVE DISORDERS CONGENITAL,10010331,10067888,10067887,10067888
GENERALIZED PALENESS,Pallor,PALE,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033546,10033546,10033532
AMIODARONE-INDUCED TORSADES DE POINTES,Torsade de pointes,TORSADES DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044067
LEFT HEMIPARESIS,Hemiparesis,HEMIPARESIS (LEFT),HEMIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019466,10019465,10019466
"EARLY MORNING DYSTONIA AT THE RIGHT FOOT, SLIGHT URINARY URGENCY, MILD ATTENTIVE DEFICITS, DAYTIME SLEEPINESS, ANXIETY, MILD POSTURAL AND KINETIC TREMOR OF THE UPPER LEFT LIMB, MILD BRADYKINESIA,PEAK",Micturition urgency,MICTURITION URGENCY,MICTURITION URGENCY,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10027566,10027566,10027566
PARAESTHESIA,Paraesthesia,PARAESTHESIA,PARAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10033775,10033775,10033775
BLOOD POTASSIUM DECREASED (2.6 MEQ/L) FOLLOWING MULTIPLE DRUG OEVRDOSE,Blood potassium decreased,BLOOD POTASSIUM DECREASED,BLOOD POTASSIUM DECREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10005724,10005724,10005724
INTOXICATION LEADING TO BRUGADA PATTERN,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
RIFAMPICIN-INDUCED THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
SPINAL OSTEOARTHRITIS,Spinal osteoarthritis,SPINAL OSTEOARTHRITIS,SPINAL OSTEOARTHRITIS,JOINT DISORDERS,OSTEOARTHROPATHIES,10028395,10041591,10041591,10041591
RECEIVE DIAZEPAM FOR DEPRESSION,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
HYDROPERICARDIUM,Pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
NON-PRODUCTIVE COUGH,non-productive cough,COUGH NONPRODUCTIVE,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011229,10011224,10011229
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
ORAL INFECTION WITH CULTURE POSITIVE FOR  RAOULTELLA PLANTICOLA,Raoultella test positive,RAOULTELLA TEST POSITIVE,RAOULTELLA TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,BACTERIA IDENTIFICATION AND SEROLOGY (EXCL MYCOBACTERIA),10022891,10070086,10070086,10070086
"MELENA (3 EPISODES OF LARGE-VOLUME, MAROON-COLORED STOOLS WITH BLOOD CLOTS)",Melena,MELENA,MELAENA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10027162,10027141,10027162
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PATIENT WAS TREATED WITH AZATHIOPRINE AND COLCHICINE FOR BEHCET'S DISEASE AND ORAL AND GENITAL ULCER BUT THEY WERE INEFFECTIVE (LACK OF DRUG EFFECT) WITH NO ADVERSE EVENT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HEMATOCHEZIA SYMPTOMS,Haematochezia,HEMATOCHEZIA,HAEMATOCHEZIA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10018836,10018836,10060544
SPLENOMEGALY,Splenomegaly,SPLENOMEGALY,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041660,10041660,10041660
FACIAL SWELLING,Swelling face,FACIAL SWELLING,SWELLING FACE,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10042682,10042682,10016065
DESPITE LONG TERM TREATMENT WITH PREDNISOLONE FOR CONJUNCTIVITIS NO EFFECT HAS BEEN SEEN,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
TENSE ABDOMEN,Abdominal discomfort,LOWER ABDOMEN TENSE FEELING OF,ABDOMINAL DISCOMFORT,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10024939,10000059,10024939
ABDOMINAL PAINS,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
GRADUAL DETERIORATION OF HIS CONDITION (TICK-BORNE VIRAL ENCEPHALITIS),Condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
BONE MARROW SUPPRESSION,Bone marrow failure,MYELOSUPPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10028584
FEBRILE,febrile,FEBRILE REACTION,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016289,10037660,10016289
SERUM CREATINE KINASE INCREASED (976 TIMES THE UPPER LIMIT OF NORMAL),Blood creatine phosphokinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
INABILITY TO WALK,walking disability,WALKING DISABILITY,WALKING DISABILITY,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10053204,10053204,10053204
PARONYCHIA,Paronychia,PARONYCHIA,PARONYCHIA,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10034016,10034016,10034016
HYPERESTROGENISM,hyperestrogenism,HYPERESTROGENISM,HYPEROESTROGENISM,ENDOCRINE DISORDERS OF GONADAL FUNCTION,ENDOCRINE ABNORMALITIES OF GONADAL FUNCTION NEC,10014698,10020624,10020689,10020624
USE OF FLUDARABINE PHOSPHATE AS CONDITIONING REGIMEN FOR HEMATOPOETIC STEM CELL TRANSPLANTATION (OFF LABEL USE FOR INDICATION) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DELIRIUM,delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
BULLOUS PEMPHIGOID AFTER WITHDRAWAL OF IMMUNOSUPPRESSIVE THERAPY,Pemphigoid,BULLOUS PEMPHIGOID,PEMPHIGOID,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006567,10034277,10006567
TEMPORARY SLOWING DOWN OF HEART RATE OCCURRED FROM 65/MIN TO 56/MIN,Heart rate decreased,HEART RATE DECREASED,HEART RATE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019301,10019301,10019301
WIDESPREAD URTICARIAL RASH,Urticaria,URTICARIAL RASH,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046758,10046735,10046758
MATERNAL EXPOSURE DURING PREGNANCY WITH NO ADVERSE EVENT,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
TWITCHING OF HER UPPER EXTREMITIES,Muscle twitching,TWITCHING,MUSCLE TWITCHING,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10045198,10028347,10045198
RECURRENT PULSELESS VT FOLLOWING MULTIPLE DRUG OVERDOSE,Ventricular fibrillation,PULSELESS VENTRICULAR TACHYCARDIA,VENTRICULAR FIBRILLATION,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10073034,10047290,10073034
USE IN CHILD LESS THAN 12 YEARS OF AGE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ACUTE STRONG NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
BUNDLE-BRANCH BLOCK FOLLOWING SEVERE HYPOKALEMIA (1.5 MMOL/L) FOLLOWING ACUTE OVERDOSE,Bundle branch block,BLOCK BUNDLE BRANCH,BUNDLE BRANCH BLOCK,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10006578,10006578,10005268
SKIN LESIONS INFECTED WITH STAPHYLOCOCCUS AUREUS AND MULTIFOCAL PNEUMONIA,skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
PROGRESSIVE RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
ADMITTED TO THE HOSPITAL WITH POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
HYPOTENSIVE SHOCK (BP 70/50 MMHG),Shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
GASTRIC SYMPTOMS,Gastric disorder,GASTRIC DISORDER,GASTRIC DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10056819,10056819,10056819
GLARING DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
BLEEDING IN JUGULAR VEIN,venous bleeding,VENOUS BLEEDING,VENOUS HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10071916,10065441,10071916
GAMMA GLOBULIN INCREASED,Immunoglobulins increased,GAMMA GLOBULIN INCREASED,IMMUNOGLOBULINS INCREASED,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOGLOBULIN ANALYSES,10022891,10017666,10021500,10017662
ANAPHYLAXIS,Anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
BILATERAL LOWER EXTREMITY MUSCLE CRAMPS,Muscle spasms,LEG CRAMPS,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10011301,10028334,10024125
INJECTION SITE REACTION,Injection site reaction,INJECTION SITE REACTION,INJECTION SITE REACTION,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022095,10022095,10022095
GRADE 4 BONE MARROW DEPRESSION,Bone marrow failure,BONE MARROW DEPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10005986
ALLERGY,Hypersensitivity,ALLERGY,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001738,10020751,10001738
RELAPSE AFTER CESSATION OF ALBENDAZOLE AFTER ACHEIVING PARASITOLOGICAL CURE,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
FOURTH VENTRICLE EFFACEMENT,cerebral ventricle dilatation,CEREBRAL VENTRICLE DILATATION,CEREBRAL VENTRICLE DILATATION,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10048824,10048824,10048824
CYTOGENETIC RELAPSE,Cytogenetic abnormality,CYTOGENETIC ABNORMALITY,CYTOGENETIC ABNORMALITY,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,CHROMOSOMAL ABNORMALITIES NEC,10010331,10067477,10067477,10067477
RHABDOMYOLYSIS,rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
PTOSIS,Eyelid ptosis,PTOSIS,EYELID PTOSIS,OCULAR NEUROMUSCULAR DISORDERS,EYELID MOVEMENT DISORDERS,10015919,10015995,10015995,10037272
BILATERAL RENAL INFARCTIONS DURING THE USE OF SUMATRIPTAN,Renal infarct,RENAL INFARCTION,RENAL INFARCT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL VASCULAR AND ISCHAEMIC CONDITIONS,10038359,10038470,10038470,10038471
GENERALIZED HYPOTONIA FOLLOWING DRUG EXPOSURE IN UTERO,Benign congenital hypotonia,BENIGN CONGENITAL HYPOTONIA,BENIGN CONGENITAL HYPOTONIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,NON-SITE SPECIFIC MUSCLE DISORDERS CONGENITAL,10010331,10051900,10051900,10051900
PATIENT HAD DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
LETHARGY,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
ULCER ON THE RIGHT LOWER LEG DEVELOPED/ [NECROTIZING CELLULITIS] WITH A CONSEQUENT ULCER ON THE RIGHT LOWER LEG,leg ulcer,LEG ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10068310,10040943,10068310
RETICULIN FIBROSIS IN BONE MARROW (GRADE2/3),Bone marrow reticulin fibrosis,BONE MARROW RETICULIN FIBROSIS,BONE MARROW RETICULIN FIBROSIS,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10069678,10069678,10069678
LIFE-THREATENING CARDIOGENIC SHOCK,Cardiogenic shock,CARDIOGENIC SHOCK,CARDIOGENIC SHOCK,HEART FAILURES,HEART FAILURES NEC,10007541,10007625,10007625,10007625
FLUDARADINE ADMINISTERED IN INFANT FOR CONDITIONING REGIMEN,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ACUTE INTERSTITIAL PNEUMONITIS,Acute interstitial pneumonitis,ACUTE INTERSTITIAL PNEUMONITIS,ACUTE INTERSTITIAL PNEUMONITIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10066728,10066728,10066728
SERUM OSMOLARITY OF 306 MOSM/L,Blood osmolarity increased,BLOOD OSMOLARITY INCREASED,BLOOD OSMOLARITY INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",WATER AND ELECTROLYTE ANALYSES NEC,10022891,10005697,10005697,10005697
SHOCK STATES,Shock,SHOCK,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040560,10040560,10040560
MASSIVE BUPRENORPHINE INTOXICATION/FATAL INTOXICATION FOLLOWING SELF-ADMINISTRATION OF A MASSIVE DOSE OF BUPRENORPHINE,Drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
VORICONAZOLE-INDUCED POLYNEUROPATHY WITH A MYOPATHIC COMPONENT,Neuromyopathy,NEUROMYOPATHY,NEUROMYOPATHY,NEUROMUSCULAR DISORDERS,NEUROMUSCULAR DISORDERS NEC,10029205,10029323,10029323,10029323
HYPOXIC,Hypoxia,HYPOXIC,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021144,10021143,10021144
ANOXIC BRAIN INJURY,anoxic brain damage,ANOXIC BRAIN DAMAGE,BRAIN INJURY,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10002663,10067967,10002663
SECONDARY WOUND INFECTION DUE TO MYCOBACTERIUM HAEMOPHILUM,wound infection bacterial,WOUND INFECTION BACTERIAL,WOUND INFECTION BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10065240,10065240,10065240
CHRONIC ALLOGRAFT DYSFUNCTION DUE TO BK VIRUS NEPHROPATHY,Complications of transplanted kidney,KIDNEY GRAFT DYSFUNCTION,COMPLICATIONS OF TRANSPLANTED KIDNEY,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10051366,10010185,10051366
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,FOETAL EXPOSURE DURING PREGNANCY,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071404,10071404,10071404
DISEASE PROGRESSION,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
HUNGRY BONE SYNDROME,Hungry bone syndrome,HUNGRY BONE SYNDROME,HUNGRY BONE SYNDROME,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10062623,10062623,10062623
CHEST PAIN,chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
TRANSITORY BILATERAL BLINDNESS DUE TO BILATERAL RETINAL EDEMA FOLLOWING MEDICATION ERROR,Bilateral blindness,BILATERAL BLINDNESS,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10004556,10005169,10004556
PORPHYRIA NON-ACUTE,Porphyria non-acute,PORPHYRIA NON-ACUTE,PORPHYRIA NON-ACUTE,METABOLIC AND NUTRITIONAL DISORDERS CONGENITAL,INBORN ERRORS OF PORPHYRIN METABOLISM,10010331,10036186,10036186,10036186
MACULOPAPULAR MORBILLIFORM RASH ACROSS HER BACK AND TORSO WHICH RAPIDLY SPREAD TO PROXIMAL ASPECTS OF ALL FOUR LIMBS,Rash morbilliform,MORBILLIFORM RASH,RASH MORBILLIFORM,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037870,10037870,10027970
DETERIORATION OF EGFR IS STRONGLY LINKED TO ENHANCED PLATELET ACTIVITY DURING DAPT,Renal impairment,RENAL FUNCTION AGGRAVATED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038453,10062237,10038453
GASTROINTESTINAL STROMAL TUMOR FOLLOWING DISESSE PROGRESSION,gastrointestinal stromal tumor following disesse progression,GASTROINTESTINAL STROMAL TUMOR,GASTROINTESTINAL STROMAL TUMOUR,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,GASTROINTESTINAL NEOPLASMS MALIGNANCY UNSPECIFIED NEC,10029104,10062427,10051066,10062427
ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
NO RESPONSE TO THE CLINICAL TREATMENT,no response to the clinical treatment,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
ST-SEGMENT ELEVATION IN THE INFERIORWALL AND DEPRESSION IN THE LATERAL AND ANTERIOR LEADS,Electrocardiogram ST segment elevation,ST SEGMENT ELEVATION,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041893,10014392,10041894
NO ADVERSE EVENT,No adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
GENERALIZED TONIC CLONIC SEIZURES,Generalised tonic-clonic seizure,GENERALIZED TONIC-CLONIC SEIZURE,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10018100,10018100,10062448
ASPARTATE AMINOTRANSFERASE (405 U/L),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
RECURRENT STATUS EPILEPTICUS// SUSPECTED STATUS EPILEPTICUS,Status epilepticus,STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10041962,10041962,10041962
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
MILD NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HYPOTHERMIA,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
AMIODARONE INDUCED NONALCOHOLIC STEATOHEPATITIS,Non-alcoholic steatohepatitis,NON-ALCOHOLIC STEATOHEPATITIS,NON-ALCOHOLIC STEATOHEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10053219,10053219,10053219
BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
"LEUKOPENIA, STOMATITIS, MTX FOR ECTOPIC PREGNANCY, DRUG USE VIA UNAPPROVED ADMINISTRATION ROUTE (MTX VIA INTRA-AMNIOTIC ROUTE)",Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
BILATERAL TEMPORAL HEADACHE,Headache temporal,HEADACHE TEMPORAL,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019225,10019211,10019225
POST-TRANSPLANT DIABETES MELLITUS,Diabetes mellitus,POST TRANSPLANT DIABETES MELLITUS,DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10063634,10012601,10063634
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CAESAREAN SECTION,Caesarean Section,CAESAREAN SECTION,CAESAREAN SECTION,OBSTETRIC AND GYNAECOLOGICAL THERAPEUTIC PROCEDURES,OBSTETRIC THERAPEUTIC PROCEDURES,10042613,10006924,10006924,10006924
DRUG EXPOSURE DURING PREGNANCY,Drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
HYPERURICAEMIA,Hyperuricaemia,HYPERURICAEMIA,HYPERURICAEMIA,PURINE AND PYRIMIDINE METABOLISM DISORDERS,DISORDERS OF PURINE METABOLISM,10027433,10020903,10020903,10020903
VOMITUS,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
RESPIRATORY DEPRESSION,Respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
CARDIAC DECOMPENSATION,Decompensation cardiac,DECOMPENSATION CARDIAC,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10011949,10007554,10011949
ACUTE EPIDIDYMITIS RIGHT,Epididymitis,EPIDIDYMITIS,EPIDIDYMITIS,INFECTIONS - PATHOGEN UNSPECIFIED,MALE REPRODUCTIVE TRACT INFECTIONS,10021881,10015000,10015000,10015000
"HAD A SOFT AND WARM FLUCTUATING MASS ON HER ANTERIOR CHEST WALL, MASS ON HER BACK IN THE INFERIOR PART OF THE CHEST, AND AXILLARY MASS WHICH WAS FISTULIZED AND",Axillary mass,AXILLARY MASS,AXILLARY MASS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,SOFT TISSUE DISORDERS NEC,10028395,10049021,10049021,10049021
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
BLOOD GLUCOSE LEVEL OF 280 MG/DL,Blood glucose increased,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10005557,10005557,10005557
QUININE INTOXICATION,Quinine intoxication,QUININE INTOXICATION,CINCHONISM,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10037736,10009189,10037736
ENCEPHALOPATHY AFTER ACETAMINOPHEN POISONING,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
THE PATIENT HAS DIFFICLULTY SWALLOWING,Dysphagia,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10013950,10013950,10013950
VOLUMINOUS SWELLING OF LEFT TONSIL,Tonsillar hypertrophy,ENLARGED TONSILS,TONSILLAR HYPERTROPHY,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),PHARYNGEAL DISORDERS (EXCL INFECTIONS AND NEOPLASMS),10038738,10066081,10044003,10066081
MYELOPROLIFERATIVE NEOPLASM,Myeloproliferative neoplasm,MYELOPROLIFERATIVE NEOPLASM,MYELOPROLIFERATIVE NEOPLASM,HAEMATOPOIETIC NEOPLASMS (EXCL LEUKAEMIAS AND LYMPHOMAS),MYELOPROLIFERATIVE DISORDERS (EXCL LEUKAEMIAS),10029104,10077465,10077465,10077465
"MULTI-ORGAN FAILURE FOLLOWING DETERIORATION OF PATIENT'S CLINICAL SYMPTOMS OF NK/T-CELL LYMPHOMA AND HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS DESPITE TREATMENT WITH DEXAMETHASONE,ETOPOSIDE AND RITUXIMAB",Multiple organ dysfunction syndrome,MULTI-ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028154
NON-TUBERCULOSIS MYCOBACTERIAL CERVICAL ADENITIS,cervical adenitis ,CERVICAL ADENITIS,LYMPHADENITIS,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10008223,10025188,10008223
INCREASED VIRAL LOAD,Viral load increased,VIRAL LOAD INCREASED,VIRAL LOAD INCREASED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10062180,10062180,10062180
"DESPITE ANTIBIOTIC THERAPY, THE PATIENT'S CONDITION WORSENED (LACK OF DRUG EFFECT)",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PSA NADIR OF 10 NG/ML,Prostatic specific antigen abnormal,PROSTATIC SPECIFIC ANTIGEN ABNORMAL,PROSTATIC SPECIFIC ANTIGEN ABNORMAL,CYTOGENETIC INVESTIGATIONS,CELL MARKER ANALYSES,10022891,10058012,10058012,10058012
PATIENT WAS IN HER TWENTY-NINTH WEEK OF PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
LACK OF EFFICACY,lack,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
DIARRHOEA,diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
SUSPECTED UPPER GASTROINTESTINAL HAEMORRHAGE,Upper gastrointestinal haemorrhage,UPPER GASTROINTESTINAL HAEMORRHAGE,UPPER GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10046274,10046274,10046274
ABNORMAL CONTACT AND INVOLUNTARY MOVEMENT OF THE UPPER LIMBS,Movements involuntary of limbs,MOVEMENTS INVOLUNTARY OF LIMBS,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028043,10013916,10028043
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
RECURRENT EPISODES OF GASTROINTESTINAL BLEEDING,gastrointestinal bleeding,GASTROINTESTINAL BLEEDING,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017936,10017955,10017936
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
DRUG RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
AGITATED,Agitation,AGITATED,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001495
"SEMI-LIQUID, PITCH BLACK STOOLS",Faeces discoloured,BLACK STOOLS,FAECES DISCOLOURED,GASTROINTESTINAL SIGNS AND SYMPTOMS,FAECAL ABNORMALITIES NEC,10017947,10004977,10016100,10004977
HANGOVER,Hangover,HANGOVER,HANGOVER,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10019133,10019133,10019133
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
CRP LEVEL INCREASED,CRP increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
ELEVATED LIVER ENZYMES,Hepatic enzyme increased,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
OFF LABEL USE FOR INDICATION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PRURITIC RASH (LOCALISED INITIALLY TO THE DORSAL ASCPECT OF BOTH FEET),Rash pruritic,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10037085
"THE TRANSESOPHAGEAL ECHOCARDIOGRAM SHOWED A VOLUPTUOUS VEGETATION OF THE MITRAL VALVE,CONDITIONING A SEVERE REGURGITATION",Mitral regurgitation,MITRAL REGURGITATION,MITRAL VALVE INCOMPETENCE,CARDIAC VALVE DISORDERS,MITRAL VALVULAR DISORDERS,10007541,10027718,10027727,10027718
ANURIA,Anuria,ANURIA,ANURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10002847,10002847,10002847
DELAYED TYPE HYPERSENSITIVITY,delayed type hypersensitivity,DELAYED TYPE HYPERSENSITIVITY,TYPE IV HYPERSENSITIVITY REACTION,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10012210,10053613,10012210
BLOODY DIARRHEA,Diarrhoea haemorrhagic,BLOODY DIARRHEA,DIARRHOEA HAEMORRHAGIC,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012741,10012741,10005872
WHITE BLOOD CELL COUNT DECREASED,White blood cell count decreased,WHITE BLOOD CELL COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10047942
DRUG-DRUG PHARMACODYNAMIC INTERACTION,Drug-drug pharmacodynamic interaction,DRUG-DRUG PHARMACODYNAMIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10065993,10013710,10065993
CHEST TIGHTNESS,Chest tightness,CHEST TIGHTNESS,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008492,10008469,10008492
INJECTION SITE REACTION,Injection site reaction,INJECTION SITE REACTION,INJECTION SITE REACTION,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022095,10022095,10022095
POOR ORAL INTAKE,Hypophagia,ORAL INTAKE REDUCED,HYPOPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10063889,10063743,10063889
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
LOST CONSCIOUSNESS,Loss of consciousness,LOST CONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10024885
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) SYNDROME,DRESS syndrome,DRESS SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10058899,10073508,10058899
EOSINOPHILIA,eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
HEMORRHAGIC SWEET'S SYNDROME,Sweet's syndrome,SWEET'S SYNDROME,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10042673,10000748,10042673
INAPPETENCE,inappetence,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
JAW PAIN,Pain in jaw,JAW PAIN,PAIN IN JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10033433,10033433,10023157
OPIUM ADDICTION,Drug dependence,OPIUM ADDICTION,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10030900,10013663,10030900
METFORMIN ASSOCIATED LACTIC ACIDOSIS,lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
FATIGUE,fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
PUPILS FIXED AND DILATED,Pupil fixed,FIXED DILATED PUPILS,PUPIL FIXED,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10016738,10037515,10016739
DYSMETRIA,Dysmetria,DYSMETRIA,DYSMETRIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10013936,10013936,10013936
NORMOCYTIC NORMOCHROMIC ANEMIA,normocytic normochromic anemia,NORMOCHROMIC ANEMIA,NORMOCHROMIC ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10054484,10029782,10054484
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
INFANTILE HEMANGIOMAS TREATED WITH ORAL PROPRANOLOL,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INTERFACE DERMATITIS,Dermatitis,INTERFACE DERMATITIS,DERMATITIS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10072824,10012431,10072824
HEMODYNAMIC INSTABILITY,Haemodynamic instability,HEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10052076,10052076,10058270
DYSPNEA,dyspnea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
FAILED TREATMENT WITH IBUPROFEN,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
HHV6 INFECTION,Human herpesvirus 6 infection,HUMAN HERPESVIRUS 6 INFECTION,HUMAN HERPESVIRUS 6 INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10020431,10020431,10020431
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
ARTERIAL HYPERTENSION (VALUE-160/100 MMHG),Hypertension,HYPERTENSION ARTERIAL,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020775,10020772,10020775
CARDIAC ARRHYTHMIA,CARDIAC ARRHYTHMIA,CARDIAC ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10007518,10003119,10007518
SUBACUTE STENT THROMBOSIS (ST),Vascular stent thrombosis,CORONARY STENT THROMBOSIS,VASCULAR STENT THROMBOSIS,COMPLICATIONS ASSOCIATED WITH DEVICE,VASCULAR COMPLICATIONS ASSOCIATED WITH DEVICE,10018065,10063933,10063934,10063933
A RESPONSE WAS NOT OBSERVED TO THESE DRUG,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PROGRESSIVE RETROSTERNAL PAIN,Retrosternal pain,RETROSTERNAL PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10038988,10008479,10038988
ELEVATED EOSINOPHILS COUNT OF 2.4 Ã— 109/L,Eosinophil count increased,EOSINOPHIL COUNT INCREASED,EOSINOPHIL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10014945,10014945,10014945
BACTERIAL MENINGITIS FOLLOWING BACTERIAL SINUSITIS,bacterial meningitis,BACTERIAL MENINGITIS,MENINGITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10004049,10027202,10004049
ADENOCARCINOMA/TUMOR RECURRENCE FOLLOWING ADMINISTRATION OF PREMETREXED (DISEASE PROGRESSION),Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
PATIENT WAS TREATED WITH FLUDARABINE PHOSPHATE AND ALEMTUZUMAB AS CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (DRUG USE FOR UNAPPROVED INDICATION) WITH NO ADVERSE DRUG REACTION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
MILD LEUCOCYTOSIS (16.3 X 10E9/1),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
ACUTE MYOCARDIAL INFARCTION,acute myocardial infarction,ACUTE MYOCARDIAL INFARCTION,ACUTE MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10000891,10000891,10000891
LICHENOID ERUPTION,eruption lichenoid,ERUPTION LICHENOID,LICHENOID KERATOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,HYPERKERATOSES,10040785,10015141,10064000,10015141
DRUG INDUCED PSEUDOPORPHYRIA,Pseudoporphyria,PSEUDOPORPHYRIA,PSEUDOPORPHYRIA,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10037145,10037145,10037145
HYPOSMIA (SUDDEN LOSS IN HER SENSE OF SMELL),Hyposmia,HYPOSMIA,HYPOSMIA,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OLFACTORY NERVE DISORDERS,10029205,10050515,10050515,10050515
"OCCASIONAL BURNING, PINPRICKS AND SWELLING OF THE CLITORIS, WHICH IN A FEW DAYS TURNED STRONGER AND REGULAR",Priapism,PRIAPISM,PRIAPISM,SEXUAL FUNCTION AND FERTILITY DISORDERS,ERECTION AND EJACULATION CONDITIONS AND DISORDERS,10038604,10036661,10036661,10036661
"HEPATIC CYTOLYSIS AND ACUTE HEPATIC FAILURE INDUCED BY A TRIPLE DRUG INTERACTION (PONATINIB, VORICONAZOLE,",acute hepatic failure,ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10000804
SELF-MEDICATION WITH BACLOFEN,self-medication,SELF-MEDICATION,SELF-MEDICATION,THERAPEUTIC PROCEDURES AND SUPPORTIVE CARE NEC,THERAPEUTIC PROCEDURES NEC,10042613,10050729,10050729,10050729
15CM WIDE BY 7 CM TALL LEFT SIDED FLANK MASS THAT DISAPPEARED WHILE LYING IN THE RIGHT LATERAL DECUBITUS POSITION,abdominal mass,ABDOMINAL MASS,ABDOMINAL MASS,GASTROINTESTINAL SIGNS AND SYMPTOMS,ABDOMINAL FINDINGS ABNORMAL,10017947,10000077,10000077,10000077
GRADE 2-3 HAND-FOOT SYNDROME,Palmar-plantar erythrodysaesthesia syndrome,HAND AND FOOT SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10019111,10033553,10019111
STATUS EPILEPTICUS,Status epilepticus,STATUS EPILEPTICUS,STATUS EPILEPTICUS,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10041962,10041962,10041962
BLEEDING FROM THE SURGICAL SITE,Haemorrhage,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10005103
RIGIDITY,Muscle rigidity,RIGIDITY,MUSCLE RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10039168,10028330,10039168
AZITHROMYCIN-INDUCED LIVER INJURY FOLLOWING DRUG EXPOSURE DURING PREGNANCY,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
URINARY TRACT INFECTION,Urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
CARDIAC FAILURE ACUTE,Cardiac failure acute,CARDIAC FAILURE ACUTE,CARDIAC FAILURE ACUTE,HEART FAILURES,HEART FAILURES NEC,10007541,10007556,10007556,10007556
MYALGIA,Myalgia,MYALGIA,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028411
MILD DYSLALIA,Dyslalia,DYSLALIA,DYSLALIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10013931,10013931,10013931
SERTRALINE USED FOR HYPERSEXUALITY,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
SHORTNESS OF BREATH,shortness of breath,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
LOW BIRTH WEIGHT,Low birth weight baby,LOW BIRTH WEIGHT BABY,LOW BIRTH WEIGHT BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10067508,10067508,10067508
POSTINFLAMMATORY HYPERPIGMENTATION/HYPERPIGMENTATION SKIN,Hyperpigmentation skin,HYPERPIGMENTATION SKIN,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10020715,10040865,10020715
RIGHT BUNDLE BRANCH BLOCK,RIGHT BUNDLE BRANCH BLOCK,RIGHT BUNDLE BRANCH BLOCK,BUNDLE BRANCH BLOCK RIGHT,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10039147,10006582,10039147
DIFFERENT STAGES OF BLISTERS TO NECROTIC SUPERFICIAL CHANGES,necrosis,NECROSIS,NECROSIS,TISSUE DISORDERS NEC,NECROSIS NEC,10018065,10028851,10028851,10028851
CIRCULATORY FAILURE,Circulatory collapse,CIRCULATORY FAILURE,CIRCULATORY COLLAPSE,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10009195,10009192,10009195
LITHIUM LEVEL WAS ELEVATED AT 1.8 (REF: 0.5-1.5 MEQ/L),Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
INCREASING DOSES OF EPHEDRINE WERE NOT EFFECTIVE,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
SYSTOLIC BLOOD PRESSURE INCREASED (170MM HG),Blood pressure systolic increased,BLOOD PRESSURE SYSTOLIC INCREASED,BLOOD PRESSURE SYSTOLIC INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005760,10005760,10005760
DORSALIS PEDIS ARTERY AND POSTERIOR TIBIAL ARTERY PULSES WERE ABSENT IN TTHE RIGHT HAND,pulse absent,PULSE ABSENT,PULSE ABSENT,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10037469,10037469,10037469
DETERIORATION OF MENTAL STATE,Mental deterioration,MENTAL DETERIORATION,MENTAL IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10027352,10027374,10027352
PRESSURE CHEST,Pressure chest,PRESSURE CHEST,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10036643,10008469,10036643
RECURRENT ERYTHRODERMA,Dermatitis exfoliative generalised,ERYTHRODERMA,DERMATITIS EXFOLIATIVE GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10015277,10012456,10015277
HYPOGLYCAEMIA (SEVERE HYPOGLYCAEMIC EPISODES),Hypoglycaemic episode,HYPOGLYCAEMIC EPISODE,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10060385,10020993,10060385
MULTI-ORGAN FAILURE,Multiple organ dysfunction syndrome,MULTI-ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028154
VISUAL ACUITY DECREASED (2/60 IN RIGHT EYE AND 1/60 IN LEFT EYE),Visual acuity reduced,VISUAL ACUITY DECREASED,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047531,10047531,10049061
VISUAL HALLUCINATIONS,visual hallucinations,VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10047570,10019075,10047570
"ON AN UNSPECIFIED DATE THE PATIENT DEVELOPED OSTEONECROSIS OF JAW, PAIN, HALITOSIS, HYPOESTESIA",Lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
"RAPID DETERIORATION, WITH ENCEPHALOPATHY, ATAXIA, AND DYSARTHRIA AND RECURRENT STATUS",Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
DISTAL TREMOR IN THE UPPER LIMBS,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
COMPRESSION OF THE THECAL SAC,Thecal sac compression,THECAL SAC COMPRESSION,THECAL SAC COMPRESSION,SPINAL CORD AND NERVE ROOT DISORDERS,LUMBAR SPINAL CORD AND NERVE ROOT DISORDERS,10029205,10074801,10074801,10074801
COMPLETE INTERNAL AND EXTERNAL OPHTHALMOPLEGIA,Ophthalmoplegia,TOTAL OPHTHALMOPLEGIA,OPHTHALMOPLEGIA,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10044103,10030875,10044103
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ITCHING,itching,ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023084,10037087,10023084
ALT INCREASED -1124 U/ L,Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
SEVERE INFUSION REACTION,Infusion related reaction,INFUSION RELATED REACTION,INFUSION RELATED REACTION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10051792,10051792,10051792
SENSORY EXAMINATION SHOWED DECREASED SENSATION AND LOSS OF SHARP/DULL DISCRIMINATION OVER THE ANTEROLATERAL THIGH,Sensory disturbance,SENSORY DISTURBANCE,SENSORY DISTURBANCE,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10040026,10040026,10040026
"INTERACTION BETWEEN TRAMADOL, ONDANSETRON AND IFOSFAMIDE WAS SUSPECTED, WHICH MIGHT HAVE ALTERED METABOLISM OF IFOSFAMIDE, RESULTING IN THE ENCEPHALOPATHY",Drug-drug pharmacokinetic interaction,DRUG-DRUG PHARMACOKINETIC INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10065994,10013710,10065994
HAEMOLYSIS,Haemolysis,HAEMOLYSIS,HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10018910,10018910,10018910
GENITAL MUCOUS EROSION,Genital erosion,GENITAL EROSION,GENITAL EROSION,REPRODUCTIVE TRACT DISORDERS NEC,REPRODUCTIVE TRACT DISORDERS NEC (EXCL NEOPLASMS),10038604,10063802,10063802,10063802
FUNCTIONAL IMPAIREMENT FOLLOWING STAPHYLOCOCCUS EPIDERMIDIS INFECTION,Impaired work ability,IMPAIRED WORK ABILITY,IMPAIRED WORK ABILITY,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10052302,10052302,10052302
AN INGUINAL LYMPHADENOPATHY THAT WAS A METASTATIC SQUAMOUS CELL CARCINOMA,Metastatic squamous cell carcinoma,METASTATIC SQUAMOUS CELL CARCINOMA,METASTATIC SQUAMOUS CELL CARCINOMA,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10063569,10063569,10063569
MULTIDRUG-RESISTANT NEISSERIA GONORRHOEAE FAILING TREATMENT WITH CEFTRIAXONE AND DOXYCYCLINE,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
HYPERNATREMIA,Hypernatremia,HYPERNATREMIA,HYPERNATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10020680,10020679,10020680
HYPOVOLEMIC SHOCK,Hypovolemic shock,HYPOVOLEMIC SHOCK,HYPOVOLAEMIC SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10021140,10021138,10021140
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
NECK SWELLING,neck swelling,NECK SWELLING,SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10049568,10042674,10049568
NECROTIC CUTANEOUS LESIONS ON HER LEGS AND FACE WITH INFLAMMATORY PERIMETER,Skin necrosis,SKIN NECROSIS,SKIN NECROSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040893,10040893,10040893
GRADE 4 ERYTHEMA MULTIFORME,Erythema multiforme,ERYTHEMA MULTIFORME,ERYTHEMA MULTIFORME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10015218,10015218,10015218
REDUCED EFFICACY/ LACK OF EFFICACY/LOW EFFICACY,Therapeutic response decreased,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10043414,10043414,10043414
EXANTHEMA GENERALISED,Rash generalised,EXANTHEMA GENERALISED,RASH GENERALISED,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10058693,10037858,10058693
ALT INCREASED (381U/L),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
ESOPHAGEAL SUBMUCOSAL HEMATOMA,Oesophageal intramural haematoma,OESOPHAGEAL INTRAMURAL HAEMATOMA,OESOPHAGEAL INTRAMURAL HAEMATOMA,GASTROINTESTINAL HAEMORRHAGES NEC,GASTRIC AND OESOPHAGEAL HAEMORRHAGES,10017947,10077486,10077486,10077486
CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
DESPITE ADDITION OF METHYLPREDNISOLONE TO SECUKINUMAB TREATMENT WAS NOT EFFECTIVE (LACK OF DRUG EFFECT),Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
AMMONIA INCREASED,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
AGONAL BREATHING,Agonal rhythm,AGONAL RHYTHM,AGONAL RHYTHM,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10054015,10054015,10054015
HEAD INJURY FOLLOWING FALLS,Head injury,HEAD INJURY,HEAD INJURY,INJURIES NEC,SITE SPECIFIC INJURIES NEC,10022117,10019196,10019196,10019196
ANTIBODY-MEDIATED REJECTION,Heart transplant rejection,HEART TRANSPLANT REJECTION,HEART TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10019315,10019315,10019315
ANTIEPILEPTIC DRUG HYPERSENSITIVITY,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
ACHILLEAR AREFLEXIA,Areflexia,AREFLEXIA,AREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10003084,10003084,10003084
FLASHES,Visual flashes,VISUAL FLASHES,PHOTOPSIA,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047569,10034962,10047569
GENERALIZED CORTICAL AND CEREBELLAR ATROPHY,Cerebellar atrophy,CEREBELLAR ATROPHY,CEREBELLAR ATROPHY,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10008027,10008027,10008027
RECURRENT ASPERGILLUS NIGER OTOMYCOSIS,Infection,RECURRENT INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10067860,10021789,10067860
FEELING OUT OF CONTROL,Psychiatric disorder NOS,PSYCHIATRIC DISORDER NOS,MENTAL DISORDER,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10037174,10061284,10037174
DRUG-INDUCED ANTIPHOSPHOLIPID SYNDROME,Antiphospholipid syndrome,ANTIPHOSPHOLIPID SYNDROME,ANTIPHOSPHOLIPID SYNDROME,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10002817,10002817,10002817
"DYSMORPHIC SYNDROME (FLAT FACE, LOW-SET EARS, UPPER LIP RETRACTION, XIPHOID FUNNEL, FINGER-LIKE CLAWS, AND LOW-SET FIFTH FINGER)",body dysmorphic disorder,BODY DYSMORPHIC DISORDER,BODY DYSMORPHIC DISORDER,ANXIETY DISORDERS AND SYMPTOMS,OBSESSIVE-COMPULSIVE DISORDERS AND SYMPTOMS,10037175,10052793,10052793,10052793
DROWSY DUE TO UTERINE RUPTURE,drowsy due to uterine rupture,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
NEUTROPHILIA (12X10E9/L),Neutrophilia,NEUTROPHILIA,NEUTROPHILIA,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10029379,10029379,10029379
SEVERE STENOSIS IN DISTAL LEFT ANTERIOR DESCENDING AND PROXIMAL MID RIGHT CORONARY ARTERIES,Coronary artery stenosis,CORONARY ARTERY STENOSIS,CORONARY ARTERY STENOSIS,CORONARY ARTERY DISORDERS,CORONARY ARTERY DISORDERS NEC,10007541,10011089,10011089,10011089
PALPITATION,palpitation,PALPITATION,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033556,10033557,10033556
SEVERE GENERALIZED CRAMPING ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
ALTERED MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
VASCULITIS,vasculitis,VASCULITIS,VASCULITIS,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10047115,10047115,10047115
HYPERLACTACIDEMIA,Hyperlactacidaemia,HYPERLACTACIDEMIA,HYPERLACTACIDAEMIA,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10020660,10020660,10054412
PALPABLE LIVER EDGE,Liver palpable,LIVER PALPABLE,LIVER PALPABLE,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10075895,10075895,10075895
FACIAL ANGIOEDEMA,facial angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
"BEHAVIOUR PROBLEMS ON SCALES OF SOMATIC COMPLAINTS,COMMUNICATION AND DELINQUENT BEHAVIOUR",Abnormal behaviour,BEHAVIOUR DISORDER,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004207,10061422,10004207
SEPTICEMIA WITH MULTIRESISTENT STAPHYLOCOCCUS AUREUS,Staphylococcal sepsis,STAPHYLOCOCCAL SEPSIS,STAPHYLOCOCCAL SEPSIS,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10056430,10056430,10056430
LACK OF EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
METHOTREXATE RELATED ENCEPHALOPATHY,Toxic encephalopathy,DRUG-INDUCED ENCEPHALOPATHY,TOXIC ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES TOXIC AND METABOLIC,10029205,10049035,10044221,10049035
CONJUNCTIVITIS,conjunctivitis,CONJUNCTIVITIS,CONJUNCTIVITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10010741,10010741,10010741
SEVERE HYPOCALCAEMIA WITH TETANY,Tetany,HYPOCALCAEMIC TETANY,TETANY,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10060381,10043380,10060381
WILMS' TUMOR PROGRESSION,Nephroblastoma,WILMS' TUMOR,NEPHROBLASTOMA,RENAL AND URINARY TRACT NEOPLASMS MALIGNANT AND UNSPECIFIED,RENAL NEOPLASMS MALIGNANT,10029104,10047986,10029145,10047987
SEVERE SCEDOSPORIUM APIOSPERMUM INFECTION IN CEREBOSPINAL FLUID,Scedosporium Apiospermum infection,SCEDOSPORIUM APIOSPERMUM INFECTION,SCEDOSPORIUM INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10076593,10059045,10076593
T2NO COLORECTAL CANCER,T2NO colorectal cancer,COLORECTAL CANCER,COLORECTAL CANCER,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,COLORECTAL NEOPLASMS MALIGNANT,10029104,10061451,10061451,10061451
GENERAL CONDITION WORSENED,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
FEVER,Fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
LEVETIRACETAM INDUCED MU RHYTHM STATUS,Electroencephalogram abnormal,EEG ABNORMAL,ELECTROENCEPHALOGRAM ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10000127,10014408,10014276
ACCIDENTAL OVERDOSE (ADMINISTERED 120 MG OF INTRATHECAL METHOTREXATE INSTEAD OF 12MG) WITH NO ADR,accidental overdose,ACCIDENTAL OVERDOSE,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10000381
PATHOLOGICAL FRACTURE DUE TO MEDICATION-RELATED OSTEONECROSIS OF THE JAW,Pathological fracture,PATHOLOGICAL FRACTURE,PATHOLOGICAL FRACTURE,FRACTURES,FRACTURES NEC,10028395,10034156,10034156,10034156
PALMAR ERYTHEMA WITH TINGLING SENSATION WAS CLAIMED,Palmar erythema,PALMAR ERYTHEMA,PALMAR ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10033551,10033551,10033551
ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
CONJUNCTIVAL ERYTHEMA,Conjunctival hyperaemia,CONJUNCTIVAL HYPERAEMIA,CONJUNCTIVAL HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","CONJUNCTIVAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10051625,10051625,10051625
COMA,coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
SCREAMING,Screaming,SCREAMING,SCREAMING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10039740,10039740,10039740
COULD NOT TOLERATE CIPROFLOXACIN,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
PEDIATRIC ACUTE KIDNEY INJURY FOLLOWING DRUG INTERACTION BETWEEN PIPERACILLIN/TAZOBACTAM AND VANCOMYCIN,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
GASTROINTESTINAL EFFECT,Gastrointestinal disorder,GASTROINTESTINAL DISORDER NOS,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017945,10017944,10017945
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
MYOCLONIC JERKS,Myoclonus,MYOCLONIC JERKS,MYOCLONUS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10028621,10028622,10028621
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
MALIGNANT NEOPLASM PROGRESSION,Malignant neoplasm progression,MALIGNANT NEOPLASM PROGRESSION,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10051398,10051398,10051398
DECREASED LEVEL OF CONSCIOUSNESS,decreased level of consciousness,CONSCIOUSNESS LOSS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010771,10024855,10010771
SERUM CREATININE INCREASED (2.5 MG/DL),Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
"SHE WAS DISORIENTATED, ANSWERING QUESTIONS SOMETIMES INADEQUATELY OR ONLY TANGENTIALLY AND WAS NOT STRUCTURABLE",disorientated,DISORIENTATED,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013394,10013395,10013394
RECEIVED DIGOXIN AND FLECAINIDE,Foetal exposure during pregnancy,"FETAL EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071426,10071404,10071427
EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
WEIGHT GAIN,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
HOARSENESS,Dysphonia,HOARSENESS,DYSPHONIA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10020201,10013952,10020201
FLUDARABINE WAS USED TO TREAT LYMPHADENOPATHY AND FOR BONE MARROW CONDITIONING (OFF LABEL USE FOR INDICATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
JAW PAIN,jaw pain,JAW PAIN,PAIN IN JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE RELATED SIGNS AND SYMPTOMS,10028395,10023157,10033433,10023157
PATIENT TREATED WITH HYDROXYCHLOROQUINE FOR IMMUNE THROMBOCYTOPENIC PURPURA (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NECROTISING MYOSITIS,Necrotising myositis,NECROTISING MYOSITIS,NECROTISING MYOSITIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10074769,10074769,10074769
LACTATE DEHYDROGENASE INCREASED (537 U/L),Blood lactate dehydrogenase increased,LACTATE DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10023654,10005630,10023654
HYPONATRAEMIA,Hyponatraemia,HYPONATRAEMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021036
FLARE-UP REACTION,Condition aggravated,CLINICAL FLARE REACTION,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10009299,10010264,10009299
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
ATROPHIC LESIONS OF THE CHEEKS,oral lesion,ORAL LESION,ORAL DISORDER,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE DISORDERS NEC,10017947,10059037,10067621,10059037
CEREBRAL HAEMORRHAGE,Cerebral haemorrhage,CEREBRAL HAEMORRHAGE,CEREBRAL HAEMORRHAGE,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM HAEMORRHAGES AND CEREBROVASCULAR ACCIDENTS,10029205,10008111,10008111,10008111
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
DIMINISHED VISION DUE TO DRUG OVERDOSE AND ACCIDENTAL OVERDOSE FOLLOWING MEDICATION ERROR,Visual impairment,VISION DECREASED,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047516,10047571,10047516
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
HYPERGLYCEMIA SECONDARY TO STEROIDS (BLOOD GLUCOSE LEVEL UPTO 350 MG/DL),Hyperglycaemia,HYPERGLYCEMIA STEROID-INDUCED,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10051346,10020635,10060488
SEVERE COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
FACE NUMBNESS,Numbness in face,NUMBNESS IN FACE,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10029836,10020937,10029836
LIVER AND SPLEEN JUST PALPABLE,Spleen palpable,SPLEEN PALPABLE,SPLEEN PALPABLE,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10057471,10057471,10057471
"ANHEDONIA/MAINTAINED DEPRESSIVE MOOD, ADYNAMIA, ANHEDONIA, ANOREXIA, ISOLATION",Anhedonia,ANHEDONIA,ANHEDONIA,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10002511,10002511,10002511
OSTEOPOROSIS,Osteoporosis,OSTEOPOROSIS,OSTEOPOROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10031282,10031282,10031282
CAPILLARY REFILLING TIME FOR BOTH TOES WAS[10 S),Capillary nail refill test abnormal,CAPILLARY NAIL REFILL TEST ABNORMAL,CAPILLARY NAIL REFILL TEST ABNORMAL,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10069381,10069381,10069381
HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
VESTIBULAR DISORDER,Vestibular disorder,VESTIBULAR DISORDER,VESTIBULAR DISORDER,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR DISORDERS NEC,10013993,10047386,10047386,10047386
DEPRESSED,Depression,DEPRESSION,DEPRESSION,DEPRESSED MOOD DISORDERS AND DISTURBANCES,DEPRESSIVE DISORDERS,10037175,10012378,10012378,10012378
ALTERED MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
MILD PATCHY INTERSTITIAL FIBROSIS,Kidney fibrosis,RENAL INTERSTITIAL FIBROSIS,KIDNEY FIBROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL DISORDERS NEC,10038359,10038475,10023421,10038475
INADEQUATE EFFICACY OF THE ANTIPLATELET DRUG,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
TREMULOUS,Tremor,TREMBLING,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044563
PRURITIC LESION AT VENIPUNCTURE SITES,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
PNEUMONIA FOLLOWING OFF LABEL USE OF METHOTREXATE FOR OCULAR CICATRICIAL PEMPHIGOID,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
GIANOTTI-CROSTI SYNDROME,Gianotti-Crosti Syndrome,GIANOTTI-CROSTI SYNDROME,GIANOTTI-CROSTI SYNDROME,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10053842,10053842,10053842
THE WOMAN RECEIVED DIGOXIN AND FLECAINIDE DURING PREGNANCY/ PATIENT RECEIVED MATERNAL TREATMENT WITH DIGOXIN,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
SQUAMOUS CELL CARCINOMA OF THE TONGUE,Squamous cell carcinoma of the tongue,SQUAMOUS CELL CARCINOMA OF THE TONGUE,SQUAMOUS CELL CARCINOMA OF THE TONGUE,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,LIP AND ORAL CAVITY NEOPLASMS MALIGNANT,10029104,10041865,10041865,10041865
"CARDIAC INFLAMMATION WAS CONTROLLED WITH DEFLAZACORT, IT RAPIDLY PROGRESSED ON THE EQUIVALENT DOSE OF PREDNISONE",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
EXITUS LETALIS,Death,DEATH,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10011906,10011906,10011906
ANTIPSYCHOTIC-INDUCED HYPERPROLACTINAEMIA,Hyperprolactinaemia,HYPERPROLACTINAEMIA,HYPERPROLACTINAEMIA,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPERFUNCTION,10014698,10020737,10020737,10020737
LACTIC ACIDOSIS,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
MUCOCUTANEOUS ULCERATION,Mucocutaneous ulceration,MUCOCUTANEOUS ULCERATION,MUCOCUTANEOUS ULCERATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10028084,10028084,10028084
ANAPHYLACTIC SHOCK,Anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
CONCENTRIC LEFT VENTRICULAR HYPERTROPHY,Left ventricular hypertrophy,LEFT VENTRICULAR HYPERTROPHY,LEFT VENTRICULAR HYPERTROPHY,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10049773,10049773,10049773
AGGRAVATION OF RECURRENT CHEST WALL LESION,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
DROWSINESS,Somnolence,DROWSINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10013649,10041349,10013649
PORTAL SYSTEMIC SHUNT,Portal shunt,PORTAL SYSTEMIC SHUNT,PORTAL SHUNT,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10052709,10036204,10052709
POSITIVE ROMBERG'S TEST,Romberg test positive,ROMBERG TEST POSITIVE,ROMBERG TEST POSITIVE,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10073242,10073242,10073242
GENERALIZED MACULOPAPULAR RASH,Generalized maculopapular rash,GENERALIZED MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10077163,10037868,10077163
TRAUMATIC FRACTURE OF THE RIGHT FEMORAL NECK,Femoral neck fracture,FEMORAL NECK FRACTURE,FEMORAL NECK FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10016450,10016450,10016450
HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
DRUG EXPOSURE IN UTERO,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
ACQUIRED FANCONI SYNDROME,Fanconi syndrome acquired,FANCONI SYNDROME ACQUIRED,FANCONI SYNDROME ACQUIRED,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10052607,10052607,10052607
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
LEUKOCYTOSIS,leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
"POORLY DEFINED PATCHES OF HYPERPIGMENTATION FORMED OF PALPABLE MINUTE GRAYISH PAPULES BILATERALLY IN THE MALAR,ZYGOMATIC, TEMPORAL AND SUPERCILIARY REGION",Skin hyperpigmentation,HYPERPIGMENTATION SKIN,SKIN HYPERPIGMENTATION,PIGMENTATION DISORDERS,HYPERPIGMENTATION DISORDERS,10040785,10040865,10040865,10020715
EPISTAXIS,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
PAIN OF LOWER RIGHT AND UPPER LIMB,Pain in extremity,PAIN IN LIMB,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033425,10033425,10033447
GROSS HEMATURIA,gross hematuria,HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10019450,10018867,10019450
ORAL ULCERATION,Mouth ulceration,ORAL ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10028034,10028034,10031027
ALTERED MENTAL STATUS,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
SECONDARY MALIGNANCY (OVARIAN),Second primary malignancy,SECOND PRIMARY MALIGNANCY,SECOND PRIMARY MALIGNANCY,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10039801,10039801,10039801
ECTROPION OF LOWER EYELIDS AND LID MARGIN HYPERAEMIA OF BOTH EYES,Erythema of eyelid,EYELID MARGIN HYPERAEMIA,ERYTHEMA OF EYELID,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","LID, LASH AND LACRIMAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10052131,10015237,10052131
TABLETS HAD GONE DOWN THE WRONG TRACT IN HIS THROAT,foreign body in trachea,FOREIGN BODY IN TRACHEA,FOREIGN BODY IN RESPIRATORY TRACT,INJURIES NEC,CHEST AND RESPIRATORY TRACT INJURIES NEC,10022117,10017038,10079847,10017038
PLASMAPHERESIS,Plasmapheresis,PLASMAPHERESIS,PLASMAPHERESIS,HAEMATOLOGICAL AND LYMPHOID TISSUE THERAPEUTIC PROCEDURES,BLOOD AND BLOOD PRODUCT TREATMENT,10042613,10035486,10035486,10035486
RENAL INSUFFICIENCY,Renal failure,RENAL INSUFFICIENCY,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038474,10038435,10038474
INTRACRANIAL COMPLICATIONS/ INTRACRANIAL COMPLICATIONS OF ANTICOAGULATION,Coagulopathy,"COAGULATION DEFECTS, OTHER AND UNSPECIFIED",COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009730,10009802,10009730
BLOODY DIARRHOEA FOLLOWING PERITONITIS DUE TO METFORMIN-ASSOCIATED LACTIC ACIDOSIS,Diarrhoea haemorrhagic,BLOODY DIARRHOEA,DIARRHOEA HAEMORRHAGIC,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012741,10012741,10055957
SWELLING OF EYELIDS,Eyelid oedema,SWELLING OF EYELID,EYELID OEDEMA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","LID, LASH AND LACRIMAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10042690,10015993,10042690
BLOOD PRESSURE LEVELS OF 80/40 MMHG,Blood pressure low,BLOOD PRESSURE LOW,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10005753,10021097,10005753
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
SHORT-TERM UNCONSCIOUSNESS,unconsciousness,UNCONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10045481,10024855,10045481
MINIMAL DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
CLONIC CONVULSION IN BOTH UPPER LIMBS,Clonic convulsion,CLONIC CONVULSION,CLONIC CONVULSION,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10053398,10053398,10053398
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
PARANOIA,paranoia,PARANOIA,PARANOIA,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10033864,10033864,10033864
ETHMOIDITIS,ethmoiditis,ETHMOIDITIS,SINUSITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10072034,10040753,10072034
RIGHT FLACCID HEMIPLEGIA,Flaccid hemiplegia,FLACCID HEMIPLEGIA,HEMIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10016743,10019468,10016743
SECONDARY SYPHILIS,Secondary syphilis,SECONDARY SYPHILIS,SECONDARY SYPHILIS,BACTERIAL INFECTIOUS DISORDERS,TREPONEMA INFECTIONS,10021881,10056883,10056883,10056883
CEREBRAL VENOUS THROMBOSIS,cerebral venous thrombosis,CEREBRAL VENOUS THROMBOSIS,CEREBRAL VENOUS THROMBOSIS,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CEREBROVASCULAR VENOUS AND SINUS THROMBOSIS,10029205,10008138,10008138,10008138
HEMATURIA,Hematuria,HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10019450,10018867,10019450
PRESENTED WITH FIVE TONIC-CLONIC SEIZURES IN BETWEEN IMPAIRED CONSCIOUSNESS PERSISTED/DE NOVO CONVULSIVE STATUS EPILEPTICUS,Generalised tonic-clonic seizure,TONIC-CLONIC SEIZURES,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10044000,10018100,10044000
NO IMPROVEMENT WITH TREATMENT (LACK OF DRUG EFFECT),Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
"NAUSEA AND DIFFUSE, ACHY, AND CONSTANT ABDOMINAL PAIN (GI SIDE EFFECTS)",Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
DECREASE OF CONSCIOUSNESS,Depressed level of consciousness,CONSCIOUSNESS DECREASED,DEPRESSED LEVEL OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010768,10012373,10010768
HYPOGLYCAEMIA,hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
DISSEMINATED INTRAVASCULAR COAGULATION (DIC),Disseminated intravascular coagulation,DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10013442,10013442,10013442
SERUM GLYCEMIA OF 901 MG/DL,Hyperglycaemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020639
PATIENT HAD PARTIAL RESPONSE WITH TREATMENT,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
ALTERED MENTAL STATUS/MENTAL STATUS CHANGES,Mental status changes,MENTAL STATUS CHANGES,MENTAL STATUS CHANGES,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048294,10048294,10048294
FEVERS,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
SEVERE HYPOGAMMAGLOBULINEMIA (REDUCTION OF ALL IG LEVELS),Hypogammaglobulinaemia,HYPOGAMMAGLOBULINAEMIA,HYPOGAMMAGLOBULINAEMIA,IMMUNODEFICIENCY SYNDROMES,PRIMARY IMMUNODEFICIENCY SYNDROMES,10021428,10020983,10020983,10020983
FIVE DAYS RISING FEVER OF UP TO 40.5 Â°C/DRUG INDUCED HYPERTHEMIC SYNDROME,Hyperthermia,HYPERTHERMIA,HYPERTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10020843,10020843,10020843
FLUCTUATING LEVELS OF CONSCIOUSNESS,Consciousness fluctuating,CONSCIOUSNESS FLUCTUATING,CONSCIOUSNESS FLUCTUATING,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10050093,10050093,10050093
PATIENT DIED 2 YEARS LATER FROM METASTASIZED DISEASE,Metastasis,METASTASIS,METASTASIS,METASTASES,METASTASES TO UNKNOWN AND UNSPECIFIED SITES,10029104,10062194,10062194,10062194
MULTIPLE ORGAN HEMORRHAGE FOLLOWING HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,Haemorrhage,HEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10019524
INAPPETENCE (G3),Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
EROSIONS WERE SPOTTED IN MOUTH MUCOSA,Mucosal erosion,MUCOSAL EROSION,MUCOSAL EROSION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10061297,10061297,10061297
TOOTH LOSS BECAUSE OF MARGINAL PERIODONTITIS,tooth loss,TOOTH LOSS,TOOTH LOSS,DENTAL AND GINGIVAL CONDITIONS,TOOTH MISSING,10017947,10044044,10044044,10044044
PATHOGEN RESISTANCE,Pathogen resistance,PATHOGEN RESISTANCE,PATHOGEN RESISTANCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10034133,10034133,10034133
FLACCID SKIN,flaccidity muscle,FLACCIDITY MUSCLE,HYPOTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10016746,10021118,10016746
URINARY TRACT INFECTION,Urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DIRECT BILIRUBIN INCREASED (6.8 MG/DL),Bilirubin conjugated increased,DIRECT BILIRUBIN INCREASED,BILIRUBIN CONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10013038,10004685,10013038
TACHYPNEA,Tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
EDEMA,Oedema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10014210
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
GROWTH RETARDATION (MARKED LEG GROWTH IMPAIRMENT),Growth retardation,GROWTH RETARDATION,GROWTH RETARDATION,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10053759,10053759,10053759
CARDIAC ARREST,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
FIXED DRUG ERUPTION,fixed drug eruption,FIXED DRUG ERUPTION,FIXED ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10016740,10016741,10016740
OLIGURIA DUE TO CONTINUED CAMPYLOBACTER BACTEREMIA,Oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
LACTIC ACIDOSIS,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
PANCYTOPENIA,pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
TTMES INCOHERENCE,incoherent,INCOHERENT,INCOHERENT,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10021630,10021630,10021630
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
CECAL WALL THICKENING AND EDEMA,Gastrointestinal wall thickening,BOWEL WALL THICKENING,GASTROINTESTINAL WALL THICKENING,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10075727,10075724,10075727
PROLONGED QT INTERVAL (QTC:464 MS),Electrocardiogram QT prolonged,QT INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037703,10014387,10037703
DRUG INTERACTION BETWEEN BISOPROLOL AND LACOSAMIDE,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
SERUM CREATININE LEVELS ALSO INCREASED TO 235 ÎœMOL/L,Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
ELEVATED LIVER ENZYMES,Hepatic enzyme increased,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
DIARRHEIC STOOLS,Stools watery,STOOLS WATERY,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10042157,10012735,10042157
MEMORY DIFFICULITIES,Memory impairment,MEMORY IMPAIRED,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027175,10027175,10027174
INSPIRATORY WHEEZING,Wheezing,WHEEZING INSPIRATORY,WHEEZING,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10047926,10047924,10047926
INCREASING RIGHT FOREARM PAIN AND TENDERNESS,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
CALCIFICATION OF THE ARACHNOID CONSISTENT WITH ARACHNOIDITIS OSSIFICANS,arachnoiditis,ARACHNOIDITIS,ARACHNOIDITIS,CENTRAL NERVOUS SYSTEM INFECTIONS AND INFLAMMATIONS,CENTRAL NERVOUS SYSTEM INFLAMMATORY DISORDERS NEC,10029205,10003074,10003074,10003074
IRIDOCORNEAL ANGLE WAS FOUND TO BE COLLAPSED,Iridocorneal endothelial syndrome,IRIDOCORNEAL ENDOTHELIAL SYNDROME,IRIDOCORNEAL ENDOTHELIAL SYNDROME,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","ANTERIOR CHAMBER STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10053678,10053678,10053678
METABOLIC ACIDOSIS,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
ELEVATED TROPONIN LEVELS,elevated troponin levels,TROPONIN INCREASED,TROPONIN INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10058267,10058267,10058267
SUICIDAL THOUGHTS,Suicidal ideation,SUICIDAL IDEATION,SUICIDAL IDEATION,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042458,10042458,10042458
GASTROINTESTINAL INTOLERANCE,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
SCREAM WHEN TOUCHED,Screaming,SCREAMING,SCREAMING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10039740,10039740,10039740
HEMOLYSIS,Haemolysis,HEMOLYSIS,HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10018910,10018910,10019491
GRADE 1 NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
BILATERAL BLURRED VISION,Vision blurred,BLURRED VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047513,10047513,10005886
BK VIRUS CYSTITIS,Cystitis,CYSTITIS,CYSTITIS,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10011781,10011781,10011781
ENCEPHALOPATHY,Encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
ASYMPTOMATIC DISCOLORATION,Discoloration skin,DISCOLORATION SKIN,SKIN DISCOLOURATION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10013076,10040829,10013076
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
INCREASED PTT (46.2 S),Activated partial thromboplastin time prolonged,PARTIAL THROMBOPLASTIN TIME PROLONGED,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10034094,10000636,10034094
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
MIDEPIGASTRIC AND DORSAL PAIN,epigastric pain,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
CERVICAL LYMPHADENOPATHY,cervical lymphadenopathy,LYMPHADENOPATHY CERVICAL,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025200,10025197,10025200
MILD SENSORY NEUROPATHY,sensory neuropathy,SENSORY NEUROPATHY,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10062975,10034620,10062975
FUNGAL INFECTION,Fungal infection,FUNGAL INFECTION,FUNGAL INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017533,10017533,10017533
SENSORY DETERIORATION,Sensory disturbance,SENSORY DISTURBANCE,SENSORY DISTURBANCE,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10040026,10040026,10040026
RIGHT NYSTAGMUS,nystagmus,NYSTAGMUS,NYSTAGMUS,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10029864,10029864,10029864
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
ERYTHEMATOUS RASH WITH RAISED VESICLES ON THE BUTTOCKS,Abscess on buttock,ABSCESS ON BUTTOCK,SUBCUTANEOUS ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10000309,10042343,10000309
GENERAL MALAISE,Malaise,GENERAL MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10018066,10025482,10018066
MITOCHONDRIAL MYOPATHY,mitochondrial myopathy,MITOCHONDRIAL MYOPATHY,MITOCHONDRIAL MYOPATHY,CYTOPLASMIC DISORDERS CONGENITAL,GENETIC MITOCHONDRIAL ABNORMALITIES NEC,10010331,10027710,10027710,10027710
TACHYPNEA,tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
BACTERIAL TRANSLOCATION,bacterial translocation,BACTERIAL TRANSLOCATION,BACTERIAL TRANSLOCATION,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10070545,10070545,10070545
SECONDARY INTRACRANIAL HYPERTENSION,Intracranial Hypertension,INTRACRANIAL HYPERTENSION,INTRACRANIAL PRESSURE INCREASED,INCREASED INTRACRANIAL PRESSURE AND HYDROCEPHALUS,INCREASED INTRACRANIAL PRESSURE DISORDERS,10029205,10022764,10022773,10022764
CHEST TIGHTNESS,Chest discomfort,CHEST TIGHTNESS,CHEST DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008492,10008469,10008492
POOR ADHERENCE TO THE TREATMENT,Product use issue,PRODUCT USE ISSUE,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076309,10076309,10076309
ALLERGIC REACTION,Hypersensitivity,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
RECURRENT ASPERGILLUS FUMIGATUS INFECTION,Aspergillus fumigatus infection,ASPERGILLUS FUMIGATUS INFECTION,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003494,10074171,10003494
LYMPHOID BLAST CRISIS DUE TO SECONDARY IMATINIB MESILATE RESISTANCE,Blast crisis in myelogenous leukaemia,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS MYELOID NEC,10029104,10050282,10050282,10050282
HISTOLOGICAL APPEARANCE SHOWED PATTERN OF LICHENOID DERMATITIS ON FACE,Dermatitis lichenoid,DERMATITIS LICHENOID,LICHENOID KERATOSIS,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,HYPERKERATOSES,10040785,10012472,10064000,10012472
HEADACHE,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
GRADE 4 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
STEROID INDUCED TOXICITIES,steroid induced toxicities,STEROID THERAPY NOS,STEROID THERAPY,ENDOCRINE GLAND THERAPEUTIC PROCEDURES,HORMONAL THERAPEUTIC PROCEDURES NEC,10042613,10042027,10062117,10042027
RENAL FAILURE,Renal failure,RENAL INSUFFICIENCY,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038474,10038435,10038474
ALT INCREASED GREATER THAN 3 FOLD UPPER LIMIT OF NORMAL,ALT increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
TYROSINE KINASE INHIBITOR ASSOCIATED DILATED CARDIOMYOPATHY,Congestive cardiomyopathy,DILATED CARDIOMYOPATHY,CONGESTIVE CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10056419,10056370,10056419
MEMANTINE-INDUCED MORNING BRADYCARDIA,bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
CHOLESTATIC HEPATOPATHY,Cholestatic liver disease,CHOLESTATIC LIVER DISEASE,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008641,10008635,10008641
"TWO EPISODES OF NONBLOODY, NONBILIOUS EMESIS",Emesis,EMESIS,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10014542,10047700,10014542
CLINICALLY SIGNIFICANT PHOTOEXACERBATION OF HER REACTION TO BRIMONIDINE IN A CONCENTRATION-DEPENDENT MANNER,Photosensitivity allergic reaction,PHOTOSENSITIVITY ALLERGIC REACTION,PHOTOSENSITIVITY REACTION,EPIDERMAL AND DERMAL CONDITIONS,PHOTOSENSITIVITY AND PHOTODERMATOSIS CONDITIONS,10040785,10034970,10034972,10034970
CARBAMAZEPINE OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
BONE MARROW EXAMINATION SHOWING EXCESS OF LYMPHOBLAST,Lymphoblast count increased,LYMPHOBLAST COUNT INCREASED,LYMPHOBLAST COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10051605,10051605,10051605
SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
ESOPHAGITIS,Oesophagitis,ESOPHAGITIS,OESOPHAGITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,OESOPHAGITIS (EXCL INFECTIVE),10017947,10030216,10030216,10015461
ADRENAL INSUFFICIENCY/ FAILURE FOLLOWING STEROID CESSATION,Adrenal insufficiency,ADRENAL INSUFFICIENCY,ADRENAL INSUFFICIENCY,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001367,10001367,10001367
UNSTABLE FLUCTUATIONS IN BLOOD SUGAR LEVELS,Blood glucose fluctuation,BLOOD SUGAR LEVEL FLUCTUATION,BLOOD GLUCOSE FLUCTUATION,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10049818,10049803,10049818
TERRIBLE RASH/ ADVERSE CUTANEOUS DRUG REACTION,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
BACTERIEMIA BY ESCHERICHIA COLI,Escherichia coli bacteremia,ESCHERICHIA COLI BACTEREMIA,ESCHERICHIA BACTERAEMIA,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10054279,10054258,10054279
MINOR MALLORY-WEISS TEAR,Mallory-Weiss syndrome,MALLORY WEISS TEAR,MALLORY-WEISS SYNDROME,GASTROINTESTINAL HAEMORRHAGES NEC,GASTRIC AND OESOPHAGEAL HAEMORRHAGES,10017947,10026711,10026712,10026711
OLFACTORY,Olfactory test abnormal,OLFACTORY TEST ABNORMAL,OLFACTORY TEST ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",SPECIAL SENSE INVESTIGATIONS NEC,10022891,10062927,10062927,10062927
PATHOGEN RESISTANCE,Pathogen resistance,PATHOGEN RESISTANCE,PATHOGEN RESISTANCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10034133,10034133,10034133
DRUG EXPOSURE DURING PREGNANCY WITH NO ADR,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
LARGE DECREASE IN LEVODOPA DOSE RESULTED IN POOR MOTOR CONTROL,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
MEDICATED WITH SERTRALINE 100 MG ID. MANIC EPISODE STARTING 3 DAYS AFTER STIMULATION ONSET,Mania,MANIA,MANIA,MANIC AND BIPOLAR MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH MANIC SYMPTOMS,10037175,10026749,10026749,10026749
CR OF 12.4 MG/DL,Blood creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
URTICARIA,urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
REPORT DESCRIBES THREE YOUNG CHILDREN WITH SIGNIFICANT OPI-OID TOXICITY WHO SUBSEQUENTLY HAD/FENTANYL TOXICITY,Toxicity to various agents,OPIOID TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10072946,10070863,10072946
ALLERGIC TO AMOXICILLIN,Drug allergy,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
DELIBERATE OVERDOSE OF 260 MG AMLODIPINE,multiple drug overdose intentional,MULTIPLE DRUG OVERDOSE INTENTIONAL,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10062764,10022523,10062764
CONVULSION,Convulsion,CONVULSION,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10010904,10039906,10010904
HYPERTROPHIC CARDIOMYOPATHY,Hypertrophic cardiomyopathy,HYPERTROPHIC CARDIOMYOPATHY,HYPERTROPHIC CARDIOMYOPATHY,CARDIAC AND VASCULAR DISORDERS CONGENITAL,CARDIAC SEPTAL DEFECTS CONGENITAL,10010331,10020871,10020871,10020871
PREDNISONE USED IN DIFFUSE LARGE B CELL LYMPHOMA,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
INCREASED SOMNOLENCE FROM OPIOIDS,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
PERIPHERAL EDEMA,Oedema peripheral,PERIPHERAL EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030124,10030124,10034570
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
DIFFUSE MACULOPAPULAR RASH,Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
"PATIENT ADMINISTERED WITH COMBINED THERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISOLONE (CHOP THERAPY), THAT ELICITED PARTIAL RESPONSE(SUBTHERAPEUTIC RESPONSE) WITH NO ADR",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
"COGWHEEL RIGIDITY IN LEFT AND RIGHT UPPER LIMBS, PERSEVERATION, ECHOLALIA, ECHOPRAXIA, WITH BRISK DEEP TENDON REFLEXES",Cogwheel rigidity,COGWHEEL RIGIDITY,COGWHEEL RIGIDITY,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10009848,10009848,10009848
OFF LABEL USE (TESTICULAR CANCER),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEPATIC FAILURE,Hepatic failure,HEPATIC FAILURE,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10019663,10019663,10019663
PARTIAL RESPONSE WITH NO ADR,partial responder to therapy,PARTIAL RESPONDER TO THERAPY,THERAPY PARTIAL RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066429,10078115,10066429
PATIENT WAS TREATED WITH METHOTREXATE FOR JUVENILE LOCALIZED SCLERODERMA MIXED SUBTYPE (OFF LABEL USE) WITH NO ADVERSE EVENT,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INTERMITTENT FEVER,Pyrexia,INTERMITTENT FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10022571,10037660,10058698
"HBA1C: 10,5%",Glycosylated haemoglobin increased,HBA1C INCREASED,GLYCOSYLATED HAEMOGLOBIN INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10056186,10018484,10052424
ALPRAZOLAM OVERDOSE IN A SUICIDE ATTEMPT,Suicide attempt,SUICIDE ATTEMPT,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042464,10042464,10042464
VENOUS BLEEDING WAS SEEN AT MANY SITES,Venous haemorrhage,VENOUS HAEMORRHAGE,VENOUS HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10065441,10065441,10065441
CONSCIOUSNESS LEVEL WAS JCS III-2,Altered state of consciousness,ALTERED STATE OF CONSCIOUSNESS,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10001854,10001854,10001854
TEMPERATURE OF 38Â°C,Body temperature increased,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10005911
MORPHINE OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
BLURRED VISION,Vision blurred,BLURRED VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047513,10047513,10005886
PROLONGED QTC OF 449 MS,electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
EXACERBATION OF CROHN'S DISEASE,Crohn's disease aggravated,CROHN'S DISEASE AGGRAVATED,CROHN'S DISEASE,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10011403,10011401,10011403
"LEUKOCYTOSIS (WHITE CELL COUNT, 13.6 X 10^9 /L)",Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
SERUM  GLUTAMIC PYRUVIC TRANSAMINASE INCREASED,SGPT increased,SGPT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10040526,10001551,10040526
HYPOXAEMIA,Hypoxia,HYPOXAEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021141,10021143,10021141
LOW THROMBOCYTES (121X10E9/L),Platelet count decreased,THROMBOCYTE COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10043546
MYCOPHENOLATE MOFETIL USED FOR ACTIVE SLE (OFF LABEL USE),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ENLARGEMENT OF PARENCHYMAL INFILTRATE,Lung infiltration,PULMONARY INFILTRATION,LUNG INFILTRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025102,10025102,10037411
DEVELOPING PUBIC HAIR WITHOUT OTHER OBVIOUS PUBERTAL SIGNS/HYPERPROLACTINEMIA/ SYMPTOMATIC HYPERPROLACTINEMIA/ DRUG INDUCED HYPERPROLACTINAEMIA,Hyperprolactinaemia,HYPERPROLACTINAEMIA,HYPERPROLACTINAEMIA,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPERFUNCTION,10014698,10020737,10020737,10020737
EXACERBATION OF ULCERATIVE COLITIS,condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
FASCIITIS GRADE IV,Fasciitis,FASCIITIS,FASCIITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE INFECTIONS AND INFLAMMATIONS NEC,10028395,10016228,10016228,10016228
ABNORMAL FAECES,Abnormal faeces,ABNORMAL FAECES,ABNORMAL FAECES,GASTROINTESTINAL SIGNS AND SYMPTOMS,FAECAL ABNORMALITIES NEC,10017947,10000133,10000133,10000133
PRIMARY RESISTANCE TO GEFITINIB,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
ESTIMATED GLOMERULAR FILTRATION RATE OF 39 ML/MIN/ 1.73 M2.,Glomerular filtration rate decreased,GLOMERULAR FILTRATION RATE LOW,GLOMERULAR FILTRATION RATE DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10018360,10018358,10018360
POLYOMA VIRUS CYSTITIS,Cystitis viral,CYSTITIS VIRAL,CYSTITIS VIRAL,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10065197,10065197,10065197
NEUTROPENIA ATTRIBUTED TO DEHYDRATION,neutropenia attributed to dehydration,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
PH DECREASED (VALUE-7.1),Blood pH decreased,PH DECREASED,BLOOD PH DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10034778,10005706,10034778
THREE RELAPSES DUE TO PROGRESSIVE ARTERIOPATHY,Condition aggravated,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10076326
HYPOESTHESIA IN BOTH LOWER LIMBS/MUSCLE DUMBNESS,Hypoaesthesia,HYPOESTHESIA,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10020937,10020937,10020976
GASTRIC PAIN,Abdominal pain upper,GASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10064906,10000087,10017814
LIVER DECOMPENSATION,Hepatic failure,HEPATIC DECOMPENSATION,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10076894,10019663,10076894
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
"CPK 1,591 U/L",Blood creatine phosphokinase increased,CPK INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011268,10005470,10011268
HYPERTENSION TREATMENT CAME OUT TO BE INSUFFICIENT,Drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
LEUCOCYTES INCREASED (21700X10E9/L),White blood cell count increased,LEUKOCYTE COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047943,10047943,10048553
WORSENING PRES (GRADE 2 SEVERITY),condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
PULMONARY TOXICITY,PULMONARY TOXICITY,PULMONARY TOXICITY,PULMONARY TOXICITY,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10061924,10061924,10061924
CUTANEOUS LESION,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
PRURIGINOUS LESION ON THE RIGHT LEG,skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
DISORIENTATION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
SEVERE HYPOCALCAEMIA,Hypocalcaemia,HYPOCALCAEMIA,HYPOCALCAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10020947,10020947,10020947
VASODILATORY SHOCK,Shock,SHOCK CIRCULATORY,SHOCK,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,CIRCULATORY COLLAPSE AND SHOCK,10047065,10040564,10040560,10040564
CONTINUED ABNORMAL MOVEMENTS OF MANDIBLE,Dyskinesia,MOVEMENTS ABNORMAL,DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10028039,10013916,10028039
UROLITHIASES,Urolithiases,UROLITHIASIS,CALCULUS URINARY,UROLITHIASES,URINARY TRACT LITHIASIS (EXCL RENAL),10038359,10046707,10007027,10046707
PRESSURE SORES OVER HIS BUTTOCKS,Decubitus ulcer,PRESSURE SORE,DECUBITUS ULCER,EPIDERMAL AND DERMAL CONDITIONS,SKIN INJURIES AND MECHANICAL DERMATOSES,10040785,10036651,10011985,10036651
EPILEPTIC CRISIS,epileptic fit,EPILEPTIC FIT,EPILEPSY,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10015051,10015037,10015051
ANAPHYLAXIS,anaphylaxis,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
SEVERE HYPERSENSITIVITY SYNDROME,hypersensitivity syndrome,HYPERSENSITIVITY SYNDROME,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10020760,10073508,10020760
PSORIASIS,Psoriasis,PSORIASIS,PSORIASIS,EPIDERMAL AND DERMAL CONDITIONS,PSORIATIC CONDITIONS,10040785,10037153,10037153,10037153
SOMNOLENCE,somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
ANHIDROSIS,Anhidrosis,ANHIDROSIS,ANHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10002512,10002512,10002512
FLACCID PARALYSIS WITH LEFT LOWER LIMB AREFLEXIA AND SEVERE RIGHT LOWER LIMB PARESIS,Flaccid paralysis,FLACCID PARALYSIS,PARALYSIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10016744,10033799,10016744
SEVERE NECROSIS OF THE LEFT UPPER LEG DUE CALCIPHYLAXIS,Calciphylaxis,CALCIPHYLAXIS,CALCIPHYLAXIS,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10051714,10051714,10051714
DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE EVENT,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
PERSISTING ATTENUATION OF MENTAL STATE,Mental state abnormal,MENTAL STATE ABNORMAL,MENTAL DISORDER,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10027381,10061284,10027381
BORTEZOMIB CAUSED A SUBCUTANEOUS INJECTION-RELATED REACTION,Injection related reaction,INJECTION RELATED REACTION,INJECTION RELATED REACTION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10071152,10071152,10071152
DISEASE RECURRENCE,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
ITCHING,Pruritus,ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10023084,10037087,10023084
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
PROGRESSION OF DISEASE,Progression of prostate cancer,PROGRESSION OF PROSTATE CANCER,PROSTATE CANCER,REPRODUCTIVE NEOPLASMS MALE MALIGNANT AND UNSPECIFIED,PROSTATIC NEOPLASMS MALIGNANT,10029104,10066489,10060862,10066489
GAMMA-GLUTAMYLTRANSFERASE INCREASED (6.42 MICROKAT/L),Gamma-glutamyltransferase increased,GAMMA-GLUTAMYLTRANSFERASE INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10017693,10017693,10017693
"DESPITE INITIATION OF THERAPY, SPONTANEOUS BLEEDING LED TO ABDOMINAL COMPARTMENT SYNDROME",Haemorrhage,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10005103
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
DILATED CARDIOMYOPATHY,Congestive cardiomyopathy,DILATED CARDIOMYOPATHY,CONGESTIVE CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10056419,10056370,10056419
CLINICAL PROGRESSION WITH DETERIORATION IN GENERAL STATE,General physical health deterioration,REDUCED GENERAL CONDITION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10057364,10049438,10057364
ASPIRATION PNEUMONIA,aspiration pneumonia,ASPIRATION PNEUMONIA,PNEUMONIA ASPIRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10003525,10035669,10003525
SEPSIS FOLLOWING PULMONARY TUBERCULOSIS AND DISSEMINATED NOCARDIOSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
FLUSHED SKIN,Flushing,FLUSHED SKIN,FLUSHING,VASCULAR DISORDERS NEC,PERIPHERAL VASCULAR DISORDERS NEC,10047065,10016824,10016825,10016824
PCO2 DECREASED - 24MM HG,PCO2 decreased,PCO2 DECREASED,PCO2 DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10034181,10034181,10034181
ACUTE LIVER INJURY,Liver injury,ACUTE LIVER INJURY,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10067970,10067125,10067970
LEFT ORBITAL INFLAMMATION,left orbital inflammation,INFLAMMATION OF ORBIT,PAROPHTHALMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","ORBITAL INFECTIONS, INFLAMMATIONS AND IRRITATIONS",10015919,10021963,10059407,10021963
INCREASED FREQUENCY OF MICTURITION,Pollakiuria,MICTURITION FREQUENCY INCREASED,POLLAKIURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10071065,10036018,10071065
SMALL OMPHALOCELE,omphalocele,OMPHALOCELE,EXOMPHALOS,GASTROINTESTINAL TRACT DISORDERS CONGENITAL,GASTROINTESTINAL TRACT DISORDERS CONGENITAL NEC,10010331,10030308,10015677,10030308
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
MYCOTIC ANEURYSM/ POSSIBLE ABNORMALITIES IN THE ABDOMINAL AORTA/INFRARENAL ABDOMINAL AORTIC ANEURYSM,Infective aneurysm,MYCOTIC ANEURYSM,INFECTIVE ANEURYSM,INFECTIONS - PATHOGEN UNSPECIFIED,VASCULAR INFECTIONS,10021881,10028517,10058017,10028517
CAPECITABINE-INDUCED VASOSPASM AND (MYO)PERICARDITIS,coronary vasospasm,CORONARY VASOSPASM,ARTERIOSPASM CORONARY,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10011110,10003225,10011110
PATIENT TRIED ON METRONIDAZOLE AND METHOTREXATE FOR VULVAR CROHN'S DISEASE (OFF LABEL USE WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
URINE KETONE BODY PRESENT (1+),Urine ketone body present,URINE KETONE BODY PRESENT,URINE KETONE BODY PRESENT,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10057597,10057597,10057597
HIGH-DOSE STEROIDS AND THE SUBSEQUENT KETOACIDOSIS MAY HAVE PRECIPITATED THE FULMINANT NATURE OF THE DISEASE PROCESS,Diabetic ketoacidosis,DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETIC COMPLICATIONS,DIABETIC COMPLICATIONS NEC,10027433,10012671,10012671,10012671
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
POOR THERAPY TOLERANCE,Product intolerance,PRODUCT INTOLERANCE,PRODUCT INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10078761,10078761,10078761
ELEVATED WHITE BLOOD CELL COUNT 12X109/L,WBC increased,WBC INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056739,10047943,10056739
"HYPERTRIGLYCERIDEMIA (TGS OF 3223 MG/DL, WITH HDL-C OF 24 MG/DL, DIRECT LDL-C OF 32 MG/DL, AND TOTAL CHOLESTEROL OF 211 MG/DL)",hypertriglyceridemia,HYPERTRIGLYCERIDEMIA,HYPERTRIGLYCERIDAEMIA,LIPID METABOLISM DISORDERS,ELEVATED TRIGLYCERIDES,10027433,10020870,10020869,10020870
MORE THAN 1/3RD OF THE PATIENTS MENTIONED AN IMPAIRED QUALITY OF LIFE,Impaired quality of life,IMPAIRED QUALITY OF LIFE,IMPAIRED QUALITY OF LIFE,LIFESTYLE ISSUES,SOCIAL ISSUES NEC,10041244,10076936,10076936,10076936
ACTIVE HEMORRHAGE OF THE INTERCOSTAL ARTERY FROM THE 5TH TO 6TH RIGHT RIBS,Arterial haemorrhage,ARTERIAL HAEMORRHAGE,ARTERIAL HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10060964,10060964,10060964
PATIENT DIED,Death,DEATH UNEXPLAINED,DEATH,FATAL OUTCOMES,DEATH AND SUDDEN DEATH,10018065,10063378,10011906,10052809
GASTRIC BLEEDING,Gastric haemorrhage,GASTRIC BLEEDING,GASTRIC HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,GASTRIC AND OESOPHAGEAL HAEMORRHAGES,10017947,10017788,10017788,10017757
TEMPERATURE ELEVATION,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PANCREATITIS ACUTE,Pancreatitis acute,PANCREATITIS ACUTE,PANCREATITIS ACUTE,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033647,10033647,10033647
BILATERAL IRIDOCYCLITIS,Iridocyclitis,IRIDOCYCLITIS,IRIDOCYCLITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10022941,10022941,10022941
KIDNEY DYSFUNCTION,Kidney dysfunction,KIDNEY DYSFUNCTION,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10023417,10062237,10023417
EPILEPTIC CRISIS,Epilepsy,EPILEPTIC FIT,EPILEPSY,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10015052,10015037,10015051
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
ENTIRE PROLABIUM WAS EROSIVE AND COVERED WITH SCABS,Scabbing,SCABBING,SCAB,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10039510,10039509,10039510
NEUTROPENIA OF GRADE 3 OR SEVERER,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
PANIC AND INHIBITED BEHAVIOR,Abnormal behaviour,BEHAVIOR DISORDER,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004207,10061422,10004204
PAIN IN EXTREMITY,Pain in extremity,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033425,10033425,10033425
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
"ELEVATION OF SEGMENT ST-T IN II,III, AVF-3 MM",Electrocardiogram ST-T segment elevation,ELECTROCARDIOGRAM ST-T SEGMENT ELEVATION,ELECTROCARDIOGRAM ST-T SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10049225,10049225,10049225
USE OF METHOTREXATE FOR ECTOPIC CESAREAN SCAR PREGNANCY (OFF LABEL USE FOR INDICATION WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CYCLOPHOSPHAMIDE AND AZATHIOPRINE FOR GRANULOMATOSIS WITH POLYANGIITIS,drug use for unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
AXILLARY LYMPHADENOPATHY,axillary lymphadenopathy,LYMPHADENOPATHY AXILLARY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10049109,10025197,10049109
MODERATE MALNUTRITION,Malnutrition NOS,MALNUTRITION NOS,MALNUTRITION,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10026713,10061273,10026713
GENERALIZED TONIC-CLONIC SEIZURE,Generalised tonic-clonic seizure,GENERALIZED TONIC-CLONIC SEIZURE,GENERALISED TONIC-CLONIC SEIZURE,SEIZURES (INCL SUBTYPES),GENERALISED TONIC-CLONIC SEIZURES,10029205,10018100,10018100,10062448
AGITATED BEHAVIOR,agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
REFUSING TO DO ANY OF HER USUAL DAILY ACTIVITIES,Loss of personal independence in daily activities,ACTIVITIES OF DAILY LIVING IMPAIRED,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10050954,10079487,10050954
":SINUSOIDAL OBSTRUCTION SYNDOME/VENO-OCCLUSIVE DISEASE,",Venoocclusive liver disease,SINUSOIDAL OBSTRUCTION SYNDROME,VENOOCCLUSIVE LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10063675,10047216,10063675
"PATIENT EXPERIENCED DEPRESSION (ONGOING), DESPITE BEING TREATED WITH ESCITALOPRAM OXALATE AND BUPROPION (LACK OF DRUG EFFECT) GIVEN FOR TYPE 1 BIPOLAR DISORDER",Lack of drug effect ,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
INTERACTION OF PHENYRAMIDOL HYDROCHLORIDE AND WARFARIN,Potentiating drug interaction,DRUG INTERACTION POTENTIATION,POTENTIATING DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013713,10068072,10013713
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
COUGHING,Cough,COUGHING,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011232
SEDATED THE PATIENT TO THE POINT THAT SHE BECAME NON-AMBULATORY,sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE EVENT,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
SEROTONIN SYNDROME,Serotonin syndrome,SEROTONIN SYNDROME,SEROTONIN SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10040108,10040108,10040108
EOSINOPHILIA (881 CELL/MCL),Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
DRUG-DRUG INTERACTIONS,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
ITCHY PATCH OF ERYTHEMA ON THE BACK,Localised itching,LOCALISED ITCHING,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10058732,10037087,10058732
HYPOESTHESIA BELOW THE KNEES,Hypoaesthesia,HYPOAESTHESIA,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10020937,10020937,10020937
KAPOSI'S SARCOMA/ HUMAN HERPESVIRUS 8 TUMOUR,Human herpesvirus 8 infection,HUMAN HERPESVIRUS 8 INFECTION,HUMAN HERPESVIRUS 8 INFECTION,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10066435,10066435,10066435
PATIENT STOPPED TAKING TRUVADA AFTER FEW MONTH BY HIS OWN DECISION [TREATMENT NONCOMPLIANCE],Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
WHO WAS ON DAILY HYDROCORTISONE FOR ADRENOMYELONEUROPATHY WITH 70% SYMPTOM RECOVERY,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
DECREASED APPETITE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
CHRONIC ALLOGRAFT DYSFUNCTION FOLLOWING BK VIRUS NEPHROPATHY,Complications of transplanted kidney,KIDNEY GRAFT DYSFUNCTION,COMPLICATIONS OF TRANSPLANTED KIDNEY,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10051366,10010185,10051366
SHE WAS CONSIDERED TREATMENT FAILURE,she was considered treatment failure,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
VISUAL ILLUSIONS,Optical illusion,OPTICAL ILLUSION,ILLUSION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10030954,10021403,10030954
HYPERTENSION,hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
"DESPITE THESE TREATMENTS, SHE CONTINUED TO HAVE ANGINA AND TACHYARRHYTHMIAS LEADING TO MULTIPLE ICD SHOCKS FOR VT",Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
SEVERE BONE MARROW SUPPRESSION DUE TO METHOTREXATE TOXICITY,Myelosuppression,MYELOSUPPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10028584,10065553,10028584
SUPRACLAVICULAR LYMPHADENOPATHY,Lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
BLOOD GLUCOSE WAS LOW AT 63MG/DL,Blood glucose decreased,BLOOD GLUCOSE DECREASED,BLOOD GLUCOSE DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",CARBOHYDRATE TOLERANCE ANALYSES (INCL DIABETES),10022891,10005555,10005555,10005555
EXENTHEMIC REACTION WAS AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
FEVER FOLLOWING METHOTREXATE TOXICITY,Pyrexia,DRUG FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037662,10037660,10013697
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
HYPOXIC BRAIN DAMAGE FOLLOWING DRUG POISONING DUE TO DRUG INTERACTION BETWEEN QUININE AND LOPERAMIDE,hypoxic brain damage,HYPOXIC BRAIN DAMAGE,BRAIN INJURY,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10021146,10067967,10021146
HEADACHES,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
FAILURE OF CIPROFLOXACIN THERAPY,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
RESPIRATORY DIFFICULITIES,Dyspnoea,BREATHING DIFFICULT,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10006338
FEVER/ BODY TEMPERATURE ELEVATION UP TO 38.5 C,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
"VISUAL ACUITY RIGHT EYE 6/7.5, LEFT EYE 6/12","visual acuity right eye 6/7.5, left eye 6/12",VISUAL ACUITY DECREASED,VISUAL ACUITY REDUCED,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10049061,10047531,10049061
HEART FAILURE RESULTING FROM DISCONTINUATION OF SGLT2 INHIBITOR,Drug withdrawal syndrome,DRUG WITHDRAWAL SYNDROME,DRUG WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10013754,10013754,10013754
"DESPITE AMIODARONE, LIDOCAINE, METOPROLOL, DILTIAZEM, MULTIPLE CARDIOVERSIONS, INTUBATION AND SEDATION, HIS VT PERSISTED",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DISSEMINATED INTRAVASCULAR COAGULATION,disseminated intravascular coagulation,DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10013442,10013442,10013442
INAPPETENCE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
MODERATE DISTRESS,Emotional distress,EMOTIONAL DISTRESS,EMOTIONAL DISTRESS,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10049119,10049119,10049119
INEFFICACY OF ALBENDAZOLE (LACK OF DRUG EFFECT) WITH NO ADR,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HYPERTENSIVE EVENTS HAD OFTEN OCCURRED,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
SEVERE METABOLIC ACIDOSIS,Metabolic acidosis exacerbated,METABOLIC ACIDOSIS EXACERBATED,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027418,10027417,10027418
SENSORY NEUROPATHY,Peripheral sensory neuropathy,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10034620,10034620,10034620
DISEASE RECURRENCE,disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
VENTRICULAR BIGEMINY,ventricular bigeminy,VENTRICULAR BIGEMINY,VENTRICULAR EXTRASYSTOLES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10050779,10047289,10050779
ERTHYMEA NODOSUM,erthymea,ERYTHEMA NODOSUM,ERYTHEMA NODOSUM,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,PANNICULITIDES,10040785,10015226,10015226,10015226
OLIGURIA,Oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
CHOLESTEROL LEVEL OF 6.3 SHOULD BE HIGHLIGHTED,Cholesterol levels raised,CHOLESTEROL LEVELS RAISED,BLOOD CHOLESTEROL INCREASED,LIPID ANALYSES,CHOLESTEROL ANALYSES,10022891,10008663,10005425,10008663
HYPOGAMMAGLOBULINEMIA,Hypogammaglobulinemia,HYPOGAMMAGLOBULINEMIA,HYPOGAMMAGLOBULINAEMIA,IMMUNODEFICIENCY SYNDROMES,PRIMARY IMMUNODEFICIENCY SYNDROMES,10021428,10054427,10020983,10054427
CLASS II LUPUS NEPHRITIS,Lupus nephritis,LUPUS NEPHRITIS,LUPUS NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10025140,10025140,10025140
HIGH RISK OF CONFUSION BETWEEN DICLOBNE 75 VIALS AND NOVAMINSULFON 1G,Product packaging confusion,PRODUCT PACKAGING CONFUSION,PRODUCT PACKAGING CONFUSION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT CONFUSION ERRORS AND ISSUES,10022117,10074776,10074776,10074776
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
LOSS OF ATTENTION,attention impaired,ATTENTION IMPAIRED,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10003738,10013496,10003738
GLOSSITIS,Glossitis,GLOSSITIS,GLOSSITIS,TONGUE CONDITIONS,TONGUE DISORDERS,10017947,10018386,10018386,10018386
KLEBSIELLA PNEUMONIAE  INFECTION,Klebsiella pneumoniae  infection,KLEBSIELLA PNEUMONIAE INFECTION,KLEBSIELLA INFECTION,BACTERIAL INFECTIOUS DISORDERS,KLEBSIELLA INFECTIONS,10021881,10052209,10061259,10052209
DRUG INDUCED SIGNIFICANT QT PROLONGATION (670 MS),Electrocardiogram QT prolonged,QT INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037703,10014387,10037703
"PAINFUL, ULCERATED LESION OVERLYING THE LEFT MANDIBULAR ALVEOLUS",Osteolysis,OSTEOLYTIC LESION,OSTEOLYSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),METABOLIC BONE DISORDERS,10028395,10051544,10031248,10051544
CARDIAC TAMPONADE,Cardiac tamponade,CARDIAC TAMPONADE,CARDIAC TAMPONADE,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10007610,10007610,10007610
LUNG ABSCESS,Lung abscess,LUNG ABSCESS,LUNG ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10025028,10025028,10025028
PSEUDOMONAS AERUGINOSA INFECTION,Pseudomonas aeruginosa,PSEUDOMONAS AERUGINOSA INFECTION NOS,PSEUDOMONAS INFECTION,BACTERIAL INFECTIOUS DISORDERS,PSEUDOMONAL INFECTIONS,10021881,10037133,10061471,10037133
DECREASED APPETITE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
"EXOPHIALA DERMATITIDIS INFECTION FOLLOWING TREATMENT WITH METHOTREXATE, CYCLOPHOSPHAMIDE AND TACROLIMUS",Fungal infection,FUNGAL INFECTION,FUNGAL INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017533,10017533,10017533
LEUCOPENIA,Leukopenia,LEUCOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024283
STENT OCCLUSION OCCURRED ON POD4,Vascular stent occlusion,ARTERIAL STENT OCCLUSION,VASCULAR STENT OCCLUSION,COMPLICATIONS ASSOCIATED WITH DEVICE,VASCULAR COMPLICATIONS ASSOCIATED WITH DEVICE,10018065,10067794,10077143,10067794
GENTLE PRODUCTIVE COUGH,Productive cough,PRODUCTIVE COUGH,PRODUCTIVE COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10036790,10036790,10036790
"MEDICATION ERROR, AS ONE (OR SEVERAL) UNINTENDED HUMAN ERROR(S) HAVE OCCURRED/MEDICATION ERROR (PRESCRIBED INCORRECT DOSAGE)",Drug prescribing error,DRUG DOSE PRESCRIBING ERROR,DRUG PRESCRIBING ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT PRESCRIBING ERRORS AND ISSUES,10022117,10064300,10064296,10064300
ADRENOCORTICOTROPIC DEFICIENCY,Adrenocorticotropic hormone deficiency,ADRENOCORTICOTROPIC HORMONE DEFICIENCY,ADRENOCORTICOTROPIC HORMONE DEFICIENCY,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPOFUNCTION,10014698,10073179,10073179,10073179
MYCOTIC SKIN INFECTION CAUSED BY ARTHRODERMA BENHAMIAE,Fungal skin infection,FUNGAL SKIN INFECTION,FUNGAL SKIN INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10017543,10017543,10017543
ISONIAZID-INDUCED THROMBOCYTOPENIC PURPURA,Thrombocytopenic purpura,THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIC PURPURA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043561,10043561,10043561
ANEMIA (HEMOGLOBIN: 9 G/DL),Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
CERVICAL LYMPH NODES WERE MODERETELY ENLARGED AND TENDER,Lymphadenopathy,LYMPHADENOPATHY CERVICAL,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025200,10025197,10025200
PRURITIS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
GR1 PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
RENAL IMPAIRMENT,Renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
NO RESPONSE,Therapy non-responder,THERAPY NON-RESPONDER,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051082,10051082,10051082
PRURITUS OCCURRED 1-3 DAYS AFTER WITHDRAWAL OF CETIRIZINE,Drug withdrawal syndrome,DRUG WITHDRAWAL SYNDROME,DRUG WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10013754,10013754,10013754
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
NSAID INDUCED URTICARIA/ANGIOEDEMA (NIUA),Angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
FALL,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
HALF COMPRESSION STENOSIS OF LEFT UPPER LOBE AND HYPEREMIC IN LEFT LOWER LOBE,Bronchostenosis,STENOSIS OF BRONCHUS,BRONCHOSTENOSIS,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10006487,10006487,10041982
THERAPY-RELATED CHRONIC MYELOMONOCYTIC LEUKEMIA,Chronic myelomonocytic leukaemia,CHRONIC MYELOMONOCYTIC LEUKEMIA,CHRONIC MYELOMONOCYTIC LEUKAEMIA,LEUKAEMIAS,MYELODYSPLASTIC SYNDROMES,10029104,10009018,10009018,10054350
REFRACTORY THROMBOPENIA,Thrombocytopenia,THROMBOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043569
LOSS OF APPETITE,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
HAEMOGLOBIN DECREASED (5.3 G/DL),Haemoglobin decreased,HAEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10018884
TREATMENT NON-COMPLIANCE/ DISCONTINUED TREATMENT,Intentional product use issue,INTENTIONAL PRODUCT USE ISSUE,INTENTIONAL PRODUCT USE ISSUE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT USE ISSUES,10022117,10076308,10076308,10076308
NO RESPONSE,Therapy non-responder,NO THERAPEUTIC RESPONSE,THERAPY NON-RESPONDER,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10063670,10051082,10063670
HEALTHY BABY GIRL,Normal newborn,NORMAL NEWBORN,NORMAL NEWBORN,"PREGNANCY, LABOUR, DELIVERY AND POSTPARTUM CONDITIONS",NORMAL NEWBORN STATUS,10036585,10029769,10029769,10029769
DRUG ASSOCIATED ACUTE INTERSTITIAL NEPHRITIS,Tubulointerstitial nephritis,TUBULOINTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10048302,10048302,10048302
CELLULITIS OF PERIANAL AREA (GRADE 3),Cellulitis,CELLULITIS,CELLULITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10007882,10007882,10007882
SLEEP DISORDER,sleep disorder,SLEEP DISORDER,SLEEP DISORDER,SLEEP DISORDERS AND DISTURBANCES,SLEEP DISORDERS NEC,10037175,10040984,10040984,10040984
LUNG SARCOMATOID CARCINOMA WITH METASTASES TO THE RIGHT ADRENAL GLAND AND PARAAORTIC LYMPH NODES,Lung cancer metastatic,LUNG CANCER METASTATIC,LUNG CANCER METASTATIC,RESPIRATORY AND MEDIASTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,RESPIRATORY TRACT AND PLEURAL NEOPLASMS MALIGNANT CELL TYPE UNSPECIFIED NEC,10029104,10050017,10050017,10050017
LACK OF DRUG EFFECT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
ASPARTATE TRANSAMINASE (AST) 151 U/L,Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
BK VIRUS NEPHROPATHY,Polyomavirus-associated nephropathy,BK VIRUS NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065333,10065381,10065333
DISEASE HAD UNFORTUNATELY PROGRESSED DESPITE TREATMENT ( LACK OF EFFECT),Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
TIREDNESS,tiredness,TIREDNESS,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10043890,10016256,10043890
"HISTOLOGY SHOWED SUBEPIDERMAL BLISTER WITH DERMAL PAPILLAE, DERMAL INFLAMMATORY INFILTRATES, DERMAL ELASTOSIS, PAS POSITIVE MATERIAL AROUND CAPILLARY VESSELS",Skin degenerative disorder,SKIN DEGENERATIVE DISORDER,SKIN DEGENERATIVE DISORDER,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10061531,10061531,10061531
FEVER OF 38-39 DEGREE C,Feverish,FEVERISH,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10073718,10037660,10073718
ATYPICAL LYMPHOCYTES,Lymphocyte morphology abnormal,ATYPICAL LYMPHOCYTES,LYMPHOCYTE MORPHOLOGY ABNORMAL,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10003751,10062047,10003751
ASPERGILLUS INFECTION,aspergillus infection,ASPERGILLUS INFECTION,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10074171,10074171,10074171
DRUG EXPOSURE DURING PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
PATIENT WITH STAGE 5 CHRONIC RENAL DISEASE TAKING ACETYLSALICYLIC ACID,Contraindicated drug administered,CONTRAINDICATED DRUG ADMINISTERED,CONTRAINDICATED PRODUCT ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10074899,10078504,10074899
HEMODYNAMIC INSTABILITY,Hemodynamic instability,HEMODYNAMIC INSTABILITY,HAEMODYNAMIC INSTABILITY,VASCULAR DISORDERS NEC,NON-SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10058270,10052076,10058270
DYSARTHRIA,Dysarthria,DYSARTHRIA,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10013887,10013887,10013887
LOW BLOOD PRESSURE,Hypotension,LOW BLOOD PRESSURE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10024895
"FISTULA IN THE REGION OF 24/25/IN THE RIGHT MANDIBLE, A HARD-ELASTIC PAINFUL SWELLING AND A FISTULA DISTAL TO 43 WERE OBSERVED",Oral cavity fistula,ORAL CAVITY FISTULA,ORAL CAVITY FISTULA,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL FISTULAE,10017947,10065720,10065720,10065720
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
LOST GRAFTS AFTER REFRACTORY AR,Renal transplant failure,RENAL GRAFT LOSS,RENAL TRANSPLANT FAILURE,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10048749,10074495,10048749
PORTAL VEIN THROMBOSIS,Portal vein thrombosis,PORTAL VEIN THROMBOSIS,PORTAL VEIN THROMBOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC VASCULAR DISORDERS,10019805,10036206,10036206,10036206
NEUTROPHIL DECRASED (G4),Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
RESTLESS,restless,RESTLESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038740,10038743,10038740
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
AGITATION INCREASED,increased agitation,INCREASED AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10021651,10001497,10021651
DRUG INTERACTION BETWEEN ETORICOXIB AND CURCUMA,drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
NO CLINICAL RESPONSE WITHIN 7 DAYS,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
MACROPHAGE ACTIVATION SYNDROME DUE TO EBV INFECTION,Macrophage activation syndrome,MACROPHAGE ACTIVATION SYNDROME,HISTIOCYTOSIS HAEMATOPHAGIC,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10053867,10048595,10053867
BILATERAL SCLERAL INJECTION,Scleral hyperaemia,SCLERAL HYPERAEMIA,SCLERAL HYPERAEMIA,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","SCLERAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10059096,10059096,10059096
GRAFT REJECTION,Kidney transplant rejection,KIDNEY TRANSPLANT REJECTION,KIDNEY TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10023439,10023439,10023439
THE PATIENT HAD A POSITIVE ORAL PROVOCATION TEST,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
URINARY BLADDER HAEMORRHAGE,Urinary bladder haemorrhage,URINARY BLADDER HAEMORRHAGE,URINARY BLADDER HAEMORRHAGE,BLADDER AND BLADDER NECK DISORDERS (EXCL CALCULI),BLADDER DISORDERS NEC,10038359,10046528,10046528,10046528
PRURITIS,Pruritus,PRURITUS,PRURITUS,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037087,10037087,10037087
PERIPHERAL RETICLUAR OPACITIES WITH FAINT TRACTION BRONCHIECTASIS ON CHEST CT SCAN,Bronchiectasis,BRONCHIECTASIS,BRONCHIECTASIS,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHIAL CONDITIONS NEC,10038738,10006445,10006445,10006445
SUBARACHNOID HEMORRHAGE,subarachnoid hemorrhage,SUBARACHNOID HEMORRHAGE,SUBARACHNOID HAEMORRHAGE,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10042320,10042316,10042320
ELEVATION OF CARDIAC BIOMARKERS WITH TROPONIN I (CTNI) AT 6.00 NG/ML,Troponin I increased,CARDIAC TROPONIN I INCREASED,TROPONIN I INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10007612,10058268,10007612
TACHYPNEA,tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
EOSINOPHIL COUNT,Eosinophil count,EOSINOPHIL COUNT,EOSINOPHIL COUNT,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10014941,10014941,10014941
HYPOTENSIVE,Hypotension,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021107
ANAPHYLACTIC SHOCK,Anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
PULMONARY EDEMA,Pulmonary oedema,PULMONARY EDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037423,10037423,10037375
OVEREXCITED,Excitement excessive,EXCITEMENT EXCESSIVE,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10015629,10001497,10015629
PATIENT TREATED WITH CLOMIPHENE FOR HYPOGONADOTROPIC HYPOGONADISM (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PERNICIOUS ANEMIA FOLLOWING VITAMIN B12 DEFICIENCY,Pernicious anaemia,PERNICIOUS ANEMIA,PERNICIOUS ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIA DEFICIENCIES,10005329,10034695,10034695,10034697
DIFFUSE CEREBRITIS,Encephalitis,CEREBRITIS,ENCEPHALITIS,INFECTIONS - PATHOGEN UNSPECIFIED,CENTRAL NERVOUS SYSTEM AND SPINAL INFECTIONS,10021881,10014581,10014581,10054860
SHORTNESS OF BREATH SECONDARY TO PRESUMPTIVE CYCLOPHOSPHAMIDE-INDUCED PNEUMONITIS,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
"LOWER LIP WAS DISTINCTLY SWOLLEN, REDDENED AND EROSIVE","lower lip was distinctly swollen, reddened and erosive",SWOLLEN LIPS,LIP SWELLING,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE SWELLING AND OEDEMA,10017947,10042723,10024570,10042723
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
CARDIAC ARREST,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
FATAL BLOOD METHADONE LEVELS IN THIS CASE SERIES RANGED FROM 69 TO 700 NG/ML,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED (5.98 MICROKAT/L),Gamma-glutamyltransferase increased,GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10017668,10017693,10017668
PATIENT DID NOT RESPOND TO 2ND LINE CONVENTIONAL CHEMOTHERAPY,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
TRANSIENT FATIGUE FOLLOWING OFF LABEL USE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
LEFT VOCAL CORD PARALYSIS PERSISTED,Vocal cord paralysis,VOCAL CORD PARALYSIS,VOCAL CORD PARALYSIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),VAGUS NERVE DISORDERS,10029205,10047674,10047674,10047674
METABOLIC ACIDOSIS FOLLOWING SEPSIS,metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
"HEART RATE, 146 BEATS/MIN",Heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME FOLLOWING HYPOMAGNESAEMIA,Reversible cerebral vasoconstriction syndrome,REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME,REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS,CENTRAL NERVOUS SYSTEM VASCULAR DISORDERS NEC,10029205,10073240,10073240,10073240
PANCYTOPENIA,Pancytopenia,PANCYTOPENIA,PANCYTOPENIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10033661,10033661,10033661
ANTICHOLINERGIC DELIRIUM,delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
DECREASED HEMOGLOBIN (6.8 G/DL),Haemoglobin decreased,DECREASED HEMOGLOBIN,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10011964
DISEASE PROGRESSION,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
TENDER CERVICAL ADENOPATHY,lymphadenopathy cervical,LYMPHADENOPATHY CERVICAL,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025200,10025197,10025200
CARDIOTOXICITY,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
EPIGASTRALGIA,Abdominal pain upper,EPIGASTRALGIA,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10048944
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
POOR TOLERANCE,Drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
LOPERAMIDE INDUCED PANCREATITIS,Pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
PHILADELPHIACHROMOSOME(PH) INDEPENDENT CLONAL CHANGES/ABERRATION,Cytogenetic abnormality,CHROMOSOME ABNORMALITY,CYTOGENETIC ABNORMALITY,CHROMOSOMAL ABNORMALITIES AND ABNORMAL GENE CARRIERS,CHROMOSOMAL ABNORMALITIES NEC,10010331,10008815,10067477,10008815
INAPPROPRIATE DOSING AND DRUG-DRUG INTERACTIONS,Incorrect dose administered,WRONG DOSE ADMINISTERED,INCORRECT DOSE ADMINISTERED,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10048054,10064355,10048054
PREDNISONE AND HYDROXYCHLOROQUINE GIVEN FOR SERUM AUTOIMMUNITY IN FEMALE INFERTILITY/ PATIENT WAS TREATED WITH PREDNISONE AND HYDROXYCHLOROQUINE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BILATERAL TINNITUS,Tinnitus,TINNITUS,TINNITUS,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10043882,10043882,10043882
SPASMS,spasms,SPASMS,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10041408,10028334,10041408
MOG-IGG SEROPOSITIVE/POST-VACCINATION AUTOIMMUNE CNS DEMYELINATION/SUSPECTED TRANSVERSE MYELITIS,Myelitis transverse,MYELITIS TRANSVERSE,MYELITIS TRANSVERSE,CENTRAL NERVOUS SYSTEM INFECTIONS AND INFLAMMATIONS,MYELITIS (INCL INFECTIVE),10029205,10028527,10028527,10028527
ACUTE ONSET OF WEAKNESS IN BOTH LOWER EXTREMITIES,Lower extremities weakness of,LOWER EXTREMITIES WEAKNESS OF,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10024947,10028372,10024947
ANTI YELLOW FEVER VIRUS IMMUNOGLOBULIN G ANTIBODY NEGATIVE,antibody test negative,ANTIBODY TEST NEGATIVE,ANTIBODY TEST NEGATIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,IMMUNOLOGY ANALYSES NEC,10022891,10061426,10061426,10061426
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
GRADE II LEFT VENTRICULAR DYSFUNCTION,Left ventricular dysfunction,LEFT VENTRICULAR DYSFUNCTION,LEFT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10049694,10049694,10049694
NITRITE-POSITIVE URINARY TRACT INFECTION WITH LEUKOCYTURIA,Urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
SOMNOLENCE,Somnolence,SOMNOLENCE,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041349,10041349,10041349
IPSILATERAL SUBDURAL HEMATOMA,Subdural haematoma,SUBDURAL HEMATOMA,SUBDURAL HAEMATOMA,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10042361,10042361,10042380
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CRP INCREASED (157 MG/DL),C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
FOR MAINTENANCE OF COMPLAINTS AND CHANGES IN THE SLEEP PATTERN,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
LEUKOCYTES DECREASED (1.940 UNITS NOS),White blood cell count decreased,LEUKOCYTE COUNT DECREASED,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047942,10047942,10048552
GASTROINTESTINAL TOXICITY,Gastrointestinal toxicity,GASTROINTESTINAL TOXICITY,GASTROINTESTINAL TOXICITY,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10059024,10059024,10059024
PULMONARY EDEMA FOLLOWING CAPILLARY LEAK SYNDROME,Pulmonary oedema,PULMONARY EDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037423,10037423,10037375
INTERMITTENT FEVER,intermittent fever,INTERMITTENT FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10058698,10037660,10058698
CARDIAC ARREST DUE TO DISEEMINATED STRONGYLOIDIASIS,Cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
STIFFNESS OF THE KNEES AND LEFT ELBOW,Joint stiffness,JOINT STIFFNESS,JOINT STIFFNESS,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023230,10023230,10023230
USE OF DESMOPRESSIN FOR EPISTAXIS (OFF LABEL USE WITH NO ADR),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
INCREASE IN THE LOCALIZED SCLERODERMA ACTIVITY INDEX/DISEASE ACTIVITY INCREASED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
"NON PRURITIC, FLORID AND ERYTHEMATOUS MACULOPAPULAR RASH ACROSS ARMS AND LEGS",Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
FATAL THROMBOEMBOLIC EVENTS,Embolism,THROMBOEMBOLIC EVENT,EMBOLISM,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10043566,10061169,10043565
MALAISE,malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
IT IS NOT CLEAR WHETHER DIAZEPAM CONTRIBUTED TO THE HYPOVENTILATION,Hypoventilation,HYPOVENTILATION,HYPOVENTILATION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10021133,10021133,10021133
PATIENT WAS TRIED TO FORCIBLY OBTAIN DEXTROMETHORPHAN,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
SKIN INDURATION,Skin induration,SKIN INDURATION,SKIN INDURATION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10051837,10051837,10051837
DEHYDRATION,dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
ELEVATED WHITE BLOOD CELL COUNT (17.91 K/MM3),White blood cell count increased,WBC INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056739,10047943,10056739
RECEIVED OFF LABEL TREATMENT WITH VENLAFAXINE AND LITHIUM CARBONATE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
QTC PROLONGED (VALUE-0.52 SEC),Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
CEA LEVEL FELL TO 349,Carcinoembryonic antigen decreased,CARCINOEMBRYONIC ANTIGEN DECREASED,CARCINOEMBRYONIC ANTIGEN DECREASED,CYTOGENETIC INVESTIGATIONS,CELL MARKER ANALYSES,10022891,10074847,10074847,10074847
GENERAL WEAKNESS,Weakness generalised,WEAKNESS GENERALISED,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047864,10003549,10047864
MALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
"FEMALE PATIENT WHO HAD COTARD'S SYNDROME, AND SHOWN CLINICAL IMPROVEMENT UPON BEING TREATED WITH BOTH DULOXETINE AND AMISULPRIDE.",Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
MILD RENAL IMPAIRMENT,mild renal impairment,RENAL IMPAIRMENT,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10062237,10062237,10062237
GAINED A LOT OF WEIGHT (APPROXIMATELY 7KG SINCE THE BEGINNING OF THE TREATMENT),Abnormal weight gain,ABNORMAL WEIGHT GAIN,ABNORMAL WEIGHT GAIN,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10000188,10000188,10000188
MYCOBACTERIUM CHELONAE ENDOCARDITIS,Endocarditis bacterial,BACTERIAL ENDOCARDITIS,ENDOCARDITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10014666,10014666,10004019
CHRONIC HEPATITIS E,HEPATITIS E,HEPATITIS E,HEPATITIS E,VIRAL INFECTIOUS DISORDERS,HEPATITIS VIRAL INFECTIONS,10021881,10019768,10019768,10019768
INTERMITTENT HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
"CSF RBC POSITIVE (14,400 CELLS/MICROL)",CSF red blood cell count positive,CSF RBC POSITIVE,CSF RED BLOOD CELL COUNT POSITIVE,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10056927,10075562,10056927
EROSION IN LOWER EXTREMITIES,Skin erosion,SKIN EROSION,SKIN EROSION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040840,10040840,10040840
SYMPTOMS DID NOT IMPROVE WITH ANTIDEPRESSANT MEDICATIONS/ MAJOR DEPRESSIVE DISORDER AND ANXIETY SYMPTOMS DID NOT IMPROVE WITH ANTIDEPRESSANT MEDICATIONS (FLUOXETINE AND THEN CITALOPRAM),lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
RENAL DYSFUNCTION FOLLOWING DRUG OVERDOSE,Renal function abnormal,RENAL FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038451,10062237,10038451
RESPIRATORY DEPRESSION,Respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
DYSARTHRIA,dysarthria,DYSARTHRIA,DYSARTHRIA,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10013887,10013887,10013887
HYPERTENSIVE,hypertensive,HYPERTENSIVE,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020800,10020772,10020800
BEHAVIORAL PROBLEMS,Behavior disorder,BEHAVIOR DISORDER,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004204,10061422,10004204
SEVERE ACIDOSIS,severe acidosis ,ACIDOSIS,ACIDOSIS,ACID-BASE DISORDERS,MIXED ACID-BASE DISORDERS,10027433,10000486,10000486,10000486
EXERTIONAL DYSPNEA,Dyspnoea exertional,EXERTIONAL DYSPNEA,DYSPNOEA EXERTIONAL,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013971,10013971,10055548
ACUTE INTERSTITIAL NEPHRITIS,Tubulointerstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029135,10048302,10000819
BLINDNESS DUE TO VASOSPASM FOLLOWING INTENTIONAL QUININE SULFATE OVERDOSE,transient blindness,TRANSIENT BLINDNESS,BLINDNESS TRANSIENT,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10044373,10005184,10044373
RECURRENT SEPSIS,sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
RASH FOLLOWED A WAXING AND WANING COURSE WITH DEVELOPMENT OF PERIPHERAL EOSINOPHILIA (1373 CELLS/MCL),Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
EAR HEMORRHAGE,Ear haemorrhage,EAR HEMORRHAGE,EAR HAEMORRHAGE,AURAL DISORDERS NEC,EAR DISORDERS NEC,10013993,10014009,10014009,10055244
NEUROLEPTIC MALIGNANT SYNDROME DUE TO AMISULPRIDE/AMISULPRIDE-RELATED NEUROLEPTIC MALIGNANT SYNDROME,Neuroleptic malignant syndrome,NEUROLEPTIC MALIGNANT SYNDROME,NEUROLEPTIC MALIGNANT SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10029282,10029282,10029282
GLOMERULAR HEMATURIA,Haematuria,GLOMERULAR HEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10072110,10018867,10072115
OVERDOSE OF THE DRUG FLECAINIDE,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
HYPONATREMIA,hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
EPILEPSY,Epilepsy,EPILEPSY,EPILEPSY,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10015037,10015037,10015037
FLUZONE HD VACCINE ADMINISTRATED TO GREATER THAN EQUAL TO 18 YEAR PATIENT,inappropriate age at vaccine administration,INAPPROPRIATE AGE AT VACCINE ADMINISTRATION,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10067927,10071062,10067927
CONGESTIVE HEART FAILURE,congestive heart failure,CONGESTIVE HEART FAILURE,CARDIAC FAILURE CONGESTIVE,HEART FAILURES,HEART FAILURES NEC,10007541,10010684,10007559,10010684
DEEP VEIN THROMBOSIS,Deep vein thrombosis,DEEP VEIN THROMBOSIS,DEEP VEIN THROMBOSIS,EMBOLISM AND THROMBOSIS,PERIPHERAL EMBOLISM AND THROMBOSIS,10047065,10051055,10051055,10051055
REDUCED URINE OUTPUT,reduced urine output,URINE OUTPUT DECREASED,URINE OUTPUT DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059895,10059895,10059895
"VIRAL LOAD INCREASED (140,000 COPIES/ML)",Viral load increased,VIRAL LOAD INCREASED,VIRAL LOAD INCREASED,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10062180,10062180,10062180
SPRUE-LIKE ENTEROPATHY ASSOCIATED WITH OMELSARTAN,Sprue-like enteropathy,SPRUE-LIKE ENTEROPATHY,SPRUE-LIKE ENTEROPATHY,MALABSORPTION CONDITIONS,MALABSORPTION SYNDROMES,10017947,10079622,10079622,10079622
DERMATOPATHIC LYMPHADENITIS,Dermatopathic lymphadenopathy,DERMATOPATHIC LYMPHADENOPATHY,DERMATOPATHIC LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10074339,10074339,10074339
USE OF KETOCONAZOLE FOR THE TREATMENT OF HYPERCORTISOLISM (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ACUTE EPSTEIN-BARR VIRUS INFECTION,Epstein-Barr virus infection,EPSTEIN-BARR VIRUS INFECTION,EPSTEIN-BARR VIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,EPSTEIN-BARR VIRAL INFECTIONS,10021881,10015108,10015108,10015108
NEUROLEPTIC MALIGNANT SYNDROME,Neuroleptic malignant syndrome,NEUROLEPTIC MALIGNANT SYNDROME,NEUROLEPTIC MALIGNANT SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10029282,10029282,10029282
ASCITES,ascites,ASCITES,ASCITES,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL DISORDERS,10017947,10003445,10003445,10003445
BEZOAR FORMATION,Bezoar,BEZOAR,BEZOAR,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10004542,10004542,10004542
TRIGLYCERIDES: 2.5 MMOL/L,Blood triglycerides increased,BLOOD TRIGLYCERIDES INCREASED,BLOOD TRIGLYCERIDES INCREASED,LIPID ANALYSES,TRIGLYCERIDE ANALYSES,10022891,10005839,10005839,10005839
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
DRUG-DISEASE INTERACTION,Drug-disease interaction,DRUG-DISEASE INTERACTION,DRUG-DISEASE INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10074868,10074868,10074868
DIRECT BILIRUBIN 0.7 MG/DL,Bilirubin conjugated increased,DIRECT BILIRUBIN INCREASED,BILIRUBIN CONJUGATED INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10013038,10004685,10013038
TOXIC EPIDERMAL NECROLYSIS LIKE ANTIFOLATE CYTOTOXIC SKIN REACTION DUE TO PEMETREXED,skin reaction,SKIN REACTION,SKIN REACTION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040914,10040914,10040914
"PROGRESSIVE, SLIGHTLY PRURITIC RASH",Rash pruritic,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10037085
CMV REACTIVATION,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION REACTIVATION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10058666,10011831,10058666
BONE AGE OF 10 YEARS DESPITE ADEQUATE PUBERTAL DEVELOPMENT,Epiphyses delayed fusion,AGE BONE RETARDED,EPIPHYSES DELAYED FUSION,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),EPIPHYSEAL DISORDERS,10028395,10001473,10015077,10001473
ELEVATED ARTERIAL LACTATE (6.3 MMOL/L),Blood lactic acid increased,LACTATE BLOOD INCREASE,BLOOD LACTIC ACID INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10023651,10005635,10023650
ACUTE HEPATITIS,Hepatitis acute,HEPATITIS ACUTE,HEPATITIS ACUTE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019727,10019727,10019727
ACUTE NECROTIZING EOSINOPHILIC MYOCARDITIS FOLLOWING DRESS SYNDROME,acute necrotizing eosinophilic myocarditis,ACUTE NECROTIZING EOSINOPHILIC MYOCARDITIS,EOSINOPHILIC MYOCARDITIS,MYOCARDIAL DISORDERS,NONINFECTIOUS MYOCARDITIS,10007541,10074281,10014961,10074281
TACHYPNEA,tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
BILATERAL PLEURAL EFFUSIONS,Pleural effusion,BILATERAL PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10078037,10035598,10078037
TWO LARGE HEMORRHAGIC CHOROIDAL DETACHMENTS WITH NO KISSING,Choroidal detachment,HAEMORRHAGIC CHOROIDAL DETACHMENT,CHOROIDAL DETACHMENT,"OCULAR STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION NEC","CHOROID AND VITREOUS STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10055851,10008783,10055851
ACCIDENTAL CONSUMPTION OF TWO TABLETS (10 MG EACH) OF OLANZAPINE,Accidental drug intake by child,ACCIDENTAL DRUG INTAKE BY CHILD,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,ACCIDENTAL EXPOSURES TO PRODUCT,10022117,10064368,10073318,10064368
NECROTIC AND PURPURIC LESIONS,necrotic and purpuric lesions,PURPURIC RASH,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037566,10037549,10037566
"DOLOR MUSCULAR EN LAS PIERNAS, SIENDO MÃS INTENSO POR LAS MAÃ‘ANAS, IMPIDIÃ‰NDOLE REALIZAR SUS ACTVIDADES COTIDIANAS NORMALES",Myalgia of lower extremities,MYALGIA OF LOWER EXTREMITIES,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10051587,10028411,10051587
SERRATIA MARCESCEBS ISOLATED FROM DRAINED PURULENT EXUDATE FOLLOWING SKIN NECROSIS,Serratia infection,SERRATIA MARCESCENS INFECTION,SERRATIA INFECTION,BACTERIAL INFECTIOUS DISORDERS,SERRATIA INFECTIONS,10021881,10054151,10061512,10054151
INTERSTITIAL FIBROSIS WITHOUT EVIDENCE OF ACTIVE MYOCARDITIS,Fibrosis,FIBROSIS,FIBROSIS,TISSUE DISORDERS NEC,FIBROSIS NEC,10018065,10016642,10016642,10016642
TYPE 1 RESPIRATORY FAILURE FOLLOWING PNEUMOCYSTIS JIROVECI PNEUMONIA,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
OESOPHAGEAL PERICARDIAL FISTULA,Oesophageal fistula,OESOPHAGEAL FISTULA,OESOPHAGEAL FISTULA,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL FISTULAE,10017947,10065835,10065835,10065835
HYDROXYCHLOROQUINE TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
LEFT VENTRICULAR INFERIOR-POSTERIOR HYPOKINESIA,Ventricular hypokinesia,LEFT VENTRICULAR HYPOKINESIA,VENTRICULAR HYPOKINESIA,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10050166,10050510,10050166
CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
KAPOSI SARCOMA,Second primary malignancy,SECOND PRIMARY MALIGNANCY,SECOND PRIMARY MALIGNANCY,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10039801,10039801,10039801
LACTATE DEHYDROGENASE WAS 3 TIMES ELEVATED,Blood lactate dehydrogenase increased,LACTATE DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10023654,10005630,10023654
HYPOXIC RESPIRATORY FAILURE,hypoxic respiratory failure,HYPOXIC RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10074615,10038695,10074615
BILATERAL MEDIAL KIDNEY HYPODENSITIES,Renal disorder,KIDNEY DISORDER,RENAL DISORDER,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL DISORDERS NEC,10038359,10038428,10038428,10051052
MARKED HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
RESPIRATORY INSUFFICIENCY,respiratory insufficiency,RESPIRATORY INSUFFICIENCY,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038701,10038695,10038701
LACK OF CLINICAL IMPROVEMENT WITH NO ADR,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
COGNITIVE DEFICITS,Cognitive disorder,COGNITIVE DISORDER,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10057668,10057668,10057668
FULMINANT BACTERIAL PERITONITIS DUE TO ANASTOMOTIC FAILURE WITH EXTENSION OF THE BOWEL ISCHEMIA FOLLOWING ISCHAEMIC COLITIS,Peritonitis bacterial,PERITONITIS BACTERIAL,PERITONITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10062070,10062070,10062070
PANCREATITIS,Pancreatitis,PANCREATITIS,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10033645,10033645,10033645
UNINTENTIONAL OVERDOSE WITH ACETAMINOPHEN,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
HYPERTROPHY OF THE OUTER CORTEX,Bone hypertrophy,BONE HYPERTROPHY,EXOSTOSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10005973,10015688,10005973
INTERMITTENT VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PSYCHOMOTOR AGITATION,psychomotor agitation,PSYCHOMOTOR AGITATION,PSYCHOMOTOR HYPERACTIVITY,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10056436,10037211,10056436
NIGHT SWEATS,Night sweats,NIGHT SWEATS,NIGHT SWEATS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10029410,10029410,10029410
2 RELAPSES HEMOPTYSIS,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
RIGHT HEMIPARESIS,Hemiparesis,HEMIPARESIS (RIGHT),HEMIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019467,10019465,10019467
HIRSUTISM,hirsutism,HIRSUTISM,HIRSUTISM,SKIN APPENDAGE CONDITIONS,HYPERTRICHOSES,10040785,10020112,10020112,10020112
SEVERE PAIN IN RIGHT METATARSOPHALANGEAL JOINT OF THE GREAT TOE,Pain in joint,PAIN IN JOINT,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10033434,10003239,10033434
CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
BACK PAIN,Back pain,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003988,10003988,10003988
SEVERE BILATERAL PLEURAL EFFUSION,Pleural effusion,BILATERAL PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10078037,10035598,10078037
DEHYDRATION,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
ACUTE EPIGASTRIC PAIN RADIATING TO THE BACK,Abdominal pain upper,EPIGASTRIC PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10015026,10000087,10015026
NUMBNESS OF FEET AND HANDS,Hypoaesthesia,NUMBNESS IN HAND,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10049681,10020937,10049681
MILD HAEMATURIA,Haematuria,HAEMATURIA,HAEMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10018867,10018867,10018867
PRIMARY BILIARY CIRRHOSIS,Primary biliary cholangitis,PRIMARY BILIARY CIRRHOSIS,PRIMARY BILIARY CHOLANGITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10004661,10080429,10036680
CONJUNCTIVITIS,Conjunctivitis,CONJUNCTIVITIS,CONJUNCTIVITIS,INFECTIONS - PATHOGEN UNSPECIFIED,EYE AND EYELID INFECTIONS,10021881,10010741,10010741,10010741
FALL,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
"ONE DAY LATER, THE PATIENT DIES DUE TO HEART FAILURE DUE TO VENTRICULAR FIBRILLATION",Ventricular fibrillation,VENTRICULAR FIBRILLATION,VENTRICULAR FIBRILLATION,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047290,10047290,10047290
NASAL EPISTAXIS WITH SEVERE BLEEDING,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
DRUG ADMINISTRATION TO A PREGNANT WOMAN,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
WORSENING PAIN OVER RIGHT KNEE,Pain knee,PAIN KNEE,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10033458,10003239,10033458
SEVERE LEG PAIN,severe leg pain,LEG PAIN,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10024130,10033425,10024130
SINUS BRADYCARDIA,sinus bradycardia,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10040741,10040741,10040741
TUMOUR LYSIS SYNDROME,Tumour lysis syndrome,TUMOUR LYSIS SYNDROME,TUMOUR LYSIS SYNDROME,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10045170,10045170,10045170
RECURRENCE OF HAEMOLYTIC URAEMIC SYNDROME,Haemolytic uraemic syndrome,HAEMOLYTIC URAEMIC SYNDROME,HAEMOLYTIC URAEMIC SYNDROME,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC MECHANICAL FACTOR,10005329,10018932,10018932,10018932
DISEASE PROGRESSION,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
SEVERE DIARRHEA,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
SUDDEN AGGRAVATION OF PATIENT WITH CIRRHOSIS AND RECENT IMMUNOSUPPRESIVE TREATMENT,Cirrhosis liver,CIRRHOSIS LIVER,HEPATIC CIRRHOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10009211,10019641,10009211
MYOCARDIAL INFARCTION,myocardial infarction,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10028596,10028596,10028596
QT PROLONGATION,Electrocardiogram QT prolonged,QT PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037705,10014387,10037705
AMOXICILLIN ALLERGY,Drug hypersensitivity,ALLERGIC REACTION TO ANTIBIOTICS,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10001720,10013700,10001720
NAUSEATED,Nausea,NAUSEATED,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028822
TRANSPLANTATION-ASSOCIATED THROMBOTIC MICROANGIOPATHY,Thrombotic microangiopathy,THROMBOTIC MICROANGIOPATHY,THROMBOTIC MICROANGIOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10043645,10043645,10043645
BLOOD SAMPLE SHOWED HIGH DOSE OF NEULEPTIL,Overdose,ACUTE OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10067695,10033295,10067695
REFRACTORY SYMPTOM,pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
PARANOIA,paranoia,PARANOIA,PARANOIA,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10033864,10033864,10033864
ITCHING AT INJECTION SITE,Injection site pruritus,INJECTION SITE PRURITUS,INJECTION SITE PRURITUS,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022093,10022093,10022093
QRS 184 MS,QRS prolonged,QRS PROLONGED,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037697,10014380,10037697
ITCHY ERUPTION,Rash pruritic,ITCHY RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037884,10037884,10023092
WORSENING OF HIS LESIONS OF LUPUS VULGARIS FOLLOWING PARADOXICAL REACTION TO ANTITUBERCULOSIS THERAPY,Lupus vulgaris,LUPUS VULGARIS,LUPUS VULGARIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10025143,10025143,10025143
EXCESSIVE WEIGHT GAIN,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
QTC PROLONGATION TO 549 MS,Electrocardiogram QT prolonged,ELECTROCARDIOGRAM QTC INTERVAL PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10053698,10014387,10053698
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
BRUISING,Contusion,BRUISING,CONTUSION,INJURIES NEC,SKIN INJURIES NEC,10022117,10050584,10050584,10006504
MARKED POSTERIOR NECK PAIN,Neck pain,NECK PAIN,NECK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10028836,10028836,10028836
WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
INTRUSIVE SUICIDAL THOUGHTS,Suicidal plans,SUICIDAL PLANS,SUICIDAL IDEATION,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10066283,10042458,10066283
HYPONATREMIA / NA 123 MMOL/L,Hyponatremia,HYPONATREMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021038,10021036,10021038
BONY EXPOSURE IN THE LOWER RIGHT QUADRANT,Exposed bone in jaw,EXPOSED BONE IN JAW,EXPOSED BONE IN JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10071014,10071014,10071014
ABSENT DIGIT FIVE SENSORY RESPONSE AND DORSAL ULNAR CUTANEOUS SENSORY RESPONSE,Reflexes absent,REFLEXES ABSENT,AREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10038256,10003084,10038256
HYPERACTIVE FORM OF ICU DELIRIUM,delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
OFF LABEL USE OF CLARITHROMYCIN FOR LYMPHOMA,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ORAL AMOXICILLIN-ASSOCIATED ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLACTIC REACTION TO DRUG,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10054844,10002198,10054844
COMA,Coma,COMA,COMA,NEUROLOGICAL DISORDERS NEC,COMA STATES,10029205,10010071,10010071,10010071
HAPTOGLOBIN DECREASED (7 MG/DL),Haptoglobin decreased,HAPTOGLOBIN DECREASED,HAPTOGLOBIN DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",HAEM METABOLISM ANALYSES,10022891,10019150,10019150,10019150
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
HEMOPTYSIS,Haemoptysis,HEMOPTYSIS,HAEMOPTYSIS,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10018964,10018964,10019523
IBUPROFEN WAS TAKEN BY AN 8-MONTHS PREGNANT MOTHER,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
DECREASED APPETITE,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
FENTANYL TOXICITY/OPIOD TOXICITY,Toxicity to various agents,OPIOID TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10072946,10070863,10072946
LUNG CANCER,Lung neoplasm malignant,LUNG CANCER,LUNG NEOPLASM MALIGNANT,RESPIRATORY AND MEDIASTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,RESPIRATORY TRACT AND PLEURAL NEOPLASMS MALIGNANT CELL TYPE UNSPECIFIED NEC,10029104,10025044,10058467,10025044
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
GENERALIZED WEAKNESS,Asthenia,WEAKNESS GENERALISED,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047864,10003549,10047864
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
DAYTIME HYPERGLYCAEMIA,Hyperglycaemia,HYPERGLYCAEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020635
ANTI-DNA ANTIBODIES POSITIVE,DNA antibody positive,ANTI-DNA ANTIBODIES POSITIVE,DNA ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10002722,10061110,10002722
SEIZURES WERE REFRACTORY TO PHENOBARBITAL AND LEVETIRACETAM,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
OSTEONECROSIS AROUND THE IMPLANT,Osteonecrosis,OSTEONECROSIS,OSTEONECROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10031264,10031264,10031264
SYMPTOMS OF THE COLITIS SIGNIFICANTLY WORSE,Colitis aggravated,COLITIS AGGRAVATED,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009890,10009887,10009890
GAMMA-GLUTAMYL TRANSFERASE (GGT) 24.78 ÎœMOL/SL,Gamma GT increased,GAMMA GT INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10017670,10017693,10017670
FOCAL NODULAR HYPERPLASIA AFTER TREATMENT WITH OXALIPLATIN,Focal nodular hyperplasia,FOCAL NODULAR HYPERPLASIA,FOCAL NODULAR HYPERPLASIA,HEPATIC AND BILIARY NEOPLASMS BENIGN,HEPATOBILIARY NEOPLASMS BENIGN,10029104,10052285,10052285,10052285
PATIENT TREATED WITH RIFAMPICIN FOR HAEMPHILIA SUFFERING SYNOVITIS (OFF LABEL USE) WITH NO ADR,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ARRHYTHMIA,Arrhythmia,ARRHYTHMIA,ARRHYTHMIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10003119,10003119,10003119
THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
DERANGED LIVER FUNCTION,acute derangement of liver function,ACUTE DERANGEMENT OF LIVER FUNCTION,HEPATIC FUNCTION ABNORMAL,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC ENZYMES AND FUNCTION ABNORMALITIES,10019805,10000704,10019670,10000704
"EBV BY ENZYME-LINKED IMMUNOSORBENT ASSAY SHOWED TRACE POSITIVE EBV VIRAL CAPSID ANTIGEN IGG, POSITIVE EPSTEIN-BARR NUCLEAR ANTIGEN IGG, AND NEGATIVE VIRAL CAPSID ANTIGEN IGM.",Epstein-Barr virus antigen positive,EBV ANTIGEN POSITIVE,EPSTEIN-BARR VIRUS ANTIGEN POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10056907,10052363,10056907
INCREASINGLY AGITATED,Agitation,AGITATED,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001495
WEAK VISUAL FIXATION/PURSUIT,Visual impairment,ABNORMAL VISION,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10000186,10047571,10000186
DXM OVERDOSE,drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
DIPHENHYDRAMINE POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
GRADE 1 DIASTOLIC DYSFUNCTION,Diastolic dysfunction,DIASTOLIC DYSFUNCTION,DIASTOLIC DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10052337,10052337,10052337
STEROID-RESISTANT VITREOUS OPACITY FOLLOWING TREATMENT WITH TRIAMCINOLONE ACETONIDE,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
GRADE I IMMEDIATE-TYPE REACTION TO PROTON PUMP INHIBITORS,Type I hypersensitivity,IMMEDIATE HYPERSENSITIVITY REACTION,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10021414,10045240,10021414
HEMOLYTIC ANEMIA (HEMOGLOBIN LEVEL 6.5 G/DL),Haemolytic anaemia,HEMOLYTIC ANEMIA,HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC NEC,10005329,10018916,10018916,10019493
SEVERE VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
ACUTE ONSET RIGHT UPPER QUADRANT PAIN,right upper quadrant pain,RIGHT UPPER QUADRANT PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10039162,10000087,10039162
VESTIBULAR DISORDERS,Vestibular disorder,VESTIBULAR DISORDER,VESTIBULAR DISORDER,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR DISORDERS NEC,10013993,10047386,10047386,10047386
HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
MARKED INCREASE OF VLDL,Very low density lipoprotein increased,VLDL RAISED,VERY LOW DENSITY LIPOPROTEIN INCREASED,LIPID ANALYSES,CHOLESTEROL ANALYSES,10022891,10021693,10047361,10047669
HYPERREFLEXIA,hyperreflexia,HYPERREFLEXIA,HYPERREFLEXIA,NEUROLOGICAL DISORDERS NEC,ABNORMAL REFLEXES,10029205,10020745,10020745,10020745
COLITIS,colitis,COLITIS,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009887,10009887,10009887
DISCHARGE FLOWING DOWN THE LEFT EARLOBE,Otorrhoea,EAR DISCHARGE,OTORRHOEA,AURAL DISORDERS NEC,EAR DISORDERS NEC,10013993,10033101,10033101,10014003
LIVER FAILURE FOLLOWING DIFFUSE ADENOVIRUS ENDOTHELIITIS IN ALL ORGANS,Hepatic failure,LIVER FAILURE,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10019663,10019663,10024678
HEPARIN INDUCED THROMBOCYTOPENIA,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
QUEASY,Nausea,QUEASY,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10037730,10028813,10037730
GRADE 3 NEUTROPENIA,Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
PALMOPLANTAR RASH,Rash,PALMOPLANTAR RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10068748,10037844,10068748
INTERMITTENT MYALGIA IN THE THIGHS,Myalgia of lower extremities,MYALGIA OF LOWER EXTREMITIES,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10051587,10028411,10051587
ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS SECONDARY TO EXEMESTANE,Acute generalized exanthematous pustulosis,ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10062372,10048799,10062372
PATHOLOGICAL FRACTURE,Pathological fracture,PATHOLOGICAL FRACTURE,PATHOLOGICAL FRACTURE,FRACTURES,FRACTURES NEC,10028395,10034156,10034156,10034156
ORAL ULCERS,oral ulceration,ORAL ULCERATION,MOUTH ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10031027,10028034,10031027
ALLERGIC REACTION WITH EXANTHEMA,exanthema,EXANTHEMA,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015587,10037844,10015587
"SYMMETRICAL, BILATERAL FACIAL DERMATOSIS OBSERVED BOTH CHEEKS AND DORSUM OF NOSE",Dermatosis,DERMATOSIS,DERMATOSIS,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10048768,10048768,10048768
ASPERGILLUS FUMIGATUS BRONCHOPULMONARY INFECTION,Bronchopulmonary aspergillosis,ASPERGILLUS FUMIGATUS BRONCHOPULMONARY INFECTION,BRONCHOPULMONARY ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003493,10006473,10003493
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
DRUG EXPOSURE IN UTERO,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
FEVER,fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
RECURRENCE,Disease recurrence,DISEASE RECURRENCE,DISEASE RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061819,10061819,10061819
ST-SEGMENT ELEVATION,ST segment Elevation,ST SEGMENT ELEVATION,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10041894,10014392,10041894
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,Immune reconstitution inflammatory syndrome,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10065042,10065042,10065042
PROLONGATION OF QRS DURATION,QRS prolonged,QRS PROLONGED,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037697,10014380,10037697
SHALLOW ANTERIOR CHAMBER,shallow anterior chamber,SHALLOW ANTERIOR CHAMBER,FLAT ANTERIOR CHAMBER OF EYE,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","ANTERIOR CHAMBER STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10040532,10016760,10040532
DYSPNEA,Dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
PULMONARY EDEMA,pulmonary edema,PULMONARY EDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037375,10037423,10037375
ACUTE KIDNEY INJURY DUE TO OLMESARTAN INDUCED SPRUE-LIKE ENTEROPATHY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
ACTIVE RASH LESIONS OVERLYING THE LUMBAR SPINE,active rash lesion,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
LETHARGY,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
REFUSAL TO EAT,Decreased appetite,DECREASED APPETITE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10061428,10061428,10061428
ALT ELEVATED (269),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
ERYTHEMA IN RIGHT CHEEK AND FLUCTUATION IN THE RIGHT TEMPORAL AREA,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
VOMITED,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SEVERE DESQUAMATIVE RASH,Exfoliative rash,RASH DESQUAMATING,EXFOLIATIVE RASH,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10037853,10064579,10037853
CRP ELEVATION TO 75 MG/L,C-reactive protein increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
PATIENTS PIGMENATIONS DIMINISHED AND IN GENERAL THE SKIN TONE AND HAIR COLOR SEEMED LIGHTER WITHIN 3 MONTHS OF IMATINIB TREATMENT,unexpected therapeutic effect,UNEXPECTED THERAPEUTIC EFFECT,THERAPEUTIC RESPONSE UNEXPECTED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10045527,10043417,10045527
CEREBROSPINAL FLUID WBC 11CELLS/UL,CSF white blood cell count increased,CSF WBC INCREASED,CSF WHITE BLOOD CELL COUNT INCREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10056937,10053805,10056937
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
ALLERGIC INTERSTITIAL NEPHRITIS,Allergic interstitial nephritis,NEPHRITIS INTERSTITIAL,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029134,10048302,10029134
VISION LOSS IN BOTH EYES FOLLOWING MULTIPLE CRANIAL NERVE PALSIES,vision loss,VISION LOSS,BLINDNESS,VISION DISORDERS,VISUAL IMPAIRMENT AND BLINDNESS (EXCL COLOUR BLINDNESS),10015919,10047522,10005169,10047522
ACQUIRED DRUG RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
TREMOR,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
BILATERAL PULMONARY HEMORRHAGING/ LEFT LUNG HEMORRHAGING,Pulmonary haemorrhage,PULMONARY HAEMORRHAGE,PULMONARY HAEMORRHAGE,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10037394,10037394,10037394
INTENTIONAL SUSPECTED SUICIDE,Completed suicide,COMPLETED SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10010144,10010144,10010144
RECURRENT ULCERATIONS,Skin ulcer,SKIN ULCERATION,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040947,10040943,10040947
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
KIEBSIELLA FOLLICULITIS,Folliculitis,FOLLICULITIS,FOLLICULITIS,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10016936,10016936,10016936
SIGNS OF INFLAMMATION AND INFECTION,Inflammation,INFLAMMATION,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10061218,10061218,10061218
SEVERE TOXICITY BY METHOTREXATE,drug toxicty,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
LYMPHADENOPATHY,Lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
DEEP CANDIDEMIA,candidemia,CANDIDEMIA,SYSTEMIC CANDIDA,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10060573,10042938,10060573
COLITIS,colitis,COLITIS,COLITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10009887,10009887,10009887
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
DIPLOPIA,diplopia,DIPLOPIA,DIPLOPIA,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10013036,10013036,10013036
HYPOGLYCAEMIC,hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
CUTANEOUS ROUND LESIONS ON THE NECK AND AXILLARY FOLDS,skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
UPPER RESPIRATORY TRACT INFECTION BACTERIAL,Upper respiratory tract infection bacterial,UPPER RESPIRATORY TRACT INFECTION BACTERIAL,UPPER RESPIRATORY TRACT INFECTION BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10057868,10057868,10057868
PURPURIC RASH,purpuric rash,PURPURIC RASH,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037566,10037549,10037566
ACIDOSIS METABOLIC,Metabolic acidosis,ACIDOSIS METABOLIC,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10000492
HEADACHES,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
PULMONARY MUCORMYCOSIS,Mucormycosis,PULMONARY MUCORMYCOSIS,MUCORMYCOSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10078354,10028098,10078354
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
PULMONARY FIBROSIS,pulmonary fibrosis,PULMONARY FIBROSIS,PULMONARY FIBROSIS,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10037383,10037383,10037383
"QUIET, BLURRED SPEECH/SPEECH DISORDER",Speech disorder,SPEECH DISORDER,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041466,10041466,10041466
ERYTHEMATOUS MACULAR RASH WITH A DISTINCTIVE RETICULAR PATTERN,Erythematous skin rash,ERYTHEMATOUS SKIN RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015244,10037855,10015244
CHOKING,Choking,CHOKING,CHOKING,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10008589,10008589,10008589
HIGH SERUM LEVELS OF Î’-HCG PERSISTED/ METHOTREXATE RESISTANT,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
PRESUMED EMBOLIC IN ORIGIN,Embolism,EMBOLISM,EMBOLISM,EMBOLISM AND THROMBOSIS,NON-SITE SPECIFIC EMBOLISM AND THROMBOSIS,10047065,10061169,10061169,10061169
ORAL CANDIDIASIS,Oral candidiasis,ORAL CANDIDIASIS,ORAL CANDIDIASIS,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10030963,10030963,10030963
ADVANCED  RIGHT VENTRICULAR DYSFUNCTION,right ventricular dysfunction,RIGHT VENTRICULAR DYSFUNCTION,RIGHT VENTRICULAR DYSFUNCTION,MYOCARDIAL DISORDERS,MYOCARDIAL DISORDERS NEC,10007541,10058597,10058597,10058597
ORAL IBUPROFEN INDUCED SPONTANEOUS INTESTINAL PERFORATION,Intestinal perforation,INTESTINAL PERFORATION,INTESTINAL PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,INTESTINAL ULCERS AND PERFORATION NEC,10017947,10022694,10022694,10022694
ANASARCA SYNDROME,Generalised oedema,ANASARCA,GENERALISED OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10002241,10018092,10002241
OCULOGYRIC CRISIS,Oculogyric crisis,OCULOGYRIC CRISIS,OCULOGYRIC CRISIS,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10030071,10030071,10030071
EPIGASTRIC DISCOMFORT,Epigastric discomfort,EPIGASTRIC DISCOMFORT,EPIGASTRIC DISCOMFORT,GASTROINTESTINAL SIGNS AND SYMPTOMS,DYSPEPTIC SIGNS AND SYMPTOMS,10017947,10053155,10053155,10053155
CARCINOMATOUS PERITONITIS,carcinomatous peritonitis,CARCINOMATOUS PERITONITIS,MALIGNANT ASCITES,NEOPLASM RELATED MORBIDITIES,ONCOLOGIC COMPLICATIONS AND EMERGENCIES,10029104,10064716,10025538,10064716
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
HYPOALBUMINEMIA,Hypoalbuminaemia,HYPOALBUMINEMIA,HYPOALBUMINAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020942,10020942,10020943
COMPLETE AIRWAY OBSTRUCTION,airways obstruction,AIRWAYS OBSTRUCTION,OBSTRUCTIVE AIRWAYS DISORDER,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10001539,10061877,10001539
ATTEMPTED SUICIDE,attempted suicide,ATTEMPTED SUICIDE,SUICIDE ATTEMPT,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10003728,10042464,10003728
MINOR INFECTION,infection,INFECTION,INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10021789,10021789,10021789
ULCERATION OF MAXILLARY MUCOSA,Mucosal ulceration,MUCOSAL ULCERATION,MUCOSAL ULCERATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028124,10028124,10028124
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
MOOD DYSREGULATION,Affective disorder,MOOD DISORDER NOS,AFFECTIVE DISORDER,MOOD DISORDERS AND DISTURBANCES NEC,MOOD DISORDERS NEC,10037175,10027945,10001443,10027945
INSOMNIA/ANXIETY,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
PATIENT RECEIVED HIGH DOSE OF HYDROCORTISONE 100 MG EVERY SIX HOURS (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BLEEDING AT THE INFERIOR HEPATIC MARGIN,Bleeding,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10005103,10055798,10005103
PSORIASIS AND PUSTULOSIS PALMOPLANTARIS,Pustular psoriasis,PALMOPLANTAR PUSTULOSIS,PUSTULAR PSORIASIS,EPIDERMAL AND DERMAL CONDITIONS,PSORIATIC CONDITIONS,10040785,10050185,10037575,10050185
LOOSE WATERY STOOLS WITH URGENCY OCCURRING UPTO 20TIMES/DAY,Diarrhoea,STOOLS WATERY,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10042157,10012735,10042157
RISE IN CK,Blood creatine phosphokinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
USE OF INDOMATHACIN FOR TOCOLYSIS (WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
USE OF PERFORMANCE ENHANCING DRUGS,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
"PRESENCE OF MILKY WHITE SYMMETRIC STAINS,ALONG LABIA MAJORA AND PERINEUM",Application site discolouration,APPLICATION SITE HYPOPIGMENTATION,APPLICATION SITE DISCOLOURATION,ADMINISTRATION SITE REACTIONS,APPLICATION AND INSTILLATION SITE REACTIONS,10018065,10003045,10059005,10003045
HYPOTENSION,hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
SEVERE DRY COUGH,Dry cough,DRY COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10013773,10011224,10013773
RASH,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
BRONCHOSCOPY WAS POSITIVE FOR PSEUDOMONAS AERUGINOSA,Pseudomonas infection,INFECTION PSEUDOMONAS AERUGINOSA,PSEUDOMONAS INFECTION,BACTERIAL INFECTIOUS DISORDERS,PSEUDOMONAL INFECTIONS,10021881,10021860,10061471,10021860
HYPONATRAEMIA,Hyponatraemia,HYPONATRAEMIA,HYPONATRAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,SODIUM IMBALANCE,10027433,10021036,10021036,10021036
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
ELEVATED CHLORIDE,Chloride increased,CHLORIDE INCREASED,BLOOD CHLORIDE INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10008577,10005420,10008577
12 FEB 2011 NO GROWTH,Culture negative,CULTURE NEGATIVE,CULTURE NEGATIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,MICROBIOLOGY AND SEROLOGY TESTS NEC,10022891,10061448,10061448,10061448
DRASTIC DECOMPENSATION OF THE CONDITION,Condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
BILATERAL PLEURAL EFFUSIONS,bilateral pleural effusions,BILATERAL PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10078037,10035598,10078037
VISUAL DISTURBANCES,Visual impairment,VISUAL DISTURBANCES,VISUAL IMPAIRMENT,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047543,10047571,10047545
PPIS INJECTION COULD MAKE ASYMPTOMATIC C. DIFFICILE COLONIZATION PROGRESS TO C. DIFFICILE ASSOCIATED DIARRHEA (CDAD),Clostridium difficile infection,CLOSTRIDIUM DIFFICILE INFECTION,CLOSTRIDIUM DIFFICILE INFECTION,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10054236,10054236,10054236
HYPERGLYCEMIA,Hyperglycaemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020639
CUMULATIVE MYELOSUPPRESSION/HEMATOPOIETIC TOXICITY,Bone marrow failure,MYELOSUPPRESSION,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10005986,10065553,10028584
PULSATING TINNITUS,Tinnitus,TINNITUS,TINNITUS,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10043882,10043882,10043882
UNABLE TO TOLERATE ANY OF THE ANTI-INFLAMMATORIES BECAUSE OF ASSOCIATED ABDOMINAL DISCOMFORT,Abdominal discomfort,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10000059,10000059,10000059
BABY'S MOTHER RECEIVED AMOXICILLIN WITH CLAVULANIC ACID 5TH DAY OF THE 40TH WEEK OF PREGNANCY/ FOETAL EXPOSURE (39-40 WEEK OF PREGNANCY),"Fetal exposure during pregnancy, third trimester","FETAL EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071427,10071404,10071427
UNRESPONSIVE AND UNCONSCIOUSNESS,unconsciousness,UNCONSCIOUSNESS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10045481,10024855,10045481
"HISTOLOGY OF A BIOPSY TAKEN FROM BLISTER SHOWED A SUBEPIDERMAL BULLA, ALONG WITH DERMAL EDEMA AND A SCANT LYMPHOHISTIOCYTIC PERIVASCULAR INFILTRATE WITH SPORADIC EOSINOPHILS",Skin oedema,SKIN EDEMA,SKIN OEDEMA,SKIN VASCULAR ABNORMALITIES,SKIN VASCULAR CONDITIONS NEC,10040785,10058679,10058679,10058724
MENINGOCOCCAL MENINGITIS,meningococcal meningitis,MENINGOCOCCAL MENINGITIS,MENINGITIS MENINGOCOCCAL,BACTERIAL INFECTIOUS DISORDERS,NEISSERIA INFECTIONS,10021881,10027276,10027249,10027276
PRERENAL FAILURE,prerenal failure,PRERENAL FAILURE,PRERENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10072370,10072370,10072370
DISEASE PROGRESSION,DISEASE PROGRESSION,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
PRURITIC RASH FOLLOWING DRUG ALLERGY TO AMOXICILLIN,Pruritic rash,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037085,10037884,10037085
POOLY CONTROLLED DIABETES,subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
DIARRHOEA,diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
JAUNDICE,Jaundice,JAUNDICE,JAUNDICE,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10023126,10023126,10023126
INFUSION ASSOCIATED REACTIONS,Infusion related reaction,INFUSION RELATED REACTION,INFUSION RELATED REACTION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10051792,10051792,10051792
INAPPETENCE,inappetence,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
CHEST PAIN,chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
SEVERE EXACERBATIONS OF ASTHMA FOLLOWING RESPIRATORY INFECTION,Asthma,EXACERBATION OF ASTHMA,ASTHMA,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10003554,10003553,10015575
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS (AGEP),acute generalized exanthematous pustulosis,ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10062372,10048799,10062372
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
"TREATMENT HAD BEEN INITIATED WITH CARBAMAZEPINE 400 MG/DAILY; HOWEVER, HE DISCONTINUED MEDICATION AFTER A SHORT NOTICE",Intentional product misuse,INTENTIONAL PRODUCT MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10074903,10074903,10074903
RABEPRAZOLE INDUCED ACUTE INTERSTITIAL NEPHRITIS,Tubulointerstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029135,10048302,10000819
PATIENT WAS ADMINISTERED ONDANSETRON AND METOCLOPRAMIDE FOR ALLEVIATION OF MODERATE TO SEVERE NAUSEA AND VOMITING (DRUG EXPOSURE DURING PREGNANCY),Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, FIRST TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076617,10073513,10076617
RIGHT UNILATERAL RETINOBLASTOMA,Retinoblastoma,RETINOBLASTOMA UNILATERAL,RETINOBLASTOMA,OCULAR NEOPLASMS,OCULAR NEOPLASMS MALIGNANT (EXCL MELANOMAS),10029104,10038919,10038916,10038919
SEVERE NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
CT SCAN OF THE THORAX AND ABDOMEN SHOWED CONSOLIDATION IN THE RIGHT UPPER LOBE,Lung consolidation,LUNG CONSOLIDATION,LUNG CONSOLIDATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10025080,10025080,10025080
LDH INCREASED,Blood lactate dehydrogenase increased,LDH INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10024051,10005630,10024051
URINARY RETENTION,Urinary retention,URINARY RETENTION,URINARY RETENTION,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046555,10046555,10046555
NINP/ NEITHER INFECTED NOR PROTECTED,Hepatitis B antibody negative,HEPATITIS B ANTIBODY NEGATIVE,HEPATITIS B ANTIBODY NEGATIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10019734,10019734,10019734
HYPOVENTILATION,Hypoventilation,HYPOVENTILATION,HYPOVENTILATION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10021133,10021133,10021133
HAND-FOOT SYNDROME,Palmar-plantar erythrodysaesthesia syndrome,HAND AND FOOT SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10019111,10033553,10019111
PURULENT SPUTUM,Sputum purulent,SPUTUM PURULENT,SPUTUM PURULENT,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10050090,10050090,10050090
MULTIPLE ORGAN DYSFUNCTION SYNDROME FOLLOWING SEPTIC SHOCK,Multiple organ dysfunction syndrome,MULTIPLE ORGAN DYSFUNCTION SYNDROME,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10077361,10077361,10077361
ACUTE PULMONARY TUBERCULOSIS,Pulmonary tuberculosis,PULMONARY TUBERCULOSIS,PULMONARY TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10037440,10037440,10037440
CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
RHABDOMYOLYSIS,Rhabdomyolysis,RHABDOMYOLYSIS,RHABDOMYOLYSIS,MUSCLE DISORDERS,MYOPATHIES,10028395,10039020,10039020,10039020
"INTRAVENOUS DILTIAZEM AND METOPROLOL WERE GIVEN, WITH INADEQUATE RATE CONTROL",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
ANXIETY DISORDER,Anxiety disorder,ANXIETY DISORDER,ANXIETY DISORDER,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY DISORDERS NEC,10037175,10057666,10057666,10057666
PATIENT DID NOT RESPOND TO THE LEVETIRACETAM,Drug ineffective for unapproved indication,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10051118,10051118,10051118
SIGNS OF PROGRESSIVE DISEASE DESPITE BEING ASYMPTOMATIC,disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
MELENA,melena,MELENA,MELAENA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10027162,10027141,10027162
DRUG EXPOSURE DURING PREGNANCY WITH NO ADVERSE DRUG REACTION,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
C-REACTIVE PROTEIN INCREASED (103 MG/L),C-reactive protein increased,C-REACTIVE PROTEIN INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10006825,10006825,10006825
MILD DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
EXTREMITY SWELLING,Peripheral swelling,PERIPHERAL SWELLING,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10048959,10048959,10048959
LAFORA DISEASE,Lafora's disease,LAFORA'S DISEASE,LAFORA'S MYOCLONIC EPILEPSY,NEUROLOGICAL DISORDERS CONGENITAL,NEUROLOGICAL DISORDERS CONGENITAL NEC,10010331,10054037,10054030,10054037
NEUROLEPTIC MALIGNANT SYNDROME,Neuroleptic malignant syndrome,NEUROLEPTIC MALIGNANT SYNDROME,NEUROLEPTIC MALIGNANT SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10029282,10029282,10029282
HAND-FOOT SYNDROME,Palmar-plantar erythrodysaesthesia syndrome,HAND AND FOOT SYNDROME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10019111,10033553,10019111
PYREXIA,Pyrexia,PYREXIA,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10037660
PRIMARY RESISTANCE TO IMATINIB MESYLATE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
STAPHYLOCOCCAL TOXIC SHOCK SYNDROME FOLLOWING RAPID PROGRESSION OF WOUND INFECTION (SKIN ULCERATION),Toxic shock syndrome staphylococcal,STAPHYLOCOCCAL TOXIC SHOCK SYNDROME,TOXIC SHOCK SYNDROME STAPHYLOCOCCAL,BACTERIAL INFECTIOUS DISORDERS,STAPHYLOCOCCAL INFECTIONS,10021881,10044250,10044250,10041934
INSOMNIA,Insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
PROLONGED HYPOGLYCAEMIA (53 MG/DL) FOLLOWING SELF-INJECTION OF MASSIVE INSULIN GLARGINE AND DAPAGLIFOZIN (OVERDOSE OF BOTH DRUGS) WITH AN INTENTION TO KILL HERSELF (INTENTIONAL OVERDOSE),Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
DRUG-DRUG INTERACTIONS OF ATORVASTATIN AND AMLODIPINE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
CEREBELLAR ATAXIA,cerebellar ataxia,CEREBELLAR ATAXIA,CEREBELLAR ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10008025,10008025,10008025
POLYMORPHIC VENTRICULAR TACHYCARDIA,Ventricular tachycardia,POLYMORPHIC VENTRICULAR TACHYCARDIA,VENTRICULAR TACHYCARDIA,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10028158,10047302,10036095
BENZODIAZEPINE USE DISORDER,Drug use disorder,DRUG USE DISORDER,DRUG USE DISORDER,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10079381,10079381,10079381
"APPLICATION SITE HYPEREMIA, OEDEMA, PAIN IN DIAMETER OF 6 CM X 5 CM",Inflammation,INFLAMMATION LOCALIZED,INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,INFLAMMATIONS,10018065,10021958,10061218,10021959
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
INCREASED URINARY FREQUENCY,increased urinary frequency,INCREASED URINARY FREQUENCY,POLLAKIURIA,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10021692,10036018,10021692
DIFFUSE HYPERPIGMENTATION ORAL MUCOSA,Oral mucosal disorder,ORAL MUCOSAL DISORDER,ORAL DISORDER,ORAL SOFT TISSUE CONDITIONS,ORAL SOFT TISSUE DISORDERS NEC,10017947,10056468,10067621,10056468
POLYCYSTIC OVARIES,Polycystic ovaries,POLYCYSTIC OVARIES,POLYCYSTIC OVARIES,OVARIAN AND FALLOPIAN TUBE DISORDERS,OVARIAN AND FALLOPIAN TUBE CYSTS AND NEOPLASMS,10038604,10036049,10036049,10036049
INTRA-ORAL FISTULAE,Oral cavity fistula,ORAL CAVITY FISTULA,ORAL CAVITY FISTULA,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL FISTULAE,10017947,10065720,10065720,10065720
CONOTRUNCAL CARDIAC DEFECT,Heart disease congenital,HEART DISEASE CONGENITAL,HEART DISEASE CONGENITAL,CARDIAC AND VASCULAR DISORDERS CONGENITAL,CARDIAC DISORDERS CONGENITAL NEC,10010331,10019273,10019273,10019273
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
MEMORY IMPAIRMENT,Memory impairment,MEMORY IMPAIRMENT,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027175,10027175,10027175
LETHARGY,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
HEIGHTENED SELF-ESTEEM,Overconfidence,OVERCONFIDENCE,OVERCONFIDENCE,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10068829,10068829,10068829
SENSORY NEUROPATHY,Peripheral sensory neuropathy,SENSORY NEUROPATHY,PERIPHERAL SENSORY NEUROPATHY,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10062975,10034620,10062975
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
ECHOCARDIOGRAM SHOWED PERICARDIAL EFFUSION,pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
MILD SWELLING AROUND PANCREATIC HEAD,Pancreatic inflammation,PANCREATIC INFLAMMATION,PANCREATITIS,EXOCRINE PANCREAS CONDITIONS,ACUTE AND CHRONIC PANCREATITIS,10017947,10076039,10033645,10076039
ELECTROLYTE DERANGEMENT,Electrolyte imbalance,ELECTROLYTE IMBALANCE,ELECTROLYTE IMBALANCE,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10014418,10014418,10014418
HIVES EPISODE,Hives,HIVES,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10020197,10046735,10020197
HIGH URIC ACID,Uric acid high,URIC ACID HIGH,BLOOD URIC ACID INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",METABOLISM TESTS NEC,10022891,10050450,10005861,10050450
"PARTIAL RESPONSE WAS ACHIEVED FOR THE THERAPY OF BORTEZOMIB, DOXORUBICIN AND DEXAMETHASONE",Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PRESYNCOPE,Presyncope,PRESYNCOPE,PRESYNCOPE,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10036653,10036653,10036653
LEUCOCYTOSIS (WBC 30*30^9/L),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
SLIGHTLY HYPOTENSIVE,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
SUSPICION OF LADA WAS CONFIRMED,Latent autoimmune diabetes in adults,LATENT AUTOIMMUNE DIABETES IN ADULTS,LATENT AUTOIMMUNE DIABETES IN ADULTS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10066389,10066389,10066389
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
WEIGHT GAIN OF 6KG IN AWEEK,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
MINIMAL IMPROVEMENT,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
VENLAFAXINE POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
ELEVATED WHITE CELLS OF 17 X 10E6/L,elevated white cells of 17 x 10E6/L,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047943,10047943,10047943
BLURRED VISION,Vision blurred,BLURRED VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10047513,10047513,10005886
BURNING AND ITCHING SENSATION AND LACRYMATION IN BOTH EYES,Eye irritation,BURNING SENSATION IN EYE,EYE IRRITATION,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","OCULAR INFECTIONS, INFLAMMATIONS AND ASSOCIATED MANIFESTATIONS",10015919,10006786,10015946,10006786
MNALAISE,Malaise,MALAISE,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10025482,10025482,10025482
WRIST TENOSYNOVITIS CAUSED BY MYCOBACTERIUM KANSASII,Tenosynovitis,TENOSYNOVITIS,TENOSYNOVITIS,"TENDON, LIGAMENT AND CARTILAGE DISORDERS",TENDON DISORDERS,10028395,10043261,10043261,10043261
THE DROPPING OXYGEN SATURATIONS,Oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
POSTICTAL PARALYSIS/TRANSIENT RIGHT HEMIPARESIS (TODD'S PALSY),postictal paralysis,TODD'S PARALYSIS,POSTICTAL PARALYSIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10054971,10052469,10054971
LEUKOCYTOSIS (18.2*10^9/L),leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
SEPTIC COMPLICATIONS FOLLOWING B-CELL LYMPHOMA RECURRENT,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
NECROTIC CUTANEOUS LESIONS ON HER LEGS AND FACE WITH INFLAMMATORY PERIMETER,Skin Inflammation,SKIN INFLAMMATION,DERMATITIS,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS AND ECZEMA,10040785,10062249,10012431,10062249
FUNGEMIA DUE TO MICROASCUS CIRROSUS,fungemia due to microascus cirrosus,FUNGEMIA,FUNGAEMIA,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10017544,10017523,10017544
ANURIC ACUTE KIDNEY INJURY DUE TO LOW DOSE ACETAZOLAMIDE WITH CRYSTALLURIA AND METABOLIC ACIDOSIS,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
PROGRESSION OF PRE-EXISTING CANCER,progression of pre-existing cancer,PROGRESSION OF PRE-EXISTING CANCER,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10057096,10051398,10057096
SEROTONINE SYNDROME,serotonin syndrome,SEROTONIN SYNDROME,SEROTONIN SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10040108,10040108,10040108
BISTERING IN THE CENTER OF THE SKIN LESIONS,Blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
ASCARIS LUMBRICOIDES DISCHARGE FROM THE MOUTH,Ascaris lumbricoides infection,ASCARIS LUMBRICOIDES INFECTION,ASCARIASIS,HELMINTHIC DISORDERS,NEMATODE INFECTIONS,10021881,10003443,10003442,10003443
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
"BOTTLE CONTAINING MEDROXYPROGESTERONE TABLETS, ALSO CONTAINED SOME TABLETS OF METHOTREXATE",wrong drug dispensed,WRONG DRUG DISPENSED,DRUG DISPENSING ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT DISPENSING ERRORS AND ISSUES,10022117,10065631,10064354,10065631
"HE REGULARLY FORGOTT TO ADMINISTER HIS EVENING DOSE OF SIMVASTATIN, OFTEN HE ALSO FORGOTT TO ADMINISTER ALSO HIS EVENING DOSE OF RAMIPRIL. THE PATIENT ALSO DID NOT MEASURE HIS BLOOD PRESSURE,",Treatment noncompliance,TREATMENT NONCOMPLIANCE,TREATMENT NONCOMPLIANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10049414,10049414,10049414
COMPLEX BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
"LOSS OF ELLIPSOID ZONE AND THINNING OF OUTER NUCLEAR LAYER, TEMPORAL, AND NASAL TO FOVEA; OVOID APPEARANCE OF FOVEA(BOTH EYES)",Optical coherence tomography abnormal,OPTICAL COHERENCE TOMOGRAPHY ABNORMAL,OPTICAL COHERENCE TOMOGRAPHY ABNORMAL,"INVESTIGATIONS, IMAGING AND HISTOPATHOLOGY PROCEDURES NEC",IMAGING PROCEDURES NEC,10022891,10073561,10073561,10073561
FETUS EXPOSED TO METHAMIZOLE IN UTERO,Drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
OXYGEN SATURATION 82%,Oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
DECREASED OXYGEN SATURATION ON ROOM AIR (88%),Oxygen saturation decreased,OXYGEN SATURATION DECREASED,OXYGEN SATURATION DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10033318,10033318,10033318
PARESTHESIA OF INFERIOR ALVEOLAR VALVE,Dental paraesthesia,DENTAL PARESTHESIA,DENTAL PARAESTHESIA,DENTAL AND GINGIVAL CONDITIONS,DENTAL PAIN AND SENSATION DISORDERS,10017947,10078276,10078276,10078278
WORSENING OF PLASMODIUM OVALE MALARIA FOLLOWING LACK OF DRUG EFFECT,Plasmodium ovale infection,PLASMODIUM OVALE INFECTION,PLASMODIUM OVALE INFECTION,PROTOZOAL INFECTIOUS DISORDERS,PLASMODIA INFECTIONS,10021881,10035502,10035502,10035502
DIFFUSELY OEDEMATOUS WITH A SLIGHT ERYTHEMATOUS RASH ON THE LEFT UPPER LIMB,Erythematous rash,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015243,10037855,10015243
VASOSPASTIC ANGINA WITH LEFT SIDED CHEST PAIN,Vasospastic angina,VASOSPASTIC ANGINA,PRINZMETAL ANGINA,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10067790,10036759,10067790
HEART RATE 106,Heart rate increased,HEART RATE HIGH,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019302,10019303,10019302
MODERATE BILATERAL HYDROTHORAX,Hydrothorax,HYDROTHORAX,HYDROTHORAX,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10048612,10048612,10048612
HYPOGLYCAEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
HYPERCALCIURIA,Hypercalciuria,HYPERCALCIURIA,HYPERCALCIURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10020590,10020590,10020590
BURNING SENSATION IN BOTH FEET,Burning sensation,BURNING SENSATION,BURNING SENSATION,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10006784,10006784,10006784
ACUTE HEART FAILURE,Cardiac failure acute,ACUTE HEART FAILURE,CARDIAC FAILURE ACUTE,HEART FAILURES,HEART FAILURES NEC,10007541,10007556,10007556,10000803
HYPOXIC RESPIRATORY FAILURE,Respiratory failure,HYPOXIC RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10074615,10038695,10074615
"PREDNISOLONE, TACROLIMUS, AND ELTROMBOPAG FAILED TO PRODUCE RECOVERY OF BLOOD CELLS (LACK OF DRUG EFFECT)",Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
HERPES SIMPLEX VIRUS,Herpes simplex,HERPES SIMPLEX,HERPES SIMPLEX,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10019948,10019948,10019948
"ZOLENDRONATE-INDUCED UVEITIS (ACUTE ANTERIOR UVEITIS WITH NON-GRANULOMATOUS, DISCRETE KERATIC PRECIPITATES IN THE ENDOTHELIUM AND A PRONOUNCED INFLAMMATORY REACTION IN THE ANTERIOR CHAMBE)",Iridocyclitis,ANTERIOR UVEITIS,IRIDOCYCLITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10002709,10022941,10002709
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
BILIAR LEAKAGE (GRADE IIIB),Post procedural bile leak,BILIARY ANASTOMOTIC LEAK,POST PROCEDURAL BILE LEAK,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,GASTROINTESTINAL AND HEPATOBILIARY PROCEDURAL COMPLICATIONS,10022117,10050458,10057586,10050458
BRONCHIAL STENOSIS DUE TO GRANULOMATOSIS WITH POLYANGIITIS,Stenosis bronchial,STENOSIS BRONCHIAL,BRONCHOSTENOSIS,BRONCHIAL DISORDERS (EXCL NEOPLASMS),BRONCHOSPASM AND OBSTRUCTION,10038738,10041976,10006487,10041976
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
EROSION ON THE RIGHT PATELLA AND CHEEK,Skin erosion,SKIN EROSION,SKIN EROSION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10040840,10040840,10040840
VENTRICULAR FIBRILLATION FOLLOWED BY BRADYCARDIA,Ventricular fibrillation,VENTRICULAR FIBRILLATION,VENTRICULAR FIBRILLATION,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10047290,10047290,10047290
DIAPHORESIS,Hyperhidrosis,DIAPHORESIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10042670,10020642,10012703
PATIENT TREATED WITH HYDROXYCHLOROQUINE FOR AUTOIMMUNE FEMALE INFERTILITY WITH NO ADR (OFF LABEL USE),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ACETAMINOPHEN OVERDOSE IN A THIRD TRIMESTER PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
"VISUAL HALLUCINATIONS, NAUSEA, VOMITING, CONSTIPATION, FLATULENCE, DIARRHEA, ABDOMINAL SWELLING, TREMORS, INCREASED PULSE RATE, DECREASED URINATION AND WEIGHT LOSS (+/- 6 KG)",Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
HYPOTENSIVE (86/39 MMHG),hypotensive,HYPOTENSIVE,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021107,10021097,10021107
URINARY TRACT INFECTION,urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
SEVERE WEAKNESS,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
RESPIRATORY FAILURE DUE TO METFORMIN ASSOCIATED LACTIC ACIDOSIS,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
DIARRHEA,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,Posterior reversible encephalopathy syndrome,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10071066,10071066,10071066
COAGULOPATHY,Coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
DIFFICULTIES WITH LEARNING,learning disorder,LEARNING DISORDER,LEARNING DISORDER,COGNITIVE AND ATTENTION DISORDERS AND DISTURBANCES,LEARNING DISORDERS,10037175,10061265,10061265,10061265
SWELLING OF FACE,Swelling face,SWELLING OF FACE,SWELLING FACE,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10042682,10042682,10042691
CUSHING SYNDROME FROM PERCUTANEOUS ABSORPTION OF TRIAMCINOLONE CREAM,Cushings syndrome,CUSHINGS SYNDROME,CUSHING'S SYNDROME,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011657,10011652,10011657
VIRUS THAT HAD CAUSED THE WART APPARENT BETWEEN HIS TOES-HUMAN PAPILLOMA VIRUS (HPV),Human papilloma virus infection,HUMAN PAPILLOMA VIRUS INFECTION,PAPILLOMA VIRAL INFECTION,VIRAL INFECTIOUS DISORDERS,PAPILLOMA VIRAL INFECTIONS,10021881,10063001,10061331,10063001
HEPATOXICITY,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
DRUG INDUCED KIDNEY INJURY,Renal injury,INJURY TO KIDNEY,RENAL INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10022221,10061481,10022221
MASS IN THE ABDOMINAL CAVITY IN THE COURSE OF THE RECTUS ABDOMINIS MUSCLE,Abdominal mass,ABDOMINAL MASS,ABDOMINAL MASS,GASTROINTESTINAL SIGNS AND SYMPTOMS,ABDOMINAL FINDINGS ABNORMAL,10017947,10000077,10000077,10000077
MIXED CYTOLYTIC AND CHOLESTATIC HEPATITIS SUGGESTIVE OF TOXIC-DRUG ETIOLOGY,Hepatitis cholestatic,CHOLESTATIC HEPATITIS,HEPATITIS CHOLESTATIC,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10019754,10019754,10008639
INTESTINAL MALROTATION,Intestinal malrotation,INTESTINAL MALROTATION,INTESTINAL MALROTATION,GASTROINTESTINAL TRACT DISORDERS CONGENITAL,INTESTINAL DISORDERS CONGENITAL,10010331,10064024,10064024,10064024
EPISODES OF FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
MEGAKARYOCYTES PROLIFERATED DURING PROGRESSION,Megakaryocytes increased,MEGAKARYOCYTES INCREASED,MEGAKARYOCYTES INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),BONE MARROW AND IMMUNE TISSUE HISTOPATHOLOGY PROCEDURES,10022891,10027120,10027120,10027120
PERIPHERAL NERVE DISORDER NOS,peripheral nerve disorder NOS,PERIPHERAL NERVE DISORDER NOS,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10051174,10029331,10051174
FANCONI SYNDROME,Fanconi syndrome,FANCONI SYNDROME,FANCONI SYNDROME,RENAL AND URINARY TRACT DISORDERS CONGENITAL,RENAL DISORDERS CONGENITAL,10010331,10016219,10016219,10016219
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
MOTTLED TEGUMENTS,Mottled skin,MOTTLED SKIN,LIVEDO RETICULARIS,SKIN VASCULAR ABNORMALITIES,SKIN VASOMOTOR CONDITIONS,10040785,10028010,10024648,10028010
OSTEONECROSIS,osteonecrosis,OSTEONECROSIS,OSTEONECROSIS,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10031264,10031264,10031264
AGRANULOCYTOSIS (230 GRANULOCYTES/ÃŒL) WAS DETECTED ON LEVOMEPROMAZINE,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
LACERATION/ SKIN TEARS OFF AND LARGE AREAS OF DERMIS ARE EXPOSED/LACERATION,laceration,LACERATION,LACERATION,INJURIES NEC,SKIN INJURIES NEC,10022117,10023572,10023572,10023572
100% OCCLUSION OF THE RIGHT CORONARY ARTERY,Coronary artery occlusion,CORONARY ARTERY OCCLUSION,CORONARY ARTERY OCCLUSION,CORONARY ARTERY DISORDERS,CORONARY ARTERY DISORDERS NEC,10007541,10011086,10011086,10011086
"COMPRESSION DEFORMITY OF SUPERIOR ENDPLATE OF L1, WITH APPROXIMATELY 40 % HEIGHT LOSS AND 1 MM FRAGMENT RETROPULSION(FOLLOWING MYOPATHY)",Lumbar vertebral fracture,LUMBAR VERTEBRAL FRACTURE L1,LUMBAR VERTEBRAL FRACTURE,BONE AND JOINT INJURIES,SPINAL FRACTURES AND DISLOCATIONS,10022117,10049957,10049947,10049957
EMPTY BOTTLE OF TRAZADONE,intentional drug misuse,INTENTIONAL DRUG MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10065679,10074903,10065679
SKIN ERUPTION,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
BILATERAL SCOTOMA,scotoma,SCOTOMA,VISUAL FIELD DEFECT,NEUROLOGICAL DISORDERS OF THE EYE,NEUROLOGIC VISUAL PROBLEMS NEC,10029205,10039729,10047555,10039729
GEOTRICHUM CAPITATUM INFECTION,Geotrichum infection,GEOTRICHUM INFECTION,GEOTRICHUM INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10056660,10056660,10056660
METOPROLOL WAS NOT TOLERATED,drug intolerance,DRUG INTOLERANCE,DRUG INTOLERANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061822,10061822,10061822
CONFUSION/ CONFUSION OF UNCLEAR ETIOLOGY,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
DISEASE PROGRESSION LEADING TO DEATH,disease progression leading to death,PROGRESSION OF PRE-EXISTING CANCER,MALIGNANT NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10057096,10051398,10057096
CRYPTOCOCCUS NEOFORMANS INFECTION,Cryptococcosis,CRYPTOCOCCUS NEOFORMANS INFECTION,CRYPTOCOCCOSIS,FUNGAL INFECTIOUS DISORDERS,CRYPTOCOCCAL INFECTIONS,10021881,10011493,10011490,10011493
PINK NONSCALY PLAQUES ON THIGHS AND LOWER LEGS,Skin plaque,SKIN PLAQUE,SKIN PLAQUE,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10067723,10067723,10067723
DIZZINESS,dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
PAIN IN THE AREA OF THE RIGHT RIBS,Musculoskeletal chest pain,RIB PAIN,MUSCULOSKELETAL CHEST PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10048711,10050819,10048722
SHORTNESS OF BREATH,shortness of breath,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
NO ADVERSE EVENT,no adverse event,NO ADVERSE EVENT,NO ADVERSE EVENT,GENERAL SYSTEM DISORDERS NEC,ADVERSE EFFECT ABSENT,10018065,10067482,10067482,10067482
"CANDIDA PARAPSILOSIS INFECTION FOLLOWING ANTIBIOTIC TREATMENT (CIPROFLOXACIN, CEFEPIME AND AMIKACIN) AND LACK OF EFFECT OF AMPHOTERICIN B",Candida infection,CANDIDA INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10074170,10074170,10074170
ARTEMISININ ALLERGY IN APRIL AND MAY 2017,drug allergy,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
"SUICIDAL ACT/TOXIC CONCENTRATIONS OF VENLAFAXINE, POSSIBLY AS A CONSEQUENCE OF A SUICIDAL ACT",Completed suicide,SUICIDE,COMPLETED SUICIDE,SUICIDAL AND SELF-INJURIOUS BEHAVIOURS NEC,SUICIDAL AND SELF-INJURIOUS BEHAVIOUR,10037175,10042462,10010144,10042462
LIVER METASTASIS,Metastases to liver,LIVER METASTASES,METASTASES TO LIVER,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027457,10027457,10024700
6 WEEKS PREGNANT WOMEN WAS TAKING METHIMAZOLE,"Drug exposure during pregnancy, first trimester","DRUG EXPOSURE DURING PREGNANCY, FIRST TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076617,10073513,10076617
PATIENT WAS TREATED WITH ANTITUBERCULAR AGENTS FOR PULMONARY TUBERCULOSIS FOR TWO MONTHS WITHOUT CLINICAL IMPROVEMENT ( LACK OF DRUG EFFECT) WITH NO ADR,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
TRACHEAL COMPRESSION,Tracheal disorder,TRACHEAL DISORDER,TRACHEAL DISORDER,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),TRACHEAL DISORDERS (EXCL INFECTIONS AND NEOPLASMS),10038738,10053490,10053490,10053490
NEUTROPHIL DECREASED (GRADE 3 AT THE LOWEST LEVELS),Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
PERSISTENCE OF CUTANEOUS LESIONS AND ALTERED LABORATORY VALUES DESPITE SYSTEMIC THERAPY WITH CORTICOSTEROID (LACK OF DRUG EFFECT) WITH NO ADR,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DRUG-INDUCED INTERSTITIAL PNEUMONIA,Interstitial lung disease,INTERSTITIAL PNEUMONIA,INTERSTITIAL LUNG DISEASE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10022617,10022611,10022617
PNEUMONIA / FEVER UP TO 38.5 DEGREE CELSIUS/OUT-OF-HOSPITAL PNEUMONIA,pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
COLLECTIONS FROM EPIDIDYMIS CONSISTENT WITH ABSCESSES BILATERALLY WITH DIMENSIONS OF 52Ã—27Ã—22 MM ON THE RIGHT SIDE AND 25Ã—27Ã—20 MM ON THE LEFT,Scrotal abscess,SCROTAL ABSCESS,SCROTAL ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,MALE REPRODUCTIVE TRACT INFECTIONS,10021881,10049571,10049571,10049571
COAGULOPATHY,Coagulopathy,COAGULOPATHY,COAGULOPATHY,COAGULOPATHIES AND BLEEDING DIATHESES (EXCL THROMBOCYTOPENIC),COAGULOPATHIES,10005329,10009802,10009802,10009802
DELAYED RECOVERY FROM ANESTHESIA,Delayed recovery from anaesthesia,DELAYED RECOVERY FROM ANESTHESIA,DELAYED RECOVERY FROM ANAESTHESIA,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,ANAESTHETIC AND ALLIED PROCEDURAL COMPLICATIONS,10022117,10012206,10012206,10012208
THE HIGHER CREATINE KINASE WAS BECAUSE OF THE INTAKE OF 80 MG ATORVASTATIN,Blood creatine phosphokinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
PRESYNCOPE,Presyncope,PRESYNCOPE,PRESYNCOPE,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10036653,10036653,10036653
GENERALIZED WEAKNESS,Asthenia,WEAKNESS GENERALISED,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047864,10003549,10047864
ABSOLUTE NEUTROPHIL COUNT 240 CELLS/CMM,Neutrophil count decreased,ABSOLUTE NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10059234,10029366,10059234
FALLS,Fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
ALLERGIC REACTION WITH URTICARIA FOLLOWING THE FIRST DOSE OF METHYLPREDNISOLONE,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
QUETIAPINE-INDUCED CERVICAL DYSTONIA/ANTEROCOLLIS CERVICAL DYSTONIA-ANTERIOR MID-LINE FLEXION OF THE NECK,Cervical dystonia,CERVICAL DYSTONIA,TORTICOLLIS,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10064124,10044074,10064124
LACK OF SLEEP AFFECTED THE PATIENT'S MOOD/DEPRESSED MOOD,Depressed mood,DEPRESSED MOOD,DEPRESSED MOOD,DEPRESSED MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH DEPRESSIVE SYMPTOMS,10037175,10012374,10012374,10012374
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
BUCCAL MUCOSA VESICLE,Mucosa vesicle,MUCOSA VESICLE,MUCOSA VESICLE,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028103,10028103,10028103
HIGH INFLAMMATION MARKERS,Inflammatory marker increased,INFLAMMATORY MARKER INCREASED,INFLAMMATORY MARKER INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,CHEMISTRY ANALYSES NEC,10022891,10069826,10069826,10069826
ISOSORBIDE DINITRATE IN NEPHRONOPHTHISIS TREATMENT,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
OLIGURIA,oliguria,OLIGURIA,OLIGURIA,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10030302,10030302,10030302
SPECIFIC DICLOFENAC ALLERGY,Drug hypersensitivity,DRUG ALLERGY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013661,10013700,10013661
"CATA-STROPHIC INFARCTS INVOLVING BOTH KIDNEYS, BOWEL AND LIVER, A LARGE NEWCEREBRAL INFARCT",Intestinal infarction,BOWEL INFARCTION,INTESTINAL INFARCTION,GASTROINTESTINAL VASCULAR CONDITIONS,GASTROINTESTINAL VASCULAR OCCLUSION AND INFARCTION,10017947,10022657,10022657,10006053
HEPATOTOXICITY,hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
ALTERED SENSORIUM,Altered state of consciousness,ALTERED STATE OF CONSCIOUSNESS,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10001854,10001854,10001854
REACTIVATION OF HIS MIGRAINE,Migraine,MIGRAINE AGGRAVATED,MIGRAINE,HEADACHES,MIGRAINE HEADACHES,10029205,10027600,10027599,10027600
PLEURAL EFFUSIONS,Pleural effusion,PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10035598,10035598,10035598
SLIGHTLY INCREASED GAMMA-GLUTAMYLTRANSFERASE,Gamma-glutamyltransferase increased,GAMMA-GLUTAMYLTRANSFERASE INCREASED,GAMMA-GLUTAMYLTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10017693,10017693,10017693
TWITCHING MOVEMENTS OF ALL LIMBS,Muscle twitching,TWITCHES,MUSCLE TWITCHING,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10045197,10028347,10045197
WITHDRAWAL SYNDROME WITH REBOUND MANIA/MANIC EPISODE,mania,MANIA,MANIA,MANIC AND BIPOLAR MOOD DISORDERS AND DISTURBANCES,MOOD ALTERATIONS WITH MANIC SYMPTOMS,10037175,10026749,10026749,10026749
RENAL FAILURE PRECIPITATED BY DICLOFENAC,Renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
LEUKOCYTOSIS (14.3K/MICROL),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
HEPATITIS,Hepatitis,HEPATITIS,HEPATITIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019717,10019717,10019717
DYSTONIC REACTION FOLLOWING CHROINC CETRIZINE OVERUSE,Dystonia,DYSTONIC REACTION,DYSTONIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSTONIAS,10029205,10013986,10013983,10013986
REDUCED NYHA STATUS,Condition aggravated,DISEASE AGGRAVATION,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10013097,10010264,10013097
BLOOD POTASSIUM INCREASED,Blood potassium increased,BLOOD POTASSIUM INCREASED,BLOOD POTASSIUM INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10005725,10005725,10005725
DRUG TROUGH LEVEL REMAINED SUPRA-THERAPEUTIC AT 6.02 MG/L,Drug level increased,DRUG LEVEL IN BLOOD INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013721,10013722,10013721
ACUTE MYELOID LEUKEMIA OF FAB M4,Acute myeloid leukemia,ACUTE MYELOID LEUKEMIA,ACUTE MYELOID LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS ACUTE MYELOID,10029104,10000886,10000880,10000886
APHASIA/ EXPRESSIVE APHASIA,Aphasia,APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002948,10002948,10002948
ARTERIAL PO2 DECREASED (55 MG HG),arterial PO2 decreased (55 mg Hg),PO2 DECREASED,PO2 DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10035768,10035768,10035768
LEUCOCYTOSIS (WBC 48.5X10E3/ML),Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
ASPARTATE AMINOTRANSFERASE ELEVATED (126U/L),Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
GENERALIZED MACULOPAPULAR LESIONS,Maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
NONVERBAL/UNABLE TO PARTICIPATE IN PROVIDING HISTORY,Aphasia,SPEECH LOSS,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10041470,10002948,10041470
"ACUTE UNILATERAL  HYPOPYON UVEITIS FOLLOWING DRUG INTERACTION OF FLUCONAZOLE, RIFABUTIN, CLARITHROMYCIN",Uveitis,ACUTE UVEITIS,UVEITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","IRIS AND UVEAL TRACT INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10066681,10046851,10066681
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
ANOREXIA,Decreased appetite,ANOREXIA,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10002646
METABOLIC ALKALOSIS,Metabolic alkalosis,METABOLIC ALKALOSIS,METABOLIC ALKALOSIS,ACID-BASE DISORDERS,METABOLIC ALKALOSES,10027433,10027423,10027423,10027423
INCREASED AMMONIA/DROWSINESS [DROWSINESS] AND BETTER GLYCEMIC CONTROL ASSESSED AS RELATED TO THE DRUG,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
PATIENT RECEIVED ASPIRIN DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
BILATERAL OCULAR EXUDATE,eye luxation,EYE LUXATION,EYE LUXATION,INJURIES NEC,EYE INJURIES NEC,10022117,10015948,10015948,10015948
"ERRATIC, RESTLESS AND EUPHORIC BEHAVIOR",Euphoric mood,EUPHORIA,EUPHORIC MOOD,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10015533,10015535,10015533
MEDICATION-RELATED OSTEONECROSIS OF THE JAW STAGE 2 [(MAXILLA (QUADRANT I)],Osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
ELEVATED SERUM CREATININE (7.3 MG/DL),Blood creatinine increased,SERUM CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10040233,10005483,10040233
CHRONICALLY DECOMPENSATED DIABETES,drug effect incomplete,DRUG EFFECT INCOMPLETE,DRUG EFFECT INCOMPLETE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013682,10013682,10013682
INCREASING FATIGUE,Fatigue,FATIGUE AGGRAVATED,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10048415,10016256,10048415
ERUPTIVE SEBACEOUS HYPERPLASIA DUE TO THE USE OF PREDNISONE,Sebaceous hyperplasia,SEBACEOUS HYPERPLASIA,SEBACEOUS HYPERPLASIA,SKIN APPENDAGE CONDITIONS,SEBACEOUS GLAND DISORDERS,10040785,10048810,10048810,10048810
BLOOD UREA 1.76 G/L,Blood urea increased,BLOOD UREA INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005851,10005851,10005851
RESPIRATORY ACIDOSIS AND DELIRIOUS ON HOSPITALS,Respiratory acidosis,RESPIRATORY ACIDOSIS,RESPIRATORY ACIDOSIS,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10038661,10038661,10038661
INSULIN-INDUCED LIPOATROPHY,Lipoatrophy injection site,LIPOATROPHY INJECTION SITE,INJECTION SITE ATROPHY,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10024605,10022048,10024605
FATIGUE WORSENED,Fatigue,FATIGUE AGGRAVATED,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10048415,10016256,10048415
SHAKING,Shaking,SHAKING,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10040528,10044565,10040528
ALT 606,ALT 606,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
URINARY RETENTION,Urinary retention,URINARY RETENTION,URINARY RETENTION,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046555,10046555,10046555
ENLARGED SPLEEN,Spleen enlarged,SPLEEN ENLARGED,SPLENOMEGALY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",SPLEEN DISORDERS,10005329,10041637,10041660,10041637
MOTHER PRESCRIBED METHADONE FOR BACK PAIN,,,,,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,10079145,10079231,10076639,
DECREASE IN HEMOGLOBIN UPTO 67G/L,Haemoglobin decreased,HEMOGLOBIN DECREASED,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10018884,10018884,10019483
RECURRENT GI BLEEDING,Gastrointestinal haemorrhage,GI BLEED,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017955,10017955,10018230
MULTI-ORGAN FAILURE DUE TO PHEOCHROMOCYTOMA CRISIS PRECIPITATED BY HYDROCORTISONE AND EPINEPHRINE,multi-organ failure,MULTI-ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028154
LACTATE DEHYDROGENASE INCREASED (963 U/L),Blood lactate dehydrogenase increased,LACTATE DEHYDROGENASE INCREASED,BLOOD LACTATE DEHYDROGENASE INCREASED,ENZYME INVESTIGATIONS NEC,TISSUE ENZYME ANALYSES NEC,10022891,10023654,10005630,10023654
LETHARGY,Lethargy,LETHARGY,LETHARGY,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024264,10024264,10024264
AGGRAVATION OF HERPES SIMPLEX VIRUS KERATITIS,Ophthalmic herpes simplex,OPHTHALMIC HERPES SIMPLEX,OPHTHALMIC HERPES SIMPLEX,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10073938,10073938,10073938
ANION GAP 41,Anion gap increased,ANION GAP INCREASED,ANION GAP INCREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10002528,10002528,10002528
ERYTHEMATOUS RAISED COIN-SHAPED RASH APPEARED ON THE MEDIAL BORDER OF HIS RIGHT FOOT,Rash erythematous,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015243
CONJUNCTIVAL EROSION DUE TO STEVENS-JOHNSON SYNDROME,Conjunctival erosion,CONJUNCTIVAL EROSION,CONJUNCTIVAL EROSION,"ANTERIOR EYE STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION","CONJUNCTIVAL STRUCTURAL CHANGE, DEPOSIT AND DEGENERATION",10015919,10010716,10010716,10010716
PROGRESSIVE RIGHT-SIDED HEMIPARESIS WITH TEMPOROSPATIAL DISORIENTATION,Disorientation,TEMPOROSPATIAL DISORIENTATION,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10066298,10013395,10066298
INTENTIONAL OVERDOSE,Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
HYPERAMMONEMIC ENCEPHALOPATHY INDUCED BY THE COMBINATION THERAPY OF VALPROATE AND TOPIRAMATE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
"ALTERED STATE OF CONSCIOUSNESS FOLLOWING DRUG INTERACTION BETWEEN QUETIAPINE, VALPROIC ACID AND ARIPIPRAZOLE",Altered state of consciousness,ALTERED STATE OF CONSCIOUSNESS,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10001854,10001854,10001854
LYMPHOCYTE TOTAL NUMBER REDUCED (UNDER 500),lymphocyte count decreased,LYMPHOCYTE COUNT DECREASED,LYMPHOCYTE COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10025256,10025256,10025256
SUSPECTED SEVERE SEPSIS,sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
PH DECREASED (7.31),Blood pH decreased,PH DECREASED,BLOOD PH DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10034778,10005706,10034778
CONFUSION,Confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
MILD LEFTÂ·SIDED LINEAR FACIAL ATROPHY,Atrophy,ATROPHY,ATROPHY,TISSUE DISORDERS NEC,TROPHIC DISORDERS,10018065,10003694,10003694,10003694
CONFUSION,Confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
HYPERACTIVE,hyperactive,HYPERACTIVE,PSYCHOMOTOR HYPERACTIVITY,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10020554,10037211,10020554
INAPPETENCE,Decreased appetite,INAPPETENCE,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10054792,10061428,10054792
ACUTE HEPATIC FAILURE,Acute hepatic failure,ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10000804
PREMATURE RUPTURE OF MEMBRANES,Premature rupture of membranes,PREMATURE RUPTURE OF MEMBRANES,PREMATURE RUPTURE OF MEMBRANES,MATERNAL COMPLICATIONS OF LABOUR AND DELIVERY,LABOUR ONSET AND LENGTH ABNORMALITIES,10036585,10036603,10036603,10036603
PLATELET COUNT DECREASED (16X10E9/L) DUE TO DRUG OVERDOSE AND ACCIDENTAL OVERDOSE FOLLOWING MEDICATION ERROR,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
WORSENING OF DYSPNEA,Dyspnoea,DYSPNEA EXACERBATED,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013970,10013968,10013965
FENTANYL TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
"LEFT VENTRICULAR THROMBOSIS, EMBOLIC STROKE, INTRACRANIAL HEMORRHAGE, HEADACHE, MACROSCOPIC HAEMATURIA AND REPORTED SUBTHERAPEUTIC RESPONSE TO CLOPIDOGREL",Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
AN ERYTHEMATOUS RASH WITH IRREGULAR BORDERS ABOVE THE UPPER LIP AND ON TRUNK,erythematous rash,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015243,10037855,10015243
DEHYDRATED,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
BODY WEIGHT INCREASED SIGNIFICANTLY BY 14 KG,Weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
UNCONSCIOUS,Loss of consciousness,UNCONSCIOUS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10045479
EXTREME MUSCLE WEAKNESS,muscle weakness,MUSCLE WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028350,10028372,10028350
ACCIDENTAL EXPOSURE WHILE PREPARING DRUG FOR ADMINISTRATION,Accidental exposure while preparing drug for administration,ACCIDENTAL EXPOSURE WHILE PREPARING DRUG FOR ADMINISTRATION,ACCIDENTAL EXPOSURE TO PRODUCT,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,ACCIDENTAL EXPOSURES TO PRODUCT,10022117,10064369,10073317,10064369
ALL THE LESIONS WERE COVERED BY A DENSELY ADHERENT THICK BLACK ESCHAR.,Eschar,ESCHAR,ESCHAR,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10051814,10051814,10051814
DYSPEPSIA,Dyspepsia,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,DYSPEPTIC SIGNS AND SYMPTOMS,10017947,10013946,10013946,10013946
TENDERNESS IN THE PALMS AND SOLES,Tenderness,TENDERNESS,TENDERNESS,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10043224,10043224,10043224
FAILURE OF IMATINIB TREATMENT,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
DISSEMINATED HISTOPLASMOSIS,Histoplasmosis disseminated,DISSEMINATED HISTOPLASMOSIS,HISTOPLASMOSIS DISSEMINATED,FUNGAL INFECTIOUS DISORDERS,HISTOPLASMA INFECTIONS,10021881,10020144,10020144,10013440
SHE DEVELOPED SHOOTING PAINS IN HER LEGS AND FEET,Pain in extremity,PAINFUL FEET,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10033429,10033425,10033506
YOUNG INFANT AFTER EXPOSURE TO CARBAMAZEPINE DURING LACTATION/ WAS BREASTFED SINCE BIRTH AND HER MOTHER WAS UNDER CHRONIC CARBAMAZEPINE THERAPY,Drug exposure via breast milk,DRUG EXPOSURE VIA BREAST MILK,EXPOSURE VIA BREAST MILK,"EXPOSURES, CHEMICAL INJURIES AND POISONING",PATHWAYS AND SOURCES OF EXPOSURE,10022117,10051075,10080751,10051075
PROGRESSION OF FATIGUE AND TIREDNESS,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
NECROTIZING FASCIITIS,Necrotizing fasciitis,NECROTIZING FASCIITIS,NECROTISING FASCIITIS,INFECTIONS - PATHOGEN UNSPECIFIED,MUSCLE AND SOFT TISSUE INFECTIONS,10021881,10055647,10028885,10055647
DRUG TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
COULD NOT WALK BECAUSE OF A DEVIATION TO THE RIGHT,Gait inability,UNABLE TO WALK,GAIT INABILITY,GENERAL SYSTEM DISORDERS NEC,GAIT DISTURBANCES,10018065,10017581,10017581,10049278
SWOLLEN TONGUE,swollen tongue,SWOLLEN TONGUE,SWOLLEN TONGUE,TONGUE CONDITIONS,TONGUE SIGNS AND SYMPTOMS,10017947,10042727,10042727,10042727
HALLUCINATIONS,Hallucination,HALLUCINATIONS,HALLUCINATION,DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019063,10019063,10019077
PARTIAL RESPONSE TO PREDNISOLONE,subtherapeutic effect,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
CONSTIPATION,Constipation,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,GASTROINTESTINAL ATONIC AND HYPOMOTILITY DISORDERS NEC,10017947,10010774,10010774,10010774
HEADACHE AND NAUSEA,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
IMATINIB INCREASES PLASMA CREATININE CONCENTRATION,Blood creatinine increased,PLASMA CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10035278,10005483,10035278
POOR GENERAL CONDITION,General physical health deterioration,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10049438,10049438,10049438
CONFUSION,Confusional state,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
DEVELOPED EXTREME BRADYCARDIA,Bradycardia,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
PAN-HYPOPITUITARISM,Hypopituitarism,PANHYPOPITUITARISM,HYPOPITUITARISM,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPOFUNCTION,10014698,10033662,10021067,10033662
URINE PROTEIN CREATININE RATIO INCREASED(2.4),Urine protein/creatinine ratio increased,URINE PROTEIN/CREATININE RATIO INCREASED,URINE PROTEIN/CREATININE RATIO INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10053538,10053538,10053538
LUNG TOXICITY,Pulmonary toxicity,PULMONARY TOXICITY,PULMONARY TOXICITY,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10061924,10061924,10061924
"THE PATIENT INGESTED 50 DIGESTIVE TABLETS (DEXTROPROPOXYPHENE HYDROCHLORIDE, PARACETAMOL), QUININE AND PROCHLORPERAZINE MALEATE",drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
DIARRHEA,diarrhea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
ABDUCTION LOSS,Eye movement disorder,EYE MOVEMENT DISORDER,EYE MOVEMENT DISORDER,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10061129,10061129,10061129
DYSPNOEA,dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
DIARRHOEA,Diarrhoea,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012735
COMMIT SUICIDE BY INGESTING 6750 MG OF PROPAFENON,Drug overdose deliberate self-inflicted,DRUG OVERDOSE DELIBERATE SELF-INFLICTED,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10013738,10022523,10013738
SKIN BIOPSY SHOWED PREDOMINATELY CHRONIC PERIVASCULAR LEUKOCYTIC INFILTRATE DISTRIBUTED IN THE SUPERFICIAL DERMIS AND DEGENERATIVE CHANGES OF BASAL CELLS WITH RESULTANT SUB-EPIDERMAL SEPARATION,Skin exfoliation,SKIN PEELING,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10034218,10040844,10040908
GRADE 4 MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
DETECTION OF A NOVEL MUTATION CONFERRING ACYCLOVIR RESISTANCE AND CONSECUTIVE TREATMENT FAILURE IN AN HIV-POSITIVE PATIENT WITH RECURRENT HSV-2 INFECTION,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
ANGIOEDEMA CAUSED BY RIVASTIGMINE PATCH,angioedema caused by rivastigmine patch,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
GRAFT LOSS FOLLOWING THROMBUS,graft loss following thrombus,GRAFT LOSS,GRAFT LOSS,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,TRANSPLANTATION COMPLICATIONS,10022117,10048748,10048748,10048748
INCREASED LOIN PAIN FOLLOWING OPIOID WITHDRAWAL,Back pain,LOIN PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10024798,10003988,10024798
SEVERE HYPERTRIGLYCERIDEMIA (TG) LEVEL OF 3083 MG/DL,Hypertriglyceridaemia,HYPERTRIGLYCERIDEMIA,HYPERTRIGLYCERIDAEMIA,LIPID METABOLISM DISORDERS,ELEVATED TRIGLYCERIDES,10027433,10020869,10020869,10020870
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
"PRURITIC RASH (BEGAN ON FOREHEAD AND EARS, SUBSEQUENTLY SPREAD TO CHEST, UPPER BACK, ARMS AND MOUTH)",pruritic rash,PRURITIC RASH,RASH PRURITIC,EPIDERMAL AND DERMAL CONDITIONS,PRURITUS NEC,10040785,10037085,10037884,10037085
ANEMIA GRADE 2/ GRADE 1,Anemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002272,10002034,10002272
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
APHASIC,aphasia,APHASIA,APHASIA,NEUROLOGICAL DISORDERS NEC,CORTICAL DYSFUNCTION NEC,10029205,10002948,10002948,10002948
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
UPPER ABDOMINAL TENDERNESS,Abdominal tenderness,UPPER ABDOMINAL TENDERNESS,ABDOMINAL TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10069064,10000097,10069064
SIGNIFICANT SWELLING OF BREAST,Breast swelling,BREAST SWELLING,BREAST SWELLING,BREAST DISORDERS,BREAST SIGNS AND SYMPTOMS,10038604,10006312,10006312,10006312
MILD ALLOGRAFT REJECTION (ISHLT AR GRADE IB),Heart transplant rejection,HEART TRANSPLANT REJECTION,HEART TRANSPLANT REJECTION,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10019315,10019315,10019315
STEROID-INDUCED DIABETES,Diabetes mellitus,DIABETES STEROID-INDUCED,DIABETES MELLITUS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012628,10012601,10012628
LEVOMEPROMAZINE-INDUCED AGRANULOCYTOSIS,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
"SHOWED DEPRESSED MOOD (BECK DEPRESSION INVENTORY, BDI, 48)/BRAIN ATROPHY",Cerebral atrophy,CEREBRAL ATROPHY,CEREBRAL ATROPHY,STRUCTURAL BRAIN DISORDERS,STRUCTURAL BRAIN DISORDERS NEC,10029205,10008096,10008096,10008096
PAIN ABDOMEN,pain abdomen,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
SINUS INFECTIONS,Sinus infection,SINUS INFECTION,SINUSITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10040745,10040753,10040745
ACUTE GRAFT VERSUS HOST DISEASE (SKIN STAGE 2 AND GASTROINTESTINAL TRACT STAGE 3) AND ITS PROGRESSION FOLLOWING NO RESPONSE TO PREDNISOLONE ( LACK OF DRUG EFFECT),Acute graft versus host disease in skin,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,IMMUNE DISORDERS NEC,IMMUNE AND ASSOCIATED CONDITIONS NEC,10021428,10066262,10066262,10066262
"25-YEAR-OLD SUICIDAL WOMAN INGESTED 20 CAPSULES OF REDOTEX, 500 MG SUMATRIPTAN, 2 IBUPROFEN TABLETS",Intentional overdose,INTENTIONAL OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10022523,10022523,10022523
SUBSTITUTION ERRORS LEADING TO HYOSCINE HYDROBROMIDE OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
DECREASE IN THE NEUTROPHIL COUNT,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
MEMORY PROBLEMS,Memory impairment,MEMORY DISTURBANCE,MEMORY IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10027175,10027175,10027172
DRUG DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
SUBTRO-CHANTERIC PATHOLOGICAL FRACTURE AFTER A PROLONGED INTAKE OF ALENDRONATE FOLLOWED BY IBANDRONATE,Femur fracture subtrochanteric,FEMUR FRACTURE SUBTROCHANTERIC,FEMUR FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10053653,10016454,10053653
ABNORMAL ELEVATION OF SERUM CA72-4 (VALUE >300U/ML),Tumour marker increased,TUMOR MARKER INCREASED,TUMOUR MARKER INCREASED,CYTOGENETIC INVESTIGATIONS,CELL MARKER ANALYSES,10022891,10048621,10048621,10048754
"WIDESPREAD MONOMORPHIC NONFOLLICULAR PUSTULES ON THE CHEST, ABDOMEN, MAJOR  EXURES, ARMS AND LEGS",Rash pustular,PUSTULE,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037578,10037888,10037578
HYPERTENSION,Hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
USE OF MYCOPHENOLATE MOFETIL FOR SYSTEMIC SCLEROSIS AND INTERSTITIAL LUNG DISEASE (OFF LABEL USE FOR INDICATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RESPIRATORY STATUS WAS SUDDENLY AGGRAVATED ON THE FOLLOWING DAY,Respiratory disorder,RESPIRATORY DISORDER,RESPIRATORY DISORDER,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10038683,10038683,10038683
IOP ROSE TO 44 MMHG,Intraocular pressure increased,INTRAOCULAR PRESSURE INCREASED,INTRAOCULAR PRESSURE INCREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",OPHTHALMIC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10022806,10022806,10022806
RETINAL NECROSIS DUE OCULAR LYMPHOMA,Necrotising retinitis,RETINAL NECROSIS,NECROTISING RETINITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","RETINAL, CHOROID AND VITREOUS INFECTIONS AND INFLAMMATIONS",10015919,10058685,10064997,10058685
WEIGHT GAIN OF 9 KILOGRAMS,Weight increased,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047896
LACK OF COORDINATION,lack of coordination,LACK OF COORDINATION,COORDINATION ABNORMAL,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10023609,10010947,10023609
GALL BLADDER DYSKINESIA,Gallbladder disorder,GALLBLADDER DISORDER,GALLBLADDER DISORDER,GALLBLADDER DISORDERS,GALLBLADDER DISORDERS NEC,10019805,10017626,10017626,10017626
LARYNGITIS DUE TO CORONAVIRUS NL63 AND PARAINFLUENZA VIRUS TYPE 3,Laryngitis,LARYNGITIS,LARYNGITIS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10023874,10023874,10023874
HYPERTHYROIDISM,hyperthyroidism,HYPERTHYROIDISM,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10020850,10020850,10020850
MACULOPAPULAR RASH,Rash maculo-papular,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037868,10037868,10025424
DECREASED CONCENTRATION/ATTENTION DIFFICULTY,Disturbance in attention,DISTURBANCE IN ATTENTION,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10013496,10013496,10013496
INSUFFICIENT CONTROL OF INTRAOCULAR PRESSURE (SUBTHERAPEUTIC RESPONSE) WITH NO ADVERSE EVENT,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
PATIENT WAS TREATED WITH MYCOPHENOLATE MOFETIL IN SYSTEMIC LUPUS ERYTHEMATOSUS ( OFF LABEL USE) WITH NO ADVERSE DRUG REACTION,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
PATE WAS DIAGNOSED,pulmonary artery thromboembolism,PULMONARY THROMBOEMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037436,10037377,10037436
LIVER DAMAGE,liver damage,LIVER DAMAGE,LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10024668,10067125,10024668
DRUG INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
FAILURE OF IMPLANON IN A WOMAN ON ANTICONVULSANT THERAPY WITH CARBAMAZEPINE,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
LESS RESPONSIVE,Hyporesponsive to stimuli,HYPORESPONSIVE TO STIMULI,HYPORESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10071552,10071552,10071552
SKIN ERUPTION,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
URINE WAS DARK,Urine discolouration,URINE DISCOLOURATION,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10046629,10008796,10046629
WEAKNESS,weakness,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
SEPTIC SHOCK,septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
ACID-BASE DISTURBANCES (UNSPECIFIED),Acid base balance abnormal,ACID BASE BALANCE ABNORMAL,ACID BASE BALANCE ABNORMAL,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10000457,10000457,10000457
HEPATONEPHRITIS,Hepatorenal syndrome,HEPATORENAL SYNDROME,HEPATORENAL SYNDROME,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10019846,10019846,10019846
LIFE-THREATENING ACUTE INTRAVASCULAR HEMOLYSIS,Intravascular haemolysis,HEMOLYSIS INTRAVASCULAR,INTRAVASCULAR HAEMOLYSIS,HAEMOLYSES AND RELATED CONDITIONS,HAEMOLYSES NEC,10005329,10022822,10022822,10019492
HEART FAILURE FOLLOWING CARDIOMYOPATHY,Cardiac failure,HEART FAILURE,CARDIAC FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10007554,10007554,10019279
WAS INEFFECTIVE IN TREATING THE SVA,Drug ineffective,DRUG INEFFECTIVE,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10013709
DRUG USE FOR UNAPPROVED INDICATION,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
ERYTHEMA FOLLOWING DRUG TOXICITY DUE TO DRUG INTERACTION,erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
MULTIPLE DRUG OVERDOSE,multiple drug overdose intentional,MULTIPLE DRUG OVERDOSE INTENTIONAL,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10062764,10022523,10062764
HYPOGAMMAGLOBULINAEMIA,hypogammaglobulinaemia,HYPOGAMMAGLOBULINAEMIA,HYPOGAMMAGLOBULINAEMIA,IMMUNODEFICIENCY SYNDROMES,PRIMARY IMMUNODEFICIENCY SYNDROMES,10021428,10020983,10020983,10020983
SUDDEN DYSPNEA,sudden dyspnea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013963,10013968,10013963
LANGUAGE DIFFICULTY,Speech disorder,SPEECH DISORDER,SPEECH DISORDER,NEUROLOGICAL DISORDERS NEC,SPEECH AND LANGUAGE ABNORMALITIES,10029205,10041466,10041466,10041466
INTOXICATION WITH PARACETAMOL,Toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
ELEVATED INFLAMMATORY MARKERS,Inflammatory marker increased,INFLAMMATORY MARKER INCREASED,INFLAMMATORY MARKER INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,CHEMISTRY ANALYSES NEC,10022891,10069826,10069826,10069826
"HE RECEIVED FOUR CYCLES OF THE COMBINATION (RCHOP REGIMENT) FOR NODAL MARGINAL ZONE LYMPHOMA ACHIEVING
PARTIAL RESPONSE",Nodal marginal zone B-cell lymphoma,NODAL MARGINAL ZONE B-CELL LYMPHOMA,NODAL MARGINAL ZONE B-CELL LYMPHOMA,LYMPHOMAS NON-HODGKIN'S B-CELL,NODAL MARGINAL ZONE B-CELL LYMPHOMAS,10029104,10029460,10029460,10029460
ANNULAR ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,acute generalized exanthematous pustulosis,ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10062372,10048799,10062372
TYPICAL ATRIAL FLUTTER WITH A 1:1 AV CONDUCTION,Atrial flutter with 1:1 atrioventricular conduction,ATRIAL FLUTTER WITH 1:1 ATRIOVENTRICULAR CONDUCTION,ATRIAL FLUTTER,CARDIAC ARRHYTHMIAS,SUPRAVENTRICULAR ARRHYTHMIAS,10007541,10076040,10003662,10076040
ORAL SQUAMOUS CELL CARCINOMA,Squamous cell carcinoma of the oral cavity,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,LIP AND ORAL CAVITY NEOPLASMS MALIGNANT,10029104,10041857,10041857,10041857
RBC PRESENT IN CSF (3375 CELLS/ MICROLITRE),CSF red blood cell count positive,CSF RBC POSITIVE,CSF RED BLOOD CELL COUNT POSITIVE,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10056927,10075562,10056927
SKIN TENDERNESS,Skin tenderness,SKIN TENDERNESS,PAIN OF SKIN,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10051797,10033474,10051797
SUBDURAL HEMATOMA EVACUATION,Subdural haematoma evacuation,SUBDURAL HEMATOMA EVACUATION,SUBDURAL HAEMATOMA EVACUATION,"NERVOUS SYSTEM, SKULL AND SPINE THERAPEUTIC PROCEDURES",SKULL AND BRAIN THERAPEUTIC PROCEDURES,10042613,10042363,10042363,10055385
ANTIEPILEPTIC DRUG HYPERSENSITIVITY,Drug hypersensitivity,DRUG HYPERSENSITIVITY,DRUG HYPERSENSITIVITY,ALLERGIC CONDITIONS,"ALLERGIES TO FOODS, FOOD ADDITIVES, DRUGS AND OTHER CHEMICALS",10021428,10013700,10013700,10013700
RIGIDITY,Muscle rigidity,RIGIDITY,MUSCLE RIGIDITY,MUSCLE DISORDERS,MUSCLE TONE ABNORMALITIES,10028395,10039168,10028330,10039168
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
DRUG TOXICITY,Drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
ARTERIAL BLOOD PH LOW (6.98),Arterial blood pH decreased,ARTERIAL BLOOD PH DECREASED,BLOOD PH DECREASED,"METABOLIC, NUTRITIONAL AND BLOOD GAS INVESTIGATIONS",BLOOD GAS AND ACID BASE ANALYSES,10022891,10053889,10005706,10053889
SUSPECTED LITHIUM POISONING,Toxicity to various agents,LITHIUM POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10024644,10070863,10024644
SEVERELY LACTIC ACIDOTIC WITH LEUCOCYTOSIS,Lactic acidosis,LACTIC ACIDOSIS,LACTIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023676,10023676,10023676
LEUKOCYTOPENIA,Leukopenia,LEUKOCYTOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10068177
MASSIVE HEMATEMESIS,Haematemesis,MASSIVE HEMATEMESIS,HAEMATEMESIS,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10026873,10018830,10060655
GASTROINTESTINAL SIDE EFFECTS,Gastrointestinal disorder,GASTROINTESTINAL DISORDER,GASTROINTESTINAL DISORDER,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10017944,10017944,10017944
RESTLESS,Restlessness,RESTLESS,RESTLESSNESS,CHANGES IN PHYSICAL ACTIVITY,INCREASED PHYSICAL ACTIVITY LEVELS,10037175,10038743,10038743,10038740
GABAPENTIN-INDUCED BULLOUS PEMPHIGOID,Bullous Pemphigoid,BULLOUS PEMPHIGOID,PEMPHIGOID,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006567,10034277,10006567
MILD SKIN ERUPTIONS ON HIS ARMS AND UPPER CHEST,Rash,SKIN ERUPTION,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040841,10037844,10040841
EXCESSIVE BLEEDING FOLLOWING VENIPUNCTURE,venipuncture site haemorrhage,VENIPUNCTURE SITE HAEMORRHAGE,VESSEL PUNCTURE SITE HAEMORRHAGE,ADMINISTRATION SITE REACTIONS,ADMINISTRATION SITE REACTIONS NEC,10018065,10050359,10054092,10050359
BACTERIAL ENDOCARDITIS,Endocarditis bacterial,BACTERIAL ENDOCARDITIS,ENDOCARDITIS BACTERIAL,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10014666,10014666,10004019
TYPE 1 ALLERGIC HYPERSENSITIVITY,Type I hypersensitivity,TYPE I HYPERSENSITIVITY,TYPE I HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10045240,10045240,10045240
CREATININE 9.07 MG/DL,Blood creatinine increased,CREATININE HIGH,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011367,10005483,10011367
"WAS READMITTED AT 7 WA VIA THE EMERGENCY DEPARTMENT/ SHE WAS GIVEN A BOLUS OF 5,000 IU OF HEPARIN BY DIRECT INTRAVENOUS INJECTION",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, FIRST TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076617,10073513,10076617
DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
SEDATION,Sedation,SEDATION,SEDATION,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10039897,10039897,10039897
MEFORMIN AND INSULINE GLARGINE THERAPY FAILURE,Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
PRIMARY RESISTANCE TO IMATINIB,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
ELEVATED MYELIN BASIC PROTEIN LEVELS (238 PG/ML)IN CSF,CSF myelin basic protein increased,CSF MYELIN BASIC PROTEIN INCREASED,CSF MYELIN BASIC PROTEIN INCREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",CEREBROSPINAL FLUID TESTS (EXCL MICROBIOLOGY),10022891,10059754,10059754,10059754
CHRONIC DIARRHEA G3,Diarrhoea,CHRONIC DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10066557,10012735,10066556
SLIGHTLY ELEVATED LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
PROGRESSION OF CORONARY ARTERY DISEASE,Coronary artery disease progression,CORONARY ARTERY DISEASE PROGRESSION,CORONARY ARTERY DISEASE,CORONARY ARTERY DISORDERS,CORONARY ARTERY DISORDERS NEC,10007541,10066521,10011078,10066521
PROGRESSIVE DISEASE,Multiple myeloma,MULTIPLE MYELOMA,PLASMA CELL MYELOMA,PLASMA CELL NEOPLASMS,PLASMA CELL MYELOMAS,10029104,10028228,10035226,10028228
OPIUM ADDICTION,Drug dependence,OPIUM ADDICTION,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10030900,10013663,10030900
PYODERMA GANGRENOSUM,Pyoderma gangrenosum,PYODERMA GANGRENOSUM,PYODERMA GANGRENOSUM,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10037635,10037635,10037635
COMPULSIVE ACTS,compulsive acts,COMPULSIVE REACTION,OBSESSIVE-COMPULSIVE DISORDER,ANXIETY DISORDERS AND SYMPTOMS,OBSESSIVE-COMPULSIVE DISORDERS AND SYMPTOMS,10037175,10010224,10029898,10010224
HICCUPS,Hiccups,HICCUPS,HICCUPS,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10020039,10020039,10020039
BLOOD IN URINE,Blood in urine,BLOOD IN URINE,BLOOD URINE PRESENT,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINALYSIS NEC,10022891,10005604,10018870,10005604
EXACERBATION OF ISCHAEMIC HEART DISEASE COMPLICATIONS,Condition aggravated,AGGRAVATION OF EXISTING DISORDER,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10001484,10010264,10001484
PARTIAL RESPONSE WITH CHEMOTHERAPY,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
GEMISTOCYTIC REACTIVE GLIOSIS,Gliosis,GLIOSIS,GLIOSIS,CENTRAL NERVOUS SYSTEM INFECTIONS AND INFLAMMATIONS,CENTRAL NERVOUS SYSTEM INFLAMMATORY DISORDERS NEC,10029205,10018341,10018341,10018341
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
ASTHENIA,Asthenia,ASTHENIA,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10003549,10003549,10003549
DRUG-INDUCED NEUROTOXICITY,Neurotoxicity,NEUROTOXICITY,NEUROTOXICITY,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10029350,10029350,10029350
LACK OF EFFICACY,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
TORSADE DE POINTES,Torsade de pointes,TORSADE DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044066
DESPITE AN ADEQUATE ANTIBITOTIC THERAPY,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PETECHIAE ON THE LOWER LIMBS FOLLOWING THROMBOCYTOPENIA,petechiae on the lower limbs,PETECHIAE,PETECHIAE,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10034754,10034754,10034754
URINARY INCONTINENCE,Urinary incontinence,URINARY INCONTINENCE,URINARY INCONTINENCE,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046543,10046543,10046543
WIDE QRS,Electrocardiogram QRS complex prolonged,QRS PROLONGED,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037697,10014380,10037697
WHITE BLOOD CELLS 8.4 X 10E9/L EOSINOPHILIA,Eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
FATAL DISSEMINATED NOCARDIA FARCINICA BACTERAEMIA,Bacteraemia,BACTERAEMIA,BACTERAEMIA,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10003997,10003997,10003997
B CELL APLASIA,B-lymphocyte count decreased,B-LYMPHOCYTE COUNT DECREASED,B-LYMPHOCYTE COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10051313,10051313,10051313
EXTENSIVE ANTERIOR STEMI DUE TO NON-COMPLIANCE,Acute myocardial infarction,ACUTE MYOCARDIAL INFARCTION,ACUTE MYOCARDIAL INFARCTION,CORONARY ARTERY DISORDERS,ISCHAEMIC CORONARY ARTERY DISORDERS,10007541,10000891,10000891,10000891
PROGRESSION OF NEONATAL CHOLESTASIS SYNDROME DESPITE TREATMENT WITH URSODEOXYCHOLIC ACID,Neonatal cholestasis,NEONATAL CHOLESTASIS,NEONATAL CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10056528,10056528,10056528
ACUTE DYSPNOEA,Dyspnoea,ACUTE DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10066607,10013968,10066607
INCREASED QT INTERVAL,Electrocardiogram QT prolonged,QT INCREASED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037705,10014387,10037700
INTRAOPERATIVE HYPOTENSION,intraoperative hypotension,INTRAOPERATIVE HYPOTENSION,PROCEDURAL HYPOTENSION,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10056679,10062300,10056679
"THE PATIENT DEVELOPED FURTHER FLARES OF PG DESPITE RESUMING PREDNISOLONE AND DESPITE BEING ON METHYLPREDNISOLONE AND IMMUNOGLOBULINS, ULCERS WERE REFRACTORY TO HEALING",Pyoderma gangrenosum,PYODERMA GANGRENOSUM,PYODERMA GANGRENOSUM,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10037635,10037635,10037635
ELEVATED C-REACTIVE PROTEIN LEVEL(65 MG/L),,,,,PROTEIN AND CHEMISTRY ANALYSES NEC,10037000,10006825,10006825,
COGNITIVE IMPAIRMENT,Cognitive disorder,COGNITIVE IMPAIRMENT,COGNITIVE DISORDER,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10057668,10057668,10009846
"SCALP DEFECT ON THE VERTEX, MEASURING 7X2CM FOLLOWING DRUG EXPOSURE IN UTERO",scalp disorder,SCALP DISORDER,SKIN DISORDER,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10053233,10040831,10053233
BISPHOSPHONATE RELATED OSTEONECROSIS OF THE RIGHT MAXILLA (BRONJ),osteonecrosis of jaw,OSTEONECROSIS OF JAW,OSTEONECROSIS OF JAW,BONE DISORDERS (EXCL CONGENITAL AND FRACTURES),BONE DISORDERS NEC,10028395,10064658,10064658,10064658
ALT INCREASED (10569 UNITS/L),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
FEVER (38 DEGREE CELSIUS),fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
TOXIC EPIDERMAL NECROLYSIS,Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
SEIZURES WERE RESISTANT TO VALPROATE AND THE FOCAL SPIKE AND WAVE COMPLEXES CHANGED TO MULTIFOCAL,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
DRUG TOXICITY,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
A URINALYSIS WAS SIGNIFICANT FOR >10 HYALINE CASTS WITH PROTEINURIA,Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
ANTI-CARDIOLIPIN IGM ANTIBODY WAS ELEVATED (26),Cardiolipin antibody positive,ANTICARDIOLIPIN ANTIBODIES POSITIVE,CARDIOLIPIN ANTIBODY POSITIVE,IMMUNOLOGY AND ALLERGY INVESTIGATIONS,AUTOIMMUNITY ANALYSES,10022891,10002755,10007630,10002755
MENSES BECAME IRREGULAR,menses irregular,MENSES IRREGULAR,MENSTRUATION IRREGULAR,MENSTRUAL CYCLE AND UTERINE BLEEDING DISORDERS,MENSTRUATION AND UTERINE BLEEDING NEC,10038604,10027317,10027339,10027317
RECURRENCE OF SYMPTOMS,Symptom recurrence,SYMPTOM RECURRENCE,SYMPTOM RECURRENCE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10080080,10080080,10080080
24 YRS OLD FEMALE RECEIVED ASPIRIN FOR ANTITHROMBIN DEFICIENCY AND CONCEIVED SHORTLY AFTER,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HYPERPROLACTINEMIA,Hyperprolactinaemia,HYPERPROLACTINEMIA,HYPERPROLACTINAEMIA,HYPOTHALAMUS AND PITUITARY GLAND DISORDERS,ANTERIOR PITUITARY HYPERFUNCTION,10014698,10020737,10020737,10020739
ERYTHEMA MULTIFORME,Erythema multiforme,ERYTHEMA MULTIFORME,ERYTHEMA MULTIFORME,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10015218,10015218,10015218
ENCEPHALOPATHY FOLLOWING HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
WITHDRAWAL SYMPTOM,Withdrawal symptom,WITHDRAWAL SYMPTOM,WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10073281,10048010,10073281
REDUCED URINE OUTPUT,Urine output decreased,URINE OUTPUT DECREASED,URINE OUTPUT DECREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,URINARY TRACT FUNCTION ANALYSES NEC,10022891,10059895,10059895,10059895
RENAL FUNCTION DECLINED,Renal impairment,RENAL FUNCTION ABNORMAL,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038451,10062237,10038451
"TEMPERATURE ELEVATION UP TO 37,5 C",Body temperature increased,TEMPERATURE ELEVATION,BODY TEMPERATURE INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10005911,10005911,10043204
NEPHROCALCINOSIS,Nephrocalcinosis,NEPHROCALCINOSIS,NEPHROCALCINOSIS,UROLITHIASES,RENAL LITHIASIS,10038359,10029146,10029146,10029146
SUBCUTANEOUS PHAEOHYPHOMYCOSIS,Phaehyphomycosis,PHAEHYPHOMYCOSIS,PHAEHYPHOMYCOSIS,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10034799,10034799,10034799
FLU LIKE SYMPTOMS,flu like symptoms,FLU LIKE SYMPTOMS,INFLUENZA LIKE ILLNESS,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10016791,10022004,10016791
ACUTE URINARY RETENTION,urinary retention,URINARY RETENTION,URINARY RETENTION,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10046555,10046555,10046555
BRAIN CT REVEALED PERI-LESIONAL EDEMA AND SLIGHT MASS OVER THE LEFT VENTRICLE,Oedema,EDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10030095,10030095,10014210
METABOLIC ACIDOSIS,metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
SEIZURE FOLLOWING PROLONGED SEVERE HYPOGLYCAEMIA,Hypoglycaemic seizure,HYPOGLYCAEMIC SEIZURE,HYPOGLYCAEMIC SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10048803,10048803,10048803
ACUTE KIDNEY INJURY,acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
11 YEAR OLD PATIENT TREATED WITH FLUDARABINE AS CONDITIONING REGIMEN (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CHOLELITHIASIS,cholelithiasis,CHOLELITHIASIS,CHOLELITHIASIS,GALLBLADDER DISORDERS,CHOLECYSTITIS AND CHOLELITHIASIS,10019805,10008629,10008629,10008629
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME/SOLELY PRES  (GRADE 2 SEVERITY),posterior reversible encephalopathy syndrome,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10071066,10071066,10071066
ALT OF 7100 IU/L,ALT increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
GENERALIZED SEIZURE,Seizure,SEIZURE,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10039906,10039906,10039906
DROP IN BLOOD PRESSURE,Drop in blood pressure,DROP IN BLOOD PRESSURE,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10013644,10005734,10013644
PREMATURE BABY,Premature baby,PREMATURE BABY,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10036590,10036590,10036590
EOSINOPHIL PERCENTAGE INCREASED,eosinophil percentage increased,EOSINOPHIL PERCENTAGE INCREASED,EOSINOPHIL PERCENTAGE INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10052222,10052222,10052222
CERVICAL ADENOPATHY,Lymphadenopathy,LYMPHADENOPATHY CERVICAL,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025200,10025197,10025200
TINNITUS,Tinnitus,TINNITUS,TINNITUS,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10043882,10043882,10043882
SYSTEMIC ARTHRALGIA,Arthralgia,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
TYPE 1 RESPIRATORY INSUFFICIENCY,respiratory insufficiency,RESPIRATORY INSUFFICIENCY,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038701,10038695,10038701
"CREATININE LEVEL WAS RAISED (3.5 MG/DL),",Blood creatinine increased,CREATININE INCREASED,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011368,10005483,10011368
CEFTAZIDIME/AVIBACTAM-MEROPENEM-FOSFOMYCIN COMBINATION CAN BE USEFUL ALSO IN DECONTAMINATION PROCEDURES,Therapeutic response unexpected,UNEXPECTED BENEFICIAL THERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE UNEXPECTED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10076884,10043417,10076885
GINGIVAL HYPERPLASIA,Gingival hypertrophy,GINGIVAL HYPERPLASIA,GINGIVAL HYPERTROPHY,DENTAL AND GINGIVAL CONDITIONS,GINGIVAL DISORDERS NEC,10017947,10018283,10018284,10018283
REDNESS OF TRUNK,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
EPISODES OF DELIRIUM,Delirium,DELIRIUM,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012218
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
ALLERGIC REACTION TO THE MINOXIDIL,Hypersensitivity,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
IN LEFT ADNEXAL REGION PERITUBAL OVARIAN ADHESION WAS NOTED AND UTERUS WAS ADHERED TO PERITONEUM OF FRONT ABDOMINAL WALL AND ALSO TO LEFT ADNEXA,Pelvic adhesions,PERITUBAL ADHESIONS,PELVIC ADHESIONS,"UTERINE, PELVIC AND BROAD LIGAMENT DISORDERS",PELVIS AND BROAD LIGAMENT DISORDERS NEC,10038604,10034689,10034238,10034689
CHEST PAIN,Chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
SEVERE RENAL FAILURE DUE TO DRUG OVERDOSE AND ACCIDENTAL OVERDOSE FOLLOWING MEDICATION ERROR,Renal failure,RENAL FAILURE,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038435,10038435,10038435
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
DUODENITIS,Duodenitis,DUODENITIS,DUODENITIS,GASTROINTESTINAL INFLAMMATORY CONDITIONS,GASTROINTESTINAL INFLAMMATORY DISORDERS NEC,10017947,10013864,10013864,10013864
PERIPHERAL NEUROPATHIC PAIN,Neuralgia,PERIPHERAL NEUROPATHIC PAIN,NEURALGIA,NEUROLOGICAL DISORDERS NEC,SENSORY ABNORMALITIES NEC,10029205,10077974,10029223,10077974
ABDOMEN WAS DISTENDED,Abdominal distension,DISTENDED ABDOMEN,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10013480
SKIN RASHES,skin rash,SKIN RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10040913,10037844,10040913
PATIENT TREATED WITH ZOLEDRONIC ACID FOR NON-INFECTIOUS OSTEOMYELITIS OF JAW (OFF LABEL USE) WITH NO ADVERSE EVENTS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
RESULTED 50% REDUCTION IN HER COMPLAINTS,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
VASODILATING MEDICATION SEEMED TO BE SYNERGISTIC WITH SPINAL ANESTHESIA,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
"HEADACHE, ANXIETY, PALPITATIONS, IRRITABILITY AND INSOMNIA",Insomnia,INSOMNIA,INSOMNIA,SLEEP DISORDERS AND DISTURBANCES,DISTURBANCES IN INITIATING AND MAINTAINING SLEEP,10037175,10022437,10022437,10022437
ABDOMINAL REBOUND TENDERNESS,Abdominal rebound tenderness,ABDOMINAL REBOUND TENDERNESS,ABDOMINAL REBOUND TENDERNESS,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10052489,10052489,10052489
SKIN PIGMENTATION,Pigmentation disorder,SKIN PIGMENTATION,PIGMENTATION DISORDER,PIGMENTATION DISORDERS,PIGMENTATION CHANGES NEC,10040785,10040910,10062080,10040910
DIARRHEA FOLLOWING OFF LABEL USE OF ILOPROST TROMETAMOL,diarrhea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012727,10012735,10012727
LEVAMIZOLE INDUCED ERYTHEMA ELEVATUM DIUTINUM (EED)-LIKE VASCULITIS,Levamizole induced erythema elevatum diutinum (EED)-like vasculitis,ERYTHEMA ELEVATUM DIUTINUM,ERYTHEMA ELEVATUM DIUTINUM,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10056968,10056968,10056968
IPILIMUMAB-RELATED ADRENAL INSUFFICIENCY,Adrenal insufficiency,ADRENAL INSUFFICIENCY,ADRENAL INSUFFICIENCY,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001367,10001367,10001367
CONGENITAL ANOMALY,Congenital anomaly,CONGENITAL ANOMALY,CONGENITAL ANOMALY,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10010356,10010356,10010356
BRADYKINETIC-RIGID PARKINSONISM,parkinsonism,PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034010,10034010,10034010
CARDIOGENIC SHOCK,Cardiogenic shock,CARDIOGENIC SHOCK,CARDIOGENIC SHOCK,HEART FAILURES,HEART FAILURES NEC,10007541,10007625,10007625,10007625
BACLOFEN ABUSE,Drug abuse,DRUG ABUSE,DRUG ABUSE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013654,10013654,10013654
"ONE OUT OF FIVE
PATIENTS NEEDED A SECOND DLI (CD3 CELL DOSE: FIRST DLI 3 X 10 /KG AND SECOND DLI 10 X 10 /KG) DUE TO PERSISTENT MDC IN CD3 SUBSET",Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
SANUINEOUS DRAINAGE,Wound drainage,WOUND DRAINAGE,WOUND DRAINAGE,THERAPEUTIC PROCEDURES AND SUPPORTIVE CARE NEC,THERAPEUTIC PROCEDURES NEC,10042613,10050325,10050325,10050325
POLYPHAGIA,Polyphagia,POLYPHAGIA,HYPERPHAGIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10036132,10020710,10036132
FAILURE TO THRIVE,failure to thrive,FAILURE TO THRIVE,FAILURE TO THRIVE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10016165,10016165,10016165
PERIPHERAL EDEMA,peripheral edema,PERIPHERAL EDEMA,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10034570,10030124,10034570
BILATERAL PLEURAL EFFUSION,Pleural effusion,BILATERAL PLEURAL EFFUSION,PLEURAL EFFUSION,PLEURAL DISORDERS,PNEUMOTHORAX AND PLEURAL EFFUSIONS NEC,10038738,10078037,10035598,10078037
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
MENTAL STATE DETERIORATED,Mental state abnormal aggravated,MENTAL STATE ABNORMAL AGGRAVATED,MENTAL DISORDER,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10048345,10061284,10048345
HILAR AND ABDOMINAL LYMPHADENOPATHY,abdominal lymphadenopathy,ABDOMINAL LYMPHADENOPATHY,ABDOMINAL LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10073485,10073485,10073485
THROMBOCYTOPENIA,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
"EXTRAPYRAMIDAL SYMPTOMS (DYSPHAGIA, DYSARTHRIA, AND IMMOBILITY)",immobile,IMMOBILE,IMMOBILE,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10021417,10021417,10021417
DRUG-DRUG INTERACTION WITH ATORVASTATIN MAY ALSO PLAY A ROLE TO DECREASE DABIGATRAN PLASMA CONCENTRATION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
MUCOUS MEMEBRANE PEMPHIGOID,Cicatricial pemphigoid,CICATRICIAL PEMPHIGOID,PEMPHIGOID,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10057052,10034277,10057052
SEROTONIN SYNDROME,Serotonin syndrome,SEROTONIN SYNDROME,SEROTONIN SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10040108,10040108,10040108
WEAKNESS OF RIGHT HAND,Asthenia,WEAKNESS,ASTHENIA,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10047862,10003549,10047862
OSTEOMYELITIS,osteomyelitis,OSTEOMYELITIS,OSTEOMYELITIS,INFECTIONS - PATHOGEN UNSPECIFIED,BONE AND JOINT INFECTIONS,10021881,10031252,10031252,10031252
REBOUND EFFECT,Rebound effect,REBOUND EFFECT,REBOUND EFFECT,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10038001,10038001,10038001
INFECTION WITH ASPERGILLUS FUMIGATUS,Aspergillus infection,ASPERGILLUS FUMIGATUS INFECTION,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003494,10074171,10003494
GUILLAINâ€“BARRE SYNDROME,guillainâ€“Barre syndrome,GUILLAIN BARRE SYNDROME,GUILLAIN-BARRE SYNDROME,PERIPHERAL NEUROPATHIES,ACUTE POLYNEUROPATHIES,10029205,10018766,10018767,10018766
AGRANULOCYTOSIS WITH CLOZAPINE,Agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
HYPOTONIC-HYPORESPONSIVE EPISODE,Hypotonic-hyporesponsive episode,HYPOTONIC-HYPORESPONSIVE EPISODE,HYPOTONIC-HYPORESPONSIVE EPISODE,NEUROMUSCULAR DISORDERS,NEUROMUSCULAR DISORDERS NEC,10029205,10021121,10021121,10021121
DRUG INDUCED MITROCHONDRIAL TOXICITY,mitochondrial toxicity,MITOCHONDRIAL TOXICITY,MITOCHONDRIAL TOXICITY,METABOLISM DISORDERS NEC,CELL METABOLISM DISORDERS NEC,10027433,10053961,10053961,10053961
NEUROLOGICAL DETERIORATION,Neurological status deterioration,NEUROLOGICAL STATUS DETERIORATION,NEUROLOGICAL DECOMPENSATION,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10064098,10068357,10064098
GLASGOW COMA SCALE ABNORMAL (8) FOLLOWING MULTIPLE DRUG OVERDOSE,Coma scale abnormal,GLASGOW COMA SCALE ABNORMAL,COMA SCALE ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10058466,10069709,10058466
SALIVATION,Salivation,SALIVATION,SALIVARY HYPERSECRETION,SALIVARY GLAND CONDITIONS,ORAL DRYNESS AND SALIVA ALTERED,10017947,10039428,10039424,10039428
MID-TRANSPLANT HYDRONEPHROSIS,hydronephrosis,HYDRONEPHROSIS,HYDRONEPHROSIS,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL OBSTRUCTIVE DISORDERS,10038359,10020524,10020524,10020524
UNRESPONSIVE,Unresponsive to stimuli,UNRESPONSIVE TO STIMULI,UNRESPONSIVE TO STIMULI,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10045555,10045555,10045555
CARDIAC TAMPONADE DUE TO PERICARDITIS TUBERCULOUS,cardiac tamponade,CARDIAC TAMPONADE,CARDIAC TAMPONADE,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10007610,10007610,10007610
VISUAL HALLUCINATIONS,"Hallucination, visual",VISUAL HALLUCINATIONS,"HALLUCINATION, VISUAL",DISTURBANCES IN THINKING AND PERCEPTION,PERCEPTION DISTURBANCES,10037175,10019075,10019075,10047570
BONE MARROW APLASIA,Bone marrow failure,APLASIA BONE MARROW,BONE MARROW FAILURE,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,MARROW DEPRESSION AND HYPOPLASTIC ANAEMIAS,10005329,10002962,10065553,10002962
MALE BREAST CANCER (MBC)/FINASTERIDE TREATMENT AND MALE BREAST CANCER,Breast cancer male,BREAST CANCER MALE,BREAST CANCER MALE,BREAST NEOPLASMS MALIGNANT AND UNSPECIFIED (INCL NIPPLE),BREAST AND NIPPLE NEOPLASMS MALIGNANT,10029104,10061020,10061020,10061020
PETECHIAL HAEMORRHAGES OF THE SKIN DUE TO METHOTREXATE INTOXICATION BECAUSE OF DRUG PRESCRIBING ERROR,skin hemorrhage,SKIN HEMORRHAGE,SKIN HAEMORRHAGE,SKIN VASCULAR ABNORMALITIES,SKIN HAEMORRHAGES,10040785,10064266,10064265,10064266
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
CATATONIA,Catatonia,CATATONIA,CATATONIA,CHANGES IN PHYSICAL ACTIVITY,DECREASED PHYSICAL ACTIVITY LEVELS,10037175,10007776,10007776,10007776
"INSPITE OF METHOTREXATE,PREDNISOLONE AND HYDROXYCHLOROQUINE EFFUSION REACCUMULATION (LACK OF DRUG EFFECT)",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH),Histiocytosis haematophagic,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,HISTIOCYTOSIS HAEMATOPHAGIC,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10071583,10048595,10071580
PARTIAL PHLEBOTHROMBOSIS OF THE LEFT-SIDED VENA TIBIALIS POSTERIOR,Thrombophlebitis,THROMBOPHLEBITIS,THROMBOPHLEBITIS,EMBOLISM AND THROMBOSIS,PERIPHERAL EMBOLISM AND THROMBOSIS,10047065,10043570,10043570,10043570
ASPIRATION PNEUMONIA,Pneumonia aspiration,ASPIRATION PNEUMONIA,PNEUMONIA ASPIRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10035669,10035669,10003525
SHORTNESS OF BREATH,Dyspnoea,SHORTNESS OF BREATH,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10040604,10013968,10040604
"HE WAS MISTAKENLY GIVEN 50 MG NALTREXONE, TOGETHER WITH THE REST OF HIS TREATMENT, WHICH INCLUDED THE 8 MG BUPRENORPHINE/ MISTAKENLY RECEIVED NALTREXONE",Drug administration error,DRUG ADMINISTRATION ERROR,DRUG ADMINISTRATION ERROR,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10064295,10064295,10064295
PAIN,Pain,PAIN,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033371,10033371,10033371
IMATINIB USED FOR CUTANEOUS HYPERPIGMENTATION,Product use in unapproved indication,PRODUCT USE IN UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076476,10076476,10076476
MYCOPHENOLATE MOFETIL AND METHOTREXATE USED FOR PYODERMA GANGRENOSUM (OFF LABEL USE WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"WHITE BLOOD CELL LOW(WBC) OF 1,800/ÎœL",White blood cell count decreased,WHITE BLOOD CELL COUNT LOW,WHITE BLOOD CELL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10051617,10047942,10051617
BLISTERS,blisters,BLISTERS,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005216,10005191,10005216
HEART RATE INCREASED (154 BPM),Heart rate increased,HEART RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10019303,10019303,10019303
AMMONIA INCREASED,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
IBUPROFEN-INDUCED ACUTE LIVER FAILURES (ALF),Acute hepatic failure,ACUTE LIVER FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10000804,10000804,10049844
CPK INCREASED (110 U/L),Blood creatine phosphokinase increased,CPK INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011268,10005470,10011268
PATIENT WAS TREATED WITH INTRAVENOUS ZOLEDRONIC ACID FOR BREAST CANCER (OFF LABEL USE FOR INDICATION),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
"THE PATIENT HAD NO RESPONSE TO STEROIDS. PATIENT CONTINUED TO HAVE EDEMA, LOW SERUM ALBUMIN AND PROTEINURIA.",Lack of drug effect ,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
TETRAPARESIS FOLLOWING GUILLAIN-BARRE DISEASE,Quadriplegia,TETRAPLEGIA,QUADRIPLEGIA,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10037714,10037714,10043385
BINASAL VISUAL FIELD DEFECT FOR 2 DAYS,visual field defect,VISUAL FIELD DEFECT,VISUAL FIELD DEFECT,NEUROLOGICAL DISORDERS OF THE EYE,NEUROLOGIC VISUAL PROBLEMS NEC,10029205,10047555,10047555,10047555
"THERE WAS NO RESPONSE TO IV ADENOSINE AND AMIODARONE, AND A SECOND ECG REVEALED ATRIAL FLUTTER",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
PATIENT WITH ANCA NEGATIVE ORBITAL VASCULITIS TREATED WITH MYCOPHENOLATE MOFETIL (DRUG USE FOR UNAPPROVED INDICATION WITH NO ADR),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
GASTRIC AND DISTAL INTESTINAL LINEAR PNEUMATOSIS,Pneumatosis intestinalis,PNEUMATOSIS INTESTINALIS,PNEUMATOSIS INTESTINALIS,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL DISORDERS NEC,10017947,10057030,10057030,10057030
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
THROMBOCYTOPENIA,THROMBOCYTOPENIA,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
ACUTE LUNG INJURY,Acute lung injury,ACUTE LUNG INJURY,ACUTE LUNG INJURY,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10069351,10069351,10069351
PSYCHIC IMPAIRMENT,psychic disturbance,PSYCHIC DISTURBANCE,MENTAL DISORDER,PSYCHIATRIC DISORDERS NEC,MENTAL DISORDERS NEC,10037175,10037183,10061284,10037183
ENTEROCOCCUS FAECALIS INFECTION,Enterococcal infection,ENTEROCOCCUS FAECALIS INFECTION,ENTEROCOCCAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,ENTEROCOCCAL INFECTIONS,10021881,10051978,10061124,10051978
ACCIDENTAL OVERDOSE WITH WHICH WAS SUGGESTIVE OF TOXICITY,drug toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
WHITE BLOOD CELL COUNT INCREASED (22000/MICROLITRE),White blood cell count increased,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10047943,10047943,10047943
ALVEOLAR HEMORRHAGE FOLLOWING ASPERGILLOSIS,Pulmonary alveolar haemorrhage,PULMONARY ALVEOLAR HAEMORRHAGE,PULMONARY ALVEOLAR HAEMORRHAGE,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PARENCHYMAL LUNG DISORDERS NEC,10038738,10037313,10037313,10037313
MODERATE HEPATOMEGALY AND SPLENOMEGALY (HEPATOSPLENOMEGALY) WITHOUT DILATATION OF THE BILE DUCTS,Hepatosplenomegaly,HEPATOSPLENOMEGALY,HEPATOSPLENOMEGALY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOBILIARY SIGNS AND SYMPTOMS,10019805,10019847,10019847,10019847
MOTOR FLUCTUATIONS/PARKINSON'S DISEASE PROGRESSION,MOTOR FLUCTUATIONS/PARKINSON'S DISEASE PROGRESSION,PARKINSON'S DISEASE,PARKINSON'S DISEASE,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10061536,10061536,10061536
OTITIS,otitis,OTITIS,EAR INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,EAR INFECTIONS,10021881,10033071,10014011,10033071
SEPTIC SHOCK FOLLOWING BACTEREMIA,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
LACK OF SLEEP AFFECTED THE PATIENT'S MOOD / SLEEPING BADLY POSSIBLY CAUSED ALSO NERVOUSNESS,Nervousness,NERVOUSNESS,NERVOUSNESS,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10029216,10029216,10029216
CONDITION WORSENED,condition worsened,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
OFF LABEL USE OF METHOTREXATE FOR TERMINATION OF PREGNANCY WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
GAMBLING/COMPULSION FOR GAMBLING,Gambling disorder,GAMBLING ADDICTION,GAMBLING DISORDER,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10017656,10078070,10017656
NO RESPONSE TO CORTICOSTEROIDS (LACK OF DRUG EFFECT) WITH NO ADVERSE DRUG REACTION,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
EXACERBATION ON PALMS AND FOOTS THEN ON THE LIMBS AND HEAD,Psoriasis,PSORIASIS AGGRAVATED,PSORIASIS,EPIDERMAL AND DERMAL CONDITIONS,PSORIATIC CONDITIONS,10040785,10037154,10037153,10037154
TYPE 2 RESPIRATORY FAILURE FOLLOWING ANAPHYLAXIS,respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
PHEOCHROMOCYTOMA,Phaeochromocytoma,PHEOCHROMOCYTOMA,PHAEOCHROMOCYTOMA,ENDOCRINE NEOPLASMS MALIGNANT AND UNSPECIFIED,ISLET CELL NEOPLASMS AND APUDOMA NEC,10029104,10034800,10034800,10034876
DID NOT RECOVER HER LEVEL OF CONSCIOUSNESS,Altered state of consciousness,CONSCIOUSNESS ABNORMAL,ALTERED STATE OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10010765,10001854,10010765
FAILED TREATMENT MODALITIES (TREATMENT FAILURE WITH NO ADR),Treatment failure,TREATMENT FAILURE,TREATMENT FAILURE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10066901,10066901,10066901
ERYTHROMYCIN AND LOVASTATIN INTERACTION,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
HYPESTHESIA IN A SOCKING AND GLOVE DISTRIBUTION,hypesthesia,HYPESTHESIA,HYPOAESTHESIA,NEUROLOGICAL DISORDERS NEC,PARAESTHESIAS AND DYSAESTHESIAS,10029205,10020922,10020937,10020922
VAGINAL ITCHING,Vulvovaginal pruritus,VAGINAL ITCHING,VULVOVAGINAL PRURITUS,VULVOVAGINAL DISORDERS (EXCL INFECTIONS AND INFLAMMATIONS),VULVOVAGINAL SIGNS AND SYMPTOMS,10038604,10046918,10056530,10046918
LYMPHADENOPATHY,Lymphadenopathy,LYMPHADENOPATHY,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025197,10025197,10025197
RISING CRP 319MG/L,CRP increased,CRP INCREASED,C-REACTIVE PROTEIN INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10011418,10006825,10011418
UNCONTROLLED DIABETES MELLITUS,Diabetes mellitus inadequate control,DIABETES MELLITUS LOSS OF CONTROL,DIABETES MELLITUS INADEQUATE CONTROL,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012607,10012607,10012610
LOWER LIMB CELLULITIS/CRYPTOCOCCAL CELLULITIS,Cellulitis,CELLULITIS,CELLULITIS,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10007882,10007882,10007882
HYPOGLYCEMIA,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
"IN HER MOUTH, ON THE INSIDE OF BOTH CHEEKS AND IN THE AREA OF THE PHARYNGEAL ARCH, A FEW ULCERS WERE VISIBLE",Ulcer,ULCER,ULCER,TISSUE DISORDERS NEC,ULCERS NEC,10018065,10045285,10045285,10045285
PERSONALITY CHANGE,Personality change,PERSONALITY CHANGE,PERSONALITY CHANGE,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10034719,10034719,10034719
COMPLETE CESSATION OF MEDICATION CAUSED IMMEDIATE EXACERBATION OF SYMPTOMS,Withdrawal syndrome,WITHDRAWAL SYMPTOM,WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10073281,10048010,10073281
SPONTANEOUS INTERCOSTAL ARTERY HAEMORRHAGE/ ACTIVE HAEMORRHAGE,Haemorrhage,HAEMORRHAGE,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10055798,10055798,10055798
ULCERATIONS AT THE LIPS MUCOSA.,Lip ulceration,LIP ULCERATION,LIP ULCERATION,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10024572,10024572,10024572
ANAPHYLACTIC REACTION GRADE III,Anaphylactic reaction,ANAPHYLACTIC REACTION,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002198,10002198,10002198
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
ANAPHYLACTIC SHOCK,Anaphylactic shock,ANAPHYLACTIC SHOCK,ANAPHYLACTIC SHOCK,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002199,10002199,10002199
PATIENT TREATED WITH METHOTREXATE FOR GRANULOMATOSIS WITH POLYANGIITIS (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DYSPNOEA,dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
DISCOMFORT,Discomfort,DISCOMFORT,DISCOMFORT,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10013082,10013082,10013082
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
APATHY,Apathy,APATHY,APATHY,MOOD DISORDERS AND DISTURBANCES NEC,MOOD DISORDERS NEC,10037175,10002942,10002942,10002942
RENAL INSUFFICIENCY,Renal failure,RENAL INSUFFICIENCY,RENAL FAILURE,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10038474,10038435,10038474
SMALL PUSTULES,Rash pustular,PUSTULE,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037578,10037888,10037578
ROCURONIUM INTOXICATION,drug intoxication,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013714,10070863,10013714
WRONG ROUTE OF ADMINISTRATION,Incorrect route of drug administration,WRONG ROUTE OF ADMINISTRATION,INCORRECT ROUTE OF DRUG ADMINISTRATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10048057,10064304,10048057
ACID-TOLERANT NOCARDIA SPP,Nocardiosis,NOCARDIA INFECTION,NOCARDIOSIS,BACTERIAL INFECTIOUS DISORDERS,NOCARDIA INFECTIONS,10021881,10064083,10029444,10064083
"PANCITOPENIA (HB 11.5 G/DL, GR 3650/MMC, PTLS 122000/MMC) CON MARCATA NEUTROPENIA (GB 370/MMC, N 10/MMC). RASH CUTANEO E FEBBRE.",Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
RELAPSE OF BIPOLAR DISORDER,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
"THE SYNERGISTIC USE OF MILRINONE AND CATECHOLAMINE INFUSIONS FOR PROLONGED PERIODS CAN CAUSE
DELETERIOUS CARDIAC REMODELING AND CARDIOMYOPATHY",Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
A 31 YEAR OLD WOMEN IS TREATED BY HALOPERIDOL (50MG/WEEK)AND OLANZAPINE (15MG/DAY),Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
LOSS OF 10 KG,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
STRETCH MARK ON HIPS AND ABDOMEN,Stretch marks,STRETCH MARKS,SKIN STRIAE,CORNIFICATION AND DYSTROPHIC SKIN DISORDERS,SKIN HYPOPLASIAS AND ATROPHIES,10040785,10042222,10040925,10042222
MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
OCCURRENCE OF NEW CUTANEOUS LESIONS,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
EROSIONS OF THE GLANS PENIS,Penile ulceration,PENILE EROSION,PENILE ULCERATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10064061,10034322,10064061
POORLY TOLERATED (MUSCLE AND JOINT PAIN),Myalgia,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028411,10028411,10028322
PYODERMA GANGRENOSUM,Pyoderma gangrenosum,PYODERMA GANGRENOSUM,PYODERMA GANGRENOSUM,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,SKIN AND SUBCUTANEOUS TISSUE ULCERATIONS,10040785,10037635,10037635,10037635
DYSPNOEA,Dyspnoea,DYSPNOEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013968
LYMPHOPENIA,lymphopenia,LYMPHOPENIA,LYMPHOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10025327,10025327,10025327
LARGE HETEROGENOUS RIGHT ADRENAL MASS (5.9 CM),Adrenal mass,ADRENAL MASS,ADRENAL MASS,ADRENAL GLAND DISORDERS,ADRENAL GLAND DISORDERS NEC,10014698,10053235,10053235,10053235
RESPIRATORY DISTRESS,Respiratory distress,RESPIRATORY DISTRESS,RESPIRATORY DISTRESS,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038687,10038687,10038687
LEUKOCYTOSIS,Leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
BREAKABLE BONES,Brittle bone disease,BRITTLE BONE DISEASE,OSTEOGENESIS IMPERFECTA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,NON-SITE SPECIFIC BONE DISORDERS CONGENITAL,10010331,10006371,10031243,10006371
SKIN DRYNESS,Dry skin,SKIN DRY,DRY SKIN,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10013786,10013786,10040835
PATIENT TREATED WITH METHOREXATE FOR CERVICAL ECTOPIC PREGNANCY (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
EOSINOPHILIA,eosinophilia,EOSINOPHILIA,EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10014950,10014950,10014950
TUMOR PROGRESSION,tumor progression,TUMOR PROGRESSION,NEOPLASM PROGRESSION,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS UNSPECIFIED MALIGNANCY AND SITE UNSPECIFIED NEC,10029104,10053563,10061309,10053563
DRUG EXPOSURE IN UTERO/PALIPERIDONE EXPOSURE DURING PREGNANCY,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
THE INFANT WAS BREAST-FED,Maternal exposure during breast feeding,EXPOSURE DURING BREAST FEEDING,MATERNAL EXPOSURE DURING BREAST FEEDING,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071402,10080752,10071402
MOOD SWINGS,Mood swings,MOOD SWINGS,MOOD SWINGS,MOOD DISORDERS AND DISTURBANCES NEC,FLUCTUATING MOOD SYMPTOMS,10037175,10027951,10027951,10027951
EOSINOPHILIC MYOCARDITIS,Eosinophilic myocarditis,EOSINOPHILIC MYOCARDITIS,EOSINOPHILIC MYOCARDITIS,MYOCARDIAL DISORDERS,NONINFECTIOUS MYOCARDITIS,10007541,10014961,10014961,10014961
BLOOD PRESSURE WAS 90/50MMHG,Blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
HIGH LOPERAMIDE CONCENTRATION (56 NG/ML) DUE TO LOPERAMIDE CHRONIC ABUSE FOLLOWING CHRONIC OVERDOSE,Drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
PATIENT ADMINISTERED MYCOPHENOLATE MOFETIL FOR TREATMENT OF EROSIVE ORAL LICHEN PLANUS (OFF LABEL USE) WITH NO ADVERSE EVENTS,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
"PROGRESSION OF THE DISEASE IN THE LIVER, IN PERITONEUM AND LYMPH NODE IN RETROPERITONEUM",adenocarcinoma of colon,ADENOCARCINOMA OF COLON,ADENOCARCINOMA OF COLON,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,COLORECTAL NEOPLASMS MALIGNANT,10029104,10001167,10001167,10001167
POLYMORPHOUS MACULOPAPULAR VESICULAR EXANTHEMA/ VESICULAR ELEMENTS ON THE VAGINAL AND PERIANAL MUCOSA,Rash vesicular,VESICULAR RASH,RASH VESICULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037898,10037898,10047377
PERICARDIAL EFFUSION,pericardial effusion,PERICARDIAL EFFUSION,PERICARDIAL EFFUSION,PERICARDIAL DISORDERS,PERICARDIAL DISORDERS NEC,10007541,10034474,10034474,10034474
MUCORMYCOSIS/INTRA-ABDOMINAL MASS,Abdominal mass,ABDOMINAL MASS,ABDOMINAL MASS,GASTROINTESTINAL SIGNS AND SYMPTOMS,ABDOMINAL FINDINGS ABNORMAL,10017947,10000077,10000077,10000077
"THE PATIENT DEVELOPED FURTHER FLARES OF PG DESPITE RESUMING PREDNISOLONE AND DESPITE BEING ON METHYLPREDNISOLONE AND IMMUNOGLOBULINS, ULCERS WERE REFRACTORY TO HEALING",condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
TRUNCAL OBESITY,Central obesity,TRUNCAL OBESITY,CENTRAL OBESITY,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10065940,10065941,10065940
MORPHINE ADDICTION,Drug addiction,DRUG ADDICTION,DRUG DEPENDENCE,PSYCHIATRIC DISORDERS NEC,SUBSTANCE RELATED AND ADDICTIVE DISORDERS,10037175,10013658,10013663,10013658
PLATELET COUNT DECREASED,Platelet count decreased,PLATELET COUNT DECREASED,PLATELET COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),PLATELET ANALYSES,10022891,10035528,10035528,10035528
GENERALIZED PRURITIC MACULOPAPULAR ERUPTION,Maculo-papular rash,MACULO-PAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025423,10037868,10025423
STOMACH PAIN,stomach pain,STOMACH PAIN,ABDOMINAL PAIN UPPER,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10042112,10000087,10042112
ELEVATED BLOOD UREA (13.11 MMOL/L),Blood urea increased,UREA BLOOD ELEVATED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005851,10005851,10046348
"AMOXICILLIN AND CLAVULANIC ACID GIVEN DUE TO THE SUSPECTING OF SCARLET FEVER, BUT THE PATIENT'S STATUS HAD BEEN GETTING WORSE",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
GRADE 3 NEUTROPENIA,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
IN-UTERO EXPOSURE OF CLOZAPINE RESULTING IN LUMBAR MENINGOMYELOCELE,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
SUDDEN AGGRAVATION OF PATIENT WITH CIRRHOSIS AND RECENT IMMUNOSUPPRESIVE TREATMENT,Disease aggravation,DISEASE AGGRAVATION,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10013097,10010264,10013097
INCREASED EXCRETION OF SODIUM (145 MEQ/L),Urine sodium increased,SODIUM URINE INCREASED,URINE SODIUM INCREASED,"WATER, ELECTROLYTE AND MINERAL INVESTIGATIONS",MINERAL AND ELECTROLYTE ANALYSES,10022891,10046672,10046672,10041281
DIFFUSE PURPURIC AND PETECHIAL SKIN LESIONS,purpura,PURPURA,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037549,10037549,10037549
VENLAFAXINE OVERDOSE,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
HIGH FEVER,Fever,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016558,10037660,10016558
LEFT SCAPULAR PAIN,Musculoskeletal pain,SCAPULA PAIN,MUSCULOSKELETAL PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10040610,10028391,10070864
DRUG ERUPTION,Drug eruption,DRUG ERUPTION,DRUG ERUPTION,EPIDERMAL AND DERMAL CONDITIONS,DERMATITIS ASCRIBED TO SPECIFIC AGENT,10040785,10013687,10013687,10013687
HYPERACTIVITY/PSYCHOMOTOR AGITATION,hyperactivity,HYPERACTIVITY,PSYCHOMOTOR HYPERACTIVITY,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10020558,10037211,10020558
CHOLESTATIC,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
CONFUSION,confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
12 YR OLD CHILD TREATED WITH ETHAMBUTOL (DRUG USE IN UNAPPROVED POPULATION) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HIS IOP WAS ELEVATED AT 24 MM HG,increase of Intraocular pressure,INCREASED INTRAOCULAR PRESSURE,INTRAOCULAR PRESSURE INCREASED,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",OPHTHALMIC FUNCTION DIAGNOSTIC PROCEDURES,10022891,10021667,10022806,10021667
PARKINSONISM AS A SIDE EFFECT OF PREDNISONE AND CHLORPORMAZINE THERAPY,Parkinsonism,PARKINSONISM,PARKINSONISM,MOVEMENT DISORDERS (INCL PARKINSONISM),PARKINSON'S DISEASE AND PARKINSONISM,10029205,10034010,10034010,10034010
EDEMA OF THE LOWER LIMB,Edema lower limb,EDEMA LOWER LIMB,OEDEMA PERIPHERAL,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10014232,10030124,10014232
FEBRILE NEUTROPENIA,Febrile neutropenia,FEBRILE NEUTROPENIA,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10016288,10016288,10016288
URTICARIA,Urticaria,URTICARIA,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10046735,10046735,10046735
"HIGH VARIABILITY OF GLYCAEMIAS, HYPERGLYCEMIA, HYPOGLYCEMIA",Hyperglycaemia,HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10020635,10020635,10020639
LEFT-SIDED PLEURITIC CHEST PAIN,chest pain,CHEST PAIN,CHEST PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10008479,10008479,10008479
WORSENING OF FATIGUE,disease aggravation,DISEASE AGGRAVATION,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10013097,10010264,10013097
BACK MYALGIA ON EZETIMIBE TREATMENT,Myalgia,LOCALISED MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10063543,10028411,10063543
RESPIRATORY FAILURE DUE TO CAMPULOBACTER BACTEREMIA,Respiratory failure,RESPIRATORY FAILURE,RESPIRATORY FAILURE,RESPIRATORY DISORDERS NEC,RESPIRATORY FAILURES (EXCL NEONATAL),10038738,10038695,10038695,10038695
DRUG RELATED FULMINANT LIVER FAILURE,Fulminant hepatic failure,FULMINANT HEPATIC FAILURE,ACUTE HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10017469,10000804,10017469
HYPOGLYCAEMIA,Hypoglycaemia,HYPOGLYCAEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10020993
HYPOGLYCEMIA (VALUE-30 MG/DL) FOLLOWING INTENTIONAL ACUTE OVERDOSE,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
DIABETES CONTROL GRADUALLY WORSENED ON SULFONYLUREA EVEN AFTER INSULIN WAS ADDED DUE TO NON ADHERENCE TO SULFONYLUREA,Diabetes mellitus inadequate control,DIABETES MELLITUS INADEQUATE CONTROL,DIABETES MELLITUS INADEQUATE CONTROL,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),DIABETES MELLITUS (INCL SUBTYPES),10027433,10012607,10012607,10012607
ERYTHEMATOUS RASH AND AN ATTACK OF THE MUCOSA,Rash erythematous,ERYTHEMATOUS RASH,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037855,10037855,10015243
ACUTE KIDNEY INJURY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
"OFF LABEL USE (MYOPHENOLATE MOFETIL, METHOTREXATE AND ANTITHUMOGLOBULIN FOR INDICATION, FLUDARABINE FOR AGE AND INDICATION)",Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
DECREASED SELF CARE,Impaired self-care,IMPAIRED SELF-CARE,IMPAIRED SELF-CARE,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10052404,10052404,10052404
FAILURE OF INTENSIVE TREATMENT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
INCREASED LIVER ENZYMES,Raised liver enzymes ,RAISED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10037823,10060795,10037823
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
DECOMPENSATED CIRRHOSIS FOLLOWING CHRONIC HEPATITIS E INFECTION,Hepatic cirrhosis,DECOMPENSATED CIRRHOSIS,HEPATIC CIRRHOSIS,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FIBROSIS AND CIRRHOSIS,10019805,10064704,10019641,10064704
MULTIPLE GENETIC RESISTANCE MUTATIONS TO ANTI-RETROVIRAL THERAPY IN HIV INFECTIONS,Pathogen resistance,MULTI-ANTIVIRAL RESISTANCE,PATHOGEN RESISTANCE,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10068294,10034133,10068294
MILD ENCEPHALOPATHY WITH NO FOCAL SIGNS,encephalopathy,ENCEPHALOPATHY,ENCEPHALOPATHY,ENCEPHALOPATHIES,ENCEPHALOPATHIES NEC,10029205,10014625,10014625,10014625
TOXIC EPIDERMAL NECROLYSIS (TEN),Toxic epidermal necrolysis,TOXIC EPIDERMAL NECROLYSIS,TOXIC EPIDERMAL NECROLYSIS,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10044223,10044223,10044223
ABDOMINAL PAIN,abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
PROGRESSIVE BACK PAIN,Back pain,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE PAIN AND DISCOMFORT,10028395,10003988,10003988,10003988
TUBULAR ATROPHY GRADE II,Renal tubular atrophy,RENAL TUBULAR ATROPHY,RENAL TUBULAR ATROPHY,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10038536,10038536,10038536
ACUTE CARDIORESPIRATORY FAILURE,Cardiopulmonary failure,CARDIOPULMONARY FAILURE,CARDIOPULMONARY FAILURE,HEART FAILURES,HEART FAILURES NEC,10007541,10051093,10051093,10051093
DRUG USE FOR UNAPPROVED POPULATION,drug use in unapproved population,DRUG USE IN UNAPPROVED POPULATION,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10071551,10076309,10071551
DRUG RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
ASPIRATION PNEUMONIA,Pneumonia aspiration,ASPIRATION PNEUMONIA,PNEUMONIA ASPIRATION,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),LOWER RESPIRATORY TRACT INFLAMMATORY AND IMMUNOLOGIC CONDITIONS,10038738,10035669,10035669,10003525
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
COUGH,Cough,COUGH,COUGH,RESPIRATORY DISORDERS NEC,COUGHING AND ASSOCIATED SYMPTOMS,10038738,10011224,10011224,10011224
PROGRESSIVE SEPTIC SHOCK,Septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
BLOOD UREA NITROGEN INCREASED (59 MG/DL),Blood urea increased,BLOOD UREA NITROGEN INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10005855,10005851,10005855
HCV RELATED NEPHROTIC SYNDROME (RELAPSE),Nephrotic syndrome,NEPHROTIC SYNDROME,NEPHROTIC SYNDROME,NEPHROPATHIES,GLOMERULONEPHRITIS AND NEPHROTIC SYNDROME,10038359,10029164,10029164,10029164
MULTIORGAN FAILURE,Multiorgan failure,MULTIORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028162,10077361,10028162
LACK OF DRUG EFFECT/PATIENT DEVELOPED THROMBOTIC EVENT WAS AN ACUTE UPPER EXTREMITY DVT AFTER SUBCUTANEOUS HEPARIN FOR DVT PROPHYLAXIS,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PATHOLOGICAL FRACTURE OF THE FEMUR,pathological fracture of the femur,PATHOLOGICAL FRACTURE,PATHOLOGICAL FRACTURE,FRACTURES,FRACTURES NEC,10028395,10034156,10034156,10034156
DEATH DUE TO TOXICOLOGICAL EXPOSURE,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
NUMEROUS 1-2MM NONFOLLICULAR PUSTULES,Rash pustular,PUSTULE,RASH PUSTULAR,INFECTIONS - PATHOGEN UNSPECIFIED,SKIN STRUCTURES AND SOFT TISSUE INFECTIONS,10021881,10037578,10037888,10037578
RESPIRATORY DISTRESS NEONATAL,Respiratory distress neonatal,RESPIRATORY DISTRESS NEONATAL,NEONATAL RESPIRATORY DISTRESS,NEONATAL RESPIRATORY DISORDERS,NEONATAL HYPOXIC CONDITIONS,10038738,10038688,10028973,10038688
LIFE THREATENING ANGIOEDEMA,angioedema,ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10002424,10002424,10002424
ACUTE TOXICITY OF TPF INDUCTION CHEMOTHERAPY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
CLARITHROMYCIN CAN SIGNIFICANTLY INCREASE THE CONCENTRATION OF SOME OF THE ACTIVE INGREDIENTS OF THE MEDICINE,Drug interaction,DRUG INTERACTION,DRUG INTERACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),INTERACTIONS,10018065,10013710,10013710,10013710
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
ALLERGIC EOSINOPHILIA,Allergic eosinophilia,ALLERGIC EOSINOPHILIA,ALLERGIC EOSINOPHILIA,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10075185,10075185,10075185
HYPERAEMIC PAPULES AND NODULES WITH CENTRAL NECROSIS ON BOTH ELBOWS AND KNEES,Eosinophilic granulomatosis with polyangiitis,CHURG STRAUSS SYNDROME,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,IMMUNE DISORDERS NEC,VASCULITIDES,10021428,10009164,10078117,10009164
 smaller amount in the left gluteal region,2017-11-13 00:00:00,,,,,CLOSTRIDIA INFECTIONS,10017737,10017737,
LOSS OF MOTOR COORDINATION,Motor dysfunction,MOTOR DYSFUNCTION,MOTOR DYSFUNCTION,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10061296,10061296,10061296
AGITATION,Agitation,AGITATION,AGITATION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10001497,10001497,10001497
"AUREOMICINA RESPONSIBLE FOR THE REACTION,  TOBREX IS ADMINISTERED AND THERE IS A SIMILAR REACTION",Adverse drug reaction,ADVERSE DRUG REACTION,ADVERSE DRUG REACTION,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061623,10061623,10061623
"MULTIPLE DISSEMINATED LESIONS WITH DIAMETER FROM 1 TO 4 CM PRESENTED IN VARIOUS FORMS AS ERYTHEMATOUS, FOLLICULAR PLAQUES AND NODULES,VERRUCOUS HYPERPLASIA WITH SCALES,CRUSTS AND EROSION",Hyperplasia,HYPERPLASIA,HYPERPLASIA,TISSUE DISORDERS NEC,TROPHIC DISORDERS,10018065,10020718,10020718,10020718
ROUND FACE,Face malformation NOS,FACE MALFORMATION NOS,DYSMORPHISM,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS CONGENITAL,MUSCULOSKELETAL DISORDERS CONGENITAL NEC,10010331,10016028,10066054,10016028
BILATERAL BLURRED DISTANCE VISION,Blurred vision,BLURRED VISION,VISION BLURRED,VISION DISORDERS,VISUAL DISORDERS NEC,10015919,10005886,10047513,10005886
ELEVATED LIVER ENZYMES (AST ELEVATED 128),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
INCREASED PROTEIN LEVEL (0.8G/L),Protein total increased,PROTEIN TOTAL INCREASED,PROTEIN TOTAL INCREASED,PROTEIN AND CHEMISTRY ANALYSES NEC,PROTEIN ANALYSES NEC,10022891,10037016,10037016,10037016
TREMORS,tremors,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
AFTER 7 CYCLES/9 CYCLES OF LENALIDOMIDE-DEXAMETHASONE RESISTANCE WAS DEVELOPED,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
WITHDRAWAL SYNDROME,withdrawal syndrome,WITHDRAWAL SYNDROME,WITHDRAWAL SYNDROME,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),WITHDRAWAL AND REBOUND EFFECTS,10018065,10048010,10048010,10048010
MECHANICAL VENTILATION,Mechanical ventilation,MECHANICAL VENTILATION,MECHANICAL VENTILATION,RESPIRATORY TRACT THERAPEUTIC PROCEDURES,RESPIRATORY TRACT THERAPEUTIC PROCEDURES NEC,10042613,10067221,10067221,10067221
MULTIPLE ORGAN FAILURE,Multiple organ dysfunction syndrome,MULTIPLE ORGAN FAILURE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10028154,10077361,10028237
RESPIRATORY STATUS WAS SUDDENLY AGGRAVATED ON THE FOLLOWING DAY,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
YELLOW DISCOLORATION OF THE CONJUNCTIVA,Ocular icterus,CONJUNCTIVA COLORING YELLOW,OCULAR ICTERUS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10010693,10058117,10062414
RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA,Chronic lymphocytic leukaemia,CHRONIC LYMPHOCYTIC LEUKEMIA,CHRONIC LYMPHOCYTIC LEUKAEMIA,LEUKAEMIAS,LEUKAEMIAS CHRONIC LYMPHOCYTIC,10029104,10008958,10008958,10008976
CLOSTRIDIUM-DIFFICILE ENTERITIS,Gastroenteritis clostridial,CLOSTRIDIAL GASTROENTERITIS,GASTROENTERITIS CLOSTRIDIAL,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10017898,10017898,10009654
HEPARIN-INDUCED THROMBOCYTOPENIA,Heparin-induced thrombocytopenia,HEPARIN-INDUCED THROMBOCYTOPENIA,HEPARIN-INDUCED THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10062506,10062506,10062506
DELAYED SEROTONIN SYNDROME,serotonin syndrome,SEROTONIN SYNDROME,SEROTONIN SYNDROME,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10040108,10040108,10040108
ACUTE KIDNEY INJURY DUE TO OLMESARTAN INDUCED SPRUE-LIKE ENTEROPATHY,Acute kidney injury,ACUTE KIDNEY INJURY,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10069339,10069339,10069339
PSYCHOSIS,Psychosis,PSYCHOSIS,PSYCHOTIC DISORDER,SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS,PSYCHOTIC DISORDER NEC,10037175,10037234,10061920,10037234
DRUG INDUCED LIVER INJURY FROM DULOXETINE,Drug-induced liver injury,DRUG-INDUCED LIVER INJURY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072268,10072268,10072268
AMMONIA INCREASED,Ammonia increased,AMMONIA INCREASED,AMMONIA INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001946,10001946,10001946
BACILLUS CALMETTE-GUERIN (BCG) INFECTION LEADING TO GRANULOMATOUS HEPATITIS,Hepatitis granulomatous,HEPATITIS GRANULOMATOUS,GRANULOMATOUS LIVER DISEASE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019774,10018704,10019774
BORN PREMATURELY AT 28 WEEKS,Premature baby,PREMATURE BABY 26 TO 32 WEEKS,PREMATURE BABY,NEONATAL AND PERINATAL CONDITIONS,GESTATIONAL AGE AND WEIGHT CONDITIONS,10036585,10053593,10036590,10053593
WHILE ON  CYCLOPHOSPHAMIDE MORE LUNG NODULES AND PURPURA APPEARED TO THE PATIENT (GRANULOMATOSIS WITH POLYANGIITIS AGGRAVATED),Granulomatosis with polyangiitis,GRANULOMATOSIS WITH POLYANGIITIS,GRANULOMATOSIS WITH POLYANGIITIS,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10072579,10072579,10072579
SEPTIC SHOCK,septic shock,SEPTIC SHOCK,SEPTIC SHOCK,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040070,10040070,10040070
DRUG OVERDOSE,Drug overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
ACUTE LOCALIZED EXANTHEMATOUS PUSTULOSIS,Acute generalised exanthematous pustulosis,ACUTE LOCALISED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10076947,10048799,10076947
OFF LABEL USE FOR INDICATION,off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
BLEPHARITIS DUE TO CONJUNCTIVITIS (BULBAR AND PALPABRAL),Blepharitis,BLEPHARITIS,BLEPHARITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","LID, LASH AND LACRIMAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10005148,10005148,10005148
LOSS OF BLADDER CONTROL,Bladder incontinence,BLADDER INCONTINENCE,URINARY INCONTINENCE,URINARY TRACT SIGNS AND SYMPTOMS,BLADDER AND URETHRAL SYMPTOMS,10038359,10005046,10046543,10005046
QTC  TIME PROLONGATION,QT prolonged,QT PROLONGED,ELECTROCARDIOGRAM QT PROLONGED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),ECG INVESTIGATIONS,10022891,10037705,10014387,10037705
HYPERAMMONAEMIA,Hyperammonaemia,HYPERAMMONAEMIA,HYPERAMMONAEMIA,PROTEIN AND AMINO ACID METABOLISM DISORDERS NEC,PROTEIN METABOLISM DISORDERS NEC,10027433,10020575,10020575,10020575
RETROPHARYNGEAL ABSCESS AGGRAVATION FOLLOWING LACK OF DRUG EFFECT,Pharyngeal abscess,PHARYNGEAL ABSCESS,PHARYNGEAL ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,UPPER RESPIRATORY TRACT INFECTIONS,10021881,10067781,10067781,10067781
SUBARACHNOID HAEMORRHAGE,Subarachnoid haemorrhage,SUBARACHNOID HAEMORRHAGE,SUBARACHNOID HAEMORRHAGE,INJURIES NEC,CEREBRAL INJURIES NEC,10022117,10042316,10042316,10042316
"THE ENDOSCOPY STUDY WAS REPEATED AND BIOPSIES WERE TAKEN IN THE SECOND PART OF THE DUODENUM AND BULB, WHERE PARTIAL ATROPHY WITH A VILLOUS PATTERN WAS OBSERVED",Endoscopy large bowel abnormal,ENDOSCOPY LARGE BOWEL ABNORMAL,ENDOSCOPY LARGE BOWEL ABNORMAL,GASTROINTESTINAL INVESTIGATIONS,GASTROINTESTINAL AND ABDOMINAL IMAGING PROCEDURES,10022891,10014810,10014810,10014810
HEMOGLOBIN DROPPED TO 5.8 GM/DL,decreased hemoglobin,DECREASED HEMOGLOBIN,HAEMOGLOBIN DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),RED BLOOD CELL ANALYSES,10022891,10011964,10018884,10011964
CANDIDA CULTURED FROM SPUTUM,Candida infection,CANDIDA INFECTION,CANDIDA INFECTION,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10074170,10074170,10074170
POLYOMAVIRUS (BKV) NEPHROPATHY (VIREMIA GREATER THAN EQUAL TO 10E4 COPIES/ML),Polyomavirus-associated nephropathy,BK VIRUS NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065333,10065381,10065333
ABSCESS/ ABSCESS ABOVE THE LEFT EAR,Abscess,ABSCESS,ABSCESS,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10000269,10000269,10000269
MOOD SWINGS,Mood swings,MOOD SWINGS,MOOD SWINGS,MOOD DISORDERS AND DISTURBANCES NEC,FLUCTUATING MOOD SYMPTOMS,10037175,10027951,10027951,10027951
MUSCLE BIOPSY SHOWED DEGENERATED MUSCLE FIBERS SURROUNDED BY NEUTROPHIL-PREDOMINANT INFILTRATION,Muscle atrophy,MUSCLE DEGENERATION,MUSCLE ATROPHY,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10028298,10028289,10028298
TONGUE OEDEMA,Tongue oedema,TONGUE OEDEMA,TONGUE OEDEMA,TONGUE CONDITIONS,TONGUE SIGNS AND SYMPTOMS,10017947,10043967,10043967,10043967
CMV ANTIGENEMIA,Cytomegalovirus antigen positive,CYTOMEGALOVIRUS ANTIGEN POSITIVE,CYTOMEGALOVIRUS TEST POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10050541,10051620,10050541
HYPOBICARBONATEMIA,electrolyte disturbance,ELECTROLYTE DISTURBANCE,ELECTROLYTE IMBALANCE,ELECTROLYTE AND FLUID BALANCE CONDITIONS,ELECTROLYTE IMBALANCE NEC,10027433,10014417,10014418,10014417
CUTANEOUS NECROSIS WAS OBSERVED AT AXILLARY REGION AND AT POSTERIOR ARM,necrosis,NECROSIS,NECROSIS,TISSUE DISORDERS NEC,NECROSIS NEC,10018065,10028851,10028851,10028851
FEVER/FEVER OF 39.5 C,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
PERIODIC DYSPEPTIC COMPLAINTS,Dyspepsia,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,DYSPEPTIC SIGNS AND SYMPTOMS,10017947,10013946,10013946,10013946
GRADE I ANAPHYLAXIS,Anaphylactic reaction,ANAPHYLAXIS,ANAPHYLACTIC REACTION,ALLERGIC CONDITIONS,ANAPHYLACTIC AND ANAPHYLACTOID RESPONSES,10021428,10002218,10002198,10002218
RESPIRATORY INFECTION,Respiratory tract infection,RESPIRATORY INFECTION,RESPIRATORY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10038700,10062352,10038700
HEPATIC FAILURE,Hepatic failure,HEPATIC FAILURE,HEPATIC FAILURE,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATIC FAILURE AND ASSOCIATED DISORDERS,10019805,10019663,10019663,10019663
BEHAVIOUR CHANGES,Abnormal behaviour,ABNORMAL BEHAVIOUR,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10061422,10061422,10061422
S.EPIDERMIDIS IN BLOOD CULTURES,Bacterial infection,GRAM-POSITIVE BACTERIAL INFECTION,BACTERIAL INFECTION,BACTERIAL INFECTIOUS DISORDERS,BACTERIAL INFECTIONS NEC,10021881,10053021,10060945,10053021
HISTOPLASMA CAPSULATUM INFECTION,Histoplasmosis,INFECTION BY HISTOPLASMA CAPSULATUM,HISTOPLASMOSIS,FUNGAL INFECTIOUS DISORDERS,HISTOPLASMA INFECTIONS,10021881,10021808,10020141,10021808
DELAYED CUTANEOUS HYPERSENSITIVITY REACTION,Type IV hypersensitivity reaction,DELAYED TYPE HYPERSENSITIVITY,TYPE IV HYPERSENSITIVITY REACTION,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10012210,10053613,10012210
URINARY TRACT INFECTION,Urinary tract infection,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10046571,10046571,10046571
BULLOUS PEMPHIGOID-LIKE SKIN ERUPTION,Pemphigoid,BULLOUS PEMPHIGOID,PEMPHIGOID,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10006567,10034277,10006567
TACHYCARDIA,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
METAMIZOLE-INDUCED AGRANULOCYTOSIS,agranulocytosis,AGRANULOCYTOSIS,AGRANULOCYTOSIS,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10001507,10001507,10001507
"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",Exposure during pregnancy,"DRUG EXPOSURE DURING PREGNANCY, THIRD TRIMESTER",EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10076615,10073513,10076615
TACHYPNEIC,tachypnea,TACHYPNEA,TACHYPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10043088,10043089,10043088
DARK URINE,Chromaturia,URINE DISCOLORATION,CHROMATURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10046629,10008796,10046628
"TREATMENT USING ITRACONAZOLE, VORICONAZOLE, AND AMPHOTERICIN B WAS NOT SUCCESSFUL (LACK OF DRUG EFFECT)",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
RECURRENT HYPOGLYCEMIA/VERY LOW BLOOD GLICOSE LEVEL,hypoglycemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10021005,10020993,10021005
HEMATOLOGICAL TOXICITY,Haematotoxicity,HEMATOTOXICITY,HAEMATOTOXICITY,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10061188,10061188,10061196
HEMOPHAGOCYTIC SYNDROME FOLLOWING ADULT ONSET STILL'S DISEASE,Histiocytosis haematophagic,HEMOPHAGOCYTIC SYNDROME,HISTIOCYTOSIS HAEMATOPHAGIC,HAEMATOLOGICAL DISORDERS NEC,HAEMATOLOGICAL DISORDERS,10005329,10058125,10048595,10058139
WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
PNEUMOCYSTIS JIROVECII INFECTION,Pneumocystis jirovecii infection,PNEUMOCYSTIS JIROVECII INFECTION,PNEUMOCYSTIS JIROVECII INFECTION,FUNGAL INFECTIOUS DISORDERS,PNEUMOCYSTIS INFECTIONS,10021881,10073756,10073756,10073756
"DURING PREGNANCY, PATIENT RECEIVED CLINDAMYCIN, METRONIDAZOLE, RIFAMPICIN, DICLOXACILLIN AND GENTAMYCIN FOR N. BRASILIENSIS ACTINOMYCETOMA (DRUG EXPOSURE DURING PREGNANCY WITH NO ADR)",Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
LEUKOPENIA,leukopenia,LEUKOPENIA,LEUKOPENIA,WHITE BLOOD CELL DISORDERS,LEUKOPENIAS NEC,10005329,10024384,10024384,10024384
A 26 YEAR OLD G3P2 PREGNANT,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ISONIAZID-INDUCED HEPATOTOXICITY AUGMENTED BY RIFAMPICIN,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
LEUKOCYTOSIS (WBC OF 23.9 K/CU MM),leukocytosis,LEUKOCYTOSIS,LEUKOCYTOSIS,WHITE BLOOD CELL DISORDERS,LEUKOCYTOSES NEC,10005329,10024378,10024378,10024378
WORSENING OF TUBERCULOUS MENINGITIS FOLLOWING MULTI-DRUG RESISTANCE,Meningitis tuberculous,TUBERCULOUS MENINGITIS,MENINGITIS TUBERCULOUS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10027259,10027259,10045080
GENERALIZED EDEMA,Generalised oedema,GENERALIZED EDEMA,GENERALISED OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10018092,10018092,10018112
HYPOCORTISOLISM,Glucocorticoid deficiency,HYPOCORTISOLEMIA,GLUCOCORTICOID DEFICIENCY,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10075913,10072079,10075908
BRIGHT RED BLOOD PER RECTUM,rectal bleeding,RECTAL BLEEDING,RECTAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,INTESTINAL HAEMORRHAGES,10017947,10038035,10038063,10038035
MARKEDLY INCREASED BREAST CALCIFICATIONS,Breast calcifications,BREAST CALCIFICATIONS,BREAST CALCIFICATIONS,BREAST DISORDERS,BREAST DISORDERS NEC,10038604,10048782,10048782,10048782
ESOPHAGEAL MUCOSAL CALCINOSIS,Gastric mucosal calcinosis,GASTRIC MUCOSAL CALCINOSIS,GASTRIC MUCOSAL CALCINOSIS,GASTROINTESTINAL CONDITIONS NEC,GASTROINTESTINAL MUCOSAL DYSTROPHIES AND SECRETION DISORDERS,10017947,10079890,10079890,10079890
MUCOSAL HEMORRHAGES,Mucosal haemorrhage,MUCOSAL HAEMORRHAGE,MUCOSAL HAEMORRHAGE,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10061298,10061298,10061298
PALE,pale,PALE,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033532,10033546,10033532
DYSPEPSIA,dyspepsia,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL SIGNS AND SYMPTOMS,DYSPEPTIC SIGNS AND SYMPTOMS,10017947,10013946,10013946,10013946
TONGUE BIT,tongue bit,TONGUE BITING,TONGUE BITING,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10050467,10050467,10050467
LACK OF EFFICACY WITHOUT AE,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
FELL WHILE SHOWERING,fall,FALL,FALL,INJURIES NEC,NON-SITE SPECIFIC INJURIES NEC,10022117,10016173,10016173,10016173
DISORIENTED,disoriented,DISORIENTATED,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013394,10013395,10013394
DELIRIOUS,Delirium,DELIRIOUS,DELIRIUM,DELIRIA (INCL CONFUSION),DELIRIA,10037175,10012218,10012218,10012217
AUTOIMMUNE HEMOLYTIC ANEMIA,autoimmune hemolytic anemia,AUTOIMMUNE HEMOLYTIC ANEMIA,AUTOIMMUNE HAEMOLYTIC ANAEMIA,HAEMOLYSES AND RELATED CONDITIONS,ANAEMIAS HAEMOLYTIC IMMUNE,10005329,10003825,10073785,10003825
BK VIRUS NEPHROPATHY,Polyomavirus-associated nephropathy,BK VIRUS NEPHROPATHY,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,VIRAL INFECTIOUS DISORDERS,POLYOMAVIRUS INFECTIONS,10021881,10065333,10065381,10065333
VERTIGO,vertigo,VERTIGO,VERTIGO,INNER EAR AND VIIITH CRANIAL NERVE DISORDERS,INNER EAR SIGNS AND SYMPTOMS,10013993,10047340,10047340,10047340
GENERAL CONVULSIONS,general convulsions,CONVULSION,SEIZURE,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10010904,10039906,10010904
CERVICAL LYMPHADENOPATHY,cervical lymphadenopathy,LYMPHADENOPATHY CERVICAL,LYMPHADENOPATHY,"SPLEEN, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEM DISORDERS",LYMPHATIC SYSTEM DISORDERS NEC,10005329,10025200,10025197,10025200
"BLISTER WITH ITCHING APPEARED MAINLY ON THE FOREARM, FOLLOWED BY DISSEMINATION ON THE EXTREMITIES AND TRUNK",Blister,BLISTER,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10005191,10005191,10005191
DEHYDRATION,Dehydration,DEHYDRATION,DEHYDRATION,ELECTROLYTE AND FLUID BALANCE CONDITIONS,TOTAL FLUID VOLUME DECREASED,10027433,10012174,10012174,10012174
VESICLES HAD AN ASSOCIATED OVERLYING CRUST WITH HEMORRHAGE,skin hemorrhage,SKIN HEMORRHAGE,SKIN HAEMORRHAGE,SKIN VASCULAR ABNORMALITIES,SKIN HAEMORRHAGES,10040785,10064266,10064265,10064266
HIGH ALDOLASE LEVEL,Aldolase increased,ALDOLASE INCREASED,ALDOLASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10001642,10001642,10001642
NAUSEA,nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
KOEBNER'S PHENOMENON,Koebner phenomenon,KOEBNER PHENOMENON,KOEBNER PHENOMENON,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10048649,10048649,10048649
FEBRILE SEIZURE,Febrile convulsion,FEBRILE CONVULSION,FEBRILE CONVULSION,SEIZURES (INCL SUBTYPES),SEIZURES AND SEIZURE DISORDERS NEC,10029205,10016284,10016284,10016284
NEONATAL NARCOSIS POST-DELIVERY FROM A MOTHER WHO HAD AN INTRATHECAL PUMP PLACED PRE-GESTATION,Foetal exposure during pregnancy,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PATIENT TREATED WITH METHOTREXATE FOR CESAREAN SCAR ECTOPIC PREGNANCY(OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
NEUTROPENIA (4TH EPISODE),Neutropenia,NEUTROPENIA,NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10029354,10029354,10029354
DIFFICULTIES WITH SOCIAL INTERACTIONS,Social problem,SOCIAL PROBLEM NOS,SOCIAL PROBLEM,LIFESTYLE ISSUES,SOCIAL ISSUES NEC,10041244,10041252,10062254,10041252
THROAT ITCHING,Throat irritation,ITCHY THROAT,THROAT IRRITATION,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10053560,10043521,10053560
DIAPHORESIS,diaphoresis,DIAPHORESIS,HYPERHIDROSIS,SKIN APPENDAGE CONDITIONS,APOCRINE AND ECCRINE GLAND DISORDERS,10040785,10012703,10020642,10012703
ATRIOVENTRICULAR (AV) BLOCK,Atrioventricular block,ATRIOVENTRICULAR BLOCK,ATRIOVENTRICULAR BLOCK,CARDIAC ARRHYTHMIAS,CARDIAC CONDUCTION DISORDERS,10007541,10003671,10003671,10003671
NEPHROTOXICITY,nephrotoxicity,NEPHROTOXICITY,NEPHROPATHY TOXIC,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10067571,10029155,10067571
VOMITING,vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
"PYURIA WITHOUT ANY NITRATE, BACTERIA OR CASTS",Pyuria,PYURIA,PYURIA,INFECTIONS - PATHOGEN UNSPECIFIED,INFECTIONS NEC,10021881,10037686,10037686,10037686
OFF LABEL USE,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
EMACIATION,emaciation,EMACIATION,CACHEXIA,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10014494,10006895,10014494
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ACUTE GENERALISED EXANTHEMATOUS,Acute generalised exanthematous pustulosis,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,EPIDERMAL AND DERMAL CONDITIONS,PUSTULAR CONDITIONS,10040785,10048799,10048799,10048799
RESPIRATORY DEPRESSION,Respiratory depression,RESPIRATORY DEPRESSION,RESPIRATORY DEPRESSION,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10038678,10038678,10038678
INR OF 4.9,INR increased,INR INCREASED,INTERNATIONAL NORMALISED RATIO INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),COAGULATION AND BLEEDING ANALYSES,10022891,10022402,10022595,10022402
IMMUNE RELATED DRUG INDUCED THROMBOCYTOPENIA SECONDARY TO PIPERACILLIN-TAZOBACTAM.,thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
NAUSEA,Nausea,NAUSEA,NAUSEA,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10028813,10028813,10028813
TORSADES DE POINTES FOLLOWING LOPERAMIDE ABUSE,Torsade de pointes,TORSADES DE POINTES,TORSADE DE POINTES,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10044066,10044066,10044067
PROFOUND HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
USE OF MYCOPHENOLATE MOFETIL FOR SYSTEMIC LUPUS ERYTHEMATOSUS (OFF LABEL USE WITH NO ADVERSE EVENT),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CHRONIC DIARRHEA,chronic diarrhea,CHRONIC DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10066556,10012735,10066556
ACUTE MUCOSITIS,mucositis,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
INCREASED APPETITE,Increased appetite,INCREASED APPETITE,INCREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10021654,10021654,10021654
DYSPNEA,Dyspnoea,DYSPNEA,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10013968,10013968,10013963
DECOMPRESSION SICKNESS/DECOMPRESSION ILLNESS,Decompression sickness,DECOMPRESSION SICKNESS,DECOMPRESSION SICKNESS,INJURIES BY PHYSICAL AGENTS,ATMOSPHERIC PRESSURE INJURIES,10022117,10011951,10011951,10011951
CARDIAC ARREST FOLLOWING DRUG OVERDOSE,cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
AGONAL BREATHING,agonal breathing,GASPING,DYSPNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10017745,10013968,10017745
HYDROXYCHLOROQUINE TOXICITY-INDUCED CARDIOMYOPATHY,Cardiomyopathy,CARDIOMYOPATHY,CARDIOMYOPATHY,MYOCARDIAL DISORDERS,CARDIOMYOPATHIES,10007541,10007636,10007636,10007636
CHILLS,chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
POSTPRANDIAL GLYCAEMIA OF 67-350 MG/DL VALUES WERE HIGHER AFTER SUPPER,Postprandial hyperglycaemia,POSTPRANDIAL HYPERGLYCAEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10075824,10020635,10075824
RETROBULBAR NEURITIS,retrobulbar neuritis,RETROBULBAR NEURITIS,OPTIC NEURITIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OPTIC NERVE DISORDERS NEC,10029205,10038962,10030942,10038962
URTICARIA,Urticaria,GENERALISED URTICARIAL RASH,URTICARIA,ANGIOEDEMA AND URTICARIA,URTICARIAS,10040785,10018103,10046735,10018103
SEPSIS,Sepsis,SEPSIS,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040047
TROUBLE IN MOVING THE BODY,Mobility decreased,MOBILITY DECREASED,MOBILITY DECREASED,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,MUSCULOSKELETAL AND CONNECTIVE TISSUE CONDITIONS NEC,10028395,10048334,10048334,10048334
RECTAL HEMORRHAGE,Rectal haemorrhage,RECTAL HEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,INTESTINAL HAEMORRHAGES,10017947,10038063,10038063,10038064
PUPILS WERE MIDSIZED AND SLOW TO REACT,Pupillary reflex impaired,PUPILLARY REACTION SLOW,PUPILLARY REFLEX IMPAIRED,OCULAR NEUROMUSCULAR DISORDERS,PUPIL DISORDERS,10015919,10037530,10037532,10037530
INVASIVE PULMONARY ASPERGILLOSIS,Bronchopulmonary aspergillosis,PULMONARY ASPERGILLOSIS,BRONCHOPULMONARY ASPERGILLOSIS,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10059259,10006473,10059259
BRADYCARDIA,BRADYCARDIA,BRADYCARDIA,BRADYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10006093,10006093,10006093
CARDIAC ARREST,cardiac arrest,CARDIAC ARREST,CARDIAC ARREST,CARDIAC ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST,10007541,10007515,10007515,10007515
HAND SWELLING,Peripheral swelling,HAND SWELLING,PERIPHERAL SWELLING,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10019121,10048959,10019121
WORSENING OF METABOLIC PARAMETERS/METABOLISM VALUES GRADUALLY WORSENED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
ALT INCREASED (1093 U/L),Alanine aminotransferase increased,ALT INCREASED,ALANINE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10001845,10001551,10001845
CUTANEOUS NOCARDIOSIS,Nocardiosis,NOCARDIOSIS,NOCARDIOSIS,BACTERIAL INFECTIOUS DISORDERS,NOCARDIA INFECTIONS,10021881,10029444,10029444,10029444
ANXIETY,Anxiety,ANXIETY,ANXIETY,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10002855,10002855,10002855
ACUTE INTERSTITIAL NEPHRITIS,Tubulointerstitial nephritis,ACUTE INTERSTITIAL NEPHRITIS,TUBULOINTERSTITIAL NEPHRITIS,NEPHROPATHIES,NEPHRITIS NEC,10038359,10029135,10048302,10000819
BILATERAL MULTIPLE INSUFFICIENCY FEMORAL FRACTURES,Atypical femur fracture bilateral,ATYPICAL FEMUR FRACTURE BILATERAL,ATYPICAL FEMUR FRACTURE,BONE AND JOINT INJURIES,LIMB FRACTURES AND DISLOCATIONS,10022117,10072259,10070884,10072259
BLEEDING FROM POSTERIOR TWO LESIONS,bleeding,BLEEDING,HAEMORRHAGE,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10005103,10055798,10005103
METABOLIC ACIDOSIS WITH NORMAL ANION GAP,Metabolic acidosis,METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10027417,10027417,10027417
INCREASED LEVEL OF TACROLIMUS CO (MAX),,,,,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,10044260,10013722,10013722,
PERIAXILLARY LESION,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
TROUSSEAU'S SIGN,Trousseau's sign,TROUSSEAU'S SIGN,TROUSSEAU'S SIGN,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",CALCIUM METABOLISM DISORDERS,10027433,10071284,10071284,10071284
RASH,rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
MILD ADVERSE REACTION RELATED TO THE CENTRAL NERVOUS SYSTEM,Nervous system disorder,CENTRAL NERVOUS SYSTEM DISORDER,NERVOUS SYSTEM DISORDER,NEUROLOGICAL DISORDERS NEC,NERVOUS SYSTEM DISORDERS NEC,10029205,10007943,10029202,10007943
APNOEA,apnoea,APNOEA,APNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10002974,10002974,10002974
PALE SKIN,Pallor,PALE SKIN,PALLOR,VASCULAR DISORDERS NEC,SITE SPECIFIC VASCULAR DISORDERS NEC,10047065,10033550,10033546,10033533
CYSTITIS,Cystitis,CYSTITIS,CYSTITIS,INFECTIONS - PATHOGEN UNSPECIFIED,URINARY TRACT INFECTIONS,10021881,10011781,10011781,10011781
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
CENTRAL CYANOSIS,Cyanosis,CYANOSIS,CYANOSIS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10011703,10011703,10011703
REDUCED NYHA STATUS,Pulmonary hypertension,PULMONARY HYPERTENSION,PULMONARY HYPERTENSION,PULMONARY VASCULAR DISORDERS,PULMONARY HYPERTENSIONS,10038738,10037400,10037400,10037400
FATAL RETROPERITONEAL HEMATOMA,Retroperitoneal haematoma,RETROPERITONEAL HEMATOMA,RETROPERITONEAL HAEMATOMA,PERITONEAL AND RETROPERITONEAL CONDITIONS,PERITONEAL AND RETROPERITONEAL HAEMORRHAGES,10017947,10058360,10058360,10058361
CSF AND SERUM METHOTREXATE LEVELS WERE 50-100 FOLD HIGHER,drug level increased,DRUG LEVEL INCREASED,DRUG LEVEL INCREASED,TOXICOLOGY AND THERAPEUTIC DRUG MONITORING,THERAPEUTIC DRUG MONITORING ANALYSES,10022891,10013722,10013722,10013722
VESICLES,vesicles,VESICLES,BLISTER,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10047368,10005191,10047368
UNSTATISFACTORY CONTROLED HYPERTENSION,hypertension,HYPERTENSION,HYPERTENSION,VASCULAR HYPERTENSIVE DISORDERS,VASCULAR HYPERTENSIVE DISORDERS NEC,10047065,10020772,10020772,10020772
ACUTE RENAL DAMAGE ON CHRONIC KIDNEY DISEASE,Acute on chronic renal failure,ACUTE ON CHRONIC RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10000952,10069339,10000952
FEBRILE ILLNESS WITHOUT IDENTIFIED SOURCE,Fever of unknown origin,FEVER OF UNKNOWN ORIGIN,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10016563,10037660,10016563
ANTICHOLINERGIC POISONING CAUSED BY THE SUBSTITUTION OF HYOSCINE HYDROBROMIDE FOR HYOSCINE BUTYLBROMIDE,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
RESPIRATORY PROBLEMS,Respiratory disorder,RESPIRATORY DISORDER,RESPIRATORY DISORDER,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10038683,10038683,10038683
SUBTLE CONFUSION,subtle confusion,CONFUSION,CONFUSIONAL STATE,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10010300,10010305,10010300
POGRESSION/RELAPSE OF METASTATIC GASTROINTESTINAL STROMAL TUMOURS (LIVER METASTASES) FOLLWOING LACK OF DRUG EFFECT,Gastrointestinal stromal tumour,GASTROINTESTINAL STROMAL TUMOR,GASTROINTESTINAL STROMAL TUMOUR,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,GASTROINTESTINAL NEOPLASMS MALIGNANCY UNSPECIFIED NEC,10029104,10051066,10051066,10062427
HEPATIC TOXICITY AFTER METHOTREXATE INFUSION,Hepatotoxicity,HEPATOTOXICITY,HEPATOTOXICITY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10019851,10019851,10019851
HAEMATOMA,Haematoma,HAEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10018852,10018852,10018852
AMNESIA DUE TO DRUG INTERACTION,amnesia,AMNESIA,AMNESIA,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10001949,10001949,10001949
CANDIDEMIA,candidemia,CANDIDEMIA,SYSTEMIC CANDIDA,FUNGAL INFECTIOUS DISORDERS,CANDIDA INFECTIONS,10021881,10060573,10042938,10060573
CLOSTRIDIUM DIFFICILE COLITIS,Clostridium difficile colitis,CLOSTRIDIUM DIFFICILE COLITIS,CLOSTRIDIUM DIFFICILE COLITIS,BACTERIAL INFECTIOUS DISORDERS,CLOSTRIDIA INFECTIONS,10021881,10009657,10009657,10009657
"GRADE 3 SOMNOLENCE, CONFUSION, AND DIZZINESS",Somnolence,SLEEPINESS,SOMNOLENCE,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10041014,10041349,10041014
ESCHERICHIA COLI INFECTION,Escherichia coli infection,ESCHERICHIA COLI INFECTION,ESCHERICHIA INFECTION,BACTERIAL INFECTIOUS DISORDERS,ESCHERICHIA INFECTIONS,10021881,10054242,10061126,10054242
FEVER (38.3 DEGREE CELSIUS),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
BLOODY STOOL,Haematochezia,BLOODY STOOL,HAEMATOCHEZIA,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10005873,10018836,10005873
TRANSIENT HYPOTHYROIDISM  FOLLOWING DRUG EXPOSURE IN UTERO,hypothyroidism,HYPOTHYROIDISM,HYPOTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPOFUNCTION DISORDERS,10014698,10021114,10021114,10021114
HYPOMAGNESEMIA,Hypomagnesaemia,HYPOMAGNESEMIA,HYPOMAGNESAEMIA,"BONE, CALCIUM, MAGNESIUM AND PHOSPHORUS METABOLISM DISORDERS",MAGNESIUM METABOLISM DISORDERS,10027433,10021027,10021027,10021028
PULMONARY MYCOBACTERIOSIS DUE TO M. SIMIAE AND M. INTRACELLULARE FOLLOWING OFF LABEL USE OF METHOTREXATE,Lung infection,LUNG INFECTION,LUNG INFECTION,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10061229,10061229,10061229
HYPERKALEMIA/DRUG-INDUCED HYPERKALIAEMIA,Hyperkalaemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020646,10020646,10020647
WIDESPREAD SKIN LESIONS,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
ESCALATED THE DOSE TO PROLONG THE THERAPEUTIC AND PSYCHOACTIVE EFFECTS LIKE EUPHORIA AND INCREASED ENERGY,Intentional product misuse,INTENTIONAL MISUSE,INTENTIONAL PRODUCT MISUSE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,INTENTIONAL PRODUCT MISUSES,10022117,10058995,10074903,10058995
ASPIRIN USE IN PREGNANCY,Exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
MATERNAL EXPOSURE DURING PREGNANCY,Maternal exposure during pregnancy,MATERNAL EXPOSURE DURING PREGNANCY,MATERNAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10071408,10071408,10071408
DRUG-INDUCED HEPATOTOXICITY,Drug-induced liver injury,DRUG-INDUCED HEPATOTOXICITY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072937,10072268,10072937
"ALT, AST, AND LDH INCREASED THREE TIMES, AND GGT INCREASED APPROXIMATELY 35 TIMES",Hepatic enzyme increased,ELEVATED LIVER ENZYMES,HEPATIC ENZYME INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10014481,10060795,10014481
MULTIPLE HAEMORRHAGIC RED NODULES DEVELOPED IN THE HEAD AND THE TRUNK,Haemangioma,HAEMANGIOMA,HAEMANGIOMA,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS BENIGN,CARDIOVASCULAR NEOPLASMS BENIGN,10029104,10018814,10018814,10018814
MUSCLE PAIN,Muscle pain,MUSCLE PAIN,MYALGIA,MUSCLE DISORDERS,MUSCLE PAINS,10028395,10028322,10028411,10028322
CYTOMEGALOVIRUS INFECTION REACTIVATION,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION REACTIVATION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10058666,10011831,10058666
KEPT FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
DECREASED THYROID FUNCTION,Hypothyroidism,THYROID FUNCTION DECREASED,HYPOTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPOFUNCTION DISORDERS,10014698,10043727,10021114,10043727
NAIL LOSS OF MOST OF NAILS,Nail loss,NAIL LOSS,ONYCHOMADESIS,SKIN APPENDAGE CONDITIONS,NAIL AND NAIL BED CONDITIONS (EXCL INFECTIONS AND INFESTATIONS),10040785,10049281,10049274,10049281
LACK OF DRUG EFFECT,Lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
IMATINIB-INDUCED PSEUDOPORPHYRIA,Pseudoporphyria,PSEUDOPORPHYRIA,PSEUDOPORPHYRIA,EPIDERMAL AND DERMAL CONDITIONS,BULLOUS CONDITIONS,10040785,10037145,10037145,10037145
POOR ADHERENCE,Product use issue,PRODUCT USE ISSUE,PRODUCT USE ISSUE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10076309,10076309,10076309
AST INCREASED (131 UI),Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
HYPOGONADISM OF OPIOID-IATROGENIC ORIGIN,Hypogonadism,HYPOGONADISM,HYPOGONADISM,ENDOCRINE DISORDERS OF GONADAL FUNCTION,ENDOCRINE ABNORMALITIES OF GONADAL FUNCTION NEC,10014698,10058359,10058359,10058359
WEAKNESS OF BILATERAL LOWER EXTREMITIES WORSENED,Muscular weakness,LOWER EXTREMITIES WEAKNESS OF,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10024947,10028372,10024947
DRUG-INDUCED CHOLESTASIS,Cholestasis,CHOLESTASIS,CHOLESTASIS,HEPATIC AND HEPATOBILIARY DISORDERS,CHOLESTASIS AND JAUNDICE,10019805,10008635,10008635,10008635
DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
"HE WAS DIAGNOSED WITH AN INTOXICATION WITH 850 MG BACLOFEN, 2,5 LITER'S BEER AND UNKNOWN AMOUNT OF HEROINE",toxicity to various agents,DRUG INTOXICATION,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10013714
MEDIUM VESSEL VASCULITIS,medium vessel vasculitis,VASCULITIS,VASCULITIS,VASCULAR INFLAMMATIONS,VASCULITIDES NEC,10047065,10047115,10047115,10047115
"NO EFFECT ON HYPERSEXUALITY, FREQUENCY OF FANTASIES AND MASTURBATION",Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
METHOTREXATE TOXICITY,Drug Toxicity,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
VERBAL AGGRESSION,Aggression,VERBAL AGGRESSION,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10079297,10001488,10079297
CLINICAL CONDITION DETERIORATED,clinical condition deteriorated,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL PHYSICAL HEALTH DETERIORATION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10049438,10049438,10049438
PROMINENT BLANK STARE,Staring,STARING,STARING,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10041953,10041953,10041953
ACUTE RENAL FAILURE DUE TO SEPTIC SHOCK FOLLOWING CAPNOCYTOPHAGA CANIMORSUS SEPSIS,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
FEBRILE MACULAR PURPURIC EXANTHEMA WITH RANGES OF SKIN DETACHMENTS,Purpuric rash,PURPURIC RASH,PURPURA,SKIN VASCULAR ABNORMALITIES,PURPURA AND RELATED CONDITIONS,10040785,10037566,10037549,10037566
"NEUROLOGIC SIGNS INCLUDING LIMBS RIGIDITY, PAIN, INCOORDINATION AND FLEXED FINGERS",Finger spasticity,FINGER SPASTICITY,MUSCLE SPASTICITY,NEUROMUSCULAR DISORDERS,NEUROMUSCULAR DISORDERS NEC,10029205,10016688,10028335,10016688
SEVERE KETOACIDOSIS,Ketoacidosis,KETOACIDOSIS,KETOACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10023379,10023379,10023379
GRADE 3 THROMBOCYTOPENIA,Thrombocytopenia,THROMBOCYTOPENIA,THROMBOCYTOPENIA,PLATELET DISORDERS,THROMBOCYTOPENIAS,10005329,10043554,10043554,10043554
CONDITION WORSENED,Condition worsened ,CONDITION WORSENED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10076326,10010264,10076326
GRAFT LOSS DUE TO CHRONIC ALLOGRAFT DYSFUNCTION,Renal transplant failure,RENAL GRAFT LOSS,RENAL TRANSPLANT FAILURE,IMMUNE DISORDERS NEC,TRANSPLANT REJECTIONS,10021428,10048749,10074495,10048749
GENERALISED OEDEMA,generalized oedema,GENERALISED OEDEMA,GENERALISED OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10018092,10018092,10018092
DRUG EXPOSURE DURING PREGNANCY,DRUG EXPOSURE DURING PREGNANCY,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
CERVICAL MASS,Neck mass,NECK MASS,NECK MASS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS NEC,SOFT TISSUE DISORDERS NEC,10028395,10049146,10049146,10049146
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
RIFAMPICIN RESISTANT TUBERCULOSIS,drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
MILD TREMOR AND DRY MOUTH/SHAKING MILDLY AND HER MOUTH WENT DR/UPPER EXTREMITY TREMOR,Tremor,TREMOR,TREMOR,MOVEMENT DISORDERS (INCL PARKINSONISM),TREMOR (EXCL CONGENITAL),10029205,10044565,10044565,10044565
HYPOXEMIA,Hypoxia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021141,10021143,10021142
G2 MUCOSITIS,Mucosal inflammation,MUCOSITIS,MUCOSAL INFLAMMATION,GENERAL SYSTEM DISORDERS NEC,MUCOSAL FINDINGS ABNORMAL,10018065,10028127,10028116,10028127
GAIT ATAXIA,Ataxia,ATAXIA,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003591,10003591,10003591
SIGNIFICANT WEIGHT GAIN,weight gain,WEIGHT GAIN,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047896,10047899,10047896
DRUG-INDUCED PULMONARY DISORDER CAUSED BY AMIODARONE,Lung disorder,LUNG DISORDER,LUNG DISORDER,RESPIRATORY DISORDERS NEC,RESPIRATORY TRACT DISORDERS NEC,10038738,10025082,10025082,10025082
PULMONARY EDEMA,Pulmonary oedema,PULMONARY EDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037423,10037423,10037375
APNOEA,apnoea,APNOEA,APNOEA,RESPIRATORY DISORDERS NEC,BREATHING ABNORMALITIES,10038738,10002974,10002974,10002974
PATIENT TREATED WITH MYCOPHENOLATE MOFETIL AND IMATINIB FOR GVHD (OFF LABEL USE) WITH NO ADR,Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
HEPATIC TOXICITY,Drug-induced liver injury,DRUG-INDUCED HEPATOTOXICITY,DRUG-INDUCED LIVER INJURY,HEPATIC AND HEPATOBILIARY DISORDERS,HEPATOCELLULAR DAMAGE AND HEPATITIS NEC,10019805,10072937,10072268,10072937
AST INCREASED (230 IU/L) FOLLOWING DRUG INTERACTION,Aspartate aminotransferase increased,AST INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003544,10003481,10003544
"RENAL ULTRASOUND SHOWED MILDLY ENLARGED KIDNEYS (RIGHT 12.3 CM, LEFT 12.9 CM)",Kidney enlargement,KIDNEY ENLARGEMENT,KIDNEY ENLARGEMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL STRUCTURAL ABNORMALITIES AND TRAUMA,10038359,10048469,10048469,10048469
RENAL PHOSPHOLIPIDOSIS,Phospholipidosis,PHOSPHOLIPIDOSIS,PHOSPHOLIPIDOSIS,LIPID METABOLISM DISORDERS,LIPID METABOLISM AND DEPOSIT DISORDERS NEC,10027433,10074564,10074564,10074564
HER MUSCLE POWER OF FOUR LIMBS WAS 0,Muscular weakness,MUSCLE WEAKNESS,MUSCULAR WEAKNESS,MUSCLE DISORDERS,MUSCLE WEAKNESS CONDITIONS,10028395,10028372,10028372,10028350
ABDOMINAL PAIN,Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
PROGRESSIVE DISEASE DUE TO LACK OF EFFICACY,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
HERPES ZOSTER INFECTION,Herpes zoster,HERPES ZOSTER,HERPES ZOSTER,VIRAL INFECTIOUS DISORDERS,HERPES VIRAL INFECTIONS,10021881,10019974,10019974,10019974
HYPOTONIA,Hypotonia,HYPOTONIA,HYPOTONIA,NEUROMUSCULAR DISORDERS,MUSCLE TONE ABNORMAL,10029205,10021118,10021118,10021118
"DIPSTICK URINE ANALYSIS SHOWED PROTEINURIA OF 3+, 24 HOURS PROTEINURIA WAS 3.5 G",Proteinuria,PROTEINURIA,PROTEINURIA,URINARY TRACT SIGNS AND SYMPTOMS,URINARY ABNORMALITIES,10038359,10037032,10037032,10037032
PATIENT TREATED WITH CISPLATIN FOR HILAR CHOLANGIOCARCINOMA (OFF LABEL USE WITH NO ADR),off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
ANAEMIA,Anaemia,ANAEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002034
BECAME MORE RELUCTANT TO ATTEND SCHOOL,School refusal,SCHOOL REFUSAL,SCHOOL REFUSAL,PSYCHIATRIC DISORDERS NEC,"INFANCY, CHILDHOOD AND ADOLESCENCE PSYCHIATRIC DISORDERS NEC",10037175,10039660,10039660,10039660
LACK OF DRUG EFFECT,Drug ineffective,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10013709,10013709,10023610
HYPERGLYCEMIA (RISE IN FASTING BLOOD LEVELS FROM 200 TO 300 MG/DL) DUE TO POOR COMPLIANCE,Hyperglycaemia,FASTING HYPERGLYCEMIA,HYPERGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPERGLYCAEMIC CONDITIONS NEC,10027433,10068939,10020635,10068938
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
PULMONARY EMBOLISM FOLLOWING TREATMENT WITH R-GDP REGIMEN,Pulmonary embolism,PULMONARY EMBOLISM,PULMONARY EMBOLISM,PULMONARY VASCULAR DISORDERS,PULMONARY THROMBOTIC AND EMBOLIC CONDITIONS,10038738,10037377,10037377,10037377
AGGRESSION,aggression,AGGRESSION,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10001488,10001488,10001488
ACETAMINOPHEN CAN CAUSE HIGH ANION GAP METABOLIC ACIDOSIS/ELEVATED ANION GAP METABOLIC ACIDOSIS,Metabolic acidosis,HIGH ANION GAP METABOLIC ACIDOSIS,METABOLIC ACIDOSIS,ACID-BASE DISORDERS,METABOLIC ACIDOSES (EXCL DIABETIC ACIDOSES),10027433,10069033,10027417,10069033
UUSUAL AMNESTIC SYNDROME ASSOCIATED WITH COMBINED FENTANYL AND COCAINE OVERDOSE,anestic syndrome,AMNESTIC SYNDROME,AMNESTIC DISORDER,MENTAL IMPAIRMENT DISORDERS,MEMORY LOSS (EXCL DEMENTIA),10029205,10001957,10061423,10001957
PERSISTENT AND INTENSIFIED PAIN,Pain,PAIN WORSENED,PAIN,GENERAL SYSTEM DISORDERS NEC,PAIN AND DISCOMFORT NEC,10018065,10033396,10033371,10033499
BLOOD PRESSURE DECREASED (92/41 MMHG),Blood pressure decreased,BLOOD PRESSURE DECREASED,BLOOD PRESSURE DECREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),VASCULAR TESTS NEC (INCL BLOOD PRESSURE),10022891,10005734,10005734,10005734
CHRONIC DIARRHOEA,Diarrhoea,CHRONIC DIARRHOEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10066557,10012735,10066557
POORLY CONTROLLED HYPERTENSION,blood pressure inadequately controlled,BLOOD PRESSURE INADEQUATELY CONTROLLED,BLOOD PRESSURE INADEQUATELY CONTROLLED,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,BLOOD PRESSURE DISORDERS NEC,10047065,10051128,10051128,10051128
"WBC INCREASED (11,800/MILIMETER CUBE)",White blood cell count increased,WBC INCREASED,WHITE BLOOD CELL COUNT INCREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10056739,10047943,10056739
SECONDARY MALIGNANCY (OROPHARYNGEAL),Second primary malignancy,SECOND PRIMARY MALIGNANCY,SECOND PRIMARY MALIGNANCY,MISCELLANEOUS AND SITE UNSPECIFIED NEOPLASMS MALIGNANT AND UNSPECIFIED,NEOPLASMS MALIGNANT SITE UNSPECIFIED NEC,10029104,10039801,10039801,10039801
"SEATED WITH ELBOWS FLEXED, FISTS CLENCHED, AND NECK FLEXED AND STIFF",Elbow deformity,ELBOW DEFORMITY,ELBOW DEFORMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DEFORMITIES (INCL INTERVERTEBRAL DISC DISORDERS),EXTREMITY DEFORMITIES,10028395,10061833,10061833,10061833
INTRAPULMONARY HAEMORRHAGE,Pulmonary haemorrhage,PULMONARY HAEMORRHAGE,PULMONARY HAEMORRHAGE,RESPIRATORY TRACT SIGNS AND SYMPTOMS,LOWER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10037394,10037394,10037394
HEMIPARESIS,Hemiparesis,HEMIPARESIS,HEMIPARESIS,MOVEMENT DISORDERS (INCL PARKINSONISM),PARALYSIS AND PARESIS (EXCL CRANIAL NERVE),10029205,10019465,10019465,10019465
OFF LABEL USE (FOR ULCERATIVE COLITIS),Off label use,OFF LABEL USE,OFF LABEL USE,OFF LABEL USES AND INTENTIONAL PRODUCT MISUSES/USE ISSUES,OFF LABEL USES,10022117,10053762,10053762,10053762
CHILLS,Chills,CHILLS,CHILLS,GENERAL SYSTEM DISORDERS NEC,FEELINGS AND SENSATIONS NEC,10018065,10008531,10008531,10008531
"I HAVE HAD 2 EPISODES OF WHERE ALL I CAN DESCRIBE IS THAT A LARGE WAVE WAHES OVER ME, I FEEL NAUSEOUS, I AM VIOLENTLY, SICK, I LOOSE MY ABILITY TO SPEACH, BECOME DISORIENTATED, I CANNOT STAND UNAIDES.",Disorientated,DISORIENTATED,DISORIENTATION,DELIRIA (INCL CONFUSION),CONFUSION AND DISORIENTATION,10037175,10013394,10013395,10013394
NEUTROPENIC FEVER (TEMPERATURE: 37.9 DEGREE CELSIUS),Febrile neutropenia,NEUTROPENIC FEVER,FEBRILE NEUTROPENIA,WHITE BLOOD CELL DISORDERS,NEUTROPENIAS,10005329,10051312,10016288,10051312
EPISTAXIS,Epistaxis,EPISTAXIS,EPISTAXIS,UPPER RESPIRATORY TRACT DISORDERS (EXCL INFECTIONS),NASAL DISORDERS NEC,10038738,10015090,10015090,10015090
FEVER (TEMPERATURE OF 38.2 DEGREES CELSIUS),Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
REFRACTORY HYPOTENSION,refractory hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
PULMONARY TUBERCULOSIS,Pulmonary tuberculosis,PULMONARY TUBERCULOSIS,PULMONARY TUBERCULOSIS,MYCOBACTERIAL INFECTIOUS DISORDERS,TUBERCULOUS INFECTIONS,10021881,10037440,10037440,10037440
DELIBERATE OVERDOSE,Deliberate overdose,DELIBERATE OVERDOSE,INTENTIONAL OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10012211,10022523,10012211
FOUL SMELLING,foul smelling,HALITOSIS,BREATH ODOUR,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL SIGNS AND SYMPTOMS NEC,10017947,10019058,10006326,10019058
SOMETIMES INATTENTIVE,sometimes inattentive,"ADHD, PREDOMINANTLY INATTENTIVE TYPE",ATTENTION DEFICIT/HYPERACTIVITY DISORDER,COGNITIVE AND ATTENTION DISORDERS AND DISTURBANCES,ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOUR DISORDERS,10037175,10068453,10003736,10068453
EYE DEVIATION,Ocular deviation,OCULAR DEVIATION,EYE MOVEMENT DISORDER,OCULAR NEUROMUSCULAR DISORDERS,OCULAR NERVE AND MUSCLE DISORDERS,10015919,10057219,10061129,10057219
ANTI-HBSAG POSITIVE,Hepatitis B surface antibody positive,ANTI-HBSAG POSITIVE,HEPATITIS B SURFACE ANTIBODY POSITIVE,MICROBIOLOGY AND SEROLOGY INVESTIGATIONS,VIRUS IDENTIFICATION AND SEROLOGY,10022891,10002723,10071346,10002723
LACERATION,Laceration,LACERATION,LACERATION,INJURIES NEC,SKIN INJURIES NEC,10022117,10023572,10023572,10023572
ASTROVIRUS ENCEPHALITIS,Encephalitis viral,ENCEPHALITIS VIRAL,ENCEPHALITIS VIRAL,VIRAL INFECTIOUS DISORDERS,VIRAL INFECTIONS NEC,10021881,10014612,10014612,10014612
PSEUDOPHAEOCHROMOCYTOMA,Pseudophaeochromocytoma,PSEUDOPHAEOCHROMOCYTOMA,PSEUDOPHAEOCHROMOCYTOMA,ADRENAL GLAND DISORDERS,ADRENAL MEDULLA DISORDERS,10014698,10049774,10049774,10049774
GRADE II CYTOMEGALOVIRUS INFECTION,Cytomegalovirus infection,CYTOMEGALOVIRUS INFECTION,CYTOMEGALOVIRUS INFECTION,VIRAL INFECTIOUS DISORDERS,CYTOMEGALOVIRAL INFECTIONS,10021881,10011831,10011831,10011831
"DIFFUSE, INTENSE ABDOMINAL, COLIC-LIKE PAIN",Abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
ERYTHEMA,Erythema,ERYTHEMA,ERYTHEMA,EPIDERMAL AND DERMAL CONDITIONS,ERYTHEMAS,10040785,10015150,10015150,10015150
"RECURRENT IN-STENT THROMBOSIS FOLLOWING LOE OF ASPIRIN, CLOPIDOGREL AND TICAGRELOR.",lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
PILOERECTION,Piloerection,PILOERECTION,PILOERECTION,SKIN APPENDAGE CONDITIONS,PILAR DISORDERS NEC,10040785,10035039,10035039,10035039
EPISCLERITIS,Episcleritis,EPISCLERITIS,EPISCLERITIS,"OCULAR INFECTIONS, IRRITATIONS AND INFLAMMATIONS","SCLERAL INFECTIONS, IRRITATIONS AND INFLAMMATIONS",10015919,10015084,10015084,10015084
MACULOPAPULAR RASH,maculopapular rash,MACULOPAPULAR RASH,RASH MACULO-PAPULAR,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10025424,10037868,10025424
BLADDER TEMPERATURE PROBE WAS INSERTED AND SHOWED A CORE TEMPERATURE OF 25.1Â°C.,Hypothermia,HYPOTHERMIA,HYPOTHERMIA,BODY TEMPERATURE CONDITIONS,BODY TEMPERATURE ALTERED,10018065,10021113,10021113,10021113
MENTALLY AND PHYSICALLY TENSE/TENSE PSYCHOMOTOR STATUS,Mental tension,MENTAL TENSION,TENSION,ANXIETY DISORDERS AND SYMPTOMS,ANXIETY SYMPTOMS,10037175,10027382,10043268,10027382
MASS IN THE LEFT PARIETAL LOBE,Metastases to central nervous system,METASTASES TO BRAIN,METASTASES TO CENTRAL NERVOUS SYSTEM,METASTASES,METASTASES TO SPECIFIED SITES,10029104,10027453,10059282,10027453
PNEUMONIA,Pneumonia,PNEUMONIA,PNEUMONIA,INFECTIONS - PATHOGEN UNSPECIFIED,LOWER RESPIRATORY TRACT AND LUNG INFECTIONS,10021881,10035664,10035664,10035664
HYPOXEMIA,Hypoxia,HYPOXEMIA,HYPOXIA,RESPIRATORY DISORDERS NEC,CONDITIONS ASSOCIATED WITH ABNORMAL GAS EXCHANGE,10038738,10021141,10021143,10021142
DIFFUSE SEVERE ALOPECIA,Alopecia,ALOPECIA,ALOPECIA,SKIN APPENDAGE CONDITIONS,ALOPECIAS,10040785,10001760,10001760,10001760
"SCALY PLAQUES LOCATED WITHIN THE FACE, UPPER CHEST, UPPER BACK AND ENTIRE UPPER",skin scaly,SKIN SCALY,SKIN EXFOLIATION,EPIDERMAL AND DERMAL CONDITIONS,EXFOLIATIVE CONDITIONS,10040785,10040920,10040844,10040920
RASH ON HER RIGHT INNER THIGH AND FOREARM,Rash,RASH,RASH,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10037844,10037844,10037844
LEFT PALPEBRAL ANGIOEDEMA,Eye angioedema,EYE ANGIOEDEMA,ANGIOEDEMA,ANGIOEDEMA AND URTICARIA,ANGIOEDEMAS,10040785,10079444,10002424,10079444
UNCONSCIOUS,Loss of consciousness,UNCONSCIOUS,LOSS OF CONSCIOUSNESS,NEUROLOGICAL DISORDERS NEC,DISTURBANCES IN CONSCIOUSNESS NEC,10029205,10024855,10024855,10045479
"RETURNED DUE TO DYSKINETIC MOVEMENTS OF HER LIPS AND JAWS AND FOCAL DYSTONIA OF THE TONGUE, WHICH WERE DIAGNOSED AS TARDIVE DYSKINESIA AND DYSTONIA",Tardive dyskinesia,TARDIVE DYSKINESIA,TARDIVE DYSKINESIA,MOVEMENT DISORDERS (INCL PARKINSONISM),DYSKINESIAS AND MOVEMENT DISORDERS NEC,10029205,10043118,10043118,10043118
PITTING OEDEMA,Oedema,PITTING OEDEMA,OEDEMA,GENERAL SYSTEM DISORDERS NEC,OEDEMA NEC,10018065,10035076,10030095,10035076
INTRACELLULAR YEAST FORMS WITHIN THE HISTIOCYTES IN THE LAMINA PROPRIA IN BOTH THE DUODENUM AND MORE DIFFUSELY IN THE COLON,Fungal infection,YEAST INFECTION,FUNGAL INFECTION,FUNGAL INFECTIOUS DISORDERS,FUNGAL INFECTIONS NEC,10021881,10049080,10017533,10049080
SERUM TRIGLYCERIDES INCREASED (295 MG/DL),Blood triglycerides increased,SERUM TRIGLYCERIDES INCREASED,BLOOD TRIGLYCERIDES INCREASED,LIPID ANALYSES,TRIGLYCERIDE ANALYSES,10022891,10040424,10005839,10040424
APPETITE CHANGES,Appetite disorder,APPETITE FLUCTUATION,APPETITE DISORDER,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10074314,10060961,10074314
ACUTE RENAL INSUFFICIENCY FOLLOWING ALLERGY TO RIFAMPICIN/ ACUTE RENAL FAILURE,Acute kidney injury,ACUTE RENAL FAILURE,ACUTE KIDNEY INJURY,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10001041,10069339,10001041
PULSE 130 /MIN,Heart rate increased,PULSE RATE INCREASED,HEART RATE INCREASED,CARDIAC AND VASCULAR INVESTIGATIONS (EXCL ENZYME TESTS),HEART RATE AND PULSE INVESTIGATIONS,10022891,10037490,10019303,10037490
TERTIARY ADRENAL INSUFFICIENCY,Adrenal insufficiency,ADRENAL INSUFFICIENCY,ADRENAL INSUFFICIENCY,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPOFUNCTIONS,10014698,10001367,10001367,10001367
"LESIONS WERE A POLYMORPHOUS ERYTHEMA, NON-PRURIGINOUS, NON-TENDER WITH NODULES",Erythema nodosum,ERYTHEMA NODOSUM-LIKE LESION,ERYTHEMA NODOSUM,SKIN AND SUBCUTANEOUS TISSUE DISORDERS NEC,PANNICULITIDES,10040785,10077522,10015226,10077522
DRUG OVERDOSE ACCIDENTAL,Accidental overdose,DRUG OVERDOSE ACCIDENTAL,ACCIDENTAL OVERDOSE,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,PRODUCT ADMINISTRATION ERRORS AND ISSUES,10022117,10000381,10000381,10013737
APPETITE LOST,Decreased appetite,APPETITE LOST,DECREASED APPETITE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,APPETITE DISORDERS,10027433,10003028,10061428,10003028
"THYROTOXICOSIS FOLLOWING OFF LABEL USE OF FLUDARABINE, ALEMTUZUMAB AND TREOSULFAN","thyrotoxicosis following off label use of fludarabine, alemtuzumab and treosulfan",THYROTOXICOSIS,HYPERTHYROIDISM,THYROID GLAND DISORDERS,THYROID HYPERFUNCTION DISORDERS,10014698,10043789,10020850,10043789
WORSENING ARTHRALGIAS,Arthralgia,ARTHRALGIA,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10003239
MAJOR CONGENITAL MALFORMATIONS,Congenital anomaly,CONGENITAL ANOMALY NOS,CONGENITAL ANOMALY,CONGENITAL AND HEREDITARY DISORDERS NEC,CONGENITAL DISORDERS NEC,10010331,10010357,10010356,10010357
VEGETATION AT THE MITRAL VALVE,vegetation at the mitral valve,CARDIAC VALVE VEGETATION,CARDIAC VALVE VEGETATION,INFECTIONS - PATHOGEN UNSPECIFIED,CARDIAC INFECTIONS,10021881,10057651,10057651,10057651
DUODENAL ULCER WITH PERFORATION,Duodenal ulcer perforation,DUODENAL ULCER PERFORATION,DUODENAL ULCER PERFORATION,GASTROINTESTINAL ULCERATION AND PERFORATION,DUODENAL ULCERS AND PERFORATION,10017947,10013849,10013849,10013849
CURRENTLY BREASTFEEDING,Exposure via breast milk,DRUG EXPOSURE VIA BREAST MILK,EXPOSURE VIA BREAST MILK,"EXPOSURES, CHEMICAL INJURIES AND POISONING",PATHWAYS AND SOURCES OF EXPOSURE,10022117,10051075,10080751,10051075
STUTTERING,Dysphemia,STUTTERING,DYSPHEMIA,COMMUNICATION DISORDERS AND DISTURBANCES,SPEECH ARTICULATION AND RHYTHM DISTURBANCES,10037175,10041912,10054964,10042267
EFFUSIONS,Effusion,EFFUSION,EFFUSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10063045,10063045,10063045
ANEMIA,Anaemia,ANEMIA,ANAEMIA,ANAEMIAS NONHAEMOLYTIC AND MARROW DEPRESSION,ANAEMIAS NEC,10005329,10002034,10002034,10002272
HYPOGLYCAEMIA UNAWARENESS,Hypoglycaemia unawareness,HYPOGLYCAEMIA UNAWARENESS,HYPOGLYCAEMIA UNAWARENESS,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020997,10020997,10020997
FEVER/ BODY TEMPERATURE ELEVATION UP TO 38 C,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
WAS STARTED ON INDOMETHACIN UP TO A DAILY DOSE OF 225 MG,Overdose,DRUG OVERDOSE,OVERDOSE,OVERDOSES AND UNDERDOSES NEC,OVERDOSES NEC,10022117,10068719,10033295,10068719
GLOMERULI SCLEROSIS,Nephrosclerosis,RENAL SCLEROSIS,NEPHROSCLEROSIS,NEPHROPATHIES,NEPHROPATHIES AND TUBULAR DISORDERS NEC,10038359,10029159,10029159,10038524
ELEVATED CREATININE,Creatinine high,CREATININE HIGH,BLOOD CREATININE INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10011367,10005483,10011367
SURGICAL WOUND DEHISCENCE FOLLOWING WORSENING OF BRAIN ABSCESS DUE TO LACK OF DRUG EFFECT,Wound dehiscence,WOUND DEHISCENCE,WOUND DEHISCENCE,PROCEDURAL RELATED INJURIES AND COMPLICATIONS NEC,NON-SITE SPECIFIC PROCEDURAL COMPLICATIONS,10022117,10048031,10048031,10048031
DIZZINESS,Dizziness,DIZZINESS,DIZZINESS,NEUROLOGICAL DISORDERS NEC,NEUROLOGICAL SIGNS AND SYMPTOMS NEC,10029205,10013573,10013573,10013573
ACCIDENTAL INGESTION OF METHOTREXATE,accidental ingestion of methotrexate,ACCIDENTAL INGESTION OF DRUG,ACCIDENTAL EXPOSURE TO PRODUCT,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,ACCIDENTAL EXPOSURES TO PRODUCT,10022117,10073319,10073317,10073319
IRRITABLE,Irritability,IRRITABLE,IRRITABILITY,MOOD DISORDERS AND DISTURBANCES NEC,EMOTIONAL AND MOOD DISTURBANCES NEC,10037175,10023000,10022998,10023000
PATIENTâ€™S NEUROLOGICAL STATUS HAD PROGRESSED DUE TO THE IMMUNE PROCESS,Disease progression,DISEASE PROGRESSION,DISEASE PROGRESSION,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10061818,10061818,10061818
THE ABSENCE OF CLINICAL OR RADIOLOGICAL IMPROVEMENT,lack of drug effect,LACK OF DRUG EFFECT,DRUG INEFFECTIVE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10023610,10013709,10023610
NEUROPATHY PERIPHERAL,Neuropathy peripheral,NEUROPATHY PERIPHERAL,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10029331,10029331,10029331
DRUG EXPOSURE DURING PREGNANCY,drug exposure during pregnancy,DRUG EXPOSURE DURING PREGNANCY,EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10049193,10073513,10049193
ATAXIC GAIT,ataxic gait,ATAXIC GAIT,ATAXIA,NEUROLOGICAL DISORDERS NEC,COORDINATION AND BALANCE DISTURBANCES,10029205,10003597,10003591,10003597
CISPLATIN TREATMENT SHOWED LITTLE EFFECT (SUBTHERAPEUTIC RESPONSE WITH NO ADVERSE EVENT),Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
SLIGHT RESPONSE,Subtherapeutic response,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
SLIGHT FUNCTIONAL DEFICIT,renal impairment,FUNCTION KIDNEY DECREASED,RENAL IMPAIRMENT,RENAL DISORDERS (EXCL NEPHROPATHIES),RENAL FAILURE AND IMPAIRMENT,10038359,10017474,10062237,10017474
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
ERYTHEMATOUS ERUPTION,Erythematous eruption,ERYTHEMATOUS ERUPTION,RASH ERYTHEMATOUS,EPIDERMAL AND DERMAL CONDITIONS,"RASHES, ERUPTIONS AND EXANTHEMS NEC",10040785,10015241,10037855,10015241
MAKE HIM FEEL GROGGY,Malaise,FEELING SICK,MALAISE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016365,10025482,10016365
SEVERE PROBLEMS WITH CONCENTRATION,Attention concentration difficulty,ATTENTION CONCENTRATION DIFFICULTY,DISTURBANCE IN ATTENTION,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10003729,10013496,10003729
HOARSENESS,Dysphonia,HOARSENESS,DYSPHONIA,RESPIRATORY TRACT SIGNS AND SYMPTOMS,UPPER RESPIRATORY TRACT SIGNS AND SYMPTOMS,10038738,10020201,10013952,10020201
PULMONARY OEDEMA CAUSED BY DRUG-INDUCED ALLERGY,Pulmonary oedema,PULMONARY OEDEMA,PULMONARY OEDEMA,LOWER RESPIRATORY TRACT DISORDERS (EXCL OBSTRUCTION AND INFECTION),PULMONARY OEDEMAS,10038738,10037423,10037423,10037423
ACUTE GASTROINTESTINAL BLEED,gastrointestinal bleed,GASTROINTESTINAL BLEED,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGES NEC,NON-SITE SPECIFIC GASTROINTESTINAL HAEMORRHAGES,10017947,10017935,10017955,10017935
INSULIN INJECTION-INDUCED LOCALIZED LIPOATROPHY,Injection site atrophy,LIPOATROPHY INJECTION SITE,INJECTION SITE ATROPHY,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022063,10022048,10024605
SERUM CREATINE KINASE LEVEL WAS MARKEDLY ELEVATED,creatine kinase increased,CREATINE KINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,ENZYME INVESTIGATIONS NEC,SKELETAL AND CARDIAC MUSCLE ANALYSES,10022891,10011336,10005470,10011336
CUSHING'S SYNDROME,Cushing's syndrome,CUSHING'S SYNDROME,CUSHING'S SYNDROME,ADRENAL GLAND DISORDERS,ADRENAL CORTICAL HYPERFUNCTIONS,10014698,10011652,10011652,10011652
ABDOMINAL DISTENTION,Abdominal distension,ABDOMINAL DISTENSION,ABDOMINAL DISTENSION,GASTROINTESTINAL SIGNS AND SYMPTOMS,"FLATULENCE, BLOATING AND DISTENSION",10017947,10000060,10000060,10000060
FUNCTIONAL DEPENDENCE,Loss of personal independence in daily activities,ACTIVITIES OF DAILY LIVING IMPAIRED,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,LIFESTYLE ISSUES,DISABILITY ISSUES,10041244,10050954,10079487,10050954
HYPERKALEMIA (POTASSIUM 6.3 MMOL/L),Hyperkalaemia,HYPERKALEMIA,HYPERKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10020646,10020646,10020647
EXTENSION SPASMS,Muscle spasms,SPASMS,MUSCLE SPASMS,MUSCLE DISORDERS,MUSCLE RELATED SIGNS AND SYMPTOMS NEC,10028395,10041408,10028334,10041408
BUN INCREASED (200 MG%),Blood urea increased,BUN INCREASED,BLOOD UREA INCREASED,RENAL AND URINARY TRACT INVESTIGATIONS AND URINALYSES,RENAL FUNCTION ANALYSES,10022891,10006576,10005851,10006576
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
BEHAVIORAL PROBLEMS,Behavior disorder,BEHAVIOR DISORDER,ABNORMAL BEHAVIOUR,PSYCHIATRIC AND BEHAVIOURAL SYMPTOMS NEC,ABNORMAL BEHAVIOUR NEC,10037175,10004204,10061422,10004204
STOMATITIS AND OTHER MUCOSAL MEMBRANE DISORDERS,Stomatitis,STOMATITIS,STOMATITIS,ORAL SOFT TISSUE CONDITIONS,STOMATITIS AND ULCERATION,10017947,10042128,10042128,10042128
PALPITATIONS,Palpitations,PALPITATIONS,PALPITATIONS,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC SIGNS AND SYMPTOMS NEC,10007541,10033557,10033557,10033557
IDIOPATHIC HYPEREOSINIPHILIC SYNDROME,Hypereosinophilic syndrome,HYPEREOSINOPHILIC SYNDROME,HYPEREOSINOPHILIC SYNDROME,WHITE BLOOD CELL DISORDERS,EOSINOPHILIC DISORDERS,10005329,10048643,10048643,10048643
THICKNESS OF SUBCUTANEOUS ADIPOSE TISSUE AT INJECTION SITE (LOWER ABDOMINAL REGION) INCREASED (15 MM),Injection site hypertrophy,INJECTION SITE SUBCUTANEOUS FATTY HYPERTROPHY,INJECTION SITE HYPERTROPHY,ADMINISTRATION SITE REACTIONS,INJECTION SITE REACTIONS,10018065,10022101,10022072,10022101
NEUTROPHIL COUNT DECREASED,Neutrophil count decreased,NEUTROPHIL COUNT DECREASED,NEUTROPHIL COUNT DECREASED,HAEMATOLOGY INVESTIGATIONS (INCL BLOOD GROUPS),WHITE BLOOD CELL ANALYSES,10022891,10029366,10029366,10029366
BODY WEIGHT INCREASED,Weight increased,WEIGHT INCREASED,WEIGHT INCREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047899,10047899,10047899
HIGH FEVER,Pyrexia,FEVER,PYREXIA,BODY TEMPERATURE CONDITIONS,FEBRILE DISORDERS,10018065,10037660,10037660,10016558
GLASGOW COMA SCORE OF 3 WITH DILATED PUPILS,Coma scale abnormal,GLASGOW COMA SCALE ABNORMAL,COMA SCALE ABNORMAL,"NEUROLOGICAL, SPECIAL SENSES AND PSYCHIATRIC INVESTIGATIONS",NEUROLOGIC DIAGNOSTIC PROCEDURES,10022891,10058466,10069709,10058466
SEVERE ALLERGIC REACTION WITH QUINCE'S EDEMA,Hypersensitivity,ALLERGIC REACTION,HYPERSENSITIVITY,ALLERGIC CONDITIONS,ALLERGIC CONDITIONS NEC,10021428,10001718,10020751,10001718
HYPOTENSION,Hypotension,HYPOTENSION,HYPOTENSION,DECREASED AND NONSPECIFIC BLOOD PRESSURE DISORDERS AND SHOCK,VASCULAR HYPOTENSIVE DISORDERS,10047065,10021097,10021097,10021097
PROFUSE DIARRHEA,Diarrhoea,DIARRHEA,DIARRHOEA,GASTROINTESTINAL MOTILITY AND DEFAECATION CONDITIONS,DIARRHOEA (EXCL INFECTIVE),10017947,10012735,10012735,10012727
INTENSE JOINT PAIN,joint pain,JOINT PAIN,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10023222,10003239,10023222
DISTAL ADENOSINE ADMINISTRATION RESULTED IN MINIMAL IMPROVEMENT IN FLOW,Therapeutic response decreased,SUBTHERAPEUTIC RESPONSE,THERAPEUTIC RESPONSE DECREASED,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10061983,10043414,10061983
DRUG USE FOR UNAPPROVED INDICATION,Product use in unapproved indication,DRUG USE FOR UNAPPROVED INDICATION,PRODUCT USE IN UNAPPROVED INDICATION,MEDICATION ERRORS AND OTHER PRODUCT USE ERRORS AND ISSUES,"MEDICATION ERRORS, PRODUCT USE ERRORS AND ISSUES NEC",10022117,10053746,10076476,10053746
FAILURE TO THRIVE,failure to thrive,FAILURE TO THRIVE,FAILURE TO THRIVE,APPETITE AND GENERAL NUTRITIONAL DISORDERS,GENERAL NUTRITIONAL DISORDERS NEC,10027433,10016165,10016165,10016165
CROHNâ€™S DISEASE,Crohnâ€™s disease,CROHN'S DISEASE,CROHN'S DISEASE,GASTROINTESTINAL INFLAMMATORY CONDITIONS,COLITIS (EXCL INFECTIVE),10017947,10011401,10011401,10011401
DRUG POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
POORLY TOLERATED (MUSCLE AND JOINT PAIN),Arthralgia,JOINT PAIN,ARTHRALGIA,JOINT DISORDERS,JOINT RELATED SIGNS AND SYMPTOMS,10028395,10003239,10003239,10023222
MENTAL DETERIORATION,Mental impairment,MENTAL DETERIORATION,MENTAL IMPAIRMENT,MENTAL IMPAIRMENT DISORDERS,MENTAL IMPAIRMENT (EXCL DEMENTIA AND MEMORY LOSS),10029205,10027352,10027374,10027352
ETHAMBUTOL-INDUCED OPTIC NEURITIS,Optic neuritis,OPTIC NEURITIS,OPTIC NEURITIS,CRANIAL NERVE DISORDERS (EXCL NEOPLASMS),OPTIC NERVE DISORDERS NEC,10029205,10030942,10030942,10030942
HEADACHE UPSURGED CONCOMITANLTY WITH CORTICOSTEROID TAPERING,Headache,HEADACHE,HEADACHE,HEADACHES,HEADACHES NEC,10029205,10019211,10019211,10019211
TACHYCARDIA 120 BPM,Tachycardia,TACHYCARDIA,TACHYCARDIA,CARDIAC ARRHYTHMIAS,RATE AND RHYTHM DISORDERS NEC,10007541,10043071,10043071,10043071
ELEVATED SERUM ASPARTATE AMINOTRANSFERASE,Aspartate aminotransferase increased,ASPARTATE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED,HEPATOBILIARY INVESTIGATIONS,LIVER FUNCTION ANALYSES,10022891,10003481,10003481,10003481
PERIPHERAL NEUROPATHY,peripheral neuropathy,PERIPHERAL NEUROPATHY,NEUROPATHY PERIPHERAL,PERIPHERAL NEUROPATHIES,PERIPHERAL NEUROPATHIES NEC,10029205,10080342,10029331,10080342
FORMATION OF GANGRENE BELOW THE KNEE JOINT,Dry gangrene,ISCHAEMIC GANGRENE,DRY GANGRENE,"ARTERIOSCLEROSIS, STENOSIS, VASCULAR INSUFFICIENCY AND NECROSIS","PERIPHERAL VASOCONSTRICTION, NECROSIS AND VASCULAR INSUFFICIENCY",10047065,10068064,10049927,10068064
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
MEDULLARY TOXICITY,Toxicity to various agents,DRUG TOXICITY,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10013746,10070863,10013746
OCCIPITAL ASPERGILLOSIS ABSCESS (POSITIVE CULTURE FOR ASPERGILLUS FUMIGATUS),Aspergillus infection,ASPERGILLUS FUMIGATUS INFECTION,ASPERGILLUS INFECTION,FUNGAL INFECTIOUS DISORDERS,ASPERGILLUS INFECTIONS,10021881,10003494,10074171,10003494
DISEASE PROGRESSION,Multiple myeloma,MULTIPLE MYELOMA,PLASMA CELL MYELOMA,PLASMA CELL NEOPLASMS,PLASMA CELL MYELOMAS,10029104,10028228,10035226,10028228
AFTER SEVERAL YEARS OF TREATMENT HE DEVELOPED SEVERE HYPOKALEMIA,Hypokalaemia,HYPOKALEMIA,HYPOKALAEMIA,ELECTROLYTE AND FLUID BALANCE CONDITIONS,POTASSIUM IMBALANCE,10027433,10021015,10021015,10021018
MUCOCUTANEOUS SYMPTOMS,Skin disorder NOS,SKIN DISORDER NOS,SKIN DISORDER,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040833,10040831,10040833
TUMOR PROGRESSION RESULTING IN METASTASIS OF SIALOBLASTOMA DESPITE ADMINISTRATION OF DRUGS,Salivary gland neoplasm,SALIVARY GLAND NEOPLASM,SALIVARY GLAND NEOPLASM,GASTROINTESTINAL NEOPLASMS MALIGNANT AND UNSPECIFIED,SALIVARY GLAND NEOPLASMS UNSPECIFIED MALIGNANCY,10029104,10061497,10061497,10061497
CONDITION AGGRAVATED,Condition aggravated,CONDITION AGGRAVATED,CONDITION AGGRAVATED,GENERAL SYSTEM DISORDERS NEC,GENERAL SIGNS AND SYMPTOMS NEC,10018065,10010264,10010264,10010264
MICROSPORIDIAL INFECTION,Microsporidia infection,MICROSPORIDIA INFECTION,MICROSPORIDIA INFECTION,PROTOZOAL INFECTIOUS DISORDERS,PROTOZOAL INFECTIONS NEC,10021881,10053982,10053982,10053982
MILD CHROMOBLASTOMYCOSIS CAUSED BY CLADOSPORIUM FONSECAEA SP.,Chromoblastomycosis,CHROMOBLASTOMYCOSIS,CHROMOBLASTOMYCOSIS,FUNGAL INFECTIOUS DISORDERS,CLADOSPORIDIA INFECTIONS,10021881,10008803,10008803,10008803
INCREASED AGGRESSIVE BEHAVIORS,Increased aggressive behaviors,AGGRESSIVE BEHAVIOR,AGGRESSION,PERSONALITY DISORDERS AND DISTURBANCES IN BEHAVIOUR,BEHAVIOUR AND SOCIALISATION DISTURBANCES,10037175,10062375,10001488,10062375
SEPTICEMIA,Sepsis,SEPTICEMIA,SEPSIS,INFECTIONS - PATHOGEN UNSPECIFIED,"SEPSIS, BACTERAEMIA, VIRAEMIA AND FUNGAEMIA NEC",10021881,10040047,10040047,10040089
FATIGUE,Fatigue,FATIGUE,FATIGUE,GENERAL SYSTEM DISORDERS NEC,ASTHENIC CONDITIONS,10018065,10016256,10016256,10016256
DRUG RESISTANCE,Drug resistance,DRUG RESISTANCE,DRUG RESISTANCE,THERAPEUTIC AND NONTHERAPEUTIC EFFECTS (EXCL TOXICITY),THERAPEUTIC AND NONTHERAPEUTIC RESPONSES,10018065,10059866,10059866,10059866
ABDOMINAL PAIN LOCATED AT THE RIGHT UPPER QUADRANT,abdominal pain,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL SIGNS AND SYMPTOMS,GASTROINTESTINAL AND ABDOMINAL PAINS (EXCL ORAL AND THROAT),10017947,10000081,10000081,10000081
SIGNIFICANT WEIGHT LOSS,Weight decreased,WEIGHT LOSS,WEIGHT DECREASED,PHYSICAL EXAMINATION AND ORGAN SYSTEM STATUS TOPICS,PHYSICAL EXAMINATION PROCEDURES AND ORGAN SYSTEM STATUS,10022891,10047895,10047895,10047900
CUTANEOUS LESION,Skin lesion,SKIN LESION,SKIN LESION,EPIDERMAL AND DERMAL CONDITIONS,DERMAL AND EPIDERMAL CONDITIONS NEC,10040785,10040882,10040882,10040882
DIGOXIN POISONING/DIGOXIN POISONING,Toxicity to various agents,DRUG POISONING,TOXICITY TO VARIOUS AGENTS,"EXPOSURES, CHEMICAL INJURIES AND POISONING",POISONING AND TOXICITY,10022117,10056943,10070863,10056943
ACUTE ANTHRACYCLINE INDUCED CARDIOTOXICITY,Cardiotoxicity,CARDIOTOXICITY,CARDIOTOXICITY,CARDIAC DISORDER SIGNS AND SYMPTOMS,CARDIAC DISORDERS NEC,10007541,10048610,10048610,10048610
VOMITING,Vomiting,VOMITING,VOMITING,GASTROINTESTINAL SIGNS AND SYMPTOMS,NAUSEA AND VOMITING SYMPTOMS,10017947,10047700,10047700,10047700
SUBCUTANEOUS HEMATOMA OF RIGHT LOWER LIMB,hematoma,HEMATOMA,HAEMATOMA,VASCULAR HAEMORRHAGIC DISORDERS,HAEMORRHAGES NEC,10047065,10019428,10018852,10019428
"MOTHER RECEIVED METHYLDOPA, VERAPAMIL AND ENALAPRIL FOR HYPERTENSION",drug exposure in utero,DRUG EXPOSURE IN UTERO,FOETAL EXPOSURE DURING PREGNANCY,"EXPOSURES, CHEMICAL INJURIES AND POISONING","EXPOSURES ASSOCIATED WITH PREGNANCY, DELIVERY AND LACTATION",10022117,10013695,10071404,10013695
HYPOGLYCEMIA,Hypoglycaemia,HYPOGLYCEMIA,HYPOGLYCAEMIA,GLUCOSE METABOLISM DISORDERS (INCL DIABETES MELLITUS),HYPOGLYCAEMIC CONDITIONS NEC,10027433,10020993,10020993,10021005
